PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McCann, FJ; Chapman, SJ; Yu, WC; Maskell, NA; Davies, RJO; Lee, YCG				McCann, Fiona J.; Chapman, Stephen J.; Yu, Wai Cho; Maskell, Nick A.; Davies, Robert J. O.; Lee, Y. C. Gary			Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; FLUID PROCALCITONIN; SEPSIS; DIAGNOSIS; PLEURODESIS; BIOMARKERS; ADULTS; SERUM	Procalcitonin has been shown to be useful in separating infection from non-infective disorders. However, infection is often paralleled by tissue inflammation. Most studies supporting the use of procalcitonin were confounded by more significant inflammation in the infection group. Few studies have examined the usefulness of procalcitonin when adjusted for inflammation. Pleural inflammation underlies the development of most exudative effusions including pleural infection and malignancy. Pleurodesis, often used to treat effusions, involves provocation of intense aseptic pleural inflammation. We conducted a two-part proof-of-concept study to test the specificity of procalcitonin in differentiating infection using cohorts of patients with pleural effusions of infective and non-infective etiologies, as well as subjects undergoing pleurodesis. Methods: We measured the blood procalcitonin level (i) in 248 patients with pleural infection or with non-infective pleural inflammation, matched for severity of systemic inflammation by C-reactive protein (CRP), age and gender; and (ii) in patients before and 24-48 hours after induction of non-infective pleural inflammation (from talc pleurodesis). Results: 1) Procalcitonin was significantly higher in patients with pleural infection compared with controls with noninfective effusions (n = 32 each group) that were case-matched for systemic inflammation as measured by CRP [median (25-75% IQR): 0.58 (0.35-1.50) vs 0.34 (0.31-0.42) mu g/L respectively, p = 0.003]. 2) Talc pleurodesis provoked intense systemic inflammation, and raised serum CRP by 360% over baseline. However procalcitonin remained relatively unaffected (21% rise). 3) Procalcitonin and CRP levels did not correlate. In 214 patients with pleural infection, procalcitonin levels did not predict the survival or need for surgical intervention. Conclusion: Using a pleural model, this proof-of-principle study confirmed that procalcitonin is a biomarker specific for infection and is not affected by non-infective inflammation. Procalcitonin is superior to CRP in distinguishing infection from non-infective pleural diseases, even when controlled for the level of systemic inflammation.	[McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Oxford Ctr Resp Med, Oxford, England; [McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Univ Oxford, Oxford, England; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yu, Wai Cho] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Maskell, Nick A.] Southmead Hosp, N Bristol Lung Ctr, Bristol, Avon, England	University of Oxford; University of Western Australia; Southmead Hospital	Lee, YCG (corresponding author), Oxford Ctr Resp Med, Oxford, England.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014	Ming, Zhangyin/0000-0002-8773-3930; Lee, Yun Chor Gary/0000-0002-0036-511X; maskell, nick/0000-0002-1276-6500	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC [G1001712] Funding Source: UKRI; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [CL-2006-13-003] Funding Source: researchfish	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the Oxford Health and Research Committee research grant (FJMcC, SJC, RJOD & YCGL). NIHR Oxford Biomedical Research Centre (RJOD), Medical Research Council Project Grant, United Kingdom and National Health & Medical Research Council (Australia) Project Grant, Westcare Grant of Western Australia (YCGL) & Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom (NAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN INFECT DIS, V53, P379, DOI 10.1093/cid/cir408; Albert SS, 2008, CLIN RESP MED, P853; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Brims FJH, 2010, EUR RESPIR REV, V19, P220, DOI 10.1183/09059180.00005610; Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016; Cuquemelle E, 2011, INTENS CARE MED, V37, P796, DOI 10.1007/s00134-011-2189-1; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; San Jose ME, 2010, J INVEST MED, V58, P971, DOI 10.231/JIM.0b013e3181f88648; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Ko YC, 2009, J KOREAN MED SCI, V24, P398, DOI 10.3346/jkms.2009.24.3.398; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Lin MC, 2009, CHEST, V136, P205, DOI 10.1378/chest.08-1134; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2004, CHEST, V126, P2022, DOI 10.1378/chest.126.6.2022; Maskell NA, 2004, AM J RESP CRIT CARE, V170, P377, DOI 10.1164/rccm.200311-1579OC; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Olah A, 2005, HEPATO-GASTROENTEROL, V52, P243; Papassotiriou I, 2008, EUR J CLIN INVEST, V38, P276, DOI 10.1111/j.1365-2362.2008.01935.x; Porcel JM, 2009, EUR RESP J IN PRESS; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; RAHMAN NM, 2008, TXB PLEURAL DIS, P341; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Russwurm S, 1999, CLIN CHEM LAB MED, V37, P789, DOI 10.1515/CCLM.1999.119; Sahn SA, 2008, TXB PLEURAL DIS, P209; Schuetz P, 2012, CHEST, V141, P1063, DOI 10.1378/chest.11-2430; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tobin CL, 2012, CURR OPIN PULM MED, V18, P321, DOI 10.1097/MCP.0b013e328352c673; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Wang CY, 2011, EUR J CLIN MICROBIOL, V30, P313, DOI 10.1007/s10096-010-1082-0; West SD, 2004, CURR OPIN PULM MED, V10, P305, DOI 10.1097/01.mcp.0000129756.87090.55	32	137	142	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49894	10.1371/journal.pone.0049894	http://dx.doi.org/10.1371/journal.pone.0049894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251674	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200021
J	Lu, J; Vlamis-Gardikas, A; Kandasamy, K; Zhao, R; Gustafsson, TN; Engstrand, L; Hoffner, S; Engman, L; Holmgren, A				Lu, Jun; Vlamis-Gardikas, Alexios; Kandasamy, Karuppasamy; Zhao, Rong; Gustafsson, Tomas N.; Engstrand, Lars; Hoffner, Sven; Engman, Lars; Holmgren, Arne			Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione	FASEB JOURNAL			English	Article						oxidative stress; thiol; ebselen; isothiazolone	ESCHERICHIA-COLI CYTOPLASM; HELICOBACTER-PYLORI; MAMMALIAN THIOREDOXIN; STAPHYLOCOCCUS-AUREUS; RIBONUCLEOTIDE REDUCTASE; EBSELEN; ANTIOXIDANT; SELENIUM; STRESS; THIOL	Increasing antibiotic resistance makes the identification of new antibacterial principles an urgent task. The thioredoxin system including thioredoxin reductase (TrxR), thioredoxin (Trx), and NADPH plays critical roles in cellular DNA synthesis and defense against oxidative stress. Notably, TrxR is very different in structure and mechanism in mammals and bacteria. Ebselen [2-phenyl-1,2 benzisoselenazol-3(2H)-one], a well-known antioxidant and a substrate for mammalian TrxR and Trx, is rapidly bacteriocidal for methicillin-resistant Staphylococcus aureus by an unknown mechanism. We have discovered that ebselen is a competitive inhibitor of Escherichia coli TrxR with a K-i of 0.52 +/- 0.13 mu M, through reaction with the active site dithiol of the enzyme. Bacteria lacking glutathione (GSH) and glutaredoxin, in which TrxR and Trx are essential for DNA synthesis, were particularly sensitive to ebselen. In growth-inhibited E. coli strains, Trx1 and Trx2 were oxidized, demonstrating that electron transfer via thioredoxin was blocked. Ebselen and its sulfur analog ebsulfur were bactericidal for GSH-negative pathogens. Ebsulfur inhibited a clinically isolated Helicobacter pylori strain with a minimum inhibitory concentration value as low as 0.39 mu g/ml. These results demonstrate that bacterial Trx and TrxR are viable antibacterial drug targets using benzisoselenazol and benzisothiazol derivates.-Lu, J., Vlamis-Gardikas, A., Kandasamy, K., Zhao, R., Gustafsson, T. N., Engstrand, L., Hoffner, S., Engman, L., Holmgren, A. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J. 27, 1394-1403 (2013). www.fasebj.org	[Lu, Jun; Vlamis-Gardikas, Alexios; Kandasamy, Karuppasamy; Zhao, Rong; Gustafsson, Tomas N.; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Engstrand, Lars; Hoffner, Sven] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; [Hoffner, Sven] WHO, Swedish Inst Communicable Dis Control, Dept Preparedness, Supranatl TB Reference Lab, Solna, Sweden; [Engman, Lars] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; World Health Organization; Uppsala University	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Vlamis, Alexios/AAF-5152-2020; Lu, Jun/E-9701-2017	Vlamis, Alexios/0000-0001-5068-6459; Lu, Jun/0000-0002-1699-8835; Gustafsson, Tomas/0000-0002-4495-8267	Swedish Cancer Society [961]; Swedish Research Council Medicine [13x-3529]; Vinnova, the K. A. Wallenberg Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); Vinnova, the K. A. Wallenberg Foundation; Karolinska Institutet(Karolinska Institutet)	The authors thank Dr. Scott B. Mulrooney (University of Michigan, Ann Arbor, MI, USA) for kindly providing E. coli A326 with plasmid pTrR316 and Dr. Hiroyuki Masayasu (Daiichi Pharmaceutical Company, Ltd., Tokyo, Japan) for help in determining the MIC of H. pylori NCTC11637 and H. pylori YS-16 strains to ebselen and ebsulfur. This work was supported by the Swedish Cancer Society (961), the Swedish Research Council Medicine (13x-3529), Vinnova, the K. A. Wallenberg Foundation, and the Karolinska Institutet. T.N.G. was the recipient of an M.D.-Ph.D. grant from the Karolinska Institutet.	Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Chew EH, 2008, FASEB J, V22, P2072, DOI 10.1096/fj.07-101477; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; COTGREAVE IA, 1989, BIOCHEM PHARMACOL, V38, P649, DOI 10.1016/0006-2952(89)90211-6; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Gustafsson TN, 2007, ACTA CRYSTALLOGR D, V63, P833, DOI 10.1107/S0907444907026303; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; He J, 2012, BIOORGAN MED CHEM, V20, P3816, DOI 10.1016/j.bmc.2012.04.033; Hoffner SE, 1997, J ANTIMICROB CHEMOTH, V40, P885, DOI 10.1093/jac/40.6.885; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KAMIGATA N, 1986, B CHEM SOC JPN, V59, P2179, DOI 10.1246/bcsj.59.2179; Kloc K, 2003, SYNTHETIC COMMUN, V33, P3805, DOI 10.1081/SCC-120025191; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; MLOCHOWSKI J, 1993, LIEBIGS ANN CHEM, P1239; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; Ogawa A, 1999, CEREBROVASC DIS, V9, P112, DOI 10.1159/000015908; Osajda M, 2001, POL J CHEM, V75, P823; Perrin D. D., 1980, PURIFICATION LAB CHE; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Rocha ER, 2007, J BACTERIOL, V189, P8015, DOI 10.1128/JB.00714-07; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Scharf C, 1998, J BACTERIOL, V180, P1869, DOI 10.1128/JB.180.7.1869-1877.1998; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Windle HJ, 2000, J BIOL CHEM, V275, P5081, DOI 10.1074/jbc.275.7.5081; Zhao F, 2006, CANCER LETT, V236, P46, DOI 10.1016/j.canlet.2005.05.010; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	46	114	121	3	52	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1394	1403		10.1096/fj.12-223305	http://dx.doi.org/10.1096/fj.12-223305			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23248236				2022-12-25	WOS:000316940800012
J	Arshad, N; Ballal, S; Visweswariah, SS				Arshad, Najla; Ballal, Suhas; Visweswariah, Sandhya S.			Site-specific N-Linked Glycosylation of Receptor Guanylyl Cyclase C Regulates Ligand Binding, Ligand-mediated Activation and Interaction with Vesicular Integral Membrane Protein 36, VIP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-STABLE ENTEROTOXIN; NATRIURETIC-PEPTIDE RECEPTOR; ESCHERICHIA-COLI; QUALITY-CONTROL; ION-TRANSPORT; DOMAIN; EXPRESSION; GLYCOPROTEINS; SECRETION; EVOLUTION	Guanylyl cyclase C (GC-C) is a multidomain, membrane-associated receptor guanylyl cyclase. GC-C is primarily expressed in the gastrointestinal tract, where it mediates fluid-ion homeostasis, intestinal inflammation, and cell proliferation in a cGMP-dependent manner, following activation by its ligands guanylin, uroguanylin, or the heat-stable enterotoxin peptide (ST). GC-C is also expressed in neurons, where it plays a role in satiation and attention deficiency/hyperactive behavior. GC-C is glycosylated in the extracellular domain, and differentially glycosylated forms that are resident in the endoplasmic reticulum (130 kDa) and the plasma membrane (145 kDa) bind the ST peptide with equal affinity. When glycosylation of human GC-C was prevented, either by pharmacological intervention or by mutation of all of the 10 predicted glycosylation sites, ST binding and surface localization was abolished. Systematic mutagenesis of each of the 10 sites of glycosylation in GC-C, either singly or in combination, identified two sites that were critical for ligand binding and two that regulated ST-mediated activation. We also show that GC-C is the first identified receptor client of the lectin chaperone vesicular integral membrane protein, VIP36. Interaction with VIP36 is dependent on glycosylation at the same sites that allow GC-C to fold and bind ligand. Because glycosylation of proteins is altered in many diseases and in a tissue-dependent manner, the activity and/or glycan-mediated interactions of GC-C may have a crucial role to play in its functions in different cell types.	[Arshad, Najla; Ballal, Suhas; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Arshad, Najla/H-9453-2019; Visweswariah, Sandhya/Q-7500-2019; Ballal, Suhas/AAD-5449-2021; Ballal, Suhas/ABA-2862-2021	Arshad, Najla/0000-0001-5553-311X; Visweswariah, Sandhya/0000-0003-2786-7344; Ballal, Suhas/0000-0002-6041-8332; 	Department of Science and Technology (India)	Department of Science and Technology (India)(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology (India).	Albano F, 2001, BIOCHEM BIOPH RES CO, V284, P331, DOI 10.1006/bbrc.2001.4973; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bakre MM, 2000, EUR J BIOCHEM, V267, P179, DOI 10.1046/j.1432-1327.2000.00986.x; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Benoit I, 2006, FEBS LETT, V580, P5815, DOI 10.1016/j.febslet.2006.09.039; Bhandari R, 2001, BIOCHEMISTRY-US, V40, P9196, DOI 10.1021/bi002595g; Boyer MZ, 2003, ARCH PEDIATRIE, V10, P590, DOI 10.1016/S0929-693X(03)00278-1; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Campbell B, 2001, SMITHSONIAN, V32, P18; Crane JK, 1996, MOL CELL BIOCHEM, V165, P111; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DEJONGE HR, 1975, FEBS LETT, V53, P237, DOI 10.1016/0014-5793(75)80028-7; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Delos SE, 2002, VIROLOGY, V294, P354, DOI 10.1006/viro.2001.1339; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fenrick R, 1997, MOL CELL BIOCHEM, V173, P25, DOI 10.1023/A:1006855522272; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1993, J CLIN INVEST, V91, P2423, DOI 10.1172/JCI116476; Ghanekar Y, 2004, BIOCHEM J, V379, P653, DOI 10.1042/BJ20040001; Ghanekar Y, 2003, EUR J BIOCHEM, V270, P3848, DOI 10.1046/j.1432-1033.2003.03779.x; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464; Hara-Kuge S, 2004, GLYCOBIOLOGY, V14, P739, DOI 10.1093/glycob/cwh082; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; Hasegawa M, 1999, EUR J BIOCHEM, V263, P338, DOI 10.1046/j.1432-1327.1999.00488.x; Hayes CA, 2012, BIOINFORMATICS, V28, P1669, DOI 10.1093/bioinformatics/bts242; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Hodson CA, 2006, TRAFFIC, V7, P456, DOI 10.1111/j.1600-0854.2006.00398.x; Jaleel M, 2006, BIOCHEMISTRY-US, V45, P1888, DOI 10.1021/bi052089x; Jaleel M, 2002, BIOL REPROD, V67, P1975, DOI 10.1095/biolreprod.102.006445; Kaczur V, 2003, MOL GENET METAB, V78, P275, DOI 10.1016/S1096-7192(03)00036-2; Kawasaki N, 2007, J BIOCHEM, V141, P221, DOI 10.1093/jh/mvm024; Kazerounian S, 2005, J PHARMACOL EXP THER, V314, P1013, DOI 10.1124/jpet.105.089052; KOCH KW, 1994, EUR J BIOCHEM, V222, P589, DOI 10.1111/j.1432-1033.1994.tb18901.x; Kopic S, 2010, TOXINS, V2, P2132, DOI 10.3390/toxins2082132; Lanctot PM, 2005, BIOCHEM J, V390, P367, DOI 10.1042/BJ20050189; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lauber T, 2009, PROTEIN ENG DES SEL, V22, P1, DOI 10.1093/protein/gzn062; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Mann EA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-86; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Nandi A, 1996, PROTEIN EXPRES PURIF, V8, P151, DOI 10.1006/prep.1996.0087; Nawa D, 2007, GLYCOBIOLOGY, V17, P913, DOI 10.1093/glycob/cwm067; PAREKH RB, 1987, EMBO J, V6, P1233, DOI 10.1002/j.1460-2075.1987.tb02359.x; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004; Shirakabe K, 2011, J BIOL CHEM, V286, P43154, DOI 10.1074/jbc.M111.275586; SINGH S, 1991, BIOCHEM BIOPH RES CO, V179, P1455, DOI 10.1016/0006-291X(91)91736-V; Stein RA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-79; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; VISWESWARIAH SS, 1994, EUR J BIOCHEM, V219, P727, DOI 10.1111/j.1432-1033.1994.tb18551.x; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Zhao XC, 2010, MOL BIOL REP, V37, P2301, DOI 10.1007/s11033-009-9724-y	68	11	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3907	3917		10.1074/jbc.M112.413906	http://dx.doi.org/10.1074/jbc.M112.413906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269669	hybrid, Green Published			2022-12-25	WOS:000314845000021
J	Jiang, CT; Kim, JH; Li, F; Qu, AJ; Gavrilova, O; Shah, YM; Gonzalez, FJ				Jiang, Changtao; Kim, Jung-Hwan; Li, Fei; Qu, Aijuan; Gavrilova, Oksana; Shah, Yatrik M.; Gonzalez, Frank J.			Hypoxia-inducible Factor 1 alpha Regulates a SOCS3-STAT3-Adiponectin Signal Transduction Pathway in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-EXPRESSION; DSBA-L; ADIPONECTIN; OBESITY; SECRETION; FIBROSIS; CELL; ARNT/HIF1-BETA	Obesity has been identified as a major risk factor for type 2 diabetes, characterized by insulin resistance in insulin target tissues. Hypoxia-inducible factor 1 alpha (HIF1 alpha) regulates pathways in energy metabolism that become dysregulated in obesity. Earlier studies revealed that HIF1 alpha in adipose tissue is markedly elevated in high-fat diet-fed mice that are obese and insulin-resistant. Genetic ablation of HIF1 alpha in adipose tissue decreased insulin resistance and obesity, accompanied by increased serum adiponectin levels. However, the exact mechanism whereby HIF1 alpha regulates adiponectin remains unclear. Here, acriflavine (ACF), an inhibitor of HIF1 alpha, induced the expression of adiponectin and reduced the expression of SOCS3 in cultured 3T3-L1 adipocytes. Mechanistic studies revealed that HIF1 alpha suppressed the expression of adiponectin through a SOCS3-STAT3 pathway. Socs3 was identified as a novel HIF1 alpha target gene based on chromatin immunoprecipitation and luciferase assays. STAT3 directly regulated adiponectin in vitro in cultured 3T3-L1 adipocytes. ACF was found to prevent diet-induced obesity and insulin resistance. In vivo, ACF also regulated the SOCS3-STAT3-adiponectin pathway, and inhibition of HIF1 alpha in adipose tissue was essential for ACF to improve the SOCS3-STAT3-adiponectin pathway to counteract insulin resistance. This study provides evidence for a novel target gene and signal transduction pathway in adipocytes and indicates that inhibitors of HIF1 alpha have potential utility for the treatment of obesity and type 2 diabetes.	[Jiang, Changtao; Kim, Jung-Hwan; Li, Fei; Qu, Aijuan; Shah, Yatrik M.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol, Sch Med, Dept Mol & Integrat Physiol & Internal Med, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov	Li, Fei/F-6849-2013	Kim, Jung Hwan/0000-0002-2975-4899; Jiang, Changtao/0000-0002-5206-2372	NCI; NIDDK; National Institutes of Health [CA148828]; NATIONAL CANCER INSTITUTE [R01CA148828, ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, ZICDK070002] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the NCI and NIDDK Intramural Research Programs and National Institutes of Health Grant CA148828 (to Y. M. S.).	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Girgis CM, 2012, TRENDS ENDOCRIN MET, V23, P372, DOI 10.1016/j.tem.2012.05.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Ii H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008089; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jiang CT, 2009, AM J PHYSIOL-CELL PH, V297, pC1466, DOI 10.1152/ajpcell.00304.2009; Jiang Y., 2012, CELL, V150; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Michailidou Z, 2012, J BIOL CHEM, V287, P4188, DOI 10.1074/jbc.M111.259325; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Moh A, 2008, DIABETES, V57, P1227, DOI 10.2337/db06-1582; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tennant DA, 2011, CELL, V145, P647, DOI 10.1016/j.cell.2011.05.009; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200; Yang SJ, 2010, MOL CELL BIOCHEM, V345, P45, DOI 10.1007/s11010-010-0558-7; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshimura Akihiko, 2011, Nihon Rinsho, V69 Suppl 1, P782; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	52	54	58	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3844	3857		10.1074/jbc.M112.426338	http://dx.doi.org/10.1074/jbc.M112.426338			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255598	hybrid, Green Published			2022-12-25	WOS:000314845000016
J	Jadav, RS; Chanduri, MVL; Sengupta, S; Bhandari, R				Jadav, Rathan S.; Chanduri, Manasa V. L.; Sengupta, Sagar; Bhandari, Rashna			Inositol Pyrophosphate Synthesis by Inositol Hexakisphosphate Kinase 1 Is Required for Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN DBP5; GENE DELETION; HISTONE H2AX; PYROPHOSPHORYLATION; PHOSPHORYLATION; PHOSPHATE; BINDING; FORKS; GLE1	Inositol pyrophosphates, such as diphosphoinositol pentakisphosphate (IP7), are water-soluble inositol phosphates that contain high energy diphosphate moieties on the inositol ring. Inositol hexakisphosphate kinase 1 (IP6K1) participates in inositol pyrophosphate synthesis, converting inositol hexakisphosphate (IP6) to IP7. In the present study, we show that mouse embryonic fibroblasts (MEFs) lacking IP6K1 exhibit impaired DNA damage repair via homologous recombination (HR). IP6K1 knock-out MEFs show decreased viability and reduced recovery after induction of DNA damage by the replication stress inducer, hydroxyurea, or the radiomimetic antibiotic, neocarzinostatin. Cells lacking IP6K1 arrest after genotoxic stress, and markers associated with DNA repair are recruited to DNA damage sites, indicating that HR repair is initiated in these cells. However, repair does not proceed to completion because these markers persist as nuclear foci long after drug removal. A fraction of IP6K1-deficient MEFs continues to proliferate despite the persistence of DNA damage, rendering the cells more susceptible to chromosomal aberrations. Expression of catalytically active but not inactive IP6K1 can restore the repair process in knock-out MEFs, implying that inositol pyrophosphates are required for HR-mediated repair. Our study there fore highlights inositol pyrophosphates as novel small molecule regulators of HR signaling in mammals.	[Jadav, Rathan S.; Chanduri, Manasa V. L.; Bhandari, Rashna] Ctr DNA Fingerprinting & Diagnost, Lab Cell Signalling, Hyderabad 500001, Andhra Pradesh, India; [Sengupta, Sagar] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhandari, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Cell Signalling, Bldg 7 Gurhakalpa,5-4-399-B Nampally, Hyderabad 500001, Andhra Pradesh, India.	rashna@cdfd.org.in	Sengupta, Sagar/AGR-1063-2022	Sengupta, Sagar/0000-0002-6365-1770; Bhandari, Rashna/0000-0003-3101-0204	Wellcome Trust/Department of Biotechnology India Alliance [500020/Z/09/Z]; Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India; Council of Scientific and Industrial Research; National Institute of Immunology; Department of Biotechnology (DBT), India [BT/PR11258/BRB/10/645/2008]; Department of Science and Technology (DST), India [SR/SO/BB-08/2010]; Indo-French Centre for the Promotion of Advanced Research (IFCPAR) [IFC/4603-A/2011/1250]; Council of Scientific and Industrial Research (CSIR), India [37(1541)/12/EMR-II]; Wellcome Trust/DBT India Alliance [500020/Z/09/Z]; DBT Innovative Young Biotechnologist Award [BT/BI/12/045/2008]	Wellcome Trust/Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Institute of Immunology; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Indo-French Centre for the Promotion of Advanced Research (IFCPAR)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); DBT Innovative Young Biotechnologist Award	This work was supported by the Wellcome Trust/Department of Biotechnology India Alliance (500020/Z/09/Z (to R.B.)) and core funds from the Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.; Recipients of Junior and Senior Research Fellowships of the Council of Scientific and Industrial Research toward the pursuit of a Ph. D. degree of the Manipal University.; Supported by National Institute of Immunology core funds; the Department of Biotechnology (DBT), India (Grant BT/PR11258/BRB/10/645/2008); the Department of Science and Technology (DST), India (Grant SR/SO/BB-08/2010); the Indo-French Centre for the Promotion of Advanced Research (IFCPAR) (Grant IFC/4603-A/2011/1250); and the Council of Scientific and Industrial Research (CSIR), India (Grant 37(1541)/12/EMR-II).; Supported by a Senior Fellowship from the Wellcome Trust/DBT India Alliance (500020/Z/09/Z); and the DBT Innovative Young Biotechnologist Award (Grant BT/BI/12/045/2008). To whom correspondence should be addressed: Laboratory of Cell Signalling, Centre for DNA Fingerprinting and Diagnostics, Bldg. 7 Gurhakalpa, 5-4-399/B Nampally, Hyderabad 500001, India. Tel.: 91-40-24749430; Fax: 91-40-24749448; E-mail: rashna@cdfd.org.in.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Azevedo C, 2011, ADV ENZYME REGUL, V51, P74, DOI 10.1016/j.advenzreg.2010.08.003; Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HUANG KN, 1995, GENETICS, V141, P1275; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Morrison BH, 2009, ONCOGENE, V28, P2383, DOI 10.1038/onc.2009.113; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Scully R, 2000, ONCOGENE, V19, P6176, DOI 10.1038/sj.onc.1203971; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Shears SB, 2011, ADV ENZYME REGUL, V51, P13, DOI 10.1016/j.advenzreg.2010.09.008; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	44	33	36	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3312	3321		10.1074/jbc.M112.396556	http://dx.doi.org/10.1074/jbc.M112.396556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255604	Green Published, hybrid			2022-12-25	WOS:000314397900037
J	Park, JH; Yoon, DS; Choi, HJ; Hahm, DH; Oh, SM				Park, Jung-Hwan; Yoon, Dae-Sung; Choi, Hye-Jin; Hahm, Dae-Hyun; Oh, Sang-Muk			Phosphorylation of I kappa B alpha at Serine 32 by T-lymphokine-activated Killer Cell-originated Protein Kinase Is Essential for Chemoresistance against Doxorubicin in Cervical Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-BINDING KINASE; DNA-DAMAGE; MITOTIC KINASE; TOPK PHOSPHORYLATION; INDUCED APOPTOSIS; BREAST-CANCER; C-DELTA; EXPRESSION; INHIBITION; PATHWAY	T-lymphokine-activated killer cell-originated protein kinase (TOPK) is known to be up-regulated in cancer cells and appears to contribute to cancer cell proliferation and survival. However, the molecular mechanism by which TOPK regulates cancer cell survival still remains elusive. Here we show that TOPK directly interacted with and phosphorylated I kappa B alpha at Ser-32, leading to p65 nuclear translocation and NF-kappa B activation. We also revealed that doxorubicin promoted the interaction between nonphosphorylated or phosphorylated TOPK and I kappa B alpha and that TOPK-mediated I kappa B alpha phosphorylation was enhanced in response to doxorubicin. Also, exogenously overexpressed TOPK augmented transcriptional activity driven by either NF-kappa B or inhibitor of apoptosis protein 2 (cIAP2) promoters. On the other hand, NF-kappa B activity including I kappa B alpha phosphorylation and p65 nuclear translocation, as well as cIAP2 gene expression, was markedly diminished in TOPK knockdown HeLa cervical cancer cells. Moreover, doxorubicin-mediated apoptosis was noticeably increased in TOPK knockdown HeLa cells, compared with control cells, which resulted from caspase-dependent signaling pathways. These results demonstrate that TOPK is a molecular target of doxorubicin and mediates doxorubicin chemoresistance of HeLa cells, suggesting a novel mechanism for TOPK barrier of doxorubicin-mediated cervical cancer cell apoptosis.	[Park, Jung-Hwan; Choi, Hye-Jin; Oh, Sang-Muk] Konyang Univ, Dept Biochem, Coll Med, Taejon 302718, South Korea; [Yoon, Dae-Sung] Konyang Univ, Dept Surg, Coll Med, Konyang Hosp, Taejon 302718, South Korea; [Hahm, Dae-Hyun] Kyung Hee Univ, Coll Oriental Med, Acupuncture & Meridian Sci Res Ctr, Seoul 130701, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Kyung Hee University	Oh, SM (corresponding author), Konyang Univ, Dept Biochem, Coll Med, 685 Gasuwon Dong, Taejon 302718, South Korea.	sangmuk_oh@konyang.ac.kr		Park, Jung-hwan/0000-0002-8880-1149	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0005899]; Konyang University Myunggok Research Fund	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Konyang University Myunggok Research Fund	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2010-0005899. This work was supported in part by Konyang University Myunggok Research Fund of 2009.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Binaschi M, 1997, MOL PHARMACOL, V51, P1053, DOI 10.1124/mol.51.6.1053; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Christiansen S, 2006, EUR J CARDIO-THORAC, V30, P611, DOI 10.1016/j.ejcts.2006.06.024; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HENDERSON IC, 1979, NEW ENGL J MED, V300, P310, DOI 10.1056/NEJM197902083000610; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jimenez-Lara AM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-15; Juliger S, 2007, CANCER RES, V67, P10984, DOI 10.1158/0008-5472.CAN-07-0519; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kinsella AR, 1997, BRIT J CANCER, V75, P935, DOI 10.1038/bjc.1997.164; Kwon HR, 2010, BIOCHEM BIOPH RES CO, V391, P830, DOI 10.1016/j.bbrc.2009.11.147; Lee SA, 2007, J BIOL CHEM, V282, P15271, DOI 10.1074/jbc.M701362200; Li SQ, 2011, J BIOL CHEM, V286, P29601, DOI 10.1074/jbc.M111.225813; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Manna SK, 2011, J BIOL CHEM, V286, P7339, DOI 10.1074/jbc.M110.191916; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200; Zhao SH, 2001, INT J BIOCHEM CELL B, V33, P631, DOI 10.1016/S1357-2725(01)00005-X; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	40	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3585	3593		10.1074/jbc.M112.422170	http://dx.doi.org/10.1074/jbc.M112.422170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250755	hybrid, Green Published			2022-12-25	WOS:000314397900063
J	Buehler, E; Chen, YC; Martin, S				Buehler, Eugen; Chen, Yu-Chi; Martin, Scott			C911: A Bench-Level Control for Sequence Specific siRNA Off-Target Effects	PLOS ONE			English	Article								Small interfering RNAs (siRNAs) have become a ubiquitous experimental tool for down-regulating mRNAs. Unfortunately, off-target effects are a significant source of false positives in siRNA experiments and an effective control for them has not previously been identified. We introduce two methods of mismatched siRNA design for negative controls based on changing bases in the middle of the siRNA to their complement bases. To test these controls, a test set of 20 highly active siRNAs (10 true positives and 10 false positives) was identified from a genome-wide screen performed in a cell-line expressing a simple, constitutively expressed luciferase reporter. Three controls were then synthesized for each of these 20 siRNAs, the first two using the proposed mismatch design methods and the third being a simple random permutation of the sequence (scrambled siRNA). When tested in the original assay, the scrambled siRNAs showed significantly reduced activity in comparison to the original siRNAs, regardless of whether they had been identified as true or false positives, indicating that they have little utility as experimental controls. In contrast, one of the proposed mismatch design methods, dubbed C911 because bases 9 through 11 of the siRNA are replaced with their complement, was able to completely distinguish between the two groups. False positives due to off-target effects maintained most of their activity when the C911 mismatch control was tested, whereas true positives whose phenotype was due to on-target effects lost most or all of their activity when the C911 mismatch was tested. The ability of control siRNAs to distinguish between true and false positives, if widely adopted, could reduce erroneous results being reported in the literature and save research dollars spent on expensive follow-up experiments.	[Buehler, Eugen; Chen, Yu-Chi; Martin, Scott] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Buehler, E (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	eugen.buehler@nih.gov		Buehler, Eugen/0000-0001-7167-676X	Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Team RDC, 2019, R LANG ENV STAT COMP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	14	81	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51942	10.1371/journal.pone.0051942	http://dx.doi.org/10.1371/journal.pone.0051942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251657	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800112
J	Davies, WIL; Tay, BH; Zheng, L; Danks, JA; Brenner, S; Foster, RG; Collin, SP; Hankins, MW; Venkatesh, B; Hunt, DM				Davies, Wayne I. L.; Tay, Boon-Hui; Zheng, Lei; Danks, Janine A.; Brenner, Sydney; Foster, Russell G.; Collin, Shaun P.; Hankins, Mark W.; Venkatesh, Byrappa; Hunt, David M.			Evolution and Functional Characterisation of Melanopsins in a Deep-Sea Chimaera (Elephant Shark, Callorhinchus milii)	PLOS ONE			English	Article							GANGLION-CELLS; DIFFERENTIAL EXPRESSION; LIGHT RESPONSE; VA-OPSIN; RHODOPSIN; RETINA; LOCALIZATION; GENES; BIOLUMINESCENCE; PHOTORECEPTORS	Non-visual photoreception in mammals is primarily mediated by two splice variants that derive from a single melanopsin (OPN4M) gene, whose expression is restricted to a subset of retinal ganglion cells. Physiologically, this sensory system regulates the photoentrainment of many biological rhythms, such as sleep via the melatonin endocrine system and pupil constriction. By contrast, melanopsin exists as two distinct lineages in non-mammals, opn4m and opn4x, and is broadly expressed in a wide range of tissue types, including the eye, brain, pineal gland and skin. Despite these findings, the evolution and function of melanopsin in early vertebrates are largely unknown. We, therefore, investigated the complement of opn4 classes present in the genome of a model deep-sea cartilaginous species, the elephant shark (Callorhinchus milii), as a representative vertebrate that resides at the base of the gnathostome (jawed vertebrate) lineage. We reveal that three melanopsin genes, opn4m1, opn4m2 and opn4x, are expressed in multiple tissues of the elephant shark. The two opn4m genes are likely to have arisen as a result of a lineage-specific duplication, whereas "long'' and "short'' splice variants are generated from a single opn4x gene. By using a heterologous expression system, we suggest that these genes encode functional photopigments that exhibit both "invertebrate-like'' bistable and classical "vertebrate-like'' monostable biochemical characteristics. We discuss the evolution and function of these melanopsin pigments within the context of the diverse photic and ecological environments inhabited by this chimaerid holocephalan, as well as the origin of non-visual sensory systems in early vertebrates.	[Davies, Wayne I. L.; Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia; [Davies, Wayne I. L.; Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia; [Davies, Wayne I. L.; Zheng, Lei; Foster, Russell G.; Hankins, Mark W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Tay, Boon-Hui; Brenner, Sydney; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Comparat Genom Lab, Biopolis, Singapore; [Danks, Janine A.] RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Comparat Endocrinol & Biochem Lab, Melbourne, Vic, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Royal Melbourne Institute of Technology (RMIT)	Hunt, DM (corresponding author), Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia.	mark.hankins@eye.ox.ac.uk; mcbbv@imcb.a-star.edu.sg; david.hunt@uwa.edu.au	Zheng, Lei/AAF-6159-2019; Hunt, David M/K-6024-2012; Collin, Shaun/K-8827-2012; Davies, Wayne/I-1547-2014	Hunt, David M/0000-0002-9264-3948; Collin, Shaun/0000-0001-6236-0771; Davies, Wayne/0000-0003-0232-1812; Venkatesh, Byrappa/0000-0003-3620-0277; FOSTER, RUSSELL/0000-0001-6055-2067	Australian Research Council (ARC); United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC); Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore	Australian Research Council (ARC)(Australian Research Council); United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants awarded by the Australian Research Council (ARC) to DMH and SPC, and as part of a Future Fellowship to WILD; the United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC) separately to DMH and MWH; and the Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Bailey MJ, 2005, MOL BRAIN RES, V134, P345, DOI 10.1016/j.molbrainres.2004.11.003; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; Davies WL, 2012, EXP EYE RES, V97, P161, DOI 10.1016/j.exer.2010.07.020; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Davies WL, 2009, GENOME RES, V19, P415, DOI 10.1101/gr.084509.108; Davies WL, 2011, ADAPTIVE GENE LOSS V; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Grone BP, 2007, J BIOL RHYTHM, V22, P558, DOI 10.1177/0748730407308285; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt DM, 2001, J EXP BIOL, V204, P3333; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Jerlov N. G., 1976, MARINE OPTICS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Last PR, 1994, SHARKS RAYS AUSTR, P513; Marshall N. B., 1979, DEV DEEP SEA BIOL; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; POTTER I C, 1979, Environmental Biology of Fishes, V4, P65, DOI 10.1007/BF00005929; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Provencio I, 2011, SCI AM, V304, P54, DOI 10.1038/scientificamerican0511-54; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; TUDGE C, 2000, VARIETY LIFE; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Zhao ZM, 1998, J MOL EVOL, V46, P494, DOI 10.1007/PL00013147	70	16	16	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51276	10.1371/journal.pone.0051276	http://dx.doi.org/10.1371/journal.pone.0051276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251480	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800038
J	Jimenez, DJ; Andreote, FD; Chaves, D; Montana, JS; Osorio-Forero, C; Junca, H; Zambrano, MM; Baena, S				Javier Jimenez, Diego; Andreote, Fernando Dini; Chaves, Diego; Salvador Montana, Jose; Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria; Baena, Sandra			Structural and Functional Insights from the Metagenome of an Acidic Hot Spring Microbial Planktonic Community in the Colombian Andes	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; BACTERIAL COMMUNITIES; GEOTHERMAL SPRINGS; SULFIDE MINE; DIVERSITY; DNA; SEQUENCES; MATS; METABOLISM; GENERATION	A taxonomic and annotated functional description of microbial life was deduced from 53 Mb of metagenomic sequence retrieved from a planktonic fraction of the Neotropical high Andean (3,973 meters above sea level) acidic hot spring El Coquito (EC). A classification of unassembled metagenomic reads using different databases showed a high proportion of Gammaproteobacteria and Alphaproteobacteria (in total read affiliation), and through taxonomic affiliation of 16S rRNA gene fragments we observed the presence of Proteobacteria, micro-algae chloroplast and Firmicutes. Reads mapped against the genomes Acidiphilium cryptum JF-5, Legionella pneumophila str. Corby and Acidithiobacillus caldus revealed the presence of transposase-like sequences, potentially involved in horizontal gene transfer. Functional annotation and hierarchical comparison with different datasets obtained by pyrosequencing in different ecosystems showed that the microbial community also contained extensive DNA repair systems, possibly to cope with ultraviolet radiation at such high altitudes. Analysis of genes involved in the nitrogen cycle indicated the presence of dissimilatory nitrate reduction to N2 (narGHI, nirS, norBCDQ and nosZ), associated with Proteobacteria-like sequences. Genes involved in the sulfur cycle (cysDN, cysNC and aprA) indicated adenylsulfate and sulfite production that were affiliated to several bacterial species. In summary, metagenomic sequence data provided insight regarding the structure and possible functions of this hot spring microbial community, describing some groups potentially involved in the nitrogen and sulfur cycling in this environment. Citation: Jimenez DJ, Andreote FD, Chaves D, Montana JS, Osorio-Forero C, et al. (2012) Structural and Functional Insights from the Metagenome of an Acidic Hot Spring Microbial Planktonic Community in the Colombian Andes. PLoS ONE 7(12): e52069. doi:10.1371/journal.pone.0052069	[Javier Jimenez, Diego; Chaves, Diego; Salvador Montana, Jose; Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria; Baena, Sandra] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia; [Salvador Montana, Jose; Baena, Sandra] Pontificia Univ Javeriana, Unidad Saneamiento & Biotecnol Ambiental, Dept Biol, Bogota, Colombia; [Andreote, Fernando Dini] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, Brazil; [Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria] Corp CorpoGen, Mol Genet Res Grp, Bogota, Colombia; [Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria] Corp CorpoGen, Microbial Ecol Res Grp, Bogota, Colombia; [Javier Jimenez, Diego] Univ Groningen, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	Pontificia Universidad Javeriana; Universidade de Sao Paulo; University of Groningen	Jimenez, DJ (corresponding author), Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia.	djimenez1909@gmail.com	Zambrano, Maria Mercedes/AAD-2805-2019; Jimenez, Diego/GNW-3973-2022; Baena, Sandra/AAF-8165-2019; Andreote, Fernando Dini/B-8499-2012; Junca, Howard/K-5525-2014; Montaña-Lara, Jose Salvador/AAE-7239-2019	Zambrano, Maria Mercedes/0000-0002-0796-4473; Andreote, Fernando Dini/0000-0002-9883-9968; Junca, Howard/0000-0003-4546-6229; Baena, Sandra/0000-0001-5377-9079; Montana-Lara, Jose Salvador/0000-0002-1970-8637; Jimenez Avella, Diego Javier/0000-0002-9339-6520	COLCIENCIAS - SENA [6570-392-19990]; MAVDT [15]	COLCIENCIAS - SENA(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MAVDT	This research was supported by COLCIENCIAS - SENA (project number 6570-392-19990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank G. Lopez, L. Bohorquez and L. Delgado for help with sampling and J.R. Bustos for technical assistance. This research was done under permits from MAVDT (contract number 15, 2008) for access to genetic resources) and UAESPNN (research permit code DTNO-N-20/2007).	Aguilera A, 2010, INT MICROBIOL, V13, P21, DOI 10.2436/20.1501.01.108; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Belnap CP, 2011, ISME J, V5, P1152, DOI 10.1038/ismej.2010.200; Bohnebeck U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-459; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Burton NP, 2000, EXTREMOPHILES, V4, P315, DOI 10.1007/s007920070019; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Dini-Andreote Francisco, 2012, Microb Ecol, V64, P1, DOI 10.1007/s00248-012-0017-y; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Edwards Robert A, 2006, BMC Genomics, V7, P57; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039948; Furuhata K, 2010, J INFECT CHEMOTHER, V16, P367, DOI 10.1007/s10156-010-0062-8; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; GILBERT JR, 2008, NATL GEOGR, V213, P8; Gomes J, 2004, FOOD TECHNOL BIOTECH, V42, P223; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Hamamura N, 2005, APPL ENVIRON MICROB, V71, P5943, DOI 10.1128/AEM.71.10.5943-5950.2005; Hao CB, 2010, EXTREMOPHILES, V14, P465, DOI 10.1007/s00792-010-0324-5; Hiraishi A, 2005, BERGEYS MANUAL SYSTE, V2, P54; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang Y, 2009, HDB MOL MICROBIAL EC, P784; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; IDEAM, 2005, ATL RAD SOL COL MAP; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jimenez DJ, 2012, WORLD J MICROB BIOT, V28, P361, DOI 10.1007/s11274-011-0828-x; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Ju X, 2008, ENVIRON MICROBIOL, V9, P1078; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato S, 2011, FEMS MICROBIOL LETT, V319, P34, DOI 10.1111/j.1574-6968.2011.02267.x; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; Kurosawa H, 2010, JPN J INFECT DIS, V63, P78; Lau MCY, 2009, EXTREMOPHILES, V13, P139, DOI 10.1007/s00792-008-0205-3; LAWRENCE ME, 1986, J HISTOCHEM CYTOCHEM, V34, P761, DOI 10.1177/34.6.2422253; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lokendra Kumar, 2011, Biotechnology, V10, P121; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; Meyer B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001514; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mirete S, 2011, FEMS MICROBIOL ECOL, V77, P165, DOI 10.1111/j.1574-6941.2011.01095.x; Mitra S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S17; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norris PR, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0000336, DOI 10.1038/NPG.ELS.0000336]; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rowe OF, 2007, ENVIRON MICROBIOL, V9, P1761, DOI 10.1111/j.1462-2920.2007.01294.x; Rzhepishevska OI, 2007, APPL ENVIRON MICROB, V73, P7367, DOI 10.1128/AEM.01497-07; Rzonca B, 2003, J HYDROL, V280, P272, DOI 10.1016/S0022-1694(03)00231-2; Montana JS, 2012, ANTON LEEUW INT J G, V101, P205, DOI 10.1007/s10482-011-9624-8; Schrenk MO, 1998, SCIENCE, V279, P1519, DOI 10.1126/science.279.5356.1519; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Siering PL, 2006, GEOMICROBIOL J, V23, P129, DOI 10.1080/01490450500533916; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Snyder TM, 2008, J AM CHEM SOC, V130, P1392, DOI 10.1021/ja076780u; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Stout LM, 2009, FEMS MICROBIOL ECOL, V70, P402, DOI 10.1111/j.1574-6941.2009.00780.x; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tekere M, 2011, AFR J BIOTECHNOL, V10, P18005, DOI 10.5897/AJB11.899; Tirawongsaroj P, 2008, J BIOTECHNOL, V133, P42, DOI 10.1016/j.jbiotec.2007.08.046; Tomova I, 2010, WORLD J MICROB BIOT, V26, P2019, DOI 10.1007/s11274-010-0386-7; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Weingart U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-390; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	82	51	54	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52069	10.1371/journal.pone.0052069	http://dx.doi.org/10.1371/journal.pone.0052069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251687	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800139
J	Pazmandi, K; Kumar, BV; Szabo, K; Boldogh, I; Szoor, A; Vereb, G; Veres, A; Lanyi, A; Rajnavolgyi, E; Bacsi, A				Pazmandi, Kitti; Kumar, Brahma V.; Szabo, Krisztina; Boldogh, Istvan; Szoor, Arpad; Vereb, Gyorgy; Veres, Agota; Lanyi, Arpad; Rajnavolgyi, Eva; Bacsi, Attila			Ragweed Subpollen Particles of Respirable Size Activate Human Dendritic Cells	PLOS ONE			English	Article							POLLEN STARCH GRANULES; HOUSE-DUST MITE; BET V 1; OXIDATIVE STRESS; AIRWAY INFLAMMATION; ELECTRON-MICROSCOPY; NADPH OXIDASE; LYMPH-NODES; HUMAN LUNG; T-CELLS	Ragweed (Ambrosia artemisiifolia) pollen grains, which are generally considered too large to reach the lower respiratory tract, release subpollen particles (SPPs) of respirable size upon hydration. These SPPs contain allergenic proteins and functional NAD(P)H oxidases. In this study, we examined whether exposure to SPPs initiates the activation of human monocyte-derived dendritic cells (moDCs). We found that treatment with freshly isolated ragweed SPPs increased the intracellular levels of reactive oxygen species (ROS) in moDCs. Phagocytosis of SPPs by moDCs, as demonstrated by confocal laser-scanning microscopy, led to an up-regulation of the cell surface expression of CD40, CD80, CD86, and HLA-DQ and an increase in the production of IL-6, TNF-alpha, IL-8, and IL-10. Furthermore, SPP-treated moDCs had an increased capacity to stimulate the proliferation of naive T cells. Co-culture of SPP-treated moDCs with allogeneic CD3(+) pan-T cells resulted in increased secretion of IFN-gamma and IL-17 by T cells of both allergic and non-allergic subjects, but induced the production of IL-4 exclusively from the T cells of allergic individuals. Addition of exogenous NADPH further increased, while heat-inactivation or pre-treatment with diphenyleneiodonium (DPI), an inhibitor of NADPH oxidases, strongly diminished, the ability of SPPs to induce phenotypic and functional changes in moDCs, indicating that these processes were mediated, at least partly, by the intrinsic NAD(P)H oxidase activity of SPPs. Collectively, our data suggest that inhaled ragweed SPPs are fully capable of activating dendritic cells (DCs) in the airways and SPPs' NAD(P)H oxidase activity is involved in initiation of adaptive immune responses against innocuous pollen proteins. Citation: Pazmandi K, Kumar BV, Szabo K, Boldogh I, Szoor A, et al. (2012) Ragweed Subpollen Particles of Respirable Size Activate Human Dendritic Cells. PLoS ONE 7(12): e52085. doi:10.1371/journal.pone.0052085	[Pazmandi, Kitti; Kumar, Brahma V.; Szabo, Krisztina; Veres, Agota; Lanyi, Arpad; Rajnavolgyi, Eva; Bacsi, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary; [Boldogh, Istvan] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX USA; [Szoor, Arpad; Vereb, Gyorgy] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, Debrecen, Hungary	University of Debrecen; University of Texas System; University of Texas Medical Branch Galveston; University of Debrecen	Bacsi, A (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary.	bacsi.attila@gmail.com	Szabó, Krisztina/AAK-3483-2021; Vereb, György/A-4241-2008; Rajnavölgyi, Éva/D-4384-2013	Vereb, György/0000-0003-2157-3265; Bacsi, Attila/0000-0002-2311-2975; Szabo, Krisztina/0000-0002-0079-3659; Pazmandi, Kitti Linda/0000-0001-7709-6707	Hungarian Scientific Research Fund [K-73347, NK-101538]; National Institutes of Environmental Health and Sciences [RO1-ES018948]; National Institute of Allergic and Infectious Diseases [AI062885-01]; European Union; European Social Fund; Janos Bolyai Fellowship from the Hungarian Academy of Sciences; Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund);  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP 4.2.2/B-10/1-2010-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Environmental Health and Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergic and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Fellowship from the Hungarian Academy of Sciences; Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Hungarian Scientific Research Fund (K-73347 to A.B. and NK-101538 to E.R.), National Institutes of Environmental Health and Sciences (RO1-ES018948 to I.B.), National Institute of Allergic and Infectious Diseases (AI062885-01 to I.B.) and the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and TAMOP 4.2.2/B-10/1-2010-0024 projects (to A.B., E.R. and K.P.). The project is co-financed by the European Union and the European Social Fund. A.B. was also supported by the Janos Bolyai Fellowship from the Hungarian Academy of Sciences and by the Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Chakra O, 2011, INT ARCH ALLERGY IMM, V154, P128, DOI 10.1159/000320227; Abou Chakra OR, 2011, WORLD ALLERGY ORGAN, V4, P4, DOI 10.1097/WOX.0b013e318205ab44; Allakhverdi Z, 2005, ALLERGY, V60, P1157, DOI 10.1111/j.1398-9995.2005.00861.x; Bacsi A, 2005, J ALLERGY CLIN IMMUN, V116, P836, DOI 10.1016/j.jaci.2005.06.002; Bacsi A, 2006, J ALLERGY CLIN IMMUN, V118, P844, DOI 10.1016/j.jaci.2006.07.006; BAER H, 1980, J ALLERGY CLIN IMMUN, V66, P281, DOI 10.1016/0091-6749(80)90022-6; Barnes C, 2000, ANN ALLERG ASTHMA IM, V84, P47, DOI 10.1016/S1081-1206(10)62740-8; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bullens DMA, 2005, CLIN EXP ALLERGY, V35, P1535, DOI 10.1111/j.1365-2222.2005.02352.x; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Csillag A, 2010, J IMMUNOL, V184, P2377, DOI 10.4049/jimmunol.0803938; Currie AJ, 2000, J IMMUNOL, V164, P3878, DOI 10.4049/jimmunol.164.7.3878; de Heer HJ, 2001, J EXP MED, V193, P51; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; DRIESSEN MNBM, 1991, EUR RESPIR J, V4, P359; Erpenbeck VJ, 2005, AM J PHYSIOL-LUNG C, V288, pL692, DOI 10.1152/ajplung.00362.2004; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Grote M, 2001, J ALLERGY CLIN IMMUN, V108, P109, DOI 10.1067/mai.2001.116431; Grote M, 2000, J ALLERGY CLIN IMMUN, V105, P1140, DOI 10.1067/mai.2000.107044; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kimura M, 2002, INT ARCH ALLERGY IMM, V127, P191, DOI 10.1159/000053863; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Okano M, 2001, AM J RESP CRIT CARE, V164, P1501, DOI 10.1164/ajrccm.164.8.2011072; Oswalt Matthew L, 2008, Allergy Asthma Clin Immunol, V4, P130, DOI 10.1186/1710-1492-4-3-130; Pazmandi K, 2012, FREE RADICAL BIO MED, V52, P635, DOI 10.1016/j.freeradbiomed.2011.11.022; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; ROSENBERG GL, 1983, J ALLERGY CLIN IMMUN, V71, P302, DOI 10.1016/0091-6749(83)90084-2; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schappi GF, 1999, ALLERGY, V54, P478, DOI 10.1034/j.1398-9995.1999.00838.x; Schleh C, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-8; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; Taylor PE, 2004, CLIN EXP ALLERGY, V34, P1591, DOI 10.1111/j.1365-2222.2004.02078.x; Taylor PE, 2002, J ALLERGY CLIN IMMUN, V109, P51, DOI 10.1067/mai.2002.120759; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Verhasselt V, 1998, EUR J IMMUNOL, V28, P3886; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wark PAB, 2002, CLIN EXP ALLERGY, V32, P1750, DOI 10.1046/j.1365-2222.2002.01556.x; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Winkler C, 2010, EXP LUNG RES, V36, P522, DOI 10.3109/01902141003790148; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	55	20	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52085	10.1371/journal.pone.0052085	http://dx.doi.org/10.1371/journal.pone.0052085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251688	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000312386800140
J	Prorok, P; Saint-Pierre, C; Gasparutto, D; Fedorova, OS; Ishchenko, AA; Leh, H; Buckle, M; Tudek, B; Saparbaev, M				Prorok, Paulina; Saint-Pierre, Christine; Gasparutto, Didier; Fedorova, Olga S.; Ishchenko, Alexander A.; Leh, Herve; Buckle, Malcolm; Tudek, Barbara; Saparbaev, Murat			Highly Mutagenic Exocyclic DNA Adducts Are Substrates for the Human Nucleotide Incision Repair Pathway	PLOS ONE			English	Article							BASE EXCISION-REPAIR; COLI ENDONUCLEASE-III; HUMAN AP ENDONUCLEASE; ESCHERICHIA-COLI; IONIZING-RADIATION; LIPID-PEROXIDATION; TARGETED DELETION; BIOLOGICAL RESPONSES; OXIDATIVE DAMAGE; N-GLYCOSYLASE	Background: Oxygen free radicals induce lipid peroxidation (LPO) that damages and breaks polyunsaturated fatty acids in cell membranes. LPO-derived aldehydes and hydroxyalkenals react with DNA leading to the formation of etheno(e)-bases including 1, N-6-ethenoadenine (epsilon A) and 3,N-4-ethenocytosine (epsilon C). The epsilon A and epsilon C residues are highly mutagenic in mammalian cells and eliminated in the base excision repair (BER) pathway and/or by AlkB family proteins in the direct damage reversal process. BER initiated by DNA glycosylases is thought to be the major pathway for the removal of non-bulky endogenous base damage. Alternatively, in the nucleotide incision repair (NIR) pathway, the apurinic/apyrimidinic (AP) endonucleases can directly incise DNA duplex 59 to a damaged base in a DNA glycosylase-independent manner. Methodology/Principal Findings: Here we have characterized the substrate specificity of human major AP endonuclease 1, APE1, towards epsilon A, epsilon C, thymine glycol (Tg) and7,8-dihydro-8-oxoguanine (8oxoG) residues when present in duplex DNA. APE1 cleaves oligonucleotide duplexes containing epsilon A, epsilon C and Tg, but not those containing 8oxoG. Activity depends strongly on sequence context. The apparent kinetic parameters of the reactions suggest that APE1 has a high affinity for DNA containing e-bases but cleaves DNA duplexes at an extremely slow rate. Consistent with this observation, oligonucleotide duplexes containing an e-base strongly inhibit AP site nicking activity of APE1 with IC50 values in the range of 5- 10 nM. MALDI-TOF MS analysis of the reaction products demonstrated that APE1-catalyzed cleavage of epsilon A.T and epsilon C.G duplexes generates, as expected, DNA fragments containing 5'-terminal epsilon-base residue. Conclusions/Significance: The fact that epsilon-bases and Tg in duplex DNA are recognized and cleaved by APE1 in vitro, suggests that NIR may act as a backup pathway to BER to remove a large variety of genotoxic base lesions in human cells. Citation: Prorok P, Saint-Pierre C, Gasparutto D, Fedorova OS, Ishchenko AA, et al. (2012) Highly Mutagenic Exocyclic DNA Adducts Are Substrates for the Human Nucleotide Incision Repair Pathway. PLoS ONE 7(12): e51776. doi:10.1371/journal.pone.0051776	[Prorok, Paulina; Ishchenko, Alexander A.; Tudek, Barbara; Saparbaev, Murat] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France; [Prorok, Paulina] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Saint-Pierre, Christine; Gasparutto, Didier] CEA, INAC, SCIB UMR CEA UJF E3, Lab Les Acides Nucl, Grenoble, France; [Fedorova, Olga S.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Leh, Herve; Buckle, Malcolm] CNRS, ENS Cachan, LBPA, Cachan, France; [Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Warsaw	Tudek, B (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France.	tudek@ibb.waw.pl; smurat@igr.fr	Ishchenko, Alexander/D-4133-2013; Fedorova, Olga/ABE-6637-2020; Fedorova, Olga S./E-1291-2013; Saparbaev, Murat K/N-3225-2015; Saparbaev, Murat/AAC-5478-2020	Ishchenko, Alexander/0000-0002-0488-8858; Fedorova, Olga/0000-0002-4001-7187; Fedorova, Olga S./0000-0002-4001-7187; Saparbaev, Murat K/0000-0002-4630-1074; Saparbaev, Murat/0000-0002-4630-1074; Prorok, Paulina/0000-0002-1427-1528	Polish-French collaborative [346/N-INCA/2008/0, 303 819540]; Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique [PICS N5479-Russie]; CNRS-INCA-MSHE Franco-Pologne [3037987]; Electricite de France; Contrat Radioprotection; Fondation de France [2012 00029161]; Russian Ministry of Education and Science; International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund; Electricite de France, EDF (Scientific Commission - Council of Radiation Protection)	Polish-French collaborative; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CNRS-INCA-MSHE Franco-Pologne; Electricite de France; Contrat Radioprotection; Fondation de France(Fondation de France); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund; Electricite de France, EDF (Scientific Commission - Council of Radiation Protection)	This work was supported by Polish-French collaborative grants No346/N-INCA/2008/0 and No303 819540 [to BT] and grants from Fondation pour la Recherche Medicale (http://www.frm.org) [EQUIPES FRM 2007 to MS]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne #3037987 to MS]; Electricite de France (http://www.edf.fr) Contrat Radioprotection [RB 2011 to MS and DG]; Fondation de France (http://www.fondationdefrance.org) [#2012 00029161 to AAI]. Russian Ministry of Education and Science (http://mon.gov.ru) [to OSF and AAI]. PP was supported by the fellowship from International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''. The project is co-financed by European Union - Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Electricite de France, EDF (Scientific Commission - Council of Radiation Protection). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; This research was funded by Electricite de France, EDF (Scientific Commission - Council of Radiation Protection). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Barbin A, 2003, CANCER RES, V63, P7699; Bartsch H, 2000, TOXICOLOGY, V153, P105, DOI 10.1016/S0300-483X(00)00307-3; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; BOLT HM, 1988, CRIT REV TOXICOL, V18, P299, DOI 10.3109/10408448809037469; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Christov PP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/850234; D'Ham C, 1999, BIOCHEMISTRY-US, V38, P3335, DOI 10.1021/bi981982b; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Guengerich F P, 1994, IARC Sci Publ, P57; Gunther T, 2006, MAGNESIUM RES, V19, P225; Guliaev AB, 2004, NUCLEIC ACIDS RES, V32, P2844, DOI 10.1093/nar/gkh594; Hang B, 1998, P NATL ACAD SCI USA, V95, P13561, DOI 10.1073/pnas.95.23.13561; Hang B, 1997, P NATL ACAD SCI USA, V94, P12869, DOI 10.1073/pnas.94.24.12869; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Huamani J, 2004, MOL CELL BIOL, V24, P8145, DOI 10.1128/MCB.24.18.8145-8153.2004; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Levine RL, 2000, CANCER RES, V60, P4098; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899; NAIR J, 1995, CARCINOGENESIS, V16, P613, DOI 10.1093/carcin/16.3.613; Nogues C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044287; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Redrejo-Rodriguez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021039; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; Speina E, 2001, J BIOL CHEM, V276, P21821, DOI 10.1074/jbc.M100998200; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang D, 2004, MOL CANCER THER, V3, P679; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	67	22	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51776	10.1371/journal.pone.0051776	http://dx.doi.org/10.1371/journal.pone.0051776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251620	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800083
J	Wei, RC; Yang, CF; Zeng, M; Terry, F; Zhu, K; Yang, CH; Altmeyer, R; Martin, W; De Groot, AS; Leng, QB				Wei, Ruicheng; Yang, Chunfu; Zeng, Mei; Terry, Frances; Zhu, Kai; Yang, Chunhui; Altmeyer, Ralf; Martin, William; De Groot, Anne S.; Leng, Qibin			A Dominant EV71-Specific CD4+T Cell Epitope Is Highly Conserved among Human Enteroviruses	PLOS ONE			English	Article							VP1 CAPSID PROTEIN; MEMORY T-CELLS; MOUTH-DISEASE; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; HUMORAL IMMUNITY; 71 INFECTION; HAND; FOOT; IDENTIFICATION	CD4+ T cell-mediated immunity plays a central role in determining the immunopathogenesis of viral infections. However, the role of CD4+ T cells in EV71 infection, which causes hand, foot and mouth disease (HFMD), has yet to be elucidated. We applied a sophisticated method to identify promiscuous CD4+ T cell epitopes contained within the sequence of the EV71 polyprotein. Fifteen epitopes were identified, and three of them are dominant ones. The most dominant epitope is highly conserved among enterovirus species, including HFMD-related coxsackieviruses, HFMD-unrelated echoviruses and polioviruses. Furthermore, the CD4+ T cells specific to the epitope indeed cross-reacted with the homolog of poliovirus 3 Sabin. Our findings imply that CD4+ T cell responses to poliovirus following vaccination, or to other enteroviruses to which individuals may be exposed in early childhood, may have a modulating effect on subsequent CD4+ T cell response to EV71 infection or vaccine.	[Wei, Ruicheng; Yang, Chunfu; Zhu, Kai; Yang, Chunhui; Altmeyer, Ralf; Leng, Qibin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Terry, Frances; Martin, William; De Groot, Anne S.] EpiVax Inc, Providence, RI USA; [Zeng, Mei] Fudan Univ, Childrens Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; University of Rhode Island	Leng, QB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	qbleng@sibs.ac.cn	Yang, Chunfu/S-3051-2019; De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459	National Basic Research Program of China [973 Program] [2011CB504903]; National Natural Science Foundation of China [81172807, 31270951, 30972726]; Li Ka Shing Foundation; 100-Talent Program of CAS; SA-SIBS Scholarship Program	National Basic Research Program of China [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation; 100-Talent Program of CAS(Chinese Academy of Sciences); SA-SIBS Scholarship Program	This work was supported by the National Basic Research Program of China [973 Program, grant number 2011CB504903], the National Natural Science Foundation of China [grant numbers 81172807, 31270951 and 30972726], the Li Ka Shing Foundation and the 100-Talent Program of CAS. QL is supported by the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P213; Bond KB, 2001, AIDS RES HUM RETROV, V17, P703, DOI 10.1089/088922201750236988; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cello J, 1996, J GEN VIROL, V77, P2097, DOI 10.1099/0022-1317-77-9-2097; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2008, PEDIATRICS, V122, P1271, DOI 10.1542/peds.2007-3735; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; De Groot A, 2011, IMMUNOME RES, V7, P3; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; De Groot AS, 2011, IMMUNOME RES, V7, P7; Deng CY, 2011, CLIN VACCINE IMMUNOL, V18, P1589, DOI 10.1128/CVI.05132-11; Dong YZ, 2004, INFECT IMMUN, V72, P2412, DOI 10.1128/IAI.72.4.2412-2415.2004; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; KUTUBUDDIN M, 1992, J VIROL, V66, P3042, DOI 10.1128/JVI.66.5.3042-3047.1992; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LECLERC C, 1991, J VIROL, V65, P711, DOI 10.1128/JVI.65.2.711-718.1991; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; MEISTER GE, 1995, VACCINE, V13, P581, DOI 10.1016/0264-410X(94)00014-E; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Moss SF, 2011, VACCINE, V29, P2085, DOI 10.1016/j.vaccine.2010.12.130; Otero M, 2006, VACCINE, V24, P4461, DOI 10.1016/j.vaccine.2005.08.010; Park SH, 2011, CLIN LAB, V57, P959; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Schanen BC, 2011, VACCINE, V29, P3299, DOI 10.1016/j.vaccine.2011.02.019; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	40	11	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51957	10.1371/journal.pone.0051957	http://dx.doi.org/10.1371/journal.pone.0051957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251663	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800118
J	Woodman, ME; Worth, RG; Wooten, RM				Woodman, Michael E.; Worth, Randall G.; Wooten, R. Mark			Capsule Influences the Deposition of Critical Complement C3 Levels Required for the Killing of Burkholderia pseudomallei via NADPH-Oxidase Induction by Human Neutrophils	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTRACELLULAR LIFE-CYCLE; FEBRILE NEUTROPENIA; SERUM RESISTANCE; SECRETION SYSTEM; MURINE MODEL; MELIOIDOSIS; INFECTION; THAILANDENSIS; PHAGOCYTOSIS	Burkholderia pseudomallei is the causative agent of melioidosis and is a major mediator of sepsis in its endemic areas. Because of the low LD50 via aerosols and resistance to multiple antibiotics, it is considered a Tier 1 select agent by the CDC and APHIS. B. pseudomallei is an encapsulated bacterium that can infect, multiply, and persist within a variety of host cell types. In vivo studies suggest that macrophages and neutrophils are important for controlling B. pseudomallei infections, however few details are known regarding how neutrophils respond to these bacteria. Our goal is to describe the capacity of human neutrophils to control highly virulent B. pseudomallei compared to the relatively avirulent, acapsular B. thailandensis using in vitro analyses. B. thailandensis was more readily phagocytosed than B. pseudomallei, but both displayed similar rates of persistence within neutrophils, indicating they possess similar inherent abilities to escape neutrophil clearance. Serum opsonization studies showed that both were resistant to direct killing by complement, although B. thailandensis acquired significantly more C3 on its surface than B. pseudomallei, whose polysaccharide capsule significantly decreased the levels of complement deposition on the bacterial surface. Both Burkholderia species showed significantly enhanced uptake and killing by neutrophils after critical levels of C3 were deposited. Serum-opsonized Burkholderia induced a significant respiratory burst by neutrophils compared to unopsonized bacteria, and neutrophil killing was prevented by inhibiting NADPH-oxidase. In summary, neutrophils can efficiently kill B. pseudomallei and B. thailandensis that possess a critical threshold of complement deposition, and the relative differences in their ability to resist surface opsonization may contribute to the distinct virulence phenotypes observed in vivo.	[Woodman, Michael E.; Worth, Randall G.; Wooten, R. Mark] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Wooten, RM (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	R.Mark.Wooten@utoledo.edu	Wooten, Ronald Mark/AAO-4263-2020	Worth, Randall/0000-0002-2626-7964	American Heart Association Postdoctoral Fellowship [11POST7320010]; Public Health Service from National Institute of Allergy and Infectious Disease [R01-AI073452, U01-AI077764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452, U01AI077764] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); Public Health Service from National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Heart Association Postdoctoral Fellowship 11POST7320010 (MEW), Public Health Service grant R01-AI073452 (RMW) from the National Institute of Allergy and Infectious Disease, and Public Health Service grant U01-AI077764 (RMW) from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 2003, FEMS MICROBIOL LETT, V218, P323, DOI 10.1111/j.1574-6968.2003.tb11536.x; Brett PJ, 2000, ACTA TROP, V74, P201, DOI 10.1016/S0001-706X(99)00071-6; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Charoensap J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-20; Cheng AC, 2004, EUR J CLIN MICROBIOL, V23, P205, DOI 10.1007/s10096-003-1088-y; Cheng AC, 2004, CLIN INFECT DIS, V38, P32, DOI 10.1086/380456; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2007, CLIN INFECT DIS, V45, P308, DOI 10.1086/519261; Christenson Bernard, 2003, Bol Asoc Med P R, V95, P17; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Corbett D, 2009, F1000 BIOL REP, V1, P1; Corral DM, 2008, CAN RESPIR J, V15, P237, DOI 10.1155/2008/290412; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2005, EMERG INF DIS 21ST C, P99; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dorman SE, 1998, CLIN INFECT DIS, V26, P889, DOI 10.1086/513928; DREVETS DA, 1994, INFECT IMMUN, V62, P2222, DOI 10.1128/IAI.62.6.2222-2228.1994; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Egan AM, 1996, INFECT IMMUN, V64, P4952, DOI 10.1128/IAI.64.12.4952-4959.1996; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; FESAP, 2011, REC SEL AG PROGR; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Harley VS, 1998, MICROBIOS, V94, P35; Healey T, 2001, INTERN MED J, V31, P406, DOI 10.1046/j.1445-5994.2001.00095.x; Heiss C, 2012, CARBOHYD RES, V349, P90, DOI 10.1016/j.carres.2011.12.011; Inglis TJJ, 2006, AM J TROP MED HYG, V75, P947, DOI 10.4269/ajtmh.2006.75.947; ISMAIL G, 1988, MICROBIOL IMMUNOL, V32, P645, DOI 10.1111/j.1348-0421.1988.tb01426.x; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Laws TR, 2011, MICROB PATHOGENESIS, V51, P471, DOI 10.1016/j.micpath.2011.07.002; Leelarasamee A, 2000, ACTA TROP, V74, P129, DOI 10.1016/S0001-706X(99)00061-3; Mandell GL, 2005, PHARMACOTHERAPY, V25, p130S, DOI 10.1592/phco.2005.25.12part2.130S; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Merino S, 2010, ENCY LIFE SCI, P1; Miralles Iracema Sampaio, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P51, DOI 10.1590/S0036-46652004000100011; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Mukhopadhyay C, 2010, TROP DOCT, V40, P165, DOI 10.1258/td.2010.090461; NAGHIBI M, 1987, DIABETES RES CLIN PR, V4, P27, DOI 10.1016/S0168-8227(87)80030-X; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Ngugi SA, 2010, VACCINE, V28, P7551, DOI 10.1016/j.vaccine.2010.08.058; PARRY MF, 1981, ANN INTERN MED, V95, P293, DOI 10.7326/0003-4819-95-3-293; Perez JM, 1997, CLIN INFECT DIS, V25, P164, DOI 10.1086/516896; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Powell K, 2003, FEMS MICROBIOL LETT, V224, P315, DOI 10.1016/S0378-1097(03)00473-7; PROKESCH RC, 1982, ANTIMICROB AGENTS CH, V21, P373, DOI 10.1128/AAC.21.3.373; RAZAK N, 1982, J GEN APPL MICROBIOL, V28, P509, DOI 10.2323/jgam.28.509; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Riyapa D, 2012, INFECT IMMU IN PRESS; ROBERTS IS, 1989, BIOCHEM SOC T, V17, P462, DOI 10.1042/bst0170462; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; SCHLESINGER LS, 1994, INFECT IMMUN, V62, P280, DOI 10.1128/IAI.62.1.280-289.1994; Sim SH, 2011, INT J ANTIMICROB AG, V38, P270, DOI 10.1016/j.ijantimicag.2011.06.002; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stephens DP, 2002, INTERN MED J, V32, P143, DOI 10.1046/j.1445-5994.2002.00195.x; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; Titball RW, 2008, T R SOC TROP MED HYG, V102; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VANDENBROEK PJ, 1989, REV INFECT DIS, V11, P213; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Warawa JM, 2009, INFECT IMMUN, V77, P5252, DOI 10.1128/IAI.00824-09; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120	100	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52276	10.1371/journal.pone.0052276	http://dx.doi.org/10.1371/journal.pone.0052276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251706	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800158
J	Marques-Vidal, P; Schmid, R; Bochud, M; Bastardot, F; von Kanel, R; Paccaud, F; Glaus, J; Preisig, M; Waeber, G; Vollenweider, P				Marques-Vidal, Pedro; Schmid, Remy; Bochud, Murielle; Bastardot, Francois; von Kaenel, Roland; Paccaud, Fred; Glaus, Jennifer; Preisig, Martin; Waeber, Gerard; Vollenweider, Peter			Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; GAMMA-GLUTAMYL-TRANSFERASE; RISK PREDICTION; INCREMENTAL VALUE; CLINICAL UTILITY; POPULATION; ADIPONECTIN; MELLITUS; MARKERS	Context: There is contradictory information regarding the prognostic importance of adipocytokines, hepatic and inflammatory biomarkers on the incidence of type 2 diabetes. The objective was to assess the prognostic relevance of adipocytokine and inflammatory markers (C-reactive protein - CRP; interleukin-1beta - IL-1 beta; interleukin-6- IL-6; tumour necrosis factor-alpha - TNF-alpha; leptin and adiponectin) and gamma-glutamyl transpeptidase (gamma GT) on the incidence of type 2 diabetes. Methods: Prospective, population-based study including 3,842 non-diabetic participants (43.3% men, age range 35 to 75 years), followed for an average of 5.5 years (2003-2008). The endpoint was the occurrence of type 2 diabetes. Results: 208 participants (5.4%, 66 women) developed type 2 diabetes during follow-up. On univariate analysis, participants who developed type 2 diabetes had significantly higher baseline levels of IL-6, CRP, leptin and gamma GT, and lower levels of adiponectin than participants who remained free of type 2 diabetes. After adjusting for a validated type 2 diabetes risk score, only the associations with adiponectin: Odds Ratio and (95% confidence interval): 0.97 (0.64-1.47), 0.84 (0.55-1.30) and 0.64 (0.40-1.03) for the second, third and forth gender-specific quartiles respectively, remained significant (P-value for trend = 0.05). Adding each marker to a validated type 2 diabetes risk score (including age, family history of type 2 diabetes, height, waist circumference, resting heart rate, presence of hypertension, HDL cholesterol, triglycerides, fasting glucose and serum uric acid) did not improve the area under the ROC or the net reclassification index; similar findings were obtained when the markers were combined, when the markers were used as continuous (log-transformed) variables or when gender-specific quartiles were used. Conclusion: Decreased adiponectin levels are associated with an increased risk for incident type 2 diabetes, but they seem to add little information regarding the risk of developing type 2 diabetes to a validated risk score.	[Marques-Vidal, Pedro; Schmid, Remy; Bochud, Murielle; Paccaud, Fred] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Bastardot, Francois; Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Bastardot, Francois; Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland; [von Kaenel, Roland] Univ Bern, Inselspital, Univ Hosp Bern, Div Psychosomat Med, CH-3010 Bern, Switzerland; [von Kaenel, Roland] Univ Bern, Bern, Switzerland; [Glaus, Jennifer; Preisig, Martin] CHU Vaudois, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Glaus, Jennifer/C-7887-2017; Colaus, PsyColaus/K-6607-2013; paccaud, fred/M-7516-2019; Bastardot, Francois/J-4013-2017; Bastardot, François/P-7809-2019; von Känel, Roland/B-1811-2019; Bochud, Murielle/A-3981-2010	Marques-Vidal, Pedro M/0000-0002-4548-8500; Glaus, Jennifer/0000-0001-8883-9473; Bastardot, Francois/0000-0003-4060-0353; Bastardot, François/0000-0003-4060-0353; von Känel, Roland/0000-0002-8929-5129; Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; Preisig, Martin/0000-0001-5689-4259	Swiss National Science Foundation [33CSCO-122661]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661) from GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. Murielle Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Aromaa, 2008, REV HLTH EXAMINATION; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Choi KM, 2004, DIABETES RES CLIN PR, V64, P99, DOI 10.1016/j.diabres.2003.10.007; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cook NR, 2012, AM J EPIDEMIOL, V176, P488, DOI 10.1093/aje/kws208; deGoma EM, 2012, ATHEROSCLEROSIS, V224, P274, DOI 10.1016/j.atherosclerosis.2012.07.017; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gautier A, 2010, DIABETOLOGIA, V53, P247, DOI 10.1007/s00125-009-1602-6; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hsiao JY, 2007, PANCREAS, V35, P343, DOI 10.1097/mpa.0b013e31811f44fd; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Kanaya AM, 2006, ARCH INTERN MED, V166, P350, DOI 10.1001/archinte.166.3.350; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Loomba R, 2012, HEPATOLOGY; Marques-Vidal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021002; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Montonen J, 2011, EUR J EPIDEMIOL, V26, P29, DOI 10.1007/s10654-010-9539-0; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Ong KL, 2011, DIABETOLOGIA, V54, P2552, DOI 10.1007/s00125-011-2227-0; Oriol-Zerbe Christina, 2007, Eur J Gen Pract, V13, P27, DOI 10.1080/13814780601050541; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Schmid R, 2012, ARCH INTERN MED, V172, P188, DOI 10.1001/archinte.172.2.188; Schmid R, 2011, DIABETES CARE, V34, P1863, DOI 10.2337/dc11-0206; Schmidt MI, 2006, DIABETOLOGIA, V49, P2086, DOI 10.1007/s00125-006-0351-z; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Skeppholm M, 2008, CLIN CHEM LAB MED, V46, P1175, DOI 10.1515/CCLM.2008.219; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Tabak AG, 2009, HORM METAB RES, V41, P626, DOI 10.1055/s-0029-1216359; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; von Kanel R, 2010, NEUROIMMUNOMODULAT, V17, P39, DOI 10.1159/000243084; Wacholder S, 2012, AM J EPIDEMIOL, V176, P495, DOI 10.1093/aje/kws255; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	54	50	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51768	10.1371/journal.pone.0051768	http://dx.doi.org/10.1371/journal.pone.0051768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251619	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200164
J	Nakamura, S; Grigoriev, I; Nogi, T; Hamaji, T; Cassimeris, L; Mimori-Kiyosue, Y				Nakamura, Satoko; Grigoriev, Ilya; Nogi, Taisaku; Hamaji, Tomoko; Cassimeris, Lynne; Mimori-Kiyosue, Yuko			Dissecting the Nanoscale Distributions and Functions of Microtubule-End-Binding Proteins EB1 and ch-TOG in Interphase HeLa Cells	PLOS ONE			English	Article							STRUCTURED ILLUMINATION MICROSCOPY; XENOPUS EGG EXTRACTS; PLUS-END; IN-VITRO; TRACKING PROTEINS; MINI SPINDLES; DYNAMICS; XMAP215; APC; DROSOPHILA	Recently, the EB1 and XMAP215/TOG families of microtubule binding proteins have been demonstrated to bind autonomously to the growing plus ends of microtubules and regulate their behaviour in in vitro systems. However, their functional redundancy or difference in cells remains obscure. Here, we compared the nanoscale distributions of EB1 and ch-TOG along microtubules using high-resolution microscopy techniques, and also their roles in microtubule organisation in interphase HeLa cells. The ch-TOG accumulation sites protruded similar to 100 nm from the EB1 comets. Overexpression experiments showed that ch-TOG and EB1 did not interfere with each other's localisation, confirming that they recognise distinct regions at the ends of microtubules. While both EB1 and ch-TOG showed similar effects on microtubule plus end dynamics and additively increased microtubule dynamicity, only EB1 exhibited microtubule-cell cortex attachment activity. These observations indicate that EB1 and ch-TOG regulate microtubule organisation differently via distinct regions in the plus ends of microtubules.	[Nakamura, Satoko; Nogi, Taisaku; Hamaji, Tomoko; Mimori-Kiyosue, Yuko] RIKEN, Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo, Japan; [Grigoriev, Ilya] Univ Utrecht, Div Cell Biol, Fac Sci, Utrecht, Netherlands; [Cassimeris, Lynne] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	RIKEN; Utrecht University; Lehigh University	Mimori-Kiyosue, Y (corresponding author), RIKEN, Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo, Japan.	y-kiyosue@cdb.riken.jp	Nogi, Taisaku/F-4675-2017	Cassimeris, Lynne/0000-0003-1058-0734	Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program); Uehara Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants from the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, the JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program), and Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Behrens J, 2012, J BIOL CHEM; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bonfils C, 2007, J BIOL CHEM, V282, P5570, DOI 10.1074/jbc.M605641200; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cassimeris L, 2001, J CELL SCI, V114, P3025; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Charrasse S, 1998, J CELL SCI, V111, P1371; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Grigoriev I, 2010, METHOD CELL BIOL, V97, P91, DOI 10.1016/S0091-679X(10)97006-4; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hotta A, 2010, J CELL BIOL, V189, P901, DOI 10.1083/jcb.200910095; Jiang K, 2012, CURR BIOL; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; Mimori-Kiyosue Y, 2011, CYTOSKELETON, V68, P603, DOI 10.1002/cm.20540; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schaefer LH, 2004, J MICROSC-OXFORD, V216, P165, DOI 10.1111/j.0022-2720.2004.01411.x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108	56	38	38	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51442	10.1371/journal.pone.0051442	http://dx.doi.org/10.1371/journal.pone.0051442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251535	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200110
J	Corcoran, C; Rani, S; O'Brien, K; O'Neill, A; Prencipe, M; Sheikh, R; Webb, G; McDermott, R; Watson, W; Crown, J; O'Driscoll, L				Corcoran, Claire; Rani, Sweta; O'Brien, Keith; O'Neill, Amanda; Prencipe, Maria; Sheikh, Rizwan; Webb, Glenn; McDermott, Ray; Watson, William; Crown, John; O'Driscoll, Lorraine			Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes	PLOS ONE			English	Article							CELL-LINES; INTERCELLULAR COMMUNICATION; DOXORUBICIN; EXPRESSION; CARCINOMA; INVASION; PROTEIN; RNA; ESTABLISHMENT; MICROVESICLES	Background: Hormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may be transferred from cell-to-cell via microvesicles/exosomes. Here we aimed to investigate phenotypic changes associated with docetaxel-resistance in order to help determine the complexity of this problem and to assess the relevance of secreted exosomes in prostate cancer. Methodology/Principal Findings: Docetaxel-resistant variants of DU145 and 22Rv1 were established and characterised in terms of cross-resistance, morphology, proliferation, motility, invasion, anoikis, colony formation, exosomes secretion their and functional relevance. Preliminary analysis of exosomes from relevant serum specimens was also performed. Acquired docetaxel-resistance conferred cross-resistance to doxorubicin and induced alterations in motility, invasion, proliferation and anchorage-independent growth. Exosomes expelled from DU145 and 22Rv1 docetaxel-resistant variants (DU145RD and 22Rv1RD) conferred docetaxel-resistance to DU145, 22Rv1 and LNCap cells, which may be partly due to exosomal MDR-1/P-gp transfer. Exosomes from prostate cancer patients' sera induced increased cell proliferation and invasion, compared to exosomes from age-matched controls. Furthermore, exosomes from sera of patients undergoing a course of docetaxel treatment compared to matched exosomes from the same patients prior to commencing docetaxel treatment, when applied to both DU145 and 22Rv1 cells, showed a correlation between cellular response to docetaxel and patients' response to treatment with docetaxel. Conclusions/Significance: Our studies indicate the complex and multifaceted nature of docetaxel-resistance in prostate cancer. Furthermore, our in vitro observations and preliminary clinical studies indicate that exosomes may play an important role in prostate cancer, in cell-cell communication, and thus may offer potential as vehicles containing predictive biomarkers and new therapeutic targets.	[Corcoran, Claire; Rani, Sweta; O'Brien, Keith; Sheikh, Rizwan; O'Driscoll, Lorraine] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Corcoran, Claire; Rani, Sweta; O'Brien, Keith; Sheikh, Rizwan; O'Driscoll, Lorraine] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland; [O'Neill, Amanda; Prencipe, Maria; Watson, William] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland; [Webb, Glenn] All Ireland Cooperat Oncol Res Grp ICORG, Dublin, Ireland; [McDermott, Ray; Crown, John] ICORG, Dublin, Ireland; [McDermott, Ray] Adelaide & Meath Hosp, Natl Childrens Hosp AMNCH, Dublin, Ireland; [Crown, John] Mol Therapeut Canc Ireland MTCI, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin; All-Ireland Cooperative Oncology Research Group; All-Ireland Cooperative Oncology Research Group; Trinity College Dublin	O'Driscoll, L (corresponding author), Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.	lodrisc@tcd.ie	Crown, John/AAL-3367-2020; Webb, Glenn/AAW-7228-2021	Crown, John/0000-0002-3125-7613; O'Driscoll, Lorraine/0000-0002-9860-8262; McDermott, Ray/0000-0002-8952-4315; Rani, Sweta/0000-0003-0937-0094; Prencipe, Maria/0000-0002-8864-1560	Science Foundation Ireland of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland [08/SRC/B1410]; Trinity College Dublin	Science Foundation Ireland of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland(Science Foundation Ireland); Trinity College Dublin	This research was supported by Science Foundation Ireland's funding of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland (08/SRC/B1410) to JC, WW, LOD; funding, to LOD, to support KOB as a Marie Keating Foundation Scholarship at Trinity College Dublin; and infrastructure and core facility support through Ireland's HEA's Programme for Research in Third Level Institutes (PRTLI) Cycle 5 to LOD among other TCD PIs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Andre F, 2004, ANN ONCOL, V15, P141, DOI 10.1093/annonc/mdh918; BASHIR I, 1994, INT J CANCER, V57, P719, DOI 10.1002/ijc.2910570519; Bhangal G, 2000, UROL ONCOL, V5, P118, DOI 10.1016/S1078-1439(99)00055-1; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; David-Beabes GL, 2000, INT J ONCOL, V17, P1077; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gabai VL, 2005, ONCOGENE, V24, P3328, DOI 10.1038/sj.onc.1208495; Germano S, 2012, INT J CANCER, V130, P1991, DOI 10.1002/ijc.26200; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Guo XX, 2008, ANTICANCER RES, V28, P9; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu B, 2001, J SURG RES, V99, P179, DOI 10.1006/jsre.2001.6126; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; O'Driscoll L, 2002, ANTICANCER RES, V22, P3117; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Rani S, 2011, METHODS MOL BIOL, V784, P181, DOI 10.1007/978-1-61779-289-2_13; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Shtanko O, 2011, J VIROL, V85, P3631, DOI 10.1128/JVI.01984-10; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Takeda M, 2007, PROSTATE, V67, P955, DOI 10.1002/pros.20581; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yu DH, 1998, ONCOGENE, V16, P2087, DOI 10.1038/sj.onc.1201729; Zhang F, 2011, ASIAN PAC J CANCER P, V12, P239	36	306	319	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50999	10.1371/journal.pone.0050999	http://dx.doi.org/10.1371/journal.pone.0050999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251413	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900031
J	Chechenova, MB; Bryantsev, AL; Cripps, RM				Chechenova, Maria B.; Bryantsev, Anton L.; Cripps, Richard M.			The Drosophila Z-disc Protein Z(210) Is an Adult Muscle Isoform of Zasp52, Which Is Required for Normal Myofibril Organization in Indirect Flight Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCULAR-DYSTROPHY; CYPHER; PDZ; EXPRESSION; MUTATIONS; MEMBER; MOTIF; FORM	The Z-disc is a critical anchoring point for thin filaments as they slide during muscle contraction. Therefore, identifying components of the Z-disc is critical for fully comprehending how myofibrils assemble and function. In the adult Drosophila musculature, the fibrillar indirect flight muscles accumulate a > 200 kDa Z-disc protein termed Z(210), the identity of which has to date been unknown. Here, we use mass spectrometry and gene specific knockdown studies, to identify Z(210) as an adult isoform of the Z-disc protein Zasp52. The Zasp52 primary transcript is extensively alternatively spliced, and we describe its splicing pattern in the flight muscles, identifying a new Zasp52 isoform, which is the one recognized by the Z(210) antibody. We also demonstrate that Zasp52 is required for the association of alpha-actinin with the flight muscle Z-disc, and for normal sarcomere structure. These studies expand our knowledge of Zasp isoforms and their functions in muscle. Given the role of Zasp proteins in mammalian muscle development and disease, our results have relevance to mammalian muscle biology.	[Chechenova, Maria B.; Bryantsev, Anton L.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu		Bryantsev, Anton/0000-0003-2775-7110	University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; National Institutes of Health from the Institute Development Award (IDeA) Program of the National Center for Research Resources [1P20RR18754]; National Institutes of Health [GM061738]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061738] Funding Source: NIH RePORTER	University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; National Institutes of Health from the Institute Development Award (IDeA) Program of the National Center for Research Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Judith Saide for the anti-Z(210) antibody and Dr. Kathleen Clark for anti-Mlp84B. Confocal images were generated in the University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on hsc.unm.edu/crtc/microscopy/acknowledgment.shtml. We acknowledge technical support from the Dept. of Biology's Molecular Biology Facility, supported by National Institutes of Health Grant Number 1P20RR18754 from the Institute Development Award (IDeA) Program of the National Center for Research Resources.; This work was supported, in whole or in part, by Grant GM061738 (to R. M. C.) from the National Institutes of Health.	Anant S, 1998, DEVELOPMENT, V125, P1361; [Anonymous], 2009, SKELETAL MUSCLE STRU; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; Bonnemann CG, 2004, CURR OPIN NEUROL, V17, P529; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Champagne MB, 2000, J MOL BIOL, V300, P759, DOI 10.1006/jmbi.2000.3802; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; CRIPPS RM, 1992, BIOCHEM GENET, V30, P159, DOI 10.1007/BF02399706; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Morriss GR, 2012, METHODS MOL BIOL, V798, P127, DOI 10.1007/978-1-61779-343-1_8; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; Patel SR, 2005, J MUSCLE RES CELL M, V26, P213, DOI 10.1007/s10974-005-9012-y; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; SAIDE JD, 1989, J CELL BIOL, V109, P2157, DOI 10.1083/jcb.109.5.2157; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Stronach BE, 1999, MOL BIOL CELL, V10, P2329, DOI 10.1091/mbc.10.7.2329; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; VIGOREAUX JO, 1991, J MUSCLE RES CELL M, V12, P340, DOI 10.1007/BF01738589; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	29	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3718	3726		10.1074/jbc.M112.401794	http://dx.doi.org/10.1074/jbc.M112.401794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271733	Green Published, hybrid			2022-12-25	WOS:000314845000004
J	Sinha, C; Ren, AX; Arora, K; Moon, CS; Yarlagadda, S; Zhang, WQ; Cheepala, SB; Schuetz, JD; Naren, AP				Sinha, Chandrima; Ren, Aixia; Arora, Kavisha; Moon, Chang-Suk; Yarlagadda, Sunitha; Zhang, Weiqiang; Cheepala, Satish B.; Schuetz, John D.; Naren, Anjaparavanda P.			Multi-drug Resistance Protein 4 (MRP4)-mediated Regulation of Fibroblast Cell Migration Reflects a Dichotomous Role of Intracellular Cyclic Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP; MRP4; ACTIVATION; KINASE; TRANSPORTER; INHIBITION; ADHESION; CFTR	It has long been known that cyclic nucleotides and cyclic nucleotide-dependent signaling molecules control cell migration. However, the concept that it is not just the absence or presence of cyclic nucleotides, but a highly coordinated balance between these molecules that regulates cell migration, is new and revolutionary. In this study, we used multidrug resistance protein 4 (MRP4)-expressing cell lines and MRP4 knock-out mice as model systems and wound healing assays as the experimental system to explore this unique and emerging concept. MRP4, a member of a large family of ATP binding cassette transporter proteins, localizes to the plasma membrane and functions as a nucleotide efflux transporter and thus plays a role in the regulation of intracellular cyclic nucleotide levels. Here, we demonstrate that mouse embryonic fibroblasts (MEFs) isolated from Mrp4(-/-) mice have higher intracellular cyclic nucleotide levels and migrate faster compared with MEFs from Mrp4(-/-) mice. Using FRET-based cAMP and cGMP sensors, we show that inhibition of MRP4 with MK571 increases both cAMP and cGMP levels, which results in increased migration. In contrast to these moderate increases in cAMP and cGMP levels seen in the absence of MRP4, a robust increase in cAMP levels was observed following treatment with forskolin and isobutylmethylxanthine, which decreases fibroblast migration. In response to externally added cell-permeant cyclic nucleotides (cpt-cAMP and cpt-cGMP), MEF migration appears to be biphasic. Altogether, our studies provide the first experimental evidence supporting the novel concept that balance between cyclic nucleotides is critical for cell migration.	[Sinha, Chandrima; Ren, Aixia; Arora, Kavisha; Moon, Chang-Suk; Yarlagadda, Sunitha; Zhang, Weiqiang; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Cheepala, Satish B.; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Naren, AP (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave,426 Nash Res Bldg, Memphis, TN 38163 USA.	anaren@uthsc.edu	Schuetz, John D/N-2692-2018		National Institutes of Health [RO1-DK080834, RO1-DK093045, RO1-GM60904]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, R01DK080834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK080834, RO1-DK093045 (to A.P.N.), and RO1-GM60904 (to J.D.S).	Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; ELFERINK JGR, 1993, EUR J PHARM-MOLEC PH, V246, P157, DOI 10.1016/0922-4106(93)90093-O; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; Ghosh MC, 2012, AM J PHYSIOL-LUNG C, V302, pL846, DOI 10.1152/ajplung.00321.2011; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kopecki Z, 2009, J INVEST DERMATOL, V129, P2031, DOI 10.1038/jid.2008.461; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Liu LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-154; Mazzalupo S, 2002, J INVEST DERMATOL, V118, P866, DOI 10.1046/j.1523-1747.2002.01736.x; Negash S, 2009, AM J PHYSIOL-HEART C, V297, pH304, DOI 10.1152/ajpheart.00077.2008; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Sellers ZM, 2012, EUR J PHARMACOL, V681, P80, DOI 10.1016/j.ejphar.2012.02.018; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tagami M, 2010, BIOCHEM BIOPH RES CO, V400, P593, DOI 10.1016/j.bbrc.2010.08.109; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850	32	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3786	3794		10.1074/jbc.M112.435925	http://dx.doi.org/10.1074/jbc.M112.435925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264633	Green Published, hybrid			2022-12-25	WOS:000314845000010
J	Vellano, CP; Brown, NE; Blumer, JB; Hepler, JR				Vellano, Christopher P.; Brown, Nicole E.; Blumer, Joe B.; Hepler, John R.			Assembly and Function of the Regulator of G protein Signaling 14 (RGS14)center dot H-Ras Signaling Complex in Live Cells Are Regulated by G alpha(i1) and G alpha(i)-linked G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; AIRWAY SMOOTH-MUSCLE; SYNAPTIC PLASTICITY; EXPRESSION ANALYSIS; SURFACE EXPRESSION; EGF RECEPTOR; H-RAS; RGS14; ALPHA; ACTIVATION	Regulator of G protein signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates heterotrimeric G protein and H-Ras signaling pathways. RGS14 possesses an RGS domain that binds active G alpha(i/o)-GTP subunits to promote GTP hydrolysis and a G protein regulatory (GPR) motif that selectively binds inactive G alpha(i1/3)-GDP subunits to form a stable heterodimer at cellular membranes. RGS14 also contains two tandem Ras/Rap binding domains (RBDs) that bind H-Ras. Here we show that RGS14 preferentially binds activated H-Ras-GTP in live cells to enhance H-Ras cellular actions and that this interaction is regulated by inactive G alpha(i1)-GDP and Gprotein-coupled receptors (GPCRs). Using bioluminescence resonance energy transfer (BRET) in live cells, we show that RGS14-Luciferase and active H-Ras(G/V)-Venus exhibit a robust BRET signal at the plasma membrane that is markedly enhanced in the presence of inactive G alpha(i1)-GDP but not active G alpha(i1)-GTP. Active H-Ras(G/V) interacts with a native RGS14.G alpha(i1) complex in brain lysates, and co-expression of RGS14 and G alpha(i1) in PC12 cells greatly enhances H-Ras(G/V) stimulatory effects on neurite outgrowth. Stimulation of the G alpha(i)-linked alpha(2A)-adrenergic receptor induces a conformational change in the G alpha(i1).RGS14.H-Ras(G/V) complex that may allow subsequent regulation of the complex by other binding partners. Together, these findings indicate that inactive G alpha(i1)-GDP enhances the affinity of RGS14 for H-Ras-GTP in live cells, resulting in a ternary signaling complex that is further regulated by GPCRs.	[Vellano, Christopher P.; Brown, Nicole E.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Emory University; Medical University of South Carolina	Hepler, JR (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr G206, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jhepler@emory.edu		Blumer, Joe/0000-0002-0020-3815; Brown, Nicole/0000-0002-3184-0550	National Institutes of Health [R01NS049195, R01NS037112, GM086510]; Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R01NS049195, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant; PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049195 and R01NS037112 (to J. R. H.) and GM086510 (to J. B. B.) and by Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077. This work was also supported by a PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship (to C. P. V).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Conway AM, 1999, BIOCHEM J, V337, P171, DOI 10.1042/0264-6021:3370171; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; DUZIC E, 1992, J BIOL CHEM, V267, P9844; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Khafizov K, 2009, J MOL MODEL, V15, P1491, DOI 10.1007/s00894-009-0516-z; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Manabe T, 2000, J NEUROSCI, V20, P2504; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rakhit S, 2000, MOL PHARMACOL, V58, P413, DOI 10.1124/mol.58.2.413; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Tonissoo T, 2003, GENE EXPR PATTERNS, V3, P591, DOI 10.1016/S1567-133X(03)00119-4; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	59	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3620	3631		10.1074/jbc.M112.440057	http://dx.doi.org/10.1074/jbc.M112.440057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250758	Green Published, hybrid			2022-12-25	WOS:000314397900066
J	Momma, K; Noguchi, S; Malicdan, MCV; Hayashi, YK; Minami, N; Kamakura, K; Nonaka, I; Nishino, I				Momma, Kazunari; Noguchi, Satoru; Malicdan, May Christine V.; Hayashi, Yukiko K.; Minami, Narihiro; Kamakura, Keiko; Nonaka, Ikuya; Nishino, Ichizo			Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies	PLOS ONE			English	Article							LINKED DILATED CARDIOMYOPATHY; OXIDATIVE STRESS; DISTAL MYOPATHY; MOLECULAR-BASIS; BODY MYOSITIS; DUCHENNE; DELETION; PATHOGENESIS; AUTOPHAGY; MUTATIONS	Rimmed vacuoles in myofibers are thought to be due to the accumulation of autophagic vacuoles, and can be characteristic in certain myopathies with protein inclusions in myofibers. In this study, we performed a detailed clinical, molecular, and pathological characterization of Becker muscular dystrophy patients who have rimmed vacuoles in muscles. Among 65 Becker muscular dystrophy patients, we identified 12 patients who have rimmed vacuoles and 11 patients who have deletions in exons 45-48 in DMD gene. All patients having rimmed vacuoles showed milder clinical features compared to those without rimmed vacuoles. Interestingly, the rimmed vacuoles in Becker muscular dystrophy muscles seem to represent autophagic vacuoles and are also associated with polyubiquitinated protein aggregates. These findings support the notion that rimmed vacuoles can appear in Becker muscular dystrophy, and may be related to the chronic changes in muscle pathology induced by certain mutations in the DMD gene. Citation: Momma K, Noguchi S, Malicdan MCV, Hayashi YK, Minami N, et al. (2012) Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies. PLoS ONE 7(12): e52002. doi: 10.1371/journal.pone.0052002	[Momma, Kazunari; Noguchi, Satoru; Malicdan, May Christine V.; Hayashi, Yukiko K.; Minami, Narihiro; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Momma, Kazunari; Kamakura, Keiko] Natl Def Med Coll, Dept Neurol, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; National Defense Medical College - Japan	Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.	noguchi@ncnp.go.jp	Malicdan, May Christine/F-2806-2013; Nishino, Ichizo/G-2676-2010; Malicdan, May Christine/AAK-7422-2021	Nishino, Ichizo/0000-0001-9452-112X; 	Japan Society for the Promotion of Science KAKENHI Grant [23390236]; Welfare and Comprehensive Research on Disability Health and Welfare; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry [22-5]; Research on rare and intractable diseases from the Ministry of Health and Labour; US National Institute of Child Health and Human Development (NICHD)	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Welfare and Comprehensive Research on Disability Health and Welfare; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry; Research on rare and intractable diseases from the Ministry of Health and Labour; US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23390236 and by Welfare and Comprehensive Research on Disability Health and Welfare and by Intramural Research Grant (22-5) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry, Research on rare and intractable diseases from the Ministry of Health and Labour. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the attending physicians, patients, and their families for their participation in this study. The authors also thank Ms. Kazu Iwasawa, Ms. Kaoru Tatezawa, Ms. Megumu, Ogawa, Dr. Nobuhiro Morone, and Ms. Kanako Goto (National Institute of Neuroscience, NCNP) for their technical assistance. The monoclonal antibody (H4A3) developed by J. T. August and James E.K. Hildreth was obtained from the Development Studies Hybridoma Bank (DSHB) developed under the auspices of the US National Institute of Child Health and Human Development (NICHD) and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242, USA.	Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Broccolini A, 2009, MUSCLE NERVE, V40, P340, DOI 10.1002/mus.21385; Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; DenDunnen JT, 2006, CURR PROTOC HUM GENE; DEVISSER M, 1990, ANN NEUROL, V27, P578, DOI 10.1002/ana.410270521; Ferlini A, 1999, NEUROMUSCULAR DISORD, V9, P339, DOI 10.1016/S0960-8966(99)00015-2; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lawler JM, 2011, J PHYSIOL-LONDON, V589, P2161, DOI 10.1113/jphysiol.2011.207456; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Malicdan MCV, 2008, CURR OPIN NEUROL, V21, P596, DOI 10.1097/WCO.0b013e32830dd595; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; Raben N, 2007, AUTOPHAGY, V3, P546, DOI 10.4161/auto.4591; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Sugie K, 2005, J NEUROPATH EXP NEUR, V64, P513, DOI 10.1093/jnen/64.6.513; TAKEMITSU M, 1993, ACTA NEUROPATHOL, V85, P256; Tasaki N, 2001, INTERNAL MED, V40, P1215, DOI 10.2169/internalmedicine.40.1215; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Yazaki M, 1999, EUR NEUROL, V42, P145, DOI 10.1159/000008089	28	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52002	10.1371/journal.pone.0052002	http://dx.doi.org/10.1371/journal.pone.0052002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251671	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800126
J	Podgorski, K; Terpetschnig, E; Klochko, OP; Obukhova, OM; Haas, K				Podgorski, Kaspar; Terpetschnig, Ewald; Klochko, Oleksii P.; Obukhova, Olena M.; Haas, Kurt			Ultra-Bright and -Stable Red and Near-Infrared Squaraine Fluorophores for In Vivo Two-Photon Imaging	PLOS ONE			English	Article							SINGLE-CELL ELECTROPORATION; QUANTUM DOTS; MOLECULES; DYES	Fluorescent dyes that are bright, stable, small, and biocompatible are needed for high-sensitivity two-photon imaging, but the combination of these traits has been elusive. We identified a class of squaraine derivatives with large two-photon action cross-sections (up to 10,000 GM) at near-infrared wavelengths critical for in vivo imaging. We demonstrate the biocompatibility and stability of a red-emitting squaraine-rotaxane (SeTau-647) by imaging dye-filled neurons in vivo over 5 days, and utility for sensitive subcellular imaging by synthesizing a specific peptide-conjugate label for the synaptic protein PSD-95.	[Podgorski, Kaspar; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Podgorski, Kaspar; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Terpetschnig, Ewald] SETA BioMed, Urbana, IL USA; [Klochko, Oleksii P.; Obukhova, Olena M.] Natl Acad Sci Ukraine, State Sci Inst, Inst Single Crystals, Kharkov, Ukraine	University of British Columbia; University of British Columbia; National Academy of Sciences Ukraine; Institute for Scintillation Materials of the National Academy of Sciences of Ukraine	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Obukhova, Olena/0000-0002-5961-3202	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya EU, 1997, TETRAHEDRON LETT, V38, P4513, DOI 10.1016/S0040-4039(97)00917-9; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Arunkumar E, 2005, J AM CHEM SOC, V127, P3288, DOI 10.1021/ja042404n; Bakalova R, 2011, INT J NANOMED, V6, P1719, DOI 10.2147/IJN.S17995; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Chung SJ, 2006, J AM CHEM SOC, V128, P14444, DOI 10.1021/ja065556m; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DICK B, 1982, J CHEM PHYS, V76, P5755, DOI 10.1063/1.442971; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; LAW KY, 1993, CHEM REV, V93, P449, DOI 10.1021/cr00017a020; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Patsenker LD, 2011, BIOANAL REV, V3, P115, DOI DOI 10.1007/S12566-011-0025-2; Patsenker LD, 2010, SPRINGER SER FLUORES, V09, P159, DOI 10.1007/978-3-642-04701-5_5; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Povrozin YA, 2009, ANAL BIOCHEM, V390, P136, DOI 10.1016/j.ab.2009.03.047; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sharma SC, 2009, BIOPOLYMERS, V92, P183, DOI 10.1002/bip.21172; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Sreejith S, 2008, J MATER CHEM, V18, P264, DOI 10.1039/b707734c; TERPETSCHNIG E, 1994, ANAL BIOCHEM, V217, P197, DOI 10.1006/abio.1994.1109; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wei GD, 2011, NANO LETT, V11, P4261, DOI 10.1021/nl2022515; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	30	34	34	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51980	10.1371/journal.pone.0051980	http://dx.doi.org/10.1371/journal.pone.0051980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251670	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800125
J	Barash, U; Arvatz, G; Farfara, R; Naroditsky, I; Doweck, I; Feld, S; Ben-Izhak, O; Ilan, N; Nativ, O; Vlodavsky, I				Barash, Uri; Arvatz, Gil; Farfara, Roy; Naroditsky, Inna; Doweck, Ilana; Feld, Sari; Ben-Izhak, Ofer; Ilan, Neta; Nativ, Ofer; Vlodavsky, Israel			Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody	PLOS ONE			English	Article							MAMMALIAN HEPARANASE; TUMOR PROGRESSION; CANCER METASTASIS; EXPRESSION; LOCALIZATION; CLONING; ACTIVATION; RECEPTOR; HEAD; VEGF	T5 is a novel splice variant of heparanase, an endo-beta-D-glucuronidase capable of cleaving heparan sulfate side chains at a limited number of sites. T5 splice variant is endowed with pro-tumorigenic properties, enhancing cell proliferation, anchorage independent growth and tumor xenograft development despite lack of heparan sulfate-degrading activity typical of heparanase. T5 is over expressed in the majority of human renal cell carcinoma biopsies examined, suggesting that this splice variant is clinically relevant. T5 is thought to assume a distinct three-dimensional conformation compared with the wild type heparanase protein. We sought to exploit this presumed feature by generating monoclonal antibodies that will recognize the unique structure of T5 without, or with minimal recognition of heparanase, thus enabling more accurate assessment of the clinical relevance of T5. We provide evidence that such a monoclonal antibody, 9c9, preferentially recognizes T5 compared with heparanase by ELISA, immunoblotting and immunohistochemistry. In order to uncover the clinical significance of T5, a cohort of renal cell carcinoma specimens was subjected to immunostaining applying the 9c9 antibody. Notably, T5 staining intensity was significantly associated with tumor size (p = 0.004) and tumor grade (p = 0.02). Our results suggest that T5 is a functional, pro-tumorigenic entity.	[Barash, Uri; Arvatz, Gil; Feld, Sari; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel; [Farfara, Roy; Nativ, Ofer] Bnai Zion Med Ctr, Dept Urol, Haifa, Israel; [Naroditsky, Inna; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Dept Pathol, Haifa, Israel; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Rambam Health Care Campus; Clalit Health Services; Carmel Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel.	Vlodavsk@cc.huji.ac.il		Barash, Uri/0000-0003-1049-270X; Doweck, Ilana/0000-0002-1065-0299	Israel Science Foundation [593/10]; National Cancer Institute, National Institutes of Health [CA106456]; Israel Cancer Research Fund (ICRF); US-Israel Binational Science Foundation (BSF); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund (ICRF); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 593/10); National Cancer Institute, National Institutes of Health (grant CA106456); the Israel Cancer Research Fund (ICRF); the US-Israel Binational Science Foundation (BSF), and the Rappaport Family Institute Fund to I. Vlodavsky. I. Vlodavsky is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barash U, 2010, FASEB J, V24, P1239, DOI 10.1096/fj.09-147074; Bertolesi GE, 2011, DEV DYNAM, V240, P2657, DOI 10.1002/dvdy.22770; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Edge SB, 2010, AJCC CANC STAGING MA; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2007, FASEB J, V21, P3986, DOI 10.1096/fj.07-8866com; Haimov-Kochman R, 2002, MOL HUM REPROD, V8, P566, DOI 10.1093/molehr/8.6.566; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Mikami S, 2008, CLIN CANCER RES, V14, P6055, DOI 10.1158/1078-0432.CCR-08-0750; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Nasser NJ, 2007, BIOCHEM BIOPH RES CO, V354, P33, DOI 10.1016/j.bbrc.2006.12.189; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ren JC, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-158; Sato M, 2008, CELL BIOCHEM FUNCT, V26, P676, DOI 10.1002/cbf.1492; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weidle UH, 2011, CANCER GENOM PROTEOM, V8, P211; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51494	10.1371/journal.pone.0051494	http://dx.doi.org/10.1371/journal.pone.0051494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251556	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200123
J	Kanzaki, S; Fujioka, M; Yasuda, A; Shibata, S; Nakamura, M; Okano, HJ; Ogawa, K; Okano, H				Kanzaki, Sho; Fujioka, Masato; Yasuda, Akimasa; Shibata, Shinsuke; Nakamura, Masaya; Okano, Hirotaka James; Ogawa, Kaoru; Okano, Hideyuki			Novel In Vivo Imaging Analysis of an Inner Ear Drug Delivery System in Mice: Comparison of Inner Ear Drug Concentrations over Time after Transtympanic and Systemic Injections	PLOS ONE			English	Article							DEXAMETHASONE PHARMACOKINETICS	Objective: Systemic steroid injections are used to treat idiopathic sudden-onset sensorineural hearing loss (ISSHL) and some inner ear disorders. Recent studies show that transtympanic (TT) steroid injections are effective for treating ISSHL. As in vivo monitoring of drug delivery dynamics for inner ear is lacking, its time course and dispersion of drugs is unknown. Here, we used a new in vivo imaging system to monitor drug delivery in live mice and to compare drug concentrations over time after TT and systemic injections. Methods: Luciferin delivered into the inner ears of GFAP-Luc transgenic mice reacted with luciferase in GFAP-expressing cells in the cochlear spiral ganglion, resulting in photon bioluminescence. We used the Xenogen IVISH imaging system to measure how long photons continued to be emitted in the inner ear after TT or systemic injections of luciferin, and then compared the associated drug dynamics. Results: The response to TT and IP injections differed significantly. Photons were detected five minutes after TT injection, peaking at,20 minutes. By contrast, photons were first detected 30 minutes after i.p. injection. TT and i.p. drug delivery time differed considerably. With TT injections, photons were detected earlier than with IP injections. Photon bioluminescence also disappeared sooner. Delivery time varied with TT injections. Conclusions: We speculate that the drug might enter the Eustachian tube from the middle ear. We conclude that inner-ear drug concentration can be maintained longer if the two injection routes are combined. As the size of luciferin differs from that of therapeutics like dexamethasone, combining drugs with luciferin may advance our understanding of in vivo drug delivery dynamics in the inner ear.	[Kanzaki, Sho; Fujioka, Masato; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Yasuda, Akimasa; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped, Shinjuku Ku, Tokyo, Japan; [Shibata, Shinsuke; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan.	skan@a7.keio.jp	Okano, Hideyuki/I-7584-2019; Nakamura, Masaya/K-4111-2013; Kanzaki, Sho/B-3100-2014; Shibata, Shinsuke/AAM-6620-2020	Kanzaki, Sho/0000-0001-9056-0850; Fujioka, Masato/0000-0002-5317-0885; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Health, Labor and Welfare [KO 2011]; Ministry of Education, Culture, Sports, Science and Technology [KO 2012]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Health, Labor and Welfare (KO 2011) and by a grant from the Ministry of Education, Culture, Sports, Science and Technology (KO 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandrasekhar SS, 2000, OTOLARYNG HEAD NECK, V122, P521, DOI 10.1016/S0194-5998(00)70094-5; Hahn H, 2006, HEARING RES, V212, P236, DOI 10.1016/j.heares.2005.12.001; Iizuka T, 2008, HUM GENE THER, V19, P384, DOI 10.1089/hum.2007.167; Kanzaki S, 2012, AURIS NASUS LARYNX, V39, P208, DOI 10.1016/j.anl.2011.04.006; Liu HJ, 2006, ORL-J OTO-RHIN-LARYN, V68, P93, DOI 10.1159/000091210; Parnes LS, 1999, LARYNGOSCOPE, V109, P1, DOI 10.1097/00005537-199907001-00001; Rauch SD, 2011, JAMA-J AM MED ASSOC, V305, P2071, DOI 10.1001/jama.2011.679; Silverstein H, 1997, AM J OTOL, V18, P586; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020	10	18	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48480	10.1371/journal.pone.0048480	http://dx.doi.org/10.1371/journal.pone.0048480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251331	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200005
J	Naturil-Alfonso, C; Saenz-de-Juano, MD; Penaranda, DS; Vicente, JS; Marco-Jimenez, F				Naturil-Alfonso, Carmen; dels Desamparats Saenz-de-Juano, Maria; Penaranda, David S.; Vicente, Jose S.; Marco-Jimenez, Francisco			Transcriptome Profiling of Rabbit Parthenogenetic Blastocysts Developed under In Vivo Conditions	PLOS ONE			English	Article							VITRO CULTURE-CONDITIONS; GENE-EXPRESSION; BOVINE EMBRYOS; STEM-CELLS; MECHANISMS	Parthenogenetic embryos are one attractive alternative as a source of embryonic stem cells, although many aspects related to the biology of parthenogenetic embryos and parthenogenetically derived cell lines still need to be elucidated. The present work was conducted to investigate the gene expression profile of rabbit parthenote embryos cultured under in vivo conditions using microarray analysis. Transcriptomic profiles indicate 2541 differentially expressed genes between parthenotes and normal in vivo fertilised blastocysts, of which 76 genes were upregulated and 16 genes downregulated in in vivo cultured parthenote blastocyst, using 3 fold-changes as a cut-off. While differentially upregulated expressed genes are related to transport and protein metabolic process, downregulated expressed genes are related to DNA and RNA binding. Using microarray data, 6 imprinted genes were identified as conserved among rabbits, humans and mice: GRB10, ATP10A, ZNF215, NDN, IMPACT and SFMBT2. We also found that 26 putative genes have at least one member of that gene family imprinted in other species. These data strengthen the view that a large fraction of genes is differentially expressed between parthenogenetic and normal embryos cultured under the same conditions and offer a new approach to the identification of imprinted genes in rabbit.	[Naturil-Alfonso, Carmen; dels Desamparats Saenz-de-Juano, Maria; Penaranda, David S.; Vicente, Jose S.; Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Peñaranda, David Sanchez/L-3003-2014; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Peñaranda, David Sanchez/0000-0002-0861-976X; Saenz-de-Juano, Mara D./0000-0002-2860-2252; Vicente, Jose/0000-0003-0481-3802	Generalitat Valenciana research programme [Prometeo 2009/125]	Generalitat Valenciana research programme(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Generalitat Valenciana research programme (Prometeo 2009/125). Carmen Naturil was supported by Generalitat Valenciana research programme (Prometeo 2009/125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoon AS, 2012, THERIOGENOLOGY, V77, P1240, DOI 10.1016/j.theriogenology.2011.11.004; Besenfelder U, 1998, J VET MED A, V45, P577, DOI 10.1111/j.1439-0442.1998.tb00861.x; BilodeauGoeseels S, 1997, BIOL REPROD, V56, P1323, DOI 10.1095/biolreprod56.5.1323; Bischoff SR, 2009, BIOL REPROD, V81, P906, DOI 10.1095/biolreprod.109.078139; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Chen ZS, 2009, STEM CELLS, V27, P2136, DOI 10.1002/stem.158; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Cruz-Correa M, 2009, EPIGENETICS-US, V4, P114, DOI 10.4161/epi.4.2.7954; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Harness JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014499; Koh CJ, 2009, METHODS, V47, P90, DOI 10.1016/j.ymeth.2008.08.002; Labrecque R, 2011, REPROD FERT DEVELOP, V23, P591, DOI 10.1071/RD10243; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Llobat L, 2012, REPROD DOMEST ANIM, V47, P629, DOI 10.1111/j.1439-0531.2011.01934.x; Lonergan P, 2003, REPRODUCTION, V126, P337, DOI 10.1530/rep.0.1260337; Lu ZY, 2010, J ASSIST REPROD GEN, V27, P285, DOI 10.1007/s10815-010-9408-5; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Marco-Jimenez F, 2010, REPROD DOMEST ANIM, V45, pE118, DOI 10.1111/j.1439-0531.2009.01532.x; Mehaisen GMK, 2006, THERIOGENOLOGY, V65, P1279, DOI 10.1016/j.theriogenology.2005.08.007; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Naturil-Alfonso C, 2011, ANIM REPROD SCI, V127, P222, DOI 10.1016/j.anireprosci.2011.08.005; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Santos AN, 2004, REPRODUCTION, V128, P517, DOI 10.1530/rep.1.00204; Sritanaudomchai H, 2010, HUM REPROD, V25, P1927, DOI 10.1093/humrep/deq144; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Vrana KE, 2003, P NATL ACAD SCI USA, V100, P11911, DOI 10.1073/pnas.2034195100; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Weltzien FA, 2005, GEN COMP ENDOCR, V142, P134, DOI 10.1016/j.ygcen.2004.12.019	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51271	10.1371/journal.pone.0051271	http://dx.doi.org/10.1371/journal.pone.0051271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251477	Green Published, gold			2022-12-25	WOS:000313236200080
J	Wang, LM; Jia, C; Yu, ZY; Liu, XL; Kang, LP; Cong, Y; Shan, YJ; Zhao, ZH; Ma, BP; Cong, YW				Wang, Limei; Jia, Chao; Yu, Zuyin; Liu, Xiaolan; Kang, Liping; Cong, Yue; Shan, Yajun; Zhao, Zhenhu; Ma, Baiping; Cong, Yuwen			Pennogenin Tetraglycoside Induces Rat Myometrial Contraction and MLC20 Phosphorylation via PLC-IP3 and RhoA/Rho Kinase Signaling Pathways	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; SMOOTH-MUSCLE CONTRACTION; RHO-ASSOCIATED KINASE; UTERINE CONTRACTILITY; STRUCTURAL REQUIREMENT; RECEPTOR ANTAGONIST; ROK-ALPHA; CELLS; ACTIVATION; GLYCOSIDES	Background: Total steroidal saponins extracted from the rhizome of Paris polyphylla Sm. var. yunnanensis (TSSPs) have been widely used in China for the treatment of abnormal uterine bleeding. We previously studied the main active constituents of TSSPs and their structure-activity relationships with respect to rat myometrial contractions. Tg (pennogenin tetraglycoside) was identified as one of the active ingredients in TSSPs able to induce rat myometrial contractions. However, the mechanisms underlying the pharmacological actions on uterine activity have not been described clearly. Methods: Here Tg was screened for effects on contractile activity in isolated uterine strips from estrogen-primed rats and on MLC20 phosphorylation and related signaling pathways in cultured rat myometrial cells as determined by Western blot. Intracellular calcium ([Ca2+](i)) was monitored under a confocal microscope using Fluo-4 AM-loaded myometrial cells. Results: Tg dose-dependently stimulated rat myometrial contractions as well as MLC20 phosphorylation in vitro, which could be completely suppressed by an inhibitor of myosin light chain kinase (MLCK). Use of Ca2+ channel blockers and kinase inhibitors demonstrated that Tg-induced myometrial contractions are mediated by activation of the phospholipase C (PLC)-inositol triphosphate (IP3) signaling pathway, resulting in increased MLC20 phosphorylation. Furthermore, Y27632, a specific inhibitor of Rho kinase (ROK), notably suppressed Tg-stimulated myometrial contractions and decreased MLC20 phosphorylation. Conclusions: These data provide evidence that rat myometrial contractility induced by Tg results from enhanced MLC20 phosphorylation, while both PLC-IP3 and RhoA/ROK signaling pathways mediate the process. These mechanisms may be responsible for the therapeutic effects of TSSPs on abnormal uterine bleeding.	[Wang, Limei; Jia, Chao; Yu, Zuyin; Liu, Xiaolan; Cong, Yue; Shan, Yajun; Zhao, Zhenhu; Cong, Yuwen] Beijing Inst Radiat Med, Dept Pathophysiol, Beijing, Peoples R China; [Kang, Liping; Ma, Baiping] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Cong, YW (corresponding author), Beijing Inst Radiat Med, Dept Pathophysiol, Beijing, Peoples R China.	congyw@nic.bmi.ac.cn			Nature Science Foundation of China [NSFC: 30672640]; NSFC joint Foundation of Yunnan [U1032601]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC joint Foundation of Yunnan	This work was supported, in part, by grants from the Nature Science Foundation of China (NSFC: 30672640) and the NSFC joint Foundation of Yunnan (U1032601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Arner A, 1999, Rev Physiol Biochem Pharmacol, V134, P63; Ascher-Landsberg J, 1999, J SOC GYNECOL INVEST, V6, P240, DOI 10.1016/S1071-5576(99)00031-3; Bae J, 1999, TOXICOL APPL PHARM, V155, P261, DOI 10.1006/taap.1998.8614; Bao JJ, 2002, P NATL ACAD SCI USA, V99, P9556, DOI 10.1073/pnas.142298599; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; CHEN C, 1983, YUNNAN ZHI WU YAN JI, V0005; Chen CX, 1992, YUNNAN ZHIWU YANJIU, V14, P111; Cong Y, 2012, THROMB RES, V129, pE209, DOI 10.1016/j.thromres.2012.02.001; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Fu YL, 2008, J THROMB HAEMOST, V6, P524, DOI 10.1111/j.1538-7836.2007.02881.x; Gao Y, 2001, IUBMB LIFE, V51, P337; GORECKA A, 1976, BIOCHEM BIOPH RES CO, V71, P325, DOI 10.1016/0006-291X(76)90286-2; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; [康利平 Kang Liping], 2005, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V15, P25; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee YH, 2001, EXP PHYSIOL, V86, P283, DOI 10.1113/eph8602184; Leung T, 1996, MOL CELL BIOL, V16, P5313; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matthew A, 2004, BIOL RES, V37, P617; NOHARA T, 1973, CHEM PHARM BULL, V21, P1240, DOI 10.1248/cpb.21.1240; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Shintani Y, 2000, BRIT J PHARMACOL, V130, P1165, DOI 10.1038/sj.bjp.0703410; Shojo H, 2001, J MOL RECOGNIT, V14, P401, DOI 10.1002/jmr.551; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Taggart MJ, 1999, EXP CELL RES, V251, P92, DOI 10.1006/excr.1999.4565; TIAN Y, 1986, Journal of Traditional Chinese Medicine, V6, P178; Woodcock NA, 2004, AM J OBSTET GYNECOL, V190, P222, DOI 10.1016/S0002-9378(03)00925-6; Wray S, 2003, J SOC GYNECOL INVEST, V10, P252, DOI 10.1016/S1071-5576(03)00089-3; Yu ZY, 2007, INT J CANCER, V121, P2084, DOI 10.1002/ijc.22945; Yu ZY, 2010, J PHARM PHARMACOL, V62, P521, DOI 10.1211/jpp.62.04.0016; Zhang JY, 1999, CLIN CHIM ACTA, V289, P79, DOI 10.1016/S0009-8981(99)00160-6; Zhao L., 2005, J PRACT TRADIT CHIN, V21, P455	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51536	10.1371/journal.pone.0051536	http://dx.doi.org/10.1371/journal.pone.0051536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251567	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200131
J	Zhang, S; Xu, ZW; Gao, Y; Wu, YH; Li, ZH; Liu, HF; Zhang, CG				Zhang, Shuang; Xu, Zhiwei; Gao, Yan; Wu, Yonghong; Li, Zhihui; Liu, Haifeng; Zhang, Chenggang			Bidirectional Crosstalk between Stress-Induced Gastric Ulcer and Depression under Chronic Stress	PLOS ONE			English	Article							CENTRAL HISTAMINERGIC MECHANISM; PITUITARY-ADRENAL AXIS; REPEATED IMMOBILIZATION; RESPONSES; MODEL; RAT; ADAPTATION; INHIBITOR; MELATONIN; DESPAIR	Stress contributes to a variety of diseases and disorders such as depression and peptic ulcer. The present study aimed to investigate the correlation between stress ulcer and depression in pathogenesis and treatment by using chronic stress depression (CSD), chronic psychological stress ulcer (CPSU) and water immersion restrain stress models in rats. Our data showed that the ulcer index of the animals after CSD exposure was significantly higher than that of controls. Depression-like behaviors were observed in rat after CPSU exposure. Fluoxetine hydrochloride significantly reduced the ulcer index of rats exposed to CPSU stress, while ranitidine inhibited depression-like behavior of the animals in CSD group. The ulcer index of rats administered with mifepristone after CPSU stress was markedly reduced compared to CPSU group, although there was no significant difference in the depression-like behavior between mifepristone-treated CSD group and naive controls. We also found that the rats exposed to CPSU or CSD stress displayed a lower level of corticosterone than naive controls, however, the acute stress (AS) group showed an opposite result. Additionally, in order to study the relevance of H-2 receptors and depression, we treated the CSD group with cimetidine and famotidine respectively. The data showed that cimetidine inhibited depression-like behavior in CSD rats, and famotidine had no impact on depression. Overall our data suggested that the hypothalamic-pituitary-adrenal (HPA) axis dysfunction may be the key role in triggering depression and stress ulcer. Acid-suppressing drugs and antidepressants could be used for treatment of depression and stress ulcer respectively. The occurrence of depression might be inhibited by blocking the central H-2 receptors.	[Zhang, Shuang; Xu, Zhiwei; Gao, Yan; Wu, Yonghong; Li, Zhihui; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Zhang, Shuang; Liu, Haifeng] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Zhang, Chenggang] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Academy of Military Medical Sciences - China; Anhui Medical University	Liu, HF (corresponding author), Chinese Peoples Armed Police Forces, Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	haifengliu333@163.com; zhangcg@bmi.ac.cn	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	National Basic Research Project (973 program) [2012CB518200]; Natural Science Foundation of China [81100979, 81070741, 30900830]; Special Key Programs for Science and Technology of China [2012ZX09102301-016]	National Basic Research Project (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Key Programs for Science and Technology of China	This work was supported by the National Basic Research Project (973 program) (2012CB518200), the General Program (81100979, 81070741, 30900830) of the Natural Science Foundation of China, and Special Key Programs for Science and Technology of China (2012ZX09102301-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater KA, 2012, EUR J PHARMACOL, V688, P42, DOI 10.1016/j.ejphar.2012.04.019; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Bielajew C, 2003, STRESS, V6, P269, DOI 10.1080/10253890310001602829; Booij S. H., 2012, PSYCHONEUROENDOCRINO; Brzozowska I, 2009, J PHYSIOL PHARMACOL, V60, P47; Brzozowski T, 2007, J PHYSIOL PHARMACOL, V58, P53; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Fraites MJP, 2009, TOXICOL SCI, V112, P88, DOI 10.1093/toxsci/kfp194; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; GADEKMICHALSKA A, 1991, AGENTS ACTIONS, V32, P203; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Harty RF, 2004, DIGEST DIS SCI, V49, P1875, DOI 10.1007/s10620-004-9586-z; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; KANOF PD, 1978, NATURE, V272, P329, DOI 10.1038/272329a0; Kato A, 2010, BIOSCI BIOTECH BIOCH, V74, P812, DOI 10.1271/bbb.90897; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; KENNETT GA, 1985, EUR J PHARMACOL, V119, P143, DOI 10.1016/0014-2999(85)90290-0; KENNETT GA, 1985, BRAIN RES, V330, P253, DOI 10.1016/0006-8993(85)90684-5; Madrigal JLM, 2001, NEUROPSYCHOPHARMACOL, V24, P420, DOI 10.1016/S0893-133X(00)00208-6; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Mei XT, 2011, PHARMACOL BIOCHEM BE, V99, P66, DOI 10.1016/j.pbb.2011.04.002; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Murison R, 2001, INTEGR PHYS BEH SCI, V36, P75, DOI 10.1007/BF02733948; NATH C, 1988, LIFE SCI, V42, P2413, DOI 10.1016/0024-3205(88)90339-6; NATH C, 1982, PSYCHOPHARMACOLOGY, V76, P228, DOI 10.1007/BF00432550; Pardon MC, 2000, PHYSIOL BEHAV, V70, P7, DOI 10.1016/S0031-9384(00)00216-X; Perdrizet GA, 1997, CELL STRESS CHAPERON, V2, P214, DOI 10.1379/1466-1268(1997)002<0214:HSABRT>2.3.CO;2; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rai D, 2003, J PHARMACOL SCI, V93, P458, DOI 10.1254/jphs.93.458; ROBINS AH, 1984, POSTGRAD MED J, V60, P353, DOI 10.1136/pgmj.60.703.353; Rybakina E G, 2009, Ross Fiziol Zh Im I M Sechenova, V95, P1324; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Saxena B, 2011, PHARMACOL REP, V63, P1413; SELYE H, 1965, Nurs Forum, V4, P28, DOI 10.1111/j.1744-6198.1965.tb01011.x; SELYE H, 1946, J ALLERGY, V17, P231, DOI 10.1016/0021-8707(46)90148-7; SELYE H, 1964, Ind Med Surg, V33, P621; SELYE H, 1954, Int Rec Med Gen Pract Clin, V167, P181; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Suleyman H, 2009, CHEM-BIOL INTERACT, V180, P318, DOI 10.1016/j.cbi.2009.03.002; Suri D, 2012, NEUROSCIENCE; Thornton LM, 2010, HEALTH PSYCHOL, V29, P333, DOI 10.1037/a0018836; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011	50	21	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51148	10.1371/journal.pone.0051148	http://dx.doi.org/10.1371/journal.pone.0051148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251441	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200064
J	Papatheodorou, I; Ziehm, M; Wieser, D; Alic, N; Partridge, L; Thornton, JM				Papatheodorou, Irene; Ziehm, Matthias; Wieser, Daniela; Alic, Nazif; Partridge, Linda; Thornton, Janet M.			Using Answer Set Programming to Integrate RNA Expression with Signalling Pathway Information to Infer How Mutations Affect Ageing	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; INSULIN-RECEPTOR; REGULATORY NETWORKS; GROWTH; GENE; NORMALIZATION; MODULATORS; LONGEVITY; APOPTOSIS; SUMMARIES	A challenge of systems biology is to integrate incomplete knowledge on pathways with existing experimental data sets and relate these to measured phenotypes. Research on ageing often generates such incomplete data, creating difficulties in integrating RNA expression with information about biological processes and the phenotypes of ageing, including longevity. Here, we develop a logic-based method that employs Answer Set Programming, and use it to infer signalling effects of genetic perturbations, based on a model of the insulin signalling pathway. We apply our method to RNA expression data from Drosophila mutants in the insulin pathway that alter lifespan, in a foxo dependent fashion. We use this information to deduce how the pathway influences lifespan in the mutant animals. We also develop a method for inferring the largest common sub-paths within each of our signalling predictions. Our comparisons reveal consistent homeostatic mechanisms across both long-and short-lived mutants. The transcriptional changes observed in each mutation usually provide negative feedback to signalling predicted for that mutation. We also identify an S6K-mediated feedback in two long-lived mutants that suggests a crosstalk between these pathways in mutants of the insulin pathway, in vivo. By formulating the problem as a logic-based theory in a qualitative fashion, we are able to use the efficient search facilities of Answer Set Programming, allowing us to explore larger pathways, combine molecular changes with pathways and phenotype and infer effects on signalling in in vivo, whole-organism, mutants, where direct signalling stimulation assays are difficult to perform. Our methods are available in the web-service NetEffects: http://www.ebi.ac.uk/thornton-srv/software/NetEffects.	[Papatheodorou, Irene; Ziehm, Matthias; Wieser, Daniela; Thornton, Janet M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Papatheodorou, Irene; Alic, Nazif; Partridge, Linda] UCL, Inst Healthy Ageing, London, England; [Papatheodorou, Irene; Alic, Nazif; Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England; [Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany	European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London; Max Planck Society	Papatheodorou, I (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	irenep@ebi.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Alic, Nazif/B-4665-2009	Alic, Nazif/0000-0003-0356-6600; Thornton, Janet/0000-0003-0824-4096; Papatheodorou, Irene/0000-0001-7270-5470; Ziehm, Matthias/0000-0001-7074-4054; Partridge, Linda/0000-0001-9615-0094	EMBL-EBI, Wellcome Trust	EMBL-EBI, Wellcome Trust(Wellcome Trust)	This work was funded by EMBL-EBI (http://www.ebi.ac.uk/), Wellcome Trust Strategic Award (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Babur O, 2010, NUCLEIC ACIDS RES, V38, P5648, DOI 10.1093/nar/gkq287; BARAL C., 2003, KNOWLEDGE REPRESENTA; Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Domingos P., 2006, P AAAI 06 21 NAT C A, P2; Dupont J, 2003, CELL CYCLE, V2, P270, DOI 10.4161/cc.2.4.408; Dworschak S, 2008, CONSTRAINTS, V13, P21, DOI 10.1007/s10601-007-9031-y; Fayruzov T, 2011, INT J DATA MIN BIOIN, V5, P209, DOI 10.1504/IJDMB.2011.039178; Fayruzov T, 2009, IEEE INT C BIOINFORM, P99, DOI 10.1109/BIBM.2009.9; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gebser M., 2010, 2010 Proceedings of 22nd International Conference on Tools with Artificial Intelligence (ICTAI 2010), P383, DOI 10.1109/ICTAI.2010.62; Gebser M, 2011, AI COMMUN, V24, P107, DOI 10.3233/AIC-2011-0491; Guziolowski C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-244; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Nielsen MD, 2008, AGING CELL, V7, P688, DOI 10.1111/j.1474-9726.2008.00420.x; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Smith G, 2010, BALLET REV, V38, P5; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Videla S, 2012, CMBS 10 COMP METH SY, V7605, P342, DOI [10.1007/978-3-642-33636-2_20, DOI 10.1007/978-3-642-33636-2_20]; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wieser D, 2011, PHILOS T R SOC B, V366, P51, DOI 10.1098/rstb.2010.0286; Wittwer F, 2005, DEV CELL, V8, P817, DOI 10.1016/j.devcel.2005.04.002	52	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50881	10.1371/journal.pone.0050881	http://dx.doi.org/10.1371/journal.pone.0050881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251396	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900024
J	Kumawat, K; Menzen, MH; Bos, IST; Baarsma, HA; Borger, P; Roth, M; Tamm, M; Halayko, AJ; Simoons, M; Prins, A; Postma, DS; Schmidt, M; Gosens, R				Kumawat, Kuldeep; Menzen, Mark H.; Bos, I. Sophie T.; Baarsma, Hoeke A.; Borger, Pieter; Roth, Michael; Tamm, Michael; Halayko, Andrew J.; Simoons, Mirjam; Prins, Alita; Postma, Dirkje S.; Schmidt, Martina; Gosens, Reinoud			Noncanonical WNT-5A signaling regulates TGF-beta-induced extracellular matrix production by airway smooth muscle cells	FASEB JOURNAL			English	Article						asthma; ECM; frizzled	GROWTH-FACTOR-BETA; ASTHMA; WNT5A; EXPRESSION; CATENIN; PATHWAY; DISEASE; CANCER; PROLIFERATION; FIBROBLASTS	Transforming growth factor beta (TGF-beta), a key mediator of fibrotic responses, is increased in asthma and drives airway remodeling by inducing expression of extracellular matrix (ECM) proteins. We investigated the molecular mechanisms underlying TGF-beta-induced ECM expression by airway smooth muscle cells and demonstrate a novel link between TGF-beta and Wingless/integrase 1 (WNT) signaling in ECM deposition. Airway smooth muscle expresses abundant WNT ligands, with the noncanonical WNT-5A being the most profoundly expressed. Interestingly, WNT-5A shows similar to 2-fold higher abundance in airway smooth muscle cells isolated from individuals with asthma than individuals without asthma. WNT-5A is markedly induced in response to TGF-beta (4 -16-fold; EC50 0.3 ng/ml) and is required for collagen and fibronectin expression by airway smooth muscle. WNT-5A engages noncanonical WNT signaling pathways, as inhibition of Ca2+ and c-Jun N-terminal kinase (JNK) signaling attenuated this TGF-beta response, whereas the canonical WNT antagonist Dickkopf 1 (DKK-1) did not. Accordingly, WNT-5A induced JNK phosphorylation and nuclear translocation of nuclear factor of activated T cells c1 (NFATc1). Furthermore, silencing of the WNT-5A receptors Frizzled 8 (FZD(8)) and RYK attenuated TGF-beta-induced ECM expression. Collectively, these findings demonstrate that noncanonical WNT-5A signaling is activated by and necessary for TGF-beta-induced ECM production by airway smooth muscle cells, which could have significance in asthma pathogenesis.-Kumawat, K., Menzen, M. H.., Bos, I. S. T., Baarsma, H. A., Borger, P., Roth, M., Tamm, M., Halayko, A. J., Simoons, M., Prins, A., Postma, D. S., Schmidt, M., and Gosens, R. Noncanonical WNT-5A signaling regulates TGF-beta-induced extracellular matrix production by airway smooth muscle cells. FASEB J. 27, 1631-1643 (2013). www.fasebj.org	[Kumawat, Kuldeep; Menzen, Mark H.; Bos, I. Sophie T.; Baarsma, Hoeke A.; Simoons, Mirjam; Prins, Alita; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Pharmacol, NL-9713 AV Groningen, Netherlands; [Kumawat, Kuldeep; Menzen, Mark H.; Bos, I. Sophie T.; Baarsma, Hoeke A.; Simoons, Mirjam; Prins, Alita; Postma, Dirkje S.; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & Chron Obstruct Pulm D, NL-9713 AV Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, NL-9713 AV Groningen, Netherlands; [Borger, Pieter] Univ Basel, Dept Biomed, Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Pneumol, CH-4031 Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	University of Groningen; University of Groningen; University of Groningen; University of Basel; University of Basel; University of Basel; University of Manitoba; University of Manitoba	Kumawat, K (corresponding author), Univ Groningen, Dept Mol Pharmacol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	k.kumawat@rug.nl	Roth, Michael/H-8657-2019; Schmidt, Martina/C-5339-2018	Roth, Michael/0000-0002-8139-2821; Schmidt, Martina/0000-0003-3075-0630; Gosens, Reinoud/0000-0002-5595-152X; Baarsma, Hoeke/0000-0002-0792-0374; Halayko, Andrew/0000-0002-7865-4552	Veni grant from the Dutch Organization for Scientific Research (NWO) [916.86.036]; Rosalind Franklin Fellowship from the University of Groningen; Swiss National Foundation [310030_130740]	Veni grant from the Dutch Organization for Scientific Research (NWO); Rosalind Franklin Fellowship from the University of Groningen; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by a Veni grant (916.86.036) from the Dutch Organization for Scientific Research (NWO) to R. G., a Rosalind Franklin Fellowship from the University of Groningen to M. S., and a Swiss National Foundation grant (310030_130740) to M.R.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bumbacea D, 2004, EUR RESPIR J, V24, P122, DOI 10.1183/09031936.04.00077803; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P1115; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Komiya Yuko, 2008, Organogenesis, V4, P68; Lazaar AL, 2003, AM J MED, V115, P652, DOI 10.1016/j.amjmed.2003.07.010; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Parameswaran K, 2006, CELL BIOCHEM BIOPHYS, V44, P139, DOI 10.1385/CBB:44:1:139; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Pini L, 2007, EUR RESPIR J, V29, P71, DOI 10.1183/09031936.00047905; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	48	84	89	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1631	1643		10.1096/fj.12-217539	http://dx.doi.org/10.1096/fj.12-217539			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23254341				2022-12-25	WOS:000316940800033
J	Hernandez-Ortega, S; Bru, S; Ricco, N; Ramirez, S; Casals, N; Jimenez, J; Isasa, M; Crosas, B; Clotet, J				Hernandez-Ortega, Sara; Bru, Samuel; Ricco, Natalia; Ramirez, Sara; Casals, Nuria; Jimenez, Javier; Isasa, Marta; Crosas, Bernat; Clotet, Josep			Defective in Mitotic Arrest 1 (Dma1) Ubiquitin Ligase Controls G(1) Cyclin Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEGRADATION; PROTEASOME PATHWAY; RAPID DEGRADATION; PROTEIN-KINASE; DNA-DAMAGE; G1 CYCLINS; S-PHASE	Progression through the G(1) phase of the cell cycle is controlled by diverse cyclin-dependent kinases (CDKs) that might be associated to numerous cyclin isoforms. Given such complexity, regulation of cyclin degradation should be crucial for coordinating progression through the cell cycle. In Saccharomyces cerevisiae, SCF is the only E3 ligase known to date to be involved in G(1) cyclin degradation. Here, we report the design of a genetic screening that uncovered Dma1 as another E3 ligase that targets G(1) cyclins in yeast. We show that the cyclin Pcl1 is ubiquitinated in vitro and in vivo by Dma1, and accordingly, is stabilized in dma1 mutants. We demonstrate that Pcl1 must be phosphorylated by its own CDK to efficiently interact with Dma1 and undergo degradation. A nonphosphorylatable version of Pcl1 accumulates throughout the cell cycle, demonstrating the physiological relevance of the proposed mechanism. Finally, we present evidence that the levels of Pcl1 and Cln2 are independently controlled in response to nutrient availability. This new previously unknown mechanism for G(1) cyclin degradation that we report here could help elucidate the specific roles of the redundant CDK-cyclin complexes in G(1).	[Hernandez-Ortega, Sara; Bru, Samuel; Ricco, Natalia; Ramirez, Sara; Casals, Nuria; Jimenez, Javier; Clotet, Josep] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona 08017, Spain; [Isasa, Marta; Crosas, Bernat] CSIC, Inst Biol Mol Barcelona, Dept Cellular Biol, E-08028 Barcelona, Spain	Universitat Internacional de Catalunya (UIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Clotet, J (corresponding author), Univ Int Catalunya, Dept Ciencies Basiques, Barcelona 08017, Spain.	jclotet@uic.es	Clotet, Josep/AAF-2618-2019; Ramírez, Sara/AAE-4400-2022; Jiménez, Javier/ABE-1795-2020; Clotet, Josep/ABC-8727-2020; Casals, Nuria/L-3378-2014	Jiménez, Javier/0000-0002-0402-4427; Clotet, Josep/0000-0001-5462-8598; Casals, Nuria/0000-0002-6719-4300; Ramirez Flores, Sara/0000-0002-2072-2495	Ministry of Economy and Competitiveness [BFU 2009-09278]; Universitat Internacional de Catalunya; l'Obra Social la Caixa	Ministry of Economy and Competitiveness; Universitat Internacional de Catalunya; l'Obra Social la Caixa(La Caixa Foundation)	This work was supported by Spanish Ministry of Science and Innovation Grant BFU 2009-09278, now known as the Ministry of Economy and Competitiveness.; Supported by a post-graduate Junior Faculty fellowship from the Universitat Internacional de Catalunya and l'Obra Social la Caixa.	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Berset G, 2002, MOL CELL BIOL, V22, P4463, DOI 10.1128/MCB.22.13.4463-4476.2002; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang K, 2007, MOL CELL, V28, P614, DOI 10.1016/j.molcel.2007.09.013; Irniger S, 1997, J CELL SCI, V110, P1523; Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Johnson AE, 2011, EMBO J, V30, P341, DOI 10.1038/emboj.2010.317; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Li WJ, 2006, MOL MICROBIOL, V62, P212, DOI 10.1111/j.1365-2958.2006.05361.x; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Loring GL, 2008, CELL CYCLE, V7, P96, DOI 10.4161/cc.7.1.5113; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Palecek SP, 2000, GENETICS, V156, P1005; Raspelli E, 2011, MOL BIOL CELL, V22, P2185, DOI 10.1091/mbc.E11-02-0127; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Sanbhnani S, 2012, CELL MOL LIFE SCI, V69, P1669, DOI 10.1007/s00018-011-0892-2; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	50	4	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4704	4714		10.1074/jbc.M112.426593	http://dx.doi.org/10.1074/jbc.M112.426593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264631	Green Published, hybrid			2022-12-25	WOS:000315340400019
J	Hebron, ML; Lonskaya, I; Sharpe, K; Weerasinghe, PPK; Algarzae, NK; Shekoyan, AR; Moussa, CEH				Hebron, Michaeline L.; Lonskaya, Irina; Sharpe, Kaydee; Weerasinghe, Puwakdandawe P. K.; Algarzae, Norah K.; Shekoyan, Ashot R.; Moussa, Charbel E. -H.			Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PATHOLOGICAL TDP-43; DEMENTIA COMPLEX; DISEASE; PHOSPHORYLATION; MUTATIONS; INCLUSIONS; COMPONENT; DROSOPHILA-PINK1	The importance of E3 ubiquitin ligases, involved in the degradation of misfolded proteins or promotion of protein-protein interaction, is increasingly recognized in neurodegeneration. TDP-43 is a predominantly nuclear protein, which regulates the transcription of thousands of genes and binds to mRNA of the E3 ubiquitin ligase Parkin to regulate its expression. Wild type and mutated TDP-43 are detected in ubiquitinated forms within the cytosol in several neurodegenerative diseases. We elucidated the mechanisms of TDP-43 interaction with Parkin using transgenic A315T mutant TDP-43(TDP43-Tg) mice, lentiviral wild type TDP-43, and Parkin gene transfer rat models. TDP-43 expression increased Parkin mRNA and protein levels. Lentiviral TDP-43 increased the levels of nuclear and cytosolic protein, whereas Parkin co-expression mediated Lys-48 and Lys-63-linked ubiquitin to TDP-43 and led to cytosolic co-localization of Parkin with ubiquitinated TDP-43. Parkin and TDP-43 formed a multiprotein complex with HDAC6, perhaps to mediate TDP-43 translocation. In conclusion, Parkin ubiquitinates TDP-43 and facilitates its cytosolic accumulation through a multiprotein complex with HDAC6.	[Hebron, Michaeline L.; Lonskaya, Irina; Sharpe, Kaydee; Weerasinghe, Puwakdandawe P. K.; Algarzae, Norah K.; Shekoyan, Ashot R.; Moussa, Charbel E. -H.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA	Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Sch Med, Dept Neurosci, Lab Dementia & Parkinsonism,TRB, 3970 Reservoir Rd NW,Rm WP09B, Washington, DC 20057 USA.	cem46@georgetown.edu		Weerasinghe, Puwakdandawe/0000-0002-1382-301X	National Institutes of Health Grant [AG30378]; Georgetown University Funding; NATIONAL INSTITUTE ON AGING [K01AG030378] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University Funding; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG30378. This work was also supported by Georgetown University Funding (to C. E.-H. M.).	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Dickson DW, 2007, ACTA NEUROPATHOL, V114, P71, DOI 10.1007/s00401-007-0234-5; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2008, ACTA NEUROPATHOL, V115, P133, DOI 10.1007/s00401-007-0257-y; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Herman AM, 2012, EXP NEUROL, V235, P297, DOI 10.1016/j.expneurol.2012.02.011; Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara K, 2008, J BIOL CHEM, V283, P6979, DOI 10.1074/jbc.M710418200; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McCluskey LF, 2009, ARCH NEUROL-CHICAGO, V66, P121, DOI 10.1001/archneur.66.1.121; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Qi JF, 2010, ONCOTARGET, V1, P379, DOI 10.18632/oncotarget.171; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	77	91	91	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4103	4115		10.1074/jbc.M112.419945	http://dx.doi.org/10.1074/jbc.M112.419945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258539	hybrid, Green Published			2022-12-25	WOS:000314845000039
J	Hong, S; Kim, HY; Kim, J; Ha, HT; Kim, YM; Bae, E; Kim, TH; Lee, KC; Kim, SJ				Hong, Suntaek; Kim, Hye-Youn; Kim, Jooyoung; Huyen Trang Ha; Kim, Young-Mi; Bae, Eunjin; Kim, Tae Hyung; Lee, Kang Choon; Kim, Seong-Jin			Smad7 Protein Induces Interferon Regulatory Factor 1-dependent Transcriptional Activation of Caspase 8 to Restore Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRAIL-INDUCED APOPTOSIS; FACTOR-KAPPA-B; TGF-BETA; GENE-EXPRESSION; NEUROBLASTOMA-CELLS; CRYSTAL-STRUCTURE; UP-REGULATION; MH1 DOMAIN; IN-VIVO	Smad7 has been known as a negative regulator for the transforming growth factor-beta (TGF-beta) signaling pathway through feedback regulation. However, Smad7 has been suspected to have other biological roles through the regulation of gene transcription. By screening differentially regulated genes, we found that the caspase 8 gene was highly up-regulated in Smad7-expressing cells. Smad7 was able to activate the caspase 8 promoter through recruitment of the interferon regulatory factor 1 (IRF1) transcription factor to the interferon-stimulated response element (ISRE) site. Interaction of Smad7 on the caspase 8 promoter was confirmed with electrophoretic mobility shift assay and chromatin immunoprecipitation experiment. Interestingly, Smad7 did not directly interact with the ISRE site, but it increased the binding activity of IRF1 with ISRE. These results support that Smad7 recruits IRF1 protein on the caspase 8 promoter and functions as a transcriptional coactivator. To confirm the biological significance of caspase 8 up-regulation, we tested tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated cell death assay in breast cancer cells. Smad7 in apoptosis-resistant MCF7 cells markedly sensitized the cells to TRAIL-induced cell death by restoring the caspase cascade. Furthermore, restoration of caspase 8-mediated apoptosis pathway repressed the tumor growth in the xenograft model. In conclusion, we suggest a novel role for Smad7 as a transcriptional coactivator for caspase 8 through the interaction with IRF1 in regulation of the cell death pathway.	[Hong, Suntaek; Kim, Hye-Youn; Kim, Jooyoung; Huyen Trang Ha; Kim, Young-Mi; Bae, Eunjin] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406840, South Korea; [Bae, Eunjin; Kim, Seong-Jin] Cha Univ, Cha Canc Inst, Seoul 135081, South Korea; [Kim, Tae Hyung] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea	Gachon University; Pochon Cha University; Sungkyunkwan University (SKKU)	Hong, S (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406840, South Korea.	sthong@gachon.ac.kr; kimsj@cha.ac.kr	Ha, Trang/AAD-6717-2019; Kim, Hye Youn/K-3590-2016	Ha, Trang/0000-0002-5238-7599; 	World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R32-10215, 2009-0081756]; Bio & Medical Technology Development Program	World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; Bio & Medical Technology Development Program	Supported by World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea Grant R32-10215. To whom correspondence may be addressed: Dept. of Molecular Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, 7-45 Songdo-dong Yeonsu-gu Incheon, 406-840, Republic of Korea. Tel.: 82-32-899-6311; Fax: 82-32-899-6039; E-mail: sthong@gachon.ac.kr.; Supported by Bio & Medical Technology Development Program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea Grant 2009-0081756. To whom correspondence may be addressed: Cha Cancer Institute, Cha University, 650-9 Yeok-sam-1-dong Kangnam-gu Seoul, 135-081, Republic of Korea. Tel.: 82-2-3468-2646; Fax: 82-2-3468- 2651; E-mail: kimsj@cha.ac.kr.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Casciano I, 2004, ANN NY ACAD SCI, V1028, P157, DOI 10.1196/annals.1322.017; Chae SY, 2010, MOL CANCER THER, V9, P1719, DOI 10.1158/1535-7163.MCT-09-1076; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cook JA, 2010, CANCER LETT, V289, P119, DOI 10.1016/j.canlet.2009.08.009; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Finlay D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013375; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Geiger K, 2012, MOL BIOL CELL, V23, P2226, DOI 10.1091/mbc.E11-06-0535; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Johnsen JI, 2004, INT J ONCOL, V25, P1849; Kennedy BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022606; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Komata T, 2005, INT J ONCOL, V26, P1345; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Menke C, 2011, CANCER RES, V71, P1883, DOI 10.1158/0008-5472.CAN-10-2252; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Muhlethaler-Mottet A, 2003, ANN NY ACAD SCI, V1010, P195, DOI 10.1196/annals.1299.033; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sanlioglu AD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-54; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Simonsson M, 2005, J BIOL CHEM, V280, P21797, DOI 10.1074/jbc.M503134200; Singh TR, 2003, CANCER RES, V63, P5390; Spector I, 2010, PANCREAS, V39, P1008, DOI 10.1097/MPA.0b013e3181da8aa3; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-32; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang YH, 2011, INT J ORAL SCI, V3, P1, DOI 10.4248/IJOS11003; Zhou B, 2008, BBA-PROTEINS PROTEOM, V1784, P747, DOI 10.1016/j.bbapap.2008.01.021	63	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3560	3570		10.1074/jbc.M112.400408	http://dx.doi.org/10.1074/jbc.M112.400408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255602	hybrid, Green Published			2022-12-25	WOS:000314397900061
J	Kamath, PL; Getz, WM				Kamath, Pauline L.; Getz, Wayne M.			Unraveling the Effects of Selection and Demography on Immune Gene Variation in Free-Ranging Plains Zebra (Equus quagga) Populations	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREQUENCY-DEPENDENT SELECTION; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; ARTHROPOD PARASITES; MICROSATELLITE LOCI; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; NATURAL-SELECTION; MHC	Demography, migration and natural selection are predominant processes affecting the distribution of genetic variation among natural populations. Many studies use neutral genetic markers to make inferences about population history. However, the investigation of functional coding loci, which directly reflect fitness, is critical to our understanding of species' ecology and evolution. Immune genes, such as those of the Major Histocompatibility Complex (MHC), play an important role in pathogen recognition and provide a potent model system for studying selection. We contrasted diversity patterns of neutral data with MHC loci, ELA-DRA and -DQA, in two southern African plains zebra (Equus quagga) populations: Etosha National Park, Namibia, and Kruger National Park, South Africa. Results from neutrality tests, along with observations of elevated diversity and low differentiation across populations, supported previous genus-level evidence for balancing selection at these loci. Despite being low, MHC divergence across populations was significant and may be attributed to drift effects typical of geographically separated populations experiencing little to no gene flow, or alternatively to shifting allele frequency distributions driven by spatially variable and fluctuating pathogen communities. At the DRA, zebra exhibited geographic differentiation concordant with microsatellites and reduced levels of diversity in Etosha due to highly skewed allele frequencies that could not be explained by demography, suggestive of spatially heterogeneous selection and local adaptation. This study highlights the complexity in which selection affects immune gene diversity and warrants the need for further research on the ecological mechanisms shaping patterns of adaptive variation among natural populations. Citation: Kamath PL, Getz WM (2012) Unraveling the Effects of Selection and Demography on Immune Gene Variation in Free-Ranging Plains Zebra (Equus quagga) Populations. PLoS ONE 7(12): e50971. doi:10.1371/journal.pone.0050971	[Kamath, Pauline L.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of California System; University of California Berkeley; University of Kwazulu Natal	Kamath, PL (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT 59717 USA.	pkamath@usgs.gov	Kamath, Pauline/H-1358-2013; Getz, Wayne/I-4521-2013	Kamath, Pauline/0000-0002-6458-4514; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health Ecology and Evolution of Infectious Disease Grant [GM083863]; National Science Foundation Doctoral Dissertation Improvement Grant [MCINS-20091291]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health Ecology and Evolution of Infectious Disease Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Institutes of Health Ecology and Evolution of Infectious Disease Grant (GM083863) to WMG and a National Science Foundation Doctoral Dissertation Improvement Grant (MCINS-20091291) to PLK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Avise J.C., 2004, MOL MARKERS NATURAL; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Bos DH, 2007, HEREDITAS, V144, P228, DOI 10.1111/j.2007.0018-0661.01994.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawford NG, MOL ECOLOGY RESOURCE, V10, P556; Cutrera AP, 2006, J MAMMAL, V87, P706, DOI 10.1644/05-MAMM-A-383R1.1; De Vos V., 1990, SALISBURY MED B S, V678, P19; Dixon CJ, 2010, MOL ECOL RESOUR, V10, P335, DOI 10.1111/j.1755-0998.2009.02749.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Drummond A.J, 2010, GENEIOUS, V5, P3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebedes H., 1976, MADOQUA, V10, P99; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Ejsmond MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-332; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Fraser DG, 1998, IMMUNOGENETICS, V47, P487, DOI 10.1007/s002510050387; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2003, EVOLUTION, V57, P1707; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen H, 2008, MOL ECOL RESOUR, V8, P282, DOI 10.1111/j.1471-8286.2007.01992.x; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Hedrick P, 1998, GENETICS EVOLUTION S, P205; Hedrick PW, 1999, GENETICS, V152, P1701; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HEDRICK PW, 1987, BIOL J LINN SOC, V31, P311, DOI 10.1111/j.1095-8312.1987.tb01996.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HOLM S, 1979, SCAND J STAT, V6, P65; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P253; HORAK IG, 1984, ONDERSTEPOORT J VET, V51, P145; HUDSON RR, 1992, GENETICS, V132, P583; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janova E, 2009, IMMUNOGENETICS, V61, P513, DOI 10.1007/s00251-009-0380-0; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamath PL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-128; KLEIN J, 1986, NATURAL HIST MAJOR H; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; KRECEK RC, 1987, J WILDLIFE DIS, V23, P404, DOI 10.7589/0090-3558-23.3.404; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; LEWONTIN RC, 1973, GENETICS, V74, P175; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Matthee S, 2004, J PARASITOL, V90, P1263, DOI 10.1645/GE-3353; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Miller HC, 2010, MOL ECOL, V19, P3894, DOI 10.1111/j.1365-294X.2010.04771.x; Miller KM, 2001, GENETICA, V111, P237, DOI 10.1023/A:1013716020351; Mona S, 2008, MOL ECOL, V17, P4053, DOI 10.1111/j.1365-294X.2008.03892.x; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, pi; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P762, DOI 10.1111/j.1365-2656.2005.00973.x; Paetkau D, 1997, GENETICS, V147, P1943; Pajewski NM, 2011, GENES IMMUN, V12, P457, DOI 10.1038/gene.2011.15; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PIENAAR UDV, 1967, FED PROC, V26, P1496; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Rambaut A, 2014, TRACER V1 6; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; SLADE RW, 1992, GENETICS, V132, P861; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; TAKAHATA N, 1990, GENETICS, V124, P967; Turner WC, 2010, J WILDLIFE DIS, V46, P1108, DOI 10.7589/0090-3558-46.4.1108; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; Vranova M, 2011, INFECT GENET EVOL, V11, P1136, DOI 10.1016/j.meegid.2011.04.010; WATTERSON GA, 1978, GENETICS, V88, P405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wickliffe J.K., 2003, OCCAS PAP MUS TEXAS, V219, P1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu L, 2005, MOL PHYLOGENET EVOL, V35, P483, DOI 10.1016/j.ympev.2005.01.017; YUHKI N, 1990, P NATL ACAD SCI USA, V87, P836, DOI 10.1073/pnas.87.2.836	112	11	11	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50971	10.1371/journal.pone.0050971	http://dx.doi.org/10.1371/journal.pone.0050971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251409	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800024
J	Rogers, EE; Stenger, DC				Rogers, Elizabeth E.; Stenger, Drake C.			A Conjugative 38 kB Plasmid Is Present in Multiple Subspecies of Xylella fastidiosa	PLOS ONE			English	Article							LEAF SCORCH DISEASE; PIERCES-DISEASE; GENOME SEQUENCES; IV SECRETION; STRAINS; RECOMBINATION; DIVERSITY; BACTERIUM; CALIFORNIA; SYSTEMS	A similar to 38kB plasmid (pXF-RIV5) was present in the Riv5 strain of Xylella fastidiosa subsp. multiplex isolated from ornamental plum in southern California. The complete nucleotide sequence of pXF-RIV5 is almost identical to that of pXFAS01 from X. fastidiosa subsp. fastidiosa strain M23; the two plasmids vary at only 6 nucleotide positions. BLAST searches and phylogenetic analyses indicate pXF-RIV5 and pXFAS01 share some similarity to chromosomal and plasmid (pXF51) sequences of X. fastidiosa subsp. pauca strain 9a5c and more distant similarity to plasmids from a wide variety of bacteria. Both pXF-RIV5 and pXFAS01 encode homologues of a complete Type IV secretion system involved in conjugation and DNA transfer among bacteria. Mating pair formation proteins (Trb) from Yersinia pseudotuberculosis IP31758 are the mostly closely related non-X. fastidiosa proteins to most of the Trb proteins encoded by pXF-RIV5 and pXFAS01. Unlike many bacterial conjugative plasmids, pXF-RIV5 and pXFAS01 do not carry homologues of known accessory modules that confer selective advantage on host bacteria. However, both plasmids encode seven hypothetical proteins of unknown function and possess a small transposon-associated region encoding a putative transposase and associated factor. Vegetative replication of pXF-RIV5 and pXFAS01 appears to be under control of RepA protein and both plasmids have an origin of DNA replication (oriV) similar to that of pRP4 and pR751 from Escherichia coli. In contrast, conjugative plasmids commonly encode TrfA and have an oriV similar to those found in IncP-1 incompatibility group plasmids. The presence of nearly identical plasmids in single strains from two distinct subspecies of X. fastidiosa is indicative of recent horizontal transfer, probably subsequent to the introduction of subspecies fastidiosa to the United States in the late 19th century.	[Rogers, Elizabeth E.; Stenger, Drake C.] USDA, ARS, Parlier, CA USA	United States Department of Agriculture (USDA)	Rogers, EE (corresponding author), USDA, ARS, Parlier, CA USA.	elizabeth.rogers@ars.usda.gov	Rogers, Elizabeth/AAB-3643-2021; Rogers, Elizabeth E/D-2087-2009	Rogers, Elizabeth/0000-0002-0545-4744; Rogers, Elizabeth E/0000-0002-0545-4744	United States Department of Agriculture [5302-22000-008-00D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was supported by United States Department of Agriculture Appropriated Project 5302-22000-008-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Chen J, 2005, PHYTOPATHOLOGY, V95, P708, DOI 10.1094/PHYTO-95-0708; Chen J, 2010, J BACTERIOL, V192, P4534, DOI 10.1128/JB.00651-10; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Guilhabert MR, 2006, PLASMID, V55, P70, DOI 10.1016/j.plasmid.2005.06.004; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Kung SH, 2011, APPL ENVIRON MICROB, V77, P5278, DOI 10.1128/AEM.00730-11; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Melanson RA, 2012, PLANT DIS, V96, P1123, DOI 10.1094/PDIS-09-11-0730-RE; Nunney L, 2012, PHYTOPATHOLOGY, V102, P456, DOI 10.1094/PHYTO-10-11-0298; Nunney L, 2011, PHYTOPATHOLOGY, V101, pS130; Nunney L, 2012, APPL ENVIRON MICROB, V78, P4702, DOI 10.1128/AEM.01126-12; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; PANSEGRAU W, 1988, BIOCHIM BIOPHYS ACTA, V951, P365, DOI 10.1016/0167-4781(88)90108-X; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Stenger DC, 2011, APPL ENVIRON MICROB, V77, P2522, DOI 10.1128/AEM.02789-10; Stenger DC, 2010, PHYSIOL MOL PLANT P, V74, P238, DOI 10.1016/j.pmpp.2010.03.003; Van der Auwera GA, 2009, ANTON LEEUW INT J G, V96, P193, DOI 10.1007/s10482-009-9316-9; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601; Zhang S, 2011, J BACTERIOL, V193, P5576, DOI 10.1128/JB.05430-11	29	17	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52131	10.1371/journal.pone.0052131	http://dx.doi.org/10.1371/journal.pone.0052131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251694	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800146
J	Tsuda, K; Yamanaka, K; Kondo, M; Matsubara, K; Sasaki, R; Tomimoto, H; Gabazza, EC; Mizutani, H				Tsuda, Kenshiro; Yamanaka, Keiichi; Kondo, Makoto; Matsubara, Kimiko; Sasaki, Ryogen; Tomimoto, Hidekazu; Gabazza, Esteban C.; Mizutani, Hitoshi			Ustekinumab Improves Psoriasis without Altering T Cell Cytokine Production, Differentiation, and T Cell Receptor Repertoire Diversity	PLOS ONE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; LONG-TERM EFFICACY; CONTROLLED-TRIAL; DOUBLE-BLIND; PHASE-III; MODERATE; SAFETY; ETANERCEPT; THERAPY; INDUCTION	Ustekinumab is a fully human IgG1 kappa monoclonal antibody targeting interleukin (IL)-12/23 p40 subunit. The role of IL-12/23-mediated pathway in the mechanism of various inflammatory disorders especially psoriasis has been well recognized. Recently the long-term efficacy and safety of ustekinumab in patients with moderate-to-severe psoriasis has been evaluated in phase 2/3 clinical trials, and the results showed no significant risk for serious adverse effects, infections, or malignancies. Ustekinumab inhibits the function of the IL-12/23 p40 subunit, and therefore it is believed that inhibition of IL-12 p40 pathway decreases IFN-gamma production. The major concern for the use of ustekinumab is the possibility of increased immunosuppression due to low IFN-gamma production. However, the effects of ustekinumab on CD4(+) T cell function have not been fully investigated so far. In this study, we explored changes in cytokine production by memory CD4(+) T cells as well as in the differentiation of naive T cells to helper T cell (Th) 1, Th2, or Th17 cells in psoriasis patients treated with ustekinumab. The effect of the treatment on T cell receptor repertoire diversity was also evaluated. The results showed that ustekinumab improves clinical manifestation in patients with psoriasis without affecting cytokine production in memory T cells, T cell maturation, or T cell receptor repertoire diversity. Although the number of patients is limited, the present study suggests that T cell immune response remains unaffected in psoriasis patients treated with ustekinumab. Citation: Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, et al. (2012) Ustekinumab Improves Psoriasis without Altering T Cell Cytokine Production, Differentiation, and T Cell Receptor Repertoire Diversity. PLoS ONE 7(12): e51819. doi:10.1371/journal.pone.0051819	[Tsuda, Kenshiro; Yamanaka, Keiichi; Kondo, Makoto; Matsubara, Kimiko; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Sasaki, Ryogen; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University	Yamanaka, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp		Gabazza, Esteban/0000-0001-5748-1499; Kondo, Makoto/0000-0003-1560-6067	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 24591647]; Grants-in-Aid for Scientific Research [23591643] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	K. Yamanaka (23591643) and H. Mizutani (24591647) receive grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors do not receive any financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J RHEUMATOL, V36, P914, DOI 10.3899/jrheum.081041; Alwawi EA, 2009, DERMATOL THER, V22, P431, DOI 10.1111/j.1529-8019.2009.01259.x; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Gordon KB, 2012, J AM ACAD DERMATOL, V66, P742, DOI 10.1016/j.jaad.2011.06.041; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hata H, 2004, INT IMMUNOL, V16, P1733, DOI 10.1093/intimm/dxh174; Igarashi A, 2012, J DERMATOL, V39, P242, DOI 10.1111/j.1346-8138.2011.01347.x; Kimball AB, 2012, BRIT J DERMATOL, V166, P861, DOI [10.1111/j.1365-2133.2011.10901.x, 10.1111/j.1365-2133.2012.10901.x]; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lebwohl M, 2012, J AM ACAD DERMATOL, V66, P731, DOI 10.1016/j.jaad.2011.06.011; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; STERN RS, 1995, J AM ACAD DERMATOL, V33, P44, DOI 10.1016/0190-9622(95)90008-X; Thaci D, 2008, BRIT J DERMATOL, V159, P18, DOI 10.1111/j.1365-2133.2008.08781.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tsuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031465; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamanaka K, 2010, ARCH DERMATOL RES, V302, P453, DOI 10.1007/s00403-009-1023-x; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044	30	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51819	10.1371/journal.pone.0051819	http://dx.doi.org/10.1371/journal.pone.0051819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251632	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800091
J	Wright, DJ; Holmes, P; Di Russo, F; Loporto, M; Smith, D				Wright, David J.; Holmes, Paul; Di Russo, Francesco; Loporto, Michela; Smith, Dave			Reduced Motor Cortex Activity during Movement Preparation following a Period of Motor Skill Practice	PLOS ONE			English	Article							POTENTIALS; ANATOMY; AREAS	Experts in a skill produce movement-related cortical potentials (MRCPs) of smaller amplitude and later onset than novices. This may indicate that, following long-term training, experts require less effort to plan motor skill performance. However, no longitudinal evidence exists to support this claim. To address this, EEG was used to study the effect of motor skill training on cortical activity related to motor planning. Ten non-musicians took part in a 5-week training study learning to play guitar. At week 1, the MRCP was recorded from motor areas whilst participants played the G Major scale. Following a period of practice of the scale, the MRCP was recorded again at week 5. Results showed that the amplitude of the later pre-movement components were smaller at week 5 compared to week 1. This may indicate that, following training, less activity at motor cortex sites is involved in motor skill preparation. This supports claims for a more efficient motor preparation following motor skill training. Citation: Wright DJ, Holmes P, Di Russo F, Loporto M, Smith D (2012) Reduced Motor Cortex Activity during Movement Preparation following a Period of Motor Skill Practice. PLoS ONE 7(12): e51886. doi:10.1371/journal.pone.0051886	[Wright, David J.; Holmes, Paul; Loporto, Michela; Smith, Dave] Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England; [Di Russo, Francesco] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Di Russo, Francesco] IRCCS, Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy	Manchester Metropolitan University; Foro Italico University of Rome; IRCCS Santa Lucia	Smith, D (corresponding author), Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England.	d.d.smith@mmu.ac.uk	Di Russo, Francesco/N-6686-2015	Di Russo, Francesco/0000-0002-3127-9433; Wright, David/0000-0001-9568-0237; Holmes, Paul/0000-0003-0821-3580	Manchester Metropolitan University through HEFCE RAE	Manchester Metropolitan University through HEFCE RAE	This research was funded by the Manchester Metropolitan University through HEFCE RAE quality rated research income. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Del Percio C, 2008, NEUROIMAGE, V42, P1544, DOI 10.1016/j.neuroimage.2008.05.061; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hatfield B, 2006, PSYCHOBIOLOGY PHYS A, P221; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kita Y, 2001, NEUROREPORT, V12, P2221, DOI 10.1097/00001756-200107200-00035; Koeneke S, 2004, NEUROREPORT, V15, P1279, DOI 10.1097/01.wnr.0000127463.10147.e7; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; LANG W, 1992, EXP BRAIN RES, V89, P435; Magill R.A, 2020, MOTOR LEARNING CONTR, V12th; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rockschool, 2008, GUIT GRAD 2; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; TAYLOR MJ, 1978, ELECTROEN CLIN NEURO, V45, P568, DOI 10.1016/0013-4694(78)90157-8; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; Wright DJ, 2012, HUM MOVEMENT SCI, V31, P567, DOI 10.1016/j.humov.2011.07.001; Wright DJ, 2011, J MOTOR BEHAV, V43, P193, DOI 10.1080/00222895.2011.557751	31	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51886	10.1371/journal.pone.0051886	http://dx.doi.org/10.1371/journal.pone.0051886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251647	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000312386800103
J	Hu, FL; Zhang, L; Zheng, J; Zhao, L; Huang, J; Shao, WW; Liao, QY; Ma, T; Geng, L; Yin, CC; Qiu, XY				Hu, Fanlei; Zhang, Li; Zheng, Jie; Zhao, Ling; Huang, Jing; Shao, Wenwei; Liao, Qinyuan; Ma, Teng; Geng, Li; Yin, C. Cameron; Qiu, Xiaoyan			Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA-CELLS; CHAIN CONSTANT-REGION; ALPHA HEAVY-CHAIN; CPG DNA; MESSENGER-RNA; TUMOR-CELLS; MOLECULAR-PATTERNS; CELLULAR INVASION	It is well known that B-1 B cells are the main cell type that is responsible for the production of natural immunoglobulin M (IgM) and can respond to infection by increasing IgM secretion. However, we unexpectedly found that some epithelial cells also can express rearranged IgM transcript that has natural IgM characteristics, such as germline-encoded and restricted rearrangement patterns. Here we studied IgM expression in human non-B cells and found that IgM was frequently expressed by many human epithelial cancer cells as well as non-cancer epithelial cells. Moreover, CD79A and CD79B, two molecules that are physically linked to membranous IgM on the surface of B cells to form the B cell antigen receptor complex, were also expressed on the cell surface of epithelial cancer cells and co-located with IgM. Like the natural IgM, the epithelial cancer cell-derived IgM recognized a series of microbial antigens, such as single-stranded DNA, double-stranded DNA, lipopolysaccharide, and the HEp-2 cell antigen. More important, stimulation of the toll-like receptor 9 (TLR9), which mimics bacterial infection, substantially increased the secretion of IgM in human epithelial cancer cells. These findings indicate that human epithelial cancer cells as well as non-cancer epithelial cells can spontaneously produce IgM with natural antibody activity.	[Hu, Fanlei] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Hu, Fanlei; Zhang, Li; Zheng, Jie; Huang, Jing; Shao, Wenwei; Liao, Qinyuan; Ma, Teng; Qiu, Xiaoyan] Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China; [Zhao, Ling; Geng, Li] Peking Univ, Hosp 3, Dept Gynaecol, Beijing 100871, Peoples R China; [Yin, C. Cameron] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Peking University; Peking University; Peking University; University of Texas System; UTMD Anderson Cancer Center	Qiu, XY (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China.	qiuxy@bjmu.edu.cn	ma, teng/C-3274-2014	ma, teng/0000-0003-2826-721X	National Natural Science Foundation of China [30973389, 30772470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30973389 and 30772470 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; FRITZ G, 1990, MUTAT RES, V244, P49, DOI 10.1016/0165-7992(90)90107-U; GOTHGOLDSTEIN R, 1987, CARCINOGENESIS, V8, P1449, DOI 10.1093/carcin/8.10.1449; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Ilvesaro JM, 2008, MOL CANCER RES, V6, P1534, DOI 10.1158/1541-7786.MCR-07-2005; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jego G, 2006, LEUKEMIA, V20, P1130, DOI 10.1038/sj.leu.2404226; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Landers CD, 2005, CLIN IMMUNOL, V116, P236, DOI 10.1016/j.clim.2005.04.013; Latz E, 2004, J ENDOTOXIN RES, V10, P406, DOI 10.1179/096805104225006525; Lee G, 2009, CANCER BIOMARK, V5, P137, DOI 10.3233/CBM-2009-0610; Lee S, 2004, J NEUROIMMUNOL, V153, P50, DOI 10.1016/j.jneuroim.2004.04.013; Li J, 2001, J PROTEIN CHEM, V20, P265, DOI 10.1023/A:1010912311564; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Liang H, 1996, J CLIN INVEST, V98, P1119, DOI 10.1172/JCI118894; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; MARTIN NH, 1969, J CLIN PATHOL, V22, P117, DOI 10.1136/jcp.22.2.117; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pisetsky DS, 1999, BIOCHEM PHARMACOL, V58, P1981, DOI 10.1016/S0006-2952(99)00294-4; Qiu XY, 2003, CANCER RES, V63, P6488; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Roberts TL, 2005, J IMMUNOL, V174, P605, DOI 10.4049/jimmunol.174.2.605; Sanada M, 2004, DNA REPAIR, V3, P413, DOI 10.1016/j.dnarep.2003.12.008; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schroering AG, 2009, CANCER RES, V69, P6307, DOI 10.1158/0008-5472.CAN-09-0899; Shimizu T, 2004, INT IMMUNOL, V16, P675, DOI 10.1093/intimm/dxh069; Stefani D V, 1971, Zh Mikrobiol Epidemiol Immunobiol, V48, P126; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tsuchimoto D, MUTAT RES, V703, P37; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wang LX, 2007, INT IMMUNOPHARMACOL, V7, P646, DOI 10.1016/j.intimp.2007.01.005; Yi AK, 1999, INT IMMUNOL, V11, P2015, DOI 10.1093/intimm/11.12.2015; Yi AK, 1996, J IMMUNOL, V157, P5394; Zhang QW, 2001, J PHARMACOL EXP THER, V298, P141; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	58	23	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51423	10.1371/journal.pone.0051423	http://dx.doi.org/10.1371/journal.pone.0051423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251529	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200104
J	Qiao, LN; Xie, L; Shi, K; Zhou, TF; Hua, YM; Liu, HM				Qiao, Lina; Xie, Liang; Shi, Kun; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin			Notch Signaling Change in Pulmonary Vascular Remodeling in Rats with Pulmonary Hypertension and Its Implication for Therapeutic Intervention	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL GROWTH-FACTOR; ARTERIAL-HYPERTENSION; IN-VITRO; DEPENDENT PATHWAY; PROGENITOR CELLS; CYCLE ARREST; FACTOR-BETA; ANGIOGENESIS; DIFFERENTIATION	Pulmonary hypertension (PH) is a fatal disease that lacks an effective therapy. Notch signaling pathway plays a crucial role in the angiogenesis and vascular remodeling. However, its roles in vascular remodeling in PH have not been well studied. In the current study, using hypoxia-induced PH model in rat, we examined the expression of Notch and its downstream factors. Then, we used vessel strip culture system and c-secretase inhibitor DAPT, a Notch signaling inhibitor to determine the effect of Notch signaling in vascular remodeling and its potential therapeutic value. Our results indicated that Notch 1-4 were detected in the lung tissue with variable levels in different cell types such as smooth muscle cells and endothelial cells of pulmonary artery, bronchia, and alveoli. In addition, following the PH induction, all of Notch1, Notch3, Notch4 receptor, and downstream factor, HERP1 in pulmonary arteries, mRNA expressions were increased with a peak at 1-2 weeks. Furthermore, the vessel wall thickness from rats with hypoxia treatment increased after cultured for 8 days, which could be decreased approximately 30% by DAPT, accompanied with significant increase of expression level of apoptotic factors (caspase-3 and Bax) and transformation of vascular smooth muscle cell (VSMC) phenotype from synthetic towards contractile. In conclusion, the current study suggested Notch pathway plays an important role in pulmonary vascular remodeling in PH and targeting Notch signaling pathway could be a valuable approach to design new therapy for PH.	[Qiao, Lina; Xie, Liang; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin] Sichuan Univ, W China Univ Hosp 2, Dept Pediat Cardiol, Chengdu 610064, Peoples R China; [Qiao, Lina; Xie, Liang; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin] Sichuan Univ, W China Univ Hosp 2, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, Chengdu 610064, Peoples R China; [Shi, Kun] Chengdu Women & Children Ctr Hosp, Dept Cardiol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Qiao, LN (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Pediat Cardiol, Chengdu 610064, Peoples R China.	iaqiao@163.com	Liu, Han/GVT-8296-2022		National Natural Science Foundation of China [30700913]; Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT" [IRT0935]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT"(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was supported by National Natural Science Foundation of China (30700913) and Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT" (IRT0935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, AM HEART J, V162, P201, DOI 10.1016/j.ahj.2011.05.012; Ahmed Zubair, 2009, V467, P3, DOI 10.1007/978-1-59745-241-0_1; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bordonaro M, 2011, EXP CELL RES, V317, P1368, DOI 10.1016/j.yexcr.2011.03.019; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; McLaughlin VV, 2011, EUR RESPIR REV, V20, P262, DOI 10.1183/09059180.00006411; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2007, AM J PHYSIOL-CELL PH, V292, pC488, DOI 10.1152/ajpcell.00337.2005; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2005, CIRC RES, V97, P102, DOI 10.1161/01.RES.0000174380.06673.81; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Qiao Li-na, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P766; [乔莉娜 QIAO LiNa], 2011, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V13, P503; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007572; Wang QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037365; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yamamoto M, 1997, HISTOCHEM CELL BIOL, V107, P279, DOI 10.1007/s004180050113; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yidiz P, 2009, CLIN CHIM ACTA, V403, P9, DOI 10.1016/j.cca.2009.01.018; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang YT, 2010, GLIA, V58, P964, DOI 10.1002/glia.20978; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	76	40	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51514	10.1371/journal.pone.0051514	http://dx.doi.org/10.1371/journal.pone.0051514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251561	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200127
J	Ramachandran, V; Malaisamy, M; Ponnaiah, M; Kaliaperuaml, K; Vadivoo, S; Gupte, MD				Ramachandran, Vidya; Malaisamy, Muniyandi; Ponnaiah, Manickam; Kaliaperuaml, Kanagasabai; Vadivoo, Selvaraj; Gupte, Mohan Digambar			Impact of Chikungunya on Health Related Quality of Life Chennai, South India	PLOS ONE			English	Article							VIRUS-INFECTION; REUNION ISLAND; EPIDEMIC; BURDEN; SF-36; FEVER	Background: Chikungunya Virus (CHIKV) infection affects large populations and leads to prolonged and debilitating pain affecting health related quality of life (HRQoL). We assess the impact of CHIKV on HRQoL of clinical CHIKV (C-CHIKV) patients in a suburban locality of Chennai City, South India. Further, we determined factors associated with clinical recovery among C-CHIKV patients. Methods: We followed-up 403 of 425 adult C-CHIKV cases identified during an outbreak. On the basis of a reassessment of their current clinical status through self-reporting, we categorized them as 'clinically recovered' (n = 308) or 'not recovered' (n = 95). In the absence of base-line information on HRQoL, we included a comparison group of healthy normal's recruited by frequency matching for age and sex from the neighbourhood (n = 308). We conducted a comparative cross-sectional study of these three groups and estimated HRQoL scores using SF-36 questionnaire. We tested the differences in the median scores by Kruksall Wallistest. We identified factors associated with 'recovery' as compared to not-recovery by calculating Adjusted Odds Ratio (AOR) and 95% Confidence Intervals through multiple regression analysis. Results: As compared to 'normals', we observed a 20 and five-fold reductions in HRQoL scores for C-CHIKV patients 'not recovered' and 'recovered' respectively. Differences in HRQoL scores for all the domains were statistically significant between three groups (p<0.001). Younger age, male, absence of rashes, affliction of less than five types of joints and two weeks of joint swelling were significantly associated with recovery. HRQoL scores improved with time among those 'clinically recovered'. Conclusion: This study provides evidence for sharp reductions in quality of life not only during active C-CHIKV associated illness but also for several months after clinical recovery compared to healthy normals. This has implications for developing intervention programmes in countries with high risk of CHIKV outbreaks.	[Ramachandran, Vidya; Ponnaiah, Manickam; Kaliaperuaml, Kanagasabai; Vadivoo, Selvaraj; Gupte, Mohan Digambar] Indian Council Med Res, Natl Inst Epidemiol, Training Div, Chennai, Tamil Nadu, India; [Malaisamy, Muniyandi] Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Ramachandran, V (corresponding author), Indian Council Med Res, Natl Inst Epidemiol, Training Div, Chennai, Tamil Nadu, India.	doctorvidya@gmail.com	Ponnaiah, Manickam/ABD-4622-2021	Ponnaiah, Manickam/0000-0002-0797-0822	intramural funds of National Institute of Epidemiology, Chennai	intramural funds of National Institute of Epidemiology, Chennai	This work was funded by intramural funds of National Institute of Epidemiology, Chennai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31; Indian Medical Association Epidemic Control cell, 2006, FACTS SHEETS CHIK; International Living, 2010, LEARN WE CALC QUAL L; Kaur P, 2008, EMERG INFECT DIS, V14, P1623, DOI 10.3201/eid1410.070569; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; SHAH KV, 1964, INDIAN J MED RES, V52, P676; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; WHO, 2006, GLOB AL RESP GAR CHI	16	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51519	10.1371/journal.pone.0051519	http://dx.doi.org/10.1371/journal.pone.0051519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251562	Green Published, gold			2022-12-25	WOS:000313236200128
J	Smith, CT; Stocken, DD; Dunn, J; Cox, T; Ghaneh, P; Cunningham, D; Neoptolemos, JP				Smith, Catrin Tudur; Stocken, Deborah D.; Dunn, Janet; Cox, Trevor; Ghaneh, Paula; Cunningham, David; Neoptolemos, John P.			The Value of Source Data Verification in a Cancer Clinical Trial	PLOS ONE			English	Article							DATA QUALITY; CONDUCT	Background: Source data verification (SDV) is a resource intensive method of quality assurance frequently used in clinical trials. There is no empirical evidence to suggest that SDV would impact on comparative treatment effect results from a clinical trial. Methods: Data discrepancies and comparative treatment effects obtained following 100% SDV were compared to those based on data without SDV. Overall survival (OS) and Progression-free survival (PFS) were compared using Kaplan-Meier curves, log-rank tests and Cox models. Tumour response classifications and comparative treatment Odds Ratios (ORs) for the outcome objective response rate, and number of Serious Adverse Events (SAEs) were compared. OS estimates based on SDV data were compared against estimates obtained from centrally monitored data. Findings: Data discrepancies were identified between different monitoring procedures for the majority of variables examined, with some variation in discrepancy rates. There were no systematic patterns to discrepancies and their impact was negligible on OS, the primary outcome of the trial (HR (95% CI): 1.18(0.99 to 1.41), p = 0.064 with 100% SDV; 1.18(0.99 to 1.42), p = 0.068 without SDV; 1.18(0.99 to 1.40), p = 0.073 with central monitoring). Results were similar for PFS. More extreme discrepancies were found for the subjective outcome overall objective response (OR (95% CI): 1.67(1.04 to 2.68), p = 0.03 with 100% SDV; 2.45(1.49 to 4.04), p = 0.0003 without any SDV) which was mostly due to differing CT scans. Interpretation: Quality assurance methods used in clinical trials should be informed by empirical evidence. In this empirical comparison, SDV was expensive and identified random errors that made little impact on results and clinical conclusions of the trial. Central monitoring using an external data source was a more efficient approach for the primary outcome of OS. For the subjective outcome objective response, an independent blinded review committee and tracking system to monitor missing scan data could be more efficient than SDV.	[Smith, Catrin Tudur] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Stocken, Deborah D.] Univ Birmingham, Birmingham Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England; [Dunn, Janet] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Cox, Trevor; Ghaneh, Paula; Neoptolemos, John P.] Univ Liverpool, Canc Res UK Liverpool Canc Trials Unit, Liverpool L69 3BX, Merseyside, England; [Cunningham, David] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England	University of Liverpool; University of Birmingham; University of Warwick; Cancer Research UK; University of Liverpool; Royal Marsden NHS Foundation Trust	Smith, CT (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	cat1@liv.ac.uk	Cox, Trevor F/E-5567-2013; Neoptolemos, John/HGU-7742-2022	Tudur Smith, Catrin/0000-0003-3051-1445; Stocken, Deborah/0000-0001-8031-1738; Dunn, Janet/0000-0001-7313-4446; Neoptolemos, John/0000-0002-6201-7399; Cunningham, David/0000-0001-5158-1069; Cox, Trevor/0000-0003-3045-5594	Medical Research Council [G0800792]; Cancer Research UK; Cancer Research UK [11883, 8968] Funding Source: researchfish; Medical Research Council [UD99999939] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CTS is supported by the Medical Research Council [grant number G0800792]. The cancer clinical trial was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PROSPECTIVE CLUSTER; [Anonymous], 1996, E6R1 INT C HARM TECH; [Anonymous], 2012, OPTIMISATION MONITOR; Baigent C, 2008, CLIN TRIALS, V5, P49, DOI 10.1177/1740774507087554; Bakobaki JM, 2012, CLIN TRIALS, V9, P257, DOI 10.1177/1740774511427325; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Clinical Trials Transformation Initiative (CTTI), 2012, EFF EFF MON COMP QUA; Eisenstein EL, 2005, AM HEART J, V149, P482, DOI 10.1016/j.ahj.2004.04.049; Favalli G, 2000, EUR J CANCER, V36, P1125, DOI 10.1016/S0959-8049(00)00090-3; Funning S, 2009, QUAL ASSUR J, V12, P3, DOI DOI 10.1002/QAJ.433; Lane JA, 2011, J CLIN EPIDEMIOL, V64, P628, DOI 10.1016/j.jclinepi.2010.10.003; Lienard JL, 2006, CLIN TRIALS, V3, P486, DOI 10.1177/1740774506070807; Morrison BW, 2011, CLIN TRIALS, V8, P342, DOI 10.1177/1740774511402703; MRC/DH/MHRA Joint Project, 2012, RISK AD APPR MAN CLI; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	15	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51623	10.1371/journal.pone.0051623	http://dx.doi.org/10.1371/journal.pone.0051623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251597	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200149
J	Yoneya, K; Uefune, M; Takabayashi, J				Yoneya, Kinuyo; Uefune, Masayoshi; Takabayashi, Junji			An Apparent Trade-Off between Direct and Signal-Based Induced Indirect Defence against Herbivores in Willow Trees	PLOS ONE			English	Article							INDUCED PLANT; VOLATILES; RESISTANCE; INDUCTION; RESPONSES; COSTS	Signal-based induced indirect defence refers to herbivore-induced production of plant volatiles that attract carnivorous natural enemies of herbivores. Relationships between direct and indirect defence strategies were studied using tritrophic systems consisting of six sympatric willow species, willow leaf beetles (Plagiodera versicolora), and their natural predators, ladybeetles (Aiolocaria hexaspilota). Relative preferences of ladybeetles for prey-infested willow plant volatiles, indicating levels of signal-based induced indirect defence, were positively correlated with the vulnerability of willow species to leaf beetles, assigned as relative levels of direct defence. This correlation suggested a possible trade-off among the species, in terms of resource limitation between direct defence and signal-based induced indirect defence. However, analyses of volatiles from infested and uninfested plants showed that the specificity of infested volatile blends (an important factor determining the costs of signal-based induced indirect defence) did not affect the attractiveness of infested plant volatiles. Thus, the suggested trade-off in resource limitation was unlikely. Rather, principal coordinates analysis showed that this 'apparent trade-off' between direct and signal-based induced indirect defence was partially explained by differential preferences of ladybeetles to infested plant volatiles of the six willow species. We also showed that relative preferences of ladybeetles for prey-infested willow plant volatiles were positively correlated with oviposition preferences of leaf beetles and with the distributions of leaf beetles in the field. These correlations suggest that ladybeetles use the specificity of infested willow plant volatiles to find suitable prey patches.	[Yoneya, Kinuyo; Uefune, Masayoshi; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Kyoto University	Takabayashi, J (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	junji@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Uefune, Masayoshi/0000-0002-9570-8938	Kyoto University; JSPS;  [19101009]	Kyoto University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was partly supported by a Grant-in-Aid for Scientific Research (S) (No. 19101009), by the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of Kyoto University, and by JSPS Core-to-Core project "Studies on ecological interaction networks that promote biodiversity -From gene to ecosystem-. KY was supported by a JSPS Research Fellowship for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; DAVIDSON DW, 1993, TRENDS ECOL EVOL, V8, P326, DOI 10.1016/0169-5347(93)90240-P; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Horikoshi M, 1997, J CHEM ECOL, V23, P1505, DOI 10.1023/B:JOEC.0000006418.49537.5d; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Maeda T, 2001, APPL ENTOMOL ZOOL, V36, P47, DOI 10.1303/aez.2001.47; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MOLE S, 1994, OIKOS, V71, P3, DOI 10.2307/3546166; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Sabelis M. W., 1992, INSECT CHEM ECOLOGY, P122; Schoonhoven L. M., 2005, Insect-plant biology; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; TAKABAYASHI J, 1991, PHYTOCHEMISTRY, V30, P1459, DOI 10.1016/0031-9422(91)84186-V; Turlings Ted C. J., 2002, P148, DOI 10.1017/CBO9780511542190.007; van Ballegooijen WM, 2004, P NATL ACAD SCI USA, V101, P18246, DOI 10.1073/pnas.0405682101; Yoneya K, 2009, PHYSIOL ENTOMOL, V34, P379, DOI 10.1111/j.1365-3032.2009.00701.x	29	10	13	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51505	10.1371/journal.pone.0051505	http://dx.doi.org/10.1371/journal.pone.0051505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251559	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200126
J	Adnan, H; Quach, H; MacIntosh, K; Antenos, M; Kirby, GM				Adnan, Humaira; Quach, Holly; MacIntosh, Kimberley; Antenos, Monica; Kirby, Gordon M.			Low Levels of GSTA1 Expression Are Required for Caco-2 Cell Proliferation	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; COLON-CANCER CELLS; LINE CACO-2; OXIDATIVE STRESS; EPITHELIAL-CELLS; SODIUM-BUTYRATE; PPAR-GAMMA; IN-VITRO; APOPTOSIS; DIFFERENTIATION	The colonic epithelium continuously regenerates with transitions through various cellular phases including proliferation, differentiation and cell death via apoptosis. Human colonic adenocarcinoma (Caco-2) cells in culture undergo spontaneous differentiation into mature enterocytes in association with progressive increases in expression of glutathione S-transferase alpha-1 (GSTA1). We hypothesize that GSTA1 plays a functional role in controlling proliferation, differentiation and apoptosis in Caco-2 cells. We demonstrate increased GSTA1 levels associated with decreased proliferation and increased expression of differentiation markers alkaline phosphatase, villin, dipeptidyl peptidase-4 and E-cadherin in postconfluent Caco-2 cells. Results of MTS assays, BrdU incorporation and flow cytometry indicate that forced expression of GSTA1 significantly reduces cellular proliferation and siRNA-mediated down-regulation of GSTA1 significantly increases cells in S-phase and associated cell proliferation. Sodium butyrate (NaB) at a concentration of 1 mM reduces Caco-2 cell proliferation, increases differentiation and increases GSTA1 activity 4-fold by 72 hours. In contrast, 10 mM NaB causes significant toxicity in preconfluent cells via apoptosis through caspase-3 activation with reduced GSTA1 activity. However, GSTA1 down-regulation by siRNA does not alter NaB-induced differentiation or apoptosis in Caco-2 cells. While 10 mM NaB causes GSTA1-JNK complex dissociation, phosphorylation of JNK is not altered. These findings suggest that GSTA1 levels may play a role in modulating enterocyte proliferation but do not influence differentiation or apoptosis.	[Adnan, Humaira; Quach, Holly; MacIntosh, Kimberley; Antenos, Monica; Kirby, Gordon M.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Kirby, GM (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	gkirby@uoguelph.ca	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911	Canadian Institutes of Health Research [86499]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (grant number 86499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AGARWAL R, 1992, BIOCHEM PHARMACOL, V44, P2047, DOI 10.1016/0006-2952(92)90108-U; Balogh LM, 2008, J BIOL CHEM, V283, P16702, DOI 10.1074/jbc.M801725200; Bull AW, 2003, CARCINOGENESIS, V24, P1717, DOI 10.1093/carcin/bgg131; Burg D, 2006, BIOCHEM PHARMACOL, V71, P268, DOI 10.1016/j.bcp.2005.11.003; Castro-Caldas M, 2009, NEUROSCI LETT, V451, P241, DOI 10.1016/j.neulet.2009.01.017; CHANTRET I, 1994, J CELL SCI, V107, P213; Chopra DP, 2010, STEM CELLS DEV, V19, P131, DOI 10.1089/scd.2009.0109; Dzierzewicz Z, 2002, ACTA BIOCHIM POL, V49, P211; Ebert MN, 2003, CARCINOGENESIS, V24, P1637, DOI 10.1093/carcin/bgg122; Ferruzza S, 2011, TOXICOL IN VITRO; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Hokaiwado N, 2008, CARCINOGENESIS, V29, P1134, DOI 10.1093/carcin/bgn097; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Liang FQ, 2005, EXP EYE RES, V80, P113, DOI 10.1016/j.exer.2004.08.017; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Louis M, 2004, INT J ONCOL, V25, P1701; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Mariadason JM, 2001, GASTROENTEROLOGY, V120, P889, DOI 10.1053/gast.2001.22472; Matthews GM, 2012, CHEMOTHERAPY, V58, P102, DOI 10.1159/000335672; Menard D, 2004, CAN J GASTROENTEROL, V18, P39, DOI 10.1155/2004/640897; Ng L, 2007, MOL PHARMACOL, V71, P201, DOI 10.1124/mol.106.028563; Orchel A, 2005, DIGEST DIS SCI, V50, P490, DOI 10.1007/s10620-005-2463-6; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; Pshezhetsky AV, 2007, PROTEOMICS, V7, P2201, DOI 10.1002/pmic.200600956; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Scharmach E, 2009, TOXICOLOGY, V265, P122, DOI 10.1016/j.tox.2009.09.017; Schwab M, 2006, APOPTOSIS, V11, P1801, DOI 10.1007/s10495-006-9788-2; Sharma A, 2006, ARCH BIOCHEM BIOPHYS, V452, P165, DOI 10.1016/j.abb.2006.04.006; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Stokrova J, 2006, INT J ONCOL, V28, P559; Tetlow N, 2004, PHARMACOGENETICS, V14, P657, DOI 10.1097/00008571-200410000-00003; Townsend DM, 2005, METHOD ENZYMOL, V401, P287, DOI 10.1016/S0076-6879(05)01019-0; Turella P, 2005, CANCER RES, V65, P3751, DOI 10.1158/0008-5472.CAN-04-3903; Uchida K, 2000, MECH AGEING DEV, V116, P135, DOI 10.1016/S0047-6374(00)00129-9	42	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51739	10.1371/journal.pone.0051739	http://dx.doi.org/10.1371/journal.pone.0051739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251616	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900117
J	Ajelli, M; Merler, S				Ajelli, Marco; Merler, Stefano			Transmission Potential and Design of Adequate Control Measures for Marburg Hemorrhagic Fever	PLOS ONE			English	Article							VIRUS-DISEASE; NONHUMAN-PRIMATES; INFLUENZA; OUTBREAK; EBOLA; STRATEGIES; EPIDEMIC; ANGOLA	Marburg hemorrhagic fever is rare yet among the most severe diseases affecting humans, with case fatality ratio even higher than 80%. By analyzing the largest documented Marburg hemorrhagic fever epidemic, which occurred in Angola in 2005 and caused 329 deaths, and data on viral load over time in non-human primates, we make an assessment of transmissibility and severity of the disease. We also give insight into the control of new Marburg hemorrhagic fever epidemics to inform appropriate health responses. We estimated the distribution of the generation time to have mean 9 days (95%CI: 8.2-10 days) and standard deviation 5.4 days (95%CI: 3.9-8.6 days), and the basic reproduction number to be R-0 = 1.59 (95%CI: 1.53-1.66). Model simulations suggest that a timely isolation of cases, starting no later than 2-3 days after symptoms onset, is sufficient to contain an outbreak. Our analysis reveals that Marburg hemorrhagic fever is characterized by a relatively small reproduction number and by a relatively long generation time. Such factors, along with the extremely high severity and fatality, support the rare occurrence of large epidemics in human populations. Our results also support the effectiveness of social distancing measures - case isolation in particular - to contain or at least to mitigate an emerging outbreak. This work represents an advance in the knowledge required to manage a potential Marburg hemorrhagic fever epidemic.	[Ajelli, Marco; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy	Fondazione Bruno Kessler	Ajelli, M (corresponding author), Bruno Kessler Fdn, Trento, Italy.	ajelli@fbk.eu	Ajelli, Marco/AAX-1113-2020; merler, stefano/I-3557-2017	Ajelli, Marco/0000-0003-1753-4749; merler, stefano/0000-0002-5117-0611	European Union FP7 EPIWORK project [231807]	European Union FP7 EPIWORK project	The authors thank the European Union FP7 EPIWORK project (contract no. 231807) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2011, EPIDEMIOL INFECT, V139, P68, DOI 10.1017/S0950268810001317; ANDERSON R M, 1991; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Bettencourt L.M., 2009, MATH STAT ESTIMATION, P143; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Embassy of Angola, 2011, PROV UIG; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Grolla A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001183; Jeffs B, 2007, J INFECT DIS, V196, pS154, DOI 10.1086/520548; Johnson ED, 1996, ARCH VIROL, P101; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kolokol'tsov AA, 2001, B EXP BIOL MED+, V132, P686, DOI 10.1023/A:1012540614713; Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P219, DOI 10.1053/j.spid.2005.05.001; MARTINI GA, 1973, POSTGRAD MED J, V49, P542, DOI 10.1136/pgmj.49.574.542; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Merler S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-117; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nishiura H, 2009, EUROSURVEILLANCE, V14; Rizzo C, 2011, VACCINE, V29, pB27, DOI 10.1016/j.vaccine.2011.02.049; SMITH DH, 1982, LANCET, V1, P816; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090051, 10.3201/eid1508.090015]; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; U.S. Census Bureau, 2012, INT DAT BAS; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; World Health Organization, 2008, MARB HAEM FEV ANG; World Health Organization, 2008, MARB HAEM FEV; World Health Organization, 2008, GLOB AL RESP MARB HA	47	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50948	10.1371/journal.pone.0050948	http://dx.doi.org/10.1371/journal.pone.0050948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251407	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900028
J	Low, JL; Naidoo, A; Yeo, G; Gehring, AJ; Ho, ZZ; Yau, YH; Shochat, SG; Kranz, DM; Bertoletti, A; Grotenbreg, GM				Low, Jianrong L.; Naidoo, Anneta; Yeo, Gladys; Gehring, Adam J.; Ho, Zi Zong; Yau, Yin Hoe; Shochat, Susana G.; Kranz, David M.; Bertoletti, Antonio; Grotenbreg, Gijsbert M.			Binding of TCR Multimers and a TCR-Like Antibody with Distinct Fine-Specificities Is Dependent on the Surface Density of HLA Complexes	PLOS ONE			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEXES; HEPATITIS-B-VIRUS; CLASS-I COMPLEXES; PEPTIDE-MHC; HIGH-AFFINITY; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODY; LIGAND RECOGNITION; VIRAL PEPTIDE	Class I Major Histocompatibility Complex (MHC) molecules evolved to sample degraded protein fragments from the interior of the cell, and to display them at the surface for immune surveillance by CD8(+) T cells. The ability of these lymphocytes to identify immunogenic peptide-MHC (pMHC) products on, for example, infected hepatocytes, and to subsequently eliminate those cells, is crucial for the control of hepatitis B virus (HBV). Various protein scaffolds have been designed to recapitulate the specific recognition of presented antigens with the aim to be exploited both diagnostically (e. g. to visualize cells exposed to infectious agents or cellular transformation) and therapeutically (e. g. for the delivery of drugs to compromised cells). In line with this, we report the construction of a soluble tetrameric form of an alpha beta T cell receptor (TCR) specific for the HBV epitope Env(183-191) restricted by HLA-A*02:01, and compare its avidity and fine-specificity with a TCR-like monoclonal antibody generated against the same HLA target. A flow cytometry-based assay with streptavidin-coated beads loaded with Env(183-191)/HLA-A*02: 01 complexes at high surface density, enabled us to probe the specific interaction of these molecules with their cognate pMHC. We demonstrate that the TCR tetramer has similar avidity for the pMHC as the antibody, but they differ in their fine-specificity, with only the TCR tetramer being capable of binding both natural variants of the Env(183-191) epitope found in HBV genotypes A/C/D (187Arg) and genotype B (187Lys). Collectively, the results highlight the promiscuity of our soluble TCR, which could be an advantageous feature when targeting cells infected with a mutation-prone virus, but that binding of the soluble oligomeric TCR relies considerably on the surface density of the presented antigen.	[Yeo, Gladys; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Low, Jianrong L.; Naidoo, Anneta; Gehring, Adam J.; Ho, Zi Zong; Bertoletti, Antonio] ASTAR, Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore; [Low, Jianrong L.; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biol Sci, Singapore 117595, Singapore; [Bertoletti, Antonio] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Yeo, Gladys; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Yau, Yin Hoe; Shochat, Susana G.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grotenbreg, GM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore.	grotenbreg@nus.edu.sg	Hoe, YAU Yin/A-2817-2011; Bertoletti, Antonio/AAD-4830-2022	Hoe, YAU Yin/0000-0001-8136-2393; Bertoletti, Antonio/0000-0002-2942-0485; Gehring, Adam/0000-0003-1150-5840	Agency for Science Technology and Research (A*Star), Singapore; Singapore National Research Foundation (NRF) Research Fellowship [NRF2007NRF-RF001-226]	Agency for Science Technology and Research (A*Star), Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation (NRF) Research Fellowship(National Research Foundation, Singapore)	This work was supported by the Agency for Science Technology and Research (A*Star), Singapore and the Singapore National Research Foundation (NRF) Research Fellowship (NRF2007NRF-RF001-226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Biddison WE, 2003, J IMMUNOL, V171, P3064, DOI 10.4049/jimmunol.171.6.3064; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chew SL, 2011, J BIOL CHEM, V286, P28466, DOI 10.1074/jbc.M111.262691; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; GUILHOT S, 1992, J VIROL, V66, P2670, DOI 10.1128/JVI.66.5.2670-2678.1992; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Ji C, 2012, HEPATOLOGY; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; MATKO J, 1994, J IMMUNOL, V152, P3353; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Messaoudi I, 1999, J IMMUNOL, V163, P3286; MURPHY DB, 1992, J IMMUNOL, V148, P3483; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sastry KSR, 2011, J VIROL, V85, P1935, DOI 10.1128/JVI.01990-10; Schodin BA, 1996, MOL IMMUNOL, V33, P819, DOI 10.1016/0161-5890(96)00038-7; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Subbramanian RA, 2004, NAT BIOTECHNOL, V22, P1429, DOI 10.1038/nbt1024; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Zhu X, 2006, J IMMUNOL, V176, P3223, DOI 10.4049/jimmunol.176.5.3223	58	2	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51397	10.1371/journal.pone.0051397	http://dx.doi.org/10.1371/journal.pone.0051397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251518	Green Published, gold			2022-12-25	WOS:000312201900078
J	Moss, FJM; Baddeley, R; Canagarajah, N				Moss, Felix Joseph Mercer; Baddeley, Roland; Canagarajah, Nishan			Eye Movements to Natural Images as a Function of Sex and Personality	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINE-RECEPTORS; GAZE; MODEL; FACES; IMPULSIVITY; PERFORMANCE; OBSERVERS; SELECTION; ESTROGEN	Women and men are different. As humans are highly visual animals, these differences should be reflected in the pattern of eye movements they make when interacting with the world. We examined fixation distributions of 52 women and men while viewing 80 natural images and found systematic differences in their spatial and temporal characteristics. The most striking of these was that women looked away and usually below many objects of interest, particularly when rating images in terms of their potency. We also found reliable differences correlated with the images' semantic content, the observers' personality, and how the images were semantically evaluated. Information theoretic techniques showed that many of these differences increased with viewing time. These effects were not small: the fixations to a single action or romance film image allow the classification of the sex of an observer with 64% accuracy. While men and women may live in the same environment, what they see in this environment is reliably different. Our findings have important implications for both past and future eye movement research while confirming the significant role individual differences play in visual attention.	[Moss, Felix Joseph Mercer; Canagarajah, Nishan] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Baddeley, Roland] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England	University of Bristol; University of Bristol	Moss, FJM (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	F.MercerMoss@Bristol.ac.uk			Engineering and Physical Sciences Research Counsel (EPSRC); British Telecom	Engineering and Physical Sciences Research Counsel (EPSRC); British Telecom	The funding for this research was from a combination of the Engineering and Physical Sciences Research Counsel (EPSRC) and British Telecom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2000, NEUROSCI BIOBEHAV R, V24, P137, DOI 10.1016/S0149-7634(99)00044-5; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Campbell R, 1996, VIS COGN, V3, P393, DOI 10.1080/135062896395643; Conway CA, 2007, HORM BEHAV, V51, P202, DOI 10.1016/j.yhbeh.2006.10.002; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Daniel JM, 2006, HORM BEHAV, V49, P38, DOI 10.1016/j.yhbeh.2005.05.001; Deligianni F, 2011, DEV PSYCHOL, V47, P1499, DOI 10.1037/a0025659; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gur RC, 1999, J NEUROSCI, V19, P4065; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isaacowitz DM, 2005, PERS SOC PSYCHOL B, V31, P407, DOI 10.1177/0146167204271599; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Leonards U, 2007, CURR BIOL, V17, pR8, DOI 10.1016/j.cub.2006.11.046; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Osgood C.E., 1957, MEASUREMENT MEANING; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Rijpkema M, 2011, HUM BRAIN MAPP; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; VANHARTESVELDT C, 1986, NEUROSCI BIOBEHAV R, V10, P1, DOI 10.1016/0149-7634(86)90029-1; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Vincent BT, 2009, VIS COGN, V17, P856, DOI 10.1080/13506280902916691; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	34	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e47870	10.1371/journal.pone.0047870	http://dx.doi.org/10.1371/journal.pone.0047870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23248740	Green Published, gold, Green Submitted			2022-12-25	WOS:000312376100009
J	Sabat, J; Egawa, T; Lu, CY; Stuehr, DJ; Gerfen, GJ; Rousseau, DL; Yeh, SR				Sabat, Joseph; Egawa, Tsuyoshi; Lu, Changyuan; Stuehr, Dennis J.; Gerfen, Gary J.; Rousseau, Denis L.; Yeh, Syun-Ru			Catalytic Intermediates of Inducible Nitric-oxide Synthase Stabilized by the W188H Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; LIGAND-PROTEIN INTERACTIONS; FE-S BOND; COMPOUND-I; CYTOCHROME P450CAM; HEME DOMAIN; NO-SYNTHASE; RAMAN-SPECTROSCOPY; L-ARGININE; 2ND STEP	Nitric-oxide synthase (NOS) catalyzes nitric oxide (NO) synthesis via a two-step process: L-arginine (L-Arg)-> N-hydroxy-L-arginine -> citrulline + NO. In the active site the heme is coordinated by a thiolate ligand, which accepts a H-bond from a nearby tryptophan residue, Trp-188. Mutation of Trp-188 to histidine in murine inducible NOS was shown to retard NO synthesis and allow for transient accumulation of a new intermediate with a Soret maximum at 420 nm during the L-Arg hydroxylation reaction (Tejero, J., Biswas, A., Wang, Z. Q., Page, R. C., Haque, M. M., Hemann, C., Zweier, J. L., Misra, S., and Stuehr, D. J. (2008) J. Biol. Chem. 283, 33498-33507). However, crystallographic data showed that the mutation did not perturb the overall structure of the enzyme. To understand how the proximal mutation affects the oxygen chemistry, we carried out biophysical studies of the W188H mutant. Our stopped-flow data showed that the 420-nm intermediate was not only populated during the L-Arg reaction but also during the N-hydroxy-L-arginine reaction. Spectroscopic data and structural analysis demonstrated that the 420-nm intermediate is a hydroxide-bound ferric heme species that is stabilized by an out-of-plane distortion of the heme macrocycle and a cation radical centered on the tetrahydrobiopterin cofactor. The current data add important new insights into the previously proposed catalytic mechanism of NOS (Li, D., Kabir, M., Stuehr, D. J., Rousseau, D. L., and Yeh, S. R. (2007) J. Am. Chem. Soc. 129, 6943-6951).	[Sabat, Joseph; Egawa, Tsuyoshi; Lu, Changyuan; Gerfen, Gary J.; Rousseau, Denis L.; Yeh, Syun-Ru] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation	Yeh, SR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	syun-ru.yeh@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health [GM54806, F31GM078679, CA53914, GM51491, HL76491]; National Science Foundation [NSF1026788, NSF0956358]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098799, R01GM051491, R01GM054806, T32GM007288, F31GM078679, R01GM086482] Funding Source: NIH RePORTER; Division Of Chemistry [1026788] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54806 (to D. L. R.), F31GM078679 (to J. S.), and CA53914, GM51491, and HL76491 (to D. J. S.). This work was also supported by National Science Foundation Grants NSF1026788 (to D. L. R.) and NSF0956358 (to S.-R. Y.).	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Baka E, 2008, J PHARMACEUT BIOMED, V46, P335, DOI 10.1016/j.jpba.2007.10.030; Bec N, 2000, J INORG BIOCHEM, V81, P207, DOI 10.1016/S0162-0134(00)00104-5; CHAMPION PM, 1982, J AM CHEM SOC, V104, P5469, DOI 10.1021/ja00384a037; Cho KB, 2009, J PHYS CHEM B, V113, P336, DOI 10.1021/jp8073199; Couture M, 2001, J BIOL CHEM, V276, P38280; Czernuszewicz RS, 1996, INORG CHEM, V35, P199, DOI 10.1021/ic950749o; CZERNUSZEWICZ RS, 1989, J AM CHEM SOC, V111, P7024, DOI 10.1021/ja00200a019; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Davydov R, 2009, J AM CHEM SOC, V131, P14493, DOI 10.1021/ja906133h; Denisov IG, 2008, J PHYS CHEM A, V112, P13172, DOI 10.1021/jp8017875; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Egawa T, 2001, J BIOL INORG CHEM, V6, P46, DOI 10.1007/s007750000181; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Giroud C, 2010, J BIOL CHEM, V285, P7233, DOI 10.1074/jbc.M109.038240; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Hurshman AR, 2002, BIOCHEMISTRY-US, V41, P3439, DOI 10.1021/bi012002h; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; Jung C, 2005, MAGN RESON CHEM, V43, pS84, DOI 10.1002/mrc.1694; Kabir M, 2008, BIOCHEMISTRY-US, V47, P12389, DOI 10.1021/bi801491e; Krymov V, 2003, J MAGN RESON, V162, P466, DOI 10.1016/S1090-7807(03)00109-5; Lang J, 2011, BIOCHEMISTRY-US, V50, P10069, DOI 10.1021/bi200965e; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Lin Y, 2003, ANAL CHEM, V75, P5381, DOI 10.1021/ac0346205; Martin NI, 2007, J AM CHEM SOC, V129, P12563, DOI 10.1021/ja0746159; Mathieu D, 2004, CHEM COMMUN, P54, DOI 10.1039/b312441j; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Spolitak T, 2008, J BIOL INORG CHEM, V13, P599, DOI 10.1007/s00775-008-0348-9; Stoll S, 2010, J AM CHEM SOC, V132, P11812, DOI 10.1021/ja105372s; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Woodward JJ, 2010, J AM CHEM SOC, V132, P5105, DOI 10.1021/ja909378n; Woodward JJ, 2009, J AM CHEM SOC, V131, P297, DOI 10.1021/ja807299t; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	55	13	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6095	6106		10.1074/jbc.M112.403238	http://dx.doi.org/10.1074/jbc.M112.403238			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23269673	Green Published, hybrid			2022-12-25	WOS:000315820700007
J	Basu, M; Roy, SS				Basu, Moitri; Roy, Sib Sankar			Wnt/beta-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT-SIGNALING PATHWAY; BETA-CATENIN; DIFFERENTIAL EXPRESSION; GROWTH-FACTOR; GENE; MUTATIONS; RECEPTOR; IDENTIFICATION; TRANSCRIPTION; ISOFORMS	Pituitary homeobox-2 (PITX2) plays a substantial role in the development of pituitary, heart, and brain. Although the role of PITX2 isoforms in embryonic development has been extensively studied, its possible involvement in regulating the Wnt signaling pathway has not been reported. Because the Wnt pathway is strongly involved in ovarian development and cancer, we focused on the possible association between PITX2 and Wnt pathway in ovarian carcinoma cells. Remarkably, we found that PITX2 interacts and regulates WNT2/5A/9A/6/2B genes of the canonical, noncanonical, or other pathways in the human ovarian cancer cell SKOV-3. Chromatin immunoprecipitation and promoter-reporter assays further indicated the significant association of PITX2 with WNT2 and WNT5A promoters. Detailed study further reveals that the PITX2 isoform specifically activates the canonical Wnt signaling pathway either directly or through Wnt ligands. Thus, the activated Wnt pathway subsequently enhances cell proliferation. Moreover, we found the activation of Wnt pathway reduces the expression of different FZD receptors that limit further Wnt activation, demonstrating the existence of an auto-regulatory feedback loop. In contrast, PITX2 could not activate the noncanonical pathway as the Wnt5A-specific ROR2 receptor does not express in SKOV-3 cells. Collectively, our findings demonstrated that, despite being a target of the canonical Wnt signaling pathway, PITX2 itself induces the same, thus leading to the activation of the cell cycle regulating genes as well as the proliferation of SKOV-3 cells. Collectively, we highlighted that the PITX2 and Wnt pathway exerts a positive feedback regulation, whereas frizzled receptors generate a negative feedback in this pathway. Our findings will help to understand the molecular mechanism of proliferation in ovarian cancer cells.	[Basu, Moitri; Roy, Sib Sankar] Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roy, SS (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja Subodh Chandra Mullick Rd, Kolkata 700032, India.	sibsankar@iicb.res.in			Council of Scientific and Industrial Research, Government of India [BSC 0101, 10-2(5)/2007(II)-E.UII]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Council of Scientific and Industrial Research, Government of India, Grant BSC 0101.; Recipient of Fellowship Award 10-2(5)/2007(II)-E.UII from the Council of Scientific and Industrial Research, Government of India.	Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cui J, 2003, J GASTROEN HEPATOL, V18, P280, DOI 10.1046/j.1440-1746.2003.02973.x; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Hirose H, 2011, ANN SURG ONCOL, V18, P3005, DOI 10.1245/s10434-011-1653-z; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Karbova E, 2002, INT J SURG PATHOL, V10, P175, DOI 10.1177/106689690201000302; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Palacios J, 1998, CANCER RES, V58, P1344; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Roy SS, 2003, ENDOCRINOLOGY, V144, P1585, DOI 10.1210/en.2002-220350; Sagae S, 1999, JPN J CANCER RES, V90, P510, DOI 10.1111/j.1349-7006.1999.tb00777.x; Saha SK, 2005, ENDOCRINOLOGY, V146, P2963, DOI 10.1210/en.2004-1440; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Vinarskaja A., 2011, UROL ONCOL IN PRESS; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	51	54	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4355	4367		10.1074/jbc.M112.409102	http://dx.doi.org/10.1074/jbc.M112.409102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250740	Green Published, hybrid			2022-12-25	WOS:000314845000063
J	Frischmann, A; Neudl, S; Gaderer, R; Bonazza, K; Zach, S; Gruber, S; Spadiut, O; Friedbacher, G; Grothe, H; Seidl-Seiboth, V				Frischmann, Alexa; Neudl, Susanna; Gaderer, Romana; Bonazza, Klaus; Zach, Simone; Gruber, Sabine; Spadiut, Oliver; Friedbacher, Gernot; Grothe, Hinrich; Seidl-Seiboth, Verena			Self-assembly at Air/Water Interfaces and Carbohydrate Binding Properties of the Small Secreted Protein EPL1 from the fungus Trichoderma atroviride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-SP PLATANI; CERATO-PLATANIN; SYSTEMIC RESISTANCE; COCCIDIOIDES-IMMITIS; CELL-WALLS; EXPRESSION; FAMILY; REESEI; GENE; TRANSFORMATION	The protein EPL1 from the fungus Trichoderma atroviride belongs to the cerato-platanin protein family. These proteins occur only in filamentous fungi and are associated with the induction of defense responses in plants and allergic reactions in humans. However, fungi with other lifestyles also express cerato-platanin proteins, and the primary function of this protein family has not yet been elucidated. In this study, we investigated the biochemical properties of the cerato-platanin protein EPL1 from T. atroviride. Our results showed that EPL1 readily self-assembles at air/water interfaces and forms protein layers that can be redissolved in water. These properties are reminiscent of hydrophobins, which are amphiphilic fungal proteins that accumulate at interfaces. Atomic force microscopy imaging showed that EPL1 assembles into irregular meshwork-like substructures. Furthermore, surface activity measurements with EPL1 revealed that, in contrast to hydrophobins, EPL1 increases the polarity of aqueous solutions and surfaces. In addition, EPL1 was found to bind to various forms of polymeric chitin. The T. atroviride genome contains three epl genes. epl1 was predominantly expressed during hyphal growth, whereas epl2 was mainly expressed during spore formation, suggesting that the respective proteins are involved in different biological processes. For epl3, no gene expression was detected under most growth conditions. Single and double gene knock-out strains of epl1 and epl2 did not reveal a detectable phenotype, showing that these proteins are not essential for fungal growth and development despite their abundant expression.	[Frischmann, Alexa; Gaderer, Romana; Zach, Simone; Gruber, Sabine; Seidl-Seiboth, Verena] Vienna Univ Technol, Res Area Biotechnol & Microbiol, Inst Chem Engn, A-1060 Vienna, Austria; [Spadiut, Oliver] Vienna Univ Technol, Res Area Biochem Engn, Inst Chem Engn, A-1060 Vienna, Austria; [Neudl, Susanna; Grothe, Hinrich] Vienna Univ Technol, Inst Mat Chem, A-1060 Vienna, Austria; [Bonazza, Klaus; Friedbacher, Gernot] Vienna Univ Technol, Inst Chem Technol & Analyt, A-1060 Vienna, Austria	Technische Universitat Wien; Technische Universitat Wien; Technische Universitat Wien; Technische Universitat Wien	Seidl-Seiboth, V (corresponding author), Vienna Univ Technol, Res Area Biotechnol & Microbiol, Inst Chem Engn, Gumpendorfer Str 1A, A-1060 Vienna, Austria.	verena.seidl@tuwien.ac.at	Grothe, Hinrich/D-8097-2013; Gruber, Sabine/AAD-5734-2021	Grothe, Hinrich/0000-0002-2715-1429; Gruber, Sabine/0000-0001-6232-763X	Austrian Science Fund (FWF) [T390]; OMV AG	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); OMV AG	This work was supported by Austrian Science Fund (FWF) Grant T390 (to V. S.-S.).; We thank OMV AG for its financial support in funding of the contact angle measurement device DSA 100. Field emission gun scanning electron microscopy imaging was carried out using facilities at the University Service Centre for Transmission Electron Microscopy (USTEM), Vienna University of Technology, Austria.	Askohn S, 2005, FEMS MICROBIOL LETT, V253, P281, DOI 10.1016/j.femsle.2005.09.047; Baccelli I, 2012, FEMS MICROBIOL LETT, V327, P155, DOI 10.1111/j.1574-6968.2011.02475.x; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; COLE GT, 1989, INFECT IMMUN, V57, P1524, DOI 10.1128/IAI.57.5.1524-1534.1989; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Gruber S, 2011, GLYCOBIOLOGY, V21, P122, DOI 10.1093/glycob/cwq142; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kurup VP, 2000, CLIN EXP ALLERGY, V30, P988, DOI 10.1046/j.1365-2222.2000.00837.x; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Ruiz-Herrera J., 1991, FUNGAL CELL WALL STR, P92; SAMBROOK J, 2001, MOL CLONING LAB MANU, P74; Scala A, 2004, J PLANT PATHOL, V86, P27; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Seidl V, 2004, FUNGAL GENET BIOL, V41, P1132, DOI 10.1016/j.fgb.2004.09.002; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Shang JY, 2010, COLLOID SURFACE A, V353, P1, DOI 10.1016/j.colsurfa.2009.10.013; Sharen A. L., 1970, PHYTOPATHOLOGY, V60, P1480; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yang D, 2010, COLLOID SURFACE A, V367, P174, DOI 10.1016/j.colsurfa.2010.07.008; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x	34	64	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4278	4287		10.1074/jbc.M112.427633	http://dx.doi.org/10.1074/jbc.M112.427633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250741	Green Published, hybrid			2022-12-25	WOS:000314845000056
J	Li, TT; Wang, HH; Sun, YM; Zhao, LN; Gang, Y; Guo, XG; Huang, R; Yang, ZP; Pan, YL; Wu, KC; Xu, L; Liu, ZG; Fan, DM				Li, Tingting; Wang, Honghong; Sun, Yimin; Zhao, Lina; Gang, Yi; Guo, Xuegang; Huang, Rei; Yang, Zhiping; Pan, Yanglin; Wu, Kaichun; Xu, Li; Liu, Zhiguo; Fan, Daiming			Transcription Factor CUTL1 Is a Negative Regulator of Drug Resistance in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; CELLS; PROTEIN; CUX1; ACTIVATION; APOPTOSIS; GENE; PROLIFERATION; CHEMOTHERAPY; MOTILITY	Gastric cancer is one of the leading causes of malignancy-related mortality worldwide, and drug resistance hampered the clinical efficacy of chemotherapy. To better understand the molecular mechanism causing drug resistance, we previously established an isogenic pair of doxorubicin-sensitive and -resistant gastric cancer cell lines, SGC7901 and SGC7901/ADR cells. Here, we investigated how modulation of CUTL1 activity affects the response of gastric cancer to frequently used chemotherapeutic agents. In this study, we demonstrated that CUTL1 transcription activity was significantly reduced in doxorubicin-resistant cells. Furthermore, decreased CUTL1 expression was strongly associated with intrinsic drug resistance in human gastric cancer tissues and could be used as a poor prognosis biomarker. Both gain-of-function (by overexpression of active CUTL1) and loss-of-function (by CUTL1-specific shRNA knockdown) studies showed that increased CUTL1 activity significantly enhanced cell sensitivity to drugs and led to increased apoptosis, whereas decreased CUTL1 expression dramatically reduced cell sensitivity to drugs and thus fewer apoptoses. Importantly, modulation of CUTL1 activity resulted in altered sensitivity to multiple drugs. In vivo mouse studies indicated that overexpression of active CUTL1 significantly resulted in increased cancer tissue response to chemotherapy and therefore inhibited growth, whereas knockdown of CUTL1 conferred resistance to chemotherapy. Taken together, our results strongly indicate that CUTL1 activity is inversely associated with drug resistance and thus is an attractive therapeutic target to modulate multidrug resistance in gastric cancer.	[Li, Tingting; Wang, Honghong; Zhao, Lina; Gang, Yi; Guo, Xuegang; Huang, Rei; Yang, Zhiping; Pan, Yanglin; Wu, Kaichun; Xu, Li; Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Li, Tingting] Chinese Peoples Liberat Army Gen Hosp, Dept Gerontal Gastroenterol, Beijing 100853, Peoples R China; [Wang, Honghong] Chinese Peoples Liberat Army, Hosp 518, Xian 710043, Peoples R China; [Sun, Yimin] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Yimin] Natl Engn Res Ctr Beijing Biochip Technol, Beijing 100084, Peoples R China	Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Tsinghua University	Xu, L (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, 15 W Changle Rd, Xian 710032, Peoples R China.	xuli@fmmu.edu.cn; liuzhiguo@fmmu.edu.cn; fandaim@fmmu.edu.cn	Zhao, Lina/GVR-7716-2022	liu, zhiguo/0000-0002-8485-7356	National Natural Scientific Foundation of China [30400541, 81172096, 30801349, 30672369, 81070350, 30901785, 81030044]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Scientific Foundation of China Grants 30400541, 81172096, 30801349, 30672369, 81070350, 30901785, and 81030044.	Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Hong L, 2006, BIOCHEM CELL BIOL, V84, P199, DOI 10.1139/O05-173; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kodera Yasuhiro, 2006, Int J Clin Oncol, V11, P449, DOI 10.1007/s10147-006-0618-x; Kohno K, 2005, EUR J CANCER, V41, P2577, DOI 10.1016/j.ejca.2005.08.007; Li XH, 2007, BIOCHEM CELL BIOL, V85, P741, DOI 10.1139/O07-141; Liang J, 2009, FEBS J, V276, P685, DOI 10.1111/j.1742-4658.2008.06816.x; Liu H, 2008, ONCOL REP, V20, P963, DOI 10.3892/or_00000097; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Ning HB, 2006, CANCER BIOL THER, V5, P950, DOI 10.4161/cbt.5.8.2877; Qiao JY, 2008, J PROTEOME RES, V7, P2769, DOI 10.1021/pr700883t; Ripka S, 2010, NEOPLASIA, V12, P659, DOI 10.1593/neo.10486; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shao W, 2005, J PROTEOME RES, V4, P1451, DOI 10.1021/pr050053l; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Sun YM, 2008, J PROTEOME RES, V7, P4455, DOI 10.1021/pr800417e; Suttana W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-99; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yamamoto K, 2009, ANTICANCER RES, V29, P4211; Zhao L, 2009, J BIOL CHEM, V284, P26273, DOI 10.1074/jbc.M109.028068; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	31	18	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4135	4147		10.1074/jbc.M112.345942	http://dx.doi.org/10.1074/jbc.M112.345942			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255599	Green Published, hybrid			2022-12-25	WOS:000314845000042
J	Peng, LM; Yang, CR; Su, JG				Peng, Limin; Yang, Chunrong; Su, Jianguo			Protective Roles of Grass Carp Ctenopharyngodon idella Mx Isoforms against Grass Carp Reovirus	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; SEABREAM SPARUS-AURATA; ANTIVIRAL ACTIVITY; EXPRESSION ANALYSIS; GENE-EXPRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; ATLANTIC SALMON; INFLUENZA-VIRUS; LEUCINE-ZIPPER	Background: Myxovirus resistance (Mx) proteins are crucial effectors of the innate antiviral response against a wide range of viruses, mediated by the type I interferon (IFN-I) signaling pathway. However, the antiviral activity of Mx proteins is diverse and complicated in different species. Methodology/Principal Findings: In the current study, two novel Mx genes (CiMx1 and CiMx3) were identified in grass carp (Ctenopharyngodon idella). CiMx1 and CiMx3 proteins exhibit high sequence identity (92.1%), and low identity with CiMx2 (49.2% and 49.5%, respectively) from the GenBank database. The predicted three-dimensional (3D) structures are distinct among the three isoforms. mRNA instability motifs also display significant differences in the three genes. The spatial and temporal expression profiles of three C. idella Mx genes and the IFN-I gene were investigated by real-time fluorescence quantitative RT-PCR (qRT-PCR) following infection with grass carp reovirus (GCRV) in vivo and in vitro. The results demonstrated that all the four genes were implicated in the anti-GCRV immune response, that mRNA expression of Mx genes might be independent of IFN-I, and that CIK cells are suitable for antiviral studies. By comparing expression patterns following GCRV challenge or poly(I: C) treatment, it was observed that GCRV blocks mRNA expression of the four genes. To determine the functions of Mx genes, three CiMx cDNAs were cloned into expression vectors and utilized for transfection of CIK cells. The protection conferred by each recombinant CiMx protein against GCRV infection was evaluated. Antiviral activity against GCRV was demonstrated by reduced cytopathic effect, lower virus titer and lower levels of expressed viral transcripts. The transcription of IFN-I gene was also monitored. Conclusions/Significance: The results indicate all three Mx genes can suppress replication of grass carp reovirus and overexpression of Mx genes mediate feedback inhibition of the IFN-I gene.	[Peng, Limin; Su, Jianguo] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Yang, Chunrong] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Su, JG (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	su.jianguo@gmail.com	Su, Jianguo/G-9277-2012; Su, Jianguo/A-7444-2015	Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-1340-6144	Program for New Century Excellent Talents in University [NCET-08-0466]; Chinese Universities Scientific Fund [QN2009022]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Universities Scientific Fund	The study was supported by the Program for New Century Excellent Talents in University (NCET-08-0466) and the Chinese Universities Scientific Fund (QN2009022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZZIGHER L, 1993, VIROLOGY, V195, P100, DOI 10.1006/viro.1993.1350; Caipang C, 2004, MAR BIOTECHNOL, V6, P475; Chen YM, 2008, DEV COMP IMMUNOL, V32, P825, DOI 10.1016/j.dci.2007.12.003; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P86, DOI 10.1016/j.fsi.2006.09.007; DeWitte-Orr SJ, 2007, FISH SHELLFISH IMMUN, V23, P670, DOI 10.1016/j.fsi.2007.01.017; DICE JF, 1975, P NATL ACAD SCI USA, V72, P3893, DOI 10.1073/pnas.72.10.3893; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Fernandez-Trujillo MA, 2011, MOL IMMUNOL, V49, P107, DOI 10.1016/j.molimm.2011.07.023; Fernandez-Trujillo MA, 2011, MOL IMMUNOL, V48, P1216, DOI 10.1016/j.molimm.2011.03.008; Fernandez-Trujillo MA, 2008, FISH SHELLFISH IMMUN, V24, P187, DOI 10.1016/j.fsi.2007.10.010; Fernandez-Trujillo MA, 2006, FISH SHELLFISH IMMUN, V21, P577, DOI 10.1016/j.fsi.2006.03.003; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P262, DOI 10.1016/j.dci.2011.08.007; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; Haller O., 2008, REV SCI TECH, V28, P219; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Jensen V, 2000, J INTERF CYTOK RES, V20, P701, DOI 10.1089/10799900050116408; Kileng O, 2007, FISH SHELLFISH IMMUN, V23, P378, DOI 10.1016/j.fsi.2006.11.011; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee JY, 2000, DEV COMP IMMUNOL, V24, P407, DOI 10.1016/S0145-305X(99)00060-9; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Lockhart K, 2007, FISH SHELLFISH IMMUN, V22, P151, DOI 10.1016/j.fsi.2006.04.002; MEIER E, 1990, J VIROL, V64, P6263, DOI 10.1128/JVI.64.12.6263-6269.1990; MELEN K, 1992, J BIOL CHEM, V267, P25898; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Schusser B, 2011, J VIROL, V85, P8307, DOI 10.1128/JVI.00535-11; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P828, DOI 10.1016/j.fsi.2008.12.007; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Tafalla C, 2004, FISH SHELLFISH IMMUN, V16, P11, DOI 10.1016/S1050-4648(03)00010-X; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Trobridge GD, 1997, J VIROL, V71, P5304, DOI 10.1128/JVI.71.7.5304-5311.1997; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; Wang L, 2011, MOL IMMUNOL, V49, P359, DOI 10.1016/j.molimm.2011.09.010; Workenhe ST, 2010, MOL IMMUNOL, V47, P2525, DOI 10.1016/j.molimm.2010.06.009; Wu YC, 2007, FISH SHELLFISH IMMUN, V23, P97, DOI 10.1016/j.fsi.2006.09.008; Wu YC, 2010, FISH SHELLFISH IMMUN, V28, P467, DOI 10.1016/j.fsi.2009.12.008; Zenke K, 2009, FISH SHELLFISH IMMUN, V26, P599, DOI 10.1016/j.fsi.2008.09.012; Zhang YB, 2004, IMMUNOGENETICS, V56, P68, DOI 10.1007/s00251-004-0658-1; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001; Zou J, 2010, CURR PHARM DESIGN, V16, P4185, DOI 10.2174/138161210794519093	55	46	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52142	10.1371/journal.pone.0052142	http://dx.doi.org/10.1371/journal.pone.0052142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251697	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800148
J	Valero, ML; de Queiroz, FM; Stuhmer, W; Viana, F; Pardo, LA				Valero, Maria Ll.; de Queiroz, Fernanda Mello; Stuehmer, Walter; Viana, Felix; Pardo, Luis A.			TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells	PLOS ONE			English	Article							MENTHOL RECEPTOR TRPM8; COLD SENSITIVITY; SENSORY NEURONS; EXPRESSION; TEMPERATURE; ACTIVATION; CARCINOMA; MARKER; RNA; IDENTIFICATION	Overexpression of the cation-permeable channel TRPM8 in prostate cancers might represent a novel opportunity for their treatment. Inhibitors of TRPM8 reduce the growth of prostate cancer cells. We have used two recently described and highly specific blockers, AMTB and JNJ41876666, and RNAi to determine the relevance of TRPM8 expression in the proliferation of non-tumor and tumor cells. Inhibition of the expression or function of the channel reduces proliferation rates and proliferative fraction in all tumor cells tested, but not of non-tumor prostate cells. We observed no consistent acceleration of growth after stimulation of the channel with menthol or icilin, indicating that basal TRPM8 expression is enough to sustain growth of prostate cancer cells. Citation: Valero MLI, Mello de Queiroz F, Stuhmer W, Viana F, Pardo LA (2012) TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells. PLoS ONE 7(12): e51825. doi:10.1371/journal.pone.0051825	[Valero, Maria Ll.; de Queiroz, Fernanda Mello; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Valero, Maria Ll.; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Stuehmer, Walter] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); German Research Foundation (DFG)	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	pardo@em.mpg.de	Pardo, Luis/C-5066-2013; Stuehmer, Walter/A-2176-2009; Viana, Felix/U-8533-2017	Pardo, Luis/0000-0003-1375-4349; Stuehmer, Walter/0000-0002-0642-7764; Viana, Felix/0000-0003-1439-949X	Max-Planck Society [SAF2010-14990, PROMETEO2010-046]; Spanish Government (F.P.I)	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Spanish Government (F.P.I)(Spanish Government)	Financed by the Max-Planck Society and grants SAF2010-14990 and PROMETEO2010-046 to FV. MV was the recipient of a predoctoral fellowship of the Spanish Government (F.P.I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bai VU, 2010, INT J ONCOL, V36, P443, DOI 10.3892/ijo_00000518; Bantounas I, 2004, J MOL ENDOCRINOL, V33, P545, DOI 10.1677/jme.1.01582; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Chodon D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-212; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Flourakis M, 2009, BBA-MOL CELL RES, V1793, P1105, DOI 10.1016/j.bbamcr.2009.01.009; Fuessel S, 2003, INT J ONCOL, V23, P221; Fuessel S, 2006, PROSTATE, V66, P811, DOI 10.1002/pros.20404; Garcia-Martinez C, 2006, J PAIN, V7, P735, DOI 10.1016/j.jpain.2006.03.008; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jimenez-Lara AM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-15; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kiessling A, 2003, PROSTATE, V56, P270, DOI 10.1002/pros.10265; Kim SH, 2009, BBA-MOL BASIS DIS, V1792, P33, DOI 10.1016/j.bbadis.2008.09.012; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Malkia A, 2011, CURR PHARM BIOTECHNO, V12, P54, DOI 10.2174/138920111793937916; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Montell C, 2006, NAT NEUROSCI, V9, P466, DOI 10.1038/nn0406-466; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Parks DJ, 2011, J MED CHEM, V54, P233, DOI 10.1021/jm101075v; Pavet V, 2011, ONCOGENE, V30, P1, DOI 10.1038/onc.2010.460; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez Luis G., 2004, V294, P23; Sanchez MG, 2005, EUR J PHARMACOL, V515, P20, DOI 10.1016/j.ejphar.2005.04.010; Stein RJ, 2004, J UROLOGY, V172, P1175, DOI 10.1097/01.ju.0000134880.55119.cf; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007; Yang ZH, 2009, ASIAN J ANDROL, V11, P157, DOI 10.1038/aja.2009.1; Zhang L, 2006, ENDOCR-RELAT CANCER, V13, P27, DOI 10.1677/erc.1.01093; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	56	49	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51825	10.1371/journal.pone.0051825	http://dx.doi.org/10.1371/journal.pone.0051825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251635	gold, Green Published			2022-12-25	WOS:000312386800093
J	Wang, Y; Teng, HL; Huang, ZH				Wang, Ying; Teng, Hong-Lin; Huang, Zhi-hui			Intrinsic Migratory Properties of Cultured Schwann Cells Based on Single-Cell Migration Assay	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; OLFACTORY ENSHEATHING CELLS; CONTUSED SPINAL-CORD; NEURONAL MIGRATION; GROWTH-FACTOR; MYOSIN-II; AXON ENSHEATHMENT; GENE-EXPRESSION; EXCHANGE FACTOR; DISTINCT ROLES	The migration of Schwann cells is critical for development of peripheral nervous system and is essential for regeneration and remyelination after nerve injury. Although several factors have been identified to regulate Schwann cell migration, intrinsic migratory properties of Schwann cells remain elusive. In this study, based on time-lapse imaging of single isolated Schwann cells, we examined the intrinsic migratory properties of Schwann cells and the molecular cytoskeletal machinery of soma translocation during migration. We found that cultured Schwann cells displayed three motile phenotypes, which could transform into each other spontaneously during their migration. Local disruption of F-actin polymerization at leading front by a Cytochalasin D or Latrunculin A gradient induced collapse of leading front, and then inhibited soma translocation. Moreover, in migrating Schwann cells, myosin II activity displayed a polarized distribution, with the leading process exhibiting higher expression than the soma and trailing process. Decreasing this front-to-rear difference of myosin II activity by frontal application of a ML-7 or BDM (myosin II inhibitors) gradient induced the collapse of leading front and reversed soma translocation, whereas, increasing this front-to-rear difference of myosin II activity by rear application of a ML-7 or BDM gradient or frontal application of a Caly (myosin II activator) gradient accelerated soma translocation. Taken together, these results suggest that during migration, Schwann cells display malleable motile phenotypes and the extension of leading front dependent on F-actin polymerization pulls soma forward translocation mediated by myosin II activity. Citation: Wang Y, Teng H-L, Huang Z-h (2012) Intrinsic Migratory Properties of Cultured Schwann Cells Based on Single-Cell Migration Assay. PLoS ONE 7(12): e51824. doi:10.1371/journal.pone.0051824	[Wang, Ying; Huang, Zhi-hui] Wenzhou Med Coll, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Ying] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Wang, Ying; Huang, Zhi-hui] Wenzhou Med Coll, Inst Neurosci, Wenzhou, Zhejiang, Peoples R China; [Teng, Hong-Lin] Wenzhou Med Coll, Affiliated Hosp 1, Dept Spine Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Huang, ZH (corresponding author), Wenzhou Med Coll, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China.	hzhzju021@163.com			Natural Science Foundation of Zhejiang Province [Y2090545, Y2110242, Y2110364]; National Natural Science Foundation [31100779, 81100903]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of Zhejiang Province (Y2090545, Y2110242, Y2110364), and National Natural Science Foundation (31100779, 81100903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356; Ban DX, 2009, BRAIN RES, V1256, P149, DOI 10.1016/j.brainres.2008.11.098; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; BARONVANEVERCOOREN A, 1993, J NEUROSCI RES, V35, P428; Bryan DJ, 1999, J RECONSTR MICROSURG, V15, P591, DOI 10.1055/s-2007-1000143; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Cao L, 2007, GLIA, V55, P897, DOI 10.1002/glia.20511; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cornejo M, 2010, NEUROCHEM RES, V35, P1643, DOI 10.1007/s11064-010-0225-0; Dubovy P, 2001, GLIA, V33, P36, DOI 10.1002/1098-1136(20010101)33:1<36::AID-GLIA1004>3.0.CO;2-B; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feltri ML, 2008, GLIA, V56, P1508, DOI 10.1002/glia.20752; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Han IS, 2007, J CELL SCI, V120, P246, DOI 10.1242/jcs.03322; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Huang ZH, 2011, EXP CELL RES, V317, P2823, DOI 10.1016/j.yexcr.2011.09.004; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jin FZ, 2011, DEVELOPMENT, V138, P1329, DOI 10.1242/dev.058677; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Novak N, 2011, J CELL BIOL, V192, P243, DOI 10.1083/jcb.201010013; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas MG, 2002, NEUROCHEM RES, V27, P1305, DOI 10.1023/A:1021615530960; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Wang HB, 2008, J CELL BIOL, V182, P1171, DOI 10.1083/jcb.200802091; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yamauchi J, 2011, J NEUROSCI, V31, P12579, DOI 10.1523/JNEUROSCI.2738-11.2011; Yu WM, 2009, J CELL SCI, V122, P929, DOI 10.1242/jcs.033928	59	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51824	10.1371/journal.pone.0051824	http://dx.doi.org/10.1371/journal.pone.0051824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251634	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800092
J	Bockisch, CJ; Khojasteh, E; Straumann, D; Hegemann, SCA				Bockisch, Christopher J.; Khojasteh, Elham; Straumann, Dominik; Hegemann, Stefan C. A.			Development of Eye Position Dependency of Slow Phase Velocity during Caloric Stimulation	PLOS ONE			English	Article							HUMAN VESTIBULOOCULAR REFLEX; ALEXANDERS LAW; NEURAL INTEGRATOR; OCULOMOTOR INTEGRATOR; GUINEA-PIG; MODEL; PLASTICITY; NYSTAGMUS; ASYMMETRY; MOVEMENTS	The nystagmus in patients with vestibular disorders often has an eye position dependency, called Alexander's law, where the slow phase velocity is higher with gaze in the fast phase direction compared with gaze in the slow phase direction. Alexander's law has been hypothesized to arise either due to adaptive changes in the velocity-to-position neural integrator, or as a consequence of processing of the vestibular-ocular reflex. We tested whether Alexander's law arises only as a consequence of non-physiologic vestibular stimulation. We measured the time course of the development of Alexander's law in healthy humans with nystagmus caused by three types of caloric vestibular stimulation: cold (unilateral inhibition), warm (unilateral excitation), and simultaneous bilateral bithermal (one side cold, the other warm) stimulation, mimicking the normal push-pull pattern of vestibular stimulation. Alexander's law, measured as a negative slope of the velocity versus position curve, was observed in all conditions. A reversed pattern of eye position dependency (positive slope) was found <10% of the time. The slope often changed with nystagmus velocity (cross-correlation of nystagmus speed and slope was significant in 50% of cases), and the average lag of the slope with the speed was not significantly different from zero. Our results do not support the hypothesis that Alexander's law can only be observed with non-physiologic vestibular stimulation. Further, the rapid development of Alexander's law, while possible for an adaptive mechanism, is nonetheless quite fast compared to most other ocular motor adaptations. These results suggest that Alexander's law may not be a consequence of a true adaptive mechanism.	[Bockisch, Christopher J.; Khojasteh, Elham; Hegemann, Stefan C. A.] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik; Hegemann, Stefan C. A.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Bockisch, CJ (corresponding author), Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland.	chris.bockisch@usz.ch	Hegemann, Stefan/B-4640-2013; Hegemann, Stefan/AAT-4425-2020	Hegemann, Stefan/0000-0002-9464-352X; Hegemann, Stefan/0000-0002-9464-352X; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [320000_122535/1]; Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; FQRNT (Fonds de Rescherch du Quebec) from Quebec, Canada	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; FQRNT (Fonds de Rescherch du Quebec) from Quebec, Canada	This study was supported by the Swiss National Science Foundation grant (number 320000_122535/1) and the Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland. E. Khojasteh receives the FQRNT (Fonds de Rescherch du Quebec) post-doctoral scholarship from Quebec, Canada. None of individuals employed or contracted by the funders (other than the named authors) played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Alexander G, 1912, HDB KINDERHEILKUNDE, P84; Anagnostou E, 2011, NEUROREPORT, V22, P239, DOI 10.1097/WNR.0b013e3283451769; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; Bockisch CJ, 2008, J NEUROPHYSIOL, V100, P3105, DOI 10.1152/jn.90381.2008; Chan WWP, 2007, P ANN INT IEEE EMBS, P1156, DOI 10.1109/IEMBS.2007.4352501; Chan WWP, 2005, J NEUROPHYSIOL, V93, P3709, DOI 10.1152/jn.00814.2004; Crane BT, 1998, J NEUROPHYSIOL, V80, P1151, DOI 10.1152/jn.1998.80.3.1151; CRAWFORD JD, 1993, EXP BRAIN RES, V96, P443; DOSLAK MJ, 1982, ANN OTO RHINOL LARYN, V91, P316, DOI 10.1177/000348948209100318; DOSLAK MJ, 1979, BIOL CYBERN, V34, P181, DOI 10.1007/BF00336969; Hegemann S, 2007, JARO-J ASSOC RES OTO, V8, P551, DOI 10.1007/s10162-007-0095-6; Hess K., 1982, NEUROSCI LETT S, V10, P242; Jeffcoat B, 2008, J NEUROPHYSIOL, V100, P154, DOI 10.1152/jn.00055.2008; JONES GM, 1988, EXP BRAIN RES, V69, P531; Khojasteh E, 2012, EUROPEAN J NEUROSCIE; Mensh BD, 2004, VISION RES, V44, P711, DOI 10.1016/j.visres.2003.10.015; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; OOSTERVELD WJ, 1987, ARCH OTO-RHINO-LARYN, V244, P155, DOI 10.1007/BF00464260; Paige GD, 1998, J NEUROPHYSIOL, V80, P2391, DOI 10.1152/jn.1998.80.5.2391; PAIGE GD, 1985, ACTA OTO-LARYNGOL, V100, P321, DOI 10.3109/00016488509126555; Peterka RJ, 2004, J NEUROPHYSIOL, V92, P2333, DOI 10.1152/jn.00174.2004; ROBINSON DA, 1968, SCIENCE, V161, P1219, DOI 10.1126/science.161.3847.1219; ROBINSON DA, 1984, ANN NEUROL, V16, P714, DOI 10.1002/ana.410160614; Robinson DA, 1975, BASIC MECH OCULAR MO, P337; SCHERER H, 1986, EXP BRAIN RES, V64, P255; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Zhou W, 2007, J NEUROPHYSIOL, V97, P2780, DOI 10.1152/jn.00812.2006	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51409	10.1371/journal.pone.0051409	http://dx.doi.org/10.1371/journal.pone.0051409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251522	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000313236200102
J	Gotoh, M; Sano-Maeda, K; Murofushi, H; Murakami-Murofushi, K				Gotoh, Mari; Sano-Maeda, Katsura; Murofushi, Hiromu; Murakami-Murofushi, Kimiko			Protection of Neuroblastoma Neuro2A Cells from Hypoxia-Induced Apoptosis by Cyclic Phosphatidic Acid (cPA)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DNA-POLYMERASE-ALPHA; LYSOPHOSPHATIDIC ACID; PC12 CELLS; BIOLOGICAL FUNCTIONS; HUMAN SERUM; AUTOTAXIN; RECEPTOR; INHIBITION; PHYLPA	Cyclic phosphatidic acid (cPA) is a naturally occurring phospholipid mediator with a unique cyclic phosphate ring at the sn-2 and sn-3 positions of its glycerol backbone. We have previously shown that cPA significantly suppresses ischemia-induced delayed neuronal death and the accumulation of glial fibrillary acidic protein in the CA1 region of the rat hippocampus. These results indicated that the systemic administration of cPA can protect hippocampal neurons against ischemia-induced delayed neuronal cell death. In the current study, we investigated the effects of cPA on neuronal cell death caused by hypoxia in vitro and the molecular mechanisms underlying these effects. We used cobalt chloride (CoCl2) to expose cells to hypoxic conditions in vitro. Treating mouse neuroblastoma (Neuro2A) cells with CoCl2 induced nuclear DNA condensation and phosphatidylserine exposure. However, adding cPA led to the suppression of CoCl2-induced apoptosis in a cPA dose-dependent manner and attenuated the increase in the Bax/Bcl-2 ratio caused by CoCl2. Quantitative PCR analysis showed that Neuro2A cells strongly express the LPA(1), LPA(2), and LPA(6), which are G-protein coupled receptors that can be activated by cPA. To date, LPA(1) and LPA(2) have been reported to exhibit antiapoptotic activity. Therefore, to assess the roles of LPA(1) and LPA(2) on cPA-induced neuroprotective functions, Ki16425, a selective LPA(1) and LPA(3) antagonist, was adopted to know the LPA(1) function and siRNA was used to knockdown the expression of LPA(2). On the basis of our results, we propose that cPA-induced protection of Neuro2A cells from CoCl2-induced hypoxia damage is mediated via LPA(2).	[Gotoh, Mari; Sano-Maeda, Katsura; Murofushi, Hiromu; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Div Life Sci, Tokyo 112, Japan	Ochanomizu University	Murakami-Murofushi, K (corresponding author), Ochanomizu Univ, Div Life Sci, Tokyo 112, Japan.	murofushi.kimiko@ocha.ac.jp	GOTOH, Mari/AAX-4457-2020	GOTOH, Mari/0000-0002-8052-4247	Princess Takamatsu Cancer Research Fund; Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project; Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type); Ministry for Education, Culture, Sports, Science and Technology of Japan [22790203]	Princess Takamatsu Cancer Research Fund; Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project; Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type); Ministry for Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Princess Takamatsu Cancer Research Fund, the Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project, Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type), a Grant-in-Aid for Scientific Research (KAKENHI, No. 22790203) from the Ministry for Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; Gotoh M, 2010, EUR J PHARMACOL, V649, P206, DOI 10.1016/j.ejphar.2010.09.052; Gupte R, 2010, BIOORG MED CHEM LETT, V20, P7525, DOI 10.1016/j.bmcl.2010.09.115; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P4047, DOI 10.1016/S0040-4039(00)60612-3; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lu N, 2007, BASIC CLIN PHARMACOL, V101, P41, DOI 10.1111/j.1742-7843.2007.00074.x; Murakami-Murofushi K, 2002, BBA-MOL CELL BIOL L, V1582, P1, DOI 10.1016/S1388-1981(02)00131-2; MURAKAMIMUROFUSHI K, 1992, J BIOL CHEM, V267, P21512; Nozaki E, 2012, BIOORGAN MED CHEM, V20, P3196, DOI 10.1016/j.bmc.2012.03.060; Nozaki E, 2011, CYTOLOGIA, V76, P73, DOI 10.1508/cytologia.76.73; Nozaki E, 2011, BBA-MOL CELL BIOL L, V1811, P271, DOI 10.1016/j.bbalip.2011.01.003; Ohta H, 2006, MOL PHARM, V64, P994; Sarada SKS, 2008, BRAIN RES, V1209, P29, DOI 10.1016/j.brainres.2008.02.041; Shan L, 2008, J CHROMATOGR B, V862, P161, DOI 10.1016/j.jchromb.2007.12.003; TAKAHASHI Y, 1993, CELL STRUCT FUNCT, V18, P135, DOI 10.1247/csf.18.135; Tanaka R, 2011, BIOORG MED CHEM LETT, V21, P4180, DOI 10.1016/j.bmcl.2011.05.083; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Valentine WJ, 2010, CELL SIGNAL, V22, P1543, DOI 10.1016/j.cellsig.2010.05.023; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	32	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51093	10.1371/journal.pone.0051093	http://dx.doi.org/10.1371/journal.pone.0051093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251428	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200058
J	Honing, H; Merchant, H; Haden, GP; Prado, L; Bartolo, R				Honing, Henkjan; Merchant, Hugo; Haden, Gabor P.; Prado, Luis; Bartolo, Ramon			Rhesus Monkeys (Macaca mulatta) Detect Rhythmic Groups in Music, but Not the Beat	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; MISMATCH NEGATIVITY; EMERGENT METER; PERCEPTION; INDUCTION	It was recently shown that rhythmic entrainment, long considered a human-specific mechanism, can be demonstrated in a selected group of bird species, and, somewhat surprisingly, not in more closely related species such as nonhuman primates. This observation supports the vocal learning hypothesis that suggests rhythmic entrainment to be a by-product of the vocal learning mechanisms that are shared by several bird and mammal species, including humans, but that are only weakly developed, or missing entirely, in nonhuman primates. To test this hypothesis we measured auditory event-related potentials (ERPs) in two rhesus monkeys (Macaca mulatta), probing a well-documented component in humans, the mismatch negativity (MMN) to study rhythmic expectation. We demonstrate for the first time in rhesus monkeys that, in response to infrequent deviants in pitch that were presented in a continuous sound stream using an oddball paradigm, a comparable ERP component can be detected with negative deflections in early latencies (Experiment 1). Subsequently we tested whether rhesus monkeys can detect gaps (omissions at random positions in the sound stream; Experiment 2) and, using more complex stimuli, also the beat (omissions at the first position of a musical unit, i.e. the 'downbeat'; Experiment 3). In contrast to what has been shown in human adults and newborns (using identical stimuli and experimental paradigm), the results suggest that rhesus monkeys are not able to detect the beat in music. These findings are in support of the hypothesis that beat induction (the cognitive mechanism that supports the perception of a regular pulse from a varying rhythm) is species-specific and absent in nonhuman primates. In addition, the findings support the auditory timing dissociation hypothesis, with rhesus monkeys being sensitive to rhythmic grouping (detecting the start of a rhythmic group), but not to the induced beat (detecting a regularity from a varying rhythm).	[Honing, Henkjan; Haden, Gabor P.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Merchant, Hugo; Prado, Luis; Bartolo, Ramon] Univ Nacl Autonoma Mexico, Dept Cognit Neurosci, Inst Neurobiol, Queretaro, Mexico	University of Amsterdam; Universidad Nacional Autonoma de Mexico	Honing, H (corresponding author), Univ Amsterdam, Cognit Sci Ctr Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.	honing@uva.nl	Bartolo, Ramon/AAB-6579-2022; Honing, Henkjan/A-1362-2012; Háden, Gábor Péter/A-2098-2011; Merchant, Hugo/E-8703-2019	Bartolo, Ramon/0000-0003-2165-9747; Honing, Henkjan/0000-0001-7046-7923; Merchant, Hugo/0000-0002-3488-9501	University of Amsterdam; Hendrik Muller chair, Royal Netherlands Academy of Arts and 8 Sciences (KNAW); Consejo Nacional de Ciencia y Tecnologia [151223]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN206508]; Hendrik Muller chair, Royal Netherlands Academy of Arts and Sciences (KNAW)	University of Amsterdam; Hendrik Muller chair, Royal Netherlands Academy of Arts and 8 Sciences (KNAW); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Hendrik Muller chair, Royal Netherlands Academy of Arts and Sciences (KNAW)	The research of HH and GH was supported by the Research Priority Area 'Brain & Cognition' at the University of Amsterdam. The first author (HH) is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and 8 Sciences (KNAW). The second author's research (HM) was supported by Consejo Nacional de Ciencia y Tecnologia Grant 151223, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grant: IN206508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research of H.H. and G.H. is part of the Research Priority Area 'Brain & Cognition' at the University of Amsterdam. The first author (H.H.) is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW). We thank Raul Paulin for his technical assistance. We are grateful to Istvan Winkler, Fleur Bouwer and two anonymous reviewers for their comments on an earlier version of this manuscript.	Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Brown S, 2000, ORIGINS OF MUSIC, P3; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P183, DOI 10.1016/B978-0-12-381460-9.00006-7; Fitch WT, 2009, CURR BIOL, V19, pR403, DOI 10.1016/j.cub.2009.04.004; Fukushima H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013366; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grube M, 2010, P NATL ACAD SCI USA, V107, P11597, DOI 10.1073/pnas.0910473107; Harris PG, 2001, ANN NY ACAD SCI, V930, P414, DOI 10.1111/j.1749-6632.2001.tb05756.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Honing H, 2009, ANN NY ACAD SCI, V1169, P93, DOI 10.1111/j.1749-6632.2009.04761.x; Horvath J, 2010, NEUROREPORT, V21, P537, DOI 10.1097/WNR.0b013e3283398094; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; Konoike N, 2012, NEUROSCI RES, V74, P64, DOI 10.1016/j.neures.2012.06.002; Ladinig O, 2011, MUSIC PERCEPT, V28, P444; Ladinig O, 2009, MUSIC PERCEPT, V26, P377, DOI 10.1525/MP.2009.26.4.377; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Yabe H, 1997, NEUROREPORT, V8, P1971, DOI 10.1097/00001756-199705260-00035; Zarco W, 2009, J NEUROPHYSIOL, V102, P3191, DOI 10.1152/jn.00066.2009	30	87	87	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51369	10.1371/journal.pone.0051369	http://dx.doi.org/10.1371/journal.pone.0051369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251509	Green Published, gold			2022-12-25	WOS:000313236200097
J	Liu, YH; Zhao, ZF; Li, TY; Liao, Q; Kushner, N; Touzjian, NY; Shao, YM; Sun, YT; Strong, AJ; Lu, YC				Liu, Yanhou; Zhao, Zhongfang; Li, Tianyi; Liao, Qi; Kushner, Nicholas; Touzjian, Neal Y.; Shao, Yiming; Sun, Yongtao; Strong, Amie J.; Lu, Yichen			High Resolution Human Leukocyte Antigen Class I Allele Frequencies and HIV-1 Infection Associations in Chinese Han and Uyghur Cohorts	PLOS ONE			English	Article							HLA CLASS-I; VIRUS TYPE-1 INFECTION; T-CELL RESPONSES; YI ETHNIC-GROUP; DISEASE PROGRESSION; POPULATION; HAPLOTYPES; GENES; SUSCEPTIBILITY; POLYMORPHISMS	Background: Host immunogenetic factors such as HLA class I polymorphism are important to HIV-1 infection risk and AIDS progression. Previous studies using high-resolution HLA class I profile data of Chinese populations appeared insufficient to provide information for HIV-1 vaccine development and clinical trial design. Here we reported HLA class I association with HIV-1 susceptibility in a Chinese Han and a Chinese Uyghur cohort. Methodology/Principal Findings: Our cohort included 327 Han and 161 Uyghur ethnic individuals. Each cohort included HIV-1 seropositive and HIV-1 seronegative subjects. Four-digit HLA class I typing was performed by sequencing-based typing and high-resolution PCR-sequence specific primer. We compared the HLA class I allele and inferred haplotype frequencies between HIV-1 seropositive and seronegative groups. A neighbor-joining tree between our cohorts and other populations was constructed based on allele frequencies of HLA-A and HLA-B loci. We identified 58 HLA-A, 75 HLA-B, and 32 HLA-Cw distinct alleles from our cohort and no novel alleles. The frequency of HLA-B*5201 and A*0301 was significantly higher in the Han HIV-1 negative group. The frequency of HLA-B*5101 was significantly higher in the Uyghur HIV-1 negative group. We observed statistically significant increases in expectation-maximization (EM) algorithm predicted haplotype frequencies of HLA-A*0201-B*5101 in the Uyghur HIV-1 negative group, and of Cw*0304-B*4001 in the Han HIV-1 negative group. The B62s supertype frequency was found to be significantly higher in the Han HIV-1 negative group than in the Han HIV-1 positive group. Conclusions: At the four-digit level, several HLA class I alleles and haplotypes were associated with lower HIV-1 susceptibility. Homogeneity of HLA class I and Bw4/Bw6 heterozygosity were not associated with HIV-1 susceptibility in our cohort. These observations contribute to the Chinese HLA database and could prove useful in the development of HIV-1 vaccine candidates.	[Liu, Yanhou; Zhao, Zhongfang; Li, Tianyi; Liao, Qi] Nankai Univ, Vaccine Lab, Tianjin 300071, Peoples R China; [Kushner, Nicholas; Touzjian, Neal Y.; Strong, Amie J.; Lu, Yichen] Vaccine Technol Inc, Wellesley, MA USA; [Shao, Yiming] Natl Ctr AIDS Prevent & Control, Beijing, Peoples R China; [Sun, Yongtao] Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China; [Lu, Yichen] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Nankai University; Air Force Military Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Lu, YC (corresponding author), Vaccine Technol Inc, Wellesley, MA USA.	yichenlu@hsph.harvard.edu			Nankai University Vaccine Laboratory; Partners AIDS Research Center at Massachusetts General Hospital [NO1-AI-30024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030024] Funding Source: NIH RePORTER	Nankai University Vaccine Laboratory; Partners AIDS Research Center at Massachusetts General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by the research subcontract between Nankai University Vaccine Laboratory and the Partners AIDS Research Center at Massachusetts General Hospital (NO1-AI-30024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TG, 2002, AIDS, V16, P1899, DOI 10.1097/00002030-200209270-00006; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; China's Ministry of Health World Health Organization UNAIDS, CHIN AIDS EP ASS REP; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FABIO G, 1990, BRIT J HAEMATOL, V75, P531, DOI 10.1111/j.1365-2141.1990.tb07794.x; Harrer T, 1996, J IMMUNOL, V156, P2616; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hong Kun-xue, 2007, Virologica Sinica, V22, P301; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Huang X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-201; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Middleton D, 2004, TISSUE ANTIGENS, V63, P555, DOI 10.1111/j.0001-2815.2004.00234.x; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB 20; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; Roshorm Y, 2009, EUR J IMMUNOL, V39, P1831, DOI 10.1002/eji.200939309; Rowland-Jones SL, 2001, IMMUNOL LETT, V79, P15, DOI 10.1016/S0165-2478(01)00261-9; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Selvaraj P, 2006, JAIDS-J ACQ IMM DEF, V43, P497, DOI 10.1097/01.qai.0000233312.36226.76; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Welzel TM, 2007, AIDS, V21, P225, DOI 10.1097/QAD.0b013e3280123840; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Yuliwulandari R, 2009, TISSUE ANTIGENS, V73, P46, DOI 10.1111/j.1399-0039.2008.01178.x; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232	50	1	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50656	10.1371/journal.pone.0050656	http://dx.doi.org/10.1371/journal.pone.0050656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251376	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200033
J	Nickerson, KP; McDonald, C				Nickerson, Kourtney P.; McDonald, Christine			Crohn's Disease-Associated Adherent-Invasive Escherichia coli Adhesion Is Enhanced by Exposure to the Ubiquitous Dietary Polysaccharide Maltodextrin	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOME; MUCOSAL FLORA; ILEAL MUCOSA; E. COLI; BIOFILM FORMATION; GROWTH; EPIDEMIOLOGY; DIVERSITY; TRANSPORT	Crohn's disease (CD) is associated with intestinal dysbiosis evidenced by an altered microbiome forming thick biofilms on the epithelium. Additionally, adherent-invasive E. coli (AIEC) strains are frequently isolated from ileal lesions of CD patients indicating a potential role for these strains in disease pathogenesis. The composition and characteristics of the host microbiome are influenced by environmental factors, particularly diet. Polysaccharides added to food as emulsifiers, stabilizers or bulking agents have been linked to bacteria-associated intestinal disorders. The escalating consumption of polysaccharides in Western diets parallels an increased incidence of CD during the latter 20th century. In this study, the effect of a polysaccharide panel on adhesiveness of the CD-associated AIEC strain LF82 was analyzed to determine if these food additives promote disease-associated bacterial phenotypes. Maltodextrin (MDX), a polysaccharide derived from starch hydrolysis, markedly enhanced LF82 specific biofilm formation. Biofilm formation of multiple other E. coli strains was also promoted by MDX. MDX-induced E. coli biofilm formation was independent of polysaccharide chain length indicating a requirement for MDX metabolism. MDX exposure induced type I pili expression, which was required for MDX-enhanced biofilm formation. MDX also increased bacterial adhesion to human intestinal epithelial cell monolayers in a mechanism dependent on type 1 pili and independent of the cellular receptor CEACAM6, suggesting a novel mechanism of epithelial cell adhesion. Analysis of mucosa-associated bacteria from individuals with and without CD showed increased prevalence of malX, a gene essential for MDX metabolism, uniquely in the ileum of CD patients. These findings demonstrate that the ubiquitous dietary component MDX enhances E. coli adhesion and suggests a mechanism by which Western diets rich in specific polysaccharides may promote dysbiosis of gut microbes and contribute to disease susceptibility.	[Nickerson, Kourtney P.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Nickerson, Kourtney P.; McDonald, Christine] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	mcdonac2@ccf.org		Nickerson, Kourtney/0000-0001-7852-593X; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [R01DK082437, R01DK050984]; Howard Hughes Medical Institute "Med into Grad" Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050984, R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute "Med into Grad" Initiative(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were funded in part by National Institutes of Health grants R01DK082437 and R01DK050984, the Howard Hughes Medical Institute "Med into Grad" Initiative and the generosity of Gerald and Nancy Goldberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Baker Phillip I, 2009, Expert Rev Gastroenterol Hepatol, V3, P535, DOI 10.1586/egh.09.47; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Beal J, 2012, J PEDIAT; BeMiller JN, 2009, J AGR FOOD CHEM, V57, P8125, DOI 10.1021/jf8039236; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Chronakis IS, 1998, CRIT REV FOOD SCI, V38, P599, DOI 10.1080/10408699891274327; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hill DR, 2012, J BIOL CHEM; Jensen SR, 2011, J MICROBIOL METH, V86, P111, DOI 10.1016/j.mimet.2011.04.002; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; KEIGHLEY MRB, 1978, GUT, V19, P1099, DOI 10.1136/gut.19.12.1099; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Martinez-Medina M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-202; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; Montagne L, 2004, J ANIM SCI, V82, P2364; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Rowan NJ, 1997, APPL ENVIRON MICROB, V63, P1182, DOI 10.1128/AEM.63.3.1182-1184.1997; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SCHWAN WR, 1992, J BACTERIOL, V174, P2367, DOI 10.1128/JB.174.7.2367-2375.1992; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sepehri S, 2011, INFLAMM BOWEL DIS, V17, P1451, DOI 10.1002/ibd.21509; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; STOWE SP, 1990, GASTROENTEROLOGY, V98, P104, DOI 10.1016/0016-5085(90)91297-J; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084; Vejborg RM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-316; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	58	93	96	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52132	10.1371/journal.pone.0052132	http://dx.doi.org/10.1371/journal.pone.0052132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251695	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200175
J	Pariyadath, V; Eagleman, DM				Pariyadath, Vani; Eagleman, David M.			Subjective Duration Distortions Mirror Neural Repetition Suppression	PLOS ONE			English	Article							TIME PERCEPTION; REPRESENTATION; ILLUSIONS; CORTEX; BRAIN; AREA	Background: Subjective duration is strongly influenced by repetition and novelty, such that an oddball stimulus in a stream of repeated stimuli appears to last longer in duration in comparison. We hypothesize that this duration illusion, called the temporal oddball effect, is a result of the difference in expectation between the oddball and the repeated stimuli. Specifically, we conjecture that the repeated stimuli contract in duration as a result of increased predictability; these duration contractions, we suggest, result from decreased neural response amplitude with repetition, known as repetition suppression. Methodology/Principal Findings: Participants viewed trials consisting of lines presented at a particular orientation (standard stimuli) followed by a line presented at a different orientation (oddball stimulus). We found that the size of the oddball effect correlates with the number of repetitions of the standard stimulus as well as the amount of deviance from the oddball stimulus; both of these results are consistent with a repetition suppression hypothesis. Further, we find that the temporal oddball effect is sensitive to experimental context - that is, the size of the oddball effect for a particular experimental trial is influenced by the range of duration distortions seen in preceding trials. Conclusions/Significance: Our data suggest that the repetition-related duration contractions causing the oddball effect are a result of neural repetition suppression. More generally, subjective duration may reflect the prediction error associated with a stimulus and, consequently, the efficiency of encoding that stimulus. Additionally, we emphasize that experimental context effects need to be taken into consideration when designing duration-related tasks.	[Pariyadath, Vani; Eagleman, David M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Eagleman, DM (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	eagleman@cpu.bcm.edu	Pariyadath, Vani/B-7904-2009	Pariyadath, Vani/0000-0001-6340-0771	NIH [RO1 NS053960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH RO1 NS053960 (DME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Helson H, 1964, ADAPTATION LEVEL THE; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Luce RD, 1986, RESPONSE TIMES THEIR; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Noguchi Y, 2006, CEREB CORTEX, V16, P1797, DOI 10.1093/cercor/bhj117; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pariyadath V, 2008, J VISION, V8, DOI 10.1167/8.16.11; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Sadeghi NG, 2011, J COGNITIVE NEUROSCI, V23, P3829, DOI 10.1162/jocn_a_00071; Schindel R, 2011, J VISION, V11, DOI 10.1167/11.2.17; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	21	43	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49362	10.1371/journal.pone.0049362	http://dx.doi.org/10.1371/journal.pone.0049362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251340	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200013
J	Tito, RY; Knights, D; Metcalf, J; Obregon-Tito, AJ; Cleeland, L; Najar, F; Roe, B; Reinhard, K; Sobolik, K; Belknap, S; Foster, M; Spicer, P; Knight, R; Lewis, CM				Tito, Raul Y.; Knights, Dan; Metcalf, Jessica; Obregon-Tito, Alexandra J.; Cleeland, Lauren; Najar, Fares; Roe, Bruce; Reinhard, Karl; Sobolik, Kristin; Belknap, Samuel; Foster, Morris; Spicer, Paul; Knight, Rob; Lewis, Cecil M., Jr.			Insights from Characterizing Extinct Human Gut Microbiomes	PLOS ONE			English	Article							ENTERS; DIET; DNA	In an effort to better understand the ancestral state of the human distal gut microbiome, we examine feces retrieved from archaeological contexts (coprolites). To accomplish this, we pyrosequenced the 16S rDNA V3 region from duplicate coprolite samples recovered from three archaeological sites, each representing a different depositional environment: Hinds Cave (similar to 8000 years B. P.) in the southern United States, Caserones (1600 years B. P.) in northern Chile, and Rio Zape in northern Mexico (1400 years B. P.). Clustering algorithms grouped samples from the same site. Phyletic representation was more similar within sites than between them. A Bayesian approach to source-tracking was used to compare the coprolite data to published data from known sources that include, soil, compost, human gut from rural African children, human gut, oral and skin from US cosmopolitan adults and non-human primate gut. The data from the Hinds Cave samples largely represented unknown sources. The Caserones samples, retrieved directly from natural mummies, matched compost in high proportion. A substantial and robust proportion of Rio Zape data was predicted to match the gut microbiome found in traditional rural communities, with more minor matches to other sources. One of the Rio Zape samples had taxonomic representation consistent with a child. To provide an idealized scenario for sample preservation, we also applied source tracking to previously published data for Otzi the Iceman and a soldier frozen for 93 years on a glacier. Overall these studies reveal that human microbiome data has been preserved in some coprolites, and these preserved human microbiomes match more closely to those from the rural communities than to those from cosmopolitan communities. These results suggest that the modern cosmopolitan lifestyle resulted in a dramatic change to the human gut microbiome.	[Tito, Raul Y.; Obregon-Tito, Alexandra J.; Cleeland, Lauren; Foster, Morris; Spicer, Paul; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Metcalf, Jessica; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Najar, Fares; Roe, Bruce] Univ Oklahoma, Dept Chem & Biochem, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Reinhard, Karl] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Sobolik, Kristin; Belknap, Samuel] Univ Maine, Climate Change Inst, Orono, ME USA; [Sobolik, Kristin; Belknap, Samuel] Univ Maine, Dept Anthropol, Orono, ME USA	University of Oklahoma System; University of Oklahoma - Norman; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Oklahoma System; University of Oklahoma - Norman; University of Nebraska System; University of Nebraska Lincoln; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Lewis, CM (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.	cmlewis@ou.edu	Tito, Raul/CAG-3546-2022; Knight, Rob/D-1299-2010; Reinhard, Karl/AAT-7881-2020	Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Obregon-Tito, Alexandra/0000-0003-2508-7176; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [R01 HG005172-01, R01 GM089886-01A1]; National Science Foundation (NSF) [0845314]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089886] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [0845314] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Support for this research is from the National Institutes of Health (grants R01 HG005172-01 and R01 GM089886-01A1) and the National Science Foundation (NSF#0845314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker GC, 2004, BIOCHEM SOC T, V32, P218, DOI 10.1042/BST0320218; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glass EM, 2010, COLD SPRING HARB PRO; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jimenez FA, 2012, J PARASITOL, V98, P304, DOI 10.1645/GE-2915.1; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lord K.J., 1984, ZOOARCHAEOLOGY HINDS; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Rollo Franco, 2006, Med Secoli, V18, P725; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tito RY, 2011, AM J PHYS ANTHROPOL, V145, P653, DOI 10.1002/ajpa.21526; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Watanabe K, 2008, CURR MICROBIOL, V56, P458, DOI 10.1007/s00284-008-9107-y; Wilkinson L, 2011, VISUALIZATION COMPUT, P1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	126	130	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51146	10.1371/journal.pone.0051146	http://dx.doi.org/10.1371/journal.pone.0051146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251439	gold, Green Published			2022-12-25	WOS:000313236200062
J	Zhang, G; Karns, R; Sun, GY; Indugula, SR; Cheng, H; Havas-Augustin, D; Novokmet, N; Durakovic, Z; Missoni, S; Chakraborty, R; Rudan, P; Deka, R				Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Havas-Augustin, Dubravka; Novokmet, Natalija; Durakovic, Zijad; Missoni, Sasa; Chakraborty, Ranajit; Rudan, Pavao; Deka, Ranjan			Finding Missing Heritability in Less Significant Loci and Allelic Heterogeneity: Genetic Variation in Human Height	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ISLAND POPULATION; VARIANTS	Genome-wide association studies (GWAS) have identified many common variants associated with complex traits in human populations. Thus far, most reported variants have relatively small effects and explain only a small proportion of phenotypic variance, leading to the issues of 'missing' heritability and its explanation. Using height as an example, we examined two possible sources of missing heritability: first, variants with smaller effects whose associations with height failed to reach genome-wide significance and second, allelic heterogeneity due to the effects of multiple variants at a single locus. Using a novel analytical approach we examined allelic heterogeneity of height-associated loci selected from SNPs of different significance levels based on the summary data of the GIANT (stage 1) studies. In a sample of 1,304 individuals collected from an island population of the Adriatic coast of Croatia, we assessed the extent of height variance explained by incorporating the effects of less significant height loci and multiple effective SNPs at the same loci. Our results indicate that approximately half of the 118 loci that achieved stringent genome-wide significance (p-value<5 x 10(-8)) showed evidence of allelic heterogeneity. Additionally, including less significant loci (i.e., p-value<5 x 10(-4)) and accounting for effects of allelic heterogeneity substantially improved the variance explained in height.	[Zhang, Ge] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH USA; [Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Havas-Augustin, Dubravka; Novokmet, Natalija; Durakovic, Zijad; Missoni, Sasa; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas Hlth Sci Ctr, Inst Appl Genet, Ctr Computat Genom, Ft Worth, TX USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Deka, R (corresponding author), Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, United States of America [R01 DK069845, R01 DK069845-4S, P30 ES006096]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; National Institutes of Environmental Health Sciences, USA [T32 ES010957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957, P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); National Institutes of Environmental Health Sciences, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the National Institutes of Health, United States of America (R01 DK069845, R01 DK069845-4S and P30 ES006096) and from the Croatian Ministry of Science, Education and Sports (196-1962766-2751, 196-1962766-2747 and 196-0342282-0291). RK was supported by a training grant fellowship from the National Institutes of Environmental Health Sciences, USA (T32 ES010957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Deka R, 2012, ANN HUM BIOL, V39, P46, DOI 10.3109/03014460.2011.637512; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Karns R, 2012, ANN HUM GENET, V76, P121, DOI 10.1111/j.1469-1809.2011.00698.x; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029475; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	21	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51211	10.1371/journal.pone.0051211	http://dx.doi.org/10.1371/journal.pone.0051211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251454	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200069
J	Rizzi, C; Bianco, MV; Blanco, FC; Soria, M; Gravisaco, MJ; Montenegro, V; Vagnoni, L; Buddle, B; Garbaccio, S; Delgado, F; Leal, KS; Cataldi, AA; Dellagostin, OA; Bigi, F				Rizzi, Caroline; Veronica Bianco, Maria; Carlos Blanco, Federico; Soria, Marcelo; Jose Gravisaco, Maria; Montenegro, Valeria; Vagnoni, Lucas; Buddle, Bryce; Garbaccio, Sergio; Delgado, Fernando; Leal, Karen Silva; Adrian Cataldi, Angel; Dellagostin, Odir Antonio; Bigi, Fabiana			Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge	PLOS ONE			English	Article							MAJOR EXTRACELLULAR PROTEINS; TUBERCULOSIS VACCINE; STABLE EXPRESSION; IMMUNE-RESPONSES; INFECTED CATTLE; T-CELLS; ANTIGENS; MEMORY; MACROPHAGES; GENERATION	Mycobacterium bovis is the causative agent of tuberculosis in cattle but also infects other animals, including humans. Previous studies in cattle have demonstrated that the protection induced by BCG is not complete. In order to improve the protection efficacy of BCG, in this study we overexpressed Ag85B in a BCG Pasteur strain, by using an expression system based on the use of an auxotrophic strain for the leucine amino acid, and complementation with leuD. We found that vaccination of cattle with BCG overexpressing Ag85B induced higher production of IL-17 and IL-4 mRNA upon purified protein derivative (PPDB) stimulation of peripheral blood mononuclear cells (PBMCs) than vaccination with BCG. Moreover, the IL-17 mRNA expression after vaccination negatively correlated with disease severity resulting from a subsequent challenge with M. bovis, suggesting that this cytokine is a potential biomarker of cattle protection against bovine tuberculosis. Importantly, vaccination with the recombinant BCG vaccine protected cattle better than the wild-type BCG Pasteur.	[Rizzi, Caroline; Leal, Karen Silva; Dellagostin, Odir Antonio] Univ Fed Pelotas, Nucleo Biotecnol, CDTec, Pelotas, Brazil; [Veronica Bianco, Maria; Carlos Blanco, Federico; Jose Gravisaco, Maria; Montenegro, Valeria; Adrian Cataldi, Angel; Bigi, Fabiana] CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, INBA CONICET, Buenos Aires, DF, Argentina; [Vagnoni, Lucas; Garbaccio, Sergio; Delgado, Fernando] CICVyA INTA, Inst Patobiol, Buenos Aires, DF, Argentina; [Buddle, Bryce] AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand	Universidade Federal de Pelotas; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); AgResearch - New Zealand	Dellagostin, OA (corresponding author), Univ Fed Pelotas, Nucleo Biotecnol, CDTec, Pelotas, Brazil.	odir@ufpel.edu.br	Dellagostin, Odir/C-2331-2009; Rizzi, Caroline/M-7187-2019; Rizzi, Caroline/H-1014-2014	Dellagostin, Odir/0000-0003-2803-4088; Rizzi, Caroline/0000-0001-5810-9592; Rizzi, Caroline/0000-0001-5810-9592; Buddle, Bryce/0000-0001-6197-6689	SECyT [PICT2324]; MinCyT UE Mercosur grant BiotechSur; INTA [AEBIO243512]; CNPq [482376/2010-4]; NIH [1R01AI083084-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083084] Funding Source: NIH RePORTER	SECyT(Secretaria de Ciencia y Tecnologia (SECYT)); MinCyT UE Mercosur grant BiotechSur; INTA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present study was supported by SECyT grant PICT2324, MinCyT UE Mercosur grant BiotechSur and INTA grant AEBIO243512, CNPq grant 482376/2010-4 and partially supported by NIH 1R01AI083084-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Badell E, 2009, VACCINE, V27, P28, DOI 10.1016/j.vaccine.2008.10.034; Bange FC, 1996, INFECT IMMUN, V64, P1794, DOI 10.1128/IAI.64.5.1794-1799.1996; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blanco FC, 2009, MICROBIOL IMMUNOL, V53, P460, DOI 10.1111/j.1348-0421.2009.00141.x; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Buddle BM, 2011, TUBERCULOSIS, V91, P400, DOI 10.1016/j.tube.2011.07.001; Cataldi A, 2010, ART & SCIENCE OF TUBERCULOSIS VACCINE DEVELOPMENT, P185; Flores-Villalva S, 2012, CLIN VACCINE IMMUNOL, V19, P797, DOI 10.1128/CVI.05668-11; Hope JC, 2011, CLIN VACCINE IMMUNOL, V18, P373, DOI 10.1128/CVI.00543-10; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2006, VACCINE, V24, P1593, DOI 10.1016/j.vaccine.2005.10.002; Horwitz MA, 2005, MICROBES INFECT, V7, P947, DOI 10.1016/j.micinf.2005.04.002; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Hu XD, 2009, DNA CELL BIOL, V28, P191, DOI 10.1089/dna.2008.0790; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Lopez-Valencia G, 2010, RES VET SCI, V88, P44, DOI 10.1016/j.rvsc.2009.05.022; Maue AC, 2007, VACCINE, V25, P4735, DOI 10.1016/j.vaccine.2007.03.052; McMurray DN, 2011, EXPERT REV VACCINES, V10, P1675, DOI [10.1586/erv.11.144, 10.1586/ERV.11.144]; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Meikle V, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-37; Nambiar JK, 2012, EUR J IMMUNOL, V42, P385, DOI 10.1002/eji.201141903; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qie YQ, 2009, SCAND J IMMUNOL, V69, P342, DOI 10.1111/j.1365-3083.2009.02231.x; Seixas FK, 2010, BIOL RES, V43, P13, DOI [10.4067/S0716-97602010000100003, /S0716-97602010000100003]; Skinner MA, 2005, INFECT IMMUN, V73, P4441, DOI 10.1128/IAI.73.7.4441-4444.2005; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; Wedlock DN, 2005, INFECT IMMUN, V73, P3540, DOI 10.1128/IAI.73.6.3540-3546.2005; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	42	38	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51396	10.1371/journal.pone.0051396	http://dx.doi.org/10.1371/journal.pone.0051396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251517	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900077
J	Fernandes, ES; Vong, CT; Quek, S; Cheong, J; Awal, S; Gentry, C; Aubdool, AA; Liang, LH; Bodkin, JV; Bevan, S; Heads, R; Brain, SD				Fernandes, Elizabeth S.; Chi Teng Vong; Quek, Samuel; Cheong, Jessica; Awal, Salma; Gentry, Clive; Aubdool, Aisah A.; Liang, Lihuan; Bodkin, Jennifer V.; Bevan, Stuart; Heads, Richard; Brain, Susan D.			Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B-4-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1	FASEB JOURNAL			English	Article						pruritus; inflammation; neutrophils; reactive oxygen species; skin	NEUTROPHIL NADPH OXIDASE; PROTEIN-COUPLED RECEPTOR; P47PHOX PHOSPHORYLATION; ATOPIC-DERMATITIS; TRPA1; B-4; SKIN; INVOLVEMENT; ANTAGONIST; INFLAMMATION	The underlying mechanisms of itch are poorly understood. We have investigated a model involving the chemoattractant leukotriene B-4 (LTB4) that is up-regulated in common skin diseases. Intradermal injection of LTB4 (0.1 nmol/site) into female CD1 mice induced significant scratching movements (used as an itch index) compared with vehicle-injected (0.1% bovine serum albumin-saline) mice. Intraperitoneal transient receptor potential (TRP) channel antagonist treatment significantly inhibited itch as follows: TRP vanilloid 1 (TRPV1) antagonist SB366791 (0.5 mg/kg, by 97%) and the TRP ankyrin 1 (TRPA1) antagonists TCS 5861528 (10 mg/kg; 82%) and HC-030031 (100 mg/kg; 76%). Leukotriene B-4 receptor 2 antagonism by LY255283 (5 mg/kg i.p.; 62%) reduced itch. Neither TRPV1-knockout (TRPV1-KO) nor TRPA1-knockout (TRPA1-KO mice exhibited LTB4-induced itch compared with their wild-type counterparts. The reactive oxygen species scavengers N-acetylcysteine (NAC; 204 mg/kg i.p.;86%) or superoxide dismutase (SOD; 10 mg/kg i.p.; 83%) also inhibited itch. LTB4-induced superoxide release was attenuated by TCS 5861528 (56%) and HC-030031 (66%), NAC (58%), SOD (50%), and LY255283 (59%) but not by the leukotriene B-4 receptor 1 antagonist U-75302 (9 nmol/site) or SB366791. Itch, superoxide, and myeloperoxidase generation were inhibited by the leukocyte migration inhibitor fucoidan (10 mg/kg i.v.) by 80, 61, and 34%, respectively. Myeloperoxidase activity was also reduced by SB366791 (35%) and SOD (28%). TRPV1-KO mice showed impaired myeloperoxidase release, whereas TRPA1-KO mice exhibited diminished production of superoxide. This result provides novel evidence that TRPA1 and TRPV1 contribute to itch via distinct mechanisms.-Fernandes, E. S., Vong, C. T., Quek, S., Cheong, J., Awal, S., Gentry, C., Aubdool, A. A., Liang, L., Bodkin, J. V., Bevan, S., Heads, R., Brain, S. D. Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B-4-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1. FASEB J. 27, 1664-1673 (2013). www.fasebj.org	[Fernandes, Elizabeth S.] Univ Ceuma, Programa Posgrad Biol Parasitaria, Sao Luis, Brazil; [Chi Teng Vong; Quek, Samuel; Cheong, Jessica; Awal, Salma; Aubdool, Aisah A.; Liang, Lihuan; Bodkin, Jennifer V.; Heads, Richard; Brain, Susan D.] Kings Coll London, Div Cardiovasc, London SE1 9NH, England; [Chi Teng Vong; Quek, Samuel; Cheong, Jessica; Awal, Salma; Aubdool, Aisah A.; Liang, Lihuan; Bodkin, Jennifer V.; Heads, Richard; Brain, Susan D.] Kings Coll London, Ctr Integrat Biomed, British Heart Fdn, Cardiovasc Ctr Excellence, London SE1 9NH, England; [Gentry, Clive; Bevan, Stuart] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9NH, England	Universidade Ceuma; University of London; King's College London; University of London; King's College London; University College London; University of London; King's College London	Brain, SD (corresponding author), Kings Coll London, Franklin Wilkins Bldg,Waterloo Campus,150 Stamfor, London SE1 9NH, England.	sue.brain@kcl.ac.uk	Fernandes, Elizabeth S./Q-7276-2019; Bevan, Stuart/A-8821-2008; Brain, Susan/L-3681-2013; Fernandes, Elizabeth S/J-9397-2012	Fernandes, Elizabeth S./0000-0002-0567-2514; Vong, Chi Teng/0000-0002-4032-657X; Quek, Samuel/0000-0002-4363-0008; Bevan, Stuart John/0000-0002-8977-1797; Brain, Susan/0000-0002-9684-8342; aubdool, aisah/0000-0003-3087-5150; Aubdool, Dr. Aisah/0000-0002-4712-9421	Arthritis Research UK [19296]; Biotechnology and Biological Sciences Research Council; Capacity Building Award in Integrative Mammalian Biology; Higher Education Funding Council for England; Knowledge Transfer Network; Medical Research Council; Scottish Funding Council; British Heart Foundation 4-Year Ph.D. program; BBSRC [BB/E527098/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish; Versus Arthritis [19296] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Capacity Building Award in Integrative Mammalian Biology; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Knowledge Transfer Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; British Heart Foundation 4-Year Ph.D. program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This work was supported by the Arthritis Research UK (grant 19296 to E. S. F.), Biotechnology and Biological Sciences Research Council(A. A. A.), a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council, Higher Education Funding Council for England, Knowledge Transfer Network, Medical Research Council, and Scottish Funding Council (L. L.), and British Heart Foundation 4-Year Ph.D. program (J.V.B.). The authors declare no conflicts of interest.	Al-Shabanah OA, 1999, RES COMMUN MOL PATH, V106, P115; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andoh T, 1998, EUR J PHARMACOL, V353, P93, DOI 10.1016/S0014-2999(98)00440-3; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Andoh T, 2011, EXP DERMATOL, V20, P894, DOI 10.1111/j.1600-0625.2011.01346.x; Arruda MA, 2009, FRONT BIOSCI-LANDMRK, V14, P4546, DOI 10.2741/3547; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Biro T, 2009, J INVEST DERMATOL, V129, P2096, DOI 10.1038/jid.2009.179; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; BRAIN S, 1984, J INVEST DERMATOL, V83, P70, DOI 10.1111/1523-1747.ep12261712; CAMP RDR, 1982, PROSTAGLANDINS, V23, P631, DOI 10.1016/S0090-6980(82)80003-8; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Costa SKP, 2000, EUR J PHARMACOL, V391, P305, DOI 10.1016/S0014-2999(00)00075-3; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; DEMETRI GD, 1991, BLOOD, V78, P2791; Dent G, 1997, BRIT J PHARMACOL, V122, P758, DOI 10.1038/sj.bjp.0701428; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Engel MA, 2012, J GASTROENTEROL, V47, P256, DOI 10.1007/s00535-011-0495-6; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Fernandes ES, 2003, BRIT J PHARMACOL, V139, P973, DOI 10.1038/sj.bjp.0705314; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gaudreault E, 2005, J IMMUNOL, V174, P3617, DOI 10.4049/jimmunol.174.6.3617; Gomides LF, 2012, PHARMACOLOGY, V89, P275, DOI 10.1159/000337378; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V287, pG243, DOI 10.1152/ajpgi.00287.2003; Guzik TJ, 2005, METH MOLEC MED, V108, P73; Hoyer FF, 2012, MOL CELL BIOCHEM, V359, P25, DOI 10.1007/s11010-011-0995-y; HUGHES SR, 1991, BRIT J PHARMACOL, V104, P738, DOI 10.1111/j.1476-5381.1991.tb12497.x; IWAMOTO I, 1993, J IMMUNOL, V151, P2116; Kato S, 2011, J NANOSCI NANOTECHNO, V11, P3814, DOI 10.1166/jnn.2011.4172; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Kim HJ, 2008, BRIT J PHARMACOL, V154, P1073, DOI 10.1038/bjp.2008.220; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; MASAKI H, 1995, BIOCHEM BIOPH RES CO, V206, P474, DOI 10.1006/bbrc.1995.1067; Metz M, 2011, VET DERMATOL, V22, P121, DOI 10.1111/j.1365-3164.2010.00945.x; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Puntambekar P, 2005, J NEUROCHEM, V95, P1689, DOI 10.1111/j.1471-4159.2005.03518.x; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Ruan T, 2006, J APPL PHYSIOL, V101, P644, DOI 10.1152/japplphysiol.00192.2006; RUZICKA T, 1986, J INVEST DERMATOL, V86, P105, DOI 10.1111/1523-1747.ep12284061; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Serezani CHC, 2005, J LEUKOCYTE BIOL, V78, P976, DOI 10.1189/jlb.1004587; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Stefanova TH, 2010, Z NATURFORSCH C, V65, P141; Terneus MV, 2008, TOXICOLOGY, V244, P25, DOI 10.1016/j.tox.2007.10.027; Tsuji F, 2010, BIOL PHARM BULL, V33, P1050, DOI 10.1248/bpb.33.1050; Tsukumo Y, 2010, J PHARMACOL SCI, V113, P255, DOI 10.1254/jphs.10050FP; Vigna SR, 2011, PANCREAS, V40, P708, DOI 10.1097/MPA.0b013e318214c8df; Wei H, 2009, ANESTHESIOLOGY, V111, P147, DOI 10.1097/ALN.0b013e3181a1642b; Willemsen MAAP, 2001, EUR J PEDIATR, V160, P711, DOI 10.1007/s004310100838; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zhu Y, 2009, INT IMMUNOPHARMACOL, V9, P1332, DOI 10.1016/j.intimp.2009.08.006	63	56	57	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1664	1673		10.1096/fj.12-221218	http://dx.doi.org/10.1096/fj.12-221218			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271050				2022-12-25	WOS:000316940800036
J	Lee, SJ; Cho, SC; Lee, EJ; Kim, S; Lee, SB; Lim, JH; Choi, YH; Kim, WJ; Moon, SK				Lee, Se-Jung; Cho, Seok-Cheol; Lee, Eo-Jin; Kim, Sangtae; Lee, Soo-Bok; Lim, Jung-Hyurk; Choi, Yung Hyun; Kim, Wun-Jae; Moon, Sung-Kwon			Interleukin-20 Promotes Migration of Bladder Cancer Cells through Extracellular Signal-regulated Kinase (ERK)-mediated MMP-9 Protein Expression Leading to Nuclear Factor (NF-kappa B) Activation by Inducing the Up-regulation of p21(WAF1) Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE GENE; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; CYCLE REGULATORS; BREAST-CANCER; INFLAMMATORY CYTOKINES; URINARY-BLADDER; CDK INHIBITORS; GROWTH-FACTOR	The role of inflammatory cytokine interleukin-20 (IL-20) has not yet been studied in cancer biology. Here, we demonstrated up-regulation of both IL-20 and IL-20R1 in muscle-invasive bladder cancer patients. The expressions of IL-20 and IL-20R1 were observed in bladder cancer 5637 and T-24 cells. We found that IL-20 significantly increased the expression of matrix metalloproteinase (MMP)-9 via binding activity of NF-kappa B and AP-1 in bladder cancer cells and stimulated the activation of ERK1/2, JNK, p38 MAPK, and JAK-STAT signaling. Among the pathways examined, only ERK1/2 inhibitor U0126 significantly inhibited IL-20-induced migration and invasion. Moreover, siRNA knockdown of IL-20R1 suppressed migration, invasion, ERK1/2 activation, and NF-kappa B-mediated MMP-9 expression induced by IL-20. Unexpectedly, the cell cycle inhibitor p21(WAF1) was induced by IL-20 treatment without altering cell cycle progression. Blockade of p21(WAF1) function by siRNA reversed migration, invasion, activation of ERK signaling, MMP-9 expression, and activation of NF-kappa B in IL-20-treated cells. In addition, IL-20 induced the activation of I kappa B kinase, the degradation and phosphorylation of I kappa B alpha, and NF-kappa B p65 nuclear translocation, which was regulated by ERK1/2. IL-20 stimulated the recruitment of p65 to the MMP-9 promoter region. Finally, the IL-20-induced migration and invasion of cells was confirmed by IL-20 gene transfection and by addition of anti-IL-20 antibody. This is the first report that p21(WAF1) is involved in ERK1/2-mediated MMP-9 expression via increased binding activity of NF-kappa B, which resulted in the induction of migration in IL-20/IL-20R1 dyad-induced bladder cancer cells. These unexpected results might provide a critical new target for the treatment of bladder cancer.	[Lee, Se-Jung; Lee, Eo-Jin; Kim, Sangtae; Moon, Sung-Kwon] Chungju Natl Univ, Dept Biotechnol, Chungju 380702, Chungbuk, South Korea; [Cho, Seok-Cheol] Seowon Univ, Dept Food & Nutr, Cheongju 3773, Chungbuk, South Korea; [Lee, Soo-Bok] Yonsei Univ, Dept Food & Nutr, Brain Korea Project 21, Seoul 120749, South Korea; [Lim, Jung-Hyurk] Chungju Natl Univ, Dept Polymer Sci & Engn, Chungju 380702, Chungbuk, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan 614052, South Korea; [Lee, Se-Jung; Lee, Eo-Jin; Kim, Wun-Jae; Moon, Sung-Kwon] Chungbuk Natl Univ, Dept Urol, Personalized Tumor Engn Res Ctr, Cheongju 361763, Chungbuk, South Korea	Seowon University; Yonsei University; Dong-Eui University; Chungbuk National University	Moon, SK (corresponding author), Chung Ang Univ, Sch Food Sci & Technol, Ansung 456756, South Korea.	sumoon66@dreamwiz.com			National Research Foundation of Korea Grant [2012-0000482]; MEST, Rural Development Administration, Republic of Korea; Next-Generation BioGreen 21 Program Grant, Rural Development Administration, Republic of Korea [PJ0081952011]	National Research Foundation of Korea Grant(National Research Foundation of Korea); MEST, Rural Development Administration, Republic of Korea; Next-Generation BioGreen 21 Program Grant, Rural Development Administration, Republic of Korea	This work was supported by National Research Foundation of Korea Grant 2012-0000482 funded by MEST and by Next-Generation BioGreen 21 Program Grant PJ0081952011, Rural Development Administration, Republic of Korea.	Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baldi Alfonso, 2011, Patholog Res Int, V2011, P605042, DOI 10.4061/2011/605042; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAVIES B, 1993, CANCER RES, V53, P5365; Di Carlo A, 2006, ONCOL REP, V15, P1321; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goswami B, 2008, INT J GYNECOL CANCER, V18, P591, DOI 10.1111/j.1525-1438.2007.01089.x; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Hsu YH, 2012, J IMMUNOL, V188, P1981, DOI 10.4049/jimmunol.1102843; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Inoue K, 2000, CANCER RES, V60, P2290; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Juan G, 2001, CANCER RES, V61, P1220; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Lee SJ, 2008, ONCOL REP, V19, P1007; LIOTTA LA, 1986, CANCER RES, V46, P1; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Metts MC, 2000, J NATL MED ASSOC, V92, P285; Moses MA, 1998, CANCER RES, V58, P1395; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; SARKIS AS, 1993, J NATL CANCER I, V85, P53, DOI 10.1093/jnci/85.1.53; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Shariat SF, 2003, UROLOGY, V61, P1140, DOI 10.1016/S0090-4295(03)00236-X; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Stein JP, 1998, J NATL CANCER I, V90, P1072, DOI 10.1093/jnci/90.14.1072; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Xu WF, 2004, INT IMMUNOPHARMACOL, V4, P627, DOI 10.1016/j.intimp.2004.01.006; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018255	51	68	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5539	5552		10.1074/jbc.M112.410233	http://dx.doi.org/10.1074/jbc.M112.410233			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271730	Green Published, hybrid			2022-12-25	WOS:000315342500028
J	Magupalli, VG; Mochida, S; Yan, J; Jiang, X; Westenbroek, RE; Nairn, AC; Scheuer, T; Catterall, WA				Magupalli, Venkat G.; Mochida, Sumiko; Yan, Jin; Jiang, Xin; Westenbroek, Ruth E.; Nairn, Angus C.; Scheuer, Todd; Catterall, William A.			Ca2+-independent Activation of Ca2+/Calmodulin-dependent Protein Kinase II Bound to the C-terminal Domain of Ca(V)2.1 Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUID GIANT SYNAPSE; CA2+ CHANNELS; PRESYNAPTIC PLASTICITY; TRANSMITTER RELEASE; INTERACTION SITE; N-TYPE; CAMKII; PHOSPHORYLATION; BRAIN; NEURONS	Ca2+/calmodulin-dependent protein kinase II (CaMKII) forms a major component of the postsynaptic density where its functions in synaptic plasticity are well established, but its presynaptic actions are poorly defined. Here we show that CaMKII binds directly to the C-terminal domain of Ca(V)2.1 channels. Binding is enhanced by autophosphorylation, and the kinase-channel signaling complex persists after dephosphorylation and removal of the Ca2+/CaM stimulus. Autophosphorylated CaMKII can bind the Ca(V)2.1 channel and synapsin-1 simultaneously. CaMKII binding to Ca(V)2.1 channels induces Ca2+-independent activity of the kinase, which phosphorylates the enzyme itself as well as the neuronal substrate synapsin-1. Facilitation and inactivation of Ca(V)2.1 channels by binding of Ca2+/CaM mediates short term synaptic plasticity in transfected superior cervical ganglion neurons, and these regulatory effects are prevented by a competing peptide and the endogenous brain inhibitor CaMKIIN, which blocks binding of CaMKII to Ca(V)2.1 channels. These results define the functional properties of a signaling complex of CaMKII and Ca(V)2.1 channels in which both binding partners are persistently activated by their association, and they further suggest that this complex is important in presynaptic terminals in regulating protein phosphorylation and short term synaptic plasticity.	[Magupalli, Venkat G.; Yan, Jin; Jiang, Xin; Westenbroek, Ruth E.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Tokyo Medical University; Yale University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.	wcatt@uw.edu		Magupalli, Venkat/0000-0003-4638-3062; Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [R01 NS22625]; National Institute on Drug Abuse [DA10044]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS22625 (to W. A. C.) and National Institute on Drug Abuse Grant DA10044 (to A. C. N.).	Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; BENNETT AF, 1992, EUR J BIOCHEM, V206, P783, DOI 10.1111/j.1432-1033.1992.tb16985.x; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee JS, 2012, P NATL ACAD SCI USA, V109, pE765, DOI 10.1073/pnas.1114072109; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; Lu FM, 2006, P NATL ACAD SCI USA, V103, P4264, DOI 10.1073/pnas.0508162103; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; Magupalli VG, 2008, J NEUROSCI, V28, P7954, DOI 10.1523/JNEUROSCI.1964-08.2008; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Ohyama A, 2002, J NEUROSCI, V22, P3342; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sakaba T, 2003, J NEUROSCI, V23, P837; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu LG, 1999, J NEUROSCI, V19, P726; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019	60	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4637	4648		10.1074/jbc.M112.369058	http://dx.doi.org/10.1074/jbc.M112.369058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255606	Green Published, hybrid			2022-12-25	WOS:000315340400013
J	Elimam, H; Papillon, J; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.			Complement-mediated Activation of Calcium-independent Phospholipase A(2)gamma ROLE OF PROTEIN KINASES AND PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; GLOMERULAR EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; A(2); INHIBITION; EXPRESSION; MEMBRANE; IPLA(2)GAMMA; MITOCHONDRIAL; GROWTH	In experimental membranous nephropathy, complement C5b-9-induces glomerular epithelial cell (GEC) injury and proteinuria. The effects of C5b-9 are mediated via signaling pathways, including calcium-independent phospholipase A(2)gamma (iPLA(2)gamma), and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. The iPLA(2)gamma pathway is cytoprotective. This study addresses the mechanisms of iPLA(2)gamma activation. iPLA(2)gamma activity was monitored by quantifying prostaglandin E-2 (PGE(2)) production. In GECs, iPLA(2)gamma localized at the endoplasmic reticulum and mitochondria. Complement-mediated production of PGE2 was amplified in GECs that overexpress iPLA(2)gamma, compared with control cells, and was blocked by the iPLA(2)gamma inhibitor bromoenol lactone in both iPLA(2)gamma-overexpressing and control GECs. In GECs that overexpress iPLA(2)gamma, complement-mediated PGE2 production was reduced by inhibitors of MAP/ERK kinase 1 (MEK1) and p38 but not JNK. In COS-1 cells that overexpress iPLA(2)gamma and cyclooxygenase-1, PGE2 production was induced by co-expression of constitutively active MEK1 or MAPK-interacting kinase 1 (MNK1) as well as by stimulation with epidermal growth factor (EGF) + ionomycin. Complement-and EGF + ionomycin-stimulated iPLA(2)gamma activity was attenuated by the S511A/S515A double mutation. Moreover, complement and EGF + ionomycin enhanced phosphorylation of Ser-511. Thus, complement-mediated activation of iPLA(2)gamma is mediated via ERK and p38 pathways, and phosphorylation of Ser-511 and/or Ser-515 plays a key role in the catalytic activity and signaling of iPLA(2)gamma. Defining the mechanisms by which complement activates iPLA(2)gamma provides opportunities for development of novel therapeutic approaches to GEC injury and proteinuria.	[Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	McGill University	Takano, T (corresponding author), McGill Univ, Div Nephrol, 3775 Univ St,Rm 236, Montreal, PQ H3A 2B4, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Elimam, Hanan/H-5858-2017; Cybulsky, Andrey V./AAG-8238-2020	Elimam, Hanan/0000-0003-2585-9957; Cybulsky, Andrey V./0000-0003-4348-2348	Canadian Institutes of Health Research [MOP-53264, MOP-53335]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-53264 (to A. V. C.) and MOP-53335 (to T. T.). This work was also supported by the Kidney Foundation of Canada (to A. V. C.).; Supported by the Catherine McLaughlin Hakim Chair. To whom correspondence may be addressed: Division of Nephrology, Royal Victoria Hospital, 687 Pine Ave. West, Montreal, Quebec H3A 1A1, Canada. Tel.: 514-398-8148; Fax: 514-843-2815. E-mail: andrey.cybulsky@mcgill.ca.	Aoto M, 2009, FEBS LETT, V583, P1611, DOI 10.1016/j.febslet.2009.04.028; Aoudjit L, 2006, AM J PHYSIOL-RENAL, V290, pF1534, DOI 10.1152/ajprenal.00267.2005; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Beckett CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1350, DOI 10.1152/ajpcell.00487.2005; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P28766, DOI 10.1074/jbc.273.44.28766; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chilton F, 1996, J CLIN INVEST, V97, P2161, DOI 10.1172/JCI118654; Coers W, 1996, EXP NEPHROL, V4, P184; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; Cybulsky AV, 1998, KIDNEY INT, V54, P360, DOI 10.1046/j.1523-1755.1998.00013.x; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Kuwata H, 2007, J BIOL CHEM, V282, P20124, DOI 10.1074/jbc.M611883200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liu JH, 2001, BIOCHEM J, V353, P79, DOI 10.1042/bj3530079; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McHowat J, 2001, BIOCHEMISTRY-US, V40, P14921, DOI 10.1021/bi0156153; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Panesar M, 1997, J IMMUNOL, V159, P3584; Pattabiraman PP, 2012, AM J PHYSIOL-CELL PH, V302, pC979, DOI 10.1152/ajpcell.00396.2011; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Portilla D, 1999, CURR OPIN NEPHROL HY, V8, P473, DOI 10.1097/00041552-199907000-00012; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Saavedra G, 2006, J PHARMACOL EXP THER, V318, P1211, DOI 10.1124/jpet.106.105650; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sun B, 2008, J PHARMACOL EXP THER, V326, P59, DOI 10.1124/jpet.108.138958; Takahashi S, 2001, J PHARMACOL EXP THER, V296, P48; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Takano T, 2003, J PHARMACOL EXP THER, V305, P240, DOI 10.1124/jpet.102.043604; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tanaka H, 2004, BIOCHEM BIOPH RES CO, V320, P1284, DOI 10.1016/j.bbrc.2004.05.225; Tran K, 2000, J BIOL CHEM, V275, P25023, DOI 10.1074/jbc.M908971199; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821	61	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3871	3885		10.1074/jbc.M112.396614	http://dx.doi.org/10.1074/jbc.M112.396614			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258543	Green Published, hybrid			2022-12-25	WOS:000314845000018
J	Gillette, DD; Shah, PA; Cremer, T; Gavrilin, MA; Besecker, BY; Sarkar, A; Knoell, DL; Cormet-Boyaka, E; Wewers, MD; Butchar, JP; Tridandapani, S				Gillette, Devyn D.; Shah, Prexy A.; Cremer, Thomas; Gavrilin, Mikhail A.; Besecker, Beth Y.; Sarkar, Anasuya; Knoell, Daren L.; Cormet-Boyaka, Estelle; Wewers, Mark D.; Butchar, Jonathan P.; Tridandapani, Susheela			Analysis of Human Bronchial Epithelial Cell Proinflammatory Response to Burkholderia cenocepacia Infection INABILITY TO SECRETE IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; CIGARETTE-SMOKE; IN-VITRO; RELEASE; IL-1-BETA; INFLAMMASOME; CULTURES; KINASE	Burkholderia cenocepacia, the causative agent of cepacia syndrome, primarily affects cystic fibrosis patients, often leading to death. In the lung, epithelial cells serve as the initial barrier to airway infections, yet their responses to B. cenocepacia have not been fully investigated. Here, we examined the molecular responses of human airway epithelial cells to B. cenocepacia infection. Infection led to early signaling events such as activation of Erk, Akt, and NF-kappa B. Further, TNF alpha, IL-6, IL-8, and IL-1 beta were all significantly induced upon infection, but no IL-1 beta was detected in the supernatants. Because caspase-1 is required for IL-1 beta processing and release, we examined its expression in airway epithelial cells. Interestingly, little to no caspase-1 was detectable in airway epithelial cells. Transfection of caspase-1 into airway epithelial cells restored their ability to secrete IL-1 beta following B. cenocepacia infection, suggesting that a deficiency in caspase-1 is responsible, at least in part, for the attenuated IL-1 beta secretion.	[Gillette, Devyn D.; Tridandapani, Susheela] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA; [Shah, Prexy A.; Cremer, Thomas; Gavrilin, Mikhail A.; Besecker, Beth Y.; Sarkar, Anasuya; Knoell, Daren L.; Cormet-Boyaka, Estelle; Wewers, Mark D.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Knoell, Daren L.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu	Cormet-Boyaka, Estelle/H-5624-2011; Tridandapani, Susheela/E-4209-2011; Besecker, Beth/E-2747-2011; Butchar, Jonathan/E-2825-2011; Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	Cystic Fibrosis Foundation [(20020527): GILLET11H0]; National Institutes of Health [K12-CA133250]; American Cancer Society [IRG-67-003-47]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Cystic Fibrosis Foundation (20020527): GILLET11H0.; Supported by National Institutes of Health Grant K12-CA133250 and American Cancer Society Grant IRG-67-003-47. To whom correspondence may be addressed. E-mail:butchar.2@osu.edu.	Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; Cremer TJ, 2011, J IMMUNOL, V187, P635, DOI 10.4049/jimmunol.1003034; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Reddi K, 2003, PEDIATR RES, V54, P297, DOI 10.1203/01.PDR.0000076661.85928.1D; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Sajjan U, 2004, INFECT IMMUN, V72, P4188, DOI 10.1128/IAI.72.7.4188-4199.2004; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Shi L, 2012, AM J RESP CELL MOL, V47, P363, DOI 10.1165/rcmb.2011-0267OC	12	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3691	3695		10.1074/jbc.C112.430298	http://dx.doi.org/10.1074/jbc.C112.430298			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269671	Green Published, hybrid			2022-12-25	WOS:000314845000001
J	Hunter, CS; Stein, R				Hunter, Chad S.; Stein, Roland			Characterization of an Apparently Novel beta-Cell Line-enriched 80-88 kDa Transcriptional Activator of the MafA and Pdx1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 3-BETA; EMBRYONIC STEM-CELLS; FACTOR-BINDING SITES; INSULIN GENE; IN-VIVO; CONSERVED SEQUENCES; PANCREATIC EXOCRINE; DIABETES-MELLITUS; REGULATORY REGION; ENDOCRINE-CELLS	MafA and Pdx1 represent critical transcriptional regulators required for the maintenance of pancreatic islet beta-cell function. The in vivo beta-cell-enriched expression pattern of these genes is principally directed by islet transcription factors binding within conserved Region 3 (base pairs (bp) -8118/-7750) of MafA and Area II (bp -2153/-1923) of the Pdx1 gene. Comprehensive mutational analysis of conserved MafA Region 3 revealed two new beta-cell line-specific cis-activation elements, termed Site 4 (bp -7997 to -7988) and Site 12 (bp -7835 to -7826). Gel mobility and antibody super-shift analysis identified Pdx1 as the Site 4 binding factor, while an 80-88 kilodalton (kDa) beta-cell line-enriched protein complex bound Site 12 and similar aligned nucleotides within Pdx1 Area II. The 80-88 kDa activator was also found in adult mouse islet extract. Strikingly, the molecular weight, DNA binding, and antibody recognition properties of this activator were unique when compared with all other key islet transcription factors tested, including Prox1 (83 kDa), Hnf1 alpha (67 kDa), FoxA2 (48 kDa), MafA (46 kDa), Isl1 (44 kDa), Pdx1 (42 kDa), and Nkx2.2 (30 kDa). Collectively, these data define an apparently novel MafA Region 3 and Pdx1 Area II activator contributing to expression in beta-cells.	[Hunter, Chad S.; Stein, Roland] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, 723 Light Hall, Nashville, TN 37232 USA.	Roland.Stein@vanderbilt.edu		Hunter, Chad/0000-0002-1644-447X	National Institutes of Health [DK050203]; NIDDK NRSA Postdoctoral Fellowship from the National Institutes of Health [F32 DK083160]; National Institutes of Health (Public Health Service) [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK090570, R01DK050203, R56DK050203, F32DK083160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NRSA Postdoctoral Fellowship from the National Institutes of Health; National Institutes of Health (Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants DK050203 (to R. S.), NIDDK NRSA Postdoctoral Fellowship F32 DK083160 (to C. S. H.) from the National Institutes of Health.; We thank Min Guo (Vanderbilt University), Brian McKenna (Vanderbilt), Dr. Shuangli Guo (Vanderbilt) for technical assistance, and Dr. Richard O'Brien (Vanderbilt) for the kind use of liver nuclear extract. The pFox-Luc reporter plasmid was provided by Dr. Raghavendra Mirmira (Indiana University), and the Pdx1 and Prox1 antibodies were generously provided by Drs. Chris Wright (Vanderbilt) and Beatriz Sosa-Pineda (St. Jude Children's Research Hospital), respectively. Other antibodies utilized in this study (e. g. Isl1 and Hb9) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. Partial support was provided to the Vanderbilt University Medical Molecular Biology Laboratory by our National Institutes of Health-funded Diabetes Research and Training Center (Public Health Service Grant P60 DK20593).	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Cui WW, 2004, J BIOL CHEM, V279, P11088, DOI 10.1074/jbc.M312414200; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hunter CS, 2011, MOL ENDOCRINOL, V25, P339, DOI 10.1210/me.2010-0362; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Locker J, 2002, NUCLEIC ACIDS RES, V30, P3809, DOI 10.1093/nar/gkf484; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Raum JC, 2010, MOL CELL BIOL, V30, P4234, DOI 10.1128/MCB.01396-09; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; STEIN R, 1993, TRENDS ENDOCRIN MET, V4, P96, DOI 10.1016/1043-2760(93)90086-T; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Vanhoose AM, 2008, J BIOL CHEM, V283, P22612, DOI 10.1074/jbc.M802902200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	42	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3795	3803		10.1074/jbc.M112.434282	http://dx.doi.org/10.1074/jbc.M112.434282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269676	hybrid, Green Published			2022-12-25	WOS:000314845000011
J	Kuo, CJ; Ptak, CP; Hsieh, CL; Akey, BL; Chang, YF				Kuo, Chih-Jung; Ptak, Christopher P.; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu			Elastin, a Novel Extracellular Matrix Protein Adhering to Mycobacterial Antigen 85 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; IMMUNOGLOBULIN-LIKE PROTEIN; STAPHYLOCOCCUS-AUREUS; ATTACHMENT PROTEIN; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURES; CALCIUM BINDS; TUBERCULOSIS; MOTIF; TROPOELASTIN	The antigen 85 complex (Ag85) consists of three predominantly secreted proteins (Ag85A, Ag85B, and Ag85C), which play a key role in the mycobacterial pathogenesis and also possess enzymatic mycolyltransferase activity involved in cell wall synthesis. Ag85 is not only considered to be a virulence factor because its expression is essential for intracellular survival within macrophages, but also because it contributes to adherence, invasion, and dissemination of mycobacteria in host cells. In this study, we report that the extracellular matrix components, elastin and its precursor (tropoelastin) derived from human aorta, lung, and skin, serve as binding partners of Ag85 from Mycobacterium tuberculosis. The binding affinity of M. tuberculosis Ag85 to human tropoelastin was characterized (K-D = 0.13 +/- 0.006 mu M), and a novel Ag85-binding motif, AAA-KAA(K/Q)(Y/F), on multiple tropoelastin modules was identified. In addition, the negatively charged Glu-258 of Ag85 was demonstrated to participate in an electrostatic interaction with human tropoelastin. Moreover, binding of Ag85 on elastin siRNA-transfected Caco-2 cells was significantly reduced (34.3%), implying that elastin acts as an important ligand contributing to mycobacterial invasion.	[Kuo, Chih-Jung; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu] Cornell Univ, Dept Populat Med, Coll Vet Med, Ithaca, NY 14853 USA; [Kuo, Chih-Jung; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu] Cornell Univ, Dept Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Ptak, Christopher P.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Hsieh, Ching-Lin/ABA-6461-2021; Ptak, Christopher/I-3126-2012; Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; HSIEH, CHING-LIN/0000-0001-9468-9969; Kuo, Chih-Jung/0000-0002-4988-5124; Hsieh, Ching-Lin/0000-0002-3665-5717	Agriculture and Food Research Initiative [2008-35204-04626, 2009-65119-05993, 2008-55620-18710, 4535-CU-USDA-8710, 3954-CU-USDA-8710]; Animal Formula Fund [NY-478455, NY-478437]; Biotechnology Research and Development Corp.	Agriculture and Food Research Initiative; Animal Formula Fund; Biotechnology Research and Development Corp.	This work was supported by the Agriculture and Food Research Initiative Competitive Grants 2008-35204-04626, 2009-65119-05993, 2008-55620-18710, 4535-CU-USDA-8710, and 3954-CU-USDA-8710, Animal Formula Fund Grant NY-478455 and NY-478437, and the Biotechnology Research and Development Corp.	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1111/j.1574-6968.2002.tb11258.x; Denis O, 1997, INFECT IMMUN, V65, P676, DOI 10.1128/IAI.65.2.676-684.1997; Graf R, 1996, CELL TISSUE RES, V283, P133; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; JANICKI BW, 1971, AM REV RESPIR DIS, V104, P602; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kuo CJ, 2012, J BIOL CHEM, V287, P1892, DOI 10.1074/jbc.M111.298687; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2011, J BIOL CHEM, V286, P3957, DOI 10.1074/jbc.M110.184523; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mamat B, 2002, PROTEIN SCI, V11, P2168, DOI 10.1110/ps.0211002; Middleton AM, 2002, TUBERCULOSIS, V82, P69, DOI 10.1054/tube.2002.0324; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; RATLIFF TL, 1993, INFECT IMMUN, V61, P1889, DOI 10.1128/IAI.61.5.1889-1894.1993; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652, DOI 10.1128/IAI.63.7.2652-2657.1995; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Secott TE, 2001, INFECT IMMUN, V69, P2075, DOI 10.1128/IAI.69.4.2075-2082.2001; Shima S, 2000, J MOL BIOL, V300, P935, DOI 10.1006/jmbi.2000.3909; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; STARCHER BC, 1986, THORAX, V41, P577, DOI 10.1136/thx.41.8.577; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Tiruviluamala P, 2002, ANNU REV PUBL HEALTH, V23, P403, DOI 10.1146/annurev.publhealth.23.100901.140519; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Zhao WC, 1999, J BIOL CHEM, V274, P4521, DOI 10.1074/jbc.274.8.4521	58	28	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3886	3896		10.1074/jbc.M112.415679	http://dx.doi.org/10.1074/jbc.M112.415679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250738	hybrid, Green Published			2022-12-25	WOS:000314845000019
J	Lowry, JL; Brovkovych, V; Zhang, YK; Skidgel, RA				Lowry, Jessica L.; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.			Endothelial Nitric-oxide Synthase Activation Generates an Inducible Nitric-oxide Synthase-like Output of Nitric Oxide in Inflamed Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; HETEROTRIMERIC G-PROTEINS; CELL-MIGRATION; POSTTRANSLATIONAL ACTIVATION; DEPENDENT ACTIVATION; CARBOXYPEPTIDASE-M; S-NITROSYLATION; CONTROL ELEMENT; BRADYKININ B-1; KININASE-I	High levels of NO generated in the vasculature under inflammatory conditions are usually attributed to inducible nitric-oxide synthase (iNOS), but the role of the constitutively expressed endothelial NOS (eNOS) is unclear. In normal human lung microvascular endothelial cells (HLMVEC), bradykinin (BK) activates kinin B2 receptor (B2R) signaling that results in Ca2+ dependent activation of eNOS and transient NO. In inflamed HLMVEC(pretreated with interleukin-1 beta and interferon-gamma), we found enhanced binding of eNOS to calcium-calmodulin at basal Ca2+ levels, thereby increasing its basal activity that was dependent on extracellular L-Arg. Furthermore, B2R stimulation generated prolonged high output eNOS-derived NO that is independent of increased intracellular Ca2+ and is mediated by a novel G alpha(i)-, MEK1/2-, and JNK1/2-dependent pathway. This high output NO stimulated with BK was blocked with a B2R antagonist, eNOS siRNA, or eNOS inhibitor but not iNOS inhibitor. Moreover, B2R-mediated NO production and JNK phosphorylation were inhibited with MEK1/2 and JNK inhibitors or MEK1/2 and JNK1/2 siRNA but not with ERK1/2 inhibitor. BK induced Ca2+-dependent eNOS phosphorylation at Ser(1177), Thr(495), and Ser(114) in cytokine-treated HLMVEC, but these modifications were not dependent on JNK1/2 activation and were not responsible for prolonged NO output. Cytokine treatment did not alter the expression of B2R, G alpha(q/11), G(alpha i1,2), JNK, or eNOS. B2R activation in control endothelial cells enhanced migration, but in cytokine-treated HLMVEC it reduced migration. Both responses were NO-dependent. Understanding how JNK regulates prolonged eNOS-derived NO may provide new therapeutic targets for the treatment of disorders involving vascular inflammation.	[Lowry, Jessica L.; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Skidgel, Randal A.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol Mc 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu			National Institutes of Health [PO1 HL60678, T32 HL072742, RO1 HL36473]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072742, R01HL036473, T32HL007829, P01HL060678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL60678, T32 HL072742, and RO1 HL36473.; Recipient of a predoctoral fellowship from the American Heart Association.	Adler V, 2005, BIOCHEMISTRY-US, V44, P10784, DOI 10.1021/bi050619j; Adomeit A, 1999, MOL CELL BIOL, V19, P5289; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bachetti T, 2004, J MOL CELL CARDIOL, V37, P939, DOI 10.1016/j.yjmcc.2004.07.006; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Casanello P, 2009, PLACENTA, V30, P625, DOI 10.1016/j.placenta.2009.04.010; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Cirino G, 2003, TRENDS PHARMACOL SCI, V24, P91, DOI 10.1016/S0165-6147(02)00049-4; Closs EI, 2000, MOL PHARMACOL, V57, P68; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Cooke JP, 1997, CIRCULATION, V96, P379; Coso OA, 1996, J BIOL CHEM, V271, P3963; DRAPEAU G, 1988, EUR J PHARMACOL, V155, P193, DOI 10.1016/0014-2999(88)90423-2; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Griffiths C, 2001, J PHYSIOL-LONDON, V536, P855, DOI 10.1111/j.1469-7793.2001.00855.x; Gross ND, 2007, CLIN CANCER RES, V13, P5910, DOI 10.1158/1078-0432.CCR-07-0352; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Ignjatovic T., 2001, MOL PHARM, V66, P1310; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Kuhr FK, 2010, FASEB J, V24, P2475, DOI 10.1096/fj.09-148783; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liesmaa I, 2009, J CELL PHYSIOL, V221, P359, DOI 10.1002/jcp.21861; Luhrs H, 2002, RESP PHYSIOL, V129, P367, DOI 10.1016/S0034-5687(01)00323-1; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Morais C, 2012, AM J PATHOL, V180, P1702, DOI 10.1016/j.ajpath.2011.12.018; Neumann P, 2006, AM J PHYSIOL-LUNG C, V290, pL674, DOI 10.1152/ajplung.00391.2005; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Park JH, 2012, BIOCHEM BIOPH RES CO, V417, P340, DOI 10.1016/j.bbrc.2011.11.112; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ramadoss J, 2012, HYPERTENSION, V59, P1052, DOI 10.1161/HYPERTENSIONAHA.111.189498; Ruan L, 2011, ARTERIOSCL THROM VAS, V31, P392, DOI 10.1161/ATVBAHA.110.213181; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Skidgel RA, 2002, AM J PHYSIOL-LUNG C, V282, pL1179, DOI 10.1152/ajplung.00045.2002; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Soneja A, 2005, PHARMACOL REP, V57, P108; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yuan SY, 2000, MICROCIRCULATION, V7, P395; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang XM, 2011, J BIOL CHEM, V286, P18547, DOI 10.1074/jbc.M110.214940; Zhang YP, 2007, AM J RESP CELL MOL, V36, P697, DOI 10.1165/rcmb.2005-0369OC; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	91	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4174	4193		10.1074/jbc.M112.436022	http://dx.doi.org/10.1074/jbc.M112.436022			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255592	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000314845000045
J	Dou, ZC; Coppens, I; Carruthers, VB				Dou, Zhicheng; Coppens, Isabelle; Carruthers, Vern B.			Non-canonical Maturation of Two Papain-family Proteases in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL CYSTEINE PROTEASES; PLASMODIUM-FALCIPARUM; CATHEPSIN-B; MALARIA PARASITES; PROCATHEPSIN-B; PROTEINASE-INHIBITORS; PROTEOMIC ANALYSIS; CELL INVASION; SECRETION; DEGRADATION	Proteases regulate key events during infection by the pervasive intracellular parasite Toxoplasma gondii. Understanding how parasite proteases mature from an inactive zymogen to an active enzyme is expected to inform new strategies for blocking their actions. Herein, we show that T. gondii cathepsin B protease (TgCPB) does not undergo self-maturation but instead requires the expression of a second papain-family cathepsin protease, TgCPL. Using recombinant enzymes we also show that TgCPL is capable of partially maturing TgCPB in vitro. Consistent with this interrelationship, antibodies with validated specificity detected TgCPB in the lysosome-like vacuolar compartment along with TgCPL. Our findings also establish that TgCPB does not localize to the rhoptries as previously reported. Accordingly, rhoptry morphology and rhoptry protein maturation are normal in TgCPB knock-out parasites. Finally, we show that although maturation of TgCPL is independent of TgCPB, it may involve an additional protease(s) in conjunction with self-maturation.	[Dou, Zhicheng; Carruthers, Vern B.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Coppens, Isabelle] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Coppens, Isabelle] Malaria Res Inst, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Carruthers, VB (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Sch Med, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895	National Institutes of Health [AI063263]; American Heart Association Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by an American Heart Association Postdoctoral Fellowship (to Z. D.).	BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Donnelly S, 2011, ADV EXP MED BIOL, V712, P192, DOI 10.1007/978-1-4419-8414-2_12; Dou ZC, 2011, ADV EXP MED BIOL, V712, P49, DOI 10.1007/978-1-4419-8414-2_4; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; Fachado A, 1997, MEM I OSWALDO CRUZ, V92, P589, DOI 10.1590/S0074-02761997000500005; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kasper LH, 1998, PARASITOL TODAY, V14, P150, DOI 10.1016/S0169-4758(97)01212-X; Kirschke H, 1998, LYSOSOMAL CYSTEINE P, P131; Larson ET, 2009, J BIOL CHEM, V284, P26839, DOI 10.1074/jbc.M109.003780; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Que XC, 2004, INFECT IMMUN, V72, P2915, DOI 10.1128/IAI.72.5.2915-2921.2004; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; ROSENTHAL PJ, 1995, EXP PARASITOL, V80, P272, DOI 10.1006/expr.1995.1033; ROSENTHAL PJ, 1989, MOL BIOCHEM PARASIT, V35, P177, DOI 10.1016/0166-6851(89)90120-5; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	44	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3523	3534		10.1074/jbc.M112.443697	http://dx.doi.org/10.1074/jbc.M112.443697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250753	hybrid, Green Published			2022-12-25	WOS:000314397900057
J	Hachiro, T; Yamamoto, T; Nakano, K; Tanaka, K				Hachiro, Takeru; Yamamoto, Takaharu; Nakano, Kenji; Tanaka, Kazuma			Phospholipid Flippases Lem3p-Dnf1p and Lem3p-Dnf2p Are Involved in the Sorting of the Tryptophan Permease Tat2p in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; P-TYPE ATPASES; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID FLIPPASES; PREVACUOLAR COMPARTMENT; ACTIN CYTOSKELETON; SECRETORY VESICLES; POLARIZED GROWTH; BINDING-PROTEINS	The type 4 P-type ATPases are flippases that generate phospholipid asymmetry in membranes. In budding yeast, heteromeric flippases, including Lem3p-Dnf1p and Lem3p-Dnf2p, translocate phospholipids to the cytoplasmic leaflet of membranes. Here, we report that Lem3p-Dnf1/2p are involved in transport of the tryptophan permease Tat2p to the plasma membrane. The lem3 Delta mutant exhibited a tryptophan requirement due to the mislocalization of Tat2p to intracellular membranes. Tat2p was relocalized to the plasma membrane when trans-Golgi network (TGN)-to-endosome transport was inhibited. Inhibition of ubiquitination by mutations in ubiquitination machinery also rerouted Tat2p to the plasma membrane. Lem3p-Dnf1/2p are localized to endosomal/TGN membranes in addition to the plasma membrane. Endocytosis mutants, in which Lem3p-Dnf1/2p are sequestered to the plasma membrane, also exhibited the ubiquitination-dependent missorting of Tat2p. These results suggest that Tat2p is ubiquitinated at the TGN and missorted to the vacuolar pathway in the lem3 Delta mutant. The NH2-terminal cytoplasmic region of Tat2p containing ubiquitination acceptor lysines interacted with liposomes containing acidic phospholipids, including phosphatidylserine. This interaction was abrogated by alanine substitution mutations in the basic amino acids downstream of the ubiquitination sites. Interestingly, a mutant Tat2p containing these substitutions was missorted in a ubiquitination-dependent manner. We propose the following model based on these results; Tat2p is not ubiquitinated when the NH2-terminal region is bound to membrane phospholipids, but if it dissociates from the membrane due to a low level of phosphatidylserine caused by perturbation of phospholipid asymmetry in the lem3 Delta mutant, Tat2p is ubiquitinated and then transported from the TGN to the vacuole.	[Hachiro, Takeru; Yamamoto, Takaharu; Nakano, Kenji; Tanaka, Kazuma] Hokkaido Univ, Div Mol Interact, Inst Med Genet, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0600815, Japan	Hokkaido University	Tanaka, K (corresponding author), Hokkaido Univ, Div Mol Interact, Inst Med Genet, Grad Sch Life Sci,Kita Ku, N15 W7, Sapporo, Hokkaido 0600815, Japan.	k-tanaka@igm.hokudai.ac.jp	Tanaka, Kazuma/A-4240-2012		Japan Society for the Promotion of Science KAKENHI [21570192, 21370085]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 21570192 and 21370085.	Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bensen ES, 2000, GENETICS, V154, P83; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Brachmann CB, 1998, YEAST, V14, P115; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guo Y, 2010, J BIOL CHEM, V285, P39564, DOI 10.1074/jbc.M110.177055; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HEITMAN J, 1993, MOL CELL BIOL, V13, P5010, DOI 10.1128/MCB.13.8.5010; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; JONES EW, 1982, GENETICS, V102, P665; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kikyo M, 1999, ONCOGENE, V18, P7046, DOI 10.1038/sj.onc.1203184; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Misu K, 2003, MOL BIOL CELL, V14, P730, DOI 10.1091/mbc.E02-06-0314; Mochida J, 2002, GENETICS, V160, P923; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Nagayama A, 2004, EXTREMOPHILES, V8, P143, DOI 10.1007/s00792-003-0373-0; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Takagi K, 2012, BIOCHEM BIOPH RES CO, V417, P490, DOI 10.1016/j.bbrc.2011.11.147; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang HY, 1997, MOL CELL BIOL, V17, P4294, DOI 10.1128/MCB.17.8.4294; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; ZUBENKO GS, 1982, GENETICS, V102, P679; [No title captured]	78	29	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3594	3608		10.1074/jbc.M112.416263	http://dx.doi.org/10.1074/jbc.M112.416263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250744	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000314397900064
J	Dawson, K; Wu, CT; Qi, XY; Nattel, S				Dawson, Kristin; Wu, Chia-Tung; Qi, Xiao Yan; Nattel, Stanley			Congestive Heart Failure Effects on Atrial Fibroblast Phenotype: Differences between Freshly-Isolated and Cultured Cells	PLOS ONE			English	Article							CARDIAC FIBROBLASTS; EXPRESSION PROFILES; GROWTH-FACTOR; FIBRILLATION; MATRIX; MYOFIBROBLASTS; RECRUITMENT; INFARCTION; MONOLAYERS; IMPROVES	Introduction: Fibroblasts are important in the atrial fibrillation (AF) substrate resulting from congestive heart failure (CHF). We previously noted changes in in vivo indices of fibroblast function in a CHF dog model, but could not detect changes in isolated cells. This study assessed CHF-induced changes in the phenotype of fibroblasts freshly isolated from control versus CHF dogs, and examined effects of cell culture on these differences. Methods/Results: Left-atrial fibroblasts were isolated from control and CHF dogs (ventricular tachypacing 240 bpmx2 weeks). Freshly-isolated fibroblasts were compared to fibroblasts in primary culture. Extracellular-matrix (ECM) gene-expression was assessed by qPCR, protein by Western blot, fibroblast morphology with immunocytochemistry, and K+-current with patch-clamp. Freshly-isolated CHF fibroblasts had increased expression-levels of collagen-1 (10-fold), collagen-3 (5-fold), and fibronectin-1 (3-fold) vs. control, along with increased cell diameter (13.4 +/- 0.4 mu m vs control 8.4 +/- 0.3 mu m) and cell spreading (shape factor 0.81 +/- 0.02 vs. control 0.87 +/- 0.02), consistent with an activated phenotype. Freshly-isolated control fibroblasts displayed robust tetraethylammonium (TEA)-sensitive K+-currents that were strongly downregulated in CHF. The TEA-sensitive K+-current differences between control and CHF fibroblasts were attenuated after 2-day culture and eliminated after 7 days. Similarly, cell-culture eliminated the ECM protein-expression and shape differences between control and CHF fibroblasts. Conclusions: Freshly-isolated CHF and control atrial fibroblasts display distinct ECM-gene and morphological differences consistent with in vivo pathology. Culture for as little as 48 hours activates fibroblasts and obscures the effects of CHF. These results demonstrate potentially-important atrial-fibroblast phenotype changes in CHF and emphasize the need for caution in relating properties of cultured fibroblasts to in vivo systems. Citation: Dawson K, Wu C-T, Qi XY, Nattel S (2012) Congestive Heart Failure Effects on Atrial Fibroblast Phenotype: Differences between Freshly-Isolated and Cultured Cells. PLoS ONE 7(12): e52032. doi: 10.1371/journal.pone.0052032	[Dawson, Kristin; Wu, Chia-Tung; Qi, Xiao Yan; Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Dawson, Kristin; Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Wu, Chia-Tung; Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Wu, Chia-Tung] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Wu, Chia-Tung] Univ Taoyuan, Tao Yuan, Taiwan; [Wu, Chia-Tung; Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; McGill University; Universite de Montreal; Chang Gung Memorial Hospital; Universite de Montreal	Nattel, S (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	stanley.nattel@icm-mhi.org		Nattel, Stanley/0000-0002-5565-3311	Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research [MGP6957, MOP44365]; Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA)	Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research; Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA)	Funding came from Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research (MGP6957, MOP44365), Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocha A, 1997, CELL TISSUE RES, V288, P87, DOI 10.1007/s004410050795; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Burstein B, 2008, CIRCULATION, V117, P1630, DOI 10.1161/CIRCULATIONAHA.107.748053; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Cardin S, 2007, CIRC RES, V100, P425, DOI 10.1161/01.RES.0000258428.09589.1a; Castella LF, 2010, J CELL SCI, V123, P1751, DOI 10.1242/jcs.066795; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Ehrlich JR, 2002, J CARDIOVASC ELECTR, V13, P399, DOI 10.1046/j.1540-8167.2002.00399.x; Fenelon G, 1996, PACE, V19, P95, DOI 10.1111/j.1540-8159.1996.tb04796.x; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hanna N, 2004, CARDIOVASC RES, V63, P236, DOI 10.1016/j.cardiores.2004.03.026; Hinchcliff M, 2012, CLIN EXP RHEUMATOL, V30, pS86; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Jarvis MD, 2006, AM J PHYSIOL-HEART C, V291, pH1952, DOI 10.1152/ajpheart.00764.2005; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kupfer P, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-23; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rohr S, 2011, J CARDIOVASC PHARM, V57, P389, DOI 10.1097/FJC.0b013e3182137e17; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Roncoroni L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-40; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Woodiwiss AJ, 2001, CIRCULATION, V103, P155; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yperman J, 2004, TISSUE ENG, V10, P1368, DOI 10.1089/ten.2004.10.1368; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; ZEYDEL M, 1991, CELL TISSUE RES, V265, P353, DOI 10.1007/BF00398083; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	39	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52032	10.1371/journal.pone.0052032	http://dx.doi.org/10.1371/journal.pone.0052032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251678	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800131
J	Desaki, Y; Otomo, I; Kobayashi, D; Jikumaru, Y; Kamiya, Y; Venkatesh, B; Tsuyumu, S; Kaku, H; Shibuya, N				Desaki, Yoshitake; Otomo, Ippei; Kobayashi, Daijiro; Jikumaru, Yusuke; Kamiya, Yuji; Venkatesh, Balakrishnan; Tsuyumu, Shinji; Kaku, Hanae; Shibuya, Naoto			Positive Crosstalk of MAMP Signaling Pathways in Rice Cells	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DEFENSE RESPONSES; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDES; PANTOEA-AGGLOMERANS; MOLECULAR-PATTERNS; ELICITORS; ACCUMULATION	Plants have evolved efficient defense mechanisms known as priming and synergy, both of which can mobilize defense responses more extensively against successive pathogen invasion or simultaneous stimulation by different signal molecules. However, the mechanisms underlying these phenomena were largely unknown. In the present study, we used cultured rice cells and combination of purified MAMP molecules as a model system to study the mechanisms of these phenomena. We found that the pretreatment of rice cells with a low concentration of bacterial lipopolysaccharide (LPS) apparently primed the defense responses induced by successive N-acetylchitooctaose (GN8) treatment. On the other hand, simultaneous treatment with GN8 and LPS also resulted in the similar enhancement of defense responses observed for the LPS-induced priming, indicating that the synergistic effects of these MAMPs are basically responsible for such enhancement of defense responses, though the effect could be interpreted as "priming'' under some experimental conditions. These results also indicate that such a positive crosstalk of signaling cascade downstream of MAMP receptors seems to occur very rapidly, probably at early step(s) of signaling pathway. Comprehensive analysis of phytohormones revealed a specific enhancement of the synthesis of jasmonic acid (JA), both in the LPS pretreatment and also simultaneous treatment, indicating a role of JA in the enhancement of downstream responses.	[Desaki, Yoshitake; Otomo, Ippei; Kobayashi, Daijiro; Kaku, Hanae; Shibuya, Naoto] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan; [Jikumaru, Yusuke; Kamiya, Yuji] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Venkatesh, Balakrishnan; Tsuyumu, Shinji] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan	Meiji University; RIKEN; Shizuoka University	Shibuya, N (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan.	shibuya@isc.meiji.ac.jp	Kamiya, Yuji/F-9420-2010; Desaki, Yoshitake/M-7264-2015	Kamiya, Yuji/0000-0003-4415-520X; Desaki, Yoshitake/0000-0002-0916-9051	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Private Universities Foundation for the Development of Fundamental Research Strategies	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Private Universities Foundation for the Development of Fundamental Research Strategies	This research was supported in part by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN, NS), Private Universities Foundation for the Development of Fundamental Research Strategies (NS) and also a Grant-in-Aid for JSPS fellow (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; DAVIS KR, 1986, PLANT MOL BIOL, V6, P23, DOI 10.1007/BF00021303; Desaki Y, 2006, PLANT CELL PHYSIOL, V47, P1530, DOI 10.1093/pcp/pcl019; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Makela SM, 2011, MOL IMMUNOL, V48, P505, DOI 10.1016/j.molimm.2010.10.005; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Nojiri H, 1996, PLANT PHYSIOL, V110, P387, DOI 10.1104/pp.110.2.387; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Ortmann I, 2006, PLANTA, V224, P963, DOI 10.1007/s00425-006-0271-7; Ortmann I, 2006, FEBS LETT, V580, P4491, DOI 10.1016/j.febslet.2006.07.025; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; SCHWACKE R, 1992, PLANTA, V187, P136, DOI 10.1007/BF00201635; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tsukada K, 2002, PHYSIOL PLANTARUM, V116, P373, DOI 10.1034/j.1399-3054.2002.1160313.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Yamaguchi T, 2002, J PLANT PHYSIOL, V159, P1147, DOI 10.1078/0176-1617-00877; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zhu YJ, 2003, PHYSIOL MOL PLANT P, V63, P237, DOI 10.1016/j.pmpp.2004.03.003	34	13	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51953	10.1371/journal.pone.0051953	http://dx.doi.org/10.1371/journal.pone.0051953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251660	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800115
J	Diz, R; Garland, A; Vincent, BG; Johnson, MC; Spidale, N; Wang, B; Tisch, R				Diz, Ramiro; Garland, Alaina; Vincent, Benjamin G.; Johnson, Mark C.; Spidale, Nicholas; Wang, Bo; Tisch, Roland			Autoreactive Effector/Memory CD4(+) and CD8(+) T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; PERIPHERAL-BLOOD; IMMUNE DYSREGULATION; STATISTICAL-ANALYSIS; GENE USAGE; FOLLOW-UP; MOUSE; REPERTOIRE; INSULITIS; MELLITUS	Islet transplantation provides a "cure'' for type 1 diabetes but is limited in part by recurrent autoimmunity mediated by beta cell-specific CD4(+) and CD8(+) T cells. Insight into the T cell receptor (TCR) repertoire of effector T cells driving recurrent autoimmunity would aid the development of immunotherapies to prevent islet graft rejection. Accordingly, we used a multi-parameter flow cytometry strategy to assess the TCR variable beta (V beta) chain repertoires of T cell subsets involved in autoimmune-mediated rejection of islet grafts in diabetic NOD mouse recipients. Naive CD4(+) and CD8(+) T cells exhibited a diverse TCR repertoire, which was similar in all tissues examined in NOD recipients including the pancreas and islet grafts. On the other hand, the effector/memory CD8(+) T cell repertoire in the islet graft was dominated by one to four TCR V beta chains, and specific TCR V beta chain usage varied from recipient to recipient. Similarly, islet graft- infiltrating effector/memory CD4(+) T cells expressed a limited number of prevalent TCR V beta chains, although generally TCR repertoire diversity was increased compared to effector/memory CD8(+) T cells. Strikingly, the majority of NOD recipients showed an increase in TCR V beta 12-bearing effector/memory CD4(+) T cells in the islet graft, most of which were proliferating, indicating clonal expansion. Importantly, TCR V beta usage by effector/memory CD4(+) and CD8(+) T cells infiltrating the islet graft exhibited greater similarity to the repertoire found in the pancreas as opposed to the draining renal lymph node, pancreatic lymph node, or spleen. Together these results demonstrate that effector/memory CD4(+) and CD8(+) T cells mediating autoimmune rejection of islet grafts are characterized by restricted TCR V beta chain usage, and are similar to T cells that drive destruction of the endogenous islets. Citation: Diz R, Garland A, Vincent BG, Johnson MC, Spidale N, et al. (2012) Autoreactive Effector/Memory CD4(+) and CD8(+) T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage. PLoS ONE 7(12): e52054. doi:10.1371/journal.pone.0052054	[Diz, Ramiro; Garland, Alaina; Vincent, Benjamin G.; Johnson, Mark C.; Spidale, Nicholas; Wang, Bo; Tisch, Roland] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Tisch, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	rmtisch@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		National Institutes of Health (NIH) grant [R01AI058014]; NIH training grant [5T32 AI07273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058014, T32AI007273] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) grant (R01AI058014, RT). AG, MCJ and NS were supported by a NIH training grant (5T32 AI07273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; BUDD RC, 1987, J IMMUNOL, V138, P3583; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; Ciupe SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000396; Codina-Busqueta E, 2011, J IMMUNOL, V186, P3787, DOI 10.4049/jimmunol.1002423; Coulombe M, 2004, ADV EXP MED BIOL, V552, P154; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; DREXLER K, 1993, IMMUNOL LETT, V37, P187, DOI 10.1016/0165-2478(93)90030-6; Eisenbarth GS, 2003, J CLIN INVEST, V111, P179, DOI 10.1172/JCI200317621; GALLEY KA, 1995, J IMMUNOL, V154, P2969; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; He M, 2005, BIOINFORMATICS, V21, P3697, DOI 10.1093/bioinformatics/bti600; Jager E, 2000, INT J CANCER, V86, P538; Kaufman DL, 2001, DIABETES, V50, P2459, DOI 10.2337/diabetes.50.11.2459; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kepler TB, 2005, BIOINFORMATICS, V21, P3394, DOI 10.1093/bioinformatics/bti539; Komagata Y, 1996, INT IMMUNOL, V8, P807, DOI 10.1093/intimm/8.6.807; Li J, 2010, BLOOD, V115, P3580, DOI 10.1182/blood-2009-10-246991; Li L, 2008, DIABETES, V57, P2099, DOI 10.2337/db08-0383; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Liu CP, 2006, ANN NY ACAD SCI, V1079, P161, DOI 10.1196/annals.1375.025; Liu ZJ, 2012, DIABETES, V61, P1160, DOI 10.2337/db11-0867; Mallone R, 2008, CURR DIABETES REP, V8, P101, DOI 10.1007/s11892-008-0019-9; Morice WG, 2004, AM J CLIN PATHOL, V121, P373, DOI 10.1309/3A32DTVMH640M2QA; NAGATA M, 1992, DIABETES, V41, P998, DOI 10.2337/diabetes.41.8.998; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Pilch H, 2002, CLIN DIAGN LAB IMMUN, V9, P257, DOI 10.1128/CDLI.9.2.257-266.2002; Plesner A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/979527; Prasad S, 2012, J AUTOIMMUN; Roep BO, 1999, J AUTOIMMUN, V13, P267, DOI 10.1006/jaut.1999.0312; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SARUKHAN A, 1995, INT IMMUNOL, V7, P139, DOI 10.1093/intimm/7.1.139; SARUKHAN A, 1994, EUR J IMMUNOL, V24, P1750, DOI 10.1002/eji.1830240805; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Tian J, 2001, J IMMUNOL, V166, P7144, DOI 10.4049/jimmunol.166.12.7144; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TOYODA H, 1992, IMMUNOL LETT, V32, P241, DOI 10.1016/0165-2478(92)90056-T; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vincent BG, 2010, J IMMUNOL, V184, P4196, DOI 10.4049/jimmunol.0903931; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WATERS SH, 1992, DIABETES, V41, P308, DOI 10.2337/diabetes.41.3.308; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong CP, 2006, J IMMUNOL, V176, P1637, DOI 10.4049/jimmunol.176.3.1637; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Young EF, 2009, AUTOIMMUNITY, V42, P678, DOI 10.3109/08916930903213993; Zechel MA, 1998, IMMUNOL REV, V164, P111, DOI 10.1111/j.1600-065X.1998.tb01213.x	63	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52054	10.1371/journal.pone.0052054	http://dx.doi.org/10.1371/journal.pone.0052054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251685	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800137
J	Hu, JCC; Chan, HC; Simmer, SG; Seymen, F; Richardson, AS; Hu, YY; Milkovich, RN; Estrella, NMRP; Yildirim, M; Bayram, M; Chen, CF; Simmer, JP				Hu, Jan C. -C.; Chan, Hui-Chen; Simmer, Stephen G.; Seymen, Figen; Richardson, Amelia S.; Hu, Yuanyuan; Milkovich, Rachel N.; Estrella, Ninna M. R. P.; Yildirim, Mine; Bayram, Merve; Chen, Chiung-Fen; Simmer, James P.			Amelogenesis Imperfecta in Two Families with Defined AMELX Deletions in ARHGAP6	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ENAMEL DEFECTS; Y-CHROMOSOME; DENTAL ENAMEL; SHORT ARM; GENE; MICE; MUTATION; TRANSCRIPT; PHENOTYPE	Amelogenesis imperfecta (AI) is a group of inherited conditions featuring isolated enamel malformations. About 5% of AI cases show an X-linked pattern of inheritance, which are caused by mutations in AMELX. In humans there are two, non-allelic amelogenin genes: AMELX (Xp22.3) and AMELY (Yp11.2). About 90% of amelogenin expression is from AMELX, which is nested within intron 1 of the gene encoding Rho GTPase activating protein 6 (ARHGAP6). We recruited two AI families and determined that their disease-causing mutations were partial deletions in ARHGAP6 that completely deleted AMELX. Affected males in both families had a distinctive enamel phenotype resembling "snow-capped'' teeth. The 96,240 bp deletion in family 1 was confined to intron 1 of ARHGAP6 (g.302534_398773del96240), but removed alternative ARHGAP6 promoters 1c and 1d. Analyses of developing teeth in mice showed that ARHGAP6 is not expressed from these promoters in ameloblasts. The 52,654 bp deletion in family 2 (g.363924_416577del52654insA) removed ARHGAP6 promoter 1d and exon 2, precluding normal expression of ARHGAP6. The male proband of family 2 had slightly thinner enamel with greater surface roughness, but exhibited the same pattern of enamel malformations characteristic of males in family 1, which themselves showed minor variations in their enamel phenotypes. We conclude that the enamel defects in both families were caused by amelogenin insufficiency, that deletion of AMELX results in males with a characteristic snow-capped enamel phenotype, and failed ARHGAP6 expression did not appreciably alter the severity of enamel defects when AMELX was absent. Citation: Hu JC-C, Chan H-C, Simmer SG, Seymen F, Richardson AS, et al. (2012) Amelogenesis Imperfecta in Two Families with Defined AMELX Deletions in ARHGAP6. PLoS ONE 7(12): e52052. doi:10.1371/journal.pone.0052052	[Hu, Jan C. -C.; Chan, Hui-Chen; Simmer, Stephen G.; Richardson, Amelia S.; Hu, Yuanyuan; Milkovich, Rachel N.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Seymen, Figen; Yildirim, Mine; Bayram, Merve] Istanbul Univ, Dept Pedodont, Fac Dent, Istanbul, Turkey; [Estrella, Ninna M. R. P.; Chen, Chiung-Fen] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Istanbul University; University of Michigan System; University of Michigan	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	janhu@umich.edu	Hu, Jan C-C./F-5679-2015; Bayram, Merve/B-1230-2018; Koruyucu, M/AAC-6713-2020; Seymen, Figen/AAC-6736-2020	Hu, Jan C-C./0000-0002-9294-0248; Bayram, Merve/0000-0002-8440-367X; Koruyucu, M/0000-0002-2077-5095; Seymen, Figen/0000-0001-7010-2035; Simmer, James/0000-0002-7192-6105	NSF grant [EAR-9911352]; NIDCR/NIH [DE015846, DE019775]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019775, R01DE015846] Funding Source: NIH RePORTER	NSF grant(National Science Foundation (NSF)); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NSF grant #EAR-9911352 and NIDCR/NIH Grants DE015846 and DE019775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akane A, 1998, Methods Mol Biol, V98, P245; BACKMAN B, 1988, HUM HERED, V38, P189, DOI 10.1159/000153785; BACKMAN B, 1988, SCAND J DENT RES, V96, P505; Barron MJ, 2010, HUM MOL GENET, V19, P1230, DOI 10.1093/hmg/ddq001; BERKMAN M D, 1971, Birth Defects Original Article Series, V7, P204; Chan HC, 2011, EUR J ORAL SCI, V119, P311, DOI 10.1111/j.1600-0722.2011.00857.x; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Crampton N, 2006, EUR J ORAL SCI, V114, P133, DOI 10.1111/j.1600-0722.2006.00274.x; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GIBSON CW, 1991, BIOCHEM BIOPH RES CO, V174, P1306, DOI 10.1016/0006-291X(91)91564-S; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hobson GM, 2009, AM J MED GENET A, V149A, P1698, DOI 10.1002/ajmg.a.32968; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Oliveira MAHD, 2010, MICROSC RES TECHNIQ, V73, P572, DOI 10.1002/jemt.20796; Iwase M, 2007, CELLS TISSUES ORGANS, V186, P49, DOI 10.1159/000102680; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kawasaki K, 2008, J DENT RES, V87, P520, DOI 10.1177/154405910808700608; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LAGERSTROM M, 1990, AM J HUM GENET, V46, P120; LAGERSTROMFERMER M, 1993, GENOMICS, V17, P89, DOI 10.1006/geno.1993.1287; Lattanzi W, 2005, HUM GENET, V116, P395, DOI 10.1007/s00439-004-1238-z; Li Y, 2011, CELLS TISSUES ORGANS, V194, P227, DOI 10.1159/000324559; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Mitchell RJ, 2006, ANN HUM BIOL, V33, P227, DOI 10.1080/03014460600594620; Ochocka AM, 2008, INT J BIOCHEM CELL B, V40, P2264, DOI 10.1016/j.biocel.2008.03.007; Ou X, 2011, INT J LEGAL MED, V7, P7; Parry DA, AM J HUM GE IN PRESS; Prakash SK, 2005, CALCIFIED TISSUE INT, V77, P23, DOI 10.1007/s00223-004-1213-7; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Simmer JP, 2011, CELLS TISSUES ORGANS, V194, P211, DOI 10.1159/000324260; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; SIMMER JP, 1995, DENT ENAMEL FORMATIO, P59; Simmer JP, 2011, J ORAL SCI; Sire JY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-246; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151; WITKOP CJ, 1989, J ORAL PATHOL, V17, P547; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Wright JT, 2011, CELLS TISSUES ORGANS, V194, P279, DOI 10.1159/000324339; Wright JT, 2003, CONNECT TISSUE RES, V44, P72, DOI 10.1080/03008200390152124; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P206, DOI 10.1111/j.1600-0722.2011.00866.x	53	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52052	10.1371/journal.pone.0052052	http://dx.doi.org/10.1371/journal.pone.0052052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251683	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800136
J	Kawahara, T; Ito, H; Terao, H; Kato, Y; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Kato, Yoshitake; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Effectiveness of Ureteroscopy-Assisted Retrograde Nephrostomy (UARN) for Percutaneous Nephrolithotomy (PCNL)	PLOS ONE			English	Article							SUPINE VALDIVIA; COMPLICATIONS; CLASSIFICATION; REMOVAL; LITHOTRIPSY; POSITION; ACCESS	Objective: To determine the impact of ureteroscopy-assisted retrograde nephrostomy (UARN) during percutaneous nephrolithotomy (PCNL). Materials and Methods: From April 2009 to September 2011, a total of 50 patients underwent PCNL for large renal stones (stone burden > 2 cm). We performed UARN in the Galdakao-modified Valdivia position for 27 patients (UARN PCNL) and ultrasonography-assisted percutaneous nephrostomy in the prone position for 23 patients (prone PCNL). Results: UARN PCNL significantly improved the stone-free rate (81.5% vs 52.2%) and the rate of residual stones (< 4 mm, 92.6% vs 65.2%, P < 0.05). The median length of the operation was significantly shorter for UARN PCNL, at 160 min, compared to 299 min for prone PCNL (P < 0.001). There was one intraoperative complication in prone PCNL, namely a hemorrhage that resulted in stopping the initial treatment, but it was cured conservatively. The postoperative complications included a high grade fever that persisted for three days in two UARN PCNL patients (7.4%) and six prone PCNL patients (26.1%). The Clavien grading scores showed significantly lower postoperative complications for UARN PCNL compared to prone PCNL. Conclusion: UARN is associated with a higher stone-free rate, shorter operation time, and fewer complications during PCNL than prone PCNL.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Kato, Yoshitake; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Ito, Hiroki; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Dept Urol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Matsuzaki, J (corresponding author), Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	j_matsuzaki@kamakura-medical.com	KAWAHARA, TAKASHI/A-4944-2013					Al-Otaibi K, 1999, J UROLOGY, V162, P674, DOI 10.1097/00005392-199909010-00009; Andreoni C, 2000, J UROLOGY, V164, P1290, DOI 10.1016/S0022-5347(05)67158-3; CASTANEDAZUNIGA WR, 1982, UROL CLIN N AM, V9, P113; Chu L, 2011, J ENDOUROL, V25, P751, DOI 10.1089/end.2010.0400; Daels F, 2009, J ENDOUROL, V23, P1615, DOI 10.1089/end.2009.1526; de la Rosette J, 2011, J ENDOUROL, V25, P11, DOI 10.1089/end.2010.0424; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; ESUVARANATHAN K, 1991, J UROLOGY, V146, P1213, DOI 10.1016/S0022-5347(17)38048-5; FERNSTROM I, 1976, SCAND J UROL NEPHROL, V10, P257, DOI 10.1080/21681805.1976.11882084; Fischbach F, 2011, CARDIOVASC INTER RAD, V34, P857, DOI 10.1007/s00270-010-0065-y; GOODWIN WE, 1955, JAMA-J AM MED ASSOC, V157, P891, DOI 10.1001/jama.1955.02950280015005; HUNTER PT, 1985, J UROLOGY, V133, P369, DOI 10.1016/S0022-5347(17)48981-6; Ibarluzea G, 2007, BJU INT, V100, P233, DOI 10.1111/j.1464-410X.2007.06960.x; Ibarluzea Gonzalez G, 2001, Arch Esp Urol, V54, P951; Kawahara T, 2011, BJU INT; Kawahara T, 2012, J ENDOUROLOGY B; Kawahara Takashi, 2012, J Med Case Rep, V6, P194, DOI 10.1186/1752-1947-6-194; Labate G, 2011, J ENDOUROL, V25, P1275, DOI 10.1089/end.2011.0067; LAWSON RK, 1983, UROLOGY, V22, P580, DOI 10.1016/0090-4295(83)90299-6; Scoffone CM, 2008, EUR UROL, V54, P1393, DOI 10.1016/j.eururo.2008.07.073; Skolarikos A, 2005, EUR UROL, V47, P22, DOI 10.1016/j.eururo.2004.08.009; Tefekli A, 2008, EUR UROL, V53, P184, DOI 10.1016/j.eururo.2007.06.049; Uria JGV, 1998, J UROLOGY, V160, P1975, DOI 10.1016/S0022-5347(01)62217-1; Valdivia JG, 2011, J ENDOUROL; Valdivia Uria J G, 1987, Arch Esp Urol, V40, P177; Wynberg JB, 2012, J ENDOUROL	26	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52149	10.1371/journal.pone.0052149	http://dx.doi.org/10.1371/journal.pone.0052149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251698	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800149
J	Rice, RH; Bradshaw, KM; Durbin-Johnson, BP; Rocke, DM; Eigenheer, RA; Phinney, BS; Sundberg, JP				Rice, Robert H.; Bradshaw, Katie M.; Durbin-Johnson, Blythe P.; Rocke, David M.; Eigenheer, Richard A.; Phinney, Brett S.; Sundberg, John P.			Differentiating Inbred Mouse Strains from Each Other and Those with Single Gene Mutations Using Hair Proteomics	PLOS ONE			English	Article							STATISTICAL-MODEL; PELAGE HAIR; MICE; FOLLICLE; PROTEINS; SHAFT	Mutant laboratory mice with distinctive hair phenotypes are useful for identifying genes responsible for hair diseases. The work presented here demonstrates that shotgun proteomic profiling can distinguish hair shafts from different inbred mouse strains. For this purpose, analyzing the total hair shaft provided better discrimination than analyzing the isolated solubilized and particulate (cross-linked) fractions. Over 100 proteins exhibited significant differences among the 11 strains and 5 mutant stocks across the wide spectrum of strains surveyed. Effects on the profile of single gene mutations causing hair shaft defects were profound. Since the hair shaft provides a discrete sampling of the species proteome, with constituents serving important functions in epidermal appendages and throughout the body, this work provides a foundation for noninvasive diagnosis of genetic diseases of hair and perhaps other tissues.	[Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Forens Sci Grad Program, Davis, CA 95616 USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Eigenheer, Richard A.; Phinney, Brett S.] Univ Calif Davis, Prote Core, Davis, CA 95616 USA; [Sundberg, John P.] Jackson Lab, Dept Res, Bar Harbor, ME 04609 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Jackson Laboratory	Rice, RH (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	rhrice@ucdavis.edu	Rocke, David M/I-7044-2013; Phinney, Brett/S-6404-2016; Rice, Robert/AAP-7813-2021	Rocke, David M/0000-0002-3958-7318; Phinney, Brett/0000-0003-3870-3302; 	NIH [AR047204, AR056635, 2 P42 ES04699]; North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047204, R01AR056635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by NIH grants AR047204, AR056635 and 2 P42 ES04699 and the North American Hair Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.014555, DOI 10.1074/MCP.M1111.014555]; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hopkins CE, 2005, ARCH BIOCHEM BIOPHYS, V443, P1, DOI 10.1016/j.abb.2005.08.020; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; Manning C.D., 2008, INTRO INFORM RETRIEV; Mecklenburg L, 2005, EXP DERMATOL, V14, P561, DOI 10.1111/j.0906-6705.2005.00343.x; Mentzer SE, 2008, VET DERMATOL, V19, P358, DOI 10.1111/j.1365-3164.2008.00709.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Rehulkova H, 2009, J MASS SPECTROM, V44, P1613, DOI 10.1002/jms.1675; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Rice RH, 1999, ANAT RECORD, V254, P231; Rice RH, 2011, J INVEST DERMATOL, V131, P1936, DOI 10.1038/jid.2011.133; Rice RH, 2010, J PROTEOME RES, V9, P6752, DOI 10.1021/pr1009349; Rice RH, 2009, J INVEST DERMATOL, V129, P2120, DOI 10.1038/jid.2009.52; Sperling L., 2003, ATLAS HAIR PATHOLOGY, Vfirst; Srogi K, 2007, REV ENVIRON CONTAM T, V189, P107, DOI 10.1007/978-0-387-35368-5_5; Sundberg, 1994, HDB MOUSE MUTATIONS; Sundberg JP, 2009, JAVMA-J AM VET MED A, V234, P1530, DOI 10.2460/javma.234.12.1530; SUNDBERG JP, 1994, J INVEST DERMATOL, V102, P847, DOI 10.1111/1523-1747.ep12382416; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; Sundberg JP, 1994, HDB MOUSE MUTATIONS, P345; Whiting D. A., 1998, COLOR ATLAS DIFFEREN; Whiting DA., 1994, DISORDERS HAIR GROWT, P91; Wu B, 2013, EXP DERMATO IN PRESS; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168	32	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51956	10.1371/journal.pone.0051956	http://dx.doi.org/10.1371/journal.pone.0051956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251662	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800117
J	Althaus, CL; Heijne, JCM; Herzog, SA; Roellin, A; Low, N				Althaus, Christian L.; Heijne, Janneke C. M.; Herzog, Sereina A.; Roellin, Adrian; Low, Nicola			Individual and Population Level Effects of Partner Notification for Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONCURRENT PARTNERSHIPS; TRANSMISSION DYNAMICS; DISEASE TRANSMISSION; SCREENING PROGRAMS; UNITED-STATES; GONORRHEA; IMPACT; MODEL; NETWORKS	Partner notification (PN or contact tracing) is an important aspect of treating bacterial sexually transmitted infections (STIs), such as Chlamydia trachomatis. It facilitates the identification of new infected cases that can be treated through individual case management. PN also acts indirectly by limiting onward transmission in the general population. However, the impact of PN, both at the level of individuals and the population, remains unclear. Since it is difficult to study the effects of PN empirically, mathematical and computational models are useful tools for investigating its potential as a public health intervention. To this end, we developed an individual-based modeling framework called Rstisim. It allows the implementation of different models of STI transmission with various levels of complexity and the reconstruction of the complete dynamic sexual partnership network over any time period. A key feature of this framework is that we can trace an individual's partnership history in detail and investigate the outcome of different PN strategies for C. trachomatis. For individual case management, the results suggest that notifying three or more partners from the preceding 18 months yields substantial numbers of new cases. In contrast, the successful treatment of current partners is most important for preventing re-infection of index cases and reducing further transmission of C. trachomatis at the population level. The findings of this study demonstrate the difference between individual and population level outcomes of public health interventions for STIs.	[Althaus, Christian L.; Heijne, Janneke C. M.; Herzog, Sereina A.; Roellin, Adrian; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Roellin, Adrian] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore	University of Bern; National University of Singapore	Althaus, CL (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	christian.althaus@alumni.ethz.ch	Low, Nicola/H-4718-2019; Herzog, Sereina A/K-8865-2017; Althaus, Christian L./F-6008-2015; Roellin, Adrian/I-4067-2015	Low, Nicola/0000-0003-4817-8986; Herzog, Sereina A/0000-0002-5373-5866; Althaus, Christian L./0000-0002-5230-6760; Rollin, Adrian/0000-0003-0488-0183	NIHR Health Technology Assessment Programme [07/42/02]; Swiss National Science Foundation [320030-118424, 320030-135654, PDFMP3-124952]; National Institute for Health Research [07/42/02] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is part of a project funded by the NIHR Health Technology Assessment Programme (project number 07/42/02). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. JCMH and SAH acknowledge financial support by the Swiss National Science Foundation (project numbers 320030-118424, 320030-135654 and PDFMP3-124952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2012, SEX TRANSM DIS, V39, P402, DOI 10.1097/OLQ.0b013e318248a550; Althaus CL, 2012, J R SOC INTERFACE, V9, P136, DOI 10.1098/rsif.2011.0131; Althaus CL, 2010, EPIDEMICS-NETH, V2, P123, DOI 10.1016/j.epidem.2010.04.002; Armbruster B, 2007, HEALTH CARE MANAG SC, V10, P341, DOI 10.1007/s10729-007-9027-6; BASHH Clinical Effectiveness Group, 2006, 2006 UK NAT GUID MAN; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Bauch C, 2000, P ROY SOC B-BIOL SCI, V267, P2019, DOI 10.1098/rspb.2000.1244; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; BUTTS CT, 2008, NETWORK CLASSES RELA; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Chow JM, 2012, SEX TRANSM DIS, V39, P89, DOI 10.1097/OLQ.0b013e318245f95c; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; de Blasio BF, 2007, P NATL ACAD SCI USA, V104, P10762, DOI 10.1073/pnas.0611337104; DIETZ K, 1988, J MATH BIOL, V26, P1, DOI 10.1007/BF00280169; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Farewell VT, 1992, AIDS EPIDEMIOLOGY ME, P143; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Heijne JCM, 2013, SEX TRANSM INFECT, V89, P57, DOI 10.1136/sextrans-2011-050468; Herzog SA, 2011, SEX TRANSM INFECT, V87, P420, DOI 10.1136/sti.2011.049320; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; KATZ BP, 1992, STAT MED, V11, P565, DOI 10.1002/sim.4780110502; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Khan A, 2005, SEX TRANSM DIS, V32, P260, DOI 10.1097/01.olq.0000161089.53411.cb; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Kretzschmar M, 2012, SEX TRANSM DIS, V39, P325, DOI 10.1097/OLQ.0b013e31824e52c2; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mercer CH, 2011, AM J PUBLIC HEALTH, V101, P2117, DOI 10.2105/AJPH.2011.300211; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; R Development Core Team, 2009, R FDN STAT COMP; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Regan DG, 2008, T ROY SOC TROP MED H, V102, P207, DOI 10.1016/j.trstmh.2007.08.009; Rogers SM, 2007, SEX TRANSM INFECT, V84, P23, DOI 10.1136/sti.2007.027029; Tayal SC, 2010, INT J STD AIDS, V21, P516, DOI 10.1258/ijsa.2010.010011; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Tu WZ, 2011, J R STAT SOC A STAT, V174, P975, DOI 10.1111/j.1467-985X.2011.00691.x; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Wolfram Research Inc, 2008, TITL MATH ED VERS 7; World Health Organisation, 1999, SEX TRANSM DIS POL P; World Health Organization, 2001, GLOB PREV INC SEL CU; Zimmerman-Rogers H, 1999, SEX TRANSM DIS, V26, P49, DOI 10.1097/00007435-199901000-00008	59	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51438	10.1371/journal.pone.0051438	http://dx.doi.org/10.1371/journal.pone.0051438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251534	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200109
J	Fujita-Jimbo, E; Yu, ZL; Li, H; Yamagata, T; Mori, M; Momoi, T; Momoi, MY				Fujita-Jimbo, Eriko; Yu, Zhi-Ling; Li, Hong; Yamagata, Takanori; Mori, Masato; Momoi, Takashi; Momoi, Mariko Y.			Mutation in Parkinson Disease-Associated, G-Protein-Coupled Receptor 37 (GPR37/PaelR) Is Related to Autism Spectrum Disorder	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROPEPTIDE HEAD ACTIVATOR; PEPTIDE RECEPTOR; PAEL RECEPTOR; BRAIN; GPR37; OXYTOCIN; CLONING; GENES; LOCUS	Little is known about the molecular pathogenesis of Autism spectrum disorder (ASD), a neurodevelopmental disorder. Here we identified two mutations in the G-protein-coupled receptor 37 gene (GPR37) localized on chromosome 7q31-33, called the AUTS1 region, of ASD patients; 1585-1587 ttc del (Del312F) in one Japanese patient and G2324A (R558Q) in one Caucasian patient. The Del312F was located in the conserved transmembrane domain, and the R558Q was located in a conserved region just distal to the last transmembrane domain. In addition, a potential ASD-related GPR37 variant, T589M, was found in 7 affected Caucasian men from five different families. Our results suggested that some alleles in GPR37 were related to the deleterious effect of ASD. GPR37 is associated with the dopamine transporter to modulate dopamine uptake, and regulates behavioral responses to dopaminergic drugs. Thus, dopaminergic neurons may be involved in the ASD. However, we also detected the Del321F mutation in the patient's unaffected father and R558Q in not only an affected brother but also an unaffected mother. The identification of unaffected parents that carried the mutated alleles suggested that the manifestation of ASD was also influenced by factors other than these mutations, including endoplasmic reticulum stress of the mutated proteins or gender. Our study will provide the new insight into the molecular pathogenesis of ASD.	[Fujita-Jimbo, Eriko; Yu, Zhi-Ling; Li, Hong; Yamagata, Takanori; Mori, Masato; Momoi, Mariko Y.] Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi, Japan; [Yu, Zhi-Ling] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China; [Li, Hong] Detroit Med Ctr, Dept Pediat, Detroit, MI USA; [Momoi, Takashi] Int Univ Hlth & Welf, Ctr Med Sci, Ohtawara, Tochigi, Japan	Jichi Medical University; China Medical University; Detroit Medical Center; International University of Health & Welfare	Momoi, MY (corresponding author), Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi, Japan.	mymomoi@jichi.ac.jp			National Institute of Mental Health [MH64547]; Ministries of Education, Science and Culture, Japan; Ministry of Health, Labour and Welfare, Japan [KAKENHI 21200011, 22591135, 23390275, 24500386]; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ministries of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the patients and their families for their participation. And also, we gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium* and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Cure Autism Now and is supported, in part, by grant MH64547 from the National Institute of Mental Health to Daniel H. Geschwind (PI). This work was supported by the grants from the Ministries of Education, Science and Culture, Japan, the Ministry of Health, Labour and Welfare, Japan (KAKENHI 21200011, 22591135, 23390275, 24500386), and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Asato MR, 2004, J CHILD NEUROL, V19, P241, DOI 10.1177/088307380401900401; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Curatolo Paolo, 2002, Eur J Paediatr Neurol, V6, P15, DOI 10.1053/ejpn.2001.0538; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Hutcheson HB, 2003, AM J MED GENET B, V117B, P90, DOI 10.1002/ajmg.b.10033; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V247, P780, DOI 10.1006/bbrc.1998.8815; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lim MM, 2005, INT J DEV NEUROSCI, V23, P235, DOI 10.1016/j.ijdevneu.2004.05.006; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Marazziti D, 1997, GENOMICS, V45, P68, DOI 10.1006/geno.1997.4900; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Momoi T, 2010, CELL BIOL INT, V34, P13, DOI 10.1042/CBI20090250; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; ODAKA A, 1995, BIOCHEM BIOPH RES CO, V206, P821, DOI 10.1006/bbrc.1995.1117; Rezgaoui M, 2006, J CELL SCI, V119, P542, DOI 10.1242/jcs.02766; SCHALLER HC, 1989, DEVELOPMENT, V107, P99; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107	34	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51155	10.1371/journal.pone.0051155	http://dx.doi.org/10.1371/journal.pone.0051155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251443	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200065
J	Granell, S; Serra-Juhe, C; Martos-Moreno, GA; Diaz, F; Perez-Jurado, LA; Baldini, G; Argente, J				Granell, Susana; Serra-Juhe, Clara; Martos-Moreno, Gabriel A.; Diaz, Francisca; Perez-Jurado, Luis A.; Baldini, Giulia; Argente, Jesus			A Novel Melanocortin-4 Receptor Mutation MC4R-P272L Associated with Severe Obesity Has Increased Propensity To Be Ubiquitinated in the ER in the Face of Correct Folding	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; FRAMESHIFT MUTATION; CHILDHOOD OBESITY; CELL-SURFACE; MC4R; GENE; PROOPIOMELANOCORTIN; POLYMORPHISMS; INTEGRATION; PREVALENCE	Heterozygous mutations in the melanocortin-4 receptor (MC4R) gene represent the most frequent cause of monogenic obesity in humans. MC4R mutation analysis in a cohort of 77 children with morbid obesity identified previously unreported heterozygous mutations (P272L, N74I) in two patients inherited from their obese mothers. A rare polymorphism (I251L, allelic frequency: 1/100) reported to protect against obesity was found in another obese patient. When expressed in neuronal cells, the cell surface abundance of wild-type MC4R and of the N74I and I251L variants and the cAMP generated by these receptors in response to exposure to the agonist, alpha-MSH, were not different. Conversely, MC4R P272L was retained in the endoplasmic reticulum and had reduced cell surface expression and signaling (by approximate to 3-fold). The chemical chaperone PBA, which promotes protein folding of wild-type MC4R, had minimal effects on the distribution and signaling of the P272L variant. In contrast, incubation with UBE-41, a specific inhibitor of ubiquitin activating enzyme E1, inhibited ubiquitination of MC4R P272L and increased its cell surface expression and signaling to similar levels as wild-type MC4R. UBE41 had much less profound effects on MC4R I316S, another obesity-linked MC4R variant trapped in the ER. These data suggest that P272L is retained in the ER by a propensity to be ubiquitinated in the face of correct folding, which is only minimally shared by MC4R I316S. Thus, studies that combine clinical screening of obese patients and investigation of the functional defects of the obesity-linked MC4R variants can identify specific ways to correct these defects and are the first steps towards personalized medicine.	[Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Serra-Juhe, Clara; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain; [Serra-Juhe, Clara; Perez-Jurado, Luis A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Martos-Moreno, Gabriel A.; Diaz, Francisca; Argente, Jesus] Hosp Infantil Univ Nino Jesus, Dept Pediat Endocrinol, Inst Invest La Princesa, Madrid, Spain; [Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Argente, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	University of Arkansas System; University of Arkansas Medical Sciences; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	gbaldini@uams.edu; argentefen@terra.es	Argente, Jesús/M-5226-2019; Serra-Juhe, Clara/M-6968-2015; Pérez Jurado, Luis Alberto/M-7706-2015; Argente, Jesús/K-1167-2014	Argente, Jesús/0000-0001-5826-0276; Serra-Juhe, Clara/0000-0001-8471-8391; Argente, Jesús/0000-0001-5826-0276; Diaz-Gonzalez, Francisca/0000-0003-1364-7586; Martos-Moreno, Gabriel Angel/0000-0001-5524-2646	Fondo de Investigacion Sanitaria [PI09/91060, PI10/02512, PI01/00747]; CIBERobn Instituto de Salud Carlos III (ISCIII); Fundacion Mutua Madrilena [AP2561/2008]; Fundacion Endocrinologia y Nutricion; National Institutes of Health [R01DK080424]; Arkansas Tobacco Settlement; ISCIII [FI08/00365, CM05/00100]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080424] Funding Source: NIH RePORTER	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBERobn Instituto de Salud Carlos III (ISCIII); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Endocrinologia y Nutricion; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Tobacco Settlement; ISCIII(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by Fondo de Investigacion Sanitaria (PI09/91060, PI10/02512, PI01/00747), CIBERobn Instituto de Salud Carlos III (ISCIII), Fundacion Mutua Madrilena (AP2561/2008), Fundacion Endocrinologia y Nutricion, the National Institutes of Health (R01DK080424 to GB), and the Arkansas Tobacco Settlement (to GB). CS-J and GAM-M were recipients of fellowships from ISCIII (FI08/00365 and CM05/00100, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EX VAR SERV; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; EMESON RB, 1986, J NEUROSCI, V6, P837; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Granell S, 2010, MOL ENDOCRINOL, V24, P1805, DOI 10.1210/me.2010-0071; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Martos-Moreno GA, 2011, AN PEDIAT BARC, V75, pe61; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang ZQ, 2011, BBA-MOL BASIS DIS, V1812, P1190, DOI 10.1016/j.bbadis.2011.06.008; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yi CX, 2011, NEUROENDOCRINOLOGY, V93, P143, DOI 10.1159/000324888	32	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50894	10.1371/journal.pone.0050894	http://dx.doi.org/10.1371/journal.pone.0050894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251400	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200046
J	Horikoshi, M; Goto, D; Segawa, S; Yoshiga, Y; Iwanami, K; Inoue, A; Tanaka, Y; Matsumoto, I; Sumida, T				Horikoshi, Masanobu; Goto, Daisuke; Segawa, Seiji; Yoshiga, Yohei; Iwanami, Keiichi; Inoue, Asuka; Tanaka, Yuki; Matsumoto, Isao; Sumida, Takayuki			Activation of Invariant NKT Cells with Glycolipid Ligand alpha-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis	PLOS ONE			English	Article							KILLER T-CELLS; COLLAGEN-INDUCED ARTHRITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED JOINT INFLAMMATION; RHEUMATOID-ARTHRITIS; IFN-GAMMA; MICE; INHIBIT; IMMUNIZATION; PROTECTS	Objective: Invariant natural killer T (iNKT) cells regulate collagen-induced arthritis (CIA) when activated by their potent glycolipid ligand, alpha-galactosylceramide (alpha-GalCer). Glucose-6-phosphate isomerase (GPI)-induced arthritis is a closer model of human rheumatoid arthritis based on its association with CD4+ T cells and cytokines such as TNF-alpha and IL-6 than CIA. Dominant T cell epitope peptide of GPI (GPI325-339) can induce arthritis similar to GPI-induced arthritis. In this study, we investigated the roles of activation of iNKT cells by alpha-GalCer in GPI peptide-induced arthritis. Methods: Arthritis was induced in susceptible DBA1 mice with GPI peptide and its severity was assessed clinically. The arthritic mice were treated with either the vehicle (DMSO) or alpha-GalCer. iNKT cells were detected in draining lymph nodes (dLNs) by flow cytometry, while serum anti-GPI antibody levels were measured by enzyme-linked immunosorbent assay. To evaluate GPI peptide-specific cytokine production from CD4+ T cells, immunized mice were euthanized and dLN CD4+ cells were re-stimulated by GPI-peptide in the presence of antigen-presenting cells. Results: alpha-GalCer induced iNKT cell expansion in dLNs and significantly decreased the severity of GPI peptide-induced arthritis. In alpha-GalCer-treated mice, anti-GPI antibody production (total IgG, IgG1, IgG2b) and IL-17, IFN-gamma, IL-2, and TNF-alpha produced by GPI peptide-specific T cells were significantly suppressed at day 10. Moreover, GPI-reactive T cells from mice immunized with GPI and alpha-GalCer did not generate any cytokines even when these cells were co-cultured with APC from mice immunized with GPI alone. In vitro depletion of iNKT cells did not alter the suppressive effect of alpha-GalCer on CD4+ T cells. Conclusion: alpha-GalCer significantly suppressed GPI peptide-induced arthritis through the suppression of GPI-specific CD4+ T cells.	[Horikoshi, Masanobu; Goto, Daisuke; Segawa, Seiji; Iwanami, Keiichi; Inoue, Asuka; Tanaka, Yuki; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan; [Yoshiga, Yohei] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of Tsukuba; University of New Mexico	Sumida, T (corresponding author), Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan.	tsumida@md.tsukuba.ac.jp	ç°ä, ææ/Q-2571-2019	ç°ä, ææ/0000-0001-9822-9804	Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labour and Welfare and from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bruns L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2777; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chiba A, 2005, ARTHRITIS RHEUM-US, V52, P1941, DOI 10.1002/art.21056; Coppieters K, 2007, J IMMUNOL, V179, P2300, DOI 10.4049/jimmunol.179.4.2300; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Frey O, 2011, J AUTOIMMUN, V36, P161, DOI 10.1016/j.jaut.2010.12.006; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hua J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027038; Iwanami K, 2008, ARTHRITIS RHEUM-US, V58, P754, DOI 10.1002/art.23222; Iwanami K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2854; Iwanami K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2545; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kaieda S, 2007, ARTHRITIS RHEUM, V56, P1836, DOI 10.1002/art.22714; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Kim HY, 2006, J CLIN INVEST, V116, P2484, DOI 10.1172/JCI27219; Mars LT, 2009, P NATL ACAD SCI USA, V106, P6238, DOI 10.1073/pnas.0809317106; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2437; Miellot A, 2005, EUR J IMMUNOL, V35, P3704, DOI 10.1002/eji.200535235; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Oh SJ, 2011, J IMMUNOL, V186, P6815, DOI 10.4049/jimmunol.1003916; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; STRUYK L, 1995, ARTHRITIS RHEUM-US, V38, P577, DOI 10.1002/art.1780380502; Tripp CH, 2009, J IMMUNOL, V182, P7644, DOI 10.4049/jimmunol.0900134; Yoshiga Y, 2011, CLIN EXP IMMUNOL, V164, P236, DOI 10.1111/j.1365-2249.2011.04369.x	29	18	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51215	10.1371/journal.pone.0051215	http://dx.doi.org/10.1371/journal.pone.0051215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251456	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200071
J	Khateb, S; Zelinger, L; Ben-Yosef, T; Merin, S; Crystal-Shalit, O; Gross, M; Banin, E; Sharon, D				Khateb, Samer; Zelinger, Lina; Ben-Yosef, Tamar; Merin, Saul; Crystal-Shalit, Ornit; Gross, Menachem; Banin, Eyal; Sharon, Dror			Exome Sequencing Identifies a Founder Frameshift Mutation in an Alternative Exon of USH1C as the Cause of Autosomal Recessive Retinitis Pigmentosa with Late-Onset Hearing Loss	PLOS ONE			English	Article							USH2A GENE; DEAFNESS; HARMONIN; DEFECTS	We used a combined approach of homozygosity mapping and whole exome sequencing (WES) to search for the genetic cause of autosomal recessive retinitis pigmentosa (arRP) in families of Yemenite Jewish origin. Homozygosity mapping of two arRP Yemenite Jewish families revealed a few homozygous regions. A subsequent WES analysis of the two index cases revealed a shared homozygous novel nucleotide deletion (c.1220delG) leading to a frameshift (p.Gly407Glufs*56) in an alternative exon (#15) of USH1C. Screening of additional Yemenite Jewish patients revealed a total of 16 homozygous RP patients (with a carrier frequency of 0.008 in controls). Funduscopic and electroretinography findings were within the spectrum of typical RP. While other USH1C mutations usually cause Usher type I (including RP, vestibular dysfunction and congenital deafness), audiometric screening of 10 patients who are homozygous for c.1220delG revealed that patients under 40 years of age had normal hearing while older patients showed mild to severe high tone sensorineural hearing loss. This is the first report of a mutation in a known USH1 gene that causes late onset rather than congenital sensorineural hearing loss. The c.1220delG mutation of USH1C accounts for 23% of RP among Yemenite Jewish patients in our cohort.	[Khateb, Samer; Zelinger, Lina; Merin, Saul; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Ben-Yosef, Tamar] Technion Israel Inst Technol, Rappaport Fac Med, Dept Genet, Haifa, Israel; [Crystal-Shalit, Ornit] Meir Med Ctr, Dept Ophthalmol, Kefar Sava, Israel; [Gross, Menachem] Hadassah Hebrew Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Banin, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	banine@cc.huji.ac.il; dror.sharon1@gmail.com	Sharon, Dror/P-4539-2015; Zelinger, Lina/L-3272-2019	Sharon, Dror/0000-0002-1789-5811; Zelinger, Lina/0000-0003-3028-7172	Foundation Fighting Blindness USA [BR-GE-0510-0490-HUJ]; Israeli Science Foundation [612/09]; Yedidut 1 research grant	Foundation Fighting Blindness USA; Israeli Science Foundation(Israel Science Foundation); Yedidut 1 research grant	This study was financially supported by the Foundation Fighting Blindness USA (BR-GE-0510-0490-HUJ to DS), by the legacy heritage biomedical program of the Israeli Science Foundation (grant number 612/09 to DS and TBY), and the Yedidut 1 research grant (to EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; Beit-Ya'acov A, 2007, INVEST OPHTH VIS SCI, V48, P4308, DOI 10.1167/iovs.07-0244; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Clark J G, 1981, ASHA, V23, P493; Engdahl B, 2002, INT J AUDIOL, V41, P78, DOI 10.3109/14992020209101315; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kaiserman N, 2007, ARCH OPHTHALMOL-CHIC, V125, P219, DOI 10.1001/archopht.125.2.219; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Rozen S, 2000, Methods Mol Biol, V132, P365; Saihan Z, 2011, RETINA-J RET VIT DIS, V31, P1708, DOI 10.1097/IAE.0b013e31820d3fd1; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P5532, DOI 10.1167/iovs.08-2009; Scanlan MJ, 1999, BBA-GENE STRUCT EXPR, V1445, P39, DOI 10.1016/S0167-4781(99)00033-0; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Xu WJ, 2011, MOL VIS, V17, P1537	23	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51566	10.1371/journal.pone.0051566	http://dx.doi.org/10.1371/journal.pone.0051566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251578	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200135
J	Saunders, DN; Tindall, EA; Shearer, RF; Roberson, J; Decker, A; Wilson, JA; Hayes, VM				Saunders, Darren N.; Tindall, Elizabeth A.; Shearer, Robert F.; Roberson, Jacquelyn; Decker, Amy; Wilson, Jean Amos; Hayes, Vanessa M.			A Novel SERPINA1 Mutation Causing Serum Alpha(1)-Antitrypsin Deficiency	PLOS ONE			English	Article							DISEASE; SERPINOPATHIES; DIVERSITY; GENE	Mutations in the SERPINA1 gene can cause deficiency in the circulating serine protease inhibitor alpha(1)-Antitrypsin (alpha(1)AT). alpha(1)AT deficiency is the major contributor to pulmonary emphysema and liver disease in persons of European ancestry, with a prevalence of 1 in 2500 in the USA. We present the discovery and characterization of a novel SERPINA1 mutant from an asymptomatic Middle Eastern male with circulating alpha(1)AT deficiency. This 49 base pair deletion mutation (T379 Delta), originally mistyped by IEF, causes a frame-shift replacement of the last sixteen alpha(1)AT residues and adds an extra twenty-four residues. Functional analysis showed that the mutant protein is not secreted and prone to intracellular aggregation.	[Saunders, Darren N.; Tindall, Elizabeth A.; Shearer, Robert F.; Hayes, Vanessa M.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Saunders, Darren N.; Shearer, Robert F.] Kinghorn Canc Ctr, Sydney, NSW, Australia; [Saunders, Darren N.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Roberson, Jacquelyn; Decker, Amy] Henry Ford Hosp, Detroit, MI 48202 USA; [Wilson, Jean Amos] Quest Diagnost Nichols Inst, Valencia, CA USA	Garvan Institute of Medical Research; University of New South Wales Sydney; Henry Ford Health System; Henry Ford Hospital; Nichols Institute	Saunders, DN (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	d.saunders@garvan.org.au	Hayes, Vanessa/W-3728-2019; Hayes, Vanessa M/GPP-2807-2022	Hayes, Vanessa M/0000-0002-4524-7280; Saunders, Darren/0000-0003-0924-0513	Cancer Institute New South Wales; National Health and Medical Research Council of Australia	Cancer Institute New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from the Cancer Institute New South Wales as a Career Development Fellowship (DNS and VMH) and a National Health and Medical Research Council of Australia training Fellowship (EAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2001, CLIN GENET, V60, P431, DOI 10.1034/j.1399-0004.2001.600605.x; Bottomley SP, 2011, EMBO REP, V12, P983, DOI 10.1038/embor.2011.187; de Serres FJ, 2003, ENVIRON HEALTH PERSP, V111, P1851, DOI 10.1289/ehp.6511; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Greene Catherine M, 2010, Proc Am Thorac Soc, V7, P346, DOI 10.1513/pats.201002-019AW; Hayes V M, 1999, Nucleic Acids Res, V27, pe29, DOI 10.1093/nar/27.20.e29; Hayes VM, 2003, HUM MUTAT, V22, P59, DOI 10.1002/humu.10231; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lomas DA, 2005, CLIN MED, V5, P249, DOI 10.7861/clinmedicine.5-3-249; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Rachelefsky G, 2008, J ALLERGY CLIN IMMUN, V121, P833, DOI 10.1016/j.jaci.2007.12.1183; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; Wu Y, 1998, NUCLEIC ACIDS RES, V26, P5432, DOI 10.1093/nar/26.23.5432; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zaimidou S, 2009, HUM MUTAT, V30, P308, DOI 10.1002/humu.20857	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51762	10.1371/journal.pone.0051762	http://dx.doi.org/10.1371/journal.pone.0051762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251618	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200163
J	Wong, YT; Ng, YM; Mak, ANS; Sze, KH; Wong, KB; Shaw, PC				Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Sze, Kong-Hung; Wong, Kam-Bo; Shaw, Pang-Chui			Maize Ribosome-Inactivating Protein Uses Lys158-Lys161 to Interact with Ribosomal Protein P2 and the Strength of Interaction Is Correlated to the Biological Activities	PLOS ONE			English	Article							POKEWEED ANTIVIRAL PROTEIN; RICIN-A-CHAIN; SHIGA TOXIN; BINDING; STALK; TRICHOSANTHIN; RNA; DEPURINATION; MECHANISM; SUBUNIT	Ribosome-inactivating proteins (RIPs) inactivate prokaryotic or eukaryotic ribosomes by removing a single adenine in the large ribosomal RNA. Here we show maize RIP (MOD), an atypical RIP with an internal inactivation loop, interacts with the ribosomal stalk protein P2 via Lys158-Lys161, which is located in the N-terminal domain and at the base of its internal loop. Due to subtle differences in the structure of maize RIP, hydrophobic interaction with the 'FGLFD' motif of P2 is not as evidenced in MOD-P2 interaction. As a result, interaction of P2 with MOD was weaker than those with trichosanthin and shiga toxin A as reflected by the dissociation constants (K-D) of their interaction, which are 1037.50 +/- 65.75 mu M, 611.70 +/- 28.13 mu M and 194.84 +/- 9.47 mu M respectively. Despite MOD and TCS target at the same ribosomal protein P2, MOD was found 48 and 10 folds less potent than trichosanthin in ribosome depurination and cytotoxicity to 293T cells respectively, implicating the strength of interaction between RIPs and ribosomal proteins is important for the biological activity of RIPs. Our work illustrates the flexibility on the docking of RIPs on ribosomal proteins for targeting the sarcin-ricin loop and the importance of protein-protein interaction for ribosome-inactivating activity.	[Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Wong, Kam-Bo; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China; [Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Wong, Kam-Bo; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Sze, Kong-Hung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Fund for the Control of Infectious Diseases [10090452]; University Grants Council, Hong Kong SAR [SEG CUHK08]	Research Fund for the Control of Infectious Diseases; University Grants Council, Hong Kong SAR	This work was supported in part by a Research Fund for the Control of Infectious Diseases (reference number: 10090452) and a University Grants Council One-Off Special Equipment Grant (SEG CUHK08) from Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; BRIGOTTI M, 1989, BIOCHEM J, V257, P723, DOI 10.1042/bj2570723; Chaddock JA, 1996, EUR J BIOCHEM, V235, P159, DOI 10.1111/j.1432-1033.1996.00159.x; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; de Virgilio M, 2010, TOXINS, V2, P2699, DOI 10.3390/toxins2112699; Endo Y, 1988, Nucleic Acids Symp Ser, P139; FERNANDEZPUENTES C, 1977, FEBS LETT, V78, P143, DOI 10.1016/0014-5793(77)80292-5; Girbes T, 2004, MINI-REV MED CHEM, V4, P461, DOI 10.2174/1389557043403891; HEY TD, 1995, PLANT PHYSIOL, V107, P1323, DOI 10.1104/pp.107.4.1323; Hudak KA, 1999, J BIOL CHEM, V274, P3859, DOI 10.1074/jbc.274.6.3859; Lancaster L, 2008, RNA, V14, P1999, DOI 10.1261/rna.1202108; Lapadula WJ, 2012, TOXICON, V59, P427, DOI 10.1016/j.toxicon.2011.12.014; Law SKY, 2010, NUCLEIC ACIDS RES, V38, P6803, DOI 10.1093/nar/gkq551; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Mak ANS, 2007, NUCLEIC ACIDS RES, V35, P6259, DOI 10.1093/nar/gkm687; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031191; Melchior WB, 2010, ANAL BIOCHEM, V396, P204, DOI 10.1016/j.ab.2009.09.024; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; Nagasawa Y, 2008, PHYTOCHEMISTRY, V69, P1653, DOI 10.1016/j.phytochem.2008.02.012; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; Rajamohan F, 2001, BIOCHEMISTRY-US, V40, P9104, DOI 10.1021/bi002851p; Robertus JD, 2004, MINI-REV MED CHEM, V4, P477, DOI 10.2174/1389557043403837; Spedding G, 1990, RIBOSOMES PROTEIN SY, P9; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Suh JK, 1998, BIOCHEMISTRY-US, V37, P9394, DOI 10.1021/bi980424u; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; VATER CA, 1995, J BIOL CHEM, V270, P12933, DOI 10.1074/jbc.270.21.12933; WALSH TA, 1991, J BIOL CHEM, V266, P23422; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	35	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49608	10.1371/journal.pone.0049608	http://dx.doi.org/10.1371/journal.pone.0049608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251345	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200018
J	Zheng, YM; Zhu, XJ; Zhou, PZ; Lan, X; Xu, HY; Li, M; Gao, ZB				Zheng, Yueming; Zhu, Xuejing; Zhou, Pingzheng; Lan, Xi; Xu, Haiyan; Li, Min; Gao, Zhaobing			Hexachlorophene Is a Potent KCNQ1/KCNE1 Potassium Channel Activator Which Rescues LQTs Mutants	PLOS ONE			English	Article							LONG-QT-SYNDROME; I-KS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; KV7 CHANNELS; MUTATIONS; KVLQT1; ISK; KCNQ1; ARRHYTHMIAS; MECHANISMS	The voltage-gated KCNQ1 potassium channel is expressed in cardiac tissues, and coassembly of KCNQ1 with an auxiliary KCNE1 subunit mediates a slowly activating current that accelerates the repolarization of action potential in cardiomyocytes. Mutations of KCNQ1 genes that result in reduction or loss of channel activity cause prolongation of repolarization during action potential, thereby causing long QT syndrome (LQTs). Small molecule activators of KCNQ1/KCNE1 are useful both for understanding the mechanism of the complex activity and for developing therapeutics for LQTs. In this study we report that hexachlorophene (HCP), the active component of the topical anti-infective prescription drug pHisoHex, is a KCNQ1/KCNE1 activator. HCP potently increases the current amplitude of KCNQ1/KCNE1 expressed by stabilizing the channel in an open state with an EC50 of 4.61 +/- 1.29 mu M. Further studies in cardiomyocytes showed that HCP significantly shortens the action potential duration at 1 mu M. In addition, HCP is capable of rescuing the loss of function of the LQTs mutants caused by either impaired activation gating or phosphatidylinositol-4,5-bisphosphate (PIP2) binding affinity. Our results indicate HCP is a novel KCNQ1/KCNE1 activator and may be a useful tool compound for the development of LQTs therapeutics.	[Zheng, Yueming; Zhu, Xuejing; Zhou, Pingzheng; Lan, Xi; Xu, Haiyan; Li, Min; Gao, Zhaobing] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Li, Min] Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Baltimore, MD USA; [Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 200031, Peoples R China.	minli@jhmi.edu; zb.gao@mail.shcnc.ac.cn			National Natural Science Foundation of China (NSFC) [81072579]; NIH [MH084691, GM070959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Natural Science Foundation of China (NSFC, 81072579) and NIH grants (MH084691, GM070959). NSFC and NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 2000, AM J PHYSIOL-HEART C, V279, pH3003, DOI 10.1152/ajpheart.2000.279.6.H3003; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Busch AE, 1997, BRIT J PHARMACOL, V122, P187, DOI 10.1038/sj.bjp.0701434; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gribkoff VK, 2008, EXPERT OPIN THER TAR, V12, P565, DOI 10.1517/14728222.12.5.565 ; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Herbert Ernest, 2002, Med Sci Monit, V8, pRA240; Hsu JTA, 2004, FEBS LETT, V574, P116, DOI 10.1016/j.febslet.2004.08.015; Jia CX, 2011, PHARMACOLOGY, V87, P297, DOI 10.1159/000327384; JUNGERMA.E, 1968, J AM OIL CHEM SOC, V45, P345, DOI 10.1007/BF02667108; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Mruk K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004236; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vatta M, 2000, CURR OPIN CARDIOL, V15, P12, DOI 10.1097/00001573-200001000-00003; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300	34	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51820	10.1371/journal.pone.0051820	http://dx.doi.org/10.1371/journal.pone.0051820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251633	gold, Green Published			2022-12-25	WOS:000313236200168
J	Hikima, J; Yi, MK; Ohtani, M; Jung, CY; Kim, YK; Mun, JY; Kim, YR; Takeyama, H; Aoki, T; Jung, TS				Hikima, Jun-ichi; Yi, Mi-Kyong; Ohtani, Maki; Jung, Chan Yong; Kim, Young Kyu; Mun, Ji Young; Kim, Young Rim; Takeyama, Haruko; Aoki, Takashi; Jung, Tae Sung			LGP2 Expression is Enhanced by Interferon Regulatory Factor 3 in Olive Flounder, Paralichthys olivaceus	PLOS ONE			English	Article							I-LIKE-RECEPTORS; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; RIG-I; JAPANESE FLOUNDER; FUNCTIONAL-CHARACTERIZATION; ANTIVIRAL RESPONSES; ATLANTIC COD; RECOGNITION; ACTIVATION	In innate immunity, LGP2 (laboratory of genetics and physiology 2) plays a very important role in the production of type I interferon (IFN) through recognition of cytosolic viral RNA. Although viral infection or stimulation with double-strand RNA dramatically induces expression of the LGP2 gene, the underlying transcriptional mechanism has never been studied. Here, we cloned and characterized the 5'-upstream region (-1,337 bp) of the LGP2 gene in olive flounder (Paralichthys olivaceus). Numerous canonical motifs for IFN-regulatory factors (IRFs) were found in this region, and reporter assays identified a poly I: C-responsive promoter region (-506 to -398) that regulated LGP2 transcription. Transcriptional activity of the LGP2 promoter was strongly enhanced by IRF3, which bound to IRF3 motif #3 (-480). The LGP2 promoter was also responsive to viral infection in vitro. These results suggest that LGP2 transcriptional control is crucially involved to regulated by IRF3 function after viral infection or stimulation with poly I:C.	[Hikima, Jun-ichi; Yi, Mi-Kyong; Ohtani, Maki; Jung, Chan Yong; Kim, Young Kyu; Mun, Ji Young; Kim, Young Rim; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Aquat Biotechnol Ctr, Coll Vet Med, Jinju, Gyeongnam, South Korea; [Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care ASMeW, Shinjuku Ku, Tokyo, Japan	Gyeongsang National University; Waseda University; Waseda University	Aoki, T (corresponding author), Gyeongsang Natl Univ, Aquat Biotechnol Ctr, Coll Vet Med, Jinju, Gyeongnam, South Korea.	aokitaka@aoni.waseda.jp; jungts@gmail.com	Hikima, Jun-ichi/AAI-6983-2020; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946	World Class University Program [R32-10253]; Ministry of Education, Science and Technology, Republic of Korea	World Class University Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Our research was supported by a grant from the World Class University Program (R32-10253) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Huang T, 2010, FISH SHELLFISH IMMUN, V29, P349, DOI 10.1016/j.fsi.2010.04.001; Jun Eun g, 2009, Journal of Bacteriology and Virology, V39, P145; Kasai H., 2001, FISH SCI HOKKAIDO U, V52, P67; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; Ohtani M, 2012, DEV COMP IMMUNOL, V36, P697, DOI 10.1016/j.dci.2011.10.008; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Ooi EL, 2006, FISH SHELLFISH IMMUN, V21, P293, DOI 10.1016/j.fsi.2005.12.004; Rise ML, 2010, PHYSIOL GENOMICS, V42, P266, DOI 10.1152/physiolgenomics.00168.2009; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seppola M, 2009, DEV COMP IMMUNOL, V33, P1205, DOI 10.1016/j.dci.2009.06.013; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P83, DOI 10.1016/j.cimid.2010.02.005; Yazawa R, 2006, TRANSGENIC RES, V15, P385, DOI 10.1007/s11248-006-0009-0; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51522	10.1371/journal.pone.0051522	http://dx.doi.org/10.1371/journal.pone.0051522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251565	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900096
J	Hilker, R; Pilatus, U; Eggers, C; Hagenah, J; Roggendorf, J; Baudrexel, S; Klein, JC; Neumaier, B; Fink, GR; Steinmetz, H; Klein, C; Hattingen, E				Hilker, Rueediger; Pilatus, Ulrich; Eggers, Carsten; Hagenah, Johann; Roggendorf, Julia; Baudrexel, Simon; Klein, Johannes C.; Neumaier, Bernd; Fink, Gereon R.; Steinmetz, Helmuth; Klein, Christine; Hattingen, Elke			The Bioenergetic Status Relates to Dopamine Neuron Loss in Familial PD with PINK1 Mutations	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; BRAIN; MYOINOSITOL; RECOMMENDATIONS; METABOLISM; ASTROCYTES; GLUTAMATE	Mutations in the PINK1 gene cause autosomal recessive familial Parkinson's disease (PD). The gene encodes a mitochondrial protein kinase that plays an important role in maintaining mitochondrial function and integrity. However, the pathophysiological link between mutation-related bioenergetic deficits and the degenerative process in dopaminergic neurons remains to be elucidated. We performed phosphorous (P-31) and proton (H-1) 3-T magnetic resonance spectroscopic imaging (MRSI) in 11 members of a German family with hereditary PD due to PINK1 mutations (PARK6) compared to 23 age-matched controls. All family members had prior 18-Fluorodopa (FDOPA) positron emission tomography (PET). The striatal FDOPA uptake was correlated with quantified metabolic brain mapping in MRSI. At group level, the heterozygous PINK1 mutation carriers did not show any MRSI abnormalities relative to controls. In contrast, homozygous individuals with manifest PD had putaminal GPC, PCr, HEP and beta-ATP levels well above the 2SD range of controls. Across all subjects, the FDOPA K-i values correlated positively with MI (r = 0.879, p<0.001) and inversely with beta-ATP (r = -0.784, p = 0.008) and GPC concentrations (r = -0.651, p = 0.030) in the putamen. Our combined imaging data suggest that the dopaminergic deficit in this family with PD due to PINK1 mutations relates to osmolyte dysregulation, while the delivery of high energy phosphates was preserved. Our results corroborate the hypothesis that PINK1 mutations result in reduced neuronal survival, most likely due to impaired cellular stress resistance.	[Hilker, Rueediger; Roggendorf, Julia; Baudrexel, Simon; Klein, Johannes C.; Steinmetz, Helmuth] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Pilatus, Ulrich; Hattingen, Elke] Goethe Univ Frankfurt, Inst Neuroradiol, Frankfurt, Germany; [Eggers, Carsten; Fink, Gereon R.] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Hagenah, Johann; Klein, Christine] Med Univ Lubeck, Sect Clin & Mol Neurogenet, Dept Neurol, D-23538 Lubeck, Germany; [Neumaier, Bernd] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Cologne; University of Lubeck; Max Planck Society	Hilker, R (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany.	hilker@med.uni-frankfurt.de	Hattingen, Elke/D-7880-2015; Fink, Gereon R./AFW-9377-2022; Klein, Christine/AGK-8003-2022; Fink, Gereon R./E-1616-2012; Neumaier, Bernd/G-7058-2019	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Hattingen, Elke/0000-0002-8392-9004; Neumaier, Bernd/0000-0001-5425-3116; Klein, Christine/0000-0003-2102-3431	Medtronic; Cephalon; Deutsche Parkinson Vereinigung (dPV); Bundesministerium fur Bildung und Forschung; Goethe-University of Frankfurt; Bachmann-Strauss Dystonia; Parkinson Foundation; Deutsche Forschungsgemeinschaft; Boehringer Ingelheim; Centogene; Hermann and Lilly Schilling Foundation; Possehl Foundation	Medtronic(Medtronic); Cephalon; Deutsche Parkinson Vereinigung (dPV); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Goethe-University of Frankfurt; Bachmann-Strauss Dystonia; Parkinson Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim); Centogene; Hermann and Lilly Schilling Foundation; Possehl Foundation	Ruediger Hilker has received speaker honoraria from Medtronic, Orion, GlaxoSmithKline, TEVA, Cephalon, Solvay, Desitin and Boehringer Ingelheim as well as travel funding from Medtronic and Cephalon. He serves or has served on a scientific advisory board for Cephalon. He has received research funding from the Deutsche Parkinson Vereinigung (dPV), Bundesministerium fur Bildung und Forschung and the Goethe-University of Frankfurt. Johann Hagenah receives funding from the Bachmann-Strauss Dystonia & Parkinson Foundation. Gereon Fink serves as an editorial board member of Cortex, Zeitschrift fur Neuropsychologie, and Fortschritte der Neurologie Psychiatrie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie and Neurologische Differentialdiagnose; received honoraria for speaking engagements from TEVA, Desitin, GlaxoSmith-Kline and Boehringer Ingelheim; and receives research support from the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft. Helmuth Steinmetz has received speaker honoraria from Boehringer Ingelheim and Sanofi Aventis and has contracts with the publishers Elsevier, Thieme and Springer. Christine Klein is a member of the editorial board of "Neurology" and has served as editor of the "Continuum Issue Neurogenetics 2008" and as faculty at the Annual Meetings of the American Academy of Neurology since 2004. She received consulting fees from Boehringer Ingelheim and Centogene and received honoraria for speaking from Boehringer Ingelheim and Shire. Klein is the recipient of a career development award from the Hermann and Lilly Schilling Foundation. She is funded by the Deutsche Forschungsgemeinschaft, the Possehl Foundation, and received institutional support from the University of Luebeck for genetics research. Ulrich Pilatus, Carsten Eggers, Julia Roggendorf, Simon Baudrexel, Johannes Klein, Bernd Neumaier and Elke Hattingen report no disclosures. None of the above funding was for this specific study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; [Anonymous], 2003, MOV DISORD, V18, P738; Brand A, 1999, J NEUROSCI RES, V58, P576, DOI 10.1002/(SICI)1097-4547(19991115)58:4<576::AID-JNR10>3.0.CO;2-D; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Eggers C, 2010, NEUROLOGY, V74, P1798, DOI 10.1212/WNL.0b013e3181e0f79c; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hetherington HP, 1996, MAGNET RESON MED, V36, P21, DOI 10.1002/mrm.1910360106; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Klein C, 2005, EUR J HUM GENET; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Papa S, 2009, J BIOENERG BIOMEMBR, V41, P509, DOI 10.1007/s10863-009-9252-4; PETTEGREW JW, 1995, NEUROBIOL AGING, V16, P973, DOI 10.1016/0197-4580(95)02017-9; PETTEGREW JW, 1988, ARCH NEUROL-CHICAGO, V45, P1093, DOI 10.1001/archneur.1988.00520340047010; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616; Prestel J, 2008, J NEUROL, V255, P643, DOI 10.1007/s00415-008-0763-4; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Ross BD, 1998, NEUROIMAG CLIN N AM, V8, P809; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; THURSTON JH, 1989, PEDIATR RES, V26, P482, DOI 10.1203/00006450-198911000-00024; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zhu XP, 2006, ALZ DIS ASSOC DIS, V20, P77, DOI 10.1097/01.wad.0000213809.12553.fc	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51308	10.1371/journal.pone.0051308	http://dx.doi.org/10.1371/journal.pone.0051308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251494	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900067
J	Jakola, AS; Unsgard, G; Myrmel, KS; Kloster, R; Torp, SH; Lindal, S; Solheim, O				Jakola, Asgeir S.; Unsgard, Geirmund; Myrmel, Kristin S.; Kloster, Roar; Torp, Sverre H.; Lindal, Sigurd; Solheim, Ole			Low Grade Gliomas in Eloquent Locations - Implications for Surgical Strategy, Survival and Long Term Quality of Life	PLOS ONE			English	Article							RESECTION; RADIOTHERAPY; VALUATIONS; EUROQOL; IMPACT; SERIES; ADULTS; EXTENT; TUMORS	Background: Surgical management of suspected LGG remains controversial. A key factor when deciding a surgical strategy is often the tumors' perceived relationship to eloquent brain regions Objective: To study the association between tumor location, survival and long-term health related quality of life (HRQL) in patients with supratentorial low-grade gliomas (LGG). Methods: Adults (>= 18 years) operated due to newly diagnosed LGG from 1998 through 2009 included from two Norwegian university hospitals. After review of initial histopathology, 153 adults with supratentorial WHO grade II LGG were included in the study. Tumors' anatomical location and the relationship to eloquent regions were graded. Survival analysis was adjusted for known prognostic factors and the initial surgical procedure (biopsy or resection). In long-term survivors, HRQL was assessed with disease specific questionnaires (EORTC QLQ-C30 and BN20) as well as a generic questionnaire (EuroQol 5D). Results: There was a significant association between eloquence and survival (log-rank, p<0.001). The estimated 5-year survival was 77% in non-eloquent tumors, 71% in intermediate located tumors and 54% in eloquent tumors. In the adjusted analysis the hazard ratio of increasing eloquence was 1.5 (95% CI 1.1-2.0, p = 0.022). There were no differences in HRQL between patients with eloquent and non-eloquent tumors. The most frequent self-reported symptoms were related to fatigue, cognition, and future uncertainty. Conclusion: Eloquently located LGGs are associated with impaired survival compared to non-eloquently located LGG, but in long-term survivors HRQL is similar. Although causal inference from observational data should be done with caution, the findings illuminate the delicate balance in surgical decision making in LGGs, and add support to the probable survival benefits of aggressive surgical strategies, perhaps also in eloquent locations.	[Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Unsgard, Geirmund; Solheim, Ole] Natl Ctr Ultrasound Surg 3D, Trondheim, Norway; [Myrmel, Kristin S.; Lindal, Sigurd] Univ Hosp No Norway, Dept Pathol, Tromso, Norway; [Kloster, Roar] Univ Hosp No Norway, Dept Ophthalmol & Neurosurg, Tromso, Norway; [Torp, Sverre H.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018; Torp, Sverre Helge/AAN-4229-2020	Jakola, Asgeir S/0000-0002-2860-9331; Torp, Sverre Helge/0000-0001-8345-6852; Solheim, Ole/0000-0002-5954-4817				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aaronson NK, 2011, J CLIN ONCOLOGY; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Duffau H, 2008, J NEUROSURG, V109, P461, DOI 10.3171/JNS/2008/109/9/0461; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2001, J CLIN ONCOL, V19, P4037, DOI 10.1200/JCO.2001.19.20.4037; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Liu R, 2009, NEURO-ONCOLOGY, V11, P330, DOI 10.1215/15228517-2008-093; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Seiz M, 2011, CEN EUR NEUROSURG; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Wessels PH, 2003, LANCET NEUROL, V2, P395, DOI 10.1016/S1474-4422(03)00434-4; Whittle IR, 2004, J NEUROL NEUROSUR PS, V75, P31, DOI 10.1136/jnnp.2004.040501; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yavas C, 2011, SUPPORT CARE CANCER, P1	26	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51450	10.1371/journal.pone.0051450	http://dx.doi.org/10.1371/journal.pone.0051450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251537	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900088
J	Loyau, A; Cornuau, JH; Clobert, J; Danchin, E				Loyau, Adeline; Cornuau, Jeremie H.; Clobert, Jean; Danchin, Etienne			Incestuous Sisters: Mate Preference for Brothers over Unrelated Males in Drosophila melanogaster	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INBREEDING AVOIDANCE; NO EVIDENCE; KIN RECOGNITION; CHOICE; DEPRESSION; RELATEDNESS; POPULATION; SIMILARITY; LEVEL	The literature is full of examples of inbreeding avoidance, while recent mathematical models predict that inbreeding tolerance or even inbreeding preference should be expected under several realistic conditions like e. g. polygyny. We investigated male and female mate preferences with respect to relatedness in the fruit fly D. melanogaster. Experiments offered the choice between a first order relative (full-sibling or parent) and an unrelated individual with the same age and mating history. We found that females significantly preferred mating with their brothers, thus supporting inbreeding preference. Moreover, females did not avoid mating with their fathers, and males did not avoid mating with their sisters, thus supporting inbreeding tolerance. Our experiments therefore add empirical evidence for inbreeding preference, which strengthens the prediction that inbreeding tolerance and preference can evolve under specific circumstances through the positive effects on inclusive fitness.	[Loyau, Adeline; Cornuau, Jeremie H.; Clobert, Jean] CNRS Moulis, CNRS, Stn Ecol Expt, USR 2936, St Girons, France; [Loyau, Adeline; Danchin, Etienne] Univ Toulouse 3, CNRS, ENFA, Lab Evolut & Diversite Biol EDB,UMR 5174, F-31062 Toulouse, France; [Loyau, Adeline; Danchin, Etienne] Univ Toulouse, UMR 5174, Toulouse, France; [Loyau, Adeline] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Loyau, A (corresponding author), CNRS Moulis, CNRS, Stn Ecol Expt, USR 2936, St Girons, France.	al@adeline-loyau.net	Loyau, Adeline/F-8682-2010; Danchin, Etienne/AAB-2091-2021	Loyau, Adeline/0000-0003-4230-5892; Danchin, Etienne/0000-0002-5013-9612	"Laboratoire d'Excellence (LABEX)" entitled TULIP [ANR-10-LABX-41]; CNRS; Ministry of Research	"Laboratoire d'Excellence (LABEX)" entitled TULIP; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was funded by the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR-10-LABX-41), a CNRS post-doc to AL, and a fellowship from the Ministry of Research to JHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2008, GENETICS, V179, P503, DOI 10.1534/genetics.107.086363; Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; Avila V, 2010, J EVOLUTION BIOL, V23, P1937, DOI 10.1111/j.1420-9101.2010.02058.x; BARNARD CJ, 1988, ANIM BEHAV, V36, P1078, DOI 10.1016/S0003-3472(88)80067-8; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; Bateson P., 1983, P257; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Daniels SJ, 2000, CONDOR, V102, P482, DOI 10.1650/0010-5422(2000)102[0482:IDAIEO]2.0.CO;2; De Luca PA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1869, DOI 10.1007/s00265-008-0616-2; Edvardsson M, 2008, ANIM BEHAV, V75, P1519, DOI 10.1016/j.anbehav.2007.10.005; Elias J, 2010, MOL ECOL, V19, P2336, DOI 10.1111/j.1365-294X.2010.04645.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Frankham R., 2002, INTRO CONSERVATION G; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Gerlach G, 2006, ANIM BEHAV, V71, P1371, DOI 10.1016/j.anbehav.2005.10.010; Guevara-Fiore P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1601, DOI 10.1007/s00265-010-0973-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Holand O, 2007, BIOL LETTERS, V3, P36, DOI 10.1098/rsbl.2006.0575; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Jones B, 2003, GENETICS, V163, P1193; KEANE B, 1990, ANIM BEHAV, V39, P264, DOI 10.1016/S0003-3472(05)80870-X; Koenig WD, 1999, ANIM BEHAV, V57, P1287, DOI 10.1006/anbe.1999.1093; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Loyau A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00768; Mack PD, 2002, EVOLUTION, V56, P1789, DOI 10.1111/j.0014-3820.2002.tb00192.x; Mack PD, 2000, GENETICA, V110, P31, DOI 10.1023/A:1017538505627; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Narraway C, 2010, J EVOLUTION BIOL, V23, P2550, DOI 10.1111/j.1420-9101.2010.02113.x; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Parker G.A., 1979, P123; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; Reid JM, 2006, AM NAT, V168, P1, DOI 10.1086/504852; Richard M, 2009, P ROY SOC B-BIOL SCI, V276, P2779, DOI 10.1098/rspb.2009.0319; Rioux-Paquette E, 2010, ANIM BEHAV, V80, P865, DOI 10.1016/j.anbehav.2010.08.006; Robinson SP, 2012, J EVOLUTION BIOL, V25, P716, DOI 10.1111/j.1420-9101.2012.02466.x; Robinson SP, 2009, BIOL J LINN SOC, V98, P501, DOI 10.1111/j.1095-8312.2009.01301.x; Ruedi EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006150; Schielzeth H, 2008, ANIM BEHAV, V76, P1927, DOI 10.1016/j.anbehav.2008.08.014; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; SHARP PM, 1984, GENETICS, V106, P601; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Swindell WR, 2006, EVOLUTION, V60, P762, DOI 10.1111/j.0014-3820.2006.tb01154.x; Szulkin M, 2009, J ANIM ECOL, V78, P778, DOI 10.1111/j.1365-2656.2009.01544.x; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Thurin N, 2009, J EVOLUTION BIOL, V22, P2481, DOI 10.1111/j.1420-9101.2009.01864.x; Tomaru M, 2000, ANIM BEHAV, V60, P797, DOI 10.1006/anbe.2000.1543; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wheelwright NT, 2006, ANIM BEHAV, V71, P631, DOI 10.1016/j.anbehav.2005.06.012; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037	63	20	20	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51293	10.1371/journal.pone.0051293	http://dx.doi.org/10.1371/journal.pone.0051293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251487	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900062
J	Ordinario, E; Han, HJ; Furuta, S; Heiser, LM; Jakkula, LR; Rodier, F; Spellman, PT; Campisi, J; Gray, JW; Bissell, MJ; Kohwi, Y; Kohwi-Shigematsu, T				Ordinario, Ellen; Han, Hye-Jung; Furuta, Saori; Heiser, Laura M.; Jakkula, Lakshmi R.; Rodier, Francis; Spellman, Paul T.; Campisi, Judith; Gray, Joe W.; Bissell, Mina J.; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi			ATM Suppresses SATB1-Induced Malignant Progression in Breast Epithelial Cells	PLOS ONE			English	Article							BINDING-PROTEIN 1; DNA-DAMAGE; MESENCHYMAL TRANSITION; ATAXIA-TELANGIECTASIA; 3-DIMENSIONAL CULTURE; CANCER PATHOGENESIS; TUMOR PROGRESSION; GASTRIC-CANCER; SATB1; EXPRESSION	SATB1 drives metastasis when expressed in breast tumor cells by radically reprogramming gene expression. Here, we show that SATB1 also has an oncogenic activity to transform certain non-malignant breast epithelial cell lines. We studied the non-malignant MCF10A cell line, which is used widely in the literature. We obtained aliquots from two different sources (here we refer to them as MCF10A-1 and MCF10A-2), but found them to be surprisingly dissimilar in their responses to oncogenic activity of SATB1. Ectopic expression of SATB1 in MCF10A-1 induced tumor-like morphology in three-dimensional cultures, led to tumor formation in immunocompromised mice, and when injected into tail veins, led to lung metastasis. The number of metastases correlated positively with the level of SATB1 expression. In contrast, SATB1 expression in MCF10A-2 did not lead to any of these outcomes. Yet DNA copy-number analysis revealed that MCF10A-1 is indistinguishable genetically from MCF10A-2. However, gene expression profiling analysis revealed that these cell lines have significantly divergent signatures for the expression of genes involved in oncogenesis, including cell cycle regulation and signal transduction. Above all, the early DNA damage-response kinase, ATM, was greatly reduced in MCF10A-1 cells compared to MCF10A-2 cells. We found the reason for reduction to be phenotypic drift due to long-term cultivation of MCF10A. ATM knockdown in MCF10A-2 and two other non-malignant breast epithelial cell lines, 184A1 and 184B4, enabled SATB1 to induce malignant phenotypes similar to that observed for MCF10A-1. These data indicate a novel role for ATM as a suppressor of SATB1-induced malignancy in breast epithelial cells, but also raise a cautionary note that phenotypic drift could lead to dramatically different functional outcomes.	[Ordinario, Ellen; Han, Hye-Jung; Furuta, Saori; Heiser, Laura M.; Jakkula, Lakshmi R.; Rodier, Francis; Spellman, Paul T.; Campisi, Judith; Gray, Joe W.; Bissell, Mina J.; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Campisi, Judith] Buck Inst Res Aging, Novato, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	TKohwi-Shigematsu@lbl.gov	Furuta, Saori/P-9677-2018; Gray, Joe/AAX-9549-2020	Furuta, Saori/0000-0003-1121-0487; Rodier, Francis/0000-0003-2523-309X	National Cancer Institute [R37CA039681]; National Institutes of Health, National Cancer Institute [P50 CA 58207, U54 CA 112970]; National Institute on Aging [R37AG009909, P01AG017242]; Low Dose Radiation Research Program, US Department of Energy [DE-AC02-05CH11231]; NRSA [F32CA138109]; NATIONAL CANCER INSTITUTE [U54CA112970, P50CA058207, R37CA039681, F32CA138109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009909, P01AG017242] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Low Dose Radiation Research Program, US Department of Energy(United States Department of Energy (DOE)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Cancer Institute grant R37CA039681 to TK-S; the National Institutes of Health, National Cancer Institute grants P50 CA 58207 and U54 CA 112970 to JG; National Institute on Aging grants R37AG009909 and P01AG017242 to JC and Low Dose Radiation Research Program, US Department of Energy (DE-AC02-05CH11231) to TK-S and JC; and NRSA fellowship (F32CA138109) to EO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alvarez JD, 2000, GENE DEV, V14, P521; Balamotis MA, 2012, MOL CELL BIOL, V32, P333, DOI 10.1128/MCB.05917-11; Bissell M J, 1981, Int Rev Cytol, V70, P27, DOI 10.1016/S0074-7696(08)61130-4; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hanker LC, 2011, BREAST, V20, P309, DOI 10.1016/j.breast.2010.10.002; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Ji HJ, 1997, CANCER RES, V57, P759; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kohwi-Shigematsu T, 2012, SEMIN CANC BIOL; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mandriota SJ, 2010, J BIOL CHEM, V285, P13092, DOI 10.1074/jbc.M109.078360; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Stampfer MR, 1997, MOL BIOL CELL, V8, P2391, DOI 10.1091/mbc.8.12.2391; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; TAIT L, 1990, CANCER RES, V50, P6087; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tysnes BB, 2007, BBA-REV CANCER, V1775, P283, DOI 10.1016/j.bbcan.2007.01.001; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wang B, 1997, ANTICANCER RES, V17, P4387; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yamayoshi A, 2011, OLIGONUCLEOTIDES, V21, P115, DOI 10.1089/oli.2010.0277; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Ye CZ, 2007, CANCER-AM CANCER SOC, V109, P1729, DOI 10.1002/cncr.22592	70	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51786	10.1371/journal.pone.0051786	http://dx.doi.org/10.1371/journal.pone.0051786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251624	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900118
J	Panuccio, G; Vicini, S; Avoli, M				Panuccio, Gabriella; Vicini, Stefano; Avoli, Massimo			Cell Type-Specific Properties of Subicular GABAergic Currents Shape Hippocampal Output Firing Mode	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MEDIATED TONIC INHIBITION; IN-VITRO; PYRAMIDAL NEURONS; GABA(A) RECEPTORS; RODENT MODEL; RAT; NETWORKS; CORTEX; EXCITABILITY	GABAergic function of the subiculum is central to the regulation of hippocampal output activity. Subicular neuronal networks are indeed under potent control by local inhibition. However, information about the properties of GABAergic currents generated by neurons of this parahippocampal area in normal tissue is still missing. Here, we describe GABA(A) receptor (GABA(A)R)-mediated phasic and tonic currents generated by principal cells (PCs) and interneurons (INs) of the rat subiculum. We show that in spite of similar synaptic current densities, INs generate spontaneous IPSCs (sIPSCs) that occur less frequently and exhibit smaller charge transfer, thus receiving less synaptic total current than PCs. Further distinction of PCs between intrinsically bursting (IB) and regular-spiking (RS) neurons suggested that sIPSCs generated by the two PC sub-types are likely to be similar. PCs and INs are also controlled by a similar tonic inhibition. However, whereas a comparable tonic current density is found in RS cells and INs, IB neurons are constrained by a greater inhibitory tone. Finally, pharmacological blockade of GABA(A)R did not promote functional switch of RS neurons to IB mode, but influenced the bursting propensity of IB cells and released fast spiking activity in INs. Our findings reveal differences in GABAergic currents between PCs and INs as well as within PC sub-types. We propose that GABAergic inhibition may shape hippocampal output activity by providing cell type-specific fine-tuning of subicular excitatory and inhibitory drives.	[Panuccio, Gabriella; Avoli, Massimo] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Panuccio, Gabriella; Avoli, Massimo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Vicini, Stefano] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC USA	McGill University; McGill University; Georgetown University	Avoli, M (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	massimo.avoli@mcgill.ca	Panuccio, Gabriella/GLR-8478-2022	Panuccio, Gabriella/0000-0002-4059-7193; Vicini, Stefano/0000-0001-8671-5194	CIHR [MOP 8109, 74609]; Epilepsy Canada; Savoy Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Epilepsy Canada; Savoy Foundation	The authors gratefully acknowledge funding from the CIHR, Grants MOP 8109 and 74609 (http://www.cihr-irsc.gc.ca/). GP received funding from Epilepsy Canada (http://www.epilepsy.ca/) and from the Savoy Foundation (http://www.savoy-foundation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Benini R, 2005, J PHYSIOL-LONDON, V566, P885, DOI 10.1113/jphysiol.2005.088708; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; de Guzman P, 2006, HIPPOCAMPUS, V16, P843, DOI 10.1002/hipo.20215; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de la Prida LM, 2003, J PHYSIOL-LONDON, V549, P219, DOI 10.1113/jphysiol.2003.039305; de la Prida LM, 2002, NEUROSCI LETT, V322, P49, DOI 10.1016/S0304-3940(02)00085-X; DeFazio RA, 2000, J NEUROSCI, V20, P8069; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; de la Prida LM, 2006, BEHAV BRAIN RES, V174, P198, DOI 10.1016/j.bbr.2006.05.033; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Panuccio G, 2010, NEUROBIOL DIS, V39, P372, DOI 10.1016/j.nbd.2010.05.003; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Vardya I, 2008, J NEUROPHYSIOL, V100, P526, DOI 10.1152/jn.01224.2007; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wozny C, 2005, EPILEPSIA, V46, P17, DOI 10.1111/j.1528-1167.2005.01066.x	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50241	10.1371/journal.pone.0050241	http://dx.doi.org/10.1371/journal.pone.0050241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251362	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900009
J	Pathai, S; Weiss, HA; Lawn, SD; Peto, T; D'Costa, LM; Cook, C; Wong, TY; Gilbert, CE				Pathai, Sophia; Weiss, Helen A.; Lawn, Stephen D.; Peto, Tunde; D'Costa, Leris M.; Cook, Colin; Wong, Tien Y.; Gilbert, Clare E.			Retinal Arterioles Narrow with Increasing Duration of Anti-Retroviral Therapy in HIV Infection: A Novel Estimator of Vascular Risk in HIV?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VESSEL DIAMETERS; CARDIOVASCULAR RISK; BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; CALIBER; AGE; INFLAMMATION; ASSOCIATION; MORTALITY	Objectives: HIV infection is associated with an increased risk of age-related morbidity mediated by immune dysfunction, atherosclerosis and inflammation. Changes in retinal vessel calibre may reflect cumulative structural damage arising from these mechanisms. The relationship of retinal vessel calibre with clinical and demographic characteristics was investigated in a population of HIV-infected individuals in South Africa. Methods: Case-control study of 491 adults >= 30 years, composed of 242 HIV-infected adults and 249 age-and gender-matched HIV-negative controls. Retinal vessel calibre was measured using computer-assisted techniques to determine mean arteriolar and venular diameters of each eye. Results: The median age was 40 years (IQR: 35-48 years). Among HIV-infected adults, 87.1% were receiving highly active antiretroviral therapy (HAART) (median duration, 58 months), their median CD4 count was 468 cells/mu L, and 84.3% had undetectable plasma viral load. Unadjusted mean retinal arteriolar diameters were 163.67+/-17.69 mu m in cases and 161.34+/-17.38 mu m in controls (p = 0.15). Unadjusted mean venular diameters were 267.77+/-18.21 mu m in cases and 270.81+/-18.98 mu m in controls (p = 0.07). Age modified the effect of retinal arteriolar and venular diameters in relation to HIV status, with a tendency towards narrower retinal diameters in HIV cases but not in controls. Among cases, retinal arteriolar diameters narrowed with increasing duration of HAART, independently of age (167.83 mu m <3 years of HAART vs. 158.89 mu m >6 years, p-trend = 0.02), and with a HIV viral load >10,000 copies/mu L while on HAART (p = 0.05). HIV-related venular changes were not detected. Conclusions: Narrowing of retinal arteriolar diameters is associated with HAART duration and viral load, and may reflect heightened inflammatory and pro-atherogenic states of the systemic vasculature. Measurement of retinal vascular calibre could be an innovative non-invasive method of estimating vascular risk in HIV-infected individuals.	[Pathai, Sophia; D'Costa, Leris M.; Gilbert, Clare E.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Pathai, Sophia; Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Weiss, Helen A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Fac Epidemiol & Populat Hlth, London WC1, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Peto, Tunde] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Cook, Colin] Univ Cape Town, Dept Ophthalmol, Fac Hlth Sci, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cape Town; National University of Singapore; Singapore National Eye Center	Pathai, S (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England.	sophia.pathai@lshtm.ac.uk; clare.gilbert@lshtm.ac.uk	Peto, Tunde/G-8812-2018; Wong, Tien Yin/AAC-9724-2020; weiss, helen/ABC-7823-2021; Pathai, Sophia/GLU-7811-2022	Peto, Tunde/0000-0001-6265-0381; Wong, Tien Yin/0000-0002-8448-1264; weiss, helen/0000-0003-3547-7936; Pathai, Sophia/0000-0002-2835-4666	Wellcome Trust [090354/Z/09/Z, 088590]; NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology	SP and SDL are funded by the Wellcome Trust (Grants 090354/Z/09/Z to SP and 088590 to SDL) (www.wellcome.ac.uk). TP is funded by NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2009, CURR OPIN HIV AIDS, V4, P176, DOI 10.1097/COH.0b013e328329c62f; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Gangaputra S, 2012, AM J OPHTHALMOL, V153, P434, DOI 10.1016/j.ajo.2011.08.028; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Ho JE, 2012, AIDS, V26, P1115, DOI 10.1097/QAD.0b013e328352ce54; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Klein R, 2006, ARCH OPHTHALMOL-CHIC, V124, P87, DOI 10.1001/archopht.124.1.87; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Lo J, 2012, J INFECT DIS, V205, pS368, DOI 10.1093/infdis/jis201; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Nguyen TT, 2010, STROKE, V41, P1343, DOI 10.1161/STROKEAHA.110.581017; PARR JC, 1974, AM J OPHTHALMOL, V77, P472, DOI 10.1016/0002-9394(74)90457-7; PARR JC, 1974, AM J OPHTHALMOL, V77, P478, DOI 10.1016/0002-9394(74)90458-9; Rochtchina E, 2008, INVEST OPHTH VIS SCI, V49, P1362, DOI 10.1167/iovs.07-0150; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Saag MS, 2011, CLIN INFECT DIS, V53, P1140, DOI 10.1093/cid/cir629; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wong TY, 2006, ARCH INTERN MED, V166, P2388, DOI 10.1001/archinte.166.21.2388; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, OPHTHALMOLOGY, V112, P553, DOI 10.1016/j.ophtha.2004.11.026; Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528	48	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51405	10.1371/journal.pone.0051405	http://dx.doi.org/10.1371/journal.pone.0051405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251521	Green Published, Green Accepted, gold			2022-12-25	WOS:000312201900080
J	Qi, WB; Tian, J; Zhang, CH; He, J; Ning, ZY; Jiao, PR; Liao, M				Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming			Potential Role of HPA Axis and Sympathetic Nervous Responses in Depletion of B Cells Induced by H9N2 Avian Influenza Virus Infection	PLOS ONE			English	Article							BONE-MARROW; CYTOKINE PRODUCTION; INDUCED APOPTOSIS; IMMUNE-SYSTEM; HOST-DEFENSE; A VIRUS; GLUCOCORTICOIDS; BRAIN; BACTERIAL; SELECTION	Except severe pulmonary disease caused by influenza virus infection, an impaired immune system is also a clinic characteristic. However, the mechanism(s) of influenza virus infection-induced depletion of B cells was unknown. Here, we compared the effect of two variant virulence H9N2 virus infections on mouse B cells. Our study found that the infection with highly pathogenic virus (V) of led to depletion of spleen B cells and bone marrow (BM) early B cells, compared to lowly pathogenic virus (Ts). Moreover, high apoptosis and cell cycle arrest in spleen and BM were detected, suggesting important factors for the reduction of B cells in both organs. Further, this effect was not caused by virus replication in spleen and BM. Compared to Ts virus infection, V virus resulted in higher glucocorticoids (GCs) and lower leptin level in plasma. Intraperitoneal GCs receptor antagonist RU486 injection was sufficient to prevent the loss of spleen B cell and BM pro-and immature B cells, but similar result was not observed in leptin-treated mice. Depletion of spleen B cells and BM pro-B cells was also reversed by chemical sympathectomy mediated by the norepinephrine (NE) analog 6-hydroxydopamine (6-OHDA), but the treatment didn't affect the GCs level. This study demonstrated that depletion of B cells induced by H9N2 AIV was dependent on HPA axis and sympathetic response.	[Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China; [Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] Key Lab Zoonoses Control & Prevent Guangdong, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liao, M (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019	Jiao, Peirong/0000-0001-7750-239X	National Science Foundation of China [81001375]; Program for National Broiler Industry [nycytx-42-G3-03]; Natural Science Foundation of Guangdong Province [10251064201000004]; Science and Technology Projects of Guangdong Province [20100206]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for National Broiler Industry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province	This work was supported by the National Science Foundation of China (No. 81001375), Program for National Broiler Industry (nycytx-42-G3-03), Natural Science Foundation of Guangdong Province (No. 10251064201000004), Science and Technology Projects of Guangdong Province (No. 20100206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADER R, 1990, ANNU REV PHARMACOL, V30, P561, DOI 10.1146/annurev.pa.30.040190.003021; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Cole SW, 1998, J IMMUNOL, V161, P610; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; DUNN AJ, 1989, PHYSIOL BEHAV, V45, P591, DOI 10.1016/0031-9384(89)90078-4; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fukuda M, 2005, J VIROL, V79, P8655, DOI 10.1128/JVI.79.13.8655-8660.2005; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; KAWAHITO Y, 1995, GUT, V37, P544, DOI 10.1136/gut.37.4.544; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Lill-Elghanian D, 2002, EXP BIOL MED, V227, P763, DOI 10.1177/153537020222700907; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mansour E, 2006, ENDOCRINOLOGY, V147, P5470, DOI 10.1210/en.2006-0223; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207	35	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51029	10.1371/journal.pone.0051029	http://dx.doi.org/10.1371/journal.pone.0051029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251416	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900033
J	Xie, P; Jiang, YJ; Zhang, XM; Yang, SB				Xie, Peng; Jiang, Yanjun; Zhang, Xiaoming; Yang, Shengbo			The Study of Intramuscular Nerve Distribution Patterns and Relative Spindle Abundance of the Thenar and Hypothenar Muscles in Human Hand	PLOS ONE			English	Article							ULNAR NERVE; MEDIAN NERVES; DENSITY; BRANCH	Background: The intramuscular nerve distribution and relative spindle abundance of the human hand have not been well defined, although this is important in guiding hand surgery. Methods: Forty human hands were dissected and subjected to modified Sihler's stain and haematoxylin and eosin stain to investigate intramuscular nerve distribution and relative spindle abundance, respectively. Results: The flexor pollicis brevis (FPB), adductor pollicis (AP), and abductor digiti minimi (ADM) contain separate nerve compartments. Neural anastomoses were observed in the thenar and hypothenar muscles, including the Y-like, O-like, H-like, and U-like appearance. We found that U-like neural anastomoses may be the characteristic of the opponens muscles. The relative spindle abundance was the greatest in the opponens muscles which may coordinate fine movements. Conclusion: Except for the two opponens muscles, the rest of the thenar and hypothenar muscles could be used as whole muscle or half-muscle donors for muscle transplant. Our nerve map of the hand offers valuable guidance for hand reconstruction.	[Xie, Peng; Jiang, Yanjun; Yang, Shengbo] Zunyi Med Coll, Dept Anat, Zunyi, Guizhou, Peoples R China; [Zhang, Xiaoming] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Zunyi Medical University; University of Kansas; University of Kansas Medical Center	Yang, SB (corresponding author), Zunyi Med Coll, Dept Anat, Zunyi, Guizhou, Peoples R China.	ShengboYangZY@hotmail.com			Provincial Natural Science Foundation of Guizhou [C-292]; Graduate Foundation of Zunyi Medical College [F-350]	Provincial Natural Science Foundation of Guizhou; Graduate Foundation of Zunyi Medical College	This work was supported by Provincial Natural Science Foundation of Guizhou (C-292) and Graduate Foundation of Zunyi Medical College (F-350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins SE, 2009, J HAND SURG-EUR VOL, V34E, P47, DOI 10.1177/1753193408097489; Banks RW, 2006, J ANAT, V208, P753, DOI 10.1111/j.1469-7580.2006.00558.x; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; BUXTON DF, 1990, J MORPHOL, V203, P345, DOI 10.1002/jmor.1052030309; Cao DY, 2009, J NEUROPHYSIOL, V101, P1722, DOI 10.1152/jn.90976.2008; Gonzalez MC, 2010, CLIN NUTR, V29, P268, DOI 10.1016/j.clnu.2009.08.012; HOMMA T, 1991, ACTA ANAT, V141, P139; HOMMA T, 1992, ACTA ANAT, V145, P44; HUTTON RS, 1992, SPORTS MED, V14, P406, DOI 10.2165/00007256-199214060-00007; Im S, 2008, AM J PHYS MED REHAB, V87, P703, DOI 10.1097/PHM.0b013e31817fa167; Kararizou E, 2005, ANAL QUANT CYTOL, V27, P1; Kulkarni V, 2001, NEUROL INDIA, V49, P355; Loukas M, 2011, CLIN ANAT, V24, P197, DOI 10.1002/ca.21093; Mu L, 2010, BIOTECH HISTOCHEM, V85, P19, DOI 10.3109/10520290903048384; Murata K, 2004, J HAND SURG-AM, V29A, P500, DOI 10.1016/j.jhsa.2004.01.006; Osterlund C, 2011, ANAT REC, V294, P683, DOI 10.1002/ar.21347; Takeuchi Y, 1995, ACTA ANAT NIPPON, V70, P313; Uysal AC, 2005, J HAND SURG-AM, V30A, P172, DOI 10.1016/j.jhsa.2004.06.001; Wang Z, 2012, J NEUROPHYSIOL, V108, P83, DOI 10.1152/jn.00074.2012; Yu DZ, 2010, SURG RADIOL ANAT, V32, P637, DOI 10.1007/s00276-010-0644-2	20	9	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51538	10.1371/journal.pone.0051538	http://dx.doi.org/10.1371/journal.pone.0051538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251569	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900099
J	Yu, R; Broady, R; Huang, YS; Wang, Y; Yu, J; Gao, M; Levings, M; Wei, SC; Zhang, SQ; Xu, A; Su, MW; Dutz, J; Zhang, XJ; Zhou, YW				Yu, Richard; Broady, Raewyn; Huang, Yuanshen; Wang, Yang; Yu, Jie; Gao, Min; Levings, Megan; Wei, Shencai; Zhang, Shengquan; Xu, Aie; Su, Mingwan; Dutz, Jan; Zhang, Xuejun; Zhou, Youwen			Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin	PLOS ONE			English	Article							NATURAL-KILLER-CELL; SUSCEPTIBILITY LOCI; GENERALIZED VITILIGO; MULTIPLE-SCLEROSIS; UP-REGULATION; T-CELLS; MELANOCYTES; RECEPTORS; EXPRESSION; LIGANDS	Background: Vitiligo is characterized by the death of melanocytes in the skin. This is associated with the presence of T cell infiltrates in the lesional borders. However, at present, there is no detailed and systematic characterization on whether additional cellular or molecular changes are present inside vitiligo lesions. Further, it is unknown if the normal appearing non-lesional skin of vitiligo patients is in fact normal. The purpose of this study is to systematically characterize the molecular and cellular characteristics of the lesional and non-lesional skin of vitiligo patients. Methods and Materials: Paired lesional and non-lesional skin biopsies from twenty-three vitiligo patients and normal skin biopsies from sixteen healthy volunteers were obtained with informed consent. The following aspects were analyzed: (1) transcriptome changes present in vitiligo skin using DNA microarrays and qRT-PCR; (2) abnormal cellular infiltrates in vitiligo skin explant cultures using flow cytometry; and (3) distribution of the abnormal cellular infiltrates in vitiligo skin using immunofluorescence microscopy. Results: Compared with normal skin, vitiligo lesional skin contained 17 genes (mostly melanocyte-specific genes) whose expression was decreased or absent. In contrast, the relative expression of 13 genes was up-regulated. The up-regulated genes point to aberrant activity of the innate immune system, especially natural killer cells in vitiligo. Strikingly, the markers of heightened innate immune responses were also found to be up-regulated in the non-lesional skin of vitiligo patients. Conclusions and Clinical Implications: As the first systematic transcriptome characterization of the skin in vitiligo patients, this study revealed previously unknown molecular markers that strongly suggest aberrant innate immune activation in the microenvironment of vitiligo skin. Since these changes involve both lesional and non-lesional skin, our results suggest that therapies targeting the entire skin surface may improve treatment outcomes. Finally, this study revealed novel mediators that may facilitate future development of vitiligo therapies.	[Yu, Richard; Huang, Yuanshen; Wang, Yang; Wei, Shencai; Zhang, Shengquan; Su, Mingwan; Dutz, Jan; Zhou, Youwen] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Yu, Richard; Gao, Min; Zhang, Shengquan; Zhang, Xuejun; Zhou, Youwen] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Broady, Raewyn] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Yu, Jie; Levings, Megan] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Xu, Aie] Third Peoples Hosp, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Dutz, Jan; Zhou, Youwen] British Columbia Canc Agcy, Skin Tumor Grp, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; Anhui Medical University; University of British Columbia; University of British Columbia; British Columbia Cancer Agency	Dutz, J (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	dutz@interchange.ubc.ca; ayzxj@vip.sina.com; ywzhou@interchange.ubc.ca	Chen, Gang/G-2722-2010	, Yang/0000-0001-7805-2861; Levings, Megan/0000-0002-0305-5790	National Natural Sciences Foundation of China [30628021]; Canadian Institutes of Health Research; Canadian Dermatology Foundation; Astellas Pharma Research Competition, Canada	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Astellas Pharma Research Competition, Canada	This work was supported by grants from National Natural Sciences Foundation of China (No. 30628021), Canadian Institutes of Health Research, Canadian Dermatology Foundation, and Astellas Pharma Research Competition, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Tahir M, 2010, AUTOIMMUN REV, V9, P516, DOI 10.1016/j.autrev.2010.02.013; Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; ALABADIE MSK, 1995, INT J DERMATOL, V34, P837, DOI 10.1111/j.1365-4362.1995.tb04417.x; Basak PY, 2008, J EUR ACAD DERMATOL, V22, P970, DOI 10.1111/j.1468-3083.2008.02681.x; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Boissy RE, 2009, EXP DERMATOL, V18, P583, DOI 10.1111/j.1600-0625.2008.00826.x; BREATHNACH AS, 1966, J INVEST DERMATOL, V47, P125, DOI 10.1038/jid.1966.117; Broady R, 2010, BLOOD, V116, P5748, DOI 10.1182/blood-2010-07-295436; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Darrah E, 2010, CELL DEATH DIFFER, V17, P624, DOI 10.1038/cdd.2009.197; Deretzi G, 2010, MULT SCLER J, V16, P1091, DOI 10.1177/1352458510375708; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; DURHAMPIERRE DG, 1995, J AM ACAD DERMATOL, V33, P26, DOI 10.1016/0190-9622(95)90005-5; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; GHONEUM M, 1987, J AM ACAD DERMATOL, V17, P600, DOI 10.1016/S0190-9622(87)70243-6; Glassman SJ, 2011, CLIN SCI, V120, P99, DOI 10.1042/CS20090603; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; Grimes PE, 2005, JAMA-J AM MED ASSOC, V293, P730, DOI 10.1001/jama.293.6.730; Harris JE, 2012, J INVEST DERMATOL; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HH, 2010, ONCOL REP, V24, P1043, DOI 10.3892/or_00000953; Jacob SE, 2008, DERMATOL SURG, V34, P844, DOI 10.1111/j.1524-4725.2008.34158.x; Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jones CD, 1996, PHOTODERMATOL PHOTO, V12, P204, DOI 10.1111/j.1600-0781.1996.tb00201.x; KAMHOLZ J, 1992, J NEUROSCI RES, V31, P231, DOI 10.1002/jnr.490310204; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Kemp EH, 2011, EXP DERMATOL, V20, P35, DOI 10.1111/j.1600-0625.2010.01181.x; Kennah E, 2009, BLOOD, V113, P4646, DOI 10.1182/blood-2008-08-174037; Kim DK, 2004, MOL IMMUNOL, V41, P53, DOI 10.1016/j.molimm.2004.01.004; Kingo K, 2008, J DERMATOL SCI, V52, P39, DOI 10.1016/j.jdermsci.2008.03.013; Kingo K, 2007, J DERMATOL SCI, V48, P113, DOI 10.1016/j.jdermsci.2007.06.004; Kitamura R, 2004, J PATHOL, V202, P463, DOI 10.1002/path.1538; Kocer B, 2009, EUR J NEUROL, V16, pE78, DOI 10.1111/j.1468-1331.2009.02563.x; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Liang YH, 2007, J INVEST DERMATOL, V127, P2552, DOI 10.1038/sj.jid.5700904; Long EO, 2002, J EXP MED, V196, P1399, DOI 10.1084/jem.20021747; MOZZANICA N, 1992, J AM ACAD DERMATOL, V26, P693, DOI 10.1016/0190-9622(92)70094-V; MOZZANICA N, 1989, J AM ACAD DERMATOL, V20, P591, DOI 10.1016/S0190-9622(89)70069-4; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Perricone R, 2008, AUTOIMMUN REV, V7, P384, DOI 10.1016/j.autrev.2008.03.002; PORTER JR, 1991, J HEALTH SOC BEHAV, V32, P192, DOI 10.2307/2137152; Pridgeon C, 2003, RHEUMATOLOGY, V42, P870, DOI 10.1093/rheumatology/keg240; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Rashtak Shadi, 2008, V10, P344, DOI 10.1159/000131754; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Renedo M, 2000, GENOMICS, V65, P129, DOI 10.1006/geno.2000.6163; Ringrose A, 2006, LEUKEMIA, V20, P1593, DOI 10.1038/sj.leu.2404321; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Senel E, 2007, INDIAN J DERMATOL VE, V73, P423, DOI 10.4103/0378-6323.37065; Serrao VV, 2008, EUR J DERMATOL, V18, P342, DOI 10.1684/ejd.2008.0402; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Spritz Richard A, 2011, J Invest Dermatol, V131, pE18, DOI 10.1038/skinbio.2011.7; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Stromberg S, 2008, PIGM CELL MELANOMA R, V21, P162, DOI 10.1111/j.1755-148X.2007.00429.x; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Thompson AR, 2002, BRIT J HEALTH PSYCH, V7, P213, DOI 10.1348/135910702169457; Trachtenberg EA, 2009, ANN NEUROL, V65, P626, DOI 10.1002/ana.21747; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wang X, 2003, J AUTOIMMUN, V21, P149, DOI 10.1016/S0896-8411(03)00087-8; Wang Y, 2011, BLOOD, V117, P3826, DOI 10.1182/blood-2010-07-294819; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Whitton ME, 2008, J AM ACAD DERMATOL, V59, P713, DOI 10.1016/j.jaad.2008.06.023; Xu SX, 2010, ACTA DERM-VENEREOL, V90, P131, DOI 10.2340/00015555-0820; Yamagiwa S, 2009, MED MOL MORPHOL, V42, P1, DOI 10.1007/s00795-008-0434-7; Yuan L, 2010, INT J CARDIOL; Zhang XJ, 2005, J DERMATOL SCI, V39, P137, DOI 10.1016/j.jdermsci.2005.06.004; Zhou Y, 1996, Exp Dermatol, V5, P138, DOI 10.1111/j.1600-0625.1996.tb00108.x; Zhu KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023089	80	60	65	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51040	10.1371/journal.pone.0051040	http://dx.doi.org/10.1371/journal.pone.0051040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251420	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900035
J	Kim, DH; Wirtz, D				Kim, Dong-Hwee; Wirtz, Denis			Focal adhesion size uniquely predicts cell migration	FASEB JOURNAL			English	Article						motility; mechanosensing; high-throughput phenotyping; systems biology	ACTIN-FILAMENT NETWORKS; ALPHA-ACTININ; MECHANICAL-PROPERTIES; MOTILITY; SUBSTRATE; POLARIZATION; FIBROBLASTS; DYNAMICS; RIGIDITY; BINDING	Focal adhesions are large protein complexes organized at the basal surface of cells, which physically connect the extracellular matrix to the cytoskeleton and have long been speculated to mediate cell migration. However, whether clustering of these molecular components into focal adhesions is actually required for these proteins to regulate cell motility is unclear. Here we use quantitative microscopy to characterize descriptors of focal adhesion and cell motility for mouse embryonic fibroblasts and human fibrosarcoma cells, across a wide range of matrix compliance and following genetic manipulations of focal adhesion proteins (vinculin, talin, zyxin, FAK, and paxilin). This analysis reveals a tight, biphasic gaussian relationship between mean size of focal adhesions (not their number, surface density, or shape) and cell speed. The predictive power of this relationship is comprehensively validated by disrupting nonfocal adhesion proteins (alpha-actinin, F-actin, and myosin II) and subcellular organelles (mitochondria, nuclear DNA, etc.) not known to affect either focal adhesions or cell migration. This study suggests that the mean size of focal adhesions robustly and precisely predicts cell speed independently of focal adhesion surface density and molecular composition.-Kim, D.-H., Wirtz, D. Focal adhesion size uniquely predicts cell migration. FASEB J. 27, 1351-1361 (2013). www.fasebj.org	Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Wirtz, D (corresponding author), Johns Hopkins Univ, 3400 N Charles St,NEB Hall Suite 100, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Kim, Dong-Hwee/AAU-4058-2021	Kim, Dong-Hwee/0000-0003-0625-0660	U.S. National Institutes of Health [U54CA143868, R01CA174388]; NATIONAL CANCER INSTITUTE [R01CA174388, U54CA143868] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Sean X. Sun (Johns Hopkins University) for helpful discussions about the interpretation of correlations discussed in this paper. The authors thank G. D. Longmore and Y. Feng (Washington University in St. Louis, School of Medicine, St. Louis, MO, USA) for using their knockdown cells. This work was supported by U.S. National Institutes of Health grants U54CA143868 and R01CA174388. The authors declare no conflicts of interest.	Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; BYRNES RW, 1994, RADIAT RES, V137, P162, DOI 10.2307/3578807; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cloos J, 1999, MUTAGENESIS, V14, P87, DOI 10.1093/mutage/14.1.87; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Esue O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004411; Fraley SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1711; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hale CM, 2011, J CELL SCI, V124, P4267, DOI 10.1242/jcs.091231; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; ILLC D, 1995, NATURE, V377, P539; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Khatau SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00488; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Kim DH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00555; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Maheshwari G, 2000, J CELL SCI, V113, P1677; Nagasaki A, 2009, CELL RES, V19, P236, DOI 10.1038/cr.2008.318; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; Small JV, 1999, FEBS LETT, V452, P96, DOI 10.1016/S0014-5793(99)00530-X; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Xu WM, 1998, DEVELOPMENT, V125, P327	48	221	225	2	84	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1351	1361		10.1096/fj.12-220160	http://dx.doi.org/10.1096/fj.12-220160			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23254340	Green Published			2022-12-25	WOS:000316940800008
J	Guo, YH; Fan, YB; Zhang, JF; Chang, L; Lin, JDD; Chen, YE				Guo, Yanhong; Fan, Yanbo; Zhang, Jifeng; Chang, Lin; Lin, Jiandie D.; Chen, Y. Eugene			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 beta (PGC-1 beta) Protein Attenuates Vascular Lesion Formation by Inhibition of Chromatin Loading of Minichromosome Maintenance Complex in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; DNA-REPLICATION; MCM PROTEINS; INDUCIBLE COACTIVATOR; GROWTH-FACTOR; METFORMIN; CANCER; ALPHA; PGC-1-ALPHA; EXPRESSION	Proliferation of vascular smooth muscle cells (VSMCs) in response to vascular injury plays a critical role in vascular lesion formation. Emerging data suggest that peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) is a key regulator of energy metabolism and other biological processes. However, the physiological role of PGC-1 beta in VSMCs remains unknown. A decrease in PGC-1 beta expression was observed in balloon-injured rat carotid arteries. PGC-1 beta overexpression substantially inhibited neointima formation in vivo and markedly inhibited VSMC proliferation and induced cell cycle arrest at the G(1)/S transition phase in vitro. Accordingly, overexpression of PGC-1 beta decreased the expression of minichromosome maintenance 4 (MCM4), which leads to a decreased loading of the MCM complex onto chromatin at the replication origins and decreased cyclin D1 levels, whereas PGC-1 beta loss of function by adenovirus containing PGC-1 beta shRNA resulted in the opposite effect. The transcription factor AP-1 was involved in the down-regulation of MCM4 expression. Furthermore, PGC-1 beta is up-regulated by metformin, and metformin-associated anti-proliferative activity in VSMCs is at least partially dependent on PGC-1 beta. Our data show that PGC-1 beta is a critical component in regulating DNA replication, VSMC proliferation, and vascular lesion formation, suggesting that PGC-1 beta may emerge as a novel therapeutic target for control of proliferative vascular diseases.	[Guo, Yanhong; Fan, Yanbo; Zhang, Jifeng; Chang, Lin; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lin, Jiandie D.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Ctr Cardiovasc, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	Fan, Yanbo/AAD-4710-2020; GUO, Yanhong/B-5325-2012; Fan, Yanbo/C-6360-2013	Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562	National Institutes of Health [HL068878, HL105114, HL089544]; American Heart Association [10POST3270008, 09SDG2230270, 0835237N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R01HL105114, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068878, HL105114, and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grants 10POST3270008 (to Y. F.), 09SDG2230270 (to L. C.), and 0835237N (to J. Z.).	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Bonta PI, 2010, CIRCULATION, V121, P2023, DOI 10.1161/CIRCULATIONAHA.109.885673; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Bruemmer D, 2003, EXP CELL RES, V290, P28, DOI 10.1016/S0014-4827(03)00311-2; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Fan YB, 2011, J BIOL CHEM, V286, P40584, DOI 10.1074/jbc.M111.232918; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu BL, 2011, CELL CYCLE, V10, P2959, DOI 10.4161/cc.10.17.16359; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Mamputu JC, 2003, DIABETES METAB, V29, pS71; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; SHARMA RV, 1995, CLIN EXP HYPERTENS, V17, P913, DOI 10.3109/10641969509033643; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zhang JF, 2002, J BIOL CHEM, V277, P11505, DOI 10.1074/jbc.M110580200; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	57	7	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4625	4636		10.1074/jbc.M112.407452	http://dx.doi.org/10.1074/jbc.M112.407452			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264620	Green Published, hybrid			2022-12-25	WOS:000315340400012
J	Rouhana, J; Padilla, A; Estaran, S; Bakari, S; Delbecq, S; Boublik, Y; Chopineau, J; Pugniere, M; Chavanieu, A				Rouhana, Jad; Padilla, Andre; Estaran, Sebastien; Bakari, Sana; Delbecq, Stephan; Boublik, Yvan; Chopineau, Joel; Pugniere, Martine; Chavanieu, Alain			Kinetics of Interaction between ADP-ribosylation Factor-1 (Arf1) and the Sec7 Domain of Arno Guanine Nucleotide Exchange Factor, Modulation by Allosteric Factors, and the Uncompetitive Inhibitor Brefeldin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RAS SUPERFAMILY; RHO GTPASES; FAMILY; ACTIVATION; PROTEINS; MECHANISM; ROLES; MG2+; GDP	The GDP/GTP nucleotide exchange of Arf1 is catalyzed by nucleotide exchange factors (GEF), such as Arno, which act through their catalytic Sec7 domain. This exchange is a complex mechanism that undergoes conformational changes and intermediate complex species involving several allosteric partners such as nucleotides, Mg2+, and Sec7 domains. Using a surface plasmon resonance approach, we characterized the kinetic binding parameters for various intermediate complexes. We first confirmed that both GDP and GTP counteract equivalently to the free-nucleotide binary Arf1-Arno complex stability and revealed that Mg2+ potentiates by a factor of 2 the allosteric effect of GDP. Then we explored the uncompetitive inhibitory mechanism of brefeldin A (BFA) that conducts to an abortive pentameric Arf1-Mg2+-GDP-BFA-Sec7 complex. With BFA, the association rate of the abortive complex is drastically reduced by a factor of 42, and by contrast, the 15-fold decrease of the dissociation rate concurs to stabilize the pentameric complex. These specific kinetic signatures have allowed distinguishing the level and nature as well as the fate in real time of formed complexes according to experimental conditions. Thus, we showed that in the presence of GDP, the BFA-resistant Sec7 domain of Arno can also associate to form a pentameric complex, which suggests that the uncompetitive inhibition by BFA and the nucleotide allosteric effect combine to stabilize such abortive complex.	[Rouhana, Jad; Estaran, Sebastien; Bakari, Sana; Chavanieu, Alain] Univ Montpellier I, CNRS, UMR 5247, IBMM,Fac Pharm, F-34093 Montpellier 5, France; [Rouhana, Jad; Estaran, Sebastien; Bakari, Sana; Chavanieu, Alain] Univ Montpellier 2, CNRS, UMR 5247, IBMM,Fac Pharm, F-34093 Montpellier 5, France; [Pugniere, Martine] Univ Montpellier I, INSERM, U896, CRLC Val dAurelle Paul Lamarque,IRCM, F-34298 Montpellier, France; [Padilla, Andre] CNRS, INSERM, UMR 5048, Ctr Biochim Struct,U554, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 1 & 2, F-34090 Montpellier, France; [Boublik, Yvan] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; [Boublik, Yvan] Univ Montpellier I, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; [Delbecq, Stephan] Univ Montpellier I, Fac Pharm, Biol Cellulaire & Mol Lab, EA Vaccinat Antiparasitaire 4558, F-34093 Montpellier, France; [Chopineau, Joel] UM1, UM2, ENSCM, Inst Charles Gerhardt Montpellier,CNRS,UMR 5253, F-34296 Montpellier, France; [Chopineau, Joel] Univ Nimes, F-30000 Nimes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Nimes	Chavanieu, A (corresponding author), Univ Montpellier I, CNRS, UMR 5247, IBMM,Fac Pharm, 15 Ave Charles Flahault,BP14491, F-34093 Montpellier 5, France.	alain.chavanieu@univ-montp1.fr	chopineau, joel/J-6674-2015; PUGNIERE, Martine/AAD-4315-2020; Pugniere, Martine/T-1355-2017	chopineau, joel/0000-0001-8307-0167; PUGNIERE, Martine/0000-0002-2049-2909; Pugniere, Martine/0000-0002-2049-2909; Delbecq, Stephane/0000-0002-2813-1219; PADILLA, ANDRE/0000-0001-9702-4612	MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government	MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government	Recipient of a MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Ben Hamida-Rebai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009142; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHANG CH, 1983, BIOCHEMISTRY-US, V22, P600, DOI 10.1021/bi00272a012; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Guo Z, 2005, BIOCHEMISTRY-US, V44, P15423, DOI 10.1021/bi0518601; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jian XY, 2012, J BIOL CHEM, V287, P24273, DOI 10.1074/jbc.M112.368084; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Kremer W, 2004, J BIOL CHEM, V279, P17004, DOI 10.1074/jbc.M312780200; Kumano-Kuramochi M, 2008, J BIOCHEM, V143, P229, DOI 10.1093/jb/mvm213; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Moss J, 2002, ARCH BIOCHEM BIOPHYS, V397, P156, DOI 10.1006/abbi.2001.2661; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Okamura H, 2011, STRUCTURE, V19, P988, DOI 10.1016/j.str.2011.04.007; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Rao YJ, 2006, BIOCHEM BIOPH RES CO, V348, P908, DOI 10.1016/j.bbrc.2006.07.148; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Smith WJ, 2005, BIOCHEMISTRY-US, V44, P13282, DOI 10.1021/bi050591b; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	53	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4659	4672		10.1074/jbc.M112.391748	http://dx.doi.org/10.1074/jbc.M112.391748			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255605	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000315340400015
J	Henderson, MJ; Richie, CT; Airavaara, M; Wang, Y; Harvey, BK				Henderson, Mark J.; Richie, Christopher T.; Airavaara, Mikko; Wang, Yun; Harvey, Brandon K.			Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Secretion and Cell Surface Binding Are Modulated by KDEL Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM STRESS-RESPONSE; BREFELDIN-A; PROTEIN; EXPRESSION; ER; THAPSIGARGIN; CHAPERONE; ISCHEMIA; DYNAMICS; REVEALS	Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER) stress-responsive protein with neuroprotective effects in animal models of neuro-degeneration, but the underlying mechanism is not understood. We constructed a set of lentiviral vectors that contain or lack the highly conserved final four amino acids of MANF ("RTDL"), which resemble the canonical ER retention signal ("KDEL"), to study MANF regulation in neuroblastoma cells and rat primary cortical neurons. The RTDL sequence was required for both ER retention and secretory response to ER stress. Overexpression of KDEL receptor paralogs (KDELRs) differentially reduced MANF secretion but had no effect on MANF lacking RTDL. MANF binding to the plasma membrane also required the RTDL sequence and was inhibited with a peptide known to interact with KDELRs, suggesting MANF binds KDELRs at the surface. We detected surface localization of FLAG-tagged KDELRs, with levels increasing following ER stress. Our study provides new insight into the regulation of MANF trafficking and has implications for other secreted proteins containing a KDEL-like retention signal.	[Henderson, Mark J.; Richie, Christopher T.; Airavaara, Mikko; Wang, Yun; Harvey, Brandon K.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Airavaara, Mikko] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Helsinki; National Health Research Institutes - Taiwan	Harvey, BK (corresponding author), NIDA, Intramural Res Program, Ste 200,Rm 06A729,251 Bayview Blvd, Baltimore, MD 21224 USA.	BHarvey@intra.nida.nih.gov	Harvey, Brandon Keith/AAY-4080-2021	Harvey, Brandon Keith/0000-0002-4036-1383; Airavaara, Mikko/0000-0002-2026-1609; Henderson, Mark/0000-0001-8590-7338	National Institutes of Health Intramural Research Program, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000443, ZICDA000555, ZIADA000576, ZIADA000461, ZIADA000429] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, National Institute on Drug Abuse.	Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Berger CL, 1997, INT J CANCER, V71, P1077; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; CLARK CC, 1994, J ORTHOPAED RES, V12, P601, DOI 10.1002/jor.1100120502; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Engelsberg A, 2003, J BIOL CHEM, V278, P22998, DOI 10.1074/jbc.M301361200; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hessler JL, 1997, BIOCHEMISTRY-US, V36, P14577, DOI 10.1021/bi971447w; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Oh-hashi K, 2012, MOL CELL BIOCHEM, V363, P35, DOI 10.1007/s11010-011-1155-0; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Saudek V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030876; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; WILSON DW, 1993, J BIOL CHEM, V268, P7465; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181	40	92	92	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4209	4225		10.1074/jbc.M112.400648	http://dx.doi.org/10.1074/jbc.M112.400648			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255601	Green Published, hybrid			2022-12-25	WOS:000314845000048
J	Almabouada, F; Diaz-Ruiz, A; Rabanal-Ruiz, Y; Peinado, JR; Vazquez-Martinez, R; Malagon, MM				Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Peinado, Juan R.; Vazquez-Martinez, Rafael; Malagon, Maria M.			Adiponectin Receptors Form Homomers and Heteromers Exhibiting Distinct Ligand Binding and Intracellular Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; AGONIST-DEPENDENT DISSOCIATION; LIVING CELLS; GABA(B) RECEPTOR; DIMERIZATION; PATHWAYS; INFLAMMATION; ACTIVATION; ADIPOSE	Adiponectin binds to two widely expressed receptors (AdipoR1 and AdipoR2) that contain seven transmembrane domains but, unlike G-protein coupled receptors, present an extracellular C terminus and a cytosolic N terminus. Recently, AdipoR1 was found to associate in high order complexes. However, it is still unknown whether AdipoR2 may also form homomers or heteromers with AdipoR1 or if such interactions may be functionally relevant. Herein, we have analyzed the oligomerization pattern of AdipoRs by FRET and immunoprecipitation and evaluated both the internalization of AdipoRs in response to various adiponectin isoforms and the effect of adiponectin binding to different AdipoR combinations on AMP-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor alpha activation. Transfection of HEK293AD cells with AdipoR1 and AdipoR2 showed that both receptors colocalize at both the plasma membrane and the endoplasmic reticulum. Co-transfection with the different AdipoR pairs yielded high FRET efficiencies in non-stimulated cells, which indicates that AdipoR1 and AdipoR2 form homo- and heteromeric complexes under resting conditions. Live FRET imaging suggested that both homo-and heteromeric AdipoR complexes dissociate in response to adiponectin, but heteromers separate faster than homomers. Finally, phosphorylation of AMP-activated protein kinase in response to adiponectin was delayed in cells wherein heteromer formation was favored. In sum, our findings indicate that AdipoR1 and AdipoR2 form homo-and heteromers that present unique interaction behaviors and signaling properties. This raises the possibility that the pleiotropic, tissue-dependent functions of adiponectin depend on the expression levels of AdipoR1 and AdipoR2 and, therefore, on the steady-state proportion of homo-and heteromeric complexes.	[Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Vazquez-Martinez, Rafael; Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba, Univ Hosp Reina Sofia, Cordoba 14014, Spain; [Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Vazquez-Martinez, Rafael; Malagon, Maria M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Peinado, Juan R.] Univ Castilla La Mancha, Dept Med Sci, E-13071 Ciudad Real, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Castilla-La Mancha	Vazquez-Martinez, R (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Campus Univ Rabanales, Cordoba 14014, Spain.	bc2vamar@uco.es; bc1mapom@uco.es	Peinado, Juan R/A-3450-2011; Rabanal, Yoana/R-9471-2019; Vazquez-Martinez, Rafael/G-1243-2016; Malagon, Maria M/L-5386-2014	Peinado, Juan R/0000-0002-0004-7963; Rabanal, Yoana/0000-0003-1904-8218; Malagon, Maria M/0000-0002-2419-2727; Diaz-Ruiz, Alberto/0000-0002-0488-4216	MINECO/FEDER [BFU2010-17116]; Andalucia/FEDER [CTS-03039, CTS-6606]; CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain	MINECO/FEDER; Andalucia/FEDER; CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain	This work was supported by MINECO/FEDER (BFU2010-17116), J. Andalucia/FEDER (CTS-03039, CTS-6606), and CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain.	Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen XP, 2011, MED ONCOL, V28, P1288, DOI 10.1007/s12032-010-9617-x; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Duran-Prado M, 2008, MOL CELL ENDOCRINOL, V286, P63, DOI 10.1016/j.mce.2007.12.006; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Heiker JT, 2009, CELL SIGNAL, V21, P936, DOI 10.1016/j.cellsig.2009.02.003; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; O'Dowd BF, 2011, EUR J PHARMACOL, V658, P74, DOI 10.1016/j.ejphar.2011.02.030; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vilardaga JP, 2010, J CELL SCI, V123, P4215, DOI 10.1242/jcs.063354; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vu V, 2007, DIABETES-METAB RES, V23, P600, DOI 10.1002/dmrr.778; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu AM, 2012, AM J PHYSIOL-HEART C, V302, pH1231, DOI 10.1152/ajpheart.00765.2011; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	56	41	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3112	3125		10.1074/jbc.M112.404624	http://dx.doi.org/10.1074/jbc.M112.404624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255609	Green Published, hybrid			2022-12-25	WOS:000314397900020
J	Ma, L; Makino, Y; Yamaza, H; Akiyama, K; Hoshino, Y; Song, GT; Kukita, T; Nonaka, K; Shi, ST; Yamaza, T				Ma, Lan; Makino, Yusuke; Yamaza, Haruyoshi; Akiyama, Kentaro; Hoshino, Yoshihiro; Song, Guangtai; Kukita, Toshio; Nonaka, Kazuaki; Shi, Songtao; Yamaza, Takayoshi			Cryopreserved Dental Pulp Tissues of Exfoliated Deciduous Teeth Is a Feasible Stem Cell Resource for Regenerative Medicine	PLOS ONE			English	Article							HUMAN BONE-MARROW; SYSTEMIC-LUPUS-ERYTHEMATOSUS; UMBILICAL-CORD BLOOD; STEM/PROGENITOR CELLS; PROGENITOR CELLS; APICAL PAPILLA; STROMAL CELLS; IN-VITRO; RECOVERY; MICE	Human exfoliated deciduous teeth have been considered to be a promising source for regenerative therapy because they contain unique postnatal stem cells from human exfoliated deciduous teeth (SHED) with self-renewal capacity, multipotency and immunomodulatory function. However preservation technique of deciduous teeth has not been developed. This study aimed to evaluate that cryopreserved dental pulp tissues of human exfoliated deciduous teeth is a retrievable and practical SHED source for cell-based therapy. SHED isolated from the cryopreserved deciduous pulp tissues for over 2 years (25-30 months) (SHED-Cryo) owned similar stem cell properties including clonogenicity, self-renew, stem cell marker expression, multipotency, in vivo tissue regenerative capacity and in vitro immunomodulatory function to SHED isolated from the fresh tissues (SHED-Fresh). To examine the therapeutic efficacy of SHED-Cryo on immune diseases, SHED-Cryo were intravenously transplanted into systemic lupus erythematosus (SLE) model MRL/lpr mice. Systemic SHED-Cryo-transplantation improved SLE-like disorders including short lifespan, elevated autoantibody levels and nephritis-like renal dysfunction. SHED-Cryo amended increased interleukin 17-secreting helper T cells in MRL/lpr mice systemically and locally. SHED-Cryo-transplantation was also able to recover osteoporosis bone reduction in long bones of MRL/lpr mice. Furthermore, SHED-Cryo-mediated tissue engineering induced bone regeneration in critical calvarial bone-defect sites of immunocompromised mice. The therapeutic efficacy of SHED-Cryo transplantation on immune and skeletal disorders was similar to that of SHED-Fresh. These data suggest that cryopreservation of dental pulp tissues of deciduous teeth provide a suitable and desirable approach for stem cell-based immune therapy and tissue engineering in regenerative medicine. Citation: Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, et al. (2012) Cryopreserved Dental Pulp Tissues of Exfoliated Deciduous Teeth Is a Feasible Stem Cell Resource for Regenerative Medicine. PLoS ONE 7(12): e51777. doi:10.1371/journal.pone.0051777	[Ma, Lan; Makino, Yusuke; Kukita, Toshio; Yamaza, Takayoshi] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan; [Ma, Lan; Yamaza, Haruyoshi; Hoshino, Yoshihiro; Nonaka, Kazuaki] Kyushu Univ, Grad Sch Dent Sci, Dept Pediat Dent, Fukuoka 812, Japan; [Akiyama, Kentaro; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent USC, Los Angeles, CA 90033 USA; [Song, Guangtai] Wuhan Univ, Sch Stomatol, Dept Pedodont, Wuhan 430072, Peoples R China	Kyushu University; Kyushu University; University of Southern California; Wuhan University	Yamaza, T (corresponding author), Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan.	yamazata@dent.kyushu-u.ac.jp	Yamaza, Haruyoshi/AAD-4011-2019	Yamaza, Haruyoshi/0000-0003-1138-3943; Yamaza, Takayoshi/0000-0001-7055-3370	Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project [24659815, 23659967]; Young Scientists of Japan Society for Promotion of Science [20790260]; National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA [R01DE17449, R01DE019156]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019156, R01DE017449] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24592806] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project; Young Scientists of Japan Society for Promotion of Science; National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project (no. 24659815 to TY and no. 23659967 to KN) and for Young Scientists (B) (no. 20790260 to HY) of Japan Society for Promotion of Science and from National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA (R01DE17449 and R01DE019156 to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; AREMAN EM, 1990, BONE MARROW TRANSPL, V6, P203; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Danjo A, 2007, BIOCHEM BIOPH RES CO, V360, P199, DOI 10.1016/j.bbrc.2007.06.028; Ding G, 2010, J CELL PHYSIOL, V223, P415, DOI 10.1002/jcp.22050; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; Garvin G, 2007, CLIN ORTHOD RELAT RE, V465, P202; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hubel A, 1997, TRANSFUS MED REV, V11, P224, DOI 10.1053/tmrv.1997.0110224; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Nourbakhsh N, 2011, INT J DEV BIOL, V55, P189, DOI 10.1387/ijdb.103090nn; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Perry BC, 2008, TISSUE ENG PART C-ME, V14, P149, DOI 10.1089/ten.tec.2008.0031; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647; Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x; Seo BM, 2005, J DENT RES, V84, P907, DOI 10.1177/154405910508401007; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Watt Suzanne M, 2007, Methods Mol Biol, V368, P237; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; Woods EJ, 2007, TRANSFUS MED HEMOTH, V34, P276, DOI 10.1159/000104183; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Yamaza T, 2009, BLOOD, V113, P2595, DOI 10.1182/blood-2008-10-182246; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Zhao ZG, 2008, CANCER INVEST, V26, P391, DOI 10.1080/07357900701788049; Zheng Y, 2012, J DENT RES, V91, P676, DOI 10.1177/0022034512449834; Zheng Y, 2009, J DENT RES, V88, P249, DOI 10.1177/0022034509333804; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	94	105	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51777	10.1371/journal.pone.0051777	http://dx.doi.org/10.1371/journal.pone.0051777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251621	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800084
J	Giljov, A; Karenina, K; Malashichev, Y				Giljov, Andrey; Karenina, Karina; Malashichev, Yegor			Does Bipedality Predict the Group-Level Manual Laterality in Mammals?	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; GORILLAS GORILLA-GORILLA; HAND PREFERENCES; CAPTIVE CHIMPANZEES; MOTOR LATERALITY; RIGHT-HANDEDNESS; GREAT APES; EVOLUTION; POSTURE	Background: Factors determining patterns of laterality manifestation in mammals remain unclear. In primates, the upright posture favours the expression of manual laterality across species, but may have little influence within a species. Whether the bipedalism acts the same in non-primate mammals is unknown. Our recent findings in bipedal and quadrupedal marsupials suggested that differences in laterality pattern, as well as emergence of manual specialization in evolution might depend on species-specific body posture. Here, we evaluated the hypothesis that the postural characteristics are the key variable shaping the manual laterality expression across mammalian species. Methodology/Principal Findings: We studied forelimb preferences in a most bipedal marsupial, brush-tailed bettong, Bettongia penicillata in four different types of unimanual behavior. The significant left-forelimb preference at the group level was found in all behaviours studied. In unimanual feeding on non-living food, catching live prey and nest-material collecting, all or most subjects were lateralized, and among lateralized bettongs a significant majority displayed left-forelimb bias. Only in unimanual supporting of the body in the tripedal stance the distribution of lateralized and non-lateralized individuals did not differ from chance. Individual preferences were consistent across all types of behaviour. The direction or the strength of forelimb preferences were not affected by the animals' sex. Conclusions/Significance: Our findings support the hypothesis that the expression of manual laterality depends on the species-typical postural habit. The interspecies comparison illustrates that in marsupials the increase of bipedality corresponds with the increase of the degree of group-level forelimb preference in a species. Thus, bipedalism can predict pronounced manual laterality at both intra-and interspecific levels in mammals. We also conclude that quadrupedal position in biped species can slightly hinder the expression of manual laterality, but the evoked biped position in quadrupedal species does not necessarily lead to the enhanced manifestation of manual laterality.	[Giljov, Andrey; Karenina, Karina; Malashichev, Yegor] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Malashichev, Yegor] St Petersburg State Univ, Dept Embryol, St Petersburg, Russia	Saint Petersburg State University; Saint Petersburg State University	Malashichev, Y (corresponding author), St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia.	malashichev@gmail.com	Giljov, Andrey/O-4755-2014; Karenina, Karina/B-9781-2012; Malashichev, Yegor/D-3511-2013	Giljov, Andrey/0000-0002-7533-1600; Karenina, Karina/0000-0001-8200-6876; Malashichev, Yegor/0000-0003-3813-5712	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" [P2379]	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia"	This research was supported by the Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" (Governmental Contract No. P2379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett M, 2002, HANDEDNESS BRAIN ASY; Austin NP, 2012, ANIM BEHAV, V83, P239, DOI 10.1016/j.anbehav.2011.10.033; Bisazza A, 1996, NATURE, V379, P408, DOI 10.1038/379408a0; Bisazza A, 2001, PHYSIOL BEHAV, V72, P575, DOI 10.1016/S0031-9384(01)00417-6; Blois-Heulin C, 2007, J COMP PSYCHOL, V121, P205, DOI 10.1037/0735-7036.121.2.205; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Braccini S, 2010, J HUM EVOL, V58, P234, DOI 10.1016/j.jhevol.2009.11.008; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Chapelain A, 2006, BEHAV BRAIN RES, V173, P237, DOI 10.1016/j.bbr.2006.06.028; CLAPHAM PJ, 1995, ANIM BEHAV, V50, P73, DOI 10.1006/anbe.1995.0222; CLARK MM, 1993, DEV PSYCHOBIOL, V26, P185, DOI 10.1002/dev.420260402; Corbetta D, 2003, BEHAV BRAIN SCI, V26, P217; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; DODSON DL, 1992, AM J PRIMATOL, V26, P191, DOI 10.1002/ajp.1350260305; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Fine ML, 1996, PHYSIOL BEHAV, V60, P753; Giljov A, BMC EVOL BI IN PRESS; Giljov AN, 2011, RUSSIAN ORNITHOLOGIC, V20, P1151, DOI 10.1016/j.cub.2015.05.043; Giljov A, 2012, ANIM BEHAV, V83, P525, DOI 10.1016/j.anbehav.2011.11.031; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; HARRIS LJ, 1989, CAN J PSYCHOL, V43, P369, DOI 10.1037/h0084228; Harrison RM, 2010, PRIMATES, V51, P251, DOI 10.1007/s10329-010-0191-9; Hook Michelle A., 2004, P325; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P403, DOI 10.1037/0735-7036.107.4.403; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P162, DOI 10.1037/0735-7036.107.2.162; Hopkins WD, 2005, INT J PRIMATOL, V26, P259, DOI 10.1007/s10764-005-2924-y; Hopkins WD, 2003, J COMP PSYCHOL, V117, P302, DOI 10.1037/0735-7036.117.3.302; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2008, AM J PHYS ANTHROPOL, V137, P113, DOI 10.1002/ajpa.20834; Hopkins WD, 2006, PSYCHOL BULL, V132, P538, DOI 10.1037/0033-2909.132.4.538; Joly M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038228; Kear Benjamin P., 2008, P25, DOI 10.1007/978-1-4020-6997-0_2; Konerding WS, 2012, J COMP PSYCHOL, V126, P15, DOI 10.1037/a0024638; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; McGreevy PD, 2007, LATERALITY, V12, P449, DOI 10.1080/13576500701275881; McGreevy PD, 2010, J VET BEHAV, V5, P318, DOI 10.1016/j.jveb.2010.05.001; McGrew W. C., 1994, HDB PSYCHOL ANTHR, P171; Megirian D, 1977, Ann N Y Acad Sci, V299, P197, DOI 10.1111/j.1749-6632.1977.tb41907.x; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; Murphy J, 2005, APPL ANIM BEHAV SCI, V91, P297, DOI 10.1016/j.applanim.2004.11.001; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; OLSON DA, 1990, AM J PRIMATOL, V20, P83, DOI 10.1002/ajp.1350200203; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; ROGERS LJ, 1993, ANIM BEHAV, V45, P409, DOI 10.1006/anbe.1993.1049; SANFORD C, 1984, BRAIN BEHAV EVOLUT, V25, P217, DOI 10.1159/000118867; Scheumann M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-52; Sieg AE, 2010, BEHAV BRAIN RES, V206, P135, DOI 10.1016/j.bbr.2009.08.023; Skoyles JR, 2006, MED HYPOTHESES, V66, P1060, DOI 10.1016/j.mehy.2006.01.042; Stancher G, 2006, BEHAV BRAIN RES, V173, P315, DOI 10.1016/j.bbr.2006.06.023; STODART ELEANOR, 1966, CSIRO WILDLIFE RES, V11, P91; Szalay F. S., 1994, EVOLUTIONARY HIST MA; TONOOKA R, 1995, INT J PRIMATOL, V16, P17; TUTTLE R. H., 1986, APES WORLD THEIR SOC; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Ward Jeannette P., 1993, P43; Ward JP, 1995, CREATURES OF THE DARK, P293; Webster KN, 2003, J COMP PHYSIOL B, V173, P549, DOI 10.1007/s00360-003-0364-6; Wells DL, 2009, ANIM BEHAV, V78, P537, DOI 10.1016/j.anbehav.2009.06.010; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Westergaard G C, 1997, Laterality, V2, P65, DOI 10.1080/135765097397657; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x	65	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51583	10.1371/journal.pone.0051583	http://dx.doi.org/10.1371/journal.pone.0051583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251583	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200139
J	Jusiak, B; Abulimiti, A; Haelterman, N; Chen, R; Mardon, G				Jusiak, Barbara; Abulimiti, Abuduaini; Haelterman, Nele; Chen, Rui; Mardon, Graeme			MAPK Target Sites of Eyes Absent Are Not Required for Eye Development or Survival in Drosophila	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RETINAL DETERMINATION GENES; KINASE SIGNALING PATHWAY; SINE-OCULIS; CELL FATE; TRANSCRIPTION FACTORS; CROSS-TALK; EXPRESSION; EYELESS; MELANOGASTER	Eyes absent (Eya) is a highly conserved transcription cofactor and protein phosphatase that plays an essential role in eye development and survival in Drosophila. Ectopic eye induction assays using cDNA transgenes have suggested that mitogen activated protein kinase (MAPK) activates Eya by phosphorylating it on two consensus target sites, S402 and S407, and that this activation potentiates the ability of Eya to drive eye formation. However, this mechanism has never been tested in normal eye development. In the current study, we generated a series of genomic rescue transgenes to investigate how loss- and gain-of-function mutations at these two MAPK target sites within Eya affect Drosophila survival and normal eye formation: eya(+)GR, the wild-type control; eya(SA)GR, which lacks phosphorylation at the two target residues; and eya(SDE)GR, which contains phosphomimetic amino acids at the same two residues. Contrary to the previous studies in ectopic eye development, all eya genomic transgenes tested rescue both eye formation and survival equally effectively. We conclude that, in contrast to ectopic eye formation, MAPK-mediated phosphorylation of Eya on S402 and S407 does not play a role in normal development. This is the first study in Drosophila to evaluate the difference in outcomes between genomic rescue and ectopic cDNA-based overexpression of the same gene. These findings indicate similar genomic rescue strategies may prove useful for re-evaluating other long-standing Drosophila developmental models.	[Jusiak, Barbara; Haelterman, Nele; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Abulimiti, Abuduaini; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Abulimiti, Abuduaini; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	gmardon@bcm.edu		/0000-0001-6439-0456	Retina Research Foundation; National Eye Institute [R01 EY011232]; NEI/NIH Core Grant for Vision Research [EY-002520]; NATIONAL EYE INSTITUTE [P30EY002520, R01EY011232] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI/NIH Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Retina Research Foundation (http://retinaresearchfnd.org/), the National Eye Institute (www.nei.nih.gov) grant R01 EY011232 and the NEI/NIH Core Grant for Vision Research EY-002520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Braid LR, 2008, GENETICS, V180, P283, DOI 10.1534/genetics.108.092155; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen R, 1999, DEVELOPMENT, V126, P935; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HADORN E, 1965, BROOKHAVEN SYM BIOL, P148; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Morillo SA, 2012, DEV BIOL, V365, P267, DOI 10.1016/j.ydbio.2012.02.030; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Niimi T, 1999, DEVELOPMENT, V126, P2253; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Rebay I, 2000, GENETICS, V154, P695; Robin TP, 2012, MOL CANC RES MCR; Salzer CL, 2010, GENETICS, V184, P185, DOI 10.1534/genetics.109.110122; Salzer CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008510; Shen WP, 1997, DEVELOPMENT, V124, P45; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Weasner BM, 2009, DEV BIOL, V334, P492, DOI 10.1016/j.ydbio.2009.04.027; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Zhang L, 2005, CANCER RES, V65, P925; Zimmerman JE, 2000, GENETICS, V154, P237	58	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50776	10.1371/journal.pone.0050776	http://dx.doi.org/10.1371/journal.pone.0050776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251383	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200038
J	Mantri, CK; Dash, JP; Mantri, JV; Dash, CCV				Mantri, Chinmay K.; Dash, Jui Pandhare; Mantri, Jyoti Velamarti; Dash, Chandravanu C. V.			Cocaine Enhances HIV-1 Replication in CD4+T Cells by Down-Regulating MiR-125b	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; MICRORNA EXPRESSION; DISEASE PROGRESSION; CRACK-COCAINE; NORMAL DONORS; DRUGS; ABUSE; INFECTION; CHEMOKINE	The main objective of this study was to examine effects of cocaine on HIV-1 replication in primary CD4+ T cells. Cocaine a commonly used drug among HIV-1 positive individuals serves as a cofactor for HIV-1 infection and progression to acquired immunodeficiency syndrome (AIDS). Accumulating evidence suggest that cocaine increases HIV-1 replication in cell cultures, peripheral blood mononuclear cells (PBMCs) and animal models. Intriguingly, there are no studies on cocaine-induced alterations in HIV-1 replication in primary CD4+ T cells that serve as the main targets for HIV-1 replication in vivo. In this report, we demonstrate cocaine-induced enhancement of HIV-1 replication in primary CD4+ T cells isolated from human PBMCs. To decipher a potential mechanism, we examined whether cocaine targets the innate antiviral immunity of CD4+ T cells mediated by cellular microRNAs (miRNAs). This is because recently a network of anti-HIV miRNAs in CD4+ T cells is highlighted to suppress viral replication. Our genome wide miRNA expression analysis indicated downregulation of several anti-HIV miRNAs (miR-28, miR-125b, miR-150, miR-223, and miR-382) in cocaine treated CD4+ T cells. However, our real-time quantitative PCR analysis revealed significant downregulation of miR-125b only. Our results illustrated that miR-125b knockdown enhances HIV-1 replication, whereas overexpression of miR-125b decreases HIV-1 replication in these cells. Therefore, we believe miR-125b is a key player for the cocaine induced enhancement of HIV-1 replication in CD4+ T cells. Since, miR-125b targets the 3' UTR regions of HIV-1 transcripts and inhibits viral protein translation, our data suggest modulation of post entry steps of HIV-1 by cocaine. Given that a plethora of studies suggest that cocaine regulates HIV entry, our results implicate a potentially novel mechanism by which cocaine can increase viral replication in CD4+ T cells.	[Mantri, Chinmay K.; Dash, Jui Pandhare; Mantri, Jyoti Velamarti; Dash, Chandravanu C. V.] Meharry Med Coll, Lab Retrovirol & Epigenet, Ctr AIDS Hlth Dispar Res, Vanderbilt Meharry Ctr AIDS Res,Dept Biochem & Ca, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University	Dash, CCV (corresponding author), Meharry Med Coll, Lab Retrovirol & Epigenet, Ctr AIDS Hlth Dispar Res, Vanderbilt Meharry Ctr AIDS Res,Dept Biochem & Ca, Nashville, TN 37208 USA.	cdash@mmc.edu	Mantri, Chinmay Kumar Kumar/AAX-6509-2021; Mantri, Chinmay Kumar/N-2704-2017	Mantri, Chinmay Kumar/0000-0002-9682-368X; Dash, Chandravanu/0000-0003-4466-8355; Pandhare, Jui/0000-0002-0356-064X	National Institute on Drug Abuse/National Institutes of Health [DA024558, DA30896, DA033892]; Vanderbilt CTSA grant from NCRR/NIH [UL1 RR024975-01]; Meharry Translational Research Center (MeTRC) CTSA from NCRR/NIH [U54 RR026140]; Meharry Translational Research Center (MeTRC) CTSA from NIMHD/NIH [U54 MD007593]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033892, R00DA024558, R03DA030896] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Institute on Drug Abuse/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Vanderbilt CTSA grant from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Meharry Translational Research Center (MeTRC) CTSA from NCRR/NIH; Meharry Translational Research Center (MeTRC) CTSA from NIMHD/NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is partly supported by grants (DA024558, DA30896, DA033892) from National Institute on Drug Abuse/National Institutes of Health, the Vanderbilt CTSA grant UL1 RR024975-01 from NCRR/NIH, and the Meharry Translational Research Center (MeTRC) CTSA grant (U54 RR026140 from NCRR/NIH and U54 MD007593 from NIMHD/NIH to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; ANTHONY JC, 1991, AM J EPIDEMIOL, V134, P1175, DOI 10.1093/oxfordjournals.aje.a116021; BAGASRA O, 1993, J INFECT DIS, V168, P1157, DOI 10.1093/infdis/168.5.1157; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; CHAISSON RE, 1989, JAMA-J AM MED ASSOC, V261, P561, DOI 10.1001/jama.261.4.561; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chiang K, 2011, FUTURE VIROL, V6, P209, DOI 10.2217/FVL.10.92; CLOUSE KA, 1989, J IMMUNOL, V142, P431; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; DONAHOE RM, 1988, ADV BIOCHEM PSYCHOPH, V44, P145; Duncan R, 2007, FRONT BIOSCI-LANDMRK, V12, P1488, DOI 10.2741/2162; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Friedman H, 1996, ADV EXP MED BIOL, V402, P225; Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x; GOEDERT JJ, 1984, ANN NY ACAD SCI, V437, P192, DOI 10.1111/j.1749-6632.1984.tb37137.x; Halpern JH, 2003, J CLIN ENDOCR METAB, V88, P1188, DOI 10.1210/jc.2002-020804; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Khalsa JH, 2004, J NEUROIMMUNOL, V147, P6, DOI 10.1016/j.jneuroim.2003.10.007; Kopnisky KL, 2007, BRAIN BEHAV IMMUN, V21, P428, DOI 10.1016/j.bbi.2007.01.011; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nair MPN, 2000, CLIN DIAGN LAB IMMUN, V7, P96, DOI 10.1128/CDLI.7.1.96-100.2000; Nair MPN, 2001, ADV EXP MED BIOL, V493, P235; PETERSON PK, 1991, J IMMUNOL, V146, P81; Reynolds JL, 2009, J CLIN IMMUNOL, V29, P646, DOI 10.1007/s10875-009-9309-5; Rofael HZ, 2003, TOXICOLOGY, V188, P101, DOI 10.1016/S0300-483X(03)00081-7; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; SIEGEL L, 1986, Journal of Substance Abuse Treatment, V3, P271, DOI 10.1016/0740-5472(86)90039-5; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Telesnitsky A., 1997, P121; VANDYKE C, 1976, SCIENCE, V191, P859, DOI 10.1126/science.56036; Wang X, 2011, AM J PATHOL, V178, P41, DOI 10.1016/j.ajpath.2010.11.042; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; WATZL B, 1990, LIFE SCI, V46, P1319, DOI 10.1016/0024-3205(90)90331-K; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	44	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51387	10.1371/journal.pone.0051387	http://dx.doi.org/10.1371/journal.pone.0051387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251514	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200099
J	Prasad, R; Atul; Soni, A; Puri, SK; Sijwali, PS				Prasad, Rajesh; Atul; Soni, Awakash; Puri, Sunil Kumar; Sijwali, Puran Singh			Expression, Characterization, and Cellular Localization of Knowpains, Papain-Like Cysteine Proteases of the Plasmodium knowlesi Malaria Parasite	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; RECOMBINANT FALCIPAIN-2; OOCYST PRODUCTION; INHIBITION; PROTEINASE; GENE; IDENTIFICATION; HEMOGLOBINASE; SPECIFICITY; INFECTIONS	Papain-like cysteine proteases of malaria parasites degrade haemoglobin in an acidic food vacuole to provide amino acids for intraerythrocytic parasites. These proteases are potential drug targets because their inhibitors block parasite development, and efforts are underway to develop chemotherapeutic inhibitors of these proteases as the treatments for malaria. Plasmodium knowlesi has recently been shown to be an important human pathogen in parts of Asia. We report expression and characterization of three P. knowlesi papain-like proteases, termed knowpains (KP2-4). Recombinant knowpains were produced using a bacterial expression system, and tested for various biochemical properties. Antibodies against recombinant knowpains were generated and used to determine their cellular localization in parasites. Inhibitory effects of the cysteine protease inhibitor E64 were assessed on P. knowlesi culture to validate drug target potential of knowpains. All three knowpains were present in the food vacuole, active in acidic pH, and capable of degrading haemoglobin at the food vacuolar pH (approximate to 5.5), suggesting roles in haemoglobin degradation. The proteases showed absolute (KP2 and KP3) to moderate (KP4) preference for peptide substrates containing leucine at the P2 position; KP4 preferred arginine at the P2 position. While the three knowpains appear to have redundant roles in haemoglobin degradation, KP4 may also have a role in degradation of erythrocyte cytoskeleton during merozoite egress, as it displayed broad substrate specificity and was primarily localized at the parasite periphery. Importantly, E64 blocked erythrocytic development of P. knowlesi, with enlargement of food vacuoles, indicating inhibition of haemoglobin hydrolysis and supporting the potential for inhibition of knowpains as a strategy for the treatment of malaria. Functional expression and characterization of knowpains should enable simultaneous screening of available cysteine protease inhibitor libraries against knowpains for developing broadly effective compounds active against multiple human malaria parasites.	[Prasad, Rajesh; Atul; Sijwali, Puran Singh] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Soni, Awakash; Puri, Sunil Kumar] Cent Drug Res Inst, Div Parasitol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sijwali, PS (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	psijwali@ccmb.res.in	Prasad, Rajesh/O-4794-2019		Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Department of Biotechnology (DBT) and the Council of Scientific and Industrial Research (CSIR), India. The funders did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Dua M, 2001, MOL BIOCHEM PARASIT, V116, P95, DOI 10.1016/S0166-6851(01)00306-1; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Eksi S, 2007, ANTIMICROB AGENTS CH, V51, P1064, DOI 10.1128/AAC.01012-06; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Ettari R, 2010, MED RES REV, V30, P136, DOI 10.1002/med.20163; Gelb MH, 2007, CURR OPIN CHEM BIOL, V11, P440, DOI 10.1016/j.cbpa.2007.05.038; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hogg T, 2006, J BIOL CHEM, V281, P25425, DOI 10.1074/jbc.M603776200; Jeong JJ, 2006, BLOOD CELL MOL DIS, V36, P429, DOI 10.1016/j.bcmd.2006.02.003; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Marco M, 2012, CURR TOP MED CHEM, V12, P408, DOI 10.2174/156802612799362913; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Na BK, 2004, BIOCHEM J, V378, P529, DOI 10.1042/BJ20031487; Na BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000849; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Ramjee MK, 2006, BIOCHEM J, V399, P47, DOI 10.1042/BJ20060422; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262; Rupp I, 2008, MOL BIOCHEM PARASIT, V158, P208, DOI 10.1016/j.molbiopara.2007.12.009; SALAS F, 1995, INFECT IMMUN, V63, P2120, DOI 10.1128/IAI.63.6.2120-2125.1995; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Singh A, 2002, BIOCHEM J, V368, P273, DOI 10.1042/BJ20020753; Singh A, 2007, PROTEIN ENG DES SEL, V20, P171, DOI 10.1093/protein/gzm009; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh N, 2006, EXP PARASITOL, V112, P187, DOI 10.1016/j.exppara.2005.10.007; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; WHO, 2011, WORLD MALARIA REPORT 2011, P1	55	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51619	10.1371/journal.pone.0051619	http://dx.doi.org/10.1371/journal.pone.0051619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251596	gold, Green Submitted, Green Published			2022-12-25	WOS:000313236200148
J	Seidl, MF; Wang, RP; Van den Ackerveken, G; Govers, F; Snel, B				Seidl, Michael F.; Wang, Rui-Peng; Van den Ackerveken, Guido; Govers, Francine; Snel, Berend			Bioinformatic Inference of Specific and General Transcription Factor Binding Sites in the Plant Pathogen Phytophthora infestans	PLOS ONE			English	Article							TATA BOX; REGULATORY ELEMENTS; GENOME SEQUENCES; PROMOTER; IDENTIFICATION; INITIATOR; MANNITOL; NETWORK; ARCHITECTURE; RECOGNITION	Plant infection by oomycete pathogens is a complex process. It requires precise expression of a plethora of genes in the pathogen that contribute to a successful interaction with the host. Whereas much effort has been made to uncover the molecular systems underlying this infection process, mechanisms of transcriptional regulation of the genes involved remain largely unknown. We performed the first systematic de-novo DNA motif discovery analysis in Phytophthora. To this end, we utilized the genome sequence of the late blight pathogen Phytophthora infestans and two related Phytophthora species (P. ramorum and P. sojae), as well as genome-wide in planta gene expression data to systematically predict 19 conserved DNA motifs. This catalog describes common eukaryotic promoter elements whose functionality is supported by the presence of orthologs of known general transcription factors. Together with strong functional enrichment of the common promoter elements towards effector genes involved in pathogenicity, we obtained a new and expanded picture of the promoter structure in P. infestans. More intriguingly, we identified specific DNA motifs that are either highly abundant or whose presence is significantly correlated with gene expression levels during infection. Several of these motifs are observed upstream of genes encoding transporters, RXLR effectors, but also transcriptional regulators. Motifs that are observed upstream of known pathogenicity-related genes are potentially important binding sites for transcription factors. Our analyses add substantial knowledge to the as of yet virtually unexplored question regarding general and specific gene regulation in this important class of pathogens. We propose hypotheses on the effects of cis-regulatory motifs on the gene regulation of pathogenicity-related genes and pinpoint motifs that are prime targets for further experimental validation.	[Seidl, Michael F.; Wang, Rui-Peng; Van den Ackerveken, Guido; Snel, Berend] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Seidl, Michael F.; Van den Ackerveken, Guido; Govers, Francine; Snel, Berend] Ctr BioSyst Genom, Wageningen, Netherlands; [Wang, Rui-Peng] Vrije Univ Amsterdam, Ctr Integrat Bioinformat VU IBIVU, Amsterdam, Netherlands; [Govers, Francine] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Utrecht University; Centre for BioSystems Genomics; Vrije Universiteit Amsterdam; Wageningen University & Research	Seidl, MF (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.	m.f.seidl@uu.nl	Van den Ackerveken, Guido/B-8568-2011; Snel, Berend/B-8886-2011; Govers, Francine/A-5616-2009; Seidl, Michael F./ABD-6042-2021	Van den Ackerveken, Guido/0000-0002-0183-8978; Snel, Berend/0000-0002-5804-8547; Govers, Francine/0000-0001-5311-929X; Seidl, Michael F/0000-0002-5218-2083	Centre for BioSystems Genomics (CBSG)	Centre for BioSystems Genomics (CBSG)	This project was financed by the Centre for BioSystems Genomics (CBSG) which is part of The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (http://www.cbsg.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chaturvedi V, 1996, MICROBIOL-UK, V142, P937, DOI 10.1099/00221287-142-4-937; Chaturvedi V, 1996, J IMMUNOL, V156, P3836; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EIDE D, 1988, MOL CELL BIOL, V8, P737, DOI 10.1128/MCB.8.2.737; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Govers F, 2006, MOL PLANT MICROBE IN, V19, P1295, DOI 10.1094/MPMI-19-1295; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Judelson HS, 2007, ADV GENET, V57, P97, DOI 10.1016/S0065-2660(06)57003-8; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1989, GENE, V79, P207, DOI 10.1016/0378-1119(89)90203-5; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Pritsker M, 2004, GENOME RES, V14, P99; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Rayko E, 2010, NEW PHYTOL, V188, P52, DOI 10.1111/j.1469-8137.2010.03371.x; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Skalamera D, 2006, AUSTRALAS PLANT PATH, V35, P593, DOI 10.1071/AP06063; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tani S, 2006, EUKARYOT CELL, V5, P745, DOI 10.1128/EC.5.4.745-752.2006; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; van Noort V, 2006, TRENDS GENET, V22, P73, DOI 10.1016/j.tig.2005.12.002; Vandepoele K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r103; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Voegele RT, 2005, PLANT PHYSIOL, V137, P190, DOI 10.1104/pp.104.051839; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029	70	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51295	10.1371/journal.pone.0051295	http://dx.doi.org/10.1371/journal.pone.0051295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251489	Green Published, gold			2022-12-25	WOS:000313236200087
J	Han, J; Lynne, AM; David, DE; Tang, HL; Xu, JS; Nayak, R; Kaldhone, P; Logue, CM; Foley, SL				Han, Jing; Lynne, Aaron M.; David, Donna E.; Tang, Hailin; Xu, Joshua; Nayak, Rajesh; Kaldhone, Pravin; Logue, Catherine M.; Foley, Steven L.			DNA Sequence Analysis of Plasmids from Multidrug Resistant Salmonella enterica Serotype Heidelberg Isolates	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; SEROVAR HEIDELBERG; VIRULENCE PLASMID; UNITED-STATES; FOOD ANIMALS; INFECTIONS; PREVALENCE; SYSTEMS	Salmonella enterica serovar Heidelberg is among the most detected serovars in swine and poultry, ranks among the top five serotypes associated with human salmonellosis and is disproportionately associated with invasive infections and mortality in humans. Salmonella are known to carry plasmids associated with antimicrobial resistance and virulence. To identify plasmid-associated genes in multidrug resistant S. enterica serovar Heidelberg, antimicrobial resistance plasmids from five isolates were sequenced using the 454 LifeSciences pyrosequencing technology. Four of the isolates contained incompatibility group (Inc) A/C multidrug resistance plasmids harboring at least eight antimicrobial resistance genes. Each of these strains also carried a second resistance plasmid including two IncFIB, an IncHI2 and a plasmid lacking an identified Inc group. The fifth isolate contained an IncI1 plasmid, encoding resistance to gentamicin, streptomycin and sulfonamides. Some of the IncA/C plasmids lacked the full concert of transfer genes and yet were able to be conjugally transferred, likely due to the transfer genes carried on the companion plasmids in the strains. Several non-IncA/C resistance plasmids also carried putative virulence genes. When the sequences were compared to previously sequenced plasmids, it was found that while all plasmids demonstrated some similarity to other plasmids, they were unique, often due to differences in mobile genetic elements in the plasmids. Our study suggests that Salmonella Heidelberg isolates harbor plasmids that co-select for antimicrobial resistance and virulence, along with genes that can mediate the transfer of plasmids within and among other bacterial isolates. Prevalence of such plasmids can complicate efforts to control the spread of S. enterica serovar Heidelberg in food animal and human populations.	[Han, Jing; Nayak, Rajesh; Foley, Steven L.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Lynne, Aaron M.; David, Donna E.; Kaldhone, Pravin; Foley, Steven L.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Tang, Hailin; Xu, Joshua] ICF Int Incorporat NCTR FDA, Jefferson, AR USA; [Logue, Catherine M.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA USA	US Food & Drug Administration (FDA); Texas State University System; Sam Houston State University; Marshfield Clinic; Iowa State University	Foley, SL (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA.	Steven.Foley@fda.hhs.gov	Kaldhone, Pravin/ABG-5075-2021	Foley, Steven/0000-0003-3146-4548; Logue, Catherine/0000-0002-6098-2662	Marshfield Clinic Research Foundation; National Center for Toxicological Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Marshfield Clinic Research Foundation; National Center for Toxicological Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was internally funded by the Marshfield Clinic Research Foundation and the National Center for Toxicological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buzby JC, 2006, AMBER WAVES, V4, P5; Buzby JC, 1996, BACTERIAL FOODBORNE; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Centers for Disease Control and Prevention, 2011, SALM SURV ANN SUMM 2; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM 2; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; FDA, 2011, NAT ANT RES MON SYST; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Frenzen P. D., 1999, FoodReview, V22, P10; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Garcia-Quintanilla M, 2006, J BACTERIOL, V188, P7963, DOI 10.1128/JB.00995-06; Han J, 2011, SEQUENCING PLASMIDS; Han J, 2011, J CLIN MICROBIOL, V49, P1130, DOI 10.1128/JCM.01931-10; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS237, DOI 10.1086/381593; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaldhone P, 2008, APPL ENVIRON MICROB, V74, P5038, DOI 10.1128/AEM.00409-08; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Poole TL, 2009, FOODBORNE PATHOG DIS, V6, P1185, DOI 10.1089/fpd.2009.0316; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sande MA, 2004, SANFORD GUIDE ANTIMI; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scharff R.L., 2010, PRODUCE SAFETY PROJE; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; WANG ZL, 1994, BIOTECHNIQUES, V16, P460; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106; Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003	41	66	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51160	10.1371/journal.pone.0051160	http://dx.doi.org/10.1371/journal.pone.0051160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251446	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900049
J	Landreau, F; Galeano, P; Caltana, LR; Masciotra, L; Chertcoff, A; Pontoriero, A; Baumeister, E; Amoroso, M; Brusco, HA; Tous, MI; Savy, VL; Arnaiz, MDL; de Erausquin, GA				Landreau, Fernando; Galeano, Pablo; Caltana, Laura R.; Masciotra, Luis; Chertcoff, Agustin; Pontoriero, A.; Baumeister, Elsa; Amoroso, Marcela; Brusco, Herminia A.; Tous, Monica I.; Savy, Vilma L.; del Rosario Lores Arnaiz, Maria; de Erausquin, Gabriel A.			Effects of Two Commonly Found Strains of Influenza A Virus on Developing Dopaminergic Neurons, in Relation to the Pathophysiology of Schizophrenia	PLOS ONE			English	Article							BACTERIAL-ENDOTOXIN EXPOSURE; INFECTION CAUSES ALTERATIONS; PARKINSONS-DISEASE; PRENATAL EXPOSURE; VIRAL-INFECTION; PREFRONTAL CORTEX; EXTRAPYRAMIDAL SYMPTOMS; PHARMACOLOGICAL CHANGES; IMMUNE ACTIVATION; A/WSN/33 VIRUS	Influenza virus (InfV) infection during pregnancy is a known risk factor for neurodevelopment abnormalities in the offspring, including the risk of schizophrenia, and has been shown to result in an abnormal behavioral phenotype in mice. However, previous reports have concentrated on neuroadapted influenza strains, whereas increased schizophrenia risk is associated with common respiratory InfV. In addition, no specific mechanism has been proposed for the actions of maternal infection on the developing brain that could account for schizophrenia risk. We identified two common isolates from the community with antigenic configurations H3N2 and H1N1 and compared their effects on developing brain with a mouse modified-strain A/WSN/33 specifically on the developing of dopaminergic neurons. We found that H1N1 InfV have high affinity for dopaminergic neurons in vitro, leading to nuclear factor kappa B activation and apoptosis. Furthermore, prenatal infection of mothers with the same strains results in loss of dopaminergic neurons in the offspring, and in an abnormal behavioral phenotype. We propose that the well-known contribution of InfV to risk of schizophrenia during development may involve a similar specific mechanism and discuss evidence from the literature in relation to this hypothesis.	[de Erausquin, Gabriel A.] Univ S Florida, Dept Psychiat & Neurosci, Roskamp Lab Brain Dev Modulat & Repair, Tampa, FL 33620 USA; [Landreau, Fernando; Pontoriero, A.; Baumeister, Elsa; Tous, Monica I.; Savy, Vilma L.] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas, Dept Virol, Buenos Aires, DF, Argentina; [Galeano, Pablo] Univ Buenos Aires, Fac Med, Lab Citoarquitectura & Plasticidad Neuronal, Inst Invest Prof Dr Alberto C Taquini ININCA, Buenos Aires, DF, Argentina; [Caltana, Laura R.; Masciotra, Luis] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Profesor E De Ro, Buenos Aires, DF, Argentina; [Chertcoff, Agustin; Brusco, Herminia A.] ANLIS Dr Carlos G Malbran, Inst Nacl Producc Biol, Buenos Aires, DF, Argentina; [del Rosario Lores Arnaiz, Maria] Univ Buenos Aires, Fac Psicol, Buenos Aires, DF, Argentina	State University System of Florida; University of South Florida; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	de Erausquin, GA (corresponding author), Univ S Florida, Dept Psychiat & Neurosci, Roskamp Lab Brain Dev Modulat & Repair, Tampa, FL 33620 USA.	gdeeraus@health.usf.edu	de Erausquin, Gabriel A/G-5840-2010; Pontoriero, Antonio/AAN-4455-2020; de Erausquin, Gabriel A./Z-1952-2019	de Erausquin, Gabriel A/0000-0001-6423-4461; Pontoriero, Antonio/0000-0003-3011-6779; de Erausquin, Gabriel A./0000-0001-6423-4461; Galeano, Pablo/0000-0003-4491-2039				ADAMS W, 1993, BRIT J PSYCHIAT, V163, P522, DOI 10.1192/bjp.163.4.522; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; Albert KA, 2002, ARCH GEN PSYCHIAT, V59, P705, DOI 10.1001/archpsyc.59.8.705; Anastasia A, 2007, J NEUROCHEM, V103, P1542, DOI 10.1111/j.1471-4159.2007.04856.x; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Aronsson F, 2003, VIRAL IMMUNOL, V16, P415, DOI 10.1089/088282403322396208; Aronsson F, 2002, J NEUROVIROL, V8, P353, DOI 10.1080/13550280290100480; Aronsson F, 2001, J NEUROVIROL, V7, P117; Asp L, 2005, NEUROREPORT, V16, P1111, DOI 10.1097/00001756-200507130-00016; Benes FM, 1997, AID SYN10 3 0 CO, P2; Beraki S, 2005, MOL PSYCHIATR, V10, P299, DOI 10.1038/sj.mp.4001545; BOGERTS B, 1983, BIOL PSYCHIAT, V18, P951; Brask J, 2005, J NEUROVIROL, V11, P395, DOI 10.1080/13550280500186916; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; CALIGIURI MP, 1993, AM J PSYCHIAT, V150, P1343; Carter CJ, 2009, SCHIZOPHRENIA BULL, V35, P1163, DOI 10.1093/schbul/sbn054; CARTER CJ, 1980, BRAIN RES, V192, P163, DOI 10.1016/0006-8993(80)91016-1; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; CHAKOS MH, 1992, PSYCHOPHARMACOL BULL, V28, P81; CHATTERJEE A, 1995, AM J PSYCHIAT, V152, P1724; Chen LC, 2004, J APPL PHYSIOL, V97, P17, DOI 10.1152/japplphysiol.01355.2003; COTTER D, 1995, SCHIZOPHR RES, V16, P233, DOI 10.1016/0920-9964(94)E0082-I; CROW TJ, 1992, BRIT J PSYCHIAT, V161, P570, DOI 10.1192/S0007125000129915; Dale RC, 2004, BRAIN, V127, P21, DOI 10.1093/brain/awh008; DASSA D, 1995, ACTA PSYCHIAT SCAND, V92, P145, DOI 10.1111/j.1600-0447.1995.tb09558.x; de Erausquin GA, 2003, MOL PHARMACOL, V63, P784, DOI 10.1124/mol.63.4.784; DEERAUSQUIN G, 1992, NEUROSCI LETT, V145, P121, DOI 10.1016/0304-3940(92)90001-N; DEERAUSQUIN G, 1994, MOL BRAIN RES, V21, P303, DOI 10.1016/0169-328X(94)90261-5; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fatemi SH, 1999, MOL PSYCHIATR, V4, P145, DOI 10.1038/sj.mp.4000520; Fatemi SH, 2000, NEUROREPORT, V11, P1493, DOI 10.1097/00001756-200005150-00026; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Fatemi SH, 1998, AID SYN8 3 0 CO, P2; Fruntes V, 2008, MED SCI MONITOR, V14, pRA71; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; GRILLI M, 1991, J NEUROCHEM, V56, P2108, DOI 10.1111/j.1471-4159.1991.tb03473.x; Holtze M, 2008, J NEUROSCI RES, V86, P3674, DOI 10.1002/jnr.21799; Honer WG, 2005, J PSYCHOPHARMACOL, V19, P277, DOI 10.1177/0269881105051539; Izumoto Y, 1999, BIOL PSYCHIAT, V46, P119, DOI 10.1016/S0006-3223(98)00359-X; Kawashima H, 2004, NEUROCHEM RES, V29, P1537, DOI 10.1023/B:NERE.0000029566.22533.c6; Kimura Y, 2000, Nihon Rinsho, V58, P2211; Kolomeets N S, 1999, Neurosci Behav Physiol, V29, P217; LAING P, 1989, P NATL ACAD SCI USA, V86, P1998, DOI 10.1073/pnas.86.6.1998; Le TQ, 2006, BIOL CHEM, V387, P467, DOI 10.1515/BC.2006.062; Leyva-Grado VH, 2009, J NEUROIMMUNOL, V211, P73, DOI 10.1016/j.jneuroim.2009.03.016; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Masciotra L., 2005, TRENDS SCHIZOPHRENIA, P27; MEDNICK SA, 1990, ARCH GEN PSYCHIAT, V47, P292; Mino Y, 2000, J PSYCHIAT RES, V34, P133, DOI 10.1016/S0022-3956(00)00003-0; Morgan V, 1997, SCHIZOPHR RES, V26, P25, DOI 10.1016/S0920-9964(97)00033-9; Mori I, 2000, MICROBES INFECT, V2, P1329, DOI 10.1016/S1286-4579(00)01286-7; Mori I, 1999, J NEUROVIROL, V5, P355, DOI 10.3109/13550289909029476; Mori I, 2000, MICROBIOL IMMUNOL, V44, P729, DOI 10.1111/j.1348-0421.2000.tb02556.x; Mori I, 2003, J GEN VIROL, V84, P2401, DOI 10.1099/vir.0.19188-0; Mori I, 2002, VIROLOGY, V303, P287, DOI 10.1006/viro.2002.1601; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Mori I, 2001, MICROBES INFECT, V3, P475, DOI 10.1016/S1286-4579(01)01403-4; Munk-Jorgensen P, 2001, BRIT J PSYCHIAT, V178, pS30, DOI 10.1192/bjp.178.40.s30; Nakajima K, 1997, Nihon Rinsho, V55, P2693; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosa A, 2004, AM J PSYCHIAT, V161, P1110, DOI 10.1176/appi.ajp.161.6.1110; Rubin SA, 2004, J NEUROVIROL, V10, P305, DOI 10.1080/13550280490499579; Selten JP, 1999, SCHIZOPHR RES, V38, P85, DOI 10.1016/S0920-9964(99)00005-5; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Sperner-Unterweger B, 2005, FORTSCHR NEUROL PSYC, V73, pS38, DOI 10.1055/s-2005-915544; Takahashi M, 2001, ADV NEUROL, V86, P91; TAKAHASHI M, 1995, J EXP MED, V181, P2161, DOI 10.1084/jem.181.6.2161; Takahashi M, 1999, JPN J INFECT DIS, V52, P89; Takahashi M, 1997, Parkinsonism Relat Disord, V3, P97, DOI 10.1016/S1353-8020(97)00010-2; TAKEI N, 1995, AM J PSYCHIAT, V152, P150; VALCHAR M, 1995, MOL NEUROBIOL, V11, P111, DOI 10.1007/BF02740689; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wolff AL, 1999, J PSYCHIATR NEUROSCI, V24, P304; Yamada T, 1996, Parkinsonism Relat Disord, V2, P187, DOI 10.1016/S1353-8020(96)00024-7; Yamada T, 1996, Parkinsonism Relat Disord, V2, P113, DOI 10.1016/1353-8020(96)00006-5; Yuede CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011374; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	84	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51068	10.1371/journal.pone.0051068	http://dx.doi.org/10.1371/journal.pone.0051068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251423	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900037
J	Levanic, DL; Horvat, T; Martincic, J; Bauer, N				Levanic, Dunja Leljak; Horvat, Tomislav; Martincic, Jelena; Bauer, Natasa			A Novel Bipartite Nuclear Localization Signal Guides BPM1 Protein to Nucleolus Suggesting Its Cullin3 Independent Function	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; DOMAIN; FAMILY; COMPLEXES; MEMBERS; EMBRYOGENESIS; SEQUENCE; INSIGHTS	BPM1 belongs to the MATH-BTB family of proteins, which act as substrate-binding adaptors for the Cullin3-based E3 ubiquitin ligase. MATH-BTB proteins associate with Cullin3 via the BTB domain and with the substrate protein via the MATH domain. Few BPM1-interacting proteins with different functions are recognized, however, specific roles of BPM1, depending on its cellular localization have not been studied so far. Here, we found a novel bipartite nuclear localization signal at the C-terminus of the BPM1 protein, responsible for its nuclear and nucleolar localization and sufficient to drive the green fluorescent protein and cytoplasmic BPM4 protein into the nucleus. Co-localization analysis in live Nicotiana tabacum BY2 cells indicates a Cullin3 independent function since BPM1 localization is predominantly nucleolar and thus devoid of Cullin3. Treatment of BY2 cells with the proteasome inhibitor MG132 blocks BPM1 and Cullin3 degradation, suggesting turnover of both proteins through the ubiquitin-proteasome pathway. Possible roles of BPM1 in relation to its in vivo localization are discussed.	[Levanic, Dunja Leljak; Horvat, Tomislav; Martincic, Jelena; Bauer, Natasa] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia	University of Zagreb	Bauer, N (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	natasa.bauer@zg.biol.pmf.hr		Bauer, Natasa/0000-0003-4124-0193	Ministry of Science, Education and Sports of the Republic of Croatia [119-1191196-1225, 119-1191196-1224]; Alexander Von Humboldt Foundation	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Alexander Von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Ministry of Science, Education and Sports of the Republic of Croatia, Projects 119-1191196-1225, leader Sibila Jelaska (NB, DLL, JM) and 119-1191196-1224, leader Vlatka Zoldos (TH), and Alexander Von Humboldt Foundation (DLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Choo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041350; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Juranic M, 2012, PLANT CELL, DOI [10.1105/tcp.112.107169, DOI 10.1105/TCP.112.107169]; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Lechner E, 2011, DEV CELL, V21, P1116, DOI 10.1016/j.devcel.2011.10.018; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Liu JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042621; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Sekimoto T, 2005, NUCL IMPORT EXPORT P; Soll J, 2002, CURR OPIN PLANT BIOL, V5, P529, DOI 10.1016/S1369-5266(02)00296-0; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takahashi I, 2002, BBA-MOL CELL RES, V1591, P63, DOI 10.1016/S0167-4889(02)00249-5; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; Thomann A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000328; Weber H, 2005, PLANT PHYSIOL, V137, P83, DOI 10.1104/pp.104.052654; Weber H, 2010, CHARAKTERISIERUNG BT; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	54	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51184	10.1371/journal.pone.0051184	http://dx.doi.org/10.1371/journal.pone.0051184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251450	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900052
J	Noguchi, K; Ishibashi, K; Miyokawa, K; Hokari, M; Kanno, T; Hirano, T; Yamamoto, N; Takaku, H				Noguchi, Kousei; Ishibashi, Keisuke; Miyokawa, Kaori; Hokari, Manami; Kanno, Tomoyuki; Hirano, Tomoya; Yamamoto, Norio; Takaku, Hiroshi			HIV-1 Suppressive Sequences Are Modulated by Rev Transport of Unspliced RNA and Are Required for Efficient HIV-1 Production	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICRORNA TARGET SITES; MESSENGER-RNA; GENOMIC RNAS; P-BODIES; INTRACELLULAR TRAFFICKING; RESPONSIVE ELEMENT; CELLULAR MICRORNA; BINDING-PROTEIN; TRANSLATION	The unspliced human immunodeficiency virus type 1 (HIV-1) RNAs are translated as Gag and Gag-Pol polyproteins or packaged as genomes into viral particles. Efficient translation is necessary before the transition to produce infective virions. The viral protein Rev exports all intron-containing viral RNAs; however, it also appears to enhance translation. Cellular microRNAs target cellular and viral mRNAs to silence their translation and enrich them at discrete cytoplasmic loci that overlap with the putative interim site of Gag and the genome. Here, we analyzed how Rev-mediated transport and the splicing status of the mRNA influenced the silencing status imposed by microRNA. Through identification and mutational analysis of the silencing sites in the HIV-1 genome, we elucidated the effect of silencing on virus production. Renilla luciferase mRNA, which contains a let-7 targeting site in its 39 untranslated region, was mediated when it was transported by Rev and not spliced, but it was either not mediated when it was spliced even in a partial way or it was Rev-independent. The silencing sites in the pol and env-nef regions of the HIV-1 genome, which were repressed in T cells and other cell lines, were Drosha-dependent and could also be modulated by Rev in an unspliced state. Mutant viruses that contained genomic mutations that reflect alterations to show more derepressive effects in the 39 untranslated region of the Renilla luciferase gene replicated more slowly than wild-type virus. These findings yield insights into the HIV-1 silencing sites that might allow the genome to avoid translational machinery and that might be utilized in coordinating virus production during initial virus replication. However, the function of Rev to modulate the silencing sites of unspliced RNAs would be advantageous for the efficient translation that is required to support protein production prior to viral packaging and particle production.	[Noguchi, Kousei; Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan; [Ishibashi, Keisuke; Miyokawa, Kaori; Hokari, Manami; Kanno, Tomoyuki; Hirano, Tomoya; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Yamamoto, Norio] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan	Chiba Institute of Technology; Chiba Institute of Technology; National Institute of Infectious Diseases (NIID)	Noguchi, K (corresponding author), Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan.	k3kousei@yahoo.co.jp; hiroshi.takaku@it-chiba.ac.jp			Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Ministry of Health, Labor; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports, and Culture, Japan	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Ministry of Health, Labor; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant from the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor, by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), and by a Grant-in-Aid for High Technology Research (HTR) from the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; BARKSDALE SK, 1995, MOL CELL BIOL, V15, P2962; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BOGERD HP, 1991, P NATL ACAD SCI USA, V88, P5704, DOI 10.1073/pnas.88.13.5704; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; BRIGHTY DW, 1994, P NATL ACAD SCI USA, V91, P8314, DOI 10.1073/pnas.91.18.8314; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cullen BR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000787; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Dorweiler IJ, 2006, J VIROL, V80, P3634, DOI 10.1128/JVI.80.7.3634-3643.2006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallego J, 2003, J BIOL CHEM, V278, P40385, DOI 10.1074/jbc.M301041200; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gibbings D, 2010, TRENDS CELL BIOL, V20, P491, DOI 10.1016/j.tcb.2010.06.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hu ZX, 2011, J VIROL, V85, P11309, DOI 10.1128/JVI.05578-11; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Keating CP, 2009, NUCLEIC ACIDS RES, V37, P945, DOI 10.1093/nar/gkn1015; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kemler I, 2010, J VIROL, V84, P6352, DOI 10.1128/JVI.00363-10; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li N, 2008, NUCLEIC ACIDS RES, V36, P4277, DOI 10.1093/nar/gkn388; Li ZH, 2009, J VIROL, V83, P12751, DOI 10.1128/JVI.01325-09; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; Mikaelian I, 1996, J MOL BIOL, V257, P246, DOI 10.1006/jmbi.1996.0160; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Sugiyama R, 2011, NUCLEIC ACIDS RES, V39, P589, DOI 10.1093/nar/gkq794; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Suzuki J, 2002, J VIROL, V76, P3015, DOI 10.1128/JVI.76.6.3015-3022.2002; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Swanson CM, 2010, J VIROL, V84, P6748, DOI 10.1128/JVI.02526-09; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Urcuqui-Inchima S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016686; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	91	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51393	10.1371/journal.pone.0051393	http://dx.doi.org/10.1371/journal.pone.0051393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251516	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900076
J	Goc, A; Al-Azayzih, A; Abdalla, M; Al-Husein, B; Kavuri, S; Lee, J; Moses, K; Somanath, PR				Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin; Somanath, Payaningal R.			P21 Activated Kinase-1 (Pak1) Promotes Prostate Tumor Growth and Microinvasion via Inhibition of Transforming Growth Factor beta Expression and Enhanced Matrix Metalloproteinase 9 Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; CELL INVASION; CANCER; KINASE; ACTIVATION; INTEGRIN; RECEPTOR; ANGIOGENESIS; AKT	P21-activated kinases (Paks) are major effectors downstream of the small Rho family of GTPases. Among the six isoforms, Pak1 is the most ubiquitous and the best characterized member. Previous studies have shown that inhibition of Pak6, which is predominantly present in the prostate compared with other tissues, inhibits prostate tumor growth in vivo. Even though Pak1 has been identified in normal prostatic epithelial cells and cancer cells, its specific role in the development of prostate cancer remains unclear. We report here that highly invasive prostate cancer cells express significantly higher levels of Pak1 protein compared with non-invasive prostate cancer cells. Furthermore, prostate tumor tissues and prostate cancer metastasized to lungs showed a higher expression of Pak1 compared with normal tissues. Interestingly, Pak6 protein expression levels did not change with the invasive/metastatic potential of the cancer cells or tumors. Although inhibition of Pak1, and not Pak6, resulted in impaired PC3 cell migration, the effects of Pak1 knockdown on transendothelial migration (microinvasion), tumor growth, and tumor angiogenesis was higher compared with Pak6 knockdown. Finally, gene array data revealed reduced expression of matrix metalloproteinase 9 with the ablation of either Pak1 or Pak6 gene expression in PC3 cells, whereas protein levels of TGF beta was elevated significantly with specific modulation of Pak1 activity or ablation of the Pak1 gene. Our observations suggest that although some level of functional redundancy exists between Pak1 and Pak6 in prostate cancer cells, targeting Pak1 is a potential option for the management of prostate tumor growth, microinvasion, and metastasis.	[Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Somanath, Payaningal R.] Univ Georgia, Coll Pharm, Augusta, GA USA; [Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin; Somanath, Payaningal R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Somanath, PR (corresponding author), Georgia Hlth Sci Univ, Coll Pharm, Univ Georgia, HM1200, Augusta, GA 30912 USA.	sshenoy@georgiahealth.edu	Al_Husin, Belal/CAF-6794-2022	Rammohan Shenoy, Somanath/0000-0003-3017-0230; Al-Husein, Belal/0000-0003-4001-5058; Abdalla, Maha/0000-0002-5644-3383	National Institutes of Health [R01HL103952]; University of Georgia Research Foundation; Wilson Pharmacy Foundation; University of Georgia College of Pharmacy; American Heart Association [0830326N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Wilson Pharmacy Foundation; University of Georgia College of Pharmacy; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL103952 (to P. R. S.). This work was also supported by the University of Georgia Research Foundation, by the Wilson Pharmacy Foundation, and by the University of Georgia College of Pharmacy through intramural grants (to P. R. S.) and by American Heart Association Scientist Development Grant 0830326N (to P. R. S.).	Al-Azayzih A., 2012, BIOCHEM BIOPH RES CO, V32, P1095; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Goc A, 2012, BRIT J CANCER, V107, P713, DOI 10.1038/bjc.2012.295; Goc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040594; Goc A, 2011, INT J ONCOL, V38, P267, DOI 10.3892/ijo_00000847; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lakka SS, 2003, CANCER RES, V63, P2454; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Richmond B., 2005, P AM ASS CANC RES, V46; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497; Somanath PR, 2009, ONCOGENE, V28, P2365, DOI 10.1038/onc.2009.114; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114	30	62	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3025	3035		10.1074/jbc.M112.424770	http://dx.doi.org/10.1074/jbc.M112.424770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258534	hybrid, Green Published			2022-12-25	WOS:000314397900013
J	Paonessa, F; Latifi, S; Scarongella, H; Cesca, F; Benfenati, F				Paonessa, Francesco; Latifi, Shahrzad; Scarongella, Helena; Cesca, Fabrizia; Benfenati, Fabio			Specificity Protein 1 (Sp1)-dependent Activation of the Synapsin I Gene (SYN1) Is Modulated by RE1-silencing Transcription Factor (REST) and 5 '-Cytosine-Phosphoguanine (CpG) Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; TATA-LESS; SYNAPTIC VESICLES; NEURONAL GENES; MOUSE-BRAIN; EXPRESSION; PROMOTER; SP1; REPRESSOR; BINDING	The development and function of the nervous system are directly dependent on a well defined pattern of gene expression. Indeed, perturbation of transcriptional activity or epigenetic modifications of chromatin can dramatically influence neuronal phenotypes. The phosphoprotein synapsin I (Syn I) plays a crucial role during axonogenesis and synaptogenesis as well as in synaptic transmission and plasticity of mature neurons. Abnormalities in SYN1 gene expression have been linked to important neuropsychiatric disorders, such as epilepsy and autism. SYN1 gene transcription is suppressed in non-neural tissues by the RE1-silencing transcription factor (REST); however, the molecular mechanisms that allow the constitutive expression of this genetic region in neurons have not been clarified yet. Herein we demonstrate that a conserved region of human and mouse SYN1 promoters contains cis-sites for the transcriptional activator Sp1 in close proximity to REST binding motifs. Through a series of functional assays, we demonstrate a physical interaction of Sp1 on the SYN1 promoter and show that REST directly inhibits Sp1-mediated transcription, resulting in SYN1 down-regulation. Upon differentiation of neuroblastoma Neuro2a cells, we observe a decrease in endogenous REST and a higher stability of Sp1 on target GC boxes, resulting in an increase of SYN1 transcription. Moreover, methylation of Sp1 cis-sites in the SYN1 promoter region could provide an additional level of transcriptional regulation. Our results introduce Sp1 as a fundamental activator of basal SYN1 gene expression, whose activity is modulated by the neural master regulator REST and CpG methylation.	[Paonessa, Francesco; Latifi, Shahrzad; Scarongella, Helena; Cesca, Fabrizia; Benfenati, Fabio] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Benfenati, F (corresponding author), Ist Italiano Tecnol, Via Morego 30, I-16163 Genoa, Italy.	fabio.benfenati@iit.it		Paonessa, Francesco/0000-0002-4729-0928; Cesca, Fabrizia/0000-0003-2190-6314	Italian Ministry of University and Research (PRIN); Compagnia di San Paolo, Torino, Italy; Telethon-Italy [GGP09134]	Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	This study was supported by research grants from the Italian Ministry of University and Research (PRIN) and the Compagnia di San Paolo, Torino, Italy. The support of Telethon-Italy (Grant GGP09134) is also acknowledged.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bogen IL, 2009, NEUROSCIENCE, V158, P231, DOI 10.1016/j.neuroscience.2008.05.055; Butta N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-17; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang L., 2011, MOL CANCER RES, V9, P1; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Clinton M., 2000, GENOME BIOL, V1; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Ekici M, 2008, NEUROCHEM INT, V53, P165, DOI 10.1016/j.neuint.2008.07.006; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Huber R, 1998, GENE, V214, P35, DOI 10.1016/S0378-1119(98)00233-9; James AB, 2004, CELL SIGNAL, V16, P1355, DOI 10.1016/j.cellsig.2004.04.001; JUNGLING S, 1994, EUR J BIOCHEM, V226, P925, DOI 10.1111/j.1432-1033.1994.00925.x; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; KUDO S, 1995, J BIOL CHEM, V270, P13298, DOI 10.1074/jbc.270.22.13298; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lietz M, 1998, BIOL CHEM, V379, P1301; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Park SY, 2007, J NEUROCHEM, V103, P2565, DOI 10.1111/j.1471-4159.2007.04947.x; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Rivero S, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-52; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Strathdee G, 2004, BIOCHEM SOC T, V32, P913, DOI 10.1042/BST0320913; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Sunkin SM, 2007, HUM MOL GENET, V16, pR209, DOI 10.1093/hmg/ddm183; THIEL G, 1994, J BIOL CHEM, V269, P15294; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wood IC, 2003, J MOL BIOL, V334, P863, DOI 10.1016/j.jmb.2003.10.017; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	56	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3227	3239		10.1074/jbc.M112.399782	http://dx.doi.org/10.1074/jbc.M112.399782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250796	Green Published, hybrid			2022-12-25	WOS:000314397900030
J	Marinkovic, T; Sysi-Aho, M; Oresic, M				Marinkovic, Tijana; Sysi-Aho, Marko; Oresic, Matej			Integrated Model of Metabolism and Autoimmune Response in beta-Cell Death and Progression to Type 1 Diabetes	PLOS ONE			English	Article							AUTO-IMMUNE DISEASE; PROTECTIVE AUTOIMMUNITY; NATURAL-HISTORY; ONSET; CHILDREN	Progression to type 1 diabetes is characterized by complex interactions of environmental, metabolic and immune system factors, involving both degenerative pathways leading to loss of pancreatic beta-cells as well as protective pathways. The interplay between the degenerative and protective pathways may hold the key to disease outcomes, but no models have so far captured the two together. Here we propose a mathematical framework, an ordinary differential equation (ODE) model, which integrates metabolism and the immune system in early stages of disease process. We hypothesize that depending on the degree of regulation, autoimmunity may also play a protective role in the initial response to stressors. We assume that beta-cell destruction follows two paths of loss: degenerative and autoimmune-induced loss. The two paths are mutually competing, leading to termination of the degenerative loss and further to elimination of the stress signal and the autoimmune response, and ultimately stopping the beta-cell loss. The model describes well our observations from clinical and non-clinical studies and allows exploration of how the rate of beta-cell loss depends on the amplitude and duration of autoimmune response.	[Marinkovic, Tijana; Sysi-Aho, Marko; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland	VTT Technical Research Center Finland	Oresic, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Oresic, Matej/AAV-3978-2020; Oresic, Matej/K-7673-2016	Oresic, Matej/0000-0002-2856-9165	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland)	The study was supported by Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-2017, Decision No. 250114, http://www.symmys.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; BURNET M, 1959, BRIT MED J, V2, P720, DOI 10.1136/bmj.2.5154.720; BURNET M, 1959, BMJ-BRIT MED J, V2, P645, DOI 10.1136/bmj.2.5153.645; De Blasio BF, 1999, DIABETES, V48, P1677, DOI 10.2337/diabetes.48.9.1677; Kimpimaki T, 2002, J CLIN ENDOCR METAB, V87, P4572, DOI 10.1210/jc.2002-020018; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Maree AFM, 2006, PHILOS T R SOC A, V364, P1267, DOI 10.1098/rsta.2006.1769; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Mehta D, 2005, AM J PHYSIOL-LUNG C, V289, pL174, DOI 10.1152/ajplung.00165.2005; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NERUP J, 1988, DIABETES CARE, V11, P16; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Nevo U, 2003, TRENDS MOL MED, V9, P88, DOI 10.1016/S1471-4914(03)00024-8; Nevo U, 2004, J THEOR BIOL, V227, P583, DOI 10.1016/j.jtbi.2003.11.031; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Topp B, 2000, J THEOR BIOL, V206, P605, DOI 10.1006/jtbi.2000.2150; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	24	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51909	10.1371/journal.pone.0051909	http://dx.doi.org/10.1371/journal.pone.0051909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251651	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800107
J	Papazi, A; Assimakopoulos, K; Kotzabasis, K				Papazi, Aikaterini; Assimakopoulos, Konstantinos; Kotzabasis, Kiriakos			Bioenergetic Strategy for the Biodegradation of p-Cresol by the Unicellular Green Alga Scenedesmus obliquus	PLOS ONE			English	Article							BACTERIAL-DEGRADATION; ALCALIGENES-EUTROPHUS; PHENOLIC-COMPOUNDS; CLEAVAGE PATHWAY; ADJUST; MICROALGAE; METHANOL; PSEUDOMONAS; CARBON; LIGHT	Cultures from the unicellular green alga Scenedesmus obliquus biodegrade the toxic p-cresol (4-methylphenol) and use it as alternative carbon/energy source. The biodegradation procedure of p-cresol seems to be a two-step process. HPLC analyses indicate that the split of the methyl group (first step) that is possibly converted to methanol (increased methanol concentration in the growth medium), leading, according to our previous work, to changes in the molecular structure and function of the photosynthetic apparatus and therefore to microalgal biomass increase. The second step is the fission of the intermediately produced phenol. A higher p-cresol concentration results in a higher p-cresol biodegradation rate and a lower total p-cresol biodegradability. The first biodegradation step seems to be the most decisive for the effectiveness of the process, because methanol offers energy for the further biodegradation reactions. The absence of LHCII from the Scenedesmus mutant wt-lhc stopped the methanol effect and significantly reduced the p-cresol biodegradation (only 9%). The present contribution deals with an energy distribution between microalgal growth and p-cresol biodegradation, activated by p-cresol concentration. The simultaneous biomass increase with the detoxification of a toxic phenolic compound (p-cresol) could be a significant biotechnological aspect for further applications. Citation: Papazi A, Assimakopoulos K, Kotzabasis K (2012) Bioenergetic Strategy for the Biodegradation of p-Cresol by the Unicellular Green Alga Scenedesmus obliquus. PLoS ONE 7(12): e51852. doi:10.1371/journal.pone.0051852	[Papazi, Aikaterini; Assimakopoulos, Konstantinos; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece	University of Crete	Kotzabasis, K (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365				Aaronson S., 1980, ALGAE BIOMASS PROD; Ahamad PYA, 1999, WORLD J MICROB BIOT, V15, P321, DOI 10.1023/A:1008821120432; BISCHOFF H, 1963, U TEXAS PUBL, V6318, P1, DOI DOI 10.1016/J.CEJ.2012.11.063; Bishop NL, 1971, PREPARATION PHOTOSYN; BRUCE NC, 1989, BIOCHEM J, V262, P303, DOI 10.1042/bj2620303; BUCKMAN NG, 1984, J CHROMATOGR, V284, P441, DOI 10.1016/S0021-9673(01)87845-6; DAGLEY S, 1957, BIOCHEM J, V66, P227, DOI 10.1042/bj0660227; DELIEU T, 1981, NEW PHYTOL, V89, P165, DOI 10.1111/j.1469-8137.1981.tb07480.x; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Diaz E, 2004, INT MICROBIOL, V7, P173; Gaffron H, 1939, BIOL ZENTRALBL, V43, P402; HAGGBLOM M, 1990, J BASIC MICROB, V30, P115, DOI 10.1002/jobm.3620300214; Holden M, 1965, CHLOROPHYLL CHEM BIO, P462; HUGHES EJL, 1983, J BACTERIOL, V154, P1363, DOI 10.1128/JB.154.3.1363-1370.1983; James MO, 1977, XENOBIOTIC METABOLIZ, P171; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; JOHNSON BF, 1971, J BACTERIOL, V107, P468, DOI 10.1128/JB.107.2.468-475.1971; Ke L, BIORESOUR TECHNOL, V101, P6961; KNACKMUSS HJ, 1978, ARCH MICROBIOL, V117, P1, DOI 10.1007/BF00689343; KOBAYASHI H, 1982, ENVIRON SCI TECHNOL, V16, pA170, DOI 10.1021/es00097a002; Komossa D, 1995, METABOLIC PROCESSES, P69; Kotzabasis K, 1999, J BIOTECHNOL, V70, P357, DOI 10.1016/S0168-1656(99)00088-7; Kuhl A, 1962, PHYSL SPEICHERUNG KO, P157; Lima SAC, 2004, WATER RES, V38, P97, DOI 10.1016/j.watres.2003.09.005; Lovell CR, 2002, MAR ECOL PROG SER, V229, P11, DOI 10.3354/meps229011; Lutz C, 2005, BBA-BIOENERGETICS, V1710, P24, DOI 10.1016/j.bbabio.2005.09.001; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P948, DOI 10.1016/j.bbabio.2007.05.003; Oswald W.J., 1957, T AM SOC CIV ENG, V122, P73, DOI [DOI 10.1061/TACEAT.0007483, 10.1061/TACEAT.0007483]; Papazi A, 2008, J BIOTECHNOL, V135, P366, DOI 10.1016/j.jbiotec.2008.05.009; Papazi A, 2007, J BIOTECHNOL, V129, P706, DOI 10.1016/j.jbiotec.2007.02.021; PIEPER DH, 1985, FEMS MICROBIOL LETT, V29, P63; Pinto G, 2002, BIOTECHNOL LETT, V24, P2047, DOI 10.1023/A:1021367304315; POWLOWSKI JB, 1985, J BACTERIOL, V163, P1126, DOI 10.1128/JB.163.3.1126-1135.1985; ROJO F, 1987, SCIENCE, V238, P1395, DOI 10.1126/science.3479842; Safonova E, 2005, ENG LIFE SCI, V5, P234, DOI 10.1002/elsc.200520077; Semple KT, 1996, APPL ENVIRON MICROB, V62, P1265, DOI 10.1128/AEM.62.4.1265-1273.1996; SENGER H, 1986, PHYSIOL PLANTARUM, V68, P119, DOI 10.1111/j.1399-3054.1986.tb06605.x; Sfichi L, 2004, PHOTOCHEM PHOTOBIOL, V80, P499, DOI 10.1562/0031-8655(2004)080<0499:TPATUS>2.0.CO;2; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; TAEGER K, 1988, APPL MICROBIOL BIOT, V28, P603, DOI 10.1007/BF00250420; Tallur PN, 2006, CURR MICROBIOL, V53, P529, DOI 10.1007/s00284-006-0309-x; Theodoridou A, 2002, BBA-GEN SUBJECTS, V1573, P189, DOI 10.1016/S0304-4165(02)00438-5; Thies F, 1996, PLANT PHYSIOL, V112, P361, DOI 10.1104/pp.112.1.361; WOOD PJ, 1971, ANAL BIOCHEM, V39, P418, DOI 10.1016/0003-2697(71)90432-5; Yan H, 2004, CHEMOSPHERE, V55, P1281, DOI 10.1016/j.chemosphere.2003.12.019	45	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51852	10.1371/journal.pone.0051852	http://dx.doi.org/10.1371/journal.pone.0051852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251641	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800098
J	Hornak, K; Corno, G				Hornak, Karel; Corno, Gianluca			Every Coin Has a Back Side: Invasion by Limnohabitans planktonicus Promotes the Maintenance of Species Diversity in Bacterial Communities	PLOS ONE			English	Article							SPRING PHYTOPLANKTON BLOOM; FRESH-WATER RESERVOIR; ECOSYSTEM ENGINEERS; IN-SITU; AEROMONAS-HYDROPHILA; BIOLOGICAL INVASIONS; PLANT INVASIONS; GROWTH; BACTERIOPLANKTON; PRODUCTIVITY	One of the earliest challenges for ecologists has been to study the impact of invasive species on microbial communities. Although bacteria are fundamental in biological processes, current knowledge on invasion effects by aquatic nonpathogenic bacteria is still limited. Using pure cultures of diverse planktonic bacteria as model organisms at two different carbon concentration levels, we tested the response of an assembled community to the invasion by Limnohabitans planktonicus, an opportunistic bacterium, successful in freshwaters. The invader, introduced at the early stationary growth phase of the resident community, caused a strong decrement of the abundance of the dominant species. This was due to competition for nutrients and a potential allelopathic interaction. Simultaneously, resident species formerly unable to successfully compete within the community, thus potentially exposed to competitive exclusion, increased their abundances. The overall result of the invasion was preservation of species diversity, the higher the lower was the substrate content available. Our study provides new insights into bacterial invasions, offering an alternative interpretation of invasions for community ecology.	[Hornak, Karel] Acad Sci Czech Republic, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Hornak, Karel] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Corno, Gianluca] CNR, Inst Ecosyst Study, Verbania, Italy	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Hornak, K (corresponding author), Acad Sci Czech Republic, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic.	hornak@hbu.cas.cz	Corno, Gianluca/K-1658-2018; CORNO, GIANLUCA/AAB-8889-2019	Corno, Gianluca/0000-0002-7423-8797; CORNO, GIANLUCA/0000-0002-7423-8797	CNR Institute of Ecosystem Study - Short Term mobility project; Czech Science Foundation [GAP504/10/1534]	CNR Institute of Ecosystem Study - Short Term mobility project; Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the CNR Institute of Ecosystem Study - Short Term mobility project 2011 awarded to G. C., and by the Czech Science Foundation under project GAP504/10/1534 awarded to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom JF, 2010, ENVIRON MICROBIOL, V12, P2486, DOI 10.1111/j.1462-2920.2010.02222.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Castilla JC, 2004, MAR ECOL PROG SER, V268, P119, DOI 10.3354/meps268119; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Corno G, 2008, J LIMNOL, V67, P107, DOI 10.4081/jlimnol.2008.107; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Davies KF, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P237; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Glockner FO, 1998, APPL ENVIRON MICROB, V64, P1895; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hervas A, 2009, ENVIRON MICROBIOL, V11, P1612, DOI 10.1111/j.1462-2920.2009.01926.x; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Hornak K, 2006, AQUAT MICROB ECOL, V45, P277, DOI 10.3354/ame045277; Hutchinson G. E., 1967, TREATISE LIMNOLOGY; Jagmann N, 2010, ENVIRON MICROBIOL, V12, P1787, DOI 10.1111/j.1462-2920.2010.02271.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; KRATZ TK, 1987, AM NAT, V129, P830, DOI 10.1086/284678; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; RIPPEY SR, 1980, MICROBIAL ECOL, V6, P45, DOI 10.1007/BF02020374; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wonham MJ, 2005, MAR ECOL PROG SER, V289, P109, DOI 10.3354/meps289109; Zeder M, 2009, ENVIRON MICROBIOL, V11, P2676, DOI 10.1111/j.1462-2920.2009.01994.x; Zotina T, 2003, FRESHWATER BIOL, V48, P1859, DOI 10.1046/j.1365-2427.2003.01134.x	49	16	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51576	10.1371/journal.pone.0051576	http://dx.doi.org/10.1371/journal.pone.0051576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251582	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313236200138
J	Le Tourneau, C; Gan, HK; Razak, ARA; Paoletti, X				Le Tourneau, Christophe; Gan, Hui K.; Razak, Albiruni R. A.; Paoletti, Xavier			Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents	PLOS ONE			English	Article							CANCER CLINICAL-TRIALS; CONTINUAL REASSESSMENT METHOD; TOXICITY; EFFICACY	Background: Statistical simulations have consistently demonstrated that new dose-escalation designs such as accelerated titration design (ATD) and continual reassessment method (CRM)-type designs outperform the standard "3+3" design in phase I cancer clinical trials. Methods: We evaluated the actual efficiency of different dose escalation methods employed in first-in-human phase I clinical trials of targeted agents administered as single agents published over the last decade. Results: Forty-nine per cent of the 84 retrieved trials used the standard "3+3" design. Newer designs used included ATD in 42%, modified CRM [mCRM] in 7%, and pharmacologically guided dose escalation in 1%. The median numbers of dose levels explored in trials using "3+3", ATD and mCRM designs were 6, 8 and 10, respectively. More strikingly, the mean MTD to starting dose ratio appeared to be at least twice as high for trials using mCRM or ATD designs as for trials using a standard "3+3" design. Despite this, the mean number of patients exposed to a dose below the MTD was similar in trials using "3+3", ATD and mCRM designs. Conclusion: Our results support a more extensive implementation of innovative dose escalation designs such as mCRM and ATD in phase I cancer clinical trials of molecularly targeted agents.	[Le Tourneau, Christophe] Inst Curie, Dept Med Oncol, Paris, France; [Gan, Hui K.] Austin Hosp, Joint Austin Ludwig Oncol Unit, Melbourne, Vic 3084, Australia; [Razak, Albiruni R. A.] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada; [Paoletti, Xavier] Inst Curie, Dept Biostat, Paris, France; [Le Tourneau, Christophe; Paoletti, Xavier] Inst Curie, INSERM, U900, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Florey Institute of Neuroscience & Mental Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Le Tourneau, C (corresponding author), Inst Curie, Dept Med Oncol, Paris, France.	Christophe.LeTourneau@curie.net	Abdul Razak, Albiruni Ryan/C-4608-2015; Gan, Hui/C-5407-2013	Abdul Razak, Albiruni Ryan/0000-0001-7657-9950; Gan, Hui/0000-0001-7319-8546	Institut National du Cancer [2010-1-PL SHS-06-IC-1]	Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by a grant from the Institut National du Cancer (#2010-1-PL SHS-06-IC-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; Eckhardt SG, 1999, P AM SOC CLIN ONCOL; Hunsberger S, 2005, STAT MED, V24, P2171, DOI 10.1002/sim.2102; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Le Tourneau C, 2011, EUR J CANCER, V47, P1468, DOI 10.1016/j.ejca.2011.03.016; Le Tourneau C, 2010, J CLIN ONCOL, V28, P1401, DOI 10.1200/JCO.2009.25.9606; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; O'Quigley J, 2003, BIOMETRICS, V59, P430, DOI 10.1111/1541-0420.00050; Postel-Vinay S, 2011, J CLIN ONCOL, V29, P1728, DOI 10.1200/JCO.2010.31.9236; Rogatko A, 2007, J CLIN ONCOL, V25, P4982, DOI 10.1200/JCO.2007.12.1012; Thall PF, 2004, BIOMETRICS, V60, P684, DOI 10.1111/j.0006-341X.2004.00218.x; Walling J, 1997, P AM SOC CLIN ONCOL; Yin GS, 2006, BIOMETRICS, V62, P777, DOI 10.1111/j.1541-0420.2006.00534.x; Zhang W, 2006, STAT MED, V25, P2365, DOI 10.1002/sim.2325	14	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51039	10.1371/journal.pone.0051039	http://dx.doi.org/10.1371/journal.pone.0051039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251419	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200055
J	Lui, NP; Chen, LW; Yung, WH; Chan, YS; Yung, KKL				Lui, Nga-Ping; Chen, Liang-Wei; Yung, Wing-Ho; Chan, Ying-Shing; Yung, Ken Kin-Lam			Endogenous Repair by the Activation of Cell Survival Signalling Cascades during the Early Stages of Rat Parkinsonism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ASTROCYTES IN-SITU; NEUROTROPHIC FACTOR; BASAL GANGLIA; NEURODEGENERATIVE DISEASE; DOPAMINERGIC-NEURONS; REACTIVE ASTROCYTES; SPLICE VARIANTS; GENE-EXPRESSION; UP-REGULATION	Here we report a previously unknown self repair mechanism during extremely early stages of rat Parkinsonism. Two important cell survival signaling cascades, Phosphatidylinositol-3 kinases (PI3K)/Akt pathway and extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathway, could be responsible for this potential endogenous rescue system. In the 6-hydroxydopamine-lesioned rat, the phosphorylated p44/42 MAPK and its downstream target, the phosphorylated Bad at Ser 112, were up-regulated at post-lesion day 3 and lasted for a couple of weeks. Although the change in the phosphorylated Akt kinase was negligible throughout the studied period, its downstream target, the phosphorylated Bad at 136, was increased from post-lesion day 3 to post-lesion day 14. In the mean time, nestin-positive reactive astrocytes with low levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) appeared at post-lesion day 3 in 6-hydroxydopamine-lesioned rat. BDNF was expressed in both striatum and substantia nigra whereas GDNF was displayed in striatum only. At post-lesion day 14, nestin, BDNF and GDNF expressions were diminished. These neurotrophic factors were believed to initiate the above anti-apoptotic signal transduction cascades as we could see that their expression patterns were similar. The data strongly suggest that there is an endogenous repair effort by evoking the cell survival signaling and possibly via the releases of BDNF and GDNF from nestin-immunoreactive reactive astrocytes. ERK/MAPK pathway was proposed to be the key endogenous neuroprotective mechanisms, particularly in early stages of rat Parkinsonism. However, the self repair effort is only functional within an extremely short time window immediately after onset.	[Lui, Nga-Ping; Yung, Ken Kin-Lam] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Chen, Liang-Wei] Forth Mil Med Univ, Inst Neurosci, Xiangtan, Peoples R China; [Yung, Wing-Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Dept Physiol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Air Force Military Medical University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong	Yung, KKL (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China.	kklyung@hkbu.edu.hk	Yung, Ho/R-6161-2018	Yung, Ho/0000-0002-5542-8173; Chan, Ying Shing/0000-0002-6228-1595; Yung, Ken KL/0000-0002-9588-2573	Hong Kong Baptist University [IRMC/12-13/1C-BIOL]; Hong Kong Research Grants Council [HKBU 212607]; National Natural Science Foundation of China [81271455]	Hong Kong Baptist University; Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by Hong Kong Baptist University (Interdisciplinary Research Scheme IRMC/12-13/1C-BIOL-YUNG KL) Hong Kong Research Grants Council (HKBU 212607) and National Natural Science Foundation of China (81271455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Blum D, 2001, BIOCHEM PHARMACOL, V62, P473, DOI 10.1016/S0006-2952(01)00680-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Chen LW, 2005, CURR DRUG TARGETS, V6, P821, DOI 10.2174/138945005774574506; Chen LW, 2004, NEUROSCIENCE, V126, P941, DOI 10.1016/j.neuroscience.2004.04.020; Chen LW, 2002, BRAIN RES, V925, P9, DOI 10.1016/S0006-8993(01)03253-X; Chlocco MJ, 2007, PARKINSONISM RELAT D, V13, pS321, DOI 10.1016/S1353-8020(08)70024-5; Collier TJ, 2005, EXP NEUROL, V191, pS60, DOI 10.1016/j.expneurol.2004.08.018; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Dodel RC, 1999, MOL BRAIN RES, V64, P141, DOI 10.1016/S0169-328X(98)00318-0; Duffy HS, 2000, J NEUROSCI, V20; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hamner S, 2001, MOL CELL NEUROSCI, V17, P97, DOI 10.1006/mcne.2000.0905; Henning J, 2008, NEUROSCI RES, V62, P246, DOI 10.1016/j.neures.2008.09.001; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Ho R, 2002, CANCER RES, V62, P6462; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jaboin J, 2002, CANCER RES, V62, P6756; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim YS, 2010, EPILEPSY RES, V92, P30, DOI 10.1016/j.eplepsyres.2010.08.004; Lev N, 2003, PROG NEURO-PSYCHOPH, V27, P245, DOI 10.1016/S0278-5846(03)00019-8; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2004, BRAIN PATHOL, V14, P275; Neff F, 2002, ANN NY ACAD SCI, V973, P70, DOI 10.1111/j.1749-6632.2002.tb04608.x; Nozaki C, 1998, ONCOGENE, V16, P293, DOI 10.1038/sj.onc.1201548; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Oh-Hashi K, 2006, NEUROSCI LETT, V405, P100, DOI 10.1016/j.neulet.2006.06.027; Oiwa Y, 2003, J NEUROSURG, V98, P136, DOI 10.3171/jns.2003.98.1.0136; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rodriguez M, 2001, EXP NEUROL, V169, P163, DOI 10.1006/exnr.2000.7624; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sgambato V, 2003, J NEUROCHEM, V86, P153, DOI 10.1046/j.1471-4159.2003.01816.x; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	67	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51294	10.1371/journal.pone.0051294	http://dx.doi.org/10.1371/journal.pone.0051294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251488	Green Published, gold			2022-12-25	WOS:000313236200086
J	Sabri, F; Boughter, JD; Gerth, D; Skalli, O; Phung, TCN; Tamula, GRM; Leventis, N				Sabri, Firouzeh; Boughter, John D., Jr.; Gerth, David; Skalli, Omar; Phung, Thien-Chuong N.; Tamula, George-Rudolph M.; Leventis, Nicholas			Histological Evaluation of the Biocompatibility of Polyurea Crosslinked Silica Aerogel Implants in a Rat Model: A Pilot Study	PLOS ONE			English	Article							RESPONSIVE CONTROLLED-RELEASE; DELIVERY-SYSTEMS; PORE-SIZE; NANOPARTICLES; POROSITY; BIOMATERIALS; SCAFFOLDS; MATRICES; DESIGN; DNA	Background: Aerogels are a versatile group of nanostructured/nanoporous materials with physical and chemical properties that can be adjusted to suit the application of interest. In terms of biomedical applications, aerogels are particularly suitable for implants such as membranes, tissue growth scaffolds, and nerve regeneration and guidance inserts. The mesoporous nature of aerogels can also be used for diffusion based release of drugs that are loaded during the drying stage of the material. From the variety of aerogels polyurea crosslinked silica aerogels have the most potential for future biomedical applications and are explored here. Methodology: This study assessed the short and long term biocompatibility of polyurea crosslinked silica aerogel implants in a Sprague-Dawley rat model. Implants were inserted at two different locations a) subcutaneously (SC), at the dorsum and b) intramuscularly (IM), between the gluteus maximus and biceps femoris of the left hind extremity. Nearby muscle and other internal organs were evaluated histologically for inflammation, tissue damage, fibrosis and movement (travel) of implant. Conclusion/Significance: In general polyurea crosslinked silica aerogel (PCSA) was well tolerated as a subcutaneous and an intramuscular implant in the Sprague-Dawley rat with a maximum incubation time of twenty months. In some cases a thin fibrous capsule surrounded the aerogel implant and was interpreted as a normal response to foreign material. No noticeable toxicity was found in the tissues surrounding the implants nor in distant organs. Comparison was made with control rats without any implants inserted, and animals with suture material present. No obvious or noticeable changes were sustained by the implants at either location. Careful necropsy and tissue histology showed age-related changes only. An effective sterilization technique for PCSA implants as well as staining and sectioning protocol has been established. These studies further support the notion that silica-based aerogels could be useful as biomaterials.	[Sabri, Firouzeh; Phung, Thien-Chuong N.; Tamula, George-Rudolph M.] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Boughter, John D., Jr.] UTHSC, Dept Anat & Neurobiol, Memphis, TN USA; [Gerth, David] UTHSC, Dept Otolaryngol Head & Neck Surg, Memphis, TN USA; [Skalli, Omar] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA	University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Missouri System; Missouri University of Science & Technology	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu	Skalli, Omar/D-4980-2013		FedEx Institute of Technology, University of Memphis	FedEx Institute of Technology, University of Memphis	The first author would like to thank the FedEx Institute of Technology, University of Memphis, for finanical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Boccaccini AR, 1998, J MATER SCI LETT, V17, P1273, DOI 10.1023/A:1006503524162; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Doherty P, 2009, BIOMEDICAL MATERIALS, P201, DOI 10.1007/978-0-387-84872-3_7; Dunn B, 1998, ACTA MATER, V46, P737, DOI 10.1016/S1359-6454(97)00254-1; Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819; Giri S, 2007, NANOMEDICINE-UK, V2, P99, DOI 10.2217/17435889.2.1.99; Hrubesh LW, 1998, J NON-CRYST SOLIDS, V225, P335, DOI 10.1016/S0022-3093(98)00135-5; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Jahanshahi M, 2008, AFR J BIOTECHNOL, V7, P4926; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358; Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l; Leventis N, 2002, NANO LETT, V2, P957, DOI 10.1021/nl025690e; Leventis N, 2007, ACCOUNTS CHEM RES, V40, P874, DOI 10.1021/ar600033s; Leveson NG, 2011, ENG SYST, P251; Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0; Liu HY, 2012, NANOSCALE, V4, P3523, DOI 10.1039/c2nr30396e; Lyons L, 1999, 76 ANN M SE SECT APS, V54; Park JC, 1999, YONSEI MED J, V40, P530, DOI 10.3349/ymj.1999.40.6.530; Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9; Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0; Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101; Sabri F, 2011, ADV SPACE RES, V47, P419, DOI 10.1016/j.asr.2010.09.014; Sabri F, 2011, P 3 ANN ORNL BIOM SC; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242; Schneider M, 1997, CATAL TODAY, V35, P339, DOI 10.1016/S0920-5861(96)00164-2; Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926; Slack M, 2006, INT UROGYNECOL J, V17, P106, DOI 10.1007/s00192-005-1320-7; Smirnova I, 2004, J NON-CRYST SOLIDS, V350, P54, DOI 10.1016/j.jnoncrysol.2004.06.031; SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269; Thomas V, 2006, CURR NANOSCI, V2, P155; Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yin W, 2010, J BIOMED MATER RES A, V92A, P1431, DOI 10.1002/jbm.a.32476	36	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50686	10.1371/journal.pone.0050686	http://dx.doi.org/10.1371/journal.pone.0050686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251378	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200035
J	Wei, H; Kamat, AM; Aldousari, S; Ye, YQ; Huang, MS; Dinney, CP; Wu, XF				Wei, Hua; Kamat, Ashish M.; Aldousari, Saad; Ye, Yuanqing; Huang, Maosheng; Dinney, Colin P.; Wu, Xifeng			Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk	PLOS ONE			English	Article							COLORECTAL-CANCER; FACTOR-C; BREAST-CANCER; RECEPTOR; EXPRESSION; APOPTOSIS; VARIANTS; CELLS; TGFBR1-ASTERISK-6A; ASSOCIATION	Bladder cancer is the fifth most common cancer in the United States, and identifying genetic markers that may predict susceptibility in high-risk population is always needed. The purpose of our study is to determine whether genetic variations in the transforming growth factor-beta (TGF-beta) pathway are associated with bladder cancer risk. We identified 356 single-nucleotide polymorphisms (SNPs) in 37 key genes from this pathway and evaluated their association with cancer risk in 801 cases and 801 controls. Forty-one SNPs were significantly associated with cancer risk, and after adjusting for multiple comparisons, 9 remained significant (Q-value <= 0.1). Haplotype analysis further revealed three haplotypes within VEGFC and two haplotypes in EGFR were significantly associated with increased bladder cancer risk compared to the most common haplotype. Classification and regression tree analysis further revealed potential high-order gene-gene interactions, with VEGFC: rs3775194 being the initial split, which suggests that this variant is responsible for the most variation in risk. Individuals carrying the common genotype for VEGFC: rs3775194 and EGFR: rs7799627 and the variant genotype for VEGFR: rs4557213 had a 4.22-fold increase in risk, a much larger effect magnitude than that conferred by common genotype for VEGFR: rs4557213. Our study provides the first epidemiological evidence supporting a connection between TGF-beta pathway variants and bladder cancer risk.	[Wei, Hua; Ye, Yuanqing; Huang, Maosheng; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Kamat, Ashish M.; Aldousari, Saad; Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org		Dinney, Colin/0000-0002-8969-711X	National Institutes of Health [U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; NATIONAL CANCER INSTITUTE [P50CA091846, R01CA074880, R01CA131335, U01CA127615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335) (www.NIH.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2006, ONCOL REP, V15, P653; Bian Y, 2005, J CLIN ONCOL, V23, P3074, DOI 10.1200/JCO.2005.00.281; Carvajal-Carmona LG, 2010, P NATL ACAD SCI USA, V107, P7858, DOI 10.1073/pnas.1002816107; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fujimoto J, 2004, BRIT J CANCER, V91, P466, DOI 10.1038/sj.bjc.6601963; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hou Y, 2011, CELL MOL NEUROBIOL, V31, P7, DOI 10.1007/s10571-010-9530-z; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Li Y, INT UROL NEPHROL, V42, P315; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Motyl T, 1998, EUR J CELL BIOL, V75, P367, DOI 10.1016/S0171-9335(98)80070-8; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Okamoto M, 1997, CELL GROWTH DIFFER, V8, P921; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Shida Atsuo, 2006, Int J Clin Oncol, V11, P38, DOI 10.1007/s10147-005-0528-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skoglund J, 2007, CLIN CANCER RES, V13, P3748, DOI 10.1158/1078-0432.CCR-06-2865; Sriplakich S, 1999, BJU INT, V83, P498; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Wu XF, 2008, BJU INT, V102, P1207, DOI 10.1111/j.1464-410X.2008.07961.x; Wu XF, 2007, FRONT BIOSCI-LANDMRK, V12, P192, DOI 10.2741/2058; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Zachos I, 2010, EXPERT OPIN INV DRUG, V19, P875, DOI 10.1517/13543784.2010.496450; Zhang ZZ, 2008, CARCINOGENESIS, V29, P1973, DOI 10.1093/carcin/bgn183; Zu XB, 2006, BJU INT, V98, P1090, DOI 10.1111/j.1464-410X.2006.06446.x	28	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51758	10.1371/journal.pone.0051758	http://dx.doi.org/10.1371/journal.pone.0051758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251617	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200162
J	Li, X; Tian, XB; Zhang, B; Zhang, YQ; Chen, JP				Li, Xi; Tian, Xiaobo; Zhang, Bo; Zhang, Yanqi; Chen, Jieping			Variation in Dicer Gene Is Associated with Increased Survival in T-Cell Lymphoma	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; LUNG-CANCER; PROGNOSIS; DROSHA; IDENTIFICATION; RECURRENCE; BAFF	Dicer, an endonuclease in RNase III family, is essential for the RNA interference (RNAi) pathway. Aberrant expression of Dicer has been shown in various cancers including some subtypes of T cell lymphoma (TCL), which influences patient prognosis. A single-nucleotide polymorphism (SNP) rs3742330A>G has been identified in the Dicer gene, located in the 3' untranslated region (3' UTR) that is important for mRNA transcript stability. We investigated whether rs3742330 is associated with the survival in 163 TCL patients. Significant association between Dicer rs3742330 and TCL survival were found. Patients carrying the GG genotype (n = 12) had a significantly increased overall survival (OS) compared with those carrying the GA and AA genotypes (n = 70 and n = 81, respectively; p = 0.031). Moreover, the significant association was maintained for patients with mature T type (n = 134; p = 0.026). In multivariate Cox-regression analysis, rs3742330 proved to be an independent predictor for OS, together with the commonly used International Prognostic Index (IPI) and BAFF rs9514828, another SNP we have previously reported to be associated with TCL survival, with hazard ratios (HRs) for patient death rate of 8.956 (95% CI, 1.210 to 66.318; p = 0.032) for the GA genotype and 10.145 (95% CI, 1.371 to 75.084; p = 0.023) for the AA genotype. Furthermore, we observed cumulative effects of Dicer rs3742330 and BAFF rs9514828 on TCL survival. Compared with patients carrying zero unfavorable genotype, those carrying one and two unfavorable genotypes had an increased risk of death with a HR of 7.104 (95% CI, 0.969-53.086; p = 0.054) and 14.932 (95% CI, 1.950-114.354; p = 0.009), respectively, with a significant dose-response trend (p(trend) = 0.004). In conclusion, Dicer rs3742330 is associated with TCL survival, suggesting that genetic variation might play a role in predicting prognosis of TCL patients.	[Li, Xi; Tian, Xiaobo; Zhang, Bo; Chen, Jieping] Third Mil Med Univ, Southwest Hosp, Dept Hematol, Chongqing, Peoples R China; [Zhang, Yanqi] Third Mil Med Univ, Dept Hlth Stat, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chen, JP (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hematol, Chongqing, Peoples R China.	chenjpxn@yahoo.com.cn		Li, Xi/0000-0001-7106-1677	National Natural Science Foundation of China [NSFC 81270605, 30971066]; Chongqing Natural Science Fund Project [2008BA5001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Fund Project	This work was supported by the National Natural Science Foundation of China (NSFC 81270605, 30971066) and the Chongqing Natural Science Fund Project (2008BA5001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; de Haas EC, 2008, J CLIN ONCOL, V26, P1817, DOI 10.1200/JCO.2007.14.1606; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kwong YL, 2009, LANCET ONCOL, V10, P1093, DOI 10.1016/S1470-2045(09)70265-7; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Nuckel H, 2007, BLOOD, V109, P290, DOI 10.1182/blood-2006-03-007567; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Piccaluga PP, 2010, CURR HEMATOL MALIG R, V5, P222, DOI 10.1007/s11899-010-0062-x; Rizvi MA, 2006, BLOOD, V107, P1255, DOI 10.1182/blood-2005-03-1306; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Suzumiya J, 2009, ANN ONCOL, V20, P715, DOI 10.1093/annonc/mdn696; Valencak J, 2011, J DERMATOL SCI, V64, P185, DOI 10.1016/j.jdermsci.2011.08.011; van Kester MS, 2011, MOL ONCOL, V5, P273, DOI 10.1016/j.molonc.2011.02.003; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yang QP, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-77; Zhai K, 2012, CLIN CANCER RES, V18, P2250, DOI 10.1158/1078-0432.CCR-11-3009; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	45	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51640	10.1371/journal.pone.0051640	http://dx.doi.org/10.1371/journal.pone.0051640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251602	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900111
J	Pacioni, S; Rueger, MA; Nistico, G; Bornstein, SR; Park, DM; McKay, RD; Androutsellis-Theotokis, A				Pacioni, Simone; Rueger, Maria Adele; Nistico, Giuseppe; Bornstein, Stefan R.; Park, Deric M.; McKay, Ron D.; Androutsellis-Theotokis, Andreas			Fast, Potent Pharmacological Expansion of Endogenous Hes3+/Sox2+Cells in the Adult Mouse and Rat Hippocampus	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEUROGENESIS IN-VITRO; SUBVENTRICULAR ZONE; GROWTH-FACTOR; PROGENITOR PROLIFERATION; DENTATE GYRUS; MAMMALIAN FOREBRAIN; HUNTINGTONS-DISEASE; GENE-EXPRESSION	The adult hippocampus is involved in learning and memory. As a consequence, it is a brain region of remarkable plasticity. This plasticity exhibits itself both as cellular changes and neurogenesis. For neurogenesis to occur, a population of local stem cells and progenitor cells is maintained in the adult brain and these are able to proliferate and differentiate into neurons which contribute to the hippocampal circuitry. There is much interest in understanding the role of immature cells in the hippocampus, in relation to learning and memory. Methods and mechanisms that increase the numbers of these cells will be valuable in this research field. We show here that single injections of soluble factors into the lateral ventricle of adult rats and mice induces the rapid (within one week) increase in the number of putative stem cells/progenitor cells in the hippocampus. The established progenitor marker Sox2 together with the more recently established marker Hes3, were used to quantify the manipulation of the Sox2/Hes3 double-positive cell population. We report that in both adult rodent species, Sox2+/Hes3+ cell numbers can be increased within one week. The most prominent increase was observed in the hilus of the dentate gyrus. This study presents a fast, pharmacological method to manipulate the numbers of endogenous putative stem cells/progenitor cells. This method may be easily modified to alter the degree of activation (e. g. by the use of osmotic pumps for delivery, or by repeat injections through implanted cannulas), in order to be best adapted to different paradigms of research (neurodegenerative disease, neuroprotection, learning, memory, plasticity, etc).	[Pacioni, Simone; Nistico, Giuseppe; Androutsellis-Theotokis, Andreas] European Brain Res Inst, Rome, Italy; [Rueger, Maria Adele] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Univ Dresden, Dept Med, Dresden, Germany; [Park, Deric M.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [McKay, Ron D.] Lieber Inst Brain Dev, Baltimore, MD USA; [Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, Dresden, Germany	University of Cologne; Technische Universitat Dresden; University of Virginia; Technische Universitat Dresden	Androutsellis-Theotokis, A (corresponding author), European Brain Res Inst, Rome, Italy.	Andreas.Theotokis@uniklinikum-dresden.de	Park, Deric/C-5675-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	Else Kroener-Fresenius-Stiftung [060_3636]; Center for Regenerative Therapies Dresden (CRTD) [043_267598]; National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH); European Brain Research Institute (EBRI-Rome)	Else Kroener-Fresenius-Stiftung; Center for Regenerative Therapies Dresden (CRTD); National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); European Brain Research Institute (EBRI-Rome)	This work was supported by a grant from the Else Kroener-Fresenius-Stiftung (060_3636), and a grant from the Center for Regenerative Therapies Dresden (CRTD, 043_267598) to AAT, as well as the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH), and the European Brain Research Institute (EBRI-Rome). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010841; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Artegiani B, 2011, J EXP MED, V208, P937, DOI 10.1084/jem.20102167; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kittappa R, 2012, MOL NEUROBIOL; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Latini L, 2010, J NEUROSCI RES, V88, P500, DOI 10.1002/jnr.22238; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JL, 1998, J NEUROSCI, V18, P7768; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rajan P, 1998, J NEUROSCI, V18, P3620; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Wexler E, 2002, TRENDS NEUROSCI, V25, P225, DOI 10.1016/S0166-2236(02)02153-7; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	76	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51630	10.1371/journal.pone.0051630	http://dx.doi.org/10.1371/journal.pone.0051630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251599	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900110
J	Radyuk, SN; Klichko, VI; Michalak, K; Orr, WC				Radyuk, Svetlana N.; Klichko, Vladimir I.; Michalak, Katarzyna; Orr, William C.			The effect of peroxiredoxin 4 on fly physiology is a complex interplay of antioxidant and signaling functions	FASEB JOURNAL			English	Article						aging; stress response; signaling pathways; apoptosis	NF-KAPPA-B; ER-OVERLOAD RESPONSE; DROSOPHILA-MELANOGASTER; OXIDATIVE STRESS; GENE FAMILY; CELL-DEATH; IV; EXPRESSION; PROTEIN; OVEREXPRESSION	Peroxiredoxin 4 (Prx4) has been implicated in a wide variety of biological processes, including development, progression of cancer, inflammation, and antioxidant function. The purpose of this study was to provide further insight into its multiple roles at the whole-animal level, using Drosophila. Reduced expression of dPrx4 (up to 90%) resulted in greater sensitivity to oxidative stress, an elevated H2O2 flux, and increases in lipid peroxidation, but no effect on longevity. Overexpression at low levels (<2-fold) gave reduced levels of oxidative damage and tended to show an increase in longevity. Flies expressing dPrx4 globally at high levels (>5-fold) had a dramatically reduced life span (by 20-80%) and increased apoptosis. Analysis of these overexpressors revealed an aberrant redistribution of the dPrx4 protein from the endoplasmic reticulum (ER) to cytosol and hemolymph. In addition to the known proapoptotic effects of the cytosolic form of dPrx4, dPrx4 overexpression triggered an NF-kappa B-mediated proinflammatory response, similar to that observed in cells under ER stress or when microbially challenged. Finally, we provide the first evidence that dPrx4, on secretion into the hemolymph, elicits a JAK/STAT-mediated response. The effects on fly survival and homeostasis appear to represent a combination of differential effects dictated in large part by dPrx4 subcellular and tissue-specific localization.-Radyuk, S. N., Klichko, V. I., Michalak, K., Orr, W. C. The effect of peroxiredoxin 4 on fly physiology is a complex interplay of antioxidant and signaling functions. FASEB J. 27, 1426-1438 (2013). www.fasebj.org	[Radyuk, Svetlana N.; Klichko, Vladimir I.; Michalak, Katarzyna; Orr, William C.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	Orr, WC (corresponding author), 6501 Airline Rd,Rm 113, Dallas, TX 75275 USA.	borr@smu.edu		Radyuk, Svetlana/0000-0002-3467-5255	National Institute on Aging, U.S. National Institutes of Health [RO1 AG15122, R01 AG032342]; NATIONAL INSTITUTE ON AGING [R01AG015122, R01AG032342] Funding Source: NIH RePORTER	National Institute on Aging, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants RO1 AG15122 (W.C.O.) and R01 AG032342 (S.N.R.) from the National Institute on Aging, U.S. National Institutes of Health.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P1479, DOI 10.1016/S0960-9822(01)00452-3; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Haridas V, 1998, J IMMUNOL, V161, P1; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kuang E, 2005, J CELL PHYSIOL, V204, P549, DOI 10.1002/jcp.20340; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matsuki S, 2002, REDOX REP, V7, P276, DOI 10.1179/135100002125000785; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Michalak K, 2008, BIOCHEM BIOPH RES CO, V368, P273, DOI 10.1016/j.bbrc.2008.01.052; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Palande K, 2011, J CELL SCI, V124, P3695, DOI 10.1242/jcs.089656; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Radyuk SN, 2010, FREE RADICAL BIO MED, V49, P1892, DOI 10.1016/j.freeradbiomed.2010.09.014; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Shikama N, 1996, GERONTOLOGY, V42, P123; Sowell RA, 2007, J PROTEOME RES, V6, P3637, DOI 10.1021/pr070224h; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tenev T, 2002, EMBO J, V21, P5118, DOI 10.1093/emboj/cdf530; Toroser D, 2007, BIOCHEM BIOPH RES CO, V363, P418, DOI 10.1016/j.bbrc.2007.08.193; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	39	26	29	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1426	1438		10.1096/fj.12-214106	http://dx.doi.org/10.1096/fj.12-214106			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271054	Green Published			2022-12-25	WOS:000316940800015
J	Gururaj, AE; Gibson, L; Panchabhai, S; Bai, MH; Manyam, G; Lu, Y; Latha, K; Rojas, ML; Hwang, Y; Liang, SD; Bogler, O				Gururaj, Anupama E.; Gibson, Laura; Panchabhai, Sonali; Bai, MingHui; Manyam, Ganiraju; Lu, Yue; Latha, Khatri; Rojas, Marta L.; Hwang, Yeohyeon; Liang, Shoudan; Bogler, Oliver			Access to the Nucleus and Functional Association with c-Myc Is Required for the Full Oncogenic Potential of Delta EGFR/EGFRvIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROGNOSTIC VALUE; BREAST-CANCER; EGF RECEPTOR; EXPRESSION; ACTIVATION; GLIOMA; LOCALIZATION; INTERACTS; SEQUENCE	Delta EGFR is a potent glioblastoma oncogene which has been studied primarily as a plasma membrane kinase. Using intracranial xenograft studies in mice, we show that blocking Delta EGFR access to the nucleus attenuates its tumorigenicity and, conversely, that promoting nuclear accumulation enhances this, providing the first in vivo evidence that the nuclear actions of Delta EGFR contribute strongly to its oncogenic function. Nuclear actions of Delta EGFR include regulation of gene expression by participation in chromatin-bound complexes, and genome-wide mapping of these sequences by chromatin immunoprecipitation and massively parallel sequencing identified 2294 peaks. Bioinformatic analysis showed enrichment of the E-box motif in the dataset, and c-Myc and Delta EGFR were corecruited to the promoters of and transcriptionally activated a subset of nuclear Delta EGFR chromatin targets. Knockdown of c-Myc decreased the expression of these targets and diminished Delta EGFR-stimulated anchorage-independent colony formation. We conclude that transcriptional regulation of target genes by association with gene regulatory chromatin in cooperation with c-Myc by nuclear Delta EGFR makes a unique contribution to its oncogenicity and propose that this venue provides new targets for therapeutic intervention.	[Gururaj, Anupama E.; Gibson, Laura; Bai, MingHui; Latha, Khatri; Rojas, Marta L.; Hwang, Yeohyeon; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Panchabhai, Sonali] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Manyam, Ganiraju; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lu, Yue] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Rojas, Marta L.; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gururaj, AE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, 6767 Bertner Ave, Houston, TX 77030 USA.	aegururaj@mdanderson.org	Manyam, Ganiraju/E-9150-2012; Manyam, Ganiraju C/B-5890-2014	Manyam, Ganiraju/0000-0001-6006-8961; Lu, Yue/0000-0002-5479-9095; Bogler, Oliver/0000-0002-3700-0480	National Cancer Institute National Institutes of Health [RO1CA108500, P50CA127001]; M.D. Anderson Cancer Center Core Grant [NCI CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA108500, P50CA127001] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); M.D. Anderson Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Cancer Institute National Institutes of Health Grants RO1CA108500 (to O. B.) and P50CA127001 (to O. B. and A. E. G.). This work was also supported by M.D. Anderson Cancer Center Core Grant NCI CA016672, including the DNA Analysis facility.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Kajiwara Y, 2008, TECHNOL CANCER RES T, V7, P329, DOI 10.1177/153303460800700407; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Latha K, 2013, INT J CANCER, V132, P509, DOI 10.1002/ijc.27690; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Psyrri A, 2008, CANCER EPIDEM BIOMAR, V17, P1486, DOI 10.1158/1055-9965.EPI-07-2684; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Shingu T, 2010, NEURO-ONCOLOGY, V12, P1269, DOI 10.1093/neuonc/noq095; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3428	3438		10.1074/jbc.M112.399352	http://dx.doi.org/10.1074/jbc.M112.399352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250739	Green Published, hybrid			2022-12-25	WOS:000314397900047
J	Irie, A; Harada, K; Araki, N; Nishimura, Y				Irie, Atsushi; Harada, Kumiko; Araki, Norie; Nishimura, Yasuharu			Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A	PLOS ONE			English	Article							T-CELL-CLONE; C-MU; ACTIVATION; REGULATOR; APOPTOSIS; PEPTIDE; RAF-1; PROLIFERATION; ASSOCIATION; DETERMINES	We previously reported that protein kinase D2 (PKD2) in T cells is promptly activated after T-cell receptor (TCR) stimulation and involved in the activation of interleukin-2 promoter and T cell death, and that one of its candidate substrate is SET protein, a natural inhibitor for protein phosphatase 2A (PP2A). In this study, we investigated the target amino acid residues of SET phosphorylated by PKD2 and the effects of phosphorylation of SET on PP2A phosphatase activity. In vitro kinase assay using various recombinant SET mutants having Ser/Thr to Ala substitutions revealed that Ser171 of SET is one of the sites phosphorylated by PKD2. Recombinant SET with phosphorylation-mimic Ser171 to Glu substitution reduced its inhibitory effects on PP2A phosphatase activity compared with Ser171 to Ala substituted or wild-type SET. In addition, knockdown of PKD2 in Jurkat cells by RNAi or treatment of human CD4(+) T cell clone with the PKD2 inhibitor Go6976 resulted in reduced PP2A activity after TCR-stimulation judged from phosphorylation status of Tyr307 of the catalytic subunit of PP2A. These results suggest that PKD2 is involved in the regulation of PP2A activity in activated T cells through phosphorylation of Ser171 of SET. Citation: Irie A, Harada K, Araki N, Nishimura Y (2012) Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A. PLoS ONE 7(12): e51242. doi:10.1371/journal.pone.0051242	[Irie, Atsushi; Harada, Kumiko; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Honjo, Kumamoto, Japan; [Araki, Norie] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Honjo, Kumamoto, Japan	Kumamoto University; Kumamoto University	Nishimura, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Honjo, Kumamoto, Japan.	mxnishim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15510165, 17510167, 20510191]; Grants-in-Aid for Scientific Research [23510243] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C) 15510165, 17510167 and 20510191 from Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen J, 2011, CARCINOGENESIS, V32, P1198, DOI 10.1093/carcin/bgr113; Chen YZ, 1996, J IMMUNOL, V157, P3783; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Irie A, 2003, EUR J IMMUNOL, V33, P1497, DOI 10.1002/eji.200323618; Irie A, 2006, INT IMMUNOL, V18, P1737, DOI 10.1093/intimm/dxl108; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kim JR, 2006, BIOCHEM BIOPH RES CO, V341, P19, DOI 10.1016/j.bbrc.2005.12.143; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li MF, 1999, J MOL BIOL, V293, P1067, DOI 10.1006/jmbi.1999.3207; Liu P, 2007, FEBS LETT, V581, P1377, DOI 10.1016/j.febslet.2007.02.055; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	40	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51242	10.1371/journal.pone.0051242	http://dx.doi.org/10.1371/journal.pone.0051242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251465	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800032
J	Shah, A; Silverstein, PS; Kumar, S; Singh, DP; Kumar, A				Shah, Ankit; Silverstein, Peter S.; Kumar, Santosh; Singh, Dhirendra P.; Kumar, Anil			Synergistic Cooperation between Methamphetamine and HIV-1 gsp120 through the P13K/Akt Pathway Induces IL-6 but not IL-8 Expression in Astrocytes	PLOS ONE			English	Article							KAPPA-B PATHWAY; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; CEREBROSPINAL-FLUID; NEURONAL APOPTOSIS; FACTOR-ALPHA; CODON USAGE; PROTEIN TAT; P38 MAPK	HIV-1 envelope protein gp120 has been extensively studied for neurotoxic effects that have been attributed to the increased expression of various proinflammatory cytokines in the CNS. Recently we have shown that methamphetamine (MA) also increases expression of proinflammatory cytokines in astrocytes. However, combined effect of gp120 and MA is not known. The present study was undertaken to determine cumulative effect and the mechanism(s)/pathways involved in the functional interaction between gp120 and MA in SVGA astrocytes. Our results clearly suggest that gp120 and MA affect IL-6 but not IL-8 in a synergistic manner and this synergy was mediated by PI3K/Akt and NF-kB pathways. Inhibition of either of these pathways could abrogate the increased expression of IL-6 due to MA or gp120 alone, as well as the increased expression of IL-6 when the astrocytes were treated with both gp120 and MA. These results were confirmed by both, using chemical inhibitors/siRNA as well as western blotting. This study therefore provides novel information regarding the interaction between MA and gp120 in terms of the expression of IL-6 and the mechanisms underlying potential synergy between MA and gp120 in astrocytes. Citation: Shah A, Silverstein PS, Kumar S, Singh DP, Kumar A (2012) Synergistic Cooperation between Methamphetamine and HIV-1 gsp120 through the P13K/Akt Pathway Induces IL-6 but not IL-8 Expression in Astrocytes. PLoS ONE 7(12): e52060. doi:10.1371/journal.pone.0052060	[Shah, Ankit; Silverstein, Peter S.; Kumar, Santosh; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA; [Singh, Dhirendra P.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Missouri System; University of Missouri Kansas City; University of Nebraska System; University of Nebraska Medical Center	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022	SHAH, ANKIT/0000-0002-9771-8777	National Institute on Drug Abuse [DA025528, DA025011]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Andre S, 1998, J VIROL, V72, P1497; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; BUZY J, 1992, BRAIN RES, V598, P10, DOI 10.1016/0006-8993(92)90161-2; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Goncalves J, 2008, ANN NY ACAD SCI, V1139, P103, DOI 10.1196/annals.1432.043; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lipton SA, 1991, BRAIN PATHOL, V1, P193, DOI 10.1111/j.1750-3639.1991.tb00659.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Medders KE, 2010, J IMMUNOL, V185, P4883, DOI 10.4049/jimmunol.0902535; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Osborne MPH, 2008, ANN NY ACAD SCI, V1139, P206, DOI 10.1196/annals.1432.034; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Reddy PV, 2011, NEUROCHEM INT; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Ribeiro FM, 2011, MOL NEUROBIOL, V43, P1, DOI 10.1007/s12035-010-8153-1; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Shah A, 2011, BIOCHEM BIOPH RES CO, V414, P112, DOI 10.1016/j.bbrc.2011.09.033; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tata DA, 2008, SYNAPSE, V62, P325, DOI 10.1002/syn.20497; Theodore S, 2006, ANN NY ACAD SCI, V1074, P178, DOI 10.1196/annals.1369.018; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; Toussi SS, 2009, AIDS RES HUM RETROV, V25, P1117, DOI 10.1089/aid.2008.0282; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Viviani B, 2006, J BIOL CHEM, V281, P30212, DOI 10.1074/jbc.M602156200; WAGNER GC, 1980, BRAIN RES, V181, P151, DOI 10.1016/0006-8993(80)91265-2; Wang SF, 2008, TOXICOLOGY, V246, P234, DOI 10.1016/j.tox.2008.01.020; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; Zou SP, 2011, BRAIN, V134, P3613, DOI 10.1093/brain/awr281	61	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52060	10.1371/journal.pone.0052060	http://dx.doi.org/10.1371/journal.pone.0052060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251686	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800138
J	Wang, G; He, J; Zhao, JY; Yun, WT; Xie, CZ; Taub, JW; Azmi, A; Mohammad, RM; Dong, Y; Kong, W; Guo, YJ; Ge, YB				Wang, Guan; He, Jing; Zhao, Jianyun; Yun, Wenting; Xie, Chengzhi; Taub, Jeffrey W.; Azmi, Asfar; Mohammad, Ramzi M.; Dong, Yan; Kong, Wei; Guo, Yingjie; Ge, Yubin			Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer	PLOS ONE			English	Article							ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE; (ARYLOXOPROPENYL)PYRROLYL HYDROXYAMIDES; VALPROIC ACID; CELL-DEATH; INHIBITORS; FAMILY; EXPRESSION; GEMCITABINE	Background: Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histone deacetylase inhibitors (HDACIs) have shown promising antitumor activities against preclinical models of pancreatic cancer, either alone or in combination with chemotherapeutic agents. In this study, we sought to identify clinically relevant histone deacetylases (HDACs) to guide the selection of HDAC inhibitors (HDACIs) tailored to the treatment of pancreatic cancer. Methodology: HDAC expression in seven pancreatic cancer cell lines and normal human pancreatic ductal epithelial cells was determined by Western blotting. Antitumor interactions between class I-and class II-selective HDACIs were determined by MTT assays and standard isobologram/CompuSyn software analyses. The effects of HDACIs on cell death, apoptosis and cell cycle progression, and histone H4, alpha-tubulin, p21, and gamma H2AX levels were determined by colony formation assays, flow cytometry analysis, and Western blotting, respectively. Results: The majority of classes I and II HDACs were detected in the pancreatic cancer cell lines, albeit at variable levels. Treatments with MGCD0103 (a class I-selective HDACI) resulted in dose-dependent growth arrest, cell death/apoptosis, and cell cycle arrest in G2/M phase, accompanied by induction of p21 and DNA double-strand breaks (DSBs). In contrast, MC1568 (a class IIa-selective HDACI) or Tubastatin A (a HDAC6-selective inhibitor) showed minimal effects. When combined simultaneously, MC1568 significantly enhanced MGCD0103-induced growth arrest, cell death/apoptosis, and G2/M cell cycle arrest, while Tubastatin A only synergistically enhanced MGCD0103-induced growth arrest. Although MC1568 or Tubastatin A alone had no obvious effects on DNA DSBs and p21 expression, their combination with MGCD0103 resulted in cooperative induction of p21 in the cells. Conclusion: Our results suggest that classes I and II HDACs are potential therapeutic targets for treating pancreatic cancer. Accordingly, treating pancreatic cancer with pan-HDACIs may be more beneficial than class-or isoform-selective inhibitors.	[Wang, Guan; He, Jing; Zhao, Jianyun; Yun, Wenting; Xie, Chengzhi; Dong, Yan; Kong, Wei; Guo, Yingjie; Ge, Yubin] Jilin Univ, Coll Life Sci, State Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Taub, Jeffrey W.; Ge, Yubin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Kong, Wei] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Xie, Chengzhi; Azmi, Asfar; Mohammad, Ramzi M.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Jilin University; Children's Hospital of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Tulane University; Jilin University; Wayne State University	Guo, YJ (corresponding author), Jilin Univ, Coll Life Sci, State Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China.	guoyinjie@jlu.edu.cn; gey@karmanos.org	xie, chengzhi/F-9615-2012	Ge, Yubin/0000-0002-8748-716X; Dong, Yan/0000-0003-1622-5354; AZMI, ASFAR/0000-0003-1178-9505	Jilin University, Changchun, China; National Natural Science Foundation of China [31071105]; Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit	Jilin University, Changchun, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit	This study was supported by grants from Jilin University, Changchun, China, the National Natural Science Foundation of China (No. 31071105), and in part by a Start-up Fund from the Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Ge YB, 2005, JNCI-J NATL CANCER I, V97, P226, DOI 10.1093/jnci/dji026; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Karagiannis TC, 2007, LEUKEMIA, V21, P61, DOI 10.1038/sj.leu.2404464; Kauh J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010376; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kullmann F, 2009, BRIT J CANCER, V100, P1032, DOI 10.1038/sj.bjc.6604983; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Ledent V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-24; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2003, J MED CHEM, V46, P4826, DOI 10.1021/jm034167p; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Sasaki H, 2004, LUNG CANCER, V46, P171, DOI 10.1016/j.lungcan.2004.03.021; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Strimpakos A, 2008, CANCER METAST REV, V27, P495, DOI 10.1007/s10555-008-9134-y; Sung V, 2011, CANCER SCI, V102, P1201, DOI 10.1111/j.1349-7006.2011.01921.x; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xie CZ, 2012, PEDIATR BLOOD CANCER, V59, P1245, DOI 10.1002/pbc.24152; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781	49	26	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52095	10.1371/journal.pone.0052095	http://dx.doi.org/10.1371/journal.pone.0052095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251689	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800141
J	Grimsley, JMS; Shanbhag, SJ; Palmer, AR; Wallace, MN				Grimsley, Jasmine M. S.; Shanbhag, Sharad J.; Palmer, Alan R.; Wallace, Mark N.			Processing of Communication Calls in Guinea Pig Auditory Cortex	PLOS ONE			English	Article							SPECIES-SPECIFIC VOCALIZATIONS; SQUIRREL-MONKEYS; PURR CALL; CONSPECIFIC VOCALIZATIONS; FUNCTIONAL SPECIALIZATION; CORTICAL DISCRIMINATION; NEURAL REPRESENTATION; SOCIAL VOCALIZATIONS; SINGLE NEURONS; RHESUS-MONKEY	Vocal communication is an important aspect of guinea pig behaviour and a large contributor to their acoustic environment. We postulated that some cortical areas have distinctive roles in processing conspecific calls. In order to test this hypothesis we presented exemplars from all ten of their main adult vocalizations to urethane anesthetised animals while recording from each of the eight areas of the auditory cortex. We demonstrate that the primary area (AI) and three adjacent auditory belt areas contain many units that give isomorphic responses to vocalizations. These are the ventrorostral belt (VRB), the transitional belt area (T) that is ventral to AI and the small area (area S) that is rostral to AI. Area VRB has a denser representation of cells that are better at discriminating among calls by using either a rate code or a temporal code than any other area. Furthermore, 10% of VRB cells responded to communication calls but did not respond to stimuli such as clicks, broadband noise or pure tones. Area S has a sparse distribution of call responsive cells that showed excellent temporal locking, 31% of which selectively responded to a single call. AI responded well to all vocalizations and was much more responsive to vocalizations than the adjacent dorsocaudal core area. Areas VRB, AI and S contained units with the highest levels of mutual information about call stimuli. Area T also responded well to some calls but seems to be specialized for low sound levels. The two dorsal belt areas are comparatively unresponsive to vocalizations and contain little information about the calls. AI projects to areas S, VRB and T, so there may be both rostral and ventral pathways for processing vocalizations in the guinea pig.	[Grimsley, Jasmine M. S.; Palmer, Alan R.; Wallace, Mark N.] MRC, Inst Hearing Res, Nottingham, England; [Grimsley, Jasmine M. S.; Shanbhag, Sharad J.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	Northeast Ohio Medical University (NEOMED)	Wallace, MN (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	markw@ihr.mrc.ac.uk	Wallace, Mark/ABC-1573-2020	Wallace, Mark/0000-0001-6894-4903; Palmer, Alan/0000-0001-5893-4525; Grimsley, Jasmine/0000-0002-7993-9699	Medical Research Council (MRC) Institute; MRC; MRC [MC_U135097126] Funding Source: UKRI; Medical Research Council [MC_U135097126] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000937] Funding Source: NIH RePORTER	Medical Research Council (MRC) Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was undertaken in a Medical Research Council (MRC) Institute by staff who are permanently employed by the MRC or were in receipt of an MRC Studentship (JMSG). No external funding was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Bolhuis JJ, 2003, ANIM BIOL, V53, P129, DOI 10.1163/157075603769700331; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; BULLOCK DC, 1988, MED BIOL ENG COMPUT, V26, P669, DOI 10.1007/BF02447511; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chase SM, 2006, J NEUROSCI, V26, P3889, DOI 10.1523/JNEUROSCI.4986-05.2006; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GLASS I, 1979, EXP BRAIN RES, V34, P489; Grimsley JMS, 2011, HEARING RES, V277, P134, DOI 10.1016/j.heares.2011.01.018; Grimsley JMS, 2011, NEUROREPORT, V22, P613, DOI 10.1097/WNR.0b013e3283495ae9; Horikawa J, 2001, NEUROREPORT, V12, P3335, DOI 10.1097/00001756-200110290-00038; Horikawa J, 2003, NEUROSCI RES, V46, pS160; Hosokawa Y, 2004, NEUROREPORT, V15, P1093, DOI 10.1097/00001756-200405190-00002; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Huetz C, 2011, HEARING RES, V271, P147, DOI 10.1016/j.heares.2010.01.010; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Kaas JH, 2011, AUDITORY CORTEX, P407, DOI 10.1007/978-1-4419-0074-6_19; Kusmierek P, 2009, J NEUROPHYSIOL, V102, P1606, DOI 10.1152/jn.00167.2009; Kyuhou S, 1999, NEUROSCI LETT, V260, P113, DOI 10.1016/S0304-3940(98)00956-2; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Narayan R, 2007, NAT NEUROSCI, V10, P1601, DOI 10.1038/nn2009; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Nelken I, 2007, HEARING RES, V229, P94, DOI 10.1016/j.heares.2007.01.012; NEWMAN JD, 1973, BRAIN RES, V54, P287, DOI 10.1016/0006-8993(73)90050-4; NEWMAN JD, 1973, EXP NEUROL, V40, P821, DOI 10.1016/0014-4886(73)90116-7; Nishimura M, 2007, J NEUROPHYSIOL, V97, P927, DOI 10.1152/jn.00689.2006; Pelleg-Toiba R., 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P257; Peterson DC, 2012, NEUROSCIENCE, V217, P154, DOI 10.1016/j.neuroscience.2012.04.069; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2008, J NEUROSCI, V28, P13184, DOI 10.1523/JNEUROSCI.3619-08.2008; REDIES H, 1989, J COMP NEUROL, V282, P473, DOI 10.1002/cne.902820402; Remedios R, 2009, J NEUROSCI, V29, P1034, DOI 10.1523/JNEUROSCI.4089-08.2009; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Rutkowski RG, 2000, HEARING RES, V145, P177, DOI 10.1016/S0378-5955(00)00087-3; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Suta D, 2003, J NEUROPHYSIOL, V90, P3794, DOI 10.1152/jn.01175.2002; Suta D, 2008, PHYSIOL RES, V57, pS149, DOI 10.33549/physiolres.931608; Suta D, 2007, EXP BRAIN RES, V183, P377, DOI 10.1007/s00221-007-1056-3; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; TANAKA H, 1991, JPN J PHYSIOL, V41, P817, DOI 10.2170/jjphysiol.41.817; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2011, HEARING RES, V274, P142, DOI 10.1016/j.heares.2010.05.012; Wallace MN, 2009, EXP BRAIN RES, V194, P395, DOI 10.1007/s00221-009-1714-8; Wallace MN, 2005, NEUROREPORT, V16, P2001, DOI 10.1097/00001756-200512190-00006; Wallace MN, 1999, NEUROREPORT, V10, P2095, DOI 10.1097/00001756-199907130-00019; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Wallace MN, 2005, HEARING RES, V204, P115, DOI 10.1016/j.heares.2005.01.007; Wallace MN, 2002, EXP BRAIN RES, V143, P106, DOI 10.1007/s00221-001-0973-9; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; WINTER P, 1973, EXP BRAIN RES, V18, P489; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212	71	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51646	10.1371/journal.pone.0051646	http://dx.doi.org/10.1371/journal.pone.0051646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251604	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200154
J	Kats, LB; Bucciarelli, GM; Schlais, DE; Blaustein, AR; Han, BA				Kats, Lee B.; Bucciarelli, Gary M.; Schlais, David E.; Blaustein, Andrew R.; Han, Barbara A.			Ultraviolet Radiation Influences Perch Selection by a Neotropical Poison-Dart Frog	PLOS ONE			English	Article							DENDROBATES-PUMILIO; B RADIATION; TERRITORIAL BEHAVIOR; AMPHIBIAN DECLINES; SENSITIVITY; VERTEBRATES; AVOIDANCE; VISION	Ambient ultraviolet-B radiation can harm amphibian eggs, larvae and adults. However, some amphibians avoid UV-B radiation when given the opportunity. The strawberry poison dart frog, Oophaga pumilio, is diurnal and males vocalize throughout the day in light gaps under forest canopies that expose them to solar radiation. Previous studies have demonstrated that males calling from high perches are more successful at mating than those at lower perches. We investigated whether frogs at higher perches receive more ultraviolet-B than those calling from lower perches. We also investigated whether frogs on perches receiving relatively low ultraviolet-B levels maintained their positions for longer compared to individuals calling from perches receiving higher levels of ultraviolet-B. Finally, since it has been hypothesized that some animals utilize levels of UV-A as a visual cue to avoid UV-B damage, we artificially elevated ultraviolet-A levels to examine whether males exposed to artificially elevated ultraviolet-A abandoned their perches sooner compared to males exposed to visible light. We found that frogs called from perches receiving low ultraviolet-B regardless of perch height, and that frogs maintain their positions longer on perches receiving low ultraviolet-B compared to perches receiving even slightly higher ultraviolet-B levels. Exposing the frogs to artificially elevated levels of ultraviolet-A radiation caused males to move off of their perches faster than when they were exposed to a control light source. These experiments suggest that ultraviolet radiation plays an important role in frog behavior related to perch selection, even in rainforests where much of the solar radiation is shielded by the forest canopy.	[Kats, Lee B.; Schlais, David E.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA; [Bucciarelli, Gary M.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Han, Barbara A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Pepperdine University; University of California System; University of California Los Angeles; Oregon State University; University System of Georgia; University of Georgia	Kats, LB (corresponding author), Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA.	lee.kats@pepperdine.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078; Bucciarelli, Gary/0000-0003-3345-1361	National Fish and Wildlife Foundation; National Science Foundation; Pepperdine University; Budweiser	National Fish and Wildlife Foundation; National Science Foundation(National Science Foundation (NSF)); Pepperdine University; Budweiser	The work was partially supported by a Budweiser Conservation Scholarship from the National Fish and Wildlife Foundation and Anheuser-Busch and a Postdoctoral Research Fellowship in Biology from the National Science Foundation. Additional funding came from Pepperdine University in the form of the Frank R. Seaver Chair (LBK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One author received funding from a commercial source (Budweiser); however, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data or materials.	Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Blaustein AR, 2003, EVOL DEV, V5, P89, DOI 10.1046/j.1525-142X.2003.03014.x; BUNNELL P, 1973, COPEIA, P277; Croteau MC, 2008, PHYSIOL BIOCHEM ZOOL, V81, P743, DOI 10.1086/591949; Cummings ME, 2008, J EXP BIOL, V211, P1203, DOI 10.1242/jeb.012963; DONNELLY MA, 1989, ECOL MONOGR, V59, P207, DOI 10.2307/1942599; GOVARDOVSKII VI, 1974, VISION RES, V14, P1317, DOI 10.1016/0042-6989(74)90003-0; Han BA, 2007, BIOTROPICA, V39, P433, DOI 10.1111/j.1744-7429.2007.00268.x; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Kats LB, 2000, ETHOLOGY, V106, P921, DOI 10.1046/j.1439-0310.2000.00608.x; KIMELDORF DJ, 1974, ENVIRON PHYSIOL BIOC, V4, P40; MCVEY ME, 1981, COPEIA, P1; Middleton EM, 2001, CONSERV BIOL, V15, P914, DOI 10.1046/j.1523-1739.2001.015004914.x; POORTER L, 1995, AM J BOT, V82, P1257, DOI 10.2307/2446248; Prohl H, 2005, J HERPETOL, V39, P354, DOI 10.1670/162-04A.1; Prohl H, 1999, BEHAV ECOL SOCIOBIOL, V46, P215, DOI 10.1007/s002650050612; ROITHMAIR ME, 1994, COPEIA, P107; Secondi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030391; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; SILBERGLIED RE, 1979, ANNU REV ECOL SYST, V10, P373, DOI 10.1146/annurev.es.10.110179.002105; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Wong S, 2009, BIOTROPICA, V41, P74, DOI 10.1111/j.1744-7429.2008.00452.x	25	9	9	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51364	10.1371/journal.pone.0051364	http://dx.doi.org/10.1371/journal.pone.0051364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251505	gold, Green Published			2022-12-25	WOS:000313236200094
J	Llorens, I; Untereiner, G; Jaillard, D; Gouget, B; Chapon, V; Carriere, M				Llorens, Isabelle; Untereiner, Guillaume; Jaillard, Danielle; Gouget, Barbara; Chapon, Virginie; Carriere, Marie			Uranium Interaction with Two Multi-Resistant Environmental Bacteria: Cupriavidus metallidurans CH34 and Rhodopseudomonas palustris	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; SPECIATION; ACCUMULATION; REDUCTION; EXAFS; COMPLEXES; ION; TRANSLOCATION; MICROSCOPY; CITRATE	Depending on speciation, U environmental contamination may be spread through the environment or inversely restrained to a limited area. Induction of U precipitation via biogenic or non-biogenic processes would reduce the dissemination of U contamination. To this aim U oxidation/reduction processes triggered by bacteria are presently intensively studied. Using X-ray absorption analysis, we describe in the present article the ability of Cupriavidus metallidurans CH34 and Rhodopseudomonas palustris, highly resistant to a variety of metals and metalloids or to organic pollutants, to withstand high concentrations of U and to immobilize it either through biosorption or through reduction to non-uraninite U(IV)-phosphate or U(IV)-carboxylate compounds. These bacterial strains are thus good candidates for U bioremediation strategies, particularly in the context of multi-pollutant or mixed-waste contaminations.	[Llorens, Isabelle] Polygone Sci Louis Neel, ESRF CRG FAME, Grenoble, France; [Llorens, Isabelle] CEA DSM INAC, Lab Nanostruct & Rayonnement Synchrotron, Grenoble, France; [Untereiner, Guillaume] UMR 3299 CEA CNRS, CEA DSM IRAMIS SIS2M, Lab Struct & Dynam Resonance Magnet, Gif Sur Yvette, France; [Jaillard, Danielle] UMR 8195 CNRS Univ Paris Sud, Ctr Commun Microscopie Elect, Orsay, France; [Gouget, Barbara] Direct Sci Labs, ANSES, Maisons Alfort, France; [Chapon, Virginie] CEA DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Chapon, Virginie] CNRS, UMR 7265, St Paul Les Durance, France; [Chapon, Virginie] Univ Aix Marseille, St Paul Les Durance, France; [Carriere, Marie] UMR E3 CEA Univ Joseph Fourier, CEA DSM INAC SCIB, Lab Les Acides Nucle, Grenoble, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Carriere, M (corresponding author), UMR E3 CEA Univ Joseph Fourier, CEA DSM INAC SCIB, Lab Les Acides Nucle, Grenoble, France.	marie.carriere@cea.fr	chapon, virginie/AAY-1669-2021; BM30, Beamline FAME/G-9313-2012; carriere, marie/F-2149-2011	chapon, virginie/0000-0002-2365-3464; carriere, marie/0000-0001-8446-6462	CEA through the Toxicology Program	CEA through the Toxicology Program	This work was funded by CEA through the Toxicology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PG, 1996, INORG CHEM, V35, P784, DOI 10.1021/ic9508536; Bailey EH, 2005, CHEM GEOL, V216, P1, DOI 10.1016/j.chemgeo.2004.10.011; Barkleit A, 2011, DALTON T, V40, P9868, DOI 10.1039/c1dt10546a; Bernier-Latmani R, 2010, ENVIRON SCI TECHNOL, V44, P9456, DOI 10.1021/es101675a; Boyanov MI, 2011, ENVIRON SCI TECHNOL, V45, P8336, DOI 10.1021/es2014049; Carriere M, 2005, NUCL INSTRUM METH B, V231, P268, DOI 10.1016/j.nimb.2005.01.069; Carriere M, 2008, J BIOL INORG CHEM, V13, P655, DOI 10.1007/s00775-008-0350-2; Carriere M, 2006, CHEM RES TOXICOL, V19, P1637, DOI 10.1021/tx060206z; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; Dusausoy Y, 1996, EUR J MINERAL, V8, P667; Fletcher KE, 2010, ENVIRON SCI TECHNOL, V44, P4705, DOI 10.1021/es903636c; FRANCIS AJ, 1994, ENVIRON SCI TECHNOL, V28, P636, DOI 10.1021/es00053a016; Gavrilescu M, 2009, J HAZARD MATER, V163, P475, DOI 10.1016/j.jhazmat.2008.07.103; Geipel G, 2000, NATO SCI S 1 DISARM, V29, P323; Gianguzza A, 2005, J CHEM ENG DATA, V50, P1576, DOI 10.1021/je050040o; Hennig C, 2001, RADIOCHIM ACTA, V89, P625, DOI 10.1524/ract.2001.89.10.625; Hennig C, 2010, DALTON T, V39, P3744, DOI 10.1039/b922624a; Hu QH, 2010, J ENVIRON RADIOACTIV, V101, P426, DOI 10.1016/j.jenvrad.2008.08.004; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Kelly SD, 2002, GEOCHIM COSMOCHIM AC, V66, P3855, DOI 10.1016/S0016-7037(02)00947-X; Kelly SD, 2007, GEOCHIM COSMOCHIM AC, V71, P821, DOI 10.1016/j.gca.2006.10.013; Kelly SD, 2010, ENVIRON SCI TECHNOL, V44, P236, DOI 10.1021/es902191s; Khijniak TV, 2005, APPL ENVIRON MICROB, V71, P6423, DOI 10.1128/AEM.71.10.6423-6426.2005; Laurette J, 2012, ENVIRON EXP BOT, V77, P96, DOI 10.1016/j.envexpbot.2011.11.007; Laurette J, 2012, ENVIRON EXP BOT, V77, P87, DOI 10.1016/j.envexpbot.2011.11.005; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; Proux O, 2006, J SYNCHROTRON RADIAT, V13, P59, DOI 10.1107/S0909049505037441; Proux O, 2005, PHYS SCRIPTA, VT115, P970; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Sarret G, 2005, APPL ENVIRON MICROB, V71, P2331, DOI 10.1128/AEM.71.5.2331-2337.2005; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Sharp JO, 2011, GEOCHIM COSMOCHIM AC, V75, P6497, DOI 10.1016/j.gca.2011.08.022; Sheppard SC, 2005, J ENVIRON RADIOACTIV, V79, P55, DOI 10.1016/j.jenvrad.2004.05.015; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; Suzuki Y, 2006, J MINER PETROL SCI, V101, P299, DOI 10.2465/jmps.060322; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5	40	21	22	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51783	10.1371/journal.pone.0051783	http://dx.doi.org/10.1371/journal.pone.0051783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251623	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200165
J	Peng, YM; Cai, J; Wang, W; Su, B				Peng, Yingmei; Cai, Jing; Wang, Wen; Su, Bing			Multiple Inter-Kingdom Horizontal Gene Transfers in the Evolution of the Phosphoenolpyruvate Carboxylase Gene Family	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; NUCLEAR GENE; ENDOSYMBIOSIS; BACTERIAL	Pepcase is a gene encoding phosphoenolpyruvate carboxylase that exists in bacteria, archaea and plants, playing an important role in plant metabolism and development. Most plants have two or more pepcase genes belonging to two gene sub-families, while only one gene exists in other organisms. Previous research categorized one plant pepcase gene as plant-type pepcase (PTPC) while the other as bacteria-type pepcase (BTPC) because of its similarity with the pepcase gene found in bacteria. Phylogenetic reconstruction showed that PTPC is the ancestral lineage of plant pepcase, and that all bacteria, protistpepcase and BTPC in plants are derived from a lineage of pepcase closely related with PTPC in algae. However, their phylogeny contradicts the species tree and traditional chronology of organism evolution. Because the diversification of bacteria occurred much earlier than the origin of plants, presumably all bacterialpepcase derived from the ancestral PTPC of algal plants after divergingfrom the ancestor of vascular plant PTPC. To solve this contradiction, we reconstructed the phylogeny of pepcase gene family. Our result showed that both PTPC and BTPC are derived from an ancestral lineage of gamma-proteobacteriapepcases, possibly via an ancient inter-kingdom horizontal gene transfer (HGT) from bacteria to the eukaryotic common ancestor of plants, protists and cellular slime mold. Our phylogenetic analysis also found 48other pepcase genes originated from inter-kingdom HGTs. These results imply that inter-kingdom HGTs played important roles in the evolution of the pepcase gene family and furthermore that HGTsare a more frequent evolutionary event than previouslythought.	[Peng, Yingmei; Wang, Wen; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Cai, Jing] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Cai, Jing] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Cai, Jing] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Peng, Yingmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wwang@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Wang, Wen/AAP-9873-2020	Cai, Jing/0000-0002-2496-4731				Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faguy DM, 1999, CURR BIOL, V9, pR883; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wagner A, 2008, MOL GENET GENOMICS, V280, P397, DOI 10.1007/s00438-008-0373-y	27	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51159	10.1371/journal.pone.0051159	http://dx.doi.org/10.1371/journal.pone.0051159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251445	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200066
J	Schafer, NP; Hoffman, RMB; Burger, A; Craig, PO; Komives, EA; Wolynes, PG				Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Komives, Elizabeth A.; Wolynes, Peter G.			Discrete Kinetic Models from Funneled Energy Landscape Simulations	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEINS; STATISTICAL-MECHANICS; RANDOM HETEROPOLYMERS; FOLDING MECHANISM; STOCHASTIC-MODELS; CONSENSUS DESIGN; TRANSITION-STATE; PREDICTION; DYNAMICS; BEHAVIOR	A general method for facilitating the interpretation of computer simulations of protein folding with minimally frustrated energy landscapes is detailed and applied to a designed ankyrin repeat protein (4ANK). In the method, groups of residues are assigned to foldons and these foldons are used to map the conformational space of the protein onto a set of discrete macrobasins. The free energies of the individual macrobasins are then calculated, informing practical kinetic analysis. Two simple assumptions about the universality of the rate for downhill transitions between macrobasins and the natural local connectivity between macrobasins lead to a scheme for predicting overall folding and unfolding rates, generating chevron plots under varying thermodynamic conditions, and inferring dominant kinetic folding pathways. To illustrate the approach, free energies of macrobasins were calculated from biased simulations of a non-additive structure-based model using two structurally motivated foldon definitions at the full and half ankyrin repeat resolutions. The calculated chevrons have features consistent with those measured in stopped flow chemical denaturation experiments. The dominant inferred folding pathway has an "inside-out'', nucleation-propagation like character.	[Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Wolynes, Peter G.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Wolynes, Peter G.] Rice Univ, Houston, TX USA	University of California System; University of California San Diego; Rice University	Wolynes, PG (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	pwolynes@rice.edu		Schafer, Nicholas/0000-0001-9789-2516	National Institute of General Medical Sciences [P01 GM071862]; D. R. Bullard-Welch Chair at Rice University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, T32GM008326] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); D. R. Bullard-Welch Chair at Rice University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Grant P01 GM071862 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institute of General Medical Sciences or the National Institutes of Health. Additional support was also provided by the D. R. Bullard-Welch Chair at Rice University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Berezhkovskii A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139063; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, CURR OPIN STRUC BIOL, V22, P52, DOI 10.1016/j.sbi.2011.12.001; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Craig PO, 2011, J AM CHEM SOC, V133, P17463, DOI 10.1021/ja207506z; Davtyan A, 2012, J PHYS CHEM B, V116, P8494, DOI 10.1021/jp212541y; Devi VS, 2004, PROTEIN SCI, V13, P2864, DOI 10.1110/ps.04935704; DeVries I, 2011, J MOL BIOL, V408, P163, DOI 10.1016/j.jmb.2011.02.021; Eastwood MP, 2002, J CHEM PHYS, V117, P4602, DOI 10.1063/1.1494417; Eastwood MP, 2001, J CHEM PHYS, V114, P4702, DOI 10.1063/1.1315994; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; Ellson J, 2004, MATH VIS, P127; Ferreiro DU, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000070; Ferreiro DU, 2007, J MOL BIOL, V365, P1201, DOI 10.1016/j.jmb.2006.11.044; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; Forrer P, 2004, CHEMBIOCHEM, V5, P183, DOI 10.1002/cbic.200300762; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; GOLDSTEIN RA, 1992, P NATL ACAD SCI USA, V89, P4918, DOI 10.1073/pnas.89.11.4918; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jonsson T, 1996, BIOCHEMISTRY-US, V35, P4795, DOI 10.1021/bi953056s; Kaya H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.258104; Kaya H, 2005, BIOPHYS J, V89, P520, DOI 10.1529/biophysj.104.057471; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Levy Y, 2002, PHYS CHEM CHEM PHYS, V4, P5052, DOI 10.1039/b203534k; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lowe AR, 2007, P NATL ACAD SCI USA, V104, P2679, DOI 10.1073/pnas.0604653104; Bradley CM, 2006, STRUCTURE, V14, P1303, DOI 10.1016/j.str.2006.06.013; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Munoz V, 2001, CURR OPIN STRUC BIOL, V11, P212, DOI 10.1016/S0959-440X(00)00192-5; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Plotkin SS, 1997, PHYSICA D, V107, P322, DOI 10.1016/S0167-2789(97)00100-0; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592153; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Shen TY, 2005, BIOCHEMISTRY-US, V44, P6433, DOI 10.1021/bi0500170; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Wang J, 1996, J CHEM PHYS, V105, P11276, DOI 10.1063/1.472869; Wang J, 1997, J PHYS I, V7, P395, DOI 10.1051/jp1:1997168; Werbeck ND, 2008, P NATL ACAD SCI USA, V105, P9982, DOI 10.1073/pnas.0705300105; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; WIDOM B, 1965, SCIENCE, V148, P1555, DOI 10.1126/science.148.3677.1555; WIDOM B, 1974, J CHEM PHYS, V61, P672, DOI 10.1063/1.1681944; WIDOM B, 1971, J CHEM PHYS, V55, P44, DOI 10.1063/1.1675541; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zong CH, 2006, BIOCHEMISTRY-US, V45, P6458, DOI 10.1021/bi060025w	60	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50635	10.1371/journal.pone.0050635	http://dx.doi.org/10.1371/journal.pone.0050635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251375	Green Published, gold			2022-12-25	WOS:000313236200032
J	Gonzalez, P; Fernandez-Martos, CM; Gonzalez-Fernandez, C; Arenas, E; Rodriguez, FJ				Gonzalez, Pau; Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Arenas, Ernest; Javier Rodriguez, Francisco			Spatio-Temporal Expression Pattern of Frizzled Receptors after Contusive Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							CORTICAL AXON OUTGROWTH; NEURAL STEM-CELLS; WNT PATHWAY; INFLAMMATORY RESPONSE; INDUCTION; GROWTH; REGENERATION; ACTIVATION; DICKKOPF-1; ASTROCYTES	Background: Wnt proteins are a large family of molecules that are critically involved in multiple central nervous system (CNS) developmental processes. Experimental evidences suggest a role for this family of proteins in many CNS disorders, including spinal cord injury (SCI), which is a major neuropathology owing to its high prevalence and chronic sensorimotor functional sequelae. Interestingly, most Wnt proteins and their inhibitors are expressed in the uninjured spinal cord, and their temporal expression patterns are dramatically altered after injury. However, little is known regarding the expression of their better-known receptors, the Frizzled family, after SCI. Thus, the aim of the present study was to evaluate the expression of Frizzled receptors in the damaged spinal cord. Findings: Based on the evidence that Wnts are expressed in the spinal cord and are transcriptionally regulated by SCI in adulthood, we analysed the spatio-temporal mRNA and protein expression patterns of Frizzled receptors after contusive SCI using quantitative RT-PCR and single and double immunohistochemistry, respectively. Our results show that almost all of the 10 known Frizzled receptors were expressed in specific spatial patterns in the uninjured spinal cords. Moreover, the Frizzled mRNAs and proteins were expressed after SCI, although their expression patterns were altered during the temporal progression of SCI. Finally, analysis of cellular Frizzled 5 expression pattern by double immunohistochemistry showed that, in the uninjured spinal cord, this receptor was expressed in neurons, oligodendrocytes, astrocytes, microglia and NG2(+) glial precursors. After injury, Frizzled 5 was not only still expressed in oligodendrocytes, astrocytes and NG2(+) glial precursors but also in axons at all evaluated time points. Moreover, Frizzled 5 was expressed in reactive microglia/macrophages from 3 to 14 days post-injury. Conclusions: Our data suggest the involvement of Frizzled receptors in physiological spinal cord function and in the cellular and molecular events that characterise its neuropathology.	[Gonzalez, Pau; Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Javier Rodriguez, Francisco] Hosp Nacl Paraplejicos, Mol Neurol Lab, Toledo, Spain; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Unit, Dept Med Biochem & Biophys, Stockholm, Sweden	Hospital Nacional de Paraplejicos; Karolinska Institutet	Rodriguez, FJ (corresponding author), Hosp Nacl Paraplejicos, Mol Neurol Lab, Toledo, Spain.	fjrodriguez@sescam.jccm.es	González, Carlos/AAG-9659-2019; Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Arenas, Ernest/AAO-5231-2020; Fernandez-Martos, Carmen/J-7770-2014	González, Carlos/0000-0002-3415-0723; Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Arenas, Ernest/0000-0003-0197-6577; Fernandez-Martos, Carmen/0000-0002-6387-4456	Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM) [PI2008-39]; Fondo de Investigacion Sanitaria (FIS) [PI08-1475]; Fondo Europeo de Desarrollo Regional [FEDER]	Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional [FEDER](European Commission)	This research was supported by grants obtained from the Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM) (Grant PI2008-39) and Fondo de Investigacion Sanitaria (FIS) (Grant PI08-1475, co-funded by Fondo Europeo de Desarrollo Regional [FEDER]). The funding agencies had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Busceti CL, 2007, EPILEPSIA, V48, P694, DOI 10.1111/j.1528-1167.2007.01055.x; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cui XP, 2011, IRISH J MED SCI, V180, P387, DOI 10.1007/s11845-010-0566-3; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LEpiscopo F, 2011, NEUROBIOL DIS; Li L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3147pt2; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Fernandez-Martos CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035594; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Polakis P, 2008, J CELL BIOL, V183, P371, DOI 10.1083/jcb.200810040; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Varela-Nallar L, 2012, CYTOSKELETON HOBOKEN; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Yin ZS, 2008, NEUROL RES, V30, P480, DOI 10.1179/174313208X284133; Zhang Z, 2006, NEUROPATH APPL NEURO, V32, P615, DOI 10.1111/j.1365-2990.2006.00770.x	76	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50793	10.1371/journal.pone.0050793	http://dx.doi.org/10.1371/journal.pone.0050793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251385	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900018
J	Jansen, T; Campbell, A; Kelly, C; Hatun, H; Payne, MR				Jansen, Teunis; Campbell, Andrew; Kelly, Ciaran; Hatun, Hjalmar; Payne, Mark R.			Migration and Fisheries of North East Atlantic Mackerel (Scomber scombrus) in Autumn and Winter	PLOS ONE			English	Article							SUBPOLAR GYRE; SCOTLAND; IMPACT; OCEAN; SEA	It has been suggested that observed spatial variation in mackerel fisheries, extending over several hundreds of kilometers, is reflective of climate-driven changes in mackerel migration patterns. Previous studies have been unable to clearly demonstrate this link. In this paper we demonstrate correlation between temperature and mackerel migration/distribution as proxied by mackerel catch data from both scientific bottom trawl surveys and commercial fisheries. We show that mackerel aggregate and migrate distances of up to 500 km along the continental shelf edge from mid-November to early March. The path of this migration coincides with the location of the relatively warm shelf edge current and, as a consequence of this affinity, mackerel are guided towards the main spawning area in the south. Using a simulated time series of temperature of the shelf edge current we show that variations in the timing of the migration are significantly correlated to temperature fluctuations within the current. The proposed proxies for mackerel distribution were found to be significantly correlated. However, the correlations were weak and only significant during periods without substantial legislative or technical developments. Substantial caution should therefore be exercised when using such data as proxies for mackerel distribution. Our results include a new temperature record for the shelf edge current obtained by embedding the available hydrographic observations within a statistical model needed to understand the migration through large parts of the life of adult mackerel and for the management of this major international fishery.	[Jansen, Teunis; Payne, Mark R.] Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark; [Campbell, Andrew; Kelly, Ciaran] Inst Marine, Fisheries Ecosyst Advisory Serv, Galway, Ireland; [Payne, Mark R.] ETHZ Swiss Fed Inst Technol, Zurich, Switzerland	Technical University of Denmark; Marine Institute Ireland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jansen, T (corresponding author), Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark.	tej@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481; Hatun, Hjalmar/0000-0002-9312-7355; Jansen, Teunis/0000-0001-8722-4493	EURO-BASIN of the European Union [264933]	EURO-BASIN of the European Union	The research was funded by EURO-BASIN of the European Union's 7th Framework Program (Grant Agreement #264933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hatun H, 2009, CAN J FISH AQUAT SCI, V66, P759, DOI 10.1139/F09-037; Hughes K, 2012, ICES J MAR IN PRESS; ICES, 1995, 1995ASSESS2 ICES CM; ICES, 2005, 2005ACFM08 ICES CM; ICES, 2012, ICES HYDR DAT; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; ICES, 2008, ICES, P10; ICES: Report of the working group on assessment of new MoU species (WGNEW), 2012, 2012ACOM20 ICES CM; Jansen T., 2012, PLOS ONE, V7; Jansen T, 2012, THESIS DTU AQUA; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Kauker F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002624; Larsen KMH, 2012, ICES J MAR SCI, V69, P802, DOI 10.1093/icesjms/fss028; Lockwood SJ, 1988, MACKEREL ITS BIOL AS; Madsen H, 1998, TIDSRAEKKEANALYSE, P145; Norges Sildesalgslag, 2009, BLANK SKJERM MAKR FI; Orvik KA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017932; Payne MR, 2012, MAR BIOL RES, V8, P475, DOI 10.1080/17451000.2011.639778; Punzon A, 2009, CONT SHELF RES, V29, P1195, DOI 10.1016/j.csr.2008.12.024; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Reid D.G., 2006, 2006B14 ICES CM; Reid DG, 1997, ICES J MAR SCI, V54, P168, DOI 10.1006/jmsc.1996.0202; Reid DG, 2001, FISH RES, V50, P141, DOI 10.1016/S0165-7836(00)00247-2; Reid DG, 2003, 2006Q19 ICES CM; Trenkel VM, 2012, PROG OCEANO IN PRESS; Utne KR, 2012, MAR BIOL RES, V8, P420, DOI 10.1080/17451000.2011.640937; WALSH M, 1995, ICES J MAR SCI, V52, P925, DOI 10.1006/jmsc.1995.0089; Walsh M., 1986, 1986H17 ICES CM; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	35	24	24	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51541	10.1371/journal.pone.0051541	http://dx.doi.org/10.1371/journal.pone.0051541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251570	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900100
J	Lundh, SH; Soylu, R; Petersen, A				Lundh, Sofia Hult; Soylu, Rana; Petersen, Asa			Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; FULL-LENGTH HUNTINGTIN; BODY-WEIGHT; NEUROENDOCRINE CHANGES; DISEASE PROGRESSION; MICE; MODELS; HYPOTHALAMUS; DYSFUNCTION; DISORDERS	Metabolic and psychiatric disturbances occur early on in the clinical manifestation of Huntington's disease (HD), a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin (HTT) gene. Hypothalamus has emerged as an important site of pathology and alterations in this area and its neuroendocrine circuits may play a role in causing early non-motor symptoms and signs in HD. Leptin is a hormone that controls energy homeostasis by signaling through leptin receptors in the hypothalamus. Disturbed leptin action is implicated in both obesity and depression and altered circulating levels of leptin have been reported in both clinical HD and rodent models of the disease. Pathological leptin signaling may therefore be involved in causing the metabolic and psychiatric disturbances of HD. Here we tested the hypothesis that expression of mutant HTT in leptin receptor carrying neurons plays a role in the development of the non-motor phenotype in the BACHD mouse model. Our results show that inactivation of mutant HTT in leptin receptor-expressing neurons in the BACHD mouse using cross-breeding based on a cre-loxP system did not have an effect on the metabolic phenotype or anxiety-like behavior. The data suggest that mutant HTT disrupts critical hypothalamic pathways by other mechanisms than interfering with intracellular leptin signaling.	[Lundh, Sofia Hult; Soylu, Rana; Petersen, Asa] Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden	Lund University	Lundh, SH (corresponding author), Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden.	sofia.hult@med.lu.se		Soylu Kucharz, Rana/0000-0002-7872-5322	Swedish Medical Research Council [K2009-61X-21520-01-1, K2011-62X-20404-05-6]; Torsten and Ragnar Soderberg foundation; province of Skane state grants; Bagadilico	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Torsten and Ragnar Soderberg foundation; province of Skane state grants; Bagadilico	This work was supported by grants from the Swedish Medical Research Council (K2009-61X-21520-01-1 and K2011-62X-20404-05-6 to A.P.), the Torsten and Ragnar Soderberg foundation, the province of Skane state grants, and Bagadilico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Bode FJ, 2009, BEHAV BRAIN RES, V205, P175, DOI 10.1016/j.bbr.2009.06.031; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Duff K, 2010, NEUROLOGY, V75, P500, DOI 10.1212/WNL.0b013e3181eccfa2; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Finger BC, 2010, PSYCHOPHARMACOLOGY, V210, P559, DOI 10.1007/s00213-010-1858-z; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Labad J, 2012, PSYCHOSOM MED, V74, P39, DOI 10.1097/PSY.0b013e31823ba8af; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Lawson EA, 2012, CLIN ENDOCRINOL, V76, P520, DOI 10.1111/j.1365-2265.2011.04182.x; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Reedeker W, 2012, PSYCHOSOMATICS, V53, P220, DOI 10.1016/j.psym.2011.12.010; Renoir T, 2012, BRIT J PHARMACOL, V165, P1375, DOI 10.1111/j.1476-5381.2011.01567.x; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Zeman M, 2009, NEUROENDOCRINOL LETT, V30, P387	51	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51168	10.1371/journal.pone.0051168	http://dx.doi.org/10.1371/journal.pone.0051168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251447	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900050
J	Rezende, AM; Folador, EL; Resende, DD; Ruiz, JC				Rezende, Antonio M.; Folador, Edson L.; Resende, Daniela de M.; Ruiz, Jeronimo C.			Computational Prediction of Protein-Protein Interactions in Leishmania Predicted Proteomes	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; INTERACTION NETWORKS; DATA INTEGRATION; GENE ONTOLOGY; DATABASE; GENOME; SCALE; IDENTIFICATION; INFORMATION; MODULARITY	The Trypanosomatids parasites Leishmania braziliensis, Leishmania major and Leishmania infantum are important human pathogens. Despite of years of study and genome availability, effective vaccine has not been developed yet, and the chemotherapy is highly toxic. Therefore, it is clear just interdisciplinary integrated studies will have success in trying to search new targets for developing of vaccines and drugs. An essential part of this rationale is related to protein-protein interaction network (PPI) study which can provide a better understanding of complex protein interactions in biological system. Thus, we modeled PPIs for Trypanosomatids through computational methods using sequence comparison against public database of protein or domain interaction for interaction prediction (Interolog Mapping) and developed a dedicated combined system score to address the predictions robustness. The confidence evaluation of network prediction approach was addressed using gold standard positive and negative datasets and the AUC value obtained was 0.94. As result, 39,420, 43,531 and 45,235 interactions were predicted for L. braziliensis, L. major and L. infantum respectively. For each predicted network the top 20 proteins were ranked by MCC topological index. In addition, information related with immunological potential, degree of protein sequence conservation among orthologs and degree of identity compared to proteins of potential parasite hosts was integrated. This information integration provides a better understanding and usefulness of the predicted networks that can be valuable to select new potential biological targets for drug and vaccine development. Network modularity which is a key when one is interested in destabilizing the PPIs for drug or vaccine purposes along with multiple alignments of the predicted PPIs were performed revealing patterns associated with protein turnover. In addition, around 50% of hypothetical protein present in the networks received some degree of functional annotation which represents an important contribution since approximately 60% of Leishmania predicted proteomes has no predicted function.	[Rezende, Antonio M.; Folador, Edson L.; Resende, Daniela de M.; Ruiz, Jeronimo C.] Fiocruz MS, Lab Parasitol Celular & Mol, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil; [Rezende, Antonio M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Folador, Edson L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Resende, Daniela de M.] Univ Fed Ouro Preto, Lab Pesquisas Clin, Ouro Preto, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Rezende, AM (corresponding author), Fiocruz MS, Lab Parasitol Celular & Mol, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.	am.rezende@cpqrr.fiocruz.br; jeronimo@cpqrr.fiocruz.br	Rezende, Antonio M/S-2126-2018; Resende, Daniela M/E-7476-2011	Rezende, Antonio M/0000-0003-4775-1779; Resende, Daniela M/0000-0002-5139-3022; /0000-0002-1361-9721; Folador, Edson Luiz/0000-0002-6752-9334	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ-02382-10, APQ-01835-10]; CNPq (National Counsel of Technological and Scientific Development) [476539/2010-2]; GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) [560943/2010-5]; CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos); CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) grant APQ-02382-10 and APQ-01835-10. CNPq (National Counsel of Technological and Scientific Development) grant 476539/2010-2 and GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) grant 560943/2010-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank for the following agencies for their past and current support for our research: CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) grant APQ-02382-10 and APQ-01835-10. CNPq (National Counsel of Technological and Scientific Development) grant 476539/2010-2, GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) grant 560943/2010-5.	[Anonymous], 1990, J MOL BIOL, V5, P7; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, LECT NOTES PHYS, V625, P46; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garlick PJ, 1980, BRIT MED J, V281; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Gong S, 2005, BIOINFORMATICS, V21, P2541, DOI 10.1093/bioinformatics/bti366; Hadighi R, 2007, PARASITOL RES, V101, P1319, DOI 10.1007/s00436-007-0638-0; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-41; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Oldfield CJ, 2007, BMC GENOMICS, V9; Pawlowski Krzysztof, 2008, Briefings in Functional Genomics & Proteomics, V7, P283, DOI 10.1093/bfgp/eln033; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Qi YJ, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P531; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Wuchty S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-122; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu HY, 2004, GENOME RES, V14; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38	70	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51304	10.1371/journal.pone.0051304	http://dx.doi.org/10.1371/journal.pone.0051304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251492	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900065
J	Danielson, LS; Park, DS; Rotllan, N; Chamorro-Jorganes, A; Guijarro, MV; Fernandez-Hernando, C; Fishman, GI; Phoon, CKL; Hernando, E				Danielson, Laura S.; Park, David S.; Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Guijarro, Maria V.; Fernandez-Hernando, Carlos; Fishman, Glenn I.; Phoon, Colin K. L.; Hernando, Eva			Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis	FASEB JOURNAL			English	Article						microRNA; mouse model; connexin43; Pten	SMOOTH-MUSCLE-CELLS; CARDIAC-HYPERTROPHY; EXPRESSION; DIFFERENTIATION; MICE; PROLIFERATION; CONDUCTION; MICRORNAS; DELETION	MicroRNA cluster miR-17-92 has been implicated in cardiovascular development and function, yet its precise mechanisms of action in these contexts are uncertain. This study aimed to investigate the role of miR-17-92 in morphogenesis and function of cardiac and smooth muscle tissues. To do so, a mouse model of conditional overexpression of miR-17-92 in cardiac and smooth muscle tissues was generated. Extensive cardiac functional studies identified a dose-dependent induction of dilated, hypertrophic cardiomyopathy, and arrhythmia inducibility in transgenic animals, which correlated with premature mortality (98.3+/-42.5 d, P<0.0001). Expression analyses revealed the abundance of Pten transcript, a known miR-17-92 target, to be inversely correlated with miR-17-92 expression levels and heart size. In addition, we demonstrated through 3'-UTR luciferase assays and expression analyses that Connexin43 (Cx43) is a novel direct target of miR-19a/b and its expression is suppressed in transgenic hearts. Taken together, these data demonstrate that dysregulated expression of miR-17-92 during cardiovascular morphogenesis results in a lethal cardiomyopathy, possibly in part through direct repression of Pten and Cx43. This study highlights the importance of miR-17-92 in both normal and pathological functions of the heart, and provides a model that may serve as a useful platform to test novel antiarrhythmic therapeutics.-Danielson, L. S., Park, D. S., Rotllan, N., Chamorro-Jorganes, A., Guijarro, M. V., Fernandez-Hernando, C., Fishman, G. I., Phoon, C. K. L., Hernando, E. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 27, 1460-1467 (2013). www.fasebj.org	[Danielson, Laura S.; Guijarro, Maria V.; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Park, David S.; Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Fernandez-Hernando, Carlos; Fishman, Glenn I.] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, New York, NY 10016 USA; [Phoon, Colin K. L.] NYU, Sch Med, Dept Pediat, Div Pediat Cardiol, New York, NY 10016 USA	New York University; New York University; New York University	Hernando, E (corresponding author), NYU, Sch Med, 550 1st Ave,Smilow 305, New York, NY 10016 USA.	colin.phoon@med.nyu.edu; eva.hernando@med.nyu.edu	Phoon, Colin K/C-9270-2009; Jorganes, Aranzazu Chamorro/N-7774-2019; Chamorro-Jorganes, Aranzazu/B-1871-2019; Rotllan, Noemi/P-1375-2014; Vila, Noemi Rotllan/AAQ-8050-2020	Jorganes, Aranzazu Chamorro/0000-0002-3505-7221; Chamorro-Jorganes, Aranzazu/0000-0002-3505-7221; Rotllan, Noemi/0000-0002-0587-8045; Vila, Noemi Rotllan/0000-0002-0587-8045; Fishman, Glenn/0000-0002-2366-8527; Hernando, Eva/0000-0003-1023-0312; Chamorro Jorganes, Aranzazu/0000-0003-2648-6945	New York University (NYU) Cancer Institute Cancer Center [5P30CA016087-32]; NYU-Health and Hospitals Corp.; Clinical and Translational Science Institute; National Center for Advancing Translational Sciences/U.S. National Institutes of Health (NIH) [UL1 TR000038]; NIH/National Center for Research Resources [1ULIRR029893]; Liddy Shriver Sarcoma Initiative; LMS Direct Research Foundation; Edna's Foundation of Hope; NIH [R01HL82727, S10RR026881, R01HL106063, R01HL107953]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107953, R01HL082727, R01HL106063] Funding Source: NIH RePORTER	New York University (NYU) Cancer Institute Cancer Center; NYU-Health and Hospitals Corp.; Clinical and Translational Science Institute; National Center for Advancing Translational Sciences/U.S. National Institutes of Health (NIH); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Liddy Shriver Sarcoma Initiative; LMS Direct Research Foundation; Edna's Foundation of Hope; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Fang-Yu Liu for technical assistance, and the Experimental Pathology Core resource, partially supported by the New York University (NYU) Cancer Institute Cancer Center, support grant 5P30CA016087-32. This work was partially funded by the NYU-Health and Hospitals Corp. Clinical and Translational Science Institute [which is supported in part by grant UL1 TR000038 from the National Center for Advancing Translational Sciences/U.S. National Institutes of Health (NIH)], NIH/National Center for Research Resources 1ULIRR029893, the Liddy Shriver Sarcoma Initiative, the LMS Direct Research Foundation, Edna's Foundation of Hope to E. H., NIH grants R01HL82727 and S10RR026881 to G. I. F., and NIH grants R01HL106063 and R01HL107953 to C.F.-H. The authors declare no conflicts of interest.	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen JH, 2012, J MOL CELL CARDIOL, V52, P949, DOI 10.1016/j.yjmcc.2012.01.012; Chen ZX, 2012, J BIOL CHEM, V287, P19018, DOI 10.1074/jbc.M112.351791; Collis LP, 2007, FASEB J, V21, P475, DOI 10.1096/fj.06-6292com; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Danielson LS, 2010, AM J PATHOL, V177, P908, DOI 10.2353/ajpath.2010.091150; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Maguire CT, 2003, PHYSIOL GENOMICS, V15, P84, DOI 10.1152/physiolgenomics.00034.2003; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; Nomura-Kitabayashi A, 2009, AM J PHYSIOL-HEART C, V297, pH1617, DOI 10.1152/ajpheart.00304.2009; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	31	88	98	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1460	1467		10.1096/fj.12-221994	http://dx.doi.org/10.1096/fj.12-221994			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271053	Green Published			2022-12-25	WOS:000316940800018
J	Oya, M; Kitaguchi, T; Pais, R; Reimann, F; Gribble, F; Tsuboi, T				Oya, Manami; Kitaguchi, Tetsuya; Pais, Ramona; Reimann, Frank; Gribble, Fiona; Tsuboi, Takashi			The G Protein-coupled Receptor Family C Group 6 Subtype A (GPRC6A) Receptor Is Involved in Amino Acid-induced Glucagon-like Peptide-1 Secretion from GLUTag Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TASTE RECEPTORS; ABSORPTION; EXOCYTOSIS; EXPRESSION; GUSTDUCIN; SEQUENCE; CALCIUM; CLONING; FUSION	Although amino acids are dietary nutrients that evoke the secretion of glucagon-like peptide 1 (GLP-1) from intestinal L cells, the precise molecular mechanism(s) by which amino acids regulate GLP-1 secretion from intestinal L cells remains unknown. Here, we show that the G protein-coupled receptor (GPCR), family C group 6 subtype A (GPRC6A), is involved in amino acid-induced GLP-1 secretion from the intestinal L cell line GLUTag. Application of L-ornithine caused an increase in intracellular Ca2+ concentration ([Ca2+](i)) in GLUTag cells. Application of a GPRC6A receptor antagonist, a phospholipase C inhibitor, or an IP3 receptor antagonist significantly suppressed the L-ornithine-induced [Ca2+](i) increase. We found that the increase in [Ca2+](i) stimulated by L-ornithine correlated with GLP-1 secretion and that L-ornithine stimulation increased exocytosis in a dose-dependent manner. Furthermore, depletion of endogenous GPRC6A by a specific small interfering RNA (siRNA) inhibited the L-ornithine-induced [Ca2+](i) increase and GLP-1 secretion. Taken together, these findings suggest that the GPRC6A receptor functions as an amino acid sensor in GLUTag cells that promotes GLP-1 secretion.	[Oya, Manami; Tsuboi, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kitaguchi, Tetsuya] Waseda Univ, Waseda Biosci Res Inst Singapore WABOIS, Cell Signaling Grp, Singapore 138667, Singapore; [Pais, Ramona; Reimann, Frank; Gribble, Fiona] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Tokyo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tsuboi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	takatsuboi@bio.c.u-tokyo.ac.jp	TSUBOI, Takashi/AAD-7976-2019; KITAGUCHI, TETSUYA/AAR-1895-2021; Kitaguchi, Tetsuya/F-5260-2017	TSUBOI, Takashi/0000-0001-8290-2021; KITAGUCHI, TETSUYA/0000-0001-6701-1933; Kitaguchi, Tetsuya/0000-0001-6701-1933; Reimann, Frank/0000-0001-9399-6377; Gribble, Fiona/0000-0002-4232-2898	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24-8221, 22790197, 24790207]; Nestle Nutrition Council, Japan; JGC-S Scholarship Foundation; Mishima Kaiun Memorial Foundation; Suntory Foundation for Life Sciences; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24790207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nestle Nutrition Council, Japan; JGC-S Scholarship Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Suntory Foundation for Life Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24-8221 (to M.O.), 22790197 (to T.K.), and 24790207 (to T.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the Nestle Nutrition Council, Japan (to T.T.), the JGC-S Scholarship Foundation (to T.K.), the Mishima Kaiun Memorial Foundation (to T.T.), the Suntory Foundation for Life Sciences (to T.T.), and the Takeda Science Foundation (to T.T.).	Aoki R, 2010, BIOCHEM J, V429, P497, DOI 10.1042/BJ20091839; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kawashima R, 2010, BIOCHEM BIOPH RES CO, V400, P225, DOI 10.1016/j.bbrc.2010.08.044; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Neu J, 1996, FASEB J, V10, P829, DOI 10.1096/fasebj.10.8.8666159; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Oya M, 2011, GENES CELLS, V16, P608, DOI 10.1111/j.1365-2443.2011.01509.x; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Sato M, 2012, BIOCHEM BIOPH RES CO, V420, P417, DOI 10.1016/j.bbrc.2012.03.010; Sato M, 2010, J NEUROCHEM, V114, P171, DOI 10.1111/j.1471-4159.2010.06739.x; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x	40	106	111	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4513	4521		10.1074/jbc.M112.402677	http://dx.doi.org/10.1074/jbc.M112.402677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269670	Green Published, hybrid			2022-12-25	WOS:000315340400002
J	Tammineni, P; Anugula, C; Mohammed, F; Anjaneyulu, M; Larner, AC; Sepuri, NBV				Tammineni, Prasad; Anugula, Chandrashekhar; Mohammed, Fareed; Anjaneyulu, Murari; Larner, Andrew C.; Sepuri, Naresh Babu Venkata			The Import of the Transcription Factor STAT3 into Mitochondria Depends on GRIM-19, a Component of the Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; REGULATORY GENE-PRODUCT; SIGNAL TRANSDUCER; PHOSPHORYLATION; EXPRESSION; MEMBRANE; SUBUNIT; BETA; TRANSLOCATION; LOCALIZATION	The signal transducer and activator of transcription 3 (STAT3), a nuclear transcription factor, is also present in mitochondria and regulates cellular respiration in a transcriptional-independent manner. The mechanism of STAT3 import into mitochondria remains obscure. In this report we show that mitochondrial-localized STAT3 resides in the inner mitochondrial membrane. In vitro import studies show that the gene associated with retinoid interferon induced cell mortality 19 (GRIM-19), a complex I subunit that acts as a chaperone to recruit STAT3 into mitochondria. In addition, GRIM-19 enhances the integration of STAT3 into complex I. A S727A mutation in STAT3 reduces its import and assembly even in the presence of GRIM-19. Together, our studies unveil a novel chaperone function for GRIM-19 in the recruitment of STAT3 into mitochondria.	[Tammineni, Prasad; Anugula, Chandrashekhar; Mohammed, Fareed; Anjaneyulu, Murari; Sepuri, Naresh Babu Venkata] Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India; [Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	University of Hyderabad; Virginia Commonwealth University	Sepuri, NBV (corresponding author), Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.	nareshuohyd@gmail.com	Murari, Anjaneyulu/AAQ-1613-2021; Sepuri, Naresh/AAF-2704-2020	Murari, Anjaneyulu/0000-0002-7532-964X; Tammineni, Prasad/0000-0002-5030-7786	Indian Council of Medical Research; Council of Scientific and Industrial Research; Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); University Grants Commission - Special Assistance Programme (UGC-SAP); Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); University Grants Commission - Special Assistance Programme (UGC-SAP)(University Grants Commission, India); Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India))	Supported by a Indian Council of Medical Research for Junior Research Fellowship.; Supported by the Council of Scientific and Industrial Research.; We thank Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB) and University Grants Commission - Special Assistance Programme (UGC-SAP) for funding the School of Life Sciences and Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions for funding the Department of Biochemistry, University of Hyderabad, Hyderabad. We thank Dr. Bramanandam, Department of Biochemistry, University of Hyderabad, Hyderabad for kindly providing the pcDNA-ER-alpha clone. We also thank members of the Sepuri laboratory for suggestions.	Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Biswas TK, 2002, J BIOL CHEM, V277, P45704, DOI 10.1074/jbc.M202565200; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Chen JQ, 2004, ANN NY ACAD SCI, V1028, P258, DOI 10.1196/annals.1322.030; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Delage L, 2003, MOL CELL BIOL, V23, P4000, DOI 10.1128/MCB.23.11.4000-4012.2003; Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; EILERS M, 1987, EMBO J, V6, P1073, DOI 10.1002/j.1460-2075.1987.tb04860.x; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; IOANNOU IM, 1988, ANTICANCER RES, V8, P1405; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; PFANNER N, 1986, FEBS LETT, V209, P152, DOI 10.1016/0014-5793(86)81101-2; Pfanner N, 1997, ANNU REV CELL DEV BI, V13, P25, DOI 10.1146/annurev.cellbio.13.1.25; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	48	145	149	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4723	4732		10.1074/jbc.M112.378984	http://dx.doi.org/10.1074/jbc.M112.378984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271731	hybrid, Green Published			2022-12-25	WOS:000315340400021
J	Longet, S; Miled, S; Lotscher, M; Miescher, SM; Zuercher, AW; Corthesy, B				Longet, Stephanie; Miled, Sarah; Loetscher, Marius; Miescher, Sylvia M.; Zuercher, Adrian W.; Corthesy, Blaise			Human Plasma-derived Polymeric IgA and IgM Antibodies Associate with Secretory Component to Yield Biologically Active Secretory-like Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-A IGA; ANTIGEN-BINDING; MUCOSAL IMMUNITY; DIMERIC IGA; RECEPTOR; PROTECTION; INNATE; NEUTRALIZATION; PURIFICATION; EXPRESSION	Immunotherapy with monoclonal and polyclonal immunoglobulin is successfully applied to improve many clinical conditions, including infection, autoimmune diseases, or immunodeficiency. Most immunoglobulin products, recombinant or plasma-derived, are based on IgG antibodies, whereas to date, the use of IgA for therapeutic application has remained anecdotal. In particular, purification or production of large quantities of secretory IgA (SIgA) for potential mucosal application has not been achieved. In this work, we sought to investigate whether polymeric IgA (pIgA) recovered from human plasma is able to associate with secretory component (SC) to generate SIgA-like molecules. We found that similar to 15% of plasma pIgA carried J chain and displayed selective SC binding capacity either in a mixture with monomeric IgA (mIgA) or after purification. The recombinant SC associated covalently in a 1:1 stoichiometry with pIgA and with similar efficacy as colostrum-derived SC. In comparison with pIgA, the association with SC delayed degradation of SIgA by intestinal proteases. Similar results were obtained with plasma-derived IgM. In vitro, plasma-derived IgA and SIgA neutralized Shigella flexneri used as a model pathogen, resulting in a delay of bacteria-induced damage targeted to polarized Caco-2 cell monolayers. The sum of these novel data demonstrates that association of plasma-derived IgA or IgM with recombinant/colostrum-derived SC is feasible and yields SIgA- and SIgM-like molecules with similar biochemical and functional characteristics as mucosa-derived immunoglobulins.	[Longet, Stephanie; Miled, Sarah; Corthesy, Blaise] CHU Vaudois, Div Immunol & Allergy, R&D Lab, CH-1011 Lausanne, Switzerland; [Loetscher, Marius; Miescher, Sylvia M.; Zuercher, Adrian W.; Corthesy, Blaise] CSL Behring AG, CH-3000 Bern 22, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CSL	Corthesy, B (corresponding author), CHU Vaudois, Div Immunol & Allergy, R&D Lab, Rue Bugnon, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Longet, Stephanie/0000-0001-5026-431X	Swiss Science Research Foundation [3100-138422]; CSL Behring PhD scholarship	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); CSL Behring PhD scholarship	This work was supported by Grant 3100-138422 from the Swiss Science Research Foundation.; Recipient of a CSL Behring PhD scholarship.	Almogren A, 2007, IMMUNOLOGY, V120, P273, DOI 10.1111/j.1365-2567.2006.02498.x; ARRANZ E, 1992, GUT, V33, P882, DOI 10.1136/gut.33.7.882; Berdoz J, 1999, P NATL ACAD SCI USA, V96, P3029, DOI 10.1073/pnas.96.6.3029; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brewer JW, 1997, MOL IMMUNOL, V34, P323, DOI 10.1016/S0161-5890(97)00029-1; Carbonare CB, 2005, PEDIAT ALLERG IMM-UK, V16, P574, DOI 10.1111/j.1399-3038.2005.00332.x; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; Corthesy B, 2002, TRENDS BIOTECHNOL, V20, P65, DOI 10.1016/S0167-7799(01)01874-1; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Corthesy Blaise, 2003, Current Pharmaceutical Biotechnology, V4, P51, DOI 10.2174/1389201033378020; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Cramer M, 2009, VOX SANG, V96, P219, DOI 10.1111/j.1423-0410.2008.01143.x; Crottet P, 1999, BIOCHEM J, V341, P299, DOI 10.1042/0264-6021:3410299; Crottet P, 1998, J IMMUNOL, V161, P5445; Eckmann L, 2011, CURR TOP MICROBIOL, V349, P145, DOI 10.1007/82_2010_103; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gregersen S, 2009, RESP MED, V103, P873, DOI 10.1016/j.rmed.2008.12.015; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Norderhaug IN, 1999, EUR J IMMUNOL, V29, P3401, DOI 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; PARR EL, 1995, J IMMUNOL METHODS, V180, P147, DOI 10.1016/0022-1759(94)00310-S; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Woof JM, 2011, MUCOSAL IMMUNOL, V4, P590, DOI 10.1038/mi.2011.39; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x	47	35	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4085	4094		10.1074/jbc.M112.410811	http://dx.doi.org/10.1074/jbc.M112.410811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250751	Green Published, hybrid			2022-12-25	WOS:000314845000037
J	Tian, XX; Liu, YJ; Liu, Y; Wang, RW; Wagenknecht, T; Liu, Z; Chen, SRW				Tian, Xixi; Liu, Yingjie; Liu, Ying; Wang, Ruiwu; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne			Ligand-dependent Conformational Changes in the Clamp Region of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; INDUCED CA2+ RELEASE; 3-DIMENSIONAL STRUCTURE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; SUDDEN-DEATH; FUNCTIONAL-CHARACTERIZATION; VENTRICULAR-TACHYCARDIA; ELECTRON CRYOMICROSCOPY	Global conformational changes in the three-dimensional structure of the Ca2+ release channel/ryanodine receptor (RyR) occur upon ligand activation. A number of ligands are able to activate the RyR channel, but whether these structurally diverse ligands induce the same or different conformational changes in the channel is largely unknown. Here we constructed a fluorescence resonance energy transfer (FRET)-based probe by inserting a CFP after residue Ser-2367 and a YFP after residue Tyr-2801 in the cardiac RyR (RyR2) to yield a CFP- and YFP-dual labeled RyR2 (RyR2(Ser-2367-CFP/Tyr-2801-YFP)). Both of these insertion sites have previously been mapped to the "clamp" region in the four corners of the square-shaped cytoplasmic assembly of the three-dimensional structure of RyR2. Using this novel FRET probe, we monitored the extent of conformational changes in the clamp region of RyR2(Ser-2367-CFP/Tyr-2801-YFP) induced by various ligands. We also monitored the extent of Ca2+ release induced by the same ligands in HEK293 cells expressing RyR2(Ser-2367-CFP/Tyr-2801-YFP). We detected conformational changes in the clamp region for the ligands caffeine, aminophylline, theophylline, ATP, and ryanodine but not for Ca2+ or 4-chloro-m-cresol, although they all induced Ca2+ release. Interestingly, caffeine is able to induce further conformational changes in the clamp region of the ryanodine-modified channel, suggesting that ryanodine does not lock RyR in a fixed conformation. Our data demonstrate that conformational changes in the clamp region of RyR are ligand-dependent and suggest the existence of multiple ligand dependent RyR activation mechanisms associated with distinct conformational changes.	[Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Liu, Ying; Wagenknecht, Terence; Liu, Zheng] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org; swchen@ucalgary.ca		Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01HL095541, R01AR040615]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta NWT and Nunavut; Alberta Innovates-Health Solutions Studentship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta NWT and Nunavut; Alberta Innovates-Health Solutions Studentship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL095541 (to Z. L.) and R01AR040615 (to T. W.). This work was also supported by research grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Alberta NWT and Nunavut (to S. R. W. C.).; Recipient of an Alberta Innovates-Health Solutions Studentship Award.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Capes EM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-18; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; Eisner DA, 2009, CIRC J, V73, P1561, DOI 10.1253/circj.CJ-09-0478; Eisner DA, 2004, CELL CALCIUM, V35, P583, DOI 10.1016/j.ceca.2004.01.012; ELHAYEK R, 1995, J BIOL CHEM, V270, P15634, DOI 10.1074/jbc.270.26.15634; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Masumiya H, 2001, J BIOL CHEM, V276, P39727, DOI 10.1074/jbc.M106557200; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; OHKUSA T, 1991, J BIOCHEM-TOKYO, V109, P609, DOI 10.1093/oxfordjournals.jbchem.a123428; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Paolini C, 2004, P NATL ACAD SCI USA, V101, P12748, DOI 10.1073/pnas.0404836101; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Xu L, 1998, ANN NY ACAD SCI, V853, P130; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224; ZORZATO F, 1993, MOL PHARMACOL, V44, P1192; Zucchi R, 1997, PHARMACOL REV, V49, P1	53	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4066	4075		10.1074/jbc.M112.427864	http://dx.doi.org/10.1074/jbc.M112.427864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258540	Green Published, hybrid			2022-12-25	WOS:000314845000035
J	Suk, HY; Zhou, C; Yang, TTC; Zhu, H; Yu, RYL; Olabisi, O; Yang, XY; Brancho, D; Kim, JY; Scherer, PE; Frank, PG; Lisanti, MP; Calvert, JW; Lefer, DJ; Molkentin, JD; Ghigo, A; Hirsch, E; Jin, JP; Chow, CW				Suk, Hee Yun; Zhou, Chen; Yang, Teddy T. C.; Zhu, Hong; Yu, Raymond Y. L.; Olabisi, Opeyemi; Yang, XiaoYong; Brancho, Deborah; Kim, Ja-Young; Scherer, Philipp E.; Frank, Philippe G.; Lisanti, Michael P.; Calvert, John W.; Lefer, David J.; Molkentin, Jeffery D.; Ghigo, Alessandra; Hirsch, Emilio; Jin, Jianping; Chow, Chi-Wing			Ablation of Calcineurin A beta Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; MULTISITE PHOSPHORYLATION; DEPENDENT PHOSPHORYLATION; ADRENERGIC-RECEPTORS; INSULIN-RESISTANCE; CELL DEVELOPMENT; DEFICIENT MICE; CYCLOSPORINE-A; TRANSCRIPTION; LOCALIZATION	Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating beta-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin A beta (CnA beta(-/-)). We show that mice lacking calcineurin A beta are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnA beta(-/-) mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by beta-adrenergic G-protein-coupled receptor signaling pathways. CnA beta(-/-) mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnA beta(-/-) mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnA beta(-/-) mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.	[Suk, Hee Yun; Zhou, Chen; Yang, Teddy T. C.; Zhu, Hong; Yu, Raymond Y. L.; Olabisi, Opeyemi; Yang, XiaoYong; Brancho, Deborah; Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Kim, Ja-Young; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Cell Biol, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Frank, Philippe G.; Lisanti, Michael P.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Frank, Philippe G.; Lisanti, Michael P.] Thomas Jefferson Univ, Dept Mol Oncol, Philadelphia, PA 19107 USA; [Calvert, John W.; Lefer, David J.] Emory Univ, Sch Med, Carlyle Fraser Heart Ctr, Dept Surg,Div Cardiothorac Surg, Atlanta, GA 30308 USA; [Molkentin, Jeffery D.] Howard Hughes Med Inst, Childrens Hosp Med Ctr, Mol Cardiovasc Biol Program, Cincinnati, OH 45229 USA; [Ghigo, Alessandra; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Jin, Jianping] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Jefferson University; Emory University; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University of Turin; University of Texas System; University of Texas Health Science Center Houston	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	chi-wing.chow@einstein.yu.edu	Frank, Philippe G/A-3463-2011; Jin, Jianping/K-5002-2018; Scherer, Philipp E/K-7819-2012; Lisanti, Michael/B-6131-2018; Olabisi, Opeyemi/AAA-1852-2022; Calvert, John W/F-4497-2014; Hirsch, Emilio/F-4848-2013; Lisanti, Michael P/C-6866-2013	Frank, Philippe G/0000-0003-4857-5279; Jin, Jianping/0000-0003-4175-9104; Scherer, Philipp E/0000-0003-0680-3392; Lisanti, Michael/0000-0003-2034-1382; Olabisi, Opeyemi/0000-0003-0886-7605; Calvert, John W/0000-0001-6858-6042; Hirsch, Emilio/0000-0002-9073-6024; Lefer, David/0000-0003-2293-7278; Molkentin, Jeffery/0000-0002-3558-6529; Ghigo, Alessandra/0000-0002-1193-5296	National Institutes of Health [5T32 GM07491]; Howard Hughes Medical Institute grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to C.-W.C., J.J., D.J.L., M.P.L., J.D.M., and P.E.S.). This work was also supported by a Howard Hughes Medical Institute grant (to J. D. M.).; Trainee sponsored by National Institutes of Health Grant 5T32 GM07491.	Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BALLANTYNE CM, 1989, JAMA-J AM MED ASSOC, V262, P53, DOI 10.1001/jama.262.1.53; Bernal-Mizrachi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011969; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Demozay D, 2011, DIABETES, V60, P2892, DOI 10.2337/db11-0341; Dufer M, 2001, MOL PHARMACOL, V60, P873; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Duranski MR, 2006, AM J PHYSIOL-HEART C, V291, pH2980, DOI 10.1152/ajpheart.01173.2005; ELIA M, 1987, METABOLISM, V36, P251, DOI 10.1016/0026-0495(87)90184-3; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; Gooch JL, 2004, AM J PATHOL, V165, P1755, DOI 10.1016/S0002-9440(10)63430-X; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Marchetti P, 2000, J ENDOCRINOL INVEST, V23, P482, DOI 10.1007/BF03343761; MARCHMONT RJ, 1980, FEBS LETT, V118, P18, DOI 10.1016/0014-5793(80)81209-9; Miki T, 1996, GENOMICS, V36, P476, DOI 10.1006/geno.1996.0493; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nakazawa A, 2001, J HISTOCHEM CYTOCHEM, V49, P187, DOI 10.1177/002215540104900206; Oknianska A, 2007, BIOCHEM BIOPH RES CO, V353, P1080, DOI 10.1016/j.bbrc.2006.12.141; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Poitout V, 2008, BIOCHEM SOC T, V36, P901, DOI 10.1042/BST0360901; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shakur Y, 2001, PROG NUCLEIC ACID RE, V66, P241; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Strosberg AD, 1995, OBES RES, V3, pS501, DOI 10.1002/j.1550-8528.1995.tb00219.x; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Usuda N, 1996, J HISTOCHEM CYTOCHEM, V44, P13, DOI 10.1177/44.1.8543776; Vaziri ND, 2000, J PHARMACOL EXP THER, V294, P778; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	65	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3477	3488		10.1074/jbc.M112.419150	http://dx.doi.org/10.1074/jbc.M112.419150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258544	Green Published, hybrid			2022-12-25	WOS:000314397900053
J	Jaiswal, D; Trivedi, S; Singh, R; Dada, R; Singh, K				Jaiswal, Deepika; Trivedi, Sameer; Singh, Rajendra; Dada, Rima; Singh, Kiran			Association of the IL1RN Gene VNTR Polymorphism with Human Male Infertility	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; RAT LEYDIG-CELLS; CYTOKINE SYNTHESIS; HUMAN MONOCYTES; INTERLEUKIN-1; EXPRESSION; STEROIDOGENESIS; BLOCKADE	Interleukin-1 (IL-1) is a regulatory cytokine that plays an important role in the maintenance of the immune environment of the testis, regulation of junction dynamics and cell differentiation during spermatogenesis. Members of the IL-1 family are pleiotropic cytokines that are involved in inflammation, immunoregulation and other homeostatic functions in the body. IL-1 alpha, IL-1 beta, and the IL-1 receptor antagonistic molecule (IL-1 Ra) are expressed in the testis under normal homeostasis and they further increase upon infection/inflammation. In the present study we have examined the association of Variable Number Tandem Repeats (VNTR) polymorphism of the Interleukin-1 receptor antagonist gene (IL1RN) with human male infertility. The case-control study comprised of two groups: 331 idiopathic infertile patients and 358 fertile healthy men. The study indicates risk of IL1RN2 variant with male infertility (OR: 1.43, CI: 1.1546 to 1.7804, P = 0.001). To our best knowledge, this is the first report that links IL1RN VNTR polymorphism with human male infertility.	[Jaiswal, Deepika; Singh, Kiran] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Trivedi, Sameer] Banaras Hindu Univ, Inst Med Sci, Dept Urol, Varanasi 221005, Uttar Pradesh, India; [Singh, Rajendra] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India; [Dada, Rima] All India Inst Med Sci, Dept Anat, New Delhi 110029, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, K (corresponding author), Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India.	singhk4@rediffmail.com	trivedi, sameer/AAN-3656-2020; Singh, Rajender/ABE-3512-2020	trivedi, sameer/0000-0001-8308-9220; SINGH, KIRAN/0000-0002-2592-6534	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance in the form of Junior Research Fellowship by Council of Scientific and Industrial Research (CSIR), New Delhi, India to the first author is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; Cudicini C, 1997, J CLIN ENDOCR METAB, V82, P1426, DOI 10.1210/jc.82.5.1426; Ganaiem M, 2009, ENDOCRINOLOGY, V150, P295, DOI 10.1210/en.2008-0848; Genc MR, 2002, AM J OBSTET GYNECOL, V187, P157, DOI 10.1067/mob.2002.122407; Gopichandran N, 2006, REPRODUCTION, V131, P613, DOI 10.1530/rep.1.00959; GRANOWITZ EV, 1992, BLOOD, V79, P2356; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Gremlich S, 2008, HUM REPROD, V23, P1200, DOI 10.1093/humrep/den034; Gruschwitz MS, 1996, J ANDROL, V17, P159; HALES DB, 1992, ENDOCRINOLOGY, V131, P2165, DOI 10.1210/en.131.5.2165; Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107; Korthagen NM, 2012, IMMUNOGENETICS, V64, P371, DOI 10.1007/s00251-012-0604-6; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Rozwadowska N, 2007, GENES IMMUN, V8, P100, DOI 10.1038/sj.gene.6364356; Soder O, 2000, ANDROLOGIA, V32, P52; Vamvakopoulos J, 2002, EUR J IMMUNOL, V32, P2988, DOI 10.1002/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9; VERHOEVEN G, 1988, MOL CELL ENDOCRINOL, V57, P51, DOI 10.1016/0303-7207(88)90031-7; WARREN DW, 1990, J ANDROL, V11, P353	18	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51899	10.1371/journal.pone.0051899	http://dx.doi.org/10.1371/journal.pone.0051899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251650	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800106
J	Jena, P; Mohanty, S; Mohanty, T; Kallert, S; Morgelin, M; Lindstrom, T; Borregaard, N; Stenger, S; Sonawane, A; Sorensen, OE				Jena, Prajna; Mohanty, Soumitra; Mohanty, Tirthankar; Kallert, Stephanie; Morgelin, Matthias; Lindstrom, Thomas; Borregaard, Niels; Stenger, Steffen; Sonawane, Avinash; Sorensen, Ole E.			Azurophil Granule Proteins Constitute the Major Mycobactericidal Proteins in Human Neutrophils and Enhance the Killing of Mycobacteria in Macrophages	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; TUBERCULOSIS INFECTION; BACTERICIDAL ACTIVITY; GENE-EXPRESSION; CATHEPSIN-G; PEPTIDES; LUNG; BCG; PHAGOCYTOSIS; ACTIVATION	Pathogenic mycobacteria reside in, and are in turn controlled by, macrophages. However, emerging data suggest that neutrophils also play a critical role in innate immunity to tuberculosis, presumably by their different antibacterial granule proteins. In this study, we purified neutrophil azurophil and specific granules and systematically analyzed the antimycobacterial activity of some purified azurophil and specific granule proteins against M. smegmatis, M. bovis-BCG and M. tuberculosis H37Rv. Using gel overlay and colony forming unit assays we showed that the defensin-depleted azurophil granule proteins (AZP) were more active against mycobacteria compared to other granule proteins and cytosolic proteins. The proteins showing antimycobacterial activity were identified by MALDI-TOF mass spectrometry. Electron microscopic studies demonstrate that the AZP disintegrate bacterial cell membrane resulting in killing of mycobacteria. Exogenous addition of AZP to murine macrophage RAW 264.7, THP-1 and peripheral blood monocyte-derived macrophages significantly reduced the intracellular survival of mycobacteria without exhibiting cytotoxic activity on macrophages. Immunofluorescence studies showed that macrophages actively endocytose neutrophil granular proteins. Treatment with AZP resulted in increase in co-localization of BCG containing phagosomes with lysosomes but not in increase of autophagy. These data demonstrate that neutrophil azurophil proteins may play an important role in controlling intracellular survival of mycobacteria in macrophages. Citation: Jena P, Mohanty S, Mohanty T, Kallert S, Morgelin M, et al. (2012) Azurophil Granule Proteins Constitute the Major Mycobactericidal Proteins in Human Neutrophils and Enhance the Killing of Mycobacteria in Macrophages. PLoS ONE 7(12): e50345. doi:10.1371/journal.pone.0050345	[Jena, Prajna; Mohanty, Soumitra; Sonawane, Avinash] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Mohanty, Tirthankar; Morgelin, Matthias; Sorensen, Ole E.] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Kallert, Stephanie; Stenger, Steffen] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Lindstrom, Thomas] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Borregaard, Niels] Univ Copenhagen, Dept Hematol, Copenhagen, Denmark	Kalinga Institute of Industrial Technology (KIIT); Lund University; Ulm University; Statens Serum Institut; University of Copenhagen	Sonawane, A (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar, Orissa, India.	asonawane@kiitbiotech.ac.in; Ole_E.Sorensen@med.lu.se	Sonawane, Avinash/S-9889-2019; Lindenstrøm, Thomas/ABE-4203-2020	Lindenstrøm, Thomas/0000-0002-7162-8124; Sorensen, Ole E./0000-0001-8681-6921; Mohanty, Soumitra/0000-0003-0919-5062	Department of Biotechnology, Government of India [BT/PR13488/GBD/27/270/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grant (BT/PR13488/GBD/27/270/2010) from Department of Biotechnology, Government of India to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; APPELBERG R, 1992, J LEUKOCYTE BIOL, V51, P472, DOI 10.1002/jlb.51.5.472; Appleberg R, 1990, CLIN EXP IMMUNOL, V83, P231; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Barrios-Payan Jorge, 2006, Gac Med Mex, V142, P273; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CAMPANELLI D, 1990, J CLIN INVEST, V85, P904, DOI 10.1172/JCI114518; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; EGESTEN A, 1994, BLOOD, V83, P2985, DOI 10.1182/blood.V83.10.2985.2985; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu LM, 2003, INT J TUBERC LUNG D, V7, P1027; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HEIFETS L, 1980, J RETICULOENDOTH SOC, V28, P391; Hwang SA, 2009, TUBERCULOSIS, V89, pS49, DOI 10.1016/S1472-9792(09)70012-5; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; MAY ME, 1987, INFECT IMMUN, V55, P2304, DOI 10.1128/IAI.55.9.2304-2307.1987; N'Diaye EN, 1998, J IMMUNOL, V161, P4983; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Sharma S, 2001, ANTIMICROB AGENTS CH, V45, P639, DOI 10.1128/AAC.45.2.639-640.2001; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Suttmann H, 2003, INFECT IMMUN, V71, P4647, DOI 10.1128/IAI.71.8.4647-4656.2003; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; WALLIS RS, 1994, J LEUKOCYTE BIOL, V55, P676, DOI 10.1002/jlb.55.5.676; YING X, 2010, MICROBES INFECT, V12, P683; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702; Zhu LM, 2011, INT J TUBERC LUNG D, V15, P369	50	54	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e5034	10.1371/journal.pone.0050345	http://dx.doi.org/10.1371/journal.pone.0050345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251364	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800012
J	Ungureanu, M; Stoliar, P; Llopis, R; Casanova, F; Hueso, LE				Ungureanu, Mariana; Stoliar, Pablo; Llopis, Roger; Casanova, Felix; Hueso, Luis E.			Non-Hebbian Learning Implementation in Light-Controlled Resistive Memory Devices	PLOS ONE			English	Article							MEMRISTOR; DOPAMINE; PLASTICITY; SYNAPSES; NEURONS	Non-Hebbian learning is often encountered in different bio-organisms. In these processes, the strength of a synapse connecting two neurons is controlled not only by the signals exchanged between the neurons, but also by an additional factor external to the synaptic structure. Here we show the implementation of non-Hebbian learning in a single solid-state resistive memory device. The output of our device is controlled not only by the applied voltages, but also by the illumination conditions under which it operates. We demonstrate that our metal/oxide/semiconductor device learns more efficiently at higher applied voltages but also when light, an external parameter, is present during the information writing steps. Conversely, memory erasing is more efficiently at higher applied voltages and in the dark. Translating neuronal activity into simple solid-state devices could provide a deeper understanding of complex brain processes and give insight into non-binary computing possibilities. Citation: Ungureanu M, Stoliar P, Llopis R, Casanova F, Hueso LE (2012) Non-Hebbian Learning Implementation in Light-Controlled Resistive Memory Devices. PLoS ONE 7(12): e52042. doi:10.1371/journal.pone.0052042	[Ungureanu, Mariana; Stoliar, Pablo; Llopis, Roger; Casanova, Felix; Hueso, Luis E.] CIC nanoGUNE Consolider, Donostia San Sebastian, Spain; [Stoliar, Pablo] CNRS UPS, LPS, Orsay, France; [Stoliar, Pablo] UNSAM, ECyT, San Martin, Buenos Aires, Argentina; [Casanova, Felix; Hueso, Luis E.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Basque Foundation for Science	Ungureanu, M (corresponding author), CIC nanoGUNE Consolider, Donostia San Sebastian, Spain.	m.ungureanu@nanogune.eu; l.hueso@nanogune.eu	Hueso, Luis E/C-8713-2009; Casanova, Felix/B-4639-2013; Stoliar, Pablo/H-3395-2012; Llorens, Roger Llopis/S-1403-2019	Hueso, Luis E/0000-0002-7918-8047; Casanova, Felix/0000-0003-0316-2163; Stoliar, Pablo/0000-0003-3065-2942; Llorens, Roger Llopis/0000-0002-5172-2690; nanoGUNE, CIC/0000-0001-7874-5254	Juan de la Cierva Program [JCI-2010-07837, MAT2009-08494]; Consolider-Ingenio from the Spanish Ministry of Science [CSD2006-53]; Marie Curie Reintegration Grant from the European Commission; ETORTEK Program from the Basque Government [IE06-172]	Juan de la Cierva Program; Consolider-Ingenio from the Spanish Ministry of Science; Marie Curie Reintegration Grant from the European Commission; ETORTEK Program from the Basque Government	This work was supported by the Juan de la Cierva Program JCI-2010-07837 and by MAT2009-08494 and Consolider-Ingenio CSD2006-53 projects all from the Spanish Ministry of Science, by the Marie Curie Reintegration Grant 2009 ITAMOSCINOM from the European Commission and by the ETORTEK Program IE06-172 from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Hebb Donald O., 1949, ORG BEHAV; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pershin YV, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021926; Porr B, 2007, NEURAL COMPUT, V19, P2694, DOI 10.1162/neco.2007.19.10.2694; Potjans W, 2010, FRONTIERS COMPUTATIO, V4, P1411; Ramon y Cajal S, 1899, IMPRENTA NACL B OFIC, VI, P20; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Seo K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254023; Sherrington C.S., 1906, INTEGRATIVE ACTION N; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Ungureanu M, 2012, ADV MATER, V24, P2496, DOI 10.1002/adma.201200382; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Zamarreno-Ramos C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00026	22	2	2	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52042	10.1371/journal.pone.0052042	http://dx.doi.org/10.1371/journal.pone.0052042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251679	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800132
J	Buchanan, RM; Tetland, S; Wilson, HL				Buchanan, Rachelle M.; Tetland, Sherry; Wilson, Heather L.			Low Dose Antigen Exposure for a Finite Period in Newborn Rats Prevents Induction of Mucosal Tolerance	PLOS ONE			English	Article							IMMUNE-RESPONSES; ORAL TOLERANCE; DENDRITIC CELLS; PROTEIN ANTIGENS; EARLY-LIFE; B-CELLS; IMMUNOGLOBULIN; ABSORPTION; SYSTEM; MICE	Background: In adult rats, initial exposure to antigens by a mucosal route triggers tolerance such that any subsequent re-exposure, even by a systemic route, results in suppression of immunity. The newborn's gut is semi-permeable for a finite period to allow maternal antibodies to enter the newborn's circulation. We propose that antigens introduced in extreme early life can readily traverse the gut wall and therefore circumvent induction of mucosal tolerance. Methodology/Principle Findings: Rat pups were gavaged with low-doses of ovalbumin (OVA; oral exposure group) or saline (parenteral control group) every second day for several weeks followed by an intraperitoneal (i.p.) injection at 1 month of age. When gavage was initiated the day after birth, newborn oral exposure pups responded with significantly higher anti-OVA IgA, IgM, IgG2a, and IgG1 titres in their serum and anti-OVA IgA, IgG2a and IgG1 titres in their lungs compared to negative control pups. Oral exposure alone failed to induce immunity. Pups exposed to the same treatment regimen starting at 14 days of age showed induction of mucosal tolerance after i.p. immunization. Newborn oral exposure groups subjected to secondary i.p. immunization responded with significantly increased humoral immunity in lung and sera suggesting that once antigen-specific mucosal tolerance if circumvented, it persists. Lymphocytes derived from mesenteric lymph node cells re-simulated with OVA ex vivo, from newborn oral exposure pups exposed to secondary immunization produced significantly higher IFN-gamma expression and lymphocyte proliferation relative to control pups indicating prevention of tolerance in the cell-mediated immune system. Conclusions/Significance: This work demonstrates that newborns may be uniquely qualified to prevent induction of mucosal tolerance to oral antigens. These results should be further explored to establish whether prevention of tolerance by early life oral vaccination can be exploited to prime for mucosal as well as systemic immunity and thus protect this susceptible population against infectious diseases.	[Buchanan, Rachelle M.; Tetland, Sherry; Wilson, Heather L.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	University of Saskatchewan	Wilson, HL (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	heather.wilson@usask.ca		Wilson, Heather/0000-0002-1261-0901	Saskatchewan Agriculture Development Fund	Saskatchewan Agriculture Development Fund	This research was funded by a grant to HLW from the Saskatchewan Agriculture Development Fund (www.agriculture.gov.sk.ca/ADF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpan O, 2001, J IMMUNOL, V166, P4843, DOI 10.4049/jimmunol.166.8.4843; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; BRANDTZAEG P, 1991, GASTROENTEROL CLIN N, V20, P397; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P383, DOI 10.1016/S0167-5699(99)01498-X; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; CORNES JS, 1965, P ROY SOC MED, V58, P716, DOI 10.1177/003591576505800930; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Czerkinsky C, 2010, MUCOSAL IMMUNOL, V3, P545, DOI 10.1038/mi.2010.55; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; Duizer E, 1999, TOXICOL APPL PHARM, V155, P117, DOI 10.1006/taap.1998.8589; El-Merhibi A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/396232; Elahi S, 2005, INFECT IMMUN, V73, P3636, DOI 10.1128/IAI.73.6.3636-3645.2005; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2003, J AUTOIMMUN, V20, P135, DOI 10.1016/S0896-8411(02)00112-9; FERGUSON A, 1972, CLIN EXP IMMUNOL, V12, P477; Garlapati S, 2010, VACCINE, V28, P8306, DOI 10.1016/j.vaccine.2010.09.080; Gerdts V, 2000, NAT MED, V6, P929, DOI 10.1038/78699; Gerdts V, 2002, J IMMUNOL, V168, P1877, DOI 10.4049/jimmunol.168.4.1877; Griebel PJ, 1996, DEV IMMUNOL, V4, P263; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V143, P408, DOI 10.1098/rspb.1955.0020; HANSON DG, 1981, J IMMUNOL, V127, P1518; Harris SP, 2011, VET IMMUNOL IMMUNOP, V141, P312, DOI 10.1016/j.vetimm.2011.03.015; Inskeep TK, 2010, CLIN VACCINE IMMUNOL, V17, P1163, DOI 10.1128/CVI.00078-10; JAKOBSSON I, 1989, ACTA PAEDIATR SCAND, P42; Jensen AR, 2001, J NUTR, V131, P3259, DOI 10.1093/jn/131.12.3259; JORDAN SM, 1968, AUST J EXP BIOL MED, V46, P465, DOI 10.1038/icb.1968.39; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; LEE WY, 1977, NATURE, V267, P618, DOI 10.1038/267618a0; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Mapletoft JW, 2008, J GEN VIROL, V89, P250, DOI 10.1099/vir.0.83300-0; MCGHEE JR, 1994, REPROD FERT DEVELOP, V6, P369, DOI 10.1071/RD9940369; Medina E, 2000, FEMS IMMUNOL MED MIC, V27, P305, DOI 10.1111/j.1574-695X.2000.tb01444.x; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; MILLER A, 1994, EUR J IMMUNOL, V24, P1026, DOI 10.1002/eji.1830240503; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; PENG HJ, 1989, PEDIATR RES, V26, P486, DOI 10.1203/00006450-198911000-00025; POLLARD M, 1970, Infection and Immunity, V2, P96; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; ROBERTON DM, 1982, ARCH DIS CHILD, V57, P369, DOI 10.1136/adc.57.5.369; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; SMITH MW, 1980, PROC R SOC SER B-BIO, V206, P411, DOI 10.1098/rspb.1980.0005; STOTT GH, 1979, J DAIRY SCI, V62, P1632, DOI 10.3168/jds.S0022-0302(79)83472-4; STROBEL S, 1984, PEDIATR RES, V18, P588, DOI 10.1203/00006450-198407000-00004; Strobel S, 1996, ANN NY ACAD SCI, V778, P88, DOI 10.1111/j.1749-6632.1996.tb21118.x; Strobel S, 2001, P NUTR SOC, V60, P437, DOI 10.1079/PNS2001119; Tezuka H, 2010, IMMUNOL REV, V234, P247, DOI 10.1111/j.0105-2896.2009.00872.x; Tobagus IT, 2004, J IMMUNOL, V172, P2274, DOI 10.4049/jimmunol.172.4.2274; VUKAVIC T, 1984, J PEDIATR GASTR NUTR, V3, P700, DOI 10.1097/00005176-198411000-00011; Wenzl HH, 2001, DIGEST DIS SCI, V46, P1120, DOI 10.1023/A:1010734717218; Wilson HL, 2010, VACCINE, V28, P8288, DOI 10.1016/j.vaccine.2010.10.006; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	56	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51437	10.1371/journal.pone.0051437	http://dx.doi.org/10.1371/journal.pone.0051437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251533	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200108
J	Shao, JB; Zhu, HP; Yao, HY; Stallones, L; Yeates, K; Wheeler, K; Xiang, HY				Shao, Jianbo; Zhu, Huiping; Yao, Hongyan; Stallones, Lorann; Yeates, Keith; Wheeler, Krista; Xiang, Huiyun			Characteristics and Trends of Pediatric Traumatic Brain Injuries Treated at a Large Pediatric Medical Center in China, 2002-2011	PLOS ONE			English	Article							COMMON OUTCOME MEASURES; UNIQUE FEATURES; YOUNG-CHILDREN; UNITED-STATES; HEAD TRAUMA; EPIDEMIOLOGY; HOSPITALIZATION; RECOMMENDATIONS; COMPLICATIONS; MECHANISMS	Background: Pediatric traumatic brain injuries (TBIs) have not been well studied in China. This study investigated characteristics and trends of hospitalized TBIs sustained by Chinese children. Methods and Findings: We analyzed 2002-2011 hospitalized TBI patients (0-17 years of age) treated at a large pediatric medical center in China. TBIs were defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes. We examined age patterns across external causes of TBIs. We reported the trend of traffic-related TBIs for each year from 2002 to 2011. Of 4,230 TBI patients, 67.1% (95% CI: 65.4%-68.8%) were city residents and 28.8% (95% CI: 26.3%-31.3%) came from rural villages. Males had disproportionately more TBIs than females (65.2% vs. 34.8%). Falls, struck by/against objects, and traffic collisions were the top three external causes of TBIs for all age groups. Falls were the leading cause of TBI for all ages but peaked at 2 years of age. There were 125 TBIs in 0-2 year olds (5.9% of all TBIs in this age group) that were caused by suspected child abuse. Suspected child abuse was significantly more likely to occur in 0-1 year olds. The proportion of traffic -related TBIs increased significantly from 12.99% in 2002 to 19.68% in 2008 but dropped each subsequent year until it reached a level of 8.91% in 2011. Conclusions: Our study confirms that falls, struck by/against objects and traffic collisions are the top external causes of TBIs in Chinese children. When compared with national data from the developed countries, gender patterns are similar, but the ranking of external causes is different. This is the first study to highlight the important role of suspected child abuse in causing TBIs in infants in China. TBIs caused by child abuse warrant further research and government attention as a social and medical problem in China.	[Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China; [Zhu, Huiping] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Stallones, Lorann] Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA; [Yeates, Keith] Ohio State Univ, Ctr Biobehav Hlth, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA; [Yeates, Keith; Wheeler, Krista; Xiang, Huiyun] Ohio State Univ, Ctr Injury Res & Policy, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA	Capital Medical University; Chinese Center for Disease Control & Prevention; Colorado State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Shao, JB (corresponding author), Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China.	jbshao2005@yahoo.com.cn; huiyun.xiang@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Stallones, Lorann/AAC-6248-2021; Xiang, Huiyun/E-4335-2011	Stallones, Lorann/0000-0001-7616-582X; Wheeler, Krista/0000-0003-3728-8928; Yeates, Keith Owen/0000-0001-7680-2892	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTER [D43TW007257] Funding Source: NIH RePORTER	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Drs. Stallones and Xiang were supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (PIs: L Stallones and H Xiang; Grant #: 1D43TW007257-01A2). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Bo Liu, 2005, J NEURO NEUROREHABIL, V2, P179; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Harrison J E, 2012, BRAIN INJ, P1; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kuang JG, 2011, JIANGXI MED J, V46, P299; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sun Y, 2006, INJURY, V37, P416, DOI 10.1016/j.injury.2005.12.002; Tieves Kelly S, 2005, WMJ, V104, P22; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 1994, INT CLASS DIS REL HL; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang SZ, 2002, CHIN J CLIN NEUROSCI, V10, P155; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao YD, 2001, WORLD J SURG, V25, P1202	46	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51634	10.1371/journal.pone.0051634	http://dx.doi.org/10.1371/journal.pone.0051634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251600	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200151
J	Larsen, S; Mancini, L; Pace, G; Scalici, M; Tancioni, L				Larsen, Stefano; Mancini, Laura; Pace, Giorgio; Scalici, Massimiliano; Tancioni, Lorenzo			Weak Concordance between Fish and Macroinvertebrates in Mediterranean Streams	PLOS ONE			English	Article							NESTED SPECIES ASSEMBLAGES; FRESH-WATER FISH; COMMUNITY CONCORDANCE; SPATIAL SCALES; LAND-USE; BENTHIC MACROINVERTEBRATES; CONSERVATION BIOLOGY; ECOLOGICAL QUALITY; EUROPEAN STREAMS; BIOTIC INTEGRITY	Although anthropogenic degradation of riverine systems stimulated a multi-taxon bioassessment of their ecological integrity in EU countries, specific responses of different taxonomic groups to human pressure are poorly investigated in Mediterranean rivers. Here, we assess if richness and composition of macroinvertebrate and fish assemblages show concordant variation along a gradient of anthropogenic pressure in 31 reaches across 13 wadeable streams in central Italy. Fish and invertebrate taxonomic richness was not correlated across sites. However, Mantel test showed that the two groups were significantly, albeit weakly, correlated even after statistically controlling for the effect of environmental variables and site proximity. Variance partitioning with partial Canonical Correspondence Analysis showed that the assemblages of the two groups were influenced by different set of environmental drivers: invertebrates were influenced by water organic content, channel and substratum features, while fish were related to stream temperature (mirroring elevation) and local land-use. Variance partitioning revealed the importance of biotic interactions between the two groups as a possible mechanisms determining concordance. Although significant, the congruence between the groups was weak, indicating that they should not be used as surrogate of each other for environmental assessments in these Mediterranean catchments. Indeed, both richness and patterns in nestedness (i.e. where depauperate locations host only a subset of taxa found in richer locations) appeared influenced by different environmental drivers suggesting that the observed concordance did not result from a co-loss of taxa along similar environmental gradients. As fish and macroinvertebrates appeared sensitive to different environmental factors, we argue that monitoring programmes should consider a multi-assemblage assessment, as also required by the Water Framework Directive.	[Larsen, Stefano] Leibniz Inst Freshwater Ecol, Berlin, Germany; [Mancini, Laura; Pace, Giorgio] Natl Inst Hlth, Dept Environm & Primary Prevent, Rome, Italy; [Scalici, Massimiliano] Roma Tre Univ, Dept Biol, Rome, Italy; [Tancioni, Lorenzo] Tor Vergata Univ, Dept Biol, Rome, Italy	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Istituto Superiore di Sanita (ISS); Roma Tre University; University of Rome Tor Vergata	Larsen, S (corresponding author), Leibniz Inst Freshwater Ecol, Berlin, Germany.	larsen@igb-berlin.de	Pace, Giorgio/AAP-4430-2020; Larsen, Stefano/I-5061-2012; Larsen, Stefano/A-5454-2016	Pace, Giorgio/0000-0003-4231-5644; Larsen, Stefano/0000-0002-6774-1407; SCALICI, Massimiliano/0000-0002-5677-8837; mancini, laura/0000-0003-3667-5221	Provincia di Roma	Provincia di Roma	This study was funded by Provincia di Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts BGW, 2003, HYDROBIOLOGIA, V500, P157, DOI 10.1023/A:1024638726162; Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Angradi TR, 1999, J N AM BENTHOL SOC, V18, P49, DOI 10.2307/1468008; APAT, 2003, MET AN ACQ; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Belfiore C, 1983, EPHEMEROPTERA GUIDA; Belpaire C, 2000, HYDROBIOLOGIA, V434, P17, DOI 10.1023/A:1004026121254; Bistoni MA, 2002, BRAZ J BIOL, V62, P753, DOI 10.1590/S1519-69842002000500004; Bonada N, 2006, J N AM BENTHOL SOC, V25, P32, DOI 10.1899/0887-3593(2006)25[32:BMAAMC]2.0.CO;2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BOWLBY JN, 1986, ECOLOGY, V67, P1670, DOI 10.2307/1939099; Buffagni A, 2000, HYDROBIOLOGIA, V435, P213, DOI 10.1023/A:1004124717508; Buffagni A, 2004, HYDROBIOLOGIA, V516, P313, DOI 10.1023/B:HYDR.0000025273.15958.6a; Buffagni A., 2007, IRSA CNR NOTIZIARIO, V1, P101; Campaioli S, 1999, MANUALE RICONOSCIMEN, P484; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Cheimonopoulou MT, 2011, ENVIRON MANAGE, V47, P279, DOI 10.1007/s00267-010-9598-8; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; Clavero M, 2010, DIVERS DISTRIB, V16, P744, DOI 10.1111/j.1472-4642.2010.00680.x; Consiglio C, 1980, PLECOPTERA GUIDA RIC; Cook RR, 2004, OECOLOGIA, V140, P639, DOI 10.1007/s00442-004-1618-z; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolph CL, 2011, FRESHWATER BIOL, V56, P1652, DOI 10.1111/j.1365-2427.2011.02589.x; Dudgeon D, 2011, CURRENT OPINION ENV, V2, P422; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; European Communities, 2000, OFFICIAL J EUROPEA L, VL 327; Fernandez-Juricic E, 2002, OECOLOGIA, V131, P269, DOI 10.1007/s00442-002-0883-y; Fleishman E, 2007, LANDSCAPE URBAN PLAN, V81, P271, DOI 10.1016/j.landurbplan.2007.02.002; Gandolfi G., 1991, PESCI ACQUE INTERNE; Ganzhorn JU, 2001, BASIC APPL ECOL, V2, P87, DOI 10.1078/1439-1791-00040; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Ghetti P.F., 1997, MACROINVERTEBRATI NE; Grenouillet G, 2008, DIVERS DISTRIB, V14, P592, DOI 10.1111/j.1472-4642.2007.00443.x; Hammer O., 2001, PALAENTOLOGIA ELECT, V4; Hecnar SJ, 2002, J BIOGEOGR, V29, P475, DOI 10.1046/j.1365-2699.2002.00686.x; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Heino J, 2010, ECOSCIENCE, V17, P345, DOI 10.2980/17-4-3263; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Heino J, 2009, BIODIVERS CONSERV, V18, P3085, DOI 10.1007/s10531-009-9626-2; Hering D, 2006, FRESHWATER BIOL, V51, P1757, DOI 10.1111/j.1365-2427.2006.01610.x; Hermoso V, 2011, MAR FRESHWATER RES, V62, P244, DOI 10.1071/MF09300; Hermoso V, 2010, ECOL INDIC, V10, P1152, DOI 10.1016/j.ecolind.2010.03.018; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JACKSON DA, 1993, CAN J FISH AQUAT SCI, V50, P2641, DOI 10.1139/f93-287; Johnson RK, 2010, ECOL APPL, V20, P978, DOI 10.1890/08-1153.1; Larsen S, 2009, FRESHWATER BIOL, V54, P203, DOI 10.1111/j.1365-2427.2008.02093.x; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Larsen S, 2010, ENVIRON MANAGE, V45, P261, DOI 10.1007/s00267-009-9419-0; Lasne E, 2007, RIVER RES APPL, V23, P877, DOI 10.1002/rra.1030; Leps J, 2003, MULTIVARIATE ANAL EC; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Louzada J, 2010, BIOL CONSERV, V143, P1102, DOI 10.1016/j.biocon.2010.02.003; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Mancini L, 2005, BIODIVERS CONSERV, V14, P351, DOI 10.1007/s10531-004-5355-8; Marques MMGSM, 1999, REV BRASILERA BIOL, V54, P1; Moretti G, 1983, TRICHOPTERA GUIDA RI; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; ORMEROD SJ, 1994, FRESHWATER BIOL, V32, P309, DOI 10.1111/j.1365-2427.1994.tb01128.x; Oster M, 2008, BASIC APPL ECOL, V9, P514, DOI 10.1016/j.baae.2007.11.006; Paavola R, 2006, ECOL APPL, V16, P368, DOI 10.1890/03-5410; Pace G, ECOLOGICAL IN PRESS; Pace G, 2011, ECOL INDIC, V11, P688, DOI 10.1016/j.ecolind.2010.09.008; Paszkowski CA, 2000, FRESHWATER BIOL, V43, P421, DOI 10.1046/j.1365-2427.2000.00512.x; Pik AJ, 1999, AUST J ECOL, V24, P555, DOI 10.1046/j.1442-9993.1999.01003.x; Pinto P, 2006, HYDROBIOLOGIA, V566, P75, DOI 10.1007/s10750-006-0069-4; POWER ME, 1992, ECOLOGY, V73, P1675, DOI 10.2307/1940019; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Robinson JL, 2005, ECOL FRESHW FISH, V14, P14, DOI 10.1111/j.1600-0633.2005.00063.x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Saetersdal M, 2011, J APPL ECOL, V48, P1236, DOI 10.1111/j.1365-2664.2011.02027.x; Sanchez-Fernandez D, 2006, BIODIVERS CONSERV, V15, P4507, DOI 10.1007/s10531-005-5101-x; Sandin L, 2004, HYDROBIOLOGIA, V516, P129, DOI 10.1023/B:HYDR.0000025262.98511.46; Sansoni G, 1988, ATLANTE RICONOSCIMEN; Scardi M, 2007, PROTOCOLLO CAMPIONAM; Scardi M, 2008, ECOL INFORM, V3, P55, DOI 10.1016/j.ecoinf.2007.10.001; Schouten MA, 2007, J BIOGEOGR, V34, P1938, DOI 10.1111/j.1365-2699.2007.01742.x; Snyder CD, 2003, LANDSCAPE ECOL, V18, P647, DOI 10.1023/B:LAND.0000004178.41511.da; Statzner B, 2001, BASIC APPL ECOL, V2, P73, DOI 10.1078/1439-1791-00039; Summerville KS, 2002, OIKOS, V97, P195, DOI 10.1034/j.1600-0706.2002.970205.x; Tancioni Lorenzo, 2006, P47, DOI 10.1002/0470863781.ch4; Tolonen KT, 2005, BIODIVERS CONSERV, V14, P961, DOI 10.1007/s10531-004-8414-2; Vila-Gispert A, 2002, AQUAT SCI, V64, P163, DOI 10.1007/s00027-002-8064-y; Villasenor JL, 2005, CONSERV BIOL, V19, P232, DOI 10.1111/j.1523-1739.2005.00264.x; Walsh C., 2007, HIERARCHICAL PARTITI; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; WATERS TF, 1995, AFS MONOGRAPHS; Wolters V, 2006, ECOLOGY, V87, P1886, DOI 10.1890/0012-9658(2006)87[1886:RATSRO]2.0.CO;2	93	38	39	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51115	10.1371/journal.pone.0051115	http://dx.doi.org/10.1371/journal.pone.0051115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251432	Green Published, gold			2022-12-25	WOS:000312201900042
J	Praslickova, D; Torchia, EC; Sugiyama, MG; Magrane, EJ; Zwicker, BL; Kolodzieyski, L; Agellon, LB				Praslickova, Dana; Torchia, Enrique C.; Sugiyama, Michael G.; Magrane, Elijah J.; Zwicker, Brittnee L.; Kolodzieyski, Lev; Agellon, Luis B.			The Ileal Lipid Binding Protein Is Required for Efficient Absorption and Transport of Bile Acids in the Distal Portion of the Murine Small Intestine	PLOS ONE			English	Article							ALPHA-OST-BETA; ORGANIC SOLUTE TRANSPORTER; MOLECULAR-CLONING; MICE; CHOLESTEROL; EXPRESSION; PLASMA; LIVER; RAT; CHROMATOGRAPHY	The ileal lipid binding protein (ilbp) is a cytoplasmic protein that binds bile acids with high affinity. However evidence demonstrating the role of this protein in bile acid transport and homeostasis is missing. We created a mouse strain lacking ilbp (Fabp6(-/-) mice) and assessed the impact of ilbp deficiency on bile acid homeostasis and transport in vivo. Elimination of ilbp increased fecal bile acid excretion (54.2%, P<0.05) in female but not male Fabp6(-/-) mice. The activity of cholesterol 7 alpha-hydroxylase (cyp7a1), the rate-controlling enzyme of the classical bile acid biosynthetic pathway, was significantly increased in female (63.5%, P<0.05) but not in male Fabp6(-/-) mice. The amount of [H-3] taurocholic acid (TCA) excreted by 24 h after oral administration was 102% (P<0.025) higher for female Fabp6(-/-) mice whereas it was 57.3% (P<0.01) lower for male Fabp6(-/-) mice, compared to wild-type mice. The retained fraction of the [H-3] TCA localized in the small and large intestines was increased by 22% (P<0.02) and decreased by 62.7% (P<0.01), respectively, in male Fabp6(-/-) mice relative wild-type mice, whereas no changes were seen in female Fabp6(-/-) mice. Mucosal to serosal bile acid transport using everted distal gut sacs was decreased by 74% (P<0.03) in both sexes of Fabp6(-/-) mice as compared to wild-type mice. The results demonstrate that ilbp is involved in the apical to basolateral transport of bile acids in ileal enterocytes, and is vital for the maintenance of bile acid homeostasis in the enterohepatic circulation (EHC) in mice.	[Praslickova, Dana; Sugiyama, Michael G.; Magrane, Elijah J.; Zwicker, Brittnee L.; Kolodzieyski, Lev; Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Torchia, Enrique C.; Agellon, Luis B.] Univ Alberta, Canadian Inst Hlth, Res Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [Kolodzieyski, Lev] ITR Labs Canada, Baie Durfe, PQ, Canada	McGill University; University of Alberta	Agellon, LB (corresponding author), McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada.	luis.agellon@mcgill.ca			Canadian Institutes of Health Research; Canada Foundation for Innovation; Novartis Pharmaceuticals Canada; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Novartis Pharmaceuticals Canada; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This research was supported in parts by grants (to LBA) from the Canadian Institutes of Health Research, Canada Foundation for Innovation and Novartis Pharmaceuticals Canada. ECT held a studentship from the Alberta Heritage Foundation for Medical Research. LBA holds the Canada Research Chair in Biochemistry and Molecular Biology of Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agellon LB, 1997, BIOCHEM CELL BIOL, V75, P255, DOI 10.1139/bcb-75-3-255; Agellon LB, 2000, BBA-MOL CELL BIOL L, V1486, P198, DOI 10.1016/S1388-1981(00)00057-3; Agellon LB, 2002, MOL CELL BIOCHEM, V239, P79, DOI 10.1023/A:1020520521025; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; FUJITA M, 1995, EUR J BIOCHEM, V233, P406, DOI 10.1111/j.1432-1033.1995.406_2.x; GONG YZ, 1994, P NATL ACAD SCI USA, V91, P4741, DOI 10.1073/pnas.91.11.4741; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Labonte ED, 2003, PROTEIN EXPRES PURIF, V28, P25, DOI 10.1016/S1046-5928(02)00561-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHNINGER A, 1990, ANAL BIOCHEM, V186, P243, DOI 10.1016/0003-2697(90)90074-J; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9; SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113; TAKIKAWA H, 1986, ARCH BIOCHEM BIOPHYS, V251, P385, DOI 10.1016/0003-9861(86)90086-X; Torchia EC, 2001, ANAL BIOCHEM, V298, P293, DOI 10.1006/abio.2001.5379; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Van der Meer R., 1985, CHOLESTEROL METABOLI, P113; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	24	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50810	10.1371/journal.pone.0050810	http://dx.doi.org/10.1371/journal.pone.0050810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251388	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900021
J	Tucker, JA; Bennett, N; Brassington, C; Durant, ST; Hassall, G; Holdgate, G; McAlister, M; Nissink, JWM; Truman, C; Watson, M				Tucker, Julie A.; Bennett, Neil; Brassington, Claire; Durant, Stephen T.; Hassall, Giles; Holdgate, Geoff; McAlister, Mark; Nissink, J. Willem M.; Truman, Caroline; Watson, Martin			Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives	PLOS ONE			English	Article							STRAND BREAK REPAIR; POLY(ADP-RIBOSE) GLYCOHYDROLASE; MAXIMUM-LIKELIHOOD; PROTEIN CRYSTALLIZATION; PARG; REFINEMENT; IDENTIFICATION; SENSITIVITY; PREDICTION; REDUCTION	Poly(ADP-ribose) glycohydrolase (PARG) is the only enzyme known to catalyse hydrolysis of the O-glycosidic linkages of ADP-ribose polymers, thereby reversing the effects of poly(ADP-ribose) polymerases. PARG deficiency leads to cell death whilst PARG depletion causes sensitisation to certain DNA damaging agents, implicating PARG as a potential therapeutic target in several disease areas. Efforts to develop small molecule inhibitors of PARG activity have until recently been hampered by a lack of structural information on PARG. We have used a combination of bio-informatic and experimental approaches to engineer a crystallisable, catalytically active fragment of human PARG (hPARG). Here, we present high-resolution structures of the catalytic domain of hPARG in unliganded form and in complex with three inhibitors: ADP-ribose (ADPR), adenosine 59-diphosphate (hydroxymethyl) pyrrolidinediol (ADP-HPD) and 8-n-octyl-amino-ADP-HPD. Our structures confirm conservation of overall fold amongst mammalian PARG glycohydrolase domains, whilst revealing additional flexible regions in the catalytic site. These new structures rationalise a body of published mutational data and the reported structure-activity relationship for ADP-HPD based PARG inhibitors. In addition, we have developed and used biochemical, isothermal titration calorimetry and surface plasmon resonance assays to characterise the binding of inhibitors to our PARG protein, thus providing a starting point for the design of new inhibitors.	[Tucker, Julie A.; Bennett, Neil; Brassington, Claire; Durant, Stephen T.; Hassall, Giles; Holdgate, Geoff; McAlister, Mark; Nissink, J. Willem M.; Truman, Caroline; Watson, Martin] AstraZeneca UK Ltd, Innovat Med, Macclesfield, Cheshire, England	AstraZeneca	Tucker, JA (corresponding author), AstraZeneca UK Ltd, Innovat Med, Macclesfield, Cheshire, England.	julie.tucker@astrazeneca.com	Nissink, J. Willem M./C-1507-2010; Tucker, Julie/AAT-1513-2021	Nissink, J. Willem M./0000-0003-2572-9140; Watson, Martin/0000-0001-8803-478X; Tucker, Julie/0000-0002-6119-676X; mcalister, mark/0000-0003-3986-1767	AstraZeneca	AstraZeneca(AstraZeneca)	This work was carried out at and financially supported by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Ame JC, 1999, CYTOGENET CELL GENET, V85, P269, DOI 10.1159/000015310; Ame JC, 2009, J CELL SCI, V122, P1990, DOI 10.1242/jcs.039115; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Botta D, 2010, BIOCHEMISTRY-US, V49, P7674, DOI 10.1021/bi100973m; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuzzocrea S, 2005, FASEB J, V19, P558, DOI 10.1096/fj.04-3117com; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Dunstan MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1889; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Fauzee NJS, 2010, PATHOL ONCOL RES, V16, P469, DOI 10.1007/s12253-010-9266-6; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hassler M, 2011, STRUCTURE, V19, P1351, DOI 10.1016/j.str.2011.09.007; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Koh DW, 2003, J MED CHEM, V46, P4322, DOI 10.1021/jm020541u; Koh DW, 2003, BIOCHEMISTRY-US, V42, P4855, DOI 10.1021/bi0272048; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; MIWA M, 1979, P NATL ACAD SCI USA, V76, P595, DOI 10.1073/pnas.76.2.595; MIWA M, 1974, J BIOL CHEM, V249, P3475; MIWA M, 1984, METHOD ENZYMOL, V106, P441; MIWA M, 1977, NUCLEIC ACIDS RES, V4, P3997, DOI 10.1093/nar/4.11.3997; Mortusewicz O, 2011, NUCLEIC ACIDS RES, V39, P5045, DOI 10.1093/nar/gkr099; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel CN, 2005, BIOCHEM J, V388, P2; Patel NSA, 2005, J AM SOC NEPHROL, V16, P712, DOI 10.1681/ASN.2004080677; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; Shirato M, 2007, BIOCHEM BIOPH RES CO, V355, P451, DOI 10.1016/j.bbrc.2007.01.171; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Steffen JD, 2011, J MED CHEM; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wlodek S, 2006, ACTA CRYSTALLOGR D, V62, P741, DOI 10.1107/S0907444906016076; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	72	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50889	10.1371/journal.pone.0050889	http://dx.doi.org/10.1371/journal.pone.0050889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251397	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900025
J	Wang, K; Li, H; Yuan, Y; Etheridge, A; Zhou, Y; Huang, D; Wilmes, P; Galas, D				Wang, Kai; Li, Hong; Yuan, Yue; Etheridge, Alton; Zhou, Yong; Huang, David; Wilmes, Paul; Galas, David			The Complex Exogenous RNA Spectra in Human Plasma: An Interface with Human Gut Biota?	PLOS ONE			English	Article							MICROBIOME; MICRORNAS; GENOME; POPULATION; MECHANISM; HEALTH	Human plasma has long been a rich source for biomarker discovery. It has recently become clear that plasma RNA molecules, such as microRNA, in addition to proteins are common and can serve as biomarkers. Surveying human plasma for microRNA biomarkers using next generation sequencing technology, we observed that a significant fraction of the circulating RNA appear to originate from exogenous species. With careful analysis of sequence error statistics and other controls, we demonstrated that there is a wide range of RNA from many different organisms, including bacteria and fungi as well as from other species. These RNAs may be associated with protein, lipid or other molecules protecting them from RNase activity in plasma. Some of these RNAs are detected in intracellular complexes and may be able to influence cellular activities under in vitro conditions. These findings raise the possibility that plasma RNAs of exogenous origin may serve as signaling molecules mediating for example the human-microbiome interaction and may affect and/or indicate the state of human health.	[Wang, Kai; Li, Hong; Yuan, Yue; Etheridge, Alton; Zhou, Yong; Huang, David; Galas, David] Inst Syst Biol, Seattle, WA USA; [Wilmes, Paul; Galas, David] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Etheridge, Alton; Huang, David; Galas, David] Pacific NW Diabet Res, Seattle, WA USA	Institute for Systems Biology (ISB); University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI)	Wang, K (corresponding author), Inst Syst Biol, Seattle, WA USA.	kwang@systemsbiology.org; paul.wilmes@uni.lu; dgalas@pnri.org	Wilmes, Paul/B-1707-2017	Wilmes, Paul/0000-0002-6478-2924	University of Luxemburg; Department of Defense [W911SR-07-C-0101, W81XWH-09-1-0107, HDTRA 1-08-C-0023]; ATTRACT program grant by the Luxembourg National Research Fund [ATTRACT/A09/03]	University of Luxemburg; Department of Defense(United States Department of Defense); ATTRACT program grant by the Luxembourg National Research Fund(Luxembourg National Research Fund)	This work was supported by the University of Luxemburg program, research contracts from the Department of Defense (W911SR-07-C-0101, W81XWH-09-1-0107 and HDTRA 1-08-C-0023), and ATTRACT program grant (ATTRACT/A09/03) awarded by the Luxembourg National Research Fund (to PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asmann YW, 2008, GASTROENTEROLOGY, V135, P1466, DOI 10.1053/j.gastro.2008.09.042; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Camussi G, 2011, AM J CANCER RES, V1, P98; Fleischhacker M, 2010, CANCER BIOMARK, V6, P211, DOI 10.3233/CBM-2009-0131; Fliessbach A, 2009, MICROB ECOL, V57, P611, DOI 10.1007/s00248-009-9489-9; Foster JA, 2012, BRIEFINGS BIOINFORMA; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Haller D, 2006, NEUROGASTROENT MOTIL, V18, P184, DOI 10.1111/j.1365-2982.2006.00762.x; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; KIREDJIAN M, 1986, INT J SYST BACTERIOL, V36, P282, DOI 10.1099/00207713-36-2-282; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000299; Luo Shujun, 2012, Methods Mol Biol, V822, P183, DOI 10.1007/978-1-61779-427-8_12; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Roume H, 2012, ISME J; Semenov DV, 2012, EXPERT OPIN BIOL TH, V12, pS43, DOI 10.1517/14712598.2012.679653; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	29	130	136	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51009	10.1371/journal.pone.0051009	http://dx.doi.org/10.1371/journal.pone.0051009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251414	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900032
J	Zhu, XF; Peng, JJ; Zou, HD; Fu, J; Wang, WW; Xu, X; Zhang, X				Zhu, Xiao-feng; Peng, Jin-juan; Zou, Hai-dong; Fu, Jiong; Wang, Wei-wei; Xu, Xun; Zhang, Xi			Prevalence and Risk Factors of Idiopathic Epiretinal Membranes in Beixinjing Blocks, Shanghai, China	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; PRERETINAL MACULAR FIBROSIS; BLUE MOUNTAINS EYE; DIABETIC-RETINOPATHY; JAPANESE POPULATION; ADULT-POPULATION; LOS-ANGELES; HANDAN EYE; ASSOCIATIONS	Background: To determine the prevalence and risk factors associated with idiopathic epiretinal membranes (iERM) in a Chinese population aged 60 years or older in Beixinjing Blocks, Shanghai. Methods: This population-based study consisted of 3727 participants (89.7% of the eligible). It was performed to describe the prevalence of iERM and possible demographic, systemic, and ocular factors associated with iERM. Each participant underwent a standardized interview and comprehensive ophthalmic examination. iERM was identified and graded from retinal photographs. Then, a case-control study comparing the participants with vs. without iERM was performed to further study the associations between iERM and blood biochemical test results (including fasting plasma glucose, serum creatinine, total cholesterol, and triglyceride), ocular biological parameters (including the axial length, corneal curvature, refractive diopter, intraocular press, and anterior chamber depth), and the data of optical coherence tomography. Results: The prevalence of iERM was 1.02%. iERM was significantly associated with diabetes (OR: 2.457; 95% CI: 1.137, 5.309) and a higher level of education (OR: 1.48; 95% CI: 1.123, 1.952). Blood biochemical test results and ocular biological parameters showed no significant differences between the iERM and control groups, whereas the incidence of posterior vitreous detachment in the iERM group was much higher than in the control group (26.5% vs. 8.8%), but this difference was not statistically significant. Moreover, the eyes with iERM had poorer visual acuity than the eyes without iERM (P<0.05). Conclusions: In Beixinjing Blocks, Shanghai, iERM was relatively rare, was associated with diabetes and a higher level of education, and caused a substantial decrease in visual acuity.	[Zhu, Xiao-feng; Peng, Jin-juan; Zou, Hai-dong; Xu, Xun; Zhang, Xi] Affiliated Shanghai Jiaotong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai, Peoples R China; [Fu, Jiong; Wang, Wei-wei] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Affiliated Shanghai Jiaotong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau [20114007]; Shanghai Leading Talent Reserve Program [40311]	Shanghai Health Bureau; Shanghai Leading Talent Reserve Program	Funding was provided by a key grant from the Shanghai Health Bureau (20114007) and a grant from the Shanghai Leading Talent Reserve Program (40311). No conflicting relationship exists for any author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPIAH AP, 1989, OPHTHALMOLOGY, V96, P389, DOI 10.1016/S0161-6420(89)32881-8; APPIAH AP, 1988, AM J OPHTHALMOL, V106, P533, DOI 10.1016/0002-9394(88)90581-8; Arichika S, 2010, RETINA-J RET VIT DIS, V30, P503, DOI 10.1097/IAE.0b013e3181bd2d65; Bouwens M, 2008, GRAEF ARCH CLIN EXP, V246, P1693, DOI 10.1007/s00417-008-0909-1; CLARKSON JG, 1977, AM J OPHTHALMOL, V84, P1; Council MD, 2005, OPHTHALMOLOGY, V112, P1218, DOI 10.1016/j.ophtha.2005.01.051; Duan XR, 2009, INVEST OPHTH VIS SCI, V50, P2018, DOI 10.1167/iovs.08-2624; FOOS RY, 1977, INVEST OPHTH VIS SCI, V16, P416; FOOS RY, 1980, OPHTHALMOLOGY, V87, P122; Fraser-Bell S, 2004, INVEST OPHTH VIS SCI, V45, P1732, DOI 10.1167/iovs.03-1295; Fraser-Bell S, 2003, OPHTHALMOLOGY, V110, P34, DOI 10.1016/S0161-6420(02)01443-4; Gandorfer A, 2002, BRIT J OPHTHALMOL, V86, P902, DOI 10.1136/bjo.86.8.902; Gatto NM, 2012, OPHTHAL EPIDEMIOL, V19, P127, DOI 10.3109/09286586.2011.615452; Ghazi-Nouri SMS, 2006, BRIT J OPHTHALMOL, V90, P559, DOI 10.1136/bjo.2005.085142; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; Huang X.Z.H., 2009, INT J OPHTHALMOL-CHI, V9, P1321; Huang Xiao-bo, 2009, Zhonghua Yan Ke Za Zhi, V45, P786; Jahn CE, 2001, J CATARACT REFR SURG, V27, P753, DOI 10.1016/S0886-3350(00)00686-6; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P1320, DOI 10.1136/bjo.2008.144626; Kawasaki R, 2009, EYE, V23, P1045, DOI 10.1038/eye.2008.238; Khaja HA, 2008, ARCH OPHTHALMOL-CHIC, V126, P632, DOI 10.1001/archopht.126.5.632; Kishi S, 1996, AM J OPHTHALMOL, V122, P622, DOI 10.1016/S0002-9394(14)70480-5; KISHI S, 1994, AM J OPHTHALMOL, V118, P451, DOI 10.1016/S0002-9394(14)75795-2; Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581; Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403; Koh V, 2012, INVEST OPHTH VIS SCI, V53, P1018, DOI 10.1167/iovs.11-8557; KRAUSHAR MF, 1988, OPHTHALMIC SURG LAS, V19, P843; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; McCarty DJ, 2005, AM J OPHTHALMOL, V140, P288, DOI 10.1016/j.ajo.2005.03.032; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Miyazaki M, 2003, GRAEF ARCH CLIN EXP, V241, P642, DOI 10.1007/s00417-003-0723-8; MOSS SE, 1989, INVEST OPHTH VIS SCI, V30, P823; Ng CH, 2011, OPHTHALMOLOGY, V118, P694, DOI 10.1016/j.ophtha.2010.08.009; Okamoto F, 2009, AM J OPHTHALMOL, V147, P869, DOI 10.1016/j.ajo.2008.11.018; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; Shanghai Bureau of Statistics, 2011, STAT B NAT EC SOC DE; SIDD RJ, 1982, AM J OPHTHALMOL, V94, P44, DOI 10.1016/0002-9394(82)90189-1; SMIDDY WE, 1989, OPHTHALMOLOGY, V96, P811; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Wilkins JR, 1996, OPHTHALMOLOGY, V103, P2142, DOI 10.1016/S0161-6420(96)30377-1; Yamashita T, 2008, GRAEF ARCH CLIN EXP, V246, P333, DOI 10.1007/s00417-007-0745-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yazici AT, 2011, RETINA-J RET VIT DIS, V31, P779, DOI 10.1097/IAE.0b013e3181ef8786; You Q, 2008, EYE, V22, P874, DOI 10.1038/sj.eye.6702786; ZAUBERMAN H, 1981, INVEST OPHTH VIS SCI, V21, P248	49	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51445	10.1371/journal.pone.0051445	http://dx.doi.org/10.1371/journal.pone.0051445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251536	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900087
J	Guan, XX; Liu, ZS; Liu, HL; Yu, HP; Wang, LE; Sturgis, EM; Li, GJ; Wei, QY				Guan, Xiaoxiang; Liu, Zhensheng; Liu, Hongliang; Yu, Hongping; Wang, Li-E; Sturgis, Erich M.; Li, Guojun; Wei, Qingyi			A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer	FASEB JOURNAL			English	Article						apoptosis; microRNA; genetic susceptibility; polymorphism	SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; GENETIC-VARIANTS; LUNG-CANCER; APOPTOSIS; POLYMORPHISMS; CASPASE-3; EXPRESSION; MICRORNA; PROMOTER	Caspases are important regulators and executioners in the apoptosis pathways and play crucial roles in carcinogenesis. We tested the hypothesis that functional variants of CASP genes are associated with risk of squamous cell carcinoma of the head and neck (SCCHN) and second primary malignancy (SPM). We genotyped 7 selected, potentially functional single nucleotide polymorphisms (SNPs) located in the microRNA binding sites of the 3' untranslational region (UTR; 2 in CASP3, 1 in CASP6, and 4 in CASP7) and evaluated their associations first with risk of SCCHN in 1066 patients with SCCHN and 1074 cancer-free control subjects and then with SPM in 846 patients in the same non-Hispanic white study population. We found that compared with the CASP3 TT genotype of rs1049253, the variant TC/CC genotypes were associated with significantly increased risk of SCCHN (adjusted odds ratio = 1.29 and 95% confidence interval = 1.07-1.56) and SPM (adjusted hazard ratio = 1.79 and 95% CI = 1.02-3.16) and worse SPM-free survival (log-rank P = 0.020), but no associations were found for the other 6 SNPs. We then performed additional experiments to seek functional relevance of the rs1049253 SNP. First, the luciferase activity and miR-885-5p mimic transfection tests suggested that CASP3 was the target of miR-885-5p and that rs1049253T>C resulted in altered regulation of the CASP3 expression. Second, the rs1049253 CC genotype was associated with reduced levels of CASP3 mRNA in peripheral blood mononuclear cells from 118 SCCHN patients and 103 cancer-free control subjects and lower levels of CASP3 protein expression in 11 head and neck cancer cell lines, compared with the TT genotype. Taken together, our data suggest that the miR-885-5p binding site rs1049253T>C SNP in the 3'-UTR of CASP3 modulates CASP3 expression at both mRNA and protein levels and thus contributes to SCCHN susceptibility. Guan, X., Liu, Z., Liu, H., Yu, H., Wang, L.-E., Sturgis, E. M., Li, G., and Wei, Q. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J. 27, 1404-1412 (2013). www.fasebj.org	[Guan, Xiaoxiang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Guan, Xiaoxiang; Liu, Zhensheng; Liu, Hongliang; Yu, Hongping; Wang, Li-E; Sturgis, Erich M.; Li, Guojun; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sturgis, Erich M.; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	Nanjing University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wei, QY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Box 189,1515 Holcombe Blvd, Houston, TX 77030 USA.	qwei@mdanderson.org	Liu, Hongliang/P-3444-2014	Liu, Hongliang/0000-0001-7639-0904; Guan, Xiaoxiang/0000-0001-6145-0046	U.S. National Institutes of Health [R01 ES 11740, R01 CA 131274, P50 CA 097007, CA 16672]; NATIONAL CANCER INSTITUTE [P50CA097007, R01CA131274, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by U.S. National Institutes of Health grants R01 ES 11740 and R01 CA 131274 (to Q. W.), P50 CA 097007 (to S. L.), and CA 16672 (to M. D. Anderson Cancer Center). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen KX, 2008, CLIN CANCER RES, V14, P6343, DOI 10.1158/1078-0432.CCR-08-1198; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DAY GL, 1994, J NATL CANCER I, V86, P131, DOI 10.1093/jnci/86.2.131; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Do KA, 2004, CANCER-AM CANCER SOC, V101, P2837, DOI 10.1002/cncr.20714; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fujikawa K, 2000, ANTICANCER RES, V20, P1927; Gilbert ES, 2003, RADIAT RES, V159, P161, DOI 10.1667/0033-7587(2003)159[0161:LCATFH]2.0.CO;2; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Isobe N, 2004, ONCOLOGY-BASEL, V66, P201, DOI 10.1159/000077996; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kania J, 2003, DIGEST DIS SCI, V48, P266, DOI 10.1023/A:1021915124064; Kurokawa H, 1999, ONCOL REP, V6, P33; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lee JW, 2006, PATHOLOGY, V38, P358, DOI 10.1080/00313020600820799; Lee WK, 2009, LUNG CANCER, V65, P19, DOI 10.1016/j.lungcan.2008.10.022; Li CY, 2010, CANCER PREV RES, V3, P246, DOI 10.1158/1940-6207.CAPR-08-0228; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Ng AK, 2008, HEMATOL ONCOL CLIN N, V22, P271, DOI 10.1016/j.hoc.2008.01.007; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Soung YH, 2004, HUM GENET, V115, P112, DOI 10.1007/s00439-004-1129-3; STURGIS EM, 1995, ANN OTO RHINOL LARYN, V104, P946, DOI 10.1177/000348949510401206; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Tormanen-Napankangas U, 2001, INT J CANCER, V93, P192, DOI 10.1002/ijc.1315; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu HL, 2009, CANCER EPIDEM BIOMAR, V18, P2114, DOI 10.1158/1055-9965.EPI-09-0152; Zafereo ME, 2009, CARCINOGENESIS, V30, P997, DOI 10.1093/carcin/bgp096; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481	46	29	30	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1404	1412		10.1096/fj.12-223420	http://dx.doi.org/10.1096/fj.12-223420			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271051	Green Published			2022-12-25	WOS:000316940800013
J	van der Vorst, EPC; Vanags, LZ; Dunn, LL; Prosser, HC; Rye, KA; Bursill, CA				van der Vorst, Emiel P. C.; Vanags, Laura Z.; Dunn, Louise L.; Prosser, Hamish C.; Rye, Kerry-Anne; Bursill, Christina A.			High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells	FASEB JOURNAL			English	Article						inflammation; scavenger receptor-B1	APOLIPOPROTEIN-A-I; ANTIINFLAMMATORY PROPERTIES; NEOINTIMAL HYPERPLASIA; ALLOGRAFT VASCULOPATHY; ADHESION MOLECULE-1; ARTERIAL INJURY; CHOLESTEROL; RECEPTORS; INHIBIT; HDL	The inflammatory chemokines CCL2, CCL5, and CX(3)CL1 stimulate vascular smooth muscle cell (SMC) proliferation. High-density lipoproteins (HDLs) exhibit potent cardioprotective and anti-inflammatory properties. We therefore sought to determine the effect of reconstituted HDLs (rHDLs) on SMC chemokine expression and proliferation and elucidate the mechanisms. Preincubation of primary human SMCs with rHDLs containing apolipoprotein (apo) A-I and phosphatidylcholine (20 mu M, final apoA-I concentration), before stimulation with TNF-alpha, inhibited CCL2 (54%), CCL5 (38%), and CX(3)CL1 (33%) protein levels. The chemokine receptors CCR2 (29%) and CX(3)CR1 (22%) were also reduced by rHDLs. Incubation with rHDLs reduced the NF-kappa B subunit p65 in the nucleus (39%) and phosphorylated I kappa B alpha (28%), both regulators of chemokine expression. Furthermore, rHDLs inhibited the upstream signaling proteins phosphoinositide 3-kinase (37%) and phosphorylated Akt (pAkt, 49%). Incubation with rHDLs strikingly suppressed SMC proliferation (84%) and ERK phosphorylation (pERK, 29%). Finally, siRNA knockdown of the scavenger receptor SR-B1 attenuated rHDL-induced inhibition of SMC chemokine expression, p65, and proliferation, indicating that SR-B1 plays a key role in mediating these effects. Thus, rHDLs reduce SMC chemokine expression (via NF-kappa B/pAkt inhibition) and proliferation (via pERK inhibition). This has important implications for preventing the pathogenesis of neointimal hyperplasia, the main cause of early vein graft/stent failure.-Van der Vorst, E. P. C., Vanags, L. Z., Dunn, L. L., Prosser, H. C., Rye, K.-A., Bursill, C. A. High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells. FASEB J. 27, 1413-1425 (2013). www.fasebj.org	[van der Vorst, Emiel P. C.; Vanags, Laura Z.; Dunn, Louise L.; Prosser, Hamish C.; Rye, Kerry-Anne; Bursill, Christina A.] Heart Res Inst, Newtown, NSW, Australia; [van der Vorst, Emiel P. C.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Vanags, Laura Z.; Rye, Kerry-Anne; Bursill, Christina A.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	University of Sydney; Heart Research Institute; Maastricht University; University of Sydney; University of Melbourne	Bursill, CA (corresponding author), 7 Eliza St, Sydney, NSW 2042, Australia.	bursillc@hri.org.au		Bursill, Christina/0000-0002-0682-8760	Heart Foundation [CR07S3331]; Bushell Foundation; National Health and Medical Research Council [222722, 537537]	Heart Foundation; Bushell Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Heart Foundation Career Development Fellowship (CR07S3331) and a Bushell Foundation grant (to C. A. B), a National Health and Medical Research Council Program grant (222722; to K-A. R), and a National Health and Medical Research Council Early Career Fellowship (537537; to L.L.D).	Ashby DT, 1998, ARTERIOSCL THROM VAS, V18, P1450, DOI 10.1161/01.ATV.18.9.1450; Baker PW, 1999, J LIPID RES, V40, P345; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Di Bartolo BA, 2011, ATHEROSCLEROSIS, V217, P395, DOI 10.1016/j.atherosclerosis.2011.04.001; Eefting D, 2009, J VASC SURG, V50, P152, DOI 10.1016/j.jvs.2009.03.027; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Ibanez B, 2012, ATHEROSCLEROSIS, V220, P72, DOI 10.1016/j.atherosclerosis.2011.10.006; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McGrath KCY, 2009, ARTERIOSCL THROM VAS, V29, P877, DOI 10.1161/ATVBAHA.109.184663; Mineo C, 2007, TRENDS CARDIOVAS MED, V17, P156, DOI 10.1016/j.tcm.2007.03.005; Murphy AJ, 2013, J PHARMACOL EXP THER, V344, P41, DOI 10.1124/jpet.112.199257; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Saddar S, 2013, CIRC RES, V112, P140, DOI 10.1161/CIRCRESAHA.112.280081; Scanu A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2930; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; Seo SM, 2011, HEART, V97, P1943, DOI 10.1136/hrt.2011.225466; Shimizu K, 2009, CIRCULATION, V120, P1800, DOI 10.1161/CIRCULATIONAHA.109.859595; Sviridov D, 2001, BIOCHEM J, V358, P79, DOI 10.1042/0264-6021:3580079; TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93, DOI 10.1016/0009-8981(77)90465-X; TAUBMAN MB, 1992, CIRC RES, V70, P314, DOI 10.1161/01.RES.70.2.314; Topakian R, 2008, EUR J NEUROL, V15, P179, DOI 10.1111/j.1468-1331.2007.02026.x; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922	39	37	37	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1413	1425		10.1096/fj.12-212753	http://dx.doi.org/10.1096/fj.12-212753			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271056				2022-12-25	WOS:000316940800014
J	Bajpai, P; Sangar, MC; Singh, S; Tang, WG; Bansal, S; Chowdhury, G; Cheng, Q; Fang, JK; Martin, MV; Guengerich, FP; Avadhani, NG				Bajpai, Prachi; Sangar, Michelle C.; Singh, Shilpee; Tang, Weigang; Bansal, Seema; Chowdhury, Goutam; Cheng, Qian; Fang, Ji-Kang; Martin, Martha V.; Guengerich, F. Peter; Avadhani, Narayan G.			Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6 IMPLICATIONS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NAPHTHOFLAVONE; GENE POLYMORPHISM; ELECTRON-TRANSFER; LIVER MICROSOMES; N-DEMETHYLATION; MESSENGER-RNA; MPTP TOXICITY; L-DEPRENYL; BRAIN; CYP2D6	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxic side product formed in the chemical synthesis of desmethylprodine opioid analgesic, which induces Parkinson disease. Monoamine oxidase B, present in the mitochondrial outer membrane of glial cells, catalyzes the oxidation of MPTP to the toxic 1-methyl-4-phenylpyridinium ion (MPP+), which then targets the dopaminergic neurons causing neuronal death. Here, we demonstrate that mitochondrion-targeted human cytochrome P450 2D6 (CYP2D6), supported by mitochondrial adrenodoxin and adrenodoxin reductase, can efficiently catalyze the metabolism of MPTP to MPP+, as shown with purified enzymes and also in cells expressing mitochondrial CYP2D6. Neuro-2A cells stably expressing predominantly mitochondrion-targeted CYP2D6 were more sensitive to MPTP-mediated mitochondrial respiratory dysfunction and complex I inhibition than cells expressing predominantly endoplasmic reticulum-targeted CYP2D6. Mitochondrial CYP2D6 expressing Neuro-2A cells produced higher levels of reactive oxygen species and showed abnormal mitochondrial structures. MPTP treatment also induced mitochondrial translocation of an autophagic marker, Parkin, and a mitochondrial fission marker, Drp1, in differentiated neurons expressing mitochondrial CYP2D6. MPTP-mediated toxicity in primary dopaminergic neurons was attenuated by CYP2D6 inhibitor, quinidine, and also partly by monoamine oxidase B inhibitors deprenyl and pargyline. These studies show for the first time that dopaminergic neurons expressing mitochondrial CYP2D6 are fully capable of activating the pro-neurotoxin MPTP and inducing neuronal damage, which is effectively prevented by the CYP2D6 inhibitor quinidine.	[Fang, Ji-Kang; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Fang, Ji-Kang; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Marie Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Chowdhury, Goutam; Cheng, Qian; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Chowdhury, Goutam; Cheng, Qian; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu		Singh, Shilpee/0000-0003-4404-6089	National Institutes of Health [R01 GM034883, R37 CA090426, T32 GM007170]; American Recovery Act supplement; Harriet Ellison Woodward endowment; NATIONAL CANCER INSTITUTE [P30CA016520, R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883, T32GM007170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery Act supplement; Harriet Ellison Woodward endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM034883, Grant R37 CA090426 (to F. P. G.), and Training Grant T32 GM007170 (to M. C. S.). This work was also supported by an American Recovery Act supplement and by a Harriet Ellison Woodward endowment (to N. G. A.).	Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1998, BIOCHEMISTRY-US, V37, P1150, DOI 10.1021/bi972046j; Anandatheerthavarada HK, 2001, EMBO J, V20, P2394, DOI 10.1093/emboj/20.10.2394; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bach MV, 2000, XENOBIOTICA, V30, P297, DOI 10.1080/004982500237686; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BLOEM BR, 1990, J NEUROL SCI, V97, P273, DOI 10.1016/0022-510X(90)90225-C; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; CHIBA K, 1985, DRUG METAB DISPOS, V13, P342; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coleman T, 1996, J PHARMACOL EXP THER, V277, P685; DIMONTE D, 1986, BIOCHEM BIOPH RES CO, V137, P310, DOI 10.1016/0006-291X(86)91211-8; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dragoni S, 2003, XENOBIOTICA, V33, P181, DOI 10.1080/0049825021000048827; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Dyck LE, 2001, DRUG METAB DISPOS, V29, P1156; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gilham DE, 1997, XENOBIOTICA, V27, P111, DOI 10.1080/004982597240802; Golab-Janowska M, 2007, NEUROL NEUROCHIR POL, V41, P113; GRACE JM, 1994, CHEM RES TOXICOL, V7, P286, DOI 10.1021/tx00039a003; Guengerich FP, 1982, PRINCIPLES METHODS T, P609; Halling J, 2008, PHARMACOGENET GENOM, V18, P209, DOI 10.1097/FPC.0b013e3282f5106e; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; Herraiz T, 2006, TOXICOL APPL PHARM, V216, P387, DOI 10.1016/j.taap.2006.06.003; KALLIO J, 1991, ACTA NEUROL SCAND, V83, P194, DOI 10.1111/j.1600-0404.1991.tb04676.x; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; KRAJL M, 1965, BIOCHEM PHARMACOL, V14, P1684, DOI 10.1016/0006-2952(65)90025-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mann A, 2012, NEUROBIOL AGING, V33, P2160, DOI 10.1016/j.neurobiolaging.2011.08.014; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; MIZUNO Y, 1988, NEUROSCI LETT, V91, P349, DOI 10.1016/0304-3940(88)90705-7; Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morgenstern J P, 1991, Methods Mol Biol, V7, P181, DOI 10.1385/0-89603-178-0:181; Murphy AN, 2009, EMBO MOL MED, V1, P81, DOI 10.1002/emmm.200900020; Narimatsu S, 1996, CHEM RES TOXICOL, V9, P93, DOI 10.1021/tx9500540; OMURA T, 1964, J BIOL CHEM, V239, P2370; PAI KS, 1991, BRAIN RES, V555, P239, DOI 10.1016/0006-8993(91)90347-X; Persad AS, 2003, NEUROEPIDEMIOLOGY, V22, P357, DOI 10.1159/000072926; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; RAMSAY RR, 1986, LIFE SCI, V39, P581, DOI 10.1016/0024-3205(86)90037-8; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; Rittenbach K A, 2007, Drug Metab Lett, V1, P97, DOI 10.2174/187231207780363589; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; ROSSETTI ZL, 1988, BIOCHEM PHARMACOL, V37, P4573, DOI 10.1016/0006-2952(88)90674-0; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2010, MOL GENET METAB, V99, P90, DOI 10.1016/j.ymgme.2009.08.009; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Sharma U, 1996, DRUG METAB DISPOS, V24, P669; Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007; SMITH CAD, 1992, LANCET, V339, P1375, DOI 10.1016/0140-6736(92)91196-F; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; SONSALLA PK, 1986, EUR J PHARMACOL, V129, P339, DOI 10.1016/0014-2999(86)90444-9; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Valoti M, 2000, EUR J PHARMACOL, V391, P199, DOI 10.1016/S0014-2999(00)00078-9; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578	68	52	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4436	4451		10.1074/jbc.M112.402123	http://dx.doi.org/10.1074/jbc.M112.402123			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258538	hybrid, Green Published			2022-12-25	WOS:000314845000070
J	Deng, H; Maitra, U; Morris, M; Li, LW				Deng, Hui; Maitra, Urmila; Morris, Matt; Li, Liwu			Molecular Mechanism Responsible for the Priming of Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; KAPPA-B ACTIVATION; HIGH-FAT DIET; ENDOTOXIN TOLERANCE; MAPK PHOSPHATASE-1; IRAK-M; LIPOPOLYSACCHARIDE; INFLAMMATION; INTERLEUKIN-1; INHIBITION	Host macrophages can be preprogrammed into opposing primed or tolerant states depending upon the nature and quantities of external stimulants. The paradigm of priming and tolerance has significant implications in the pathogenesis and resolution of both acute and chronic inflammatory diseases. However, the responsible mechanisms are not well understood. Here, we report that super low dose bacterial endotoxin lipopolysaccharide (LPS), as low as 5 pg/ml, primes the expression of proinflammatory mediators in macrophages upon a second high dose LPS challenge (100 ng/ml), although 5 pg/ml LPS itself does not trigger noticeable macrophage activation. Mice primed with super low dose LPS (0.5 mu g/kg body weight) in vivo experience significantly elevated mortality following a second hit of high dose LPS as compared with saline-primed control mice. Mechanistically, we demonstrate that LPS primes macrophages by removing transcriptional suppressive RelB through interleukin receptor-associated kinase 1 and Tollip (Toll-interacting protein)-dependent mechanisms. This is in sharp contrast to the well documented RelB stabilization and induction by high dose LPS, potentially through the phosphoinositide 3-kinase (PI3K) pathway. Super low dose and high dose LPS cause opposing modulation of interleukin receptor-associated kinase 1 and PI3K pathways and lead to opposing regulation of RelB. The pathway switching induced by super low versus high dose LPS underscores the importance of competing intracellular circuitry during the establishment of macrophage priming and tolerance.	[Deng, Hui; Maitra, Urmila; Morris, Matt; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Lab Inflammat Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu		Morris, Matthew/0000-0002-1236-1255; Li, Liwu/0000-0001-8870-5299	National Institutes of Health [RO1 HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL115835 (to L. L.).	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; DOFFERHOFF ASM, 1991, SCAND J INFECT DIS, V23, P745, DOI 10.3109/00365549109024303; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Gan L, 2010, MOL IMMUNOL, V47, P1278, DOI 10.1016/j.molimm.2009.12.004; GOTO T, 1994, CLIN DIAGN LAB IMMUN, V1, P684, DOI 10.1128/CDLI.1.6.684-688.1994; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Hirohashi N, 1996, INFECT IMMUN, V64, P1011, DOI 10.1128/IAI.64.3.1011-1015.1996; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee JY, 2011, P NATL ACAD SCI USA, V108, P14157, DOI 10.1073/pnas.1107747108; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanaa N, 2004, J BIOL CHEM, V279, P25189, DOI 10.1074/jbc.M312431200; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; VOGEL SN, 1983, J INTERFERON RES, V3, P153, DOI 10.1089/jir.1983.3.153; Weih F, 1997, J IMMUNOL, V158, P5211; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Xia YY, 1997, AM J PATHOL, V151, P375; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694; Zahr F, 2011, ANN THORAC SURG, V92, P1420, DOI 10.1016/j.athoracsur.2011.05.085; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	66	84	86	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3897	3906		10.1074/jbc.M112.424390	http://dx.doi.org/10.1074/jbc.M112.424390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264622	hybrid, Green Published			2022-12-25	WOS:000314845000020
J	Katnani, HA; Van Opstal, AJ; Gandhi, NJ				Katnani, Husam A.; Van Opstal, A. J.; Gandhi, Neeraj J.			Blink Perturbation Effects on Saccades Evoked by Microstimulation of the Superior Colliculus	PLOS ONE			English	Article							PONTINE OMNIPAUSE NEURONS; EYE-MOVEMENTS; ELECTRICAL-STIMULATION; GENERATION; MONKEY; MOTOR; PARAMETERS; SYSTEM; CAT	Current knowledge of saccade-blink interactions suggests that blinks have paradoxical effects on saccade generation. Blinks suppress saccade generation by attenuating the oculomotor drive command in structures like the superior colliculus (SC), but they also disinhibit the saccadic system by removing the potent inhibition of pontine omnipause neurons (OPNs). To better characterize these effects, we evoked the trigeminal blink reflex by delivering an air puff to one eye as saccades were evoked by sub-optimal stimulation of the SC. For every stimulation site, the peak and average velocities of stimulation with blink movements (SwBMs) were lower than stimulation-only saccades (SoMs), supporting the notion that the oculomotor drive is weakened in the presence of a blink. In contrast, the duration of the SwBMs was longer, consistent with the hypothesis that the blink-induced inhibition of the OPNs could prolong the window of time available for oculomotor commands to drive an eye movement. The amplitude of the SwBM could also be larger than the SoM amplitude obtained from the same site, particularly for cases in which blink-associated eye movements exhibited the slowest kinematics. The results are interpreted in terms of neural signatures of saccade-blink interactions. Citation: Katnani HA, Van Opstal AJ, Gandhi NJ (2012) Blink Perturbation Effects on Saccades Evoked by Microstimulation of the Superior Colliculus. PLoS ONE 7(12): e51843. doi:10.1371/journal.pone.0051843	[Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Gandhi, Neeraj J.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Van Opstal, A. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, Nijmegen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Radboud University Nijmegen	Katnani, HA (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	hkatnani@gmail.com	van Opstal, John/D-1907-2010	van Opstal, John/0000-0001-5957-5712	National Institute of General Medical Science [T32 GM081760]; Nation Science Foundation [DGE-0549352]; National Eye Institute [R01 EY015485, P30 EY008098]; National Institute of Deafness and Communication Disorders [P30 DC0025205]; Radboud University Nijmegen; Dutch NWO [805.05.003]; NATIONAL EYE INSTITUTE [P30EY008098, R01EY015485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081760] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nation Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Radboud University Nijmegen; Dutch NWO(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.A.K. is supported by an institutional training grant from the National Institute of General Medical Science (T32 GM081760) and institutional training grant from the Nation Science Foundation (DGE-0549352). N.J.G. is supported by the National Eye Institute (R01 EY015485, P30 EY008098) and National Institute of Deafness and Communication Disorders (P30 DC0025205). A.J.V.O. is supported by the Radboud University Nijmegen and by a VICI grant from the Dutch NWO (ALW grant 805.05.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; Breznen B, 1996, EXP BRAIN RES, V111, P337; Bryant CL, 2005, J NEUROSCI METH, V142, P193, DOI 10.1016/j.jneumeth.2004.08.019; Edelman JA, 2001, J NEUROPHYSIOL, V86, P676, DOI 10.1152/jn.2001.86.2.676; Gandhi N. J., 2011, OXFORD HDB EYE MOVEM, P323; Gandhi NJ, 2012, EXP BRAIN RES, V216, P321, DOI 10.1007/s00221-011-2937-z; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Gandhi NJ, 2005, J NEUROPHYSIOL, V93, P1718, DOI 10.1152/jn.00854.2004; Gnadt JW, 1997, EXP BRAIN RES, V116, P389, DOI 10.1007/PL00005767; Goossens HHLM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002508; Goossens HHLM, 2010, J NEUROPHYSIOL, V103, P1685, DOI 10.1152/jn.00788.2009; Goossens HHLM, 2006, J NEUROPHYSIOL, V95, P2326, DOI 10.1152/jn.00889.2005; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3411, DOI 10.1152/jn.2000.83.6.3411; Groh JM, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00130; Groh JM, 2001, BIOL CYBERN, V85, P159, DOI 10.1007/s004220100249; HUERTA MF, 1981, BRAIN RES, V211, P1, DOI 10.1016/0006-8993(81)90063-9; Katnani HA, 2012, J NEUROPHYSIOL, V108, P528, DOI 10.1152/jn.00257.2012; Katnani HA, 2012, J NEUROPHYSIOL, V107, P2442, DOI 10.1152/jn.00992.2011; KELLER EL, 1974, J NEUROPHYSIOL, V37, P316, DOI 10.1152/jn.1974.37.2.316; Missal M, 1996, EXP BRAIN RES, V107, P382; Ndiaye A, 2002, J COMP NEUROL, V448, P373, DOI 10.1002/cne.10269; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Paul K, 2006, VISION RES; Rambold H, 2002, J NEUROPHYSIOL, V88, P1220, DOI 10.1152/jn.2002.88.3.1220; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Rottach KG, 1998, J NEUROPHYSIOL, V79, P2895, DOI 10.1152/jn.1998.79.6.2895; Schultz KP, 2010, J NEUROPHYSIOL, V103, P2255, DOI 10.1152/jn.01150.2009; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; TAKADA M, 1984, NEUROSCI LETT, V50, P251, DOI 10.1016/0304-3940(84)90494-4; Van Horn MR, 2010, J NEUROSCI, V30, P10905, DOI 10.1523/JNEUROSCI.0393-10.2010; van Opstal AJ, 2008, BIOL CYBERN, V98, P561, DOI 10.1007/s00422-008-0219-z; VANOPSTAL AJ, 1990, EXP BRAIN RES, V79, P299, DOI 10.1007/BF00608239; Williamson SS, 2005, J NEUROPHYSIOL, V93, P627, DOI 10.1152/jn.00820.2004; Yoshida K, 1999, J NEUROPHYSIOL, V82, P1198, DOI 10.1152/jn.1999.82.3.1198	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51843	10.1371/journal.pone.0051843	http://dx.doi.org/10.1371/journal.pone.0051843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251639	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800096
J	Khan, SN; Danishuddin, M; Varshney, B; Lal, SK; Khan, AU				Khan, Shahper N.; Danishuddin, Mohd; Varshney, Bhavna; Lal, Sunil K.; Khan, Asad U.			Inhibition of N-Terminal Lysines Acetylation and Transcription Factor Assembly by Epirubicin Induced Deranged Cell Homeostasis	PLOS ONE			English	Article							HISTONE ACETYLATION; CRYSTAL-STRUCTURE; DNA; BINDING; PROTEIN; DAUNOMYCIN; CHROMATIN; CYCLE; SITE	Epirubicin (EPI), an anthracycline antitumour antibiotic, is a known intercalating and DNA damaging agent. Here, we study the molecular interaction of EPI with histones and other cellular targets. EPI binding with histone core protein was predicted with spectroscopic and computational techniques. The molecular distance r, between donor (histone H3) and acceptor (EPI) was estimated using Forster's theory of non-radiation energy transfer and the detailed binding phenomenon is expounded. Interestingly, the concentration dependent reduction in the acetylated states of histone H3 K9/K14 was observed suggesting more repressed chromatin state on EPI treatment. Its binding site near N-terminal lysines is further characterized by thermodynamic determinants and molecular docking studies. Specific DNA binding and inhibition of transcription factor (Tf)-DNA complex formation implicates EPI induced transcriptional inhibition. EPI also showed significant cell cycle arrest in drug treated cells. Chromatin fragmentation and loss of membrane integrity in EPI treated cells is suggestive of their commitment to cell death. This study provides an analysis of nucleosome dynamics during EPI treatment and provides a novel insight into its action. Citation: Khan SN, Danishuddin M, Varshney B, Lal SK, Khan AU (2012) Inhibition of N-Terminal Lysines Acetylation and Transcription Factor Assembly by Epirubicin Induced Deranged Cell Homeostasis. PLoS ONE 7(12): e51850. doi: 10.1371/journal.pone.0051850	[Khan, Shahper N.; Danishuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Varshney, Bhavna; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Khan, Asad U/K-8157-2013	Khan, Asad U/0000-0001-9191-9423; Khan, Shahper N./0000-0002-3931-6702	internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University; CSIR	internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was suppoprted by internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Barbara Jacobs, Taussig Cancer Institute, USA; for critical reading of the manuscript. Author acknowledges the central facilities of Interdisciplinary Biotechnology Unit, AMU, Aligarh and Dr. Shahid Jameel for accessibility to the central facilities in virology section, ICGEB, New Delhi. SNK acknowledges CSIR for Senior Research Fellowship	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGGINI M, 1994, ANTI-CANCER DRUG DES, V9, P373; Chen Y., 2005, MOL IMAGING FRET MIC, P126; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Clifford J, 1996, EMBO J, V15, P4142, DOI 10.1002/j.1460-2075.1996.tb00789.x; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Forster T., 1996, MODERN QUANTUM CHEM, V3; Gao H, 2004, J PHOTOCH PHOTOBIO A, V167, P213, DOI 10.1016/j.jphotochem.2004.05.017; Gottesfeld JM, 2000, GENE EXPRESSION, V9, P77; GRANA X, 1995, ONCOGENE, V11, P211; Gray S. G., 2001, Current Molecular Medicine (Hilversum), V1, P401, DOI 10.2174/1566524013363537; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Hu YJ, 2004, J PHARMACEUT BIOMED, V36, P915, DOI 10.1016/j.jpba.2004.08.021; KESSEL D, 1979, MOL PHARMACOL, V16, P306; Khan SN, 2011, CELL BIOCHEM BIOPHYS, V60, P209, DOI 10.1007/s12013-010-9141-9; Khan SN, 2010, CLIN CHIM ACTA, V411, P1401, DOI 10.1016/j.cca.2010.06.020; Khan SN, 2008, J PHARMACEUT BIOMED, V48, P1096, DOI 10.1016/j.jpba.2008.08.030; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Koyama Y, 2007, CHEM PHARM BULL, V55, P520, DOI 10.1248/cpb.55.520; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Larouche K, 1996, BIOTECHNIQUES, V20, P439; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Liu YQ, 2008, CANCER INVEST, V26, P575, DOI 10.1080/07357900701837168; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mahlknecht U, 2000, MOL MED, V6, P623, DOI 10.1007/BF03402044; MILES JL, 1962, J BIOL CHEM, V237, P1319; Mir MA, 2004, BIOPHYS CHEM, V109, P121, DOI 10.1016/j.bpc.2003.10.023; Munishkina LA, 2004, J MOL BIOL, V342, P1305, DOI 10.1016/j.jmb.2004.06.094; MURPHREE SA, 1976, BIOCHEM PHARMACOL, V25, P1227, DOI 10.1016/0006-2952(76)90374-9; Nafisi S, 2005, DNA CELL BIOL, V24, P634, DOI 10.1089/dna.2005.24.634; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; PONTICELLI AS, 1990, MOL CELL BIOL, V10, P2832, DOI 10.1128/MCB.10.6.2832; Priebe W, 2001, METHOD ENZYMOL, V340, P529; Rabbani A, 2004, BIOCHEMISTRY-US, V43, P16497, DOI 10.1021/bi048524p; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; STURM RA, 1991, CELL GROWTH DIFFER, V2, P519; THOMSON JAF, 1993, PIGM CELL RES, V6, P13, DOI 10.1111/j.1600-0749.1993.tb00576.x; Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200; Tyagi S, 2000, BIOCHEM BIOPH RES CO, V277, P589, DOI 10.1006/bbrc.2000.3720; Umov FD, 2003, ANN NY ACAD SCI, V983, P5; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51850	10.1371/journal.pone.0051850	http://dx.doi.org/10.1371/journal.pone.0051850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251640	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800097
J	Kobayashi, M; Kashino, M				Kobayashi, Maori; Kashino, Makio			Effect of Flanking Sounds on the Auditory Continuity Illusion	PLOS ONE			English	Article							AUDIOVISUAL SIMULTANEITY; ATTENTIONAL BLINK; INDUCTION; MASKING; MOTION; TASK	Background: The auditory continuity illusion or the perceptual restoration of a target sound briefly interrupted by an extraneous sound has been shown to depend on masking. However, little is known about factors other than masking. Methodology/Principal Findings: We examined whether a sequence of flanking transient sounds affects the apparent continuity of a target tone alternated with a bandpass noise at regular intervals. The flanking sounds significantly increased the limit of perceiving apparent continuity in terms of the maximum target level at a fixed noise level, irrespective of the frequency separation between the target and flanking sounds: the flanking sounds enhanced the continuity illusion. This effect was dependent on the temporal relationship between the flanking sounds and noise bursts. Conclusions/Significance: The spectrotemporal characteristics of the enhancement effect suggest that a mechanism to compensate for exogenous attentional distraction may contribute to the continuity illusion.	[Kobayashi, Maori] Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan; [Kashino, Makio] NTT Corp, NTT, Commun Sci Labs, Atsugi, Kanagawa, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan	Meiji University; Nippon Telegraph & Telephone Corporation; Tokyo Institute of Technology	Kobayashi, M (corresponding author), Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan.	te11001@meiji.ac.jp			MEXT [22700268]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the MEXT Grant-in-Aid for Young Scientists (B) (No. 22700268) awarded to MKO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell KM, 2004, PERCEPT PSYCHOPHYS, V66, P1147, DOI 10.3758/BF03196842; BACON SP, 1987, J ACOUST SOC AM, V81, P1073, DOI 10.1121/1.395125; Bregman A.S., 1994, AUDITORY SCENE ANAL; Drake C, 1999, J ACOUST SOC AM, V106, P3529, DOI 10.1121/1.428206; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Heinrich A, 2011, J COGNITIVE NEUROSCI, V23, P2675, DOI 10.1162/jocn.2011.21627; HOUTGAST T, 1972, J ACOUST SOC AM, V51, P1885, DOI 10.1121/1.1913048; Kashino M, 1996, PERCEPT PSYCHOPHYS, V58, P899, DOI 10.3758/BF03205491; Kobayashi M, 2007, PERCEPT PSYCHOPHYS, V69, P393, DOI 10.3758/BF03193760; Micheyl C, 2003, J COGNITIVE NEUROSCI, V15, P747, DOI 10.1162/089892903322307456; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; Moore BC, 2012, INTRO PSYCHOL HEARIN; Neff DL, 1993, J ACOUST SOC AM, V94, P3111; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Riecke L, 2008, PERCEPT PSYCHOPHYS, V70, P1, DOI 10.3758/PP.70.1.1; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Tse CY, 2006, PSYCHOPHYSIOLOGY, V43, P172, DOI 10.1111/j.1469-8986.2006.389.x; Warren R. M., 1999, AUDITORY PERCEPTION; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; Watanabe K, 1998, PERCEPTION, V27, P1041, DOI 10.1068/p271041; YANTIS S, 1994, CAN J EXP PSYCHOL, V48, P182, DOI 10.1037/1196-1961.48.2.182; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329	26	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51969	10.1371/journal.pone.0051969	http://dx.doi.org/10.1371/journal.pone.0051969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251666	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800121
J	Campbell, LJ; Willoughby, JJ; Jensen, AM				Campbell, Leah J.; Willoughby, John J.; Jensen, Abbie M.			Two Types of Tet-On Transgenic Lines for Doxycycline-Inducible Gene Expression in Zebrafish Rod Photoreceptors and a Gateway-Based Tet-On Toolkit	PLOS ONE			English	Article							SYSTEM; CELLS	The ability to control transgene expression within specific tissues is an important tool for studying the molecular and cellular mechanisms of development, physiology, and disease. We developed a Tet-On system for spatial and temporal control of transgene expression in zebrafish rod photoreceptors. We generated two transgenic lines using the Xenopus rhodopsin promoter to drive the reverse tetracycline-controlled transcriptional transactivator (rtTA), one with self-reporting GFP activity and one with an epitope tagged rtTA. The self-reporting line includes a tetracycline response element (TRE)-driven GFP and, in the presence of doxycycline, expresses GFP in larval and adult rods. A time-course of doxycycline treatment demonstrates that maximal induction of GFP expression, as determined by the number of GFP-positive rods, is reached within approximately 24 hours of drug treatment. The epitope-tagged transgenic line eliminates the need for the self-reporting GFP activity by expressing a FLAG-tagged rtTA protein. Both lines demonstrate strong induction of TRE-driven transgenes from plasmids microinjected into one-cell embryos. These results show that spatial and temporal control of transgene expression can be achieved in rod photoreceptors. Additionally, system components are constructed in Gateway compatible vectors for the rapid cloning of doxycycline-inducible transgenes and use in other areas of zebrafish research.	[Campbell, Leah J.; Willoughby, John J.; Jensen, Abbie M.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Jensen, Abbie M.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Jensen, AM (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	ajensen@bio.umass.edu		Campbell, Leah/0000-0002-1666-2143	National Institutes of Health, National Eye Institute [EY015420]; NATIONAL EYE INSTITUTE [R56EY015420, R01EY015420] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute (EY015420 to AMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeletti B, 2003, INVEST OPHTH VIS SCI, V44, P755, DOI 10.1167/iovs.02-0340; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Chang MA, 2000, INVEST OPHTH VIS SCI, V41, P4281; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Koga A, 2008, DEV DYNAM, V237, P2466, DOI 10.1002/dvdy.21688; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Newman Morgan, 2010, BMC Res Notes, V3, P282, DOI 10.1186/1756-0500-3-282; Ohnaka M, 2012, J NEUROCHEM; Ohno-Matsui K, 2002, AM J PATHOL, V160, P711, DOI 10.1016/S0002-9440(10)64891-2; Okoye G, 2003, J NEUROSCI, V23, P4164; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; ROHLICH P, 1989, EXP EYE RES, V49, P999, DOI 10.1016/S0014-4835(89)80022-3; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	31	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51270	10.1371/journal.pone.0051270	http://dx.doi.org/10.1371/journal.pone.0051270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251476	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200079
J	Cao, L; Li, LL; Lin, DW; Zuo, ZY				Cao, Lin; Li, Liaoliao; Lin, Daowei; Zuo, Zhiyi			Isoflurane Induces Learning Impairment That Is Mediated by Interleukin 1 beta in Rodents	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; AGED RATS; LIDOCAINE; CYTOKINE; BRAIN; MICE; DECLINE; INJURY; NEUROPROTECTION	Postoperative cognitive decline is a clinical syndrome. Volatile anesthetics are commonly used during surgery. It is conceivable that volatile anesthetics may contribute to postoperative cognitive decline. Isoflurane can impair cognitive functions of animals under certain conditions. However, the mechanisms for this impairment are not clear. Here, male 18-month old Fisher 344 rats or 10-week old mice were exposed to 1.2 or 1.4% isoflurane for 2 h. Our studies showed that isoflurane impaired the cognitive functions of the rats in Barnes maze. Isoflurane-exposed rats had reduced freezing behavior during the training sessions in the fear conditioning test. This isoflurane effect was attenuated by lidocaine, a local anesthetic with anti-inflammatory property. Rats that had training sessions and were exposed to isoflurane 30 min later had freezing behavior similar to that of control animals. Isoflurane increased the expression of interleukin 1 beta (IL-1 beta), interleukin-6 and activated caspase 3 in the hippocampus of the 18-month old rats. IL-1 beta positive staining was co-localized with that of NeuN, a neuronal marker. The increase of IL-1 beta and activated caspase 3 but not interleukin-6 was attenuated by lidocaine. Isoflurane also impaired the cognitive functions of 10-week old C57BL/6J mice and increased IL-1 beta in their hippocampi. However, isoflurane did not affect the cognitive functions of IL-1 beta deficient mice. Our results suggest that isoflurane impairs the learning but may not affect the recall of the aged rats. IL-1 beta may play an important role in this isoflurane effect.	[Cao, Lin; Li, Liaoliao; Lin, Daowei; Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Cao, Lin; Lin, Daowei; Zuo, Zhiyi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; Sun Yat Sen University	Zuo, ZY (corresponding author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health, Bethesda, Maryland [R01 GM065211]; International Anesthesia Research Society, Cleveland, Ohio; American Heart Association Mid-Atlantic Affiliate, Baltimore, Maryland [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065211, R01GM098308] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society, Cleveland, Ohio; American Heart Association Mid-Atlantic Affiliate, Baltimore, Maryland(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant (R01 GM065211 to ZZ) from the National Institutes of Health, Bethesda, Maryland, by a grant from the International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award to ZZ), Cleveland, Ohio, by a Grant-in-Aid from the American Heart Association Mid-Atlantic Affiliate (10GRNT3900019 to ZZ), Baltimore, Maryland, and the Robert M. Epstein Professorship endowment, University of Virginia. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; DICKSTEIN RA, 1984, J LEUKOCYTE BIOL, V36, P621, DOI 10.1002/jlb.36.5.621; Fidalgo AR, 2012, ACTA ANAESTH SCAND, V56, P1052, DOI 10.1111/j.1399-6576.2012.02691.x; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KOMATSU H, 1993, ANESTH ANALG, V76, P609; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li LL, 2008, EUR J PHARMACOL, V586, P106, DOI 10.1016/j.ejphar.2008.02.073; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; PARDRIDGE WM, 1983, J CLIN INVEST, V71, P900, DOI 10.1172/JCI110844; Caracas HCPM, 2009, J DENT, V37, P93, DOI 10.1016/j.jdent.2008.10.005; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Sanderson DJ, 2009, BEHAV BRAIN RES, V201, P103, DOI 10.1016/j.bbr.2009.01.038; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Silva AC, 2006, J ORAL MAXIL SURG, V64, P1385, DOI 10.1016/j.joms.2006.05.024; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stratmann G, 2010, ANESTHESIOLOGY, V112, P305, DOI 10.1097/ALN.0b013e3181ca33a1; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Vizcaychipi MP, 2011, ANESTHESIOLOGY, V114, P891, DOI 10.1097/ALN.0b013e31820ad3ce; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172; Zhou ZH, 2005, AM J RESP CRIT CARE, V172, P344, DOI 10.1164/rccm.200503-343OC	36	100	109	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51431	10.1371/journal.pone.0051431	http://dx.doi.org/10.1371/journal.pone.0051431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251531	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200106
J	Duch, J; Zeng, XHT; Sales-Pardo, M; Radicchi, F; Otis, S; Woodruff, TK; Amaral, LAN				Duch, Jordi; Zeng, Xiao Han T.; Sales-Pardo, Marta; Radicchi, Filippo; Otis, Shayna; Woodruff, Teresa K.; Amaral, Luis A. Nunes			The Possible Role of Resource Requirements and Academic Career-Choice Risk on Gender Differences in Publication Rate and Impact	PLOS ONE			English	Article							WOMENS UNDERREPRESENTATION; SEX-DIFFERENCES; BABIES MATTER; SCIENCE; PRODUCTIVITY; INDEX; GAP; METAANALYSIS; LEADERSHIP; MEDICINE	Many studies demonstrate that there is still a significant gender bias, especially at higher career levels, in many areas including science, technology, engineering, and mathematics (STEM). We investigated field-dependent, gender-specific effects of the selective pressures individuals experience as they pursue a career in academia within seven STEM disciplines. We built a unique database that comprises 437,787 publications authored by 4,292 faculty members at top United States research universities. Our analyses reveal that gender differences in publication rate and impact are discipline-specific. Our results also support two hypotheses. First, the widely-reported lower publication rates of female faculty are correlated with the amount of research resources typically needed in the discipline considered, and thus may be explained by the lower level of institutional support historically received by females. Second, in disciplines where pursuing an academic position incurs greater career risk, female faculty tend to have a greater fraction of higher impact publications than males. Our findings have significant, field-specific, policy implications for achieving diversity at the faculty level within the STEM disciplines.	[Duch, Jordi; Zeng, Xiao Han T.; Sales-Pardo, Marta; Otis, Shayna; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Duch, Jordi] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Sales-Pardo, Marta; Radicchi, Filippo] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain; [Radicchi, Filippo; Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Inst Womens Hlth Res, Chicago, IL 60611 USA; [Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL USA	Northwestern University; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Howard Hughes Medical Institute; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	amaral@northwestern.edu	Sales-Pardo, Marta/C-1725-2008; Duch, Jordi/A-7000-2008; Sales-Pardo, Marta/O-9797-2019; Amaral, Luis N./C-5485-2009; Radicchi, Filippo/B-4407-2009; Amaral, LAN/A-4980-2008	Sales-Pardo, Marta/0000-0002-8140-6525; Duch, Jordi/0000-0003-2639-6333; Sales-Pardo, Marta/0000-0002-8140-6525; Amaral, LAN/0000-0002-3762-789X; Woodruff, Teresa/0000-0002-1197-3399; Radicchi, Filippo/0000-0002-8352-1287; Zeng, Xiaohan/0000-0001-8771-9314	NSF [SBE 0624318, IIS 0830388]	NSF(National Science Foundation (NSF))	The authors acknowledge the support of NSF awards SBE 0624318 and IIS 0830388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, US NEWS; Association of American Medical Colleges, 2008, TECHNICAL REPORT; Beaman L, 2012, SCIENCE, V335, P582, DOI 10.1126/science.1212382; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; CaseWestern Reserve University Equity Study Committee, 2003, TECHNICAL REPORT; Cech EA, 2010, SOC PROBL, V57, P371, DOI 10.1525/sp.2010.57.3.371; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; Cole JR., 1984, ADV MOTIVATION ACHIE, V2, P217; Committee on Women Faculty in the School of Science, 1999, TECHNICAL REPORT; Doucet C, 2012, RELAT IND-IND RELAT, V67, P51, DOI 10.7202/1008195ar; Etzkowitz H., 2011, BRUSSELS EC REV, V54, P131; Furnham A, 2011, J SOCIO-ECON, V40, P623, DOI 10.1016/j.socec.2011.04.019; Ginther D. K., 2003, B SCI TECHNOL SOC, V23, P21, DOI DOI 10.1177/0270467602239767; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Lariviere V, 2011, SCIENTOMETRICS, V87, P483, DOI 10.1007/s11192-011-0369-y; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; Mason MA, 2004, ACADEME, V90, P10, DOI 10.2307/40252699; Mason MA, 2002, ACADEME, V88, P21, DOI 10.2307/40252436; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; National Research Council, 2001, TECHNICAL REPORT; Petersen AM, 2012, P NATL ACAD SCI USA, V109, P5213, DOI 10.1073/pnas.1121429109; Petersen AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00181; Princeton University, 2003, TECHNICAL REPORT; Prpic K, 2002, SCIENTOMETRICS, V55, P27, DOI 10.1023/A:1016046819457; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Rovner SL, 2011, CHEM ENG NEWS, V89, P42; Sarfaty S, 2007, J WOMENS HEALTH, V16, P235, DOI 10.1089/jwh.2006.0037; Stringer M., 2008, PLOS ONE, V3, P1; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; University of Pennsylvania Gender Equity Committee, 2001, TECHNICAL REPORT; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; Xie Y., 2003, WOMEN SCI CAREER PRO	42	133	135	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51332	10.1371/journal.pone.0051332	http://dx.doi.org/10.1371/journal.pone.0051332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251502	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200092
J	Zhang, C; Lu, XM; Tan, Y; Li, B; Miao, X; Jin, LT; Shi, X; Zhang, X; Miao, LN; Li, XK; Cai, L				Zhang, Chi; Lu, Xuemian; Tan, Yi; Li, Bing; Miao, Xiao; Jin, Litai; Shi, Xue; Zhang, Xiang; Miao, Lining; Li, Xiaokun; Cai, Lu			Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model	PLOS ONE			English	Article							FATTY LIVER-DISEASE; APOPTOSIS; ACTIVATION; PATHWAY; TPEN; DEGRADATION; MORTALITY; CHELATOR; DEFENSE; TYPE-2	Objectives: Zinc (Zn) deficiency often occurs in the patients with diabetes. Effects of Zn deficiency on diabetes-induced hepatic injury were investigated. Methods: Type 1 diabetes was induced in FVB mice with multiple low-dose streptozotocin. Hyperglycemic and age-matched control mice were treated with and without Zn chelator, N,N,N',N'-tetrakis (2-pyridylemethyl) ethylenediamine (TPEN), at 5 mg/kg body-weight daily for 4 months. Hepatic injury was examined by serum alanine aminotransferase (ALT) level and liver histopathological and biochemical changes. Results: Hepatic Zn deficiency (lower than control level, p<0.05) was seen in the mice with either diabetes or TPEN treatment and more evident in the mice with both diabetes and TPEN. Zn deficiency exacerbated hepatic injuries, shown by further increased serum ALT, hepatic lipid accumulation, inflammation, oxidative damage, and endoplasmic reticulum stress-related cell death in Diabetes/TPEN group compared to Diabetes alone. Diabetes/TPEN group also showed a significant decrease in nuclear factor-erythroid 2-related factor 2 (Nrf2) expression and transcription action along with significant increases in Akt negative regulators, decrease in Akt and GSK-3 beta phosphorylation, and increase in nuclear accumulation of Fyn (a Nrf2 negative regulator). In vitro study with HepG2 cells showed that apoptotic effect of TPEN at 0.5-1.0 mu M could be completely prevented by simultaneous Zn supplementation at the dose range of 30-50 mu M. Conclusions: Zn is required for maintaining Akt activation by inhibiting the expression of Akt negative regulators; Akt activation can inhibit Fyn nuclear translocation to export nuclear Nrf2 to cytoplasm for degradation. Zn deficiency significantly enhanced diabetes-induced hepatic injury likely through down-regulation of Nrf2 function.	[Zhang, Chi; Lu, Xuemian; Li, Xiaokun; Cai, Lu] Wenzhou Med Coll, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Zhejiang, Peoples R China; [Zhang, Chi; Tan, Yi; Li, Bing; Miao, Xiao; Cai, Lu] Univ Louisville, Sch Med, Dept Pediat, Kosair Children Hosp Res Inst, Louisville, KY 40292 USA; [Li, Bing; Miao, Xiao; Miao, Lining] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Shi, Xue; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA	Wenzhou Medical University; University of Louisville; Jilin University; University of Louisville; University of Louisville; University of Louisville	Li, XK (corresponding author), Wenzhou Med Coll, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Zhejiang, Peoples R China.	xiaokunli@163.net; l0cai001@louisville.edu	Shi, Xue/N-6907-2015; Cai, Lu/AAG-9920-2019	Shi, Xue/0000-0003-2040-7425; 	American Diabetes Association [1-11-BA-17]; Zhejiang Province Extremely Key Subject Building Project; Wenzhou Medical College; National Science Foundation of China [81000294]	American Diabetes Association(American Diabetes Association); Zhejiang Province Extremely Key Subject Building Project; Wenzhou Medical College; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Basic Research Award from American Diabetes Association (1-11-BA-17, to LC), Zhejiang Province Extremely Key Subject Building Project (Pharmacology and Biochemical Pharmaceutics 2009) and a Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College (to LC, XL & YT), and Young Scientist Award from National Science Foundation of China (81000294, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, CURR DIABETES REP, V8, P60, DOI 10.1007/s11892-008-0011-4; Adler M, 1997, TOXICON, V35, P1089, DOI 10.1016/S0041-0101(96)00215-2; Alexandraki KI, 2008, J CLIN IMMUNOL, V28, P314, DOI 10.1007/s10875-007-9164-1; Baig NA, 2001, CLIN LAB MED, V21, P193; BODE JC, 1988, HEPATOLOGY, V8, P1605, DOI 10.1002/hep.1840080622; Brandao-Neto J, 2000, BIOMETALS, V13, P141, DOI 10.1023/A:1009223105246; Bulum T, 2011, DIGEST DIS SCI, V56, P3655, DOI 10.1007/s10620-011-1807-7; Cai Lu, 2002, Int J Exp Diabetes Res, V3, P193, DOI 10.1080/15604280214281; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chai FG, 1999, IMMUNOL CELL BIOL, V77, P272, DOI 10.1046/j.1440-1711.1999.00825.x; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; DEFRONZO RA, 1982, DIABETES, V31, P795, DOI 10.2337/diab.31.9.795; DISILVESTRO RA, 1994, FREE RADICAL BIO MED, V16, P57, DOI 10.1016/0891-5849(94)90243-7; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; EXTREMERA BG, 1990, ACTA GASTRO-ENT BELG, V53, P292; GOODE HF, 1990, GUT, V31, P694, DOI 10.1136/gut.31.6.694; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Harrison SA, 2006, J CLIN GASTROENTEROL, V40, P68, DOI 10.1097/01.mcg.0000190774.91875.d2; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; KINLAW WB, 1983, AM J MED, V75, P273, DOI 10.1016/0002-9343(83)91205-6; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lopez JJ, 2009, J THROMB HAEMOST, V7, P992, DOI 10.1111/j.1538-7836.2009.03431.x; Manna P, 2010, FREE RADICAL BIO MED, V48, P1465, DOI 10.1016/j.freeradbiomed.2010.02.025; Mocanu MM, 2009, AM J PHYSIOL-HEART C, V296, pH233, DOI 10.1152/ajpheart.00985.2008; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; Nakatani T, 2000, CHEM-BIOL INTERACT, V125, P151, DOI 10.1016/S0009-2797(99)00166-0; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Ra H, 2009, FEBS LETT, V583, P1516, DOI 10.1016/j.febslet.2009.04.008; Shen HY, 2008, J AM COLL NUTR, V27, P577, DOI 10.1080/07315724.2008.10719741; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Szuster-Ciesielska A, 2005, TOXICOLOGY, V212, P124, DOI 10.1016/j.tox.2005.04.009; Takamatsu S, 2008, HEPATO-GASTROENTEROL, V55, P609; Vignolini F, 1997, LIFE SCI, V62, P131, DOI 10.1016/S0024-3205(97)01059-X; Walker CLF, 2009, EUR J CLIN NUTR, V63, P591, DOI 10.1038/ejcn.2008.9; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; YIP J, 1993, LANCET, V342, P883, DOI 10.1016/0140-6736(93)91943-G; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9	47	74	79	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49257	10.1371/journal.pone.0049257	http://dx.doi.org/10.1371/journal.pone.0049257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251339	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200012
J	Zhang, L; Diaz-Diaz, N; Zarringhalam, K; Hermansson, M; Somerharju, P; Chuang, J				Zhang, Lu; Diaz-Diaz, Norberto; Zarringhalam, Kourosh; Hermansson, Martin; Somerharju, Pentti; Chuang, Jeffrey			Dynamics of the Ethanolamine Glycerophospholipid Remodeling Network	PLOS ONE			English	Article							MASS-SPECTROMETRY; INDEPENDENT TRANSACYLASE; ELECTROSPRAY-IONIZATION; PARAMETER-ESTIMATION; LIPIDOMICS; CARDIOLIPIN; METABOLISM; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; INHIBITORS	Acyl chain remodeling in lipids is a critical biochemical process that plays a central role in disease. However, remodeling remains poorly understood, despite massive increases in lipidomic data. In this work, we determine the dynamic network of ethanolamine glycerophospholipid (PE) remodeling, using data from pulse-chase experiments and a novel bioinformatic network inference approach. The model uses a set of ordinary differential equations based on the assumptions that (1) sn1 and sn2 acyl positions are independently remodeled; (2) remodeling reaction rates are constant over time; and (3) acyl donor concentrations are constant. We use a novel fast and accurate two-step algorithm to automatically infer model parameters and their values. This is the first such method applicable to dynamic phospholipid lipidomic data. Our inference procedure closely fits experimental measurements and shows strong cross-validation across six independent experiments with distinct deuterium-labeled PE precursors, demonstrating the validity of our assumptions. In constrast, fits of randomized data or fits using random model parameters are worse. A key outcome is that we are able to robustly distinguish deacylation and reacylation kinetics of individual acyl chain types at the sn1 and sn2 positions, explaining the established prevalence of saturated and unsaturated chains in the respective positions. The present study thus demonstrates that dynamic acyl chain remodeling processes can be reliably determined from dynamic lipidomic data.	[Zhang, Lu; Zarringhalam, Kourosh; Chuang, Jeffrey] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Diaz-Diaz, Norberto] Pablo de Olavide Univ, Sch Engn, Seville, Spain; [Hermansson, Martin; Somerharju, Pentti] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland	Boston College; Universidad Pablo de Olavide; University of Helsinki	Chuang, J (corresponding author), Jackson Lab Genom Med, Farmington, CT USA.	chuangj@bc.edu	Hermansson, Martin/B-7854-2008; Diaz-Diaz, Norberto/G-3309-2013	Hermansson, Martin/0000-0003-3387-8365; Diaz-Diaz, Norberto/0000-0001-8100-8781; Chuang, Jeffrey/0000-0002-3298-2358	Boston College Biology Department; Ministry of Science and Innovation [TIN2007-68084-C02-00, PCI2006-A7-0575]; Junta de Andalucia [P07-TIC-02611, TIC-200]	Boston College Biology Department; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	JC was supported by funds from the Boston College Biology Department. NDD was in part supported by the Ministry of Science and Innovation, projects TIN2007-68084-C02-00 and PCI2006-A7-0575, and by the Junta de Andalucia, projects P07-TIC-02611 and TIC-200. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEN N, 1982, CHEM ENG J BIOCH ENG, V23, P1, DOI 10.1016/0300-9467(82)85001-6; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; BELLMAN RICHARD, 1967, MATH BIOSCI, V1, P71, DOI 10.1016/0025-5564(67)90027-2; Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; Brewer D, 2008, PHILOS T R SOC A, V366, P519, DOI 10.1098/rsta.2007.2108; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; CHILTON FH, 1995, BIOCHEMISTRY-US, V34, P5403, DOI 10.1021/bi00016a011; De Boor C., 1978, APPL MATH SCI, V27, DOI DOI 10.1007/978-1-4612-6333-3; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Ejsing CS, 2009, P NATL ACAD SCI USA, V106; Forrester JS, 2004, MOL PHARMACOL, V65, P813, DOI 10.1124/mol.65.4.813; Golub GH, 1992, SCI COMPUTING DIFFER; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Haimi P, 2010, J BIOL CHEM, V285, P751, DOI 10.1074/jbc.M109.061218; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hou WM, 2011, RAPID COMMUN MASS SP, V25, P205, DOI 10.1002/rcm.4846; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li ZF, 2005, IMA J NUMER ANAL, V25, P264, DOI 10.1093/imanum/drh016; Meikle PJ, 2011, CURR OPIN LIPIDOL, V22, P210, DOI 10.1097/MOL.0b013e3283453dbe; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Postle AD, 2009, J CHROMATOGR B, V877, P2716, DOI 10.1016/j.jchromb.2009.03.046; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Trimboli AJ, 1999, CANCER RES, V59, P6171; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Zarringhalam K, 2012, PLOS ONE; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]	38	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50858	10.1371/journal.pone.0050858	http://dx.doi.org/10.1371/journal.pone.0050858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251394	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900023
J	King, GJ; Chanson, AH; McCallum, EJ; Ohme-Takagi, M; Byriel, K; Hill, JM; Martin, JL; Mylne, JS				King, Gordon J.; Chanson, Aurelie H.; McCallum, Emily J.; Ohme-Takagi, Masaru; Byriel, Karl; Hill, Justine M.; Martin, Jennifer L.; Mylne, Joshua S.			The Arabidopsis B3 Domain Protein VERNALIZATION1 (VRN1) Is Involved in Processes Essential for Development, with Structural and Mutational Studies Revealing Its DNA-binding Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CHIMERIC REPRESSOR; MOTIF; GENE; RECOGNITION; EXPRESSION; SEQUENCE; SYSTEM	The B3 DNA-binding domain is a plant-specific domain found throughout the plant kingdom from the alga Chlamydomonas to grasses and flowering plants. Over 100 B3 domain-containing proteins are found in the model plant Arabidopsis thaliana, and one of these is critical for accelerating flowering in response to prolonged cold treatment, an epigenetic process called vernalization. Despite the specific phenotype of genetic vrn1 mutants, the VERNALIZATION1 (VRN1) protein localizes throughout the nucleus and shows sequence-nonspecific binding in vitro. In this work, we used a dominant repressor tag that overcomes genetic redundancy to show that VRN1 is involved in processes beyond vernalization that are essential for Arabidopsis development. To understand its sequence-nonspecific binding, we crystallized VRN1(208-341) and solved its crystal structure to 1.6 angstrom resolution using selenium/single-wavelength anomalous diffraction methods. The crystallized construct comprises the second VRN1 B3 domain and a preceding region conserved among VRN1 orthologs but absent in other B3 domains. We established the DNA-binding face using NMR and then mutated positively charged residues on this surface with a series of 16 Ala and Glu substitutions, ensuring that the protein fold was not disturbed using heteronuclear single quantum correlation NMR spectra. The triple mutant R249E/R289E/R296E was almost completely incapable of DNA binding in vitro. Thus, we have revealed that although VRN1 is sequence-nonspecific in DNA binding, it has a defined DNA-binding surface.	[King, Gordon J.; Chanson, Aurelie H.; McCallum, Emily J.; Byriel, Karl; Martin, Jennifer L.; Mylne, Joshua S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Ohme-Takagi, Masaru] AIST, Bioprod Res Inst, AIST 4, Tsukuba, Ibaraki 3058562, Japan	University of Queensland; University of Queensland; University of Queensland; National Institute of Advanced Industrial Science & Technology (AIST)	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.martin@imb.uq.edu.au; joshua.mylne@uwa.edu.au	Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009; Hill, Justine M/C-5781-2009; King, Gordon/J-8718-2014; Byriel, Karl/Y-4155-2019; Martin, Jennifer L./A-6039-2010	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; Byriel, Karl/0000-0003-1615-1551; Benfield, Aurelie/0000-0002-3068-906X; Martin, Jennifer L./0000-0002-9225-8863; Ohme-Takagi, Masaru/0000-0003-2700-4119; McCallum, Emily/0000-0001-8783-4873	University of Queensland early career research award; Australian Research Council Queen Elizabeth II Fellowship [DP0879133]; National Health and Medical Research Council R.D. Wright Fellowship [401748]; Australian Research Council Australian Laureate Fellowship [FL0992138]; Honorary National Health and Medical Research Council Research Fellowship [455829]	University of Queensland early career research award(University of Queensland); Australian Research Council Queen Elizabeth II Fellowship(Australian Research Council); National Health and Medical Research Council R.D. Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Australian Laureate Fellowship(Australian Research Council); Honorary National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a University of Queensland early career research award and Australian Research Council Queen Elizabeth II Fellowship DP0879133 (to J.S.M.), a National Health and Medical Research Council R.D. Wright Fellowship 401748 (to J.M.H.), and by Australian Research Council Australian Laureate Fellowship FL0992138 and Honorary National Health and Medical Research Council Research Fellowship 455829 (to J.L.M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, CCP4 NEWSL, V42; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Golovenko D, 2009, NUCLEIC ACIDS RES, V37, P6613, DOI 10.1093/nar/gkp699; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; King G, 2009, ACTA CRYSTALLOGR F, V65, P291, DOI [10.1107/S174430910900421, 10.1107/S1744309109004217]; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mitsuda N, 2006, PLANT BIOTECHNOL J, V4, P325, DOI 10.1111/j.1467-7652.2006.00184.x; Mylne JS, 2012, BIOMOL NMR ASSIGN, V6, P5, DOI 10.1007/s12104-011-9313-6; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Oshima Y, 2011, PLANT BIOTECHNOL-NAR, V28, P201, DOI 10.5511/plantbiotechnology.11.0124a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrodinger L., 2020, PYMOL; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K., 2012, TRENDS PLAN IN PRESS; Zhou XYE, 2004, J MOL BIOL, V335, P307, DOI 10.1016/j.jmb.2003.10.030	33	24	31	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3198	3207		10.1074/jbc.M112.438572	http://dx.doi.org/10.1074/jbc.M112.438572			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255593	hybrid, Green Published			2022-12-25	WOS:000314397900027
J	Mant, A; Williams, S; Roncoroni, L; Lowry, E; Johnson, D; O'Kelly, I				Mant, Alexandra; Williams, Sarah; Roncoroni, Laura; Lowry, Eleanor; Johnson, Daniel; O'Kelly, Ita			N-Glycosylation-dependent Control of Functional Expression of Background Potassium Channels K(2P)3.1 and K(2P)9.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; TRAFFICKING; MODULATION; RETENTION; TRANSPORT; PROTEINS; TASK-1	Two-pore domain potassium (K-2P) channels play fundamental roles in cellular processes by enabling a constitutive leak of potassium from cells in which they are expressed, thus influencing cellular membrane potential and activity. Hence, regulation of these channels is of critical importance to cellular function. A key regulatory mechanism of K-2P channels is the control of their cell surface expression. Membrane protein delivery to and retrieval from the cell surface is controlled by their passage through the secretory and endocytic pathways, and post-translational modifications regulate their progression through these pathways. All but one of the K-2P channels possess consensus N-linked glycosylation sites, and here we demonstrate that the conserved putative N-glycosylation site in K(2P)3.1 and K(2P)9.1 is a glycan acceptor site. Patch clamp analysis revealed that disruption of channel glycosylation reduced K(2P)3.1 current, and flow cytometry was instrumental in attributing this to a decreased number of channels on the cell surface. Similar findings were observed when cells were cultured in reduced glucose concentrations. Disruption of N-linked glycosylation has less of an effect on K(2P)9.1, with a small reduction in number of channels on the surface observed, but no functional implications detected. Because nonglycosylated channels appear to pass through the secretory pathway in a manner comparable with glycosylated channels, the evidence presented here suggests that the decreased number of nonglycosylated K(2P)3.1 channels on the cell surface may be due to their decreased stability.	[Mant, Alexandra; Williams, Sarah; Roncoroni, Laura; O'Kelly, Ita] Univ Southampton, Ctr Human Dev Stem Cells & Regenerat, Fac Med, Southampton SO16 6YD, Hants, England; [Lowry, Eleanor; Johnson, Daniel] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Southampton; University of Manchester	O'Kelly, I (corresponding author), Univ Southampton, Duthie Bldg,Mail Point 808, Southampton SO16 6YD, Hants, England.	I.M.O'Kelly@southampton.ac.uk		Mant, Alexandra/0000-0001-7169-209X	Biotechnology and Biological Sciences Research Council Grant [BB/J00168/1]; Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council [BB/J008168/1, BB/E014453/2] Funding Source: researchfish; BBSRC [BB/E014453/2, BB/J008168/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/J00168/1 (to I. O).; Supported by the Gerald Kerkut Charitable Trust.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Egenberger B, 2010, BIOCHEM BIOPH RES CO, V391, P1262, DOI 10.1016/j.bbrc.2009.12.056; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; HAYTER PM, 1992, BIOTECHNOL BIOENG, V39, P327, DOI 10.1002/bit.260390311; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jing L, 2012, J NEUROSCI, V32, P4080, DOI 10.1523/JNEUROSCI.5021-11.2012; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Richardson DS, 2010, J FLUORESC, V20, P401, DOI 10.1007/s10895-009-0548-x; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; Zhu I, 2009, BRAIN RES, V1251, P16, DOI 10.1016/j.brainres.2008.11.033	40	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3251	3264		10.1074/jbc.M112.405167	http://dx.doi.org/10.1074/jbc.M112.405167			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250752	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000314397900032
J	Aggarwal, M; Tapas, S; Preeti; Siwach, A; Kumar, P; Kuhn, RJ; Tomar, S				Aggarwal, Megha; Tapas, Satya; Preeti; Siwach, Anjul; Kumar, Pravindra; Kuhn, Richard J.; Tomar, Shailly			Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; CYTOPLASMIC DOMAIN; SERINE PROTEINASE; ANTIVIRAL AGENTS; SPIKE PROTEIN; CORE PROTEIN; ALPHAVIRUS; E2; MUTATIONS	The nucleocapsid core interaction with endodomains of glycoproteins plays a critical role in the alphavirus life cycle that is essential to virus budding. Recent cryo-electron microscopy (cryo-EM) studies provide structural insights into key interactions between capsid protein (CP) and trans-membrane glycoproteins E1 and E2. CP possesses a chymotrypsin-like fold with a hydrophobic pocket at the surface responsible for interaction with glycoproteins. In the present study, crystal structures of the protease domain of CP from Aura virus and its complex with dioxane were determined at 1.81 and 1.98 angstrom resolution respectively. Due to the absence of crystal structures, homology models of E1 and E2 from Aura virus were generated. The crystal structure of CP and structural models of E1 and E2 were fitted into the cryo-EM density map of Venezuelan equine encephalitis virus (VEEV) for detailed analysis of CP-glycoprotein interactions. Structural analysis revealed that the E2 endodomain consists of a helix-loop-helix motif where the loop region fits into the hydrophobic pocket of CP. Our studies suggest that Cys397, Cys418 and Tyr401 residues of E2 are involved in stabilizing the structure of E2 endodomain. Density map fitting analysis revealed that Pro405, a conserved E2 residue is present in the loop region of the E2 endodomain helix-loop-helix structure and makes intermolecular hydrophobic contacts with the capsid. In the Aura virus capsid protease (AVCP)-dioxane complex structure, dioxane occupies the hydrophobic pocket on CP and structurally mimics the hydrophobic pyrollidine ring of Pro405 in the loop region of E2.	[Aggarwal, Megha; Tapas, Satya; Preeti; Siwach, Anjul; Kumar, Pravindra; Tomar, Shailly] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kuhn, Richard J.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tomar, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	shailfbt@iitr.ernet.in	KUMAR, PRAVINDRA/AAF-2859-2020; Kuhn, Richard/AAR-2722-2021; Aggarwal, Megha/AAC-9406-2019	KUMAR, PRAVINDRA/0000-0003-2128-7736; Kuhn, Richard/0000-0003-4148-1026; 	Defence Research and Development Organization (DRDO), Government of India	Defence Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO))	This research was supported by the Defence Research and Development Organization (DRDO), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2011, ACTA CRYSTALLOGR F, V67, P1394, DOI 10.1107/S174430911103404X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTH BU, 1992, J VIROL, V66, P7560, DOI 10.1128/JVI.66.12.7560-7564.1992; CHENG RH, 1995, CELL, V80, P621; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Choi HK, 1996, J MOL BIOL, V262, P151, DOI 10.1006/jmbi.1996.0505; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAHN CS, 1985, P NATL ACAD SCI USA, V82, P4648, DOI 10.1073/pnas.82.14.4648; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong EM, 2006, J VIROL, V80, P8848, DOI 10.1128/JVI.00619-06; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Jose J, 2012, J VIROL, V86, P2585, DOI 10.1128/JVI.05860-11; KAIL M, 1991, EMBO J, V10, P2343, DOI 10.1002/j.1460-2075.1991.tb07773.x; Kielian M, 2002, MOL CELL, V9, P454, DOI 10.1016/S1097-2765(02)00492-6; Kim HY, 2007, BIOORGAN MED CHEM, V15, P2667, DOI 10.1016/j.bmc.2007.01.040; Kim HY, 2005, BIOORG MED CHEM LETT, V15, P3207, DOI 10.1016/j.bmcl.2005.05.013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE H, 1994, VIROLOGY, V204, P471, DOI 10.1006/viro.1994.1557; Lee SY, 1998, PROTEINS, V33, P311, DOI 10.1002/(SICI)1097-0134(19981101)33:2<311::AID-PROT13>3.0.CO;2-N; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Levine B, 1996, J VIROL, V70, P1255, DOI 10.1128/JVI.70.2.1255-1260.1996; LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; METSIKKO K, 1990, J VIROL, V64, P4678; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996; Owen KE, 1997, VIROLOGY, V230, P187, DOI 10.1006/viro.1997.8480; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichert E, 2009, BIOSECUR BIOTERROR, V7, P413, DOI 10.1089/bsp.2009.0032; RUMENAPF T, 1994, J VIROL, V68, P56; Ryan C, 1998, VIROLOGY, V243, P380, DOI 10.1006/viro.1998.9074; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHERMAN LA, 1990, J VIROL, V64, P2041, DOI 10.1128/JVI.64.5.2041-2046.1990; Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1; Sjoberg M, 2003, J VIROL, V77, P3441, DOI 10.1128/JVI.77.6.3441-3450.2003; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; Skoging-Nyberg U, 2000, ARCH VIROL, V145, P1225, DOI 10.1007/s007050070121; STRAUSS JH, 1995, TRENDS MICROBIOL, V3, P346, DOI 10.1016/S0966-842X(00)88973-8; SUOMALAINEN M, 1992, J VIROL, V66, P4737, DOI 10.1128/JVI.66.8.4737-4747.1992; Tang JL, 2011, NATURE, V473, P414, DOI 10.1038/473414a; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONG L, 1993, J MOL BIOL, V230, P228, DOI 10.1006/jmbi.1993.1139; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAUX DJT, 1988, NATURE, V336, P36, DOI 10.1038/336036a0; WEISS B, 1989, J VIROL, V63, P5310, DOI 10.1128/JVI.63.12.5310-5318.1989; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261; ZHAO HX, 1994, EMBO J, V13, P4204, DOI 10.1002/j.1460-2075.1994.tb06740.x	58	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51288	10.1371/journal.pone.0051288	http://dx.doi.org/10.1371/journal.pone.0051288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251484	Green Published, gold			2022-12-25	WOS:000312386800039
J	Geller, J; Nazarova, L; Katargina, O; Jarvekulg, L; Fomenko, N; Golovljova, I				Geller, Julia; Nazarova, Lidia; Katargina, Olga; Jaervekuelg, Lilian; Fomenko, Natalya; Golovljova, Irina			Detection and Genetic Characterization of Relapsing Fever Spirochete Borrelia miyamotoi in Estonian Ticks	PLOS ONE			English	Article							IXODES-RICINUS TICKS; LYME-DISEASE AGENT; SP-NOV; VECTOR; PERSULCATUS; RUSSIA; TRANSMISSION; BURGDORFERI; PREVALENCE; DIVERSITY	During the years 2008-2010 I. ricinus and I. persulcatus ticks were collected from 64 sites in mainland Estonia and on the island Saaremaa. Presence of B. miyamotoi was found in 0.9% (23/2622) of ticks. The prevalence in I. persulcatus and I. ricinus ticks differed significantly, 2.7% (15/561) and 0.4% (8/2061), respectively. The highest prevalence rates were in found South-Eastern Estonia in an area of I. persulcatus and I. ricinus sympatry and varied from 1.4% (1/73) to 2.8% (5/178). Co-infections with B. burgdorferi s.l. group spirochetes and tick-borne encephalitis virus were also revealed. Genetic characterization of partial 16S rRNA, p66 and glpQ genes demonstrated that Estonian sequences belong to two types of B. miyamotoi and cluster with sequences from Europe and the European part of Russia, as well as with sequences from Siberia, Asia and Japan, here designated as European and Asian types, respectively. Estonian sequences of the European type were obtained from I. ricinus ticks only, whereas the Asian type of B. miyamotoi was shown for both tick species in the sympatric regions.	[Geller, Julia; Nazarova, Lidia; Katargina, Olga; Golovljova, Irina] Natl Inst Hlth Dev, Tallinn, Estonia; [Geller, Julia; Nazarova, Lidia; Jaervekuelg, Lilian] Tallinn Univ Technol, Fac Sci, Dept Gene Technol, Tallinn, Estonia; [Fomenko, Natalya] JSC VECTOR BEST, Novosibirsk, Russia; [Fomenko, Natalya] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia	National Institute for Health Development - Estonia; Tallinn University of Technology; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Geller, J (corresponding author), Natl Inst Hlth Dev, Tallinn, Estonia.	julia.geller@tai.ee	Geller, Julia/A-7889-2019	Geller, Julia/0000-0001-6496-9687	Estonian Science Foundation [ETF 8691]; Estonian Ministry of Education and Research [SF0940033s09]; European Regional Development Fund (Estonian Research Council) [ZoonRisk 3.2.1002.11-0002]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Estonian Research Council)	This work was supported by Estonian Science Foundation (www.hm.ee) (Grant ETF 8691), Estonian Ministry of Education and Research (www.etf.ee) (project SF0940033s09) and the European Regional Development Fund (Estonian Research Council (www.etag.ee), programme TerVE, project ZoonRisk 3.2.1002.11-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Borgoiakov V, 2011, PARAZITOLOGIIA, V44, P543; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Davis S, 2011, J THEOR BIOL, V269, P96, DOI 10.1016/j.jtbi.2010.10.011; [Фоменко Н.В. Fomenko N.V.], 2010, [Молекулярная медицина, Molekulyarnaya meditsina], P28; Fomenko N V, 2011, Mol Gen Mikrobiol Virusol, P12; Fomenko N. V., 2010, Parazitologiya (St. Petersburg), V44, P201; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; FUKUNAGA M, 1995, FEMS MICROBIOL LETT, V134, P255, DOI 10.1111/j.1574-6968.1995.tb07947.x; Karan L. S., 2010, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P72; Korotkov Yu. S., 2008, Parazitologiya (St. Petersburg), V42, P441; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Richter D, 2003, EMERG INFECT DIS, V9, P697; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Scott MC, 2010, J MED ENTOMOL, V47, P1238, DOI 10.1603/ME10075; Skarpaas T, 2006, EMERG INFECT DIS, V12, P1136, DOI 10.3201/eid1207.051567; Steere AC, 2005, TICK-BORNE DISEASES OF HUMANS, P176; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	27	65	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51914	10.1371/journal.pone.0051914	http://dx.doi.org/10.1371/journal.pone.0051914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251652	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800108
J	Li, HYS; Greeley, N; Sugimoto, N; Liu, YJ; Watowich, SS				Li, Haiyan S.; Greeley, Nathaniel; Sugimoto, Naoshi; Liu, Yong-Jun; Watowich, Stephanie S.			miR-22 Controls Irf8 mRNA Abundance and Murine Dendritic Cell Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2-2; IN-VIVO; SUBSET DEVELOPMENT; CUTTING EDGE; TARGET GENES; FLT3 LIGAND; STEM-CELLS; T-CELLS; EXPRESSION; MICRORNA	MicroRNAs (miRNAs) have emerged as critical regulators of many cellular responses, through the action of miRNA-induced silencing complex (miRISC)- or. miRNA ribonucleoprotein complex (miRNP)-mediated gene repression. Here we studied the role of miRNAs in the development of dendritic cells (DCs), an important immune cell type that is divided into conventional DC (cDC) and plasmacytoid DC (pDC) subsets. We found that miR-22 was highly expressed in mouse CD11c(+) CD11b(+) B220(-) cDCs compared to pDCs, and was induced in DC progenitor cell cultures with GM-CSF, which stimulate CD11c(+) CD11b(+) B220(-) cDC differentiation. Enforced overexpression of miR-22 during DC development enhanced CD11c(+) CD11b(+) B220(-) cDC generation at the expense of pDCs, while miR-22 knockdown demonstrated opposite effects. Moreover, overexpression and knockdown of miR-22 showed significant effects on the mRNA abundance of Irf8, which encodes the transcription factor IRF8 that plays essential roles in DC development. Luciferase reporter assays confirmed that miR-22 binds directly to the 3'UTR of the mouse Irf8 mRNA. Collectively, these results suggest that miR-22 targets Irf8 mRNA for posttranscriptional repression and controls DC subset differentiation.	[Li, Haiyan S.; Greeley, Nathaniel; Liu, Yong-Jun; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sugimoto, Naoshi; Liu, Yong-Jun] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX USA; [Greeley, Nathaniel; Watowich, Stephanie S.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; University of Texas Health Science Center Houston	Li, HYS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	haiyanli@mdanderson.org; swatowic@mdanderson.org		Watowich, Stephanie/0000-0003-1969-659X	National Institutes of Health [AI073587, AI098099]; MD Anderson Center for Cancer Epigenetics; R.E. Bob Smith Education Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098099, R21AI073587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Center for Cancer Epigenetics; R.E. Bob Smith Education Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI073587 and AI098099, SSW), the MD Anderson Center for Cancer Epigenetics (SSW), and the R.E. Bob Smith Education Fund (HSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Belver L, 2011, CURR OPIN IMMUNOL, V23, P368, DOI 10.1016/j.coi.2011.02.001; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuipers H, 2010, MOL IMMUNOL, V48, P333, DOI 10.1016/j.molimm.2010.07.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li HYS, 2012, J LEUKOCYTE BIOL, V92, P445, DOI 10.1189/jlb.0212052; Li HS, 2011, BLOOD, V118, P3879, DOI 10.1182/blood-2011-04-349761; Li HS, 2012, BLOOD IN PRESS; Li J, 2012, ONCOL REP, V27, P1835, DOI 10.3892/or.2012.1744; Li XQ, 2010, BRIT J HAEMATOL, V148, P69, DOI 10.1111/j.1365-2141.2009.07920.x; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; PAGLIA P, 1993, J EXP MED, V178, P1893, DOI 10.1084/jem.178.6.1893; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Takata A, 2011, BIOCHEM BIOPH RES CO, V411, P826, DOI 10.1016/j.bbrc.2011.07.048; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Zanoni I, 2010, J MOL MED, V88, P873, DOI 10.1007/s00109-010-0638-x; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106	64	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52341	10.1371/journal.pone.0052341	http://dx.doi.org/10.1371/journal.pone.0052341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251709	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800161
J	Pichard, V; Aubert, D; Boni, S; Battaglia, S; Ivacik, D; Nguyen, TH; Arbuthnot, P; Ferry, N				Pichard, Virginie; Aubert, Dominique; Boni, Sebastien; Battaglia, Severine; Ivacik, Dejana; Tuan Huy Nguyen; Arbuthnot, Patrick; Ferry, Nicolas			Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-I; GENE-TRANSFER; LENTIVIRAL VECTORS; IMMUNE-RESPONSE; MAMMALIAN-CELLS; HEMOPHILIA-A; MURINE MODEL; PROMOTERS; THERAPY; LIVER	Precise control of transgene expression in a tissue-specific and temporally regulated manner is desirable for many basic and applied investigations gene therapy applications. This is important to regulate dose of transgene products and minimize unwanted effects. Previously described methods have employed tissue specific promoters, miRNA-based transgene silencing or tetR-KRAB-mediated suppression of transgene promoters. To improve on versatility of transgene expression control, we have developed expression systems that use combinations of a tetR-KRAB artificial transgene-repressor, endogenous miRNA silencing machinery and tissue specific promoters. Precise control of transgene expression was demonstrated in liver-, macrophage- and muscle-derived cells. Efficiency was also demonstrated in vivo in murine muscle. This multicomponent and modular regulatory system provides a robust and easily adaptable method for achieving regulated transgene expression in different tissue types. The improved precision of regulation will be useful for many gene therapy applications requiring specific spatiotemporal transgene regulation.	[Pichard, Virginie; Boni, Sebastien; Tuan Huy Nguyen; Ferry, Nicolas] INSERM, Unite Mixte Rech UMR 948, Nantes, France; [Aubert, Dominique] INSERM, UMR 1089, Nantes, France; [Battaglia, Severine] INSERM, UMR 957, Nantes, France; [Pichard, Virginie; Tuan Huy Nguyen] INSERM, UMR 1064, Nantes, France; [Ivacik, Dejana; Arbuthnot, Patrick] Univ Witwatersrand, Sch Pathol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Witwatersrand	Pichard, V (corresponding author), INSERM, Unite Mixte Rech UMR 948, Nantes, France.	Virginie.pichard@univ-nantes.fr	BATTAGLIA, Severine/K-8715-2015		Association Francaise contre les Myopathies (AFM) [RAE10092NNA]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by grants from the Association Francaise contre les Myopathies (AFM) (RAE10092NNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Andrianaki A, 2010, GENE THER, V17, P380, DOI 10.1038/gt.2009.147; Aubert D, 2002, MOL THER, V5, P388, DOI 10.1006/mthe.2002.0561; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; Brown BD, 2004, J THROMB HAEMOST, V2, P111, DOI 10.1111/j.1538-7836.2004.00552.x; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Di Domenico C, 2006, HUM GENE THER, V17, P1112; Di Domenico C, 2005, HUM GENE THER, V16, P81; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hoffman BE, 2011, MOL THER, V19, P1263, DOI 10.1038/mt.2011.33; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Laurenti E, 2010, STEM CELLS, V28, P1390, DOI 10.1002/stem.460; Le Guiner C, 2007, CURR GENE THER, V7, P334; Matsui H, 2011, MOL THER, V19, P723, DOI 10.1038/mt.2010.290; Nicklin SA, 2001, HYPERTENSION, V38, P65, DOI 10.1161/01.HYP.38.1.65; Pastore L, 1999, HUM GENE THER, V10, P1773, DOI 10.1089/10430349950017455; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Rittner K, 1997, J VIROL, V71, P3307, DOI 10.1128/JVI.71.4.3307-3311.1997; Schmitt F, 2010, GASTROENTEROLOGY, V139, P999, DOI 10.1053/j.gastro.2010.05.008; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200	33	15	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51952	10.1371/journal.pone.0051952	http://dx.doi.org/10.1371/journal.pone.0051952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251659	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800114
J	Edwards, S; Vanhooydonck, B; Herrel, A; Measey, GJ; Tolley, KA				Edwards, Shelley; Vanhooydonck, Bieke; Herrel, Anthony; Measey, G. John; Tolley, Krystal A.			Convergent Evolution Associated with Habitat Decouples Phenotype from Phylogeny in a Clade of Lizards	PLOS ONE			English	Article							HEAD SHAPE EVOLUTION; LACERTID LIZARDS; DWARF CHAMELEONS; MICROHABITAT USE; DNA SEQUENCES; BRADYPODION; SPEED; PERFORMANCE; SQUAMATA; POPULATIONS	Convergent evolution can explain similarity in morphology between species, due to selection on a fitness-enhancing phenotype in response to local environmental conditions. As selective pressures on body morphology may be strong, these have confounded our understanding of the evolutionary relationships between species. Within the speciose African radiation of lacertid lizards (Eremiadini), some species occupy a narrow habitat range (e. g. open habitat, cluttered habitat, strictly rupicolous, or strictly psammophilic), which may exert strong selective pressures on lizard body morphology. Here we show that the overall body plan is unrelated to shared ancestry in the African radiation of Eremiadini, but is instead coupled to habitat use. Comprehensive Bayesian and likelihood phylogenies using multiple representatives from all genera (2 nuclear, 2 mitochondrial markers) show that morphologically convergent species thought to represent sister taxa within the same genus are distantly related evolutionary lineages (Ichnotropis squamulosa and Ichnotropis spp.; Australolacerta rupicola and A. australis). Hierarchical clustering and multivariate analysis of morphological characters suggest that body, and head, width and height (stockiness), all of which are ecologically relevant with respect to movement through habitat, are similar between the genetically distant species. Our data show that convergence in morphology, due to adaptation to similar environments, has confounded the assignment of species leading to misidentification of the taxonomic position of I. squamulosa and the Australolacerta species.	[Edwards, Shelley; Measey, G. John; Tolley, Krystal A.] S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa; [Edwards, Shelley; Tolley, Krystal A.] Univ Stellenbosch, Dept Bot & Zool, Matieland, South Africa; [Vanhooydonck, Bieke] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Herrel, Anthony] UMR 7179 CNRS MNHN, Dept Ecol & Gest Biodivers, Paris, France; [Measey, G. John] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	South African National Biodiversity Institute; Stellenbosch University; University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Nelson Mandela University	Edwards, S (corresponding author), S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa.	s.edwards@sanbi.org.za	Tolley, Krystal A/D-9738-2011; Measey, John/F-2028-2010; Herrel, Anthony/C-3712-2013; Edwards, Shelley/AAV-9259-2021	Measey, John/0000-0001-9939-7615; Herrel, Anthony/0000-0003-0991-4434; Edwards, Shelley/0000-0002-0962-6523; Tolley, Krystal/0000-0002-7778-1963	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC); International Foundation of Science (IFS) of Sweden [D/5009-1]; Oppenheimer Sons; NRF [74973]; SABI	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC); International Foundation of Science (IFS) of Sweden; Oppenheimer Sons; NRF; SABI	The authors thank the National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC) and the International Foundation of Science (IFS) of Sweden (D/5009-1) and Oppenheimer & Sons for funding this work. SE was supported by NRF Free-standing (Grant no: 74973) and SABI Grant-holder linked bursaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold E.N., 2004, P11; Arnold E.N., 1989, Bulletin of the British Museum (Natural History) Zoology, V55, P209; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Arnold EN, 2002, J MORPHOL, V252, P145, DOI 10.1002/jmor.1096; ARNOLD EN, 1994, PHILOS T ROY SOC B, V344, P277, DOI 10.1098/rstb.1994.0066; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.x; Bauer AM, 2005, AFR J HERPETOL, V54, P105, DOI 10.1080/21564574.2005.9635525; Bauer AM, 1993, BIOL RELATIONSHIPS A, P245; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Becker R, 1988, COMPUTER SCI SERIES; Bonine KE, 1999, J ZOOL, V248, P255, DOI 10.1111/j.1469-7998.1999.tb01201.x; BRANCH W, 1998, FIELD GUIDE SNAKES O, P160; Branch WR, 2006, BIODIVERSITY SERIES, V5; BROADLEY DG, 1979, S AFR J ZOOL, V14, P133; Bruford Michael W., 1992, P225; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fitzsimons Vivian F., 1943, TRANSVAAL MUS MEM, V1, P1; Gifford ME, 2003, HERPETOLOGICAL NATUR, V9, P15; Glor RE, 2003, EVOLUTION, V57, P2383; Goldberg SR, 2008, TEX J SCI, V60, P1; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harmon LJ, 2005, EVOLUTION, V59, P409; Harris DJ, 1998, P ROY SOC B-BIOL SCI, V265, P1939, DOI 10.1098/rspb.1998.0524; Herrel A, 2002, BIOL J LINN SOC, V77, P149, DOI 10.1046/j.1095-8312.2002.00101.x; Herrel A, 2011, BIOL J LINN SOC, V104, P692, DOI 10.1111/j.1095-8312.2011.01764.x; Herrel Anthony, 2011, Breviora, P1; Herrel Anthony, 2008, Bulletin of the Museum of Comparative Zoology, V159, P213, DOI 10.3099/0027-4100-159.4.213; Hopkins KP, 2011, BIOL J LINN SOC, V102, P878, DOI 10.1111/j.1095-8312.2011.01618.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Jacobsen N.H.G., 1987, Journal of the Herpetological Association of Africa, V33, P13; Kapli Paschalia, 2011, Basic and Applied Herpetology, V25, P97; Kearney M, 2004, P ROY SOC B-BIOL SCI, V271, P1677, DOI 10.1098/rspb.2004.2771; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Leache Adam D., 2009, Bonner Zoologische Beitraege, V56, P273; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Losos JB, 2002, ANIM BEHAV, V64, P313, DOI 10.1006/anbe.2002.3051; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Mayer W, 2007, MOL PHYLOGENET EVOL, V44, P1155, DOI 10.1016/j.ympev.2007.05.015; Measey GJ, 2009, ZOOLOGY, V112, P217, DOI 10.1016/j.zool.2008.09.005; Melville J, 2000, BIOL J LINN SOC, V70, P667; Palumbi Stephen R., 1996, P205; Portik DM, 2012, CONSERV GENET RESOUR, V4, P1, DOI 10.1007/s12686-011-9460-1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER VERSION 1 5 C; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stayton CT, 2006, EVOLUTION, V60, P824; Suzuki R, 2004, 15 INT C GEN INF, P34; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Templeton AR, 1996, EVOLUTION, V50, P909, DOI 10.1111/j.1558-5646.1996.tb03899.x; Tolley KA, 2006, MOL ECOL, V15, P781, DOI 10.1111/j.1365-294X.2006.02836.x; Tolley KA, 2004, MOL PHYLOGENET EVOL, V30, P354, DOI 10.1016/S1055-7903(03)00211-2; Tolley KA, 2008, J BIOGEOGR, V35, P1402, DOI 10.1111/j.1365-2699.2008.01889.x; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Vanhooydonck B, 1999, EVOL ECOL RES, V1, P785; Vanhooydonck B, 2002, J EXP BIOL, V205, P1037; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8; Wiens JJ, 2001, EVOLUTION, V55, P2303; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	75	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51636	10.1371/journal.pone.0051636	http://dx.doi.org/10.1371/journal.pone.0051636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251601	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200152
J	Russell, BD; Connell, SD; Mellin, C; Brook, BW; Burnell, OW; Fordham, DA				Russell, Bayden D.; Connell, Sean D.; Mellin, Camille; Brook, Barry W.; Burnell, Owen W.; Fordham, Damien A.			Predicting the Distribution of Commercially Important Invertebrate Stocks under Future Climate	PLOS ONE			English	Article							BLACKLIP HALIOTIS-RUBRA; ABALONE GENUS-HALIOTIS; H-LAEVIGATA ABALONE; AUSTRALIAN ABALONE; GREENLIP ABALONE; MARINE FISHES; TEMPERATURE; ECOLOGY; COMMUNITIES; RECRUITMENT	The future management of commercially exploited species is challenging because techniques used to predict the future distribution of stocks under climate change are currently inadequate. We projected the future distribution and abundance of two commercially harvested abalone species (blacklip abalone, Haliotis rubra and greenlip abalone, H. laevigata) inhabiting coastal South Australia, using multiple species distribution models (SDM) and for decadal time slices through to 2100. Projections are based on two contrasting global greenhouse gas emissions scenarios. The SDMs identified August (winter) Sea Surface Temperature (SST) as the best descriptor of abundance and forecast that warming of winter temperatures under both scenarios may be beneficial to both species by allowing increased abundance and expansion into previously uninhabited coasts. This range expansion is unlikely to be realised, however, as projected warming of March SST is projected to exceed temperatures which cause up to 10-fold increases in juvenile mortality. By linking fine-resolution forecasts of sea surface temperature under different climate change scenarios to SDMs and physiological experiments, we provide a practical first approximation of the potential impact of climate-induced change on two species of marine invertebrates in the same fishery.	[Russell, Bayden D.; Connell, Sean D.; Burnell, Owen W.] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia; [Mellin, Camille] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Mellin, Camille; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia	University of Adelaide; Australian Institute of Marine Science; University of Adelaide	Russell, BD (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia.	bayden.russell@adelaide.edu.au	Brook, Barry W./G-2686-2011; Connell, Sean D/A-8874-2008; Russell, Bayden D./A-9942-2008; Mellin, Camille/X-9161-2019; Mellin, Camille/AAB-1768-2019; Fordham, Damien A/E-9255-2013; Russell, Bayden D./R-9325-2019	Brook, Barry W./0000-0002-2491-1517; Connell, Sean D/0000-0002-5350-6852; Russell, Bayden D./0000-0003-1282-9978; Mellin, Camille/0000-0002-7369-2349; Fordham, Damien A/0000-0003-2137-5592; Russell, Bayden D./0000-0003-1282-9978	Australian Research Council; Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)	Australian Research Council(Australian Research Council); Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)(Australian Government)	The research was partly funded by Australian Research Council Grants to D.A. Fordham, B.W. Brook and S.D. Connell. C. Mellin was funded by the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Convertino M, 2012, ECOL MODEL, V240, P1, DOI 10.1016/j.ecolmodel.2012.04.012; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Fordham DA, 2010, BIODIVERS CONSERV, V19, P329, DOI 10.1007/s10531-008-9529-7; Gilroy A, 1998, AQUAC RES, V29, P481, DOI 10.1046/j.1365-2109.1998.00241.x; Grubert MA, 2004, INVERTEBR REPROD DEV, V45, P185, DOI 10.1080/07924259.2004.9652590; Grubert MA, 2004, INVERTEBR REPROD DEV, V45, P197, DOI 10.1080/07924259.2004.9652591; Harris JO, 2005, AQUAC RES, V36, P1400, DOI 10.1111/j.1365-2109.2005.01360.x; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; HULME M, 1995, ENERG POLICY, V23, P347, DOI 10.1016/0301-4215(95)90159-5; Hutchinson M.F, 2006, ANUSPLIN VERSION 4 3; IPCC, 2007, INT PAN CLIM CHANG A; Kamenos NA, 2010, P NATL ACAD SCI USA, V107, P22442, DOI 10.1073/pnas.1006141107; Mayfield S, 2011, REV FISH SCI, V19, P216, DOI 10.1080/10641262.2011.585431; Mayfield S, REV FISHERI IN PRESS; Mellin C, 2012, DIVERS DISTRIB, V18, P133, DOI 10.1111/j.1472-4642.2011.00822.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pierce DW, 2009, P NATL ACAD SCI USA, V106, P8441, DOI 10.1073/pnas.0900094106; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Randall DA, 2007, PHYS SCI BASIS CONTR, P589; Robinson LM, 2011, GLOBAL ECOL IN PRESS; Rogers LA, 2011, P NATL ACAD SCI USA, V108, P1961, DOI 10.1073/pnas.1010314108; Rossetto M, 2012, OECOLOGIA, V168, P989, DOI 10.1007/s00442-011-2163-1; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Searle T, 2006, AQUAC RES, V37, P1441, DOI 10.1111/j.1365-2109.2006.01580.x; Sequeira A, 2011, DIVERSITY D IN PRESS; Shephard S, 2010, MAR BIOL, V157, P91, DOI 10.1007/s00227-009-1298-7; SHEPHERD SA, 1993, CAN J FISH AQUAT SCI, V50, P2001, DOI 10.1139/f93-224; SHEPHERD SA, 1973, AUST J MAR FRESH RES, V24, P217, DOI 10.1071/MF9730217; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; SHEPHERD SA, 1995, MAR FRESHWATER RES, V46, P669, DOI 10.1071/MF9950669; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Takami H, 2008, MAR ECOL PROG SER, V367, P203, DOI 10.3354/meps07557; Watts MJ, 2011, ECOL MODEL, V222, P2606, DOI 10.1016/j.ecolmodel.2011.04.024; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wigley TML, 2009, CLIMATIC CHANGE, V97, P85, DOI 10.1007/s10584-009-9585-3; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wilby R, 2004, GUIDELINES USE CLIMA; Wilby RL, 2000, GEOPHYS RES LETT, V27, P1199, DOI 10.1029/1999GL006078	52	9	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e46554	10.1371/journal.pone.0046554	http://dx.doi.org/10.1371/journal.pone.0046554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251326	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200001
J	Linnerth-Petrik, NM; Santry, LA; Yu, DL; Wootton, SK				Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Yu, Darrick L.; Wootton, Sarah K.			Adeno-Associated Virus Vector Mediated Expression of an Oncogenic Retroviral Envelope Protein Induces Lung Adenocarcinomas in Immunocompetent Mice	PLOS ONE			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; GROWTH-FACTOR RECEPTOR; HUMAN BRONCHIOLOALVEOLAR CARCINOMA; P38-ALPHA MAP KINASE; CELL-PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; INDUCED TRANSFORMATION; SIGNAL TRANSDUCER; RODENT FIBROBLAST; CYTOPLASMIC TAIL	Lung cancer is the most common cause of cancer-related death worldwide. A poor overall survival rate of 16% necessitates the need for novel treatment strategies. Mouse models of lung cancer are important tools for analyzing the significance of somatic mutations in the initiation and progression of lung cancer. Of additional importance, however, are animal models of virally induced cancers. JSRV is a simple betaretrovirus that causes contagious lung cancer in sheep known as ovine pulmonary adenocarcinoma and closely resembles human lung adenocarcinoma. Previously we showed that expression of the JSRV envelope (Env) from an AAV vector induced lung tumors in immunodeficient mice, but not in immunocompetent mice. Because of the importance of studying lung cancer in the context of an intact immune system we sought to improve our mouse model. In this report, we employed the use of a strong JSRV enhancer-promoter combination to express Env at high levels and demonstrate for the first time, lung tumor induction in immunocompetent mice. This occurred despite a robust Env-specific antibody-mediated immune response. The PI3K/Akt and MAPK pathways were activated in both immunocompetent and immunodeficient mice, however, differential activation of PTEN, GSK alpha, p70S6K, p38MAPK, ATF2 and STAT5 was observed. A JSRV Env lung tumor-derived cell line was shown to have a similar signal transduction activation profile as Env-induced lung tumors in C57BL/6 mice. Given the similarities between our model and pulmonary adenocarcinomas in humans, and the ease with which tumors can be induced in any transgenic mouse, this system can be used to uncover novel mechanisms involved lung tumorigenesis.	[Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Yu, Darrick L.; Wootton, Sarah K.] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada	University of Guelph	Wootton, SK (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	kwootton@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Cancer Research Society (CRS); Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF); Ontario Veterinary College (OVC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research Society (CRS); Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF)(Canada Foundation for Innovation); Ontario Veterinary College (OVC)	This work was supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/index_eng. asp), the Cancer Research Society (CRS; http://www.src-crs.ca/en-CA), and the Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF; http://www.innovation.ca/OurFunds/CFIFunds/LeadersOpportunityFund). DLY and LAS were supported by Ontario Veterinary College (OVC) PhD and MSc Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen JM, 2000, MOL THER, V1, P88, DOI 10.1006/mthe.1999.0010; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown JR, 2004, CLIN CANCER RES, V10, p4266S, DOI 10.1158/1078-0432.CCR-040014; Caporale M, 2006, J VIROL, V80, P8030, DOI 10.1128/JVI.00474-06; Castelao JE, 2003, ANN THORAC SURG, V76, P1327, DOI 10.1016/S0003-4975(03)00334-5; Chitra E, 2009, VIROLOGY, V393, P120, DOI 10.1016/j.virol.2009.07.023; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dakessian RM, 2007, VIRUS GENES, V35, P73, DOI 10.1007/s11262-006-0031-6; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; De las Heras M, 2006, J COMP PATHOL, V135, P1, DOI 10.1016/j.jcpa.2006.02.002; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Ganti AK, 2010, CANCER INVEST, V28, P515, DOI 10.3109/07357900903476760; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Griffiths DJ, 2010, J COMP PATHOL, V142, P260, DOI 10.1016/j.jcpa.2009.12.013; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Hull S, 2006, J VIROL, V80, P8069, DOI 10.1128/JVI.00013-06; Johnson C, 2010, J VIROL, V84, P5379, DOI 10.1128/JVI.02323-09; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; LACKNER AA, 1988, J VIROL, V62, P2134, DOI 10.1128/JVI.62.6.2134-2142.1988; Liu SL, 2005, J VIROL, V79, P927, DOI 10.1128/JVI.79.2.927-933.2005; Liu SL, 2003, J VIROL, V77, P7924, DOI 10.1128/JVI.77.14.7924-7935.2003; Maeda N, 2005, J VIROL, V79, P4440, DOI 10.1128/JVI.79.7.4440-4450.2005; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Mornex JF, 2003, CURR TOP MICROBIOL, V275, P225; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Palmarini M, 2001, J VIROL, V75, P11002, DOI 10.1128/JVI.75.22.11002-11009.2001; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Rocca S, 2008, HUM PATHOL, V39, P303, DOI 10.1016/j.humpath.2007.10.008; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarid R, 2011, CANCER LETT, V305, P218, DOI 10.1016/j.canlet.2010.09.011; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suau F, 2006, EUR RESPIR J, V27, P1175, DOI 10.1183/09031936.06.00125105; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Varela M, 2008, VIROLOGY, V371, P206, DOI 10.1016/j.virol.2007.09.041; Vaughan AE, 2012, MOL CANCER RES, V10, P86, DOI 10.1158/1541-7786.MCR-11-0285; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh SR, 2010, VIRUS RES, V151, P74, DOI 10.1016/j.virusres.2010.04.002; Wolff H, 1998, CANCER RES, V58, P4997; Wootton SK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-94; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Yu DL, 2011, J VIROL, V85, P7535, DOI 10.1128/JVI.00400-11; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zavala G, 2003, VIROLOGY, V312, P95, DOI 10.1016/S0042-6822(03)00205-8; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	72	16	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51400	10.1371/journal.pone.0051400	http://dx.doi.org/10.1371/journal.pone.0051400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251519	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900079
J	Orlowski, K; Bley, CR; Zimmermann, M; Vuong, V; Hug, D; Soltermann, A; Broggini-Tenzer, A; Pruschy, M				Orlowski, Katrin; Bley, Carla Rohrer; Zimmermann, Martina; Van Vuong; Hug, Daniel; Soltermann, Alex; Broggini-Tenzer, Angela; Pruschy, Martin			Dynamics of Tumor Hypoxia in Response to Patupilone and Ionizing Radiation	PLOS ONE			English	Article							GENE-EXPRESSION; EPOTHILONE B; MITOTIC EXIT; CANCER-CELLS; OXYGEN; CARCINOMA; AGENTS; RADIOSENSITIZATION; RADIOTHERAPY; ANGIOGENESIS	Tumor hypoxia is one of the most important parameters that determines treatment sensitivity and is mainly due to insufficient tumor angiogenesis. However, the local oxygen concentration in a tumor can also be shifted in response to different treatment modalities such as cytotoxic agents or ionizing radiation. Thus, combined treatment modalities including microtubule stabilizing agents could create an additional challenge for an effective treatment response due to treatment-induced shifts in tumor oxygenation. Tumor hypoxia was probed over a prolonged observation period in response to treatment with different cytotoxic agents, using a non-invasive bioluminescent ODD-Luc reporter system, in which part of the oxygen-dependent degradation (ODD) domain of HIF-1 alpha is fused to luciferase. As demonstrated in vitro, this system not only detects hypoxia at an ambient oxygen concentration of 1% O-2, but also discriminates low oxygen concentrations in the range from 0.2 to 1% O-2. Treatment of A549 lung adenocarcinoma-derived tumor xenografts with the microtubule stabilizing agent patupilone resulted in a prolonged increase in tumor hypoxia, which could be used as marker for its antitumoral treatment response, while irradiation did not induce detectable changes in tumor hypoxia. Furthermore, despite patupilone-induced hypoxia, the potency of ionizing radiation (IR) was not reduced as part of a concomitant or adjuvant combined treatment modality.	[Orlowski, Katrin; Zimmermann, Martina; Van Vuong; Hug, Daniel; Broggini-Tenzer, Angela; Pruschy, Martin] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland; [Bley, Carla Rohrer] Univ Zurich, Div Radiat Oncol, Vetsuisse Fac, Zurich, Switzerland; [Soltermann, Alex] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Orlowski, Katrin; Pruschy, Martin] Univ Zurich, KFSP Tumor Oxygenat, CH-8006 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Pruschy, M (corresponding author), Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland.	martin.pruschy@usz.ch	Rohrer Bley, Carla/G-1192-2013; Soltermann, Alex/AAE-3012-2020	Rohrer Bley, Carla/0000-0002-5733-2722; Soltermann, Alex/0000-0001-9509-6938; Pruschy, Martin/0000-0002-3124-9015	Swiss Cancer League; Swiss National Science Foundation; Vontobel-Stiftung; KFSP Tumor Oxygenation of the University Zurich	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Vontobel-Stiftung; KFSP Tumor Oxygenation of the University Zurich	This work was supported by the Swiss Cancer League, the Swiss National Science Foundation, the Vontobel-Stiftung (all to MP) and the KFSP Tumor Oxygenation of the University Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann KH, 2007, CHEMMEDCHEM, V2, P396, DOI 10.1002/cmdc.200600206; Altmann KH, 2000, BBA-REV CANCER, V1470, pM79, DOI 10.1016/S0304-419X(00)00009-3; Bley CR, 2011, LUNG CANCER, V73, P294, DOI 10.1016/j.lungcan.2011.01.010; Bley CR, 2009, CLIN CANCER RES, V15, P1335, DOI 10.1158/1078-0432.CCR-08-0969; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Chao SK, 2011, P NATL ACAD SCI USA, V108, P391, DOI 10.1073/pnas.1016962108; CHAPMAN JD, 1974, INT J RADIAT BIOL, V26, P383, DOI 10.1080/09553007414551361; Chen JG, 2003, CANCER RES, V63, P7891; Dubois L, 2004, BRIT J CANCER, V91, P1947, DOI 10.1038/sj.bjc.6602219; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Ferretti S, 2005, CLIN CANCER RES, V11, P7773, DOI 10.1158/1078-0432.CCR-05-1165; Fogh S, 2010, INT J RADIAT ONCOL, V77, P1009, DOI 10.1016/j.ijrobp.2009.06.050; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; Gradishar W, 2009, DRUG DES DEV THER, V3, P163; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hofstetter B, 2005, CLIN CANCER RES, V11, P1588, DOI 10.1158/1078-0432.CCR-04-1800; Jordan MA, 1996, CANCER RES, V56, P816; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Kim HA, 2007, J CONTROL RELEASE, V121, P218, DOI 10.1016/j.jconrel.2007.05.036; Knocke TH, 1999, RADIOTHER ONCOL, V53, P99, DOI 10.1016/S0167-8140(99)00139-5; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lehmann S, 2009, P NATL ACAD SCI USA, V106, P14004, DOI 10.1073/pnas.0901194106; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Melichar B, 2011, BRIT J CANCER, V105, P1646, DOI 10.1038/bjc.2011.438; Milas L, 1996, RADIOTHER ONCOL, V40, P163, DOI 10.1016/0167-8140(96)01778-1; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nordsmark M, 2004, ACTA ONCOL, V43, P396, DOI 10.1080/02841860410026189; Oehler C, 2011, NEURO-ONCOLOGY, V13, P1000, DOI 10.1093/neuonc/nor069; Oehler-Janne C, 2007, MOL CANCER THER, V6, P2496, DOI 10.1158/1535-7163.MCT-07-0253; Ogasawara M, 2001, BIOL PHARM BULL, V24, P720, DOI 10.1248/bpb.24.720; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Riesterer O, 2006, CLIN CANCER RES, V12, P3518, DOI 10.1158/1078-0432.CCR-05-2816; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sparano J A, 2000, Clin Breast Cancer, V1, P32, DOI 10.3816/CBC.2000.n.002; Sparano JA, 2000, CLIN BREAST CANCER, V1, P41; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stupp R, 2011, ANN ONCOL, V22, P2144, DOI 10.1093/annonc/mdq729; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; WALDMAN T, 1995, CANCER RES, V55, P5187; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Westerlund A, 1997, CLIN EXP METASTAS, V15, P318, DOI 10.1023/A:1018481617275; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015	53	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51476	10.1371/journal.pone.0051476	http://dx.doi.org/10.1371/journal.pone.0051476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251549	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000312201900093
J	Wintermute, S; Betts, S; Ferris, JL; Fincham, JM; Anderson, JR				Wintermute, Samuel; Betts, Shawn; Ferris, Jennifer L.; Fincham, Jon M.; Anderson, John R.			Brain Networks Supporting Execution of Mathematical Skills versus Acquisition of New Mathematical Competence	PLOS ONE			English	Article							COGNITIVE CONTROL; PARIETAL CORTEX; FRONTAL-CORTEX; REPRESENTATION; NUMBER; VISUALIZATION; ORGANIZATION; ACTIVATION; SOFTWARE	This fMRI study examines how students extend their mathematical competence. Students solved a set of algebra-like problems. These problems included Regular Problems that have a known solution technique and Exception Problems that but did not have a known technique. Two distinct networks of activity were uncovered. There was a Cognitive Network that was mainly active during the solution of problems and showed little difference between Regular Problems and Exception Problems. There was also a Metacognitive Network that was more engaged during a reflection period after the solution and was much more engaged for Exception Problems than Regular Problems. The Cognitive Network overlaps with prefrontal and parietal regions identified in the ACT-R theory of algebra problem solving and regions identified in the triple-code theory as involved in basic mathematical cognition. The Metacognitive Network included angular gyrus, middle temporal gyrus, and anterior prefrontal regions. This network is mainly engaged by the need to modify the solution procedure and not by the difficulty of the problem. Only the Metacognitive Network decreased with practice on the Exception Problems. Activity in the Cognitive Network during the solution of an Exception Problem predicted both success on that problem and future mastery. Activity in the angular gyrus and middle temporal gyrus during feedback on errors predicted future mastery.	[Wintermute, Samuel; Betts, Shawn; Ferris, Jennifer L.; Fincham, Jon M.; Anderson, John R.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Anderson, JR (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	ja+@cmu.edu			National Science Foundation [DRL-1007945]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant DRL-1007945 to JRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Anderson JR, 2011, COGN AFFECT BEHAV NE, V11, P52, DOI 10.3758/s13415-010-0011-0; Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Baldo JV, 2006, NEUROPSYCHOLOGY, V20, P529, DOI 10.1037/0894-4105.20.5.529; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buckner RL, 2003, J NEUROSCI, V23, P3999; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Danker JF, 2007, NEUROIMAGE, V35, P1365, DOI 10.1016/j.neuroimage.2007.01.032; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Kadosh RC, 2008, PROG NEUROBIOL, V84, P132, DOI 10.1016/j.pneurobio.2007.11.001; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-70; Krueger F, 2008, NEUROREPORT, V19, P1095, DOI 10.1097/WNR.0b013e328303fd85; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Qin YL, 2004, P NATL ACAD SCI USA, V101, P5686, DOI 10.1073/pnas.0401227101; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ravizza SM, 2008, BRAIN RES, V1238, P118, DOI 10.1016/j.brainres.2008.08.030; Rosenberg-Lee M, 2009, COGN AFFECT BEHAV NE, V9, P270, DOI 10.3758/CABN.9.3.270; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Sohn MH, 2004, NAT NEUROSCI, V7, P1193, DOI 10.1038/nn1337; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	40	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50154	10.1371/journal.pone.0050154	http://dx.doi.org/10.1371/journal.pone.0050154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251361	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900008
J	Maiden, SL; Harrison, N; Keegan, J; Cain, B; Lynch, AM; Pettitt, J; Hardin, J				Maiden, Stephanie L.; Harrison, Neale; Keegan, Jack; Cain, Brian; Lynch, Allison M.; Pettitt, Jonathan; Hardin, Jeff			Specific Conserved C-terminal Amino Acids of Caenorhabditis elegans HMP-1/alpha-Catenin Modulate F-actin Binding Independently of Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-E-CATENIN; CELL-CELL ADHESION; E-CADHERIN; BETA-CATENIN; CYTOPLASMIC DOMAIN; MYOSIN PHOSPHATASE; JUNCTIONAL COMPLEX; APICAL JUNCTIONS; IN-VITRO; MORPHOGENESIS	Stable intercellular adhesions formed through the cadherin-catenin complex are important determinants of proper tissue architecture and help maintain tissue integrity during morphogenetic movements in developing embryos. A key regulator of this stability is alpha-catenin, which connects the cadherin-catenin complex to the actin cytoskeleton. Although the C-terminal F-actin-binding domain of alpha-catenin has been shown to be crucial for its function, a more detailed in vivo analysis of discrete regions and residues required for actin binding has not been performed. Using Caenorhabditis elegans as a model system, we have characterized mutations in hmp-1/alpha-catenin that identify HMP-1 residues 687-742 and 826-927, as well as amino acid 802, as critical to the localization of junctional proximal actin during epidermal morphogenesis. We also find that the S823F transition in a hypomorphic allele, hmp-1(fe4), decreases actin binding in vitro. Using hmp-1(fe4) animals in a mutagenesis screen, we were then able to identify 11 intragenic suppressors of hmp-1(fe4) that revert actin binding to wild-type levels. Using homology modeling, we show that these amino acids are positioned at key conserved sites within predicted alpha-helices in the C terminus. Through the use of transgenic animals, we also demonstrate that HMP-1 residues 315-494, which correspond to a putative mechanotransduction domain that binds vinculin in vertebrate alpha E-catenin, are not required during epidermal morphogenesis but may aid efficient recruitment of HMP-1 to the junction. Our studies are the first to identify key conserved amino acids in the C terminus of alpha-catenin that modulate F-actin binding in living embryos of a simple metazoan.	[Maiden, Stephanie L.; Keegan, Jack; Cain, Brian; Lynch, Allison M.; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Maiden, Stephanie L.; Hardin, Jeff] Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Harrison, Neale; Pettitt, Jonathan] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Aberdeen	Hardin, J (corresponding author), Univ Wisconsin, Dept Zool, 1117 W Johnson St, Madison, WI 53706 USA.	jdhardin@wisc.edu		Maiden, Stephanie/0000-0002-5144-386X; Pettitt, Jonathan/0000-0001-7988-6833	National Institutes of Health [RO1 GM58038]; American Heart Association [0815662G]; Wellcome Trust [073317/Z/03/Z]; Michael Guyer postdoctoral fellowship; National Institutes of Health Office of Research Infrastructure Program [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058038] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Wellcome Trust(Wellcome TrustEuropean Commission); Michael Guyer postdoctoral fellowship; National Institutes of Health Office of Research Infrastructure Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM58038 (to J. D. H.), American Heart Association Grant 0815662G (to S. L. M.), Wellcome Trust Grant 073317/Z/03/Z (to J. P.), and a Michael Guyer postdoctoral fellowship (to A. M. L.).; We thank Shoichiro Ono, Bill Bement, Josh Sandquist, and Kevin Sonnemann for helpful discussions regarding experiments, and Jim Priess for providing hmp-1 mutant lines used in this analysis. Some strains were provided by the CGC, which is funded by the National Institutes of Health Office of Research Infrastructure Program Grant P40 OD010440.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; ABERLE H, 1994, J CELL SCI, V107, P3655; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bar RZ, 2010, J CELL BIOL, V191, P761, DOI 10.1083/jcb.201005082; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; BRENNER S, 1974, GENETICS, V77, P71; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Cox-Paulson EA, 2012, CURR BIOL, V22, P1500, DOI 10.1016/j.cub.2012.06.025; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huber O, 1997, J CELL SCI, V110, P1759; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; King RS, 2009, DEV BIOL, V328, P234, DOI 10.1016/j.ydbio.2009.01.017; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lockwood C, 2008, CURR BIOL, V18, P1333, DOI 10.1016/j.cub.2008.07.086; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; MacPyMOL, 2010, PYMOL MOL GRAPH SYST; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; McMahon L, 2001, J CELL SCI, V114, P2265; Mello C, 1995, METHOD CELL BIOL, V48, P451; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nieset JE, 1997, J CELL SCI, V110, P1013; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Piekny AJ, 2000, GENETICS, V156, P1671; Piekny AJ, 2002, J CELL SCI, V115, P2271; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	66	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5694	5706		10.1074/jbc.M112.438093	http://dx.doi.org/10.1074/jbc.M112.438093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271732	Green Published, hybrid			2022-12-25	WOS:000315342500042
J	Hughes, CE; Sinha, U; Pandey, A; Eble, JA; O'Callaghan, CA; Watson, SP				Hughes, Craig E.; Sinha, Uma; Pandey, Anjali; Eble, Johannes A.; O'Callaghan, Christopher A.; Watson, Steve P.			Critical Role for an Acidic Amino Acid Region in Platelet Signaling by the HemITAM (Hemi-immunoreceptor Tyrosine-based Activation Motif) Containing Receptor CLEC-2 (C-type Lectin Receptor-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYK; KINASE; PHOSPHORYLATION; SPECIFICITY; BINDING; BLOOD; RECONSTITUTION; RECOGNITION; SEPARATION; EXPRESSION	CLEC-2 is a member of new family of C-type lectin receptors characterized by a cytosolic YXXL downstream of three acidic amino acids in a sequence known as a hemITAM (hemi-immunoreceptor tyrosine-based activation motif). Dimerization of two phosphorylated CLEC-2 molecules leads to recruitment of the tyrosine kinase Syk via its tandem SH2 domains and initiation of a downstream signaling cascade. Using Syk-deficient and Zap-70-deficient cell lines we show that hemITAM signaling is restricted to Syk and that the upstream triacidic amino acid sequence is required for signaling. Using surface plasmon resonance and phosphorylation studies, we demonstrate that the triacidic amino acids are required for phosphorylation of the YXXL. These results further emphasize the distinct nature of the proximal events in signaling by hemITAM relative to ITAM receptors.	[Hughes, Craig E.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Sinha, Uma; Pandey, Anjali] Portola Pharmaceut Inc, San Francisco, CA 94080 USA; [Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med, D-60590 Frankfurt, Germany; [O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England	University of Birmingham; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Oxford	Hughes, CE (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	c.e.hughes@bham.ac.uk	Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820	Wellcome Trust [073107, 088410]; British Heart Foundation [PG/07/116, PG/05/134]; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust Grants 073107 and 088410 and by British Heart Foundation Grants PG/07/116 and PG/05/134. U.S. and A.P. are employees of Portola Pharmaceuticals.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hernanz-Falcon P, 2001, IMMUNOGENETICS, V53, P288, DOI 10.1007/s002510100326; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Konigsberger S, 2012, EMBO J, V31, P3363, DOI 10.1038/emboj.2012.169; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; McCarty OJT, 2004, J THROMB HAEMOST, V2, P1823, DOI 10.1111/j.1538-7836.2004.00925.x; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Qi RM, 1999, BBA-MOL CELL RES, V1451, P353, DOI 10.1016/S0167-4889(99)00105-6; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tomlinson MG, 2004, MOL CELL BIOL, V24, P2455, DOI 10.1128/MCB.24.6.2455-2466.2004; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388	42	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5127	5135		10.1074/jbc.M112.411462	http://dx.doi.org/10.1074/jbc.M112.411462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264619	Green Published, hybrid			2022-12-25	WOS:000315340400060
J	Li, HQ; Gakh, O; Smith, DY; Ranatunga, WK; Isaya, G				Li, Hongqiao; Gakh, Oleksandr; Smith, Douglas Y.; Ranatunga, Wasantha K.; Isaya, Grazia			Missense Mutations Linked to Friedreich Ataxia Have Different but Synergistic Effects on Mitochondrial Frataxin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; IRON HOMEOSTASIS; ASSEMBLY COMPLEX; PROTEIN; DISEASE; DETOXIFICATION; ACCUMULATION; BIOGENESIS; METABOLISM	Friedreich ataxia is an early-onset multisystemic disease linked to a variety of molecular defects in the nuclear gene FRDA. This gene normally encodes the iron-binding protein frataxin (FXN), which is critical for mitochondrial iron metabolism, global cellular iron homeostasis, and antioxidant protection. In most Friedreich ataxia patients, a large GAA-repeat expansion is present within the first intron of both FRDA alleles, that results in transcriptional silencing ultimately leading to insufficient levels of FXN protein in the mitochondrial matrix and probably other cellular compartments. The lack of FXN in turn impairs incorporation of iron into iron-sulfur cluster and heme cofactors, causing widespread enzymatic deficits and oxidative damage catalyzed by excess labile iron. In a minority of patients, a typical GAA expansion is present in only one FRDA allele, whereas a missense mutation is found in the other allele. Although it is known that the disease course for these patients can be as severe as for patients with two expanded FRDA alleles, the underlying pathophysiological mechanisms are not understood. Human cells normally contain two major mitochondrial isoforms of FXN (FXN42-210 and FXN81-210) that have different biochemical properties and functional roles. Using cell-free systems and different cellular models, we show that two of the most clinically severe FXN point mutations, I154F and W155R, have unique direct and indirect effects on the stability, biogenesis, or catalytic activity of FXN42-210 and FXN81-210 under physiological conditions. Our data indicate that frataxin point mutations have complex biochemical effects that synergistically contribute to the pathophysiology of Friedreich ataxia.	Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Mayo Clin Childrens Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health Grant [RO1 AG15709]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG15709 (to G. I.). Mayo Clinic has a financial interest associated with technology used in the authors' research that has been licensed to a commercial entity. Mayo Clinic, but not the authors, has received royalties of less than the federal threshold for significant financial interest.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Jeffery CJ, 2011, IUBMB LIFE, V63, P489, DOI 10.1002/iub.504; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaubel R. A., 2012, MOL CELL NE IN PRESS; Vaubel RA, 2011, J BIOL CHEM, V286, P40232, DOI 10.1074/jbc.M111.274415; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Xia HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047847; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	44	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4116	4127		10.1074/jbc.M112.435263	http://dx.doi.org/10.1074/jbc.M112.435263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269675	Green Published, hybrid			2022-12-25	WOS:000314845000040
J	Roloff, S; Spillner, C; Kehlenbach, RH				Roloff, Stephanie; Spillner, Christiane; Kehlenbach, Ralph H.			Several Phenylalanine-Glycine Motives in the Nucleoporin Nup214 Are Essential for Binding of the Nuclear Export Receptor CRM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL BASIS; IMPORTIN-BETA; CRYSTAL-STRUCTURE; FG-REPEAT; SET-CAN; SIGNAL; LOCALIZATION; CAN/NUP214	Nucleoporins containing phenylalanine glycine (FG) repeats play an important role in nucleocytoplasmic transport as they bind to transport receptors and mediate translocation of transport complexes across the nuclear pore complex (NPC). Nup214/CAN, a nucleoporin that is found at the cytoplasmic side of the NPC, interacts with both import and export receptors. In functional assays, dominant-negative fragments of Nup214 inhibited CRM1-dependent nuclear export, as the export receptor became rate-limiting. Several nuclear import pathways, by contrast, were not affected by the Nup214 fragments. We now characterize the CRM1-binding region of Nup214 in detail and identify several FG motives that are required for this interaction. Our results support a model where CRM1, like other transport receptors, contacts FG-Nups via multiple binding sites.	[Roloff, Stephanie; Spillner, Christiane; Kehlenbach, Ralph H.] Univ Gottingen, Dept Biochem 1, Fac Med, D-37073 Gottingen, Germany	University of Gottingen	Kehlenbach, RH (corresponding author), Univ Gottingen, Dept Biochem 1, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916	Deutsche Forschungsgemeinschaft [KE 660/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KE 660/9-1 (to R. H. K.).	Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fernandez-Martinez J, 2012, CURR OPIN CELL BIOL, V24, P92, DOI 10.1016/j.ceb.2011.12.013; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORNEROD M, 1995, ONCOGENE, V10, P1739; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Walde S, 2012, TRAFFIC, V13, P218, DOI 10.1111/j.1600-0854.2011.01302.x; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451	63	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3952	3963		10.1074/jbc.M112.433243	http://dx.doi.org/10.1074/jbc.M112.433243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264634	Green Published, hybrid			2022-12-25	WOS:000314845000025
J	Du, BW; Cawthorn, WP; Su, A; Doucette, CR; Yao, Y; Hemati, N; Kampert, S; McCoin, C; Broome, DT; Rosen, CJ; Yang, GS; MacDougald, OA				Du, Baowen; Cawthorn, William P.; Su, Alison; Doucette, Casey R.; Yao, Yao; Hemati, Nahid; Kampert, Sarah; McCoin, Colin; Broome, David T.; Rosen, Clifford J.; Yang, Gongshe; MacDougald, Ormond A.			The Transcription Factor Paired-Related Homeobox 1 (Prrx1) Inhibits Adipogenesis by Activating Transforming Growth Factor-beta (TGF beta) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PPAR-GAMMA ACTIVITY; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ADIPOSE-TISSUE; FACTOR-ALPHA; STEM-CELLS; PROTEIN; PRX1; RECEPTOR	Differentiation of adipocytes from preadipocytes contributes to adipose tissue expansion in obesity. Impaired adipogenesis may underlie the development of metabolic diseases such as insulin resistance and type 2 diabetes. Mechanistically, a well defined transcriptional network coordinates adipocyte differentiation. The family of paired-related homeobox transcription factors, which includes Prrx1a, Prrx1b, and Prrx2, is implicated with regulation of mesenchymal cell fate, including myogenesis and skeletogenesis; however, whether these proteins impact adipogenesis remains to be addressed. In this study, we identify Prrx1a and Prrx1b as negative regulators of adipogenesis. We show that Prrx1a and Prrx1b are down-regulated during adipogenesis in vitro and in vivo. Stable knockdown of Prrx1a/b enhances adipogenesis, with increased expression of peroxisome proliferator-activated receptor-gamma, CCAAT/enhancer-binding protein-alpha and FABP4 and increased secretion of the adipokines adiponectin and chemerin. Although stable low-level expression of Prrx1a, Prrx1b, or Prrx2 does not affect 3T3-L1 adipogenesis, transient overexpression of Prrx1a or Prrx1b inhibits peroxisome proliferator-activated receptor-gamma activity. Prrx1 knockdown decreases expression of Tgfb2 and Tgfb3, and inhibition of TGF beta signaling during adipogenesis mimics the effects of Prrx1 knockdown. These data support the hypothesis that endogenous Prrx1 restrains adipogenesis by regulating expression of TGF beta ligands and thereby activating TGF beta signaling. Finally, we find that expression of Prrx1a or Prrx1b in adipose tissue increases during obesity and strongly correlates with Tgfb3 expression in BL6 mice. These observations suggest that increased Prrx1 expression may promote TGF beta activity in adipose tissue and thereby contribute to aberrant adipocyte function during obesity.	[Du, Baowen; Yang, Gongshe] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Du, Baowen; Cawthorn, William P.; Su, Alison; Yao, Yao; Hemati, Nahid; McCoin, Colin; Broome, David T.; MacDougald, Ormond A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [MacDougald, Ormond A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; [Kampert, Sarah; MacDougald, Ormond A.] Univ Michigan, Sch Med, Cell & Mol Biol Program, Ann Arbor, MI 48105 USA; [Doucette, Casey R.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Northwest A&F University - China; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Maine Medical Center	Yang, GS (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	gsyang999@hotmail.com; macdouga@umich.edu	Cawthorn, William P./Y-2115-2019	Cawthorn, William P./0000-0001-7832-5057; Yang, Gongshe/0000-0003-2003-979X; McCoin, Colin/0000-0002-8557-6441; MacDougald, Ormond/0000-0001-6907-7960	National Institutes of Health [RO1 DK62876, R24 DK092759, R25 DK088752]; Royal Commission for the Exhibition of 1851 (United Kingdom); Lilly Innovation Fellowship Award; China Scholarship Council; National Basic Research Program of China [2012CB124705]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK062876, R56DK062876, R24DK092759, R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Commission for the Exhibition of 1851 (United Kingdom); Lilly Innovation Fellowship Award; China Scholarship Council(China Scholarship Council); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK62876 (to O. A. M.), R24 DK092759 (to O. A. M. and C. J. R.), and R25 DK088752 (to A. S.). This work was also supported by a Postdoctoral Research Fellowship from the Royal Commission for the Exhibition of 1851 (United Kingdom) and a Lilly Innovation Fellowship Award (to W. P. C.), and a fellowship from the China Scholarship Council and Grant 2012CB124705 from the National Basic Research Program of China (to B. D.).	Ahdjoudj S, 2005, EXP CELL RES, V303, P138, DOI 10.1016/j.yexcr.2004.09.013; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bogazzi F, 2004, EUR J ENDOCRINOL, V150, P863, DOI 10.1530/eje.0.1500863; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chan GK, 2001, ENDOCRINOLOGY, V142, P4900, DOI 10.1210/en.142.11.4900; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; HAWLEY RG, 1994, GENE THER, V1, P136; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hu YS, 1998, MOL ENDOCRINOL, V12, P1721, DOI 10.1210/me.12.11.1721; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jiang F, 2008, EXP BIOL MED, V233, P286, DOI 10.3181/0707-RM-177; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; KERN MJ, 1992, NUCLEIC ACIDS RES, V20, P5189, DOI 10.1093/nar/20.19.5189; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lu MF, 1999, DEVELOPMENT, V126, P495; Lu XH, 2011, J BONE MINER RES, V26, P209, DOI 10.1002/jbmr.203; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; ten Berge D, 1998, DEVELOPMENT, V125, P3831; ten Berge D, 2001, DEVELOPMENT, V128, P2929; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; WEINER FR, 1991, J BIOL CHEM, V266, P23525; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	63	44	49	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3036	3047		10.1074/jbc.M112.440370	http://dx.doi.org/10.1074/jbc.M112.440370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250756	Green Published, hybrid			2022-12-25	WOS:000314397900014
J	Chen, GF; Liu, XQ; Zhang, YL; Lin, SZ; Yang, ZJ; Johansson, J; Rising, A; Meng, Q				Chen, Gefei; Liu, Xiangqin; Zhang, Yunlong; Lin, Senzhu; Yang, Zijiang; Johansson, Jan; Rising, Anna; Meng, Qing			Full-Length Minor Ampullate Spidroin Gene Sequence	PLOS ONE			English	Article							SPIDER SILK PROTEINS; EGG CASE SILK; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; DRAGLINE SILK; MESSENGER-RNA; EVOLUTION; FIBERS; FLAGELLIFORM; EXPRESSION	Spider silk includes seven protein based fibers and glue-like substances produced by glands in the spider's abdomen. Minor ampullate silk is used to make the auxiliary spiral of the orb-web and also for wrapping prey, has a high tensile strength and does not supercontract in water. So far, only partial cDNA sequences have been obtained for minor ampullate spidroins (MiSps). Here we describe the first MiSp full-length gene sequence from the spider species Araneus ventricosus, using a multidimensional PCR approach. Comparative analysis of the sequence reveals regulatory elements, as well as unique spidroin gene and protein architecture including the presence of an unusually large intron. The spliced full-length transcript of MiSp gene is 5440 bp in size and encodes 1766 amino acid residues organized into conserved nonrepetitive N- and C-terminal domains and a central predominantly repetitive region composed of four units that are iterated in a non regular manner. The repeats are more conserved within A. ventricosus MiSp than compared to repeats from homologous proteins, and are interrupted by two nonrepetitive spacer regions, which have 100% identity even at the nucleotide level.	[Johansson, Jan; Rising, Anna] Karolinska Inst, KI Alzheimer Dis Res Ctr, NVS Neurobiol Care Sci & Soc Dept, Stockholm, Sweden; [Chen, Gefei; Zhang, Yunlong; Lin, Senzhu; Yang, Zijiang; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Liu, Xiangqin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Johansson, Jan; Rising, Anna] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Johansson, Jan] Tallinn Univ, Inst Math & Nat Sci, Tallinn, Estonia	Karolinska Institutet; Donghua University; Dalhousie University; Swedish University of Agricultural Sciences; Tallinn University	Rising, A (corresponding author), Karolinska Inst, KI Alzheimer Dis Res Ctr, NVS Neurobiol Care Sci & Soc Dept, Stockholm, Sweden.	anna.rising@ki.se; mengqing@dhu.edu.cn	Rising, Anna/ABE-8822-2020; Chen, Gefei/J-2919-2013	Rising, Anna/0000-0002-1872-1207; Chen, Gefei/0000-0002-5543-5963; Johansson, Jan/0000-0002-8719-4703	Chinese National High Technology Research and Development Program 863 [2006AA03Z451]; Chinese National Natural Science Foundation [31070698]; Shanghai key projects of basic research [10JC1400300]; Swedish Research Council [10371]; Karolinska Institutet research funds	Chinese National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet research funds	This work was supported by Chinese National High Technology Research and Development Program 863 [no. 2006AA03Z451], the Chinese National Natural Science Foundation [no. 31070698], the Shanghai key projects of basic research [no. 10JC1400300], the Swedish Research Council [no. 10371] and Karolinska Institutet research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Foelix RF, 1996, BIOL SPIDERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Geurts P, 2010, BIOMACROMOLECULES, V11, P3495, DOI 10.1021/bm101002w; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Guinea GV, 2012, BIOMACROMOLECULES, V13, P2087, DOI 10.1021/bm3004644; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Patterton HG, 2000, BIOINFORMATICS, V16, P652, DOI 10.1093/bioinformatics/16.7.652; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Sakharkar MK, 2002, BIOINFORMATICS, V18, P1266, DOI 10.1093/bioinformatics/18.9.1266; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; STAUFFER SL, 1994, J ARACHNOL, V22, P5; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Viney C, 2000, J TEXT I, V91, P2, DOI 10.1080/00405000008659539; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	56	63	73	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52293	10.1371/journal.pone.0052293	http://dx.doi.org/10.1371/journal.pone.0052293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251707	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800159
J	Stefanidis, A; Spencer, SJ				Stefanidis, Aneta; Spencer, Sarah J.			Effects of Neonatal Overfeeding on Juvenile and Adult Feeding and Energy Expenditure in the Rat	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; EARLY OVERNUTRITION; METABOLIC SYNDROME; WEIGHT-GAIN; BODY-FAT; OBESITY; LEPTIN; FOOD; EXPRESSION; GENDER	Overfeeding during perinatal life leads to an overweight phenotype that persists throughout the juvenile stage and into adulthood, however, the mechanim(s) underlying this effect are poorly understood. We hypothesized that obesity due to neonatal overfeeding is maintained by changes in energy expenditure and that these changes differ between males and females. We investigated feeding, physical activity, hormonal and metabolic alterations that occur in adult rats made obese by having been nursed in small litters (SL) compared with those from control litters (CL). There were no differences in absolute food intake between the groups, and juvenile and adult SL rats ate less chow per gram body weight than the CL did in the dark (active) phase. Juvenile, but not adult SL rats did have reduced whole body energy expenditure, but there were no differences between the groups by the time they reached adulthood. Adult SL females (but not males) had reduced brown adipose tissue (BAT) temperatures compared with CL in the first half of the dark phase. Our results indicate a persistent overweight phenotype in rats overfed as neonates is not associated with hyperphagia at any stage, but is reflected in reduced energy expenditure into the juvenile phase. The reduced dark phase BAT activity in adult SL females is not sufficient to reduce total energy expenditure at this stage of life and there is an apparently compensatory effect that prevents SL and CL from continuing to diverge in weight that appears between the juvenile and adult stages.	[Stefanidis, Aneta; Spencer, Sarah J.] Monash Univ, Fac Med, Dept Physiol, Melbourne, Vic 3004, Australia; [Spencer, Sarah J.] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Spencer, Sarah J.] RMIT Univ, Hlth Innovat Res Inst HIRI, Melbourne, Vic, Australia	Monash University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Spencer, SJ (corresponding author), Monash Univ, Fac Med, Dept Physiol, Melbourne, Vic 3004, Australia.	sarah.spencer@rmit.edu.au	Spencer, Sarah J/D-5777-2018	Spencer, Sarah/0000-0001-8832-4824	Australian Research Council (ARC) [DP109339]; NHMRC Peter Doherty Research Fellowship [465167]; Endocrine Society of Australia	Australian Research Council (ARC)(Australian Research Council); NHMRC Peter Doherty Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society of Australia	This work was supported by a Discovery Project Grant from the Australian Research Council to SJS (ARC; DP109339). SJS was supported by an NHMRC Peter Doherty Research Fellowship (465167) and an Endocrine Society of Australia Postdoctoral Fellowship, she is also an ARC Future Fellow (FT110100084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorntorp P, 1996, INT J OBESITY, V20, P291; Bulfin LJ, 2011, PSYCHONEUROENDOCRINO, V36, P1080, DOI 10.1016/j.psyneuen.2011.01.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clarke MA, 2011, J NEUROENDOCRINOL; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Lee JM, 2008, ARCH PEDIAT ADOL MED, V162, P682, DOI 10.1001/archpedi.162.7.682; Lopez M, 2007, INT J OBESITY, V31, P371, DOI 10.1038/sj.ijo.0803425; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Masaki T, 2000, AM J PHYSIOL-REG I, V279, pR1305, DOI 10.1152/ajpregu.2000.279.4.R1305; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; MCCANCE RA, 1962, LANCET, V2, P671; Mozes S, 2004, PHYSIOL RES, V53, P177; OSCAI LB, 1978, AM J PHYSIOL, V235, pR141, DOI 10.1152/ajpregu.1978.235.3.R141; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; Ramsey JJ, 1996, COMP BIOCHEM PHYS B, V113, P461, DOI 10.1016/0305-0491(95)02071-3; Razzouk L, 2009, CURR HYPERTENS REP, V11, P127, DOI 10.1007/s11906-009-0023-8; Remmers F, 2008, BRIT J NUTR, V99, P1149, DOI 10.1017/S0007114507843546; Robinson WR, 2009, AM J CLIN NUTR, V89, P1204, DOI 10.3945/ajcn.2007.25751; Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046; Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; Shaw NJ, 2007, ARCH DIS CHILD, V92, P872, DOI 10.1136/adc.2007.117911; Spencer SJ, 2007, AM J PHYSIOL-REG I, V293, pR581, DOI 10.1152/ajpregu.00262.2007; Spencer SJ, 2009, PSYCHONEUROENDOCRINO, V34, P1133, DOI 10.1016/j.psyneuen.2009.02.013; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373	32	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52130	10.1371/journal.pone.0052130	http://dx.doi.org/10.1371/journal.pone.0052130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251693	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800145
J	Tereshchenko, LG; McNitt, S; Han, L; Berger, RD; Zareba, W				Tereshchenko, Larisa G.; McNitt, Scott; Han, Lichy; Berger, Ronald D.; Zareba, Wojciech			ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; LEFT-VENTRICULAR HYPERTROPHY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; HIBERNATING MYOCARDIUM; QRS DURATION; HEART; ARRHYTHMIAS; VARIABILITY	Background: Post-myocardial infarction (MI) structural remodeling is characterized by left ventricular dilatation, fibrosis, and hypertrophy of the non-infarcted myocardium. Objective: The goal of our study was to quantify post-MI electrical remodeling by measuring the sum absolute QRST integral (SAI QRST). We hypothesized that adverse electrical remodeling predicts outcomes in MADIT II study participants. Methods: Baseline orthogonal ECGs of 750 MADIT II study participants (448 [59.7%] ICD arm) were analyzed. SAI QRST was measured as the arithmetic sum of absolute QRST integrals over all three orthogonal ECG leads. The primary endpoint was defined as sudden cardiac death (SCD) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate ICD therapies. All-cause mortality served as a secondary endpoint. Results: Adverse electrical remodeling in post-MI patients was characterized by wide QRS, increased magnitudes of spatial QRS and T vectors, J-point deviation, and QTc prolongation. In multivariable Cox regression analysis after adjustment for age, QRS duration, atrial fibrillation, New York Heart Association heart failure class and blood urea nitrogen, SAI QRST predicted SCD/VT/VF (HR 1.33 per 100 mV*ms (95% CI 1.11-1.59); P = 0.002), and all-cause death (HR 1.27 per 100 mV*ms (95% CI 1.03-1.55), P = 0.022) in both arms. No interaction with therapy arm and bundle branch block (BBB) status was found. Conclusions: In MADIT II patients, increased SAI QRST is associated with increased risk of sustained VT/VF with appropriate ICD therapies and all-cause death in both ICD and in conventional medical therapy arms, and in patients with and without BBB. Further studies of SAI QRST are warranted. Citation: Tereshchenko LG, McNitt S, Han L, Berger RD, Zareba W (2012) ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study. PLoS ONE 7(12): e51812. doi:10.1371/journal.pone.0051812	[Tereshchenko, Larisa G.; Berger, Ronald D.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [McNitt, Scott; Zareba, Wojciech] Univ Rochester, Med Ctr, Div Cardiol, Rochester, NY 14642 USA; [Han, Lichy] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA	Johns Hopkins University; University of Rochester; Johns Hopkins University	Tereshchenko, LG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	lteresh1@jhmi.edu	Tereshchenko, Larisa/X-4253-2019	Tereshchenko, Larisa/0000-0002-6976-1313	American Heart Association [AHA 10CRP2600257]; Open Access Promotion Fund of the Johns Hopkins University Libraries	American Heart Association(American Heart Association); Open Access Promotion Fund of the Johns Hopkins University Libraries	This project was partially supported by the American Heart Association, grant AHA 10CRP2600257 (PI Larisa Tereshchenko). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bacharova L, 2007, ANN NONINVAS ELECTRO, V12, P260, DOI 10.1111/j.1542-474X.2007.00170.x; Bacharova L, 2010, J ELECTROCARDIOL, V43, P200, DOI 10.1016/j.jelectrocard.2009.07.014; Berkowitsch A, 2004, ANN NONINVAS ELECTRO, V9, P270, DOI 10.1111/j.1542-474X.2004.93600.x; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; BRODY DA, 1956, CIRC RES, V4, P731, DOI 10.1161/01.RES.4.6.731; Bunch TJ, 2007, CIRCULATION, V115, P2451, DOI 10.1161/CIRCULATIONAHA.106.683235; Canty JM, 2004, CIRC RES, V94, P1142, DOI 10.1161/01.RES.0000125628.57672.CF; CHIANG BN, 1970, CIRCULATION, V41, P31, DOI 10.1161/01.CIR.41.1.31; Connelly KA, 2012, CARDIOVASC IN PRESS; Couderc JP, 2007, EUROPACE, V9, P717, DOI 10.1093/europace/eum131; COX MM, 1991, J MOL CELL CARDIOL, V23, P127, DOI 10.1016/0022-2828(91)90100-Z; Dhar R, 2008, HEART RHYTHM, V5, P807, DOI 10.1016/j.hrthm.2008.02.013; Fallavollita JA, 2010, J NUCL CARDIOL, V17, P85, DOI 10.1007/s12350-009-9164-z; Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115; Florian A, 2012, JACC-CARDIOVASC IMAG, V5, P1003, DOI 10.1016/j.jcmg.2012.02.018; GULRAJANI RM, 1983, CIRC RES, V52, P45, DOI 10.1161/01.RES.52.1.45; Haigney MC, 2009, HEART RHYTHM, V6, P180, DOI 10.1016/j.hrthm.2008.10.045; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; KANNEL WB, 1985, J AM COLL CARDIOL, V5, pB141, DOI 10.1016/S0735-1097(85)80545-3; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; Morin DP, 2009, EUR HEART J, V30, P2908, DOI 10.1093/eurheartj/ehp321; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2008, NEW ENGL J MED, V359, P2245, DOI 10.1056/NEJMra0803409; Obreztchikova MN, 2003, CIRCULATION, V108, P1389, DOI 10.1161/01.CIR.0000086461.86642.22; Okin PM, 2009, J ELECTROCARDIOL, V42, P584, DOI 10.1016/j.jelectrocard.2009.06.020; OKIN PM, 1995, HYPERTENSION, V25, P242, DOI 10.1161/01.HYP.25.2.242; Ostman-Smith I, 2010, EUR HEART J, V31, P439, DOI 10.1093/eurheartj/ehp443; Peters NS, 1998, CIRCULATION, V97, P1746, DOI 10.1161/01.CIR.97.17.1746; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pietrasik G, 2007, AM J CARDIOL, V100, P583, DOI 10.1016/j.amjcard.2007.03.063; PYE MP, 1992, CARDIOVASC RES, V26, P740, DOI 10.1093/cvr/26.8.740; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; Spach MS, 2004, HEART RHYTHM, V1, P500, DOI 10.1016/j.hrthm.2004.06.010; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X; Tereshchenko LG, 2011, J ELECTROCARDIOL, V44, P208, DOI 10.1016/j.jelectrocard.2010.08.012; Tereshchenko LG, 2010, HEART RHYTHM, V7, P1606, DOI 10.1016/j.hrthm.2010.08.022; Tereshchenko LG, 2010, J ELECTROCARDIOL, V43, P548, DOI 10.1016/j.jelectrocard.2010.07.013; Tereshchenko LG, 2011, HEART RHYTHM, V8, pS130; URSELL PC, 1985, CIRC RES, V56, P436, DOI 10.1161/01.RES.56.3.436; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Wachtell K, 2007, CIRCULATION, V116, P700, DOI 10.1161/CIRCULATIONAHA.106.666594; Yeh CC, 2012, J CELL BIOC IN PRESS; Zareba W, 2003, J ELECTROCARDIOL, V36, P101, DOI 10.1016/j.jelectrocard.2003.09.022; Zong W, 2003, COMPUT CARDIOL, V30, P737, DOI 10.1109/CIC.2003.1291261; Zong W, 2006, COMPUT CARDIOL, V33, P377	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51812	10.1371/journal.pone.0051812	http://dx.doi.org/10.1371/journal.pone.0051812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251630	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800089
J	Zach, L; Guez, D; Last, D; Daniels, D; Grober, Y; Nissim, O; Hoffmann, C; Nass, D; Talianski, A; Spiegelmann, R; Cohen, ZR; Mardor, Y				Zach, Leor; Guez, David; Last, David; Daniels, Dianne; Grober, Yuval; Nissim, Ouzi; Hoffmann, Chen; Nass, Dvora; Talianski, Alisa; Spiegelmann, Roberto; Cohen, Zvi R.; Mardor, Yael			Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE PERFUSION; RADIATION NECROSIS; MALIGNANT GLIOMA; GLIOBLASTOMA; PSEUDOPROGRESSION; RADIOTHERAPY; RECURRENCE; TEMOZOLOMIDE; DIFFERENTIATION	The current standard of care for newly diagnosed glioblastoma multiforme (GBM) is resection followed by radiotherapy with concomitant and adjuvant temozolomide. Recent studies suggest that nearly half of the patients with early radiological deterioration post treatment do not suffer from tumor recurrence but from pseudoprogression. Similarly, a significant number of patients with brain metastases suffer from radiation necrosis following radiation treatments. Conventional MRI is currently unable to differentiate tumor progression from treatment-induced effects. The ability to clearly differentiate tumor from non-tumoral tissues is crucial for appropriate patient management. Ten patients with primary brain tumors and 10 patients with brain metastases were scanned by delayed contrast extravasation MRI prior to surgery. Enhancement subtraction maps calculated from high resolution MR images acquired up to 75 min after contrast administration were used for obtaining stereotactic biopsies. Histological assessment was then compared with the pre-surgical calculated maps. In addition, the application of our maps for prediction of progression was studied in a small cohort of 13 newly diagnosed GBM patients undergoing standard chemoradiation and followed up to 19.7 months post therapy. The maps showed two primary enhancement populations: the slow population where contrast clearance from the tissue was slower than contrast accumulation and the fast population where clearance was faster than accumulation. Comparison with histology confirmed the fast population to consist of morphologically active tumor and the slow population to consist of non-tumoral tissues. Our maps demonstrated significant correlation with perfusion-weighted MR data acquired simultaneously, although contradicting examples were shown. Preliminary results suggest that early changes in the fast volumes may serve as a predictor for time to progression. These preliminary results suggest that our high resolution MRI-based delayed enhancement subtraction maps may be applied for clear depiction of tumor and non-tumoral tissues in patients with primary brain tumors and patients with brain metastases. Citation: Zach L, Guez D, Last D, Daniels D, Grober Y, et al. (2012) Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors. PLoS ONE 7(12): e52008. doi: 10.1371/journal.pone.0052008	[Guez, David; Last, David; Daniels, Dianne; Mardor, Yael] Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel; [Zach, Leor; Talianski, Alisa] Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Grober, Yuval; Nissim, Ouzi; Spiegelmann, Roberto; Cohen, Zvi R.] Sheba Med Ctr, Dept Neurosurg, Ramat Gan, Israel; [Hoffmann, Chen] Sheba Med Ctr, Inst Radiol, Ramat Gan, Israel; [Nass, Dvora] Sheba Med Ctr, Inst Pathol, Ramat Gan, Israel; [Zach, Leor; Daniels, Dianne; Hoffmann, Chen; Spiegelmann, Roberto; Cohen, Zvi R.; Mardor, Yael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mardor, Y (corresponding author), Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel.	yael.mardor@sheba.health.gov.il	Zach, Leor/HGU-0915-2022	Daniels, Dianne/0000-0002-0912-8719; guez, david/0000-0002-9143-2575	Kamin program of the Israeli Ministry of Industry and Commerce	Kamin program of the Israeli Ministry of Industry and Commerce	This research is supported by the Kamin program of the Israeli Ministry of Industry and Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2012, CURR ONCOL REP, V14, P79, DOI 10.1007/s11912-011-0201-0; Aronen HJ, 2002, NEUROIMAG CLIN N AM, V12, P501, DOI 10.1016/S1052-5149(02)00026-6; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Barboriak DP, 2008, J MAGN RESON IMAGING, V27, P1388, DOI 10.1002/jmri.21344; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chan YL, 2003, J COMPUT ASSIST TOMO, V27, P674, DOI 10.1097/00004728-200309000-00003; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Fink J, 2011, CURR TREAT OPTION ON, V12, P240, DOI 10.1007/s11864-011-0157-1; FORSYTH PA, 1995, J NEUROSURG, V82, P436, DOI 10.3171/jns.1995.82.3.0436; Gahramanov S, 2011, INT J RADIAT ONCOL, V79, P514, DOI 10.1016/j.ijrobp.2009.10.072; Gasparetto EL, 2009, RADIOLOGY, V250, P887, DOI 10.1148/radiol.2502071444; Hazle JD, 1997, JMRI-J MAGN RESON IM, V7, P1084, DOI 10.1002/jmri.1880070622; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Hu LS, 2012, NEUROONCOL; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jahangiri A, 2012, NEUROSURG CLIN N AM, V23, P277, DOI 10.1016/j.nec.2012.01.002; Kim JH, 2012, AM J SURG PATHOL, V36, P620, DOI 10.1097/PAS.0b013e318246040c; Kim YH, 2010, CLIN NEUROL NEUROSUR, V112, P758, DOI 10.1016/j.clineuro.2010.06.005; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Lacerda S, 2009, NEUROIMAG CLIN N AM, V19, P527, DOI 10.1016/j.nic.2009.08.007; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; Matsusue E, 2010, NEURORADIOLOGY, V52, P297, DOI 10.1007/s00234-009-0613-9; Mills SJ, 2010, AM J NEURORADIOL, V31, P726, DOI 10.3174/ajnr.A1925; MOSES LE, 1952, PSYCHOL BULL, V49, P122, DOI 10.1037/h0056813; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; Peto R, 1972, J ROY STAT SOC A STA, V135, P195; Rane N, 2012, CLIN RADIOL, V67, P61, DOI 10.1016/j.crad.2011.01.010; Ricci PE, 1998, AM J NEURORADIOL, V19, P407; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Russell SM, 2009, SURG NEUROL, V72, P242, DOI 10.1016/j.surneu.2008.11.012; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; Taal W, 2008, CANCER, V113, P405, DOI 10.1002/cncr.23562; Tihan T, 2006, HUM PATHOL, V37, P272, DOI 10.1016/j.humpath.2005.11.010; Tonn JC, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mds363; Tsuyuguchi N, 2004, ANN NUCL MED, V18, P291, DOI 10.1007/BF02984466; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Xu JL, 2010, NEURORADIOLOGY, V52, P1193, DOI 10.1007/s00234-010-0731-4; Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7; Zeng QS, 2007, J NEURO-ONCOL, V84, P63, DOI 10.1007/s11060-007-9341-3	54	26	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52008	10.1371/journal.pone.0052008	http://dx.doi.org/10.1371/journal.pone.0052008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251672	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800127
J	Park, SC; Kim, YH; Ji, CY; Park, S; Jeong, JC; Lee, HS; Kwak, SS				Park, Sung-Chul; Kim, Yun-Hee; Ji, Chang Yoon; Park, Seyeon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo			Stable Internal Reference Genes for the Normalization of Real-Time PCR in Different Sweetpotato Cultivars Subjected to Abiotic Stress Conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; PHOSPHOLIPASE-D; HOUSEKEEPING GENES; EXPRESSION; SELECTION; VALIDATION; IDENTIFICATION; INVOLVEMENT; ROOTS	Reverse transcription quantitative real-time PCR (RT-qPCR) has become one of the most widely used methods for gene expression analysis, but its successful application depends on the stability of suitable reference genes used for data normalization. In plant studies, the choice and optimal number of reference genes must be experimentally determined for the specific conditions, plant species, and cultivars. In this study, ten candidate reference genes of sweetpotato (Ipomoea batatas) were isolated and the stability of their expression was analyzed using two algorithms, geNorm and NormFinder. The samples consisted of tissues from four sweetpotato cultivars subjected to four different environmental stress treatments, i.e., cold, drought, salt and oxidative stress. The results showed that, for sweetpotato, individual reference genes or combinations thereof should be selected for use in data normalization depending on the experimental conditions and the particular cultivar. In general, the genes ARF, UBI, COX, GAP and RPL were validated as the most suitable reference gene set for every cultivar across total tested samples. Interestingly, the genes ACT and TUB, although widely used, were not the most suitable reference genes in different sweetpotato sample sets. Taken together, these results provide guidelines for reference gene(s) selection under different experimental conditions. In addition, they serve as a foundation for the more accurate and widespread use of RT-qPCR in various sweetpotato cultivars.	[Park, Sung-Chul; Kim, Yun-Hee; Ji, Chang Yoon; Park, Seyeon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo] Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea; [Park, Sung-Chul; Ji, Chang Yoon; Park, Seyeon; Lee, Haeng-Soon; Kwak, Sang-Soo] Univ Sci & Technol, Dept Green Chem & Environm Biotechnol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwak, SS (corresponding author), Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea.	sskwak@kribb.re.kr			National Center for GM Crops [PJ008097]; Systems & Synthetic Agrobiotech Center [PJ008119]; Biogreen21 Project for Next Generation Rural Development Administration, Korea; KRIBB initiative program	National Center for GM Crops; Systems & Synthetic Agrobiotech Center; Biogreen21 Project for Next Generation Rural Development Administration, Korea; KRIBB initiative program	This work was supported by grants from the National Center for GM Crops (PJ008097) and the Systems & Synthetic Agrobiotech Center (PJ008119), Biogreen21 Project for Next Generation Rural Development Administration, Korea and the KRIBB initiative program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kim KY, 1999, MOL GEN GENET, V261, P941, DOI 10.1007/s004380051041; Kim SH, 2009, BMB REP, V42, P271, DOI 10.5483/BMBRep.2009.42.5.271; Kim YH, 2011, PLANT PHYSIOL BIOCH, V49, P1436, DOI 10.1016/j.plaphy.2011.09.002; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Oki T, 2002, J FOOD SCI, V67, P1752, DOI 10.1111/j.1365-2621.2002.tb08718.x; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; UEKI J, 1995, PLANT CELL PHYSIOL, V36, P903, DOI 10.1093/oxfordjournals.pcp.a078837; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Xu LW, 1997, PLANT PHYSIOL, V115, P387, DOI 10.1104/pp.115.2.387; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044	41	58	69	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51502	10.1371/journal.pone.0051502	http://dx.doi.org/10.1371/journal.pone.0051502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251557	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200124
J	Badr, G; Al-Sadoon, MK; Abdel-Maksoud, MA; Rabah, DM; El-Toni, AM				Badr, Gamal; Al-Sadoon, Mohamed K.; Abdel-Maksoud, Mostafa A.; Rabah, Danny M.; El-Toni, Ahmed M.			Cellular and Molecular Mechanisms Underlie the Anti-Tumor Activities Exerted by Walterinnesia aegyptia Venom Combined with Silica Nanoparticles against Multiple Myeloma Cancer Cell Types	PLOS ONE			English	Article							VIPERA-LEBETINA-TURANICA; CHEMOKINE RECEPTORS; IN-VIVO; KAPPA-B; APOPTOSIS; GROWTH; INDUCTION; TOXIN; THERAPY; CXCR4	Multiple myeloma (MM) is a clonal disease of plasma cells that remains incurable despite the advent of several novel therapeutics. In this study, we aimed to delineate the impact of snake venom extracted from Walterinnesia aegyptia (WEV) alone or in combination with silica nanoparticles (WEV+NP) on primary MM cells isolated from patients diagnosed with MM as well as on two MM cell lines, U266 and RPMI 8226. The IC50 values of WEV and WEV+NP that significantly decreased MM cell viability without affecting the viability of normal peripheral mononuclear cells (PBMCs) were determined to be 25 ng/ml and 10 ng/ml, respectively. Although both WEV (25 ng/ml) and WEV+NP (10 ng/ml) decreased the CD54 surface expression without affecting the expression of CXCR4 (CXCL12 receptor) on MM cells, they significantly reduced the ability of CXC chemokine ligand 12 (CXCL12) to induce actin cytoskeleton rearrangement and the subsequent reduction in chemotaxis. It has been established that the binding of CXCL12 to its receptor CXCR4 activates multiple intracellular signal transduction pathways that regulate MM cell chemotaxis, adhesion, and proliferation. We found that WEV and WEV+NP clearly decreased the CXCL12/CXCR4-mediated activation of AKT, ERK, NF kappa B and Rho-A using western blot analysis; abrogated the CXCL12-mediated proliferation of MM cells using the CFSE assay; and induced apoptosis in MM cell as determined by PI/annexin V double staining followed by flow cytometry analysis. Monitoring the expression of B-cell CCL/Lymphoma 2 (Bcl-2) family members and their role in apoptosis induction after treatment with WEV or WEV+NP revealed that the combination of WEV with NP robustly decreased the expression of the anti-apoptotic effectors Bcl-2, Bcl(XL) and Mcl-1; conversely increased the expression of the pro-apoptotic effectors Bak, Bax and Bim; and altered the mitochondrial membrane potential in MM cells. Taken together, our data reveal the biological effects of WEV and WEV+NP and the underlying mechanisms against myeloma cancer cells.	[Badr, Gamal; Rabah, Danny M.] King Saud Univ, Coll Med, Princess Johara Alibrahim Ctr Canc Res, Prostate Canc Res Chair, Riyadh 11461, Saudi Arabia; [Badr, Gamal] Assiut Univ, Fac Sci, Dept Zool, Immunol & Mol Biol Lab, Assiut, Egypt; [Al-Sadoon, Mohamed K.; Abdel-Maksoud, Mostafa A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11461, Saudi Arabia; [Rabah, Danny M.] King Saud Univ, Coll Med, Dept Urol Surg, Riyadh 11461, Saudi Arabia; [El-Toni, Ahmed M.] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh 11461, Saudi Arabia; [El-Toni, Ahmed M.] CMRDI, Helwan, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; King Saud University; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Central Metallurgical Research & Development Institute (CMRDI); Helwan University	Badr, G (corresponding author), King Saud Univ, Coll Med, Princess Johara Alibrahim Ctr Canc Res, Prostate Canc Res Chair, Riyadh 11461, Saudi Arabia.	badr73@yahoo.com	Badr, Gamal/I-4891-2014; Rabah, Danny/J-2709-2018; El-Toni, Ahmed/D-1594-2015	Badr, Gamal/0000-0002-6157-7319; Rabah, Danny/0000-0002-0092-5789; El-Toni, Ahmed/0000-0002-3667-8812; Abdel-Maksoud, Mostafa A./0000-0002-6964-4846	National Plan for Science and Technology; King Abdulaziz City for Science and Technology [10-BIO969-02]	National Plan for Science and Technology; King Abdulaziz City for Science and Technology	This work was supported by the National Plan for Science and Technology (http://npst.ksu.edu.sa/index.php?module=news&page=details_en&id=40) funded by King Abdulaziz City for Science and Technology (http://www.kacst.edu.sa/en/Pages/default.aspx) through project number 10-BIO969-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Al-Sadoon MK, 2012, CELL PHYSIOL BIOCHEM, V30, P653, DOI 10.1159/000341446; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Arya M, 2003, CURR MED RES OPIN, V19, P557, DOI 10.1185/030079903125002216; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2012, LIPIDS HLTH DIS, V15, P11; Badr G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023741; Barratt G, 2003, CELL MOL LIFE SCI, V60, P21, DOI 10.1007/s000180300002; Bruckheimer EM, 2000, CELL TISSUE RES, V301, P153, DOI 10.1007/s004410000196; Chen DZ, 2012, INT J NANOMED, V7, P4973, DOI 10.2147/IJN.S35140; Coleman EJ, 2006, J IMMUNOTHER, V29, P489, DOI 10.1097/01.cji.0000210079.52554.c3; D'Souza M.J., 2012, J DRUG TARGET; dos Santos T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024438; El-Toni AM, 2012, J COLLOID INTERF SCI, V378, P83, DOI 10.1016/j.jcis.2012.04.006; Francis S., 2001, HAEMOSTASIS, V31, P183; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gao Q, 2012, MOL MED REP, V5, P1409, DOI 10.3892/mmr.2012.840; Haque F, 2012, NANO TODAY, V7, P245, DOI 10.1016/j.nantod.2012.06.010; Helferman MJ, 2010, ANTICANCER RES, V30, P73; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Ishii Y, 2006, CANCER GENET CYTOGEN, V167, P131, DOI 10.1016/j.cancergencyto.2006.01.002; Johrer K, 2012, EXPERT OPIN BIOL TH, V12, P425, DOI 10.1517/14712598.2012.664128; Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138; Koppolu B, 2012, J BIOMED NANOTECHNOL, V8, P983, DOI 10.1166/jbn.2012.1465; Kouri FM, 2012, SCI WORLD J, P1, DOI 10.1100/2012/838916; Kozako T, 2012, INT J NANOMED, V7, P4943, DOI 10.2147/IJN.S30726; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040152; Lim SM, 2011, BIOMATERIALS, V32, P3538, DOI 10.1016/j.biomaterials.2011.01.054; Luhmann T, 2008, BIOCONJUGATE CHEM, V19, P1907, DOI 10.1021/bc800206r; Menu E, 2006, HAEMATOLOGICA, V91, P605; Moller C, 2003, LEUKEMIA, V17, P203, DOI 10.1038/sj.leu.2402717; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Nishihori T, 2011, CANCER CONTROL, V18, P258, DOI 10.1177/107327481101800406; Oliva IB, 2007, TOXICON, V50, P1053, DOI 10.1016/j.toxicon.2007.07.016; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Park MH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-228; Park MH, 2009, ARCH PHARM RES, V32, P1545, DOI 10.1007/s12272-009-2106-0; Pelus LM, 2002, CRIT REV ONCOL HEMAT, V43, P257, DOI 10.1016/S1040-8428(01)00202-5; Picot J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15410; Rossi M, 2012, CURR CANCER DRUG TAR, V12, P757, DOI 10.2174/156800912802429300; Salido M, 2007, MOL CANCER THER, V6, P1292, DOI 10.1158/1535-7163.MCT-06-0681; Son DJ, 2007, MOL CANCER THER, V6, P675, DOI 10.1158/1535-7163.MCT-06-0328; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Song JK, 2012, ARCH PHARM RES, V35, P867, DOI 10.1007/s12272-012-0512-1; Sun H, 2012, ANTI-CANCER DRUG, V23, P1039, DOI 10.1097/CAD.0b013e32835679b8; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tiberio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039968; Tuchman SA, 2012, ADV HEMATOL, V2012; Wang JQ, 2010, CURR DRUG METAB, V11, P129, DOI 10.2174/138920010791110827; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zhang Aiqun, 2004, Neuroembryology, V3, P47, DOI 10.1159/000085404; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039870; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhao WR, 2005, J AM CHEM SOC, V127, P8916, DOI 10.1021/ja051113r	57	15	15	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51661	10.1371/journal.pone.0051661	http://dx.doi.org/10.1371/journal.pone.0051661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251606	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900113
J	Lamothe, B; Lai, YJ; Hur, L; Orozco, NM; Wang, J; Campos, AD; Xie, M; Schneider, MD; Lockworth, CR; Jakacky, J; Tran, D; Ho, M; Dawud, S; Dong, C; Lin, HK; Hu, P; Estrov, Z; Bueso-Ramos, CE; Darnay, BG				Lamothe, Betty; Lai, YunJu; Hur, Lana; Orozco, Natalia Martin; Wang, Jing; Campos, Alejandro D.; Xie, Min; Schneider, Michael D.; Lockworth, Cynthia R.; Jakacky, Jared; Tran, Diep; Ho, Michael; Dawud, Sity; Dong, Chen; Lin, Hui-Kuan; Hu, Peter; Estrov, Zeev; Bueso-Ramos, Carlos E.; Darnay, Bryant G.			Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice	PLOS ONE			English	Article							NF-KAPPA-B; CHROMOSOMAL INSTABILITY; SIGNALING PATHWAYS; KINASE ACTIVATION; IKK-BETA; CANCER; REGULATOR; APOPTOSIS; PHOSPHORYLATION; DIFFERENTIATION	Previous studies of the conditional ablation of TGF-beta activated kinase 1 (TAK1) in mice indicate that TAK1 has an obligatory role in the survival and/or development of hematopoietic stem cells, B cells, T cells, hepatocytes, intestinal epithelial cells, keratinocytes, and various tissues, primarily because of these cells' increased apoptotic sensitivity, and have implicated TAK1 as a critical regulator of the NF-kappa B and stress kinase pathways and thus a key intermediary in cellular survival. Contrary to this understanding of TAK1's role, we report a mouse model in which TAK1 deletion in the myeloid compartment that evoked a clonal myelomonocytic cell expansion, splenomegaly, multi-organ infiltration, genomic instability, and aggressive, fatal myelomonocytic leukemia. Unlike in previous reports, simultaneous deletion of TNF receptor 1 (TNFR1) failed to rescue this severe phenotype. We found that the features of the disease in our mouse model resemble those of human chronic myelomonocytic leukemia (CMML) in its transformation to acute myeloid leukemia (AML). Consequently, we found TAK1 deletion in 13 of 30 AML patients (43%), thus providing direct genetic evidence of TAK1's role in leukemogenesis.	[Lamothe, Betty; Lai, YunJu; Hur, Lana; Campos, Alejandro D.; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Orozco, Natalia Martin; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wang, Jing; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xie, Min] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, London, England; [Lockworth, Cynthia R.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Jakacky, Jared; Tran, Diep; Ho, Michael; Dawud, Sity; Hu, Peter] Univ Texas MD Anderson Canc Ctr, Sch Hlth Profess, Houston, TX 77030 USA; [Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos E.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Imperial College London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Darnay, BG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	bdarnay@mdanderson.org	dong, chen/B-3181-2009; Lai, Yun-Ju/AAV-7018-2021	dong, chen/0000-0002-0084-9130; Lai, Yun-Ju/0000-0003-0802-937X; Schneider, Michael/0000-0001-9645-1938	National Institutes of Health through the MD Anderson Cancer Center Support Grant [CA016672]; National Institutes of Health [R01AR053540]; Ladies Leukemia Foundation; National Cancer Institute (NCI Leukemia SPORE) [P50 CA100632-06]; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053540] Funding Source: NIH RePORTER	National Institutes of Health through the MD Anderson Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ladies Leukemia Foundation; National Cancer Institute (NCI Leukemia SPORE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported in part by the National Institutes of Health through the MD Anderson Cancer Center Support Grant (CA016672); National Institutes of Health grant R01AR053540 (BGD), the Ladies Leukemia Foundation (BGD), and the National Cancer Institute (NCI Leukemia SPORE P50 CA100632-06 to CB-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Germing U, 2004, LEUKEMIA LYMPHOMA, V45, P1311, DOI 10.1080/1042819042000207271; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu W, 2007, CLIN CANCER RES, V13, P5028, DOI 10.1158/1078-0432.CCR-07-0300; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sakurai H, 2012, TRENDS PHARM SCI; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wiktor AE, 2006, GENET MED, V8, P16, DOI 10.1097/01.gim.0000195645.00446.61; Wu M, 2012, CANCER RES, V72, P2833, DOI 10.1158/0008-5472.CAN-11-2724; Xiao Y, 2011, BLOOD; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387	52	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51228	10.1371/journal.pone.0051228	http://dx.doi.org/10.1371/journal.pone.0051228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251462	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900055
J	Rodrigues, AA; Clemente, TM; dos Santos, MA; Machado, FC; Gomes, RGB; Moreira, HHT; Cruz, MC; Brigido, PC; dos Santos, PCF; Martins, FA; Bahia, D; Maricato, JT; Janini, LMR; Reboredo, EH; Mortara, RA; da Silva, CV				Rodrigues, Adele A.; Clemente, Tatiana M.; dos Santos, Marlus A.; Machado, Fabricio C.; Gomes, Rafael G. B.; Moreira, Heline Hellen T.; Cruz, Mario C.; Brigido, Paula C.; dos Santos, Paulo C. F.; Martins, Flavia A.; Bahia, Diana; Maricato, Juliana T.; Janini, Luiz M. R.; Reboredo, Eduardo H.; Mortara, Renato A.; da Silva, Claudio V.			A Recombinant Protein Based on Trypanosoma cruzi P21 Enhances Phagocytosis	PLOS ONE			English	Article							ACTIVATION; AKT; RECEPTOR; MACROPHAGES; ENDOCYTOSIS; CHEMOTAXIS; RESPONSES; INVASION; PATHWAY; CXCR4	Background: P21 is a secreted protein expressed in all developmental stages of Trypanosoma cruzi. The aim of this study was to determine the effect of the recombinant protein based on P21 (P21-His(6)) on inflammatory macrophages during phagocytosis. Findings: Our results showed that P21-His(6) acts as a phagocytosis inducer by binding to CXCR4 chemokine receptor and activating actin polymerization in a way dependent on the PI3-kinase signaling pathway. Conclusions: Thus, our results shed light on the notion that native P21 is a component related to T. cruzi evasion from the immune response and that CXCR4 may be involved in phagocytosis. P21-His(6) represents an important experimental control tool to study phagocytosis signaling pathways of different intracellular parasites and particles.	[Rodrigues, Adele A.; Clemente, Tatiana M.; dos Santos, Marlus A.; Machado, Fabricio C.; Gomes, Rafael G. B.; Brigido, Paula C.; dos Santos, Paulo C. F.; Martins, Flavia A.; da Silva, Claudio V.] Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil; [Cruz, Mario C.; Bahia, Diana; Maricato, Juliana T.; Janini, Luiz M. R.; Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Moreira, Heline Hellen T.; Reboredo, Eduardo H.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	da Silva, CV (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	silva_cv@yahoo.com.br	Mortara, Renato A./C-1864-2012; 4, INCT/H-4499-2013; Maricato, Juliana/F-1608-2012; Cruz, Mario/V-7522-2019; da Silva, Claudio Vieira/AAK-1485-2021; Santos, Paulo César/I-3997-2014; Inbeqmedi, Inct/I-1929-2013; Bahia, Diana/W-3974-2019; Gomes, Rafael Gonçalves Barbosa/W-8926-2019	Mortara, Renato A./0000-0002-2311-8349; da Silva, Claudio Vieira/0000-0002-5052-3139; Gomes, Rafael Gonçalves Barbosa/0000-0002-1428-7685; Janini, Luiz Mario/0000-0002-6186-6284; Machado, Fabricio C/0000-0001-8658-8471; Teixeira Moreira, Heline Hellen/0000-0003-2640-505X; Mordente clemente, Tatiana/0000-0002-0817-7711	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-00621-11]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [23038005295/2011-40]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process number: APQ-00621-11), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Process number: 23038005295/2011-40) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA A, 1980, EXP PARASITOL, V50, P1, DOI 10.1016/0014-4894(80)90002-8; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Atayde VD, 2008, MELANOMA RES, V18, P172, DOI 10.1097/CMR.0b013e3282feeaab; Barbero S, 2003, CANCER RES, V63, P1969; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; da Silva CV, 2009, MICROBES INFECT, V11, P563, DOI 10.1016/j.micinf.2009.03.007; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Garcia-Exposito L, 2011, MOL BIOL CELL, V22, P1148, DOI 10.1091/mbc.E10-08-0722; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; KAHN S, 1995, J EXP MED, V182, P1243, DOI 10.1084/jem.182.5.1243; Krauss M, 2011, REV PHYSIOL BIOCH P, V161, P45, DOI 10.1007/112_2008_2; Lee EJ, 2011, BIOCHEM BIOPH RES CO, V414, P384, DOI 10.1016/j.bbrc.2011.09.083; Maganto-Garcia E, 2008, TRAFFIC, V9, P1299, DOI 10.1111/j.1600-0854.2008.00760.x; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Okada M, 2012, BIOCHEM BIOPH RES CO, V420, P479, DOI 10.1016/j.bbrc.2012.03.057; Park H, 2011, ARCH BIOCHEM BIOPHYS, V510, P101, DOI 10.1016/j.abb.2011.02.019; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vieira M, 2002, HISTOCHEM CELL BIOL, V118, P491, DOI 10.1007/s00418-002-0477-0; Woolsey AM, 2003, J CELL SCI, V116, P3611, DOI 10.1242/jcs.00666	26	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51384	10.1371/journal.pone.0051384	http://dx.doi.org/10.1371/journal.pone.0051384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251513	gold, Green Submitted, Green Published			2022-12-25	WOS:000312201900075
J	Jinwal, UK; Akoury, E; Abisambra, JF; O'Leary, JC; Thompson, AD; Blair, LJ; Jin, Y; Bacon, J; Nordhues, BA; Cockman, M; Zhang, J; Li, PF; Zhang, B; Borysov, S; Uversky, VN; Biernat, J; Mandelkow, E; Gestwicki, JE; Zweckstetter, M; Dickey, CA				Jinwal, Umesh K.; Akoury, Elias; Abisambra, Jose F.; O'Leary, John C., III; Thompson, Andrea D.; Blair, Laura J.; Jin, Ying; Bacon, Justin; Nordhues, Bryce A.; Cockman, Matthew; Zhang, Juan; Li, Pengfei; Zhang, Bo; Borysov, Sergiy; Uversky, Vladimir N.; Biernat, Jacek; Mandelkow, Eckhard; Gestwicki, Jason E.; Zweckstetter, Markus; Dickey, Chad A.			Imbalance of Hsp70 family variants fosters tau accumulation	FASEB JOURNAL			English	Article						chaperones; CHIP; Hsc70; Hsp72; Alzheimer's	PAIRED HELICAL FILAMENTS; BETA-STRUCTURE; MOLECULAR CHAPERONE; TRANSGENIC MICE; PROTEIN; AGGREGATION; CHIP; NEURONS; STRESS; MICROTUBULES	Dysfunctional tau accumulation is a major contributing factor in tauopathies, and the heat-shock protein 70 (Hsp70) seems to play an important role in this accumulation. Several reports suggest that Hsp70 proteins can cause tau degradation to be accelerated or slowed, but how these opposing activities are controlled is unclear. Here we demonstrate that highly homologous variants in the Hsp70 family can have opposing effects on tau clearance kinetics. When overexpressed in a tetracycline (Tet)-based protein chase model, constitutive heat shock cognate 70 (Hsc70) and inducible Hsp72 slowed or accelerated tau clearance, respectively. Tau synergized with Hsc70, but not Hsp72, to promote microtubule assembly at nearly twice the rate of either Hsp70 homologue in reconstituted, ATP-regenerating Xenopus extracts supplemented with rhodamine-labeled tubulin and human recombinant Hsp72 and Hsc70. Nuclear magnetic resonance spectroscopy with human recombinant protein revealed that Hsp72 had greater affinity for tau than Hsc70 (I/I-0 ratio difference of 0.3), but Hsc70 was 30 times more abundant than Hsp72 in human and mouse brain tissue. This indicates that the predominant Hsp70 variant in the brain is Hsc70, suggesting that the brain environment primarily supports slower tau clearance. Despite its capacity to clear tau, Hsp72 was not induced in the Alzheimer's disease brain, suggesting a mechanism for age-associated onset of the disease. Through the use of chimeras that blended the domains of Hsp72 and Hsc70, we determined that the reason for these differences between Hsc70 and Hsp72 with regard to tau clearance kinetics lies within their C-terminal domains, which are essential for their interactions with substrates and cochaperones. Hsp72 but not Hsc70 in the presence of tau was able to recruit the cochaperone ubiquitin ligase CHIP, which is known to facilitate the ubiquitination of tau, describing a possible mechanism of how the C-termini of these homologous Hsp70 variants can differentially regulate tau triage. Thus, efforts to promote Hsp72 expression and inhibit Hsc70 could be therapeutically relevant for tauopathies.-Jinwal, U. K., Akoury, E., Abisambra, J. F., O'Leary, J. C., III, Thompson, A. D., Blair, L. J., Jin, Y., Bacon, J., Nordhues, B. A., Cockman, M., Zhang, J., Li, P., Zhang, B., Borysov, S., Uversky, V. N., Biernat, J., Mandelkow, E., Gestwicki, J. E., Zweckstetter, M., Dickey, C. A. Imbalance of Hsp70 family variants fosters tau accumulation. FASEB J. 27, 1450-1459 (2013). www.fasebj.org	[Jinwal, Umesh K.; Zhang, Juan] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Tampa, FL 33613 USA; [Abisambra, Jose F.; O'Leary, John C., III; Blair, Laura J.; Jin, Ying; Bacon, Justin; Nordhues, Bryce A.; Cockman, Matthew; Li, Pengfei; Zhang, Bo; Borysov, Sergiy; Uversky, Vladimir N.; Dickey, Chad A.] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Akoury, Elias; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Thompson, Andrea D.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Russia; [Biernat, Jacek; Mandelkow, Eckhard] Deutsch Elektronen Synchrotron DESY, Max Planck Unit Struct Mol Biol, Hamburg, Germany; [Biernat, Jacek; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, CAESAR, Bonn, Germany; [Zweckstetter, Markus] DZNE, Gottingen, Germany	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Max Planck Society; University of Michigan System; University of Michigan; Russian Academy of Sciences; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Dickey, CA (corresponding author), Univ S Florida, 4001 E Fletcher Ave,Room 325, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Uversky, Vladimir N./F-4515-2011; Thompson, Andrea/AAQ-5735-2020; Akoury, Elias/AAG-2881-2019; Abisambra, Jose/V-6860-2019; Abisambra, Joe/AAP-3269-2020	Uversky, Vladimir N./0000-0002-4037-5857; Akoury, Elias/0000-0001-5202-8935; Abisambra, Jose/0000-0001-6341-679X; Thompson, Andrea/0000-0001-8798-2024; Zweckstetter, Markus/0000-0002-2536-6581; Blair, Laura/0000-0002-4981-5564	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) [R00AG031291]; NIH/National Institute of Neurological Disorders and Stroke (NINDS) [R01NS073899]; Alzheimer's Association; CurePSP; NIH/NINDS [NS059690]; NIH/NIA [P50 AG16573]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690, R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042813, R00AG031291, P50AG016573] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001637] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA); NIH/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); CurePSP; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	C.A.D. was supported by grants from the U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA; R00AG031291), NIH/National Institute of Neurological Disorders and Stroke (NINDS; R01NS073899), the Alzheimer's Association, and CurePSP. U.K.J. was supported by the Alzheimer's Association. J.E.G. was supported by NIH/NINDS (NS059690) and the Alzheimer's Association. Funding for the University of California at Irvine Alzheimer's Disease Research Center (UCI-ADRC; Irvine, CA, USA) was provided by NIH/NIA grant P50 AG16573. The authors declare no conflicts of interest.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BLACK MM, 1991, J NEUROSCI, V11, P1163; BRION JP, 1994, NEUROSCIENCE, V63, P895, DOI 10.1016/0306-4522(94)90533-9; Budde PP, 2006, METHODS, V38, P29, DOI 10.1016/j.ymeth.2005.07.008; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; HAMMOND GL, 1982, P NATL ACAD SCI-BIOL, V79, P3485, DOI 10.1073/pnas.79.11.3485; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Jo H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010318; Koren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035566; MATTSON MP, 1992, BRAIN RES, V582, P107, DOI 10.1016/0006-8993(92)90323-2; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; WILLIAMS GT, 1990, MOL CELL BIOL, V10, P3125, DOI 10.1128/MCB.10.6.3125; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	46	87	90	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1450	1459		10.1096/fj.12-220889	http://dx.doi.org/10.1096/fj.12-220889			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271055	Green Published, Green Submitted			2022-12-25	WOS:000316940800017
J	Ho, D; Lugo, MR; Merrill, AR				Ho, Derek; Lugo, Miguel R.; Merrill, A. Rod			Harmonic Analysis of the Fluorescence Response of Bimane Adducts of Colicin E1 at Helices 6, 7, and 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TOPOLOGY; MOLECULAR-BASIS; FORMING DOMAIN; INSERTION; PROTEINS; MECHANISM; PATHWAY; SURFACE; IMPORT; ENERGY	The pre-channel state of helices 6, 7, and 10 (Val(447)-Gly(475) and Ile(508)-Ile(522)) of colicin E1 was investigated by a site-directed fluorescence labeling technique. A total of 44 cysteine variants were purified and covalently labeled with monobromobimane fluorescent probe. A variety of fluorescence properties of the bimane fluorophore were measured for both the soluble and membrane-bound states of the channel peptide, including the fluorescence emission maximum, fluorescence anisotropy, and membrane bilayer penetration depth. Using site-directed fluorescence labeling combined with our novel helical periodicity analysis method, the data revealed that helices 6, 7, and 10 are separate amphipathic +/- -helices with a calculated periodicity of T = 3.34 +/- 0.08 for helix 6, T = 3.56 +/- 0.03 for helix 7, and T = 2.99 +/- 0.12 for helix 10 in the soluble state. In the membrane-bound state, the helical periodicity was determined to be T = 3.00 +/- 0.15 for helix 6, T = 3.68 +/- 0.03 for helix 7, and T = 3.47 +/- 0.04 for helix 10. Dual fluorescence quencher analysis showed that both helices 6 and 7 adopt a tilted topology that correlates well with the analysis based on the fluorescence anisotropy profile. These data provide further support for the umbrella model of the colicin E1 channel domain.	[Ho, Derek; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Council of Canada (to A. R. M.).	Berne S, 2005, BIOCHEMISTRY-US, V44, P11137, DOI 10.1021/bi051013y; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COOPER PC, 1984, J GEN MICROBIOL, V130, P209; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; ELKINS PA, 1994, PROTEINS, V19, P150, DOI 10.1002/prot.340190208; Eraso JM, 1996, J BACTERIOL, V178, P1928, DOI 10.1128/jb.178.7.1928-1935.1996; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gouaux E, 1997, STRUCTURE, V5, P313, DOI 10.1016/S0969-2126(97)00188-3; GOULD JM, 1977, J BIOL CHEM, V252, P5491; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Ho D, 2011, BIOCHEMISTRY-US, V50, P4830, DOI 10.1021/bi101934e; Ho D, 2009, BIOCHEMISTRY-US, V48, P1369, DOI 10.1021/bi801906v; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Ladokhin AS, 2002, BIOCHEMISTRY-US, V41, P13617, DOI 10.1021/bi0264418; Lazdunski CJ, 1998, J BACTERIOL, V180, P4993, DOI 10.1128/JB.180.19.4993-5002.1998; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Lins L, 2007, MOL MEMBR BIOL, V24, P419, DOI 10.1080/09687860701228254; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; Musse AA, 2003, J BIOL CHEM, V278, P24491, DOI 10.1074/jbc.M302371200; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; Ridley H, 2010, ADV EXP MED BIOL, V677, P81; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 2000, METHOD ENZYMOL, V322, P274; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STEER BA, 1994, BIOCHEMISTRY-US, V33, P1108, DOI 10.1021/bi00171a009; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Tian C, 2006, BBA-BIOMEMBRANES, V1758, P693, DOI 10.1016/j.bbamem.2006.03.025; Tory MC, 2002, BBA-BIOMEMBRANES, V1564, P435, DOI 10.1016/S0005-2736(02)00493-5; Wei ZK, 2007, BIOCHEMISTRY-US, V46, P6074, DOI 10.1021/bi700317k; White D, 2006, J BIOL CHEM, V281, P32375, DOI 10.1074/jbc.M605880200; Zakharov SD, 2004, FRONT BIOSCI-LANDMRK, V9, P1311, DOI 10.2741/1334; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5; Zhao G, 2005, BIOCHEMISTRY-US, V44, P4488, DOI 10.1021/bi047705o	41	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5136	5148		10.1074/jbc.M112.436303	http://dx.doi.org/10.1074/jbc.M112.436303			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264635	Green Published, hybrid			2022-12-25	WOS:000315340400061
J	Suzuki-Anekoji, M; Suzuki, A; Wu, SW; Angata, K; Murai, KK; Sugihara, K; Akama, TO; Khoo, KH; Nakayama, J; Fukuda, MN; Fukuda, M				Suzuki-Anekoji, Misa; Suzuki, Atsushi; Wu, Sz-Wei; Angata, Kiyohiko; Murai, Keith K.; Sugihara, Kazuhiro; Akama, Tomoya O.; Khoo, Kay-Hooi; Nakayama, Jun; Fukuda, Michiko N.; Fukuda, Minoru			In Vivo Regulation of Steroid Hormones by the Chst10 Sulfotransferase in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MYELIN-ASSOCIATED GLYCOPROTEIN; L-SELECTIN; HNK-1 SULFOTRANSFERASE; EXPRESSION CLONING; HEPARAN-SULFATE; O-GLYCANS; CARBOHYDRATE; ANTIBODY; BIOSYNTHESIS	Chst10 adds sulfate to glucuronic acid to form a carbohydrate antigen, HNK-1, in glycoproteins and glycolipids. To determine the role of Chst10 in vivo, we generated systemic Chst10-deficient mutant mice. Although Chst10(-/-) mice were born and grew to adulthood with no gross defects, they were subfertile. Uteri from Chst10(-/-) females at the pro-estrus stage were larger than those from wild-type females and exhibited a thick uterine endometrium. Serum estrogen levels in Chst10(-/-) females were higher than those from wild-type females, suggesting impaired down-regulation of estrogen. Because steroid hormones are often conjugated to glucuronic acid, we hypothesized that Chst10 sulfates glucuronidated steroid hormone to regulate steroid hormone in vivo. Enzymatic activity assays and structural analysis of Chst10 products by HPLC and mass spectrometry revealed that Chst10 indeed sulfates glucuronidated estrogen, testosterone, and other steroid hormones. We also identified an HPLC peak corresponding to sulfated and glucuronidated estradiol in serum from wild-type but not from Chst10 null female mice. Estrogen-response element reporter assays revealed that Chst10-modified estrogen likely did not bind to its receptor. These results suggest that subfertility exhibited by female mice following Chst10 loss results from dysregulation of estrogen. Given that Chst10 transfers sulfates to several steroid hormones, Chst10 likely functions in widespread regulation of steroid hormones in vivo.	[Suzuki-Anekoji, Misa; Suzuki, Atsushi; Angata, Kiyohiko; Murai, Keith K.; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, Glycobiol Unit, La Jolla, CA 92037 USA; [Wu, Sz-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Sugihara, Kazuhiro] Hamamatsu Univ Sch Med, Dept Gynecol & Obstet, Hamamatsu, Shizuoka 4313192, Japan; [Akama, Tomoya O.] Kansai Med Univ, Dept Pharmacol, Osaka 5708506, Japan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hamamatsu University School of Medicine; Kansai Medical University; Shinshu University	Fukuda, MN (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	michiko@sanfordburnham.org; minoru@sanfordburnham.org	Angata, Kiyohiko/M-2749-2018; Khoo, Kay-Hooi/E-1989-2019	Angata, Kiyohiko/0000-0001-5561-1368; Khoo, Kay-Hooi/0000-0003-2906-406X	National Institutes of Health [P01CA071932, EY014620, CA33895]; Japanese Ministry of Education [24592530]; NATIONAL CANCER INSTITUTE [P01CA071932, U01CA168925, R01CA033895] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01CA071932 (to M. N. F. and M. F.), EY014620 (to T. O. A.), and CA33895 (to M. F.). This work was also supported by Japanese Ministry of Education Grant 24592530 (to A. S.).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ABO T, 1982, J EXP MED, V155, P321, DOI 10.1084/jem.155.1.321; ABO T, 1981, J IMMUNOL, V127, P1024; Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; ARIGA T, 1987, J BIOL CHEM, V262, P848; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Caligioni C. S, 2009, CURR PROTOC NEUROSCI, V48, pA411; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Ghosh R, 2001, CONTRACEPTION, V64, P261, DOI 10.1016/S0010-7824(01)00257-8; HIRAIWA N, 1990, CANCER RES, V50, P2917; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; ILYAS AA, 1984, BIOCHEM BIOPH RES CO, V122, P1206, DOI 10.1016/0006-291X(84)91220-8; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JENSEN EV, 1973, SCIENCE, V182, P126, DOI 10.1126/science.182.4108.126; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Loveless RW, 1998, GLYCOBIOLOGY, V8, P1237, DOI 10.1093/glycob/8.12.1237; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Ong E, 1999, J BIOL CHEM, V274, P25608, DOI 10.1074/jbc.274.36.25608; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 2006, J IMMUNOL, V177, P3, DOI 10.4049/jimmunol.177.1.3; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki-Anekoji M, 2011, J BIOL CHEM, V286, P32824, DOI 10.1074/jbc.M111.245886; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; TSUJI Y, 1992, J REPROD IMMUNOL, V22, P225, DOI 10.1016/0165-0378(92)90045-6; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Yamakawa N, 2007, BIOCHIMIE, V89, P1396, DOI 10.1016/j.biochi.2007.04.010; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yuen CT, 1997, J BIOL CHEM, V272, P8924	60	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5007	5016		10.1074/jbc.M112.433474	http://dx.doi.org/10.1074/jbc.M112.433474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269668	Green Published, hybrid			2022-12-25	WOS:000315340400047
J	Ma, QL; Zuo, XH; Yang, FS; Ubeda, OJ; Gant, DJ; Alaverdyan, M; Teng, E; Hu, SX; Chen, PP; Maiti, P; Teter, B; Cole, GM; Frautschy, SA				Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.			Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE MOUSE MODELS; DETERMINES AGGREGATION; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; PHOSPHORYLATION; RECEPTORS; PATHOLOGY; PLAQUES; DOMAIN	The mechanisms underlying Tau-related synaptic and cognitive deficits and the interrelationships between Tau species, their clearance pathways, and synaptic impairments remain poorly understood. To gain insight into these mechanisms, we examined these interrelationships in aged non-mutant genomic human Tau mice, with established Tau pathology and neuron loss. We also examined how these interrelationships changed with an intervention by feeding mice either a control diet or one containing the brain permeable beta-amyloid and Tau aggregate binding molecule curcumin. Transgene-dependent elevations in soluble and insoluble phospho-Tau monomer and soluble Tau dimers accompanied deficits in behavior, hippocampal excitatory synaptic markers, and molecular chaperones (heat shock proteins (HSPs)) involved in Tau degradation and microtubule stability. In human Tau mice but not control mice, HSP70, HSP70/HSP72, and HSP90 were reduced in membrane-enriched fractions but not in cytosolic fractions. The synaptic proteins PSD95 and NR2B were reduced in dendritic fields and redistributed into perikarya, corresponding to changes observed by immunoblot. Curcumin selectively suppressed levels of soluble Tau dimers, but not of insoluble and monomeric phospho-Tau, while correcting behavioral, synaptic, and HSP deficits. Treatment increased PSD95 co-immunoprecipitating with NR2B and, independent of transgene, increased HSPs implicated in Tau clearance. It elevated HSP90 and HSC70 without increasing HSP mRNAs; that is, without induction of the heat shock response. Instead curcumin differentially impacted HSP90 client kinases, reducing Fyn without reducing Akt. In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau-dependent behavioral and synaptic deficits can be corrected.	[Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90073 USA; [Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.] Vet Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA; [Zuo, Xiaohong] Capital Med Univ, Xuanwu Hosp, Dept Neurobiol, Key Lab Neurodegenerat Disorders,Minist Educ,Beij, Beijing 10053, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Geriatric Research Education & Clinical Center; Capital Medical University	Cole, GM (corresponding author), Vet Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, 11301 Wilshire Blvd,Bldg 113,Rm 312, Los Angeles, CA 90073 USA.	gmcole@ucla.edu; frautsch@ucla.edu	Zuo, Xiaohong/H-6254-2016	Frautschy, Sally A./0000-0003-0194-0363	National Institutes of Health [R01 AG021975, U0128583, RC1 AG035878, AT006816, P01 AG16570, P30-AG028748, K08 AG34628]; Alzheimer's Association Grant [NIRG-07-59659]; UCLA Mary S. Easton Translation Center; Veterans Affairs Merit grants; National Center for Complementary & Integrative Health [R01AT006816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG021975, RC1AG035878, P30AG028748, K08AG034628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Grant(Alzheimer's Association); UCLA Mary S. Easton Translation Center; Veterans Affairs Merit grants; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG021975 (to S. A. F.), U0128583 (to S. A. F.), RC1 AG035878 (to S. A. F. and G. M. C.), AT006816 (to G. M. C.), P01 AG16570 (UCLA Alzheimer Disease Research Center; to G. M. C.), P30-AG028748 (UCLA Older Americans Independence Center; NIA), and K08 AG34628 (to E. T.). This work was also supported by Alzheimer's Association Grant NIRG-07-59659 (to Q-L. M.), the UCLA Mary S. Easton Translation Center (S. A. F., G. M. C.), and Veterans Affairs Merit grants (to G. M. C. and S. A. F.). S.A.F. and G.M.C. are coinventors on a UC Regents and Veteran's pending patent on a bioavailable curcumin formulation, which has been licensed by UC Regents to Verdure Sciences, Indianapolis, IN. These authors contributed equal funding to this project.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Chen J, 2005, PHARMAZIE, V60, P57; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dadhaniya P, 2011, FOOD CHEM TOXICOL, V49, P1834, DOI 10.1016/j.fct.2011.05.001; Delint-Ramirez I, 2008, J NEUROCHEM, V106, P1658, DOI 10.1111/j.1471-4159.2008.05523.x; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Gota VS, 2010, J AGR FOOD CHEM, V58, P2095, DOI 10.1021/jf9024807; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Marshall GA, 2006, DEMENT GERIATR COGN, V21, P144, DOI 10.1159/000090674; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Vana L, 2011, BIOCHEMISTRY-US, V50, P1203, DOI 10.1021/bi101735m; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	65	132	137	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4056	4065		10.1074/jbc.M112.393751	http://dx.doi.org/10.1074/jbc.M112.393751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264626	hybrid, Green Published			2022-12-25	WOS:000314845000034
J	Manso, AM; Li, RX; Monkley, SJ; Cruz, NM; Ong, S; Lao, DH; Koshman, YE; Gu, YS; Peterson, KL; Chen, J; Abel, ED; Samarel, AM; Critchley, DR; Ross, RS				Manso, Ana Maria; Li, Ruixia; Monkley, Susan J.; Cruz, Nathalia M.; Ong, Shannon; Lao, Dieu H.; Koshman, Yevgeniya E.; Gu, Yusu; Peterson, Kirk L.; Chen, Ju; Abel, E. Dale; Samarel, Allen M.; Critchley, David R.; Ross, Robert S.			Talin1 Has Unique Expression versus Talin 2 in the Heart and Modifies the Hypertrophic Response to Pressure Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-SPECIFIC EXCISION; DILATED CARDIOMYOPATHY; CARDIAC MYOCYTES; GENE; PROTEIN; KINASE; CONTRACTILITY; LOCALIZATION; CONNECTION; ACTIVATION	Integrins are adhesive, signaling, and mechanotransduction proteins. Talin (Tln) activates integrins and links it to the actin cytoskeleton. Vertebrates contain two talin genes, tln1 and tln2. How Tln1 and Tln2 function in cardiac myocytes (CMs) is unknown. Tln1 and Tln2 expression were evaluated in the normal embryonic and adult mouse heart as well as in control and failing human adult myocardium. Tln1 function was then tested in the basal and mechanically stressed myocardium after cardiomyocyte-specific excision of the Tln1 gene. During embryogenesis, both Tln forms are highly expressed in CMs, but in the mature heart Tln2 becomes the main Tln isoform, localizing to the costameres. Tln1 expression is minimal in the adult CM. With pharmacological and mechanical stress causing hypertrophy, Tln1 is up-regulated in CMs and is specifically detected at costameres, suggesting its importance in the compensatory response to CM stress. In human failing heart, CM Tln1 also increases compared with control samples from normal functioning myocardium. To directly test Tln1 function in CMs, we generated CM-specific Tln1 knock-out mice (Tln1cKO). Tln1cKO mice showed normal basal cardiac structure and function but when subjected to pressure overload showed blunted hypertrophy, less fibrosis, and improved cardiac function versus controls. Acute responses of ERK1/2, p38, Akt, and glycogen synthase kinase 3 after mechanical stress were strongly blunted in Tln1cKO mice. Given these results, we conclude that Tln1 and Tln2 have distinct functions in the myocardium. Our data show that reduction of CM Tln1 expression can lead to improved cardiac remodeling following pressure overload.	[Manso, Ana Maria; Li, Ruixia; Cruz, Nathalia M.; Ong, Shannon; Ross, Robert S.] Vet Adm Healthcare, San Diego, CA 92161 USA; [Manso, Ana Maria; Li, Ruixia; Cruz, Nathalia M.; Ong, Shannon; Lao, Dieu H.; Gu, Yusu; Peterson, Kirk L.; Chen, Ju; Ross, Robert S.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84108 USA; [Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84108 USA; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Koshman, Yevgeniya E.; Samarel, Allen M.] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA	University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leicester; Loyola University Chicago	Ross, RS (corresponding author), VA San Diego Healthcare Syst, Cardiol Sect, 3350 La Jolla Village Dr,111A, San Diego, CA 92161 USA.	rross@ucsd.edu	gu, yu/GSD-4507-2022; Chen, Ju/E-5579-2011; Ross, Robert/ABE-1109-2020; Samarel, Allen/Q-9810-2019	Ross, Robert/0000-0003-2195-8982; Monkley, Susan/0000-0001-9174-6278; Abel, E. Dale/0000-0001-5290-0738; Samarel, Allen/0000-0001-8765-9884	National Institutes of Health [HL046345, HL103566]; Veterans Administration Merit Award; Wellcome Trust; Cancer Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103566, P01HL046345, R01HL066100, R01HL106968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL046345 and HL103566 (to R. S. R.). This work was also supported by a Veterans Administration Merit Award (to R. S. R.) and by Wellcome Trust and Cancer Research UK (to D. R. C.).	Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boudoukha S, 2010, MOL CELL BIOL, V30, P5710, DOI 10.1128/MCB.00665-10; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Harston Rebecca K, 2011, J Signal Transduct, V2011, P521742, DOI 10.1155/2011/521742; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kim DJ, 2003, CELL BIOCHEM FUNCT, V21, P41, DOI 10.1002/cbf.988; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li RX, 2012, AM J PATHOL, V180, P952, DOI 10.1016/j.ajpath.2011.12.007; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Praekelt U, 2012, EUR J CELL BIOL, V91, P180, DOI 10.1016/j.ejcb.2011.12.003; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Yund EE, 2009, J MOL CELL CARDIOL, V47, P520, DOI 10.1016/j.yjmcc.2009.06.006; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	48	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4252	4264		10.1074/jbc.M112.427484	http://dx.doi.org/10.1074/jbc.M112.427484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23266827	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000314845000054
J	Ward, PS; Lu, C; Cross, JR; Abdel-Wahab, O; Levine, RL; Schwartz, GK; Thompson, CB				Ward, Patrick S.; Lu, Chao; Cross, Justin R.; Abdel-Wahab, Omar; Levine, Ross L.; Schwartz, Gary K.; Thompson, Craig B.			The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDH2 MUTATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; ALPHA-KETOGLUTARATE; GROWTH; CELLS; TET2; LIPOGENESIS; LEUKEMIA; NADPH; CARBOXYLATION	Monoallelic point mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) and its mitochondrial homolog IDH2 can lead to elevated levels of 2-hydroxyglutarate (2HG) in multiple cancers. Here we report that cellular 2HG production from cytosolic IDH1 mutation is dependent on the activity of a retained wild-type IDH1 allele. In contrast, expression of mitochondrial IDH2 mutations led to robust 2HG production in a manner independent of wild-type mitochondrial IDH function. Among the recurrent IDH2 mutations at Arg-172 and Arg-140, IDH2 Arg-172 mutations consistently led to greater 2HG accumulation than IDH2 Arg-140 mutations, and the degree of 2HG accumulation correlated with the ability of these mutations to block cellular differentiation. Cytosolic IDH1 Arg-132 mutations, although structurally analogous to mutations at mitochondrial IDH2 Arg-172, were only able to elevate intracellular 2HG to comparable levels when an equivalent level of wild-type IDH1 was co-expressed. Consistent with 2HG production from cytosolic IDH1 being limited by substrate production from wildtype IDH1, we observed 2HG levels to increase in cancer cells harboring an endogenous monoallelic IDH1 mutation when mitochondrial IDH flux was diverted to the cytosol. Finally, expression of an IDH1 construct engineered to localize to the mitochondria rather than the cytosol resulted in greater 2HG accumulation. These data demonstrate that allelic and subcellular compartment differences can regulate the potential for IDH mutations to produce 2HG in cells. The consequences of 2HG elevation are dose-dependent, and the non-equivalent 2HG accumulation resulting from IDH1 and IDH2 mutations may underlie their differential prognosis and prevalence in various cancers.	[Ward, Patrick S.; Lu, Chao; Cross, Justin R.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Leukemia Serv, New York, NY 10065 USA; [Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Sarcoma Serv, New York, NY 10065 USA; [Ward, Patrick S.; Lu, Chao] Univ Penn, Perelman Sch Med, Mol Biol Grad Grp, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), 1275 York Ave, New York, NY 10065 USA.	craig@mskcc.org	levine, ross/AAE-7658-2019; Ward, Patrick/H-2361-2014	Ward, Patrick/0000-0001-6437-8174; Lu, Chao/0000-0003-0982-8122; Abdel-Wahab, Omar/0000-0002-3907-6171; Cross, Justin/0000-0002-6356-057X	National Institutes of Health; National Cancer Institute; University of Pennsylvania Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA168802, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pennsylvania Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health and National Cancer Institute. C. B. Thompson is a co-founder of Agios Pharmaceuticals and a member of the board directors of Merck.; Supported by the University of Pennsylvania Medical Scientist Training Program.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Atai NA, 2011, J HISTOCHEM CYTOCHEM, V59, P489, DOI 10.1369/0022155411400606; Boissel N, 2011, BLOOD, V117, P3696, DOI 10.1182/blood-2010-11-320937; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Contreras-Shannon V, 2004, ARCH BIOCHEM BIOPHYS, V423, P235, DOI 10.1016/j.abb.2003.12.038; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Ghiam AF, 2012, ONCOGENE, V31, P3826, DOI 10.1038/onc.2011.546; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Green CL, 2011, BLOOD, V118, P409, DOI 10.1182/blood-2010-12-322479; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pichler MM, 2011, BRIT J HAEMATOL, V152, P669, DOI 10.1111/j.1365-2141.2010.08404.x; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Susa M, 2009, ANTICANCER RES, V29, P1879; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	47	111	118	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3804	3815		10.1074/jbc.M112.435495	http://dx.doi.org/10.1074/jbc.M112.435495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264629	hybrid, Green Published			2022-12-25	WOS:000314845000012
J	Hezel, F; Thalhammer, C; Waiczies, S; Schulz-Menger, J; Niendorf, T				Hezel, Fabian; Thalhammer, Christof; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf			High Spatial Resolution and Temporally Resolved T-2* Mapping of Normal Human Myocardium at 7.0 Tesla: An Ultrahigh Field Magnetic Resonance Feasibility Study	PLOS ONE			English	Article							THALASSEMIA MAJOR PATIENTS; CORONARY-ARTERY STENOSIS; NORMAL HUMAN HEART; IN-VIVO; IRON OVERLOAD; CARDIAC MRI; HUMAN BRAIN; BOLD-MRI; OXYGENATION; CAPILLARY	Myocardial tissue characterization using T-2* relaxation mapping techniques is an emerging application of (pre)clinical cardiovascular magnetic resonance imaging. The increase in microscopic susceptibility at higher magnetic field strengths renders myocardial T-2* mapping at ultrahigh magnetic fields conceptually appealing. This work demonstrates the feasibility of myocardial T-2* imaging at 7.0 T and examines the applicability of temporally-resolved and high spatial resolution myocardial T-2* mapping. In phantom experiments single cardiac phase and dynamic (CINE) gradient echo imaging techniques provided similar T-2* maps. In vivo studies showed that the peak-to-peak B-0 difference following volume selective shimming was reduced to approximately 80 Hz for the four chamber view and mid-ventricular short axis view of the heart and to 65 Hz for the left ventricle. No severe susceptibility artifacts were detected in the septum and in the lateral wall for T-2* weighting ranging from TE = 2.04 ms to TE = 10.2 ms. For TE > 7 ms, a susceptibility weighting induced signal void was observed within the anterior and inferior myocardial segments. The longest T-2* values were found for anterior (T-2* = 14.0 ms), anteroseptal (T-2* = 17.2 ms) and inferoseptal (T-2* = 16.5 ms) myocardial segments. Shorter T-2* values were observed for inferior (T-2* = 10.6 ms) and inferolateral (T-2* = 11.4 ms) segments. A significant difference (p = 0.002) in T-2* values was observed between end-diastole and end-systole with T-2* changes of up to approximately 27% over the cardiac cycle which were pronounced in the septum. To conclude, these results underscore the challenges of myocardial T-2* mapping at 7.0 T but demonstrate that these issues can be offset by using tailored shimming techniques and dedicated acquisition schemes.	[Hezel, Fabian; Thalhammer, Christof; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf] Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil BUFF, Berlin, Germany; [Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf] Expt & Clin Res Ctr, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken	Niendorf, T (corresponding author), Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil BUFF, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013; Waiczies, Sonia/H-4181-2012	Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Schulz-Menger, Jeanette/0000-0003-3100-1092	Max Delbruck Centrum for Molecular Medicine	Max Delbruck Centrum for Molecular Medicine	This study was founded through institutional funding provided by the Max Delbruck Centrum for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IEC60601233; Bauer WR, 1999, MAGN RESON MED, V42, P1004, DOI 10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M; Bauer WR, 1999, MAGN RESON MED, V41, P51, DOI 10.1002/(SICI)1522-2594(199901)41:1<51::AID-MRM9>3.0.CO;2-G; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dharmakumar R, 2008, J MAGN RESON IMAGING, V27, P1037, DOI 10.1002/jmri.21345; Donahue MJ, 2011, NMR BIOMED, V24, P25, DOI 10.1002/nbm.1552; Egred M, 2006, EUR J INTERN MED, V17, P551, DOI 10.1016/j.ejim.2006.04.015; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Friedrich MG, 2010, JACC-CARDIOVASC IMAG, V3, P385, DOI 10.1016/j.jcmg.2010.02.001; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; He T, 2008, MAGN RESON MED, V60, P350, DOI 10.1002/mrm.21625; He TG, 2007, J MAGN RESON IMAGING, V25, P1205, DOI 10.1002/jmri.20929; Heinrichs U, 2009, MAGN RESON MED, V62, P822, DOI 10.1002/mrm.22054; Hernando D, 2011, MAGN RESON MED; Hetherington HP, 2010, MAGN RESON MED, V63, P9, DOI 10.1002/mrm.22182; Jahnke C, 2010, JACC-CARDIOVASC IMAG, V3, P375, DOI 10.1016/j.jcmg.2009.12.008; Karamitsos TD, 2010, CIRC-CARDIOVASC IMAG, V3, P32, DOI 10.1161/CIRCIMAGING.109.860148; Kirk P, 2010, J MAGN RESON IMAGING, V32, P315, DOI 10.1002/jmri.22245; Kohler S, 2003, MAGNET RESON MED, V49, P371, DOI 10.1002/mrm.10346; Li DB, 1996, MAGNET RESON MED, V36, P16, DOI 10.1002/mrm.1910360105; Manka R, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-54; Mavrogeni S, 2011, HELL J CARDIOL, V52, P385; Meloni A, 2012, MAGN RESON MED, V68, P543, DOI 10.1002/mrm.23236; Meloni A, 2011, J MAGN RESON IMAGING, V33, P348, DOI 10.1002/jmri.22417; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; O'Regan DP, 2008, EUR RADIOL, V18, P800, DOI 10.1007/s00330-007-0814-8; Pan JW, 2012, MAGN RESON MED, V68, P1007, DOI 10.1002/mrm.24122; Pennell DJ, 2011, HAEMATOL-HEMATOL J, V96, P48, DOI 10.3324/haematol.2010.031468; Pennell DJ, 2010, CIRC-CARDIOVASC IMAG, V3, P2, DOI 10.1161/CIRCIMAGING.109.932079; Pepe A, 2006, J MAGN RESON IMAGING, V23, P662, DOI 10.1002/jmri.20566; Positano V, 2007, NMR BIOMED, V20, P578, DOI 10.1002/nbm.1121; Ramazzotti A, 2008, HEMOGLOBIN, V32, P97, DOI 10.1080/03630260701879514; Reeder SB, 1998, MAGNET RESON MED, V39, P988, DOI 10.1002/mrm.1910390617; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Restaino G, 2011, MAGN RESON MED, V65, P764, DOI 10.1002/mrm.22640; Schar M, 2010, MAGN RESON MED, V63, P419, DOI 10.1002/mrm.22234; Schar M, 2004, MAGN RESON MED, V51, P1091, DOI 10.1002/mrm.20123; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Shah S, 2009, P INT SOC MAG RESON, V17, P566; Smith GC, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-21; Tanner MA, 2006, HAEMATOLOGICA, V91, P1388; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; Tsaftaris SA, 2011, P INT SOC MAG RESON; Tsaftaris SA, 2012, J MAGN RESON IMAGING, V35, P1338, DOI 10.1002/jmri.23577; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; Utz W, 2005, ARTERIOSCL THROM VAS, V25, P1408, DOI 10.1161/01.ATV.0000170131.13683.d7; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Vohringer M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-20; Wacker CM, 1999, MAGN RESON MATER PHY, V8, P48; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5; Wacker CM, 1999, MAGN RESON MED, V41, P686, DOI 10.1002/(SICI)1522-2594(199904)41:4<686::AID-MRM6>3.0.CO;2-9; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863; Ziener CH, 2012, MAGN RESON IMAGING, V30, P540, DOI 10.1016/j.mri.2011.12.006	59	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52324	10.1371/journal.pone.0052324	http://dx.doi.org/10.1371/journal.pone.0052324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251708	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000312386800160
J	Brants, J; Semenchenko, K; Wasylyk, C; Robert, A; Carles, A; Zambrano, A; Pradeau-Aubreton, K; Birck, C; Schalken, JA; Poch, O; de Mey, J; Wasylyk, B				Brants, Jan; Semenchenko, Kostyantyn; Wasylyk, Christine; Robert, Aude; Carles, Annaick; Zambrano, Alberto; Pradeau-Aubreton, Karine; Birck, Catherine; Schalken, Jack A.; Poch, Olivier; de Mey, Jan; Wasylyk, Bohdan			Tubulin Tyrosine Ligase Like 12, a TTLL Family Member with SET- and TTL-Like Domains and Roles in Histone and Tubulin Modifications and Mitosis	PLOS ONE			English	Article							PROTEIN LYSINE METHYLTRANSFERASES; CELL-CYCLE; CHROMOSOME SEGREGATION; MAMMALIAN-CELLS; POSTTRANSLATIONAL MODIFICATIONS; CONSTITUTIVE HETEROCHROMATIN; MICROTUBULE CYTOSKELETON; METHYLATION; PR-SET7; ENZYMES	hTTLL12 is a member of the tubulin tyrosine ligase (TTL) family that is highly conserved in phylogeny. It has both SET-like and TTL-like domains, suggesting that it could have histone methylation and tubulin tyrosine ligase activities. Altered expression of hTTLL12 in human cells leads to specific changes in H4K20 trimethylation, and tubulin detyrosination, hTTLL12 does not catalyse histone methylation or tubulin tyrosination in vitro, as might be expected from the lack of critical amino acids in its SET-like and TTLL-like domains. hTTLL12 misexpression increases mitotic duration and chromosome numbers. These results suggest that hTTLL12 has non-catalytic functions related to tubulin and histone modification, which could be linked to its effects on mitosis and chromosome number stability.	[Brants, Jan; Semenchenko, Kostyantyn; Wasylyk, Christine; Carles, Annaick; Zambrano, Alberto; Pradeau-Aubreton, Karine; Birck, Catherine; Poch, Olivier; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, UMR CNRS UDS INSERM 7104 U964, Illkirch Graffenstaden, France; [Robert, Aude; de Mey, Jan] Univ Strasbourg, Ecole Super Biotechnol Strasbourg CNRS UMR7100, Equipe Microtubules & Morphogenese, Illkirch Graffenstaden, France; [Schalken, Jack A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Radboud University Nijmegen	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, UMR CNRS UDS INSERM 7104 U964, Illkirch Graffenstaden, France.	boh@igbmc.fr	Wasylyk, Bohdan/ABG-6778-2020; Zambrano, Alberto/Q-6188-2019; Zambrano, Alberto/A-1580-2013; robert, aude/F-9584-2015; Schalken, Jack A/B-1277-2014	Wasylyk, Bohdan/0000-0002-1718-1237; Zambrano, Alberto/0000-0001-5677-2999; Zambrano, Alberto/0000-0001-5677-2999; robert, aude/0000-0003-3095-4190; Schalken, Jack A/0000-0001-8274-7797	European Union [QLK6-2000-00159, 504587]; Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut-Rhin); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Bas-Rhin); Association pour la Recherche sur le Cancer; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Canceropole Grand-Est; INCa [PL099]	European Union(European Commission); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut-Rhin); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Bas-Rhin); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canceropole Grand-Est(Region Grand-Est); INCa(Institut National du Cancer (INCA) France)	The authors are thankful for the financial support from the European Union (FP5 Procure project QLK6-2000-00159 and FP6 Prima project #504587), the Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut- and Bas-Rhin), the Association pour la Recherche sur le Cancer, the Centre National de la Recherche Scientifique, and the Institut National de la Sante et de la Recherche Medicale, the Canceropole Grand-Est (Axe IV and DKFZ-CGE projects) and INCa (PL099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Artymiuk PJ, 1996, NAT STRUCT BIOL, V3, P128, DOI 10.1038/nsb0296-128; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bianchi DW, 2010, EARLY HUM DEV, V86, P747, DOI 10.1016/j.earlhumdev.2010.08.001; Brustel J, 2011, TRENDS CELL BIOL, V21, P452, DOI 10.1016/j.tcb.2011.04.006; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Dideberg O, 1998, TRENDS BIOCHEM SCI, V23, P57, DOI 10.1016/S0968-0004(97)01149-3; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; FORREST GL, 1978, J CELL BIOL, V78, P441, DOI 10.1083/jcb.78.2.441; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gardiner J, 2011, J EXP BOT, V62, P89, DOI 10.1093/jxb/erq278; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; Hastie AR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm894; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hebben M, 2007, PROTEIN EXPRES PURIF, V56, P269, DOI 10.1016/j.pep.2007.08.003; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KELLUM R, 1995, J CELL SCI, V108, P1419; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wasylyk C, 2010, INT J CANCER, V127, P2542, DOI 10.1002/ijc.25261; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xu DZ, 2009, CELL CYCLE, V8, P3688, DOI 10.4161/cc.8.22.9908; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	59	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51258	10.1371/journal.pone.0051258	http://dx.doi.org/10.1371/journal.pone.0051258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251473	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200078
J	Ferrari, MCO; Brown, GE; Chivers, DP				Ferrari, Maud C. O.; Brown, Grant E.; Chivers, Douglas P.			Temperature-Mediated Changes in Rates of Predator Forgetting in Woodfrog Tadpoles	PLOS ONE			English	Article							MEMORY; RECOGNITION; INFORMATION; ANIMALS; ECOLOGY; TROUT; RISK; FISH	Hundreds of studies have investigated the sources and nature of information that prey gather about their predators and the ways in which prey use this information to mediate their risk of predation. However, relatively little theoretical or empirical work has considered the question of how long information should be maintained and used by prey animals in making behavioural decisions. Here, we tested whether the size of the memory window associated with predator recognition could be affected by an intrinsic factor, such as size and growth rate of the prey. We maintained groups of predator-naive woodfrog, Lithobates sylvaticus, tadpoles at different temperatures for 8 days to induce differences in tadpole size. We then conditioned small and large tadpoles to recognize the odour of a predatory tiger salamander, Ambystoma tigrinum. Tadpoles were then maintained either on a high or low growth trajectory for another 8 days, after which they were tested for their response to the predator. Our results suggest that the memory window related to predator recognition of tadpoles is determined by both their size and/or growth rate at the time of learning and their subsequent growth rate post-learning.	[Ferrari, Maud C. O.] Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK, Canada; [Brown, Grant E.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Concordia University - Canada; University of Saskatchewan	Ferrari, MCO (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK, Canada.	maud.ferrari@usask.ca	Brown, Grant E/B-7182-2013	Brown, Grant E/0000-0003-3493-3477; Chivers, Douglas/0000-0002-9497-4329	NSERC (Natural Science and Engineering Research Council)	NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded through NSERC (Natural Science and Engineering Research Council) Discovery Grants to DPC and GEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; Brown GE, 1998, CAN J FISH AQUAT SCI, V55, P611, DOI 10.1139/cjfas-55-3-611; Brown GE, 2011, BEHAV ECOL SOCIOBIOL, V65, P1267, DOI 10.1007/s00265-011-1140-3; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dukas R, 1999, J THEOR BIOL, V197, P41, DOI 10.1006/jtbi.1998.0856; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2010, P ROY SOC B-BIOL SCI, V277, P2205, DOI 10.1098/rspb.2009.2117; Ferrari MCO, ANIMAL COGN IN PRESS; Gonzalo A, 2009, ANIM COGN, V12, P745, DOI 10.1007/s10071-009-0232-1; Hazlett BA, 2002, J CRUSTACEAN BIOL, V22, P439, DOI 10.1651/0278-0372(2002)022[0439:DIMCII]2.0.CO;2; Hirvonen H, 1999, ECOL MODEL, V115, P177, DOI 10.1016/S0304-3800(98)00191-4; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; MANGEL M, 1990, J THEOR BIOL, V146, P317, DOI 10.1016/S0022-5193(05)80742-8; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mirza RS, 2000, CAN J ZOOL, V78, P2198, DOI 10.1139/cjz-78-12-2198; Neisser U, 2004, DEV REV, V24, P154, DOI 10.1016/j.dr.2003.09.002; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Sangha S, 2003, NEUROBIOL LEARN MEM, V80, P130, DOI 10.1016/S1074-7427(03)00065-0; Shettleworth, 2010, COGNITION EVOLUTION; Van Buskirk J, 2000, J EXP BIOL, V203, P2149	24	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51143	10.1371/journal.pone.0051143	http://dx.doi.org/10.1371/journal.pone.0051143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251438	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200061
J	Halsey, LG; Watkins, DAR; Duggan, BM				Halsey, Lewis G.; Watkins, David A. R.; Duggan, Brendan M.			The Energy Expenditure of Stair Climbing One Step and Two Steps at a Time: Estimations from Measures of Heart Rate	PLOS ONE			English	Article							EXERCISE; HEALTH; COSTS; WOMEN	Stairway climbing provides a ubiquitous and inconspicuous method of burning calories. While typically two strategies are employed for climbing stairs, climbing one stair step per stride or two steps per stride, research to date has not clarified if there are any differences in energy expenditure between them. Fourteen participants took part in two stair climbing trials whereby measures of heart rate were used to estimate energy expenditure during stairway ascent at speeds chosen by the participants. The relationship between rate of oxygen consumption ((V) over dotO(2)) and heart rate was calibrated for each participant using an inclined treadmill. The trials involved climbing up and down a 14.05 m high stairway, either ascending one step per stride or ascending two stair steps per stride. Single-step climbing used 8.5 +/- 0.1 kcal min(-1), whereas double step climbing used 9.2 +/- 0.1 kcal min(-1). These estimations are similar to equivalent measures in all previous studies, which have all directly measured (V) over dotO(2) : The present study findings indicate that (1) treadmill-calibrated heart rate recordings can be used as a valid alternative to respirometry to ascertain rate of energy expenditure during stair climbing; (2) two step climbing invokes a higher rate of energy expenditure; however, one step climbing is energetically more expensive in total over the entirety of a stairway. Therefore to expend the maximum number of calories when climbing a set of stairs the single-step strategy is better.	[Halsey, Lewis G.; Watkins, David A. R.] Univ Roehampton, Dept Life Sci, London, England; [Duggan, Brendan M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	Roehampton University; University of Edinburgh	Halsey, LG (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	l.halsey@roehampton.ac.uk	Halsey, Lewis/B-8498-2011	Halsey, Lewis/0000-0002-0786-7585				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Aziz Abdul Rashid, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P253, DOI 10.2114/jpa.24.253; Bassett DR, 1997, MED SCI SPORT EXER, V29, P1250, DOI 10.1097/00005768-199709000-00019; Benedict FG, 1928, AM J PHYSIOL, V84, P675, DOI 10.1152/ajplegacy.1928.84.3.675; Biewener AA., 2007, ANIMAL LOCOMOTION; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; BUTTS NK, 1993, MED SCI SPORT EXER, V25, P378; FARDY PS, 1975, MED SCI SPORT EXER, V7, P91; Franks B.D., 1998, FITNESS LEADERS HDB; Gottschall JS, 2010, J STRENGTH COND RES, V24, P2558, DOI 10.1519/JSC.0b013e3181e83a6f; Green JA, 2001, J EXP BIOL, V204, P673; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P247, DOI 10.1016/j.cbpa.2011.01.001; HERMANSEN L, 1972, ERGONOMICS, V15, P15, DOI 10.1080/00140137208924403; Kang JIE, 2004, RES SPORTS MED, V12, p:251; Minetti AE, 2011, SCAND J MED SCI SPOR, V21, P293, DOI 10.1111/j.1600-0838.2009.01043.x; Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D; Nejat EJ, 2010, MATURITAS, V65, P106, DOI 10.1016/j.maturitas.2009.09.006; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; *SPORTS COUNC HLTH, 1992, ALL DUNB NAT FITN SU; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; WENZEL C, 1990, INT ARCH OCC ENV HEA, V62, P101, DOI 10.1007/BF00397856	24	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51213	10.1371/journal.pone.0051213	http://dx.doi.org/10.1371/journal.pone.0051213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251455	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200070
J	Li, J; Zhao, GZ; Varma, A; Qin, S; Xiong, Z; Huang, HY; Zhu, WY; Zhao, LX; Xu, LH; Zhang, S; Li, WJ				Li, Jie; Zhao, Guo-Zhen; Varma, Ajit; Qin, Sheng; Xiong, Zhi; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Zhang, Si; Li, Wen-Jun			An Endophytic Pseudonocardia Species Induces the Production of Artemisinin in Artemisia annua	PLOS ONE			English	Article							GENE-EXPRESSION; SP NOV.; AMORPHA-4,11-DIENE SYNTHASE; PAENIBACILLUS-POLYMYXA; PIRIFORMOSPORA-INDICA; ANTIMALARIAL-DRUG; HAIRY ROOTS; BIOSYNTHESIS; ACTINOBACTERIA; STIMULATION	Endophytic actinobacteria colonize internal tissues of their host plants and are considered as a rich and reliable source of diverse species and functional microorganisms. In this study, endophytic actinobacterial strain YIM 63111 was isolated from surface-sterilized tissue of the medicinal plant Artemisia annua. We identified strain YIM 63111 as a member of the genus Pseudonocardia. A. annua seedlings grown under both sterile and greenhouse conditions were inoculated with strain YIM 63111. The growth of A. annua seedlings was strongly reduced when YIM 63111 was inoculated at higher concentrations under sterile conditions. However, no growth inhibition was observed when A. annua was grown under greenhouse conditions. Using an enhanced green fluorescent protein (EGFP) expressing YIM 63111 strain, we also observed the endophytic colonization of A. annua seedling using confocal laser-scanning microscopy. The transcription levels of the key genes involved in artemisinin biosynthesis were investigated using real time RT-PCR, revealing that cytochrome P450 monooxygenase (CYP71AV1) and cytochrome P450 oxidoreductase (CPR) expression were up-regulated in A. annua upon inoculation with strain YIM 63111 under certain conditions. The up-regulation of these genes was associated with the increased accumulation of artemisinin. These results suggest that endophytic actinobacteria effectively stimulate certain plant defense responses. Our data also demonstrate the use of Pseudonocardia sp. strain YIM 63111 as a promising means to enhance artemisinin production in plants.	[Li, Jie; Zhao, Guo-Zhen; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Li, Wen-Jun] Yunnan Univ, Key Lab Microbial Divers SW China, Minist Educ, Kunming, Peoples R China; [Li, Jie; Zhao, Guo-Zhen; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Li, Wen-Jun] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan Inst Microbiol, Kunming, Peoples R China; [Li, Jie; Zhang, Si] Chinese Acad Sci, Key Lab Marine Bioresource Sustainable Utilizat C, Guangdong Key Lab Marine Mat Med, S China Sea Inst Oceanol,RNAM Ctr Marine Microbio, Guangzhou, Guangdong, Peoples R China; [Varma, Ajit] Amity Univ Uttar Pradesh, Amity Inst Microbial Technol, Noida, India; [Qin, Sheng] Jiangsu Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou, Peoples R China; [Xiong, Zhi] SW Forestry Univ, Sch Forestry Resources, Kunming, Peoples R China; [Li, Wen-Jun] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land CAS, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Yunnan University; Yunnan University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Amity University Noida; Jiangsu Normal University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Li, WJ (corresponding author), Yunnan Univ, Key Lab Microbial Divers SW China, Minist Educ, Kunming, Peoples R China.	wjli@ynu.edu.cn	xu, li/GNH-3667-2022; 秦, 盛/D-9911-2018		National Basic Research Program of China [2010CB833801]; Key Project of International Cooperation of Ministry of Science & Technology (MOST) [S2012ZR0069]; National Natural Science Foundation of China [U0932601]; Yunnan Provincial Natural Science Foundation [2009AC017, 2009DA002]; Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Key Project of International Cooperation of Ministry of Science & Technology (MOST); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (No. 2010CB833801), Key Project of International Cooperation of Ministry of Science & Technology (MOST) (No. S2012ZR0069), National Natural Science Foundation of China (No. U0932601), and Yunnan Provincial Natural Science Foundation (Nos. 2009AC017, 2009DA002). W-J Li was also supported by the 'Hundred Talents Program' of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin MZ, 2003, PLANTA MED, V69, P289, DOI 10.1055/s-2003-38871; Banyai W, 2011, PLANT GROWTH REGUL, V63, P45, DOI 10.1007/s10725-010-9510-9; Bouwmeester HJ, 1999, PHYTOCHEMISTRY, V52, P843, DOI 10.1016/S0031-9422(99)00206-X; Caretto S, 2011, PLANT BIOLOGY, V13, P51, DOI 10.1111/j.1438-8677.2009.00306.x; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chaudhary V, 2008, APPL SOIL ECOL, V40, P174, DOI 10.1016/j.apsoil.2008.04.003; Chen HH, 2009, INT J SYST EVOL MICR, V59, P559, DOI 10.1099/ijs.0.64740-0; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Duangmal K, 2009, INT J SYST EVOL MICR, V59, P1487, DOI 10.1099/ijs.0.007724-0; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; Durante M, 2011, APPL MICROBIOL BIOT, V90, P1905, DOI 10.1007/s00253-011-3232-4; EVTUSHENKO LI, 1989, INT J SYST BACTERIOL, V39, P72, DOI 10.1099/00207713-39-1-72; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54, DOI 10.1099/00207713-24-1-54; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Jessing KK, 2009, ENVIRON TOXICOL CHEM, V28, P701, DOI 10.1897/08-153R.1; Kapoor R, 2007, MYCORRHIZA, V17, P581, DOI 10.1007/s00572-007-0135-4; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kogel KH, 2006, CURR OPIN PLANT BIOL, V9, P358, DOI 10.1016/j.pbi.2006.05.001; Lal S, 2009, INDIAN J MICROBIOL, V49, P2, DOI 10.1007/s12088-009-0008-y; Li J, 2012, ANTON LEEUW INT J G, V101, P515, DOI 10.1007/s10482-011-9661-3; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Oelmuller R, 2009, SYMBIOSIS, V49, P1, DOI 10.1007/s13199-009-0009-y; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Satheesan J, 2012, MYCORRHIZA, V22, P195, DOI 10.1007/s00572-011-0394-y; Schulz Barbara J. E., 2006, V9, P1; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Smibert Robert M., 1994, P607; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A, 2012, AGR RES, V1, P117, DOI 10.1007/s40003-012-0019-5; Wang HH, 2010, IND CROP PROD, V31, P214, DOI 10.1016/j.indcrop.2009.10.008; Wang JW, 2009, APPL MICROBIOL BIOT, V85, P285, DOI 10.1007/s00253-009-2090-9; Wang JW, 2001, BIOTECHNOL LETT, V23, P857, DOI 10.1023/A:1010535001943; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Yang RY, 2008, PLANTA MED, V74, P1510, DOI 10.1055/s-2008-1081333; Yin Lulu, 2008, Chinese Journal of Applied and Environmental Biology, V14, P1; Yuan ZL, 2007, AFR J BIOTECHNOL, V6, P1266; Zeng QP, 2008, SCI CHINA SER C, V51, P232, DOI 10.1007/s11427-008-0032-x; Zhang B, 2010, AFR J BIOTECHNOL, V9, P3437	46	37	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51410	10.1371/journal.pone.0051410	http://dx.doi.org/10.1371/journal.pone.0051410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251523	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200103
J	Liu, KN; Meng, HX; Hou, JX				Liu, Kaining; Meng, Huanxin; Hou, Jianxia			Activity of 25-Hydroxylase in Human Gingival Fibroblasts and Periodontal Ligament Cells	PLOS ONE			English	Article							VITAMIN-D 25-HYDROXYLASE; TOLL-LIKE RECEPTORS; STEROL 27-HYDROXYLASE; HUMAN-SKIN; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CEREBROTENDINOUS XANTHOMATOSIS; AGGRESSIVE PERIODONTITIS; CYTOCHROME P450SCC; HUMAN MACROPHAGES; PROSTATE CELLS	Background: We previously demonstrated that 25-hydroxyvitamin D-3 concentrations in gingival crevicular fluid are 300 times higher than those in the plasma of patients with aggressive periodontitis. Here we explored whether 25-hydroxyvitamin D-3 can be synthesized by periodontal soft tissue cells. We also investigated which of the two main kinds of hydroxylases, CYP27A1 and CYP2R1, is the key 25-hydroxylase in periodontal soft tissue cells. Methodology/Principal Findings: Primary cultures of human gingival fibroblasts and periodontal ligament cells from 5 individual donors were established. CYP27A1 mRNA, CYP2R1 mRNA and CYP27A1 protein were detected in human gingival fibroblasts and periodontal ligament cells, whereas CYP2R1 protein was not. After incubation with the 25-hydroxylase substrate vitamin D-3, human gingival fibroblasts and periodontal ligament cells generated detectable 25-hydroxyvitamin D-3 that resulted in the production of 1 alpha,25-dihydroxyvitamin D-3. Specific knockdown of CYP27A1 in human gingival fibroblasts and periodontal ligament cells using siRNA resulted in a significant reduction in both 25-hydroxyvitamin D-3 and 1 alpha,25-dihydroxyvitamin D-3 production. Knockdown of CYP2R1 did not significantly influence 25-hydroxyvitamin D-3 synthesis. Sodium butyrate did not influence significantly CYP27A1 mRNA expression; however, interleukin-1 beta and Porphyromonas gingivalis lipopolysaccharide strongly induced CYP27A1 mRNA expression in human gingival fibroblasts and periodontal ligament cells. Conclusions: The activity of 25-hydroxylase was verified in human gingival fibroblasts and periodontal ligament cells, and CYP27A1 was identified as the key 25-hydroxylase in these cells.	[Liu, Kaining; Meng, Huanxin; Hou, Jianxia] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University	Meng, HX (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China.	kqhxmeng@bjmu.edu.cn	hou, joye/AAT-9545-2020		National Natural Science Foundations of China [30772420, 81100749]; Beijing Natural Science Foundation [7102164]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was funded by National Natural Science Foundations of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (30772420, 81100749) and Beijing Natural Science Foundation (http://www.bjkw.gov.cn/n1143/n1240/n1465/n2276/index.html) (7102164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2006, STEROIDS, V71, P849, DOI 10.1016/j.steroids.2006.04.009; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bashutski JD, 2011, J DENT RES, V90, P1007, DOI 10.1177/0022034511407771; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; BIKLE DD, 1986, J CLIN INVEST, V78, P557, DOI 10.1172/JCI112609; BJORKHEM I, 1978, J BIOL CHEM, V253, P842; BJORKHEM I, 1994, P NATL ACAD SCI USA, V91, P8592, DOI 10.1073/pnas.91.18.8592; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Flanagan JN, 2006, ANTICANCER RES, V26, P2567; Garcia MN, 2011, J PERIODONTOL, V82, P25, DOI 10.1902/jop.2010.100207; Gupta RP, 2004, J BONE MINER RES, V19, P680, DOI 10.1359/JBMR.0301257; Hansson M, 2005, BBA-MOL CELL BIOL L, V1687, P44, DOI 10.1016/j.bbalip.2004.11.002; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kurita-Ochiai T, 2002, INFECT IMMUN, V70, P2361, DOI 10.1128/IAI.70.5.2361-2367.2002; Lehmann B, 1998, J DERMATOL SCI, V18, P118, DOI 10.1016/S0923-1811(98)00033-4; Lehmann B, 2000, EXP DERMATOL, V9, P97, DOI 10.1034/j.1600-0625.2000.009002097.x; Li Qi-qiang, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P208; Liu KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039878; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; Liu KN, 2009, J PERIODONTOL, V80, P1114, DOI 10.1902/jop.2009.080675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; OKUDA KI, 1995, J LIPID RES, V36, P1641; Quinn CM, 2005, BIOCHEM J, V385, P823, DOI 10.1042/BJ20041776; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schuessler M, 2001, STEROIDS, V66, P399, DOI 10.1016/S0039-128X(00)00229-4; SKREDE S, 1986, J CLIN INVEST, V78, P729, DOI 10.1172/JCI112633; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Tang WJ, 2007, ARCH BIOCHEM BIOPHYS, V462, P13, DOI 10.1016/j.abb.2007.04.001; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Yamasaki T, 2004, J BIOL CHEM, V279, P22848, DOI 10.1074/jbc.M311346200	48	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52053	10.1371/journal.pone.0052053	http://dx.doi.org/10.1371/journal.pone.0052053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251684	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200174
J	Styner, M; Meyer, MB; Galior, K; Case, N; Xie, ZH; Sen, B; Thompson, WR; Pike, JW; Rubin, J				Styner, Maya; Meyer, Mark B.; Galior, Kornelia; Case, Natasha; Xie, Zhihui; Sen, Buer; Thompson, William R.; Pike, John Wesley; Rubin, Janet			Mechanical Strain Downregulates C/EBP beta in MSC and Decreases Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESENCHYMAL STEM-CELLS; ACTIVATED-RECEPTOR-GAMMA; MARROW STROMAL CELLS; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; INHIBITS ADIPOGENESIS; PPAR-GAMMA; ER STRESS; BONE	Exercise prevents marrow mesenchymal stem cell (MSC) adipogenesis, reversing trends that accompany aging and osteoporosis. Mechanical input, the in-vitro analogue to exercise, limits PPAR gamma expression and adipogenesis in MSC. We considered whether C/EBP beta might be mechanoresponsive as it is upstream to PPAR gamma, and also is known to upregulate endoplasmic reticulum (ER) stress. MSC (C3H10T1/2 pluripotent cells as well as mouse marrow-derived MSC) were cultured in adipogenic media and a daily mechanical strain regimen was applied. We demonstrate herein that mechanical strain represses C/EBP beta mRNA (0.6-fold +/- 0.07, p<0.05) and protein (0.4-fold +/- 0.1, p<0.01) in MSC. SiRNA silencing of beta-catenin prevented mechanical repression of C/EBP beta. C/EBP beta overexpression did not override strain's inhibition of adipogenesis, which suggests that mechanical control of C/EBP beta is not the primary site at which adipogenesis is regulated. Mechanical inhibition of C/EBP beta, however, might be critical for further processes that regulate MSC health. Indeed, overexpression of C/EBP beta in MSC induced ER stress evidenced by a dose-dependent increase in the pro-apoptotic CHOP (protein 4-fold +/- 0.5, p<0.05) and a threshold reduction in the chaperone BiP (protein 0.6-fold +/- 0.1, p = 0.2; mRNA 0.3-fold +/- 0.1, p<0.01). ChIP-seq demonstrated a significant association between C/EBP beta and both CHOP and BiP genes. The strain regimen, in addition to decreasing C/EBP beta mRNA (0.5-fold +/- 0.09, p<0.05), expanded ER capacity as measured by an increase in BiP mRNA (2-fold +/- 0.2, p<0.05) and protein. Finally, ER stress induced by tunicamycin was ameliorated by mechanical strain as demonstrated by decreased C/EBP beta, increased BiP and decreased CHOP protein expression. Thus, C/EBP beta is a mechanically responsive transcription factor and its repression should counter increases in marrow fat as well as improve skeletal resistance to ER stress.	[Styner, Maya; Galior, Kornelia; Case, Natasha; Xie, Zhihui; Sen, Buer; Thompson, William R.; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Meyer, Mark B.; Pike, John Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Styner, M (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	mstyner@med.unc.edu	Thompson, William R./B-2658-2009; Styner, Maya/I-2044-2019	Thompson, William R./0000-0002-7022-585X; Styner, Maya/0000-0001-9790-8645	National Institutes of Health [5K12HD001441, 1K08AR062097, AR056655, AR042360, DK072281]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR042360, R01AR042360, K08AR062097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following National Institutes of Health awards: 5K12HD001441, 1K08AR062097, AR056655 and AR042360, DK072281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Blanco-Gelaz MA, 2010, STEM CELL REV REP, V6, P462, DOI 10.1007/s12015-010-9135-4; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bezy O, 2005, J BIOL CHEM, V280, P11432, DOI 10.1074/jbc.M411741200; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Cho YM, 2009, EXP MOL MED, V41, P440, DOI 10.3858/emm.2009.41.6.049; DALSKY GP, 1988, ANN INTERN MED, V108, P824, DOI 10.7326/0003-4819-108-6-824; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hirasawa H, 2010, FEBS LETT, V584, P745, DOI 10.1016/j.febslet.2009.12.028; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEICHTER I, 1989, J ORTHOPAED RES, V7, P86, DOI 10.1002/jor.1100070112; Liu J, 2011, J BONE MINERAL RES; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Menuki K, 2008, BONE, V43, P613, DOI 10.1016/j.bone.2008.04.022; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; MINAIRE P, 1984, CALCIFIED TISSUE INT, V36, P338, DOI 10.1007/BF02405340; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sen B, 2010, J BIOMECH; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Styner M, 2010, J CELL BIOCH; Styner M, 2010, J CELL BIOCHEM, V111, P1042, DOI 10.1002/jcb.22793; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Thompson WR, 2012, GENE; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51613	10.1371/journal.pone.0051613	http://dx.doi.org/10.1371/journal.pone.0051613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251594	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200146
J	Mi, DH; Zhang, LQ; Wang, CX; Liu, LP; Pu, YH; Zhao, XQ; Wang, YL; Wang, YJ				Mi, Donghua; Zhang, Liqun; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun			Impact of Metabolic Syndrome on the Prognosis of Ischemic Stroke Secondary to Symptomatic Intracranial Atherosclerosis in Chinese Patients	PLOS ONE			English	Article							ARTERY STENOSIS; DISEASE; RISK; RACE; PROGRESSION; PREVALENCE; COMPONENTS; DIAGNOSIS; EVENTS; SEX	Objectives: To analyze the effect of metabolic syndrome (MetS) on prognosis of ischemic stroke secondary to intracranial stenosis in Chinese patients. Methods: A prospective cohort of 701 patients with ischemic stroke, caused by intracranial stenosis, were followed at 3-month intervals for 1 year to monitor development of recurrent stroke or death. Imaging was performed using magnetic resonance angiography. MetS was defined using International Diabetes Federation (IDF) criteria. Results: MetS was identified in 26.0% of the cohort of stroke patients. Patients with MetS were more likely to be female, nonsmokers, and more likely to have a prior history of diabetes mellitus, high blood glucose and a family history of stroke than patients without MetS. During 1-year follow-up, patients with MetS had a non-significantly higher rate of stroke recurrence (7.1%) than patients without MetS (3.9%; P = 0.07). There was no difference in mortality (3.3% versus 3.5%, respectively). Multivariate Cox proportional hazards analysis (adjusting for gender, BMI, smoking, diabetes, and LDL-C) identified an association between that 1-year stroke recurrence and the presence of MetS (hazard ratio 2.30; 95% CI: 1.01-5.22) and large waist circumference (hazard ratio: 2.39; 95% CI: 1.05-5.42). However, multivariable analysis adjusting for the individual components of MetS found no significant associations between MetS and stroke recurrence. There were no associations between these parameters and mortality. Conclusions: Chinese patients with symptomatic intracranial atherosclerosis who have MetS, are at higher risk of recurrent stroke than those without MetS. However, MetS was not predictive of stroke recurrence beyond its individual components and one-year mortality.	[Mi, Donghua; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Liqun] St George Hosp, Dept Neurol, London, England	Capital Medical University; St Georges University London	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022	zhang, liqun/0000-0001-6983-7915	Research Special Fund For Public Welfare Industry of Health [200902004]; Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2011BAI08B02]	Research Special Fund For Public Welfare Industry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study was funded by the Research Special Fund For Public Welfare Industry of Health (200902004), the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (2011BAI08B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2003, ASS AH HEART DIS STR; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; Arenillas JF, 2007, STROKE, V38, P2196, DOI 10.1161/STROKEAHA.106.480004; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Grundy S, 2008, ARTERIOSCL THROM VAS, V28, P8; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Lee WY, 2004, DIABETES RES CLIN PR, V65, P143, DOI 10.1016/j.diabres.2003.12.007; Liou CW, 2008, EUR J NEUROL, V15, P802, DOI 10.1111/j.1468-1331.2008.02181.x; Mazighi M, 2006, NEUROLOGY, V66, P1187, DOI 10.1212/01.wnl.0000208404.94585.b2; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Thijs VN, 2000, NEUROLOGY, V55, P490, DOI 10.1212/WNL.55.4.490; Turkoglu C, 2003, OBES SURG, V13, P699, DOI 10.1381/096089203322509255; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Wu G, 2002, CHIN J PREV MED CHIN, V36, P298	27	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51421	10.1371/journal.pone.0051421	http://dx.doi.org/10.1371/journal.pone.0051421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251528	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900086
J	Sirbu, A; Kerr, G; Crane, M; Ruskin, HJ				Sirbu, Alina; Kerr, Grainne; Crane, Martin; Ruskin, Heather J.			RNA-Seq vs Dual- and Single-Channel Microarray Data: Sensitivity Analysis for Differential Expression and Clustering	PLOS ONE			English	Article							GENE-EXPRESSION; OLIGONUCLEOTIDE	With the fast development of high-throughput sequencing technologies, a new generation of genome-wide gene expression measurements is under way. This is based on mRNA sequencing (RNA-seq), which complements the already mature technology of microarrays, and is expected to overcome some of the latter's disadvantages. These RNA-seq data pose new challenges, however, as strengths and weaknesses have yet to be fully identified. Ideally, Next (or Second) Generation Sequencing measures can be integrated for more comprehensive gene expression investigation to facilitate analysis of whole regulatory networks. At present, however, the nature of these data is not very well understood. In this paper we study three alternative gene expression time series datasets for the Drosophila melanogaster embryo development, in order to compare three measurement techniques: RNA-seq, single-channel and dual-channel microarrays. The aim is to study the state of the art for the three technologies, with a view of assessing overlapping features, data compatibility and integration potential, in the context of time series measurements. This involves using established tools for each of the three different technologies, and technical and biological replicates (for RNA-seq and microarrays, respectively), due to the limited availability of biological RNA-seq replicates for time series data. The approach consists of a sensitivity analysis for differential expression and clustering. In general, the RNA-seq dataset displayed highest sensitivity to differential expression. The single-channel data performed similarly for the differentially expressed genes common to gene sets considered. Cluster analysis was used to identify different features of the gene space for the three datasets, with higher similarities found for the RNA-seq and single-channel microarray dataset.	[Sirbu, Alina; Crane, Martin; Ruskin, Heather J.] Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland; [Sirbu, Alina] Inst Sci Interchange Fdn, Turin, Italy; [Kerr, Grainne] German Canc Res Ctr, D-6900 Heidelberg, Germany	Dublin City University; Helmholtz Association; German Cancer Research Center (DKFZ)	Sirbu, A (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland.	asirbu@computing.dcu.ie	Sirbu, Alina/I-3288-2014; Crane, Martin/V-6823-2019	Sirbu, Alina/0000-0002-3947-7143; Crane, Martin/0000-0001-7598-3126	Irish Research Council for Science Engineering and Technology EMBARK Initiative; Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD [IST-265432]	Irish Research Council for Science Engineering and Technology EMBARK Initiative(Irish Research Council for Science, Engineering and Technology); Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD	Most of this work has been conducted with support from the Irish Research Council for Science Engineering and Technology EMBARK Initiative. The authors also thank the EveryAware project funded by the Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD contract IST-265432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2002, DNA MICROARRAY GENE; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Cabanski CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009905; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Kaiser S, 2008, TECHNICAL REPORTS, V28; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kerr G, 2009, THESIS DUBLIN CITY U; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Leisch F, 2006, COMPUT STAT DATA AN, V51, P526, DOI 10.1016/j.csda.2005.10.006; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Speed T., 2003, STAT ANAL GENE EXPRE	33	55	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50986	10.1371/journal.pone.0050986	http://dx.doi.org/10.1371/journal.pone.0050986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251411	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900030
J	Ong, SS; Wickneswari, R				Ong, Seong Siang; Wickneswari, Ratnam			Characterization of microRNAs Expressed during Secondary Wall Biosynthesis in Acacia mangium	PLOS ONE			English	Article							CLASS IIIHD-ZIP; ALTERED LIGNIN BIOSYNTHESIS; TRANSCRIPTIONAL REGULATION; COMPRESSION WOOD; PLANT MICRORNAS; DOWN-REGULATION; LEAF POLARITY; GENE FAMILY; ARABIDOPSIS; POPULUS	MicroRNAs (miRNAs) play critical regulatory roles by acting as sequence specific guide during secondary wall formation in woody and non-woody species. Although thousands of plant miRNAs have been sequenced, there is no comprehensive view of miRNA mediated gene regulatory network to provide profound biological insights into the regulation of xylem development. Herein, we report the involvement of six highly conserved amg-miRNA families (amg-miR166, amg-miR172, amg-miR168, amg-miR159, amg-miR394, and amg-miR156) as the potential regulatory sequences of secondary cell wall biosynthesis. Within this highly conserved amg-miRNA family, only amg-miR166 exhibited strong differences in expression between phloem and xylem tissue. The functional characterization of amg-miR166 targets in various tissues revealed three groups of HD-ZIP III: ATHB8, ATHB15, and REVOLUTA which play pivotal roles in xylem development. Although these three groups vary in their functions, -psRNA target analysis indicated that miRNA target sequences of the nine different members of HD-ZIP III are always conserved. We found that precursor structures of amg-miR166 undergo exhaustive sequence variation even within members of the same family. Gene expression analysis showed three key lignin pathway genes: C4H, CAD, and CCoAOMT were upregulated in compression wood where a cascade of miRNAs was downregulated. This study offers a comprehensive analysis on the involvement of highly conserved miRNAs implicated in the secondary wall formation of woody plants.	[Ong, Seong Siang; Wickneswari, Ratnam] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Ong, SS (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia.	ong.siang@gmail.com; wicki@ukm.my	Ratnam, Wickneswari/V-7863-2017; Ratnam, Wickneswari/AAR-5100-2020	Ratnam, Wickneswari/0000-0002-2085-6434	Ministry of Science, Technology and Innovation Malaysia [05-01-02-SF1020]	Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research was funded by e-Science Grant No. 05-01-02-SF1020 from the Ministry of Science, Technology and Innovation Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Cano-Delgado A, 2010, ANNU REV CELL DEV BI, V26, P605, DOI 10.1146/annurev-cellbio-100109-104107; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chaffey N, 1999, TREES-STRUCT FUNCT, V13, P138, DOI 10.1007/PL00009745; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; del Rio JC, 2005, J ANAL APPL PYROL, V74, P110, DOI 10.1016/j.jaap.2004.10.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han KH, 2007, BIOFUEL BIOPROD BIOR, V1, P135, DOI 10.1002/bbb.14; Hancock JE, 2008, PLANT SOIL, V308, P239, DOI 10.1007/s11104-008-9624-2; Hancock JE, 2007, NEW PHYTOL, V173, P732, DOI 10.1111/j.1469-8137.2006.01965.x; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Ibarra D, 2005, J ANAL APPL PYROL, V74, P116, DOI 10.1016/j.jaap.2004.12.009; Jia CH, 2004, CHINESE SCI BULL, V49, P905, DOI 10.1360/03wc0529; Jin H, 2009, J WOOD SCI, V55, P401, DOI 10.1007/s10086-009-1053-1; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lohrasebi H, 1999, J WOOD CHEM TECHNOL, V19, P13, DOI 10.1080/02773819909349597; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Moon D, 2011, FOR SCI TECHNOL, V7, P53, DOI 10.1080/21580103.2011.572612; Newman LJ, 2000, EXPTL BIOL REV, P437; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Novaes E, 2010, PLANT PHYSIOL, V154, P555, DOI 10.1104/pp.110.161281; Oh S, 2003, J EXP BOT, V54, P2709, DOI 10.1093/jxb/erg304; Ohashi-Ito K, 2005, PLANT CELL PHYSIOL, V46, P1646, DOI 10.1093/pcp/pci180; Ong SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S13; Pang SL, 2008, THESIS U KEBANGSAAN; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Quentin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000264; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Song CNA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010861; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; SUNDBERG B, 2000, CELL MOL BIOL WOOD F; TIMELL TE, 1982, WOOD SCI TECHNOL, V16, P83, DOI 10.1007/BF00351097; Timell TE, 1986, COMPRESSION WOOD GYM, P1338; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Varkonyi-Gasic E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-159; Victor M., 2006, MICRORNAS DIFFERENTI; Voelker SL, 2010, PLANT PHYSIOL, V110, P159; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Yeh TF, 2005, HOLZFORSCHUNG, V59, P669, DOI 10.1515/HF.2005.107; Yong SYC, 2011, TREE GENET GENOMES, V7, P143, DOI 10.1007/s11295-010-0321-y; Zhang J, 2010, ACM T SENSOR NETWORK, V7, DOI 10.1145/1806895.1806897; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong R, 2007, PLANT SIGNAL BEHAV, V2, P351, DOI 10.4161/psb.2.5.4119; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	91	27	28	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49662	10.1371/journal.pone.0049662	http://dx.doi.org/10.1371/journal.pone.0049662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23251324	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800013
J	Cabrera, M; Arlt, H; Epp, N; Lachmann, J; Griffith, J; Perz, A; Reggiori, F; Ungermann, C				Cabrera, Margarita; Arlt, Henning; Epp, Nadine; Lachmann, Jens; Griffith, Janice; Perz, Angela; Reggiori, Fulvio; Ungermann, Christian			Functional Separation of Endosomal Fusion Factors and the Class C Core Vacuole/Endosome Tethering (CORVET) Complex in Endosome Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEINS; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; SYNTAXIN HOMOLOG; RAB INTERACTIONS; VACUOLE FUSION; SNARE COMPLEX; SEC1 HOMOLOG; SMALL GTPASE	Transport along the endolysosomal system requires multiple fusion events at early and late endosomes. Deletion of several endosomal fusion factors, including the Vac1 tether and the Class C core vacuole/endosome tethering (CORVET) complex-specific subunits Vps3 and Vps8, results in a class D vps phenotype. As these mutants have an apparently similar defect in endosomal transport, we asked whether CORVET and Vac1 could still act in distinct tethering reactions. Our data reveal that CORVET mutants can be rescued by Vac1 overexpression in the endocytic pathway but not in CPY or Cps1 sorting to the vacuole. Moreover, when we compared the ultrastructure, CORVET mutants were most similar to deletions of the Rab Vps21 and its guanine nucleotide exchange factor Vps9 and different from vac1 deletion, indicating separate functions. Likewise, CORVET still localized to endosomes even in the absence of Vac1, whereas Vac1 localization became diffuse in CORVET mutants. Importantly, CORVET localization requires the Rab5 homologs Vps21 and Ypt52, whereas Vac1 localization is strictly Vps21-dependent. In this context, we also uncover that Muk1 can compensate for loss of Vps9 in CORVET localization, indicating that two Rab5 guanine nucleotide exchange factors operate in the endocytic pathway. Overall, our study reveals a unique role of CORVET in the sorting of biosynthetic cargo to the vacuole/lysosome.	[Cabrera, Margarita; Arlt, Henning; Epp, Nadine; Lachmann, Jens; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	University Osnabruck; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Cabrera, M (corresponding author), Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	Margarita.Cabrera@biologie.uni-osnabrueck.de; cu@uos.de	Cabrera, Margarita/Y-1225-2019; Reggiori, Fulvio/U-8327-2019; Cabrera, Margarita/F-3306-2016	Cabrera, Margarita/0000-0002-2978-8255; Reggiori, Fulvio/0000-0003-2652-2686; Cabrera, Margarita/0000-0002-2978-8255; Arlt, Henning/0000-0001-6395-9620	project P11 [Sonderforschungsbereich (SFB) 944]; Hans Muhlenhoff Foundation; European Community Humanitarian Office (ECHO) [700.59.003]; Earth and Life Science ALW Open Program [821.02.017]; Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO) [DN 82-303, UN111/7-1]	project P11; Hans Muhlenhoff Foundation; European Community Humanitarian Office (ECHO); Earth and Life Science ALW Open Program; Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO)	This work was supported by Sonderforschungsbereich (SFB) 944 (project P11); by the Hans Muhlenhoff Foundation (to C. U.); and by European Community Humanitarian Office (ECHO) Grant 700.59.003, Earth and Life Science ALW Open Program Grant 821.02.017, and Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO) Cooperation Grant DN 82-303 (to F. R.) and UN111/7-1 (to C. U.).	Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; COWLES CR, 1994, J CELL SCI, V107, P3449; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Epp N, 2011, EUR J CELL BIOL, V90, P779, DOI 10.1016/j.ejcb.2011.04.007; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kauppi M, 2002, J CELL SCI, V115, P899; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pawelec A, 2010, EUKARYOT CELL, V9, P602, DOI 10.1128/EC.00286-09; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Russell MRG, 2012, J CELL SCI, V125, P5208, DOI 10.1242/jcs.111310; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; Subramanian S, 2004, MOL BIOL CELL, V15, P2593, DOI 10.1091/mbc.E03-10-0767; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Webb GC, 1997, GENETICS, V147, P467; WEISMAN LS, 1990, P NATL ACAD SCI USA, V87, P1076, DOI 10.1073/pnas.87.3.1076; Woolford CA, 1998, GENETICS, V148, P71; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	56	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5166	5175		10.1074/jbc.M112.431536	http://dx.doi.org/10.1074/jbc.M112.431536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264632	Green Published, hybrid			2022-12-25	WOS:000315340400064
J	Thomas, WA; Boscher, C; Chu, YS; Cuvelier, D; Martinez-Rico, C; Seddiki, R; Heysch, J; Ladoux, B; Thiery, JP; Mege, RM; Dufour, S				Thomas, William A.; Boscher, Cecile; Chu, Yeh-Shiu; Cuvelier, Damien; Martinez-Rico, Clara; Seddiki, Rima; Heysch, Julie; Ladoux, Benoit; Thiery, Jean Paul; Mege, Rene-Marc; Dufour, Sylvie			alpha-Catenin and Vinculin Cooperate to Promote High E-cadherin-based Adhesion Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; N-CADHERIN; INTERCELLULAR-ADHESION; FORCE MEASUREMENTS; COMPLEX-FORMATION; CELL-JUNCTIONS; ACTIN; MODULATION; ACTIVATION; PROTEIN	Maintaining cell cohesiveness within tissues requires that intercellular adhesions develop sufficient strength to support traction forces applied by myosin motors and by neighboring cells. Cadherins are transmembrane receptors that mediate intercellular adhesion. The cadherin cytoplasmic domain recruits several partners, including catenins and vinculin, at sites of cell-cell adhesion. Our study used force measurements to address the role of alpha E-catenin and vinculin in the regulation of the strength of E-cadherin-based adhesion. alpha E-catenin-deficient cells display only weak aggregation and fail to strengthen intercellular adhesion over time, a process rescued by the expression of alpha E-catenin or chimeric E-cadherin center dot alpha E-catenins, including a chimera lacking the alpha E-catenin dimerization domain. Interestingly, an alpha E-catenin mutant lacking the modulation and actin-binding domains restores cadherin-dependent cell-cell contacts but cannot strengthen intercellular adhesion. The expression of alpha E-catenin mutated in its vinculin-binding site is defective in its ability to rescue cadherin-based adhesion strength in cells lacking alpha E-catenin. Vinculin depletion or the overexpression of the alpha E-catenin modulation domain strongly decreases E-cadherin-mediated adhesion strength. This supports the notion that both molecules are required for intercellular contact maturation. Furthermore, stretching of cell doublets increases vinculin recruitment and alpha 18 anti-alpha E-catenin conformational epitope immunostaining at cell-cell contacts. Taken together, our results indicate that alpha E-catenin and vinculin cooperatively support intercellular adhesion strengthening, probably via a mechanoresponsive link between the E-cadherin beta-catenin complexes and the underlying actin cytoskeleton.	[Thomas, William A.] Colby Sawyer Coll, Dept Nat Sci, New London, NH 03257 USA; [Thomas, William A.; Martinez-Rico, Clara; Heysch, Julie; Dufour, Sylvie] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Boscher, Cecile; Seddiki, Rima; Mege, Rene-Marc] Univ Paris 06, F-75005 Paris, France; [Boscher, Cecile; Mege, Rene-Marc] Inst Fer Moulin, INSERM, U839, F-75005 Paris, France; [Chu, Yeh-Shiu; Thiery, Jean Paul] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cuvelier, Damien] Inst Curie, CNRS, UMR168, F-75005 Paris, France; [Seddiki, Rima; Ladoux, Benoit] Univ Paris 07, Lab MSC, F-75013 Paris, France; [Ladoux, Benoit; Thiery, Jean Paul] Mechanobiol Inst, Singapore 117411, Singapore; [Thiery, Jean Paul] Cancer Sci Inst, Singapore 117599, Singapore; [Thiery, Jean Paul] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; National University of Singapore	Dufour, S (corresponding author), Inst Curie, UMR144, Sect Rech, 26 Rue Ulm, F-75248 Paris 05, France.	sylvie.dufour@curie.fr	Thiery, Jean Paul/M-9387-2019; DUFOUR, Sylvie/G-2253-2019; cuvelier, damien/A-3530-2013; Mege, Rene Marc/M-9569-2013; Thiery, Jean Paul/H-1550-2011	Dufour, Sylvie/0000-0002-6663-0676; Ladoux, Benoit/0000-0003-2086-1556; Mege, Rene-Marc/0000-0001-8128-5543; Thiery, Jean Paul/0000-0003-0478-5020	National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program; Agence National de la Recherche (ANR) [PCV07-186757, 1515 02]; Programme Incitatif et Cooperatif (PIC) of Institut Curie; Fondation Pierre Gilles de Gennes; Association pour la Recherche sur le Cancer (ARC); Association Francaise contre les Myopathies; Institute of Molecular and Cell Biology A*STAR; ARC; NICHD, National Institutes of Health	National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program; Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Programme Incitatif et Cooperatif (PIC) of Institut Curie; Fondation Pierre Gilles de Gennes; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institute of Molecular and Cell Biology A*STAR; ARC(Australian Research Council); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program. This work was also supported by grants from the Agence National de la Recherche (ANR) (Physique et Chimie du Vivant I (PCVI) program, Grant PCV07-186757; BLANC program, Grant 1515 02), Programme Incitatif et Cooperatif (PIC) of Institut Curie, and Fondation Pierre Gilles de Gennes, as well as by grants from the Association pour la Recherche sur le Cancer (ARC), Association Francaise contre les Myopathies, and Institute of Molecular and Cell Biology A*STAR core funding.; Supported by an ARC Ph.D. fellowship. Present address: Dept. of Cellular and Physiolical Sciences, University of British Columbia, Vancouver, British Columbia VTZ 1Z4, Canada.; We acknowledge A. Nagafuchi for the generous gift of the mAb alpha 18, M. Lambert for advice and help in the construction of the alpha E-catenin expression vectors, and C. Carlier for technical help. We acknowledge Rebecca Jackson for critical reading of the manuscript. We acknowledge Z. Maciorowski and S. Grondin from the Flow cytometry facility, L. Sengmanivong from the Nikon Imaging Centre-Institut Curie, and V. Fraisier and F. Waharte from the PICT-IBiSA facility for help with cell sorting, imaging, and computerized video microscopy, respectively. Part of the wide field microscopy was also performed at the Institut du Fer a Moulin Cell Imaging Facility. Hybridomas obtained from the Developmental Studies Hybridoma Bank were developed under the auspices of the NICHD, National Institutes of Health, and maintained by the University of Iowa (Iowa City, IA).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Azioune A, 2011, LANGMUIR, V27, P7349, DOI 10.1021/la200970t; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chervin-Petinot A, 2012, J BIOL CHEM, V287, P7556, DOI 10.1074/jbc.M111.328682; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Chu YS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028102; Dufour S, 1999, J CELL BIOL, V146, P501, DOI 10.1083/jcb.146.2.501; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Lambert M, 2007, EXP CELL RES, V313, P4025, DOI 10.1016/j.yexcr.2007.07.035; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Martinez-Rico C, 2005, J BIOL CHEM, V280, P4753, DOI 10.1074/jbc.M412544200; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Ozawa M, 2003, J BIOL CHEM, V278, P46014, DOI 10.1074/jbc.M307778200; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Stockinger P, 2011, DEVELOPMENT, V138, P4673, DOI 10.1242/dev.071233; Sumida GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-48; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; THIERY JP, 1984, DEV BIOL, V102, P61, DOI 10.1016/0012-1606(84)90175-1; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001; Yonemura S, 2011, BIOESSAYS, V33, P732, DOI 10.1002/bies.201100064; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	54	104	106	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4957	4969		10.1074/jbc.M112.403774	http://dx.doi.org/10.1074/jbc.M112.403774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23266828	Green Published, hybrid			2022-12-25	WOS:000315340400043
J	de Miranda, MP; Lopes, FB; McVey, CE; Bustelo, XR; Simas, JP				de Miranda, Marta Pires; Lopes, Filipa B.; McVey, Colin E.; Bustelo, Xose R.; Pedro Simas, J.			Role of Src Homology Domain Binding in Signaling Complexes Assembled by the Murid gamma-Herpesvirus M2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; SH2 DOMAINS; ACTIVATION; MECHANISM; LATENCY; VAV; GAMMAHERPESVIRUS-68; IDENTIFICATION	gamma-Herpesviruses express proteins that modulate B lymphocyte signaling to achieve persistent latent infections. One such protein is the M2 latency-associated protein encoded by the murid herpesvirus-4. M2 has two closely spaced tyrosine residues, Tyr(120) and Tyr(129), which are phosphorylated by Src family tyrosine kinases. Here we used mass spectrometry to identify the binding partners of tyrosine-phosphorylated M2. Each M2 phosphomotif is shown to bind directly and selectively to SH2-containing signaling molecules. Specifically, Src family kinases, NCK1 and Vav1, bound to the Tyr(P)(120) site, PLC gamma 2 and the SHP2 phosphatase bound to the Tyr(P)(129) motif, and the p85 alpha subunit of PI3K associated with either motif. Consistent with these data, we show that M2 coordinates the formation of multiprotein complexes with these proteins. The effect of those interactions is functionally bivalent, because it can result in either the phosphorylation of a subset of binding proteins (Vav1 and PLC gamma 2) or in the inactivation of downstream targets (AKT). Finally, we show that translocation to the plasma membrane and subsequent M2 tyrosine phosphorylation relies on the integrity of a C-terminal proline-rich SH3 binding region of M2 and its interaction with Src family kinases. Unlike other gamma-herpesviruses, that encode transmembrane proteins that mimic the activation of ITAMs, murid herpesvirus-4 perturbs B cell signaling using a cytoplasmic/membrane shuttling factor that nucleates the assembly of signaling complexes using a bilayered mechanism of phosphotyrosine and proline-rich anchoring motifs.	[de Miranda, Marta Pires; Lopes, Filipa B.; Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [de Miranda, Marta Pires; Lopes, Filipa B.; Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Microbiol, P-1649028 Lisbon, Portugal; [McVey, Colin E.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, E-37007 Salamanca, Spain; [Bustelo, Xose R.] Univ Salamanca, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain	Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Simas, JP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal.	psimas@fm.ul.pt	McVey, Colin E/C-2110-2008; Simas, J Pedro/M-5157-2013; Bustelo, Xose R./AAD-2081-2022; Bustelo, Xose R./A-9526-2010	McVey, Colin E/0000-0001-7457-2130; Simas, J Pedro/0000-0001-6982-9253; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072	Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-MII/099314/2008]; Spanish Association Against Cancer [SAF2009-07172]; Spanish Ministry of Economy and Competitiveness [RD06/0020/0001]; European FEDER program; FCT [PNRC/692/BIO/2264/2005]	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Spanish Association Against Cancer; Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER program(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia (FCT) Grant PTDC/SAU-MII/099314/2008 (to J. P. S.) and Spanish Association Against Cancer and Spanish Ministry of Economy and Competitiveness Grants SAF2009-07172 and RD06/0020/0001, respectively (to X. R. B.). Spanish funding is co-sponsored by the European FEDER program. The SPR equipment at the Instituto de Tecnologia Quimica e Biologica was acquired with FCT Grant PNRC/692/BIO/2264/2005. The Proteomics Laboratory at the Centro de Investigacion del Cancer is a member of ProteoRed-ISCIII.	Albrecht JC, 1999, J VIROL, V73, P4631, DOI 10.1128/JVI.73.6.4631-4639.1999; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Lee BS, 2005, J VIROL, V79, P12173, DOI 10.1128/JVI.79.19.12173-12184.2005; Lee H, 1998, MOL CELL BIOL, V18, P5219, DOI 10.1128/MCB.18.9.5219; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macrae AI, 2003, J VIROL, V77, P9700, DOI 10.1128/JVI.77.17.9700-9709.2003; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pietrek M, 2010, J VIROL, V84, P8231, DOI 10.1128/JVI.01696-09; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Rodrigues L, 2009, EMBO J, V28, P1283, DOI 10.1038/emboj.2009.74; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Simas JP, 2004, J GEN VIROL, V85, P2789, DOI 10.1099/vir.0.80138-0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200	44	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3858	3870		10.1074/jbc.M112.439810	http://dx.doi.org/10.1074/jbc.M112.439810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258536	Green Published, hybrid			2022-12-25	WOS:000314845000017
J	Fonseca, MB; Nunes, AF; Morgado, AL; Sola, S; Rodrigues, CMP				Fonseca, Maria B.; Nunes, Ana F.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.			TAp63 gamma Demethylation Regulates Protein Stability and Cellular Distribution during Neural Stem Cell Differentiation	PLOS ONE			English	Article							SELF-RENEWAL; NS CELLS; P63; P73; P53; MOUSE; TRANSCRIPTION; MAINTENANCE; APOPTOSIS; DEATH	p63 is a close relative of the p53 tumor suppressor and transcription factor that modulates cell fate. The full-length isoform of p63, containing a transactivation (TA) domain (TAp63) is an essential proapoptotic protein in neural development. The role of p63 in epithelial development is also well established; however, its precise function during neural differentiation remains largely controversial. Recently, it has been demonstrated that several conserved elements of apoptosis are also integral components of cellular differentiation; p53 directly interacts with key regulators of neurogenesis. The aim of this study was to evaluate the role of p63 during mouse neural stem cell (NSC) differentiation and test whether the histone H3 lysine 27-specific demethylase JMJD3 interacts with p63 to redirect NSCs to neurogenesis. Our results showed that JMJD3 and TAp63 gamma are coordinately regulated to establish neural-specific gene expression programs in NSCs undergoing differentiation. JMJD3 overexpression increased TAp63 gamma levels in a demethylase activity-dependent manner. Importantly, overexpression of TAp63 gamma increased beta-III tubulin whereas downregulation of TAp63 gamma by specific p63 siRNA decreased beta-III tubulin. Immunoprecipitation assays demonstrated direct interaction between TAp63 gamma and JMJD3, and modulation of TAp63 gamma methylation status by JMJD3-demethylase activity. Importantly, the demethylase activity of JMJD3 influenced TAp63 gamma protein stabilization and cellular distribution, as well as TAp63 gamma-regulated neurogenesis. These findings clarify the role of p63 in adult neural progenitor cells and reveal TAp63 gamma as a direct target for JMJD3-mediated neuronal commitment.	[Fonseca, Maria B.; Nunes, Ana F.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Rodrigues, CMP (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Solá, Susana/M-5251-2013; Morgado, Ana Luísa/A-8683-2015; Solá, Susana/AAI-4580-2021; Rodrigues, Cecilia MP/M-3572-2013; iMed.ULisboa, CellFun/A-4244-2014	Solá, Susana/0000-0003-2036-797X; Morgado, Ana Luísa/0000-0003-3153-4665; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; 	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/SAU-NMC/117877/2010, Pest-OE/SAU/UI4013/2011, SFRH/BD/43959/2008, SFRH/BPD/34603/2007]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants PTDC/SAU-NMC/117877/2010 and Pest-OE/SAU/UI4013/2011, and fellowships SFRH/BD/43959/2008 (M.B.F.) and SFRH/BPD/34603/2007 (A.F.N.) from Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2010, BIOCHEM BIOPH RES CO, V403, P13, DOI 10.1016/j.bbrc.2010.10.087; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Hernandez-Acosta NC, 2011, BRAIN RES, V1372, P29, DOI 10.1016/j.brainres.2010.11.041; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fonseca MB, 2012, J ALZHEIMERS DIS, V28, P685, DOI 10.3233/JAD-2011-111547; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gonzalez-Cano L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.87; Holembowski L, 2011, CELL CYCLE, V10, P680, DOI 10.4161/cc.10.4.14859; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Marcel V, 2012, CELL DEATH DIFFER, V19, P816, DOI 10.1038/cdd.2011.152; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Nicotera P, 2005, NEURON, V48, P707, DOI 10.1016/j.neuron.2005.11.023; Paris M, 2012, CELL DEATH DIFFER, V19, P186, DOI 10.1038/cdd.2011.181; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	39	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52417	10.1371/journal.pone.0052417	http://dx.doi.org/10.1371/journal.pone.0052417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251711	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800163
J	Layton, A; Reap, J; Bras, B; Weissburg, M				Layton, Astrid; Reap, John; Bras, Bert; Weissburg, Marc			Correlation between Thermodynamic Efficiency and Ecological Cyclicity for Thermodynamic Power Cycles	PLOS ONE			English	Article							INDUSTRIAL ECOLOGY	A sustainable global community requires the successful integration of environment and engineering. In the public and private sectors, designing cyclical ("closed loop") resource networks increasingly appears as a strategy employed to improve resource efficiency and reduce environmental impacts. Patterning industrial networks on ecological ones has been shown to provide significant improvements at multiple levels. Here, we apply the biological metric cyclicity to 28 familiar thermodynamic power cycles of increasing complexity. These cycles, composed of turbines and the like, are scientifically very different from natural ecosystems. Despite this difference, the application results in a positive correlation between the maximum thermal efficiency and the cyclic structure of the cycles. The immediate impact of these findings results in a simple method for comparing cycles to one another, higher cyclicity values pointing to those cycles which have the potential for a higher maximum thermal efficiency. Such a strong correlation has the promise of impacting both natural ecology and engineering thermodynamics and provides a clear motivation to look for more fundamental scientific connections between natural and engineered systems. Citation: Layton A, Reap J, Bras B, Weissburg M (2012) Correlation between Thermodynamic Efficiency and Ecological Cyclicity for Thermodynamic Power Cycles. PLoS ONE 7(12): e51841. doi:10.1371/journal.pone.0051841	[Layton, Astrid; Bras, Bert] Georgia Inst Technol, George W Woodruff Sch Mech Engn Sustainable Desig, Atlanta, GA 30332 USA; [Reap, John] Quinnipiac Univ, Sch Business & Engn, Hamden, CT USA; [Weissburg, Marc] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bras, Bert; Weissburg, Marc] Georgia Inst Technol, Ctr Biol Inspired Design, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Quinnipiac University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Layton, A (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn Sustainable Desig, Atlanta, GA 30332 USA.	alayton6@gatech.edu		Layton, Astrid/0000-0003-3790-2916	National Science Foundation [CMMI-0600243, 0628190];  [CBET-0967536]; Direct For Education and Human Resources [1022778] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0967536] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This material is based upon work supported by the National Science Foundation under Grant Nos. CMMI-0600243 and 0628190, and CBET-0967536. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2005, OIKOS, V110, P164, DOI 10.1111/j.0030-1299.2005.13082.x; [Anonymous], 1999, ENERGY RESOURCES OCC; Borrett SR, 2007, J THEOR BIOL, V245, P98, DOI 10.1016/j.jtbi.2006.09.024; Brokowiski ME, 1998, IMPROVING AIR STANDA; Ehrenfeld J., 1997, J IND ECOL, V1, P67, DOI [10.1162/jiec.1997.1.1.67, DOI 10.1162/JIEC.1997.1.1.67]; European Parliament, 2003, OFF J EUR UNION; Fath BD, 1998, NETWORK ANAL FDN EXT; Fath BD, 2007, ECOL MODEL, V208, P391, DOI 10.1016/j.ecolmodel.2007.06.013; Fath BD, 2007, ECOL MODEL, V208, P17, DOI 10.1016/j.ecolmodel.2007.04.020; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; FROSCH RA, 1992, P NATL ACAD SCI USA, V89, P800, DOI 10.1073/pnas.89.3.800; FROSCH RA, 1989, SCI AM, V261, P144, DOI 10.1038/scientificamerican0989-144; Garmestani AS, 2006, ENVIRON DEV ECON, V11, P533, DOI 10.1017/S1355770X06003081; GRAEDEL T. E., 1995, IND ECOLOGY; Hardy Catherine, 2002, Journal of Industrial Ecology, V6, P29, DOI 10.1162/108819802320971623; HO MW, 1998, RAINBOW WORM; JELINSKI LW, 1992, P NATL ACAD SCI USA, V89, P793, DOI 10.1073/pnas.89.3.793; Kadem L, 2007, VAPOR COMBINED POWER, P6; LEWIS ER, 1995, BIOSYSTEMS, V34, P47, DOI 10.1016/0303-2647(94)01456-H; MULLER F, 1998, ECO TARGETS GOAL FUN; Naish J, 2008, ECOLOGIST, V38, P36; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; OSTER G, 1971, NATURE, V234, P393, DOI 10.1038/234393a0; Reap, 2009, HOLISTIC BIOMIMICRY; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Sonntag RE., 2003, FUNDAMENTALS THERMOD; World Commission on Environment and Development (WCED), 1987, OUR COMMON FUTURE	27	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51841	10.1371/journal.pone.0051841	http://dx.doi.org/10.1371/journal.pone.0051841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251638	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800095
J	Yagound, B; Blacher, P; Chameron, S; Chaline, N				Yagound, Boris; Blacher, Pierre; Chameron, Stephane; Chaline, Nicolas			Social Context and Reproductive Potential Affect Worker Reproductive Decisions in a Eusocial Insect	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; BUMBLEBEE BOMBUS-TERRESTRIS; COMPLEX SOCIOGENETIC ORGANIZATION; DIVISION-OF-LABOR; HONEYBEE WORKERS; INTRASPECIFIC PARASITISM; LASIOGLOSSUM-MALACHURUM; QUEEN INFLUENCE; SWEAT BEE; COLONIES	Context-dependent decision-making conditions individual plasticity and is an integrant part of alternative reproductive strategies. In eusocial Hymenoptera (ants, bees and wasps), the discovery of worker reproductive parasitism recently challenged the view of workers as a homogeneous collective entity and stressed the need to consider them as autonomous units capable of elaborate choices which influence their fitness returns. The reproductive decisions of individual workers thus need to be investigated and taken into account to understand the regulation of reproduction in insect societies. However, we know virtually nothing about the proximate mechanisms at the basis of worker reproductive decisions. Here, we test the hypothesis that the capacity of workers to reproduce in foreign colonies lies in their ability to react differently according to the colonial context and whether this reaction is influenced by a particular internal state. Using the bumble bee Bombus terrestris, we show that workers exhibit an extremely high reproductive plasticity which is conditioned by the social context they experience. Fertile workers reintroduced into their mother colony reverted to sterility, as expected. On the contrary, a high level of ovary activity persisted in fertile workers introduced into a foreign nest, and this despite more frequent direct contacts with the queen and the brood than control workers. Foreign workers' reproductive decisions were not affected by the resident queen, their level of fertility being similar whether or not the queen was removed from the host colony. Workers' physiological state at the time of introduction is also of crucial importance, since infertile workers failed to develop a reproductive phenotype in a foreign nest. Therefore, both internal and environmental factors appear to condition individual reproductive strategies in this species, suggesting that more complex decision-making mechanisms are involved in the regulation of worker reproduction than previously thought. Citation: Yagound B, Blacher P, Chameron S, Chaline N (2012) Social Context and Reproductive Potential Affect Worker Reproductive Decisions in a Eusocial Insect. PLoS ONE 7(12): e52217. doi:10.1371/journal.pone.0052217	[Yagound, Boris; Blacher, Pierre; Chameron, Stephane; Chaline, Nicolas] Univ Paris 13, EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France	Universite Paris 13	Yagound, B (corresponding author), Univ Paris 13, EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	boris.yagound@leec.univ-paris13.fr	Chaline, Nicolas/J-7276-2012; Yagound, Boris/C-7956-2018	Chaline, Nicolas/0000-0001-6714-9297; Yagound, Boris/0000-0003-0466-8326; Chaline, Nicolas/0000-0002-4905-5702	French National Research Agency [ANR-09-JCJC-0031-01 SEUILS]	French National Research Agency(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR-09-JCJC-0031-01 SEUILS to NC), www.agence-nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE R D, 1976, Journal of the Kansas Entomological Society, V49, P63; Alaux C, 2004, INSECT SOC, V51, P287, DOI 10.1007/s00040-004-0741-5; Alaux C, 2007, BEHAV ECOL SOCIOBIOL, V62, P213, DOI 10.1007/s00265-007-0455-6; Alaux C, 2006, BEHAV ECOL SOCIOBIOL, V60, P439, DOI 10.1007/s00265-006-0184-2; Alves DA, 2009, MOL ECOL, V18, P4102, DOI 10.1111/j.1365-294X.2009.04323.x; Amsalem E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018238; Beekman M, 2008, ANNU REV ENTOMOL, V53, P19, DOI 10.1146/annurev.ento.53.103106.093515; Birmingham AL, 2004, CAN J ZOOL, V82, P1843, DOI 10.1139/Z04-181; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; CAMERON SA, 1989, ETHOLOGY, V80, P137, DOI 10.1111/j.1439-0310.1989.tb00735.x; Cepeda OI, 2006, APIDOLOGIE, V37, P175, DOI 10.1051/apido:2006018; Chapman NC, 2010, BEHAV ECOL SOCIOBIOL, V64, P419, DOI 10.1007/s00265-009-0858-7; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Foster RL, 2004, PHYSIOL ENTOMOL, V29, P327, DOI 10.1111/j.0307-6962.2004.00388.x; Hartel S, 2006, INSECT SOC, V53, P183, DOI 10.1007/s00040-005-0857-2; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nanork P, 2007, MOL ECOL, V16, P1107, DOI 10.1111/j.1365-294X.2006.03207.x; Nanork P, 2005, NATURE, V437, P829, DOI 10.1038/437829a; Neumann P, 2003, APIDOLOGIE, V34, P585, DOI 10.1051/apido:2003048; Neumann P, 2001, BEHAV ECOL, V12, P419, DOI 10.1093/beheco/12.4.419; Paxton RJ, 2002, MOL ECOL, V11, P2405, DOI 10.1046/j.1365-294X.2002.01620.x; Pfeiffer KJ, 1998, INSECT SOC, V45, P151, DOI 10.1007/s000400050076; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Roseler P.-F., 1973, Apidologie, V4, P267, DOI 10.1051/apido:19730303; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Soro A, 2009, INSECT SOC, V56, P55, DOI 10.1007/s00040-008-1037-y; Sumner S, 2007, CURR BIOL, V17, P140, DOI 10.1016/j.cub.2006.11.064; Takahashi J, 2010, J ETHOL, V28, P61, DOI 10.1007/s10164-009-0155-y; VANDOORN A, 1986, INSECT SOC, V33, P3, DOI 10.1007/BF02224031; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Wilson E.O., 1971, INSECT SOC; Zanette LRS, 2012, EVOLUTION, V66, P3765, DOI 10.1111/j.1558-5646.2012.01709.x	45	16	16	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52217	10.1371/journal.pone.0052217	http://dx.doi.org/10.1371/journal.pone.0052217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251701	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800152
J	Heng, WL; Lim, CH; Tan, BH; Chlebicki, MP; Lee, WHL; Seck, T; Lim, YP				Heng, Wee Ling; Lim, Chong Hee; Tan, Ban Hock; Chlebicki, Maciej Piotr; Lee, Winnie Hui Ling; Seck, Tracy; Lim, Yeong Phang			From Penicillin-Streptomycin to Amikacin-Vancomycin: Antibiotic Decontamination of Cardiovascular Homografts in Singapore	PLOS ONE			English	Article							RESISTANCE	Background: In February 2012, the National Cardiovascular Homograft Bank (NCHB) became the first tissue bank outside of North America to receive accreditation from the American Association of Tissue Banks. From 2008 to 2009, NCHB had been decontaminating its cardiovascular homografts with penicillin and streptomycin. The antibiotic decontamination protocol was changed in January 2010 as amikacin and vancomycin were recommended, in order to cover bacteria isolated from post-recovery and post-antibiotic incubation tissue cultures. Aim: The objective of this study is to determine the optimal incubation conditions for decontamination of homografts by evaluating the potencies of amikacin and vancomycin in different incubation conditions. Retrospective reviews of microbiological results were also performed for homografts recovered from 2008 to 2012, to compare the effectiveness of penicillin-streptomycin versus the amikacin-vancomycin regimens. Methods: Based on microbiological assays stated in United States Pharmacopeia 31, potency of amikacin was evaluated by turbidimetric assay using Staphylococcus aureus, while vancomycin was by diffusion assay using Bacillus subtilis sporulate. Experiments were performed to investigate the potencies of individual antibiotic 6-hours post incubation at 4 degrees C and 37 degrees C and 4 degrees C for 24 hours, after the results suggested that amikacin was more potent at lower temperature. Findings: Tissue incubation at 4 degrees C for 24 hours is optimal for both antibiotics, especially for amikacin, as its potency falls drastically at 37 degrees C. Conclusion: The decontamination regimen of amikacin-vancomycin at 4 degrees C for 24 hours is effective. Nevertheless, it is imperative to monitor microbiological trends closely and evaluate the efficacy of current antibiotics regimen against emerging strains of micro-organisms.	[Heng, Wee Ling; Lim, Chong Hee; Seck, Tracy; Lim, Yeong Phang] Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Natl Cardiovasc Homograft Bank, Singapore, Singapore; [Tan, Ban Hock; Chlebicki, Maciej Piotr] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore	National Heart Centre Singapore; Singapore General Hospital	Heng, WL (corresponding author), Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Natl Cardiovasc Homograft Bank, Singapore, Singapore.	heng.wee.ling@nhcs.com.sg			Ministry of Health Singapore's Health Service Development Programme (HSDP) grant	Ministry of Health Singapore's Health Service Development Programme (HSDP) grant	The funders, Ministry of Health Singapore's Health Service Development Programme (HSDP) grant, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander Karen, 2006, Cell and Tissue Banking, V7, P23, DOI 10.1007/s10561-005-3393-4; BENEDICT RG, 1945, J BACTERIOL, V49, P85, DOI 10.1128/JB.49.1.85-95.1945; BROCKBANK KGM, 2001, DISINFECTION STERILI, P1011; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gad GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017224; GALL K, 1995, J THORAC CARDIOV SUR, V110, P680, DOI 10.1016/S0022-5223(95)70099-4; GAVIN JJ, 1957, APPL MICROBIOL, V5, P235, DOI 10.1128/AEM.5.4.235-243.1957; Germain M, 2010, CELL TISSUE BANK, V11, P197, DOI 10.1007/s10561-009-9155-y; Gilbert DN, 1999, CLINICAL INFECTIOUS DISEASES, P273; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Leeming JP, 2005, J HOSP INFECT, V60, P231, DOI 10.1016/j.jhin.2004.12.022; Parker R, 2010, ESSENTIALS OF TISSUE BANKING, P69, DOI 10.1007/978-90-481-9142-0_5; Pezzella C, 2004, ANTIMICROB AGENTS CH, V48, P903, DOI 10.1128/AAC.48.3.903-908.2004; Prescott LM, 2003, MICROBIOLOGY, P805; Sulaiman AS, 1999, CLINICAL INFECTIOUS DISEASES, P285; TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149; Verghese Susan, 2004, Indian Heart J, V56, P299; WATANAKUNAKORN C, 1984, J ANTIMICROB CHEMOTH, V14, P7, DOI 10.1093/jac/14.suppl_D.7	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51605	10.1371/journal.pone.0051605	http://dx.doi.org/10.1371/journal.pone.0051605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251592	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200144
J	Huang, HY; Cheng, YY; Liao, WC; Tien, YW; Yang, CHJ; Hsu, SM; Huang, PH				Huang, Hsin-Yi; Cheng, Yu-Yao; Liao, Wei-Chih; Tien, Yu-Wen; Yang, Chih-Hsin James; Hsu, Su-Ming; Huang, Pei-Hsin			SOX4 Transcriptionally Regulates Multiple SEMA3/Plexin Family Members and Promotes Tumor Growth in Pancreatic Cancer	PLOS ONE			English	Article							IN-VITRO; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; CELL-DEATH; EXPRESSION; GENES; CARCINOMA; TARGET; OVEREXPRESSION; SEMAPHORINS	Semaphorin signaling through Plexin frequently participates in tumorigenesis and malignant progression in various types of cancer. In particular, the role of semaphorin signaling in pancreatic ductal adenocarcinoma (PDAC) remains unexplored, despite a high likelihood of metastasis and mortality. Unlike other epithelial malignancies that often express a small number of specific genes in the Semaphorin/Plexin family, five or more are often expressed in human PDAC. Such concomitant expression of these SEMA3/Plexin family members is not a result of gene amplification, but (at least partially) from increased gene transcription activated by SOX4 de novo expressed in PDAC. Via chromatin-immunoprecipitation, luciferase promoter activity assay and electrophoresis mobility shift assay, SOX4 is demonstrated to bind to the consensus site at the promoter of each SEMA3 and Plexin gene to enhance transcription activity. Conversely, RNAi-knockdown of SOX4 in PDAC cell lines results in decreased expression of SEMA3/Plexin family members and is associated with restricted tumor growth both in vitro and in SCID mice. We further demonstrate that SOX4 levels parallel with the summed expression of SEMA3/Plexin family members (P = 0.033, NPar Kruskal-Wallis one-way analysis), which also correlates with poor survival in human PDAC (P = 0.0409, Kaplan-Meier analysis). Intriguingly, miR-129-2 and miR-335, both of which target SOX4 for degradation, are core-pressed in human PDAC cases associated with up-regulated SOX4 in a statistically significant way. In conclusion, we disclose a miR-129-2(miR-335)/SOX4/Semaphorin-Plexin regulatory axis in the tumorigenesis of pancreatic cancer.	[Huang, Hsin-Yi; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Huang, Hsin-Yi; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Cheng, Yu-Yao; Liao, Wei-Chih] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Chih-Hsin James] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Huang, PH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan.	phhuang@ntu.edu.tw		LIAO, WEI-CHIH/0000-0001-5362-6953; Huang, Hsin-Yi/0000-0003-0062-3091; HUANG, PEI-HSIN/0000-0002-2414-1487; TIEN, YU-WEN/0000-0002-9126-2705	National Taiwan University Hospital [NTUH.96-M-037]	National Taiwan University Hospital(National Taiwan University)	This work was supported by National Taiwan University Hospital internal fund granted to P-H Huang and to H-Y Huang (NTUH.96-M-037). The funder had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Baumgart M, 2005, CELL ONCOL, V27, P3; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hur EH, 2004, BIOCHEM BIOPH RES CO, V325, P59, DOI 10.1016/j.bbrc.2004.09.215; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim EJ, 2011, CURR OPIN GASTROEN, V27, P460, DOI 10.1097/MOG.0b013e328349e31f; Kim HD, 2011, MOL ENDOCRINOL, V25, P1184, DOI 10.1210/me.2010-0332; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Kusy S, 2005, BBA-GENE STRUCT EXPR, V1730, P66, DOI 10.1016/j.bbaexp.2005.05.008; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liao YH, 2007, CANCER RES, V67, P11547, DOI 10.1158/0008-5472.CAN-07-1930; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu ET, 2008, CURR OPIN GENET DEV, V18, P251, DOI 10.1016/j.gde.2008.07.014; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Moreno CS, 2010, AM J PATHOL, V176, P518, DOI 10.2353/ajpath.2010.090657; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sato N, 2003, CANCER RES, V63, P4158; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Tseng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019396; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548	52	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48637	10.1371/journal.pone.0048637	http://dx.doi.org/10.1371/journal.pone.0048637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251334	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200007
J	Kutty, S; Wu, JF; Hammel, JM; Xie, F; Gao, SJ; Drvol, LK; Lof, J; Radio, SJ; Therrien, SL; Danford, DA; Porter, TR				Kutty, Shelby; Wu, Juefei; Hammel, James M.; Xie, Feng; Gao, Shunji; Drvol, Lucas K.; Lof, John; Radio, Stanley J.; Therrien, Stacey L.; Danford, David A.; Porter, Thomas R.			Microbubble Mediated Thrombus Dissolution with Diagnostic Ultrasound for the Treatment of Chronic Venous Thrombi	PLOS ONE			English	Article							CAVITATIONAL MECHANISMS; DIALYSIS GRAFTS; THROMBOEMBOLISM; COMPLICATIONS; THERAPY	Background: Central venous catheter (CVC) thrombi result in significant morbidity in children, and currently available treatments are associated with significant risk. We sought to investigate the therapeutic efficacy of microbubble (MB) enhanced sonothrombolysis for aged CVC associated thrombi in vivo. Methods and Results: A model of chronic indwelling CVC in the low superior vena cava with thrombus in situ was established after feasibility and safety testing in 7 pigs; and subsequently applied for repeated, sonothrombolytic treatments in 9 pigs (total 24 treatments). Baseline intracardiac echocardiography (ICE, 10.5F, Siemens), fluoroscopy and saline flushing confirmed the absence of any pre-existing CVC thrombus. A thrombus was then allowed to form and age over 24 hours. The created thrombus was localized and measured by ICE, and transthoracic image guided high mechanical index (MI) two-dimensional US treatments (1.1-1.7 MI; iE33, Philips) applied intermittently whenever intravenously infused MBs (3% MRX-801; NuVox) were visualized near the thrombus (n = 10; Group A). Control pigs (n = 10; Group B) received US without MB. All treatments were randomized. Post-treatment thrombus area by ICE planimetry was compared with pretreatment measurements. Thrombus area measurements before and after treatment were 0.22 and 0.10 cm(2) respectively in Group A; compared to 0.24 and 0.21 cm(2) in Group B (p = 0.0003). Effectiveness of longer duration US and MB thrombolytic treatments were studied (n = 4), which suggested that near complete thrombus dissolution is possible. No pulmonary emboli, alterations in oxygen saturation, or hemodynamics occurred with either treatment. Conclusions: Guided high MI diagnostic US+systemic MB facilitates reduction of aged CVC associated thrombi in vivo. MB enhanced sonothrombolytic therapy may be a non-invasive safe alternative to thrombolytic agents in treating thrombotic CVC occlusions.	[Kutty, Shelby; Danford, David A.] Creighton Univ, Childrens Hosp & Med Ctr, Univ Nebraska Coll Med, Joint Div Pediat Cardiol, Omaha, NE 68178 USA; [Wu, Juefei; Xie, Feng; Gao, Shunji; Drvol, Lucas K.; Lof, John; Therrien, Stacey L.; Porter, Thomas R.] Univ Nebraska Med Ctr, Dept Internal Med, Cardiol Sect, Omaha, NE USA; [Hammel, James M.] Univ Nebraska Med Ctr, Div Cardiovasc Surg, Omaha, NE USA; [Radio, Stanley J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Porter, TR (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Cardiol Sect, Omaha, NE USA.	trporter@unmc.edu	Wu, Juefei/GRE-7093-2022	KUTTY, SHELBY/0000-0001-9428-0979	American College of Cardiology Foundation; Edna Ittner Foundation; National Institutes of Health NIH/NIBIB [R01 EB009050-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009050] Funding Source: NIH RePORTER	American College of Cardiology Foundation(General Electric); Edna Ittner Foundation; National Institutes of Health NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was supported by grants from the American College of Cardiology Foundation (SK), the Edna Ittner Foundation (SK) and the National Institutes of Health NIH/NIBIB R01 EB009050-01 (FX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum Y, 1998, CIRCULATION, V97, P130, DOI 10.1161/01.CIR.97.2.130; Boersma RS, 2008, ANN ONCOL, V19, P433, DOI 10.1093/annonc/mdm350; Chan AK, 2003, J THROMB HAEMOST, V1, P1443, DOI 10.1046/j.1538-7836.2003.00308.x; Culp WC, 2003, J VASC INTERV RADIOL, V14, P343, DOI 10.1097/01.RVI.0000058409.01661.B4; Culp WC, 2001, CARDIOVASC INTER RAD, V24, P407, DOI 10.1007/s00270-001-0052-4; Everbach EC, 2000, ULTRASOUND MED BIOL, V26, P1153, DOI 10.1016/S0301-5629(00)00250-7; Journeycake JM, 2006, J CLIN ONCOL, V24, P4575, DOI 10.1200/JCO.2005.05.5343; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF182, DOI 10.1136/fn.82.3.F182; Kutty S, 2012, EUR HEART J-CARD IMG, V13, P500, DOI 10.1093/ejechocard/jer287; Kutty S, 2010, J AM SOC ECHOCARDIOG, V23, P1001, DOI 10.1016/j.echo.2010.06.024; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Meairs Stephen, 2009, Cerebrovasc Dis, V27 Suppl 2, P55, DOI 10.1159/000203127; Monagle P, 2000, PEDIATR RES, V47, P763, DOI 10.1203/00006450-200006000-00013; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Parasuraman S, 2006, CIRCULATION, V113, pE12, DOI 10.1161/CIRCULATIONAHA.105.583773; Porter TR, 2009, CARDIOVASC RES, V83, P636, DOI 10.1093/cvr/cvp206; Porter TR, 2001, J ULTRAS MED, V20, P1313, DOI 10.7863/jum.2001.20.12.1313; Prokop AF, 2007, ULTRASOUND MED BIOL, V33, P924, DOI 10.1016/j.ultrasmedbio.2006.11.022; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Shivakumar SP, 2009, J CLIN ONCOL, V27, P4858, DOI 10.1200/JCO.2009.22.6126; Xie F, 2011, ULTRASOUND MED BIOL, V37, P280, DOI 10.1016/j.ultrasmedbio.2010.10.022; Xie F, 2009, JACC-CARDIOVASC IMAG, V2, P511, DOI 10.1016/j.jcmg.2009.02.002	22	19	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51453	10.1371/journal.pone.0051453	http://dx.doi.org/10.1371/journal.pone.0051453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251539	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200112
J	Lev, S; Desmarini, D; Chayakulkeeree, M; Sorrell, TC; Djordjevic, JT				Lev, Sophie; Desmarini, Desmarini; Chayakulkeeree, Methee; Sorrell, Tania C.; Djordjevic, Julianne T.			The Crz1/Sp1 Transcription Factor of Cryptococcus neoformans Is Activated by Calcineurin and Regulates Cell Wall Integrity	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; SIGNALING PATHWAY; INHIBITOR AGENTS; GENE-EXPRESSION; FULL VIRULENCE; GROWTH	Cryptococcus neoformans survives host temperature and regulates cell wall integrity via a calcium-dependent phosphatase, calcineurin. However, downstream effectors of C. neoformans calcineurin are largely unknown. In S. cerevisiae and other fungal species, a calcineurin-dependent transcription factor Crz1, translocates to nuclei upon activation and triggers expression of target genes. We now show that the C. neoformans Crz1 ortholog (Crz1/Sp1), previously identified as a protein kinase C target during starvation, is a bona fide target of calcineurin under non-starvation conditions, during cell wall stress and growth at high temperature. Both the calcineurin-defective mutant, Delta cna1, and a CRZ1/SP1 mutant (Delta crz1) were susceptible to cell wall perturbing agents. Furthermore, expression of the chitin synthase encoding gene, CHS6, was reduced in both mutants. We tracked the subcellular localization of Crz1-GFP in WT C. neoformans and Delta cna1 in response to different stimuli, in the presence and absence of the calcineurin inhibitor, FK506. Exposure to elevated temperature (30-37 degrees C vs 25 degrees C) and extracellular calcium caused calcineurin-dependent nuclear accumulation of Crz1-GFP. Unexpectedly, 1M salt and heat shock triggered calcineurin-independent Crz1-GFP sequestration within cytosolic and nuclear puncta. To our knowledge, punctate cytosolic distribution, as opposed to nuclear targeting, is a unique feature of C. neoformans Crz1. We conclude that Crz1 is selectively activated by calcium/calcineurin-dependent and independent signals depending on the environmental conditions.	[Lev, Sophie; Desmarini, Desmarini; Sorrell, Tania C.; Djordjevic, Julianne T.] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Westmead, NSW 2145, Australia; [Lev, Sophie; Desmarini, Desmarini; Sorrell, Tania C.; Djordjevic, Julianne T.] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Chayakulkeeree, Methee] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Mahidol University	Djordjevic, JT (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Westmead, NSW 2145, Australia.	julianne.djordjevic@sydney.edu.au	Sorrell, Tania/AAZ-5286-2020; Chayakulkeeree, Methee/AAT-8461-2020; Chayakulkeeree, Methee/W-2944-2019	Chayakulkeeree, Methee/0000-0002-4582-4914; Lev, Sophie/0000-0003-3511-457X; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115; Desmarini, Desmarini/0000-0001-9322-3198	University of Sydney; National Health and Medical Research Council of Australia; Sydney Medical School Foundation; SMS Foundation	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; SMS Foundation	This work was supported by a University of Sydney Bridging grant (for SL), a National Health and Medical Research Council of Australia grant and a Sydney Medical School Foundation Fellowship and grant from the SMS Foundation to the Sydney Institute for Emerging Infections and Biosecurity, University of Sydney (for TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobakar EF, 2011, EUKARYOT CELL; Adler A, 2011, J BIOL CHEM, V286, P20977, DOI 10.1074/jbc.M111.230268; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Cruz MC, 2000, ANTIMICROB AGENTS CH, V44, P143, DOI 10.1128/AAC.44.1.143-149.2000; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kim S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000909; Kontoyiannis DP, 2008, ANTIMICROB AGENTS CH, V52, P735, DOI 10.1128/AAC.00990-07; Kozubowski L, 2011, EUKARYOT CELL; Kozubowski L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025280; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Williams KE, 2001, EMBO J, V20, P3473, DOI 10.1093/emboj/20.13.3473; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x	39	60	63	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51403	10.1371/journal.pone.0051403	http://dx.doi.org/10.1371/journal.pone.0051403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251520	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200101
J	Mavromatis, K; Land, ML; Brettin, TS; Quest, DJ; Copeland, A; Clum, A; Goodwin, L; Woyke, T; Lapidus, A; Klenk, HP; Cottingham, RW; Kyrpides, NC				Mavromatis, Konstantinos; Land, Miriam L.; Brettin, Thomas S.; Quest, Daniel J.; Copeland, Alex; Clum, Alicia; Goodwin, Lynne; Woyke, Tanja; Lapidus, Alla; Klenk, Hans Peter; Cottingham, Robert W.; Kyrpides, Nikos C.			The Fast Changing Landscape of Sequencing Technologies and Their Impact on Microbial Genome Assemblies and Annotation	PLOS ONE			English	Article							GENERATION	Background: The emergence of next generation sequencing (NGS) has provided the means for rapid and high throughput sequencing and data generation at low cost, while concomitantly creating a new set of challenges. The number of available assembled microbial genomes continues to grow rapidly and their quality reflects the quality of the sequencing technology used, but also of the analysis software employed for assembly and annotation. Methodology/Principal Findings: In this work, we have explored the quality of the microbial draft genomes across various sequencing technologies. We have compared the draft and finished assemblies of 133 microbial genomes sequenced at the Department of Energy-Joint Genome Institute and finished at the Los Alamos National Laboratory using a variety of combinations of sequencing technologies, reflecting the transition of the institute from Sanger-based sequencing platforms to NGS platforms. The quality of the public assemblies and of the associated gene annotations was evaluated using various metrics. Results obtained with the different sequencing technologies, as well as their effects on downstream processes, were analyzed. Our results demonstrate that the Illumina HiSeq 2000 sequencing system, the primary sequencing technology currently used for de novo genome sequencing and assembly at JGI, has various advantages in terms of total sequence throughput and cost, but it also introduces challenges for the downstream analyses. In all cases assembly results although on average are of high quality, need to be viewed critically and consider sources of errors in them prior to analysis. Conclusion: These data follow the evolution of microbial sequencing and downstream processing at the JGI from draft genome sequences with large gaps corresponding to missing genes of significant biological role to assemblies with multiple small gaps (Illumina) and finally to assemblies that generate almost complete genomes (Illumina+PacBio).	[Mavromatis, Konstantinos; Copeland, Alex; Clum, Alicia; Woyke, Tanja; Lapidus, Alla; Kyrpides, Nikos C.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Land, Miriam L.; Brettin, Thomas S.; Quest, Daniel J.; Cottingham, Robert W.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Goodwin, Lynne] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Klenk, Hans Peter] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany	United States Department of Energy (DOE); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Mavromatis, K (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Land, Miriam L/A-6200-2011; Cottingham, Robert/D-2628-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Land, Miriam L/0000-0001-7102-0031; Cottingham, Robert/0000-0002-2775-3905; Mavrommatis, Konstantinos/0000-0003-4549-385X	US Department of Energy Office of Science, Biological and Environmental Research Program; University of California; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Oak Ridge National Laboratory [DE-AC05-00OR22725]	US Department of Energy Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Oak Ridge National Laboratory(United States Department of Energy (DOE))	This work was performed under the auspices of the US Department of Energy Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396, Oak Ridge National Laboratory under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elahi Elahe, 2004, Methods Mol Biol, V255, P211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Ribeiro F., 2012, GENOME RES; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112	19	112	114	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48837	10.1371/journal.pone.0048837	http://dx.doi.org/10.1371/journal.pone.0048837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251337	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200011
J	Medema-Wijnveen, JS; Onono, M; Bukusi, EA; Miller, S; Cohen, CR; Turan, JM				Medema-Wijnveen, Jose S.; Onono, Maricianah; Bukusi, Elizabeth A.; Miller, Suellen; Cohen, Craig R.; Turan, Janet M.			How Perceptions of HIV-Related Stigma Affect Decision-Making Regarding Childbirth in Rural Kenya	PLOS ONE			English	Article							MATERNITY CARE; SKILLED ATTENDANCE; HEALTH FACILITIES; HIV/AIDS STIGMA; PREGNANT-WOMEN; DELIVERY; BIRTH; DISCRIMINATION; ATTITUDES; TRANSMISSION	Introduction: HIV prevalence among pregnant women in Kenya is high. Furthermore, there is a high risk of maternal mortality, as many women do not give birth with a skilled healthcare provider. Previous research suggests that fears of HIV testing and unwanted disclosure of HIV status may be important barriers to utilizing maternity services. We explored relationships between women's perceptions of HIV-related stigma and their attitudes and intentions regarding facility-based childbirth. Methods: 1,777 pregnant women were interviewed at their first antenatal care visit. We included socio-demographic characteristics, stigma scales, HIV knowledge measures, and an 11-item scale measuring health facility birth attitudes (HFBA). HFBA includes items on cost, transport, comfort, interpersonal relations, and services during delivery at a health facility versus at home. A higher mean HFBA score indicates a more positive attitude towards facility-based childbirth. The mean HFBA score was dichotomized at the median and analyses were conducted with this dichotomized HFBA score using mixed effects logit models. Results: Women who anticipated HIV-related stigma from their male partner had lower adjusted odds of having positive attitudes about giving birth at the health facility (adjusted OR = .63, 95% CI 0.50-0.78) and less positive attitudes about health facility birth were strongly related to women's intention to give birth outside a health facility (adjusted OR = 5.56, 95% CI 2.69-11.51). Conclusions: In this sample of pregnant women in rural Kenya, those who anticipated HIV-related stigma were less likely to have positive attitudes towards facility-based childbirth. Furthermore, negative attitudes about facility-based childbirth were associated with the intention to deliver outside a health facility. Thus, HIV-related stigma reduction efforts might result in more positive attitudes towards facility-based childbirth, and thereby lead to an increased level of skilled birth attendance, and reductions in maternal and infant mortality.	[Medema-Wijnveen, Jose S.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Medema-Wijnveen, Jose S.; Bukusi, Elizabeth A.; Miller, Suellen; Cohen, Craig R.; Turan, Janet M.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Onono, Maricianah; Bukusi, Elizabeth A.] Kenya Med Res Inst KEMRI, Ctr Microbiol Res, Res Care & Training Program, Nairobi, Kenya; [Miller, Suellen; Cohen, Craig R.] Univ Calif San Francisco, Global Hlth Inst, Ctr Expertise Womens Hlth & Empowerment, San Francisco, CA 94143 USA; [Turan, Janet M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA	University of Groningen; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Medema-Wijnveen, JS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	j.s.wijnveen@umcg.nl		Turan, Janet/0000-0002-7802-6206	Marco Polo Fonds; Groninger Universiteitsfonds; J.K. de Cock Stichting; Hendrik Muller Vaderlandsch Fonds; National Institute of Mental Health (NIMH), National Institutes of Health (NIH) [K01MH081777]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH081777] Funding Source: NIH RePORTER	Marco Polo Fonds; Groninger Universiteitsfonds; J.K. de Cock Stichting; Hendrik Muller Vaderlandsch Fonds; National Institute of Mental Health (NIMH), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the Marco Polo Fonds, the Groninger Universiteitsfonds, the J.K. de Cock Stichting (www.decockstichting.nl) and the Hendrik Muller Vaderlandsch Fonds (www.mullerfonds.nl) for supporting the work of Jose Medema-Wijnveen. The project described was supported by Award Number K01MH081777 from the National Institute of Mental Health (NIMH), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Byamugisha R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-52; Danforth EJ, 2009, J HEALTH POPUL NUTR, V27, P696; Family Care International Kenya, 2007, TEST APPR INCR SKILL; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gage AJ, 1998, POP STUD-J DEMOG, V52, P21, DOI 10.1080/0032472031000150156; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Kasenga F, 2010, MIDWIFERY, V26, P27, DOI 10.1016/j.midw.2008.04.007; Kenya National Bureau of Statistics (KNBS) ICF Macro, 2010, DEM HLTH SURV 2008 2; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mbaruku G, 2009, INT J GYNECOL OBSTET, V107, P8, DOI 10.1016/j.ijgo.2009.05.008; Medema-Wijnveen JS, 2011, INT AIDS SOC C 2011; Miller S, 2003, INT J GYNECOL OBSTET, V82, P89, DOI 10.1016/S0020-7292(03)00148-6; Nangendo S. M., 2006, AFRICAN STUDIES MONO, V27, P145; NASCOP, 2002, NAT GUID PREV MOTH T; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P155; SPSS, 2008, SPSS WIND REL 16 0 2; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; StataCorp, 2019, STATA STAT SOFTWARE; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Switzer GE, 1999, SOC PSYCH PSYCH EPID, V34, P399, DOI 10.1007/s001270050161; Thorsen VC, 2008, DEV WORLD BIOETH, V8, P43, DOI 10.1111/j.1471-8847.2008.00227.x; Turan JM, 2008, AIDS CARE, V20, P938, DOI 10.1080/09540120701767224; Turan JM, 2008, JOGNN-J OBST GYN NEO, V37, P588, DOI 10.1111/j.1552-6909.2008.00281.x; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; Ujiji OA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-151; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Vittinghof E, 2005, ANONYMOUS REGRESSION; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2010, TRENDS MAT MORT 1990; Wild K, 2010, SOC SCI MED, V71, P2038, DOI 10.1016/j.socscimed.2010.09.012; World Health Organization, 1999, RED MAT MORT	45	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51492	10.1371/journal.pone.0051492	http://dx.doi.org/10.1371/journal.pone.0051492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251555	Green Published, gold			2022-12-25	WOS:000313236200122
J	Miller, KA; Williams, LH; Rose, E; Kuiper, M; Dahl, HHM; Manji, SSM				Miller, Kerry A.; Williams, Louise H.; Rose, Elizabeth; Kuiper, Michael; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.			Inner Ear Morphology Is Perturbed in Two Novel Mouse Models of Recessive Deafness	PLOS ONE			English	Article							MYOSIN VIIA GENE; ENU MUTAGENESIS; HEARING-LOSS; MOLECULAR-GENETICS; MUTATION; MYO7A; EXPRESSION; DOMAIN; PHENOTYPE; DYNAMICS	Human MYO7A mutations can cause a variety of conditions involving the inner ear. These include dominant and recessive non-syndromic hearing loss and syndromic conditions such as Usher syndrome. Mouse models of deafness allow us to investigate functional pathways involved in normal and abnormal hearing processes. We present two novel mouse models with mutations in the Myo7a gene with distinct phenotypes. The mutation in Myo7a(I487N/I487N) ewaso is located within the head motor domain of Myo7a. Mice exhibit a profound hearing loss and manifest behaviour associated with a vestibular defect. A mutation located in the linker region between the coiled-coil and the first MyTH4 domains of the protein is responsible in Myo7a(F947I/F947I) dumbo. These mice show a less severe hearing loss than in Myo7a(I487N/I487N) ewaso; their hearing loss threshold is elevated at 4 weeks old, and progressively worsens with age. These mice show no obvious signs of vestibular dysfunction, although scanning electron microscopy reveals a mild phenotype in vestibular stereocilia bundles. The Myo7a(F947I/F947I) dumbo strain is therefore the first reported Myo7a mouse model without an overt vestibular phenotype; a possible model for human DFNB2 deafness. Understanding the molecular basis of these newly identified mutations will provide knowledge into the complex genetic pathways involved in the maintenance of hearing, and will provide insight into recessively inherited sensorineural hearing loss in humans.	[Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Rose, Elizabeth; Manji, Shehnaaz S. M.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Otolaryngol, Melbourne, Vic, Australia; [Kuiper, Michael] Univ Melbourne, Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Univ Melbourne, HEARing CRC Audiol Hearing & Speech Sci, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Miller, KA (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	kerry.miller@mcri.edu.au			NHMRC [284550, 436944]; J. & J. Calvert-Jones; Victorian Government; HEARing CRC; Australian Government's Cooperative Research Centers Program	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones; Victorian Government; HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centers Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by NHMRC grants #284550 and #436944, J. & J. Calvert-Jones and the Victorian Government's Operational Infrastructure Support (OIS) Program. The authors acknowledge the financial support from the HEARing CRC, established and supported under the Australian Government's Cooperative Research Centers Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Ahituv N, 2002, TRENDS MOL MED, V8, P447, DOI 10.1016/S1471-4914(02)02388-2; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Avraham KB, 2003, EAR HEARING, V24, P332, DOI 10.1097/01.AUD.0000079840.96472.DB; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Caspary T, 2010, METHOD ENZYMOL, V477, P313, DOI 10.1016/S0076-6879(10)77016-6; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Hoyne GF, 2006, IMMUNOL REV, V210, P27, DOI 10.1111/j.0105-2896.2006.00363.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; KITAMURA K, 1991, ACTA OTO-LARYNGOL, V111, P61, DOI 10.3109/00016489109137355; KITAMURA K, 1992, ACTA OTO-LARYNGOL, V112, P622, DOI 10.3109/00016489209137451; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Luijendijk MWJ, 2004, HUM GENET, V115, P149, DOI 10.1007/s00439-004-1137-3; Manji SSM, 2011, AM J PATHOL, V179, P903, DOI 10.1016/j.ajpath.2011.04.002; Manji SSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017607; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Mburu Philomena, 1997, Genes and Function, V1, P191; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nolan Patrick M., 2002, Briefings in Functional Genomics & Proteomics, V1, P278, DOI 10.1093/bfgp/1.3.278; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piatto Vania B, 2005, Braz J Otorhinolaryngol, V71, P216; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reardon W, 1996, J MED GENET, V33, P1037, DOI 10.1136/jmg.33.12.1037; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51284	10.1371/journal.pone.0051284	http://dx.doi.org/10.1371/journal.pone.0051284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251483	Green Published, gold			2022-12-25	WOS:000313236200085
J	Pedersen, M; Pedersen, KK; Bruunsgaard, H; Krabbe, KS; Thomsen, C; Faerch, K; Pedersen, BK; Mortensen, EL				Pedersen, Maria; Pedersen, Karin Kaereby; Bruunsgaard, Helle; Krabbe, Karen Suarez; Thomsen, Carsten; Faerch, Kristine; Pedersen, Bente Klarlund; Mortensen, Erik Lykke			Cognitive Functions in Middle Aged Individuals Are Related to Metabolic Disturbances and Aerobic Capacity: A Cross-Sectional Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CENTRAL OBESITY; INCREASED RISK; DEMENTIA; SENSITIVITY; DYSFUNCTION; EXERCISE; PEOPLE	Aims: Metabolic disturbances may contribute to cognitive dysfunction in patients with type 2 diabetes. We investigated the relation between cognitive impairment and metabolic deteriorations, low physical fitness, low-grade inflammation and abdominal obesity in middle aged individuals. Methods: We conducted a cross-sectional study including 40 to 65 year-old patients with type 2 diabetes and limited co morbidity (N = 56), age-matched individuals with impaired glucose tolerance (N = 56) as well as age-matched controls with normal glucose tolerance (N = 72). Specific cognitive functions were assessed with focus on verbal memory, processing speed, executive functions, and a composite overall mean score. Oral glucose tolerance test, VO(2)max test, systemic inflammation, DXA scanning and abdominal MRI were measured. Results: Multiple linear regression analyses adjusting for age, gender and verbal intelligence demonstrated that a low score in processing speed, executive functions and overall cognitive function were related to high fasting C-peptide, as well as low insulin sensitivity, beta-cell function and VO(2)max. Measurements of blood glucose, obesity and inflammation were not associated with cognitive function. Conclusion: Low cognitive scores are seen in middle aged individuals with hyperinsulinemia, low insulin sensitivity, beta-cell function and low aerobic capacity. These findings emphasize the importance of appropriate lifestyle and not only blood glucose control in prevention of cognitive disability.	[Pedersen, Maria; Pedersen, Karin Kaereby; Bruunsgaard, Helle; Krabbe, Karen Suarez; Pedersen, Bente Klarlund] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Bruunsgaard, Helle] Univ Copenhagen, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Thomsen, Carsten] Univ Copenhagen, Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark; [Faerch, Kristine] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen	Pedersen, M (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark.	mariapedersen@dadlnet.dk	Bruunsgaard, Helle/AAY-3293-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Bruunsgaard, Helle/0000-0003-2330-0834; Pedersen, Bente Klarlund/0000-0001-6508-6288; Faerch, Kristine/0000-0002-6127-0448; Mortensen, Erik Lykke/0000-0002-6985-451X	Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55)(http://www.dg.dk/en/). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation (http://foodfitnesspharma.ku.dk/). CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724) (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aastrand, 1986, TXB WORK PHYSL; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Angevaren M, 2008, COCHRANE DATABASE SY; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Cooray G, 2011, PSYCHONEUROENDOCRINO, V36, P77, DOI 10.1016/j.psyneuen.2010.06.009; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060; Hartmann P, 2007, WAIS IIIDK WECHSLER; International Diabetes Federation (IDF), 2006, DEF DIAGN DIAB MELL; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lennon OC, 2012, DISABIL REHABIL, V34, P1149, DOI 10.3109/09638288.2011.635748; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Miles WR, 1922, ARCH INTERN MED, V30, P767, DOI 10.1001/archinte.1922.00110120086003; Mortensen EL, 2011, GEROPSYCHOLOGY PSYCH, P65; Nelson HE., 1982, NATL ADULT READING T; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V109, P96, DOI 10.1046/j.0001-690X.2003.00231.x; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen BK, 2012, NAT REV ENDOCRINOL, V10; Pradhan A, 2007, NUTR REV, V65, pS152, DOI [10.1111/j.1753-4887.2007.tb00354.x, 10.1301/nr.2007.dec.S152-S156]; Ryan CM, 2000, DIABETES CARE, V23, P1486, DOI 10.2337/diacare.23.10.1486; Sommerfield AJ, 2004, DIABETES CARE, V27, P2335, DOI 10.2337/diacare.27.10.2335; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263	40	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51132	10.1371/journal.pone.0051132	http://dx.doi.org/10.1371/journal.pone.0051132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251434	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200060
J	Winbanks, CE; Beyer, C; Qian, HW; Gregorevic, P				Winbanks, Catherine E.; Beyer, Claudia; Qian, Hongwei; Gregorevic, Paul			Transduction of Skeletal Muscles with Common Reporter Genes Can Promote Muscle Fiber Degeneration and Inflammation	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; DUCHENNE MUSCULAR-DYSTROPHY; IMMUNE-RESPONSES; EFFICIENT TRANSDUCTION; VIRAL VECTORS; IN-VIVO; EXPRESSION; AAV; DELIVERY; CONSTRUCTS	Recombinant adeno-associated viral vectors (rAAV vectors) are promising tools for delivering transgenes to skeletal muscle, in order to study the mechanisms that control the muscle phenotype, and to ameliorate diseases that perturb muscle homeostasis. Many studies have employed rAAV vectors carrying reporter genes encoding for beta-galactosidase (beta-gal), human placental alkaline phosphatase (hPLAP), and green fluorescent protein (GFP) as experimental controls when studying the effects of manipulating other genes. However, it is not clear to what extent these reporter genes can influence signaling and gene expression signatures in skeletal muscle, which may confound the interpretation of results obtained in experimentally manipulated muscles. Herein, we report a strong pro-inflammatory effect of expressing reporter genes in skeletal muscle. Specifically, we show that the administration of rAAV6:hPLAP vectors to the hind limb muscles of mice is associated with dose-and time-dependent macrophage recruitment, and skeletal muscle damage. Dose-dependent expression of hPLAP also led to marked activity of established pro-inflammatory IL-6/Stat3, TNF alpha, IKK beta and JNK signaling in lysates obtained from homogenized muscles. These effects were independent of promoter type, as expression cassettes featuring hPLAP under the control of constitutive CMV and muscle-specific CK6 promoters both drove cellular responses when matched for vector dose. Importantly, the administration of rAAV6: GFP vectors did not induce muscle damage or inflammation except at the highest doses we examined, and administration of a transgene-null vector (rAAV6:MCS) did not cause damage or inflammation at any of the doses tested, demonstrating that GFP-expressing, or transgene-null vectors may be more suitable as experimental controls. The studies highlight the importance of considering the potential effects of reporter genes when designing experiments that examine gene manipulation in vivo.	[Winbanks, Catherine E.; Beyer, Claudia; Qian, Hongwei; Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic, Australia; [Gregorevic, Paul] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Gregorevic, Paul] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; University of Washington; University of Washington Seattle; Monash University; University of Melbourne	Gregorevic, P (corresponding author), Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic, Australia.	paul.gregorevic@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021	Gregorevic, Paul/0000-0002-7418-8945	National Health & Medical Research Council, Australia [526648, 586649]; Muscular Dystrophy Association, United States of America [69684]; Pfizer Australia; Operational Infrastructure Support Program of the Victorian Government	National Health & Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Muscular Dystrophy Association, United States of America(Muscular Dystrophy Association); Pfizer Australia(PfizerPfizer Australia); Operational Infrastructure Support Program of the Victorian Government	This work was supported by funding from the National Health & Medical Research Council, Australia (grants# 526648 and 586649, http://www.nhmrc.gov.au/) and from the Muscular Dystrophy Association, United States of America (grant# 69684, http://mdausa.org/) awarded to PG. PG is supported by a Senior Research Fellowship sponsored by Pfizer Australia (http://www.pfizer.com.au/sites/au/research_and_development/Pages/default.aspx). The Baker IDI Heart & Diabetes Institute is supported in part by the Operational Infrastructure Support Program of the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoli M, 2006, GENE THER, V13, P20, DOI 10.1038/sj.gt.3302594; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Brockstedt DG, 1999, CLIN IMMUNOL, V92, P67, DOI 10.1006/clim.1999.4724; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Dressman D, 2002, HUM GENE THER, V13, P1631, DOI 10.1089/10430340260201725; Ghosh A, 2011, HUM GENE THER, V22, P77, DOI 10.1089/hum.2010.122; Gonin P, 2005, J GENE MED, V7, P782, DOI 10.1002/jgm.716; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Gregorevic P, 2009, MOL THER, V17, P1427, DOI 10.1038/mt.2009.116; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hartigan-O'Connor D, 2001, MOL THER, V4, P525, DOI 10.1006/mthe.2001.0496; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; Manning WC, 1997, J VIROL, V71, P7960, DOI 10.1128/JVI.71.10.7960-7962.1997; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Ohshima S, 2009, MOL THER, V17, P73, DOI 10.1038/mt.2008.225; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rasband W., 2006, IMAGEJ; Ren C, 2005, HUM GENE THER, V16, P1047, DOI 10.1089/hum.2005.16.1047; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sarukhan A, 2001, J VIROL, V75, P269, DOI 10.1128/JVI.75.1.269-277.2001; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Subramanian IV, 2009, J CARDIOVASC TRANSL, V2, P81, DOI 10.1007/s12265-008-9063-8; Vandenberghe LH, 2007, CURR GENE THER, V7, P325, DOI 10.2174/156652307782151416; Wang LX, 2005, BLOOD, V105, P4226, DOI 10.1182/blood-2004-03-0848; Wang MP, 2001, GENE, V279, P99, DOI 10.1016/S0378-1119(01)00754-5; Wang ZJ, 2007, HUM GENE THER, V18, P18, DOI 10.1089/hum.2006.093; Wang ZJ, 2010, MOL THER, V18, P617, DOI 10.1038/mt.2009.294; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Winbanks CE, 2012, J CELL BIOL; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51627	10.1371/journal.pone.0051627	http://dx.doi.org/10.1371/journal.pone.0051627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251598	Green Published, gold			2022-12-25	WOS:000313236200150
J	Lussier, YA; Khodarev, NN; Regan, K; Corbin, K; Li, HQ; Ganai, S; Khan, SA; Gnerlich, J; Darga, TE; Fan, HL; Karpenko, O; Paty, PB; Posner, MC; Chmura, SJ; Hellman, S; Ferguson, MK; Weichselbaum, RR				Lussier, Yves A.; Khodarev, Nikolai N.; Regan, Kelly; Corbin, Kimberly; Li, Haiquan; Ganai, Sabha; Khan, Sajid A.; Gnerlich, Jennifer; Darga, Thomas E.; Fan, Hanli; Karpenko, Oleksiy; Paty, Philip B.; Posner, Mitchell C.; Chmura, Steven J.; Hellman, Samuel; Ferguson, Mark K.; Weichselbaum, Ralph R.			Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs	PLOS ONE			English	Article							BODY RADIATION-THERAPY; GERM-CELL TUMORS; PULMONARY METASTASES; COLORECTAL-CANCER; HEPATIC RESECTION; EXPRESSION; GENE; PHASE; SIGNATURES; PATHOGENESIS	Rationale: Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed oligometastasis(es) characterized by limited progression has been proposed. Oligometastases are amenable to treatment by surgical resection or radiotherapy. Methods: We analyzed microRNA expression patterns from lung metastasis samples of patients with <= 5 initial metastases resected with curative intent. Results: Patients were stratified into subgroups based on their rate of metastatic progression. We prioritized microRNAs between patients with the highest and lowest rates of recurrence. We designated these as high rate of progression (HRP) and low rate of progression (LRP); the latter group included patients with no recurrences. The prioritized microRNAs distinguished HRP from LRP and were associated with rate of metastatic progression and survival in an independent validation dataset. Conclusion: Oligo-and poly-metastasis are distinct entities at the clinical and molecular level.	[Lussier, Yves A.; Weichselbaum, Ralph R.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Ctr Biomed Informat, Dept Med, Chicago, IL 60637 USA; [Lussier, Yves A.; Khodarev, Nikolai N.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Lussier, Yves A.; Regan, Kelly; Li, Haiquan; Fan, Hanli] Univ Illinois, Dept Med, Chicago, IL USA; [Lussier, Yves A.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Lussier, Yves A.; Karpenko, Oleksiy] Univ Illinois, Ctr Intervent Hlth Informat, Chicago, IL USA; [Lussier, Yves A.] Univ Illinois, Ctr Canc, Chicago, IL USA; [Khodarev, Nikolai N.; Corbin, Kimberly; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Ganai, Sabha; Khan, Sajid A.; Gnerlich, Jennifer; Darga, Thomas E.; Posner, Mitchell C.; Ferguson, Mark K.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center	Lussier, YA (corresponding author), Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA.	yLussier@uic.edu; rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022; Lussier, Yves/N-4891-2017; Chmura, Steven Joseph/ACU-8438-2022; , haiquan/H-3507-2019; Ganai, Sabha/M-8022-2016	Lussier, Yves/0000-0001-9854-1005; , haiquan/0000-0002-8049-0278; Ganai, Sabha/0000-0001-6160-3559; Darga, Thomas/0000-0002-8968-6701; Regan-Fendt, Kelly/0000-0002-7033-6787	Ludwig Center for Metastasis Research Grant; Center for Radiation Therapy; Chicago Tumor Institute; Ludwig Foundation for Cancer Research; Foglia Foundation; Lung Cancer Research Foundation; Cancer Research Foundation; Institutes of Health (NIH) [K22 LM008308-04, 5UL1RR024999-04]; University of Chicago Comprehensive Cancer Center [5P30CA014599-35]; University of Illinois Cancer Center; University of Illinois Center for Clinical and Translational Science [UL1RR029879]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999, UL1RR029879] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Ludwig Center for Metastasis Research Grant; Center for Radiation Therapy; Chicago Tumor Institute; Ludwig Foundation for Cancer Research; Foglia Foundation; Lung Cancer Research Foundation; Cancer Research Foundation; Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; University of Illinois Cancer Center; University of Illinois Center for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Ludwig Center for Metastasis Research Grant, the Center for Radiation Therapy, the Chicago Tumor Institute, The Ludwig Foundation for Cancer Research, Mr. and Mrs. Vincent Foglia and the Foglia Foundation, Lung Cancer Research Foundation, the Cancer Research Foundation and the following National Institutes of Health (NIH) Grants: K22 LM008308-04, 5UL1RR024999-04, University of Chicago Comprehensive Cancer Center (5P30CA014599-35), the University of Illinois Cancer Center, and the University of Illinois Center for Clinical and Translational Science (UL1RR029879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Brown RE, 2010, SURG CLIN N AM, V90, P839, DOI 10.1016/j.suc.2010.04.012; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Capulli M, 2012, J BONE MINER RES, V27, P2387, DOI 10.1002/jbmr.1686; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, CANCER-AM CANCER SOC, V40, P46, DOI 10.1002/1097-0142(197707)40:1<46::AID-CNCR2820400110>3.0.CO;2-T; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Garcia-Yuste M, 2010, J THORAC ONCOL, V5, pS161, DOI 10.1097/JTO.0b013e3181dcf787; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta N, 2006, CLIN CANCER RES, V12, P3115, DOI 10.1158/1078-0432.CCR-05-0513; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lee JH, 1997, CANCER RES, V57, P2384; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lussier YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028650; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Metha N, 2004, INT J ONCOL, V25, P1677; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Nichols FC, 2012, THORAC SURG CLIN, V22, P91, DOI 10.1016/j.thorsurg.2011.08.017; NICHOLSON BJ, 1985, IEEE T RELIAB, V34, P227, DOI 10.1109/TR.1985.5222126; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Saxman SB, 1998, J CLIN ONCOL, V16, P702, DOI 10.1200/JCO.1998.16.2.702; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sousa JF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-19; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang XA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002350	48	158	163	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50141	10.1371/journal.pone.0050141	http://dx.doi.org/10.1371/journal.pone.0050141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251360	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900007
J	Wojcik, EA; Brzostek, A; Bacolla, A; Mackiewicz, P; Vasquez, KM; Korycka-Machala, M; Jaworski, A; Dziadek, J				Wojcik, Ewelina A.; Brzostek, Anna; Bacolla, Albino; Mackiewicz, Pawel; Vasquez, Karen M.; Korycka-Machala, Malgorzata; Jaworski, Adam; Dziadek, Jaroslaw			Direct and Inverted Repeats Elicit Genetic Instability by Both Exploiting and Eluding DNA Double-Strand Break Repair Systems in Mycobacteria	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; REPLICATION PROTEIN REPB; ESCHERICHIA-COLI; PLASMID PAL5000; HUMAN-DISEASE; CHROMOSOMAL TRANSLOCATIONS; MOLECULAR-BIOLOGY; TRIPLET REPEATS; OPEN SOFTWARE; HUMAN-CELLS	Repetitive DNA sequences with the potential to form alternative DNA conformations, such as slipped structures and cruciforms, can induce genetic instability by promoting replication errors and by serving as a substrate for DNA repair proteins, which may lead to DNA double-strand breaks (DSBs). However, the contribution of each of the DSB repair pathways, homologous recombination (HR), non-homologous end-joining (NHEJ) and single-strand annealing (SSA), to this sort of genetic instability is not fully understood. Herein, we assessed the genome-wide distribution of repetitive DNA sequences in the Mycobacterium smegmatis, Mycobacterium tuberculosis and Escherichia coli genomes, and determined the types and frequencies of genetic instability induced by direct and inverted repeats, both in the presence and in the absence of HR, NHEJ, and SSA. All three genomes are strongly enriched in direct repeats and modestly enriched in inverted repeats. When using chromosomally integrated constructs in M. smegmatis, direct repeats induced the perfect deletion of their intervening sequences similar to 1,000-fold above background. Absence of HR further enhanced these perfect deletions, whereas absence of NHEJ or SSA had no influence, suggesting compromised replication fidelity. In contrast, inverted repeats induced perfect deletions only in the absence of SSA. Both direct and inverted repeats stimulated excision of the constructs from the attB integration sites independently of HR, NHEJ, or SSA. With episomal constructs, direct and inverted repeats triggered DNA instability by activating nucleolytic activity, and absence of the DSB repair pathways (in the order NHEJ>HR>SSA) exacerbated this instability. Thus, direct and inverted repeats may elicit genetic instability in mycobacteria by 1) directly interfering with replication fidelity, 2) stimulating the three main DSB repair pathways, and 3) enticing L5 site-specific recombination.	[Wojcik, Ewelina A.; Brzostek, Anna; Korycka-Machala, Malgorzata; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Wojcik, Ewelina A.; Jaworski, Adam] Univ Lodz, Inst Microbiol & Immunol, Dept Genet Microorganisms, PL-90131 Lodz, Poland; [Bacolla, Albino; Vasquez, Karen M.] Univ Texas Austin, Div Pharmacol & Toxicol, Dell Pediat Res Inst, Austin, TX 78712 USA; [Mackiewicz, Pawel] Univ Wroclaw, Dept Genom, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Texas System; University of Texas Austin; University of Wroclaw	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Bacolla, Albino/AAP-1727-2020; Bacolla, Albino/N-3877-2013	Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Wojcik, Ewelina/0000-0002-9743-9268; Dziadek, Jaroslaw/0000-0003-1427-884X	State Committee for Scientific Research [N303 3582 33]; European Regional Development Fund under the Operational Programme Innovative Economy [POIG.01.01.02-10-107/09]; National Cancer Institute/National Institutes of Health [HHSN261200800001E, CA093729]; European Social Fund; national budget of Poland; NATIONAL CANCER INSTITUTE [R01CA093729] Funding Source: NIH RePORTER	State Committee for Scientific Research(Polish State Committee for Scientific Research); European Regional Development Fund under the Operational Programme Innovative Economy; National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Social Fund(European Social Fund (ESF)); national budget of Poland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the State Committee for Scientific Research (contract N303 3582 33), European Regional Development Fund under the Operational Programme Innovative Economy, grant POIG.01.01.02-10-107/09, and in part from the National Cancer Institute/National Institutes of Health contract HHSN261200800001E and CA093729. E. W. was partially supported by the European Social Fund and the national budget of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Basu A, 2002, J BACTERIOL, V184, P2204, DOI 10.1128/JB.184.8.2204-2214.2002; Basu A, 2012, J BACTERIOL, V194, P1331, DOI 10.1128/JB.06218-11; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; BOWATER RP, 1994, BIOCHEMISTRY-US, V33, P9266, DOI 10.1021/bi00197a030; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Caimi K, 2004, COMP FUNCT GENOM, V5, P116, DOI 10.1002/cfg.380; Campbell NH, 2009, BIOCHEMISTRY-US, V48, P1675, DOI 10.1021/bi802233v; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Dahle UR, 2003, J CLIN MICROBIOL, V41, P2968, DOI 10.1128/JCM.41.7.2968-2973.2003; DAYN A, 1992, NUCLEIC ACIDS RES, V20, P5991, DOI 10.1093/nar/20.22.5991; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dennehy M, 2005, VACCINE, V23, P1209, DOI 10.1016/j.vaccine.2004.08.039; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Griffin S, 2009, TUBERCULOSIS, V89, P225, DOI 10.1016/j.tube.2009.03.006; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; JAWORSKI A, 1989, J MOL BIOL, V207, P513, DOI 10.1016/0022-2836(89)90461-0; Kha DT, 2010, J MOL BIOL, V398, P471, DOI 10.1016/j.jmb.2010.03.035; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; Krishna R, 2007, J MOL BIOL, V367, P1130, DOI 10.1016/j.jmb.2007.01.058; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kurahashi H, 2006, CELL CYCLE, V5, P1297, DOI 10.4161/cc.5.12.2809; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lewis JA, 2003, J MOL BIOL, V326, P805, DOI 10.1016/S0022-2836(02)01475-4; Lin YF, 2011, CELL CYCLE, V10, P611, DOI 10.4161/cc.10.4.14729; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Madiraju MVVS, 2000, LETT APPL MICROBIOL, V30, P38, DOI 10.1046/j.1472-765x.2000.00619.x; Majchrzak M, 2006, J MOL BIOL, V364, P612, DOI 10.1016/j.jmb.2006.08.093; MCDONALD JP, 1994, GENETICS, V137, P393; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Muttucumaru DGN, 2004, CURR ISSUES MOL BIOL, V6, P145; Napierala M, 2005, J BIOL CHEM, V280, P37366, DOI 10.1074/jbc.M508065200; Oh DB, 2002, P NATL ACAD SCI USA, V99, P16666, DOI 10.1073/pnas.262672699; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Raghavan SC, 2004, CELL CYCLE, V3, P762; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seier T, 2011, GENETICS, V188, P247, DOI 10.1534/genetics.111.127746; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinden RR, 1999, ANN NY ACAD SCI, V870, P173, DOI 10.1111/j.1749-6632.1999.tb08878.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Springer B, 2001, INT J MED MICROBIOL, V290, P669; Sreenu VB, 2007, J BIOSCIENCES, V32, P3, DOI 10.1007/s12038-007-0002-7; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stolt P, 1997, NUCLEIC ACIDS RES, V25, P3840, DOI 10.1093/nar/25.19.3840; Voineagu I, 2009, MOL CARCINOGEN, V48, P309, DOI 10.1002/mc.20512; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang XM, 2008, TUBERCULOSIS, V88, P399, DOI 10.1016/j.tube.2008.02.003; WELLS R D, 1974, P41; Wells R.D., 2006, GENETIC INSTABILITIE; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1997, AM J PSYCHIAT, V154, P887; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	93	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51064	10.1371/journal.pone.0051064	http://dx.doi.org/10.1371/journal.pone.0051064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251422	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900036
J	Roff, AN; Panganiban, RP; Bond, JS; Ishmael, FT				Roff, Alanna N.; Panganiban, Ronaldo P.; Bond, Judith S.; Ishmael, Faoud T.			Post-transcriptional Regulation of Meprin alpha by the RNA-binding Proteins Hu Antigen R (HuR) and Tristetraprolin (TTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; AU-RICH ELEMENTS; METALLOPROTEASE MEPRIN; GENE; EXPRESSION; SUBUNIT; IDENTIFICATION; TRANSMEMBRANE; TRANSCRIPTOME; SECRETION	Meprins are multimeric proteases that are implicated in inflammatory bowel disease by both genetic association studies and functional studies in knock-out mice. Patients with inflammatory bowel disease show decreased colonic expression of meprin alpha, although regulation of expression, particularly under inflammatory stimuli, has not been studied. The studies herein demonstrate that the human meprin alpha transcript is bound and stabilized by Hu antigen R at baseline, and that treatment with the inflammatory stimulus phorbol 12-myristate 13-acetate downregulates meprin alpha expression by inducing tristetraprolin. The enhanced binding of tristetraprolin to the MEP1A 3'-UTR results in destabilization of the transcript and occurs at a discrete site from Hu antigen R. This is the first report to describe a mechanism for post-transcriptional regulation of meprin alpha and will help clarify the role of meprins in the inflammatory response and disease.	[Roff, Alanna N.; Bond, Judith S.; Ishmael, Faoud T.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Panganiban, Ronaldo P.; Ishmael, Faoud T.] Penn State Univ, Sect Allergy & Immunol, Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ishmael, FT (corresponding author), Penn State Univ, Dept Med, Coll Med, 500 Univ Dr,Mail Code H171, Hershey, PA 17033 USA.	fishmael@hmc.psu.edu		Panganiban, Ronaldo/0000-0002-5626-3147	NIH [1K08HL114100-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL114100] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by institutional funds and NIH Grant 1K08HL114100-01 (to F. T. I.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brown JF, 1999, AM J PHYSIOL-GASTR L, V276, pG583, DOI 10.1152/ajpgi.1999.276.3.G583; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; FRETLAND DJ, 1990, INFLAMMATION, V14, P143, DOI 10.1007/BF00917453; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jang SI, 2006, LIFE SCI, V78, P2937, DOI 10.1016/j.lfs.2005.11.020; Jiang WP, 2000, ARCH BIOCHEM BIOPHYS, V379, P183, DOI 10.1006/abbi.2000.1873; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Meisner NC, 2009, J MOL BIOL, V386, P435, DOI 10.1016/j.jmb.2008.12.020; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tsukuba T, 2002, ARCH BIOCHEM BIOPHYS, V397, P191, DOI 10.1006/abbi.2001.2672; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Villa JP, 2003, BIOCHEM SOC SYMP, V70, P53, DOI 10.1042/bss0700053; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008	58	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4733	4743		10.1074/jbc.M112.444208	http://dx.doi.org/10.1074/jbc.M112.444208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269677	Green Published, hybrid			2022-12-25	WOS:000315340400022
J	Jaiswal, M; Dvorsky, R; Ahmadian, MR				Jaiswal, Mamta; Dvorsky, Radovan; Ahmadian, Mohammad Reza			Deciphering the Molecular and Functional Basis of Dbl Family Proteins A NOVEL SYSTEMATIC APPROACH TOWARD CLASSIFICATION OF SELECTIVE ACTIVATION OF THE Rho FAMILY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; RAS; DOMAIN; COMPLEX; RAC1; GEFS; MECHANISM	The diffuse B-cell lymphoma (Dbl) family of the guanine nucleotide exchange factors is a direct activator of the Rho family proteins. The Rho family proteins are involved in almost every cellular process that ranges from fundamental (e.g. the establishment of cell polarity) to highly specialized processes (e. g. the contraction of vascular smooth muscle cells). Abnormal activation of the Rho proteins is known to play a crucial role in cancer, infectious and cognitive disorders, and cardiovascular diseases. However, the existence of 74 Dbl proteins and 25 Rho-related proteins in humans, which are largely uncharacterized, has led to increasing complexity in identifying specific upstream pathways. Thus, we comprehensively investigated sequence-structure-function-property relationships of 21 representatives of the Dbl protein family regarding their specificities and activities toward 12 Rho family proteins. The meta-analysis approach provides an unprecedented opportunity to broadly profile functional properties of Dbl family proteins, including catalytic efficiency, substrate selectivity, and signaling specificity. Our analysis has provided novel insights into the following: (i) understanding of the relative differences of various Rho protein members in nucleotide exchange; (ii) comparing and defining individual and overall guanine nucleotide exchange factor activities of a large representative set of the Dbl proteins toward 12 Rho proteins; (iii) grouping the Dbl family into functionally distinct categories based on both their catalytic efficiencies and their sequence-structural relationships; (iv) identifying conserved amino acids as fingerprints of the Dbl and Rho protein interaction; and (v) defining amino acid sequences conserved within, but not between, Dbl subfamilies. Therefore, the characteristics of such specificity-determining residues identified the regions or clusters conserved within the Dbl subfamilies.	[Jaiswal, Mamta; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	jaiswal, mamta/E-5148-2016; Dvorsky, Radovan/ABE-3042-2020	jaiswal, mamta/0000-0002-5862-7506; 	Deutsche Forschungsgemeinschaft [AH 92/5-1, SFB 974]; Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program) [01GS08100]; Research Committee of the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf [F-2012/79-6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program); Research Committee of the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AH 92/5-1 and SFB 974, Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program) Grant 01GS08100, and the Research Committee of the Strategic Research Fund (SFF) Grant F-2012/79-6 of the Heinrich-Heine University Dusseldorf.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Cheng L, 2002, MOL CELL BIOL, V22, P6895, DOI 10.1128/MCB.22.19.6895-6905.2002; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Garavini H, 2002, BIOCHEMISTRY-US, V41, P6303, DOI 10.1021/bi025651h; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Gu Y, 2005, CELL CYCLE, V4, P201; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Hwang HS, 2011, J CELL BIOL, V195, P377, DOI 10.1083/jcb.201106138; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kostenko EV, 2006, MOL CELL BIOL, V26, P8964, DOI 10.1128/MCB.00670-06; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Loirand G, 2008, CURR OPIN PHARMACOL, V8, P174, DOI 10.1016/j.coph.2007.12.006; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marinissen MJ, 2005, TRENDS BIOCHEM SCI, V30, P423, DOI 10.1016/j.tibs.2005.06.006; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mulinari Shai, 2010, Small GTPases, V1, P28; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nimnual Anjaruwee, 2002, Sci STKE, V2002, ppe36, DOI 10.1126/stke.2002.145.pe36; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rittinger K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe63; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	91	64	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4486	4500		10.1074/jbc.M112.429746	http://dx.doi.org/10.1074/jbc.M112.429746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255595	Green Published, hybrid			2022-12-25	WOS:000314845000074
J	Manhart, CM; McHenry, CS				Manhart, Carol M.; McHenry, Charles S.			The PriA Replication Restart Protein Blocks Replicase Access Prior to Helicase Assembly and Directs Template Specificity through Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; COORDINATED LEADING-STRAND; INITIATION; PRIMOSOME; HOLOENZYME; REPLISOME; FORK; PURIFICATION; MUTANTS; COMPLEX	The PriA protein serves as an initiator for the restart of DNA replication on stalled replication forks and as a checkpoint protein that prevents the replicase from advancing in a strand displacement reaction on forks that do not contain a functional replicative helicase. We have developed a primosomal protein-dependent fluorescence resonance energy transfer (FRET) assay using a minimal fork substrate composed of synthetic oligonucleotides. We demonstrate that a self-loading reaction, which proceeds at high helicase concentrations, occurs by threading of a preassembled helicase over free 5'-ends, an event that can be blocked by attaching a steric block to the 5'-end or coating DNA with single-stranded DNA binding protein. The specificity of PriA for replication forks is regulated by its intrinsic ATPase. ATPase-defective PriA K230R shows a strong preference for substrates that contain no gap between the leading strand and the duplex portion of the fork, as demonstrated previously. Wild-type PriA prefers substrates with larger gaps, showing maximal activity on substrates on which PriA K230R is inactive. We demonstrate that PriA blocks replicase function on forks by blocking its binding.	[Manhart, Carol M.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave,UCB596, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	Manhart, Carol/AAQ-4938-2020		National Science Foundation [MCB-0919961]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0919961 from the National Science Foundation.	BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dallmann HG, 2010, BIOCHEMISTRY-US, V49, P2551, DOI 10.1021/bi9020764; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HOUSTON P, 1994, P NATL ACAD SCI USA, V91, P5471, DOI 10.1073/pnas.91.12.5471; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McHenry CS, 2011, EMBO REP, V12, P408, DOI 10.1038/embor.2011.51; MOK M, 1987, J BIOL CHEM, V262, P16644; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; WU CA, 1992, J BIOL CHEM, V267, P4030; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	45	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3989	3999		10.1074/jbc.M112.435966	http://dx.doi.org/10.1074/jbc.M112.435966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264623	hybrid, Green Published			2022-12-25	WOS:000314845000028
J	Murphy, EJ; Booth, JC; Davrazou, F; Port, AM; Jones, DNM				Murphy, Emma J.; Booth, Jamie C.; Davrazou, Foteini; Port, Alex M.; Jones, David N. M.			Interactions of Anopheles gambiae Odorant-binding Proteins with a Human-derived Repellent IMPLICATIONS FOR THE MODE OF ACTION OF N,N-DIETHYL-3-METHYLBENZAMIDE (DEET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING; INSECT REPELLENTS; CRYSTAL-STRUCTURE; LIGAND-BINDING; GYPSY-MOTH; NMR STRUCTURE; RELEASE; MECHANISM; MOSQUITOS; SENSITIVITY	The Anopheles gambiae mosquito, which is the vector for Plasmodium falciparum malaria, uses a series of olfactory cues emanating from human sweat to select humans as their source for a blood meal. Perception of these odors within the mosquito olfactory system involves the interplay of odorant-binding proteins (OBPs) and odorant receptors and disrupting the normal responses to those odorants that guide mosquito-human interactions represents an attractive approach to prevent the transmission of malaria. Previously, it has been shown that DEET targets multiple components of the olfactory system, including OBPs and odorant receptors. Here, we present the crystal structure of A. gambiae OBP1 (OBP1) in the complex it forms with a natural repellent 6-methyl-5-heptene-2-one (6-MH). We find that 6-MH binds to OBP1 at exactly the same site as DEET. However, key interactions with a highly conserved water molecule that are proposed to be important for DEET binding are not involved in binding of 6-MH. We show that 6-MH and DEET can compete for the binding of attractive odorants and in doing so disrupt the interaction that OBP1 makes with OBP4. We further show that 6-MH and DEET can bind simultaneously to OBPs with other ligands. These results suggest that the successful discovery of novel reagents targeting OBP function requires knowledge about the specific mechanism of binding to the OBP rather than their binding affinity.	[Murphy, Emma J.; Davrazou, Foteini; Port, Alex M.; Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Booth, Jamie C.; Jones, David N. M.] Univ Colorado, Sch Med, Program Struct Biol & Biophys, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, DNM (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	david.jones@ucdenver.edu	Jones, David N/C-5764-2013	Murphy, Emma/0000-0003-4551-8068	National Institutes of Health [DC008834]; Program in Structural Biology and Biophysics; University of Colorado Cancer Center (National Institutes of Health) [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program in Structural Biology and Biophysics; University of Colorado Cancer Center (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008834 (to D. N. M. J.).; We thank Dr. Jay Nix for assistance in x-ray data collection; and Patrick Jones, Jason Pitts, and Dr. Larry Zwiebel for A. gambiae cDNA libraries. Operation of the x-ray crystallography and NMR spectroscopy facilities at University of Colorado School of Medicine is supported by the Program in Structural Biology and Biophysics, and the University of Colorado Cancer Center (National Institutes of Health Grant P30-CA046934).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; Crawford JE, 2010, MOL BIOL EVOL, V27, P1739, DOI 10.1093/molbev/msq070; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; RUTLEDGE LC, 1978, J MED ENTOMOL, V14, P536, DOI 10.1093/jmedent/14.5.536; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; VOGT RG, 1989, J NEUROSCI, V9, P3332; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	54	30	34	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4475	4485		10.1074/jbc.M112.436386	http://dx.doi.org/10.1074/jbc.M112.436386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23261834	Green Published, hybrid			2022-12-25	WOS:000314845000073
J	Tasseva, G; Bai, HD; Davidescu, M; Haromy, A; Michelakis, E; Vance, JE				Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Haromy, Alois; Michelakis, Evangelos; Vance, Jean E.			Phosphatidylethanolamine Deficiency in Mammalian Mitochondria Impairs Oxidative Phosphorylation and Alters Mitochondrial Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; YEAST MITOCHONDRIA; BARTH-SYNDROME; CARDIOLIPIN BIOSYNTHESIS; EMBRYONIC-DEVELOPMENT; PROTEOLYTIC CLEAVAGE	Mitochondrial dysfunction is implicated in neurodegenerative, cardiovascular, and metabolic disorders, but the role of phospholipids, particularly the nonbilayer-forming lipid phosphatidylethanolamine (PE), in mitochondrial function is poorly understood. Elimination of mitochondrial PE (mtPE) synthesis via phosphatidylserine decarboxylase in mice profoundly alters mitochondrial morphology and is embryonic lethal (Steen-bergen, R., Nanowski, T. S., Beigneux, A., Kulinski, A., Young, S. G., and Vance, J. E. (2005) J. Biol. Chem. 280, 40032-40040). We now report that moderate <30% depletion of mtPE alters mitochondrial morphology and function and impairs cell growth. Acute reduction of mtPE by RNAi silencing of phosphatidylserine decarboxylase and chronic reduction of mtPE in PSB-2 cells that have only 5% of normal phosphatidylserine synthesis decreased respiratory capacity, ATP production, and activities of electron transport chain complexes (C) I and CIV but not CV. Blue native-PAGE analysis revealed defects in the organization of CI and CIV into supercomplexes in PE-deficient mitochondria, correlated with reduced amounts of CI and CIV proteins. Thus, mtPE deficiency impairs formation and/or membrane integration of respiratory supercomplexes. Despite normal or increased levels of mitochondrial fusion proteins in mtPE-deficient cells, and no reduction in mitochondrial membrane potential, mitochondria were extensively fragmented, and mitochondrial ultrastructure was grossly aberrant. In general, chronic reduction of mtPE caused more pronounced mitochondrial defects than did acute mtPE depletion. The functional and morphological changes in PSB-2 cells were largely reversed by normalization of mtPE content by supplementation with lyso-PE, a mtPE precursor. These studies demonstrate that even a modest reduction of mtPE in mammalian cells profoundly alters mitochondrial functions.	[Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Haromy, Alois; Michelakis, Evangelos; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (to J.E.V.).	Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BORKENHAGEN L, 1961, J BIOL CHEM, V236, pPC28; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; da Cunha ES, 2011, ANAL BIOCHEM, V418, P158, DOI 10.1016/j.ab.2011.06.044; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gottesman M M, 1987, Methods Enzymol, V151, P3, DOI 10.1016/S0076-6879(87)51004-7; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Johi A., 2012, J PHARMACOL EXP THER, V342, P619; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kainu V., 2012, BIOCHIM BIOPHYS ACTA, V1831, P429; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; KUGE O, 1991, J BIOL CHEM, V266, P6370; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; MENON AK, 1992, J BIOL CHEM, V267, P15277; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nebauer R, 2007, J BIOL CHEM, V282, P16736, DOI 10.1074/jbc.M611345200; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Saito S, 1997, J BIOL CHEM, V272, P9503; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Seelert H, 2011, BBA-BIOENERGETICS, V1807, P1185, DOI 10.1016/j.bbabio.2011.05.023; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vance J. E., 2013, BIOCH BIOPH IN PRESS; VANCE JE, 1991, J BIOL CHEM, V266, P89; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200	95	191	191	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4158	4173		10.1074/jbc.M112.434183	http://dx.doi.org/10.1074/jbc.M112.434183			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250747	Green Published, hybrid			2022-12-25	WOS:000314845000044
J	Zhu, B; Tabor, S; Raytcheva, DA; Hernandez, A; King, JA; Richardson, CC				Zhu, Bin; Tabor, Stanley; Raytcheva, Desislava A.; Hernandez, Alfredo; King, Jonathan A.; Richardson, Charles C.			The RNA Polymerase of Marine Cyanophage Syn5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM PHORMIDIUM-FOVEOLARUM; RIBONUCLEIC-ACID POLYMERASE; PHOTOSYNTHESIS GENES; GENOME SEQUENCE; SYNECHOCOCCUS; DNA; PROCHLOROCOCCUS; VIRUSES; BACTERIOPHAGE; WIDESPREAD	A single subunit DNA-dependent RNA polymerase was identified and purified to apparent homogeneity from cyanophage Syn5 that infects the marine cyanobacteria Synechococcus. Syn5 is homologous to bacteriophage T7 that infects Escherichia coli. Using the purified enzyme its promoter has been identified by examining transcription of segments of Syn5 DNA and sequencing the 5'-termini of the transcripts. Only two Syn5 RNAP promoters, having the sequence 5'-ATTGGGCACCCGTAA-3', are found within the Syn5 genome. One promoter is located within the Syn5 RNA polymerase gene and the other is located close to the right genetic end of the genome. The purified enzyme and its promoter have enabled a determination of the requirements for transcription. Unlike the salt-sensitive bacteriophage T7 RNA polymerase, this marine RNA polymerase requires 160 mM potassium for maximal activity. The optimal temperature for Syn5 RNA polymerase is 24 degrees C, much lower than that for T7 RNA polymerase. Magnesium is required as a cofactor although some activity is observed with ferrous ions. Syn5 RNA polymerase is more efficient in utilizing low concentrations of ribonucleotides than T7 RNA polymerase.	[Richardson, Charles C.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Raytcheva, Desislava A.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Zhu, B (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	Bin_Zhu@hms.harvard.edu; ccr@hms.harvard.edu	Hernandez, Alfredo J/ABC-8311-2020; Hernandez, Alfredo/AAV-5584-2021	Hernandez, Alfredo J/0000-0002-0903-8932; 	National Institutes of Health [GM54397, GM17980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980, R01GM054397, F32GM017980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54397 (to C. C. R.) and GM17980 (to J. K.).	CHAMBERL.M, 1973, J BIOL CHEM, V248, P2235; CHAMBERL.M, 1973, J BIOL CHEM, V248, P2245; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Chen ZH, 2005, NUCLEIC ACIDS RES, V33, P6172, DOI 10.1093/nar/gki915; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Gao EB, 2012, J VIROL, V86, P236, DOI 10.1128/JVI.06282-11; Imashimizu M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/572689; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu XY, 2008, MICROB ECOL, V56, P671, DOI 10.1007/s00248-008-9386-7; Liu XY, 2007, VIROLOGY, V366, P28, DOI 10.1016/j.virol.2007.04.019; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; Raytcheva DA, 2011, J VIROL, V85, P2406, DOI 10.1128/JVI.01601-10; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	32	13	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3545	3552		10.1074/jbc.M112.442350	http://dx.doi.org/10.1074/jbc.M112.442350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258537	Green Published, hybrid			2022-12-25	WOS:000314397900059
J	El-kereamy, A; Bi, YM; Ranathunge, K; Beatty, PH; Good, AG; Rothstein, SJ				El-kereamy, Ashraf; Bi, Yong-Mei; Ranathunge, Kosala; Beatty, Perrin H.; Good, Allen G.; Rothstein, Steven J.			The Rice R2R3-MYB Transcription Factor OsMYB55 Is Involved in the Tolerance to High Temperature and Modulates Amino Acid Metabolism	PLOS ONE			English	Article							HEAT-STRESS RESPONSE; ASCORBATE PEROXIDASE; ENHANCED TOLERANCE; GENE FAMILY; PLANTS; TOBACCO; ACCUMULATION; PROTEINS; PROLINE; GROWTH	Temperatures higher than the optimum negatively affects plant growth and development. Tolerance to high temperature is a complex process that involves several pathways. Understanding this process, especially in crops such as rice, is essential to prepare for predicted climate changes due to global warming. Here, we show that OsMYB55 is induced by high temperature and overexpression of OsMYB55 resulted in improved plant growth under high temperature and decreased the negative effect of high temperature on grain yield. Transcriptome analysis revealed an increase in expression of several genes involved in amino acids metabolism. We demonstrate that OsMYB55 binds to the promoter regions of target genes and directly activates expression of some of those genes including glutamine synthetase (OsGS1;2) glutamine amidotransferase (GAT1) and glutamate decarboxylase 3 (GAD3). OsMYB55 overexpression resulted in an increase in total amino acid content and of the individual amino acids produced by the activation of the above mentioned genes and known for their roles in stress tolerance, namely L-glutamic acid, GABA and arginine especially under high temperature condition. In conclusion, overexpression of OsMYB55 improves rice plant tolerance to high temperature, and this high tolerance is associated with enhanced amino acid metabolism through transcription activation. Citation: El-kereamy A, Bi Y-M, Ranathunge K, Beatty PH, Good AG, et al. (2012) The Rice R2R3-MYB Transcription Factor OsMYB55 Is Involved in the Tolerance to High Temperature and Modulates Amino Acid Metabolism. PLoS ONE 7(12): e52030. doi: 10.1371/journal.pone.0052030	[El-kereamy, Ashraf; Bi, Yong-Mei; Ranathunge, Kosala; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Beatty, Perrin H.; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [El-kereamy, Ashraf] Ain Shams Univ, Fac Agr, Dept Hort, Cairo, Egypt	University of Guelph; University of Alberta; Egyptian Knowledge Bank (EKB); Ain Shams University	Rothstein, SJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rothstei@uoguelph.ca	EL-KEREAMY, ASHRAF/GON-9302-2022; Rothstein, Steven J/A-4947-2013; Ranathunge, Kosala/AAH-9849-2021; Beatty, Perrin H./H-6487-2019	Rothstein, Steven J/0000-0003-0737-1878; Beatty, Perrin H./0000-0002-9240-447X; Ranathunge, Kosala/0000-0003-2826-9936	Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada; Syngenta Biotech Inc.	Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Syngenta Biotech Inc.(Syngenta)	The research was supported by Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada; and Syngenta Biotech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly funded by Syngenta Biotech Inc. The authors thank Shannon McDonald, from Syngenta Biotechnology Inc., (North Carolina, United States of America) for performed microarray hybridization. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Alia, 1998, PLANT J, V16, P155, DOI 10.1046/j.1365-313x.1998.00284.x; ASHRAF M, 1994, ENVIRON EXP BOT, V34, P275, DOI 10.1016/0098-8472(94)90048-5; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; BECKER TW, 1986, PHOTOSYNTH RES, V8, P267, DOI 10.1007/BF00037134; Cheng L, 2009, J INTEGR PLANT BIOL, V51, P489, DOI 10.1111/j.1744-7909.2009.00816.x; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Guijin Z, 1997, PHYTOCHEMISTRY, V44, P1007, DOI DOI 10.1016/S0031-9422(96)00626-7; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; Hozayn M., 2010, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P95; IPCC, 2007, CLIM CHANG PHYS SCI, V9, P1; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Ko CB, 2007, PLANT PHYSIOL BIOCH, V45, P722, DOI 10.1016/j.plaphy.2007.07.010; Kolupaev YE, 2005, RUSS J PLANT PHYSL+, V52, P199, DOI 10.1007/s11183-005-0030-9; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Lee U, 2007, PLANT J, V49, P115, DOI 10.1111/j.1365-313X.2006.02940.x; Lin CJ, 2010, J AGR FOOD CHEM, V58, P10545, DOI 10.1021/jf101575j; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maestri E, 2002, PLANT MOL BIOL, V48, P667, DOI 10.1023/A:1014826730024; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Morita S, 2005, ANN BOT-LONDON, V95, P695, DOI 10.1093/aob/mci071; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Mu RL, 2009, CELL RES, V19, P1291, DOI 10.1038/cr.2009.83; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; Ogweno JO, 2008, J PLANT GROWTH REGUL, V27, P49, DOI 10.1007/s00344-007-9030-7; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Rivero RM, 2004, PLANT BIOLOGY, V6, P702, DOI 10.1055/s-2004-821293; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Shi WM, 2001, GENE, V273, P23, DOI 10.1016/S0378-1119(01)00566-2; Singh Amanjot, 2008, Physiology and Molecular Biology of Plants, V14, P155, DOI 10.1007/s12298-008-0014-2; Smolen GA, 2002, GENETICS, V161, P1235; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sugimoto K, 2000, PLANT CELL, V12, P2511, DOI 10.1105/tpc.12.12.2511; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wen XP, 2008, TRANSGENIC RES, V17, P251, DOI 10.1007/s11248-007-9098-7; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	55	109	129	17	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52030	10.1371/journal.pone.0052030	http://dx.doi.org/10.1371/journal.pone.0052030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251677	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800130
J	Lacsina, JR; Marks, OA; Liu, XF; Reid, DW; Jagannathan, S; Nicchitta, CV				Lacsina, Joshua R.; Marks, Odessa A.; Liu, Xiongfei; Reid, David W.; Jagannathan, Sujatha; Nicchitta, Christopher V.			Premature Translational Termination Products Are Rapidly Degraded Substrates for MHC Class I Presentation	PLOS ONE			English	Article							PEPTIDYL-TRANSFER-RNA; DEFECTIVE RIBOSOMAL PRODUCTS; NEWLY SYNTHESIZED PROTEINS; GENOME-WIDE ANALYSIS; ESCHERICHIA-COLI; METABOLIC ROLE; VIABLE CELLS; DEGRADATION; PROTEASOME; GENERATION	Nearly thirty percent of all newly synthesized polypeptides are targeted for rapid proteasome-mediated degradation. These rapidly degraded polypeptides (RDPs) are a source of antigenic substrates for the MHC class I presentation pathway, allowing for immunosurveillance of newly synthesized proteins by cytotoxic T lymphocytes. Despite the recognized role of RDPs in MHC I presentation, it remains unclear what molecular characteristics distinguish RDPs from their more stable counterparts. It has been proposed that premature translational termination products may constitute a form of RDP; indeed, in prokaryotes translational drop-off products are normal by-products of protein synthesis and are subsequently rapidly degraded. To study the cellular fate of premature termination products, we used the antibiotic puromycin as a means to experimentally manipulate prematurely terminated polypeptide production in human cells. At low concentrations, puromycin enhanced flux into rapidly degraded polypeptide pools, with small polypeptides being markedly more labile then high molecular weight puromycin adducts. Immunoprecipitation experiments using anti-puromycin antisera demonstrated that the majority of peptidyl-puromycins are rapidly degraded in a proteasome-dependent manner. Low concentrations of puromycin increased the recovery of cell surface MHC I-peptide complexes, indicating that prematurely terminated polypeptides can be processed for presentation via the MHC I pathway. In the continued presence of puromycin, however, MHC I export to the cell surface was inhibited, coincident with the accumulation of polyubiquitinated proteins. The time-and dose-dependent effects of puromycin suggest that the pool of peptidyl-puromycin adducts differ in their targeting to various proteolytic pathways that, in turn, differ in the efficiency with which they access the MHC I presentation machinery. These studies highlight the diversity of cellular proteolytic pathways necessary for the metabolism and immunosurveillance of prematurely terminated polypeptides that are, by their nature, highly heterogeneous.	[Lacsina, Joshua R.; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Lacsina, Joshua R.; Liu, Xiongfei; Jagannathan, Sujatha; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27706 USA; [Marks, Odessa A.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA.	christopher.nicchitta@duke.edu	Lacsina, Joshua/AAV-5282-2020	Lacsina, Joshua/0000-0002-9956-8039; Jagannathan, Sujatha/0000-0001-9039-2631	National Institutes of Health (NIH) [R01GM077382, F31GM086127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086127, R01GM101533, R01GM077382] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health (NIH) R01GM077382 (CVN) and NIH F31GM086127 (JRL). Details available at http://report.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Cardinaud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008692; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dolan BP, 2010, J IMMUNOL, V185, P6728, DOI 10.4049/jimmunol.1002543; Farfan-Arribas DJ, 2012, P NATL ACAD SCI USA, V109, P16998, DOI 10.1073/pnas.1210271109; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gileadi U, 1999, J IMMUNOL, V163, P6045; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Golovina TN, 2005, J IMMUNOL, V174, P2763, DOI 10.4049/jimmunol.174.5.2763; Huang L, 2011, EMBO J, V30, P1634, DOI 10.1038/emboj.2011.62; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishii T, 2006, EMBO J, V25, P5492, DOI 10.1038/sj.emboj.7601418; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; MANLEY JL, 1978, J MOL BIOL, V125, P407, DOI 10.1016/0022-2836(78)90308-X; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Qian Shu-Bing, 2005, V301, P271; Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; TSUNG K, 1989, J BIOL CHEM, V264, P4428; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Vazquez D, 1979, Mol Biol Biochem Biophys, V30, pi; Vazquez D, 1979, MOL BIOL BIOCH BIOPH, V30, P1, DOI 10.1007/978-3-642-81309-2; Wherry EJ, 2006, J IMMUNOL, V176, P2249, DOI 10.4049/jimmunol.176.4.2249; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823	45	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51968	10.1371/journal.pone.0051968	http://dx.doi.org/10.1371/journal.pone.0051968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251665	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800120
J	Press, C; Catmur, C; Cook, R; Widmann, H; Heyes, C; Bird, G				Press, Clare; Catmur, Caroline; Cook, Richard; Widmann, Hannah; Heyes, Cecilia; Bird, Geoffrey			fMRI Evidence of 'Mirror' Responses to Geometric Shapes	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; INFERIOR FRONTAL GYRUS; AUTOMATIC IMITATION; MOTOR; NEURONS; EXPERIENCE; REPETITION; BRAIN; REPRESENTATION; ORGANIZATION	Mirror neurons may be a genetic adaptation for social interaction [1]. Alternatively, the associative hypothesis [2,3] proposes that the development of mirror neurons is driven by sensorimotor learning, and that, given suitable experience, mirror neurons will respond to any stimulus. This hypothesis was tested using fMRI adaptation to index populations of cells with mirror properties. After sensorimotor training, where geometric shapes were paired with hand actions, BOLD response was measured while human participants experienced runs of events in which shape observation alternated with action execution or observation. Adaptation from shapes to action execution, and critically, observation, occurred in ventral premotor cortex (PMv) and inferior parietal lobule (IPL). Adaptation from shapes to execution indicates that neuronal populations responding to the shapes had motor properties, while adaptation to observation demonstrates that these populations had mirror properties. These results indicate that sensorimotor training induced populations of cells with mirror properties in PMv and IPL to respond to the observation of arbitrary shapes. They suggest that the mirror system has not been shaped by evolution to respond in a mirror fashion to biological actions; instead, its development is mediated by stimulus-general processes of learning within a system adapted for visuomotor control.	[Press, Clare; Widmann, Hannah; Bird, Geoffrey] Birkbeck Coll, Dept Psychol Sci, London, England; [Press, Clare] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Catmur, Caroline] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Cook, Richard] City Univ London, Dept Psychol, London EC1V 0HB, England; [Heyes, Cecilia] Univ Oxford, All Souls Coll, Oxford, England; [Bird, Geoffrey] UCL, Inst Cognit Neurosci, London, England	University of London; Birkbeck University London; University of London; University College London; University of Surrey; City University London; University of Oxford; University of London; University College London	Bird, G (corresponding author), Birkbeck Coll, Dept Psychol Sci, London, England.	g.bird@bbk.ac.uk	Bird, Geoff/AAA-3652-2020; Heyes, Cecilia/F-8262-2014; Catmur, Caroline/J-5413-2013	Bird, Geoffrey/0000-0002-2310-0202; Catmur, Caroline/0000-0001-6996-4295; Press, Clare/0000-0002-4777-2249	Interdisciplinary Postdoctoral Fellowship; ESRC (Economic and Social Research Council) [G0800071, RES-538-28-1001]; MRC (Medical Research Council); Medical Research Council [G0800071] Funding Source: researchfish; MRC [G0800071] Funding Source: UKRI	Interdisciplinary Postdoctoral Fellowship; ESRC (Economic and Social Research Council); MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CP was funded by an Interdisciplinary Postdoctoral Fellowship awarded by the MRC (Medical Research Council) (www.mrc.ac.uk) and ESRC (Economic and Social Research Council) (www.esrc.ac.uk, grant no. G0800071). CC was funded by the ESRC (grant no. RES-538-28-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bonini L, 2011, ANN NY ACAD SCI, V1225, P166, DOI 10.1111/j.1749-6632.2011.06002.x; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cook R, 2012, BIOL LETTERS, V8, P856, DOI 10.1098/rsbl.2012.0192; Cook R, 2012, J EXP PSYCHOL GEN, V141, P774, DOI 10.1037/a0027561; Cook R, 2010, J EXP PSYCHOL HUMAN, V36, P840, DOI 10.1037/a0019256; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gillmeister H, 2008, BRAIN RES, V1217, P157, DOI 10.1016/j.brainres.2007.12.076; Glenberg AM, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/fnhum.2010.00204, 10.3389/fnhum.2010.00206]; Gough PM, 2005, J NEUROSCI, V25, P8010, DOI 10.1523/JNEUROSCI.2307-05.2005; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hartwigsen G, 2010, NEUROPSYCHOLOGIA, V48, P3155, DOI 10.1016/j.neuropsychologia.2010.06.032; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Landmann C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026859; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Malach R, 2012, NEUROIMAGE, V62, P1163, DOI 10.1016/j.neuroimage.2012.01.002; MITZ AR, 1991, J NEUROSCI, V11, P1855; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petroni A, 2010, J NEUROPHYSIOL, V104, P1867, DOI 10.1152/jn.00386.2010; Pinker S., 1997, MIND WORKS; Press C, 2007, P ROY SOC B-BIOL SCI, V274, P2509, DOI 10.1098/rspb.2007.0774; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; SHANKS DR, 1991, MEM COGNITION, V19, P353, DOI 10.3758/BF03197139; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Waddington C., 1957, STRATEGY GENES; Wiggett AJ, 2011, BRAIN COGNITION, V76, P87, DOI 10.1016/j.bandc.2011.02.014	56	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51934	10.1371/journal.pone.0051934	http://dx.doi.org/10.1371/journal.pone.0051934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251653	Green Accepted, Green Published, gold			2022-12-25	WOS:000312386800109
J	van der Meulen, T; Xie, RY; Kelly, OG; Vale, WW; Sander, M; Huising, MO				van der Meulen, Talitha; Xie, Ruiyu; Kelly, Olivia G.; Vale, Wylie W.; Sander, Maike; Huising, Mark O.			Urocortin 3 Marks Mature Human Primary and Embryonic Stem Cell-Derived Pancreatic Alpha and Beta Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; IN-VIVO; ISLET ARCHITECTURE; PROGENITOR CELLS; GLUCOSE; EXPRESSION; FETAL; DIFFERENTIATION; MATURATION; CONVERSION	The peptide hormone Urocortin 3 (Ucn 3) is abundantly and exclusively expressed in mouse pancreatic beta cells where it regulates insulin secretion. Here we demonstrate that Ucn 3 first appears at embryonic day (E) 17.5 and, from approximately postnatal day (p) 7 and onwards throughout adult life, becomes a unifying and exclusive feature of mouse beta cells. These observations identify Ucn 3 as a potential beta cell maturation marker. To determine whether Ucn 3 is similarly restricted to beta cells in humans, we conducted comprehensive immunohistochemistry and gene expression experiments on macaque and human pancreas and sorted primary human islet cells. This revealed that Ucn 3 is not restricted to the beta cell lineage in primates, but is also expressed in alpha cells. To substantiate these findings, we analyzed human embryonic stem cell (hESC)-derived pancreatic endoderm that differentiates into mature endocrine cells upon engraftment in mice. Ucn 3 expression in hESC-derived grafts increased robustly upon differentiation into mature endocrine cells and localized to both alpha and beta cells. Collectively, these observations confirm that Ucn 3 is expressed in adult beta cells in both mouse and human and appears late in beta cell differentiation. Expression of Pdx1, Nkx6.1 and PC1/3 in hESC-derived Ucn 3(+) beta cells supports this. However, the expression of Ucn 3 in primary and hESC-derived alpha cells demonstrates that human Ucn 3 is not exclusive to the beta cell lineage but is a general marker for both the alpha and beta cell lineages. Ucn 3(+) hESC-derived alpha cells do not express Nkx6.1, Pdx1 or PC1/3 in agreement with the presence of a separate population of Ucn 3(+) alpha cells. Our study highlights important species differences in Ucn 3 expression, which have implications for its utility as a marker to identify mature beta cells in (re) programming strategies.	[van der Meulen, Talitha; Vale, Wylie W.; Huising, Mark O.] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Xie, Ruiyu; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Kelly, Olivia G.] ViaCyte Inc, San Diego, CA USA; [Huising, Mark O.] Salk Inst Biol Studies, Salk Ctr Nutr Genom, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute	Huising, MO (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	huising@salk.edu	Huising, Mark O./H-3885-2019; Sander, Maike/N-6615-2016	Huising, Mark O./0000-0002-6594-2205; Xie, Ruiyu/0000-0003-0518-2897; Sander, Maike/0000-0001-5308-7785	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P01 DK026741-31]; Juvenile Diabetes Research Foundation (JDRF); Clayton Medical Research Foundation, Inc.; Salk Center for Nutritional Genomics; Leona M. & Harry B. Helmsley Charitable Trust; NIH/NIDDK [U01 DK089567, R01 DK068471]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089567, R01DK068471, P01DK026741] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Clayton Medical Research Foundation, Inc.; Salk Center for Nutritional Genomics; Leona M. & Harry B. Helmsley Charitable Trust; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.O.H. is supported by award P01 DK026741-31 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Juvenile Diabetes Research Foundation (JDRF), the Clayton Medical Research Foundation, Inc., the Salk Center for Nutritional Genomics and the Leona M. & Harry B. Helmsley Charitable Trust. M.S. is supported by the NIH/NIDDK grants U01 DK089567 and R01 DK068471. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; FREINKEL N, 1984, DIABETES, V33, P1028, DOI 10.2337/diabetes.33.11.1028; Halban PA, 2010, J CLIN ENDOCR METAB, V95, P1034, DOI 10.1210/jc.2009-1819; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Huising MO, 2011, ENDOCRINOLOGY, V152, P138, DOI 10.1210/en.2010-0791; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Huising MO, 2008, ENCY NEUROSCIENCE; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Nagaya M, 2009, J ENDOCRINOL, V201, P37, DOI 10.1677/JOE-08-0482; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rafael E, 1999, CELL TRANSPLANT, V8, P317, DOI 10.1177/096368979900800302; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Weir GC, 2011, GENOME MED, V3, DOI 10.1186/gm277; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799	42	63	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52181	10.1371/journal.pone.0052181	http://dx.doi.org/10.1371/journal.pone.0052181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251699	gold, Green Published			2022-12-25	WOS:000312386800150
J	Alcaide, M; Messina, E; Richter, M; Bargiela, R; Peplies, J; Huws, SA; Newbold, CJ; Golyshin, PN; Simon, MA; Lopez, G; Yakimov, MM; Ferrer, M				Alcaide, Maria; Messina, Enzo; Richter, Michael; Bargiela, Rafael; Peplies, Joerg; Huws, Sharon A.; Newbold, Charles J.; Golyshin, Peter N.; Simon, Miguel A.; Lopez, Guillermo; Yakimov, Michail M.; Ferrer, Manuel			Gene Sets for Utilization of Primary and Secondary Nutrition Supplies in the Distal Gut of Endangered Iberian Lynx	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MICROBIAL DIVERSITY; PHYLOGENETIC ANALYSIS; CENTRIC METAGENOMICS; RNA GENES; METAPOPULATION; LANDSCAPE; DATABASE; MANNOSE; SYSTEM	Recent studies have indicated the existence of an extensive trans-genomic trans-mural co-metabolism between gut microbes and animal hosts that is diet-, host phylogeny- and provenance-influenced. Here, we analyzed the biodiversity at the level of small subunit rRNA gene sequence and the metabolic composition of 18 Mbp of consensus metagenome sequences and activity characteristics of bacterial intra-cellular extracts, in wild Iberian lynx (Lynx pardinus) fecal samples. Bacterial signatures (14.43% of all of the Firmicutes reads and 6.36% of total reads) related to the uncultured anaerobic commensals Anaeroplasma spp., which are typically found in ovine and bovine rumen, were first identified. The lynx gut was further characterized by an over-representation of 'presumptive' aquaporin aqpZ genes and genes encoding 'active' lysosomal-like digestive enzymes that are possibly needed to acquire glycerol, sugars and amino acids from glycoproteins, glyco(amino) lipids, glyco(amino) glycans and nucleoside diphosphate sugars. Lynx gut was highly enriched (28% of the total glycosidases) in genes encoding alpha-amylase and related enzymes, although it exhibited low rate of enzymatic activity indicative of starch degradation. The preponderance of beta-xylosidase activity in protein extracts further suggests lynx gut microbes being most active for the metabolism of beta-xylose containing plant N-glycans, although beta-xylosidases sequences constituted only 1.5% of total glycosidases. These collective and unique bacterial, genetic and enzymatic activity signatures suggest that the wild lynx gut microbiota not only harbors gene sets underpinning sugar uptake from primary animal tissues (with the monotypic dietary profile of the wild lynx consisting of 80-100% wild rabbits) but also for the hydrolysis of prey-derived plant biomass. Although, the present investigation corresponds to a single sample and some of the statements should be considered qualitative, the data most likely suggests a tighter, more coordinated and complex evolutionary and nutritional ecology scenario of carnivore gut microbial communities than has been previously assumed.	[Alcaide, Maria; Bargiela, Rafael; Ferrer, Manuel] CSIC, Inst Catalysis, Dept Appl Biocatalysis, Madrid, Spain; [Messina, Enzo; Yakimov, Michail M.] Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Messina, Italy; [Richter, Michael; Peplies, Joerg] Ribocon GmbH, Bremen, Germany; [Huws, Sharon A.; Newbold, Charles J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Newbold, Charles J.; Golyshin, Peter N.] Bangor Univ Partnership CIRRE, Aberystwyth Univ, Ctr Integrated Res Rural Environm, Aberystwyth, Ceredigion, Wales; [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Simon, Miguel A.] Consejeria Medio Ambiente Junta Andalucia, Jaen, Spain; [Lopez, Guillermo] Agencia Medio Ambiente & Agua Andalucia, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Aberystwyth University; Bangor University	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Dept Appl Biocatalysis, Madrid, Spain.	mferrer@icp.csic.es	Huws, Sharon/A-7768-2015; Bargiela, Rafael/K-6783-2014; Yakimov, Michail/H-1829-2016; Ferrer, Manuel/K-4535-2014	Huws, Sharon/0000-0002-0966-5354; Bargiela, Rafael/0000-0003-1442-3269; Messina, Enzo/0000-0001-9042-0014; Huws, Sharon/0000-0002-9284-2453; Golyshin, Peter/0000-0002-5433-0350; Yakimov, Michail/0000-0003-1418-363X; Ferrer, Manuel/0000-0003-4962-4714	Ministerio de Agricultura, Alimentacion y Medio Ambiente; LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia"; European Regional Development Fund (ERDF) funds; Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE); Biosciences, Environment and Agriculture Alliance (BEAA);  [CSD2007-00005]; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01C, BBS/E/W/10964A01B, BBS/E/W/10964A01A] Funding Source: researchfish; BBSRC [BBS/E/W/10964A01A, BBS/E/W/10964A01C, BBS/E/W/10964A01B] Funding Source: UKRI	Ministerio de Agricultura, Alimentacion y Medio Ambiente; LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia"; European Regional Development Fund (ERDF) funds; Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE); Biosciences, Environment and Agriculture Alliance (BEAA); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors greatly acknowledge Ministerio de Agricultura, Alimentacion y Medio Ambiente (former Ministerio de Medio Ambiente, Medio Rural y Marino), and the LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia" for their support and collaboration. This research was supported by the Spanish CSD2007-00005 and by European Regional Development Fund (ERDF) funds. The Regional Government of Environment of the Junta de Andalucia provided permission for the collection of samples (permit SGYB/FOA/AFR/CFS) during routine conservation management works. SAH, PNG and CJN acknowledge the support of Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE) and Biosciences, Environment and Agriculture Alliance (BEAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bohle LA, 2011, FEMS MICROBIOL LETT, V325, P123, DOI 10.1111/j.1574-6968.2011.02419.x; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Delibes M., 2000, ACTION PLAN CONSERVA; Ferrer M, 2004, CONSERV BIOL, V18, P344, DOI 10.1111/j.1523-1739.2004.00096.x; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Garnier M, 2001, CR ACAD SCI III-VIE, V324, P923, DOI 10.1016/S0764-4469(01)01372-5; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guzman JN, 2004, LINCE IBERICO; Helbling DE, 2012, ISME J, V6, P902, DOI [10.1038/ISMEJ.2011.158, 10.1038/ismej.2011.158]; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; IUCN, 2022, IUCN RED LIST THREAT; Jimenez I, 2006, ARCH ANDROLOGY, V52, P455, DOI 10.1080/01485010600694690; Jung HK, 2008, BIOTECHNOL LETT, V30, P1545, DOI 10.1007/s10529-008-9732-3; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Millan J, 2008, SCI TOTAL ENVIRON, V399, P193, DOI 10.1016/j.scitotenv.2008.03.038; Millan J, 2009, VECTOR-BORNE ZOONOT, V9, P549, DOI 10.1089/vbz.2008.0081; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Naumoff DG, 2004, MOL BIOL+, V38, P388, DOI 10.1023/B:MBIL.0000032210.97006.de; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; PALOMARES F, 2001, WILDLIFE MONOGRAPHS; Pan D, 2000, MOL GENET METAB, V70, P170, DOI 10.1006/mgme.2000.3012; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C., 2006, THESIS; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Scupham AJ, 2007, ENVIRON MICROBIOL, V9, P1801, DOI 10.1111/j.1462-2920.2007.01300.x; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Simon MA, 2012, CONSERV BIOL, V26, P731, DOI 10.1111/j.1523-1739.2012.01871.x; Simon Miguel A., 2009, P42; Singh KM, 2011, MOL BIOL REP; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x; Wells JE, 1996, J DAIRY SCI, V79, P1487, DOI 10.3168/jds.S0022-0302(96)76508-6; Yang LY, 2010, MOL BIOL REP, V37, P553, DOI 10.1007/s11033-009-9794-x; Yang SL, 2010, MOL BIOL REP, V37, P2063, DOI 10.1007/s11033-009-9664-6; Zhang HH, 2010, MOL BIOL REP, V37, P4013, DOI 10.1007/s11033-010-0060-z; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	72	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51521	10.1371/journal.pone.0051521	http://dx.doi.org/10.1371/journal.pone.0051521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251564	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200130
J	Cavallo, F; Graziani, G; Antinozzi, C; Feldman, DR; Houldsworth, J; Bosl, GJ; Chaganti, RSK; Moynahan, ME; Jasin, M; Barchi, M				Cavallo, Francesca; Graziani, Grazia; Antinozzi, Cristina; Feldman, Darren R.; Houldsworth, Jane; Bosl, George J.; Chaganti, Raju S. K.; Moynahan, Mary Ellen; Jasin, Maria; Barchi, Marco			Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition	PLOS ONE			English	Article							CROSS-LINK REPAIR; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; VASCULAR INVASION; CANCER CELLS; REPLICATION; DEFICIENCY; DAMAGE; BRCA1; STAGE	Testicular Germ Cell Tumors (TGCT) and patient-derived cell lines are extremely sensitive to cisplatin and other interstrand cross-link (ICL) inducing agents. Nevertheless, a subset of TGCTs are either innately resistant or acquire resistance to cisplatin during treatment. Understanding the mechanisms underlying TGCT sensitivity/resistance to cisplatin as well as the identification of novel strategies to target cisplatin-resistant TGCTs have major clinical implications. Herein, we have examined the proficiency of five embryonal carcinoma (EC) cell lines to repair cisplatin-induced ICLs. Using gamma H2AX staining as a marker of double strand break formation, we found that EC cell lines were either incapable of or had a reduced ability to repair ICL-induced damage. The defect correlated with reduced Homologous Recombination (HR) repair, as demonstrated by the reduction of RAD51 foci formation and by direct evaluation of HR efficiency using a GFP-reporter substrate. HR-defective tumors cells are known to be sensitive to the treatment with poly(ADP-ribose) polymerase (PARP) inhibitor. In line with this observation, we found that EC cell lines were also sensitive to PARP inhibitor monotherapy. The magnitude of sensitivity correlated with HR-repair reduced proficiency and with the expression levels and activity of PARP1 protein. In addition, we found that PARP inhibition strongly enhanced the response of the most resistant EC cells to cisplatin, by reducing their ability to overcome the damage. These results point to a reduced proficiency of HR repair as a source of sensitivity of ECs to ICL-inducing agents and PARP inhibitor monotherapy, and suggest that pharmacological inhibition of PARP can be exploited to target the stem cell component of the TGCTs (namely ECs) and to enhance the sensitivity of cisplatin-resistant TGCTs to standard treatments.	[Cavallo, Francesca; Antinozzi, Cristina; Barchi, Marco] Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy; [Cavallo, Francesca; Moynahan, Mary Ellen; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Graziani, Grazia] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Feldman, Darren R.; Bosl, George J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Houldsworth, Jane; Chaganti, Raju S. K.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	University of Rome Tor Vergata; Memorial Sloan Kettering Cancer Center; University of Rome Tor Vergata; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Barchi, M (corresponding author), Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy.	marco.barchi@uniroma2.it	; GRAZIANI, GRAZIA/G-5747-2012	Bosl, George/0000-0002-7842-6584; GRAZIANI, GRAZIA/0000-0002-0221-768X; Moynahan, Mary Ellen/0000-0002-0167-1020; Barchi, Marco/0000-0003-1104-6234; Feldman, Darren/0000-0003-2424-4635	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4765]; Ministry of Education, Universities and Research of Italy [CII11RLETZ]; AIRC; Byrne Foundation	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Education, Universities and Research of Italy(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); Byrne Foundation	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) grant n. 4765 to MB) and from Ministry of Education, Universities and Research of Italy (Cooperlink grant 2011, n. CII11RLETZ, to MB). FC was supported by AIRC Fellowship for abroad 2010, and Byrne Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; ANDREWS PW, 1994, LAB INVEST, V71, P243; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bhagwat NR, 2009, CANCER RES, V69, P6831, DOI 10.1158/0008-5472.CAN-09-1237; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; DAMJANOV I, 1993, LAB INVEST, V68, P220; Di Vizio D, 2005, ONCOGENE, V24, P1882, DOI 10.1038/sj.onc.1208368; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Heidenreich A, 1998, CANCER, V83, P1002, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.3.CO;2-F; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Loser DA, 2010, MOL CANCER THER, V9, P1775, DOI 10.1158/1535-7163.MCT-09-1027; Mangerich A, 2011, INT J CANCER, V128, P251, DOI 10.1002/ijc.25683; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Masters JRW, 1996, EUR J CANCER, V32A, P1248, DOI 10.1016/0959-8049(96)00033-0; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; MOUL JW, 1994, CANCER RES, V54, P362; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce AJ, 2005, METH MOL B, V291, P373; PONT J, 1990, J CLIN ONCOL, V8, P16, DOI 10.1200/JCO.1990.8.1.16; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Tentori L, 2007, EUR J CANCER, V43, P2124, DOI 10.1016/j.ejca.2007.07.010; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; YAGI T, 1983, MUTAT RES, V112, P59, DOI 10.1016/0167-8817(83)90024-X; Yuan SSF, 1999, CANCER RES, V59, P3547; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166	57	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51563	10.1371/journal.pone.0051563	http://dx.doi.org/10.1371/journal.pone.0051563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251575	gold, Green Published			2022-12-25	WOS:000313236200133
J	Freund, P; Schneider, T; Nagy, Z; Hutton, C; Weiskopf, N; Friston, KJ; Wheeler-Kingshott, CA; Thompson, AJ				Freund, Patrick; Schneider, Torben; Nagy, Zoltan; Hutton, Chloe; Weiskopf, Nikolaus; Friston, Karl J.; Wheeler-Kingshott, Claudia A.; Thompson, Alan J.			Degeneration of the Injured Cervical Cord Is Associated with Remote Changes in Corticospinal Tract Integrity and Upper Limb Impairment	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SPINAL-CORD; MULTIPLE-SCLEROSIS; WHITE-MATTER; WALLERIAN DEGENERATION; MRI; MOTOR; ATROPHY; PATHWAYS; RECOVERY	Background: Traumatic spinal cord injury (SCI) leads to disruption of axons and macroscopic tissue loss. Using diffusion tensor imaging (DTI), we assessed degeneration of the corticospinal tract (CST) in the cervical cord above a traumatic lesion and explored its relationship with cervical atrophy, remote axonal changes within the cranial CST and upper limb function. Methods: Nine cervical injured volunteers with bilateral motor and sensory impairment and ten controls were studied. DTI of the cervical cord and brain provided measurements of fractional anisotropy (FA), while anatomical MRI assessed cross-sectional spinal cord area (i.e. cord atrophy). Spinal and central regions of interest (ROI) included the bilateral CST in the cervical cord and brain. Regression analysis identified correlations between spinal FA and cranial FA in the CST and disability. Results: In individuals with SCI, FA was significantly lower in both CSTs throughout the cervical cord and brain when compared with controls (p <= 0.05). Reduced FA of the cervical cord in patients with SCI was associated with smaller cord area (p = 0.002) and a lower FA of the cranial CST at the internal capsule level (p = 0.001). Lower FA in the cervical CST also correlated with impaired upper limb function, independent of cord area (p = 0.03). Conclusion: Axonal degeneration of the CST in the atrophic cervical cord, proximal to the site of injury, parallels cranial CST degeneration and is associated with disability. This DTI protocol can be used in longitudinal assessment of microstructural changes immediately following injury and may be utilised to predict progression and monitor interventions aimed at promoting spinal cord repair.	[Freund, Patrick; Thompson, Alan J.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Freund, Patrick; Nagy, Zoltan; Hutton, Chloe; Weiskopf, Nikolaus; Friston, Karl J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Freund, Patrick] UCL, Royal Natl Orthopaed Hosp, Spinal Cord Injury Ctr, London, England; [Freund, Patrick] Swiss Parapleg Res, Nottwil, Switzerland; [Schneider, Torben; Wheeler-Kingshott, Claudia A.] UCL, Inst Neurol, Dept Neuroinflammat, NMR Res Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Swiss Paraplegic Research; University of London; University College London	Freund, P (corresponding author), UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England.	p.freund@ucl.ac.uk	Weiskopf, Nikolaus/B-9357-2008; Freund, Patrick/D-4193-2013; Friston, Karl/D-9230-2011; Thompson, Alan J/C-2654-2008; Nagy, Zoltan/AAI-2485-2019; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Weiskopf, Nikolaus/0000-0001-5239-1881; Freund, Patrick/0000-0002-4851-2246; Friston, Karl/0000-0001-7984-8909; Thompson, Alan J/0000-0002-4333-8496; Nagy, Zoltan/0000-0001-6611-6362; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300	Swiss National Science Foundation [PBFR33-120920]; Schweizerische Stiftung fur medizinische und biologische Stipendien [PASMP3-124194]; Swiss Paraplegic Research (Nottwil); Wellcome Trust; Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Stiftung fur medizinische und biologische Stipendien; Swiss Paraplegic Research (Nottwil); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme	This study was supported by the Swiss National Science Foundation (Grant No: PBFR33-120920), Schweizerische Stiftung fur medizinische und biologische Stipendien (Grant No: PASMP3-124194), the Swiss Paraplegic Research (Nottwil) and the Wellcome Trust. This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Ellaway PH, 2011, BRAIN RES BULL, V84, P343, DOI 10.1016/j.brainresbull.2010.08.007; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Hoogervorst ELJ, 2002, ARCH NEUROL-CHICAGO, V59, P113, DOI 10.1001/archneur.59.1.113; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Schneider T, 2011, 19 ANN SCI M EXH 201, P4556; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	39	42	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51729	10.1371/journal.pone.0051729	http://dx.doi.org/10.1371/journal.pone.0051729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251612	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200158
J	Hatch, SL; Woodhead, C; Frissa, S; Fear, NT; Verdecchia, M; Stewart, R; Reichenberg, A; Morgan, C; Bebbington, P; McManus, S; Brugha, T; Kankulu, B; Clark, JL; Gazard, B; Medcalf, R; Hotopf, M				Hatch, Stephani L.; Woodhead, Charlotte; Frissa, Souci; Fear, Nicola T.; Verdecchia, Maria; Stewart, Robert; Reichenberg, Abraham; Morgan, Craig; Bebbington, Paul; McManus, Sally; Brugha, Traolach; Kankulu, Bwalya; Clark, Jennifer L.; Gazard, Billy; Medcalf, Robert; Hotopf, Matthew		SELCoH Study Team	Importance of Thinking Locally for Mental Health: Data from Cross-Sectional Surveys Representing South East London and England	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; NEUROTIC DISORDERS; GREAT-BRITAIN; POPULATION; DEPRESSION; PREVALENCE; EPIDEMIOLOGY; COMMUNITY; CARE	Background: Reliance on national figures may be underestimating the extent of mental ill health in urban communities. This study demonstrates the necessity for local information on common mental disorder (CMD) and substance use by comparing data from the South East London Community Health (SELCoH) study with those from a national study, the 2007 English Adult Psychiatric Morbidity Study (APMS). Methodology/Principal Findings: Data were used from two cross-sectional surveys, 1698 men and women residing in south London and 7403 men and women in England. The main outcome, CMD, was indicated by a score of 12 or above on the Revised Clinical Interview Schedule. Secondary outcomes included hazardous alcohol use and illicit drug use. SELCoH sample prevalence estimates of CMD were nearly twice that of the APMS England sample estimates. There was a four-fold greater proportion of depressive episode in the SELCoH sample than the APMS sample. The prevalence of hazardous alcohol use was higher in the national sample. Illicit drug use in the past year was higher in the SELCoH sample, with cannabis and cocaine the illicit drugs reported most frequently in both samples. In comparisons of the SELCoH sample with the APMS England sample and the APMS sample from the Greater London area in combined datasets, these differences remained after adjusting for socio-demographic and socioeconomic indicators for all outcomes. Conclusions/Significance: Local information for estimating the prevalence of CMD and substance use is essential for surveillance and service planning. There were similarities in the demographic and socioeconomic factors related to CMD and substance use across samples.	[Hatch, Stephani L.; Woodhead, Charlotte; Frissa, Souci; Verdecchia, Maria; Reichenberg, Abraham; Kankulu, Bwalya; Clark, Jennifer L.; Gazard, Billy; Medcalf, Robert; Hotopf, Matthew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Fear, Nicola T.] Kings Coll London, Acad Ctr Def Mental Hlth, London WC2R 2LS, England; [Stewart, Robert] Kings Coll London, Epidemiol Sect, Hlth Serv, London WC2R 2LS, England; [Stewart, Robert; Morgan, Craig] Inst Psychiat, Populat Res Dept, London, England; [Morgan, Craig] Kings Coll London, Sect Social Psychiat, Hlth Serv, London WC2R 2LS, England; [Bebbington, Paul] UCL, Dept Mental Hlth Sci, London, England; [McManus, Sally] Natl Ctr Social Res, London, England; [Brugha, Traolach] Leicester Gen Hosp, Dept Hlth Sci, New Acad Unit, Leicester LE5 4PW, Leics, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Hatch, SL (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	stephani.hatch@kcl.ac.uk	Medcalf, Robert L/E-9632-2011; Brugha, Traolach/T-9326-2019; Fear, Nicola/A-1917-2012; McManus, Sally/S-4697-2019; Stewart, Robert/B-1667-2010; Hotopf, Matthew/E-4971-2010; Hatch, Stephani L/B-4235-2010; McManus, Sally/HGD-4860-2022; Reichenberg, Abraham/GQB-1227-2022; Bebbington, Paul Ernest/C-1939-2008; Morgan, Craig/B-2100-2010	Brugha, Traolach/0000-0002-9786-9591; Fear, Nicola/0000-0002-5792-2925; Stewart, Robert/0000-0002-4435-6397; McManus, Sally/0000-0003-2711-0819; Bebbington, Paul Ernest/0000-0002-6030-7456; Morgan, Craig/0000-0002-1386-2369; Gazard, Billy/0000-0002-7562-5393; Hatch, Stephani/0000-0001-9103-2427; Hotopf, Matthew/0000-0002-3980-4466	Biomedical Research Nucleus data management and informatics facility at South London; Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Department of Health	Biomedical Research Nucleus data management and informatics facility at South London; Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); King's College London(General Electric); Guy's and St Thomas' Charity; Maudsley Charity; Department of Health	This research was supported by the Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust, which is funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. These funders had no involvement in study design, data collection, analysis or the decision to submit for publication. The Department of Health funded the APMS 2007 and had no involvement in study design, data collection, analysis or the decision to submit for publication.	Bebbington PE, 2000, PSYCHOL MED, V30, P1359, DOI 10.1017/S0033291799002950; Bebbington PE, 2000, PSYCHOL MED, V30, P1369, DOI 10.1017/S0033291799002974; BEBBINGTON PE, 1981, SOC PSYCHIATR, V16, P43, DOI 10.1007/BF00578068; Brugha T, 2009, ADULT PSYCHIAT MORBI; Brugha TS, 1999, PSYCHOL MED, V29, P1013, DOI 10.1017/S0033291799008880; Coulthard M, 2002, TOBACCO ALCOHOL DRUG; Das-Munshi J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5367; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Galea S, 2007, ANN EPIDEMIOL, V17, P171, DOI 10.1016/j.annepidem.2006.07.008; Glover G, 2004, SOC PSYCH PSYCH EPID, V39, P730, DOI 10.1007/s00127-004-0779-8; Hatch SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-861; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Jenkins R, 2003, INT REV PSYCHIATR, V15, P188, DOI 10.1080/0954026021000046164; Jenkins R, 1997, PSYCHOL MED, V27, P765, DOI 10.1017/S003329179700531X; Kirkbride JB, 2007, SOC PSYCH PSYCH EPID, V42, P438, DOI 10.1007/s00127-007-0193-0; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Midanik LT, 2007, DRUG ALCOHOL DEPEN, V90, P72, DOI 10.1016/j.drugalcdep.2007.02.024; Paykel ES, 2000, PSYCHOL MED, V30, P269, DOI 10.1017/S003329179900183X; Peen J, 2007, SOC PSYCH PSYCH EPID, V42, P984, DOI 10.1007/s00127-007-0256-2; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P2, DOI 10.1136/jech.52.1.2; Rezaeian M, 2004, SOC PSYCH PSYCH EPID, V39, P947, DOI 10.1007/s00127-004-0829-2; Singleton N, 2003, INT REV PSYCHIATR, V15, P65, DOI 10.1080/0954026021000045967; StataCorp, 2019, STATA STAT SOFTWARE; Stuckler D, 2011, DEPRESSION AMIDST DE; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Weich S, 2003, AM J EPIDEMIOL, V157, P730, DOI 10.1093/aje/kwg035; Whitley R, 2005, J EPIDEMIOL COMMUN H, V59, P893, DOI 10.1136/jech.2004.030353; World Health Organization website, 2011, IMP EC CRIS MENT HLT	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48012	10.1371/journal.pone.0048012	http://dx.doi.org/10.1371/journal.pone.0048012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251330	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000313236200004
J	Li, K; Jiang, TY; Yu, B; Wang, LM; Gao, C; Ma, CQ; Xu, P; Ma, YH				Li, Kun; Jiang, Tianyi; Yu, Bo; Wang, Limin; Gao, Chao; Ma, Cuiqing; Xu, Ping; Ma, Yanhe			Transcription Elongation Factor GreA Has Functional Chaperone Activity	PLOS ONE			English	Article							CLEAVAGE FACTORS GREA; PAPD-LIKE CHAPERONES; ESCHERICHIA-COLI; RNA-POLYMERASE; CRYSTAL-STRUCTURE; HIGH-TEMPERATURE; SALT TOLERANCE; PROTEIN; STRESS; HEAT	Background: Bacterial GreA is an indispensable factor in the RNA polymerase elongation complex. It plays multiple roles in transcriptional elongation, and may be implicated in resistance to various stresses. Methodology/Principal Findings: In this study, we show that Escherichia coli GreA inhibits aggregation of several substrate proteins under heat shock condition. GreA can also effectively promote the refolding of denatured proteins. These facts reveal that GreA has chaperone activity. Distinct from many molecular chaperones, GreA does not form stable complexes with unfolded substrates. GreA overexpression confers the host cells with enhanced resistance to heat shock and oxidative stress. Moreover, GreA expression in the greA/greB double mutant could suppress the temperature-sensitive phenotype, and dramatically alleviate the in vivo protein aggregation. The results suggest that bacterial GreA may act as chaperone in vivo. Conclusions/Significance: These results suggest that GreA, in addition to its function as a transcription factor, is involved in protection of cellular proteins against aggregation.	[Li, Kun; Yu, Bo; Wang, Limin; Ma, Yanhe] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Inst Microbiol, Beijing, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Li, Kun; Jiang, Tianyi; Gao, Chao; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Li, Kun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn	MA, YAN/HHN-2912-2022	Gao, Chao/0000-0002-5205-0670; Ma, Cuiqing/0000-0002-7468-1027	National Basic Research Program of China [2011CBA00800]; Chinese National Programs for High Technology Research [2011AA02A202, 2011AA02A207]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Programs for High Technology Research	The work was supported by National Basic Research Program of China (2011CBA00800) and Chinese National Programs for High Technology Research (2011AA02A202 and 2011AA02A207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; CAI H, 1994, J BIOL CHEM, V269, P24550; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Chaurasia AK, 2009, APPL ENVIRON MICROB, V75, P6008, DOI 10.1128/AEM.00838-09; Doherty GP, 2006, J BACTERIOL, V188, P4101, DOI 10.1128/JB.01934-05; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jofre A, 2003, PLANTA, V217, P813, DOI 10.1007/s00425-003-1048-x; Kawamoto J, 2007, EXTREMOPHILES, V11, P819, DOI 10.1007/s00792-007-0098-6; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kotlyar AB, 2010, FEBS LETT, V584, P159, DOI 10.1016/j.febslet.2009.11.022; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Montero-Barrientos M, 2007, CURR GENET, V52, P45, DOI 10.1007/s00294-007-0140-3; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; SPARKOWSKI J, 1990, NUCLEIC ACIDS RES, V18, P6443, DOI 10.1093/nar/18.21.6443; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; Wei W, 2004, LETT APPL MICROBIOL, V39, P278, DOI 10.1111/j.1472-765X.2004.01577.x	36	21	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e47521	10.1371/journal.pone.0047521	http://dx.doi.org/10.1371/journal.pone.0047521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251328	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200002
J	Roberts, SE; Button, LA; Williams, JG				Roberts, Stephen E.; Button, Lori A.; Williams, John G.			Prognosis following Upper Gastrointestinal Bleeding	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; POPULATION-BASED COHORT; NONVARICEAL UPPER; HOSPITAL ADMISSION; ENGLISH POPULATION; NATIONWIDE COHORT; LIVER-CIRRHOSIS; RECORD LINKAGE; HEMORRHAGE; OUTCOMES	Background: Upper gastrointestinal (GI) bleeding is one of the most common, high risk emergency disorders in the western world. Almost nothing has been reported on longer term prognosis following upper GI bleeding. The aim of this study was to establish mortality up to three years following hospital admission with upper GI bleeding and its relationship with aetiology, co-morbidities and socio-demographic factors. Methods: Systematic record linkage of hospital inpatient and mortality data for 14 212 people in Wales, UK, hospitalised with upper GI bleeding between 1999 and 2004 with three year follow-up to 2007. The main outcome measures were mortality rates, standardised mortality ratios (SMRs) and relative survival. Results: Mortality at three years was 36.7% overall, based on 5215 fatalities. It was highest for upper GI malignancy (95% died within three years) and varices (52%). Compared with the general population, mortality was increased 27-fold during the first month after admission. It fell to 4.3 by month four, but remained significantly elevated during every month throughout the three years following admission. The most important independent prognostic predictors of mortality at three years were older age (mortality increased 53 fold for people aged 85 years and over compared with those under 40 years); oesophageal and gastric/duodenal malignancy (48 and 32 respectively) and gastric varices aetiologies (2.8) when compared with other bleeds; non-upper GI malignancy, liver disease and renal failure co-morbidities (15, 7.9 and 3.9); social deprivation (29% increase for quintile V vs I); incident bleeds as an inpatient (31% vs admitted with bleeding) and male patients (25% vs female). Conclusion: Our study shows a high late as well as early mortality for upper GI bleeding, with very poor longer term prognosis following bleeding due to malignancies and varices. Aetiologies with the worst prognosis were often associated with high levels of social deprivation.	[Roberts, Stephen E.; Button, Lori A.; Williams, John G.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University	Roberts, SE (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	stephen.e.roberts@swansea.ac.uk			Health Foundation [5091]; Wales Office of Research and Development	Health Foundation; Wales Office of Research and Development	The study was funded by The Health Foundation [Grant no: 5091] (http://www.health.org.uk/). The views expressed in this manuscript are those of the authors and not necessarily those of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Ashley Akbari and Mark Atkinson, College of Medicine, Swansea University, for data programming and extraction; and the Health Information Research Unit (HIRU), College of Medicine, Swansea University, for preparing and providing access to the project specific linked datasets from the Secure Anonymised Information Linkage (SAIL) system, which is funded by the Wales Office of Research and Development.	Ahsberg K, 2010, SCAND J GASTROENTERO, V45, P1404, DOI 10.3109/00365521.2010.510567; Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Ananthakrishnan AN, 2009, CLIN GASTROENTEROL H, V7, P296, DOI 10.1016/j.cgh.2008.08.013; Barkun A, 2004, AM J GASTROENTEROL, V99, P1238, DOI 10.1111/j.1572-0241.2004.30272.x; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; Brooks CJ, 2010, PHARMACOEPIDEM DR S, V19, P983, DOI 10.1002/pds.2012; Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x; Button LA, 2010, WORLD J GASTROENTERO, V16, P431, DOI 10.3748/wjg.v16.i4.431; Crooks C, 2011, GASTROENTEROLOGY, V141, P62, DOI 10.1053/j.gastro.2011.03.048; Crooks CJ, 2012, GUT, V61, P514, DOI 10.1136/gutjnl-2011-300186; Di Fiore F, 2005, EUR J GASTROEN HEPAT, V17, P641, DOI 10.1097/00042737-200506000-00008; Fleming KM, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02517.x; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Goldacre MJ, 2004, BRIT MED J, V328, P1466, DOI 10.1136/bmj.328.7454.1466; GOLDACRE MJ, 1993, J EPIDEMIOL COMMUN H, V47, P491, DOI 10.1136/jech.47.6.491; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; HUDSON N, 1995, GUT, V37, P177, DOI 10.1136/gut.37.2.177; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kapur KC, 1998, J ROY COLL PHYS LOND, V32, P246; Lanas A, 2011, ALIMENT PHARM THER, V33, P1225, DOI 10.1111/j.1365-2036.2011.04651.x; Lyons RA, 2003, INJ PREV, V9, P33, DOI 10.1136/ip.9.1.33; Lyons RA, 2008, ACCIDENT ANAL PREV, V40, P1406, DOI 10.1016/j.aap.2008.03.011; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Marmo R, 2008, AM J GASTROENTEROL, V103, P1639, DOI 10.1111/j.1572-0241.2008.01865.x; Office for National Statistics, 2007, INT MIGR 2006; Office for National Statistics, POP EST UK ENGL WAL; Palmer KR, 2003, POSTGRAD MED J, V31, P19; Paranjothy S, 2009, ARCH DIS CHILD, V94, P421, DOI 10.1136/adc.2008.144881; Public Health Wales Observatory, MORT DAT MAIN CAUS; Roberts SE, 2005, GUT, V54, P1615, DOI 10.1136/gut.2004.058636; Roberts SE, 2012, EUR RESPIR J, V40, P785, DOI 10.1183/09031936.00043311; Roberts SE, 2011, FRONTLINE GASTROENTE, V2, P153, DOI 10.1136/fg.2009.000208; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Sanders DS, 2004, EUR J GASTROEN HEPAT, V16, P487, DOI 10.1097/00042737-200405000-00009; SAUNDERS JB, 1981, BRIT MED J, V282, P263, DOI 10.1136/bmj.282.6260.263; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Targownik LE, 2006, CLIN GASTROENTEROL H, V4, P1459, DOI 10.1016/j.cgh.2006.08.018; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5; vonHolstein CS, 1997, EUR J GASTROEN HEPAT, V9, P33, DOI 10.1097/00042737-199701000-00010; Vreeburg EM, 1997, AM J GASTROENTEROL, V92, P236; Welsh Assembly Government, 2010, 942010 SB WELSH ASS; Welsh Government, WELSH IND MULT DEPR	43	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49507	10.1371/journal.pone.0049507	http://dx.doi.org/10.1371/journal.pone.0049507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251344	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200017
J	Oyola, SO; Evans, KJ; Smith, TK; Smith, BA; Hilley, JD; Mottram, JC; Kaye, PM; Smith, DF				Oyola, Samuel O.; Evans, Krystal J.; Smith, Terry K.; Smith, Barbara A.; Hilley, James D.; Mottram, Jeremy C.; Kaye, Paul M.; Smith, Deborah F.			Functional Analysis of Leishmania Cyclopropane Fatty Acid Synthetase	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; MYCOLIC ACIDS; TRYPANOSOMA-BRUCEI; MOLECULAR-CLONING; INFECTIVE STAGES; DRUG-RESISTANCE; GENE-EXPRESSION; SYNTHASE; DONOVANI	The single gene encoding cyclopropane fatty acid synthetase (CFAS) is present in Leishmania infantum, L. mexicana and L. braziliensis but absent from L. major, a causative agent of cutaneous leishmaniasis. In L. infantum, usually causative agent of visceral leishmaniasis, the CFAS gene is transcribed in both insect (extracellular) and host (intracellular) stages of the parasite life cycle. Tagged CFAS protein is stably detected in intracellular L. infantum but only during the early log phase of extracellular growth, when it shows partial localisation to the endoplasmic reticulum. Lipid analyses of L. infantum wild type, CFAS null and complemented parasites detect a low abundance CFAS-dependent C19 Delta fatty acid, characteristic of a cyclopropanated species, in wild type and add-back cells. Sub-cellular fractionation studies locate the C19 Delta fatty acid to both ER and plasma membrane-enriched fractions. This fatty acid is not detectable in wild type L. major, although expression of the L. infantum CFAS gene in L. major generates cyclopropanated fatty acids, indicating that the substrate for this modification is present in L. major, despite the absence of the modifying enzyme. Loss of the L. infantum CFAS gene does not affect extracellular parasite growth, phagocytosis or early survival in macrophages. However, while endocytosis is also unaffected in the extracellular CFAS nulls, membrane transporter activity is defective and the null parasites are more resistant to oxidative stress. Following infection in vivo, L. infantum CFAS nulls exhibit lower parasite burdens in both the liver and spleen of susceptible hosts but it has not been possible to complement this phenotype, suggesting that loss of C19 Delta fatty acid may lead to irreversible changes in cell physiology that cannot be rescued by re-expression. Aberrant cyclopropanation in L. major decreases parasite virulence but does not influence parasite tissue tropism.	[Oyola, Samuel O.; Evans, Krystal J.; Smith, Barbara A.; Kaye, Paul M.; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Smith, Terry K.] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; [Hilley, James D.; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Hull; University of York - UK; University of St Andrews; University of Glasgow	Smith, DF (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	deborah.smith@york.ac.uk		Oyola, Samuel O./0000-0002-6425-7345; Kaye, Paul/0000-0002-8796-4755; Mottram, Jeremy/0000-0001-5574-3766	Wellcome Trust [076355, 067441, 086658, 085349]; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust programme grant 076355 to DFS, JCM, PMK. TKS is supported by a Wellcome Trust Senior Research Fellowship (067441) and Wellcome Trust project grant 086658. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003; Alce TM, 1999, MOL BIOCHEM PARASIT, V102, P191, DOI 10.1016/S0166-6851(99)00074-2; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BANGS JD, 1993, J CELL SCI, V105, P1101; Bao XM, 2003, J BIOL CHEM, V278, P12846, DOI 10.1074/jbc.M212464200; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BEIL W, 1994, GUT, V35, P1176, DOI 10.1136/gut.35.9.1176; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724; Chang YY, 2000, J BACTERIOL, V182, P4288, DOI 10.1128/JB.182.15.4288-4294.2000; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Courtois F, 2005, BIOCHEMISTRY-US, V44, P13583, DOI 10.1021/bi051159x; Courtois F, 2004, EUR J BIOCHEM, V271, P4769, DOI 10.1111/j.1432-1033.2004.04441.x; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; FISH WR, 1981, MOL BIOCHEM PARASIT, V3, P103, DOI 10.1016/0166-6851(81)90010-4; FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9; Grandvalet C, 2008, MICROBIOL-SGM, V154, P2611, DOI 10.1099/mic.0.2007/016238-0; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Haque M, 1996, J BACTERIOL, V178, P2065, DOI 10.1128/jb.178.7.2065-2070.1996; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones SE, 2011, GUT MICROBES, V2, P69, DOI 10.4161/gmic.2.2.15282; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KNIVETT VA, 1965, BIOCHEM J, V96, P771, DOI 10.1042/bj0960771; KUIPER PJC, 1972, PLANT PHYSIOL, V49, P307, DOI 10.1104/pp.49.3.307; Lang T, 2005, CELL MICROBIOL, V7, P383, DOI 10.1111/j.1462-5822.2004.00468.x; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; Liu Y, 2006, GENETICS, V172, P873, DOI 10.1534/genetics.105.045542; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mukherjee P, 2003, IMMUNOL LETT, V86, P131, DOI 10.1016/S0165-2478(03)00021-X; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; OUDEJANS RCHM, 1976, COMP BIOCHEM PHYS B, V54, P227, DOI 10.1016/0305-0491(76)90147-4; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Sadlova J, 2010, CELL MICROBIOL, V12, P1765, DOI 10.1111/j.1462-5822.2010.01507.x; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; TAYLOR FR, 1979, BIOCHEMISTRY-US, V18, P3292, DOI 10.1021/bi00582a015; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; ZILBERSTEIN D, 1984, MOL BIOCHEM PARASIT, V12, P327, DOI 10.1016/0166-6851(84)90089-6; ZILBERSTEIN D, 1985, P NATL ACAD SCI USA, V82, P1716, DOI 10.1073/pnas.82.6.1716	61	20	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51300	10.1371/journal.pone.0051300	http://dx.doi.org/10.1371/journal.pone.0051300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251490	Green Published, Green Accepted, gold			2022-12-25	WOS:000312201900063
J	Sauvat, F; Bouilly, J; Capito, C; Lefevre, A; Blachere, T; Borenstein, N; Sarnacki, S; Dandolo, L; Binart, N				Sauvat, Frederique; Bouilly, Justine; Capito, Carmen; Lefevre, Annick; Blachere, Thierry; Borenstein, Nicolas; Sarnacki, Sabine; Dandolo, Luisa; Binart, Nadine			Ovarian function is restored after grafting of cryopreserved immature ovary in ewes	FASEB JOURNAL			English	Article						epigenetics; puberty; fertility preservation; cancer	BECKWITH-WIEDEMANN-SYNDROME; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; TISSUE CRYOPRESERVATION; FERTILITY PRESERVATION; SYNDROME BORN; TRANSPLANTATION; SHEEP; PREGNANCIES; AUTOGRAFTS	As a result of advances in medical treatment, almost 80% of children who are diagnosed with cancer survive long-term. The adverse consequences of cancer treatments include impaired puberty and fertility. In prepubertal girls, the only therapeutic option is the cryopreservation of an ovary. To date, a dozen births have been reported after reimplantation of cryopreserved mature ovaries. To analyze ovarian function after immature grafts, we performed ovarian grafting in a ewe model. Fresh or cryopreserved ovaries from immature ewes were autografted in prepubertal or adult ewes. Cyclic hormonal activity was recovered 3 mo after grafting. Histological analysis demonstrated the presence of all follicle populations and corpora lutea not affected by cryopreservation. After 3 reproductive seasons, births had been observed in all groups, and the follicle-stimulating hormone status was under the limit, which indicated an exhausted ovary. As an indicator of potential imprinting default, the methylation status of the Igf2r gene was analyzed and did not show significant alteration compared with that of non-manipulated animals. Taken together, these results demonstrate that immature ovarian grafting is able to restore spontaneous puberty and fertility and could guide the reimplantation of immature cortex in women.-Sauvat, F., Bouilly, J., Capito, C., Lefevre, A., Blachere, T., Borenstein, N., Sarnacki, S., Dandolo, L., Binart, N. Ovarian function is restored after grafting of cryopreserved immature ovary in ewes. FASEB J. 27, 1511-1518 (2013). www.fasebj.org	[Sauvat, Frederique; Bouilly, Justine; Binart, Nadine] INSERM, U693, F-94276 Le Kremlin Bicetre, France; [Sauvat, Frederique; Bouilly, Justine; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Capito, Carmen; Sarnacki, Sabine] Assistance Publ Hop Paris, Paris, France; [Capito, Carmen; Dandolo, Luisa] Univ Paris 05, Paris, France; [Lefevre, Annick; Blachere, Thierry] INSERM, U846, F-69008 Lyon, France; [Borenstein, Nicolas; Sarnacki, Sabine] Inst Mutualiste Montsouris IMM Rech Paris, Paris, France; [Dandolo, Luisa] Inst Cochin, CNRS, UMR 8104, INSERM,U1016, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Binart, N (corresponding author), INSERM, U693, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Binart, Nadine/F-2949-2013; Sarnacki, Sabine/I-2692-2017	Binart, Nadine/0000-0002-5606-3866; Sarnacki, Sabine/0000-0003-4304-5578	Fondation pour l'Avenir; Agence de Biomedecine; Institut National de la Sante et de la Recherche Medicale-Assistance Publique-Hopitaux de Paris Interface	Fondation pour l'Avenir; Agence de Biomedecine; Institut National de la Sante et de la Recherche Medicale-Assistance Publique-Hopitaux de Paris Interface	The authors thank C. Poirot and F. Jaubert for helpful discussions and A. L. Laine for FSH measurement. This work was supported by the Fondation pour l'Avenir and the Agence de Biomedecine. N.B. was awarded an Institut National de la Sante et de la Recherche Medicale-Assistance Publique-Hopitaux de Paris Interface contract.	Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; Arav A, 2005, HUM REPROD, V20, P3554, DOI 10.1093/humrep/dei278; Arnaud Philippe, 2005, Birth Defects Res C Embryo Today, V75, P81, DOI 10.1002/bdrc.20039; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Bedaiwy MA, 2003, FERTIL STERIL, V79, P594, DOI 10.1016/S0015-0282(02)04842-2; BenEzra D, 2005, BRIT J OPHTHALMOL, V89, P393, DOI 10.1136/bjo.2004.056739; Chang AS, 2005, FERTIL STERIL, V83, P349, DOI 10.1016/j.fertnstert.2004.07.964; Courbiere B, 2009, FERTIL STERIL, V91, P2697, DOI 10.1016/j.fertnstert.2008.03.012; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; Denschlag D, 2005, FERTIL STERIL, V83, P501, DOI 10.1016/j.fertnstert.2004.07.958; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Donnez J, 2010, CLIN OBSTET GYNECOL, V53, P787, DOI 10.1097/GRF.0b013e3181f97a55; Donnez J, 2010, BEST PRACT RES CL OB, V24, P87, DOI 10.1016/j.bpobgyn.2009.09.003; Ernst E, 2010, HUM REPROD, V25, P1280, DOI 10.1093/humrep/deq033; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Imhof M, 2006, FERTIL STERIL, V85, P1208, DOI 10.1016/j.fertnstert.2005.11.030; Jadoul P, 2010, HUM REPROD UPDATE, V16, P617, DOI 10.1093/humupd/dmq010; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Ludwig M, 2005, J MED GENET, V42, P289, DOI 10.1136/jmg.2004.026930; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Meirow D, 1999, FERTIL STERIL, V71, P948, DOI 10.1016/S0015-0282(99)00067-9; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; MUSSETT MV, 1961, J REPROD FERTIL, V2, P80, DOI 10.1530/jrf.0.0020080; Nativio R, 2011, HUM MOL GENET, V20, P1363, DOI 10.1093/hmg/ddr018; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Paoloni-Giacobino A, 2007, PEDIATR RES, V61, p51R, DOI 10.1203/pdr.0b013e318039d978; Poirot C, 2005, Gynecol Obstet Fertil, V33, P799, DOI 10.1016/j.gyobfe.2005.07.032; Poirot C, 2012, LANCET, V379, P588, DOI 10.1016/S0140-6736(11)61781-9; Poirot CJ, 2007, PEDIATR BLOOD CANCER, V49, P74, DOI 10.1002/pbc.21027; Revel A, 2004, FERTIL STERIL, V82, P1714, DOI 10.1016/j.fertnstert.2004.06.046; Rodriguez-Wallberg KA, 2012, BEST PRACT RES CL OB, V26, P391, DOI 10.1016/j.bpobgyn.2012.01.001; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Roux C, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.12.022; Salle B, 2003, FERTIL STERIL, V80, P172, DOI 10.1016/S0015-0282(03)00554-5; Salle B, 2002, FERTIL STERIL, V77, P403, DOI 10.1016/S0015-0282(01)02960-0; Sauvat F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001972; Schmidt KT, 2010, BJOG-INT J OBSTET GY, V117, P163, DOI 10.1111/j.1471-0528.2009.02408.x; Shaw JM, 2000, MOL CELL ENDOCRINOL, V161, P103, DOI 10.1016/S0303-7207(99)00230-0; Shaw JM, 2002, SEMIN REPROD MED, V20, P51, DOI 10.1055/s-2002-24950; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Tierling S, 2010, J MED GENET, V47, P371, DOI 10.1136/jmg.2009.073189; Wang HB, 2002, AM J OBSTET GYNECOL, V187, P370, DOI 10.1067/mob.2002.123606; Wilkins-Haug L, 2008, CLIN OBSTET GYNECOL, V51, P96, DOI 10.1097/GRF.0b013e318161d25a; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	52	11	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1511	1518		10.1096/fj.12-218297	http://dx.doi.org/10.1096/fj.12-218297			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271057				2022-12-25	WOS:000316940800023
J	He, C; Li, FD; Zhang, JH; Wu, JH; Shi, YY				He, Chao; Li, Fudong; Zhang, Jiahai; Wu, Jihui; Shi, Yunyu			The Methyltransferase NSD3 Has Chromatin-binding Motifs, PHD5-C5HCH, That Are Distinct from Other NSD (Nuclear Receptor SET Domain) Family Members in Their Histone H3 Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; TANDEM PHD FINGER; LYSINE 36; COMBINATORIAL READOUT; MULTIPLE-MYELOMA; LINKS; GENE; METHYLATION; MECHANISM; BROMODOMAIN	The NSD (nuclear receptor SET domain-containing) family members, consisting of NSD1, NSD2 (MMSET/WHSC1), and NSD3 (WHSC1L1), are SET domain-containing methyltransferases and aberrant expression of each member has been implicated in multiple diseases. They have specific mono-and dimethylase activities for H3K36, whereas play nonredundant roles during development. Aside from the well characterized catalytic SET domain, NSD proteins have multiple potential chromatin-binding motifs that are clinically relevant, including the fifth plant homeodomain (PHD5) and the adjacent Cys-His-rich domain (C5HCH) located at the C terminus. Herein, we report the crystal structures of the PHD5-C5HCH module of NSD3, in the free state and in complex with H3(1-7) (H3 residues 1-7), H3(1-15) (H3 residues 1-15), and H3(1-15)K9me3 (H3 residues 1-15 with trimethylation on K9) peptides. These structures reveal that the PHD5 and C5HCH domains fold into a novel integrated PHD-PHD-like structural module with H3 peptide bound only on the surface of PHD5 and provide the molecular basis for the recognition of unmodified H3K4 and trimethylated H3K9 by NSD3 PHD5. Structural studies and binding assays show that differences exist in histone binding specificity of the PHD5 domain between three members of the NSD family. For NSD2, the PHD5-C5HCH: H3 N terminus interaction is largely conserved, although with a stronger preference for unmethylated H3K9 (H3K9me0) than trimethylated H3K9 (H3K9me3), and NSD1 PHD5-C5HCH does not bind to H3 peptides. Our results shed light on how NSD proteins that mediate H3K36 methylation are localized to specific genomic sites and provide implications for the mechanism of functional diversity of NSD proteins.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	National Basic Research Program of China 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [30830031, 31170693]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302, 2012CB917201, and 2011CB911104 and Chinese National Natural Science Foundation Grants 30830031 and 31170693.	Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Chignola Francesca, 2009, Nucleic Acids Res, V37, P2951, DOI 10.1093/nar/gkp166; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas J, 2005, EUR J HUM GENET, V13, P150, DOI 10.1038/sj.ejhg.5201298; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Faravelli F, 2005, AM J MED GENET C, V137C, P24, DOI 10.1002/ajmg.c.30061; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Slama P, 2011, NUCLEIC ACIDS RES, V39, P1666, DOI 10.1093/nar/gkq947; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	50	40	44	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4692	4703		10.1074/jbc.M112.426148	http://dx.doi.org/10.1074/jbc.M112.426148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269674	hybrid, Green Published			2022-12-25	WOS:000315340400018
J	Toichi, K; Yamanaka, K; Furukawa, Y				Toichi, Keisuke; Yamanaka, Koji; Furukawa, Yoshiaki			Disulfide Scrambling Describes the Oligomer Formation of Superoxide Dismutase (SOD1) Proteins in the Familial Form of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN-SUPEROXIDE DISMUTASE; POSTTRANSLATIONAL MODIFICATIONS; DECREASED STABILITY; AGGREGATION; APO; MUTATIONS; MUTANTS; CU	Dominant mutations in Cu,Zn-superoxide dismutase (SOD1) are a cause of a familial form of amyotrophic lateral sclerosis. Wild-type SOD1 forms a highly conserved intra-molecular disulfide bond, whereas pathological SOD1 proteins are crosslinked via intermolecular disulfide bonds and form insoluble oligomers. A thiol-disulfide status in SOD1 will thus play a regulatory role in determining its folding/misfolding pathways; however, it remains unknown how pathogenic mutations in SOD1 affect the thiol-disulfide status to facilitate the protein misfolding. Here, we show that the structural destabilization of SOD1 scrambles a disulfide bond among four Cys residues in an SOD1 molecule. The disulfide scrambling produces SOD1 monomers with distinct electrophoretic mobility and also reproduces the formation of disulfide-linked oligomers. We have also found that the familial form of amyotrophic lateral sclerosis-causing mutations facilitate the disulfide scrambling in SOD1. Based upon our results, therefore, scrambling of the conserved disulfide bond will be a key event to cause the pathological changes in disease-associated mutant SOD1 proteins.	[Toichi, Keisuke; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan; [Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Yamanaka, Koji/ABD-1034-2020; Furukawa, Yoshiaki/F-2871-2014; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X; Yamanaka, Koji/0000-0003-4655-0035	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111542, 23111006, 24657093]; Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan; CREST, Japan Science and Technology Agency; Japan ALS association; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan ALS association; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by Grants-in-aid 24111542 (to Y. F.) and 23111006 (to K. Y.) for Scientific Research on Innovative Areas and 24657093 (to Y. F.) for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan and from CREST, Japan Science and Technology Agency (to K. Y.), a grant from Japan ALS association (to Y. F.), and a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Y. F.).	Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200	32	53	54	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4970	4980		10.1074/jbc.M112.414235	http://dx.doi.org/10.1074/jbc.M112.414235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264618	Green Published, hybrid			2022-12-25	WOS:000315340400044
J	Efendiev, R; Bavencoffe, A; Hu, HZ; Zhu, MX; Dessauer, CW				Efendiev, Riad; Bavencoffe, Alexis; Hu, Hongzhen; Zhu, Michael X.; Dessauer, Carmen W.			Scaffolding by A-Kinase Anchoring Protein Enhances Functional Coupling between Adenylyl Cyclase and TRPV1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED ION-CHANNEL; CAPSAICIN RECEPTOR; PROSTAGLANDIN E-2; MICE LACKING; INFLAMMATORY PAIN; COMPLEX; AKAP79; DESENSITIZATION; SENSITIZATION; MEMBRANE	Scaffolding proteins often bring kinases together with their substrates to facilitate cell signaling. This arrangement is critical for the phosphorylation and regulation of the transient receptor potential vanilloid 1 (TRPV1) channel, a key target of inflammatory mediators such as prostaglandins. The protein kinase A anchoring protein AKAP79/150 organizes a multiprotein complex to position protein kinase A (PKA) and protein kinase C (PKC) in the immediate proximity of TRPV1 channels to enhance phosphorylation efficiency. This arrangement suggests that regulators upstream of the kinases must also be present in the signalosome. Here, we show that AKAP79/150 facilitates a complex containing TPRV1 and adenylyl cyclase (AC). The anchoring of AC to this complex generates local pools of cAMP, shifting the concentration of forskolin required to attenuate capsaicin-dependent TRPV1 desensitization by similar to 100-fold. Anchoring of AC to the complex also sensitizes the channel to activation by beta-adrenergic receptor agonists. Significant AC activity is found associated with TRPV1 in dorsal root ganglia. The dissociation of AC from an AKAP150-TRPV1 complex in dorsal root ganglia neurons abolishes sensitization of TRPV1 induced by forskolin and prostaglandin E-2. Thus, the direct anchoring of both PKA and AC to TRPV1 by AKAP79/150 facilitates the response to inflammatory mediators and may be critical in the pathogenesis of thermal hyperalgesia.	[Efendiev, Riad; Bavencoffe, Alexis; Hu, Hongzhen; Zhu, Michael X.; Dessauer, Carmen W.] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dessauer, CW (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	Carmen.W.Dessauer@uth.tmc.edu	; Dessauer, Carmen/N-6933-2018	Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Dessauer, Carmen/0000-0003-1210-4280; Hu, Hongzhen/0000-0002-8967-7522	National Institutes of Health [GM60419, GM60419-10S1, DK081654, GM081658, GM092759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM081658, R01GM092759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 and GM60419-10S1 (to C. W. D.) and DK081654, GM081658, and GM092759 (to M. X. Z.).	Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bhave G, 2004, J NEUROBIOL, V61, P88, DOI 10.1002/neu.20083; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Distler C, 2003, J NEUROPHYSIOL, V89, P2499, DOI 10.1152/jn.00713.2002; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Holzer P, 2008, BRIT J PHARMACOL, V155, P1145, DOI 10.1038/bjp.2008.351; Hu HJ, 2002, J NEUROSCI, V22, P7444; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kim KS, 2007, GENES BRAIN BEHAV, V6, P120, DOI 10.1111/j.1601-183X.2006.00238.x; Kim KS, 2006, P NATL ACAD SCI USA, V103, P3908, DOI 10.1073/pnas.0508812103; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Li Y, 2012, J BIOL CHEM, V287, P29815, DOI 10.1074/jbc.M112.380568; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nagy I, 2004, EUR J PHARMACOL, V500, P351, DOI 10.1016/j.ejphar.2004.07.037; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Palazzo E, 2012, CURR OPIN PHARMACOL, V12, P9, DOI 10.1016/j.coph.2011.10.022; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Por ED, 2010, BIOCHEM J, V432, P549, DOI 10.1042/BJ20100936; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Sadana R, 2009, MOL PHARMACOL, V76, P1256, DOI 10.1124/mol.109.058370; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Vadakkan KI, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-7; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Yang DN, 2002, J NEUROSCI, V22, P6388; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	51	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3929	3937		10.1074/jbc.M112.428144	http://dx.doi.org/10.1074/jbc.M112.428144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264624	Green Published, hybrid			2022-12-25	WOS:000314845000023
J	Liu, ZX; Liu, H; Desai, S; Schmitt, DC; Zhou, M; Khong, HT; Klos, KS; McClellan, S; Fodstad, O; Tan, M				Liu, Zixing; Liu, Hao; Desai, Shruti; Schmitt, David C.; Zhou, Ming; Khong, Hung T.; Klos, Kristine S.; McClellan, Steven; Fodstad, Oystein; Tan, Ming			miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MICRORNA EXPRESSION; PACLITAXEL TAXOL; GENE-EXPRESSION; DOWN-REGULATION; RESISTANCE; OVARIAN; DIFFERENTIATION; DEREGULATION	Chemoresistance is a major obstacle in cancer treatment. Our previous studies have shown that miR-125b plays an important role in chemoresistance. Here we report a novel mechanism that up-regulation of miR-125b through Wnt signaling by Snail enriches cancer stem cells. Overexpression of Snail dramatically increases the expression of miR-125b through the Snail-activated Wnt/beta-catenin/TCF4 axis. Snail confers chemoresistance by repressing Bak1 through up-regulation of miR-125b. Restoring the expression of Bak1 or depleting miR-125b re-sensitizes Snail-expressing cancer cells to Taxol, indicating that miR-125b is critical in Snail-induced chemoresistance. Moreover, overexpression of miR-125b significantly increases the cancer stem cell population (CD24-CD44+), while depletion of miR-125b or rescue of the expression of Bak1 increases the non-stem cell population (CD24+CD44+) in Snail-overexpressing cells. These findings strongly support that miR-125b functions as a key mediator in Snail-induced cancer stem cell enrichment and chemoresistance. This novel mechanism for Snail-induced stem cell propagation and chemoresistance may have important implications in the development of strategies for overcoming cancer cell resistance to chemotherapy.	[Liu, Zixing; Liu, Hao; Desai, Shruti; Schmitt, David C.; McClellan, Steven; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Liu, Hao] Sichuan Univ, W China Med Ctr, Dept Biochem & Mol Biol, Chengdu 610041, Peoples R China; [Zhou, Ming] Cent S Univ, Canc Res Inst, Changsha 41008, Hunan, Peoples R China; [Khong, Hung T.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Klos, Kristine S.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Fodstad, Oystein] Univ Oslo, Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36608 USA	University of South Alabama; Sichuan University; Central South University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Oslo; University of South Alabama	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898	National Institutes of Health/NCI [R01CA149646]; Vincent F. Kilborn, Jr. Cancer Research Foundation; Norwegian Radiumhospitalet Legater [334003]; NATIONAL CANCER INSTITUTE [R01CA149646] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vincent F. Kilborn, Jr. Cancer Research Foundation; Norwegian Radiumhospitalet Legater; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Grant R01CA149646 (to M. T.), the Vincent F. Kilborn, Jr. Cancer Research Foundation (to M. T.), and The Norwegian Radiumhospitalet Legater (Project 334003, to M. T. and O. F.).	ARBUCK SG, 1994, HEMATOL ONCOL CLIN N, V8, P121, DOI 10.1016/S0889-8588(18)30191-6; Bishop J F, 1997, Oncology (Williston Park), V11, P19; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen Wei-Juan, 2010, Chin J Cancer, V29, P151; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Giaccone, 1996, Oncologist, V1, P82; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; HORTOBAGYI GN, 1994, ONCOLOGY, V51, P29, DOI 10.1159/000227413; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MEDEN H, 1994, GEBURTSH FRAUENHEILK, V54, P187, DOI 10.1055/s-2007-1023580; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Parekh H, 1997, BIOCHEM PHARMACOL, V53, P461, DOI 10.1016/S0006-2952(97)83383-7; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; SLEDGE GW, 1994, SEMIN ONCOL, V21, P15; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	46	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4334	4345		10.1074/jbc.M112.419168	http://dx.doi.org/10.1074/jbc.M112.419168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255607	Green Published, hybrid			2022-12-25	WOS:000314845000061
J	Hoekstra, EJ; von Oerthel, L; van der Linden, AJA; Smidt, MP				Hoekstra, Elisa J.; von Oerthel, Lars; van der Linden, Annemarie J. A.; Smidt, Marten P.			Phox2b Influences the Development of a Caudal Dopaminergic Subset	PLOS ONE			English	Article							HOMEOBOX GENE PHOX2B; NEUROTRANSMITTER BIOSYNTHETIC GENES; TRANSCRIPTION FACTOR LMX1B; HOMEODOMAIN PROTEIN; ISTHMIC ORGANIZER; WNT1 EXPRESSION; MOTOR-NEURON; DIFFERENTIATION; SPECIFICATION; PHENOTYPE	The developing mesodiencephalic dopaminergic (mdDA) neuronal field can be subdivided into several molecularly distinct domains that arise due to spatiotemporally distinct origins of the neurons and distinct transcriptional pathways controlling these neuronal subsets. Two large anatomically and functionally different subdomains are formed that eventually give rise to the SNc and VTA, but more subsets exist which require detailed characterization in order to better understand the development of the functionally different mdDA subsets, and subset-specific vulnerability. In this study, we aimed to characterize the role of transcription factor Phox2b in the development of mdDA neurons. We provide evidence that Phox2b is co-expressed with TH in a dorsal-caudal subset of neurons in the mdDA neuronal field during embryonic development. Moreover, Phox2b transcripts were identified in FAC-sorted Pitx3 positive neurons. Subsequent analysis of Phox2b mutant embryos revealed that in the absence of Phox2b, a decrease of TH expression occurred specifically in the midbrain neuronal subset that normally co-expresses Phox2b with TH. Our data suggest that Phox2b is, next to the known role in the development of the oculomotor complex, involved in the development of a specific caudal mdDA neuronal subset.	[Hoekstra, Elisa J.; van der Linden, Annemarie J. A.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Hoekstra, Elisa J.; von Oerthel, Lars; van der Linden, Annemarie J. A.; Smidt, Marten P.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam	Smidt, MP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	TIPharma grant (Netherlands) [T5-207]; NWO VICI grant (Netherlands) [865.09.002]	TIPharma grant (Netherlands); NWO VICI grant (Netherlands)	This work was supported by a TIPharma grant (T5-207, Netherlands) and by an NWO VICI grant (865.09.002, Netherlands) to M.P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Asbreuk CHJ, 2002, MOL CELL NEUROSCI, V21, P410, DOI 10.1006/mcne.2002.1182; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Coppola E, 2010, DEVELOPMENT, V137, P4211, DOI 10.1242/dev.056747; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hasan KB, 2010, DEVELOPMENT, V137, P1205, DOI 10.1242/dev.041251; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pla P, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-14; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Swanson DJ, 2000, J BIOL CHEM, V275, P2911, DOI 10.1074/jbc.275.4.2911; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zellmer E, 1995, J NEUROSCI, V15, P8109	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52118	10.1371/journal.pone.0052118	http://dx.doi.org/10.1371/journal.pone.0052118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251691	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800143
J	Huang, CW; Hales, BF				Huang, Chunwei; Hales, Barbara F.			Effects of Exposure to a DNA Damaging Agent on the Hypoxia Inducible Factors in Organogenesis Stage Mouse Limbs	PLOS ONE			English	Article							CULTURED RAT EMBRYOS; BUD MESENCHYME; FACTOR 1-ALPHA; CELL-DEATH; MICE; DIFFERENTIATION; HIF-1-ALPHA; EXPRESSION; HIF1-ALPHA; P53	Hypoxia plays a critical role in coordinating cell survival, differentiation and death in normal embryogenesis; during limb pattern formation, hypoxia affects two key processes, chondrogenesis and cell death. Hypoxia promotes chondrocyte differentiation and cartilage matrix synthesis and suppresses terminal differentiation. Depending on the context, hypoxia may induce cell cycle arrest, pro- or anti-apoptotic genes, or autophagy. The response to hypoxia is controlled by hypoxia inducible transcription factors, specifically Hif1a, Hif2a and Hif3a. Under normoxia, the hypoxia-inducible factors respond to a variety of stimuli that include several well established teratogens, such as retinoic acid, heavy metals and hyperglycemia. We hypothesize that teratogenic exposures disrupt limb development by altering the hypoxia signalling pathway. To test this hypothesis, we assessed the effects of a DNA damaging alkylating agent, 4-hydroperoxycyclophosphamide, on the hypoxia inducible factor (HIF) transcription factors and on hypoxia in the murine limb bud culture system. 4-Hydroperoxycyclophosphamide exposure increased HIF1 DNA binding activity and HIF1A and HIF2A, but not HIF3A, protein concentrations. HIF1A and HIF2A immunoreactivities were detected in the apical ectodermal ridge and interdigital regions, where cell death sculpts the limb; 4-hydroperoxycyclophosphamide treatment enhanced their immunoreactivities, specifically in these regions. In contrast, hypoxia was localized to areas of chondrogenesis, the cartilaginous anlagen of the developing long bone and phalanges, and was not enhanced by drug exposure. Thus, the exposure of limb buds in vitro to a DNA damaging teratogen triggered a hypoxia signalling response that was associated with cell death. During limb development the HIFs have oxygen-independent functions.	[Huang, Chunwei; Hales, Barbara F.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University	Hales, BF (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	barbara.hales@mcgill.ca			Canadian Institutes of Health Research [MOP-86511]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-86511 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Fernandez-Martinez AB, 2011, INT J BIOCHEM CELL B, V43, P1198, DOI 10.1016/j.biocel.2011.04.013; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; HALES BF, 1986, TERATOLOGY, V34, P303, DOI 10.1002/tera.1420340310; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Huang CW, 2009, REPROD TOXICOL, V27, P103, DOI 10.1016/j.reprotox.2009.01.014; Huang CW, 2002, TERATOLOGY, V66, P288, DOI 10.1002/tera.10100; Ito T, 2012, TOHOKU J EXP MED, V226, P37, DOI 10.1620/tjem.226.37; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; MIRKES PE, 1985, TERATOGEN CARCIN MUT, V5, P75, DOI 10.1002/tcm.1770050202; Moallem SA, 1998, DEVELOPMENT, V125, P3225; MORRISS GM, 1979, J EMBRYOL EXP MORPH, V54, P17; Ornoy A, 2010, BIRTH DEFECTS RES B, V89, P106, DOI 10.1002/bdrb.20230; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schipani E, 2001, GENE DEV, V15, P2865; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shum Lillian, 2003, Birth Defects Research, V69, P102, DOI 10.1002/bdrc.10012; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Xu Y, 2012, ARCH TOXICOL, V86, P947, DOI 10.1007/s00204-012-0810-x; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07	39	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51937	10.1371/journal.pone.0051937	http://dx.doi.org/10.1371/journal.pone.0051937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251655	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800111
J	Levis, B; Burri, A; Hudson, M; Baron, M; Thombs, BD				Levis, Brooke; Burri, Andrea; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp CSRG	Sexual Activity and Impairment in Women with Systemic Sclerosis Compared to Women from a General Population Sample	PLOS ONE			English	Article							FUNCTION INDEX FSFI; PREVALENCE; SCLERODERMA; VALIDATION; DISEASE; ASSOCIATION; DYSFUNCTION; HEALTH; PAIN	Objective: Reports of low sexual activity rates and high impairment rates among women with chronic diseases have not included comparisons to general population data. The objective of this study was to compare sexual activity and impairment rates of women with systemic sclerosis (SSc) to general population data and to identify domains of sexual function driving impairment in SSc. Methods: Canadian women with SSc were compared to women from a UK population sample. Sexual activity and, among sexually active women, sexual impairment were evaluated with a 9-item version of the Female Sexual Function Index (FSFI). Results: Among women with SSc (mean age = 57.0 years), 296 of 730 (41%) were sexually active, 181 (61%) of whom were sexually impaired, resulting in 115 of 730 (16%) who were sexually active without impairment. In the UK population sample (mean age = 55.4 years), 956 of 1,498 women (64%) were sexually active, 420 (44%) of whom were impaired, with 536 of 1,498 (36%) sexually active without impairment. Adjusting for age and marital status, women with SSc were significantly less likely to be sexually active (OR = 0.34, 95% CI = 0.28-0.42) and, among sexually active women, significantly more likely to be sexually impaired (OR = 1.88, 95% CI = 1.42-2.49) than general population women. Controlling for total FSFI scores, women with SSc had significantly worse lubrication and pain scores than general population women. Conclusions: Sexual functioning is a problem for many women with scleroderma and is associated with pain and poor lubrication. Evidence-based interventions to support sexual activity and function in women with SSc are needed.	[Levis, Brooke; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Burri, Andrea] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Burri, Andrea] Univ Zurich, Inst Psychol, Zurich, Switzerland; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counseling Psychol, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; University of London; King's College London; University of Zurich; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	brett.thombs@mcgill.ca	Pope, Janet/G-3342-2011; Baron, Murray/AAF-9486-2019	Pope, Janet/0000-0003-1479-5302; Thombs, Brett D./0000-0002-5644-8432; Burri, Andrea/0000-0002-4705-3551	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis; Skin Health and Arthritis Across the Lifespan [SMA 112834]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); Fonds de la recherche en sante du Quebec (FRSQ); Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals; Wellcome Trust; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award with King's College London; Chronic Disease Research Foundation; Euroimmun; Mikrogen GmbH; Pfizer Inc.; CIHR [FRN 83518]; INOVA Diagnostics Inc	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis; Skin Health and Arthritis Across the Lifespan; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals; Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award with King's College London; Chronic Disease Research Foundation; Euroimmun; Mikrogen GmbH; Pfizer Inc.(Pfizer); CIHR(Canadian Institutes of Health Research (CIHR)); INOVA Diagnostics Inc	Ms. Levis' work was supported by a Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Oral, and Skin Health and Arthritis Across the Lifespan (# SMA 112834). Drs. Thombs and Hudson were supported by New Investigator Awards from the Canadian Institutes of Health Research. The CSRG was funded by the CIHR (grant # FRN 83518), the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en sante du Quebec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received eductional grants from Pfizer and Actelion pharmaceuticals. The UK Adult Twins registry received financial support from the Wellcome Trust, the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London, and the Chronic Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian Scleroderma Research Group (CSRG) has received commercial funding from INOVA Diagnostics Inc, Dr. Fooke Laboratorien GmbH, Euroimmun, Mikrogen GmbH, Actelion Pharmaceuticals and Pfizer Inc. For the present study, the authors used data collected via the CSRG Registry. Apart from this, no commercial funding was used to conduct the present study, and the commercial funders of the CSRG have no knowledge that the present study was conducted. Nonetheless, for full transparency, the authors declare that INOVA Diagnostics Inc, Dr. Fooke Laboratorien GmbH, Euroimmun, Mikrogen GmbH, Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. The commercial funding that provides support to the CSRG does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson E, 2009, CURR RHEUMATOL REV, V5, P126, DOI 10.2174/157339709788298446; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; BHADAURIA S, 1995, AM J OBSTET GYNECOL, V172, P580, DOI 10.1016/0002-9378(95)90576-6; Burri A, 2011, J SEX MED, V8, P2420, DOI 10.1111/j.1743-6109.2011.02341.x; Burri AV, 2009, J SEX MED, V6, P1930, DOI 10.1111/j.1743-6109.2009.01297.x; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Dunn KM, 2005, BIOL LETT-UK, V1, P260, DOI 10.1098/rsbl.2005.0308; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Impens AJ, 2009, CLIN EXP RHEUMATOL, V27, pS38; Jewett LR, 2010, ARTHRIT CARE RES, V62, P1779, DOI 10.1002/acr.20307; Knafo R, 2011, RHEUMATOLOGY, V50, P1125, DOI 10.1093/rheumatology/keq443; Knafo R, 2009, RHEUMATOLOGY, V48, P1300, DOI 10.1093/rheumatology/kep240; LEROY EC, 1988, J RHEUMATOL, V15, P202; Levis B, 2012, ARTHRIT CARE RES, V64, P340, DOI 10.1002/acr.20696; Lutfey KE, 2009, ARCH SEX BEHAV, V38, P514, DOI 10.1007/s10508-007-9290-0; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Meston CM, 2003, J SEX MARITAL THER, V29, P39, DOI 10.1080/713847100; Meston CM, 2002, J SEX MARITAL THER, V28, P155, DOI 10.1080/00926230252851276; Meyer-Bahlburg HFL, 2007, J SEX MARITAL THER, V33, P217, DOI 10.1080/00926230701267852; Nusbaum MRH, 2003, AM FAM PHYSICIAN, V67, P347; Razykov I, 2009, ARTHRIT RHEUM-ARTHR, V61, P1765, DOI 10.1002/art.25010; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Saad SC, 1996, J SEX RES, V33, P215, DOI 10.1080/00224499609551837; Saad SC, 1999, SEX DISABIL, V17, P103, DOI 10.1023/A:1021468216623; Sampaio-Barros PD, 2000, CLIN RHEUMATOL, V19, P184, DOI 10.1007/s100670050152; Schieir O, 2010, ARTHRIT CARE RES, V62, P409, DOI 10.1002/acr.20108; Schouffoer AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1601, DOI 10.1002/art.24728; SCHOVER LR, 1988, SEXUALITY CHRONIC IL; SEIBOLD J, 2005, KELLEYS TXB RHEUMATO; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; Thombs BD, 2010, ARTHRIT CARE RES, V62, P1181, DOI 10.1002/acr.20187; Thombs BD, 2009, ARTHRIT RHEUM-ARTHR, V61, P966, DOI 10.1002/art.24614; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206	34	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52129	10.1371/journal.pone.0052129	http://dx.doi.org/10.1371/journal.pone.0052129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251692	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000312386800144
J	van Waas, M; Neggers, SJCMM; Raat, H; van Rij, CM; Pieters, R; van den Heuvel-Eibrink, MM				van Waas, Marjolein; Neggers, Sebastian J. C. M. M.; Raat, Hein; van Rij, Caroline M.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.			Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors	PLOS ONE			English	Article							LONG-TERM SURVIVORS; RISK-FACTORS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; CHILDHOOD-CANCER; BODY-COMPOSITION; ADULT SURVIVORS; ADIPOSE-TISSUE; CELL FUNCTION; OBESITY	Background: Reports on metabolic syndrome in nephroblastoma and neuroblastoma survivors are scarce. Aim was to evaluate the occurrence of and the contribution of treatment regimens to the metabolic syndrome. Patients and Methods: In this prospective study 164 subjects participated (67 adult long-term nephroblastoma survivors (28 females), 36 adult long-term neuroblastoma survivors (21 females) and 61 control subjects (28 females)). Controls were recruited cross-sectionally. Waist and hip circumference as well as blood pressure were measured. Body composition and abdominal fat were assessed by dual energy X-ray absorptiometry (DXA-scan). Laboratory measurements included fasting triglyceride, high density lipoprotein-cholesterol (HDL-C), glucose, insulin, low-density lipoprotein-cholesterol (LDL-C) and free fatty acids (FFA) levels. Results: Median age at follow-up was 30 (range 19-51) years in survivors and 32 (range 18-62) years in controls. Median follow-up time in survivors was 26 (6-49) years. Nephroblastoma (OR = 5.2, P<0.0001) and neuroblastoma (OR 6.5, P<0.001) survivors had more components of the metabolic syndrome than controls. Survivors treated with abdominal irradiation had higher blood pressure, triglycerides, LDL-C, FFA and lower waist circumference. The latter can not be regarded as a reliable factor in these survivors as radiation affects the waist circumference. When total fat percentage was used as a surrogate marker of adiposity the metabolic syndrome was three times more frequent in abdominally irradiated survivors (27.5%) than in non-irradiated survivors (9.1%, P = 0.018). Conclusions: Nephroblastoma and neuroblastoma survivors are at increased risk for developing components of metabolic syndrome, especially after abdominal irradiation. We emphasize that survivors treated with abdominal irradiation need alternative adiposity measurements for assessment of metabolic syndrome. Citation: van Waas M, Neggers SJCMM, Raat H, van Rij CM, Pieters R, et al. (2012) Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors. PLoS ONE 7(12): e52237. doi:10.1371/journal.pone.0052237	[van Waas, Marjolein; Neggers, Sebastian J. C. M. M.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.] Erasmus MC Sophia Childrens Hosp Rotterdam, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Neggers, Sebastian J. C. M. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Med, Endocrinol Sect, Rotterdam, Netherlands; [Raat, Hein] Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [van Rij, Caroline M.] Erasmus Univ, Med Ctr Rotterdam, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van den Heuvel-Eibrink, MM (corresponding author), Erasmus MC Sophia Childrens Hosp Rotterdam, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	m.vandenheuvel@erasmusmc.nl			KiKa (Kinderen Kankervrij) [2009-030]; KOCR (Kinderoncologisch Centrum Rotterdam)	KiKa (Kinderen Kankervrij); KOCR (Kinderoncologisch Centrum Rotterdam)	The authors thank KiKa (Kinderen Kankervrij) (Grant number 2009-030) and KOCR (Kinderoncologisch Centrum Rotterdam) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein L, 1999, CANC INCIDENCE SURVI, P79; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; Blijdorp K, 2011, PEDIAT BLOOD CANC; Blokstra A, 1997, MONITORING RISICOFAC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Vathaire F, LANCET ONCOL; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Geenen MM, 2010, PEDIATR BLOOD CANCER, V55, P690, DOI 10.1002/pbc.22518; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Hermans MP, 1999, DIABETOLOGIA, V42, P678, DOI 10.1007/s001250051215; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KHOSLA T, 1967, BRIT J PREV SOC MED, V21, P122; Laverdiere C, 2005, PEDIATR BLOOD CANCER, V45, P324, DOI 10.1002/pbc.20331; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mackay J, 2004, ATLAS HEART DIS STRO; Marette A, 2003, INT J OBESITY, V27, pS46, DOI 10.1038/sj.ijo.0802500; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Pimenta N, 2010, REV PORT CARDIOL, V29, P1163; Radiation CotBEoI, 1990, HLTH EFF EXP LOW LEV; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sasso G, 2010, J PEDIAT HEMATOL ONC, V32, pE264, DOI 10.1097/MPH.0b013e3181e7931a; SHIMIZU Y, 1990, RADIAT RES, V121, P120, DOI 10.2307/3577495; van Beek RD, 2009, J CLIN ENDOCR METAB, V94, P1904, DOI 10.1210/jc.2008-0622; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; van Dijk IWEM, 2010, INT J RADIAT ONCOL, V78, P370, DOI 10.1016/j.ijrobp.2009.08.016; van Waas M, 2010, ANN ONCOL, V21, P1121, DOI 10.1093/annonc/mdp414; van Waas M, 2011, ANN ONCOL; Van Waas M, 2012, EUROPEAN J CANC; van Waas M, 2010, J PEDIAT HEMATOL ONC, V32, P171, DOI 10.1097/MPH.0b013e3181d419c3; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; World Health Organization, 2008, WAIST CIRCUMFERENCE; Wright KD, 2009, PEDIATR HEMAT ONCOL, V26, P407, DOI [10.1080/08880010903019344, 10.3109/08880010903019344]; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52237	10.1371/journal.pone.0052237	http://dx.doi.org/10.1371/journal.pone.0052237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251703	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800154
J	Le Port, A; Gueguen, A; Kesse-Guyot, E; Melchior, M; Lemogne, C; Nabi, H; Goldberg, M; Zins, M; Czernichow, S				Le Port, Agnes; Gueguen, Alice; Kesse-Guyot, Emmanuelle; Melchior, Maria; Lemogne, Cedric; Nabi, Hermann; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien			Association between Dietary Patterns and Depressive Symptoms Over Time: A 10-Year Follow-Up Study of the GAZEL Cohort	PLOS ONE			English	Article							FOOD-CONSUMPTION FREQUENCY; GENDER-DIFFERENCE; PERCEIVED STRESS; MOOD; OMEGA-3-FATTY-ACIDS; STUDENTS; QUALITY; ADULTS	Background: Data on the association between dietary patterns and depression are scarce. The objective of this study was to examine the longitudinal association between dietary patterns and depressive symptoms assessed repeatedly over 10 years in the French occupational GAZEL cohort. Methods: A total of 9,272 men and 3,132 women, aged 45-60 years in 1998, completed a 35-item Food Frequency Questionnaire (FFQ) at baseline. Dietary patterns were derived by Principal Component Analysis. Depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale (CES-D) in 1999, 2002, 2005 and 2008. The main outcome measure was the repeated measures of CES-D. Longitudinal analyses were performed with logistic regression based on generalized estimating equations. Principal Findings: The highest quartile of low-fat, western, high snack and high fat-sweet diets in men and low-fat and high snack diets in women were associated with higher likelihood of depressive symptoms at the start of the follow-up compared to the lowest quartile (OR between 1.16 and 1.50). Conversely, the highest quartile of traditional diet (characterized by fish and fruit consumption) was associated with a lower likelihood of depressive symptoms in women compared to the lowest quartile, with OR = 0.63 [95% CI, 0.50 to 0.80], as the healthy pattern (characterized by vegetables consumption) with OR = 0.72 [95% CI, 0.63 to 0.83] and OR = 0.75 [95% CI, 0.61 to 0.93] in men and women, respectively. However, there was probably a reverse causality effect for the healthy pattern. Conclusion: This longitudinal study shows that several dietary patterns are associated with depressive symptoms and these associations track over time.	[Le Port, Agnes; Gueguen, Alice; Melchior, Maria; Lemogne, Cedric; Nabi, Hermann; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien] Univ Versailles St Quentin, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Kesse-Guyot, Emmanuelle] Univ Paris 13, Conservatoire Natl Arts & Metiers, INSERM, UMR,U557,INRA,U1125, Bobigny, France; [Lemogne, Cedric] Hop Univ Paris Ouest, APHP, Serv Univ Psychiat Adulte & Sujet Age, Paris, France; [Lemogne, Cedric] Univ Paris 05, Fac Med, Paris, France; [Czernichow, Sebastien] Hop Ambroise Pare, APHP, Dept Nutr, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Le Port, A (corresponding author), Univ Versailles St Quentin, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France.	agnesleport@yahoo.fr	Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019; Zins, Marie/AAX-6551-2021; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Melchior, Maria/E-3992-2017; Kesse-Guyot, Emmanuelle/K-4689-2012	Goldberg, Marcel/0000-0002-6161-5880; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Le Port, Agnes/0000-0002-8337-6569; Nabi, Hermann/0000-0002-7832-0413	Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS); Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS); EDF-GDF; INSERM; Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET)	Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS); Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS); EDF-GDF; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET)	The GAZEL study is supported by the Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS) and the Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agnes Le Port had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors express their thanks to EDF-GDF, especially to the Service General de Medecine de Controle, and to the "Caisse centrale d'action sociale du personnel des industries electrique et gaziere". We also wish to acknowledge the Population-based Cohort Platform, Epidemiology and Public Health Research Center, UMRS INSERM Versailles St-Quentin University 1018, - responsible for the GAZEL data base management. The GAZEL Cohort Study was funded by EDF-GDF and INSERM, and received grants from the 'Cohortes Sante TGIR Program', Agence nationale de la recherche (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Chavance M, 2000, REV EPIDEMIOL SANTE, V48, P389; Cottrell G, 2009, REV EPIDEMIOL SANTE, V57, P361, DOI 10.1016/j.respe.2009.04.011; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Drewnowski A, 1995, ADDICT BEHAV, V20, P733, DOI 10.1016/0306-4603(95)00105-0; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kiecolt-Glaser JK, 2010, PSYCHOSOM MED, V72, P365, DOI 10.1097/PSY.0b013e3181dbf489; Kurland BF, 2009, STAT SCI, V24, P211, DOI 10.1214/09-STS293; Lepine JP, 2005, ENCEPHALE, V31, P182; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Liu CH, 2007, PHYSIOL BEHAV, V92, P748, DOI 10.1016/j.physbeh.2007.05.068; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; McDowell I., 2006, MEASURING HLTH GUIDE; Melchior M, 2010, PSYCHIAT RES, V177, P92, DOI 10.1016/j.psychres.2009.08.002; Melchior M, 2009, AM J PUBLIC HEALTH, V99, P1417, DOI 10.2105/AJPH.2008.142273; Mikolajczyk RT, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-31; Murakami K, 2010, MOL NUTR FOOD RES, V54, P471, DOI 10.1002/mnfr.200900157; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Niedhammer I, 1998, SCAND J WORK ENV HEA, V24, P197, DOI 10.5271/sjweh.299; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Rosenstrom T, 2012, PSYCHOL MED, V30, P1; Sabia S, 2011, ADDICTION, V106, P93, DOI 10.1111/j.1360-0443.2010.03106.x; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077; WHO, 2001, WORLD HLTH REP MENT; Yanovski S, 2003, J NUTR, V133, p835S, DOI 10.1093/jn/133.3.835S	40	101	103	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51593	10.1371/journal.pone.0051593	http://dx.doi.org/10.1371/journal.pone.0051593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251585	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200141
J	Pamenter, ME; Perkins, GA; McGinness, AK; Gu, XQ; Ellisman, MH; Haddad, GG				Pamenter, Matthew E.; Perkins, Guy A.; McGinness, Anelah K.; Gu, Xiang Q.; Ellisman, Mark H.; Haddad, Gabriel G.			Autophagy and Apoptosis Are Differentially Induced in Neurons and Astrocytes Treated with an In Vitro Mimic of the Ischemic Penumbra	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; ARTERY OCCLUSION; UP-REGULATION; CYTOCHROME-C; INFARCT RIM; BLOOD-FLOW; BRAIN; STROKE	The development of clinical stroke therapies remains elusive. The neuroprotective efficacies of thousands of molecules and compounds have not yet been determined; however, screening large volumes of potential targets in vivo is severely rate limiting. High throughput screens (HTS) may be used to discover promising candidates, but this approach has been hindered by the lack of a simple in vitro model of the ischemic penumbra, a clinically relevant region of stroke-afflicted brain. Recently, our laboratory developed such a mimic (ischemic solution: IS) suitable for HTS, but the etiology of stress pathways activated by this model are poorly understood. The aim of the present study was to determine if the cell death phenotype induced by IS accurately mimics the in vivo penumbra and thus whether our model system is suitable for use in HTS. We treated cultured neuron and astrocyte cell lines with IS for up to 48 hrs and examined cellular energy state ([ATP]), cell and organelle morphology, and gene and molecular profiles related to stress pathways. We found that IS-treated cells exhibited a phenotype of mixed apoptosis/autophagy characteristic of the in vivo penumbra, including: (1) short-term elevation of [ATP] followed by progressive ATP depletion and Poly ADP Ribose Polymerase cleavage, (2) increased vacuole number in the cytoplasm, (3) mitochondrial rupture, decreased mitochondrial and cristae density, release of cytochrome C and apoptosis inducing factor, (4) chromatin condensation, nuclear lamin A and DNA cleavage, fragmentation of the nuclear envelope, and (5) altered expression of mRNA and proteins consistent with autophagy and apoptosis. We conclude that our in vitro model of the ischemic penumbra induces autophagy and apoptosis in cultured neuron and astrocyte cell lines and that this mimic solution is suitable for use in HTS to elucidate neuroprotective candidates against ischemic penumbral cell death.	[Pamenter, Matthew E.; McGinness, Anelah K.; Gu, Xiang Q.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Pamenter, ME (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	mpamenter@ucsd.edu	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health [5P01HD032573, P30 NS047101]; Heart and Stroke Foundation of Canada fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada fellowship(Heart & Stroke Foundation of Canada); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants 5P01HD032573 to GGH and P30 NS047101 to the University of California San Diego Neurosciences Microscopy Shared Facility, and a Heart and Stroke Foundation of Canada fellowship to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanda N, 2006, BIOPHYS J, V90, P4405, DOI 10.1529/biophysj.105.080028; Anderson R E, 1999, J Stroke Cerebrovasc Dis, V8, P368, DOI 10.1016/S1052-3057(99)80044-5; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Banasiak KJ, 1999, MOL BRAIN RES, V72, P214, DOI 10.1016/S0169-328X(99)00189-8; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrer I, 2003, NEUROPATH APPL NEURO, V29, P472, DOI 10.1046/j.1365-2990.2003.00485.x; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gelot A, 2009, DEV NEUROSCI-BASEL, V31, P459, DOI 10.1159/000232564; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hattori K, 2010, ANTIOXID REDOX SIGN, V13, P1157, DOI 10.1089/ars.2010.3290; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Ju WK, 2009, MOL VIS, V15, P120; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Krupinski J, 2000, NEUROBIOL DIS, V7, P332, DOI 10.1006/nbdi.2000.0310; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matsushita K, 1998, NEUROSCIENCE, V83, P439, DOI 10.1016/S0306-4522(97)00391-6; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Morin D, 2004, BIOCHEM PHARMACOL, V68, P2065, DOI 10.1016/j.bcp.2004.07.006; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043995; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rami A, 2008, AUTOPHAGY, V4, P422, DOI 10.4161/auto.5778; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; ROBERTON AM, 1968, BIOCHEM J, V108, P445, DOI 10.1042/bj1080445; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yao H, 2001, MOL BRAIN RES, V91, P112, DOI 10.1016/S0169-328X(01)00135-8; Yao H, 2007, J NEUROCHEM, V103, P1644, DOI 10.1111/j.1471-4159.2007.04879.x; Yao H, 2007, J NEUROCHEM, V100, P1224, DOI 10.1111/j.1471-4159.2006.04299.x; Yao H, 2009, J NEUROCHEM, V108, P835, DOI 10.1111/j.1471-4159.2008.05838.x; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	62	36	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51469	10.1371/journal.pone.0051469	http://dx.doi.org/10.1371/journal.pone.0051469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251543	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200114
J	Fernandez-Sirera, L; Cabezon, O; Allepuz, A; Rosell, R; Riquelme, C; Serrano, E; Lavin, S; Marco, I				Fernandez-Sirera, Laura; Cabezon, Oscar; Allepuz, Alberto; Rosell, Rosa; Riquelme, Cristina; Serrano, Emmanuel; Lavin, Santiago; Marco, Ignasi			Two Different Epidemiological Scenarios of Border Disease in the Populations of Pyrenean chamois (Rupicapra p. pyrenaica) after the First Disease Outbreaks	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; PESTIVIRUS INFECTION; ROE DEER; SHEEP; WILD; SEROPREVALENCE; ANIMALS; CATTLE	Since 2001 several outbreaks of a new disease associated with Border disease virus (BDV) infection have caused important declines in Pyrenean chamois (Rupicapra pyrenaica) populations in the Pyrenees. The goal of this study was to analyze the post-outbreak BDV epidemiology in the first two areas affected by disease with the aim to establish if the infection has become endemic. We also investigated if BDV infected wild and domestic ruminants sharing habitat with chamois. Unexpectedly, we found different epidemiological scenarios in each population. Since the disease outbreaks, some chamois populations recuperated quickly, while others did not recover as expected. In chamois from the first areas, prevalence was high (73.47%) and constant throughout the whole study period and did not differ between chamois born before and after the BDV outbreak; in all, BDV was detected by RT-PCR in six chamois. In the other areas, prevalence was lower (52.79%) and decreased during the study period; as well, prevalence was significantly lower in chamois born after the disease outbreak. No BDV were detected in this population. A comparative virus neutralisation test performed with four BDV strains and one Bovine viral diarrhoea virus (BVDV) strain showed that all the chamois had BDV-specific antibodies. Pestivirus antibodies were detected in all the rest of analyzed species, with low prevalence values in wild ruminants and moderate values in domestic ruminants. No viruses were detected in these species. These results confirm the hypothesis that outbreaks of BDV infection only affect the Pyrenean chamois, although other wild ruminants can occasionally be infected. In conclusion, two different scenarios have appeared since the first border disease outbreaks in Pyrenean chamois: on the one hand frequent BDV circulation with possible negative impact on population dynamics in some areas and on the other, lack of virus circulation and quick recovery of the chamois population.	[Fernandez-Sirera, Laura; Cabezon, Oscar; Serrano, Emmanuel; Lavin, Santiago; Marco, Ignasi] Univ Autonoma Barcelona, Fac Vet, Servei Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain; [Fernandez-Sirera, Laura; Cabezon, Oscar; Allepuz, Alberto; Rosell, Rosa; Riquelme, Cristina] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, E-08193 Barcelona, Spain; [Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Rosell, Rosa] Dept Agr Alimentacio & Accio Rural, Barcelona, Spain; [Serrano, Emmanuel] Univ Lleida, Dept Matemat, Lleida, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Universitat de Lleida	Fernandez-Sirera, L (corresponding author), Univ Autonoma Barcelona, Fac Vet, Servei Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain.	laura@montx.com	Marco, Ignasi/E-8633-2015; Cabezón, Oscar/AAV-7876-2020; SERRANO-FERRON, Emmanuel/J-4489-2013; Cabezon, Oscar/L-3812-2014; Allepuz, Alberto/N-2398-2014; Lavín, Santiago/L-5975-2014	Marco, Ignasi/0000-0001-7479-3419; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Cabezon, Oscar/0000-0001-7543-8371; Allepuz, Alberto/0000-0003-3518-1991; Lavín, Santiago/0000-0001-5655-588X; Rosell, Rosa/0000-0002-8294-1159	University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion); Beatriu de Pinos programme (BP-DGR) of the Catalan Science and Technology System; Spanish government [CGL2006-11518/BOS, CGL2009-09071/BOS]	University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion); Beatriu de Pinos programme (BP-DGR) of the Catalan Science and Technology System; Spanish government(Spanish GovernmentEuropean Commission)	The PhD studies of LFS are funded by a University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion) and ES by the Beatriu de Pinos programme (BP-DGR 2011) of the Catalan Science and Technology System. This research was supported by grant CGL2006-11518/BOS and CGL2009-09071/BOS from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2008, SMALL RUMINANT RES, V78, P80, DOI 10.1016/j.smallrumres.2008.05.004; Altman DG, 2000, BRIT MED J, P116; Arnal MC, 2004, J GEN VIROL, V85, P3653, DOI 10.1099/vir.0.80235-0; Cabezon O, 2011, J GEN VIROL, V92, P2494, DOI 10.1099/vir.0.034595-0; Chappuis G, 1984, EPIDEMIOL SANTE ANIM, V6, P117; COLLETT MS, 1988, VIROLOGY, V165, P200, DOI 10.1016/0042-6822(88)90673-3; Fernandez-Sirera L, 2012, EUR J WILDLIFE RES, V58, P425, DOI 10.1007/s10344-011-0591-1; Fernandez-Sirera L, 2012, J WILDL DIS IN PRESS; Fischer S, 1998, J WILDLIFE DIS, V34, P47, DOI 10.7589/0090-3558-34.1.47; FROLICH K, 1995, J WILDLIFE DIS, V31, P243; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; Garcia-Perez AL, 2009, RES VET SCI, V86, P345, DOI 10.1016/j.rvsc.2008.07.004; Hurtado A, 2004, J WILDLIFE DIS, V40, P796, DOI 10.7589/0090-3558-40.4.796; Krametter R, 2004, J WILDLIFE DIS, V40, P791, DOI 10.7589/0090-3558-40.4.791; Krametter-Froetscher R, 2010, VET J, V186, P342, DOI 10.1016/j.tvjl.2009.09.006; Lillehaug A, 2003, J WILDLIFE DIS, V39, P779, DOI 10.7589/0090-3558-39.4.779; LOKEN T, 1995, VET CLIN N AM-FOOD A, V11, P597, DOI 10.1016/S0749-0720(15)30469-2; Marco I, 2008, RES VET SCI, V87, P149; Marco I, 2008, VET MICROBIOL, V127, P29, DOI 10.1016/j.vetmic.2007.08.015; Marco I, 2007, VET MICROBIOL, V120, P33, DOI 10.1016/j.vetmic.2006.10.007; Marco I, 2009, EMERG INFECT DIS, V15, P448, DOI 10.3201/eid1503.081155; Martin C, 2011, VET MICROBIOL, V147, P320, DOI 10.1016/j.vetmic.2010.07.010; Monies RJ, 2004, VET REC, V155, P765; Nettleton P F, 1990, Rev Sci Tech, V9, P131; NETTLETON PF, 1995, BRIT VET J, V151, P615, DOI 10.1016/S0007-1935(95)80145-6; Nettleton PF, 1998, VET RES, V29, P327; NEUMANN W, 1980, DEUT TIERARZTL WOCH, V87, P94; Nielsen SS, 2000, J WILDLIFE DIS, V36, P584, DOI 10.7589/0090-3558-36.3.584; OIE, 2008, MAN DIAGN TESTS VACC; REED L. J., 1938, AMER JOUR HYG, V27, P493; Registration dossier N&DEGASBVD6 Version n&DEG8 BVD p80 Ag Mono Indirect, 2012, REG DOSS ASBVD6 VERS; Riekerink RGMO, 2005, VET MICROBIOL, V108, P297, DOI 10.1016/j.vetmic.2005.04.014; ROMVARY J, 1965, ACTA VET ACAD SCI H, V15, P451; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHELLNER HP, 1977, TIERARZTL UMSCHAU, V32, P225; Schirrmeier H, 2004, J GEN VIROL, V85, P3647, DOI 10.1099/vir.0.80238-0; Valdazo-Gonzalez B, 2007, VET J, V174, P316, DOI 10.1016/j.tvjl.2006.10.002; Validation Data Report, 2011, POURQUIER ELISA BVD; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; Vilcek S, 1997, J GEN VIROL, V78, P725, DOI 10.1099/0022-1317-78-4-725; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060	42	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51031	10.1371/journal.pone.0051031	http://dx.doi.org/10.1371/journal.pone.0051031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251417	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900034
J	Hajrezaie, M; Golbabapour, S; Hassandarvish, P; Gwaram, NS; Hadi, AHA; Ali, HM; Majid, N; Abdulla, MA				Hajrezaie, Maryam; Golbabapour, Shahram; Hassandarvish, Pouya; Gwaram, Nura Suleiman; Hadi, A. Hamid A.; Ali, Hapipah Mohd; Majid, Nazia; Abdulla, Mahmood Ameen			Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Copper (II) Complex against Ethanol-Induced Acute Gastric Lesions in Rats	PLOS ONE			English	Article							ANTI-ULCEROGENIC ACTIVITY; PROCUMBENS LEAF EXTRACT; MUCOSAL INJURY; LIPID-PEROXIDATION; ANTIULCER ACTIVITY; STRESS; ANTIOXIDANT; ULCER; HEAT-SHOCK-PROTEIN-70; STOMACH	Background: Copper is an essential element in various metabolisms. The investigation was carried out to evaluate acute gastroprotective effects of the Copper (II) complex against ethanol-induced superficial hemorrhagic mucosal lesions in rats. Methodology/Principal Findings: Rats were divided into 7 groups. Groups 1 and 2 were orally administered with Tween 20 (10% v/v). Group 3 was orally administered with 20 mg/kg omeprazole (10% Tween 20). Groups 4-7 received 10, 20, 40, and 80 mg/kg of the complex (10% Tween 20), respectively. Tween 20 (10% v/v) was given orally to group 1 and absolute ethanol was given orally to groups 2-7, respectively. Rats were sacrificed after 1 h. Group 2 exhibited severe superficial hemorrhagic mucosal lesions. Gastric wall mucus was significantly preserved by the pre-treatment complex. The results showed a significant increase in glutathione (GSH), superoxide dismutase (SOD), nitric oxide (NO), and Prostaglandin E2 (PGE(2)) activities and a decrease in malondialdehyde (MDA) level. Histology showed marked reduction of hemorrhagic mucosal lesions in groups 4-7. Immunohistochemical staining showed up-regulation of Hsp70 and down-regulation of Bax proteins. PAS staining of groups 4-7 showed intense stain uptake of gastric mucosa. The acute toxicity revealed the nontoxic nature of the compound. Conclusions/Significance: The gastroprotective effect of the Copper (II) complex may possibly be due to preservation of gastric wall mucus; increase in PGE(2) synthesis; GSH, SOD, and NO up-regulation of Hsp70 protein; decrease in MDA level; and down-regulation of Bax protein.	[Hajrezaie, Maryam; Golbabapour, Shahram; Hassandarvish, Pouya; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Gwaram, Nura Suleiman; Hadi, A. Hamid A.; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Hajrezaie, Maryam; Golbabapour, Shahram; Majid, Nazia] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	MAJID, NAZIA ABDUL/B-9215-2010; Hassandarvish, Pouya/K-8112-2012; Gwaram, Nura Suleiman/AEQ-1882-2022; Gwaram, Nura/F-6667-2011	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Hassandarvish, Pouya/0000-0003-0364-5587; Gwaram, Nura Suleiman/0000-0002-8423-6111; Golbabapour, Shahram/0000-0001-8790-0316	University of Malaya [RG373/11HTM]; HIR-MOHE [F000009-21001]	University of Malaya(Universiti Malaya); HIR-MOHE	The authors would like to thank the University of Malaya for funding this research, RG373/11HTM and HIR-MOHE (F000009-21001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; AJITHA M, 2001, INDIAN DRUGS, V38, P545; Al Mofleh Ibrahim A, 2008, Saudi J Gastroenterol, V14, P128, DOI [10.1159/000106092, 10.4103/1319-3767.41731]; ARAUJO DAOV, 2011, BRAZILIAN J PHARMACO, V21, P721, DOI DOI 10.1590/S0102-695X2011005000117; Bagchi K, 1998, E MEDITERRANEAN HLTH, V4, P60; Bagchi M, 1999, NUTR RES, V19, P1189, DOI 10.1016/S0271-5317(99)00080-9; Behmer O, 1976, MANUAL HISTOLOGIA NO, P225; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; Chen W, 2010, EUR J MED CHEM, V45, P4473, DOI 10.1016/j.ejmech.2010.07.007; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Creaven BS, 2010, INORG CHIM ACTA, V363, P4048, DOI 10.1016/j.ica.2010.08.009; Creaven BS, 2010, POLYHEDRON, V29, P813, DOI 10.1016/j.poly.2009.11.002; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Ei-Sherif AA, 2011, SPECTROCHIM ACTA A, V79, P1803, DOI 10.1016/j.saa.2011.05.062; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Gwaram NS, 2011, ACTA CRYSTALLOGR E, V67, pM931, DOI 10.1107/S1600536811022045; HAWKEY CJ, 1985, GASTROENTEROLOGY, V89, P1162, DOI 10.1016/0016-5085(85)90225-2; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Khazaei M., 2006, IRAN J PHARM THER, V5, P43; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mahmood AA, 2010, J MED PLANTS RES, V4, P685; Mcmanus J, 1964, PAS REACTION STAININ; Mehmood A, 2010, INT J APPL BIOL PHAR, V1, P1337; MILLER TA, 1985, AM J PHYSIOL, V249, pG137, DOI 10.1152/ajpgi.1985.249.1.G137; Mradul Goswami, 2011, Journal of Applied Pharmaceutical Science, V1, P69; Mustafa IM, 2009, POLYHEDRON, V28, P3993, DOI 10.1016/j.poly.2009.10.004; NAGELE A, 1994, BIOCHEM PHARMACOL, V47, P555, DOI 10.1016/0006-2952(94)90188-0; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; OECD Guideline for testing of chemicals, 2005, OECD GUID TEST CHEM; Polat B, 2010, CHEM-BIOL INTERACT, V186, P82, DOI 10.1016/j.cbi.2010.03.041; Qui BS, 2004, WORLD J GASTROENTERO, V10, P594, DOI 10.3748/wjg.v10.i4.594; Raman N, 2011, SPECTROCHIM ACTA A, V79, P873, DOI 10.1016/j.saa.2011.03.017; Raman N, 2010, EUR J MED CHEM, V45, P5438, DOI 10.1016/j.ejmech.2010.09.004; ROCKCLIFFE DA, 1995, J MOL CATAL A-CHEM, V99, P87, DOI 10.1016/1381-1169(95)00032-1; Salga MS, 2011, MOLECULES, V16, P8654, DOI 10.3390/molecules16108654; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Shichijo K, 2003, DIGEST DIS SCI, V48, P340, DOI 10.1023/A:1021939829515; Takeuchi K., 2002, GASTROINTESTINAL MUC, P227; Tarnawski A, 2001, J PHYSIOL-PARIS, V95, P337, DOI 10.1016/S0928-4257(01)00046-8; Tuchinda P, 2002, PHYTOCHEMISTRY, V59, P169, DOI 10.1016/S0031-9422(01)00451-4; Umamaheswari M, 2007, J ETHNOPHARMACOL, V109, P547, DOI 10.1016/j.jep.2006.08.020; Vandenplas Y, 2000, WORLD J GASTROENTERO, V6, P20, DOI 10.3748/wjg.v6.i1.20; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Xiong RG, 1997, POLYHEDRON, V16, P2315; Yildirim A, 2007, J PHYSIOL PHARMACOL, V58, P105; Zahra AA, 2011, J MED PLANTS RES, V5, P2551; Zhao W, 2009, ACTA BIOCH BIOPH SIN, V41, P301, DOI 10.1093/abbs/gmp014	54	54	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51537	10.1371/journal.pone.0051537	http://dx.doi.org/10.1371/journal.pone.0051537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251568	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900098
J	Huang, H; Li, YJ; Liu, JH; Zheng, MH; Feng, YL; Hu, KH; Huang, YW; Huang, QD				Huang, He; Li, Yujie; Liu, Jihong; Zheng, Minghui; Feng, Yanling; Hu, Kunhua; Huang, Yongwen; Huang, Qidan			Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers	PLOS ONE			English	Article							MICROENVIRONMENT; PROTEOMICS	Objective: The ability to predict responses to chemotherapy for serous epithelial ovarian cancer (EOC) would be valuable since intrinsically chemoresistant EOC patients (persistent or recurrent disease within 6 months) gain little benefit from standard chemotherapy. The aim of this study was to screen and identify distinctive biomarkers in ascites of serous EOC associated with intrinsic chemoresistance. Methods: Protein samples from ascites of 12 chemosensitive and 7 intrinsically chemoresistant serous EOC patients were analyzed using two-dimensional fluorescence difference in gel electrophoresis (2-D DIGE) coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS). Furthermore, the identified proteins were validated by ELISA in ascites samples from 19 chemosensitive and 9 intrinsically chemoresistant EOC patients. Results: The number of spots detected in all 2-D DIGE gels ranged from 1523-1711 using DeCyder software analysis. Thirty-four spots were differentially expressed based on the criteria of an average ratio of more than 1.5 and a student t-test P value <0.05. After MALDI-TOF/TOF MS analysis, 11 differentially expressed proteins, including 3 up-regulated and 8 down-regulated proteins, in ascites of chemoresistant tumors were successfully identified. Of the four selected proteins (ceruloplasmin, apoliprotein A-IV, transthyretin and haptoglobin) in ascites tested by ELISA, only ceruloplasmin was present at significantly different levels between the chemoresistant and chemosensitive ascites samples with average concentrations of 192.2 mu g/ml and 157.5 mg/ml, respectively (P = 0.001). Conclusion: The significantly up-regulated level of ceruloplasmin in the ascites fluid of intrinsic chemoresistant serous EOC patients suggests its potential as a prognostic biomarker for responses to chemotherapy. This finding prompts further investigation with a larger study in order to validate the clinical utility of ceruloplasmin. Citation: Huang H, Li Y, Liu J, Zheng M, Feng Y, et al. (2012) Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers. PLoS ONE 7(12): e51256. doi:10.1371/journal.pone.0051256	[Huang, He; Li, Yujie; Liu, Jihong; Feng, Yanling; Huang, Yongwen; Huang, Qidan] Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Minghui] Sun Yat Sen Univ, Dept Clin Lab, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Kunhua] Sun Yat Sen Univ, Prote Ctr, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Liu, JH (corresponding author), Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	Liujh@sysucc.org.cn	Li, YuJie/HGT-8657-2022; Li, yu/HHZ-5236-2022	Liu, Jihong/0000-0003-3464-2901	Natural Science Foundation of Guangdong Province, China [7001535]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by a grant from the Natural Science Foundation of Guangdong Province, China (No. 7001535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RA, 2004, J AM COLL SURGEONS, V198, P999, DOI 10.1016/j.jamcollsurg.2004.01.035; Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Altinoz MA, 2004, NEOPLASMA, V51, P239; Bachvarov D, 2006, INT J ONCOL, V29, P919; Berek J., 2010, BEREK HACKERS GYNECO; CHAKRAVARTY PK, 1986, ACTA MED OKAYAMA, V40, P103; Cox C, 2001, LARYNGOSCOPE, V111, P696, DOI 10.1097/00005537-200104000-00024; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Hall MD, 2004, J INORG BIOCHEM, V98, P1614, DOI 10.1016/j.jinorgbio.2004.05.017; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Hu LM, 2002, AM J PATHOL, V161, P1917, DOI 10.1016/S0002-9440(10)64467-7; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Kassis J, 2005, DIAGN CYTOPATHOL, V33, P316, DOI 10.1002/dc.20280; Kluger HM, 2004, LAB INVEST, V84, P320, DOI 10.1038/labinvest.3700044; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Nayak Shivananda B, 2003, Indian J Physiol Pharmacol, V47, P108; Onizuka Keiichiro, 1999, Fukuoka Acta Medica, V90, P46; Petricoin EF, 2002, J MAMMARY GLAND BIOL, V7, P433, DOI 10.1023/A:1024042200521; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Spriggs D, 2003, GYNECOL ONCOL, V90, pS39, DOI 10.1016/S0090-8258(03)00471-2	24	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51256	10.1371/journal.pone.0051256	http://dx.doi.org/10.1371/journal.pone.0051256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251472	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900059
J	Riese, A; Eilert, Y; Meyer, Y; Arin, M; Baron, JM; Eming, S; Krieg, T; Kurschat, P				Riese, Anna; Eilert, Yvonne; Meyer, Yvonne; Arin, Meral; Baron, Jens M.; Eming, Sabine; Krieg, Thomas; Kurschat, Peter			Epidermal Expression of Neuropilin 1 Protects Murine keratinocytes from UVB-induced apoptosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AUTOCRINE SURVIVAL FACTOR; TUMOR-CELLS; SEMAPHORIN; SKIN; INITIATION; RECEPTORS; CARCINOMA; MCL-1	Background: Neuropilin 1 (NRP1) is expressed on several cell types including neurons and endothelial cells, where it functions as an important regulator in development and during angiogenesis. As a cell surface receptor, NRP1 is able to bind to members of the VEGF family of growth factors and to secreted class 3 semaphorins. Neuropilin 1 is also highly expressed in keratinocytes, but the function of NRP1 in epidermal physiology and pathology is still unclear. Methods and Results: To elucidate the role of NRP1 in skin in vivo we generated an epidermis-specific neuropilin 1 knock out mouse model by using the Cre-LoxP-System. Mice were viable and fertile and did not display any obvious skin or hair defects. After challenge with UVB irradiation, we found that deletion of epidermal NRP1 leads to increased rates of apoptosis both in vitro and in vivo. NRP1-deficient primary keratinocytes cultured in vitro showed significantly higher rates of apoptosis 24 hours after UVB. Likewise, there is a significant increase of active caspase 3 positive cells in the epidermis of Keratin 14-Cre-NRP1 (-/-) mice 24 hours after UVB irradiation. By Western Blot analysis we could show that NRP1 influences the cytosolic levels of Bcl-2, a pro-survival member of the Bcl-2 family. After UVB irradiation the amounts of Bcl-2 decrease in both protein extracts from murine epidermis and in NRP1-deficient keratinocytes in vitro, whereas wild type cells retain their Bcl-2 levels. Likewise, levels of phospho-Erk and Rac1 were lower in NRP1-knock out keratinocytes, whereas levels of pro-apoptotic p53 were higher. Conclusion: NRP1 expression in keratinocytes is dispensable for normal skin development. Upon UVB challenge, NRP1 contributes to the prevention of keratinocyte apoptosis. This pro-survival function of NRP1 is accompanied by the maintenance of high levels of the antiapoptotic regulator Bcl-2 and by lower levels of pro-apoptotic p53.	[Riese, Anna; Eilert, Yvonne; Meyer, Yvonne; Arin, Meral; Eming, Sabine; Krieg, Thomas; Kurschat, Peter] Univ Hosp Cologne, Dept Dermatol & Venerol, Cologne, Germany; [Baron, Jens M.] Rhein Westfal TH Aachen, Dept Dermatol & Allergol, D-52062 Aachen, Germany	University of Cologne; RWTH Aachen University	Kurschat, P (corresponding author), Univ Hosp Cologne, Dept Dermatol & Venerol, Cologne, Germany.	peter.kurschat@uk-koeln.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946	Deutsche Forschungsgemeinschaft (DFG) [SFB 829]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to PK (SFB 829, project B5) and SE (SFB 829, project B7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa Z, 2005, BBA-REV CANCER, V1755, P90, DOI 10.1016/j.bbcan.2005.04.001; Bachelder RE, 2001, CANCER RES, V61, P5736; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Cariboni A, 2011, DEVELOPMENT, V138, P3723, DOI 10.1242/dev.063362; Chang FM, 2003, INT J ONCOL, V22, P469; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Droin NM, 2004, BBA-MOL CELL RES, V1644, P179, DOI 10.1016/j.bbamcr.2003.10.011; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nishigori C, 2006, PHOTOCH PHOTOBIO SCI, V5, P208, DOI 10.1039/b507471a; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Sitailo LA, 2009, J INVEST DERMATOL, V129, P1351, DOI 10.1038/jid.2008.363; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi H, 2001, PHOTOCHEM PHOTOBIOL, V74, P579, DOI 10.1562/0031-8655(2001)074<0579:IVAIVT>2.0.CO;2; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Trakatelli M, 2007, BRIT J DERMATOL, V156, P1, DOI 10.1111/j.1365-2133.2007.07861.x; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8	41	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50944	10.1371/journal.pone.0050944	http://dx.doi.org/10.1371/journal.pone.0050944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251405	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900027
J	Thal, SC; Luh, C; Schaible, EV; Timaru-Kast, R; Hedrich, J; Luhmann, HJ; Engelhard, K; Zehendner, CM				Thal, Serge C.; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Hedrich, Jana; Luhmann, Heiko J.; Engelhard, Kristin; Zehendner, Christoph M.			Volatile Anesthetics Influence Blood-Brain Barrier Integrity by Modulation of Tight Junction Protein Expression in Traumatic Brain Injury	PLOS ONE			English	Article							ISOFLURANE ANESTHESIA; OCCLUDIN EXPRESSION; NEUROVASCULAR UNIT; CEREBRAL VESSELS; EDEMA FORMATION; SEVOFLURANE; FLOW; GLUTAMATE; ISCHEMIA; WATER	Disruption of the blood-brain barrier (BBB) results in cerebral edema formation, which is a major cause for high mortality after traumatic brain injury (TBI). As anesthetic care is mandatory in patients suffering from severe TBI it may be important to elucidate the effect of different anesthetics on cerebral edema formation. Tight junction proteins (TJ) such as zonula occludens-1 (ZO-1) and claudin-5 (cl5) play a central role for BBB stability. First, the influence of the volatile anesthetics sevoflurane and isoflurane on in-vitro BBB integrity was investigated by quantification of the electrical resistance (TEER) in murine brain endothelial monolayers and neurovascular co-cultures of the BBB. Secondly brain edema and TJ expression of ZO-1 and cl5 were measured in-vivo after exposure towards volatile anesthetics in native mice and after controlled cortical impact (CCI). In in-vitro endothelial monocultures, both anesthetics significantly reduced TEER within 24 hours after exposure. In BBB co-cultures mimicking the neurovascular unit (NVU) volatile anesthetics had no impact on TEER. In healthy mice, anesthesia did not influence brain water content and TJ expression, while 24 hours after CCI brain water content increased significantly stronger with isoflurane compared to sevoflurane. In line with the brain edema data, ZO-1 expression was significantly higher in sevoflurane compared to isoflurane exposed CCI animals. Immunohistochemical analyses revealed disruption of ZO-1 at the cerebrovascular level, while cl5 was less affected in the pericontusional area. The study demonstrates that anesthetics influence brain edema formation after experimental TBI. This effect may be attributed to modulation of BBB permeability by differential TJ protein expression. Therefore, selection of anesthetics may influence the barrier function and introduce a strong bias in experimental research on pathophysiology of BBB dysfunction. Future research is required to investigate adverse or beneficial effects of volatile anesthetics on patients at risk for cerebral edema.	[Thal, Serge C.; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Mainz, Germany; [Hedrich, Jana; Luhmann, Heiko J.; Zehendner, Christoph M.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Mainz, Germany.	thal@uni-mainz.de; zehendner@uni-mainz.de	Thal, Serge/D-6593-2011; Luhmann, Heiko J./N-8797-2019	Thal, Serge/0000-0002-1222-8729; Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft [TH1430/3-1]; Focus Program Translational Neurosciences (FTN); University Medical Center of the Johannes Gutenberg-University; University Medical Center of the Johannes Gutenberg-University Mainz; IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Focus Program Translational Neurosciences (FTN); University Medical Center of the Johannes Gutenberg-University; University Medical Center of the Johannes Gutenberg-University Mainz; IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz	This work was supported by grants of the Deutsche Forschungsgemeinschaft (TH1430/3-1), the Focus Program Translational Neurosciences (FTN) and a stage 1 grant of the University Medical Center of the Johannes Gutenberg-University to SCT. CMZ is supported by a stage 1 grant of the University Medical Center of the Johannes Gutenberg-University Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicting financial interest to declare.; The authors want to thank Dana Pieter, Tobias Hirnet, Sabine Rickheim-Lowack, Beate Kohler and Beate Krumm for her excellent technical assistance. Support by the IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz is gratefully acknowledged.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; D'Atri F, 2002, MOL MEMBR BIOL, V19, P103, DOI 10.1080/09687680210129236; Dittmar MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038260; Eberspacher E, 2009, ACTA ANAESTH SCAND, V53, P774, DOI 10.1111/j.1399-6576.2009.01954.x; FISCHER S, 1995, ANESTHESIOLOGY, V82, P451, DOI 10.1097/00000542-199502000-00015; Fischer S, 1996, BRAIN RES, V707, P47, DOI 10.1016/0006-8993(95)01219-2; Fukui K, 2010, J CLIN NEUROPHYSIOL, V27, P110, DOI 10.1097/WNP.0b013e3181d64da1; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hoffmann U, 2013, ACTA NEUROCHIR SUPPL, V115, P161, DOI 10.1007/978-3-7091-1192-5_31; Holmstrom A, 2004, J NEUROSURG ANESTH, V16, P136, DOI 10.1097/00008506-200404000-00005; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kandatsu N, 2005, ANESTHESIOLOGY, V102, P1182, DOI 10.1097/00000542-200506000-00018; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; LUNDEEN G, 1983, ANESTH ANALG, V62, P499; MANOHAR M, 1984, J PHARMACOL EXP THER, V231, P640; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Mills CD, 1997, J NEUROTRAUM, V14, P943, DOI 10.1089/neu.1997.14.943; Ritz MF, 2006, INT J NEUROSCI, V116, P191, DOI 10.1080/00207450500341555; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; SCHETTINI A, 1979, BRIT J ANAESTH, V51, P1117, DOI 10.1093/bja/51.12.1117; Seo JH, 2012, CURRENT PHARM DESIGN; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; SMITH AL, 1976, ANESTHESIOLOGY, V45, P64, DOI 10.1097/00000542-197607000-00012; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Werner C, 2009, CAN J ANAESTH, V56, P883, DOI 10.1007/s12630-009-9166-y; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	48	62	66	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50752	10.1371/journal.pone.0050752	http://dx.doi.org/10.1371/journal.pone.0050752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251381	gold, Green Published			2022-12-25	WOS:000312201900015
J	Shabbeer, S; Omer, D; Berneman, D; Weitzman, O; Alpaugh, A; Pietraszkiewicz, A; Metsuyanim, S; Shainskaya, A; Papa, MZ; Yarden, RI				Shabbeer, S.; Omer, D.; Berneman, D.; Weitzman, O.; Alpaugh, A.; Pietraszkiewicz, A.; Metsuyanim, S.; Shainskaya, A.; Papa, M. Z.; Yarden, R. I.			BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation	ONCOGENE			English	Article						BRCA1; cyclin B; Cdc25; ubiquitination; proteasome; G2/M cell cycle checkpoint	E3 LIGASE ACTIVITY; KEN-BOX; BINDING; PHOSPHORYLATION; CHECKPOINT; RING; COMPLEX; DOMAIN; CHK1; B1	The BRCA1 tumor suppressor protein heterodimerizes with its partner protein, BARD1, via the RING domain present in both proteins. The heterodimer contains an E3 ubiquitin ligase activity and participates in multiple cellular functions such as cell cycle control, DNA repair and regulation of gene transcription, collectively aimed at maintaining genomic stability and tumor suppression. Yet, the precise role of BRCA1 E3 ligase in these cellular functions is poorly understood. We present data showing that BRCA1 ubiquitinates G2/M cell cycle proteins, cyclin B and Cdc25C, leading to their accelerated degradation via a mechanism that is independent of APC/C. BRCA1-dependent degradation of cyclin B and Cdc25C is reversed by proteasome inhibitors and is enhanced following DNA damage, which may represent a possible mechanism to prevent cyclin B and Cdc25C accumulation, a requirement for mitotic entry. Our data provide mechanistic insight into how BRCA1 E3 ligase activity regulates the G2/M cell cycle checkpoint and, thus, contributes to maintenance of genomic stability.	[Shabbeer, S.; Alpaugh, A.; Pietraszkiewicz, A.; Yarden, R. I.] Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA; [Shabbeer, S.; Yarden, R. I.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Omer, D.; Berneman, D.; Weitzman, O.; Metsuyanim, S.; Papa, M. Z.; Yarden, R. I.] Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, Israel; [Shainskaya, A.] Weizmann Inst Sci, Laraine & Alan A Fischer Lab Biol Mass Spectromet, IL-76100 Rehovot, Israel	Georgetown University; Georgetown University; Chaim Sheba Medical Center; Weizmann Institute of Science	Yarden, RI (corresponding author), Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, St Marys Hall Rm 260,3700 Reservoir Rd NW, Washington, DC 20057 USA.	riy2@georgetown.edu		Pietraszkiewicz, Alexandra/0000-0002-9982-6261	Israel Cancer Research Fund; Health Ministry; Israeli Cancer Association; Georgetown University, SNHS; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Israel Cancer Research Fund; Health Ministry; Israeli Cancer Association; Georgetown University, SNHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs B Henderson, J Pines, R Agami, E Rosen and M Brandeis for providing plasmids and Dr L Brody for reagents. We thank the microscopy unit in Bar-Ilan University for assistance with immunofluorescence studies and Dr I Goldstein and the flow cytometry unit at the Sheba medical center for assistance with fluorescence-activated cell sorting analysis. We thank Allison Hall for technical assistance. We thank Drs Eliot Rosen, Claire Pollack, Michael Brandeis and Gad Lavie for stimulating discussions and critical reading of the manuscript. This study was supported by a Research Career Development Award from the Israel Cancer Research Fund (to RIY) and by the funding from the Health Ministry (to RIY and MZP), the Israeli Cancer Association (RIY) and funds from Georgetown University, SNHS to RIY.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Aprelikova O, 2001, J BIOL CHEM, V276, P25647, DOI 10.1074/jbc.C100265200; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Brodie S G, 2001, Trends Genet, V17, pS18, DOI 10.1016/S0168-9525(01)02451-9; Calvo V, 2011, CANCER RES, V71, P3422, DOI 10.1158/0008-5472.CAN-10-3670; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Pfleger CM, 2000, GENE DEV, V14, P655; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wu WW, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-1; Wu WW, 2007, CANCER RES, V67, P951, DOI 10.1158/0008-5472.CAN-06-3187; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Wu-Baer F, 2010, MOL CELL BIOL, V30, P2787, DOI 10.1128/MCB.01056-09; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xu B, 2002, CANCER RES, V62, P4588; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471; Yarden RI, 2012, INT J BIOCHEM CELL B, V44, P1761, DOI 10.1016/j.biocel.2012.06.026; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	53	43	44	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5005	5016		10.1038/onc.2012.522	http://dx.doi.org/10.1038/onc.2012.522			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23246971	Green Accepted			2022-12-25	WOS:000325937900002
J	Paintlia, MK; Paintlia, AS; Singh, AK; Singh, I				Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Avtar K.; Singh, Inderjit			S-Nitrosoglutathione Induces Ciliary Neurotrophic Factor Expression in Astrocytes, Which Has Implications to Protect the Central Nervous System under Pathological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; ACTIVATED-RECEPTOR-GAMMA; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE ACTIVATION; IN-VITRO; SIGNALING PATHWAY; GLIAL-CELLS; CYCLOOXYGENASE-2 EXPRESSION; OLIGODENDROCYTE PROGENITORS; DEMYELINATING DISEASES	Accumulating evidence suggests that reactive astrogliosis has beneficial and detrimental outcomes in various CNS disorders, but the mechanism behind this dichotomy is unclear. Recent advances in this direction suggested that NO signaling is critical to regulate the outcomes of reactive astrogliosis in vivo. Using biochemical and genetic approaches, we here investigated the effect of S-nitrosoglutathione (GSNO; a physiological NO donor) in astrocytes in vitro settings. GSNO enhanced the expressions of glial fibrillary acidic protein and neurotrophic factors including ciliary neurotrophic factor (CNTF) in astrocytes in a dose-dependent manner. The enhanced CNTF expression in GSNO-treated astrocytes was ascribed to NO-mediated sGC/cGMP/PKG signaling. It was associated with p38 MAPK-dependent increased peroxisome proliferator-activated receptor-gamma transactivation. In addition, the chromatin accessibility of peroxisome proliferator-activated receptor-gamma accompanied with ATF2 and CREB (cAMP-response element-binding protein) was enhanced across the CNTF gene promoter in GSNO treated astrocytes. Interestingly, secreted CNTF was responsible for increased expression of glial fibrillary acidic protein in GSNO-treated astrocytes in an autocrine manner via a JAK2- and STAT3-dependent mechanism. In addition, CNTF secreted by GSNO-treated astrocytes enhanced the differentiation of immature oligodendrocytes in vitro. These effects of GSNO were consistent with an endogenously produced NO in astrocytes stimulated with proinflammatory cytokines in vitro. We conclude that NO signaling induces CNTF expression in astrocytes that favors the beneficial outcomes of reactive astrogliosis in vivo. Our data suggest that the endogenously produced NO or its exogenous source has potential to modulate the outcomes of reactive astrogliosis to protect CNS under pathological conditions.	[Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Darby Childrens Res Inst, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Affairs Med Ctr, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, 173 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu	Singh, Ashok/HGF-2506-2022		National Institutes of Health [NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022576, R01NS037766, R01NS022576, R01NS072511] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, and C06 RR015455.	Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Albrecht PJ, 2003, NEUROBIOL DIS, V13, P89, DOI 10.1016/S0969-9961(03)00019-6; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bishop A, 2005, TOXICOLOGY, V208, P193, DOI 10.1016/j.tox.2004.11.034; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; BRUHWYLER J, 1993, NEUROSCI BIOBEHAV R, V17, P373, DOI 10.1016/S0149-7634(05)80114-9; Chien WL, 2008, EUR J PHARMACOL, V590, P233, DOI 10.1016/j.ejphar.2008.06.040; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Crowe DL, 2000, ANTICANCER RES, V20, P2945; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hebert MA, 2000, ANN NY ACAD SCI, V914, P238, DOI 10.1111/j.1749-6632.2000.tb05200.x; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Janabi N, 2002, J IMMUNOL, V168, P4747, DOI 10.4049/jimmunol.168.9.4747; Kacem K, 1998, GLIA, V23, P1; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu B, 2001, ARCH OPHTHALMOL-CHIC, V119, P240; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; MAGRINAT G, 1992, BLOOD, V80, P1880; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Paintlia AS, 2006, J IMMUNOL, V176, P4385, DOI 10.4049/jimmunol.176.7.4385; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230; Paintlia AS, 2005, FASEB J, V19, P1407, DOI 10.1096/fj.05-3861com; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Vega-Avelaira D, 2007, BRAIN BEHAV IMMUN, V21, P617, DOI 10.1016/j.bbi.2006.10.007; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	69	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3831	3843		10.1074/jbc.M112.405654	http://dx.doi.org/10.1074/jbc.M112.405654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264628	Green Published, hybrid			2022-12-25	WOS:000314845000015
J	Duan, HC; Wang, JN				Duan, Haichuan; Wang, Joanne			Impaired Monoamine and Organic Cation Uptake in Choroid Plexus in Mice with Targeted Disruption of the Plasma Membrane Monoamine Transporter (Slc29a4) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-CSF BARRIER; CEREBROSPINAL-FLUID; FUNCTIONAL-CHARACTERIZATION; EPITHELIAL-CELLS; PRIMARY CULTURE; HUMAN BRAIN; RAT-BRAIN; EXPRESSION; PEPT2; LOCALIZATION	The choroid plexus (CP) forms the blood-cerebrospinal fluid (CSF) barrier and protects the brain from circulating metabolites, drugs, and toxins. The plasma membrane monoamine transporter (PMAT, SLC29A4) is a new polyspecific organic cation transporter that transports a wide variety of organic cations including biogenic amines, cationic drugs, and neurotoxins. PMAT is known to be expressed in the CP, but its specific role in CP transport of organic cations has not been clearly defined. Here we showed that PMAT transcript is highly expressed in human and mouse CPs, whereas transcripts of other functionally related transporters are minimally expressed in the CPs. Immunofluorescence staining further revealed that PMAT protein is localized to the apical (CSF-facing) membrane of the CP epithelium, consistent with a role of transporting organic cations from the CSF into CP epithelial cells. To further evaluate the role of PMAT in the CP, mice with targeted deletion of the Slc29a4 gene were generated and validated. Although Pmat(-/-) mice showed no overt abnormalities, the uptake of monoamines and the neurotoxin 1-methyl-4-phenylpyridinium was significantly reduced in CP tissues isolated from the knock-out mice. Together, our data demonstrated that PMAT is a major transporter for CP uptake of bioactive amines and xenobiotic cations. By removing its substrates from the CSF, PMAT may play an important role in protecting the brain from cationic neurotoxins and other potentially toxic organic cations.	[Duan, Haichuan; Wang, Joanne] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wang, JN (corresponding author), Univ Washington, Dept Pharmaceut, H272J Hlth Sci Bldg, Seattle, WA 98195 USA.	jowang@uw.edu			National Institutes of Health [GM066233, GM066233-07S1]; National Disease Research Interchange with from National Institutes of Health [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Disease Research Interchange with from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066233 and GM066233-07S1 (to J. W.). This work was also supported by National Disease Research Interchange with support from National Institutes of Health Grant 5 U42 RR006042.	Choudhuri S, 2003, DRUG METAB DISPOS, V31, P1337, DOI 10.1124/dmd.31.11.1337; Collins MA, 2000, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, P115; Dahlin A, 2007, NEUROSCIENCE, V146, P1193, DOI 10.1016/j.neuroscience.2007.01.072; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Engel K, 2005, MOL PHARMACOL, V68, P1397, DOI 10.1124/mol.105.016832; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Graff CL, 2004, CURR DRUG METAB, V5, P95, DOI 10.2174/1389200043489126; Ho Horace T B, 2012, Front Pharmacol, V3, P154, DOI 10.3389/fphar.2012.00154; Ho HTB, 2011, J PHARMACOL EXP THER, V339, P376, DOI 10.1124/jpet.111.184036; Hu YJ, 2007, J NEUROCHEM, V103, P2058, DOI 10.1111/j.1471-4159.2007.04905.x; Itagaki S, 2012, DRUG METAB DISPOS, V40, P1138, DOI 10.1124/dmd.111.042432; KAPLAN GP, 1981, BRAIN RES, V204, P353, DOI 10.1016/0006-8993(81)90594-1; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kusuhara H, 2004, ADV DRUG DELIVER REV, V56, P1741, DOI 10.1016/j.addr.2004.07.007; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; LINDVALL M, 1980, ACTA PHYSIOL SCAND, V108, P215, DOI 10.1111/j.1748-1716.1980.tb06525.x; Mignini F, 2000, J AUTON PHARMACOL, V20, P325, DOI 10.1046/j.1365-2680.2000.00198.x; Miller DS, 1999, AM J PHYSIOL-CELL PH, V276, pC955, DOI 10.1152/ajpcell.1999.276.4.C955; Nagatsu T, 1997, NEUROSCI RES, V29, P99, DOI 10.1016/S0168-0102(97)00083-7; Okura T, 2011, J PHARM SCI-US, V100, P3924, DOI 10.1002/jps.22594; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Pavone LM, 2007, ANAT REC, V290, P1492, DOI 10.1002/ar.20610; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Roberts JC, 2002, BRAIN RES, V934, P49, DOI 10.1016/S0006-8993(02)02360-0; Shen H, 2003, J BIOL CHEM, V278, P4786, DOI 10.1074/jbc.M207397200; Shu C, 2002, J PHARMACOL EXP THER, V301, P820, DOI 10.1124/jpet.301.3.820; Smith DE, 2011, J CEREBR BLOOD F MET, V31, P250, DOI 10.1038/jcbfm.2010.84; Smith DE, 2004, ADV DRUG DELIVER REV, V56, P1765, DOI 10.1016/j.addr.2004.07.008; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Spector R, 2010, J NEUROCHEM, V112, P13, DOI 10.1111/j.1471-4159.2009.06451.x; SUZUKI H, 1986, J PHARMACOL EXP THER, V239, P927; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 2001, J BIOL CHEM, V276, P41611, DOI 10.1074/jbc.M108472200; Teuscher NS, 2000, J PHARMACOL EXP THER, V294, P494; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vialou V, 2007, NEUROSCIENCE, V144, P616, DOI 10.1016/j.neuroscience.2006.09.058; Villalobos AR, 1997, J PHARMACOL EXP THER, V282, P1109; Vitalis T, 2002, J COMP NEUROL, V442, P331, DOI 10.1002/cne.10093; Xia L, 2007, AM J PHYSIOL-RENAL, V292, pF682, DOI 10.1152/ajprenal.00302.2006; Xia L, 2009, AM J PHYSIOL-RENAL, V296, pF1307, DOI 10.1152/ajprenal.00046.2009; Zhou MY, 2010, DRUG METAB DISPOS, V38, P1798, DOI 10.1124/dmd.110.032987	46	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3535	3544		10.1074/jbc.M112.436972	http://dx.doi.org/10.1074/jbc.M112.436972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255610	hybrid, Green Published			2022-12-25	WOS:000314397900058
J	Korschen, HG; Yildiz, Y; Raju, DN; Schonauer, S; Bonigk, W; Jansen, V; Kremmer, E; Kaupp, UB; Wachten, D				Koerschen, Heinz G.; Yildiz, Yildiz; Raju, Diana Nancy; Schonauer, Sophie; Boenigk, Wolfgang; Jansen, Vera; Kremmer, Elisabeth; Kaupp, U. Benjamin; Wachten, Dagmar			The Non-lysosomal beta-Glucosidase GBA2 Is a Non-integral Membrane-associated Protein at the Endoplasmic Reticulum (ER) and Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLOTHO-RELATED PROTEIN; GAUCHERS-DISEASE; GLYCOSPHINGOLIPID SYNTHESIS; GLUCOCEREBROSIDASE GENE; MOLECULAR-CLONING; HUMAN LIVER; RAT-LIVER; GLUCOSYLCERAMIDE; RECONSTITUTION; MUTATION	GBA1 and GBA2 are both beta-glucosidases, which cleave glucosylceramide (GlcCer) to glucose and ceramide. GlcCer is a main precursor for higher order glycosphingolipids but might also serve as intracellular messenger. Mutations in the lysosomal GBA1 underlie Gaucher disease, the most common lysosomal storage disease in humans. Knocking out the non-lysosomal GBA2 in mice results in accumulation of GlcCer outside the lysosomes in various tissues (e. g. testis and liver) and impairs sperm development and liver regeneration. However, the underlying mechanisms are not well understood. To reveal the physiological function of GBA2 and, thereby, of the non-lysosomal GlcCer pool, it is important to characterize the localization of GBA2 and its activity in different tissues. Thus, we generated GBA2-specific antibodies and developed an assay that discriminates between GBA1 and GBA2 without the use of detergent. We show that GBA2 is not, as previously thought, an integral membrane protein but rather a cytosolic protein that tightly associates with cellular membranes. The interaction with the membrane, in particular with phospholipids, is important for its activity. GBA2 is localized at the ER and Golgi, which puts GBA2 in a key position for a lysosome-independent route of GlcCer-dependent signaling. Furthermore, our results suggest that GBA2 might affect the phenotype of Gaucher disease, because GBA2 activity is reduced in Gba1 knock-out fibroblasts and fibroblasts from a Gaucher patient. Our results provide the basis to understand the mechanism for GBA2 function in vivo and might help to unravel the role of GBA2 during pathogenesis of Gaucher disease.	[Koerschen, Heinz G.; Raju, Diana Nancy; Schonauer, Sophie; Boenigk, Wolfgang; Jansen, Vera; Kaupp, U. Benjamin; Wachten, Dagmar] Ctr Adv European Studies & Res, Dept Mol Sensory Syst, D-53175 Bonn, Germany; [Yildiz, Yildiz; Raju, Diana Nancy] Univ Klinikum Bonn, Med Klin 1, D-53105 Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Center of Advanced European Studies & Research (CAESAR); University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wachten, D (corresponding author), Ctr Adv European Studies & Res, Dept Mol Sensory Syst, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	dagmar.wachten@caesar.de			Deutsche Forschungsgemeinschaft Grant [SFB 645]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 645.	Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; BENYOSEPH Y, 1978, J CLIN PATHOL, V31, P1091, DOI 10.1136/jcp.31.11.1091; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; COOK NJ, 1986, J BIOL CHEM, V261, P7033; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Graaf M, 2001, BIOCHEM J, V356, P907, DOI 10.1042/0264-6021:3560907; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Germain DP, 1998, AM J HUM GENET, V63, P415, DOI 10.1086/301969; Gonzalez-Carmona MA, 2012, LIVER INT, V32, P1354, DOI 10.1111/j.1478-3231.2012.02841.x; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Hirabayashi Y, 2012, P JPN ACAD B-PHYS, V88, P129, DOI 10.2183/pjab.88.129; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; Lachmann RH, 2004, QJM-INT J MED, V97, P199, DOI 10.1093/qjmed/hch036; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Legler G, 1977, Methods Enzymol, V46, P368; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Matern H, 2001, J BIOL CHEM, V276, P37929; Matern H, 1997, J BIOL CHEM, V272, P11261; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Paul P, 1996, J BIOL CHEM, V271, P2287, DOI 10.1074/jbc.271.4.2287; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROBINSON D, 1956, BIOCHEM J, V63, P39, DOI 10.1042/bj0630039; Stanley P, 2009, ESSENTIALS GLYCOBIOL; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P442, DOI 10.1016/0005-2744(77)90036-5; TURNER BM, 1978, AM J HUM GENET, V30, P346; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Yahata K, 2000, J MOL MED, V78, P389, DOI 10.1007/s001090000131; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	41	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3381	3393		10.1074/jbc.M112.414714	http://dx.doi.org/10.1074/jbc.M112.414714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250757	Green Published, hybrid			2022-12-25	WOS:000314397900043
J	Zhang, L; Li, WH; He, ZG				Zhang, Lei; Li, Weihui; He, Zheng-Guo			DarR, a TetR-like Transcriptional Factor, Is a Cyclic Di-AMP-responsive Repressor in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; GENE-REGULATION; INDUCIBLE GENE; REVEALS; GMP; RESISTANCE; RECEPTOR; DAMAGE	Cyclic dinucleotides, including cyclic di-AMP (c-di-AMP), are known to be ubiquitous second messengers involved in bacterial signal transduction. However, no transcriptional regulator has been characterized as a c-di-AMP receptor/effector to date. In the present study, using a c-di-AMP/transcription factor binding screen, we identified Ms5346, a TetR family regulator in Mycobacterium smegmatis, as a c-di-AMP receptor in bacteria. Ms5346 could specifically bind c-di-AMP with K-d of 2.3 +/- 0.5 mu M. Using EMSA and DNase I footprinting assays, c-di-AMP was found to stimulate the DNA binding activity of Ms5346 and to enhance its ability to protect its target DNA sequence. A conserved 14-bp palindromic motif was identified as the DNA-binding site for Ms5346. Further, Ms5346 was found to negatively regulate expression of three target genes including Ms5347 (encoding a major facilitator family transporter), Ms5348 (encoding a medium chain fatty acyl-CoA ligase), and Ms5696 (encoding a cold shock protein, CspA). Ms5346 is the first cyclic di-AMP receptor regulator to be identified in bacteria, and we have designated it as DarR. Our findings enhance our understanding of the function and regulatory mechanism of the second messenger c-di-AMP in bacteria.	[Zhang, Lei; Li, Weihui; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Zhang, Lei/M-6146-2013	Zhang, Lei/0000-0002-8566-6068	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31025002 and 30930003, Fundamental Research Funds for the Central Universities Grant 2011PY140, Creative Research Groups of Hubei, and Hubei Chutian Scholar Program (to H. Z.-G.).	Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Cha DM, 2009, J CHROMATOGR A, V1216, P1450, DOI 10.1016/j.chroma.2008.12.039; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jiang WN, 1997, J BIOL CHEM, V272, P196; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; O'Sullivan DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032836; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; Uppal S, 2011, J BACTERIOL, V193, P6142, DOI 10.1128/JB.05728-11; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	33	86	97	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3085	3096		10.1074/jbc.M112.428110	http://dx.doi.org/10.1074/jbc.M112.428110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250743	hybrid, Green Published			2022-12-25	WOS:000314397900018
J	Blouet, C; Schwartz, GJ				Blouet, Clemence; Schwartz, Gary J.			Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats	PLOS ONE			English	Article							ADIPOSE-TISSUE; FOS EXPRESSION; FOOD-INTAKE; ATTENUATES SUPPRESSION; NUTRIENT INFUSIONS; SMALL-INTESTINE; CHOLECYSTOKININ; NEURONS; RECEPTORS; NUCLEUS	Previous evidence indicates that duodenal lipid sensing engages gut-brain neurocircuits to determine food intake and hepatic glucose production, but a potential role for gut-brain communication in the control of energy expenditure remains to be determined. Here, we tested the hypothesis that duodenal lipid sensing activates a gut-brain-brown adipose tissue neuraxis to regulate thermogenesis. We demonstrate that direct administration of lipids into the duodenum increases brown fat temperature. Co-infusion of the local anesthetic tetracaine with duodenal lipids abolished the lipid-induced increase in brown fat temperature. Systemic administration of the CCKA receptor antagonist devazepide blocked the ability of duodenal lipids to increase brown fat thermogenesis. Parenchymal administration of the N-methyl-d-aspartate receptor blocker MK-801 directly into the caudomedial nucleus of the solitary tract also abolished duodenal lipid-induced activation of brown fat thermogenesis. These findings establish that duodenal lipid sensing activates a gut-brain-brown fat axis to determine brown fat temperature, and thereby reveal a previously unappreciated pathway that regulates thermogenesis. Citation: Blouet C, Schwartz GJ (2012) Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats. PLoS ONE 7(12): e51898. doi:10.1371/journal.pone.0051898	[Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Albert Einstein Coll Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Neurosci, Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Schwartz, GJ (corresponding author), Albert Einstein Coll Med, Dept Med, Albert Einstein Coll Med, Bronx, NY 10467 USA.	gary.schwartz@einstein.yu.edu		Blouet, Clemence/0000-0002-1752-1270	National Institutes of Health (NIH) New York Obesity Research Center [DK026667]; NIH Albert Einstein Diabetes Research and Training Center [DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026667, P60DK020541, P30DK020541] Funding Source: NIH RePORTER	National Institutes of Health (NIH) New York Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Albert Einstein Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) DK026667 New York Obesity Research Center and NIH DK020541 Albert Einstein Diabetes Research and Training Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher SA, 1999, NEUROSCIENCE, V91, P119, DOI 10.1016/S0306-4522(98)00530-2; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Berthoud HR, 1996, ACTA ANAT, V156, P123; Berthoud HR, 2001, BRAIN RES, V915, P143, DOI 10.1016/S0006-8993(01)02826-8; Blouet C, 2012, CELL METAB; BRENNER L, 1993, AM J PHYSIOL, V264, pR972, DOI 10.1152/ajpregu.1993.264.5.R972; Campos CA, 2012, ENDOCRINOLOGY; Cao WH, 2010, AM J PHYSIOL-REG I, V299, pR277, DOI 10.1152/ajpregu.00039.2010; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Czaja K, 2006, BRAIN RES, V1119, P86, DOI 10.1016/j.brainres.2006.08.042; DINDA PK, 1969, CAN J PHYSIOL PHARM, V47, P445, DOI 10.1139/y69-079; GREEN GM, 1989, AM J PHYSIOL, V256, pG1016, DOI 10.1152/ajpgi.1989.256.6.G1016; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Guard DB, 2009, BRAIN RES, V1266, P37, DOI 10.1016/j.brainres.2009.02.003; Kang YH, 2012, NEUROSCIENCE, V209, P39, DOI 10.1016/j.neuroscience.2012.02.025; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Madden CJ, 2005, J PHYSIOL-LONDON, V566, P559, DOI 10.1113/jphysiol.2005.086322; Matzinger D, 1999, AM J PHYSIOL-REG I, V277, pR1718, DOI 10.1152/ajpregu.1999.277.6.R1718; Monnikes H, 1997, BRAIN RES, V770, P277, DOI 10.1016/S0006-8993(97)00865-2; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TH, 1990, BRAIN RES, V526, P95, DOI 10.1016/0006-8993(90)90253-8; Nakamura K, 2005, NEUROSCI RES, V51, P1, DOI 10.1016/j.neures.2004.09.007; Phifer CB, 1998, AM J PHYSIOL-REG I, V274, pR1725, DOI 10.1152/ajpregu.1998.274.6.R1725; Rasmussen BA, 2012, GASTROENTEROLOGY, V142, P834, DOI 10.1053/j.gastro.2011.12.053; Reidelberger RD, 2003, AM J PHYSIOL-REG I, V284, pR389, DOI 10.1152/ajpregu.00529.2002; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Sabbatini M, 2008, NEUROSCIENCE, V152, P449, DOI 10.1016/j.neuroscience.2008.01.008; SCHUTZ Y, 1984, AM J CLIN NUTR, V40, P542, DOI 10.1093/ajcn/40.3.542; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; SHIBATA H, 1987, J APPL PHYSIOL, V63, P465, DOI 10.1152/jappl.1987.63.2.465; SIMS EAH, 1987, J CLIN INVEST, V79, P1019, DOI 10.1172/JCI112913; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; STEWART A, 1988, ANESTH ANALG, V67, P833; TAMURA CS, 1994, AM J PHYSIOL, V267, pR561, DOI 10.1152/ajpregu.1994.267.2.R561; TANSY MF, 1972, J PHARM SCI, V61, P1141, DOI 10.1002/jps.2600610723; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wright J, 2011, AM J PHYSIOL-REG I, V301, pR448, DOI 10.1152/ajpregu.00026.2011; YOX DP, 1988, AM J PHYSIOL, V255, pR569, DOI 10.1152/ajpregu.1988.255.4.R569	42	55	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51898	10.1371/journal.pone.0051898	http://dx.doi.org/10.1371/journal.pone.0051898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251649	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800105
J	Sato, S; Drake, AW; Tsuji, I; Fan, JH				Sato, Shuji; Drake, Andrew W.; Tsuji, Isamu; Fan, Jinhong			A Potent Anti-HB-EGF Monoclonal Antibody Inhibits Cancer Cell Proliferation and Multiple Angiogenic Activities of HB-EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DIPHTHERIA-TOXIN-RECEPTOR; OVARIAN-CANCER; ATHEROSCLEROTIC PLAQUES; TERMINAL FRAGMENT; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; TGF-ALPHA; BINDING; EXPRESSION	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family and has a variety of physiological and pathological functions. Modulation of HB-EGF activity might have a therapeutic potential in the oncology area. We explored the therapeutic possibilities by characterizing the in vitro biological activity of anti-HB-EGF monoclonal antibody Y-142. EGF receptor (EGFR) ligand and species specificities of Y-142 were tested. Neutralizing activities of Y-142 against HB-EGF were evaluated in EGFR and ERBB4 signaling. Biological activities of Y-142 were assessed in cancer cell proliferation and angiogenesis assays and compared with the anti-EGFR antibody cetuximab, the HB-EGF inhibitor CRM197, and the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab. The binding epitope was determined with alanine scanning. Y-142 recognized HB-EGF as well as the EGFR ligand amphiregulin, and bound specifically to human HB-EGF, but not to rodent HB-EGF. In addition, Y-142 neutralized HB-EGF-induced phosphorylation of EGFR and ERBB4, and blocked their downstream ERK1/2 and AKT signaling. We also found that Y-142 inhibited HB-EGF-induced cancer cell proliferation, endothelial cell proliferation, tube formation, and VEGF production more effectively than cetuximab and CRM197 and that Y-142 was superior to bevacizumab in the inhibition of HB-EGF-induced tube formation. Six amino acids in the EGF-like domain were identified as the Y-142 binding epitope. Among the six amino acids, the combination of F115 and Y123 determined the amphiregulin cross-reactivity and that F115 accounted for the species selectivity. Furthermore, it was suggested that the potent neutralizing activity of Y-142 was derived from its recognition of R142 and Y123 and its high affinity to HB-EGF. Y-142 has a potent HB-EGF neutralizing activity that modulates multiple biological activities of HB-EGF including cancer cell proliferation and angiogenic activities. Y-142 may have a potential to be developed into a therapeutic agent for the treatment of HB-EGF-dependent cancers.	[Tsuji, Isamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Sato, Shuji; Drake, Andrew W.; Fan, Jinhong] Takeda San Francisco Inc, San Francisco, CA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Sato, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shuji.sato@takeda.com		Sato, Shuji/0000-0002-8423-9750	Takeda San Francisco, Inc.; Takeda Pharmaceutical Company Limited	Takeda San Francisco, Inc.; Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	The authors have the following interests. This study was funded by Takeda San Francisco, Inc. and Takeda Pharmaceutical Company Limited. All authors were employees of Takeda San Francisco, Inc. or Takeda Pharmaceutical Company Limited and were paid as such. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abramovitch R, 1998, FEBS LETT, V425, P441, DOI 10.1016/S0014-5793(98)00283-X; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blake RC, 2003, BIOCHEMISTRY-US, V42, P497, DOI 10.1021/bi0267339; Brooke JS, 1998, BIOCHEM BIOPH RES CO, V248, P297, DOI 10.1006/bbrc.1998.8953; Buzzi S, 2004, CANCER IMMUNOL IMMUN, V53, P1041, DOI 10.1007/s00262-004-0546-4; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; DAS SK, 1994, DEVELOPMENT, V120, P1071; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hamaoka M, 2010, J BIOCHEM, V148, P55, DOI 10.1093/jb/mvq033; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; Hoskins JT, 2008, BIOCHEM BIOPH RES CO, V375, P506, DOI 10.1016/j.bbrc.2008.08.062; Inui S, 1997, J CELL PHYSIOL, V171, P291, DOI 10.1002/(SICI)1097-4652(199706)171:3<291::AID-JCP7>3.0.CO;2-J; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jin P, 2009, MOL MED, V15, P11, DOI 10.2119/molmed.2008.00103; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; KOIDE H, 1992, BIOCHIM BIOPHYS ACTA, V1120, P257, DOI 10.1016/0167-4838(92)90245-9; McIntyre E, 2010, BREAST CANCER RES TR, V122, P105, DOI 10.1007/s10549-009-0536-5; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Miyamoto S, 2011, CLIN CANCER RES, V17, P6733, DOI 10.1158/1078-0432.CCR-11-1029; Naef M, 1996, INT J CANCER, V66, P315; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; O-Charoenrat P, 2000, INT J CANCER, V88, P759, DOI 10.1002/1097-0215(20001201)88:5<759::AID-IJC12>3.0.CO;2-0; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; POWELL PP, 1993, AM J PATHOL, V143, P784; Raab G, 1996, DEVELOPMENT, V122, P637; Ruck A, 1998, ANTICANCER RES, V18, P1447; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Thogersen VB, 2001, CANCER RES, V61, P6227; Thomas SM, 2005, NEOPLASIA, V7, P426, DOI 10.1593/neo.04454; Torring N, 2000, ANTICANCER RES, V20, P91; Tsuji I, 2012, MABS; Tsujioka H, 2011, ANTICANCER RES, V31, P2461; Ushiro S, 1996, JPN J CANCER RES, V87, P68, DOI 10.1111/j.1349-7006.1996.tb00202.x; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Yu LL, 2011, BIOCHEM BIOPH RES CO, V408, P276, DOI 10.1016/j.bbrc.2011.04.014	59	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51964	10.1371/journal.pone.0051964	http://dx.doi.org/10.1371/journal.pone.0051964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251664	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800119
J	Arora, PK				Arora, Pankaj Kumar			Decolourization of 4-Chloro-2-Nitrophenol by a Soil Bacterium, Bacillus subtilis RKJ 700	PLOS ONE			English	Article							AEROBIC CONDITIONS; DEGRADATION; BIODEGRADATION; BIOTRANSFORMATION; STRAINS	A 4-Chloro-2-nitrophenol (4C2NP) decolourizing strain RKJ 700 was isolated from soil collected from a pesticide contaminated site of India and identified as Bacillus subtilis on the basis of the 16S rRNA gene sequence analysis. Bacillus subtilis RKJ 700 decolourized 4C2NP up to concentration of 1.5 mM in the presence of additional carbon source. The degradation pathway of 4C2NP was studied and 4-chloro-2-aminophenol, 4-chloro-2-acetaminophenol and 5-chloro-2-methylbenzoxazole (5C2MBZ) were identified as metabolites by high performance liquid chromatography and gas chromatography-mass spectrometry. Resting cell studies showed that Bacillus subtilis RKJ 700 depleted 4C2NP completely with stoichiometric formation of 5C2MBZ. This is the first report of (i) the degradation of 4C2NP at high concentration (1.5 mM) and, (ii) the formation of 5C2MBZ by a soil bacterium.	CSIR Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arora, PK (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	arora484@gmail.com	ARORA, PANKAJ K/F-9418-2014	ARORA, PANKAJ K/0000-0002-4106-8859	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi and the University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PK, 2013, ANN MICROBIOL, V63, P913, DOI 10.1007/s13213-012-0544-2; Arora PK, 2013, 3 BIOTECH, V3, P29, DOI 10.1007/s13205-012-0066-4; Arora PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038676; Arora PK, 2012, BIODEGRADATION, V23, P325, DOI 10.1007/s10532-011-9512-y; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Arora PK, 2011, INT J SYST EVOL MICR, V61, P1859, DOI 10.1099/ijs.0.023184-0; BEUNINK J, 1990, APPL MICROBIOL BIOT, V34, P108, DOI 10.1007/BF00170933; BRUHN C, 1988, ARCH MICROBIOL, V150, P171, DOI 10.1007/BF00425158; CORBETT MD, 1981, APPL ENVIRON MICROB, V41, P942, DOI 10.1128/AEM.41.4.942-949.1981; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; Donlon D, 1995, APPL ENVIRON MICROB, V61, P3889; Gharbani P, 2010, INT J ENVIRON SCI TE, V7, P377, DOI 10.1007/BF03326147; GILCREASE PC, 1995, APPL ENVIRON MICROB, V61, P4209, DOI 10.1128/AEM.61.12.4209-4214.1995; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; Mathur HB, 2005, 212005 CSEPMLPR; Mehrizad A, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-5; Myresiotis CK, 2012, BIODEGRADATION, V23, P297, DOI 10.1007/s10532-011-9509-6; Noguera DR, 1996, APPL ENVIRON MICROB, V62, P2257, DOI 10.1128/AEM.62.7.2257-2263.1996; Park HS, 1999, APPL ENVIRON MICROB, V65, P1083; Perreault NN, 2012, BIODEGRADATION, V23, P287, DOI 10.1007/s10532-011-9508-7; Saritha P, 2007, J HAZARD MATER, V149, P609, DOI 10.1016/j.jhazmat.2007.06.111; Vryzas Z, 2012, CHEMOSPHERE, V89, P1330, DOI 10.1016/j.chemosphere.2012.05.087; Zang SY, 2010, J ENVIRON SCI, V22, P669, DOI 10.1016/S1001-0742(09)60161-3; Zissi U, 1997, J IND MICROBIOL BIOT, V19, P49, DOI 10.1038/sj.jim.2900418	24	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52012	10.1371/journal.pone.0052012	http://dx.doi.org/10.1371/journal.pone.0052012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251673	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200172
J	Davidson, DC; Hirschman, MP; Sun, A; Singh, MV; Kasischke, K; Maggirwar, SB				Davidson, Donna C.; Hirschman, Michael P.; Sun, Anita; Singh, Meera V.; Kasischke, Karl; Maggirwar, Sanjay B.			Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TAT PROTEIN; PLATELET ACTIVATION; IMMUNE-RESPONSES; TARGETING CD40L; MONOCYTE SUBSET; LIGAND; INFLAMMATION; INFECTION; CD40-CD40L	Despite the use of anti-retroviral therapies, a majority of HIV-infected individuals still develop HIV-Associated Neurocognitive Disorders (HAND), indicating that host inflammatory mediators, in addition to viral proteins, may be contributing to these disorders. Consistently, we have previously shown that levels of the inflammatory mediator soluble CD40L (sCD40L) are elevated in the circulation of HIV-infected, cognitively impaired individuals as compared to their infected, non-impaired counterparts. Recent studies from our group suggest a role for the CD40/CD40L dyad in blood brain barrier (BBB) permeability and interestingly, sCD40L is thought to regulate BBB permeability in other inflammatory disorders of the CNS. Using complementary multiphoton microscopy and quantitative analyses in wild-type and CD40L deficient mice, we now reveal that the HIV transactivator of transcription (Tat) can induce BBB permeability in a CD40L-dependent manner. This permeability of the BBB was found to be the result of aberrant platelet activation induced by Tat, since depletion of platelets prior to treatment reversed Tat-induced BBB permeability. Furthermore, Tat treatment led to an increase in granulocyte antigen 1 (Gr1) positive monocytes, indicating an expansion of the inflammatory subset of cells in these mice, which were found to adhere more readily to the brain microvasculature in Tat treated animals. Exploring the mechanisms by which the BBB becomes compromised during HIV infection has the potential to reveal novel therapeutic targets, thereby aiding in the development of adjunct therapies for the management of HAND, which are currently lacking.	[Davidson, Donna C.; Hirschman, Michael P.; Singh, Meera V.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Sun, Anita; Kasischke, Karl] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Kasischke, Karl] Univ Ulm, Dept Neurol, Med Ctr, D-89069 Ulm, Germany	University of Rochester; University of Rochester; Ulm University	Maggirwar, SB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu		Kasischke, Karl/0000-0003-0582-4319	National Institutes of Health [RO1NS054578, RO1NS066801]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801, R01NS054578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants: RO1NS054578 and RO1NS066801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Beck WS, 1991, HEMATOLOGY, Vxvi; Beland JL, 1998, BLOOD, V92, P4472, DOI 10.1182/blood.V92.11.4472.423k47_4472_4478; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; CHAMBERLAIN KG, 1990, AM J HEMATOL, V34, P161, DOI 10.1002/ajh.2830340302; Chen CY, 2008, BLOOD, V112, P3205, DOI 10.1182/blood-2008-03-143479; Chen L, 2012, NEUROBIOL AGING; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; Daoussis D, 2004, CLIN DIAGN LAB IMMUN, V11, P635, DOI 10.1128/CDLI.11.4.635-641.2004; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Del Sorbo L, 2001, EUR J IMMUNOL, V31, P376, DOI 10.1002/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5; Del Sorbo L, 1999, EUR J IMMUNOL, V29, P1513, DOI 10.1002/(SICI)1521-4141(199905)29:05<1513::AID-IMMU1513>3.3.CO;2-O; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Fiala M, 1997, MOL MED, V3, P553, DOI 10.1007/BF03401701; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giunta B, 2010, CNS NEUROL DISORD-DR, V9, P149, DOI 10.2174/187152710791012099; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Hurst RD, 2001, BRAIN RES, V894, P181, DOI 10.1016/S0006-8993(01)01992-8; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Law CL, 2009, ADV EXP MED BIOL, V647, P8, DOI 10.1007/978-0-387-89520-8_2; Lazarevic V, 2003, IMMUNITY, V19, P823, DOI 10.1016/S1074-7613(03)00324-8; Li GR, 2005, BIOCHEM PHARMACOL, V69, P233, DOI 10.1016/j.bcp.2004.10.003; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Liu YY, 2010, J IMMUNOL, V185, P2773, DOI 10.4049/jimmunol.1000772; Lu SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023915; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nieswandt B, 2000, BLOOD, V96, P2520; O'Dea KP, 2011, AM J PHYSIOL-LUNG C, V301, pL812, DOI 10.1152/ajplung.00092.2011; Otterdal K, 2004, THROMB RES, V114, P167, DOI 10.1016/j.thromres.2004.05.007; Perry SW, 2010, J NEUROSCI, V30, P14153, DOI 10.1523/JNEUROSCI.1042-10.2010; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; Polesskaya O, 2012, JOVE-J VIS EXP, DOI 10.3791/3466; Polesskaya O, 2011, BRAIN RES, V1373, P91, DOI 10.1016/j.brainres.2010.12.017; Ragin AB, 2011, J NEUROVIROL, V17, P487, DOI 10.1007/s13365-011-0053-2; Ramirez SH, 2010, J NEUROSCI, V30, P9454, DOI 10.1523/JNEUROSCI.5796-09.2010; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rieg G, 2007, AIDS RES HUM RETROV, V23, P1257, DOI 10.1089/aid.2006.0311; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Rumbaugh J, 2006, FASEB J, V20, P1736, DOI 10.1096/fj.05-5619fje; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Schifitto G, 2006, NEUROLOGY, V66, P919, DOI 10.1212/01.wnl.0000204294.28189.03; Schulze C, 1997, J NEUROCHEM, V68, P991; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh MV, 2012, J VIROL METHODS; STADDON JM, 1995, J CELL SCI, V108, P609; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 1999, J NEUROIMMUNOL, V97, P77, DOI 10.1016/S0165-5728(99)00053-3; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Toneatto S, 1999, AIDS, V13, P2343, DOI 10.1097/00002030-199912030-00005; Torre D, 2008, CURR HIV RES, V6, P411, DOI 10.2174/157016208785861140; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yacoub D, 2010, ARTERIOSCL THROM VAS, V30, P2424, DOI 10.1161/ATVBAHA.110.216143; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	97	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51793	10.1371/journal.pone.0051793	http://dx.doi.org/10.1371/journal.pone.0051793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251626	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200167
J	Dhanik, A; McMurray, JS; Kavraki, LE				Dhanik, Ankur; McMurray, John S.; Kavraki, Lydia E.			Binding Modes of Peptidomimetics Designed to Inhibit STAT3	PLOS ONE			English	Article							MOLECULAR DOCKING PROGRAMS; SIGNAL TRANSDUCER; FLUORESCENCE POLARIZATION; DYNAMICS SIMULATIONS; PROTEIN FLEXIBILITY; AUTOMATED DOCKING; GENETIC ALGORITHM; DRUG DISCOVERY; LIGAND DOCKING; HYDROGEN-BONDS	STAT3 is a transcription factor that has been found to be constitutively activated in a number of human cancers. Dimerization of STAT3 via its SH2 domain and the subsequent translocation of the dimer to the nucleus leads to transcription of anti-apoptotic genes. Prevention of the dimerization is thus an attractive strategy for inhibiting the activity of STAT3. Phosphotyrosine-based peptidomimetic inhibitors, which mimic pTyr-Xaa-Yaa-Gln motif and have strong to weak binding affinities, have been previously investigated. It is well-known that structures of protein-inhibitor complexes are important for understanding the binding interactions and designing stronger inhibitors. Experimental structures of inhibitors bound to the SH2 domain of STAT3 are, however, unavailable. In this paper we describe a computational study that combined molecular docking and molecular dynamics to model structures of 12 peptidomimetic inhibitors bound to the SH2 domain of STAT3. A detailed analysis of the modeled structures was performed to evaluate the characteristics of the binding interactions. We also estimated the binding affinities of the inhibitors by combining MMPB/GBSA-based energies and entropic cost of binding. The estimated affinities correlate strongly with the experimentally obtained affinities. Modeling results show binding modes that are consistent with limited previous modeling studies on binding interactions involving the SH2 domain and phosphotyrosine(pTyr)-based inhibitors. We also discovered a stable novel binding mode that involves deformation of two loops of the SH2 domain that subsequently bury the C-terminal end of one of the stronger inhibitors. The novel binding mode could prove useful for developing more potent inhibitors aimed at preventing dimerization of cancer target protein STAT3.	[Dhanik, Ankur; Kavraki, Lydia E.] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA; [McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Rice University; University of Texas System; UTMD Anderson Cancer Center	Kavraki, LE (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	kavraki@rice.edu	Kavraki, Lydia E/N-6325-2018	Kavraki, Lydia E/0000-0003-0699-8038	Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia [CPRIT RP101489]; Texas Higher Education Coordinating Board [NHARP 01907]; National Cancer Institute [RO1 CA096652]; John and Ann Doerr Fund for Computational Biomedicine at Rice University; National Science Foundation [CNS-0821727]; NATIONAL CANCER INSTITUTE [R01CA096652] Funding Source: NIH RePORTER	Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia; Texas Higher Education Coordinating Board; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John and Ann Doerr Fund for Computational Biomedicine at Rice University; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by a training fellowship from the Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT RP101489), The Texas Higher Education Coordinating Board (NHARP 01907), The National Cancer Institute (RO1 CA096652), The John and Ann Doerr Fund for Computational Biomedicine at Rice University, and the Cyberinfrastructure for Computational Research funded by National Science Foundation under Grant CNS-0821727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Buettner R, 2002, CLIN CANCER RES, V8, P945; Case D.A., 2022, AMBER 2020; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Chang MW, 2007, J CHEM INF MODEL, V47, P1258, DOI 10.1021/ci700044s; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhanik A., 2012, Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), P48, DOI 10.1109/BIBMW.2012.6470370; Dhanik A, 2012, PROTEIN LIGAND INTER, DOI [10.1002/9780470015902.a0004105.pub2, DOI 10.1002/9780470015902.A0004105.PUB2]; Dhanik A, 2011, IEEE ENG MED BIO, P3229, DOI 10.1109/IEMBS.2011.6090878; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garcia-Nieto R, 2000, J COMPUT AID MOL DES, V14, P147, DOI 10.1023/A:1008110924479; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jain AN, 2000, J COMPUT AID MOL DES, V14, P199, DOI 10.1023/A:1008100132405; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Khalil IG, 2005, CURR OPIN ONCOL, V17, P44, DOI 10.1097/01.cco.0000150951.38222.16; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kubinyi H, 2006, SUCCESS STORIES COMP, P377, DOI [10.1002/0470037237.ch16, DOI 10.1002/0470037237.CH16]; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010126; Li X, 2010, J COMPUT CHEM, V31, P2109, DOI 10.1002/jcc.21498; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mandal PK, 2009, J MED CHEM, V52, P6126, DOI 10.1021/jm901105k; Mandal PK, 2009, J MED CHEM, V52, P2429, DOI 10.1021/jm801491w; Mangoni R, 1999, PROTEINS, V35, P153, DOI 10.1002/(SICI)1097-0134(19990501)35:2<153::AID-PROT2>3.0.CO;2-E; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matter H, 2011, APPL SUCCESS STORIES, P319, DOI [10.1002/9783527633326.ch12, DOI 10.1002/9783527633326.CH12]; McMurray JS, 2008, BIOPOLYMERS, V90, P69, DOI 10.1002/bip.20901; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Onodera K, 2007, J CHEM INF MODEL, V47, P1609, DOI 10.1021/ci7000378; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Park In-Hee, 2011, J Mol Recognit, V24, P254, DOI 10.1002/jmr.1047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce AC, 2002, PROTEINS, V49, P567, DOI 10.1002/prot.10259; Plewczynski D, 2010, J COMPUT CHEM, V32, P1; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Projan SJ, 2007, NAT REV DRUG DISCOV, V6, P115; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; SHOICHET BK, 1991, J MOL BIOL, V221, P327, DOI 10.1016/0022-2836(91)80222-G; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WADE RC, 1993, J MED CHEM, V36, P148, DOI 10.1021/jm00053a019; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Xing L, 2011, J MED CHEM, V54, P1211, DOI 10.1021/jm101382t; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	85	20	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51603	10.1371/journal.pone.0051603	http://dx.doi.org/10.1371/journal.pone.0051603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251591	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200143
J	Espada, L; Meo-Evoli, N; Sancho, P; Real, S; Fabregat, I; Ambrosio, S; Tauler, A				Espada, Lilia; Meo-Evoli, Nathalie; Sancho, Patricia; Real, Sebastian; Fabregat, Isabel; Ambrosio, Santiago; Tauler, Albert			ROS Production Is Essential for the Apoptotic Function of E2F1 in Pheochromocytoma and Neuroblastoma Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F1; CYTOCHROME-C RELEASE; NEURONAL APOPTOSIS; BAX TRANSLOCATION; COPPER CHAPERONE; OXIDATIVE STRESS; DEATH DECISIONS; REACTIVE OXYGEN; CANCER-THERAPY; ACTIVATION	In this study we demonstrate that accumulation of reactive oxygen species (ROS) is essential for E2F1 mediated apoptosis in ER-E2F1 PC12 pheochromocytoma, and SH-SY5Y and SK-N-JD neuroblastoma stable cell lines. In these cells, the ER-E2F1 fusion protein is expressed in the cytosol; the addition of 4-hydroxytamoxifen (OHT) induces its translocation to the nucleus and activation of E2F1target genes. Previously we demonstrated that, in ER-E2F1 PC12 cells, OHT treatment induced apoptosis through activation of caspase-3. Here we show that caspase-8 activity did not change upon treatment with OHT. Moreover, over-expression of Bcl-xL arrested OHT-induced apoptosis; by contrast, over-expression of c-FLIP, did not have any effect on OHT-induced apoptosis. OHT addition induces BimL expression, its translocation to mitochondria and activation of Bax, which is paralleled by diminished mitochondrial enrichment of Bcl-xL. Treatment with a Bax-inhibitory peptide reduced OHT-induced apoptosis. These results point out the essential role of mitochondria on the apoptotic process driven by E2F1. ROS accumulation followed E2F1 induction and treatment with the antioxidant N-acetylcysteine, inhibited E2F1-induced Bax translocation to mitochondria and subsequent apoptosis. The role of ROS in mediating OHT-induced apoptosis was also studied in two neuroblastoma cell lines, SH-SY5Y and SK-N-JD. In SH-SY5Y cells, activation of E2F1 by the addition of OHT induced ROS production and apoptosis, whereas over-expression of E2F1 in SK-N-JD cells failed to induce either response. Transcriptional profiling revealed that many of the genes responsible for scavenging ROS were down-regulated following E2F1-induction in SH-SY5Y, but not in SK-N-JD cells. Finally, inhibition of GSK3 beta blocked ROS production, Bax activation and the down regulation of ROS scavenging genes. These findings provide an explanation for the apparent contradictory role of E2F1 as an apoptotic agent versus a cell cycle activator.	[Espada, Lilia; Meo-Evoli, Nathalie; Real, Sebastian; Tauler, Albert] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Catalunya, Spain; [Meo-Evoli, Nathalie; Tauler, Albert] Bellvitge Biomed Res Inst IDIBELL, Canc & Metab Grp, Lhospitalet De Llobregat, Catalunya, Spain; [Sancho, Patricia; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Lhospitalet De Llobregat, Catalunya, Spain; [Fabregat, Isabel; Ambrosio, Santiago] Univ Barcelona, Campus Univ Bellvitge IDIBELL, Fac Med, Unitat Bioquim,Dept Ciencies Fisiol 2, Lhospitalet De Llobregat, Catalunya, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Tauler, A (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Catalunya, Spain.	tauler@ub.edu	Ambrosio, Santiago/ABC-8753-2021; Sancho, Patricia/ABH-5258-2020; Tauler, Albert/D-5183-2014; Fabregat, Isabel/H-7038-2015	Sancho, Patricia/0000-0002-1092-5395; Tauler, Albert/0000-0003-0193-0667; Fabregat, Isabel/0000-0003-0136-8440; Espada, Lilia/0000-0002-6218-7785	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain [BFU2009-09933]; Universitat de Barcelona; Generalitat de Catalunya; Ministerio de Asuntos Exteriores	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universitat de Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Asuntos Exteriores	This work was supported by Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain (BFU2009-09933) and the publication cost was provided by Vicerectorat de Politica Docent i Cientifica de la Universitat de Barcelona. Lilia Espada, Nathalie Meo-Evoli and Sebastian Real were the recipients of a fellowship from Universitat de Barcelona, Generalitat de Catalunya and Ministerio de Asuntos Exteriores, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Calvisi DF, 2005, J HEPATOL, V42, P842, DOI 10.1016/j.jhep.2005.01.029; Cao QY, 2004, J IMMUNOL, V173, P1111, DOI 10.4049/jimmunol.173.2.1111; Chen MJ, 2007, BIOCHEM BIOPH RES CO, V358, P559, DOI 10.1016/j.bbrc.2007.04.167; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Dittmann LM, 2012, ONCOGENE, V31, P3409, DOI 10.1038/onc.2011.513; Espada L, 2007, J NEUROCHEM, V102, P2020, DOI 10.1111/j.1471-4159.2007.04686.x; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Ganguly A, 2010, MOL VIS, V16, P1292; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Hou ST, 2001, J NEUROCHEM, V78, P287, DOI 10.1046/j.1471-4159.2001.00402.x; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; Ochiai T, 2004, NEUROSCI LETT, V362, P61, DOI 10.1016/j.neulet.2004.02.067; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pickrell AM, 2010, METHODS MOL BIOL, V648, P63, DOI 10.1007/978-1-60761-756-3_4; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Qin Q, 2004, NEUROSCI LETT, V372, P17, DOI 10.1016/j.neulet.2004.08.075; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Turanov AA, 2010, BIOCHEM J, V430, P285, DOI 10.1042/BJ20091378; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wang XD, 2001, GENE DEV, V15, P2922; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200	56	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51544	10.1371/journal.pone.0051544	http://dx.doi.org/10.1371/journal.pone.0051544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251571	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200132
J	Ketola, K; Kallioniemi, O; Iljin, K				Ketola, Kirsi; Kallioniemi, Olli; Iljin, Kristiina			Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells	PLOS ONE			English	Article							IN-VITRO; INHIBITOR; GROWTH; DOCETAXEL; BREAST; SURVIVAL	Background: Current treatment options for castration- and treatment-resistant prostate cancer are limited and novel approaches are desperately needed. Our recent results from a systematic chemical biology sensitivity screen covering most known drugs and drug-like molecules indicated that aldehyde dehydrogenase inhibitor disulfiram is one of the most potent cancer-specific inhibitors of prostate cancer cell growth, including TMPRSS2-ERG fusion positive cancers. However, the results revealed that disulfiram alone does not block tumor growth in vivo nor induce apoptosis in vitro, indicating that combinatorial approaches may be required to enhance the anti-neoplastic effects. Methods and Findings: In this study, we utilized a chemical biology drug sensitivity screen to explore disulfiram mechanistic details and to identify compounds potentiating the effect of disulfiram in TMPRSS2-ERG fusion positive prostate cancer cells. In total, 3357 compounds including current chemotherapeutic agents as well as drug-like small molecular compounds were screened alone and in combination with disulfiram. Interestingly, the results indicated that androgenic and antioxidative compounds antagonized disulfiram effect whereas inhibitors of receptor tyrosine kinase, proteasome, topoisomerase II, glucosylceramide synthase or cell cycle were among compounds sensitizing prostate cancer cells to disulfiram. The combination of disulfiram and an antiangiogenic agent sunitinib was studied in more detail, since both are already in clinical use in humans. Disulfiram-sunitinib combination induced apoptosis and reduced androgen receptor protein expression more than either of the compounds alone. Moreover, combinatorial exposure reduced metastatic characteristics such as cell migration and 3D cell invasion as well as induced epithelial differentiation shown as elevated E-cadherin expression. Conclusions: Taken together, our results propose novel combinatorial approaches to inhibit prostate cancer cell growth. Disulfiram-sunitinib combination was identified as one of the potent synergistic approaches. Since sunitinib alone has been reported to lack efficacy in prostate cancer clinical trials, our results provide a rationale for novel combinatorial approach to target prostate cancer more efficiently.	[Ketola, Kirsi; Iljin, Kristiina] Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland; [Ketola, Kirsi; Iljin, Kristiina] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki	Ketola, K (corresponding author), Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland.	kirsi.h.ketola@gmail.com	Ketola, Kirsi/O-1071-2016; Kallioniemi, Olli P/H-5111-2011	Ketola, Kirsi/0000-0001-6484-9861; Kallioniemi, Olli P/0000-0002-3231-0332; Iljin, Kristiina/0000-0002-5161-0584	EU-PRIMA project [LSHC-CT-204-504587]; Cancer Organizations of Finland; Sigrid Juselius Foundation; Academy of Finland	EU-PRIMA project; Cancer Organizations of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	Funding was provided by EU-PRIMA project (contract # LSHC-CT-204-504587), the Cancer Organizations of Finland, Sigrid Juselius Foundation and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Brar SS, 2004, MOL CANCER THER, V3, P1049; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Cumashi A, 2008, CANCER LETT, V270, P229, DOI 10.1016/j.canlet.2008.05.007; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Guerin O, 2008, J CANCER RES CLIN, V134, P51, DOI 10.1007/s00432-007-0247-4; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Iljin K, 2009, CLIN CANCER RES, V15, P6070, DOI 10.1158/1078-0432.CCR-09-1035; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong CW, 2013, UROL ONCOL-SEMIN ORI, V31, P1448, DOI 10.1016/j.urolonc.2012.03.022; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Ketola K, 2012, OXIDATIVE STRESS DIS; Ketola K, 2010, MOL CANCER THER, V9, P3175, DOI 10.1158/1535-7163.MCT-10-0368; Korenchuk S, 2001, IN VIVO, V15, P163; Kutikov A, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.07.1384; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Lovborg H, 2006, INT J CANCER, V118, P1577, DOI 10.1002/ijc.21534; Marijon H, 2011, J HEPATOL, V54, P1073, DOI 10.1016/j.jhep.2010.11.011; Morrison BW, 2010, MELANOMA RES, V20, P11, DOI 10.1097/CMR.0b013e328334131d; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Ortholan C, 2010, EUR J CANCER, V46, P3022, DOI 10.1016/j.ejca.2010.07.021; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Papaetis GS, 2009, BIODRUGS, V23, P377, DOI 10.2165/11318860-000000000-00000; Platz EA, 2011, NOVEL 2 STAGE TRANSD; Sauna ZE, 2005, MOL BIOSYST, V1, P127, DOI 10.1039/b504392a; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; Yakisich JS, 2001, BIOCHEM BIOPH RES CO, V289, P586, DOI 10.1006/bbrc.2001.6027; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126	33	25	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51470	10.1371/journal.pone.0051470	http://dx.doi.org/10.1371/journal.pone.0051470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251544	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200115
J	Poulsen, L; Andersen, MR; Lantz, AE; Thykaer, J				Poulsen, Lars; Andersen, Mikael Rordam; Lantz, Anna Eliasson; Thykaer, Jette			Identification of a Transcription Factor Controlling pH-Dependent Organic Acid Response in Aspergillus niger	PLOS ONE			English	Article							CITRIC-ACID; MORPHOLOGY; GENOMICS; BACTERIA; DELETION; CLONING	Acid formation in Aspergillus niger is known to be subjected to tight regulation, and the acid production profiles are fine-tuned to respond to the ambient pH. Based on transcriptome data, putative trans-acting pH responding transcription factors were listed and through knock out studies, mutants exhibiting an oxalate overproducing phenotype were identified. The yield of oxalate was increased up to 158% compared to the wild type and the corresponding transcription factor was therefore entitled Oxalic Acid repression Factor, OafA. Detailed physiological characterization of one of the Delta oafA mutants, compared to the wild type, showed that both strains produced substantial amounts of gluconic acid, but the mutant strain was more efficient in re-uptake of gluconic acid and converting it to oxalic acid, particularly at high pH (pH 5.0). Transcriptional profiles showed that 241 genes were differentially expressed due to the deletion of oafA and this supported the argument of OafA being a trans-acting transcription factor. Furthermore, expression of two phosphoketolases was down-regulated in the Delta oafA mutant, one of which has not previously been described in fungi. It was argued that the observed oxalate overproducing phenotype was a consequence of the efficient re-uptake of gluconic acid and thereby a higher flux through glycolysis. This results in a lower flux through the pentose phosphate pathway, demonstrated by the down-regulation of the phosphoketolases. Finally, the physiological data, in terms of the specific oxygen consumption, indicated a connection between the oxidative phosphorylation and oxalate production and this was further substantiated through transcription analysis.	[Poulsen, Lars; Andersen, Mikael Rordam; Lantz, Anna Eliasson; Thykaer, Jette] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Thykaer, J (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	jt@bio.dtu.dk	Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Lantz, Anna Eliasson/G-8569-2012	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Lantz, Anna Eliasson/0000-0003-1547-9299; Poulsen, Lars/0000-0001-9106-8956	Danish Research Agency for Technology and Production [09-064967]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Danish Research Agency for Technology and Production; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Research Agency for Technology and Production, grant # 09-064967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r47; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CLELAND WW, 1954, J BIOL CHEM, V208, P679; de Jongh WA, 2008, METAB ENG, V10, P87, DOI 10.1016/j.ymben.2007.11.002; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HEINRICH M, 1982, EUR J APPL MICROBIOL, V15, P88, DOI 10.1007/BF00499512; Ingram-Smith C, 2006, TRENDS MICROBIOL, V14, P249, DOI 10.1016/j.tim.2006.04.001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; LEGISA M, 1986, ENZYME MICROB TECH, V8, P258, DOI 10.1016/0141-0229(86)90018-9; MA H, 1981, FEMS MICROBIOL LETT, V12, P147; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602; McIntyre M, 1997, ENZYME MICROB TECH, V21, P479, DOI 10.1016/S0141-0229(97)00007-0; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Muller C, 2002, APPL ENVIRON MICROB, V68, P1827, DOI 10.1128/AEM.68.4.1827-1836.2002; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Pedersen H, 2000, MOL GEN GENET, V263, P281, DOI 10.1007/s004380051169; Pedersen H, 2000, METAB ENG, V2, P34, DOI 10.1006/mben.1999.0136; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Punt PJ, 2008, FUNGAL GENET BIOL, V45, P1591, DOI 10.1016/j.fgb.2008.09.007; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Roopashri AN, 2009, APPL MICROBIOL BIOT, V83, P1115, DOI 10.1007/s00253-009-1991-y; Ruijter GJG, 1999, MICROBIOL-SGM, V145, P2569, DOI 10.1099/00221287-145-9-2569; Sambrook J, 2001, MOL CLONING LAB MANU; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorensen LM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-255; Thykaer J, 2007, PROCESS BIOCHEM, V42, P1050, DOI 10.1016/j.procbio.2007.04.004; WITTEVEEN CFB, 1993, CURR GENET, V24, P408, DOI 10.1007/BF00351849	37	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50596	10.1371/journal.pone.0050596	http://dx.doi.org/10.1371/journal.pone.0050596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251373	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200031
J	Zhang, ZF; Sun, P; Yu, FX; Yan, L; Yuan, F; Zhang, WX; Wang, T; Wan, ZY; Shao, Q; Li, ZD				Zhang, Zifu; Sun, Peng; Yu, Fuxian; Yan, Li; Yuan, Fang; Zhang, Wenxin; Wang, Tao; Wan, Zhiyi; Shao, Qiang; Li, Zandong			Transgenic Quail Production by Microinjection of Lentiviral Vector into the Early Embryo Blood Vessels	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; GREEN FLUORESCENT PROTEIN; CHIMERIC CHICKENS; EGG-WHITE; TRANSMISSION; EXPRESSION; MIGRATION; GENERATION; SYSTEM	Several strategies have been used to generate transgenic birds. The most successful method so far has been the injection of lentiviral vectors into the subgerminal cavity of a newly laid egg. We report here a new, easy and effective way to produce transgenic quails through direct injection of a lentiviral vector, containing an enhanced-green fluorescent protein (eGFP) transgene, into the blood vessels of quail embryos at Hamburger-Hamilton stage 13-15 (HH13-15). A total of 80 embryos were injected and 48 G0 chimeras (60%) were hatched. Most injected embryo organs and tissues of hatched quails were positive for eGFP. In five out of 21 mature G0 male quails, the semen was eGFP-positive, as detected by polymerase chain reaction (PCR), indicating transgenic germ line chimeras. Testcross and genetic analyses revealed that the G0 quail produced transgenic G1 offspring; of 46 G1 hatchlings, 6 were transgenic (6/46, 13.0%). We also compared this new method with the conventional transgenesis using stage X subgerminal cavity injection. Total 240 quail embryos were injected by subgerminal cavity injection, of which 34 (14.1%) were hatched, significantly lower than the new method. From these hatched quails semen samples were collected from 19 sexually matured males and tested for the transgene by PCR. The transgene was present in three G0 male quails and only 4/236 G1 offspring (1.7%) were transgenic. In conclusion, we developed a novel bird transgenic method by injection of lentiviral vector into embryonic blood vessel at HH 13-15 stage, which result in significant higher transgenic efficiency than the conventional subgerminal cavity injection.	[Zhang, Zifu; Yu, Fuxian; Yan, Li; Yuan, Fang; Zhang, Wenxin; Wang, Tao; Wan, Zhiyi; Shao, Qiang; Li, Zandong] China Agr Univ, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China; [Sun, Peng] Beijing Educ Examinat Author, Beijing, Peoples R China	China Agricultural University	Li, ZD (corresponding author), China Agr Univ, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	lzdws@cau.edu.cn	Shao, Eric Qiang/I-1359-2019; Rui, Core/AAW-5603-2021	Shao, Eric Qiang/0000-0001-5307-8264; 	State 863 High-technology R&D Project of China [2007AA100504]	State 863 High-technology R&D Project of China	This work was supported by grant 2007AA100504 from the State 863 High-technology R&D Project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGEGIL V, 1991, RES VET SCI, V50, P139, DOI 10.1016/0034-5288(91)90096-7; ANDO Y, 1983, DEV GROWTH DIFFER, V25, P345; CARSIENCE RS, 1993, DEVELOPMENT, V117, P669; Chapman SC, 2005, DEVELOPMENT, V132, P935, DOI 10.1242/dev.01652; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kawabe Y, 2008, J BIOSCI BIOENG, V106, P598, DOI 10.1263/jbb.106.598; Koo BC, 2006, FASEB J, V20, P2251, DOI 10.1096/fj.06-5866com; KUWANA T, 1993, DEV GROWTH DIFFER, V35, P237; Kwon MS, 2004, BIOCHEM BIOPH RES CO, V320, P442, DOI 10.1016/j.bbrc.2004.05.197; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P175; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MEYER DB, 1964, DEV BIOL, V10, P154, DOI 10.1016/0012-1606(64)90009-0; Motono M, 2010, J BIOSCI BIOENG, V109, P315, DOI 10.1016/j.jbiosc.2009.10.007; Mozdziak PE, 2003, J NUTR, V133, P3076, DOI 10.1093/jn/133.10.3076; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Sang H, 2004, MECH DEVELOP, V121, P1179, DOI 10.1016/j.mod.2004.05.012; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Scott BB, 2006, NAT PROTOC, V1, P1406, DOI 10.1038/nprot.2006.187; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; UKESHIMA A, 1991, J ELECTRON MICROSC, V40, P124; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	33	15	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50817	10.1371/journal.pone.0050817	http://dx.doi.org/10.1371/journal.pone.0050817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251391	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200040
J	Angelucci, C; Maulucci, G; Lama, G; Proietti, G; Colabianchi, A; Papi, M; Maiorana, A; De Spirito, M; Micera, A; Balzamino, OB; Di Leone, A; Masetti, R; Sica, G				Angelucci, Cristiana; Maulucci, Giuseppe; Lama, Gina; Proietti, Gabriella; Colabianchi, Anna; Papi, Massimiliano; Maiorana, Alessandro; De Spirito, Marco; Micera, Alessandra; Balzamino, Omar Bijorn; Di Leone, Alba; Masetti, Riccardo; Sica, Gigliola			Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness	PLOS ONE			English	Article							SPAN DETERMINANT P66(SHCA); GENE-EXPRESSION PROFILES; TUMOR-GROWTH; IN-VITRO; MESENCHYMAL TRANSITION; CARCINOMA CELLS; FIBROBLASTS; DIFFERENTIATION; METASTASIS; RESISTANCE	Interactions occurring between malignant cells and the stromal microenvironment heavily influence tumor progression. We investigated whether this cross-talk affects some molecular and functional aspects specifically correlated with the invasive phenotype of breast tumor cells (i.e. adhesion molecule expression, membrane fluidity, migration) by co-culturing mammary cancer cells exhibiting different degrees of metastatic potential (MDA-MB-231>MCF-7) with fibroblasts isolated from breast healthy skin (normal fibroblasts, NFs) or from breast tumor stroma (cancer-associated fibroblasts, CAFs) in 2D or 3D (nodules) cultures. Confocal immunofluorescence analysis of the epithelial adhesion molecule E-cadherin on frozen nodule sections demonstrated that NFs and CAFs, respectively, induced or inhibited its expression in MCF-7 cells. An increase in the mesenchymal adhesion protein N-cadherin was observed in CAFs, but not in NFs, as a result of the interaction with both kinds of cancer cells. CAFs, in turn, promoted N-cadherin up-regulation in MDA-MB-231 cells and its de novo expression in MCF-7 cells. Beyond promotion of "cadherin switching", another sign of the CAF-triggered epithelial-mesenchymal transition (EMT) was the induction of vimentin expression in MCF-7 cells. Plasma membrane labeling of monolayer cultures with the fluorescent probe Laurdan showed an enhancement of the membrane fluidity in cancer cells co-cultured with NFs or CAFs. An increase in lipid packing density of fibroblast membranes was promoted by MCF-7 cells. Time-lapsed cell tracking analysis of mammary cancer cells co-cultured with NFs or CAFs revealed an enhancement of tumor cell migration velocity, even with a marked increase in the directness induced by CAFs. Our results demonstrate a reciprocal influence of mammary cancer and fibroblasts on various adhesiveness/invasiveness features. Notably, CAFs' ability to promote EMT, reduction of cell adhesion, increase in membrane fluidity, and migration velocity and directness in mammary cancer cells can be viewed as an overall progression-and invasion-promoting effect.	[Maulucci, Giuseppe; Papi, Massimiliano; Maiorana, Alessandro; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Angelucci, Cristiana; Lama, Gina; Proietti, Gabriella; Colabianchi, Anna; Sica, Gigliola] Univ Cattolica Sacro Cuore, Ist Istol & Embriol, Rome, Italy; [Micera, Alessandra; Balzamino, Omar Bijorn] Fdn GB Bietti, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Di Leone, Alba; Masetti, Riccardo] Univ Cattolica Sacro Cuore, Dipartimento Tutela Salute Donna & Vita Nascente, Unita Operat Chirurg Senol, Fac Med & Chirurg A Gemelli, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Spirito, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	De Spirito, Marco/U-3817-2019; Maulucci, Giuseppe/C-7400-2009; balzamino, bijorn omar/A-4433-2013; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Micera, Alessandra/J-3373-2013; Di Leone, Alba/AAD-2050-2022; micera, alessandra/AAY-4696-2020	De Spirito, Marco/0000-0003-4260-5107; Maulucci, Giuseppe/0000-0002-2154-319X; balzamino, bijorn omar/0000-0002-2254-1647; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; micera, alessandra/0000-0002-9375-6071; MASETTI, Riccardo/0000-0002-7520-9111	Susan G. Komen Italian Affiliate (Rome, Italy)	Susan G. Komen Italian Affiliate (Rome, Italy)	Funding was provided by the Susan G. Komen Italian Affiliate (Rome, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Beaupain Rene, 1999, Methods in Cell Science, V21, P25, DOI 10.1023/A:1009899527587; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Santos RPC, 2011, TUMOR BIOL, V32, P145, DOI 10.1007/s13277-010-0108-7; DELICONSTANTINOS G, 1987, ANTICANCER RES, V7, P1011; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Fu LW, 2002, EUR J CANCER, V38, P418, DOI 10.1016/S0959-8049(01)00356-2; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Greco E, 2012, P NATL ACAD SCI USA, V109, pE1360, DOI 10.1073/pnas.1200484109; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; HUBNER C, 1989, J NEUROL SCI, V92, P205, DOI 10.1016/0022-510X(89)90137-8; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Kunz-Schughart LA, 2003, AM J PHYSIOL-CELL PH, V284, pC209, DOI 10.1152/ajpcell.00557.2001; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P623, DOI 10.14670/HH-17.623; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LeBedis C, 2002, INT J CANCER, V100, P2, DOI 10.1002/ijc.10481; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mardia Kanti V, 1999, DIRECTIONAL STAT; Maulucci G, 2010, NUOVO CIM B, V125, P645, DOI 10.1393/ncb/i2010-10865-7; Maulucci G, 2010, EUR BIOPHYS J BIOPHY, V39, P993, DOI 10.1007/s00249-009-0470-9; Maulucci G, 2009, BIOSENS BIOELECTRON, V25, P682, DOI 10.1016/j.bios.2009.07.038; Maulucci G, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143pl3; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Montel V, 2006, INT J CANCER, V119, P251, DOI 10.1002/ijc.21757; NAKAZAWA I, 1989, TOHOKU J EXP MED, V157, P193, DOI 10.1620/tjem.157.193; Owen DM, 2010, IMMUNOLOGY, V131, P1, DOI 10.1111/j.1365-2567.2010.03319.x; Panieri E, 2010, AGING-US, V2, P487, DOI 10.18632/aging.100183; Papi M, 2011, J NANOPART RES, V13, P6141, DOI 10.1007/s11051-011-0327-x; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; RABER J, 1989, MED HYPOTHESES, V28, P169, DOI 10.1016/0306-9877(89)90046-7; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rozenchan PB, 2009, INT J CANCER, V125, P2767, DOI 10.1002/ijc.24646; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shekhar MPV, 2001, CANCER RES, V61, P1320; SINGER C, 1995, CANCER RES, V55, P2448; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Wang TN, 2002, SURGERY, V132, P220, DOI 10.1067/msy.2002.125353; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Zeisig R, 2007, ARCH BIOCHEM BIOPHYS, V459, P98, DOI 10.1016/j.abb.2006.09.030	57	78	78	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50804	10.1371/journal.pone.0050804	http://dx.doi.org/10.1371/journal.pone.0050804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251387	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900020
J	Hinz, C; Gebhardt, K; Hartmann, AK; Sigman, L; Gerlach, G				Hinz, Cornelia; Gebhardt, Katharina; Hartmann, Alexander K.; Sigman, Lauren; Gerlach, Gabriele			Influence of Kinship and MHC Class II Genotype on Visual Traits in Zebrafish Larvae (Danio rerio)	PLOS ONE			English	Article							KIN RECOGNITION; IFN-GAMMA; CELLS; PREFERENCES; STICKLEBACK	Kin recognition can drive kin selection and the evolution of social behaviour. In zebrafish (Danio rerio, Hamilton 1822), kin recognition is based on olfactory and visual imprinting processes. If larvae are exposed to visual and chemical cues of kin at day 5 and 6 post fertilization they will recognize kin throughout life, while exposure to non-kin fails to trigger any recognition. Chemical imprinting signals are transcribed by polymorphic genes of the major histocompatibility complex (MHC) code; however, the underlying mechanism for visual imprinting remains unclear. Here we provide evidence for the existence of family-specific differences in morphometry and pigmentation pattern of six day old zebrafish larvae. While rump, tail and body pigmentation were dependent on relatedness, iris pigmentation and morphometry were also influenced by MHC class II genotype. Our study revealed that the MHC not only influences the chemical signature of individuals, but also their visual appearance.	[Hinz, Cornelia; Gebhardt, Katharina; Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-2900 Oldenburg, Germany; [Hartmann, Alexander K.] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-2900 Oldenburg, Germany; [Sigman, Lauren] Marine Biol Lab, Woods Hole, MA 02543 USA	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Marine Biological Laboratory - Woods Hole	Hinz, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-2900 Oldenburg, Germany.	cornelia.hinz@uni-oldenburg.de	Gerlach, Gabriele/K-5919-2012		DFG [GE 842/5-1, SPP 1392]	DFG(German Research Foundation (DFG))	The project is funded by the DFG (GE 842/5-1) and is part of the SPP 1392 (integrative analysis of olfaction). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Eifuku S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018913; Eluvathingal LM, 2009, J BIOSCIENCES, V34, P435, DOI 10.1007/s12038-009-0050-2; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Hartmann A. K., 2009, PRACTICAL GUIDE COMP; Hepper PG., 1991, KIN RECOGNITION; Jager I, 2007, J EVOLUTION BIOL, V20, P2005, DOI 10.1111/j.1420-9101.2007.01366.x; Jain AK., 1988, TECHNOMETRICS; Kuroda N, 2002, IMMUNOGENETICS, V54, P418, DOI 10.1007/s00251-002-0473-5; Le Vin AL, 2010, ANIM BEHAV, V79, P1109, DOI 10.1016/j.anbehav.2010.02.006; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; LIVERSIDGE JM, 1988, CLIN EXP IMMUNOL, V73, P489; Maaswinkel H, 2003, J EXP BIOL, V206, P2201, DOI 10.1242/jeb.00397; Makhoul M, 2012, ACTA OPHTHALMOL, V90, pE38, DOI 10.1111/j.1755-3768.2011.02241.x; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Patterson L, 2008, ANIM BEHAV, V76, P717, DOI 10.1016/j.anbehav.2008.03.018; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Press WH, 1995, NUMERICAL RECIPES C; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Setchell JM, 2009, INT J PRIMATOL, V30, P825, DOI 10.1007/s10764-009-9371-0; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050	27	11	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51182	10.1371/journal.pone.0051182	http://dx.doi.org/10.1371/journal.pone.0051182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251449	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900051
J	Phillips, JM; Everling, S				Phillips, Jessica M.; Everling, Stefan			Neural Activity in the Macaque Putamen Associated with Saccades and Behavioral Outcome	PLOS ONE			English	Article							MONKEY CAUDATE NEURONS; FRONTAL EYE FIELD; PRIMATE PREFRONTAL CORTEX; BASAL GANGLIA; ANTERIOR CINGULATE; FUNCTIONAL-PROPERTIES; REWARD EXPECTATION; CORTICOSTRIATAL PROJECTIONS; INTERNAL GENERATION; DIFFERENTIAL ROLES	It is now widely accepted that the basal ganglia nuclei form segregated, parallel loops with neocortical areas. The prevalent view is that the putamen is part of the motor loop, which receives inputs from sensorimotor areas, whereas the caudate, which receives inputs from frontal cortical eye fields and projects via the substantia nigra pars reticulata to the superior colliculus, belongs to the oculomotor loop. Tracer studies in monkeys and functional neuroimaging studies in human subjects, however, also suggest a potential role for the putamen in oculomotor control. To investigate the role of the putamen in saccadic eye movements, we recorded single neuron activity in the caudal putamen of two rhesus monkeys while they alternated between short blocks of pro- and anti-saccades. In each trial, the instruction cue was provided after the onset of the peripheral stimulus, thus the monkeys could either generate an immediate response to the stimulus based on the internal representation of the rule from the previous trial, or alternatively, could await the visual rule-instruction cue to guide their saccadic response. We found that a subset of putamen neurons showed saccade-related activity, that the preparatory mode (internally-versus externally-cued) influenced the expression of task-selectivity in roughly one third of the task-modulated neurons, and further that a large proportion of neurons encoded the outcome of the saccade. These results suggest that the caudal putamen may be part of the neural network for goal-directed saccades, wherein the monitoring of saccadic eye movements, context and performance feedback may be processed together to ensure optimal behavioural performance and outcomes are achieved during ongoing behaviour.	[Phillips, Jessica M.; Everling, Stefan] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Everling, Stefan] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Everling, Stefan] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Everling, Stefan] Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Everling, S (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON, Canada.	severlin@uwo.ca	Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Phillips, Jessica M/0000-0002-8240-7327	Canadian Institutes of Health Research (CIHR) [44067]; province of Ontario	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); province of Ontario	The work was funded by a grant to SE from Canadian Institutes of Health Research (CIHR #44067 www.cihr.ca) and a scholarship to JMP from the province of Ontario. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert DS, 2012, PSYCHOPHYSIOLOGY, V49, P345, DOI 10.1111/j.1469-8986.2011.01306.x; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; AOSAKI T, 1994, J NEUROSCI, V14, P3969; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brovelli A, 2011, NEUROIMAGE, V57, P1580, DOI 10.1016/j.neuroimage.2011.05.059; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calzavara R, 2007, EUR J NEUROSCI, V26, P2005, DOI 10.1111/j.1460-9568.2007.05825.x; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Deffains M, 2010, J NEUROPHYSIOL, V104, P1355, DOI 10.1152/jn.00355.2010; Dejardin S, 1998, EUR J NEUROSCI, V10, P2328, DOI 10.1046/j.1460-9568.1998.00245.x; Dyckman KA, 2007, NEUROIMAGE, V36, P774, DOI 10.1016/j.neuroimage.2007.03.023; Emeric EE, 2010, J NEUROPHYSIOL, V104, P1523, DOI 10.1152/jn.01001.2009; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ford KA, 2009, J NEUROPHYSIOL, V102, P2334, DOI 10.1152/jn.00125.2009; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gerardin E, 2003, CEREB CORTEX, V13, P162, DOI 10.1093/cercor/13.2.162; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hatanaka N, 2003, J COMP NEUROL, V462, P121, DOI 10.1002/cne.10720; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, REV NEUROL, V145, P580; HIKOSAKA O, 1986, EXP BRAIN RES, V63, P659, DOI 10.1007/BF00237489; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Hori Y, 2009, J NEUROPHYSIOL, V102, P3530, DOI 10.1152/jn.00104.2009; Hutchison R.M., 2012, HUM BRAIN MAPP; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; JOHNSON TN, 1971, EXP NEUROL, V33, P584, DOI 10.1016/0014-4886(71)90129-4; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Kunimatsu J, 2010, J NEUROSCI, V30, P5108, DOI 10.1523/JNEUROSCI.0406-10.2010; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muranishi M, 2011, EXP BRAIN RES, V209, P235, DOI 10.1007/s00221-011-2545-y; Neggers SFW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029517; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Petit L, 1996, J NEUROSCI, V16, P3714; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Phillips JM, 2011, J COGNITIVE NEUROSCI, V23, P481, DOI 10.1162/jocn.2010.21482; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; ROMO R, 1992, EXP BRAIN RES, V91, P385, DOI 10.1007/BF00227835; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; SCHULTZ W, 1988, EXP BRAIN RES, V71, P431; Seifert S, 2011, J NEUROSCI, V31, P3375, DOI 10.1523/JNEUROSCI.6242-10.2011; SELEMON LD, 1985, J NEUROSCI, V5, P776; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; SZABO J, 1967, EXP NEUROL, V19, P463, DOI 10.1016/0014-4886(67)90166-5; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Watanabe K, 1998, J NEUROPHYSIOL, V79, P2568, DOI 10.1152/jn.1998.79.5.2568; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Watanabe M, 2011, J COGNITIVE NEUROSCI, V23, P1794, DOI 10.1162/jocn.2010.21554; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Watanabe M, 2010, J NEUROSCI, V30, P2700, DOI 10.1523/JNEUROSCI.5011-09.2010; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	97	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51596	10.1371/journal.pone.0051596	http://dx.doi.org/10.1371/journal.pone.0051596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251586	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900106
J	Youmans, L; Taylor, C; Shin, E; Harrell, A; Ellis, AE; Seguin, B; Ji, XL; Zhao, SY				Youmans, Lydia; Taylor, Cynthia; Shin, Edwin; Harrell, Adrienne; Ellis, Angela E.; Seguin, Bernard; Ji, Xinglai; Zhao, Shaying			Frequent Alteration of the Tumor Suppressor Gene APC in Sporadic Canine Colorectal Tumors	PLOS ONE			English	Article							DOMESTIC DOG; COLON-CANCER; SOMATIC MUTATIONS; GENOME SEQUENCE; BETA-CATENIN; E-CADHERIN; EXPRESSION; MEDICINE; SCIENCE; CLUSTER	Sporadic canine colorectal cancers (CRCs) should make excellent models for studying the corresponding human cancers. To molecularly characterize canine CRC, we investigated exonic sequence mutations of adenomatous polyposis coli (APC), the best known tumor suppressor gene of human CRC, in 23 sporadic canine colorectal tumors, including 8 adenomas and 15 adenocarcinomas, via exon-resequencing analysis. As a comparison, we also performed the same sequencing analysis on 10 other genes, either located at human 5q22 (the same locus as APC) or 18q21 (also frequently altered in human CRC), or known to play a role in human carcinogenesis. We noted that APC was the most significantly mutated gene in both canine adenomas and adenocarcinomas among the 11 genes examined. Significantly, we detected large deletions of >= 10 bases, many clustered near the mutation cluster region, as well as single or two base deletions in similar to 70% canine tumors of both subtypes. These observations indicate that like in the human, APC is also frequently altered in sporadic colorectal tumors in the dog and its alteration is an early event in canine colorectal tumorigenesis. Our study provides further evidence demonstrating the molecular similarity in pathogenesis between sporadic human and canine CRCs. This work, along with our previous copy number abnormality study, supports that sporadic canine CRCs are valid models of human CRCs at the molecular level.	[Youmans, Lydia; Taylor, Cynthia; Shin, Edwin; Harrell, Adrienne; Zhao, Shaying] Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA; [Ellis, Angela E.] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA; [Seguin, Bernard] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Ji, Xinglai] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Ji, Xinglai] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Oregon State University; Yunnan University; Yunnan University	Zhao, SY (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA.	szhao@bmb.uga.edu		seguin, bernard/0000-0002-3663-983X	American Cancer Society; Georgia Cancer Coalition; National Science Foundation of China [31160021, 31270131]; Science and Technological Project of Yunnan Province [2011CI]; Foundation for Key Teacher of Yunnan University; NCI [P50 CA128613, GM085354]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Georgia Cancer Coalition; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Project of Yunnan Province; Foundation for Key Teacher of Yunnan University; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the American Cancer Society and the Georgia Cancer Coalition (PI: Zhao); the National Science Foundation of China (31160021 and 31270131), Science and Technological Project of Yunnan Province (2011CI) and Foundation for Key Teacher of Yunnan University (PI: Ji); the NCI P50 CA128613 (PI: Dr. Dong M. Shin) and GM085354 (PI: Dr. Stephen Dalton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CE, 2012, MAMM GENOME, V23, P144, DOI 10.1007/s00335-011-9369-8; Aresu L, 2010, RES VET SCI, V89, P409, DOI 10.1016/j.rvsc.2010.04.008; Argyle DJ, 2005, VET J, V170, P147, DOI 10.1016/j.tvjl.2004.08.003; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Crist RC, 2010, MAMM GENOME, V21, P450, DOI 10.1007/s00335-010-9288-0; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2008, NAT METHODS, V5, P225, DOI 10.1038/nmeth0308-225; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Habermann JK, 2011, MODERN PATHOL, V24, P542, DOI 10.1038/modpathol.2010.217; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-455; Ji XL, 2008, GENOMICS, V91, P249, DOI 10.1016/j.ygeno.2007.10.014; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; MA LB, 1994, MOL CELL BIOL, V14, P4126, DOI 10.1128/MCB.14.6.4126; McEntee MF, 1999, VET PATHOL, V36, P228, DOI 10.1354/vp.36-3-228; Michell AR, 2005, VET J, V170, P153, DOI 10.1016/j.tvjl.2004.06.004; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Restucci B, 2009, ANTICANCER RES, V29, P2919; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Shibata H, 2007, P NATL ACAD SCI USA, V104, P18199, DOI 10.1073/pnas.0705730104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Taketo M M, 2000, Hum Cell, V13, P85; Tang J, 2010, GENOME RES, V20, P341, DOI 10.1101/gr.092726.109; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837	44	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50813	10.1371/journal.pone.0050813	http://dx.doi.org/10.1371/journal.pone.0050813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251390	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900022
J	Flacke, JP; Flacke, H; Appukuttan, A; Palisaar, RJ; Noldus, J; Robinson, BD; Reusch, HP; Zippin, JH; Ladilov, Y				Flacke, Jan-Paul; Flacke, Hanna; Appukuttan, Avinash; Palisaar, Rein-Jueri; Noldus, Joachim; Robinson, Brian D.; Reusch, H. Peter; Zippin, Jonathan H.; Ladilov, Yury			Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; G(2)/M TRANSITION; CAMP; APOPTOSIS; EPAC; MELANOMA; SIGNAL; DIFFERENTIATION; ACTIVATION; SURVIVAL	cAMP signaling plays an essential role in modulating the proliferation of different cell types, including cancer cells. Until now, the regulation of this pathway was restricted to the transmembrane class of adenylyl cyclases. In this study, significant overexpression of soluble adenylyl cyclase (sAC), an alternative source of cAMP, was found in human prostate carcinoma, and therefore, the contribution of this cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3. Suppression of sAC activity by treatment with the sAC-specific inhibitor KH7 or by sAC-specific knockdown mediated by siRNA or shRNA transfection prevented the proliferation of prostate carcinoma cells, led to lactate dehydrogenase release, and induced apoptosis. Cell cycle analysis revealed a significant rise in the G(2) phase population 12 h after sAC inhibition, which was accompanied by the down-regulation of cyclin B-1 and CDK1. sAC-dependent regulation of proliferation involves the EPAC/Rap1/B-Raf signaling pathway. In contrast, protein kinase A does not play a role. In conclusion, this study suggests a novel sAC-dependent signaling pathway that controls the proliferation of prostate carcinoma cells.	[Flacke, Jan-Paul; Flacke, Hanna; Appukuttan, Avinash; Reusch, H. Peter; Ladilov, Yury] Ruhr Univ Bochum, Dept Clin Pharmacol, D-44801 Bochum, Germany; [Palisaar, Rein-Jueri; Noldus, Joachim] Ruhr Univ Bochum, Urol Clin, D-44801 Bochum, Germany; [Robinson, Brian D.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Robinson, Brian D.] Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; [Zippin, Jonathan H.] Weill Cornell Med Coll, Dept Dermatol, New York, NY 10065 USA	Ruhr University Bochum; Ruhr University Bochum; Cornell University; Cornell University; Cornell University	Ladilov, Y (corresponding author), Ruhr Univ Bochum, Dept Clin Pharmacol, Univ Str 150, D-44801 Bochum, Germany.	yury.ladilov@rub.de	Ladilov, Yury/AAN-2603-2020; Ladilov, Yury/AAD-3547-2021		Deutsche Forschungsgemeinschaft [LA 1159/7-1]; Ruhr University Bochum [F690-2010, F719-2011]; Clinique Clinical Scholars fellowship; National Institutes of Health from NCI [K08 CA160657]; NATIONAL CANCER INSTITUTE [K08CA160657] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr University Bochum; Clinique Clinical Scholars fellowship; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant LA 1159/7-1 from the Deutsche Forschungsgemeinschaft and by Forum Grants F690-2010 and F719-2011 from Ruhr University Bochum.; Supported by a Clinique Clinical Scholars fellowship and National Institutes of Health Grant K08 CA160657 from NCI.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Appukuttan A, 2012, CARDIOVASC RES, V93, P340, DOI 10.1093/cvr/cvr306; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao JN, 2010, CANCER RES, V70, P6004, DOI 10.1158/0008-5472.CAN-09-4490; Chen TC, 1998, LAB INVEST, V78, P165; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Magro CM, 2012, ARCH DERMATOL, V148, P335, DOI 10.1001/archdermatol.2011.338; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rinne A, 2006, J MUSCLE RES CELL M, V27, P413, DOI 10.1007/s10974-006-9087-0; Rudolph JA, 2004, J BIOL CHEM, V279, P14828, DOI 10.1074/jbc.M310289200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2010, J INVEST DERMATOL, V130, P1279, DOI 10.1038/jid.2009.440	41	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3126	3135		10.1074/jbc.M112.403279	http://dx.doi.org/10.1074/jbc.M112.403279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255611	hybrid, Green Published			2022-12-25	WOS:000314397900021
J	Garcia-Prieto, C; Ahmed, KBR; Chen, Z; Zhou, Y; Hammoudi, N; Kang, Y; Lou, CG; Mei, Y; Jin, ZD; Huang, P				Garcia-Prieto, Celia; Ahmed, Kausar Begam Riaz; Chen, Zhao; Zhou, Yan; Hammoudi, Naima; Kang, Ying; Lou, Changgang; Mei, Yan; Jin, Zhendong; Huang, Peng			Effective Killing of Leukemia Cells by the Natural Product OSW-1 through Disruption of Cellular Calcium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT ANTITUMOR SAPONIN; ENDOPLASMIC-RETICULUM; GLYCOSIDES BEARING; MALIGNANT GLIOMAS; STEROIDAL SAPONIN; PROSTATE-CANCER; CA2+ TRANSPORT; UP-REGULATION; PROTEIN; ANALOGS	3 beta,16 beta,17 alpha-Trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1 -> 3)-2-O-acetyl-alpha-L-arabinopyranoside (OSW-1) is a natural product with potent antitumor activity against various types of cancer cells, but the exact mechanisms of action remain to be defined. In this study, we showed that OSW-1 effectively killed leukemia cells at subnanomolar concentrations through a unique mechanism by causing a time-dependent elevation of cytosolic Ca2+ prior to induction of apoptosis. A mechanistic study revealed that this compound inhibited the sodium-calcium exchanger 1 on the plasma membrane, leading to an increase in cytosolic Ca2+ and a decrease in cytosolic Na+. The elevated cytosolic Ca2+ caused mitochondrial calcium overload and resulted in a loss of mitochondrial membrane potential, release of cytochrome c, and activation of caspase-3. Furthermore, OSW-1 also caused a Ca2+-dependent cleavage of the survival factor GRP78. Inhibition of Ca2+ entry into the mitochondria by the uniporter inhibitor RU360 or by cyclosporin A significantly prevented the OSW-1-induced cell death, indicating the important role of mitochondria in mediating the cytotoxic activity. The extremely potent activity of OSW-1 against leukemia cells and its unique mechanism of action suggest that this compound may be potentially useful in the treatment of leukemia.	[Garcia-Prieto, Celia; Ahmed, Kausar Begam Riaz; Chen, Zhao; Hammoudi, Naima; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Garcia-Prieto, Celia] Univ Texas MD Anderson Canc Ctr, Canc Prevent Div, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Ahmed, Kausar Begam Riaz; Hammoudi, Naima] Univ Texas Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Zhao] Univ Penn, Sch Med, Dept Genet, Genet Diagnost Lab, Philadelphia, PA 19104 USA; [Kang, Ying] E Tennessee State Univ, Dept Internal Med, James H Quillen Coll Med, Johnson City, TN 37614 USA; [Kang, Ying; Lou, Changgang; Mei, Yan; Jin, Zhendong] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; East Tennessee State University; University of Iowa	Huang, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Unit 0951,1515 Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org			National Institutes of Health [CA085563, CA100428, CA109041, CA16672, P60MD000503]; NATIONAL CANCER INSTITUTE [R01CA109041, P30CA016672, R01CA100428, R01CA085563] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085563, CA100428, CA109041, CA16672, and P60MD000503.	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; BERAN M, 1993, CANCER RES, V53, P3603; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Deng SJ, 1999, J ORG CHEM, V64, P202, DOI 10.1021/jo981685c; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Guan YY, 2011, BIOORG MED CHEM LETT, V21, P2921, DOI 10.1016/j.bmcl.2011.03.065; Guo CX, 1998, TETRAHEDRON LETT, V39, P1099, DOI 10.1016/S0040-4039(97)10814-0; Harley W, 2010, BRAIN RES, V1363, P159, DOI 10.1016/j.brainres.2010.09.059; Iwamoto T, 2006, J PHARMACOL SCI, V102, P32, DOI 10.1254/jphs.FMJ06002X6; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; KUBO S, 1992, PHYTOCHEMISTRY, V31, P3969, DOI 10.1016/S0031-9422(00)97565-4; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Ma XQ, 2001, BIOORG MED CHEM LETT, V11, P2153, DOI 10.1016/S0960-894X(01)00389-4; Ma XQ, 2000, CARBOHYD RES, V329, P495, DOI 10.1016/S0008-6215(00)00225-1; Ma XQ, 2001, CARBOHYD RES, V334, P159, DOI 10.1016/S0008-6215(01)00171-9; Maj J, 2011, J MED CHEM, V54, P3298, DOI 10.1021/jm101648h; McConkey DJ, 1996, J LEUKOCYTE BIOL, V59, P775, DOI 10.1002/jlb.59.6.775; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morzycki JW, 2004, BIOORG MED CHEM LETT, V14, P3323, DOI 10.1016/j.bmcl.2004.03.102; Morzycki JW, 2002, CARBOHYD RES, V337, P1269, DOI 10.1016/S0008-6215(02)00126-X; Newman RA, 2007, INTEGR CANCER THER, V6, P354, DOI 10.1177/1534735407309623; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pathak S, 2000, ANTI-CANCER DRUG, V11, P455, DOI 10.1097/00001813-200007000-00006; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ribiczey P, 2007, CELL CALCIUM, V42, P590, DOI 10.1016/j.ceca.2007.02.003; Rizzuto R, 2003, J CELL BIOL, V163, P441, DOI 10.1083/jcb.200309111; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Shi BF, 2005, J ORG CHEM, V70, P10354, DOI 10.1021/jo051536b; Tamura K, 1997, BRIT J PHARMACOL, V121, P1796, DOI 10.1038/sj.bjp.0701309; Tang PP, 2007, BIOORG MED CHEM LETT, V17, P1003, DOI 10.1016/j.bmcl.2006.11.032; Tschamber T, 2007, BIOORG MED CHEM LETT, V17, P5101, DOI 10.1016/j.bmcl.2007.07.017; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Wojtkielewicz A, 2007, J MED CHEM, V50, P3667, DOI 10.1021/jm0613572; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yokoyama S., 2005, MATER TECHNOL, V23, P54; Yu WS, 2002, J AM CHEM SOC, V124, P6576, DOI 10.1021/ja012119t; Yu WS, 2001, J AM CHEM SOC, V123, P3369, DOI 10.1021/ja004098t; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zheng D, 2011, BIOORG MED CHEM LETT, V21, P3257, DOI 10.1016/j.bmcl.2011.04.030; Zheng D, 2010, BIOORG MED CHEM LETT, V20, P5439, DOI 10.1016/j.bmcl.2010.07.085; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P1781, DOI 10.1093/jnci/dji404; Zhu JB, 2005, MOL PHARMACOL, V68, P1831, DOI 10.1124/mol.105.015826	59	43	44	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3240	3250		10.1074/jbc.M112.384776	http://dx.doi.org/10.1074/jbc.M112.384776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250754	Green Published, hybrid			2022-12-25	WOS:000314397900031
J	Arthurs, E; Steele, RJ; Hudson, M; Baron, M; Thombs, BD				Arthurs, Erin; Steele, Russell J.; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp	Are Scores on English and French Versions of the PHQ-9 Comparable? An Assessment of Differential Item Functioning	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; CONFIRMATORY FACTOR-ANALYSIS; MENTAL-STATE-EXAMINATION; SYSTEMIC-SCLEROSIS; REPORTED OUTCOMES; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; LANGUAGE VERSIONS; RESPONSE THEORY; FIT INDEXES	Background: Medical research increasingly utilizes patient-reported outcome measures administered and scored in different languages. In order to pool or compare outcomes from different language versions, instruments should be measurement equivalent across linguistic groups. The objective of this study was to examine the cross-language measurement equivalence of the Patient Health Questionnaire-9 (PHQ-9) between English- and French-speaking Canadian patients with systemic sclerosis (SSc). Methods: The sample consisted of 739 English- and 221 French-speaking SSc patients. Multiple-Indicator Multiple-Cause (MIMIC) modeling was used to identify items displaying possible differential item functioning (DIF). Results: A one-factor model for the PHQ-9 fit the data well in both English- and French-speaking samples. Statistically significant DIF was found for 3 of 9 items on the PHQ-9. However, the overall estimate in depression latent scores between English- and French-speaking respondents was not influenced substantively by DIF. Conclusions: Although there were several PHQ-9 items with evidence of minor DIF, there was no evidence that these differences influenced overall scores meaningfully. The PHQ-9 can reasonably be used without adjustment in Canadian English- and French-speaking samples. Analyses assessing measurement equivalence should be routinely conducted prior to pooling data from English and French versions of patient-reported outcome measures. Citation: Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, et al. (2012) Are Scores on English and French Versions of the PHQ-9 Comparable? An Assessment of Differential Item Functioning. PLoS ONE 7(12): e52028. doi: 10.1371/journal.pone.0052028	[Arthurs, Erin; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Steele, Russell J.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Div Rheumatol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Arthurs, Erin; Steele, Russell J.; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Steele, Russell J/G-6926-2017; Baron, Murray/AAF-9486-2019	Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research; Scleroderma Society of Canada; Actelion Pharmaceuticals; Pfizer Inc.; Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Actelion Pharmaceuticals; Pfizer Inc.(Pfizer); Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Dr. Baron is the director of the Canadian Scleroderma Research Group, which receives grant funding from the Canadian Institutes of Health Research, the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, the Ontario Arthritis Society, and educational grants from Actelion Pharmaceuticals and Pfizer Inc. Drs. Thombs and Hudson are supported by New Investigator Awards from the Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs awards from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. The commercial funding that provides support to the CSRG does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1189, DOI 10.1016/S0895-4356(98)00111-5; Boers M, 1998, J RHEUMATOL, V25, P198; Bren Linda, 2006, FDA Consum, V40, P26; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; BYRNE BM, 1994, APPL PSYCHOL-INT REV, V43, P33, DOI 10.1111/j.1464-0597.1994.tb00808.x; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Carballeira Y, 2007, PSYCHOL PSYCHOTHER-T, V80, P69, DOI 10.1348/147608306X103641; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Clements PJ, 2004, SEMIN ARTHRITIS RHEU, V33, P249, DOI 10.1053/S0049-0172(03)00135-5; Couture S, 2010, EUR EAT DISORD REV, V18, P234, DOI 10.1002/erv.996; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Dorans NJ, 2006, MED CARE, V44, pS107, DOI 10.1097/01.mlr.0000245182.36914.4a; DRASGOW F, 1985, J APPL PSYCHOL, V70, P662, DOI 10.1037/0021-9010.70.4.662; Edelen MO, 2006, MED CARE, V44, pS134, DOI 10.1097/01.mlr.0000245251.83359.8c; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fairclough DL, 2004, STAT METHODS MED RES, V13, P115, DOI 10.1191/0962280204sm357ra; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jones RN, 2006, MED CARE, V44, pS124, DOI 10.1097/01.mlr.0000245250.50114.0f; Kojima M, 2001, J PSYCHOSOM RES, V51, P487, DOI 10.1016/S0022-3999(01)00253-7; Krause JS, 2008, REHABIL PSYCHOL, V53, P513, DOI 10.1037/a0013354; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Meyer JP, 2004, J EDUC MEAS, V41, P331, DOI 10.1111/j.1745-3984.2004.tb01169.x; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; O'Rourke N, 2003, CAN J AGING, V22, P323, DOI 10.1017/S0714980800003937; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Petersen MA, 2003, QUAL LIFE RES, V12, P373, DOI 10.1023/A:1023488915557; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Richardson EJ, 2008, REHABIL PSYCHOL, V53, P243, DOI 10.1037/0090-5550.53.2.243; Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89; SEIBOLD J, 2005, KELLEYS TXB RHEUMATO; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stephenson Randolph, 1999, Scandinavian Journal of Behaviour Therapy, V28, P58; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Teresi JA, 2006, MED CARE, V44, pS152, DOI 10.1097/01.mlr.0000245142.74628.ab; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Wells G, 2008, ANN RHEUM DIS, V67, P260, DOI 10.1136/ard.2007.069690; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004; Yeung A, 2008, COMPR PSYCHIAT, V49, P211, DOI 10.1016/j.comppsych.2006.06.002	53	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52028	10.1371/journal.pone.0052028	http://dx.doi.org/10.1371/journal.pone.0052028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251676	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800129
J	Xu, H; Krolikowski, JG; Jones, DW; Ge, ZD; Pagel, PS; Pritchard, KA; Weihrauch, D				Xu, Hao; Krolikowski, John G.; Jones, Deron W.; Ge, Zhi-Dong; Pagel, Paul S.; Pritchard, Kirkwood A., Jr.; Weihrauch, Dorothee			4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice	PLOS ONE			English	Article							REGULATORY FACTOR 5; MIMETIC PEPTIDE; FIBRILLIN-1 EXPRESSION; SYSTEMIC-SCLEROSIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; MOUSE MODEL; APOA-I; PROTEIN; CELLS	The apoAI mimetic 4F was designed to inhibit atherosclerosis by improving HDL. We reported that treating tight skin (Tsk(-/+)) mice, a model of systemic sclerosis (SSc), with 4F decreases inflammation and restores angiogenic potential in Tsk(-/+) hearts. Interferon regulating factor 5 (IRF5) is important in autoimmunity and apoptosis in immune cells. However, no studies were performed investigating IRF5 in myocardium. We hypothesize that 4F differentially modulates IRF5 expression and activation in Tsk(-/+) hearts. Posterior wall thickness was significantly increased in Tsk(-/+) compared to C57Bl/6J (control) and Tsk(-/+) mice with 4F treatment assessed by echoradiography highlighting reduction of fibrosis in 4F treated Tsk(-/+) mice. IRF5 in heart lysates from control and Tsk/+ with and without 4F treatment (sc, 1 mg/kg/d, 6-8 weeks) was determined. Phosphoserine, ubiquitin, ubiquitin K-63 on IRF5 were determined on immunoprecipitates of IRF5. Immunofluorescence and TUNEL assays in heart sections were used to determine positive nuclei for IRF5 and apoptosis, respectively. Fluorescence-labeled streptavidin (SA) was used to determine endothelial cell uptake of biotinylated 4F. SA-agarose pulldown and immunoblotting for IRF5 were used to determine 4F binding IRF5 in endothelial cell cytosolic fractions and to confirm biolayer interferometry studies. IRF5 levels in Tsk(-/+) hearts were similar to control. 4F treatments decrease IRF5 in Tsk(-/+) hearts and decrease phosphoserine and ubiquitin K 63 but increase total ubiquitin on IRF5 in Tsk(-/+) compared with levels on IRF5 in control hearts. 4F binds IRF5 by mechanisms favoring association over dissociation strong enough to pull down IRF5 from a mixture of endothelial cell cytosolic proteins. IRF5 positive nuclei and apoptotic cells in Tsk(-/+) hearts were increased compared with controls. 4F treatments decreased both measurements in Tsk(-/+) hearts. IRF5 activation in Tsk(-/+) hearts is increased. 4F treatments decrease IRF5 expression and activation in Tsk(-/+) hearts by a mechanism related to 4F's ability to bind IRF5. Citation: Xu H, Krolikowski JG, Jones DW, Ge Z-D, Pagel PS, et al. (2012) 4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice. PLoS ONE 7(12): e52046. doi:10.1371/journal.pone.0052046	[Krolikowski, John G.; Ge, Zhi-Dong; Weihrauch, Dorothee] Childrens Res Inst, Dept Surg, Div Anesthesiol, Milwaukee, WI USA; [Xu, Hao; Jones, Deron W.; Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI USA; [Pagel, Paul S.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA		Weihrauch, D (corresponding author), Childrens Res Inst, Dept Surg, Div Anesthesiol, Milwaukee, WI USA.	dorothee@mcw.edu			Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery [HL-089779, HL-102836, HL-102996]; departmental funds from the Department of Anesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089779, R21HL102996, R01HL112270, R01HL102836] Funding Source: NIH RePORTER	Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery; departmental funds from the Department of Anesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dorothee Weihrauch HL-089779, Kirkwood A. Pritchard Jr. HL-102836 and HL-102996, Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery, and departmental funds from the Department of Anesthesiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2006, ARTHRITIS RHEUM-US, V54, P2250, DOI 10.1002/art.21952; Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Anda KS, 2011, AUTOIMMUNITY REVIEWS; Balkhi MY, 2010, CELL SIGNAL, V22, P117, DOI 10.1016/j.cellsig.2009.09.021; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; BOCCHIERI MH, 1991, ARTHRITIS RHEUM, V34, P599, DOI 10.1002/art.1780340512; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Krolikowski J, 2012, ATHEROSCLEROSIS THRO, P32; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2007, J CLIN LIPIDOL, V1, P142, DOI 10.1016/j.jacl.2007.03.002; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Orikasa C, 2002, P NATL ACAD SCI USA, V99, P3306, DOI 10.1073/pnas.052707299; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; PARDRIDGE WM, 1991, FEBS LETT, V288, P30, DOI 10.1016/0014-5793(91)80996-G; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Sharif R, 2012, ANN RHEUMATIC DIS; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; Vecoli C, 2011, J CELL BIOCHEM, V112, P2616, DOI 10.1002/jcb.23188; Weihrauch D, 2004, CIRCULATION, V109, P2343, DOI 10.1161/01.CIR.0000129225.67353.1F; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Wool GD, 2009, J LIPID RES, V50, P1889, DOI 10.1194/jlr.M900151-JLR200; Xu H, 2011, AM J PHYSIOL-CELL PH, V300, pC550, DOI 10.1152/ajpcell.00123.2010	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52046	10.1371/journal.pone.0052046	http://dx.doi.org/10.1371/journal.pone.0052046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251680	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800133
J	Dimmock, NJ; Dove, BK; Scott, PD; Meng, B; Taylor, I; Cheung, L; Hallis, B; Marriott, AC; Carroll, MW; Easton, AJ				Dimmock, Nigel J.; Dove, Brian K.; Scott, Paul D.; Meng, Bo; Taylor, Irene; Cheung, Linda; Hallis, Bassam; Marriott, Anthony C.; Carroll, Miles W.; Easton, Andrew J.			Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; H1N1; OSELTAMIVIR; TRANSMISSION; DISEASE; ANTIVIRALS; INFECTION; EFFICACY; VACCINE; HUMANS	Influenza A viruses are a major cause of morbidity and mortality in the human population, causing epidemics in the winter, and occasional worldwide pandemics. In addition there are periodic outbreaks in domestic poultry, horses, pigs, dogs, and cats. Infections of domestic birds can be fatal for the birds and their human contacts. Control in man operates through vaccines and antivirals, but both have their limitations. In the search for an alternative treatment we have focussed on defective interfering (DI) influenza A virus. Such a DI virus is superficially indistinguishable from a normal virus but has a large deletion in one of the eight RNAs that make up the viral genome. Antiviral activity resides in the deleted RNA. We have cloned one such highly active DI RNA derived from segment 1 (244 DI virus) and shown earlier that intranasal administration protects mice from lethal disease caused by a number of different influenza A viruses. A more cogent model of human influenza is the ferret. Here we found that intranasal treatment with a single dose of 2 or 0.2 mu g 244 RNA delivered as A/PR/8/34 virus particles protected ferrets from disease caused by pandemic virus A/California/04/09 (A/Cal; H1N1). Specifically, 244 DI virus significantly reduced fever, weight loss, respiratory symptoms, and infectious load. 244 DI RNA, the active principle, was amplified in nasal washes following infection with A/Cal, consistent with its amelioration of clinical disease. Animals that were treated with 244 DI RNA cleared infectious and DI viruses without delay. Despite the attenuation of infection and disease by DI virus, ferrets formed high levels of A/Cal-specific serum haemagglutination-inhibiting antibodies and were solidly immune to rechallenge with A/Cal. Together with earlier data from mouse studies, we conclude that 244 DI virus is a highly effective antiviral with activity potentially against all influenza A subtypes.	[Dimmock, Nigel J.; Scott, Paul D.; Meng, Bo; Cheung, Linda; Marriott, Anthony C.; Easton, Andrew J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Dove, Brian K.; Taylor, Irene; Hallis, Bassam; Carroll, Miles W.] Hlth Protect Agcy, Salisbury, Wilts, England	University of Warwick; Health Protection Agency	Dimmock, NJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	n.j.dimmock@warwick.ac.uk		Marriott, Anthony/0000-0002-8862-9852	Wellcome Trust [090441Z09Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors received a technology transfer award (no. 090441Z09Z) from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Cox NJ, 2007, NEW ENGL J MED, V356, P729, DOI 10.1056/NEJMe078003; Dimmock NJ, 2008, J VIROL, V82, P8570, DOI 10.1128/JVI.00743-08; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Duhaut SD, 1998, VIROLOGY, V248, P241, DOI 10.1006/viro.1998.9267; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Easton AJ, 2011, VACCINE, V29, P2777, DOI 10.1016/j.vaccine.2011.01.102; Francis T, 1934, SCIENCE, V80, P457, DOI 10.1126/science.80.2081.457-a; GARD S, 1947, ARK KEM MINERAL GEOL, V24, P1; Govorkova EA, 2006, ANTIVIR RES, V70, pA29; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; JENNINGS PA, 1983, CELL, V34, P619, DOI 10.1016/0092-8674(83)90394-X; Laver G, 2002, MICROBES INFECT, V4, P1309, DOI 10.1016/S1286-4579(02)00013-8; Layton RC, 2009, PROCEDIA VACCINOL, V1, P30, DOI 10.1016/j.provac.2009.07.006; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mann A, 2006, VACCINE, V24, P4290, DOI 10.1016/j.vaccine.2006.03.004; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Meng B, 2010, INFLUENZA OTHER RESP, V4, P147, DOI 10.1111/j.1750-2659.2010.00130.x; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Oxford JS, 2007, INFLUENZA OTHER RESP, V1, P27, DOI 10.1111/j.1750-2659.2006.00006.x; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Scott PD, 2011, J GEN VIROL, V92, P2122, DOI 10.1099/vir.0.034132-0; Scott PD, 2011, VACCINE, V29, P6584, DOI 10.1016/j.vaccine.2011.06.114; Scott PD, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-212; Smith J, 2006, LANCET, V367, P1571, DOI 10.1016/S0140-6736(06)68683-2; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Ujike M, 2011, EMERG INFECT DIS, V17, P470, DOI 10.3201/eid1703.101188; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Webster RG, 2003, AM SCI, V91, P122, DOI 10.1511/2003.2.122; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Yun NE, 2008, VIROLOGY, V374, P198, DOI 10.1016/j.virol.2007.12.029	56	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49394	10.1371/journal.pone.0049394	http://dx.doi.org/10.1371/journal.pone.0049394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251341	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200014
J	Oppenheim, FG; Helmerhorst, EJ; Lendenmann, U; Offner, GD				Oppenheim, Frank G.; Helmerhorst, Eva J.; Lendenmann, Urs; Offner, Gwynneth D.			Anti-Candidal Activity of Genetically Engineered Histatin Variants with Multiple Functional Domains	PLOS ONE			English	Article							HISTIDINE-RICH POLYPEPTIDES; HUMAN-PAROTID SECRETION; SALIVARY MUCIN MUC7; ANTIMICROBIAL PEPTIDES; ANTICANDIDAL ACTIVITY; FUNGICIDAL ACTIVITY; MOLECULAR-CLONING; INNATE IMMUNITY; ALBICANS; ANTIFUNGAL	The human bodily defense system includes a wide variety of innate antimicrobial proteins. Histatins are small molecular weight proteins produced by the human salivary glands that exhibit antifungal and antibacterial activities. While evolutionarily old salivary proteins such as mucins and proline-rich proteins contain large regions of tandem repeats, relatively young proteins like histatins do not contain such repeated domains. Anticipating that domain duplications have a functional advantage, we genetically engineered variants of histatin 3 with one, two, three, or four copies of the functional domain by PCR and splice overlap. The resulting proteins, designated reHst3 1-mer, reHist3 2-mer, reHis3 3-mer and reHist3 4-mer, exhibited molecular weights of 4,062, 5,919, 7,777, and 9,634 Da, respectively. The biological activities of these constructs were evaluated in fungicidal assays toward Candida albicans blastoconidia and germinated cells. The antifungal activities per mole of protein increased concomitantly with the number of functional domains present. This increase, however, was higher than could be anticipated from the molar concentration of functional domains present in the constructs. The demonstrated increase in antifungal activity may provide an evolutionary explanation why such domain multiplication is a frequent event in human salivary proteins.	[Oppenheim, Frank G.; Helmerhorst, Eva J.; Lendenmann, Urs; Offner, Gwynneth D.] Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Offner, Gwynneth D.] Boston Univ, Med Ctr, Dept Med, Boston, MA USA	Boston University; Boston University	Oppenheim, FG (corresponding author), Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.	fropp@bu.edu		Offner, Gwynneth/0000-0002-3687-9809; Helmerhorst, Eva/0000-0002-4803-3018	NIH [DE05672, DE07652, AI087803, DE14080, DE11691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, R01DE011691, R37DE005672, R01DE014080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The studies were supported by NIH Grants DE05672 (FO), DE07652 (FO), AI087803 (EH), DE14080 (GO) and DE11691 (GO). (http://www.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEN EA, 1978, NATURE, V273, P775, DOI 10.1038/273775a0; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; BRUSILOW SW, 1959, AM J PHYSIOL, V196, P831, DOI 10.1152/ajplegacy.1959.196.4.831; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Driscoll J, 1996, GENE, V177, P29, DOI 10.1016/0378-1119(96)00265-X; Edgerton M, 2000, Adv Dent Res, V14, P16; Helmerhorst EJ, 1997, BIOCHEM J, V326, P39, DOI 10.1042/bj3260039; Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1; Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033818; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kumar R, 2011, J BIOL CHEM, V286, P43748, DOI 10.1074/jbc.M111.311175; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RAJ PA, 1990, J BIOL CHEM, V265, P3898; RAYHAN R, 1992, ORAL MICROBIOL IMMUN, V7, P51, DOI 10.1111/j.1399-302X.1992.tb00020.x; Rothstein David M, 2002, Expert Opin Emerg Drugs, V7, P47, DOI 10.1517/14728214.7.1.47; SABATINI LM, 1989, J DENT RES, V68, P1138, DOI 10.1177/00220345890680070101; Situ H, 2000, ANTIMICROB AGENTS CH, V44, P1485, DOI 10.1128/AAC.44.6.1485-1493.2000; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Troxler RF, 1997, GLYCOBIOLOGY, V7, P965, DOI 10.1093/glycob/7.7.965; Tsai H, 1997, ANTIMICROB AGENTS CH, V41, P2224, DOI 10.1128/AAC.41.10.2224; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, LANCET, V360, P1116, DOI 10.1016/S0140-6736(02)11239-6; ZUO Y, 1995, GENE, V161, P87, DOI 10.1016/0378-1119(95)00237-Z	36	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51479	10.1371/journal.pone.0051479	http://dx.doi.org/10.1371/journal.pone.0051479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251551	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200118
J	Petrov, Y; Nador, J; Qian, JH				Petrov, Yury; Nador, Jeffrey; Qian, Jiehui			VEP Correlates of Feedback in Human Cortex	PLOS ONE			English	Article							INFEROTEMPORAL CORTEX; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; MACAQUE MONKEY; V1; NEURONS; CONDUCTIVITY; CONNECTIONS; TISSUE	It is known that neural responses become less dependent on the stimulus size and location along the visual pathway. This study aimed to use this property to find evidence of neural feedback in visually evoked potentials (VEP). High-density VEPs evoked by a contrast reversing checkerboard were collected from 15 normal observers using a 128-channel EEG system. Surface Laplacian method was used to calculate skull-scalp currents corresponding to the measured scalp potentials. This allowed us to identify several distinct foci of skull-scalp currents and to analyse their individual time-courses. Response nonlinearity as a function of the stimulus size increased markedly from the occipital to temporal loci. Similarly, the nonlinearity of reactivations (late evoked response peaks) over the occipital, lateral-occipital, and frontal scalp regions increased with the peak latency. Response laterality (contralateral vs. ipsilateral) was analysed in lateral-occipital and temporal loci. Early lateral-occipital responses were strongly contralateral but the response laterality decreased and then disappeared for later peaks. Responses in temporal loci did not differ significantly between contralateral and ipsilateral stimulation. Overall, the results suggest that feedback from higher-tier visual areas, e. g., those in temporal cortices, may significantly contribute to reactivations in early visual areas.	[Petrov, Yury; Nador, Jeffrey; Qian, Jiehui] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Northeastern University	Petrov, Y (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	y.petrov@neu.edu	Nador, Jeffrey/AAF-3783-2021	Nador, Jeffrey/0000-0002-6502-7226				Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2003, J NEUROSCI, V23, P7690; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hillyard S, 1987, ELECTROPHYSIOLOGY CO; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Juan CH, 2003, EXP BRAIN RES, V150, P259, DOI 10.1007/s00221-003-1478-5; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; Petrov Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011917; Petrov Y, 2009, J VISION, V9, DOI 10.1167/9.1.21; Picton T W, 1980, Prog Brain Res, V54, P17, DOI 10.1016/S0079-6123(08)61604-0; Reagan D, 1989, HUMAN BRAIN ELECTROP; ROCHAMIRANDA CE, 1975, J NEUROPHYSIOL, V38, P475, DOI 10.1152/jn.1975.38.3.475; Rugg M., 1995, ELECTROPHYSIOLOGY MI; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Wingeier BM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051916; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51791	10.1371/journal.pone.0051791	http://dx.doi.org/10.1371/journal.pone.0051791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251625	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200166
J	Wu, ZH; Lu, MK; Hu, LY; Li, XT				Wu, Zhen Hua; Lu, Ming-ke; Hu, Long Yu; Li, Xiaotong			Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth	PLOS ONE			English	Article							X-LINKED-INHIBITOR; COLORECTAL-CANCER; MITOTIC ARREST; SCHISTOSOMA-MANSONI; APOPTOSIS-PROTEIN; TUMOR-CELLS; ARTEMISININ; DRUGS; ANTICANCER; CYTOTOXICITY	The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel (PZQ), an anti-parasite agent, could greatly enhance the anticancer efficacy of PTX in various cancer cell lines, including PTX-resistant cell lines. Based on the combination index value, we demonstrated that PZQ synergistically enhanced PTX-induced cell growth inhibition. The co-treatment of PZQ and PTX also induced significant mitotic arrest and activated the apoptotic cascade. Moreover, PZQ combined with PTX resulted in a more pronounced inhibition of tumor growth compared with either drug alone in a mouse xenograft model. We tried to investigate the possible mechanisms of this synergistic efficacy induced by PZQ and PTX, and we found that the co-treatment of the two drugs could markedly decrease expression of X-linked inhibitor of apoptosis protein (XIAP), an antiapoptotic protein. Our data further demonstrated that down-regulation of XIAP was required for the synergistic interaction between PZQ and PTX. Together, this study suggested that the combination of PZQ and PTX may represent a novel and effective anticancer strategy for optimizing PTX therapy.	[Wu, Zhen Hua; Lu, Ming-ke; Hu, Long Yu; Li, Xiaotong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University	Li, XT (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	xtli@xmu.edu.cn	Li, xiaotong/GYV-4890-2022		National Foundation for Fostering Talents of Basic Science, China [J1030626]; Key Project of Fujian Provincial Programs for Science and Technology [2011Y0050]; Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China [2011S0567]	National Foundation for Fostering Talents of Basic Science, China; Key Project of Fujian Provincial Programs for Science and Technology; Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China	This work was supported by the National Foundation for Fostering Talents of Basic Science, China (J1030626) (http://www.nsfc.gov.cn/Portal0/default152.htm); The Key Project of Fujian Provincial Programs for Science and Technology (2011Y0050); and The Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China (2011S0567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Aoki D, 2009, CLIN CANCER RES, V15, P1473, DOI 10.1158/1078-0432.CCR-08-1274; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; BRINDLEY PJ, 1987, J IMMUNOL, V139, P215; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Efferth T, 2001, INT J ONCOL, V18, P767; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fromberg A, 2011, CANCER CHEMOTH PHARM, V67, P1157, DOI 10.1007/s00280-010-1418-6; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Ichim TE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-25; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012; Le XF, 2011, JNCI-J NATL CANCER I, V103, P1403, DOI 10.1093/jnci/djr280; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Nakase I, 2008, INT J PHARM, V354, P28, DOI 10.1016/j.ijpharm.2007.09.003; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Posner GH, 2003, J MED CHEM, V46, P1060, DOI 10.1021/jm020461q; Qi YF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031539, 10.1371/journal.pone.0033859]; Rodriguez-Antona C, 2010, PHARMACOGENOMICS, V11, P621, DOI 10.2217/PGS.10.32; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Takeuchi H, 2005, CLIN CANCER RES, V11, P7621, DOI 10.1158/1078-0432.CCR-05-0479; Tang J, 1999, IN VITRO CELL DEV-AN, V35, P1; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wu ZH, 2012, ASSAY DRUG DEV TECHN, V10, P344, DOI 10.1089/adt.2011.416; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	38	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51721	10.1371/journal.pone.0051721	http://dx.doi.org/10.1371/journal.pone.0051721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251610	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200156
J	Yang, Y; Li, XJ; Chen, Z; Zhu, XX; Wang, J; Zhang, LB; Qiang, L; Ma, YJ; Li, ZY; Guo, QL; You, QD				Yang, Yong; Li, Xian-Jing; Chen, Zhen; Zhu, Xuan-Xuan; Wang, Jing; Zhang, Lin-bo; Qiang, Lei; Ma, Yan-jun; Li, Zhi-yu; Guo, Qing-Long; You, Qi-Dong			Wogonin Induced Calreticulin/Annexin A1 Exposure Dictates the Immunogenicity of Cancer Cells in a PERK/AKT Dependent Manner	PLOS ONE			English	Article							APOPTOTIC CELLS; CA2+-BINDING PROTEIN; EXTRACELLULAR ATP; DNA-PKCS; IN-VIVO; ACTIVATION; KINASE; PKB/AKT; HMGB1; IDENTIFICATION	In response to ionizing irradiation and certain chemotherapeutic agents, dying tumor cells elicit a potent anticancer immune response. However, the potential effect of wogonin (5,7-dihydroxy-8-methoxyflavone) on cancer immunogenicity has not been studied. Here we demonstrated for the first time that wogonin elicits a potent antitumor immunity effect by inducing the translocation of calreticulin (CRT) and Annexin A1 to cell plasma membrane as well as the release of high-mobility group protein 1 (HMGB1) and ATP. Signal pathways involved in this process were studied. We found that wogonin-induced reactive oxygen species (ROS) production causes an endoplasmic reticulum (ER) stress response, including the phosphorylation of PERK (PKR-like endoplasmic reticulum kinase)/PKR (protein kinase R) and eIF2 alpha (eukaryotic initiation factor 2 alpha), which served as upstream signal for the activation of phosphoinositide 3-kinase (PI3K)/AKT, inducing calreticulin (CRT)/Annexin A1 cell membrane translocation. P22/CHP, a Ca2+-binding protein, was associated with CRT and was required for CRT translocation to cell membrane. The releases of HMGB1 and ATP from wogonin treated MFC cells, alone or together with other possible factors, activated dendritic cells and induced cytokine releases. In vivo study confirmed that immunization with wogonin-pretreated tumor cells vaccination significantly inhibited homoplastic grafted gastric tumor growth in mice and a possible inflammatory response was involved. In conclusion, the activation of PI3K pathway elicited by ER stress induced CRT/Annexin A1 translocation ("eat me" signal) and HMGB1 release, mediating wogonin-induced immunity of tumor cell vaccine. This indicated that wogonin is a novel effective candidate of immunotherapy against gastric tumor.	[Yang, Yong; Li, Xian-Jing; Chen, Zhen; Wang, Jing; Zhang, Lin-bo; Qiang, Lei; Ma, Yan-jun; Li, Zhi-yu; Guo, Qing-Long; You, Qi-Dong] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Xuan-Xuan] Jiangsu Prov Hosp Tradit Chinese Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Chinese Medicine	Guo, QL (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	anticancer_drug@yahoo.com.cn; youqd@cpu.edu.cn	Qiang, Lei/B-2763-2012; ZHANG, LIN/GYD-9123-2022	Qiang, Lei/0000-0002-7164-3164; 	National Natural Science Foundation of China [91129731, 81072661]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201102]; Ministry of Education of China [NCET-09-0771]; Fundamental Research Funds for the Central Universities [JKZ2009006]; Natural Science Foundation of Jiangsu Province [BK2012025, BK2011632]; "Major Drug Discovery'' science and technology major projects of China [2011ZX09102-001-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery'' science and technology major projects of China	This work was supported by the National Natural Science Foundation of China (Nos. 91129731 and 81072661), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201102) the New Century Excellent Talents Program for Dr. Yong Yang supported by Ministry of Education of China (NCET-09-0771), the Fundamental Research Funds for the Central Universities (No. JKZ2009006), the Natural Science Foundation of Jiangsu Province (No. BK2012025 and BK2011632), and "Major Drug Discovery'' science and technology major projects of China (No. 2011ZX09102-001-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Clarke C, 2007, NAT BIOTECHNOL, V25, P192, DOI 10.1038/nbt0207-192; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hyoda K, 2006, BIOCHEM BIOPH RES CO, V340, P286, DOI 10.1016/j.bbrc.2005.12.007; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kepp O, 2009, CELL CYCLE, V8, P3971, DOI 10.4161/cc.8.23.10191; Kim DY, 2009, J AGR FOOD CHEM, V57, P10573, DOI 10.1021/jf902700h; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Madeo F, 2009, CELL CYCLE, V8, P639, DOI 10.4161/cc.8.4.7794; Martins I, 2011, ONCOGENE; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yang L, 2009, BIOCHEM CELL BIOL, V87, P933, DOI [10.1139/O09-060, 10.1139/o09-060]; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	44	50	56	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50811	10.1371/journal.pone.0050811	http://dx.doi.org/10.1371/journal.pone.0050811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251389	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200039
J	Guillot, R; Ceinos, RM; Cal, R; Rotllant, J; Cerda-Reverter, JM				Guillot, Raul; Maria Ceinos, Rosa; Cal, Rosa; Rotllant, Josep; Miguel Cerda-Reverter, Jose			Transient Ectopic Overexpression of Agouti-Signalling Protein 1 (Asip1) Induces Pigment Anomalies in Flatfish	PLOS ONE			English	Article							NMR STRUCTURE; NEURAL-CREST; RECEPTOR; GOLDFISH; GENE; DIFFERENTIATION; MICROPHTHALMIA; MELANIZATION; INVOLVEMENT; ANTAGONIST	While flatfish in the wild exhibit a pronounced countershading of the dorso-ventral pigment pattern, malpigmentation is commonly observed in reared animals. In fish, the dorso-ventral pigment polarity is achieved because a melanization inhibition factor (MIF) inhibits melanoblast differentiation and encourages iridophore proliferation in the ventrum. A previous work of our group suggested that asip1 is the uncharacterized MIF concerned. In order to further support this hypothesis, we have characterized asip1 mRNAs in both turbot and sole and used deduced peptide alignments to analyze the evolutionary history of the agouti-family of peptides. The putative asip precursors have the characteristics of a secreted protein, displaying a putative hydrophobic signal. Processing of the potential signal peptide produces mature proteins that include an N-terminal region, a basic central domain with a high proportion of lysine residues as well as a proline-rich region that immediately precedes the C-terminal poly-cysteine domain. The expression of asip1 mRNA in the ventral area was significantly higher than in the dorsal region. Similarly, the expression of asip1 within the unpigmented patches in the dorsal skin of pseudoalbino fish was higher than in the pigmented dorsal regions but similar to those levels observed in the ventral skin. In addition, the injection/electroporation of asip1 capped mRNA in both species induced long term dorsal skin paling, suggesting the inhibition of the melanogenic pathways. The data suggest that fish asip1 is involved in the dorsal-ventral pigment patterning in adult fish, where it induces the regulatory asymmetry involved in precursor differentiation into mature chromatophore. Adult dorsal pseudoalbinism seems to be the consequence of the expression of normal developmental pathways in an inaccurate position that results in unbalanced asip1 production levels. This, in turn, generates a ventral-like differentiation environment in dorsal regions.	[Guillot, Raul; Miguel Cerda-Reverter, Jose] Consejo Super Invest Cient IATS CSIC, Dept Fish Physiol & Biotechnol, Inst Acuicultura Torre Sal, Castellon de La Plana, Spain; [Maria Ceinos, Rosa; Rotllant, Josep] Consejo Super Invest Cient IIM CSIC, Aquat Mol Pathobiol Grp, Inst Invest Marinas, Vigo, Spain; [Cal, Rosa] Inst Espanol Oceanog Vigo IEO, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Cerda-Reverter, JM (corresponding author), Consejo Super Invest Cient IATS CSIC, Dept Fish Physiol & Biotechnol, Inst Acuicultura Torre Sal, Castellon de La Plana, Spain.	cerdarev@iats.csic.es	Rotllant, Josep/K-1146-2014; Cerda-Reverter, Jose Miguel/K-4934-2014; Ceinos, Rosa RM/F-1683-2016; Cal, Rosa/B-8185-2008; Guillot, Raúl/Z-1884-2019	Rotllant, Josep/0000-0001-5331-807X; Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Ceinos, Rosa RM/0000-0002-3321-2961; Cal, Rosa/0000-0003-4757-9112; Guillot, Raul/0000-0001-9248-7263	Xunta de Galicia Science Program INCITE [Incite09 402 193]; Science and Innovation Ministry [AGL2010-22247-C03-01, ALG2011-23581]; Generalitat Valenciana [PROMETEO 2010/006]; Consejo Superior de Investigaciones Cientificas (CSIC)	Xunta de Galicia Science Program INCITE(Xunta de Galicia); Science and Innovation Ministry; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Consejo Superior de Investigaciones Cientificas (CSIC)	This research was carried out with the financial support of the Xunta de Galicia Science Program INCITE (Incite09 402 193 PR to JR) and Science and Innovation Ministry (AGL2010-22247-C03-01 to JMC-R and ALG2011-23581 to JR). Additional funding was obtained from the "Generalitat Valenciana" (research grant PROMETEO 2010/006) to JMC-R. RMC was recipient of a JAE-postdoctoral fellowship from Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; BAGNARA JT, 1990, PIGM CELL RES, V3, P243, DOI 10.1111/j.1600-0749.1990.tb00296.x; Bolin KA, 1999, FEBS LETT, V451, P125, DOI 10.1016/S0014-5793(99)00553-0; Bolker JA, 2005, ZOOLOGY, V108, P183, DOI 10.1016/j.zool.2005.05.001; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Bures EJ, 1998, BIOCHEMISTRY-US, V37, P12172, DOI 10.1021/bi981082v; Burton D, 2010, REV FISH BIOL FISHER, V20, P31, DOI 10.1007/s11160-009-9119-0; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; Fujii Ryozo, 1993, P535; FUKUZAWA T, 1988, DEV BIOL, V129, P25, DOI 10.1016/0012-1606(88)90158-3; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Jackson PJ, 2002, BIOCHEMISTRY-US, V41, P7565, DOI 10.1021/bi012000x; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Kurokawa T, 2006, PEPTIDES, V27, P3165, DOI 10.1016/j.peptides.2006.09.013; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lister JA, 1999, DEVELOPMENT, V126, P3757; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MANNE J, 1995, P NATL ACAD SCI USA, V92, P4721, DOI 10.1073/pnas.92.11.4721; MATSUMOTO J, 1992, PIGM CELL RES, P275; McNulty JC, 2001, BIOCHEMISTRY-US, V40, P15520, DOI 10.1021/bi0117192; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Cerda-Reverter JM, 2011, EUR J PHARMACOL, V660, P53, DOI 10.1016/j.ejphar.2010.10.108; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miltenberger RJ, 1999, P NATL ACAD SCI USA, V96, P8579, DOI 10.1073/pnas.96.15.8579; Miltenberger RJ, 2002, GENETICS, V160, P659; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Patel MP, 2010, J MOL BIOL, V404, P45, DOI 10.1016/j.jmb.2010.08.054; Perry WL, 1996, GENETICS, V144, P255; Sanchez E, 2010, GEN COMP ENDOCR, V165, P163, DOI 10.1016/j.ygcen.2009.06.008; Sanchez E, 2009, AM J PHYSIOL-REG I, V296, pR1293, DOI 10.1152/ajpregu.90948.2008; Schioth HB, 2011, P NATL ACAD SCI USA, V108, pE49, DOI 10.1073/pnas.1102120108; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Sviderskaya EV, 2001, DEV DYNAM, V221, P373, DOI 10.1002/dvdy.1153; Watanabe K, 2008, DEV GROWTH DIFFER, V50, P731, DOI 10.1111/j.1440-169X.2008.01071.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yamada T, 2010, DEV DYNAM, V239, P3147, DOI 10.1002/dvdy.22440; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107; Zuasti A, 2002, MICROSC RES TECHNIQ, V58, P488, DOI 10.1002/jemt.10167; ZUASTI A, 1992, PIGM CELL RES, V5, P253, DOI 10.1111/j.1600-0749.1992.tb00545.x	49	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e48526	10.1371/journal.pone.0048526	http://dx.doi.org/10.1371/journal.pone.0048526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251332	Green Published, gold			2022-12-25	WOS:000312201900002
J	Hayette, S; Thomas, X; Jallades, L; Chabane, K; Charlot, C; Tigaud, I; Gazzo, S; Morisset, S; Cornillet-Lefebvre, P; Plesa, A; Huet, S; Renneville, A; Salles, G; Nicolini, FE; Magaud, JP; Michallet, M				Hayette, Sandrine; Thomas, Xavier; Jallades, Laurent; Chabane, Kaddour; Charlot, Carole; Tigaud, Isabelle; Gazzo, Sophie; Morisset, Stephane; Cornillet-Lefebvre, Pascale; Plesa, Adriana; Huet, Sarah; Renneville, Aline; Salles, Gilles; Nicolini, Franck Emmanuel; Magaud, Jean-Pierre; Michallet, Mauricette			High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid Leukemia	PLOS ONE			English	Article							FUSION GENE TRANSCRIPTS; MYELODYSPLASTIC SYNDROMES; ICF SYNDROME; AML PATIENTS; MUTATIONS; METHYLATION; EVI1; EXPRESSION; CANCER; DIFFERENTIATION	It has been recently shown that DNA methyl transferase overexpression is correlated with unfavourable prognosis in human malignancies while methylation deregulation remains a hallmark that defines acute myeloid leukemia (AML). The oncogenic transcription factor EVI1 is involved in methylation deregulation and its overexpression plays a major role for predicting an adverse outcome. Moreover, the identification of DNMT3A mutations in AML patients has recently been described as a poor prognostic indicator. In order to clarify relationship between these key actors in methylation mechanisms and their potential impact on patient outcomes, we analysed 195 de novo AML patients for the expression of DNMT3A, 3B (and its non-catalytic variant 3B(NC)) and their correlations with the outcome and the expression of other common prognostic genetic biomarkers (EVI1, NPM1, FLT3ITD/TKD and MLL) in adult AML. The overexpression of DNMT3B/3B(NC) is (i) significantly correlated with a shorter overall survival, and (ii) inversely significantly correlated with event-free survival and DNMT3A expression level. Moreover, multivariate analysis showed that a high expression level of DNMT3B/3B(NC) is statistically a significant independent poor prognostic indicator. This study represents the first report showing that the overexpression of DNMT3B/3B(NC) is an independent predictor of poor survival in AML. Its quantification should be implemented to the genetic profile used to stratify patients for therapeutical strategies and should be useful to identify patients who may benefit from therapy based on demethylating agents.	[Hayette, Sandrine; Jallades, Laurent; Chabane, Kaddour; Charlot, Carole; Tigaud, Isabelle; Gazzo, Sophie; Plesa, Adriana; Huet, Sarah; Magaud, Jean-Pierre] Hosp Civils Lyon, Serv Hematol Biol, Ctr Hosp Lyon Sud, Lyon, France; [Hayette, Sandrine; Jallades, Laurent; Chabane, Kaddour; Gazzo, Sophie; Huet, Sarah; Salles, Gilles; Magaud, Jean-Pierre] Univ Lyon 1, Pathol Cellules Lymphoides UMR5239, F-69365 Lyon, France; [Thomas, Xavier; Morisset, Stephane; Salles, Gilles; Nicolini, Franck Emmanuel; Michallet, Mauricette] Hosp Civils Lyon, Serv Hematol, Clin Ctr Hosp Lyon Sud, Lyon, France; [Cornillet-Lefebvre, Pascale] CHU, Lab Hematol, Reims, France; [Renneville, Aline] CHRU Lille, Ctr Biol Pathol, Lab Hematol, Lille, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon; CHU de Reims; Universite de Lille - ISITE; CHU Lille	Hayette, S (corresponding author), Hosp Civils Lyon, Serv Hematol Biol, Ctr Hosp Lyon Sud, Lyon, France.	sandrine.hayette@chu-lyon.fr	HAYETTE, sandrine/Z-2283-2019; Renneville, Aline/AAW-5451-2020; Salles, Gilles/Z-2336-2019; Morisset, Stephane/B-9629-2019	Renneville, Aline/0000-0003-0805-9640; Salles, Gilles/0000-0002-9541-8666; Morisset, Stephane/0000-0002-7747-113X	Pense a moelle; Cent pour sang la vie	Pense a moelle; Cent pour sang la vie	This work was supported by "Pense a moelle" and "Cent pour sang la vie" associations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; ARBER DA, 2008, WHO CLASSIFICATION T, P110; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Boissel N, 2005, BLOOD, V106, P3618, DOI 10.1182/blood-2005-05-2174; Boissel N, 2002, LEUKEMIA, V16, P1699, DOI 10.1038/sj.leu.2402622; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; LaRochelle O, 2011, ONCOTARGET, V2, P850; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Nucifora G, 2006, GENE, V368, P1, DOI 10.1016/j.gene.2005.09.020; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostler KR, 2012, CANCER RES, V72, P4714, DOI 10.1158/0008-5472.CAN-12-0886; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Poirel H, 1996, BLOOD, V87, P2496, DOI 10.1182/blood.V87.6.2496.bloodjournal8762496; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Renneville A, 2012, LEUKEMIA; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Senyuk V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020793; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Thol F, 2011, HAEMATOL-HEMATOL J, V96, P1870, DOI 10.3324/haematol.2011.045559; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Thomas X, 2011, BLOOD, V118, P1754, DOI 10.1182/blood-2011-04-349258; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang J, 2006, CANCER RES, V66, P8361, DOI 10.1158/0008-5472.CAN-06-2031; Weisser M, 2004, LEUKEMIA, V18, P1551, DOI 10.1038/sj.leu.2403438; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Zhang JJ, 2012, CLIN TRANSL ONCOL, V14, P116, DOI 10.1007/s12094-012-0770-x	46	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51527	10.1371/journal.pone.0051527	http://dx.doi.org/10.1371/journal.pone.0051527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251566	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900097
J	Jegla, T; Marlow, HQ; Chen, BH; Simmons, DK; Jacobo, SM; Martindale, MQ				Jegla, Timothy; Marlow, Heather Q.; Chen, Bihan; Simmons, David K.; Jacobo, Sarah M.; Martindale, Mark Q.			Expanded Functional Diversity of Shaker K+ Channels in Cnidarians Is Driven by Gene Expansion	PLOS ONE			English	Article							POTASSIUM CHANNELS; ALPHA-SUBUNITS; GENOME; EVOLUTION; INACTIVATION; SHAB; STOICHIOMETRY; RECOGNITION; MODULATION; ACTIVATION	The genome of the cnidarian Nematostella vectensis (starlet sea anemone) provides a molecular genetic view into the first nervous systems, which appeared in a late common ancestor of cnidarians and bilaterians. Nematostella has a surprisingly large and diverse set of neuronal signaling genes including paralogs of most neuronal signaling molecules found in higher metazoans. Several ion channel gene families are highly expanded in the sea anemone, including three subfamilies of the Shaker K+ channel gene family: Shaker (Kv1), Shaw (Kv3) and Shal (Kv4). In order to better understand the physiological significance of these voltage-gated K+ channel expansions, we analyzed the function of 18 members of the 20 gene Shaker subfamily in Nematostella. Six of the Nematostella Shaker genes express functional homotetrameric K+ channels in vitro. These include functional orthologs of bilaterian Shakers and channels with an unusually high threshold for voltage activation. We identified 11 Nematostella Shaker genes with a distinct "silent" or "regulatory" phenotype; these encode subunits that function only in heteromeric channels and serve to further diversify Nematostella Shaker channel gating properties. Subunits with the regulatory phenotype have not previously been found in the Shaker subfamily, but have evolved independently in the Shab (Kv2) family in vertebrates and the Shal family in a cnidarian. Phylogenetic analysis indicates that regulatory subunits were present in ancestral cnidarians, but have continued to diversity at a high rate after the split between anthozoans and hydrozoans. Comparison of Shaker family gene complements from diverse metazoan species reveals frequent, large scale duplication has produced highly unique sets of Shaker channels in the major metazoan lineages.	[Jegla, Timothy] Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA; [Jegla, Timothy] Penn State Univ, Huck Inst Life Sci, Eberly Coll Sci, University Pk, PA 16802 USA; [Marlow, Heather Q.; Simmons, David K.; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Chen, Bihan; Jacobo, Sarah M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hawaii System; Scripps Research Institute	Jegla, T (corresponding author), Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA.	tjj3@psu.edu		Jacobo, Sarah Melissa/0000-0002-1341-7222; Jegla, Timothy/0000-0001-8616-2390	Penn State Department of Biology; National Institute of Neurological Disorders and Stroke (NINDS); National Science Foundation (NSF); NASA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093116] Funding Source: NIH RePORTER	Penn State Department of Biology; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TJ is supported by grants from Penn State Department of Biology and the National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/). MQM is supported by grants from the National Science Foundation (NSF) (http://www.nsf.gov/) and NASA (http://www.nasa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON PAV, 1977, SCIENCE, V197, P186, DOI 10.1126/science.17918; Bardien-Kruger S, 2002, EUR J HUM GENET, V10, P36, DOI 10.1038/sj.ejhg.5200739; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Dodson PD, 2002, J NEUROSCI, V22, P6953; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jegla T, 1995, J NEUROSCI, V15, P7989; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Lin Yi-Chan James, 2001, Invertebrate Neuroscience, V4, P65; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Piraino S, 2011, J COMP NEUROL, V519, P1931, DOI 10.1002/cne.22614; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reissner KJ, 2008, J NEUROCHEM, V105, P1006, DOI 10.1111/j.1471-4159.2007.05202.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSENGCRANK J, 1993, J GEN PHYSIOL, V102, P1057, DOI 10.1085/jgp.102.6.1057; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	64	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51366	10.1371/journal.pone.0051366	http://dx.doi.org/10.1371/journal.pone.0051366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251506	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900072
J	Tanimura, N; Saito, M; Ebisuya, M; Nishida, E; Ishikawa, F				Tanimura, Nobuyuki; Saito, Motoki; Ebisuya, Miki; Nishida, Eisuke; Ishikawa, Fuyuki			Stemness-related Factor Sall4 Interacts with Transcription Factors Oct-3/4 and Sox2 and Occupies Oct-Sox Elements in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; INTERACTION NETWORK; DROSOPHILA EMBRYO; GENE-EXPRESSION; FINGER PROTEIN; HOMEOTIC GENE; POU-DOMAIN; PLURIPOTENCY; COMPLEX; DIFFERENTIATION	A small number of transcription factors, including Oct-3/4 and Sox2, constitute the transcriptional network that maintains pluripotency in embryonic stem (ES) cells. Previous reports suggested that some of these factors form a complex that binds the Oct-Sox element, a composite sequence consisting of closely juxtaposed Oct-3/4 binding and Sox2 binding sites. However, little is known regarding the components of the complex. In this study we show that Sall4, a member of the Spalt-like family of proteins, directly interacts with Sox2 and Oct-3/4. Sall4 in combination with Sox2 or Oct-3/4 simultaneously occupies the Oct-Sox elements in mouse ES cells. Overexpression of Sall4 in ES cells increased reporter activities in a luciferase assay when the Pou5f1- or Nanog-derived Oct-Sox element was included in the reporter. Microarray analyses revealed that Sall4 and Sox2 bound to the same genes in ES cells significantly more frequently than expected from random coincidence. These factors appeared to bind the promoter regions of a subset of the Sall4 and Sox2 double-positive genes in precisely similar distribution patterns along the promoter regions, suggesting that Sall4 and Sox2 associate with such Sall4/Sox2-overlapping genes as a complex. Importantly, gene ontology analyses indicated that the Sall4/Sox2-overlapping gene set is enriched for genes involved in maintaining pluripotency. Sall4/Sox2/Oct-3/4 triple-positive genes identified by referring to a previous study identifying Oct3/4-bound genes in ES cells were further enriched for pluripotency genes than Sall4/Sox2 double-positive genes. These results demonstrate that Sall4 contributes to the transcriptional network operating in pluripotent cells together with Oct-3/4 and Sox2.	[Tanimura, Nobuyuki; Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan; [Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Ebisuya, Miki/N-5388-2015	Ishikawa, Fuyuki/0000-0002-5580-2305; Ebisuya, Miki/0000-0003-1854-7496	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	39	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5027	5038		10.1074/jbc.M112.411173	http://dx.doi.org/10.1074/jbc.M112.411173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269686	Green Published, hybrid			2022-12-25	WOS:000315340400049
J	Chambers, JW; Pachori, A; Howard, S; Iqbal, S; LoGrasso, PV				Chambers, Jeremy W.; Pachori, Alok; Howard, Shannon; Iqbal, Sarah; LoGrasso, Philip V.			Inhibition of JNK Mitochondrial Localization and Signaling Is Protective against Ischemia/Reperfusion Injury in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PYRUVATE-DEHYDROGENASE ACTIVITY; ACTIVATION; APOPTOSIS; PATHWAY; PROTEIN; DEATH; IDENTIFICATION; BIOENERGETICS; REPERFUSION	To build upon recent findings that mitochondrial JNK signaling is inhibited by selectively blocking the interaction between JNK and Sab, we utilized a cell-permeable peptide to demonstrate that ischemia/reperfusion (I/R) injury could be protected in vivo and that JNK mitochondrial signaling was the mechanism by which reactive oxygen species (ROS) generation, mitochondrial dysfunction, and cardiomyocyte cell death occur. We also demonstrated that 5 mg/kg SR-3306 (a selective JNK inhibitor) was able to protect against I/R injury, reducing infarct volume by 34% (p < 0.05) while also decreasing I/R-induced increases in the activity of creatine phosphokinase and creatine kinase-MB. TUNEL staining showed that the percent TUNEL positive nuclei in rat hearts increased 10-fold after I/R injury and that this was reduced 4-fold (p < 0.01) by SR-3306. These data suggest that blocking JNK mitochondrial translocation or JNK inhibition prevents ROS increases and mitochondrial dysfunction and may be an effective treatment for I/R-induced cardiomyocyte death.	Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), 130 Scripps Way,A2A, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [NS057153]; Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. V. L.). This work was also supported by the Saul and Theresa Esman Foundation. Philip LoGrasso serves as a consultant for OPKO Health.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chambers JW, 2011, ACS CHEM NEUROSCI, V2, P198, DOI 10.1021/cn100109k; Chen T, 2009, BIOCHEM J, V420, P283, DOI 10.1042/BJ20081899; De SK, 2010, BIOORGAN MED CHEM, V18, P590, DOI 10.1016/j.bmc.2009.12.013; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; De SK, 2009, BIOORGAN MED CHEM, V17, P2712, DOI 10.1016/j.bmc.2009.02.046; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	31	60	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4000	4011		10.1074/jbc.M112.406777	http://dx.doi.org/10.1074/jbc.M112.406777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258542	Green Published, hybrid			2022-12-25	WOS:000314845000029
J	Mollan, TL; Banerjee, S; Wu, G; Siburt, CJP; Tsai, AL; Olson, JS; Weiss, MJ; Crumbliss, AL; Alayash, AI				Mollan, Todd L.; Banerjee, Sambuddha; Wu, Gang; Siburt, Claire J. Parker; Tsai, Ah-Lim; Olson, John S.; Weiss, Mitchell J.; Crumbliss, Alvin L.; Alayash, Abdu I.			alpha-Hemoglobin Stabilizing Protein (AHSP) Markedly Decreases the Redox Potential and Reactivity of alpha-Subunits of Human HbA with Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-THALASSEMIA; IN-VIVO; MOLECULAR-MECHANISM; HUMAN OXYHEMOGLOBIN; GLOBIN BINDING; GUINEA-PIGS; CHAINS; OXIDATION; HEME; MYOGLOBIN	alpha-Hemoglobin stabilizing protein (AHSP) is a molecular chaperone that binds monomeric alpha-subunits of human hemoglobin A (HbA) and modulates heme iron oxidation and subunit folding states. Although AHSP center dot alpha Hb complexes autoxidize more rapidly than HbA, the redox mechanisms appear to be similar. Both metHbA and isolated met-beta-subunits undergo further oxidation in the presence of hydrogen peroxide (H2O2) to form ferryl heme species. Surprisingly, much lower levels of H2O2-induced ferryl heme are produced by free met-alpha-subunits as compared with met-beta-subunits, and no ferryl heme is detected in H2O2-treated AHSP center dot met-alpha-complex at pH values from 5.0 to 9.0 at 23 degrees C. Ferryl heme species were similarly not detected in AHSP center dot met-alpha Pro-30 mutants known to exhibit different rates of autoxidation and hemin loss. EPR data suggest that protein-based radicals associated with the ferryl oxidation state exist within HbA alpha- and beta-subunits. In contrast, treatment of free alpha-subunits with H2O2 yields much smaller radical signals, and no radicals are detected when H2O2 is added to AHSP center dot alpha-complexes. AHSP binding also dramatically reduces the redox potential of alpha-subunits, from +40 to -78 mV in 1 M glycine buffer, pH 6.0, at 8 degrees C, demonstrating independently that AHSP has a much higher affinity for Fe(III) versus Fe(II) alpha-subunits. Hexacoordination in the AHSP center dot met-alpha complex markedly decreases the rate of the initial H2O2 reaction with iron and thus provides alpha-subunits protection against damaging oxidative reactions.	[Mollan, Todd L.; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20852 USA; [Banerjee, Sambuddha; Siburt, Claire J. Parker; Crumbliss, Alvin L.] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Wu, Gang; Tsai, Ah-Lim] Univ Texas Houston, Sch Med, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; [Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA	US Food & Drug Administration (FDA); Duke University; University of Texas System; University of Texas Health Science Center Houston; Rice University; University of Pennsylvania	Alayash, AI (corresponding author), US FDA, CBER, NIH, 8800 Rockville Pike,Bldg 29,Rm 112, Bethesda, MD 20852 USA.	abdu.alayash@fda.hhs.gov	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; , Sambuddha/0000-0002-4810-9561	National Institutes of Health [HL110900, HL095821, HL47020, GM35649, DK61692, HL087427, GM008362]; Welch Grant [C-0612]; National Science Foundation [CHE 0809466]; United States Food and Drug Administration [MODSCI 2011]; Duke University; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427, P01HL110900, R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061692, R01DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Grant; National Science Foundation(National Science Foundation (NSF)); United States Food and Drug Administration; Duke University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL110900 (to A. I. A.), HL095821 (to A.-L. T.), HL47020 (to J. S. O.), HL110900 (to J. S. O.), GM35649 (to J. S. O.), DK61692 (to M. J. W.), HL087427 (to M. J. W.), and GM008362 (to T. L. M.), Welch Grant C-0612 (to J. S. O.), National Science Foundation Grant CHE 0809466 (to A. L. C.), and the United States Food and Drug Administration (MODSCI 2011) (to A. I. A.).; Supported by a grant from Duke University.	ABRAHAM EC, 1975, J BIOL CHEM, V250, P3929; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; BANERJEE R, 1969, J MOL BIOL, V42, P337, DOI 10.1016/0022-2836(69)90047-3; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brittain T, 1997, BIOCHEM J, V326, P109, DOI 10.1042/bj3260109; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Cooper C.E., 2012, ANTIOXID RE IN PRESS; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; JAROLIM P, 1990, BLOOD, V76, P2125; Kaim W, 2008, SPECTROELECTROCHEMISTRY, P1, DOI 10.1039/9781847558404; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; MAIORINO M, 1994, FREE RADICAL BIO MED, V16, P661, DOI 10.1016/0891-5849(94)90067-1; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Reeder BJ, 2001, FREE RADICAL BIO MED, V30, P1311, DOI 10.1016/S0891-5849(01)00534-2; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; SCHRIER SL, 1989, BLOOD, V74, P2194; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Silaghi-Dumitrescu R, 2007, BIOCHEM J, V403, P391, DOI 10.1042/BJ20061421; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Taboy CH, 1999, BIOELECTROCH BIOENER, V48, P79, DOI 10.1016/S0302-4598(98)00236-0; TOMODA A, 1978, BIOCHEM J, V171, P329, DOI 10.1042/bj1710329; Tsai AL, 1996, J BIOL CHEM, V271, P32563, DOI 10.1074/jbc.271.51.32563; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; VALDES R, 1978, P NATL ACAD SCI USA, V75, P311, DOI 10.1073/pnas.75.1.311; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; WATKINS JA, 1985, BIOCHEM BIOPH RES CO, V132, P742, DOI 10.1016/0006-291X(85)91195-7; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	58	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4288	4298		10.1074/jbc.M112.412064	http://dx.doi.org/10.1074/jbc.M112.412064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264625	Green Published, hybrid			2022-12-25	WOS:000314845000057
J	Pearson, RJ; Morf, L; Singh, U				Pearson, Richard J.; Morf, Laura; Singh, Upinder			Regulation of H2O2 Stress-responsive Genes through a Novel Transcription Factor in the Protozoan Pathogen Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BINDING-PROTEIN; EXPRESSION; IDENTIFICATION; VIRULENCE; ACTIVATION; PARASITE; REGULON; OXYR	Outcome of infection depends upon complex interactions between the invading pathogen and the host. As part of the host's innate immune response, the release of reactive oxygen and nitrogen species by phagocytes represents a major obstacle to the establishment of infection. The ability of the human parasite Entamoeba histolytica to survive reactive oxygen and nitrogen species is central to its pathogenic potential and contributes to disease outcome. In order to define the transcriptional network associated with oxidative stress, we utilized the MEME and MAST programs to analyze the promoter regions of 57 amoebic genes that had increased expression specifically in response to H2O2 exposure. We functionally characterized an H2O2-regulatory motif (HRM) ((1)AAACCTCAATGAAGA(15)), which was enriched in these promoters and specifically bound amoebic nuclear protein(s). Assays with promoter-luciferase fusions established the importance of key residues and that the HRM motif directly impacted the ability of H2O2-responsive promoters to drive gene expression. DNA affinity chromatography and mass spectrometry identified EHI_108720 as an HRM DNA-binding protein. Overexpression and down-regulation of EHI_108720 demonstrated the specificity of EHI_108720 protein binding to the HRM, and overexpression increased basal expression from an H2O2-responsive wild-type promoter but not from its mutant counterpart. Thus, EHI_108720, or HRM binding protein, represents a new stress-responsive transcription factor in E. histolytica that controls a transcriptional regulatory network associated with oxidative stress. Overexpression of EHI_108720 increased parasite virulence. Insight into how E. histolytica responds to oxidative stress increases our understanding of how this important human pathogen establishes invasive disease.	[Pearson, Richard J.; Morf, Laura; Singh, Upinder] Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA; [Singh, Upinder] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Singh, U (corresponding author), Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, S-143 Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	usingh@stanford.edu		Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [AI053724, T32 AI07328]; Stanford University; Swiss National Foundation [PBZHP3]; National Center for Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI053724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI053724 (to U. S.) and Training Grant in Microbiology T32 AI07328 (to R. P.). This work was also supported by a Stanford University Dean's Fellowship (to R. P.) and a Swiss National Foundation PBZHP3 grant (to L. M.). Mass spectrometry was supported by National Center for Research Resources Award S10RR027425.	Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bruchhaus I, 1997, BIOCHEM J, V326, P785, DOI 10.1042/bj3260785; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; de Dios-Bravo G, 2005, FEBS J, V272, P1354, DOI 10.1111/j.1742-4658.2005.04566.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dinamarco TM, 2012, EUKARYOT CELL, V11, P518, DOI 10.1128/EC.00016-12; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; Gilchrist CA, 2003, J BIOL CHEM, V278, P4646, DOI 10.1074/jbc.M211271200; Gilchrist CA, 2001, J BIOL CHEM, V276, P11838, DOI 10.1074/jbc.M007375200; Gilchrist CA, 1998, INFECT IMMUN, V66, P2383, DOI 10.1128/IAI.66.5.2383-2386.1998; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Hackney JA, 2007, NUCLEIC ACIDS RES, V35, P2141, DOI 10.1093/nar/gkm028; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Masloboeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043421; MATTERN CFT, 1978, AM J TROP MED HYG, V27, P882, DOI 10.4269/ajtmh.1978.27.882; Meneses E, 2010, GENE, V455, P32, DOI 10.1016/j.gene.2010.02.004; Meng ZJ, 2006, J PROTEOME RES, V5, P1931, DOI 10.1021/pr060009l; Moreno H, 2010, EUKARYOT CELL, V9, P695, DOI 10.1128/EC.00346-09; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Ning JL, 2010, CHINESE MED J-PEKING, V123, P1063, DOI 10.3760/cma.j.issn.0366-6999.2010.08.016; Pearson RJ, 2010, CELL MICROBIOL, V12, P1681, DOI 10.1111/j.1462-5822.2010.01524.x; Purdy JE, 1996, MOL BIOCHEM PARASIT, V78, P91, DOI 10.1016/S0166-6851(96)02614-X; PURDY JE, 1994, P NATL ACAD SCI USA, V91, P7099, DOI 10.1073/pnas.91.15.7099; Rastew E, 2012, INT J PARASITOL, V42, P1007, DOI 10.1016/j.ijpara.2012.08.006; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith AJ, 2011, MOL CELL BIOL, V31, P1444, DOI 10.1128/MCB.00745-10; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Vicente JB, 2012, EUKARYOT CELL, V11, P1112, DOI 10.1128/EC.00149-12; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	54	29	30	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4462	4474		10.1074/jbc.M112.423467	http://dx.doi.org/10.1074/jbc.M112.423467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250742	Green Published, hybrid			2022-12-25	WOS:000314845000072
J	Sathanoori, R; Olde, B; Erlinge, D; Goransson, O; Wierup, N				Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David; Goransson, Olga; Wierup, Nils			Cocaine- and Amphetamine-regulated Transcript (CART) Protects Beta Cells against Glucotoxicity and Increases Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; RECEPTOR SUBSTRATE 2; MESSENGER-RNA; IRS PROTEINS; KINASE-A; GLUCOSE; EXPRESSION; ACTIVATION; SURVIVAL; APOPTOSIS	Cocaine- and amphetamine-regulated transcript (CART) is an islet peptide that promotes glucose-stimulated insulin secretion in beta cells via cAMP/PKA-dependent pathways. In addition, CART is a regulator of neuronal survival. In this study, we examined the effect of exogenous CART 55-102 on beta cell viability and dissected its signaling mechanisms. Evaluation of DNA fragmentation and chromatin condensation revealed that CART 55-102 reduced glucotoxicity-induced apoptosis in both INS-1 (832/13) cells and isolated rat islets. Glucotoxicity in INS-1 (832/13) cells also caused a 50% reduction of endogenous CART protein. We show that CART increased proliferation in INS-1 (832/13) cells, an effect that was blocked by PKA, PKB, and MEK1 inhibitors. In addition, CART induced phosphorylation of CREB, IRS, PKB, FoxO1, p44/42 MAPK, and p90RSK in INS-1 (832/13) cells and isolated rat islets, all key mediators of cell survival and proliferation. Thus, we demonstrate that CART 55-102 protects beta cells against glucotoxicity and promotes proliferation. Taken together our data point to the potential use of CART in therapeutic interventions targeted at enhancing functional beta cell mass and long-term insulin secretion in T2D.	[Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David] Lund Univ, Dept Cardiol, SE-22184 Lund, Sweden; [Goransson, Olga] Lund Univ, Prot Phosphorylat Res Grp, SE-22184 Lund, Sweden; [Wierup, Nils] Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden	Lund University; Lund University; Lund University	Wierup, N (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci, Scania Univ Hosp,Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.	nils.wierup@med.lu.se		Goransson, Olga/0000-0002-7209-8022	Swedish Medical Research Council [2008-4216]; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Merck Sharpe and Dohme; Medical Faculty at Lund University; The Crafoord Foundation; The Gyllenstiernska Krapperup Foundation; The Tore Nilsson Foundation; The Ake Wibergs Foundation; The Fredrik and Ingrid Thuring Foundation; The Magnus Bergwall Foundation; The Albert Pahlsson Foundation; Novo Nordisk Fonden [NNF13OC0005033] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Merck Sharpe and Dohme(Merck & Company); Medical Faculty at Lund University; The Crafoord Foundation; The Gyllenstiernska Krapperup Foundation; The Tore Nilsson Foundation; The Ake Wibergs Foundation; The Fredrik and Ingrid Thuring Foundation; The Magnus Bergwall Foundation; The Albert Pahlsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Medical Research Council (Project Number 2008-4216), the Novo Nordisk Foundation, the European Foundation for the Study of Diabetes and Merck Sharpe and Dohme, the Medical Faculty at Lund University, The Crafoord Foundation, The Gyllenstiernska Krapperup Foundation, The Tore Nilsson Foundation, The Ake Wibergs Foundation, The Fredrik and Ingrid Thuring Foundation, The Magnus Bergwall Foundation, and The Albert Pahlsson Foundation.	Arumugam R, 2007, ENDOCRINOLOGY, V148, P258, DOI 10.1210/en.2006-0888; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Costes S, 2004, ANN NY ACAD SCI, V1030, P230, DOI 10.1196/annals.1329.029; Dalle Stephane, 2011, Curr Mol Pharmacol, V4, P187; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jia J, 2008, NEUROPEPTIDES, V42, P653, DOI 10.1016/j.npep.2008.05.006; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Jones DC, 2008, SYNAPSE, V62, P122, DOI 10.1002/syn.20476; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kuhar MJ, 1999, SYNAPSE, V33, P163, DOI 10.1002/(SICI)1098-2396(19990901)33:3<163::AID-SYN1>3.0.CO;2-T; Lakatos A, 2005, NEUROSCI LETT, V384, P198, DOI 10.1016/j.neulet.2005.04.072; Landerholm K, 2012, CLIN CANCER RES, V18, P3668, DOI 10.1158/1078-0432.CCR-11-2513; Landerholm K, 2011, NEUROENDOCRINOLOGY, V94, P228, DOI 10.1159/000329044; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; Lin YM, 2011, NEUROPEPTIDES, V45, P351, DOI 10.1016/j.npep.2011.07.006; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V204, P85, DOI 10.1016/S0303-7207(03)00124-2; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maedler K, 2008, DIABETES OBES METAB, V10, P408, DOI 10.1111/j.1463-1326.2007.00718.x; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ritzel RA, 2009, FRONT BIOSCI-LANDMRK, V14, P1835, DOI 10.2741/3345; Rogge GA, 2009, BRAIN RES, V1251, P42, DOI 10.1016/j.brainres.2008.11.011; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Thim L, 1998, FEBS LETT, V428, P263, DOI 10.1016/S0014-5793(98)00543-2; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wang HW, 2011, METABOLISM, V60, P1081, DOI 10.1016/j.metabol.2010.11.004; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P169, DOI 10.1177/002215540405200204; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xie T, 2010, J ENDOCRINOL, V206, P261, DOI 10.1677/JOE-10-0030; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103	62	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3208	3218		10.1074/jbc.M112.437145	http://dx.doi.org/10.1074/jbc.M112.437145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250745	hybrid, Green Published			2022-12-25	WOS:000314397900028
J	Regenbogen, C; De Vos, M; Debener, S; Turetsky, BI; Mossnang, C; Finkelmeyer, A; Habel, U; Neuner, I; Kellermann, T				Regenbogen, Christina; De Vos, Maarten; Debener, Stefan; Turetsky, Bruce I.; Moessnang, Carolin; Finkelmeyer, Andreas; Habel, Ute; Neuner, Irene; Kellermann, Thilo			Auditory Processing under Cross-Modal Visual Load Investigated with Simultaneous EEG-fMRI	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; WORKING-MEMORY; ATTENTIONAL LOAD; SELECTIVE-ATTENTION; MR SCANNER; DYNAMICS; REMOVAL; BRAIN; PERFORMANCE	Cognitive task demands in one sensory modality (T1) can have beneficial effects on a secondary task (T2) in a different modality, due to reduced top-down control needed to inhibit the secondary task, as well as crossmodal spread of attention. This contrasts findings of cognitive load compromising a secondary modality's processing. We manipulated cognitive load within one modality (visual) and studied the consequences of cognitive demands on secondary (auditory) processing. 15 healthy participants underwent a simultaneous EEG-fMRI experiment. Data from 8 participants were obtained outside the scanner for validation purposes. The primary task (T1) was to respond to a visual working memory (WM) task with four conditions, while the secondary task (T2) consisted of an auditory oddball stream, which participants were asked to ignore. The fMRI results revealed fronto-parietal WM network activations in response to T1 task manipulation. This was accompanied by significantly higher reaction times and lower hit rates with increasing task difficulty which confirmed successful manipulation of WM load. Amplitudes of auditory evoked potentials, representing fundamental auditory processing showed a continuous augmentation which demonstrated a systematic relation to cross-modal cognitive load. With increasing WM load, primary auditory cortices were increasingly deactivated while psychophysiological interaction results suggested the emergence of auditory cortices connectivity with visual WM regions. These results suggest differential effects of crossmodal attention on fundamental auditory processing. We suggest a continuous allocation of resources to brain regions processing primary tasks when challenging the central executive under high cognitive load. Citation: Regenbogen C, De Vos M, Debener S, Turetsky BI, Mossnang C, et al. (2012) Auditory Processing under Cross-Modal Visual Load Investigated with Simultaneous EEG-fMRI. PLoS ONE 7(12): e52267. doi:10.1371/journal.pone.0052267	[Regenbogen, Christina; Moessnang, Carolin; Finkelmeyer, Andreas; Habel, Ute; Neuner, Irene; Kellermann, Thilo] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sch Med, Aachen, Germany; [Regenbogen, Christina; Moessnang, Carolin; Habel, Ute; Neuner, Irene; Kellermann, Thilo] Carl von Ossietzky Univ Oldenburg, JARA Translat Brain Med, D-2900 Oldenburg, Germany; [De Vos, Maarten; Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-2900 Oldenburg, Germany; [De Vos, Maarten] Katholieke Univ Leuven, ESAT SCD, Dept Elect Engn, Louvain, Belgium; [Debener, Stefan] Univ Hosp Jena, Biomagnet Ctr, Dept Neurol, Jena, Germany; [Turetsky, Bruce I.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	RWTH Aachen University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; KU Leuven; Friedrich Schiller University of Jena; University of Pennsylvania; Newcastle University - UK	Regenbogen, C (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sch Med, Aachen, Germany.	cregenbogen@ukaachen.de	Kellermann, Thilo/B-1712-2012; Regenbogen, Christina/A-9691-2016; Neuner, Irene/J-6619-2013; Moessnang, Carolin/V-8095-2017	Kellermann, Thilo/0000-0003-4081-5581; Regenbogen, Christina/0000-0001-5950-798X; Moessnang, Carolin/0000-0003-4357-2706; Habel, Ute/0000-0003-0703-7722; Finkelmeyer, Andreas/0000-0001-7491-5113; Neuner, Irene/0000-0002-5164-8873	Deutsche Forschungsgemeinschaft [DFG: IRTG1328, KFO-112/TP9: Ha3202/2-2]; Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University [N2-6, N4-4]; Research Council KUL (GOA MaNet); Flemish Government [FWO G.0427.10N]; DFG [IRTG1328]; Alexander von Humboldt stipend	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University; Research Council KUL (GOA MaNet); Flemish Government(European Commission); DFG(German Research Foundation (DFG)); Alexander von Humboldt stipend(Alexander von Humboldt Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG: IRTG1328, KFO-112/TP9: Ha3202/2-2), the Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University (N2-6, N4-4), the Research Council KUL (GOA MaNet), and the Flemish Government (FWO G.0427.10N, Integrated EEG-fMRI).CR is supported by a start-up grant of the IRTG1328 (DFG). MDV is supported by an Alexander von Humboldt stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bendixen A, 2010, NEUROPSYCHOLOGIA, V48, P2130, DOI 10.1016/j.neuropsychologia.2010.04.004; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Fockert JW, 2011, COGNITION, V121, P400, DOI 10.1016/j.cognition.2011.08.016; De Vos M, 2011, SIGNAL PROCESS, V91, P1963, DOI 10.1016/j.sigpro.2011.02.019; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Debener S, 2007, NEUROIMAGE, V34, P587, DOI 10.1016/j.neuroimage.2006.09.031; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gallinat J, 2002, NEUROIMAGE, V17, P110, DOI 10.1006/nimg.2002.1213; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Haroush K, 2011, J NEUROSCI, V31, P922, DOI 10.1523/JNEUROSCI.0420-10.2011; Haroush K, 2010, J COGNITIVE NEUROSCI, V22, P1440, DOI 10.1162/jocn.2009.21284; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Janson Jolanda, 2011, Adv Cogn Psychol, V7, P92, DOI 10.2478/v10053-008-0089-x; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Karns CM, 2009, J COGNITIVE NEUROSCI, V21, P669, DOI 10.1162/jocn.2009.21037; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lazeyras F, 2001, J MAGN RESON IMAGING, V13, P943, DOI 10.1002/jmri.1135; Leavitt VM, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00023; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Mayhew SD, 2010, NEUROIMAGE, V49, P849, DOI 10.1016/j.neuroimage.2009.06.080; Mijovic B, 2012, NEUROIMAGE, V60, P1171, DOI 10.1016/j.neuroimage.2012.01.063; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Mulert C., 2009, EEG FMRI PHYSL BASIS; Muller-Gass A, 2007, BRAIN RES, V1170, P71, DOI 10.1016/j.brainres.2007.07.023; Munka L, 2006, NEUROSCI LETT, V396, P177, DOI 10.1016/j.neulet.2005.11.035; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Neuner I, 2010, HUM BRAIN MAPP, V31, P1675, DOI 10.1002/hbm.20965; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten LJ, 2000, NEUROREPORT, V11, P875, DOI 10.1097/00001756-200003200-00043; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Tellinghuisen DJ, 2003, PERCEPT PSYCHOPHYS, V65, P817, DOI 10.3758/BF03194817; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullsperger M., 2010, SIMULTANEOUS EEG FMR; Vanderperren K, 2010, NEUROIMAGE, V50, P920, DOI 10.1016/j.neuroimage.2010.01.010; Warbrick T, 2008, INT J PSYCHOPHYSIOL, V67, P169, DOI 10.1016/j.ijpsycho.2007.05.014; Zhang P, 2006, NEUROIMAGE, V33, P715, DOI 10.1016/j.neuroimage.2006.07.015; Zimmer U, 2010, EUR J NEUROSCI, V31, P1744, DOI 10.1111/j.1460-9568.2010.07229.x	64	22	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52267	10.1371/journal.pone.0052267	http://dx.doi.org/10.1371/journal.pone.0052267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251704	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800155
J	Al-Daghri, NM; Bindahman, LS; Al-Attas, OS; Saleem, TH; Alokail, MS; Alkharfy, KM; Draz, HM; Yakout, S; Mohamed, AO; Harte, AL; McTernan, PG				Al-Daghri, Nasser M.; Bindahman, Lotfi S.; Al-Attas, Omar S.; Saleem, Tahia H.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Yakout, Sobhy; Mohamed, Amany O.; Harte, Alison L.; McTernan, Philip G.			Increased Circulating ANG II and TNF-alpha Represents Important Risk Factors in Obese Saudi Adults with Hypertension Irrespective of Diabetic Status and BMI	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RENIN-ANGIOTENSIN SYSTEM; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BLOOD-PRESSURE; BODY-MASS; LEPTIN; INFLAMMATION; ADIPONECTIN; EXPRESSION	Central adiposity is a significant determinant of obesity-related hypertension risk, which may arise due to the pathogenic inflammatory nature of the abdominal fat depot. However, the influence of pro-inflammatory adipokines on blood pressure in the obese hypertensive phenotype has not been well established in Saudi subjects. As such, our study investigated whether inflammatory factors may represent useful biomarkers to delineate hypertension risk in a Saudi cohort with and without hypertension and/or diabetes mellitus type 2 (DMT2). Subjects were subdivided into four groups: healthy lean controls (age: 47.9 +/- 5.1 yr; BMI: 22.9 +/- 2.1 Kg/m(2)), non-hypertensive obese (age: 46.1 +/- 5.0 yr; BMI: 33.7 +/- 4.2 Kg/m(2)), hypertensive obese (age: 48.6 +/- 6.1 yr; BMI: 36.5 +/- 7.7 Kg/m(2)) and hypertensive obese with DMT2 (age: 50.8 +/- 6.0 yr; BMI: 35.3 +/- 6.7 Kg/m(2)). Anthropometric data were collected from all subjects and fasting blood samples were utilized for biochemical analysis. Serum angiotensin II (ANG II) levels were elevated in hypertensive obese (p<0.05) and hypertensive obese with DMT2 (p<0.001) compared with normotensive controls. Systolic blood pressure was positively associated with BMI (p<0.001), glucose (p<0.001), insulin (p<0.05), HOMA-IR (p<0.001), leptin (p<0.01), TNF-alpha (p<0.001) and ANG II (p<0.05). Associations between ANG II and TNF-alpha with systolic blood pressure remained significant after controlling for BMI. Additionally CRP (p<0.05), leptin (p<0.001) and leptin/adiponectin ratio (p<0.001) were also significantly associated with the hypertension phenotype. In conclusion our data suggests that circulating pro-inflammatory adipokines, particularly ANG II and, TNF-alpha, represent important factors associated with a hypertension phenotype and may directly contribute to predicting and exacerbating hypertension risk.	[Al-Daghri, Nasser M.; Bindahman, Lotfi S.; Al-Attas, Omar S.; Alokail, Majed S.; Draz, Hossam M.; Yakout, Sobhy] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Al-Attas, Omar S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh 11451, Saudi Arabia; [Bindahman, Lotfi S.; Saleem, Tahia H.; Mohamed, Amany O.] Assiut Univ, Fac Med, Dept Biochem, Assiut, Egypt; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh 11451, Saudi Arabia; [Draz, Hossam M.] Natl Res Ctr, Dept Biochem, Cairo, Egypt; [Harte, Alison L.; McTernan, Philip G.] Univ Warwick, Univ Hosp Coventry & Warwickshire Trust, Div Metab & Vasc Hlth, CSRL,Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Warwick	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com; a.harte@warwick.ac.uk	Al-Daghri, Nasser/A-8360-2011; Al-Daghri, Nasser/G-7736-2011; yakout, sobhy/E-7509-2019; Bin Dahman, Lotfi Saeed/AAQ-5741-2021; Al-okail, Majed S/E-5565-2016	Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; Bin Dahman, Lotfi Saeed/0000-0002-1526-4952; Al-okail, Majed S/0000-0001-8147-3499; Draz, Hossam/0000-0002-7351-3339; Mohamed, Amany/0000-0003-3131-3846; McTernan, Philip/0000-0001-9023-0261	National Plan for Science and Technology (NPST), Riyadh, Saudi Arabia [08-MED-603-2]; British Heart Foundation	National Plan for Science and Technology (NPST), Riyadh, Saudi Arabia; British Heart Foundation(British Heart Foundation)	This study was supported by a grant from National Plan for Science and Technology (NPST), (08-MED-603-2) Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the primary care physicians and nurses who recruited and collected the data of the subjects. We also thank the British Heart Foundation for the intermediate Fellowship to support Dr Alison Harte. Special thanks is also noted to Mr. Benjamin Vinodson and Saim Ul-Haq Quddusi for the statistical analysis of data.	Adamczak M, 2003, AM J HYPERTENS, V16, P72, DOI 10.1016/S0895-7061(02)03197-7; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al-Daghri NM, 2010, ADV MED SCI-POLAND, V55, P179, DOI 10.2478/v10039-010-0052-1; Al-Daghri N, 2010, ANN SAUDI MED, V30, P209, DOI 10.4103/0256-4947.62835; Al-Homrany MA, 2008, SAUDI J KIDNEY DIS T, V19, P990; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Androulakis ES, 2009, CARDIOL REV, V17, P216, DOI 10.1097/CRD.0b013e3181b18e03; Asferg C, 2011, BLOOD PRESSURE, V20, P362, DOI 10.3109/00365599.2011.586248; Asferg C, 2010, AM J HYPERTENS, V23, P327, DOI 10.1038/ajh.2009.244; Baden MY, 2012, CLIN ENDOCRINOL OXF; Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Celoria Bruno M J, 2010, Clin Cardiol, V33, pE61, DOI 10.1002/clc.20657; Chamarthi B, 2011, AM J HYPERTENS, V24, P1143, DOI 10.1038/ajh.2011.113; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; do Carmo JM, 2011, HYPERTENSION, V57, P918, DOI 10.1161/HYPERTENSIONAHA.110.161349; Feber J, 2010, CLIN SCI, V119, P151, DOI 10.1042/CS20090544; Fogari R, 2005, HYPERTENS RES, V28, P209, DOI 10.1291/hypres.28.209; Fowler JD, 2009, AM J PHYSIOL-ENDOC M, V296, pE343, DOI 10.1152/ajpendo.90693.2008; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Galletti F, 2012, NUTR METAB CARDIOVAS, V22, P300, DOI 10.1016/j.numecd.2011.05.007; Gao X, 2007, FASEB J, V21, pA1198; Goodwin BL, 2007, AM J PHYSIOL-HEART C, V293, pH1115, DOI 10.1152/ajpheart.01100.2006; Gurantz D, 1999, CIRC RES, V85, P272, DOI 10.1161/01.RES.85.3.272; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Itani H, 2009, HYPERTENSION, V53, P1070, DOI 10.1161/HYPERTENSIONAHA.109.130633; Kalra D, 2002, CIRCULATION, V105, P2198, DOI 10.1161/01.CIR.0000015603.84788.47; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Ma D, 2009, HYPERTENSION, V53, P473, DOI 10.1161/HYPERTENSIONAHA.108.118133; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Patel JV, 2009, ANN MED, V41, P291, DOI 10.1080/07853890802672839; Pruijm M, 2012, J HUM HYPERTENS; Sabo RT, 2012, OBESITY SILVER SPRIN; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Summer Ross, 2011, Pulm Circ, V1, P440, DOI 10.4103/2045-8932.93542; Takeshita Y, 2008, EUR J PHARMACOL, V579, P426, DOI 10.1016/j.ejphar.2007.11.016; Taube A, 2012, AM J PHYSL HEART CIR; Tohidi M, 2011, J HUM HYPERTENS; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Wago T, 2010, HYPERTENS RES, V33, P796, DOI 10.1038/hr.2010.107; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	52	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51255	10.1371/journal.pone.0051255	http://dx.doi.org/10.1371/journal.pone.0051255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251471	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200076
J	Anderson, RC; Klofstad, CA				Anderson, Rindy C.; Klofstad, Casey A.			Preference for Leaders with Masculine Voices Holds in the Case of Feminine Leadership Roles	PLOS ONE			English	Article							PITCH	Human voice pitch research has focused on perceptions of attractiveness, strength, and social dominance. Here we examine the influence of pitch on selection of leaders, and whether this influence varies by leadership role. Male and female leaders with lower-pitched (i.e., masculine) voices are generally preferred by both men and women. We asked whether this preference shifts to favor higher-pitch (i.e., feminine) voices within the specific context of leadership positions that are typically held by women (i.e., feminine leadership roles). In hypothetical elections for two such positions, men and women listened to pairs of male and female voices that differed only in pitch, and were asked which of each pair they would vote for. As in previous studies, men and women preferred female candidates with masculine voices. Likewise, men preferred men with masculine voices. Women, however, did not discriminate between male voices. Overall, contrary to research showing that perceptions of voice pitch can be influenced by social context, these results suggest that the influence of voice pitch on perceptions of leadership capacity is largely consistent across different domains of leadership.	[Anderson, Rindy C.] Duke Univ, Dept Biol, Durham, NC USA; [Klofstad, Casey A.] Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA	Duke University; University of Miami	Klofstad, CA (corresponding author), Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA.	klofstad@gmail.com						Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Nishio M, 2008, FOLIA PHONIATR LOGO, V60, P120, DOI 10.1159/000118510; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Titze IR, 1994, PRINCIPLES VOICE PRO; TRAUNMULLER H, 1990, J ACOUST SOC AM, V88, P97, DOI 10.1121/1.399849; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5	12	34	36	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51216	10.1371/journal.pone.0051216	http://dx.doi.org/10.1371/journal.pone.0051216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251457	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200072
J	Batra, R; Harder, N; Gogolin, S; Diessl, N; Soons, Z; Jager-Schmidt, C; Lawerenz, C; Eils, R; Rohr, K; Westermann, F; Konig, R				Batra, Richa; Harder, Nathalie; Gogolin, Sina; Diessl, Nicolle; Soons, Zita; Jaeger-Schmidt, Christina; Lawerenz, Christian; Eils, Roland; Rohr, Karl; Westermann, Frank; Koenig, Rainer			Time-Lapse Imaging of Neuroblastoma Cells to Determine Cell Fate upon Gene Knockdown	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DNA-BINDING PROTEIN; STATISTICAL-METHODS; THERAPEUTIC TARGET; SPINDLE DYNAMICS; TUMOR-SUPPRESSOR; C-MYC; RNAI; EXPRESSION; IDENTIFICATION	Neuroblastoma is the most common extra-cranial solid tumor of early childhood. Standard therapies are not effective in case of poor prognosis and chemotherapy resistance. To improve drug therapy, it is imperative to discover new targets that play a substantial role in tumorigenesis of neuroblastoma. The mitotic machinery is an attractive target for therapeutic interventions and inhibitors can be developed to target mitotic entry, spindle apparatus, spindle activation checkpoint, and mitotic exit. We present an elaborate analysis pipeline to determine cancer specific therapeutic targets by first performing a focused gene expression analysis to select genes followed by a gene knockdown screening assay of live cells. We interrogated gene expression studies of neuroblastoma tumors and selected 240 genes relevant for tumorigenesis and cell cycle. With these genes we performed time-lapse screening of gene knockdowns in neuroblastoma cells. We classified cellular phenotypes and used the temporal context of the perturbation effect to determine the sequence of events, particularly the mitotic entry preceding cell death. Based upon this phenotype kinetics from the gene knockdown screening, we inferred dynamic gene functions in mitosis and cell proliferation. We identified six genes (DLGAP5, DSCC1, SMO, SNRPD1, SSBP1, and UBE2C) with a vital role in mitosis and these are promising therapeutic targets for neuroblastoma. Images and movies of every time point of all screened genes are available at https://ichip.bioquant.uni-heidelberg.de.	[Batra, Richa; Harder, Nathalie; Soons, Zita; Eils, Roland; Rohr, Karl; Koenig, Rainer] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Batra, Richa; Harder, Nathalie; Soons, Zita; Jaeger-Schmidt, Christina; Lawerenz, Christian; Eils, Roland; Rohr, Karl; Koenig, Rainer] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Gogolin, Sina; Westermann, Frank] German Canc Res Ctr, Div Tumor Genet, Heidelberg, Germany; [Diessl, Nicolle] German Canc Res Ctr, Dept Genom, Heidelberg, Germany; [Diessl, Nicolle] German Canc Res Ctr, Prote Core Facil, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Konig, R (corresponding author), Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	r.koenig@dkfz.de	Batra, Richa/ABF-1240-2021; Eils, Roland/B-6121-2009; Westermann, Frank/F-7509-2013	Batra, Richa/0000-0003-3708-0086; Eils, Roland/0000-0002-0034-4036; Harder, Nathalie/0000-0002-6171-6462; Soons, Zita/0000-0002-0767-8856	Nationales Genom-Forschungs-Netz (NGFN) project ENGINE [01GS0898]; Helmholtz Alliance on Systems Biology (SB Cancer) [D.141100/07.997]; BMBF CancerSys-Verbundprojekt: MYCNET [0316076C]; Deutscher Akademischer Auslandsdienst (DAAD)	Nationales Genom-Forschungs-Netz (NGFN) project ENGINE; Helmholtz Alliance on Systems Biology (SB Cancer); BMBF CancerSys-Verbundprojekt: MYCNET; Deutscher Akademischer Auslandsdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the Nationales Genom-Forschungs-Netz (NGFN, www.ngfn.de) project ENGINE (#01GS0898), the Helmholtz Alliance on Systems Biology (SB Cancer, D.141100/07.997, http://www.dkfz.de/en/sbcancer/index.html), the BMBF (www.bmbf.de) CancerSys-Verbundprojekt: MYCNET (0316076C), and the Deutscher Akademischer Auslandsdienst (DAAD, www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000712; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dickey A, 2011, J NEURO-ONCOL, V104, P145, DOI 10.1007/s11060-010-0491-3; Dimitriadou E, 2011, SUPPORT VECTOR MACHI; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duan Z, CLIN CANC RES; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harder N, 2011, P 6 INT WORKSH MICR; Harder N, 2006, LECT NOTES COMPUT SC, V4190, P840; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; HOTHORN T, 2003, COMPUTATIONAL STAT D; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000655; Merkle CJ, 2003, J BIOL CHEM, V278, P30051, DOI 10.1074/jbc.M211591200; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oberthuer A, 2010, PHARMACOGENOMICS J, V10, P258, DOI 10.1038/tpj.2010.53; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Terry Therneau, 2012, PACKAGE SURVIVAL ANA; Tuszynski J, 2012, CATOOLS PACKAGE; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Wu TF, 2004, J MACH LEARN RES, V5, P975; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022176; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	70	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50988	10.1371/journal.pone.0050988	http://dx.doi.org/10.1371/journal.pone.0050988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251412	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200052
J	Coltharp, C; Kessler, RP; Xiao, J				Coltharp, Carla; Kessler, Rene P.; Xiao, Jie			Accurate Construction of Photoactivated Localization Microscopy (PALM) Images for Quantitative Measurements	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENT PROTEIN; SUPERRESOLUTION; PROBES; CELLS; FTSZ; ORGANIZATION; COEFFICIENTS; PERFORMANCE; SYSTEM	Localization-based superresolution microscopy techniques such as Photoactivated Localization Microscopy (PALM) and Stochastic Optical Reconstruction Microscopy (STORM) have allowed investigations of cellular structures with unprecedented optical resolutions. One major obstacle to interpreting superresolution images, however, is the overcounting of molecule numbers caused by fluorophore photoblinking. Using both experimental and simulated images, we determined the effects of photoblinking on the accurate reconstruction of superresolution images and on quantitative measurements of structural dimension and molecule density made from those images. We found that structural dimension and relative density measurements can be made reliably from images that contain photoblinking-related overcounting, but accurate absolute density measurements, and consequently faithful representations of molecule counts and positions in cellular structures, require the application of a clustering algorithm to group localizations that originate from the same molecule. We analyzed how applying a simple algorithm with different clustering thresholds (t(Thresh) and d(Thresh)) affects the accuracy of reconstructed images, and developed an easy method to select optimal thresholds. We also identified an empirical criterion to evaluate whether an imaging condition is appropriate for accurate superresolution image reconstruction with the clustering algorithm. Both the threshold selection method and imaging condition criterion are easy to implement within existing PALM clustering algorithms and experimental conditions. The main advantage of our method is that it generates a superresolution image and molecule position list that faithfully represents molecule counts and positions within a cellular structure, rather than only summarizing structural properties into ensemble parameters. This feature makes it particularly useful for cellular structures of heterogeneous densities and irregular geometries, and allows a variety of quantitative measurements tailored to specific needs of different biological systems.	[Coltharp, Carla; Kessler, Rene P.; Xiao, Jie] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Xiao, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	xiao@jhmi.edu		Xiao, Jie/0000-0003-1433-5437	National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant [MCB-1019000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086447] Funding Source: NIH RePORTER	National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant MCB-1019000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Chien FC, 2011, SMALL, V7, P2906, DOI 10.1002/smll.201100753; David CC, 2012, PHOTOCHEMICAL PHOTOB, P11; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; FU G, 2010, PLOS ONE, V0005; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hsu CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023586; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; Jennings PC, 2011, MICRON, V42, P336, DOI 10.1016/j.micron.2010.09.003; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lelek M, 2012, P NATL ACAD SCI; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wolter S, 2011, OPT EXPRESS, V19, P7020, DOI 10.1364/OE.19.007020; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r	45	42	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51725	10.1371/journal.pone.0051725	http://dx.doi.org/10.1371/journal.pone.0051725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251611	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200157
J	Li, G; Yang, X; Shu, ZH; Chen, XY; Wang, YQ				Li, Guang; Yang, Xi; Shu, ZongHuang; Chen, XiaoYing; Wang, YiQuan			Consecutive Spawnings of Chinese Amphioxus, Branchiostoma belcheri, in Captivity	PLOS ONE			English	Article							DEVELOPMENTAL BIOLOGY; CHORDATE AMPHIOXUS; XIAMEN WATERS; EVOLUTION; CEPHALOCHORDATA; LANCEOLATUM; VERTEBRATES; LANCELETS; GENOME; MODEL	Cephalochordate amphioxus is a promising model animal for studying the evolutionary and developmental mechanisms of vertebrates because its unique phylogenetic position, simple body plan and sequenced genome. However, one major drawback for using amphioxus as a model organism is the restricted supply of living embryos since they are available only during spawning season that varies from a couple of days to several months according to species. Therefore we are aiming to develop methods for obtaining viable amphioxus embryos in non-spawning season. In the current study, we found that Branchiostoma belcheri could develop their gonads and spawn consecutively in the laboratory when cultured in a low density at a high temperature (25-28 degrees C) supplied with sufficient food and proper cleanness. Among the approximate 150 observed animals, which spawned spontaneously between November and December 2011, 10% have spawned twice, 10% three times, and 80% four times, through April 2012. The quality and quantity of the gametes reproduced in the consecutive spawning have no obvious difference with those spawned once naturally. Spawning intervals varied dramatically both among different animals (from 1 to 5 months) and between intervals of a single individual (from 27 to 74 days for one animal). In summary, we developed a method with which, for the first time, consecutive spawnings of amphioxus in captivity can be achieved. This has practical implications for the cultivation of other amphioxus species, and eventually will greatly promote the utilization of amphioxus as a model system.	[Li, Guang; Yang, Xi; Shu, ZongHuang; Chen, XiaoYing; Wang, YiQuan] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Guang; Wang, YiQuan] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University	Wang, YQ (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	wangyq@xmu.edu.cn			National High Technology Research and Development Program of China [2008AA092602]; National Natural Science Foundation of China [30830023, 31101631]; Department of Science and Technology of Shenzhen [JSF201006290026A]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shenzhen	This work was supported by the National High Technology Research and Development Program of China (2008AA092602), the National Natural Science Foundation of China (30830023 and 31101631) and Social Development and Technological Project by the Department of Science and Technology of Shenzhen (JSF201006290026A). The funders had no role in study design, data collection and manuscript.	Beaster-Jones L, 2012, BRIEF FUNCT GENOMICS, V11, P118, DOI 10.1093/bfgp/els006; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Candiani S, 2012, BRIEF FUNCT GENOMICS, V11, P107, DOI 10.1093/bfgp/els004; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Holland ND, 2011, ITAL J ZOOL, V78, P478, DOI 10.1080/11250003.2011.594097; Koop Demian, 2008, Birth Defects Research, V84, P175, DOI 10.1002/bdrc.20128; Ma De-you, 2010, Marine Sciences (Beijing), V34, P6; Orton JH., 1914, J MAR BIOL ASSOC UK, V10, P506, DOI [10.1017/S0025315400008262, DOI 10.1017/S0025315400008262]; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Poss Stuart G., 1996, Israel Journal of Zoology, V42, P13; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stokes D, 1991, INVERTEBRA BIOL, V115, P349; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; Wang Y, 2002, NATURAL SCI J HAINAN, V20, P62; Wang Yi-quan, 2006, Zoological Research, V27, P631; Wang Yi-quan, 2005, Zoological Research, V26, P666; Wu Xian-Han, 1994, Chinese Journal of Oceanology and Limnology, V12, P289; Xu QS, 2005, J EXP ZOOL PART B, V304B, P259, DOI 10.1002/jez.b.21036; Yamaguchi T, 2003, ZOOL SCI, V20, P907, DOI 10.2108/zsj.20.907; Zhang QJ, 2007, J EXP ZOOL PART B, V308B, P464, DOI 10.1002/jez.b.21172; Zhang QJ, 2006, ZOOL SCI, V23, P573, DOI 10.2108/zsj.23.573; Zhang Shicui, 2000, Studia Marina Sinica, V42, P74	28	30	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50838	10.1371/journal.pone.0050838	http://dx.doi.org/10.1371/journal.pone.0050838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251392	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200041
J	Ni, PH; Xu, H; Chen, CQ; Wang, JY; Liu, XF; Hu, YQ; Fan, QS; Hou, ZY; Lu, Y				Ni, Peihua; Xu, Hong; Chen, Changqiang; Wang, Jiayi; Liu, Xiangfan; Hu, Yiqun; Fan, Qishi; Hou, Zhaoyuan; Lu, Yang			Serum Starvation Induces DRAM Expression in Liver Cancer Cells via Histone Modifications within Its Promoter Locus	PLOS ONE			English	Article							P53 TARGET GENE; TRANSCRIPTIONAL REPRESSION; H3K4 METHYLATION; AUTOPHAGY; DEATH; ROLES; RNA; ACETYLATION; APOPTOSIS; CHROMATIN	DRAM is a lysosomal membrane protein and is critical for p53-mediated autophagy and apoptosis. DRAM has a potential tumor-suppressive function and is downregulated in many human cancers. However, the regulation of DRAM expression is poorly described so far. Here, we demonstrated that serum deprivation strongly induces DRAM expression in liver cancer cells and a core DNA sequence in the DRAM promoter is essential for its responsiveness to serum deprivation. We further observed that euchromatin markers for active transcriptions represented by diacetyl-H3, tetra-acetyl-H4 and the trimethyl-H3K4 at the core promoter region of DRAM gene are apparently increased in a time-dependent manner upon serum deprivation, and concomitantly the dimethyl-H3K9, a herterochromatin marker associated with silenced genes, was time-dependently decreased. Moreover, the chromatin remodeling factor Brg-1 is enriched at the core promoter region of the DRAM gene and is required for serum deprivation induced DRAM expression. These observations lay the ground for further investigation of the DRAM gene expression.	[Ni, Peihua; Lu, Yang] Shanghai Jiao Tong Univ, Dept Pharm, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Ni, Peihua; Chen, Changqiang; Wang, Jiayi; Liu, Xiangfan; Hu, Yiqun; Fan, Qishi] Shanghai Jiao Tong Univ, Dept Lab Med, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xu, Hong; Hou, Zhaoyuan] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hou, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China.	houzy@sjtu.edu.cn; luyangssmu@yahoo.com		Wang, Jiayi/0000-0003-1688-2864	Science and Technology Committee of Shanghai Metropolitan [11ZR1423100]; National Science Foundation of China [30772233, 30873057, 81172028]; Key Basic Project of Shanghai Municipal Science and Technology Commission [08JC1413600]; Shanghai Committee of Science and Technology [11DZ2260200]; 985 Tumor Joint Foundation	Science and Technology Committee of Shanghai Metropolitan; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Basic Project of Shanghai Municipal Science and Technology Commission; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); 985 Tumor Joint Foundation	This work was supported by the Science and Technology Committee of Shanghai Metropolitan (11ZR1423100); the National Science Foundation of China (grant No.: 30772233, 30873057 to Y. Lu, and 81172028 to Z. Hou); Key Basic Project of Shanghai Municipal Science and Technology Commission (No.: 08JC1413600); Shanghai Committee of Science and Technology (11DZ2260200); and 985 Tumor Joint Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Felsenfeld G, 2000, BIOPHYS CHEM, V86, P231, DOI 10.1016/S0301-4622(00)00134-4; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Kerley-Hamilton JS, 2007, BBA-GENE STRUCT EXPR, V1769, P209, DOI 10.1016/j.bbaexp.2007.02.002; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Ryan KM, 2011, EUR J CANCER, V47, P44, DOI 10.1016/j.ejca.2010.10.020; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50502	10.1371/journal.pone.0050502	http://dx.doi.org/10.1371/journal.pone.0050502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251372	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200030
J	Tilleman, L; De Henau, S; Pauwels, M; Nagy, N; Pintelon, I; Braeckman, BP; De Wael, K; Van Doorslaer, S; Adriaensen, D; Timmermans, JP; Moens, L; Dewilde, S				Tilleman, Lesley; De Henau, Sasha; Pauwels, Martje; Nagy, Nora; Pintelon, Isabel; Braeckman, Bart P.; De Wael, Karolien; Van Doorslaer, Sabine; Adriaensen, Dirk; Timmermans, Jean-Pierre; Moens, Luc; Dewilde, Sylvia			An N-Myristoylated Globin with a Redox-Sensing Function That Regulates the Defecation Cycle in Caenorhabditis elegans	PLOS ONE			English	Article							PROTEIN SUBCELLULAR LOCATION; NH2-TERMINAL BLOCKING GROUP; ELECTRON-PARAMAGNETIC-RES; CYTOCHROME-C PEROXIDASE; HEME-POCKET STRUCTURE; HYDROGEN-PEROXIDE; ACID-COMPOSITION; LIGAND-BINDING; GENE FAMILY; ION-CHANNEL	Globins occur in all kingdoms of life where they fulfill a wide variety of functions. In the past they used to be primarily characterized as oxygen transport/storage proteins, but since the discovery of new members of the globin family like neuroglobin and cytoglobin, more diverse and complex functions have been assigned to this heterogeneous family. Here we propose a function for a membrane-bound globin of C. elegans, GLB-26. This globin was predicted to be myristoylated at its N-terminus, a post-translational modification only recently described in the globin family. In vivo, this globin is found in the membrane of the head mesodermal cell and in the tail stomato-intestinal and anal depressor muscle cells. Since GLB-26 is almost directly oxidized when exposed to oxygen, we postulate a possible function as electron transfer protein. Phenotypical studies show that GLB-26 takes part in regulating the length of the defecation cycle in C. elegans under oxidative stress conditions.	[Tilleman, Lesley; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [De Henau, Sasha; Braeckman, Bart P.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Pauwels, Martje; De Wael, Karolien] Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium; [Nagy, Nora; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium; [Nagy, Nora] Hungarian Acad Sci, Inst Struct Chem, Chem Res Ctr, Budapest, Hungary; [Pintelon, Isabel; Adriaensen, Dirk; Timmermans, Jean-Pierre] Univ Antwerp, Dept Vet Sci, B-2020 Antwerp, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Antwerp; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Antwerp	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.	sylvia.dewilde@ua.ac.be	De Wael, Karolien/U-5545-2018; Van Doorslaer, Sabine/E-5050-2017	Van Doorslaer, Sabine/0000-0002-1685-9202; De Wael, Karolien/0000-0003-4495-0748; May, Nora V./0000-0003-4770-4681; Timmermans, Jean-Pierre/0000-0003-2506-6252	University of Antwerp; FWO project [G.0247.09]; Hercules Foundation [Hercules Type 1: AUHA 09/001]	University of Antwerp; FWO project(FWO); Hercules Foundation	SDH is a Ph.D. fellow of the Fund for Scientific Research (FWO). Financial support to SD and LM was provided by the University of Antwerp (BOF UA TOP 2006) and to SD, LM, BPB, by FWO project G.0247.09. The UltraVIEW VoX spinning disk confocal microscope was purchased with support of the Hercules Foundation (Hercules Type 1: AUHA 09/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; ANDERSSON KK, 1986, J BIOL CHEM, V261, P1126; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Branicky R, 2005, DEVELOPMENT, V132, P4999, DOI 10.1242/dev.02069; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; CROLL NA, 1978, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; De Wael K, 2012, BIOELECTROCHEMISTRY, V83, P15, DOI 10.1016/j.bioelechem.2011.07.001; De Wael K, 2011, INT J ELECTROCHEM SC, V6, P1810; De Wael K, 2010, TALANTA, V82, P1980, DOI 10.1016/j.talanta.2010.08.019; Desmet F, 2010, J INORG BIOCHEM, V104, P1022, DOI 10.1016/j.jinorgbio.2010.05.009; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dhakal BK, 2006, BIOCH BIOPHYSICAL RE; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geuens E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-17; GILMOUR R, 1993, BIOCHEM J, V294, P745, DOI 10.1042/bj2940745; Hayashi N, 2010, P JPN ACAD B-PHYS, V86, P494, DOI 10.2183/pjab.86.494; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Hoffmann FG, 2012, MOL BIOL EVOL; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Ioanitescu AI, 2007, MOL PHYS, V105, P2073, DOI 10.1080/00268970701616030; Ioanitescu AI, 2009, METALLOMICS, V1, P256, DOI 10.1039/b902059b; Iruthayanathan M, 2011, STEROIDS, V76, P1483, DOI 10.1016/j.steroids.2011.08.002; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; Kniazeva M, 2003, GENETICS, V163, P159; Kobayashi Y, 2011, GENES CELLS, V16, P565, DOI 10.1111/j.1365-2443.2011.01508.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee MS, 2007, MOL CELLS, V23, P1; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; LEIGH JS, 1975, BIOCHIM BIOPHYS ACTA, V387, P95, DOI 10.1016/0005-2728(75)90054-7; LIU DWC, 1994, J NEUROSCI, V14, P1953; MALKIN R, 1980, FEBS LETT, V111, P228, DOI 10.1016/0014-5793(80)80799-X; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; ORMEJOHNSON NR, 1974, J BIOL CHEM, V249, P1928; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pellegriti K, 2011, INCREASED SUSCEPTIBI; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; RANDLES JEB, 1948, T FARADAY SOC, V44, P327, DOI 10.1039/tf9484400327; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; Sevik A, 1948, COLLECT CZECH CHEM C, V13, P349, DOI [10.1135/cccc19480349, DOI 10.1135/CCCC19480349]; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Take-uchi M, 1998, P NATL ACAD SCI USA, V95, P11775, DOI 10.1073/pnas.95.20.11775; Take-uchi M, 2005, MOL BIOL CELL, V16, P1355, DOI 10.1091/mbc.E04-04-0273; THOMAS JH, 1990, GENETICS, V124, P855; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Vinck E, 2006, J BIOL INORG CHEM, V11, P467, DOI 10.1007/s00775-006-0100-2; Vinck E, 2004, J AM CHEM SOC, V126, P4516, DOI 10.1021/ja0383322; Walker DS, 2004, MOL BIOL CELL, V15, P3073, DOI 10.1091/mbc.E04-01-0039; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Yatsunyk LA, 2006, INORG CHEM, V45, P5417, DOI 10.1021/ic060283h; Yoon J, 2010, BIOCHEMISTRY-US, V49, P5662, DOI 10.1021/bi100710a; Yoshida M, 1999, PLANT CELL PHYSIOL, V40, P192, DOI 10.1093/oxfordjournals.pcp.a029527; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	95	7	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48768	10.1371/journal.pone.0048768	http://dx.doi.org/10.1371/journal.pone.0048768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251335	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200008
J	Wiech, M; Olszewski, MB; Tracz-Gaszewska, Z; Wawrzynow, B; Zylicz, M; Zylicz, A				Wiech, Milena; Olszewski, Maciej B.; Tracz-Gaszewska, Zuzanna; Wawrzynow, Bartosz; Zylicz, Maciej; Zylicz, Alicja			Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; CORE DOMAIN; GENE AMPLIFICATION; DEPENDENT MANNER; ATP HYDROLYSIS; RNA-POLYMERASE; BREAST-CANCER; BINDING-SITE	Numerous p53 missense mutations possess gain-of-function activities. Studies in mouse models have demonstrated that the stabilization of p53 R172H (R175H in human) mutant protein, by currently unknown factors, is a prerequisite for its oncogenic gain-of-function phenotype such as tumour progression and metastasis. Here we show that MDM2-dependent ubiquitination and degradation of p53 R175H mutant protein in mouse embryonic fibroblasts is partially inhibited by increasing concentration of heat shock protein 70 (HSP70/HSPA1-A). These phenomena correlate well with the appearance of HSP70-dependent folding intermediates in the form of dynamic cytoplasmic spots containing aggregate-prone p53 R175H and several molecular chaperones. We propose that a transient but recurrent interaction with HSP70 may lead to an increase in mutant p53 protein half-life. In the presence of MDM2 these pseudoaggregates can form stable amyloid-like structures, which occasionally merge into an aggresome. Interestingly, formation of folding intermediates is not observed in the presence of HSC70/HSPA8, the dominant-negative K71S variant of HSP70 or HSP70 inhibitor. In cancer cells, where endogenous HSP70 levels are already elevated, mutant p53 protein forms nuclear aggregates without the addition of exogenous HSP70. Aggregates containing p53 are also visible under conditions where p53 is partially unfolded: 37 degrees C for temperature-sensitive variant p53 V143A and 42 degrees C for wild-type p53. Refolding kinetics of p53 indicate that HSP70 causes transient exposure of p53 aggregate-prone domain(s). We propose that formation of HSP70- and MDM2-dependent protein coaggregates in tumours with high levels of these two proteins could be one of the mechanisms by which mutant p53 is stabilized. Moreover, sequestration of p73 tumour suppressor protein by these nuclear aggregates may lead to gain-of-function phenotypes.	[Wiech, Milena; Olszewski, Maciej B.; Tracz-Gaszewska, Zuzanna; Wawrzynow, Bartosz; Zylicz, Maciej; Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, Warsaw, Poland; [Wiech, Milena] PAS, Nencki Inst Expt Biol, Warsaw, Poland; [Tracz-Gaszewska, Zuzanna] PAS, Inst Biochem & Biophys, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, Warsaw, Poland.	mzylicz@iimcb.gov.pl; alicja.zylicz@iimcb.gov.pl	Olszewski, Maciej/G-8396-2016; Olszewski, Maciej/C-2021-2015; Wiech, Milena/AAC-5188-2020	Olszewski, Maciej/0000-0003-0961-0801; Olszewski, Maciej/0000-0003-0961-0801; Wiech, Milena/0000-0003-4388-1648; Zylicz, Alicja/0000-0003-4174-3073; Tracz-Gaszewska, Zuzanna/0000-0003-1340-6379	National Center of Science [NN 302621838, 2011/01/N/NZ1/00202]; Foundation for Polish Science [Ventures/2010-6/8]	National Center of Science(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The work was funded by the National Center of Science - grants NN 302621838 (AZ) and 2011/01/N/NZ1/00202 (MW) and by the Foundation for Polish Science - project Ventures/2010-6/8 (ZTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; [Anonymous], J BIOL CHEM; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; BARTEK J, 1991, ONCOGENE, V6, P1699; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; CORDONCARDO C, 1994, CANCER RES, V54, P794; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dreiseidler M, 2012, METHODS MOL BIOL, V832, P473, DOI 10.1007/978-1-61779-474-2_34; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fortun J, 2003, J NEUROSCI, V23, P10672; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LADANYI M, 1993, CANCER RES, V53, P16; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lo Nigro C, 2012, BRIT J CANCER, V106, P397, DOI 10.1038/bjc.2011.464; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; SHEIKH MS, 1993, CANCER RES, V53, P3226; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Steiner K, 2006, LEUKEMIA, V20, P2076, DOI 10.1038/sj.leu.2404391; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Walerych D, 2010, J BIOL CHEM, V285, P32020, DOI 10.1074/jbc.M110.112110; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	89	81	85	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51426	10.1371/journal.pone.0051426	http://dx.doi.org/10.1371/journal.pone.0051426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251530	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200105
J	Das, S; Czarnek, M; Bzowska, M; Mezyk-Kopec, R; Stalinska, K; Wyroba, B; Sroka, J; Jucha, J; Deneka, D; Stoklosa, P; Ogonek, J; Swartz, MA; Madeja, Z; Bereta, J				Das, Sudipta; Czarnek, Maria; Bzowska, Monika; Mezyk-Kopec, Renata; Stalinska, Krystyna; Wyroba, Barbara; Sroka, Jolanta; Jucha, Jaroslaw; Deneka, Dawid; Stoklosa, Paulina; Ogonek, Justyna; Swartz, Melody A.; Madeja, Zbigniew; Bereta, Joanna			ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING ENZYME; GROWTH-FACTOR; BREAST-CANCER; PRESENILIN/GAMMA-SECRETASE; ENDOTHELIAL-CELLS; AUTONOMOUS GROWTH; REGULATES VEGF; OVARIAN-CANCER; EGFR	ADAM17 (a disintegrin and metalloprotease 17) is a major sheddase for numerous growth factors, cytokines, receptors, and cell adhesion molecules and is often overexpressed in malignant cells. It is generally accepted that ADAM17 promotes tumor development via activating growth factors from the EGF family, thus facilitating autocrine stimulation of tumor cell proliferation and migration. Here we show, using MC38CEA murine colon carcinoma model, that ADAM17 also regulates tumor angiogenesis and cytokine profile. When ADAM17 was silenced in MC38CEA cells, in vivo tumor growth and in vitro cell motility were significantly diminished, but no effect was seen on in vitro cell proliferation. ADAM17-silencing was accompanied by decreased in vitro expression of vascular endothelial growth factor-A and matrix metalloprotease-9, which was consistent with the limited angiogenesis and slower growth seen in ADAM17-silenced tumors. Among the growth factors susceptible to shedding by ADAM17, neuregulin-1 was the only candidate to mediate the effects of ADAM17 on MC38CEA motility and tumor angiogenesis. Concentrations of TNF and IFN gamma, cytokines that synergistically induced proapoptotic effects on MC38CEA cells, were significantly elevated in the lysates of ADAM17-silenced tumors compared to mock transfected controls, suggesting a possible role for ADAM17 in host immune suppression. These results introduce new, complex roles of ADAM17 in tumor progression, including its impact on the anti-tumor immune response.	[Das, Sudipta; Czarnek, Maria; Bzowska, Monika; Mezyk-Kopec, Renata; Stalinska, Krystyna; Wyroba, Barbara; Jucha, Jaroslaw; Deneka, Dawid; Stoklosa, Paulina; Ogonek, Justyna; Bereta, Joanna] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sroka, Jolanta; Madeja, Zbigniew] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland	Jagiellonian University; Jagiellonian University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Bereta, J (corresponding author), Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	joanna.bereta@uj.edu.pl	Das, Sudipta/AAE-4236-2019	Madeja, Zbigniew/0000-0002-5523-1215; Sroka, Jolanta/0000-0003-3728-752X; Bereta, Joanna/0000-0001-7930-2770; Bzowska, Monika/0000-0003-1921-0334; Deneka, Dawid/0000-0001-9472-0663	Ministry of Science and Higher Education, Poland [3144/B/P01/2007/33]; New Member State of EU (Sciex NMS-CH) [10.085-2]; New Member State of Switzerland (Sciex NMS-CH) [10.085-2]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); New Member State of EU (Sciex NMS-CH); New Member State of Switzerland (Sciex NMS-CH)	This work was supported by grant 3144/B/P01/2007/33 from the Ministry of Science and Higher Education, Poland and the Scientific Exchange Program between the New Member States of the EU and Switzerland (Sciex NMS-CH; grant no. 10.085-2 to R.M-K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Bereta M, 2007, VACCINE, V25, P4183, DOI 10.1016/j.vaccine.2007.03.008; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Braun AH, 2005, CLIN CANCER RES, V11, P4639, DOI 10.1158/1078-0432.CCR-05-0973; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Cells J., 1998, CELL BIOL LAB HDB; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Coligan J.E., 1997, CURRENT PROTOCOLS PR; CORBETT TH, 1975, CANCER RES, V35, P2434; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Finigan JH, 2011, J BIOL CHEM, V286, P10660, DOI 10.1074/jbc.M110.208041; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Guan YQ, 2010, BIOMATERIALS, V31, P9074, DOI 10.1016/j.biomaterials.2010.08.044; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; HOFER DR, 1991, CANCER RES, V51, P2780; Hofman F., 2002, CURRENT PROTOCOLS IM; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Katakowski M, 2009, CANCER SCI, V100, P1597, DOI 10.1111/j.1349-7006.2009.01221.x; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Stamenkovic I, 2009, J INVEST DERMATOL, V129, P1321, DOI 10.1038/jid.2009.13; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; WU JC, 1994, CANCER RES, V54, P5964; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Yonezawa M, 2009, DIGESTION, V80, P215, DOI 10.1159/000229775; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zheng XG, 2012, MOL CARCINOGEN, V51, P150, DOI 10.1002/mc.20772; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	60	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50791	10.1371/journal.pone.0050791	http://dx.doi.org/10.1371/journal.pone.0050791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251384	Green Published, gold			2022-12-25	WOS:000312201900017
J	Wang, Y; Wong, HC; Gullen, EA; Lam, W; Yang, XM; Shi, Q; Lee, KH; Cheng, YC				Wang, Ying; Wong, Hui-Chyn; Gullen, Elizabeth A.; Lam, Wing; Yang, Xiaoming; Shi, Qian; Lee, Kuo-Hsiung; Cheng, Yung-Chi			Cryptopleurine Analogs with Modification of E Ring Exhibit Different Mechanism to Rac-Cryptopleurine and Tylophorine	PLOS ONE			English	Article							INHIBITION; ALKALOIDS; CANCER	Tylophorine analogs exhibit a broad range of pharmacological activities, including anti-cancer, anti-inflammatory, anti-autoimmune, and anti-virus effects. Structure-activity relationship study of different structure tylophorine analogs can provide further understanding of their biological activity. Modifications on the E ring of the quinolizidine moiety of cryptopleurine analogs changed the potency and the selective inhibitory effect on NF-kappa B, AP-1, and CRE signaling pathways. Functional cryptopleurine analogs showed potent inhibition of NF-kappa B signaling pathway in both HepG2 and HEK-293 cell lines. The E ring structure analogs also differed in suppression of protein translation, and expression of cyclin D1. Our results showed that DCB-3503 or Rac-cryptopleurine could be a scaffold for modification to yield compounds with different mechanisms of action.	[Yang, Xiaoming; Shi, Qian; Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA; [Wang, Ying; Wong, Hui-Chyn; Gullen, Elizabeth A.; Lam, Wing; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; Yale University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, KH (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA.	khlee@unc.edu; yccheng@yale.edu	Wang, Ying/T-9438-2018	Wang, Ying/0000-0002-1407-2668	National Science Fellowship (NSF) by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation; National Cancer Institute of National Institute of Health of USA [PO1 CA-154295]; National Institute of Health of USA [RO1 CA-17625-32]; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence [DOH100-TD-C-111-005]; NATIONAL CANCER INSTITUTE [P01CA154295, R01CA017625] Funding Source: NIH RePORTER	National Science Fellowship (NSF) by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation; National Cancer Institute of National Institute of Health of USA; National Institute of Health of USA; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. David C. Baker for providing the compound DCB-3503. They thank Dr. Susan L. Morris-Natschke and Eileen Belding for proof reading of the manuscript. Yung-Chi Cheng is a fellow of the National Foundation for Cancer Research. Hui-Chyn Wong is partially supported by the National Science Fellowship (NSF) awarded by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation. This work was supported by grants PO1 CA-154295 funded by National Cancer Institute of National Institute of Health of USA (YCC) and RO1 CA-17625-32 funded by National Institute of Health of USA (KHL). This study was also supported in part by the Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence (DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Choi JY, 2006, ARTHRITIS RHEUM, V54, P3277, DOI 10.1002/art.22119; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; RAINA V, 1980, BIOCHEM BIOPH RES CO, V94, P1074, DOI 10.1016/0006-291X(80)90528-8; Shiah HS, 2006, MOL CANCER THER, V5, P2484, DOI 10.1158/1535-7163.MCT-06-0146; Wang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011607; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; Yang XM, 2012, J MED CHEM, V55, P6751, DOI 10.1021/jm3001218; Yang XM, 2011, J MED CHEM, V54, P5097, DOI 10.1021/jm200330s; Yang XM, 2010, ORG LETT, V12, P1416, DOI 10.1021/ol902819j; You X, 2006, ARTHRITIS RHEUM-US, V54, P877, DOI 10.1002/art.21640	17	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51138	10.1371/journal.pone.0051138	http://dx.doi.org/10.1371/journal.pone.0051138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251437	gold, Green Submitted, Green Published			2022-12-25	WOS:000312201900046
J	Wang, JQ; Chen, Q; Wang, XH; Wang, QC; Wang, Y; Cheng, HP; Guo, CX; Sun, QM; Chen, Q; Tang, TS				Wang, Jiu-Qiang; Chen, Qian; Wang, Xianhua; Wang, Qiao-Chu; Wang, Yun; Cheng, He-Ping; Guo, Caixia; Sun, Qinmiao; Chen, Quan; Tang, Tie-Shan			Dysregulation of Mitochondrial Calcium Signaling and Superoxide Flashes Cause Mitochondrial Genomic DNA Damage in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED EXCITOTOXICITY; TRANSGENIC MOUSE MODEL; D-ASPARTATE RECEPTORS; MUTANT HUNTINGTIN; OXIDATIVE-STRESS; 2-AMINOETHOXYDIPHENYL BORATE; NEURODEGENERATIVE DISEASES; PERMEABILITY TRANSITION; SINGLE MITOCHONDRIA; PARKINSONS-DISEASE	Huntington disease (HD) is an inherited, fatal neurodegenerative disorder characterized by the progressive loss of striatal medium spiny neurons. Indications of oxidative stress are apparent in brain tissues from both HD patients and HD mouse models; however, the origin of this oxidant stress remains a mystery. Here, we used a yeast artificial chromosome transgenic mouse model of HD (YAC128) to investigate the potential connections between dysregulation of cytosolic Ca2+ signaling and mitochondrial oxidative damage in HD cells. We found that YAC128 mouse embryonic fibroblasts exhibit a strikingly higher level of mitochondrial matrix Ca2+ loading and elevated superoxide generation compared with WT cells, indicating that both mitochondrial Ca2+ signaling and superoxide generation are dysregulated in HD cells. The excessive mitochondrial oxidant stress is critically dependent on mitochondrial Ca2+ loading in HD cells, because blocking mitochondrial Ca2+ uptake abolished elevated superoxide generation. Similar results were obtained using neurons from HD model mice and fibroblast cells from HD patients. More importantly, mitochondrial Ca2+ loading in HD cells caused a 2-fold higher level of mitochondrial genomic DNA (mtDNA) damage due to the excessive oxidant generation. This study provides strong evidence to support a new causal link between dysregulated mitochondrial Ca2+ signaling, elevated mitochondrial oxidant stress, and mtDNA damage in HD. Our results also indicate that reducing mitochondrial Ca2+ uptake could be a therapeutic strategy for HD.	[Wang, Jiu-Qiang; Chen, Qian; Wang, Qiao-Chu; Wang, Yun; Sun, Qinmiao; Chen, Quan; Tang, Tie-Shan] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Wang, Xianhua; Cheng, He-Ping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Beijing 100871, Peoples R China; [Guo, Caixia] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individual Med, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Tang, TS (corresponding author), State Key Lab Biomembrane & Membrane Biotechnol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	tangtsh@ioz.ac.cn	Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011	Heping, Cheng/0000-0002-9604-6702; 	National Basic Research Program of China [2011CB965003, 2012CB944702, 2011CB809102, NSFC30970931, NSFC31130067]; Chinese Academy of Sciences [KSCX2-YW-R-148]; One-Hundred-Talent Program	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); One-Hundred-Talent Program(Chinese Academy of Sciences)	This work was supported National Basic Research Program of China Grants 2011CB965003, 2012CB944702, 2011CB809102, NSFC30970931, and NSFC31130067 and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-YW-R-148, and by the One-Hundred-Talent Program (to C. G. and Q. S.).	Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004; ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHOE CU, 2006, SCI STKE, pRE15; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fernandes HB, 2007, J NEUROSCI, V27, P13614, DOI 10.1523/JNEUROSCI.3455-07.2007; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Isakson BE, 2008, J CELL SCI, V121, P3664, DOI 10.1242/jcs.037481; Jones L, 2011, BBA-BIOMEMBRANES, V1808, P745, DOI 10.1016/j.bbamem.2010.12.013; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wu J, 2011, CHEM BIOL, V18, P777, DOI 10.1016/j.chembiol.2011.04.012; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhang H, 2008, NEUROBIOL DIS, V31, P80, DOI 10.1016/j.nbd.2008.03.010	81	64	66	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3070	3084		10.1074/jbc.M112.407726	http://dx.doi.org/10.1074/jbc.M112.407726			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250749	hybrid, Green Published			2022-12-25	WOS:000314397900017
J	Basak, S; Jiang, RR				Basak, Souvik; Jiang, Rongrong			Enhancing E-coli Tolerance towards Oxidative Stress via Engineering Its Global Regulator cAMP Receptor Protein (CRP)	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; HYDROGEN-PEROXIDE; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; NADH OXIDASE; SALMONELLA-TYPHIMURIUM; H-NS; MUTAGENESIS; GENE; PROTECTION	Oxidative damage to microbial hosts often occurs under stressful conditions during bioprocessing. Classical strain engineering approaches are usually both time-consuming and labor intensive. Here, we aim to improve E. coli performance under oxidative stress via engineering its global regulator cAMP receptor protein (CRP), which can directly or indirectly regulate redox-sensing regulators SoxR and OxyR, and other similar to 400 genes in E. coli. Error-prone PCR technique was employed to introduce modifications to CRP, and three mutants (OM1 similar to OM3) were identified with improved tolerance via H2O2 enrichment selection. The best mutant OM3 could grow in 12 mM H2O2 with the growth rate of 0.6 h(-1), whereas the growth of wild type was completely inhibited at this H2O2 concentration. OM3 also elicited enhanced thermotolerance at 48 degrees C as well as resistance against cumene hydroperoxide. The investigation about intracellular reactive oxygen species (ROS), which determines cell viability, indicated that the accumulation of ROS in OM3 was always lower than in WT with or without H2O2 treatment. Genome-wide DNA microarray analysis has shown not only CRP-regulated genes have demonstrated great transcriptional level changes (up to 8.9-fold), but also RpoS- and OxyR-regulated genes (up to 7.7-fold). qRT-PCR data and enzyme activity assay suggested that catalase (katE) could be a major antioxidant enzyme in OM3 instead of alkyl hydroperoxide reductase or superoxide dismutase. To our knowledge, this is the first work on improving E. coli oxidative stress resistance by reframing its transcription machinery through its native global regulator. The positive outcome of this approach may suggest that engineering CRP can be successfully implemented as an efficient strain engineering alternative for E. coli. Citation: Basak S, Jiang R (2012) Enhancing E. coli Tolerance towards Oxidative Stress via Engineering Its Global Regulator cAMP Receptor Protein (CRP). PLoS ONE 7(12): e51179. doi:10.1371/journal.pone.0051179	[Basak, Souvik; Jiang, Rongrong] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Jiang, RR (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.	rrjiang@ntu.edu.sg	Jiang, Rongrong/G-6217-2010	Basak, Souvik/0000-0003-0380-6264	National Research Foundation, Singapore [NRF-CRP5-2009-03]	National Research Foundation, Singapore(National Research Foundation, Singapore)	This work is supported by National Research Foundation (NRF-CRP5-2009-03), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna LG, 2009, ARCH MICROBIOL, V191, P473, DOI 10.1007/s00203-009-0473-z; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Asad NR, 1998, MUTAT RES-DNA REPAIR, V407, P253, DOI 10.1016/S0921-8777(98)00010-X; BAIRD L, 1990, J BACTERIOL, V172, P1587, DOI 10.1128/jb.172.3.1587-1594.1990; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Basak S, 2012, PROCESS BIOCHEM, V47, P2152, DOI 10.1016/j.procbio.2012.08.006; BECKERHAPAK M, 1995, FEMS MICROBIOL LETT, V134, P39, DOI 10.1111/j.1574-6968.1995.tb07911.x; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHAPON C, 1982, J BACTERIOL, V150, P722, DOI 10.1128/JB.150.2.722-729.1982; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Dalmau M, 2008, BIOTECHNOL BIOENG, V101, P654, DOI 10.1002/bit.21988; Dalmau M, 2009, BIOMACROMOLECULES, V10, P3199, DOI 10.1021/bm900674v; DELANEY JM, 1990, J GEN MICROBIOL, V136, P2113, DOI 10.1099/00221287-136-10-2113; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; Freitas SS, 2007, MOL BIOTECHNOL, V36, P151, DOI 10.1007/s12033-007-0028-y; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Gao CJ, 2010, APPL MICROBIOL BIOT, V87, P1821, DOI 10.1007/s00253-010-2648-6; Gerard F, 1999, MICROBIOL-UK, V145, P1547, DOI 10.1099/13500872-145-7-1547; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; GonzalezFlecha B, 1997, J BACTERIOL, V179, P6181, DOI 10.1128/jb.179.19.6181-6186.1997; GOTTESMAN S, 1984, ANNU REV GENET, V18, P415; GREENBERG JT, 1988, EMBO J, V7, P2611, DOI 10.1002/j.1460-2075.1988.tb03111.x; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Huang L, 2008, PROTEIN EXPRES PURIF, V61, P168, DOI 10.1016/j.pep.2008.05.016; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Jiang RR, 2005, ADV SYNTH CATAL, V347, P1139, DOI 10.1002/adsc.200505063; Jiang RR, 2004, TETRAHEDRON-ASYMMETR, V15, P2939, DOI 10.1016/j.tetasy.2004.07.057; Kim IS, 2009, MOL CELLS, V28, P479, DOI 10.1007/s10059-009-0168-y; Klein-Marcuschamer D, 2009, APPL ENVIRON MICROB, V75, P2705, DOI 10.1128/AEM.01888-08; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; Kumari S, 2009, MOL BIOTECHNOL, V42, P195, DOI 10.1007/s12033-009-9153-0; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Li M, 2005, PROTEIN EXPRES PURIF, V42, P85, DOI 10.1016/j.pep.2005.03.027; Lim S, 2004, FEMS MICROBIOL LETT, V238, P101, DOI 10.1111/j.1574-6968.2004.tb09743.x; Lim S, 2009, EXTREMOPHILES, V13, P191, DOI 10.1007/s00792-008-0209-z; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Macphee DG, 1999, J GENET, V78, P29, DOI 10.1007/BF02994700; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McArthur GH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/459760; MOORE J, 1992, J BACTERIOL, V174, P8030, DOI 10.1128/JB.174.24.8030-8035.1992; Mulder MA, 1999, MICROBIOL-UK, V145, P2011, DOI 10.1099/13500872-145-8-2011; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; O'Donnell A, 2007, BIOTECHNOL LETT, V29, P895, DOI 10.1007/s10529-007-9336-3; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Patil S, 2011, J APPL MICROBIOL, V111, P136, DOI 10.1111/j.1365-2672.2011.05021.x; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; PRIETOALAMO MJ, 1993, CARCINOGENESIS, V14, P237, DOI 10.1093/carcin/14.2.237; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Schroder I, 2004, J BACTERIOL, V186, P7680, DOI 10.1128/JB.186.22.7680-7689.2004; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Song H, 2006, ACS CHEM BIOL, V1, P681, DOI 10.1021/cb6004596; Song H, 2007, BIOPHYS J, V92, P3407, DOI 10.1529/biophysj.106.096891; Song H, 2011, BIOTECHNOL J, V6, P837, DOI 10.1002/biot.201100132; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Wang JQ, 2012, BIOTECHNOL BIOENG, V109, P3133, DOI 10.1002/bit.24574; Wang L, 2012, APPL MICROBIOL BIOT, V96, P1265, DOI 10.1007/s00253-012-3919-1; Wang L, 2012, APPL MICROBIOL BIOT, V94, P1233, DOI 10.1007/s00253-011-3699-z; Wang L, 2012, J MOL CATAL B-ENZYM, V76, P9, DOI 10.1016/j.molcatb.2011.11.016; Wang LA, 2011, J MOL CATAL B-ENZYM, V69, P120, DOI 10.1016/j.molcatb.2011.01.005; Wang LA, 2010, J BIOTECHNOL, V150, P57, DOI 10.1016/j.jbiotec.2010.07.005; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yu YY, 2011, CHEM COMMUN, V47, P12825, DOI 10.1039/c1cc15874k; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhang HF, 2012, APPL MICROBIOL BIOT, V94, P1107, DOI 10.1007/s00253-012-4012-5; Zhang HF, 2012, BIOTECHNOL BIOENG, V109, P1165, DOI 10.1002/bit.24411; Zhang HF, 2010, APPL MICROBIOL BIOT, V88, P117, DOI 10.1007/s00253-010-2735-8; Zhao Xinqing, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P1312; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhu Caiqing, 2003, Weishengwu Xuebao, V43, P460	89	40	47	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51179	10.1371/journal.pone.0051179	http://dx.doi.org/10.1371/journal.pone.0051179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251448	gold, Green Published			2022-12-25	WOS:000312386800029
J	Majumdar, S; Farris, CL; Kabat, BE; Jung, DO; Ellsworth, BS				Majumdar, Sreeparna; Farris, Corrie L.; Kabat, Brock E.; Jung, Deborah O.; Ellsworth, Buffy S.			Forkhead Box O1 Is Present in Quiescent Pituitary Cells during Development and Is Increased in the Absence of p27(Kip1)	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; BETA-GENE-EXPRESSION; LUTEINIZING-HORMONE; ANTERIOR-PITUITARY; GONADOTROPE DIFFERENTIATION; PERSISTENT EXPRESSION; CYCLE CONTROL; PROLIFERATION; GROWTH; HES1	Congenital pituitary hormone deficiencies have been reported in approximately one in 4,000 live births, however studies reporting mutations in some widely studied transcription factors account for only a fraction of congenital hormone deficiencies in humans. Anterior pituitary hormones are required for development and function of several glands including gonads, adrenals, and thyroid. In order to identify additional factors that contribute to human congenital hormone deficiencies, we are investigating the forkhead transcription factor, FOXO1, which has been implicated in development of several organs including ovary, testis, and brain. We find that FOXO1 is present in the nuclei of non-dividing pituitary cells during embryonic development, consistent with a role in limiting proliferation and/or promoting differentiation. FOXO1 is present in a subset of differentiated cells at e18.5 and in adult with highest level of expression in somatotrope cells. We detected FOXO1 in p27(Kip1) -positive cells at e14.5. In the absence of p27(Kip1) the number of pituitary cells containing FOXO1 is significantly increased at e14.5 suggesting that a feedback loop regulates the interplay between FOXO1 and p27(Kip1)	[Majumdar, Sreeparna; Farris, Corrie L.; Kabat, Brock E.; Jung, Deborah O.; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Jung, Deborah/0000-0002-8307-8772; Majumdar, Sreeparna/0000-0002-3564-3853	National Institute of Child Health and Human Development [R15HD063469]; Southern Illinois University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD063469] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Southern Illinois University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funding from a National Institute of Child Health and Human Development Grant R15HD063469 (B.S.E.) as well as a REACH Award (B.E.K.), startup funds (B.S.E.), an ORDA Faculty Seed Grant (B.S.E.), and a Central Research Committee Award (B.S..) from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Aujla PK, 2011, DEV BIOL, V353, P61, DOI 10.1016/j.ydbio.2011.02.018; Bilodeau S, 2009, MOL CELL BIOL; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Cushman LJ, 2001, MAMM GENOME, V12, P485, DOI 10.1007/s003350040002; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Davis SW, 2007, DEV BIOL, V305, P145, DOI 10.1016/j.ydbio.2007.02.001; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Drouin J, 2010, FRONT HORM RES, V38, P15, DOI 10.1159/000318490; Ericson J, 1998, DEVELOPMENT, V125, P1005; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Himes AD, 2009, DEV BIOL, V325, P151, DOI 10.1016/j.ydbio.2008.10.010; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kita A, 2007, MOL ENDOCRINOL, V21, P1458, DOI 10.1210/me.2007-0039; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mehta A, 2008, BEST PRACT RES CL EN, V22, P191, DOI 10.1016/j.beem.2007.07.007; Monahan P, 2012, MECH DEVELOP, V128, P640, DOI 10.1016/j.mod.2011.11.002; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Raetzman LT, 2006, MOL ENDOCRINOL, V20, P2898, DOI 10.1210/me.2005-0394; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Savage JJ, 2003, GENE, V319, P1, DOI 10.1016/S0378-1119(03)00804-7; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SOLDANI R, 1995, FERTIL STERIL, V64, P634, DOI 10.1016/S0015-0282(16)57804-2; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Tulipano G, 2012, ENDOCRINE; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vesper AH, 2006, ENDOCRINOLOGY, V147, P1654, DOI 10.1210/en.2005-1080; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52136	10.1371/journal.pone.0052136	http://dx.doi.org/10.1371/journal.pone.0052136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251696	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800147
J	Tran, BX; Ohinmaa, A; Mills, S; Duong, AT; Nguyen, LT; Jacobs, P; Houston, S				Bach Xuan Tran; Ohinmaa, Arto; Mills, Steve; Anh Thuy Duong; Long Thanh Nguyen; Jacobs, Philip; Houston, Stan			Multilevel Predictors of Concurrent Opioid Use during Methadone Maintenance Treatment among Drug Users with HIV/AIDS	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL ECOLOGICAL MODEL; COST-EFFECTIVENESS; SUBSTANCE USE; HIV TREATMENT; RETENTION; THERAPY; RISK; COHORT; MANAGEMENT	Background: Ongoing drug use during methadone maintenance treatment (MMT) negatively affects outcomes of HIV/AIDS care and treatment for drug users. This study assessed changes in opioid use, and longitudinal predictors of continued opioid use during MMT among HIV-positive drug users in Vietnam, with the aim of identifying changes that might enhance program efficacy. Methods: We analyze data of 370 HIV-positive drug users (mean age 29.5; 95.7% male) taking MMT at multi-sites. Opioid use was assessed at baseline, 3, 6, and 9 months using interviews and heroin confirmatory urine tests. A social ecological model was applied to explore multilevel predictors of continued opioid use, including individual, interpersonal, community and service influences. Generalized estimating equations (GEE) statistical models were constructed to adjust for intra-individual correlations. Results: Over 9 month follow-up, self-reported opioid use and positive heroin urine test substantially decreased to 14.6% and 14.4%. MMT helped improve referrals and access to health care and social services. However, utilization of social integration services was small. GEE models determined that participants who were older (Adjusted Odd Ratio -AOR = 0.97 for 1 year increase), had economic dependents (AOR = 0.33), or were referred to TB treatment (AOR = 0.53) were less likely to continue opioid use. Significant positive predictors of ongoing opioid use included frequency of opioid use prior to MMT, peer pressure, living with sexual partners, taking antiretroviral treatment, other health concerns and TB treatment. Conclusion: These findings show that MMT in the Vietnamese context can dramatically reduce opioid use, which is known to be associated with reduced antiretroviral (ART) adherence. Disease stage and drug interactions between antiretrovirals or TB drugs and MMT could explain some of the observed predictors of ongoing drug use; these findings could inform changes in MMT program design and implementation.	[Bach Xuan Tran; Ohinmaa, Arto; Houston, Stan] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Ohinmaa, Arto; Jacobs, Philip] Inst Hlth Econ, Edmonton, AB, Canada; [Mills, Steve] Family Hlth Int, Hanoi, Vietnam; [Anh Thuy Duong; Long Thanh Nguyen] Minist Hlth, Adm HIV AIDS Control, Hanoi, Vietnam; [Jacobs, Philip; Houston, Stan] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; Hanoi Medical University; University of Alberta	Tran, BX (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	bach@hmu.edu.vn	Duong, Anh/GPW-9558-2022					Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Tran BX, 2012, AIDS CARE, V24, P1187, DOI 10.1080/09540121.2012.658752; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Banta-Green CJ, 2009, ADDICTION, V104, P775, DOI 10.1111/j.1360-0443.2009.02538.x; Bao YP, 2009, AM J DRUG ALCOHOL AB, V35, P28, DOI 10.1080/00952990802342899; Bell J, 2009, ADDICTION, V104, P1193, DOI 10.1111/j.1360-0443.2009.02627.x; Bruce RD, 2006, JAIDS-J ACQ IMM DEF, V41, P563, DOI 10.1097/01.qai.0000219769.89679.ec; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; El-Bassel N, 2006, J URBAN HEALTH, V83, P602, DOI 10.1007/s11524-006-9075-0; Fareed A, 2009, J PSYCHIATR PRACT, V15, P227, DOI 10.1097/01.pra.0000351884.83377.e2; Havens JR, 2009, J SUBST ABUSE TREAT, V36, P306, DOI 10.1016/j.jsat.2008.07.002; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185; Lawrinson P, 2008, ADDICTION, V103, P1484, DOI 10.1111/j.1360-0443.2008.02249.x; Lin C, 2011, PUBLIC HEALTH, V125, P269, DOI 10.1016/j.puhe.2011.01.009; Liu EW, 2009, INT J DRUG POLICY, V20, P304, DOI 10.1016/j.drugpo.2008.09.004; Ministry of Health, 2012, ANN REP HIV AIDS 201; Naar-King S, 2006, J CONSULT CLIN PSYCH, V74, P785, DOI 10.1037/0022-006X.74.4.785; Nosyk B, 2010, J SUBST ABUSE TREAT, V39, P22, DOI 10.1016/j.jsat.2010.03.008; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Raffa JD, 2007, DRUG ALCOHOL DEPEN, V89, P306, DOI 10.1016/j.drugalcdep.2007.02.007; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Soyka M, 2008, INT J NEUROPSYCHOPH, V11, P641, DOI 10.1017/S146114570700836X; Tran BX, 2012, GLOBAL PUBLIC HLTH, P7; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; White B, 2007, AIDS CARE, V19, P441, DOI 10.1080/09540120701192837; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed	35	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51569	10.1371/journal.pone.0051569	http://dx.doi.org/10.1371/journal.pone.0051569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251580	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200137
J	Frisch, AJ; Cole, AJ; Hobbs, JPA; Rizzari, JR; Munkres, KP				Frisch, Ashley J.; Cole, Andrew J.; Hobbs, Jean-Paul A.; Rizzari, Justin R.; Munkres, Katherine P.			Effects of Spearfishing on Reef Fish Populations in a Multi-Use Conservation Area	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TAKE MARINE RESERVES; CORAL-REEFS; MANAGEMENT; FISHERIES; BIOMASS	Although spearfishing is a popular method of capturing fish, its ecological effects on fish populations are poorly understood, which makes it difficult to assess the legitimacy and desirability of spearfishing in multi-use marine reserves. Recent management changes within the Great Barrier Reef Marine Park (GBRMP) fortuitously created a unique scenario by which to quantify the effects of spearfishing on fish populations. As such, we employed underwater visual surveys and a before-after-control-impact experimental design to investigate the effects of spearfishing on the density and size structure of target and non-target fishes in a multi-use conservation park zone (CPZ) within the GBRMP. Three years after spearfishing was first allowed in the CPZ, there was a 54% reduction in density and a 27% reduction in mean size of coral trout (Plectropomus spp.), the primary target species. These changes were attributed to spearfishing because benthic habitat characteristics and the density of non-target fishes were stable through time, and the density and mean size of coral trout in a nearby control zone (where spearfishing was prohibited) remained unchanged. We conclude that spearfishing, like other forms of fishing, can have rapid and substantial negative effects on target fish populations. Careful management of spearfishing is therefore needed to ensure that conservation obligations are achieved and that fishery resources are harvested sustainably. This is particularly important both for the GBRMP, due to its extraordinarily high conservation value and world heritage status, and for tropical island nations where people depend on spearfishing for food and income. To minimize the effects of spearfishing on target species and to enhance protection of functionally important fishes (herbivores), we recommend that fishery managers adjust output controls such as size-and catch-limits, rather than prohibit spearfishing altogether. This will preserve the cultural and social importance of spearfishing in coastal communities where it is practised.	[Frisch, Ashley J.; Cole, Andrew J.; Rizzari, Justin R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cole, Andrew J.; Rizzari, Justin R.; Munkres, Katherine P.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia	James Cook University; James Cook University; University of Western Australia; University of Western Australia	Frisch, AJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ashley.frisch@jcu.edu.au	cole, andrew J/L-5764-2013; Hobbs, Jean-Paul/I-8743-2012; Cole, Andrew/G-5220-2011	Hobbs, Jean-Paul/0000-0003-0331-354X; 	Australian Research Council; Great Barrier Reef Marine Park Authority; Project AWARE; PADI Foundation	Australian Research Council(Australian Research Council); Great Barrier Reef Marine Park Authority; Project AWARE; PADI Foundation	Financial support was provided by the Australian Research Council, the Great Barrier Reef Marine Park Authority, Project AWARE, and the PADI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, FISHERIES MANAGEMENT; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Dalzell P., 1996, REEF FISHERIES, V20, P161, DOI [DOI 10.1007/978-94-015-8779-2, 10.1007/978-94-015-8779-2\_7.500]; Davis KLF, 2004, COAST MANAGE, V32, P373, DOI 10.1080/08920750490487223; Day J, 2008, GREAT BARRIER REEF B, P114; Eckersley Y, 1997, GEO AUSTRALASIA, V19, P18; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FERREIRA BP, 1994, FISH B-NOAA, V92, P46; FERREIRA BP, 1992, AUST J MAR FRESH RES, V43, P1301; Frisch AJ, 2008, CORAL REEFS, V27, P85, DOI 10.1007/s00338-007-0293-z; Gillett R., 2006, SPEARFISHING PACIFIC; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; GOEDEN GB, 1982, BIOL CONSERV, V22, P273, DOI 10.1016/0006-3207(82)90022-2; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings Simon, 1996, Fish and Fisheries Series, V20, P193; Mapstone BD, 1996, GREAT BARRIER REEF S, V2, P196; Meyer CG, 2007, FISH RES, V84, P301, DOI 10.1016/j.fishres.2006.11.004; Rousseau Y, 2010, CYBIUM, V34, P243; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Sadovy Yvonne J., 1996, Fish and Fisheries Series, V20, P15; Tobin A, 2010, 11 J COOK U FISH FIS; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	30	40	40	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51938	10.1371/journal.pone.0051938	http://dx.doi.org/10.1371/journal.pone.0051938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251656	Green Published, gold, Green Accepted			2022-12-25	WOS:000313236200171
J	Ukena, SN; Velaga, S; Goudeva, L; Ivanyi, P; Olek, S; Falk, CS; Ganser, A; Franzke, A				Ukena, Sya N.; Velaga, Sarvari; Goudeva, Lilia; Ivanyi, Philipp; Olek, Sven; Falk, Christine S.; Ganser, Arnold; Franzke, Anke			Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD; BONE-MARROW; SUPPRESSION; GENERATION; EXPANSION; EXPRESSION; RECEPTOR; IMPACT; FOXP3	Recent clinical studies demonstrate the high potency of regulatory T cells (Tregs) to control graft-versus-host disease in hematopoietic stem cell transplantation (SCT). However, the adoptive transfer of Tregs is limited by their low frequency in unstimulated donors and considerable concerns that G-CSF induced SC mobilization might have negative effects on the stability and function of Tregs. The isolation of Tregs from the G-CSF mobilized SC grafts would extend this novel strategy for tolerance induction to the unrelated setting and simplify global clinical application. We characterized CD4(+)CD25(high)CD127(-) Tregs from SC donors before and after G-CSF mobilization for their phenotype, function, and stability. After G-CSF application the Treg cell yield increased significantly. Donor Tregs retained their cytokine profile, phenotypic characteristics and in vitro expansion capacity after SC mobilization. Most importantly, in vivo G-CSF stimulated Tregs remained highly suppressive on the proliferation of effector T cells, also after in vitro expansion, and displayed a stable phenotype in epigenetic studies. The surface expression of CXCR3 is transiently reduced. However, donor-derived Tregs maintain their migratory properties after G-CSF stimulation. Therefore, the adoptive transfer of Tregs from G-CSF mobilized SC donors seems to be a feasible and safe strategy for clinical application in allogeneic SCT.	[Ukena, Sya N.; Velaga, Sarvari; Ivanyi, Philipp; Ganser, Arnold; Franzke, Anke] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Goudeva, Lilia] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplant Immunol, IFB Tx, Hannover, Germany; [Olek, Sven] Epiontis GmbH, Berlin, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Epiontis GmbH	Franzke, A (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	franzke.anke@mh-hannover.de	Ivanyi, Philipp/ABE-8130-2020; Falk, Christine/Q-4143-2016; Franzke, Anke/AAE-7883-2021; Ivanyi, Philipp/G-5983-2019	Ivanyi, Philipp/0000-0002-2862-7302; Falk, Christine/0000-0003-1376-7318; Ivanyi, Philipp/0000-0002-2862-7302	German Federal Ministry of Education and Research [01EO0802]; Helmholz Alliance for Immunotherapy;  [SFB738]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholz Alliance for Immunotherapy; 	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802) and by the SFB738 (CF) and the Helmholz Alliance for Immunotherapy (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Franzke A, 2003, BLOOD, V102, P734, DOI 10.1182/blood-2002-04-1200; Franzke A, 2006, CYTOKINE GROWTH F R, V17, P235, DOI 10.1016/j.cytogfr.2006.05.002; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Kean LS, 2011, BLOOD, V118, P6580, DOI 10.1182/blood-2011-06-359331; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Klangsinsirikul P, 2002, EXP HEMATOL, V30, P495, DOI 10.1016/S0301-472X(02)00785-3; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Mielcarek M, 1997, BLOOD, V89, P1629, DOI 10.1182/blood.V89.5.1629; Mielcarek M, 1998, BLOOD, V92, P215, DOI 10.1182/blood.V92.1.215.413k10_215_222; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; PAN LY, 1995, BLOOD, V86, P4422, DOI 10.1182/blood.V86.12.4422.bloodjournal86124422; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rutella S, 2004, EUR J IMMUNOL, V34, P1291, DOI 10.1002/eji.200324651; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Ukena SN, 2011, BLOOD, V118, pE82, DOI 10.1182/blood-2011-05-352708; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zeng D, 1997, J ALLERGY CLIN IMMUN, V99, P1900; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51644	10.1371/journal.pone.0051644	http://dx.doi.org/10.1371/journal.pone.0051644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251603	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200153
J	Farhat, YM; Al-Maliki, AA; Chen, T; Juneja, SC; Schwarz, EM; O'Keefe, RJ; Awad, HA				Farhat, Youssef M.; Al-Maliki, Alaa A.; Chen, Tony; Juneja, Subhash C.; Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.			Gene Expression Analysis of the Pleiotropic Effects of TGF-beta 1 in an In Vitro Model of Flexor Tendon Healing	PLOS ONE			English	Article							BETA SIGNAL-TRANSDUCTION; TGF-BETA; FIBROBLAST CONTRACTION; NEUTRALIZING ANTIBODY; ADHESION FORMATION; STEM-CELLS; COLLAGEN; SCLERAXIS; REPAIR; TENDINOPATHY	Flexor tendon injuries are among the most challenging problems for hand surgeons and tissue engineers alike. Not only do flexor tendon injuries heal with poor mechanical strength, they can also form debilitating adhesions that may permanently impair hand function. While TGF-beta 1 is a necessary factor for regaining tendon strength, it is associated with scar and adhesion formation in the flexor tendons and other tissues as well as fibrotic diseases. The pleiotropic effects of TGF-beta 1 on tendon cells and tissue have not been characterized in detail. The goal of the present study was to identify the targets through which the effects of TGF-beta 1 on tendon healing could be altered. To accomplish this, we treated flexor tendon tenocytes cultured in pinned collagen gels with 1, 10 or 100 ng/mL of TGF-beta 1 and measured gel contraction and gene expression using RT-PCR up to 48 hours after treatment. Specifically, we studied the effects of TGF-beta 1 on the expression of collagens, fibronectin, proteoglycans, MMPs, MMP inhibitors, and the neotendon transcription factors, Scleraxis and Mohawk. Area contraction of the gels was not dose-dependent with the TGF-beta 1 concentrations tested. We observed dose-dependent downregulation of MMP-16 (MT3-MMP) and decorin, and upregulation of biglycan, collagen V, collagen XII, PAI-1, Scleraxis, and Mohawk by TGF-beta 1. Inter-gene analyses were also performed to further characterize the expression of ECM and MMP genes in the tenocyte-seeded collagen gels. These analyses illustrate that TGF-beta 1 tilts the balance of gene expression in favor of ECM synthesis rather than the matrix-remodeling MMPs, a possible means by which TGF-beta 1 promotes adhesion formation.	[Farhat, Youssef M.; Chen, Tony; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Farhat, Youssef M.; Al-Maliki, Alaa A.; Chen, Tony; Juneja, Subhash C.; Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Awad, HA (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	hani_awad@urmc.rochester.edu	Mostafa, Taymour/H-6834-2019; Awad, Hani A/G-6976-2014	Mostafa, Taymour/0000-0003-3627-0662; Awad, Hani A/0000-0003-2197-2610; Juneja, Subhash/0000-0002-8536-5724	National Institutes of Health [T32 GM07356]; National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health [R01AR056696]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053459, R01AR056696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Youssef Farhat is a trainee in the Medical Scientist Training Program funded by National Institutes of Health T32 GM07356. The study was supported by Grant Number R01AR056696 from National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, MATRIX BIOL, V21, P243, DOI 10.1016/S0945-053X(02)00005-7; Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Bal S, 2011, AM J PHYS MED REHAB, V90, P17, DOI 10.1097/PHM.0b013e3181fc7a46; Campbell BH, 2004, BIOMECH MODEL MECHAN, V2, P239, DOI [10.1007/s10237-004-0041-z, 10.1007/S10237-004-0041-Z]; Caulfield RH, 2008, J HAND SURG-EUR VOL, V33E, P412, DOI 10.1177/1753193408090758; Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x; Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025; Cordeiro MF, 2000, INVEST OPHTH VIS SCI, V41, P756; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fu SC, 2008, J ORTHOP RES, V26, P374, DOI 10.1002/jor.20483; GELBERMAN RH, 1986, J ORTHOPAED RES, V4, P119, DOI 10.1002/jor.1100040116; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Ingraham JM, 2003, PLAST RECONSTR SURG, V112, P844, DOI 10.1097/01.PRS.0000070180.62037.FC; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; John J, 2010, ANN BIOMED ENG, V38, P658, DOI 10.1007/s10439-009-9856-1; Jorgensen HG, 2005, CYTOKINE, V30, P195, DOI 10.1016/j.cyto.2004.12.017; Jung JC, 2009, CELL TISSUE RES, V336, P79, DOI 10.1007/s00441-009-0755-4; Katzel EB, 2011, J ORTHOP RES, V29, P684, DOI 10.1002/jor.21235; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; Leask A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1976; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Margulis A, 2009, AM J PHYSIOL-LUNG C, V296, pL236, DOI 10.1152/ajplung.90462.2008; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1016/S0363-5023(03)00366-6; Parkinson J, 2011, J MUSCULOSKEL NEURON, V11, P86; PERCIVAL NJ, 1989, J HAND SURG-BRIT EUR, V14B, P412, DOI 10.1016/0266-7681(89)90157-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; [Statistics BoL Labor USDo], 2010, NONF OCC INJ ILLN RE; Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; WILLIAMS IF, 1984, CONNECT TISSUE RES, V12, P211, DOI 10.3109/03008208409013684; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10	60	58	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51411	10.1371/journal.pone.0051411	http://dx.doi.org/10.1371/journal.pone.0051411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251524	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900081
J	Gui, YX; Xu, ZP; Lv, W; Liu, HM; Zhao, JJ; Hu, XY				Gui, Ya-xing; Xu, Zhong-ping; Lv, Wen; Liu, Hong-mei; Zhao, Jin-Jia; Hu, Xing-Yue			Association of Mitochondrial DNA Polymerase gamma Gene POLG1 Polymorphisms with Parkinsonism in Chinese Populations	PLOS ONE			English	Article							IN-VITRO; DISEASE; MUTATION; VARIANTS; TRANSCRIPTION; FAMILY; TRACT; CELLS	Background: Mitochondrial DNA polymerase gamma (POLG1) mutations were associated with levodopa-responsive Parkinsonism. POLG1 gene contains a number of common nonsynonymous SNPs and intronic regulatory SNPs which may have functional consequences. It is of great interest to discover polymorphisms variants associated with Parkinson's disease (PD), both in isolation and in combination with specific SNPs. Materials and Methods: We conducted a case-control study and genotyped twenty SNPs and poly-Q polymorphisms of POLG1 gene including in 344 Chinese sporadic PD patients and 154 healthy controls. All the polymorphisms of POLG1 we found in this study were sequenced by PCR products with dye terminator methods using an ABI-3100 sequencer. Hardy-Weinberg equilibrium and linkage disequilibrium (LD) for association between twenty POLG1 SNPs and PD were calculated using the program Haploview. Principal Results: We provided evidence for strong association of four intronic SNPs of the POLG1 gene (new report: c. 2070-12T>A and rs2307439: c.2070-64G>A in intron 11, P = 0.00011, OR = 1.727; rs2302084: c. 3105-11T>C and rs2246900: c.3105-36A>G in intron 19, P = 0.00031, OR = 1.648) with PD. However, we did not identify any significant association between ten exonic SNPs of POLG1 and PD. Linkage disequilibrium analysis indicated that c.2070-12T>A and c.2070-64G>A could be parsed into one block as Haplotype 1 as well as c.3105-11T>C and c.3105-36A>G in Haplotype 2. In addition, case and control study on association of POLG1 CAG repeat (poly-Q) alleles with PD showed a significant association (P = 0.03, OR = 2.16) of the non-10/11Q variants with PD. Although intronic SNPs associated with PD didn't influence POLG1 mRNA alternative splicing, there was a strong association of c.2070-12T>A and c.2070-64G>A with decreased POLG1 mRNA level and protein levels. Conclusions: Our findings indicate that POLG1 may play a role in the pathogenesis of PD in Chinese populations.	[Gui, Ya-xing; Lv, Wen; Zhao, Jin-Jia; Hu, Xing-Yue] Zhejiang Univ, Dept Neurol, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hong-mei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Zhong-ping] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chicago	Hu, XY (corresponding author), Zhejiang Univ, Dept Neurol, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	Huxingyue2003@163.com		GUI, YAXING/0000-0002-0466-3608				Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bereznai B, 2009, IDEGGYOGY SZEMLE, V62, P155; Bruggenwirth HT, 1997, AM J HUM GENET, V61, P1067, DOI 10.1086/301605; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021; Fujimaru M, 1998, HUM GENET, V103, P462, DOI 10.1007/s004390050851; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Grzesiak JJ, 2005, ENDOCRINOLOGY, V146, P3567, DOI 10.1210/en.2005-0351; Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553; Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Montes M, 2012, GENE, V501, P104, DOI 10.1016/j.gene.2012.04.006; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Westerlund M, 2010, PROG NEUROBIOL, V90, P146, DOI 10.1016/j.pneurobio.2009.11.001; Yu CA, 2003, GENOMICS, V82, P575, DOI 10.1016/S0888-7543(03)00175-7	31	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50086	10.1371/journal.pone.0050086	http://dx.doi.org/10.1371/journal.pone.0050086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251356	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900005
J	Wake-Buck, AK; Gatenby, JC; Gore, JC				Wake-Buck, Amanda K.; Gatenby, J. Christopher; Gore, John C.			Hemodynamic Characteristics of the Vertebrobasilar System Analyzed Using MRI-Based Models	PLOS ONE			English	Article							WALL SHEAR-STRESS; HUMAN CAROTID BIFURCATION; PULSATILE FLOW; PHASE-CONTRAST; ENTRY FLOW; ARTERY; DYNAMICS; PATTERNS; STEADY; ATHEROSCLEROSIS	The vertebrobasilar system (VBS) is unique in human anatomy in that two arteries merge into a single vessel, and it is especially important because it supplies the posterior circulation of the brain. Atherosclerosis develops in this region, and atherosclerotic plaques in the vertebrobasilar confluence can progress with catastrophic consequences, including artery occlusion. Quantitative assessments of the flow characteristics in the VBS could elucidate the factors that influence flow patterns in this confluence, and deviations from normal patterns might then be used to predict locations to monitor for potential pathological changes, to detect early signs of disease, and to evaluate treatment options and efficacy. In this study, high-field MRI was used in conjunction with computational fluid dynamics (CFD) modeling to investigate the hemodynamics of subject-specific confluence models (n = 5) and to identify different geometrical classes of vertebrobasilar systems (n = 12) of healthy adult subjects. The curvature of the vessels and their mutual orientation significantly affected flow parameters in the VBS. The basilar artery geometry strongly influenced both skewing of the velocity profiles and the wall shear stress distributions in the VBS. All five subjects modeled possessed varying degrees of vertebral asymmetry, and helical flow was observed in four cases, suggesting that factors other than vertebral asymmetry influence mixing of the vertebral artery flow contributions. These preliminary studies verify that quantitative, MR imaging techniques in conjunction with subject-specific CFD models of healthy adult subjects may be used to characterize VBS hemodynamics and to predict flow features that have been related to the initiation and development of atherosclerosis in large arteries. This work represents an important first step towards applying this approach to study disease initiation and progression in the VBS.	[Wake-Buck, Amanda K.; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Gatenby, J. Christopher] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gore, John C.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	Vanderbilt University; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wake-Buck, AK (corresponding author), Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA.	amanda.buck@vanderbilt.edu	Buck, Amanda Kathleen Wake/GYK-0734-2022	Buck, Amanda/0000-0003-1042-6374	American Heart Association (AHA) [10POST3450046]; National Institutes of Health (NIH) NIH/NIBIB [5T32 EB001628-07]; NIH/NCRR [UL1 RR024975-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH) NIH/NIBIB; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	American Heart Association (AHA) 10POST3450046 (www.heart.org), National Institutes of Health (NIH) NIH/NIBIB 5T32 EB001628-07 (www.nih.gov), and NIH/NCRR UL1 RR024975-01 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2007, J MAGN RESON IMAGING, V25, P1120, DOI 10.1002/jmri.20928; BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5; BHARADVAJ BK, 1982, J BIOMECH, V15, P349, DOI 10.1016/0021-9290(82)90057-4; Boussel L, 2009, MAGN RESON MED, V61, P409, DOI 10.1002/mrm.21861; Caro C. G., 2012, MECH CIRCULATION, VSecond; CHONG BW, 1994, AM J NEURORADIOL, V15, P733; CRAWSHAW HM, 1980, ARCH SURG-CHICAGO, V115, P1280; Dammers R, 2002, ULTRASOUND MED BIOL, V28, P1015, DOI 10.1016/S0301-5629(02)00544-6; Dean WR, 1928, PHILOS MAG, V5, P673; Dean WR, 1927, PHILOS MAG, V4, P208; Dur O, 2011, CARDIOVASC ENG TECHN, V2, P35, DOI DOI 10.1007/S13239-010-0029-Z; Ford MD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900724; Ford MD, 2005, PHYSIOL MEAS, V26, P477, DOI 10.1088/0967-3334/26/4/013; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Hong JM, 2009, J NEUROL NEUROSUR PS, V80, P1087, DOI 10.1136/jnnp.2008.169805; Jozwik K, 2010, J BIOMECH, V43, P177, DOI 10.1016/j.jbiomech.2009.09.026; Kobayashi N, 2010, J NEUROSURG, V113, P810, DOI 10.3171/2010.1.JNS09575; Korn SDI, 2010, ISR MED ASSOC J, V12, P671; Kornet L, 2000, J VASC RES, V37, P112, DOI 10.1159/000025722; KRIJGER JKB, 1992, J BIOMECH, V25, P1451, DOI 10.1016/0021-9290(92)90058-9; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; MASARYK TJ, 1990, MAGNET RESON MED, V14, P308, DOI 10.1002/mrm.1910140215; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; NAYLER GL, 1986, J COMPUT ASSIST TOMO, V10, P715, DOI 10.1097/00004728-198609000-00001; OJHA M, 1990, J VASC SURG, V12, P747, DOI 10.1067/mva.1990.24365; Oshinski JN, 2006, J CARDIOVASC MAGN R, V8, P717, DOI 10.1080/10976640600723839; Pekkan K, 2008, MED BIOL ENG COMPUT, V46, P1139, DOI 10.1007/s11517-008-0377-0; PELC N J, 1991, Magnetic Resonance Quarterly, V7, P229; Ravensbergen J, 1996, J BIOMECH, V29, P281, DOI 10.1016/0021-9290(95)00064-X; Ravensbergen J, 1997, J BIOMECH ENG-T ASME, V119, P195, DOI 10.1115/1.2796080; Ravensbergen J, 1998, ARTERIOSCL THROM VAS, V18, P708, DOI 10.1161/01.ATV.18.5.708; Rayz VL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2970056; RUGGIERI PM, 1989, RADIOLOGY, V171, P785, DOI 10.1148/radiology.171.3.2717753; Samijo SK, 1997, ULTRASOUND MED BIOL, V23, P583, DOI 10.1016/S0301-5629(97)00044-6; Schonewille WJ, 2005, J NEUROL NEUROSUR PS, V76, P1238, DOI 10.1136/jnnp.2004.049924; SINGH MP, 1974, J FLUID MECH, V65, P517, DOI 10.1017/S0022112074001522; SMITH AS, 1995, AM J NEURORADIOL, V16, P1587; Steinman DA, 2002, ANN BIOMED ENG, V30, P483, DOI 10.1114/1.1467679; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Tang DL, 2004, J BIOMECH ENG-T ASME, V126, P363, DOI 10.1115/1.1762898; Tropea Bradford I., 1997, P107; YAO LS, 1975, J FLUID MECH, V67, P177, DOI 10.1017/S0022112075000237; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	44	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51346	10.1371/journal.pone.0051346	http://dx.doi.org/10.1371/journal.pone.0051346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251503	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900071
J	Li, L; Nelson, CJ; Carrie, C; Gawryluk, RMR; Solheim, C; Gray, MW; Whelan, J; Millar, AH				Li, Lei; Nelson, Clark J.; Carrie, Chris; Gawryluk, Ryan M. R.; Solheim, Cory; Gray, Michael W.; Whelan, James; Millar, A. Harvey			Subcomplexes of Ancestral Respiratory Complex I Subunits Rapidly Turn Over in Vivo as Productive Assembly Intermediates in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; MITOCHONDRIAL PROTEOME; MEMBRANE ARM; COMPONENTS; CHAIN; CHAPERONES; PROTEINS; INSIGHTS; OXIDASE; MODULES	Subcomplexes of mitochondrial respiratory complex I (CI; EC 1.6.5.3) are shown to turn over in vivo, and we propose a role in an ancestral assembly pathway. By progressively labeling Arabidopsis cell cultures with N-15 and isolating mitochondria, we have identified CI subcomplexes through differences in N-15 incorporation into their protein subunits. The 200-kDa subcomplex, containing the ancestral gamma-carbonic anhydrase (gamma-CA), gamma-carbonic anhydrase-like, and 20.9-kDa subunits, had a significantly higher turnover rate than intact CI or CI + CIII2. In vitro import of precursors for these CI subunits demonstrated rapid generation of subcomplexes and revealed that their specific abundance varied when different ancestral subunits were imported. Time course studies of precursor import showed the further assembly of these subcomplexes into CI and CI + CIII2, indicating that the subcomplexes are productive intermediates of assembly. The strong transient incorporation of new subunits into the 200-kDa subcomplex in a gamma-CA mutant is consistent with this subcomplex being a key initiator of CI assembly in plants. This evidence alongside the pattern of coincident occurrence of genes encoding these particular proteins broadly in eukaryotes, except for opisthokonts, provides a framework for the evolutionary conservation of these accessory subunits and evidence of their function in ancestral CI assembly.	[Li, Lei; Nelson, Clark J.; Carrie, Chris; Solheim, Cory; Millar, A. Harvey] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Li, Lei; Nelson, Clark J.; Solheim, Cory; Whelan, James; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia; [Gawryluk, Ryan M. R.; Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada	University of Western Australia; University of Western Australia; Dalhousie University	Millar, AH (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, M316,35 Stirling Highway, Crawley, WA 6009, Australia.	harvey.millar@uwa.edu.au	Carrie, Chris/A-2638-2010; Li, Lei/A-1631-2012; Whelan, James/F-6402-2011; Millar, A. Harvey/A-5452-2008	Carrie, Chris/0000-0002-4240-4674; Li, Lei/0000-0003-1508-5484; Whelan, James/0000-0001-5754-025X; Millar, A. Harvey/0000-0001-9679-1473; Gawryluk, Ryan/0000-0003-1251-882X; Gray, Michael/0000-0001-7125-2625; Nelson, Clark/0000-0002-8796-8326	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant [CE0561495]; Scholarship International Research Fees, a University International Stipend (UIS); Top Up Scholarship; ARC [FT110100242]	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant(Australian Research Council); Scholarship International Research Fees, a University International Stipend (UIS); Top Up Scholarship; ARC(Australian Research Council)	This work was supported by Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant CE0561495 (to A. H. M. and J. W.).; Supported by Scholarship International Research Fees, a University International Stipend (UIS), and a Top Up Scholarship for UIS.; An ARC Australian Future Fellow (Grant FT110100242). To whom correspondence should be addressed. Tel.: 61-8-6488-7245; Fax: 61-8-64884401; E-mail: harvey.millar@uwa.edu.au.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Brown MW, 2012, CURR BIOL, V22, P1123, DOI 10.1016/j.cub.2012.04.021; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P1390, DOI 10.1016/j.bbabio.2011.06.015; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Czarna M, 2010, PROTEOMICS, V10, P6, DOI 10.1002/pmic.200900352; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Klodmann J, 2011, PROTEOMICS, V11, P1834, DOI 10.1002/pmic.201000638; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Perales M, 2004, PLANT MOL BIOL, V56, P947, DOI 10.1007/s11103-004-6324-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHULTE U, 1994, BBA-BIOENERGETICS, V1187, P121, DOI 10.1016/0005-2728(94)90096-5; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Videira A, 2001, J BIOENERG BIOMEMBR, V33, P197, DOI 10.1023/A:1010778802236; Villarreal F, 2009, PLANT MOL BIOL, V70, P471, DOI 10.1007/s11103-009-9484-z; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; Wang Q, 2012, PLANT PHYSIOL, V160, P1373, DOI 10.1104/pp.112.204339; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zabaleta E, 2012, PLANT SCI, V187, P97, DOI 10.1016/j.plantsci.2012.02.001	51	39	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5707	5717		10.1074/jbc.M112.432070	http://dx.doi.org/10.1074/jbc.M112.432070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271729	Green Published, hybrid			2022-12-25	WOS:000315342500043
J	Amritraj, A; Wang, YL; Revett, TJ; Vergote, D; Westaway, D; Kar, S				Amritraj, Asha; Wang, Yanlin; Revett, Timothy J.; Vergote, David; Westaway, David; Kar, Satyabrata			Role of Cathepsin D in U18666A-induced Neuronal Cell Death POTENTIAL IMPLICATION IN NIEMANN-PICK TYPE C DISEASE PATHOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; CHOLESTEROL TRANSPORT; PRECURSOR PROTEIN; OXIDATIVE STRESS; LYSOSOMAL CHOLESTEROL; ALZHEIMERS-DISEASE; CHRONIC EXPOSURE; AUTOPHAGY; NEURODEGENERATION; CASPASE	Cathepsin D is an aspartyl protease that plays a crucial role in normal cellular functions and in a variety of neurodegenerative disorders, including Niemann-Pick type C (NPC) disease, which is characterized by intracellular accumulation of cholesterol and glycosphingolipids in many tissues, including the brain. There is evidence that the level and activity of cathepsin D increased markedly in vulnerable neurons in NPC pathology, but its involvement in neurodegeneration remains unclear. In the present study, using mouse hippocampal cultured neurons, we evaluated the significance of cathepsin D in toxicity induced by U18666A, a class II amphiphile, which triggers cell death by impairing the trafficking of cholesterol, as observed in NPC pathology. Our results showed that U18666A-mediated toxicity is accompanied by an increase in cathepsin D mRNA and enzyme activity but a decrease in the total peptide content. The cytosolic level of cathepsin D, on the other hand, was increased along with cytochrome c and activated caspase-3 in U18666A-treated neurons. The cathepsin D inhibitor, pepstatin A, partially protected neurons against toxicity by attenuating these signaling mechanisms. Additionally, down-regulation of cathepsin D level prevented, whereas overexpression of the protease increased, vulnerability of cultured N2a cells to U18666A-induced toxicity. We also showed that extracellular cathepsin D from U18666A-treated neurons or application of exogenous enzyme can induce neurotoxicity by activating the autophagic pathway. These results suggest that increased release/activation of cathepsin D can trigger neurodegeneration and possibly development of NPC pathology. Thus, targeting cathepsin D level/activity may provide a new therapeutic opportunity for the treatment of NPC pathology.	[Amritraj, Asha; Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Psychiat, Edmonton, AB T6G 2M8, Canada; [Revett, Timothy J.; Vergote, David; Westaway, David; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Med Neurol, Edmonton, AB T6G 2M8, Canada	University of Alberta; University of Alberta	Kar, S (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Psychiat, Edmonton, AB T6G 2M8, Canada.	skar@ualberta.ca		Vergote, David/0000-0002-1298-3783	Canadian Institutes of Health Research [MOP-94375, MOP-97837]; Alberta Innovated Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovated Health Solutions	This work was supported by grants from the Canadian Institutes of Health Research (MOP-94375 and MOP-97837).; Recipient of a Tier-I Canada Research Chair and Scientist award from Alberta Innovated Health Solutions.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bi XN, 2005, AM J PATHOL, V167, P1081, DOI 10.1016/S0002-9440(10)61197-2; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Castino R, 2007, FREE RADICAL BIO MED, V42, P1305, DOI 10.1016/j.freeradbiomed.2006.12.030; Ceccariglia S, 2011, NEUROSCIENCE, V174, P160, DOI 10.1016/j.neuroscience.2010.11.024; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cheung NS, 2004, BIOCHEM BIOPH RES CO, V315, P408, DOI 10.1016/j.bbrc.2004.01.066; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; Davis W, 2008, CURR ALZHEIMER RES, V5, P448, DOI 10.2174/156720508785908900; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Figueiredo C, 2008, J NEUROCHEM, V107, P73, DOI 10.1111/j.1471-4159.2008.05577.x; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Gowran A, 2008, J NEUROCHEM, V105, P1513, DOI 10.1111/j.1471-4159.2008.05278.x; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; Hawkes C, 2006, AM J PATHOL, V169, P1140, DOI 10.2353/ajpath.2006.051208; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang ZL, 2006, J NEUROCHEM, V97, P280, DOI 10.1111/j.1471-4159.2006.03733.x; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; Iliev AI, 2003, FASEB J, V17, P412, DOI 10.1096/fj.03-0670fje; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kodam A, 2008, NEUROBIOL AGING, V29, P724, DOI 10.1016/j.neurobiolaging.2006.12.005; Koh CHV, 2006, J NEUROCHEM, V98, P1278, DOI 10.1111/j.1471-4159.2006.03958.x; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Krantic S, 2007, PROG NEUROBIOL, V81, P179, DOI 10.1016/j.pneurobio.2006.12.002; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2002, J LIPID RES, V43, P198; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; MATUS A, 1987, BIOCHEMISTRY-US, V26, P8083, DOI 10.1021/bi00399a010; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Peake KB, 2011, BBA-MOL BASIS DIS, V1812, P1121, DOI 10.1016/j.bbadis.2011.06.003; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Roberg K, 1998, AM J PATHOL, V152, P1151; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tang Y, 2010, CLIN EXP PHARMACOL P, V37, P132, DOI 10.1111/j.1440-1681.2009.05235.x; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tofighi R, 2011, NEUROTOX RES, V19, P183, DOI 10.1007/s12640-010-9159-1; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Umeda A, 2003, J LIPID RES, V44, P1821, DOI 10.1194/jlr.M300153-JLR200; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vene R, 2007, MOL CANCER THER, V6, P286, DOI 10.1158/1535-7163.MCT-06-0346; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006; WILLIAMS KR, 1986, J NEUROSCI RES, V15, P137, DOI 10.1002/jnr.490150203; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zampieri S, 2009, J CELL MOL MED, V13, P3786, DOI 10.1111/j.1582-4934.2008.00493.x; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027	101	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3136	3152		10.1074/jbc.M112.412460	http://dx.doi.org/10.1074/jbc.M112.412460			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250759	Green Published, hybrid			2022-12-25	WOS:000314397900022
J	Moen, RJ; Thomas, DD; Klein, JC				Moen, Rebecca J.; Thomas, David D.; Klein, Jennifer C.			Conformationally Trapping the Actin-binding Cleft of Myosin with a Bifunctional Spin Label	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MICROSECOND ROTATIONAL MOTIONS; ATP-INDUCED DISSOCIATION; TIME-RESOLVED EPR; STRUCTURAL DYNAMICS; FORCE-GENERATION; MUSCLE; HEADS; ACTOMYOSIN; SITE	We have trapped the catalytic domain of Dictyostelium (Dicty) myosin II in a weak actin-binding conformation by chemically crosslinking two engineered cysteines across the actin-binding cleft, using a bifunctional spin label (BSL). By connecting the lower and upper 50 kDa domains of myosin, the crosslink restricts the conformation of the actin-binding cleft. Crosslinking has no effect on the basal ATPase activity of isolated myosin, but it impairs rigor actin binding and actin-activation of myosin ATPase. EPR spectra of BSL provide insight into actomyosin structural dynamics. BSL is highly immobilized within the actin-binding cleft and is thus exquisitely sensitive to the global orientation and rotational motions of the myosin head. Conventional EPR shows that myosin heads bound to oriented actin filaments are highly disordered with respect to the actin filament axis, in contrast to the nearly crystalline order of myosin heads in rigor. This disorder is similar to that of weakly bound heads induced by ATP, but saturation transfer EPR shows that the disorder of crosslinked myosin is at least 100 times slower. Thus this cleft-crosslinked myosin is remarkably similar, in both actin affinity and rotational dynamics, to SH1-SH2 crosslinked BSL-myosin S1. We conclude that, whether myosin is trapped at the actin-myosin interface or in the force-generating region between the active site and lever arm, the structural state of myosin is intermediate between the weak-binding state preceding phosphate release and the strong-binding state that succeeds it. We propose that it represents the threshold of force generation.	[Moen, Rebecca J.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Klein, Jennifer C.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ddt@umn.edu; jklein@uwlax.edu		Thomas, David D./0000-0002-8822-2040	National Institutes of Health [AR32961, AG26160, AR057220, AG037303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032961, T32AR007612, R01AR032961, P30AR057220, R01AR063007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R01AG026160, F31AG037303, R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or in part, by National Institutes of Health Grants AR32961, AG26160, and AR057220 (to D. D. T.).; Supported by National Institutes of Health Fellowship Grant AG037303.	Agafonov RV, 2008, P NATL ACAD SCI USA, V105, P13397, DOI 10.1073/pnas.0801342105; Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BERGER CL, 1989, P NATL ACAD SCI USA, V86, P8753, DOI 10.1073/pnas.86.22.8753; BERGER CL, 1993, BIOCHEMISTRY-US, V32, P3812, DOI 10.1021/bi00065a038; BERGER CL, 1991, BIOCHEMISTRY-US, V30, P11036, DOI 10.1021/bi00110a005; BERGER CL, 1994, BIOPHYS J, V67, P250, DOI 10.1016/S0006-3495(94)80476-X; Bobkov AA, 2000, BIOPHYS J, V79, P460, DOI 10.1016/S0006-3495(00)76307-7; CHALOVICH JM, 1983, P NATL ACAD SCI-BIOL, V80, P4909, DOI 10.1073/pnas.80.16.4909; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; COOKE R, 1982, NATURE, V300, P776, DOI 10.1038/300776a0; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; FAJER PG, 1990, P NATL ACAD SCI USA, V87, P5538, DOI 10.1073/pnas.87.14.5538; FAJER PG, 1991, BIOPHYS J, V60, P642, DOI 10.1016/S0006-3495(91)82093-8; FAJER PG, 1990, J MAGN RESON, V88, P111, DOI 10.1016/0022-2364(90)90112-M; Fajer PG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285208; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GEEVES MA, 1986, BIOCHEMISTRY-US, V25, P8454, DOI 10.1021/bi00374a020; GOLDMAN SA, 1972, J PHYS CHEM-US, V76, P1858, DOI 10.1021/j100657a013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kirby TL, 2004, BIOCHEMISTRY-US, V43, P5842, DOI 10.1021/bi035749b; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Klein JC, 2011, BIOCHEMISTRY-US, V50, P10318, DOI 10.1021/bi201279u; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; LaConte LEW, 2003, BIOCHEMISTRY-US, V42, P9797, DOI 10.1021/bi034288r; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mello RN, 2012, BIOPHYS J, V102, P1088, DOI 10.1016/j.bpj.2011.11.4027; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Onishi H, 2006, P NATL ACAD SCI USA, V103, P6136, DOI 10.1073/pnas.0601595103; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 2001, BIOCHEMISTRY-US, V40, P13933, DOI 10.1021/bi010893n; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Rasband W.S., 1997, IMAGE J; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROOPNARINE O, 1995, BIOPHYS J, V68, P1461, DOI 10.1016/S0006-3495(95)80319-X; ROOPNARINE O, 1994, BIOPHYS J, V67, P1634, DOI 10.1016/S0006-3495(94)80636-8; Sasaki N, 2002, J MUSCLE RES CELL M, V23, P697, DOI 10.1023/A:1024415409406; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; Sasaki N, 2000, J BIOL CHEM, V275, P38705, DOI 10.1074/jbc.M001966200; SQUIER TC, 1986, BIOPHYS J, V49, P921, DOI 10.1016/S0006-3495(86)83720-1; STEIN RA, 1990, BIOCHEMISTRY-US, V29, P10023, DOI 10.1021/bi00495a003; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; SVENSSON EC, 1986, BIOPHYS J, V50, P999, DOI 10.1016/S0006-3495(86)83541-X; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Thomas DD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P226, DOI 10.1016/B978-0-12-374920-8.00415-X; Thomas DD, 2009, ANNU REV BIOPHYS, V38, P347, DOI 10.1146/annurev.biophys.35.040405.102118; THOMAS DD, 1976, J CHEM PHYS, V65, P3006, DOI 10.1063/1.433512; THOMAS DD, 1980, BIOPHYS J, V32, P891, DOI 10.1016/S0006-3495(80)85024-7; THOMAS DD, 1975, P NATL ACAD SCI USA, V72, P1729, DOI 10.1073/pnas.72.5.1729; THOMAS DD, 1995, BIOPHYS J, V68, pS135; THOMAS DD, 1980, BIOPHYS J, V32, P873, DOI 10.1016/S0006-3495(80)85023-5; Thompson A. R., 2009, THESIS U MINNESOTA M; Thompson AR, 2008, BIOPHYS J, V95, P5238, DOI 10.1529/biophysj.108.138982; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200	68	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3016	3024		10.1074/jbc.M112.428565	http://dx.doi.org/10.1074/jbc.M112.428565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250750	Green Published, hybrid			2022-12-25	WOS:000314397900012
J	Comuzzie, AG; Cole, SA; Laston, SL; Voruganti, VS; Haack, K; Gibbs, RA; Butte, NF				Comuzzie, Anthony G.; Cole, Shelley A.; Laston, Sandra L.; Voruganti, V. Saroja; Haack, Karin; Gibbs, Richard A.; Butte, Nancy F.			Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population	PLOS ONE			English	Article							VIVA LA FAMILIA; QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FASTING GLUCOSE-LEVELS; BODY-MASS INDEX; XERODERMA-PIGMENTOSUM; EUROPEAN POPULATIONS; PHYSICAL-ACTIVITY; ENERGY-BALANCE; CHILDREN	Genetic variants responsible for susceptibility to obesity and its comorbidities among Hispanic children have not been identified. The VIVA LA FAMILIA Study was designed to genetically map childhood obesity and associated biological processes in the Hispanic population. A genome-wide association study (GWAS) entailed genotyping 1.1 million single nucleotide polymorphisms (SNPs) using the Illumina Infinium technology in 815 children. Measured genotype analysis was performed between genetic markers and obesity-related traits i.e., anthropometry, body composition, growth, metabolites, hormones, inflammation, diet, energy expenditure, substrate utilization and physical activity. Identified genome-wide significant loci: 1) corroborated genes implicated in other studies (MTNR1B, ZNF259/APOA5, XPA/FOXE1 (TTF-2), DARC, CCR3, ABO); 2) localized novel genes in plausible biological pathways (PCSK2, ARHGAP11A, CHRNA3); and 3) revealed novel genes with unknown function in obesity pathogenesis (MATK, COL4A1). Salient findings include a nonsynonymous SNP (rs1056513) in INADL (p = 1.2E-07) for weight; an intronic variant in MTNR1B associated with fasting glucose (p = 3.7E-08); variants in the APOA5-ZNF259 region associated with triglycerides (p = 2.5-4.8E-08); an intronic variant in PCSK2 associated with total antioxidants (p = 7.6E-08); a block of 23 SNPs in XPA/FOXE1 (TTF-2) associated with serum TSH (p = 5.5E-08 to 1.0E-09); a nonsynonymous SNP (p = 1.3E-21), an intronic SNP (p = 3.6E-13) in DARC identified for MCP-1; an intronic variant in ARHGAP11A associated with sleep duration (p = 5.0E-08); and, after adjusting for body weight, variants in MATK for total energy expenditure (p = 2.7E-08) and in CHRNA3 for sleeping energy expenditure (p = 6.0E-08). Unprecedented phenotyping and high-density SNP genotyping enabled localization of novel genetic loci associated with the pathophysiology of childhood obesity.	[Butte, Nancy F.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Comuzzie, Anthony G.; Cole, Shelley A.; Laston, Sandra L.; Voruganti, V. Saroja; Haack, Karin] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas Biomedical Research Institute; Baylor College of Medicine	Butte, NF (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.	nbutte@bcm.edu			National Institutes of Health (NIH) [DK080457]; USDA/ARS [6250-51000-053]; National Center for Research Resources, NIH [C06 RR013556, C06 RR017515]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515, C06RR013556] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080457] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH) (DK080457), and the USDA/ARS (Cooperative Agreement 6250-51000-053). Work performed at the Texas Biomedical Research Institute in San Antonio, Texas was conducted in facilities constructed with support from the Research Facilities Improvement Program of the National Center for Research Resources, NIH (C06 RR013556, C06 RR017515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Bouatia-Naji N, 2009, M S-MED SCI, V25, P897, DOI 10.1051/medsci/20092511897; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Butte NF, 2007, MED SCI SPORT EXER, V39, P1257, DOI 10.1249/mss.0b013e3180621fb6; Butte NF, 2007, AM J CLIN NUTR, V85, P1478, DOI 10.1093/ajcn/85.6.1478; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Butte NF, 2005, PEDIATR RES, V58, P1243, DOI 10.1203/01.pdr.0000185272.46705.18; Cai G, 2008, INT J OBESITY, V32, P579, DOI 10.1038/ijo.2008.20; Cai G, 2007, J CLIN ENDOCR METAB, V92, P4893, DOI 10.1210/jc.2007-1695; Cai GW, 2006, OBESITY, V14, P1596, DOI 10.1038/oby.2006.184; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Cai GW, 2004, DIABETES, V53, P1369, DOI 10.2337/diabetes.53.5.1369; Cole SA, 2010, AM J CLIN NUTR, V91, P191, DOI 10.3945/ajcn.2009.28514; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Fisher JO, 2007, OBESITY, V15, P1484, DOI 10.1038/oby.2007.177; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hakonarson H, 2011, DIABETES-METAB RES, V27, P685, DOI 10.1002/dmrr.1221; Holzapfel C, 2011, EUR J ENDOCRINOL, V164, P205, DOI 10.1530/EJE-10-0588; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Kelly-Pieper K, 2011, MINERVA PEDIATR, V63, P473; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Muller MJ, 2010, OBES REV, V11, P612, DOI 10.1111/j.1467-789X.2010.00734.x; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reinehr T, 2011, PEDIATR DIABETES, V12, P435, DOI 10.1111/j.1399-5448.2010.00738.x; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Sobel E, 1996, AM J HUM GENET, V58, P1323; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; Torrado M, 2007, AM J MED GENET A, V143A, P460, DOI 10.1002/ajmg.a.31520; Voruganti VS, 2007, PEDIATR RES, V62, P445, DOI 10.1203/PDR.0b013e31813cbf02; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Zhao JH, 2011, J OBES, V2011, DOI 10.1155/2011/845148; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	63	252	256	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51954	10.1371/journal.pone.0051954	http://dx.doi.org/10.1371/journal.pone.0051954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251661	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800116
J	de Vries, SJ; Zacharias, M				de Vries, Sjoerd J.; Zacharias, Martin			ATTRACT-EM: A New Method for the Computational Assembly of Large Molecular Machines Using Cryo-EM Maps	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; GROEL-GROES COMPLEX; ATOMIC MODELS; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; ELECTRON; DENSITY; OPTIMIZATION; COMPONENTS; RIBOSOME	Many of the most important functions in the cell are carried out by proteins organized in large molecular machines. Cryoelectron microscopy (cryo-EM) is increasingly being used to obtain low resolution density maps of these large assemblies. A new method, ATTRACT-EM, for the computational assembly of molecular assemblies from their components has been developed. Based on concepts from the protein-protein docking field, it utilizes cryo-EM density maps to assemble molecular subunits at near atomic detail, starting from millions of initial subunit configurations. The search efficiency was further enhanced by recombining partial solutions, the inclusion of symmetry information, and refinement using a molecular force field. The approach was tested on the GroES-GroEL system, using an experimental cryo-EM map at 23.5 angstrom resolution, and on several smaller complexes. Inclusion of experimental information on the symmetry of the systems and the application of a new gradient vector matching algorithm allowed the efficient identification of docked assemblies in close agreement with experiment. Application to the GroES-GroEL complex resulted in a top ranked model with a deviation of 4.6 angstrom (and a 2.8 angstrom model within the top 10) from the GroES-GroEL crystal structure, a significant improvement over existing methods. Citation: de Vries SJ, Zacharias M (2012) ATTRACT-EM: A New Method for the Computational Assembly of Large Molecular Machines Using Cryo-EM Maps. PLoS ONE 7(12): e49733. doi:10.1371/journal.pone.0049733	[de Vries, Sjoerd J.; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, D-8046 Garching, Germany	Technical University of Munich	de Vries, SJ (corresponding author), Tech Univ Munich, Phys Dept T38, D-8046 Garching, Germany.	sjoerd@tum.de			Marie Curie Intra-European Fellowship programme; FP7 of the European Commission [No 273003]	Marie Curie Intra-European Fellowship programme; FP7 of the European Commission	The presented work was made possible by the Marie Curie Intra-European Fellowship programme, financed by the FP7 of the European Commission (http://cordis.europa.eu/fp7) (contract-No 273003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Beck M, 2011, J STRUCT BIOL, V173, P483, DOI 10.1016/j.jsb.2010.11.011; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Ceulemans H, 2004, J MOL BIOL, V338, P783, DOI 10.1016/j.jmb.2004.02.066; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fabiola F, 2005, STRUCTURE, V13, P389, DOI 10.1016/j.str.2005.01.007; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grubisic I, 2010, J STRUCT BIOL, V169, P95, DOI 10.1016/j.jsb.2009.09.010; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Henrick K, 2003, J STRUCT BIOL, V144, P228, DOI 10.1016/j.jsb.2003.09.009; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jolley CC, 2008, BIOPHYS J, V94, P1613, DOI 10.1529/biophysj.107.115949; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kanno R, 2009, STRUCTURE, V17, P287, DOI 10.1016/j.str.2008.12.012; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kawabata T, 2008, BIOPHYS J, V95, P4643, DOI 10.1529/biophysj.108.137125; Kovacs JA, 2003, ACTA CRYSTALLOGR D, V59, P1371, DOI 10.1107/S0907444903011247; Kovacs JA, 2008, BIOPHYS J, V95, P3192, DOI 10.1529/biophysj.108.132357; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Lasker K, 2009, J MOL BIOL, V388, P180, DOI 10.1016/j.jmb.2009.02.031; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; May A, 2005, BBA-PROTEINS PROTEOM, V1754, P225, DOI 10.1016/j.bbapap.2005.07.045; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Quammen C., 2007, CLARITY C OPEN SOURC; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Saha M, 2010, BIOINFORMATICS, V26, pi301, DOI 10.1093/bioinformatics/btq195; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X; Tagari M, 2002, TRENDS BIOCHEM SCI, V27, P589, DOI 10.1016/S0968-0004(02)02176-X; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Vasishtan D, 2011, J STRUCT BIOL, V174, P333, DOI 10.1016/j.jsb.2011.01.012; Velazquez-Muriel JA, 2007, J STRUCT BIOL, V158, P165, DOI 10.1016/j.jsb.2006.10.014; Velazquez-Muriel JA, 2006, STRUCTURE, V14, P1115, DOI 10.1016/j.str.2006.05.013; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303; Zhang SH, 2010, BIOINFORMATICS, V26, pi261, DOI 10.1093/bioinformatics/btq201	73	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49733	10.1371/journal.pone.0049733	http://dx.doi.org/10.1371/journal.pone.0049733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251350	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800009
J	Xu, J; Wen, ZR; Gong, ZJ; Zhang, M; Xie, P; Hansson, LA				Xu, Jun; Wen, Zhourui; Gong, Zhijun; Zhang, Min; Xie, Ping; Hansson, Lars-Anders			Seasonal Trophic Niche Shift and Cascading Effect of a Generalist Predator Fish	PLOS ONE			English	Article							STABLE-ISOTOPES; COMMUNITY STRUCTURE; ONTOGENIC NICHE; SHALLOW LAKES; BODY-SIZE; PREY; FOOD; POSITION; ZOOPLANKTON; ABUNDANCE	Few studies have examined how foraging niche shift of a predator over time cascade down to local prey communities. Here we examine patterns of temporal foraging niche shifts of a generalist predator (yellow catfish, Pelteobagrus fulvidraco) and the abundance of prey communities in a subtropical lake. We predicted that the nature of these interactions would have implications for patterns in diet shifts and growth of the predator. Our results show significant decreases in planktivory and benthivory from late spring to summer and autumn, whereas piscivory increased significantly from mid-summer until late autumn and also increased steadily with predator body length. The temporal dynamics in predator/prey ratios indicate that the predation pressure on zooplankton and zoobenthos decreased when the predation pressure on the prey fish and shrimps was high. Yellow catfish adjusted their foraging strategies to temporal changes in food availability, which is in agreement with optimal foraging theory. Meanwhile the decrease in planktivory and benthivory of yellow catfish enabled primary consumers, such as zooplankton and benthic invertebrates, to develop under low grazing pressure via trophic cascading effects in the local food web. Thus, yellow catfish shifts its foraging niche to intermediate consumers in the food web to benefit the energetic demand on growth and reproduction during summer, which in turn indirectly facilitate the primary consumers. In complex food webs, trophic interactions are usually expected to reduce the strength and penetrance of trophic cascades. However, our study demonstrates strong associations between foraging niche of piscivorous fish and abundance of prey. This relationship appeared to be an important factor in producing top-down effects on both benthic and planktonic food webs. Citation: Xu J, Wen Z, Gong Z, Zhang M, Xie P, et al. (2012) Seasonal Trophic Niche Shift and Cascading Effect of a Generalist Predator Fish. PLoS ONE 7(12): e49691. doi:10.1371/journal.pone.0049691	[Xu, Jun; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China; [Wen, Zhourui] Hubei Fishery Sci Inst, Wuhan, Hubei, Peoples R China; [Gong, Zhijun] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Min] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China; [Hansson, Lars-Anders] Lund Univ, Inst Biol Aquat Ecol, Lund, Sweden	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Huazhong Agricultural University; Lund University	Xu, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China.	xujun@ihb.ac.cn; xieping@ihb.ac.cn	Xie, Ping/AAL-7532-2020; Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317	National Natural Science Foundation of China [31170439]; National Basic Research Program of China [2008CB418001-1]; Ministry of Science and Technology of the People's Republic of China [2007BAC26B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This research was partially supported by the National Natural Science Foundation of China (Grant No. 31170439 to JX), the National Basic Research Program of China (2008CB418001-1), and the Ministry of Science and Technology of the People's Republic of China (Grant No. 2007BAC26B02). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adams R. A., 2000, ONTOGENY FUNCTIONAL; Akin S, 2008, ACTA OECOL, V33, P144, DOI 10.1016/j.actao.2007.08.002; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Cai YJ, 2011, ANN LIMNOL-INT J LIM, V47, P85, DOI 10.1051/limn/2010028; Carpenter S. R., 1996, TROPHIC CASCADE LAKE; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Eloranta AP, 2010, J FISH BIOL, V77, P80, DOI 10.1111/j.1095-8649.2010.02656.x; Ginter K, 2011, HYDROBIOLOGIA, V660, P79, DOI 10.1007/s10750-010-0393-6; Grey J, 2001, ECOL FRESHW FISH, V10, P168, DOI 10.1034/j.1600-0633.2001.100306.x; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Iglesias C, 2007, HYDROBIOLOGIA, V584, P179, DOI 10.1007/s10750-007-0599-4; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Kolasinski J, 2009, MAR ECOL PROG SER, V386, P181, DOI 10.3354/meps08081; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lopez-Bao JV, 2011, OIKOS, V120, P1489, DOI 10.1111/j.1600-0706.2011.19194.x; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tan B, 1997, WATER RESOURCE FISHE, V5, P1; TISELIUS P, 1993, B MAR SCI, V53, P247; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Xu J, 2008, HYDROBIOLOGIA, V605, P45, DOI 10.1007/s10750-008-9299-y; Xu J, 2007, ECOSCIENCE, V14, P170, DOI 10.2980/1195-6860(2007)14[170:SSIROB]2.0.CO;2; Xu J, 2011, LIMNOLOGY, V12, P107, DOI 10.1007/s10201-010-0327-z; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060; Zou S, 1999, J HUBEI AGR COLL, V19, P240	44	8	9	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49691	10.1371/journal.pone.0049691	http://dx.doi.org/10.1371/journal.pone.0049691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251347	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800006
J	Leger, PL; Bonnin, P; Nguyen, T; Renolleau, S; Baud, O; Charriaut-Marlangue, C				Leger, Pierre-Louis; Bonnin, Philippe; Thao Nguyen; Renolleau, Sylvain; Baud, Olivier; Charriaut-Marlangue, Christiane			Ischemic Postconditioning Fails to Protect against Neonatal Cerebral Stroke	PLOS ONE			English	Article							BLOOD-FLOW; ARTERY OCCLUSION; FOCAL ISCHEMIA; COLLATERAL CIRCULATION; CASPASE INHIBITOR; HYPOXIA-ISCHEMIA; BRAIN-DAMAGE; NITRIC-OXIDE; RATS; REPERFUSION	The lack of efficient neuroprotective strategies for neonatal stroke could be ascribed to pathogenic ischemic processes differentiating adults and neonates. We explored this hypothesis using a rat model of neonatal ischemia induced by permanent occlusion of the left distal middle cerebral artery combined with 50 min of occlusion of both common carotid arteries (CCA). Postconditioning was performed by repetitive brief release and occlusion (30 s, 1 and/or 5 min) of CCA after 50 min of CCA occlusion. Alternative reperfusion was generated by controlled release of the bilateral CCA occlusion. Blood-flow velocities in the left internal carotid artery were measured using color-coded pulsed Doppler ultrasound imaging. Cortical perfusion was measured using laser Doppler. Cerebrovascular vasoreactivity was evaluated after inhalation with the hypercapnic gas or inhaled nitric oxide (NO). Whatever the type of serial mechanical interruptions of blood flow at reperfusion, postconditioning did not reduce infarct volume after 72 hours. A gradual perfusion was found during early re-flow both in the left internal carotid artery and in the cortical penumbra. The absence of acute hyperemia during early CCA re-flow, and the lack of NO-dependent vasoreactivity in P7 rat brain could in part explain the inefficiency of ischemic postconditioning after ischemia-reperfusion.	[Leger, Pierre-Louis; Thao Nguyen; Baud, Olivier; Charriaut-Marlangue, Christiane] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U676, Paris, France; [Bonnin, Philippe] Univ Paris Diderot, Hop Lariboisiere, AP HP, Sorbonne Paris Cite,Physiol Clin, Paris, France; [Bonnin, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U965, Paris, France; [Leger, Pierre-Louis; Renolleau, Sylvain] UPMC Paris6, Hop Armand Trousseau, AP HP, Serv Reanimat Pediat, Paris, France; [Baud, Olivier] Univ Paris Diderot, Hop Robert Debre, AP HP, Sorbonne Paris Cite,Serv Reanimat Neonatale & Ped, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Charriaut-Marlangue, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U676, Paris, France.	christiane.marlangue@gmail.com	, CHARRIAUT-MARLANGUE/H-3249-2019; Bonnin, Philippe/Y-5872-2019	Bonnin, Philippe/0000-0003-3184-3740	Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The "Fondation pour la Recherche Medicale" supported PL Leger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bonnin P, 2012, EXP NEUROL, V236, P50, DOI 10.1016/j.expneurol.2012.04.001; Bonnin P, 2011, J NEUROSCI METH, V198, P103, DOI 10.1016/j.jneumeth.2011.02.030; BONVENTO G, 1994, J CEREBR BLOOD F MET, V14, P699, DOI 10.1038/jcbfm.1994.90; Charriaut-Marlangue C, 2012, STROKE; Chauvier D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.87; Choy M, 2006, J CEREBR BLOOD F MET, V26, P1066, DOI 10.1038/sj.jcbfm.9600259; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Fabian RH, 2008, AM J PHYSIOL-HEART C, V295, pH1809, DOI 10.1152/ajpheart.00301.2007; Fisher M, 2008, CURR OPIN DRUG DISC, V11, P626; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Golomb MR, 2008, J CHILD NEUROL, V23, P279, DOI 10.1177/0883073807309246; KIRSCH JR, 1990, AM J PHYSIOL, V259, pH1551; Liebeskind DS, 2009, NAT REV NEUROL, V5, P645, DOI 10.1038/nrneurol.2009.193; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Qiao M, 2004, MAGN RESON MATER PHY, V17, P117, DOI 10.1007/s10334-004-0058-4; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Renolleau S, 2008, NEUROSCIENTIST, V14, P46, DOI 10.1177/1073858407308889; Renolleau S, 2007, J NEUROCHEM, V100, P1062, DOI 10.1111/j.1471-4159.2006.04269.x; Sutherland BA, 2011, J PHYSIOL-LONDON, V589, P4105, DOI 10.1113/jphysiol.2011.209601; van Laar PJ, 2007, RADIOLOGY, V242, P526, DOI 10.1148/radiol.2422060179; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Willis AP, 2001, AM J PHYSIOL-HEART C, V281, pH2366, DOI 10.1152/ajpheart.2001.281.6.H2366; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49695	10.1371/journal.pone.0049695	http://dx.doi.org/10.1371/journal.pone.0049695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251348	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200019
J	Lin, WY; Pi-Sunyer, FX; Liu, CS; Li, CI; Davidson, LE; Li, TC; Lin, CC				Lin, Wen-Yuan; Pi-Sunyer, F. Xavier; Liu, Chiu-Shong; Li, Chia-Ing; Davidson, Lance E.; Li, Tsai-Chung; Lin, Cheng-Chieh			Central Obesity and Albuminuria: Both Cross-Sectional and Longitudinal Studies in Chinese	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; NONDIABETIC SUBJECTS; INSULIN-RESISTANCE; RENAL-DISEASE; MICROALBUMINURIA; IMPACT; HEALTH; ADIPONECTIN	Background: Albuminuria is recognized as a marker of vascular dysfunction. Central obesity increases the risk of cardiovascular disease. Little is known about the association between albuminuria and central obesity in Chinese. We aimed to assess the association between central obesity and prevalence and incidence of albuminuria in a middle-aged population-based cohort study. Methods: This is a cross-sectional and longitudinal cohort study. A total of 2350 subjects aged >= 40 years were recruited in 2004 in Taiwan for cross-sectional analysis. Longitudinal analysis included 1432 baseline normoalbuminuria subjects with a mean 2.8 years follow-up, 67 of whom exhibited incident albuminuria. Albuminuria was defined as urinary albumin-to-creatinine ratio >= 30 mg/g creatinine. Multiple logistic regression analyses were used to evaluate the relationship between central obesity and prevalence and incidence of albuminuria after adjustment for age, gender, body mass index, blood pressure, renal function, glucose, high sensitivity c-reactive protein, smoking, betel nut chewing, alcohol drinking, and physical activity. Results: At baseline, albuminuria is significantly associated with central obesity. The adjusted odds ratio of having albuminuria among subjects with central obesity was 1.73(95% confidence interval (CI): 1.04-2.85), compared to the subjects without central obesity. In multivariable models, participants with central obesity at baseline had a 112% increase in risk of incident albuminuria (adjusted incidence rate ratio (95% CI): 2.12(1.01-4.44)) compared with participants with non-central obesity. Conclusions: Abdominal adiposity was independently associated with increased prevalence and incidence of albuminuria in Chinese. The mechanisms linking adiposity and albuminuria need to be addressed.	[Lin, Wen-Yuan; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Wen-Yuan; Liu, Chiu-Shong; Li, Chia-Ing; Lin, Cheng-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung; Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan; [Pi-Sunyer, F. Xavier] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, New York Obes & Nutr Res Ctr, New York, NY 10032 USA; [Davidson, Lance E.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Utah System of Higher Education; University of Utah	Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015; Davidson, Lance E./AAA-9689-2019; Stefanadis, Christodoulos/ABH-2232-2020	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216; Davidson, Lance E./0000-0002-1383-0666; Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council of Taiwan [NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3]; China Medical University Hospital [DMR-99-110]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; US National Institutes of Health [DK 026687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by grants from National Science Council of Taiwan (NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3), from China Medical University Hospital (DMR-99-110), from Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH101-TD-B-111-004), and from the US National Institutes of Health (DK 026687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman RD, 2002, CURR OPIN NEPHROL HY, V11, P331, DOI 10.1097/00041552-200205000-00010; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Christopher JR, 2007, 13181 NBER; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Deurenberg-Yap M, 1999, Asia Pac J Clin Nutr, V8, P177, DOI 10.1046/j.1440-6047.1999.00091.x; Dhaliwal SS, 2009, PREV MED, V49, P153, DOI 10.1016/j.ypmed.2009.07.019; Foster MC, 2011, OBESITY, V19, P1284, DOI 10.1038/oby.2010.308; Fujikawa R, 2001, DIABETES RES CLIN PR, V53, P99, DOI 10.1016/S0168-8227(01)00241-8; Gilardini L, 2010, INT J OBESITY, V34, P287, DOI 10.1038/ijo.2009.227; Hall JE, 2003, CURR HYPERTENS REP, V5, P386, DOI 10.1007/s11906-003-0084-z; Hall JE, 2002, AM J MED SCI, V324, P127, DOI 10.1097/00000441-200209000-00003; Hsu HS, 2011, EUR J CLIN INVEST, V41, P393, DOI 10.1111/j.1365-2362.2010.02421.x; Huang KC, 2002, INT J OBESITY, V26, P1060, DOI 10.1038/sj.ijo.0802047; Kadakia MB, 2011, HEART, V97, P1782, DOI 10.1136/heartjnl-2011-300231; KANNEL WB, 1991, J CLIN EPIDEMIOL, V44, P183, DOI 10.1016/0895-4356(91)90265-B; Khalili S, 2012, METABOLIC SYNDROME R; Klausen KP, 2009, CLIN ENDOCRINOL, V71, P40, DOI 10.1111/j.1365-2265.2008.03427.x; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Lai MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-429; Lin CC, 2007, EUR J CLIN INVEST, V37, P783, DOI 10.1111/j.1365-2362.2007.01865.x; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Lin WY, 2009, J ATHEROSCLER THROMB, V16, P105, DOI 10.5551/jat.E603; Liu CS, 2010, ATHEROSCLEROSIS, V211, P315, DOI 10.1016/j.atherosclerosis.2010.02.015; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Papafragkaki Dafni-Kalliopi, 2005, Hormones (Athens), V4, P90; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Sarafidis PA, 2006, NEPHROL DIAL TRANSPL, V21, P2366, DOI 10.1093/ndt/gfl309; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Sharma K, 2009, KIDNEY INT, V76, P145, DOI 10.1038/ki.2009.137; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Sukhija R, 2006, AM J CARDIOL, V98, P279, DOI 10.1016/j.amjcard.2006.01.098; Sullivan JC, 2007, AM J PHYSIOL-REG I, V293, pR1573, DOI 10.1152/ajpregu.00429.2007; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; U.S. Renal Data System, 2011, USRDS 2011 ANN DAT R; Vedovato M, 2004, DIABETOLOGIA, V47, P300, DOI 10.1007/s00125-003-1303-5; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wang YF, 2005, AM J CLIN NUTR, V81, P555; World Health Organization, 2021, OB OV FACT SHEETS; Yano Yuichiro, 2007, J Clin Hypertens (Greenwich), V9, P775, DOI 10.1111/j.1524-6175.2007.07321.x; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	47	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e47960	10.1371/journal.pone.0047960	http://dx.doi.org/10.1371/journal.pone.0047960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251329	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200003
J	Miyadera, K; Brierley, I; Aguirre-Hernandez, J; Mellersh, CS; Sargan, DR				Miyadera, Keiko; Brierley, Ian; Aguirre-Hernandez, Jesus; Mellersh, Cathryn S.; Sargan, David R.			Multiple Mechanisms Contribute to Leakiness of a Frameshift Mutation in Canine Cone-Rod Dystrophy	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; MINIATURE LONGHAIRED DACHSHUND; TRANSCRIPTIONAL SLIPPAGE; ESCHERICHIA-COLI; GENE-THERAPY; RPGRIP1; IDENTIFICATION; SEQUENCES; PROTEIN; DNA	Mutations in RPGRIP1 are associated with early onset retinal degenerations in humans and dogs. Dogs homozygous for a 44 bp insertion including a polyA(29) tract potentially leading to premature truncation of the protein, show cone rod degeneration. This is rapid and blinding in a colony of dogs in which the mutation was characterised but in dogs with the same mutation in the pet population there is very variable disease severity and rate of progression. Objective: We hypothesized that this variability must be associated with leakiness of the RPGRIP1 mutation, allowing continued RPGRIP1 production. The study was designed to discover mechanisms that might allow such leakiness. Methods: We analysed alternate start sites and splicing of RPGRIP1 transcripts; variability of polyA(n) length in the insertion and slippage at polyA(n) during transcription/translation. Results and Significance: We observed a low rate of use of alternative start codons having potential to allow forms of transcript not including the insertion, with the possibility of encoding truncated functional RPGRIP1 protein isoforms. Complex alternative splicing was observed, but did not increase this potential. Variable polyA(n) length was confirmed in DNA from different RPGRIP1(-/-) dogs, yet polyA(n) variability did not correspond with the clinical phenotypes and no individual was found that carried a polyA(n) tract capable of encoding an in-frame variant. Remarkably though, in luciferase reporter gene assays, out-of-frame inserts still allowed downstream reporter gene expression at some 40% of the efficiency of in-frame controls. This indicates a major role of transcriptional or translational frameshifting in RPGRIP1 expression. The known slippage of reverse transcriptases as well as RNA polymerases and thermostable DNA polymerases on oligoA homopolymers meant that we could not distinguish whether the majority of slippage was transcriptional or translational. This leakiness at the mutation site may allow escape from severe effects of the mutation for some dogs.	[Miyadera, Keiko; Aguirre-Hernandez, Jesus; Sargan, David R.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Mellersh, Cathryn S.] Anim Hlth Trust, Canine Genet Sect, Newmarket, Suffolk, England	University of Cambridge; University of Cambridge; Animal Health Trust	Sargan, DR (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	drs20@cam.ac.uk	Miyadera, Keiko/AAQ-8196-2020; Aguirre-Hernandez, Jesus/M-7955-2018	Aguirre-Hernandez, Jesus/0000-0002-2715-6422; Sargan, David Richard/0000-0001-9897-2489	Kennel Club Charitable Trust; Japan Kennel Club; BBSRC [CCC55]; BBSRC [BBS/E/T/000PR6193, BB/G008205/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BB/G008205/1] Funding Source: researchfish	Kennel Club Charitable Trust; Japan Kennel Club; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from from the Kennel Club Charitable Trust (http://www.thekennelclub.org.uk/charitabletrust) and the Japan Kennel Club (http://www.jkc.or.jp/). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sequencing study providing results in Table S1 was performed by The Genome Analysis Centre, supported by the BBSRC, grant CCC55. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson KF, 2004, NUCLEIC ACIDS RES, V32, P6327, DOI 10.1093/nar/gkh974; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; CURTIS R, 1993, BRIT VET J, V149, P71, DOI 10.1016/S0007-1935(05)80211-8; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Grentzmann G, 1998, RNA, V4, P479; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kuznetsova T, 2011, INVEST OPHTH VIS SCI, V52, P2989, DOI 10.1167/iovs.10-6094; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lheriteau E, 2009, MOL VIS, V15, P349; Linton MF, 1997, J BIOL CHEM, V272, P14127, DOI 10.1074/jbc.272.22.14127; Lu XR, 2005, INVEST OPHTH VIS SCI, V46, P1882, DOI 10.1167/iovs.04-1286; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Miyadera K, 2012, MAMM GENOME, V23, P212, DOI 10.1007/s00335-011-9384-9; Miyadera K, 2009, MOL VIS, V15, P2287; Paoloni-Giacobino A, 2001, HUM GENET, V109, P40, DOI 10.1007/s004390100541; Penno C, 2006, MOL MICROBIOL, V62, P1460, DOI 10.1111/j.1365-2958.2006.05456.x; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Strathern JN, 2012, BBA-GENE REGUL MECH, V1819, P694, DOI 10.1016/j.bbagrm.2012.02.005; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Turney C, 2007, INVEST OPHTH VIS SCI, V48, P4240, DOI 10.1167/iovs.04-0737; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Zhou Y, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-95	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51598	10.1371/journal.pone.0051598	http://dx.doi.org/10.1371/journal.pone.0051598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251588	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200142
J	Nejadnik, H; Henning, TD; Do, T; Sutton, EJ; Baehner, F; Horvai, A; Sennino, B; McDonald, D; Meier, R; Misselwitz, B; Link, TM; Daldrup-Link, HE				Nejadnik, Hossein; Henning, Tobias D.; Thuy Do; Sutton, Elizabeth J.; Baehner, Frederick; Horvai, Andrew; Sennino, Barbara; McDonald, Donald; Meier, Reinhard; Misselwitz, Bernd; Link, Thomas M.; Daldrup-Link, Heike E.			MR Imaging Features of Gadofluorine-Labeled Matrix-Associated Stem Cell Implants in Cartilage Defects	PLOS ONE			English	Article							AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VIVO; CONTRAST AGENTS; REPAIR; TRANSPLANTATION; KNEE; CHONDROGENESIS; FERUCARBOTRAN; REGENERATION; TRACKING	Objectives: The purpose of our study was to assess the chondrogenic potential and the MR signal effects of GadofluorineM-Cy labeled matrix associated stem cell implants (MASI) in pig knee specimen. Materials and Methods: Human mesenchymal stem cells (hMSCs) were labeled with the micelle-based contrast agent GadofluorineM-Cy. Ferucarbotran-labeled hMSCs, non-labeled hMSCs and scaffold only served as controls. Chondrogenic differentiation was induced and gene expression and histologic evaluation were performed. The proportions of spindle-shaped vs. round cells of chondrogenic pellets were compared between experimental groups using the Fisher's exact test. Labeled and unlabeled hMSCs and chondrocytes in scaffolds were implanted into cartilage defects of porcine femoral condyles and underwent MR imaging with T1- and T2-weighted SE and GE sequences. Contrast-to-noise ratios (CNR) between implants and adjacent cartilage were determined and analyzed for significant differences between different experimental groups using the Kruskal-Wallis test. Significance was assigned for p<0.017, considering a Bonferroni correction for multiple comparisons. Results: Collagen type II gene expression levels were not significantly different between different groups (p>0.017). However, hMSC differentiation into chondrocytes was superior for unlabeled and GadofluorineM-Cy-labeled cells compared with Ferucarbotran-labeled cells, as evidenced by a significantly higher proportion of spindle cells in chondrogenic pellets (p<0.05). GadofluorineM-Cy-labeled hMSCs and chondrocytes showed a positive signal effect on T1-weighted images and a negative signal effect on T2-weighted images while Ferucarbotran-labeled cells provided a negative signal effect on all sequences. CNR data for both GadofluorineM-Cy-labeled and Ferucarbotran-labeled hMSCs were significantly different compared to unlabeled control cells on T1-weighted SE and T2*-weighted MR images (p<0.017). Conclusion: hMSCs can be labeled by simple incubation with GadofluorineM-Cy. The labeled cells provide significant MR signal effects and less impaired chondrogenesis compared to Ferucarbotran-labeled hMSCs. Thus, GadoflurineM-Cy might represent an alternative MR cell marker to Ferucarbotran, which is not distributed any more in Europe or North America.	[Nejadnik, Hossein; Thuy Do; Daldrup-Link, Heike E.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Henning, Tobias D.; Meier, Reinhard] Univ Hosp Cologne, Dept Diagnost Radiol, Cologne, Germany; [Sutton, Elizabeth J.] Mt Auburn Hosp, Dept Radiol, Boston, MA USA; [Baehner, Frederick; Horvai, Andrew] Univ Calif San Francisco, Dept Pathol, UCSF Canc Ctr, San Francisco, CA 94140 USA; [Sennino, Barbara; McDonald, Donald] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Sennino, Barbara; McDonald, Donald] Univ Calif San Francisco, CVRI, San Francisco, CA 94143 USA; [Misselwitz, Bernd] Res Labs Bayer Schering Pharma AG, Berlin, Germany; [Link, Thomas M.] Univ Calif San Francisco, Dept Radiol, UCSF Med Ctr, San Francisco, CA USA	Stanford University; University of Cologne; Harvard University; Mount Auburn Hospital; University of California System; University of California San Francisco; UCSF Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center	Daldrup-Link, HE (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	heiked@stanford.edu	Meier, Reinhard/B-2882-2014; Daldrup-Link, Heike E./D-9829-2012; Link, Thomas M. M/E-7522-2012; Nejadnik, Hossein/P-6214-2019	Meier, Reinhard/0000-0002-2169-4780; Daldrup-Link, Heike E./0000-0002-4929-819X; Sutton, Elizabeth/0000-0002-1407-7012	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [2R01AR054458-05, NIH/NIAMS R21AR059861]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054458, R21AR059861] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) 2R01AR054458-05 and NIH/NIAMS R21AR059861 grants. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ED, 2009, JACC-CARDIOVASC IMAG, V2, P1114, DOI 10.1016/j.jcmg.2009.04.015; Bendszus M, 2005, ANN NEUROL, V57, P388, DOI 10.1002/ana.20404; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chu CR, 1999, CLIN ORTHOP RELAT R, P159; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Ding W, 2004, NUCL MED BIOL, V31, P719, DOI 10.1016/j.nucmedbio.2004.04.001; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Giesel FL, 2006, INVEST RADIOL, V41, P868, DOI 10.1097/01.rli.0000246147.44835.4c; Henderson IJP, 2003, J BONE JOINT SURG BR, V85B, P1060, DOI 10.1302/0301-620X.85B7.13782; Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005; HENNING TD, 2008, J VIS EXP; Henning TD, 2007, EUR RADIOL, V17, P1226, DOI 10.1007/s00330-006-0522-9; Henning TD, 2009, CONTRAST MEDIA MOL I, V4, P165, DOI 10.1002/cmmi.276; Henning TD, 2009, MAGN RESON MED, V62, P325, DOI 10.1002/mrm.22011; Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001; Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855; Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003; Ko IK, 2007, ANN BIOMED ENG, V35, P101, DOI 10.1007/s10439-006-9204-7; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Li X, 2009, CLIN RADIOL, V64, P1000, DOI 10.1016/j.crad.2009.07.008; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Misselwitz B, 2004, RADIOLOGY, V231, P682, DOI 10.1148/radiol.2313021000; Nedopil A, 2010, INVEST RADIOL, V45, P634, DOI 10.1097/RLI.0b013e3181ed566c; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Sirol M, 2004, CIRCULATION, V109, P2890, DOI 10.1161/01.CIR.0000129310.17277.E7; Tolar J, 2005, MOL THER, V12, P42, DOI 10.1016/j.ymthe.2005.02.023; Trattnig S, 2007, EUR RADIOL, V17, P103, DOI 10.1007/s00330-006-0333-z; Wada Yuichi, 2003, J Orthop Sci, V8, P514, DOI 10.1007/s00776-003-0677-z; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Wolff SD, 1997, RADIOLOGY, V202, P25, DOI 10.1148/radiology.202.1.8988186	34	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49971	10.1371/journal.pone.0049971	http://dx.doi.org/10.1371/journal.pone.0049971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251354	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200022
J	Wu, L; Yang, JZ				Wu, Liang; Yang, Jinzeng			Identifications of Captive and Wild Tilapia Species Existing in Hawaii by Mitochondrial DNA Control Region Sequence	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PACIFIC THREADFIN; MICROSATELLITE; HETEROCHROMATIN; HYBRIDIZATION; POPULATIONS; CHROMOSOMES; TELEOSTEI; MARKERS; AFRICA	Background: The tilapia family of the Cichlidae includes many fish species, which live in freshwater and saltwater environments. Several species, such as O. niloticus, O. aureus, and O. mossambicus, are excellent for aquaculture because these fish are easily reproduced and readily adapt to diverse environments. Historically, tilapia species, including O. mossambicus, S. melanotheron, and O. aureus, were introduced to Hawaii many decades ago, and the state of Hawaii uses the import permit policy to prevent O. niloticus from coming into the islands. However, hybrids produced from O. niloticus may already be present in the freshwater and marine environments of the islands. The purpose of this study was to identify tilapia species that exist in Hawaii using mitochondrial DNA analysis. Methodology/Principal Findings: In this study, we analyzed 382 samples collected from 13 farm (captive) and wild tilapia populations in Oahu and the Hawaii Islands. Comparison of intraspecies variation between the mitochondrial DNA control region (mtDNA CR) and cytochrome c oxidase I (COI) gene from five populations indicated that mtDNA CR had higher nucleotide diversity than COI. A phylogenetic tree of all sampled tilapia was generated using mtDNA CR sequences. The neighbor-joining tree analysis identified seven distinctive tilapia species: O. aureus, O. mossambicus, O. niloticus, S. melanotheron, O. urolepies, T. redalli, and a hybrid of O. massambicus and O. niloticus. Of all the populations examined, 10 populations consisting of O. aureus, O. mossambicus, O. urolepis, and O. niloticus from the farmed sites were relatively pure, whereas three wild populations showed some degree of introgression and hybridization. Conclusions/Significance: This DNA-based tilapia species identification is the first report that confirmed tilapia species identities in the wild and captive populations in Hawaii. The DNA sequence comparisons of mtDNA CR appear to be a valid method for tilapia species identification. The suspected tilapia hybrids that consist of O. niloticus are present in captive and wild populations in Hawaii.	[Wu, Liang; Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Yang, Jinzeng] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Huazhong Agricultural University	Yang, JZ (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	jinzeng@hawaii.edu			Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA) [2010-38500-20948]; USDA Hatch Project [HAW00244-R]	Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA); USDA Hatch Project	This work was supported by Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA) grant (No. 2010-38500-20948) and the USDA Hatch Project (HAW00244-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 1999, J FISH BIOL, V54, P1119; B-Rao C, 1998, J FISH BIOL, V52, P1199, DOI 10.1111/j.1095-8649.1998.tb00966.x; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Brummett RE, 2004, AQUACULTURE, V242, P157, DOI 10.1016/j.aquaculture.2004.01.036; Canapa A, 2002, CHROMOSOME RES, V10, P297, DOI 10.1023/A:1016519708187; Ch'ang MT, 1971, SOVIET GENETICS, V7, P1550; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; Devick WS, 1991, NEW DIRECTIONS RES M, P199; Falk TM, 2003, MOL PHYLOGENET EVOL, V27, P81, DOI 10.1016/S1055-7903(02)00369-X; Gupta M. V., 2004, Aquaculture Asia Magazine, V9, P7; Hsieh CH, 2010, FOOD CHEM, V121, P1305, DOI 10.1016/j.foodchem.2010.02.004; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; Laoong-u-thai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019959; Martins C, 2004, AQUACULTURE, V231, P37, DOI 10.1016/j.aquaculture.2003.08.017; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; Oliveira C, 1998, CHROMOSOME RES, V6, P205, DOI 10.1023/A:1009211701829; Pan G, 2010, INT J BIOL SCI, V6, P827; RANDALL JE, 1987, B MAR SCI, V41, P490; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Romana-Eguia MRR, 2004, AQUACULTURE, V236, P131, DOI 10.1016/j.aquaculture.2004.01.026; Song HongMei, 2009, Chinese Journal of Agricultural Biotechnology, V6, P119, DOI 10.1017/S1479236209990258; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tave D, 1988, ICLARM C P, V15, P285; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; TREWAVAS E, 1982, AQUACULTURE, V27, P79, DOI 10.1016/0044-8486(82)90112-0; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Wang H, 2010, J WORLD AQUACULT SOC, V41, P640, DOI 10.1111/j.1749-7345.2010.00405.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe WO, 1997, SALTWATER CULTURE FL, V1, P54; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030621, 10.1371/journal.pone.0039076]; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017	34	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51731	10.1371/journal.pone.0051731	http://dx.doi.org/10.1371/journal.pone.0051731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251613	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200159
J	Yang, XL; Wu, F; Lin, XL; Du, XQ; Chong, K; Gramzow, L; Schilling, S; Becker, A; Theissen, G; Meng, Z				Yang, Xuelian; Wu, Feng; Lin, Xuelei; Du, Xiaoqiu; Chong, Kang; Gramzow, Lydia; Schilling, Susanne; Becker, Annette; Theissen, Guenter; Meng, Zheng			Live and Let Die - The B-sister MADS-Box Gene OsMADS29 Controls the Degeneration of Cells in Maternal Tissues during Seed Development of Rice (Oryza sativa)	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; DEATH; DNA; PROTEIN; FAMILY; PLANT; EVOLUTION; CARYOPSIS; NUCELLUS; IDENTITY	B-sister genes have been identified as the closest relatives of class B floral homeotic genes. Previous studies have shown that B-sister genes from eudicots are involved in cell differentiation during ovule and seed development. However, the complete function of B-sister genes in eudicots is masked by redundancy with other genes and little is known about the function of B-sister genes in monocots, and about the evolution of B-sister gene functions. Here we characterize OsMADS29, one of three MADS-box B-sister genes in rice. Our analyses show that OsMADS29 is expressed in female reproductive organs including the ovule, ovule vasculature, and the whole seed except for the outer layer cells of the pericarp. Knock-down of OsMADS29 by double-stranded RNA-mediated interference (RNAi) results in shriveled and/or aborted seeds. Histological analyses of the abnormal seeds at 7 days after pollination (DAP) indicate that the symplastic continuity, including the ovular vascular trace and the nucellar projection, which is the nutrient source for the filial tissue at early development stages, is affected. Moreover, degeneration of all the maternal tissues in the transgenic seeds, including the pericarp, ovular vascular trace, integuments, nucellar epidermis and nucellar projection, is blocked as compared to control plants. Our results suggest that OsMADS29 has important functions in seed development of rice by regulating cell degeneration of maternal tissues. Our findings provide important insights into the ancestral function of B-sister genes.	[Yang, Xuelian; Wu, Feng; Lin, Xuelei; Du, Xiaoqiu; Chong, Kang; Meng, Zheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Yang, Xuelian; Lin, Xuelei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gramzow, Lydia; Schilling, Susanne; Theissen, Guenter] Univ Jena, Dept Genet, Jena, Germany; [Becker, Annette] Univ Giessen, Plant Evo Devo Grp, Inst Bot, D-35390 Giessen, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Friedrich Schiller University of Jena; Justus Liebig University Giessen	Theissen, G (corresponding author), Univ Jena, Dept Genet, Jena, Germany.	guenter.theissen@uni-jena.de; zhmeng@ibcas.ac.cn	Becker, Annette/F-2355-2014; Becker, Annette/AAD-5156-2019	Becker, Annette/0000-0002-3229-2162; Becker, Annette/0000-0002-3229-2162; Gramzow, Lydia/0000-0003-1919-6077; Lin, Xuelei/0000-0002-7472-5202	Ministry of Science and Technology of China [2011CB100405, 2011ZX08009-004]; National Nature Science Foundation of China [31100867, 31121065]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Ministry of Science and Technology of China (grants 2011CB100405; 2011ZX08009-004) and National Nature Science Foundation of China (grants 31100867 and 31121065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Becker A, 2000, MOL BIOL EVOL, V17, P1425, DOI 10.1093/oxfordjournals.molbev.a026243; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; Deng MJ, 2011, FEBS J, V278, P4797, DOI 10.1111/j.1742-4658.2011.08380.x; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Erdmann R, 2010, PLANT J, V63, P914, DOI 10.1111/j.1365-313X.2010.04290.x; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Fukuda H, 1997, CELL DEATH DIFFER, V4, P684, DOI 10.1038/sj.cdd.4400310; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hoshikawa K., 1993, SCI RICE PLANT, P339; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kaufmann K, 2005, MOL GENET GENOMICS, V274, P103, DOI 10.1007/s00438-005-0010-y; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; OPARKA KJ, 1984, PLANT GROWTH REGUL, V2, P297, DOI 10.1007/BF00027289; OPARKA KJ, 1981, PLANTA, V151, P561, DOI 10.1007/BF00387436; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Radchuk V, 2011, J EXP BOT, V62, P1217, DOI 10.1093/jxb/erq348; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1997, BIOL CHEM, V378, P1079; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yamada K, 2009, PLANT MOL BIOL, V71, P1, DOI 10.1007/s11103-009-9504-z; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhou ZQ, 2009, PROTOPLASMA, V236, P49, DOI 10.1007/s00709-009-0046-7	48	52	60	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51435	10.1371/journal.pone.0051435	http://dx.doi.org/10.1371/journal.pone.0051435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251532	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200107
J	Brisighelli, F; Alvarez-Iglesias, V; Fondevila, M; Blanco-Verea, A; Carracedo, A; Pascali, VL; Capelli, C; Salas, A				Brisighelli, Francesca; Alvarez-Iglesias, Vanesa; Fondevila, Manuel; Blanco-Verea, Alejandro; Carracedo, Angel; Pascali, Vincenzo L.; Capelli, Cristian; Salas, Antonio			Uniparental Markers of Contemporary Italian Population Reveals Details on Its Pre-Roman Heritage	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MTDNA CONTROL REGION; HUMAN Y-CHROMOSOME; SEQUENCE DIVERSITY; GENETIC-STRUCTURE; MIGRATORY EVENTS; HAPLOGROUP-H; EUROPE; LINEAGES; HISTORY	Background: According to archaeological records and historical documentation, Italy has been a melting point for populations of different geographical and ethnic matrices. Although Italy has been a favorite subject for numerous population genetic studies, genetic patterns have never been analyzed comprehensively, including uniparental and autosomal markers throughout the country. Methods/Principal Findings: A total of 583 individuals were sampled from across the Italian Peninsula, from ten distant (if homogeneous by language) ethnic communities - and from two linguistic isolates (Ladins, Grecani Salentini). All samples were first typed for the mitochondrial DNA (mtDNA) control region and selected coding region SNPs (mtSNPs). This data was pooled for analysis with 3,778 mtDNA control-region profiles collected from the literature. Secondly, a set of Y-chromosome SNPs and STRs were also analyzed in 479 individuals together with a panel of autosomal ancestry informative markers (AIMs) from 441 samples. The resulting genetic record reveals clines of genetic frequencies laid according to the latitude slant along continental Italy - probably generated by demographical events dating back to the Neolithic. The Ladins showed distinctive, if more recent structure. The Neolithic contribution was estimated for the Y-chromosome as 14.5% and for mtDNA as 10.5%. Y-chromosome data showed larger differentiation between North, Center and South than mtDNA. AIMs detected a minor sub-Saharan component; this is however higher than for other European non-Mediterranean populations. The same signal of sub-Saharan heritage was also evident in uniparental markers. Conclusions/Significance: Italy shows patterns of molecular variation mirroring other European countries, although some heterogeneity exists based on different analysis and molecular markers. From North to South, Italy shows clinal patterns that were most likely modulated during Neolithic times.	[Brisighelli, Francesca; Alvarez-Iglesias, Vanesa; Fondevila, Manuel; Blanco-Verea, Alejandro; Carracedo, Angel; Salas, Antonio] Univ Santiago Compostela, Unidade Xenet, Fac Med, Inst Med, Galicia, Spain; [Brisighelli, Francesca; Pascali, Vincenzo L.] Univ Cattolica Sacro Cuore, Forens Genet Lab, Inst Legal Med, Rome, Italy; [Brisighelli, Francesca; Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Carracedo, Angel] Fdn Publ Galega Med Xen FPGMX SERGAS, CIBER Enfermedades Raras, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Salas, A (corresponding author), Univ Santiago Compostela, Unidade Xenet, Fac Med, Inst Med, Galicia, Spain.	antonio.salas@usc.es	pascali, vincenzo lorenzo/AAC-8436-2022; Álvarez, María Sonia Fondevila/D-4385-2014; Salas, Antonio/E-3977-2012; Carracedo, Angel/D-4257-2012; Salas, Antonio/U-2029-2019	Salas, Antonio/0000-0002-2336-702X; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Brisighelli, Francesca/0000-0001-5469-4413; Capelli, Cristian/0000-0001-9348-9084	European Union [290344]; Ministerio de Ciencia e Innovacion [SAF2008-02971, SAF2011-26983]; British Academy	European Union(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); British Academy	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/under REA grant agreement number 290344, and the Ministerio de Ciencia e Innovacion (SAF2008-02971 and SAF2011-26983)(AS). CC and FB were partially funded by the British Academy for the project "The Greeks in the West: the genetic legacy of the colonisation in South Italy and Sicily". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia D, 2001, GREAT SEA HUMAN HIST; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Amigo J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S5; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Babalini C, 2005, EUR J HUM GENET, V13, P902, DOI 10.1038/sj.ejhg.5201439; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Bini C, 2003, FORENSIC SCI INT, V135, P48, DOI 10.1016/S0379-0738(03)00167-1; Bisol GD, 2008, J ANTHROPOL SCI, V86, P179; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brigaglia M, 1989, STORIA SARDEGNA; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Brisighelli F, 2012, FORENSIC SCI INT-GEN, V6, P834, DOI 10.1016/j.fsigen.2012.03.003; Brisighelli F, 2012, FORENSIC SC IN PRESS; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Buti GG, 1974, PREISTORIA STORIA RE; Cali F, 2001, INT J LEGAL MED, V114, P229, DOI 10.1007/s004140000169; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Carducci L, 1993, STORIA SALENTO TERRA; Castagnetti A, 2004, STORIA TRENTINO ETA, P2000; Cerezo M, 2012, GENOME RES IN PRESS; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; CHILDE VG, 1934, NEW LIGHT MOST ANCIE; Coia V, 2012, J HUM GENET, V57, P254, DOI 10.1038/jhg.2012.14; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cunliffe B, 2001, OXFORD ILLUSTRATED H; De Concini W, 1997, GLI ALTRI ALPI MINOR; De Concini W, 2003, GLI ALTRI ITALIA MIN; Devoto G, 1977, GLI ANTICHI ITALICI; Di Gaetano C, 2009, EUR J HUM GENET, V17, P91, DOI 10.1038/ejhg.2008.120; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Ferri G, 2009, FORENSIC SCI INT-GEN, V3, pE31, DOI 10.1016/j.fsigen.2008.05.004; Ferri G, 2008, FORENSIC SCI INT, V175, P250, DOI 10.1016/j.forsciint.2007.06.007; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Forster P, 2002, INT J LEGAL MED, V116, P99, DOI 10.1007/s00414-001-0261-z; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Francalacci P, 2008, J ANTHROPOL SCI, V86, P59; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Goncalves R, 2005, ANN HUM GENET, V69, P443, DOI 10.1111/j.1529-8817.2005.00161.x; Guidi A, 2005, ITALIA PREISTORICA; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Messina F, 2010, ANN HUM BIOL, V37, P385, DOI 10.3109/03014461003720304; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montanini L, 2005, J NEURO-ONCOL, V74, P87, DOI 10.1007/s11060-004-4036-5; Nei N, 1987, MOL EVOLUTIONARY GEN; Norman D, 1975, ARABS MEDIEVAL EUROP; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Onofri V, 2007, INT J LEGAL MED, V121, P234, DOI 10.1007/s00414-007-0153-y; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pallottino M, 1981, GENTI CULTURE ITALIA, V136; Pichler I, 2006, HUM BIOL, V78, P441, DOI 10.1353/hub.2006.0057; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Stenico M, 1998, P ROY SOC B-BIOL SCI, V265, P555, DOI 10.1098/rspb.1998.0330; Stenico M, 1996, AM J HUM GENET, V59, P1363; Tagliabracci A, 2001, INT J LEGAL MED, V114, P224, DOI 10.1007/s004140000168; TAJIMA F, 1993, MOL BIOL EVOL, V10, P677; TAJIMA F, 1983, GENETICS, V105, P437; Thomas MG, 2008, EUR J HUM GENET, V16, P124, DOI 10.1038/sj.ejhg.5201906; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verginelli F, 2003, J FORENSIC SCI, V48, P443; Vernesi C, 2002, HUM BIOL, V74, P725, DOI 10.1353/hub.2002.0060; Vona G, 2001, AM J HUM BIOL, V13, P576, DOI 10.1002/ajhb.1096; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023	99	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50794	10.1371/journal.pone.0050794	http://dx.doi.org/10.1371/journal.pone.0050794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251386	Green Published, gold			2022-12-25	WOS:000312201900019
J	Liu, CL; Gao, M; Jin, GZ; Zhen, XC				Liu, Chang-Liang; Gao, Ming; Jin, Guo-Zhang; Zhen, Xuechu			GABA Neurons in the Ventral Tegmental Area Responding to Peripheral Sensory Input	PLOS ONE			English	Article							DOPAMINE NEURONS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; REWARD; INHIBITION; VTA; PREPULSES; RESPONSES; DISRUPTS; PROJECT	Dopamine (DA) neurons in the ventral tegmental area (VTA) not only participate in reward processing, but also respond to aversive stimuli. Although GABA neurons in this area are actively involved in regulating the firing of DA neurons, few data exist concerning the responses of these neurons to aversive sensory input. In this study, by employing extracellular single-unit recording and spectral analysis techniques in paralyzed and ventilated rats, we found that the firing pattern in 44% (47 of 106) of GABA cells in the VTA was sensitive to the sensory input produced by the ventilation, showing a significant ventilation-associated oscillation in the power spectra. Detailed studies revealed that most ventilation-sensitive GABA neurons (38 of 47) were excited by the stimuli, whereas most ventilation-sensitive DA neurons (11 of 14) were inhibited. When the animals were under anesthesia or the sensory pathways were transected, the ventilation-associated oscillation failed to appear. Systemic administration of non-competitive N-methyl-D-aspartase (NMDA) receptor antagonist MK-801 completely disrupted the association between the firing of GABA neurons and the ventilation. Interestingly, local MK-801 injection into the VTA dramatically enhanced the sensitivity of GABA neurons to the ventilation. Our data demonstrate that both GABA and DA neurons in the VTA can be significantly modulated by sensory input produced by the ventilation, which may indicate potential functional roles of VTA in processing sensation-related input.	[Liu, Chang-Liang; Gao, Ming; Jin, Guo-Zhang; Zhen, Xuechu] Chinese Acad Sci, Dept Pharmacol, State Key Lab Drug Res, Shanghai Inst Biol Sci,Inst Mat Med, Shanghai, Peoples R China; [Zhen, Xuechu] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Zhen, XC (corresponding author), Chinese Acad Sci, Dept Pharmacol, State Key Lab Drug Res, Shanghai Inst Biol Sci,Inst Mat Med, Shanghai, Peoples R China.	xczhen@mail.shcnc.ac.cn	Liu, Changliang/H-6531-2017	Liu, Changliang/0000-0002-0915-8408; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB522000, 2011CB5C4403]; National Natural Science Foundation of China [30825042, 81130023]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors gratefully acknowledge the financial support from National Basic Research Program of China (2009CB522000, 2011CB5C4403) and the National Natural Science Foundation of China (30825042, 81130023). The support from the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions is also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 2006, SYNAPSE, V60, P20, DOI 10.1002/syn.20272; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; CAMPEAU S, 1995, PSYCHOPHARMACOLOGY, V117, P267, DOI 10.1007/BF02246101; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; DAVIS M, 1990, PSYCHOPHARMACOLOGY, V102, P1, DOI 10.1007/BF02245735; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2001, J NEUROSCI, V21, P1757; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Li W, 2012, J NEUROPHYSIOL; LJUNGBERG T, 1976, EXP NEUROL, V53, P585, DOI 10.1016/0014-4886(76)90140-0; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; NAGAI T, 1983, J COMP NEUROL, V218, P220, DOI 10.1002/cne.902180209; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51507	10.1371/journal.pone.0051507	http://dx.doi.org/10.1371/journal.pone.0051507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251560	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900095
J	Lorenzi, V; Earley, RL; Grober, MS				Lorenzi, Varenka; Earley, Ryan L.; Grober, Matthew S.			Differential Responses of Brain, Gonad and Muscle Steroid Levels to Changes in Social Status and Sex in a Sequential and Bidirectional Hermaphroditic Fish	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; GROUPER EPINEPHELUS-MERRA; GOBY LYTHRYPNUS-DALLI; AROMATASE-ACTIVITY; PLASMA-CONCENTRATIONS; STOPLIGHT PARROTFISH; TESTOSTERONE LEVELS; PROTOGYNOUS WRASSE; MELOSPIZA-MELODIA; SPARISOMA-VIRIDE	Sex steroids can both modulate and be modulated by behavior, and their actions are mediated by complex interactions among multiple hormone sources and targets. While gonadal steroids delivered via circulation can affect behavior, changes in local brain steroid synthesis also can modulate behavior. The relative steroid load across different tissues and the association of these levels with rates of behavior have not been well studied. The bluebanded goby (Lythrypnus dalli) is a sex changing fish in which social status determines sexual phenotype. We examined changes in steroid levels in brain, gonad and body muscle at either 24 hours or 6 days after social induction of protogynous sex change, and from individuals in stable social groups not undergoing sex change. For each tissue, we measured levels of estradiol (E-2), testosterone (T) and 11-ketotestosterone (KT). Females had more T than males in the gonads, and more E-2 in all tissues but there was no sex difference in KT. For both sexes, E-2 was higher in the gonad than in other tissues while androgens were higher in the brain. During sex change, brain T levels dropped while brain KT increased, and brain E-2 levels did not change. We found a positive relationship between androgens and aggression in the most dominant females but only when the male was removed from the social group. The results demonstrate that steroid levels are responsive to changes in the social environment, and that their concentrations vary in different tissues. Also, we suggest that rapid changes in brain androgen levels might be important in inducing behavioral and/or morphological changes associated with protogynous sex change.	[Lorenzi, Varenka] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; Georgia State Univ, Ctr Behav Neurosci, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Lorenzi, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	varenka.lorenzi@csulb.edu			Center for Behavioral Neuroscience; STC Program of the NSF [IBN-9876754]; NSF [IBO-0548567]	Center for Behavioral Neuroscience; STC Program of the NSF; NSF(National Science Foundation (NSF))	This work was supported by the Center for Behavioral Neuroscience, an STC Program of the NSF under Agreement No. IBN-9876754 (to MSG and VL), and an NSF grant IBO-0548567 (to MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON E, 1988, GEN COMP ENDOCR, V72, P394, DOI 10.1016/0016-6480(88)90161-X; AVVAKUMOV GV, 1986, BIOCHIM BIOPHYS ACTA, V881, P489, DOI 10.1016/0304-4165(86)90043-7; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barnett LAK, 2009, MAR BIOL, V156, P301, DOI 10.1007/s00227-008-1084-y; BEHRENTS KC, 1983, THESIS U SO CALIFORN; Bhandari RK, 2006, ZOOL SCI, V23, P65, DOI 10.2108/zsj.23.65; Bhandari RK, 2005, J EXP ZOOL PART A, V303A, P497, DOI 10.1002/jez.a.178; Black MP, 2005, P ROY SOC B-BIOL SCI, V272, P2435, DOI 10.1098/rspb.2005.3210; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Caldwell JD, 2007, NEUROENDOCRINOLOGY, V86, P84, DOI 10.1159/000107072; CARDWELL JR, 1991, GEN COMP ENDOCR, V81, P7, DOI 10.1016/0016-6480(91)90120-U; CARDWELL JR, 1991, HORM BEHAV, V25, P1, DOI 10.1016/0018-506X(91)90035-G; Carlisle SL, 2000, J FISH BIOL, V57, P445, DOI 10.1006/jfbi.2000.1320; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; Desjardins JK, 2006, BEHAV ECOL, V17, P149, DOI 10.1093/beheco/arj018; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Elekonich MM, 2000, ETHOLOGY, V106, P493, DOI 10.1046/j.1439-0310.2000.00555.x; Frisch Ashley, 2004, Reviews in Fish Biology and Fisheries, V14, P481, DOI 10.1007/s11160-005-3586-8; GODWIN JR, 1993, GEN COMP ENDOCR, V91, P144, DOI 10.1006/gcen.1993.1114; KAMEL F, 1975, HORM BEHAV, V6, P277, DOI 10.1016/0018-506X(75)90014-8; KOBAYASHI M, 1991, ZOOL SCI, V8, P389; Kroon FJ, 2003, J FISH BIOL, V62, P153, DOI 10.1046/j.1095-8649.2003.00017.x; Kroon FJ, 2000, GEN COMP ENDOCR, V118, P273, DOI 10.1006/gcen.2000.7459; Li GL, 2007, ANIM REPROD SCI, V99, P156, DOI 10.1016/j.anireprosci.2006.05.015; LILEY NR, 1986, GEN COMP ENDOCR, V62, P145, DOI 10.1016/0016-6480(86)90103-6; Lone KP, 2001, J FISH BIOL, V58, P305, DOI 10.1111/j.1095-8649.2001.tb02255.x; Lorenzi V, 2008, GEN COMP ENDOCR, V155, P438, DOI 10.1016/j.ygcen.2007.07.010; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; MAYER I, 1990, GEN COMP ENDOCR, V79, P23, DOI 10.1016/0016-6480(90)90084-Y; Miguel-Queralt S, 2005, MOL CELL ENDOCRINOL, V229, P21, DOI 10.1016/j.mce.2004.10.004; Miguel-Queralt S, 2004, ENDOCRINOLOGY, V145, P5221, DOI 10.1210/en.2004-0678; NAKAMURA M, 1989, ENVIRON BIOL FISH, V24, P117, DOI 10.1007/BF00001282; Neat FC, 1999, J FISH BIOL, V54, P695, DOI 10.1111/j.1095-8649.1999.tb00649.x; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Ohta K, 2001, ZOOL SCI, V18, P937, DOI 10.2108/zsj.18.937; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; PASMANIK M, 1986, BIOL REPROD, V35, P838, DOI 10.1095/biolreprod35.4.838; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pinxten R, 2003, HORM BEHAV, V44, P103, DOI 10.1016/S0018-506X(03)00120-X; Reavis Robert H., 1999, Acta Ethologica, V2, P51, DOI 10.1007/PL00012232; Remage-Healey L, 2005, HORM BEHAV, V47, P297, DOI 10.1016/j.yhbeh.2004.11.017; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2006, BRAIN RES, V1126, P27, DOI 10.1016/j.brainres.2006.06.049; Remage-Healey L, 2006, HORM BEHAV, V50, P432, DOI 10.1016/j.yhbeh.2006.05.007; Rodgers EW, 2007, J FISH BIOL, V70, P1660, DOI 10.1111/j.1095-8649.2007.01427.x; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Schultz DR, 2005, J APPL ICHTHYOL, V21, P394, DOI 10.1111/j.1439-0426.2005.00650.x; SCHULZ R, 1991, GEN COMP ENDOCR, V82, P197, DOI 10.1016/0016-6480(91)90184-8; Taves Matthew D, 2011, Front Endocrinol (Lausanne), V2, P39, DOI 10.3389/fendo.2011.00039; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P417, DOI 10.1016/0016-6480(84)90084-4; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; YEUNG WSB, 1987, GEN COMP ENDOCR, V66, P353, DOI 10.1016/0016-6480(87)90244-9	56	29	30	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51158	10.1371/journal.pone.0051158	http://dx.doi.org/10.1371/journal.pone.0051158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251444	Green Published, gold			2022-12-25	WOS:000312201900048
J	Marzinelli, EM; Burrows, MT; Jackson, AC; Mayer-Pinto, M				Marzinelli, Ezequiel M.; Burrows, Michael T.; Jackson, Angus C.; Mayer-Pinto, Mariana			Positive and Negative Effects of Habitat-Forming Algae on Survival, Growth and Intra-Specific Competition of Limpets	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; INTERTIDAL ROCK-PLATFORM; PATELLA-VULGATA L.; NEW-SOUTH-WALES; INTERSPECIFIC COMPETITION; INTRASPECIFIC COMPETITION; FIELD EXPERIMENTS; CLIMATE-CHANGE; GASTROPODS; ABUNDANCE	Understanding the effects of environmental change on the distribution and abundance of strongly interacting organisms, such as intertidal macroalgae and their grazers, needs a thorough knowledge of their underpinning ecological relationships. Control of grazer-plant interactions is bi-directional on northwestern European coasts: grazing by limpets structures populations of macroalgae, while macroalgae provide habitat and food for limpets. Scottish shores dominated by the macroalga Fucus vesiculosus support lower densities and larger sizes of limpets Patella vulgata than shores with less Fucus. These patterns may be due to differences in inter-size-class competitive interactions of limpets among shores with different covers of Fucus. To examine this model, densities of small and large limpets were manipulated in plots with and without Fucus. Amounts of biofilm were measured in each plot. The presence of Fucus increased survival but hindered growth of small (15 mm TL) limpets, which were negatively affected by the presence of large limpets (31 mm TL). In contrast, large limpets were not affected by the presence of Fucus or of small limpets. This suggests the occurrence of asymmetric inter-size-class competition, which was influenced by the presence of macroalgae. Macroalgae and increased densities of limpets did not influence amounts of biofilm. Our findings highlight the role of interactions among organisms in generating ecological responses to environmental change.	[Marzinelli, Ezequiel M.; Mayer-Pinto, Mariana] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia; [Burrows, Michael T.] Scottish Marine Inst, Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland; [Jackson, Angus C.] Univ Highlands & Isl, N Highland Coll, Environm Res Inst, Thurso, Caithness, Scotland	University of Sydney; UHI Millennium Institute; UHI Millennium Institute	Marzinelli, EM (corresponding author), Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia.	e.marzinelli@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Burrows, Michael/ABF-4844-2020	Marzinelli, Ezequiel/0000-0002-3762-3389; Burrows, Michael/0000-0003-4620-5899; Mayer-Pinto, Mariana/0000-0001-9679-7023	Rhum Travelling Fellowship (EICC); International Postgraduate Award (University of Sydney); International Postgraduate Research Scholarship (Australian Government); Oceans 2025 programme; UK Natural Environment Research Council	Rhum Travelling Fellowship (EICC); International Postgraduate Award (University of Sydney)(University of Sydney); International Postgraduate Research Scholarship (Australian Government)(Australian Government); Oceans 2025 programme; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	EMM was supported by funds from the Rhum Travelling Fellowship (EICC), an International Postgraduate Award (University of Sydney) and an International Postgraduate Research Scholarship (Australian Government). MTB was supported by the Oceans 2025 programme funded by the UK Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaventura D, 2003, J ANIM ECOL, V72, P435, DOI 10.1046/j.1365-2656.2003.00713.x; Boaventura D, 2002, J EXP MAR BIOL ECOL, V271, P171, DOI 10.1016/S0022-0981(02)00044-8; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; BURROWS MT, 1990, J ANIM ECOL, V59, P723, DOI 10.2307/4891; Chung IK, 2011, J APPL PHYCOL, V23, P877, DOI 10.1007/s10811-010-9604-9; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Darwin C, 1872, ORIGIN SPECIES; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; FISCHERPIETTE E, 1958, CR HEBD ACAD SCI, V246, P1301; FLETCHER WJ, 1987, ECOLOGY, V68, P387, DOI 10.2307/1939270; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; HARTNOLL RG, 1985, OPHELIA, V24, P53, DOI 10.1080/00785236.1985.10426619; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; HILL AS, 1991, J MAR BIOL ASSOC UK, V71, P403, DOI 10.1017/S0025315400051675; Ivesa L, 2010, MAR ECOL PROG SER, V407, P55, DOI 10.3354/meps08539; Jackson AC, 2009, MAR ECOL PROG SER, V376, P153, DOI 10.3354/meps07807; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; JERNAKOFF P, 1985, MAR ECOL PROG SER, V23, P71, DOI 10.3354/meps023071; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Mann KH, 2000, ECOLOGY COASTAL WATE; MARSHALL PA, 1994, J EXP MAR BIOL ECOL, V177, P121, DOI 10.1016/0022-0981(94)90147-3; Moore P, 2007, J EXP MAR BIOL ECOL, V344, P170, DOI 10.1016/j.jembe.2006.12.012; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Morelissen B, 2007, J EXP MAR BIOL ECOL, V348, P162, DOI 10.1016/j.jembe.2007.04.006; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V380, P68, DOI 10.1016/j.jembe.2009.09.002; Murphy RJ, 2006, MAR ECOL PROG SER, V312, P45, DOI 10.3354/meps312045; Murphy RJ, 2005, J EXP MAR BIOL ECOL, V316, P69, DOI 10.1016/j.jembe.2004.10.006; Notman G.M., 2011, COMP TROPHIC ECOLOGY; ORTON J. H., 1928, JOUR MARINE BIOL ASSOC, V15, P863; PALMER AR, 1982, MALACOLOGIA, V23, P63; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Silva ACF, 2008, J EXP MAR BIOL ECOL, V367, P259, DOI 10.1016/j.jembe.2008.10.010; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; SOUTHWARD A. J., 1964, GRAZING TERRESTRIAL, P265; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Thompson RC, 2000, HYDROBIOLOGIA, V440, P357, DOI 10.1023/A:1004116505004; Thompson RC, 2004, ECOLOGY, V85, P1372, DOI 10.1890/03-0279; Thompson RC, 1999, J MAR BIOL ASSOC UK, V79, P551, DOI 10.1017/S0025315498000678; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Underwood A.J., 1986, P240; Underwood A.J., 1979, Advances in Marine Biology, V16, P111, DOI 10.1016/S0065-2881(08)60293-X; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; UNDERWOOD AJ, 1984, J EXP MAR BIOL ECOL, V78, P199, DOI 10.1016/0022-0981(84)90159-X; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1984, OECOLOGIA, V64, P211, DOI 10.1007/BF00376873; UNDERWOOD AJ, 1976, J EXP MAR BIOL ECOL, V23, P145, DOI 10.1016/0022-0981(76)90138-6; UNDERWOOD AJ, 1992, SYST ASSOC SPEC VOL, V46, P443; UNDERWOOD AJ, 1997, GMAV 5 WINDOWS	53	9	9	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51601	10.1371/journal.pone.0051601	http://dx.doi.org/10.1371/journal.pone.0051601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251589	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900108
J	Voronova, A; Coyne, E; Al Madhoun, A; Fair, JV; Bosiljcic, N; St-Louis, C; Li, G; Thurig, S; Wallace, VA; Wiper-Bergeron, N; Skerjanc, IS				Voronova, Anastassia; Coyne, Erin; Al Madhoun, Ashraf; Fair, Joel V.; Bosiljcic, Neven; St-Louis, Catherine; Li, Grace; Thurig, Sherry; Wallace, Valerie A.; Wiper-Bergeron, Nadine; Skerjanc, Ilona S.			Hedgehog Signaling Regulates MyoD Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SONIC HEDGEHOG; TRANSCRIPTION-FACTOR; SATELLITE CELLS; GENE-EXPRESSION; REDUNDANT FUNCTIONS; OTHERS EXPRESSION; PRECURSOR CELLS; FAMILY-MEMBERS	The inhibition of MyoD expression is important for obtaining muscle progenitors that can replenish the satellite cell niche during muscle repair. Progenitors could be derived from either embryonic stem cells or satellite cells. Hedgehog (Hh) signaling is important for MyoD expression during embryogenesis and adult muscle regeneration. To date, the mechanistic understanding of MyoD regulation by Hh signaling is unclear. Here, we demonstrate that the Hh effector, Gli2, regulates MyoD expression and associates with MyoD gene elements. Gain- and loss-of-function experiments in pluripotent P19 cells show that Gli2 activity is sufficient and required for efficient MyoD expression during skeletal myogenesis. Inhibition of Hh signaling reduces MyoD expression during satellite cell activation in vitro. In addition to regulating MyoD expression, Hh signaling regulates MyoD transcriptional activity, and MyoD activates Hh signaling in myogenic conversion assays. Finally, Gli2, MyoD, and MEF2C form a protein complex, which enhances MyoD activity on skeletal muscle-related promoters. We therefore link Hh signaling to the function and expression of MyoD protein during myogenesis in stem cells.	[Voronova, Anastassia; Coyne, Erin; Al Madhoun, Ashraf; Fair, Joel V.; Bosiljcic, Neven; Thurig, Sherry; Wallace, Valerie A.; Skerjanc, Ilona S.] Dasman Diabet Inst, Dept Biochem Microbiol & Immunol, Dasman 15462, Kuwait; [Al Madhoun, Ashraf] Dasman Diabet Inst, Pancreat Islet Biol & Transplantat Unit, Dasman 15462, Kuwait; [St-Louis, Catherine; Li, Grace; Wiper-Bergeron, Nadine] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Thurig, Sherry; Wallace, Valerie A.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Skerjanc, IS (corresponding author), Dasman Diabet Inst, Dept Biochem Microbiol & Immunol, Dasman 15462, Kuwait.	iskerjan@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021; Voronova, Anastassia/GLR-8891-2022; Skerjanc, Ilona/AAN-3318-2020	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Voronova, Anastassia/0000-0001-7504-1905; Al Madhoun, Ashraf/0000-0001-8593-3878	Canadian Institutes of Health Research [MOP-84458]; Heart and Stroke Foundation of Canada; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by Grant MOP-84458 (to I. S. S.) from the Canadian Institutes of Health Research.; Supported by a doctoral research award from the Heart and Stroke Foundation of Canada.; Supported by an Ontario Graduate Scholarship.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Anderson C, 2012, GENE DEV, V26, P2103, DOI 10.1101/gad.187807.112; Archer TK, 1997, METHODS, V11, P235, DOI 10.1006/meth.1996.0410; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Astigiano S, 2005, DIFFERENTIATION, V73, P484, DOI 10.1111/j.1432-0436.2005.00043.x; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Buscher D, 1998, DEV DYNAM, V211, P88; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chen JCJ, 2004, DEV BIOL, V265, P502, DOI 10.1016/j.ydbio.2003.09.018; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Dufort D, 1998, DEVELOPMENT, V125, P3015; Duprez D, 1998, DEVELOPMENT, V125, P495; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Froeschle A, 1998, ONCOGENE, V16, P3369, DOI 10.1038/sj.onc.1201894; Gayraud-Morel B, 2012, J CELL SCI, V125, P1738, DOI 10.1242/jcs.097006; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Hu JKH, 2012, GENE DEV, V26, P2088, DOI 10.1101/gad.187385.112; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Jamali M, 2001, J BIOL CHEM, V276, P42252, DOI 10.1074/jbc.M107814200; Karamboulas Christina, 2006, J Cell Sci, V119, P4315, DOI 10.1242/jcs.03186; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kruger M, 2001, DEVELOPMENT, V128, P743; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Xiaopeng, 2004, BMC Dev Biol, V4, P9, DOI 10.1186/1471-213X-4-9; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mo R, 1997, DEVELOPMENT, V124, P113; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montross WT, 2000, J CELL SCI, V113, P1759; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Osborn DPS, 2011, DEV BIOL, V350, P464, DOI 10.1016/j.ydbio.2010.12.010; OTT MO, 1991, DEVELOPMENT, V111, P1097; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Park HL, 2000, DEVELOPMENT, V127, P1593; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	111	32	34	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4389	4404		10.1074/jbc.M112.400184	http://dx.doi.org/10.1074/jbc.M112.400184			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23266826	Green Published, hybrid			2022-12-25	WOS:000314845000066
J	Budczies, J; Klauschen, F; Sinn, BV; Gyorffy, B; Schmitt, WD; Darb-Esfahani, S; Denkert, C				Budczies, Jan; Klauschen, Frederick; Sinn, Bruno V.; Gyoerffy, Balazs; Schmitt, Wolfgang D.; Darb-Esfahani, Silvia; Denkert, Carsten			Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization	PLOS ONE			English	Article							TREATMENT-COVARIATE INTERACTIONS; 1 MESSENGER-RNA; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; OPTIMAL CUTPOINTS; PROGNOSTIC-FACTOR; GENE-EXPRESSION; SURVIVAL; PREDICTOR; SUBSETS	Gene or protein expression data are usually represented by metric or at least ordinal variables. In order to translate a continuous variable into a clinical decision, it is necessary to determine a cutoff point and to stratify patients into two groups each requiring a different kind of treatment. Currently, there is no standard method or standard software for biomarker cutoff determination. Therefore, we developed Cutoff Finder, a bundle of optimization and visualization methods for cutoff determination that is accessible online. While one of the methods for cutoff optimization is based solely on the distribution of the marker under investigation, other methods optimize the correlation of the dichotomization with respect to an outcome or survival variable. We illustrate the functionality of Cutoff Finder by the analysis of the gene expression of estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer tissues. This distribution of these important markers is analyzed and correlated with immunohistologically determined ER status and distant metastasis free survival. Cutoff Finder is expected to fill a relevant gap in the available biometric software repertoire and will enable faster optimization of new diagnostic biomarkers. The tool can be accessed at http://molpath.charite.de/cutoff. Citation: Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, et al. (2012) Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization. PLoS ONE 7(12): e51862. doi: 10.1371/journal.pone.0051862	[Budczies, Jan; Klauschen, Frederick; Sinn, Bruno V.; Schmitt, Wolfgang D.; Darb-Esfahani, Silvia; Denkert, Carsten] Charite, Inst Pathol, D-13353 Berlin, Germany; [Gyoerffy, Balazs] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hungarian Academy of Sciences	Budczies, J (corresponding author), Charite, Inst Pathol, D-13353 Berlin, Germany.	jan.budczies@charite.de	Klauschen, Frederick/C-5637-2015; Budczies, Jan/AAG-8122-2020; Schmitt, Wolfgang D/B-4729-2008; Gyorffy, Balazs/AAA-9135-2021; Denkert, Carsten/AHE-2675-2022	Klauschen, Frederick/0000-0002-9131-2389; Schmitt, Wolfgang D/0000-0002-7870-138X; Gyorffy, Balazs/0000-0002-5772-3766; Denkert, Carsten/0000-0002-2249-0982	European Commission within FP7 [200327, 257669]; OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund) [PD 83154]	European Commission within FP7; OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was funded by the European Commission within FP7, grants #200327 (METAcancer) and #257669 (ARROWS), and by OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund) PD 83154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bonetti M, 2004, BIOSTATISTICS, V5, P465, DOI 10.1093/biostatistics/kxh002; Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO;2-M; Bonetti M, 2009, STAT MED, V28, P1255, DOI 10.1002/sim.3524; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; Darb-Esfahani S, 2009, ENDOCR-RELAT CANCER, V16, P1229, DOI 10.1677/ERC-08-0338; Dorai-Raj S., 2009, BINOM BINOMIAL CONFI; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faraggi D, 1996, STAT MED, V15, P2203, DOI 10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.3.CO;2-7; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HALPERN J, 1982, BIOMETRICS, V38, P1017, DOI 10.2307/2529882; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HILSENBECK SG, 1992, BREAST CANCER RES TR, V22, P197, DOI 10.1007/BF01840833; KOZIOL JA, 1991, BIOMETRICS, V47, P1557, DOI 10.2307/2532406; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Leisch F, 2004, J STAT SOFTW, V11, P1, DOI DOI 10.18637/JSS.V011.I08; Lumley T, 2011, R PACKAGE VERSION, V2, P36, DOI DOI 10.HTTP://CRAN.R-PR0JECT.0RG/PACKAGE; Magdelenat H, 1982, Breast Cancer Res Treat, V2, P195, DOI 10.1007/BF01806456; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; R Core Team, 2021, R LANG ENV STAT COMP; REMMELE W, 1987, PATHOLOGE, V8, P138; Sinn BV, 2011, HISTOPATHOLOGY, V59, P918, DOI 10.1111/j.1365-2559.2011.04028.x; Sinn BV, 2009, VIRCHOWS ARCH, V455, P461, DOI 10.1007/s00428-009-0851-6; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Urbanek S, 2011, RSERVE BINARY R SERV; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	802	814	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51862	10.1371/journal.pone.0051862	http://dx.doi.org/10.1371/journal.pone.0051862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251644	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800100
J	Ferber, M; Zoete, V; Michielin, O				Ferber, Mathias; Zoete, Vincent; Michielin, Olivier			T-Cell Receptors Binding Orientation over Peptide/MHC Class I Is Driven by Long-Range Interactions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREE-ENERGY DECOMPOSITION; MOLECULAR-DYNAMICS METHOD; MHC COMPLEX; MM-GBSA; RECOGNITION; ASSOCIATION; SOLVATION; RESIDUES; WATER	Crystallographic data about T-Cell Receptor - peptide - major histocompatibility complex class I (TCRpMHC) interaction have revealed extremely diverse TCR binding modes triggering antigen recognition. Understanding the molecular basis that governs TCR orientation over pMHC is still a considerable challenge. We present a simplified rigid approach applied on all non-redundant TCRpMHC crystal structures available. The CHARMM force field in combination with the FACTS implicit solvation model is used to study the role of long-distance interactions between the TCR and pMHC. We demonstrate that the sum of the coulomb interactions and the electrostatic solvation energies is sufficient to identify two orientations corresponding to energetic minima at 0 degrees and 180 degrees from the native orientation. Interestingly, these results are shown to be robust upon small structural variations of the TCR such as changes induced by Molecular Dynamics simulations, suggesting that shape complementarity is not required to obtain a reliable signal. Accurate energy minima are also identified by confronting unbound TCR crystal structures to pMHC. Furthermore, we decompose the electrostatic energy into residue contributions to estimate their role in the overall orientation. Results show that most of the driving force leading to the formation of the complex is defined by CDR1,2/MHC interactions. This long-distance contribution appears to be independent from the binding process itself, since it is reliably identified without considering neither short-range energy terms nor CDR induced fit upon binding. Ultimately, we present an attempt to predict the TCR/pMHC binding mode for a TCR structure obtained by homology modeling. The simplicity of the approach and the absence of any fitted parameters make it also easily applicable to other types of macromolecular protein complexes.	[Ferber, Mathias; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Ferber, Mathias; Michielin, Olivier] Lausanne Univ Hosp CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Zoete, V (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	vincent.zoete@unil.ch; olivier.michielin@unil.ch	Michielin, Olivier/ABE-7924-2020		Swiss National Science Foundation [3200B0-103173]; OncoSuisse [OCS 01381-08-2003]; National Center of Competence in Research (NCCR); Swiss Institute of Bioinformatics	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse; National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss Institute of Bioinformatics	Funding was provided by the Swiss National Science Foundation (Grant Number: 3200B0-103173), OncoSuisse (Grant Number: OCS 01381-08-2003), the National Center of Competence in Research (NCCR), and the Swiss Institute of Bioinformatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; ALMAGRO JC, 1995, PROTEIN SCI, V4, P1708, DOI 10.1002/pro.5560040906; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS4, DOI 10.1186/1745-7580-6-S2-S4; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khan JM, 2011, BIOINFORMATICS, V27, P1192, DOI 10.1093/bioinformatics/btr104; Khan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017194; Leimgruber A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026301; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Michielin O, 2000, J MOL BIOL, V300, P1205, DOI 10.1006/jmbi.2000.3788; Michielin O, 2002, J MOL BIOL, V324, P547, DOI 10.1016/S0022-2836(02)00880-X; Nose S, 2002, MOL PHYS, V100, P191, DOI 10.1080/00268970110089108; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roomp K, 2011, MOL IMMUNOL, V48, P553, DOI 10.1016/j.molimm.2010.10.014; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schamel WWA, 2007, P NATL ACAD SCI USA, V104, P16398, DOI 10.1073/pnas.0708462104; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	41	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51943	10.1371/journal.pone.0051943	http://dx.doi.org/10.1371/journal.pone.0051943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251658	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800113
J	Mishra, SK; Funair, L; Cressley, A; Gittes, GK; Burns, RC				Mishra, Sanjay K.; Funair, Lacey; Cressley, Alex; Gittes, George K.; Burns, R. Cartland			High-Affinity Dkk1 Receptor Kremen1 Is Internalized by Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN; DISABLED-2 DAB2; BETA-CATENIN; AP2 COMPLEX; COATED PITS; AP-2; CARGO; ADAPTERS; BINDING; CELLS	Kremens are high-affinity receptors for Dickkopf 1 (Dkk1) and regulate the Wnt/beta-catenin signaling pathway by down-regulating the low-density lipoprotein receptor-related protein 6 (LRP6). Dkk1 competes with Wnt for binding to LRP6; binding of Dkk1 inhibits canonical signaling through formation of a ternary complex with Kremen. The majority of downregulated clathrin-mediated endocytic receptors contain short conserved regions that recognize tyrosine or dileucine sorting motifs. In this study, we found that Kremen1 is internalized from the cell surface in a clathrin-dependent manner. Kremen1 contains an atypical dileucine motif with the sequence DXXXLV. Mutation of LV to AA in this motif blocked Kremen1 internalization; as reported previously for other proteins, the aspartic acid residue in Kremen1 is not critical. Inhibition of expression of the adaptor protein 2 (AP-2) or inhibition of clathrin by pitstop 2 also blocked Kremen1 internalization. The novel amino acid sequence identified in Kremen1 is similar to the motif previously identified in hydra, yeast, and other organisms known to signal from the trans-Golgi network to the endosomal compartment. Citation: Mishra SK, Funair L, Cressley A, Gittes GK, Burns RC (2012) High-Affinity Dkk1 Receptor Kremen1 Is Internalized by Clathrin-Mediated Endocytosis. PLoS ONE 7(12): e52190. doi:10.1371/journal.pone.0052190	[Mishra, Sanjay K.; Funair, Lacey; Cressley, Alex; Gittes, George K.] Childrens Hosp Pittsburgh, Dept Pediat Surg, Pittsburgh, PA 15213 USA; [Burns, R. Cartland] Nemours Childrens Hosp, Div Pediat Gen & Thorac Surg, Orlando, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mishra, SK (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat Surg, Pittsburgh, PA 15213 USA.	skm25@pitt.edu; Cartland.Burns@nemours.org			Children's Hospital of Pittsburgh; National Institute of Health [R01DK064952, R01DK83541-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064952, R01DK083541] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Children's Hospital of Pittsburgh, and G.K.G. was supported by funding from National Institute of Health (R01DK064952 and R01DK83541-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kikuchi A, 2007, J BIOCHEM, V141, P443, DOI 10.1093/jb/mvm061; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Mishra SK, 2008, J CELL SCI, V121, P1264, DOI 10.1242/jcs.025833; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MURPHY JE, 1992, J BIOL CHEM, V267, P10850; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Nakamura T, 2001, BBA-GENE STRUCT EXPR, V1518, P63, DOI 10.1016/S0167-4781(01)00168-3; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	48	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52190	10.1371/journal.pone.0052190	http://dx.doi.org/10.1371/journal.pone.0052190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251700	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800151
J	Arnes, L; Hill, JT; Gross, S; Magnuson, MA; Sussel, L				Arnes, Luis; Hill, Jonathon T.; Gross, Stefanie; Magnuson, Mark A.; Sussel, Lori			Ghrelin Expression in the Mouse Pancreas Defines a Unique Multipotent Progenitor Population	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; ALPHA-CELLS; ENDOCRINE PANCREAS; ISLET-CELL; INSULIN-SECRETION; DIFFERENTIATION; NKX2.2; ARX; NEUROGENIN3	Pancreatic islet cells provide the major source of counteractive endocrine hormones required for maintaining glucose homeostasis; severe health problems result when these cell types are insufficiently active or reduced in number. Therefore, the process of islet endocrine cell lineage allocation is critical to ensure there is a correct balance of islet cell types. There are four endocrine cell types within the adult islet, including the glucagon-producing alpha cells, insulin-producing beta cells, somatostatin-producing delta cells and pancreatic polypeptide-producing PP cells. A fifth islet cell type, the ghrelin-producing epsilon cells, is primarily found during gestational development. Although hormone expression is generally assumed to mark the final entry to a determined cell state, we demonstrate in this study that ghrelin-expressing epsilon cells within the mouse pancreas do not represent a terminally differentiated endocrine population. Ghrelin cells give rise to significant numbers of alpha and PP cells and rare beta cells in the adult islet. Furthermore, pancreatic ghrelin-producing cells are maintained in pancreata lacking the essential endocrine lineage regulator Neurogenin3, and retain the ability to contribute to cells within the pancreatic ductal and exocrine lineages. These results demonstrate that the islet ghrelin-expressing epsilon cells represent a multi-potent progenitor cell population that delineates a major subgrouping of the islet endocrine cell populations. These studies also provide evidence that many of hormone-producing cells within the adult islet represent heterogeneous populations based on their ontogeny, which could have broader implications on the regulation of islet cell ratios and their ability to effectively respond to fluctuations in the metabolic environment during development.	[Arnes, Luis; Hill, Jonathon T.; Gross, Stefanie; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Nashville, TN 37212 USA	Columbia University; Vanderbilt University; Vanderbilt University	Sussel, L (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA.	lgs2@columbia.edu	Magnuson, Mark/AAY-7172-2021; Arnes, Luis/K-9911-2016; Magnuson, Mark A/B-1335-2009; Arnes, Luis/AAH-6671-2019	Magnuson, Mark/0000-0002-8824-6499; Arnes, Luis/0000-0002-4158-8301; Magnuson, Mark A/0000-0002-8824-6499; Hill, Jonathon/0000-0003-1190-6302	National Institutes of Health [DK082590, DK089523, BCBC, DK63608];  [T32 DK07328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089523, P30DK063608, R01DK082590, U01DK072473, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health grants DK082590 (LS), DK089523; BCBC (LS and MM) and DK63608 (Columbia DERC). JH was supported by the T32 DK07328 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andralojc KM, 2009, DIABETOLOGIA, V52, P486, DOI 10.1007/s00125-008-1238-y; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arnes L, 2012, GENESIS; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Chanoine JP, 2004, ENDOCRINOLOGY; Chen SX, 2011, DIS MODEL MECH; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hill JT, 2009, REGUL PEPTIDES, V157, P51, DOI 10.1016/j.regpep.2009.02.013; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kaiya H, 2011, PEPTIDES, V32, P2155, DOI 10.1016/j.peptides.2011.04.027; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kordowich S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-52; Long QM, 2004, GENESIS, V39, P256, DOI 10.1002/gene.20053; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madsen OD, 2007, CR BIOL, V330, P534, DOI 10.1016/j.crvi.2007.03.006; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; PICTET R, 1972, DEV EMBRYONIC ENDOCR; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stengel A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00024; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sussel L, 1998, DEVELOPMENT, V125, P2213; TEITELMAN G, 1987, DEV BIOL, V121, P454, DOI 10.1016/0012-1606(87)90182-5; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Volante M, 2002, J CLIN ENDOCR METAB, V87, P1300, DOI 10.1210/jc.87.3.1300; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P301, DOI 10.1177/002215540405200301; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52026	10.1371/journal.pone.0052026	http://dx.doi.org/10.1371/journal.pone.0052026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251675	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200173
J	Azoulay, L; Assimes, TL; Yin, H; Bartels, DB; Schiffrin, EL; Suissa, S				Azoulay, Laurent; Assimes, Themistocles L.; Yin, Hui; Bartels, Dorothee B.; Schiffrin, Ernesto L.; Suissa, Samy			Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; CONVERTING-ENZYME-INHIBITORS; CALCIUM-CHANNEL BLOCKERS; ANTIHYPERTENSIVE DRUGS; COHORT; METAANALYSIS; INFORMATION; VALIDATION	The association between angiotensin receptor blockers (ARBs) and cancer is controversial with meta-analyses of randomized controlled trials and observational studies reporting conflicting results. Thus, the objective of this study was to determine whether ARBs are associated with an overall increased risk of the four most common cancers, namely, lung, colorectal, breast and prostate cancers, and to explore these effects separately for each cancer type. We conducted a retrospective cohort study using a nested case-control analysis within the United Kingdom (UK) General Practice Research Database. We assembled a cohort of patients prescribed antihypertensive agents between 1995, the year the first ARB (losartan) entered the UK market, and 2008, with follow-up until December 31, 2010. Cases were patients newly-diagnosed with lung, colorectal, breast and prostate cancer during follow-up. We used conditional logistic regression to estimate adjusted rate ratios (RRs) and 95% confidence intervals (CIs) of cancer incidence, comparing ever use of ARBs with ever use of diuretics and/or beta-blockers. The cohort included 1,165,781 patients, during which 41,059 patients were diagnosed with one of the cancers under study (rate 554/100,000 person-years). When compared to diuretics and/or beta-blockers, ever use of ARBs was not associated with an increased rate of cancer overall (RR: 1.00; 95% CI: 0.96-1.03) or with each cancer site separately. The use of angiotensin-converting enzyme inhibitors and calcium channel blockers was associated with an increased rate of lung cancer (RR: 1.13; 95% CI: 1.06-1.20 and RR: 1.19; 95% CI: 1.12-1.27, respectively). This study provides additional evidence that the use of ARBs does not increase the risk of cancer overall or any of the four major cancer sites. Additional research is needed to further investigate a potentially increased risk of lung cancer with angiotensin-converting enzyme inhibitors and calcium channel blockers.	[Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Bartels, Dorothee B.] Boehringer Ingelheim GmbH & Co KG, Dept Global Epidemiol, Ingelheim, Germany; [Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Schiffrin, Ernesto L.] McGill Univ, Hypertens & Vasc Res Unit, Montreal, PQ H3T 1E2, Canada; [Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; Stanford University; Boehringer Ingelheim; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019; Schiffrin, Ernesto L/AAB-9061-2019; Assimes, Themistocles Leonard/D-9696-2015	Schiffrin, Ernesto L/0000-0002-4502-2823; Assimes, Themistocles Leonard/0000-0003-2349-0009; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research (CIHR); Boehringer-Ingelheim; Canadian Foundation for Innovation (CFI)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Boehringer-Ingelheim(Boehringer Ingelheim); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by grants from the Canadian Institutes of Health Research (CIHR), Boehringer-Ingelheim, and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FDA DRUG SAF COMM NO; Assimes TL, 2008, PHARMACOEPIDEM DR S, V17, P1039, DOI 10.1002/pds.1656; Assimes TL, 2011, AM J CARDIOL, V108, P902, DOI 10.1016/j.amjcard.2011.06.031; Assimes TL, 2009, CANCER CAUSE CONTROL, V20, P1811, DOI 10.1007/s10552-009-9374-3; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Friis S, 2001, CANCER-AM CANCER SOC, V92, P2462, DOI 10.1002/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L; Gonzalez-Perez A, 2005, CANCER CAUSE CONTROL, V16, P1055, DOI 10.1007/s10552-005-4705-5; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Hallas J, 2012, BR J CLIN PHARM; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Michels KB, 1998, CANCER, V83, P2003, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.3.CO;2-V; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tenenbaum A, 2001, AM J MED, V110, P143, DOI 10.1016/S0002-9343(00)00674-4; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497	25	68	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50893	10.1371/journal.pone.0050893	http://dx.doi.org/10.1371/journal.pone.0050893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251399	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200045
J	Dueholm, MS; Albertsen, M; Otzen, D; Nielsen, PH				Dueholm, Morten S.; Albertsen, Mads; Otzen, Daniel; Nielsen, Per Halkjaer			Curli Functional Amyloid Systems Are Phylogenetically Widespread and Display Large Diversity in Operon and Protein Structure	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; THIN AGGREGATIVE FIMBRIAE; SALMONELLA-ENTERITIDIS; BIOFILM FORMATION; FIBER BIOGENESIS; BINDING CURLI; FIBRONECTIN; IDENTIFICATION; TYPHIMURIUM; ATTACHMENT	Escherichia coli and a few other members of the Enterobacteriales can produce functional amyloids known as curli. These extracellular fibrils are involved in biofilm formation and studies have shown that they may act as virulence factors during infections. It is not known whether curli fibrils are restricted to the Enterobacteriales or if they are phylogenetically widespread. The growing number of genome-sequenced bacteria spanning many phylogenetic groups allows a reliable bioinformatic investigation of the phylogenetic diversity of the curli system. Here we show that the curli system is phylogenetically much more widespread than initially assumed, spanning at least four phyla. Curli fibrils may consequently be encountered frequently in environmental as well as pathogenic biofilms, which was supported by identification of curli genes in public metagenomes from a diverse range of habitats. Identification and comparison of curli subunit (CsgA/B) homologs show that these proteins allow a high degree of freedom in their primary protein structure, although a modular structure of tightly spaced repeat regions containing conserved glutamine, asparagine and glycine residues has to be preserved. In addition, a high degree of variability within the operon structure of curli subunits between bacterial taxa suggests that the curli fibrils might have evolved to fulfill specific functions. Variations in the genetic organization of curli genes are also seen among different bacterial genera. This suggests that some genera may utilize alternative regulatory pathways for curli expression. Comparison of phylogenetic trees of Csg proteins and the 16S rRNA genes of the corresponding bacteria showed remarkably similar overall topography, suggesting that horizontal gene transfer is a minor player in the spreading of the curli system.	[Dueholm, Morten S.; Albertsen, Mads; Nielsen, Per Halkjaer] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Otzen, Daniel] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark	Aalborg University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	phn@bio.aau.dk	Dueholm, Morten Simonsen/T-6718-2018; Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	Dueholm, Morten Simonsen/0000-0003-4135-2670; Nielsen, Per Halkjær/0000-0002-6402-1877; Albertsen, Mads/0000-0002-6151-190X; Otzen, Daniel/0000-0002-2918-8989	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation; Aalborg University	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation(Lundbeckfonden); Aalborg University	The authors are grateful to funding from the Villum Kann Rasmussen Foundation (BioNET), the Lundbeck Foundation and Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2; Carranza P, 2010, PROTEOMICS, V10, P3248, DOI 10.1002/pmic.200900460; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Hadi N, 2012, INFECT IMMUN, V80, P1351, DOI 10.1128/IAI.06304-11; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Nasr Abdelhakim Ben, 1996, Molecular Microbiology, V20, P927, DOI 10.1111/j.1365-2958.1996.tb02534.x; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; Otzen DE, 2011, STRUCTURE, V19, P1207, DOI 10.1016/j.str.2011.08.005; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Ryu JH, 2004, LETT APPL MICROBIOL, V39, P359, DOI 10.1111/j.1472-765X.2004.01591.x; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Taylor JD, 2011, STRUCTURE, V19, P1307, DOI 10.1016/j.str.2011.05.015; Thornley JP, 1997, REV MED MICROBIOL, V8; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; Yang S, 2009, STRUCTURAL BIOINFORM, P561; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	49	92	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51274	10.1371/journal.pone.0051274	http://dx.doi.org/10.1371/journal.pone.0051274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251478	gold, Green Published			2022-12-25	WOS:000313236200081
J	Keddy, PGW; Dunlop, K; Warford, J; Samson, ML; Jones, QRD; Rupasinghe, HPV; Robertson, GS				Keddy, Paul G. W.; Dunlop, Kate; Warford, Jordan; Samson, Michel L.; Jones, Quinton R. D.; Rupasinghe, H. P. Vasantha; Robertson, George S.			Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury	PLOS ONE			English	Article							NF-KAPPA-B; OXYGEN-GLUCOSE DEPRIVATION; COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; ERYTHROPOIETIN-MEDIATED NEUROPROTECTION; HIPPOCAMPAL NEURONAL DEATH; CYCLIN-DEPENDENT KINASES; FOCAL CEREBRAL-ISCHEMIA; GREEN TEA POLYPHENOL; X-LINKED INHIBITOR	We report here neuroprotective and anti-inflammatory effects of a flavonoid-enriched fraction isolated from the peel of Northern Spy apples (AF4) in a mouse of model of hypoxic-ischemic (HI) brain damage. Oral administration of AF4 (50 mg/kg, once daily for 3 days) prior to 50 min of HI completely prevented motor performance deficits assessed 14 days later that were associated with marked reductions in neuronal cell loss in the dorsal hippocampus and striatum. Pre-treatment with AF4 (5, 10, 25 or 50 mg/kg, p.o.; once daily for 3 days) produced a dose-dependent reduction in HI-induced hippocampal and striatal neuron cell loss, with 25 mg/kg being the lowest dose that achieved maximal neuroprotection. Comparison of the effects of 1, 3 or 7 doses of AF4 (25 mg/kg; p.o.) prior to HI revealed that at least 3 doses of AF4 were required before HI to reduce neuronal cell loss in both the dorsal hippocampus and striatum. Quantitative RT-PCR measurements revealed that the neuroprotective effects of AF4 (25 mg/kg; p.o.; once daily for 3 days) in the dorsal hippocampus were associated with a suppression of HI-induced increases in the expression of IL-1 beta, TNF-alpha and IL-6. AF4 pre-treatment enhanced mRNA levels for pro-survival proteins such as X-linked inhibitor of apoptosis and erythropoietin following HI in the dorsal hippocampus and striatum, respectively. Primary cultures of mouse cortical neurons incubated with AF4 (1 mu g/ml), but not the same concentrations of either quercetin or quercetin-3-O-glucose or its metabolites, were resistant to cell death induced by oxygen glucose deprivation. These findings suggest that the inhibition of HI-induced brain injury produced by AF4 likely involves a transcriptional mechanism resulting from the co-operative actions of various phenolics in this fraction which not only reduce the expression of pro-inflammatory mediators but also enhance pro-survival gene signalling.	[Keddy, Paul G. W.; Dunlop, Kate; Warford, Jordan; Samson, Michel L.; Jones, Quinton R. D.; Robertson, George S.] Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS, Canada; [Rupasinghe, H. P. Vasantha] Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS, Canada; [Robertson, George S.] Dalhousie Univ, Fac Med, Dept Psychiat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Robertson, GS (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS, Canada.	George.Robertson@dal.ca	Rupasinghe, H.P. Vasantha/B-6049-2013	Rupasinghe, H.P. Vasantha/0000-0003-3435-0052; Robertson, George/0000-0001-8411-7721; Warford, Jordan/0000-0003-1654-4929	Nova Scotia Heart and Stroke Foundation; Atlantic Innovation Funds; Proof-of-Concept Award (Springboard Atlantic Inc.); Natural Sciences and Engineering Council of Canada; MS Society of Canada	Nova Scotia Heart and Stroke Foundation; Atlantic Innovation Funds; Proof-of-Concept Award (Springboard Atlantic Inc.); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MS Society of Canada	This work was supported by grants from the Nova Scotia Heart and Stroke Foundation (Robertson), Atlantic Innovation Funds (Rupasinghe), Proof-of-Concept Award (Springboard Atlantic Inc.; Robertson and Rupasinghe), Natural Sciences and Engineering Council of Canada (Rupasinghe) and MS Society of Canada (Robertson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova MV, 2005, CURR NEUROVASC RES, V2, P73, DOI 10.2174/1567202052773463; Aneja R, 2004, MOL MED, V10, P55, DOI 10.2119/2004-00032.Aneja; Awad MA, 2000, SCI HORTIC-AMSTERDAM, V83, P249, DOI 10.1016/S0304-4238(99)00124-7; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cassidy A, 2012, STROKE, V43, P946, DOI 10.1161/STROKEAHA.111.637835; Chao JF, 2010, NEUROSCI LETT, V469, P360, DOI 10.1016/j.neulet.2009.12.028; Chen HH, 2007, EXP CELL RES, V313, P3106, DOI 10.1016/j.yexcr.2007.04.026; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Cherubini A, 2008, CURR MED CHEM, V15, P1236, DOI 10.2174/092986708784310431; Chinnici F, 2004, J AGR FOOD CHEM, V52, P3, DOI 10.1021/jf030459n; Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang Lumei, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1051; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Ge QF, 2007, PHARMACOL RES, V55, P148, DOI 10.1016/j.phrs.2006.11.007; Ginis I, 2000, MOL MED, V6, P1028, DOI 10.1007/BF03402054; Gutierrez-Merino C, 2011, CURR MED CHEM, V18, P1195, DOI 10.2174/092986711795029735; Ha HJ, 2003, BIOL PHARM BULL, V26, P544, DOI 10.1248/bpb.26.544; Haase VH, 2010, KIDNEY INT, V78, P10, DOI 10.1038/ki.2010.112; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Hollman PCH, 2010, J NUTR, V140, P600, DOI 10.3945/jn.109.116632; Honkaniemi J, 1996, RESTOR NEUROL NEUROS, V9, P227, DOI 10.3233/RNN-1996-9405; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; Hu K, 2011, ACTA NEUROL BELG, V111, P205; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hwang SL, 2009, J AGR FOOD CHEM, V57, P2576, DOI 10.1021/jf8033607; Inanami O, 1998, FREE RADICAL RES, V29, P359, DOI 10.1080/10715769800300401; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jeon H, 2007, MOL PHARMACOL, V71, P1676, DOI 10.1124/mol.107.034041; Jones QRD, 2012, TRENDS PHARMACOL SCI, V33, P602, DOI 10.1016/j.tips.2012.08.002; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kahle K, 2005, MOL NUTR FOOD RES, V49, P797, DOI 10.1002/mnfr.200500064; Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004; Kim SH, 2009, BIOORG MED CHEM LETT, V19, P6009, DOI 10.1016/j.bmcl.2009.09.062; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kovalenko T M, 2006, Fiziol Zh, V52, P21; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lan XF, 2008, TOHOKU J EXP MED, V216, P117, DOI 10.1620/tjem.216.117; Lapchak PA, 2007, BRAIN RES, V1167, P123, DOI 10.1016/j.brainres.2007.06.072; Lapi D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00032; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee JK, 2011, ACTA NEUROCHIR, V153, P1321, DOI 10.1007/s00701-010-0889-x; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu M, 2009, ANAT REC, V292, P412, DOI 10.1002/ar.20864; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Luke JJ, 2012, CLIN CANCER RES, V18, P2638, DOI 10.1158/1078-0432.CCR-11-3203; Ma L, 2010, NEUROCHEM RES, V35, P130, DOI 10.1007/s11064-009-0038-1; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Marczylo TH, 2009, CANCER CHEMOTH PHARM, V64, P1261, DOI 10.1007/s00280-009-0996-7; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; McGahan L, 1998, MOL BRAIN RES, V56, P133, DOI 10.1016/S0169-328X(98)00038-2; McGhie TK, 2005, J AGR FOOD CHEM, V53, P3065, DOI 10.1021/jf047832r; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Min JY, 2011, NEUROSCI LETT, V500, P157, DOI 10.1016/j.neulet.2011.05.048; Mizrahi A, 2009, BRIT J NUTR, V102, P1075, DOI 10.1017/S0007114509359097; Morand C, 2000, BIOFACTORS, V12, P169, DOI 10.1002/biof.5520120127; Mursu J, 2008, BRIT J NUTR, V100, P890, DOI 10.1017/S0007114508945694; Newcomb EW, 2004, ANTI-CANCER DRUG, V15, P411, DOI 10.1097/01.cad.0000127332.06439.47; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Nijboer CHA, 2008, STROKE, V39, P2129, DOI 10.1161/STROKEAHA.107.504175; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Olson EE, 2004, J NEUROL SCI, V227, P7, DOI 10.1016/j.jns.2004.07.021; Ossola B, 2009, EXPERT OPIN DRUG SAF, V8, P397, DOI 10.1517/14740330903026944; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Panickars KS, 2009, NUTR NEUROSCI, V12, P105, DOI 10.1179/147683009X423300; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Peluso MR, 2006, EXP BIOL MED, V231, P1287, DOI 10.1177/153537020623100802; Prasain JK, 2010, MATURITAS, V66, P163, DOI 10.1016/j.maturitas.2010.01.010; Price KR, 1999, FOOD CHEM, V66, P489, DOI 10.1016/S0308-8146(99)00099-0; Pu FL, 2007, J PHARMACOL SCI, V104, P329, DOI 10.1254/jphs.FP0070247; Pu FL, 2004, J PHARMACOL SCI, V94, P393, DOI 10.1254/jphs.94.393; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Reinboth M, 2010, BRIT J NUTR, V104, P198, DOI 10.1017/S000711451000053X; Ritz MF, 2008, BRAIN RES, V1239, P226, DOI 10.1016/j.brainres.2008.08.073; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Rupasinghe HPV, 2010, J AGR FOOD CHEM, V58, P1233, DOI 10.1021/jf903162k; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schroeter H, 2000, FREE RADICAL BIO MED, V29, P1222, DOI 10.1016/S0891-5849(00)00415-9; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Simonyi A, 2005, MOL NEUROBIOL, V31, P135, DOI 10.1385/MN:31:1-3:135; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Triantafyllou A, 2007, FREE RADICAL RES, V41, P342, DOI 10.1080/10715760601055324; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Tu XK, 2011, INFLAMMATION, V34, P463, DOI 10.1007/s10753-010-9254-8; Tunon MJ, 2009, CURR DRUG METAB, V10, P256, DOI 10.2174/138920009787846369; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Veberic R, 2005, J SCI FOOD AGR, V85, P1687, DOI 10.1002/jsfa.2113; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vrhovsek U, 2004, J AGR FOOD CHEM, V52, P6532, DOI 10.1021/jf049317z; Wagner C, 2010, ARCH TOXICOL, V84, P89, DOI 10.1007/s00204-009-0482-3; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang XQ, 2011, BRAIN RES BULL, V86, P277, DOI 10.1016/j.brainresbull.2011.07.014; Wang Z, 2007, VASC PHARMACOL, V47, P319, DOI 10.1016/j.vph.2007.09.002; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Weinreb O, 2003, ANN NY ACAD SCI, V993, P351, DOI 10.1111/j.1749-6632.2003.tb07544.x; Weinreb O, 2003, FASEB J, V17, P935, DOI 10.1096/fj.02-0712fje; Wheeler DS, 2004, J NUTR, V134, P1039, DOI 10.1093/jn/134.5.1039; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wilson WJ, 2002, BIOCHEM BIOPH RES CO, V293, P446, DOI 10.1016/S0006-291X(02)00244-9; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xie KQ, 2009, ACTA PHARMACOL SIN, V30, P889, DOI 10.1038/aps.2009.80; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xu XH, 2005, PLANTA MED, V71, P585, DOI 10.1055/s-2005-871261; Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007; Zhang ZJ, 2005, ACTA PHARMACOL SIN, V26, P307, DOI 10.1111/j.1745-7254.2005.00051.x; Zhu JTT, 2009, NEUROSCI LETT, V461, P172, DOI 10.1016/j.neulet.2009.06.010	145	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51324	10.1371/journal.pone.0051324	http://dx.doi.org/10.1371/journal.pone.0051324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251498	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200089
J	Venet, D; Detours, V; Bersini, H				Venet, David; Detours, Vincent; Bersini, Hugues			A Measure of the Signal-to-Noise Ratio of Microarray Samples and Studies Using Gene Correlations	PLOS ONE			English	Article							QUALITY-CONTROL; CELL-LINES; EXPRESSION; CANCER; ASSOCIATION; PHENOTYPE; SUBTYPES; DATABASE; MODELS; GRADE	Background: The quality of gene expression data can vary dramatically from platform to platform, study to study, and sample to sample. As reliable statistical analysis rests on reliable data, determining such quality is of the utmost importance. Quality measures to spot problematic samples exist, but they are platform-specific, and cannot be used to compare studies. Results: As a proxy for quality, we propose a signal-to-noise ratio for microarray data, the "Signal-to-Noise Applied to Gene Expression Experiments", or SNAGEE. SNAGEE is based on the consistency of gene-gene correlations. We applied SNAGEE to a compendium of 80 large datasets on 37 platforms, for a total of 24,380 samples, and assessed the signal-to-noise ratio of studies and samples. This allowed us to discover serious issues with three studies. We show that signal-to-noise ratios of both studies and samples are linked to the statistical significance of the biological results. Conclusions: We showed that SNAGEE is an effective way to measure data quality for most types of gene expression studies, and that it often outperforms existing techniques. Furthermore, SNAGEE is platform-independent and does not require raw data files. The SNAGEE R package is available in BioConductor.	[Venet, David; Bersini, Hugues] Univ Libre Bruxelles, IRIDIA, Brussels, Belgium; [Detours, Vincent] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Detours, Vincent] Univ Libre Bruxelles, WELBIO Walloon Excellence Lifesci & Biotechnol, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Venet, D (corresponding author), Univ Libre Bruxelles, IRIDIA, Brussels, Belgium.	davenet@ulb.ac.be			ICT Impulse program, Brussels Capital Region, Belgium - project In Silico	ICT Impulse program, Brussels Capital Region, Belgium - project In Silico	This work was funded by the ICT Impulse program 2006, Brussels Capital Region, Belgium - project In Silico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Asare AL, 2009, BIOINFORMATICS, V25, P48, DOI 10.1093/bioinformatics/btn591; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Chao A, 2008, RADIAT RES, V169, P76, DOI 10.1667/RR1045.1; Cope L., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1046, DOI 10.2202/1544-6115.1046]; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Freue GVC, 2007, BIOINFORMATICS, V23, P3162, DOI 10.1093/bioinformatics/btm487; GAYEN AK, 1951, BIOMETRIKA, V38, P219, DOI 10.1093/biomet/38.1-2.219; Hayashi T, 2006, PSYCHOTHER PSYCHOSOM, V75, P62, DOI 10.1159/000089228; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jumppanen M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1649; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-137; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Savonet V, 1997, ANAL BIOCHEM, V247, P165, DOI 10.1006/abio.1997.2055; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Wang JB, 2002, BIOINFORMATICS, V18, P1139, DOI 10.1093/bioinformatics/18.8.1139; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51013	10.1371/journal.pone.0051013	http://dx.doi.org/10.1371/journal.pone.0051013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251415	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200053
J	Weigel, S; Osterwalder, T; Tobler, U; Yao, L; Wiesli, M; Lehnert, T; Pandit, A; Bruinink, A				Weigel, Stefan; Osterwalder, Thomas; Tobler, Ursina; Yao, Li; Wiesli, Manuel; Lehnert, Thomas; Pandit, Abhay; Bruinink, Arie			Surface Microstructures on Planar Substrates and Textile Fibers Guide Neurite Outgrowth: A Scaffold Solution to Push Limits of Critical Nerve Defect Regeneration?	PLOS ONE			English	Article							PERIPHERAL-NERVE; GROWTH CONES; CONTACT GUIDANCE; IN-VITRO; TOPOGRAPHICAL CONTROL; AXONAL GROWTH; CELL BEHAVIOR; SCHWANN-CELLS; MIGRATION; NEURONS	The treatment of critical size peripheral nerve defects represents one of the most serious problems in neurosurgery. If the gap size exceeds a certain limit, healing can't be achieved. Connection mismatching may further reduce the clinical success. The present study investigates how far specific surface structures support neurite outgrowth and by that may represent one possibility to push distance limits that can be bridged. For this purpose, growth cone displacement of fluorescent embryonic chicken spinal cord neurons was monitored using time-lapse video. In a first series of experiments, parallel patterns of polyimide ridges of different geometry were created on planar silicon oxide surfaces. These channel-like structures were evaluated with and without amorphous hydrogenated carbon (a-C:H) coating. In a next step, structured and unstructured textile fibers were investigated. All planar surface materials (polyimide, silicon oxide and a-C:H) proved to be biocompatible, i.e. had no adverse effect on nerve cultures and supported neurite outgrowth. Mean growth cone migration velocity measured on 5 minute base was marginally affected by surface structuring. However, surface structure variability, i.e. ridge height, width and inter-ridge spacing, significantly enhanced the resulting net velocity by guiding the growth cone movement. Ridge height and inter-ridge distance affected the frequency of neurites crossing over ridges. Of the evaluated dimensions ridge height, width, and inter-ridge distance of respectively 3, 10, and 10 mu m maximally supported net axon growth. Comparable artificial grooves, fabricated onto the surface of PET fibers by using an excimer laser, showed similar positive effects. Our data may help to further optimize surface characteristics of artificial nerve conduits and bioelectronic interfaces.	[Weigel, Stefan; Osterwalder, Thomas; Tobler, Ursina; Wiesli, Manuel; Bruinink, Arie] EMPA Mat Sci & Technol, MaTisMed, Mat Biol Interact Lab, St Gallen, Switzerland; [Weigel, Stefan] Tech Univ Munich, Freising Weihenstephan, Germany; [Yao, Li; Pandit, Abhay] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Yao, Li] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA; [Lehnert, Thomas] Ecole Polytech Fed Lausanne, Lab Microsyst 2, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Technical University of Munich; Ollscoil na Gaillimhe-University of Galway; Wichita State University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bruinink, A (corresponding author), EMPA Mat Sci & Technol, MaTisMed, Mat Biol Interact Lab, St Gallen, Switzerland.	arie.bruinink@empa.ch	Weigel, Stefan/AAG-4531-2021; Pandit, Abhay/B-6187-2008; Weigel, Stefan/AAV-7453-2021; Yao, Le/J-1372-2016	Pandit, Abhay/0000-0002-6292-4933; Weigel, Stefan/0000-0002-2463-816X; 	EMPA	EMPA	The study was supported by the EMPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075; Anderson M, 2006, HEARING RES, V215, P97, DOI 10.1016/j.heares.2006.03.014; Bernard A, 2001, NAT BIOTECHNOL, V19, P866, DOI 10.1038/nbt0901-866; Bilsland J, 1999, J NEUROSCI METH, V92, P75, DOI 10.1016/S0165-0270(99)00099-0; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017; Brown MD, 2000, J NEUROBIOL, V43, P352, DOI 10.1002/1097-4695(20000615)43:4<352::AID-NEU4>3.0.CO;2-T; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; CLARK P, 1990, DEVELOPMENT, V108, P635; CLARK P, 1991, J CELL SCI, V99, P73; CLARK P, 1987, DEVELOPMENT, V99, P439; Corey JM, 1997, J NEUROSCI METH, V75, P91, DOI 10.1016/S0165-0270(97)00062-9; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.3.CO;2-L; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5; Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.0.CO;2-M; Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; KATZ MJ, 1985, J NEUROSCI, V5, P589; Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001; Kim Y-H, 2005, J SEMICONDUCTOR TECH, V5, P11; Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042; Klinkhammer K, 2010, J MATER SCI-MATER M, V21, P2637, DOI 10.1007/s10856-010-4112-7; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lee TH, 2010, NEUROMODULATION, V13, P299, DOI 10.1111/j.1525-1403.2010.00296.x; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015; Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Morelli S, 2010, BIOMATERIALS, V31, P7000, DOI 10.1016/j.biomaterials.2010.05.079; NAGATA I, 1993, DEVELOPMENT, V117, P401; Odde DJ, 1996, BIOTECHNOL BIOENG, V50, P452, DOI 10.1002/(SICI)1097-0290(19960520)50:4<452::AID-BIT13>3.0.CO;2-L; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656; Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0; Shah A, 2004, J NEUROSCI METH, V136, P123, DOI 10.1016/j.jneumeth.2004.01.010; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; SONDEREGGER P, 1985, EMBO J, V4, P1395, DOI 10.1002/j.1460-2075.1985.tb03792.x; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song M, 2007, ANN BIOMEDICAL ENG; Stepien E, 1999, CELL BIOL INT, V23, P105, DOI 10.1006/cbir.1998.0256; STIER H, 1995, DEVELOPMENT, V121, P1443; Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681; Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; TORIMITSU K, 1990, DEV BRAIN RES, V51, P128, DOI 10.1016/0165-3806(90)90265-Z; Trumble TE, 2004, J AM SOC SURG HAND, V4, P134; Wagner F, 2000, APPL SURF SCI, V168, P158, DOI 10.1016/S0169-4332(00)00577-8; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002; Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013; Zhang Q, 2012, ACTA BIOMATER, V8, P11	62	11	11	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50714	10.1371/journal.pone.0050714	http://dx.doi.org/10.1371/journal.pone.0050714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251379	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200036
J	Xu, TY; Guo, LL; Wang, P; Song, J; Le, YY; Viollet, B; Miao, CY				Xu, Tian-Ying; Guo, Ling-Ling; Wang, Pei; Song, Jie; Le, Ying-Ying; Viollet, Benoit; Miao, Chao-Yu			Chronic Exposure to Nicotine Enhances Insulin Sensitivity through alpha 7 Nicotinic Acetylcholine Receptor-STAT3 Pathway	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; STROKE; RESISTANCE; ROSIGLITAZONE; HYPERTENSION; AUTOPHAGY; RISK; PHOSPHORIBOSYLTRANSFERASE; DETERIORATION; CONTRIBUTES	This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in alpha 7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective alpha 7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-alpha 2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating alpha 7-nAChR- STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.	[Xu, Tian-Ying; Guo, Ling-Ling; Wang, Pei; Song, Jie; Miao, Chao-Yu] Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China; [Le, Ying-Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai, Peoples R China; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Viollet, Benoit] INSERM, U567, Paris, France	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Miao, CY (corresponding author), Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China.	cymiao@smmu.edu.cn	Le, Yingying/L-9785-2017; Viollet, Benoit/O-6927-2017; WANG, PEI/AAH-3926-2019; Viollet, Benoit/N-2397-2019	Le, Yingying/0000-0002-7990-3899; Viollet, Benoit/0000-0002-0121-0224; WANG, PEI/0000-0002-1650-3353; Viollet, Benoit/0000-0002-0121-0224; Miao, Chao-Yu/0000-0002-8176-3434	National Natural Science Foundation of China [81102487, 81130061]; National Basic Research Program of China [2009CB521902]; National Science and Technology Major Project [2009ZX09303-002]; Program of Shanghai Subject Chief Scientist [10XD1405300]; Shanghai 'Shu Guang' Project [10GG19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project; Program of Shanghai Subject Chief Scientist; Shanghai 'Shu Guang' Project	This research was supported by grants from the National Natural Science Foundation of China (81102487 to T-YX, 81130061 to C-YM), the National Basic Research Program of China (2009CB521902 to C-YM), the National Science and Technology Major Project (2009ZX09303-002 to C-YM), the Program of Shanghai Subject Chief Scientist (10XD1405300 to C-YM), and the Shanghai 'Shu Guang' Project (10GG19 to C-YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assali AR, 1999, CLIN CARDIOL, V22, P357, DOI 10.1002/clc.4960220512; Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; BERTRAND D, 1992, NEUROSCI LETT, V146, P87, DOI 10.1016/0304-3940(92)90179-B; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Faulds MH, 2012, CURR OPIN ONCOL, V24, P58, DOI 10.1097/CCO.0b013e32834e0582; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; [蓝晓红 LAN Xiaohong], 2008, [第二军医大学学报, Academic Journal of Second Military Medical University], V29, P156; LEVINE RR, 1960, J PHARMACOL EXP THER, V129, P296; Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077; Liu C, 2009, CRIT CARE MED, V37, P634, DOI 10.1097/CCM.0b013e31819598f5; Liu RH, 2004, J PHARMACOL EXP THER, V310, P52, DOI 10.1124/jpet.103.065037; Liu RH, 2003, EUR J PHARMACOL, V458, P227, DOI 10.1016/S0014-2999(02)02726-7; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Marrero MB, 2010, J PHARMACOL EXP THER, V332, P173, DOI 10.1124/jpet.109.154633; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moh A, 2008, DIABETES, V57, P1227, DOI 10.2337/db06-1582; Morgan TM, 2004, METABOLISM, V53, P578, DOI 10.1016/j.metabol.2003.12.006; Orrico KB, 2010, AM J MANAG CARE, V16, pE111; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; PERKINS KA, 1989, NEW ENGL J MED, V320, P898, DOI 10.1056/NEJM198904063201404; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Strader AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE447, DOI 10.1152/ajpendo.00153.2004; Swislocki ALM, 1997, METABOLISM, V46, P1008, DOI 10.1016/S0026-0495(97)90270-5; Swislocki ALM, 2003, METABOLISM, V52, P67, DOI 10.1053/meta.2003.50006; Szwaya J, 2007, J BIOMOL SCREEN, V12, P159, DOI 10.1177/1087057106297787; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wada T, 2007, ENDOCRINOLOGY, V148, P790, DOI 10.1210/en.2006-0907; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2011, CNS NEUROSCI THER, V17, P327, DOI 10.1111/j.1755-5949.2011.00265.x; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang P, 2010, J PHYSIOL SCI, V60, P317, DOI 10.1007/s12576-010-0103-1; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Waring JF, 2008, NEUROSCI RES, V60, P266, DOI 10.1016/j.neures.2007.11.008; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Winder WW, 2008, DIABETOLOGIA, V51, P1761, DOI 10.1007/s00125-008-1115-8; Xu TY, 2010, CLIN EXP PHARMACOL P, V37, P441, DOI 10.1111/j.1440-1681.2009.05328.x; Yan JG, 2010, AUTOPHAGY, V6, P67, DOI 10.4161/auto.6.1.10437; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870; Yu JG, 2011, CNS NEUROSCI THER, V17, P577, DOI 10.1111/j.1755-5949.2011.00264.x; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	58	35	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51217	10.1371/journal.pone.0051217	http://dx.doi.org/10.1371/journal.pone.0051217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251458	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200073
J	Cebecauerova, D; Strautnieks, SS; Byrne, JA; Jirsa, M; Thompson, RJ				Cebecauerova, Dita; Strautnieks, Sandra S.; Byrne, Jane A.; Jirsa, Milan; Thompson, Richard J.			ATP8B1 Gene Expression Is Driven by a Housekeeping-Like Promoter Independent of Bile Acids and Farnesoid X Receptor	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; OPEN READING FRAME; TRANSLATIONAL REGULATION; HEREDITARY CHOLESTASIS; 5'-UNTRANSLATED REGION; CANALICULAR MEMBRANE; UNTRANSLATED REGIONS; EPITHELIAL-CELLS; MESSENGER-RNA; TRANSCRIPTION	Background: Mutations in ATP8B1 gene were identified as a cause of low gamma-glutamyltranspeptidase cholestasis with variable phenotype, ranging from Progressive Familial Intrahepatic Cholestasis to Benign Recurrent Intrahepatic Cholestasis. However, only the coding region of ATP8B1 has been described. The aim of this research was to explore the regulatory regions, promoter and 5'untranslated region, of the ATP8B1 gene. Methodology/Principal Findings: 5'Rapid Amplification of cDNA Ends using human liver and intestinal tissue was performed to identify the presence of 59 untranslated exons. Expression levels of ATP8B1 transcripts were determined by quantitative reverse-transcription PCR and compared with the non-variable part of ATP8B1. Three putative promoters were examined in vitro using a reporter gene assay and the main promoter was stimulated with chenodeoxycholic acid. Four novel untranslated exons located up to 71 kb upstream of the previously published exon 1 and twelve different splicing variants were found both in the liver and the intestine. Multiple transcription start sites were identified within exon -3 and the proximal promoter upstream of this transcription start site cluster was proven to be an essential regulatory element responsible for 70% of total ATP8B1 transcriptional activity. In vitro analysis demonstrated that the main promoter drives constitutive ATP8B1 gene expression independent of bile acids. Conclusions/Significance: The structure of the ATP8B1 gene is complex and the previously published transcription start site is not significant. The basal expression of ATP8B1 is driven by a housekeeping-like promoter located 71 kb upstream of the first protein coding exon.	[Cebecauerova, Dita; Strautnieks, Sandra S.; Byrne, Jane A.; Thompson, Richard J.] Kings Coll Hosp London, Sch Med, Kings Coll London, Inst Liver Studies, London SE5 8RX, England; [Cebecauerova, Dita; Jirsa, Milan] Inst Clin & Expt Med, Lab Expt Hepatol, Prague, Czech Republic	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Institute for Clinical & Experimental Medicine (IKEM)	Cebecauerova, D (corresponding author), Kings Coll Hosp London, Sch Med, Kings Coll London, Inst Liver Studies, London SE5 8RX, England.	dita22@seznam.cz; richard.j.thompson@kcl.ac.uk	Jirsa, Milan/C-9340-2017; Thompson, Richard J/B-7954-2009; Cebecauerova, Dita/N-7612-2017	Jirsa, Milan/0000-0001-7300-6735; Thompson, Richard J/0000-0001-5652-0150; Cebecauerova, Dita/0000-0002-6529-2740	EASL Sheila Sherlock Post-doc Fellowship;  [IKEM MZO 00023001]	EASL Sheila Sherlock Post-doc Fellowship; 	Supported by EASL Sheila Sherlock Post-doc Fellowship (DC) and Institutional grant IKEM MZO 00023001 (MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; ARRICK BA, 1994, MOL CELL BIOL, V14, P619, DOI 10.1128/MCB.14.1.619; Barker DF, 2006, PHARMACOGENET GENOM, V16, P515, DOI 10.1097/01.fpc.0000215066.29342.26; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Chen F, 2004, GASTROENTEROLOGY, V126, P756, DOI 10.1053/j.gastro.2003.12.013; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Demeilliers C, 2006, HEPATOLOGY, V43, P1125, DOI 10.1002/hep.21160; Diba F, 2001, J CELL BIOCHEM, V81, P149, DOI 10.1002/1097-4644(20010401)81:1<149::AID-JCB1031>3.3.CO;2-N; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Husain A, 2007, DRUG METAB DISPOS, V35, P1649, DOI 10.1124/dmd.107.016485; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Zhang YY, 2010, MOL PHARMACOL, V77, P237, DOI 10.1124/mol.109.058982; Zhao CY, 2010, J BIOL CHEM, V285, P8552, DOI 10.1074/jbc.M109.070920; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	38	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51650	10.1371/journal.pone.0051650	http://dx.doi.org/10.1371/journal.pone.0051650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251605	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900112
J	Esezobor, CI; Ladapo, TA; Osinaike, B; Lesi, FEA				Esezobor, Christopher Imokhuede; Ladapo, Taiwo Augustina; Osinaike, Babayemi; Lesi, Foluso Ebun Afolabi			Paediatric Acute Kidney Injury in a Tertiary Hospital in Nigeria: Prevalence, Causes and Mortality Rate	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL CHILDREN; RISK-FACTORS; EPIDEMIOLOGY; LENGTH	Background: The modest decline in child mortality in Africa raises the question whether the pattern of diseases associated with acute kidney injury (AKI) in children in Nigeria has changed. Methods: A database of children, aged between one month and 16 years, with AKI (using modified pediatric RIFLE criteria) was reviewed. The cause of AKI was defined as the major underlying disease. The clinical and laboratory features of children with AKI who survived were compared to those who died. Results: Of the 4 015 children admitted into Lagos University Teaching Hospital between July 2010 and July 2012, 70 episodes of AKI were recorded equalling 17.4 cases per 1000 children. The median age of the children with AKI was 4.8 (range 0.1-14.4) years and 68.6% were males. Acute kidney injury was present in 58 (82.9%) children at admission with 70% in 'failure' category. Primary kidney disease (38.6%), sepsis (25.7%) and malaria (11.4%) were the commonest causes. The primary kidney diseases were acute glomerulonephritis (11) and nephrotic syndrome (8). Nineteen (28.4%) children with AKI died. Need for dialysis [odds ratio: 10.04 (2.94-34.33)], white cell.15 000/mm(3) [odds ratio: 5.72 (1.65-19.89)] and platelet,100 000/mm3 [odds ratio: 9.56 (2.63-34.77)] were associated with death. Conclusion: Acute kidney injury is common in children admitted to hospitals. The common causes remain primary kidney diseases, sepsis and malaria but the contribution of sepsis is rising while malaria and gastroenteritis are declining. Acute kidney injury-related mortality remains high. Citation: Esezobor CI, Ladapo TA, Osinaike B, Lesi FEA (2012) Paediatric Acute Kidney Injury in a Tertiary Hospital in Nigeria: Prevalence, Causes and Mortality Rate. PLoS ONE 7(12): e51229. doi:10.1371/journal.pone.0051229	[Esezobor, Christopher Imokhuede; Lesi, Foluso Ebun Afolabi] Univ Lagos, Dept Paediat, Coll Med, Idi Araba, Lagos State, Nigeria; [Esezobor, Christopher Imokhuede; Ladapo, Taiwo Augustina; Osinaike, Babayemi; Lesi, Foluso Ebun Afolabi] Univ Lagos, Dept Paediat, Teaching Hosp, Idi Araba, Lagos State, Nigeria	University of Lagos; University of Lagos	Esezobor, CI (corresponding author), Univ Lagos, Dept Paediat, Coll Med, Idi Araba, Lagos State, Nigeria.	esezobor@gmail.com	Esezobor, Christopher Imokhuede/AAP-2230-2020	Esezobor, Christopher Imokhuede/0000-0003-1736-4794; Ladapo, Taiwo/0000-0002-9969-6233; Lesi, Foluso/0000-0002-1737-1524	International Pediatric Nephrology Association	International Pediatric Nephrology Association	We acknowledge the contribution of the International Pediatric Nephrology Association which provided sponsorship to CIE and TAL to undertake fellowship training in paediatric nephrology including basic clinical research. We are also grateful to the unit's resident doctors who helped in maintaining the accuracy of the database.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Andreoli SP, 2009, PEDIATR NEPHROL, V24, P253, DOI 10.1007/s00467-008-1074-9; Anochie IC, 2005, PEDIATR NEPHROL, V20, P1610, DOI 10.1007/s00467-005-1984-8; [Anonymous], 2004, PEDIATRICS, V114, P22; Assounga A G, 2000, Saudi J Kidney Dis Transpl, V11, P40; Bailey D, 2007, PEDIATR CRIT CARE ME, V8, P29, DOI 10.1097/01.pcc.0000256612.40265.67; Ball EF, 2008, J PAEDIATR CHILD H, V44, P642, DOI 10.1111/j.1440-1754.2008.01373.x; Bresolin N, 2009, PEDIATR NEPHROL, V24, P537, DOI 10.1007/s00467-008-1054-0; Bunchman TE, 2001, PEDIATR NEPHROL, V16, P1067, DOI 10.1007/s004670100029; Chang JW, 2008, CLIN NEPHROL, V70, P485; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Duzova A, 2010, PEDIATR NEPHROL, V25, P1453, DOI 10.1007/s00467-010-1541-y; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hui-Stickle S, 2005, AM J KIDNEY DIS, V45, P96, DOI 10.1053/j.ajkd.2004.09.028; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Olowu WA, 2004, KIDNEY INT, V66, P1541, DOI 10.1111/j.1523-1755.2004.00918.x; Olowu WA, 2003, PEDIATR NEPHROL, V18, P1249, DOI 10.1007/s00467-003-1255-5; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Vachvanichsanong P, 2006, PEDIATRICS, V118, pE786, DOI 10.1542/peds.2006-0557; Van Biljon G, 2008, J TROP PEDIATRICS, V54, P233, DOI 10.1093/tropej/fmm079	21	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51229	10.1371/journal.pone.0051229	http://dx.doi.org/10.1371/journal.pone.0051229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251463	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900056
J	Huang, CY; Chen, CA; Chen, YL; Chiang, CJ; Hsu, TH; Lin, MC; Lai, MS; Chen, CJ; You, SL; Cheng, WF				Huang, Chia-Yen; Chen, Chi-An; Chen, Yu-Li; Chiang, Chun-Ju; Hsu, Tsui-Hsia; Lin, Ming-Chieh; Lai, Mei-Shu; Chen, Chien-Jen; You, San-Lin; Cheng, Wen-Fang			Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan	PLOS ONE			English	Article							CLEAR-CELL-CARCINOMA; ENDOMETRIAL CANCER; BREAST-CANCER; PROGNOSIS; NORWAY; TRENDS; IMPACT; TUMORS; RISK	Introduction: Uterine cancer was the most rapidly increasing malignancy and the second most common gynecologic malignancy in Taiwan. Methods: We analyzed the secular trend of uterine cancer incidence and compare the survival of women with uterine carcinomas and uterine sarcomas in Taiwan. Data on women diagnosed with uterine cancer between 1979 and 2008 were obtained from the Taiwan cancer registry. Survival data were analyzed by using Kaplan-Meier and Cox proportional hazards regression methods. Results: Records of 11,558 women with uterine carcinomas and 1,226 women with uterine sarcomas were analyzed. The age-adjusted incidence rate of endometrioid adenocarcinoma increased from 0.83 per 100,000 women per year between 1979 and 1983 to 7.50 per 100,000 women per year between 2004 and 2008. The 5-year survival rate of women with endometrioid adenocarcinoma (83.2%) was higher than that for women with clear cell carcinoma (58.3%), serous carcinoma (54.4%), and carcinosarcoma (35.2%) (p<0.0001, log-rank test). The 5-year survival rates of women with low grade endometrial stromal sarcoma, endometrial stromal sarcoma, leiomyosarcoma (LMS), and adenosarcoma were 97.5%, 73.5%, 60.1%, and 77.2%, respectively (p<0.0001, log rank test). The histologic type of endometrioid adenocarcinoma, young age, and treatment period after 2000 were independent, favorable prognostic factors in women with uterine carcinomas by multivariate analysis. The histologic type of LMS, old age, and treatment period after 2000 were independent, poor prognostic factors in women with uterine sarcomas by multivariate analysis. Conclusions: An increase over time in the number of patients with endometrioid adenocarcinomas was noted in this 30-year, nationwide, population-based study. Histologic type, age and treatment period were survival factors for uterine cancers. A more comprehensive assessment of uterine cancers and patient care should be undertaken on this increasingly common type of cancer.	[You, San-Lin] Natl Def Med Ctr, Inst Life Sci, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chia-Yen; Chen, Yu-Li] Cathay Gen Hosp, Gynecol Canc Ctr, Taipei, Taiwan; [Chen, Chi-An; Cheng, Wen-Fang] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chiang, Chun-Ju; Lai, Mei-Shu; Chen, Chien-Jen] Natl Taiwan Univ, Grad Inst Epidemiol, Coll Publ Hlth, Taipei 10764, Taiwan; [Hsu, Tsui-Hsia] Execut Yuan, Bur Hlth Promot, Dept Hlth, Taipei, Taiwan; [Lin, Ming-Chieh] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; [Huang, Chia-Yen; Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan	National Defense Medical Center; Cathay General Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	You, SL (corresponding author), Natl Def Med Ctr, Inst Life Sci, Sch Publ Hlth, Taipei, Taiwan.	yousl1990@ntu.edu.tw; wenfangcheng@yahoo.com	Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	CHIANG, CHUN-JU/0000-0002-1330-5319; CHENG, WEN-FANG/0000-0002-3282-6304; Lai, Mei-shu/0000-0001-6130-3468; You, San-Lin/0000-0002-3192-3356; CHEN, CHI-AN/0000-0001-6670-7939				Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y; ABELER VM, 1992, INT J GYNECOL CANCER, V2, P9, DOI 10.1046/j.1525-1438.1992.02010009.x; Albrektsen G, 2009, INT J GYNECOL CANCER, V19, P1062, DOI 10.1111/IGC.0b013e3181aaa950; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boll D, 2012, INT J GYNECOL CANCER, V22, P599, DOI 10.1097/IGC.0b013e318244cedc; BRINTON LA, 1992, AM J OBSTET GYNECOL, V167, P1317, DOI 10.1016/S0002-9378(11)91709-8; Chan JK, 2011, J CLIN ONCOL, V29, P832, DOI 10.1200/JCO.2010.31.2124; Chen CY, 2007, SCI TOTAL ENVIRON, V378, P352, DOI 10.1016/j.scitotenv.2007.02.038; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Dijkhuizen FPHLJ, 2000, CANCER, V89, P1765, DOI 10.1002/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Fang GC, 2004, CHEMOSPHERE, V54, P443, DOI 10.1016/S0045-6535(03)00706-9; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; KAY S, 1957, CANCER, V10, P124, DOI 10.1002/1097-0142(195701/02)10:1<124::AID-CNCR2820100118>3.0.CO;2-2; KILGORE LC, 1995, GYNECOL ONCOL, V56, P29, DOI 10.1006/gyno.1995.1005; Lai Fu-Ming, 1996, Proceedings of the National Science Council Republic of China Part B Life Sciences, V20, P71; Lee MM, 2005, CANCER CAUSE CONTROL, V16, P929, DOI 10.1007/s10552-005-4932-9; Lin CH, 2012, INT J CANCER, V130, P2629, DOI 10.1002/ijc.26249; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; MACMAHON B, 1974, Gynecologic Oncology, V2, P122, DOI 10.1016/0090-8258(74)90003-1; Mariani A, 2000, GYNECOL ONCOL, V76, P348, DOI 10.1006/gyno.1999.5688; McCluggage WG, 2002, INT J GYNECOL CANCER, V12, P687, DOI 10.1046/j.1525-1438.2002.01151.x; Nordal RR, 1997, EUR J CANCER, V33, P907, DOI 10.1016/S0959-8049(97)00040-3; OLAH KS, 1991, EUR J CANCER, V27, P1095, DOI 10.1016/0277-5379(91)90300-3; OLAH KS, 1992, BRIT J OBSTET GYNAEC, V99, P590, DOI 10.1111/j.1471-0528.1992.tb13827.x; PARAZZINI F, 1991, GYNECOL ONCOL, V41, P1, DOI 10.1016/0090-8258(91)90246-2; Park JY, 2011, GYNECOL ONCOL, V122, P255, DOI 10.1016/j.ygyno.2011.04.021; PIVER MS, 1984, OBSTET GYNECOL, V64, P173; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILVERBERG SG, 1973, CANCER-AM CANCER SOC, V31, P1127, DOI 10.1002/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E; Silverberg SGKR., 1992, AFIP ATLAS SER; Tavassoeli FA, 2003, WHO CLASSIFICATION T; TCRTF, 2009, CANC REG ANN REP; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.075; Yang PS, 1997, BRIT J CANCER, V75, P752, DOI 10.1038/bjc.1997.133	41	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51372	10.1371/journal.pone.0051372	http://dx.doi.org/10.1371/journal.pone.0051372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251510	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900073
J	Millrud, CR; Kvarnhammar, AM; Uddman, R; Bjornsson, S; Riesbeck, K; Cardell, LO				Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Uddman, Rolf; Bjornsson, Sven; Riesbeck, Kristian; Cardell, Lars Olaf			The Activation Pattern of Blood Leukocytes in Head and Neck Squamous Cell Carcinoma Is Correlated to Survival	PLOS ONE			English	Article							TUMOR-ASSOCIATED NEUTROPHILS; NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; LYMPHOCYTE RATIO; PREDICTS SURVIVAL; MONOCYTE COUNTS; OVARIAN-CANCER; T-LYMPHOCYTE; CYTOKINES; DISEASE	Head and neck squamous cell carcinoma (HNSCC) is known to cause substantial immunosuppression. The present study was designed to characterize blood leukocyte activation in HNSCC and to investigate if the individual activation pattern could be related to tumor progress and survival. The leukocyte activation profile of HNSCC patients and healthy controls was assessed with flow cytometry. HNSCC patients displayed increased numbers of monocytes, neutrophils and total leukocytes as well as an enhanced neutrophil/lymphocyte ratio. In addition, patients had a higher percentage of CD69(+), CD71(+) and CD98(+) T cell subsets and NK cells, and a reduced expression of L-selectin in CD14(high)CD16(+) monocytes and neutrophils, when compared to controls. These changes could be correlated to both tumor burden and spread to lymph nodes. Among the cancer patients an increased neutrophil/lymphocyte ratio, a low neutrophil and CD14(high) CD16(+) monocyte activation state and an elevated CD4/CD8 ratio were related to poor survival. In contrast, a high percentage of CD98(+) Th cells appeared to be associated with a better outcome. Taken together, the present data indicate that HNSCC causes activation of blood leukocytes and that the individual activation pattern can be linked to prognosis.	[Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Cardell, Lars Olaf] Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Uddman, Rolf] Lund Univ, Skane Univ Hosp, Dept Otorhinolaryngol, Malmo, Sweden; [Bjornsson, Sven; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Lab Med Malmo, Malmo, Sweden	Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Cardell, LO (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Rydberg Millrud, Camilla/0000-0002-5873-2197; Riesbeck, Kristian/0000-0001-6274-6965	Swedish Medical Research Council; Karolinska Institutet; Skane University Hospital in Malmo	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); Skane University Hospital in Malmo	The present work was supported by the Swedish Medical Research Council, Karolinska Institutet and Skane University Hospital in Malmo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Bose A, 2006, ORAL ONCOL, V42, P161, DOI 10.1016/j.oraloncology.2005.06.025; Bose Anamika, 2008, Cancer Immun, V8, P10; Boucek J, 2009, J CELL MOL MED; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Cho H, 2009, BIOMARKERS, V14, P161, DOI 10.1080/13547500902777616; da Silveira EJD, 2010, EXP MOL PATHOL, V88, P171, DOI 10.1016/j.yexmp.2009.11.009; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Giuntoli RL, 2009, ANTICANCER RES, V29, P2875; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Heimdal JH, 2000, LARYNGOSCOPE, V110, P402, DOI 10.1097/00005537-200003000-00013; Heimdal JH, 1999, EUR ARCH OTO-RHINO-L, V256, P250, DOI 10.1007/s004050050152; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; Hirashima M, 1998, J CANCER RES CLIN, V124, P329, DOI 10.1007/s004320050178; Karlsson M, 2010, SCAND J IMMUNOL, V71, P362, DOI 10.1111/j.1365-3083.2010.02377.x; Koga Y, 2004, CANCER RES, V64, P1037, DOI 10.1158/0008-5472.CAN-03-1808; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lathers DMR, 2003, HUM IMMUNOL, V64, P1160, DOI 10.1016/j.humimm.2003.08.024; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sheu BC, 1999, CANCER-AM CANCER SOC, V86, P1537, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Woods KV, 1998, CANCER RES, V58, P3132; Xie L, 2007, INT J MOL MED, V20, P493; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	29	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51120	10.1371/journal.pone.0051120	http://dx.doi.org/10.1371/journal.pone.0051120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251433	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900043
J	Otterbein, S; Abel, C; Heinemann, LV; Kaiser, J; Schmidt-Kassow, M				Otterbein, Sascha; Abel, Cornelius; Heinemann, Linda V.; Kaiser, Jochen; Schmidt-Kassow, Maren			P3b Reflects Periodicity in Linguistic Sequences	PLOS ONE			English	Article							ENTRAINMENT; ATTENTION; TIME; REGULARITY; LANGUAGE; SYNTAX	Temporal predictability is thought to affect stimulus processing by facilitating the allocation of attentional resources. Recent studies have shown that periodicity of a tonal sequence results in a decreased peak latency and a larger amplitude of the P3b compared with temporally random, i.e., aperiodic sequences. We investigated whether this applies also to sequences of linguistic stimuli (syllables), although speech is usually aperiodic. We compared aperiodic syllable sequences with two temporally regular conditions. In one condition, the interval between syllable onset was fixed, whereas in a second condition the interval between the syllables' perceptual center (p-center) was kept constant. Event-related potentials were assessed in 30 adults who were instructed to detect irregularities in the stimulus sequences. We found larger P3b amplitudes for both temporally predictable conditions as compared to the aperiodic condition and a shorter P3b latency in the p-center condition than in both other conditions. These findings demonstrate that even in acoustically more complex sequences such as syllable streams, temporal predictability facilitates the processing of deviant stimuli. Furthermore, we provide first electrophysiological evidence for the relevance of the p-center concept in linguistic stimulus processing.	[Otterbein, Sascha; Abel, Cornelius; Heinemann, Linda V.; Kaiser, Jochen; Schmidt-Kassow, Maren] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany	Goethe University Frankfurt	Schmidt-Kassow, M (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany.	schmidt.kassow@yahoo.de	Kaiser, Jochen/T-9184-2017	Kaiser, Jochen/0000-0001-6740-5000	German Research Foundation [DFG SCHM 2693/1-1]	German Research Foundation(German Research Foundation (DFG))	MSK was supported by a grant from the German Research Foundation (DFG SCHM 2693/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Boersma P, 2001, GLOT INT, V5, P341; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Coulson S, 1998, LANG COGNITIVE PROC, V13, P653, DOI 10.1080/016909698386410; Cummins F, 1998, J PHONETICS, V26, P145, DOI 10.1006/jpho.1998.0070; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dutoit T., 1997, INTRO TEXT TO SPEECH, DOI [DOI 10.1007/978-94-011-5730-8, 10.1007/978-94-011-5730-8]; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Janker P., 1996, ELEMENTS GEN PHONETI, V7, P94; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lange K, 2010, INT J PSYCHOPHYSIOL, V78, P231, DOI 10.1016/j.ijpsycho.2010.08.003; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schmidt-Kassow M, 2008, BRAIN RES, V1226, P144, DOI 10.1016/j.brainres.2008.06.017; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P1643, DOI 10.1097/WNR.0b013e328333b0c6; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Scott SK, 1998, PSYCHOL RES-PSYCH FO, V61, P4, DOI 10.1007/PL00008162; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661	32	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51419	10.1371/journal.pone.0051419	http://dx.doi.org/10.1371/journal.pone.0051419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251527	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900085
J	Peng, B; Gu, YX; Xiong, Y; Zheng, GP; He, ZM				Peng, Bo; Gu, Yixue; Xiong, Yan; Zheng, Guopei; He, Zhimin			Microarray-Assisted Pathway Analysis Identifies MT1X & NF kappa B as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; GASTRIC-CANCER; METALLOTHIONEIN; EXPRESSION; GENES; APOPTOSIS; PROTEINS; HEAD; CHEMORESISTANCE; CHEMOTHERAPY	We recently reported that TCRP1, a novel multidrug-resistance associated human gene, can mediate cisplatin resistance in OSCC cells. However, the molecular mechanism underlying this role of TCRP1 remained to be elucidated. In this study, by using Human Toxicology and Drug Resistance Microarray, we identified 30 genes with significantly different expression levels between Tca/PYM and TCRP1 knockdown cell lines. Co-immunoprecipitation experiments and GST-pull down assays showed that metallothionein1X (MT1X) and Akt interact with TCRP1. siRNA-mediated knockdown of TCRP1 and MT1X was found to sensitize cells to cisplatin, leading to increased apoptosis and inhibition of cell proliferation. These functions of TCRP1 may be caused at least in part via activation of the PI3K/Akt/NF-kappa B signaling pathway. Taken together, our findings indicate that TCRP1 may be an important drug target for improvement of the treatment and survival of patients with oral squamous cell carcinoma.	[Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Xiong, Yan] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Peng, Bo] Univ S China, Canc Res Inst, Coll Med, Hengyang, Hunan, Peoples R China; [Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; University of South China; Central South University	He, ZM (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China.	hezhimin2005@yahoo.com			National Natural Science Foundation of China [30873088]; Nature Science Foundation of Guangdong Province in China [S2012010008995]; Science and Technology Committee of Hunan Province, China [2012SK3157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangdong Province in China; Science and Technology Committee of Hunan Province, China	This research was supported by grants from the National Natural Science Foundation of China (30873088), Nature Science Foundation of Guangdong Province in China (S2012010008995) and the Science and Technology Committee of Hunan Province, China (2012SK3157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2006, P NATL ACAD SCI USA, V103, P1699, DOI 10.1073/pnas.0510407103; Chock KL, 2010, CANCER RES, V70, P8782, DOI 10.1158/0008-5472.CAN-10-1352; CHU G, 1994, J BIOL CHEM, V269, P787; Chun JH, 2004, CANCER RES, V64, P4703, DOI 10.1158/0008-5472.CAN-04-1063; Fraser M, 2003, CANCER RES, V63, P7081; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Gu YX, 2011, MOL CELL BIOCHEM, V357, P107, DOI 10.1007/s11010-011-0880-8; Gu YX, 2011, FEBS LETT, V585, P881, DOI 10.1016/j.febslet.2010.12.045; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hebbring SJ, 2008, CYTOGENET GENOME RES, V123, P205, DOI 10.1159/000184710; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kim HG, 2009, TOXICOL SCI, V112, P435, DOI 10.1093/toxsci/kfp230; Kim MO, 2008, CANCER LETT, V271, P25, DOI 10.1016/j.canlet.2008.05.034; Kim MJ, 2007, CANCER LETT, V245, P284, DOI 10.1016/j.canlet.2006.01.017; Konkimalla VB, 2008, IN VIVO, V22, P279; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lepper ER, 2005, CLIN CANCER RES, V11, P7398, DOI 10.1158/1078-0432.CCR-05-0520; Marsh S, 2009, PHARMACOGENET GENOM, V19, P563, DOI 10.1097/FPC.0b013e32832e0ed7; Meijer C, 2000, INT J CANCER, V85, P777, DOI 10.1002/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Peng B, 2012, PROTEIN EXPR PURIF; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; SATOH M, 1994, CANCER RES, V54, P5255; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Vernhet L, 2003, J PHARMACOL EXP THER, V304, P145, DOI 10.1124/jpet.102.042176; WINGE DR, 1991, METHOD ENZYMOL, V205, P438; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yang F, 2007, PROTEIN EXPRES PURIF, V53, P186, DOI 10.1016/j.pep.2006.12.007; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zhang P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-224; Zheng GP, 2012, FEBS LETT, V586, P163, DOI 10.1016/j.febslet.2011.11.034; Zheng GP, 2010, FEBS J, V277, P4506, DOI 10.1111/j.1742-4658.2010.07836.x	37	28	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51413	10.1371/journal.pone.0051413	http://dx.doi.org/10.1371/journal.pone.0051413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251525	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900082
J	Sun, DF; Sun, GL				Sun, Dongfa; Sun, Genlou			Untangling Nucleotide Diversity and Evolution of the H Genome in Polyploid Hordeum and Elymus Species Based on the Single Copy of Nuclear Gene DMC1	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; RECURRENT FORMATION; RPB2 GENE; ADH LOCI; ORIGIN; POACEAE; WHEAT; DIFFERENTIATION; INTROGRESSION; POLYMORPHISM	Numerous hybrid and polypoid species are found within the Triticeae. It has been suggested that the H subgenome of allopolyploid Elymus (wheatgrass) species originated from diploid Hordeum (barley) species, but the role of hybridization between polyploid Elymus and Hordeum has not been studied. It is not clear whether gene flow across polyploid Hordeum and Elymus species has occurred following polyploid speciation. Answering these questions will provide new insights into the formation of these polyploid species, and the potential role of gene flow among polyploid species during polyploid evolution. In order to address these questions, disrupted meiotic cDNA1 (DMC1) data from the allopolyploid StH Elymus are analyzed together with diploid and polyploid Hordeum species. Phylogenetic analysis revealed that the H copies of DMC1 sequence in some Elymus are very close to the H copies of DMC1 sequence in some polyploid Hordeum species, indicating either that the H genome in theses Elymus and polyploid Hordeum species originated from same diploid donor or that gene flow has occurred among them. Our analysis also suggested that the H genomes in Elymus species originated from limited gene pool, while H genomes in Hordeum polyploids have originated from broad gene pools. Nucleotide diversity (pi) of the DMC1 sequences on H genome from polyploid species (pi = 0.02083 in Elymus, pi = 0.01680 in polyploid Hordeum) is higher than that in diploid Hordeum (pi = 0.01488). The estimates of Tajima's D were significantly departure from the equilibrium neutral model at this locus in diploid Hordeum species (P<0.05), suggesting an excess of rare variants in diploid species which may not contribute to the origination of polyploids. Nucleotide diversity (pi) of the DMC1 sequences in Elymus polyploid species (pi = 0.02083) is higher than that in polyploid Hordeum (pi = 0.01680), suggesting that the degree of relationships between two parents of a polyploid might be a factor affecting nucleotide diversity in allopolyploids.	[Sun, Dongfa; Sun, Genlou] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Saint Marys University - Canada	Sun, GL (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	genlou.sun@smu.ca			Natural Sciences and Engineering Research Council of Canada [238425]; Canadian Foundation for Innovation; Saint Mary's University; earmarked fund for China Agriculture Research System	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Saint Mary's University; earmarked fund for China Agriculture Research System	This research was supported by a discovery grant (238425) from Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation, and a Senate research grant at Saint Mary's University to GS, and the earmarked fund for China Agriculture Research System to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Barrier M, 2001, P NATL ACAD SCI USA, V98, P10208, DOI 10.1073/pnas.181257698; BAUM BR, 1991, CAN J BOT, V69, P2421, DOI 10.1139/b91-300; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Bothmer R. von, 1986, Canadian Journal of Genetics and Cytology, V28, P525; Bothmer von R, 1987, EVOL TREND PLANT, V1, P42; BROCHMANN C, 1992, PLANT SYST EVOL, V182, P35, DOI 10.1007/BF00941414; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; DEWEY D R, 1984, P209; DOEBLEY J, 1992, AM J BOT, V79, P576, DOI 10.2307/2444870; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Espinoza NR, 2002, J HERED, V93, P81, DOI 10.1093/jhered/93.2.81; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FU YX, 1993, GENETICS, V133, P693; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; JORGENSEN RB, 1986, HEREDITAS, V104, P273, DOI 10.1111/j.1601-5223.1986.tb00541.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lawton-Rauh A, 2003, MOL ECOL, V12, P1301, DOI 10.1046/j.1365-294X.2003.01814.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1994, PLANT SYST EVOL, V192, P165, DOI 10.1007/BF00986250; Love A., 1984, Feddes Repertorium, V95, P425; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; Mason-Gamer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010989; Nishikawa T, 2002, GENOME, V45, P1157, DOI [10.1139/g02-088, 10.1139/G02-088]; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Petersen G, 2000, MOL BIOL EVOL, V17, P1589, DOI 10.1093/oxfordjournals.molbev.a026258; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Petersen G, 2004, SYST BOT, V29, P862, DOI 10.1600/0363644042451080; Petersen G, 2003, SYST BOT, V28, P293; RAJHATHY T, 1966, CAN J BOTANY, V44, P1224, DOI 10.1139/b66-135; Sha LN, 2010, MOL PHYLOGENET EVOL, V54, P327, DOI 10.1016/j.ympev.2009.05.005; Slotte T, 2008, MOL BIOL EVOL, V25, P1472, DOI 10.1093/molbev/msn092; Small RL, 1999, MOL BIOL EVOL, V16, P491, DOI 10.1093/oxfordjournals.molbev.a026131; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun GL, 2011, GENOME, V54, P655, DOI [10.1139/G11-036, 10.1139/g11-036]; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Sun G, 2009, BREEDING SCI, V59, P487, DOI 10.1270/jsbbs.59.487; Sun GL, 1997, GENOME, V40, P806, DOI 10.1139/g97-804; SVITASHEV S, 1994, THEOR APPL GENET, V89, P801, DOI 10.1007/BF00224500; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TAJIMA F, 1989, GENETICS, V123, P585; Taketa S, 2005, ANN BOT-LONDON, V96, P23, DOI 10.1093/aob/mci147; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Vanichanon A, 2003, THEOR APPL GENET, V106, P804, DOI 10.1007/s00122-002-1092-0; von Bothmer R., 1994, P 2 INT TRIT S UT ST, P1; Wang H, 2011, BOTANY, V89, P405, DOI [10.1139/B11-030, 10.1139/b11-030]; WANG RRC, 1986, CAN J GENET CYTOL, V28, P947, DOI 10.1139/g86-132; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	65	9	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50369	10.1371/journal.pone.0050369	http://dx.doi.org/10.1371/journal.pone.0050369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251367	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900011
J	Thelen, K; Jaehrling, S; Spatz, JP; Pollerberg, GE				Thelen, Karsten; Jaehrling, Steffen; Spatz, Joachim P.; Pollerberg, G. Elisabeth			Depending on Its Nano-Spacing, ALCAM Promotes Cell Attachment and Axon Growth	PLOS ONE			English	Article							MOLECULE DM-GRASP; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; GANGLION-CELLS; MESSENGER-RNA; PROTEIN; EXPRESSION; NEURONS; BEN; NANOPATTERNS	ALCAM is a member of the cell adhesion molecule (CAM) family which plays an important role during nervous system formation. We here show that the two neuron populations of developing dorsal root ganglia (DRG) display ALCAM transiently on centrally and peripherally projecting axons during the two phases of axon outgrowth. To analyze the impact of ALCAM on cell adhesion and axon growth, DRG single cells were cultured on ALCAM-coated coverslips or on nanopatterns where ALCAM is presented in physiological amino-carboxyl terminal orientation at highly defined distances (29, 54, 70, 86, and 137 nm) and where the interspaces are passivated to prevent unspecific protein deposition. Some axonal features (branching, lateral deviation) showed density dependence whereas others (number of axons per neuron, various axon growth parameters) turned out to be an all-or-nothing reaction. Time-lapse analyses revealed that ALCAM density has an impact on axon velocity and advance efficiency. The behavior of the sensory axon tip, the growth cone, partially depended on ALCAM density in a dose-response fashion (shape, dynamics, detachment) while other features did not (size, complexity). Whereas axon growth was equally promoted whether ALCAM was presented at high (29 nm) or low densities (86 nm), the attachment of non-neuronal cells depended on high ALCAM densities. The attachment of non-neuronal cells to the rather unspecific standard proteins presented by conventional implants designed to enhance axonal regeneration is a severe problem. Our findings point to ALCAM, presented as 86 nm pattern, for a promising candidate for the improvement of such implants since this pattern drives axon growth to its full extent while at the same time non-neuronal cell attachment is clearly reduced.	[Thelen, Karsten; Jaehrling, Steffen; Pollerberg, G. Elisabeth] Heidelberg Univ, Dept Dev Neurobiol, Ctr Organismal Studies, Heidelberg, Germany; [Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg	Pollerberg, GE (corresponding author), Heidelberg Univ, Dept Dev Neurobiol, Ctr Organismal Studies, Heidelberg, Germany.	G.E.Pollerberg@cos.uni-heidelberg.de	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	German Research Council (DFG) [GK791, PO289, SFB488]	German Research Council (DFG)(German Research Foundation (DFG))	The project is funded by the German Research Council (DFG; GK791, PO289 and SFB488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Avci HX, 2004, DEV BIOL, V271, P291, DOI 10.1016/j.ydbio.2004.03.035; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Chedotal A, 1996, J NEUROSCI, V16, P3296; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; De Jonge F, 2004, AM J PHYSIOL-GASTR L, V287, pG178, DOI 10.1152/ajpgi.00528.2003; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; He Y, 2003, METHOD CELL BIOL, V71, P17, DOI 10.1016/S0091-679X(03)01002-1; Heffron DS, 2000, J NEUROSCI, V20, P2287; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42; Jaehrling S, 2009, NANO LETT, V9, P4115, DOI 10.1021/nl9023325; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; POLLERBERG GE, 1994, DEV BIOL, V165, P670, DOI 10.1006/dbio.1994.1284; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1993, DEV BIOL, V156, P324, DOI 10.1006/dbio.1993.1081; POURQUIE O, 1990, DEVELOPMENT, V109, P743; POURQUIE O, 1992, J NEUROSCI, V12, P1548; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SENIOR PV, 1988, DEVELOPMENT, V104, P431; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; STOECKLI ET, 1989, EUR J BIOCHEM, V180, P249, DOI 10.1111/j.1432-1033.1989.tb14640.x; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; Thelen K, 2007, SOFT MATTER, V3, P1486, DOI 10.1039/b707250c; Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Wolfram T, 2007, BIOINTERPHASES, V2, P44, DOI 10.1116/1.2713991; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934	42	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e40493	10.1371/journal.pone.0040493	http://dx.doi.org/10.1371/journal.pone.0040493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251325	gold, Green Submitted, Green Published			2022-12-25	WOS:000312201900001
J	Xu, J; Tian, HR; Wang, W; Liang, AH				Xu, Jing; Tian, Huaru; Wang, Wei; Liang, Aihua			The Zinc Finger Protein Zfr1p Is Localized Specifically to Conjugation Junction and Required for Sexual Development in Tetrahymena thermophila	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; GENOME REARRANGEMENT; MACRONUCLEAR ANLAGEN; GENE; EXCHANGE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; ARGONAUTE; SEQUENCE	Conjugation in Tetrahymena thermophila involves a developmental program consisting of three prezygotic nuclear divisions, pronuclear exchange and fusion, and postzygotic and exconjugant stages. The conjugation junction structure appears during the initiation of conjugation development, and disappears during the exconjugant stage. Many structural and functional proteins are involved in the establishment and maintenance of the junction structure in T. thermophila. In the present study, a zinc finger protein-encoding gene ZFR1 was found to be expressed specifically during conjugation and to localize specifically to the conjugation junction region. Truncated Zfr1p localized at the plasma membrane in ordered arrays and decorated Golgi apparatus located adjacent to basal body. The N-terminal zinc finger and C-terminal hydrophobic domains of Zfr1p were found to be required for its specific conjugation junction localization. Conjugation development of ZFR1 somatic knockout cells was aborted at the pronuclear exchange and fusion conjugation stages. Furthermore, Zfr1p was found to be important for conjugation junction stability during the prezygotic nuclear division stage. Taken together, our data reveal that Zfr1p is required for the stability and integrity of the conjugation junction structure and essential for the sexual life cycle of the Tetrahymena cell.	[Xu, Jing; Tian, Huaru; Wang, Wei; Liang, Aihua] Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan, Peoples R China	Shanxi University	Wang, W (corresponding author), Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan, Peoples R China.	gene@sxu.edu.cn			National Natural Scientific Foundation of China [30770295, 31072000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by grants from the National Natural Scientific Foundation of China (30770295 and 31072000) to W. Wang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIS CD, 1982, DEV BIOL, V93, P519, DOI 10.1016/0012-1606(82)90139-7; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; CassidyHanley D, 1997, GENETICS, V146, P135; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Cole ES, 2008, J EUKARYOT MICROBIOL, V55, P245, DOI 10.1111/j.1550-7408.2008.00337.x; Cole ES, 1997, DEV BIOL, V189, P233, DOI 10.1006/dbio.1997.8649; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DASILVA PP, 1982, CELL, V28, P441, DOI 10.1016/0092-8674(82)90198-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Elde NC, 2005, PLOS GENET, V1, P514, DOI 10.1371/journal.pgen.0010052; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P590, DOI 10.1111/j.1550-7408.2000.tb00095.x; Gleason EJ, 2006, GENETICS, V172, P145, DOI 10.1534/genetics.105.047340; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; KURZ S, 1993, J EUKARYOT MICROBIOL, V40, P10, DOI 10.1111/j.1550-7408.1993.tb04874.x; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; MCDONALD BB, 1966, J PROTOZOOL, V13, P277, DOI 10.1111/j.1550-7408.1966.tb01908.x; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Noto T, 2010, CELL, V140, P692, DOI 10.1016/j.cell.2010.02.010; ORIAS JD, 1983, SCIENCE, V222, P181, DOI 10.1126/science.6623070; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Pucciarelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039694; SHASTRY BS, 1984, J BIOL CHEM, V259, P1373; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; SUGANUMA Y, 1984, J ELECTRON MICROSC, V33, P10; Sugiura M, 2001, P NATL ACAD SCI USA, V98, P14446, DOI 10.1073/pnas.221457698; WOLFE J, 1982, J MORPHOL, V172, P159, DOI 10.1002/jmor.1051720204; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yin LH, 2010, EUKARYOT CELL, V9, P1343, DOI 10.1128/EC.00089-10; Zweifel E, 2009, EUKARYOT CELL, V8, P899, DOI 10.1128/EC.00342-08	40	5	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e52799	10.1371/journal.pone.0052799	http://dx.doi.org/10.1371/journal.pone.0052799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251712	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900119
J	Cagliero, J; Forget, A; Daldello, E; Silber, J; Zider, A				Cagliero, Julie; Forget, Antoine; Daldello, Enrico; Silber, Joel; Zider, Alain			The Hippo kinase promotes Scalloped cytoplasmic localization independently of Warts in a CRM1/Exportin1-dependent manner in Drosophila	FASEB JOURNAL			English	Article						transcription factor; subcellular localization; tissue growth	CELL-CYCLE EXIT; TUMOR-SUPPRESSOR; WING FORMATION; YORKIE PHOSPHORYLATION; CONTACT INHIBITION; TEAD/TEF FAMILY; GENE-EXPRESSION; SIZE-CONTROL; PROLIFERATION; PATHWAY	Scalloped (SD) is a transcription factor characterized by a TEA/ATTS DNA binding domain. To activate transcription, SD must interact with its coactivators, including Yorkie (YKI) or Vestigial (VG). YKI is the downstream effector of the Hippo signaling pathway that plays a key role in the control of tissue growth. The core components of this pathway are two kinases, Hippo (HPO) and Warts (WTS), which negatively regulate the activity of the SD/YKI complex, retaining YKI in the cytoplasm. We previously showed that HPO kinase can also reduce SD/VG transcriptional activity in Drosophila S2 cells. We further investigated the relationship between the SD/VG complex and the Hippo pathway. We show here that HPO overexpression suppresses overgrowth induced by SD/VG in vivo during Drosophila development. Using S2 cells, we show that HPO promotes the translocation of SD to the cytoplasm in a CRM1-dependent manner, thereby inhibiting the induction of SD/VG target genes. Using RNAi-mediated depletion of yki and a mutant SD protein unable to interact with YKI, we demonstrate that HPO regulates SD localization independently of YKI. This function requires HPO kinase activity, yet surprisingly, not its downstream effector kinase WTS. Taken together, these observations reveal a new and unexpected role of HPO kinase in the regulation of a transcription factor independently of YKI.-Cagliero, J., Forget, A., Daldello, E., Silber, J., Zider, A. The Hippo kinase promotes Scalloped cytoplasmic localization independently of Warts in a CRM1/Exportin1-dependent manner in Drosophila. FASEB J. 27, 1330-1341 (2013). www.fasebj.org	[Cagliero, Julie; Forget, Antoine; Daldello, Enrico; Silber, Joel; Zider, Alain] Univ Paris Diderot, Mol Oncol Team, CNRS, IJM,UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Zider, A (corresponding author), CNRS, Mol Oncol Team, IJM, UMR 7592, F-75205 Paris 13, France.	zider.alain@ijm.univ-paris-diderot.fr	Daldello, enrico/AAJ-1607-2021; Forget, Antoine/AAA-4967-2020	Daldello, enrico/0000-0002-0456-8950; 	Ministere de l'Enseignement Superieur et de la Recherche; Association pour la Recherche sur le Cancer [5119]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	The authors acknowledge B. Legois for her excellent technical assistance and D. Pan (Johns Hopkins University School of Medicine, Baltimore, MD, USA), Nicolas Tapon (Cancer Research UK, London, UK), Kenneth D. Irvine (Rutgers University, Piscataway, NJ, USA), and Jin Jiang (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing Drosophila strains, antibodies, and plasmids. The authors also thank the Developmental Studies Hybridoma Bank (DSHB) for providing monoclonal antibodies, developed under the control of the U. S. National Institute of Child Health and Human Development and maintained by The University of Iowa (Iowa City, IA, USA). The authors also thank the Imaging facility at the Jacques Monod Institute (Paris, France) for their precious help in confocal microscopy. J.C. is the recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by the Association pour la Recherche sur le Cancer, grant 5119. The manuscript was revised by Anglo-Scribe (Nimes, France) for English language editing.	Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halder G, 2001, DEVELOPMENT, V128, P3295; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu XF, 2000, DEV BIOL, V228, P287, DOI 10.1006/dbio.2000.9939; Maeda T, 2002, J BIOL CHEM, V9, P9; Magico A. C., PLOS ONE, V6; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Srivastava A, 2002, GENESIS, V33, P40, DOI 10.1002/gene.10086; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vaudin P, 1999, DEVELOPMENT, V126, P4807; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B., GENES DEV, V24, P862; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	52	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1330	1341		10.1096/fj.12-216424	http://dx.doi.org/10.1096/fj.12-216424			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271049				2022-12-25	WOS:000316940800006
J	Li, M; Zhang, Z; Koh, HL; Lu, R; Jiang, ZR; Alioua, A; Garcia-Valdes, J; Stefani, E; Toro, L				Li, Min; Zhang, Zhu; Koh, Huilin; Lu, Rong; Jiang, Zhaorong; Alioua, Abderrahmane; Garcia-Valdes, Jesus; Stefani, Enrico; Toro, Ligia			The beta 1-Subunit of the MaxiK Channel Associates with the Thromboxane A(2) Receptor and Reduces Thromboxane A(2) Functional Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; VASCULAR SMOOTH-MUSCLE; LARGE-CONDUCTANCE; BK CHANNEL; BETA-1 SUBUNIT; BETA(1) SUBUNIT; POTASSIUM CHANNELS; DOWN-REGULATION; HYPERTENSION; ACTIVATION	The large conductance voltage-and Ca2+-activated K+ channel (MaxiK, BKCa, BK) is composed of four pore-forming alpha-subunits and can be associated with regulatory beta-subunits. One of the functional roles of MaxiK is to regulate vascular tone. We recently found that the MaxiK channel from coronary smooth muscle is trans-inhibited by activation of the vasoconstricting thromboxane A(2) prostanoid receptor (TP), a mechanism supported by MaxiK alpha-subunit (MaxiK alpha)-TP physical interaction. Here, we examined the role of the MaxiK beta 1-subunit in TP-MaxiK association. We found that the beta 1-subunit can by itself interact with TP and that this association can occur independently of MaxiK alpha. Subcellular localization analysis revealed that beta 1 and TP are closely associated at the cell periphery. The molecular mechanism of beta 1-TP interaction involves predominantly the beta 1 extracellular loop. As reported previously, TP activation by the thromboxane A(2) analog U46619 caused inhibition of MaxiK alpha macroscopic conductance or fractional open probability (FPo) as a function of voltage. However, the positive shift of the FPo versus voltage curve by U46619 relative to the control was less prominent when beta 1 was coexpressed with TP and MaxiK alpha proteins (20 +/- 6 mV, n = 7) than in cells expressing TP and MaxiK alpha alone (51 +/- 7 mV, n = 7). Finally, beta 1 gene ablation reduced the EC50 of the U46619 agonist in mediating aortic contraction from 18 +/- 1 nM (n = 12) to 9 +/- 1 nM (n = 12). The results indicate that the beta 1-subunit can form a tripartite complex with TP and MaxiK alpha, has the ability to associate with each protein independently, and diminishes U46619-induced MaxiK channel trans-inhibition as well as vasoconstriction.	[Li, Min; Zhang, Zhu; Koh, Huilin; Lu, Rong; Jiang, Zhaorong; Alioua, Abderrahmane; Garcia-Valdes, Jesus; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Stefani, E (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA.	estefani@ucla.edu			National Institutes of Health [HL096740, HL107418, HL088640]; American Heart Association [0825273F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096740, R01HL107418, R01HL088640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096740 and HL107418 (to E. S. and L. T.) and HL088640 (to E. S.). This work was also supported by American Heart Association Postdoctoral Fellowship 0825273F (to M. L.).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361	21	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3668	3677		10.1074/jbc.M112.426585	http://dx.doi.org/10.1074/jbc.M112.426585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255603	Green Published, hybrid			2022-12-25	WOS:000314397900070
J	Schilling, JD; Machkovech, HM; He, L; Sidhu, R; Fujiwara, H; Weber, K; Ory, DS; Schaffer, JE				Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.			Palmitate and Lipopolysaccharide Trigger Synergistic Ceramide Production in Primary Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; SPHINGOLIPID HOMEOSTASIS; DIABETIC MOUSE; CELL-DEATH; INFLAMMATION; OBESITY; TLR4; INFLAMMASOMES; BIOSYNTHESIS	Macrophages play a key role in host defense and in tissue repair after injury. Emerging evidence suggests that macrophage dysfunction in states of lipid excess can contribute to the development of insulin resistance and may underlie inflammatory complications of diabetes. Ceramides are sphingolipids that modulate a variety of cellular responses including cell death, autophagy, insulin signaling, and inflammation. In this study we investigated the intersection between TLR4-mediated inflammatory signaling and saturated fatty acids with regard to ceramide generation. Primary macrophages treated with lipopolysaccharide (LPS) did not produce C16 ceramide, whereas palmitate exposure led to a modest increase in this sphingolipid. Strikingly, the combination of LPS and palmitate led to a synergistic increase in C16 ceramide. This response occurred via cross-talk at the level of de novo ceramide synthesis in the ER. The synergistic response required TLR4 signaling via MyD88 and TIR-domain-containing adaptor-inducing interferon beta (TRIF), whereas palmitate-induced ceramide production occurred independent of these inflammatory molecules. This ceramide response augmented IL-1 beta and TNF alpha release, a process that may contribute to the enhanced inflammatory response in metabolic diseases characterized by dyslipidemia.	[Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA.	jschaff@wustl.edu	Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167	National Institutes of Health [R01 DK064989, P20 HL113444, K08HL098373, U24 DK076169, P60 DK020579]; Burroughs Wellcome Foundation [1005935]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113444, K08HL098373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, U24DK076169, R01DK064989, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK064989 and P20 HL113444 (to J. E. S.), K08HL098373 (to J. D. S.), U24 DK076169, and P60 DK020579. This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J. E. S.).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Assimacopoulos-Jeannet F, 2004, INT J OBESITY, V28, pS53, DOI 10.1038/sj.ijo.0802857; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; CZYZK A, 1980, DIABETES CARE, V3, P526, DOI 10.2337/diacare.3.4.526; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	43	108	110	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2923	2932		10.1074/jbc.M112.419978	http://dx.doi.org/10.1074/jbc.M112.419978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250746	hybrid, Green Published			2022-12-25	WOS:000314397900003
J	Vishnivetskiy, SA; Chen, QY; Palazzo, MC; Brooks, EK; Altenbach, C; Iverson, TM; Hubbell, WL; Gurevich, VV				Vishnivetskiy, Sergey A.; Chen, Qiuyan; Palazzo, Maria C.; Brooks, Evan K.; Altenbach, Christian; Iverson, Tina M.; Hubbell, Wayne L.; Gurevich, Vsevolod V.			Engineering Visual Arrestin-1 with Special Functional Characteristics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; BETA-ARRESTIN; PHOSPHORYLATION-RECOGNITION; NONVISUAL ARRESTINS; RHODOPSIN KINASE; CONE ARRESTIN; RETINAL RODS; GENE-THERAPY; BINDING	Arrestin-1 preferentially binds active phosphorylated rhodopsin. Previously, a mutant with enhanced binding to unphosphorylated active rhodopsin (Rh*) was shown to partially compensate for lack of rhodopsin phosphorylation in vivo. Here we showed that reengineering of the receptor binding surface of arrestin-1 further improves the binding to Rh* while preserving protein stability. In mammals, arrestin-1 readily self-associates at physiological concentrations. The biological role of this phenomenon can only be elucidated by replacing wild type arrestin-1 in living animals with a non-oligomerizing mutant retaining all other functions. We demonstrate that constitutively monomeric forms of arrestin-1 are sufficiently stable for in vivo expression. We also tested the idea that individual functions of arrestin-1 can be independently manipulated to generate mutants with the desired combinations of functional characteristics. Here we showed that this approach is feasible; stable forms of arrestin-1 with high Rh* binding can be generated with or without the ability to self-associate. These novel molecular tools open the possibility of testing of the biological role of arrestin-1 self-association and pave the way to elucidation of full potential of compensational approach to gene therapy of gain-of-function receptor mutations.	[Vishnivetskiy, Sergey A.; Chen, Qiuyan; Palazzo, Maria C.; Iverson, Tina M.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Brooks, Evan K.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Gurevich, Vsevolod/0000-0002-3950-5351; Kraemer, Maria/0000-0002-1806-5641	National Institutes of Health [EY011500, GM077561, GM081756, EY05216, GM079419, GM095633]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE [R01EY011500, R37EY005216, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM079419, R01GM077561, R01GM095633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM077561, and GM081756 (to V. V. G.), and EY05216 (to W. L. H.), and GM079419 and GM095633 (to T. M. I.). This work was also supported by and the Jules Stein Professorship Endowment (to W. L. H.).	APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Caruso G, 2011, P NATL ACAD SCI USA, V108, P7804, DOI 10.1073/pnas.1018960108; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich V. V., 1995, J BIOL CHEM, V270, ps731; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2012, CELL SIGNAL, V24, P1899, DOI 10.1016/j.cellsig.2012.05.012; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	70	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3394	3405		10.1074/jbc.M112.445437	http://dx.doi.org/10.1074/jbc.M112.445437			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250748	Green Published, hybrid			2022-12-25	WOS:000314397900044
J	Bianco, G; Fontanella, B; Severino, L; Quaroni, A; Autore, G; Marzocco, S				Bianco, Giuseppe; Fontanella, Bianca; Severino, Lorella; Quaroni, Andrea; Autore, Giuseppina; Marzocco, Stefania			Nivalenol and Deoxynivalenol Affect Rat Intestinal Epithelial Cells: A Concentration Related Study	PLOS ONE			English	Article							NATURAL OCCURRENCE; FUSARIUM TOXINS; OCHRATOXIN-A; MYCOTOXINS; TRICHOTHECENES; EXPOSURE; SURVIVAL; PROTEIN; FOOD; PHOSPHORYLATION	The integrity of the gastrointestinal tract represents a crucial first level defence against ingested toxins. Among them, Nivalenol is a trichotecenes mycotoxin frequently found on cereals and processed grains; when it contaminates human food and animal feed it is often associated with another widespread contaminant, Deoxynivalenol. Following their ingestion, intestinal epithelial cells are exposed to concentrations of these trichothecenes high enough to cause mycotoxicosis. In this study we have investigated the effects of Nivalenol and Deoxynivalenol on intestinal cells in an in vitro model system utilizing the non-tumorigenic rat intestinal epithelial cell line IEC-6. Both Nivalenol and Deoxynivalenol (5-80 mu M) significantly affected IEC-6 viability through a pro-apoptotic process which mainly involved the following steps: (i) Bax induction; (ii) Bcl-2 inhibition, and (iii) caspase-3 activation. Moreover, treatment with Nivalenol produced a significant cell cycle arrest of IEC-6 cells, primarily at the G(0)/G(1) interphase and in the S phase, with a concomitant reduction in the fraction of cells in G(2). Interestingly, when administered at lower concentrations (0.1-2.5 mu M), both Nivalenol and Deoxynivalenol affected epithelial cell migration (restitution), representing the initial step in gastrointestinal wound healing in the gut. This reduced motility was associated with significant remodelling of the actin cytoskeleton, and changes in expression of connexin-43 and focal adhesion kinase. The concentration range of Nivalenol or Deoxynivalenol we have tested is comparable with the mean estimated daily intake of consumers eating contaminated food. Thus, our results further highlight the risks associated with intake of even low levels of these toxins. Citation: Bianco G, Fontanella B, Severino L, Quaroni A, Autore G, et al. (2012) Nivalenol and Deoxynivalenol Affect Rat Intestinal Epithelial Cells: A Concentration Related Study. PLoS ONE 7(12): e52051. doi:10.1371/journal.pone.0052051	[Bianco, Giuseppe; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Sch Pharm, Dept Pharmaceut & Biomed Sci, Fisciano, Italy; [Fontanella, Bianca] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Severino, Lorella] Univ Naples Federico II, Sch Vet Med, Div Toxicol, Dept Pathol & Anim Hlth, Naples, Italy; [Quaroni, Andrea] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	University of Salerno; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Cornell University	Marzocco, S (corresponding author), Univ Salerno, Sch Pharm, Dept Pharmaceut & Biomed Sci, Fisciano, Italy.	smarzocco@unisa.it	Marzocco, Stefania/AAI-1493-2020	Severino, Lorella/0000-0001-8597-0724; SEVERINO, LORELLA/0000-0002-0734-9649	University of Salerno; Fondazione Telethon Funding Source: Custom	University of Salerno; Fondazione Telethon(Fondazione Telethon)	This work was supported by grant from the University of Salerno (FARB 2011). No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBASSAM MA, 1987, VET PATHOL, V24, P427, DOI 10.1177/030098588702400510; AZCONAOLIVERA JI, 1995, TOXICOL APPL PHARM, V133, P109, DOI 10.1006/taap.1995.1132; Bianco G, 2012, TOXICON, V59, P644, DOI 10.1016/j.toxicon.2012.02.010; Bony S, 2007, TOXICOL IN VITRO, V21, P457, DOI 10.1016/j.tiv.2006.10.014; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Bretz M, 2006, J AGR FOOD CHEM, V54, P6445, DOI 10.1021/jf061008g; Cioffi G, 2006, J NAT PROD, V69, P1323, DOI 10.1021/np060257w; EC, 2003, REP TASK SCI COOP; Edwards SG, 2004, TOXICOL LETT, V153, P29, DOI 10.1016/j.toxlet.2004.04.022; Eriksen GS, 2003, FOOD ADDIT CONTAM A, V20, P579, DOI 10.1080/0265203031000102573; Eskola M, 2001, FOOD ADDIT CONTAM A, V18, P707, DOI 10.1080/02652030110047667; GOODENOU.DA, 1974, J CELL BIOL, V61, P557, DOI 10.1083/jcb.61.2.557; GOODENOUGH DA, 1975, AM J CLIN PATHOL, V63, P636; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; Hazel CM, 2004, TOXICOL LETT, V153, P51, DOI 10.1016/j.toxlet.2004.04.040; Heussner AH, 2006, TOXICOL IN VITRO, V20, P332, DOI 10.1016/j.tiv.2005.08.003; Hsia CC, 2004, ONCOL REP, V12, P449; HSIA CC, 1988, CANCER DETECT PREV, V13, P79; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Kasuga F, 1998, MYCOPATHOLOGIA, V142, P161, DOI 10.1023/A:1006923808748; Kenichi S, 2006, J GASTROENTEROL, V41, P450; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Larsen JC, 2004, TOXICOL LETT, V153, P1, DOI 10.1016/j.toxlet.2004.04.020; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Leblanc JC, 2005, FOOD ADDIT CONTAM, V22, P652, DOI 10.1080/02652030500159938; Luongo D, 2008, TOXICON, V52, P156, DOI 10.1016/j.toxicon.2008.04.162; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Marzocco S, 2010, NEUROCHEM INT, V57, P518, DOI 10.1016/j.neuint.2010.06.016; Marzocco S, 2009, TOXICOL LETT, V189, P21, DOI 10.1016/j.toxlet.2009.04.024; MCGUIRE PG, 1989, J CELL BIOCHEM, V40, P215, DOI 10.1002/jcb.240400210; Meky FA, 2003, FOOD CHEM TOXICOL, V41, P265, DOI 10.1016/S0278-6915(02)00228-4; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Prelusky DB, 1996, FOOD ADDIT CONTAM, V13, P155, DOI 10.1080/02652039609374393; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rotter BA, 1996, J ENVIRON SCI HEAL B, V31, P1279, DOI 10.1080/03601239609373067; RYU JC, 1988, FUND APPL TOXICOL, V11, P38, DOI 10.1016/0272-0590(88)90268-0; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; SHEPHARD GS, 1995, FOOD CHEM TOXICOL, V33, P591, DOI 10.1016/0278-6915(95)00022-T; Speijers GJA, 2004, TOXICOL LETT, V153, P91, DOI 10.1016/j.toxlet.2004.04.046; SUGIURA Y, 1993, APPL ENVIRON MICROB, V59, P3334, DOI 10.1128/AEM.59.10.3334-3338.1993; TANAKA T, 1985, FOOD ADDIT CONTAM, V2, P259, DOI 10.1080/02652038509373554; UENO Y, 1985, CRC CR REV TOXICOL, V14, P99, DOI 10.3109/10408448509089851; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	55	53	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52051	10.1371/journal.pone.0052051	http://dx.doi.org/10.1371/journal.pone.0052051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251682	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800135
J	Atchley, RA; Strayer, DL; Atchley, P				Atchley, Ruth Ann; Strayer, David L.; Atchley, Paul			Creativity in the Wild: Improving Creative Reasoning through Immersion in Natural Settings	PLOS ONE			English	Article							ATTENTION; BENEFITS	Adults and children are spending more time interacting with media and technology and less time participating in activities in nature. This life-style change clearly has ramifications for our physical well-being, but what impact does this change have on cognition? Higher order cognitive functions including selective attention, problem solving, inhibition, and multi-tasking are all heavily utilized in our modern technology-rich society. Attention Restoration Theory (ART) suggests that exposure to nature can restore prefrontal cortex-mediated executive processes such as these. Consistent with ART, research indicates that exposure to natural settings seems to replenish some, lower-level modules of the executive attentional system. However, the impact of nature on higher-level tasks such as creative problem solving has not been explored. Here we show that four days of immersion in nature, and the corresponding disconnection from multi-media and technology, increases performance on a creativity, problem-solving task by a full 50% in a group of naive hikers. Our results demonstrate that there is a cognitive advantage to be realized if we spend time immersed in a natural setting. We anticipate that this advantage comes from an increase in exposure to natural stimuli that are both emotionally positive and low-arousing and a corresponding decrease in exposure to attention demanding technology, which regularly requires that we attend to sudden events, switch amongst tasks, maintain task goals, and inhibit irrelevant actions or cognitions. A limitation of the current research is the inability to determine if the effects are due to an increased exposure to nature, a decreased exposure to technology, or to other factors associated with spending three days immersed in nature.	[Atchley, Ruth Ann; Atchley, Paul] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Strayer, David L.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	University of Kansas; Utah System of Higher Education; University of Utah	Strayer, DL (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	david.strayer@utah.edu		Atchley, Paul/0000-0002-5261-4130; Strayer, David/0000-0002-1653-730X				[Anonymous], 2011, OFCOM COMM MARK REP; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; CIMPRICH B, 1993, CANCER NURS, V16, P83; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Immordino-Yang MH, 2012, PERSPECT PSYCHOL SCI, V7, P352, DOI 10.1177/1745691612447308; Juster F, CHANGING TIMES AM YO; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; MEDNICK SA, 1968, J CREATIVE BEHAV, V2, P213, DOI 10.1002/j.2162-6057.1968.tb00104.x; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Rideout V.J., 2010, HENRY J KAIS FAM FOU; TENNESSEN CM, 1995, J ENVIRON PSYCHOL, V15, P77, DOI 10.1016/0272-4944(95)90016-0; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009	16	133	135	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51474	10.1371/journal.pone.0051474	http://dx.doi.org/10.1371/journal.pone.0051474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251547	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200116
J	Skalamera, D; Dahmer, M; Purdon, AS; Wilson, BM; Ranall, MV; Blumenthal, A; Gabrielli, B; Gonda, TJ				Skalamera, Dubravka; Dahmer, Mareike; Purdon, Amy S.; Wilson, Benjamin M.; Ranall, Max V.; Blumenthal, Antje; Gabrielli, Brian; Gonda, Thomas J.			Generation of a Genome Scale Lentiviral Vector Library for EF1 alpha Promoter-Driven Expression of Human ORFs and Identification of Human Genes Affecting Viral Titer	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENHANCER-BINDING-PROTEIN; CELL-DEATH; TRANSIENT TRANSFECTION; TRANSGENE EXPRESSION; HEK293T CELLS; CMV PROMOTER; FAMILY; MICROARRAYS; RNA	The bottleneck in elucidating gene function through high-throughput gain-of-function genome screening is the limited availability of comprehensive libraries for gene overexpression. Lentiviral vectors are the most versatile and widely used vehicles for gene expression in mammalian cells. Lentiviral supernatant libraries for genome screening are commonly generated in the HEK293T cell line, yet very little is known about the effect of introduced sequences on the produced viral titer, which we have shown to be gene dependent. We have generated an arrayed lentiviral vector library for the expression of 17,030 human proteins by using the GATEWAY (R) cloning system to transfer ORFs from the Mammalian Gene Collection into an EF1alpha promoter-dependent lentiviral expression vector. This promoter was chosen instead of the more potent and widely used CMV promoter, because it is less prone to silencing and provides more stable long term expression. The arrayed lentiviral clones were used to generate viral supernatant by packaging in the HEK293T cell line. The efficiency of transfection and virus production was estimated by measuring the fluorescence of IRES driven GFP, co-expressed with the ORFs. More than 90% of cloned ORFs produced sufficient virus for downstream screening applications. We identified genes which consistently produced very high or very low viral titer. Supernatants from select clones that were either high or low virus producers were tested on a range of cell lines. Some of the low virus producers, including two previously uncharacterized proteins were cytotoxic to HEK293T cells. The library we have constructed presents a powerful resource for high-throughput gain-of-function screening of the human genome and drug-target discovery. Identification of human genes that affect lentivirus production may lead to improved technology for gene expression using lentiviral vectors.	[Skalamera, Dubravka; Dahmer, Mareike; Purdon, Amy S.; Wilson, Benjamin M.; Ranall, Max V.; Blumenthal, Antje; Gabrielli, Brian; Gonda, Thomas J.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia	University of Queensland	Skalamera, D (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia.	d.skalamera@uq.edu.au	Blumenthal, Antje/A-3608-2011; Gabrielli, Brian G/B-3655-2011	Blumenthal, Antje/0000-0003-3673-7015; Gabrielli, Brian G/0000-0003-3933-1651; Skalamera, Dubravka/0000-0002-5301-302X; Dahmer-Heath, Mareike/0000-0002-1667-7820	National Health and Medical Research Council of Australia (NHMRC) [ID401608]; Australia Research Council (ARC) [LE0668241]; Australian Cancer Research Foundation (ACRF); University of Queensland Diamantina Institute; Balzan Foundation; University of Queensland [2009001743]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF); University of Queensland Diamantina Institute; Balzan Foundation; University of Queensland(University of Queensland)	The funding for this study was provided by the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au/; grant ID401608), the Australia Research Council (ARC, http://www.arc.gov.au/; grant LE0668241) and the Australian Cancer Research Foundation (ACRF, http://www.acrf.com.au/) and University of Queensland Diamantina Institute. AB is supported by Fellowships funded by the Balzan Foundation and by the University of Queensland (grant 2009001743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Ansorge S, 2009, J GENE MED, V11, P868, DOI 10.1002/jgm.1370; Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen HL, 2010, J NEUROSCI RES, V88, P3508, DOI 10.1002/jnr.22506; Chenal A, 2012, J MOL BIOL, V415, P584, DOI 10.1016/j.jmb.2011.11.024; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Devitt G, 2007, J VIROL METHODS, V146, P298, DOI 10.1016/j.jviromet.2007.07.011; Dokka S, 2000, INT J PHARM, V206, P97, DOI 10.1016/S0378-5173(00)00531-7; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamensek U, 2011, MOL IMAGING BIOL, V13, P43, DOI 10.1007/s11307-010-0300-6; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lamarca V, 2008, EUR J CELL BIOL, V87, P325, DOI 10.1016/j.ejcb.2008.02.004; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Mao Gensheng, 2008, Acta Biomed, V79, P192; Marcotte EM, 2009, CELL, V138, P16, DOI 10.1016/j.cell.2009.06.024; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Palmer E, 2011, METHODS MOL BIOL, V706, P27, DOI 10.1007/978-1-61737-970-3_3; Palmer EL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-145; Patzel V, 1997, BIOCHEM BIOPH RES CO, V231, P864, DOI 10.1006/bbrc.1997.6205; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Prus W, 2011, AMINO ACIDS, V41, P781, DOI 10.1007/s00726-010-0526-2; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ramezani A, 2002, MOL BIOL; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Schuller M, 2005, J NEUROIMMUNOL, V169, P172, DOI 10.1016/j.jneuroim.2005.08.019; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUDO T, 1992, GENOMICS, V12, P167, DOI 10.1016/0888-7543(92)90423-P; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tokushige K, 1997, J VIROL METHODS, V64, P73, DOI 10.1016/S0166-0934(96)02143-X; TSURUGI K, 1977, J BIOL CHEM, V252, P3961; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51733	10.1371/journal.pone.0051733	http://dx.doi.org/10.1371/journal.pone.0051733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251614	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200160
J	Gruber, EV; Stock, S; Stollenwerk, B				Gruber, Emil Victor; Stock, Stephanie; Stollenwerk, Bjoern			Breast Cancer Attributable Costs in Germany: A Top-Down Approach Based on Sickness Funds Data	PLOS ONE			English	Article							ECONOMIC BURDEN; CARE; PREVALENCE; MAMMOGRAPHY; MORTALITY; ILLNESS; WOMEN	Background: Breast cancer is the leading cause of death from cancer among women in Germany. Despite its clinical and economic relevance, no attributable costs for breast cancer have been reported for Germany so far. The objective of this study is to estimate age-specific breast cancer attributable health expenditures for Germany. Methods: Sickness fund data from 1999 representing about 26 million insured (i.e. 32% of the total German population) have been analysed using generalized additive models and the error propagation law. Costs have been inflated to 2010. Results: Breast cancer attributable costs decreased with age. Among breast cancer patients aged 30-45 years, about 90% of all health expenditures were due to breast cancer, whereas in breast cancer patients aged 80-90 years, about 50% were due to breast cancer. Breast cancer attributable costs amounted to about (sic)9,000 annually for patients below 55 years of age and declined to about (sic)3,000 in 90-year-old breast cancer patients. Conclusion: This analysis provides estimates of attributable breast cancer costs in Germany. Compared with the international literature, the estimates were plausible but had a tendency to underestimate breast cancer attributable costs.	[Gruber, Emil Victor; Stollenwerk, Bjoern] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Stock, Stephanie] Univ Cologne, Inst Hlth Econ & Clin Epidemiol, D-50931 Cologne, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne	Stollenwerk, B (corresponding author), Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	bjoern.stollenwerk@helmholtz-muenchen.de	Stollenwerk, Björn/G-5408-2013	Stollenwerk, Bjorn/0000-0002-3189-409X	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; University of Cologne	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; University of Cologne	Financial support for this study was provided by Helmholtz Zentrum Munchen, German Research Center for Environmental Health and by the University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barron JJ, 2008, BREAST CANCER RES TR, V109, P367, DOI 10.1007/s10549-007-9650-4; Baser O, 2012, CURR MED RES OPIN, V28, P419, DOI 10.1185/03007995.2011.628649; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Braun S, 2009, BREAST CARE, V4, P389, DOI 10.1159/000255840; Broekx S, 2011, EUR J HEALTH ECON, V12, P311, DOI 10.1007/s10198-010-0237-3; Calvo A, 2001, INT ELECT J HLTH ED, V4, P19; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Grunfeld E, 1999, BRIT J CANCER, V79, P1227, DOI 10.1038/sj.bjc.6690197; Ihbe-Heffinger A, 2011, ONKOLOGIE, V34, P241, DOI 10.1159/000327711; Katalinic A, 2009, BREAST CARE, V4, P75, DOI 10.1159/000211526; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Khanna R, 2011, J WOMENS HEALTH, V20, P739, DOI 10.1089/jwh.2010.2298; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lauterbach KW, 2001, MODELL FAIREN WETTBE; Lux MP, 2009, BREAST CANCER RES TR, V117, P305, DOI 10.1007/s10549-008-0294-9; Max W, 2009, BREAST CANCER RES TR, V116, P201, DOI 10.1007/s10549-008-0149-4; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Paterson A, 2008, J INT MED RES, V36, P400, DOI 10.1177/147323000803600304; Pisani P, 2009, BREAST CANC INTERVEN; RAJAN R, 1995, J CLIN ONCOL, V13, P42, DOI 10.1200/JCO.1995.13.1.42; Shenoy AU, 2012, EUR J VASC ENDOVASC, V44, P505, DOI 10.1016/j.ejvs.2012.08.010; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Stock SAK, 2006, DIABETIC MED, V23, P299, DOI 10.1111/j.1464-5491.2005.01779.x; Stock SAK, 2008, J WOMENS HEALTH, V17, P343, DOI 10.1089/jwh.2007.0422; Stollenwerk B, 2010, MED DECIS MAKING, V30, P304, DOI 10.1177/0272989X09347015; WAHL RL, 1993, J CLIN ONCOL, V11, P2101, DOI 10.1200/JCO.1993.11.11.2101; Wilking N, 2005, PANEUROPEAN COMP REG; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S.N., 2010, MGCV GAMS GCV AIC RE; Zindel S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-192	34	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51312	10.1371/journal.pone.0051312	http://dx.doi.org/10.1371/journal.pone.0051312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251495	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900068
J	Hede, MS; Salimova, E; Piszczek, A; Perlas, E; Winn, N; Nastasi, T; Rosenthal, N				Hede, Marianne Smedegaard; Salimova, Ekaterina; Piszczek, Agnieszka; Perlas, Emarald; Winn, Nadine; Nastasi, Tommaso; Rosenthal, Nadia			E-Peptides Control Bioavailability of IGF-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; (IGF)-I E-PEPTIDES; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; ACCELERATES MUSCLE; GENE-EXPRESSION; MESSENGER-RNAS; REGENERATION; HYPERTROPHY	Insulin-like growth factor 1 (IGF-1) is a potent cytoprotective growth factor that has attracted considerable attention as a promising therapeutic agent. Transgenic over-expression of IGF-1 propeptides facilitates protection and repair in a broad range of tissues, although transgenic mice over-expressing IGF-1 propeptides display little or no increase in IGF-1 serum levels, even with high levels of transgene expression. IGF-1 propeptides are encoded by multiple alternatively spliced transcripts including C-terminal extension (E) peptides, which are highly positively charged. In the present study, we use decellularized mouse tissue to show that the E-peptides facilitate in vitro binding of murine IGF-1 to the extracellular matrix (ECM) with varying affinities. This property is independent of IGF-1, since proteins consisting of the E-peptides fused to relaxin, a related member of the insulin superfamily, bound equally avidly to decellularized ECM. Thus, the E-peptides control IGF-1 bioavailability by preventing systemic circulation, offering a potentially powerful way to tether IGF-1 and other therapeutic proteins to the site of synthesis and/or administration.	[Hede, Marianne Smedegaard; Salimova, Ekaterina; Piszczek, Agnieszka; Perlas, Emarald; Winn, Nadine; Nastasi, Tommaso; Rosenthal, Nadia] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy; [Salimova, Ekaterina; Rosenthal, Nadia] Monash Univ, Australian Regenerat Med Inst, EMBL Australia, Melbourne, Vic 3004, Australia; [Rosenthal, Nadia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	European Molecular Biology Laboratory (EMBL); Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University; Imperial College London	Salimova, E (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Rome, Italy.	ekaterina.salimova@monash.edu; nadia.rosenthal@monash.edu	Rosenthal, Nadia/O-7009-2015; nastasi, tommaso/AAR-8730-2020; Rosenthal, Nadia/H-4012-2013	, Ekaterina/0000-0002-4362-7108; Rosenthal, Nadia/0000-0002-7599-7365	European Molecular Biology Laboratory; FP7 ENDOSTEM grant from European Commission [HEALTH-2009-1.4-3, 241440]; Novartis	European Molecular Biology Laboratory; FP7 ENDOSTEM grant from European Commission; Novartis(Novartis)	This work was supported by funds from European Molecular Biology Laboratory and the FP7 ENDOSTEM grant from European Commission HEALTH-2009-1.4-3 Grant agreement No. 241440, and by a sponsored research agreement with Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 1996, ENDOCRINOLOGY, V137, P4571, DOI 10.1210/en.137.11.4571; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; BACH MA, 1990, MOL ENDOCRINOL, V4, P899, DOI 10.1210/mend-4-6-899; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Carpenter V, 2008, HEART LUNG CIRC, V17, P33, DOI 10.1016/j.hlc.2007.04.013; Casellas A, 2006, DIABETES, V55, P3246, DOI 10.2337/db06-0328; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Cox MM, 2004, LEHNINGER PRINCIPLES; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Flintegaard TV, 2010, ENDOCRINOLOGY, V151, P5326, DOI 10.1210/en.2010-0574; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; Kandalla PK, 2011, MECH AGEING DEV, V132, P154, DOI 10.1016/j.mad.2011.02.007; Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pfeffer LA, 2009, MOL BIOL CELL, V20, P3810, DOI 10.1091/mbc.E08-12-1202; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Santini Maria Paola, 2006, Novartis Found Symp, V274, P228; Santini MP, 2006, NOVART FDN SYMP, V274, P239; Santini MP, 2006, NOVART FDN SYMP, V274, P272; Schertzer JD, 2008, AM J PHYSIOL-CELL PH, V294, pC161, DOI 10.1152/ajpcell.00399.2007; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Shavlakadze T, 2006, GROWTH HORM IGF RES, V16, P157, DOI 10.1016/j.ghir.2005.11.003; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; SIMMONS JG, 1993, GROWTH FACTORS, V9, P205, DOI 10.3109/08977199309010833; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Temmerman L, 2010, GROWTH HORM IGF RES, V20, P255, DOI 10.1016/j.ghir.2010.03.002; Wilson HE, 2001, GROWTH HORM IGF RES, V11, P10, DOI 10.1054/ghir.2000.0182; Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	42	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51152	10.1371/journal.pone.0051152	http://dx.doi.org/10.1371/journal.pone.0051152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251442	Green Submitted, Green Published, gold			2022-12-25	WOS:000312201900047
J	Selva, N; Hobson, KA; Cortes-Avizanda, A; Zalewski, A; Donazar, JA				Selva, Nuria; Hobson, Keith A.; Cortes-Avizanda, Ainara; Zalewski, Andrzej; Antonio Donazar, Jose			Mast Pulses Shape Trophic Interactions between Fluctuating Rodent Populations in a Primeval Forest	PLOS ONE			English	Article							TISSUE-DIET DISCRIMINATION; DENSITY-DEPENDENCE; MARINE SUBSIDIES; CARBON-ISOTOPE; COMPETITION; DYNAMICS; NITROGEN; RESOURCES; TURNOVER; PROTEIN	How different functional responses of consumers exploiting pulsed resources affect community dynamics is an ongoing question in ecology. Tree masting is a common resource pulse in terrestrial ecosystems that can drive rodent population cycles. Using stable isotope (delta C-13, delta N-15) analyses, we investigated the dietary response of two fluctuating rodent species, the yellow-necked mouse Apodemus flavicollis and the bank vole Myodes glareolus, to mast events in Bialowieza Forest (NE Poland). Rodent hair samples were obtained non-invasively from faeces of their predators for an 11-year period that encompassed two mast events. Spectacular seed crops of deciduous trees, namely oak Quercus robur and hornbeam Carpinus betulus, occur after several intermediate years of moderate seed production, with a post-mast year characterised by a nil crop. While a Bayesian isotopic (SIAR) mixing model showed a variety of potential vegetation inputs to rodent diets, the isotopic niche of the yellow-necked mouse was strongly associated with mast of deciduous trees (>80% of diet), showing no variation among years of different seed crop. However, bank voles showed a strong functional response; in mast years the vole shifted its diet from herbs in deciduous forest (similar to 66% of diet) to mast (similar to 74%). Only in mast years did the isotopic niche of both rodent species overlap. Previous research showed that bank voles, subordinate and more generalist than mice, showed higher fluctuations in numbers in response to masting. This study provides unique data on the functional response of key pulse consumers in forest food webs, and contributes to our understanding of rodent population fluctuations and the mechanisms governing pulse-consumer interactions. Citation: Selva N, Hobson KA, Cortes-Avizanda A, Zalewski A, Donazar JA (2012) Mast Pulses Shape Trophic Interactions between Fluctuating Rodent Populations in a Primeval Forest. PLoS ONE 7(12): e51267. doi:10.1371/journal.pone.0051267	[Selva, Nuria] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Cortes-Avizanda, Ainara; Antonio Donazar, Jose] CSIC, Dept Conservat Biol, Estn Biol Donana, Seville, Spain; [Zalewski, Andrzej] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	Polish Academy of Sciences; Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	nuriselva@gmail.com	Hobson, Keith/Q-9306-2019; CORTES-AVIZANDA, AINARA/O-3248-2019; Cortés-Avizanda, Ainara/C-6634-2013; Zalewski, Andrzej/K-7271-2012; Selva, Nuria/J-6970-2013	CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Cortés-Avizanda, Ainara/0000-0002-9674-6434; Zalewski, Andrzej/0000-0003-4518-2787; Selva, Nuria/0000-0003-3389-201X; Donazar, Jose Antonio/0000-0002-9433-9755	Polish-Spanish joint research projects CSIC-PAS [2006PL0013, 2008PL002]; Polish Ministry of Science and Higher Education [NN304294037]; Environment Canada	Polish-Spanish joint research projects CSIC-PAS; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Environment Canada(CGIAR)	This study was partly supported by the Polish-Spanish joint research projects CSIC-PAS (2006PL0013 and 2008PL002), by the Polish Ministry of Science and Higher Education (project NN304294037) and an operating grant by Environment Canada to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRZEJEWSKI ROMAN, 1963, ACTA THERIOL, V7, P155; Butet A, 2011, ACTA THERIOL, V56, P297, DOI 10.1007/s13364-011-0049-6; DeMots RL, 2010, CAN J ZOOL, V88, P961, DOI 10.1139/Z10-063; Dhondt A.A., 2012, INTERSPECIFIC COMPET; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; Eccard JA, 2003, EVOL ECOL, V17, P423, DOI 10.1023/A:1027305410005; GEBCZYNSKA Z, 1976, Acta Theriologica, V21, P223; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hansson L, 1985, S ZOOL SOC LOND, V55, P141; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Massey FP, 2008, BIOL LETTERS, V4, P419, DOI 10.1098/rsbl.2008.0106; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Miller JF, 2008, CAN J ZOOL, V86, P685, DOI 10.1139/Z08-042; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pianka E.R., 1976, P114; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Samelius G, 2007, J ANIM ECOL, V76, P873, DOI 10.1111/j.1365-2656.2007.01278.x; Sare DTJ, 2005, CAN J ZOOL, V83, P717, DOI 10.1139/Z05-064; Schmidt KA, 2008, J ANIM ECOL, V77, P830, DOI 10.1111/j.1365-2656.2008.01378.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shaner PJL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017970; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; Stenseth NC, 2002, ACTA THERIOL, V47, P39, DOI 10.1007/BF03192479; WIENS JA, 1993, TRENDS ECOL EVOL, V8, P348, DOI 10.1016/0169-5347(93)90216-C; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Zalewski A, 2007, ACTA THERIOL, V52, P237, DOI 10.1007/BF03194220	37	33	34	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51267	10.1371/journal.pone.0051267	http://dx.doi.org/10.1371/journal.pone.0051267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251475	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900060
J	Xu, W; Wang, HS; Cheng, WQ; Fu, D; Xia, T; Kibbe, WA; Lin, SM				Xu, Wei; Wang, Huisong; Cheng, Wenqing; Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.			A Framework for Annotating Human Genome in Disease Context	PLOS ONE			English	Article							GENE ONTOLOGY	Identification of gene-disease association is crucial to understanding disease mechanism. A rapid increase in biomedical literatures, led by advances of genome-scale technologies, poses challenge for manually-curated-based annotation databases to characterize gene-disease associations effectively and timely. We propose an automatic method-The Disease Ontology Annotation Framework (DOAF) to provide a comprehensive annotation of the human genome using the computable Disease Ontology (DO), the NCBO Annotator service and NCBI Gene Reference Into Function (GeneRIF). DOAF can keep the resulting knowledgebase current by periodically executing automatic pipeline to re-annotate the human genome using the latest DO and GeneRIF releases at any frequency such as daily or monthly. Further, DOAF provides a computable and programmable environment which enables large-scale and integrative analysis by working with external analytic software or online service platforms. A user-friendly web interface (doa.nubic.northwestern.edu) is implemented to allow users to efficiently query, download, and view disease annotations and the underlying evidences.	[Xu, Wei; Wang, Huisong; Cheng, Wenqing; Xia, Tian] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.] Northwestern Univ, Biomed Informat Ctr NUBIC, NUCATS, Feinberg Sch Med, Chicago, IL 60611 USA; [Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Lin, Simon M.] Marshfield Ctr, Biomed Informat Res Ctr, Marshfield, WI USA	Huazhong University of Science & Technology; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Xia, T (corresponding author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China.	tianxia@northwestern.edu; wakibbe@northwestern.edu; LINMD.SIMON@mcrf.mfldclin.edu	Kibbe, Warren/B-2106-2010	Kibbe, Warren/0000-0001-5622-7659	American Recovery and Reinvestment Act through National Institutes of Health, National Center for Research Resources [1R01RR025342]; CTSA Clinical and Translational Science award [UL1RR025741]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, R01RR025342] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act through National Institutes of Health, National Center for Research Resources; CTSA Clinical and Translational Science award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project has been funded under the American Recovery and Reinvestment Act of 2009 through National Institutes of Health, National Center for Research Resources award 1R01RR025342 and the CTSA Clinical and Translational Science award UL1RR025741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Gobeill J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S9; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kann MG, 2010, BRIEF BIOINFORM, V11, P96, DOI 10.1093/bib/bbp048; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Rubinstein R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-12; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Sintchenko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009535; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Zaremba S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-177	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e49686	10.1371/journal.pone.0049686	http://dx.doi.org/10.1371/journal.pone.0049686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251346	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900003
J	Zhang, BL; Yang, YW; Chen, TZ; Yu, WG; Liu, TL; Li, HJ; Fan, XH; Ren, YZ; Shen, DY; Liu, L; Dou, DL; Chang, YH				Zhang, Baolong; Yang, Yuwen; Chen, Tianzi; Yu, Wengui; Liu, Tingli; Li, Hongjuan; Fan, Xiaohui; Ren, Yongzhe; Shen, Danyu; Liu, Li; Dou, Daolong; Chang, Youhong			Island Cotton Gbve1 Gene Encoding A Receptor-Like Protein Confers Resistance to Both Defoliating and Non-Defoliating Isolates of Verticillium dahliae	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GOSSYPIUM-HIRSUTUM L.; LEAF-CRUMPLE-VIRUS; WILT RESISTANCE; CLADOSPORIUM-FULVUM; TOMATO; ARABIDOPSIS; VE; EXPRESSION; CLONING	Verticillium wilt caused by soilborne fungus Verticillium dahliae could significantly reduce cotton yield. Here, we cloned a tomato Ve homologous gene, Gbve1, from an island cotton cultivar that is resistant to Verticillium wilt. We found that the Gbve1 gene was induced by V. dahliae and by phytohormones salicylic acid, jasmonic acid, and ethylene, but not by abscisic acid. The induction of Gbve1 in resistant cotton was quicker and stronger than in Verticillium-susceptible upland cotton following V. dahliae inoculation. Gbve1 promoter-driving GUS activity was found exclusively in the vascular bundles of roots and stems of transgenic Arabidopsis. Virus-induced silencing of endogenous genes in resistant cotton via targeting a fragment of the Gbve1 gene compromised cotton resistance to V. dahliae. Furthermore, we transformed the Gbve1 gene into Arabidopsis and upland cotton through Agrobacterium-mediated transformation. Overexpression of the Gbve1 gene endowed transgenic Arabidopsis and upland cotton with resistance to high aggressive defoliating and non-defoliating isolates of V. dahliae. And HR-mimic cell death was observed in the transgenic Arabidopsis. Our results demonstrate that the Gbve1 gene is responsible for resistance to V. dahliae in island cotton and can be used for breeding cotton varieties that are resistant to Verticillium wilt.	[Zhang, Baolong; Yang, Yuwen; Chen, Tianzi; Yu, Wengui; Fan, Xiaohui; Ren, Yongzhe; Chang, Youhong] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China; [Liu, Tingli; Li, Hongjuan; Shen, Danyu; Liu, Li; Dou, Daolong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Zhang, BL (corresponding author), Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	zhbl2248@yahoo.com.cn; cyh@jaas.ac.cn	Shen, Danyu/AAF-1644-2019; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Chen, Tianzi/0000-0003-2634-6694	National Natural Science Foundation of China [30971830]; fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [cx(12) 2023]; National Science and Technology Major Project for Transgenic Breeding [2009ZX08005-003B]; Natural Science Foundation of Jiangsu Province [BK2009308]; Ministry of Education of China [20090097110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; National Science and Technology Major Project for Transgenic Breeding; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ministry of Education of China(Ministry of Education, China)	This work was supported to B.Z. by grants from the National Natural Science Foundation of China (No. 30971830), fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (No. cx(12) 2023) and National Science and Technology Major Project for Transgenic Breeding (No. 2009ZX08005-003B), and D. D. by grants Natural Science Foundation of Jiangsu Province (BK2009308) and Doctoral Fund of Ministry of Education of China (20090097110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Chai YR, 2003, DNA SEQUENCE, V14, P375, DOI 10.1080/10425170310001605509; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAAYF F, 1995, EUR J PLANT PATHOL, V101, P69, DOI 10.1007/BF01876095; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Diwan N, 1999, THEOR APPL GENET, V98, P315, DOI 10.1007/s001220051075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fei J, 2004, DNA SEQUENCE, V15, P88, DOI 10.1080/1042517042000199942; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gore ME, 2009, CROP PROT, V28, P215, DOI 10.1016/j.cropro.2008.10.004; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Idris AM, 2010, PHYSIOL MOL PLANT P, V75, P13, DOI 10.1016/j.pmpp.2010.07.002; Jefferson R A, 1987, EMBO J, V6, P3901; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Ochsenbein C, 2006, PLANT J, V47, P445, DOI 10.1111/j.1365-313X.2006.02793.x; Parkhi V, 2010, J PHYTOPATHOL, V158, P822, DOI 10.1111/j.1439-0434.2010.01714.x; Parkhi V, 2010, TRANSGENIC RES, V19, P959, DOI 10.1007/s11248-010-9374-9; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qin QM, 2008, PLANT DIS, V92, P69, DOI 10.1094/PDIS-92-1-0069; Rajasekaran K, 2005, PLANT BIOTECHNOL J, V3, P545, DOI 10.1111/j.1467-7652.2005.00145.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tian JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014218; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wang YQ, 2004, PLANT BREEDING, V123, P454, DOI 10.1111/j.1439-0523.2004.01005.x; Wu SJ, 2008, PLANT MOL BIOL REP, V26, P174, DOI 10.1007/s11105-008-0032-9; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Zhang JF, 2012, EUPHYTICA, V187, P147, DOI 10.1007/s10681-011-0549-0; Zhang Y, 2011, PLANT CELL REP, V30, P2085, DOI 10.1007/s00299-011-1115-x	47	69	95	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51091	10.1371/journal.pone.0051091	http://dx.doi.org/10.1371/journal.pone.0051091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251427	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900040
J	Woo, SK; Kwon, MS; Ivanov, A; Gerzanich, V; Simard, JM				Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc			The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; REACTIVE ASTROCYTES; CELLS; SUR1; STOICHIOMETRY; TRAFFICKING	The sulfonylurea receptor 1 (Sur1)-NCCa-ATP channel plays a central role in necrotic cell death in central nervous system (CNS) injury, including ischemic stroke, and traumatic brain and spinal cord injury. Here, we show that Sur1-NCCa-ATP channels are formed by co-assembly of Sur1 and transient receptor potential melastatin 4 (Trpm4). Co-expression of Sur1 and Trpm4 yielded Sur1-Trpm4 heteromers, as shown in experiments with Forster resonance energy transfer (FRET) and co-immunoprecipitation. Co-expression of Sur1 and Trpm4 also yielded functional Sur1-Trpm4 channels with biophysical properties of Trpm4 and pharmacological properties of Sur1. Co-assembly with Sur1 doubled the affinity of Trpm4 for calmodulin and doubled its sensitivity to intracellular calcium. Experiments with FRET and co-immunoprecipitation showed de novo appearance of Sur1-Trpm4 heteromers after spinal cord injury in rats. Our findings depart from the long-held view of an exclusive association between Sur1 and K-ATP channels and reveal an unexpected molecular partnership with far-ranging implications for CNS injury.	[Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu			National Institutes of Health [NS060801, NS061808, HL082517, NS061934, NS072501]; Department of Veterans Affairs (Baltimore, MD); Department of the Army [W81XWH 1010898]; Christopher and Dana Reeve Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060801, R01NS061934, R01NS061808, R01NS072501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Baltimore, MD)(US Department of Veterans Affairs); Department of the Army; Christopher and Dana Reeve Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS060801 and NS061808 (NINDS) and HL082517 (NHLBI) (to J. M. S.) and NS061934 and NS072501 (NINDS) (to V. G.). This work was also supported by grants from the Department of Veterans Affairs (Baltimore, MD), the Department of the Army (Grant W81XWH 1010898), and the Christopher and Dana Reeve Foundation (to J. M. S.). J. M. S. holds a United States patent (Number 7,285,574), "A novel non-selective cation channel in neural cells and methods for treating brain swelling." J. M. S. is a member of the scientific advisory board and holds shares in Remedy Pharmaceuticals. No support, direct or indirect, was provided to J. M. S., or for this project, by Remedy Pharmaceuticals.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2002, J BIOL CHEM, V277, P25416, DOI 10.1074/jbc.M203109200; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Meissner M, 2011, TRP CHANNELS, P135; Mikhailov MV, 2001, FEBS LETT, V499, P154, DOI 10.1016/S0014-5793(01)02538-8; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, PFLUG ARCH EUR J PHY, V464, P573, DOI 10.1007/s00424-012-1166-z; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vennekens R., 2007, V179, P269; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	38	127	140	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3655	3667		10.1074/jbc.M112.428219	http://dx.doi.org/10.1074/jbc.M112.428219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255597	Green Published, hybrid			2022-12-25	WOS:000314397900069
J	Beleigoli, AM; Boersma, E; Diniz, MDH; Lima-Costa, MF; Ribeiro, AL				Beleigoli, Alline M.; Boersma, Eric; Diniz, Maria de Fatima H.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.			Overweight and Class I Obesity Are Associated with Lower 10-Year Risk of Mortality in Brazilian Older Adults: The Bambui Cohort Study of Ageing	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIORESPIRATORY FITNESS; WEIGHT-LOSS; NATRIURETIC PEPTIDE; VISCERAL FAT; FOLLOW-UP; PARADOX; WOMEN; MEN	Background: Prospective studies mostly with European and North-American populations have shown inconsistent results regarding the association of overweight/obesity and mortality in older adults. Our aim was to investigate the relationship between overweight/obesity and mortality in an elderly Brazilian population. Methods and Findings: Participants were 1,450 (90.2% from total) individuals aged 60 years and over from the community-based Bambui (Brazil) Cohort Study of Ageing. From 1997 to 2007, 521 participants died and 89 were lost, leading to 12,905 person-years of observation. Body mass index (BMI) and waist circumference (WC) were assessed at baseline and at the 3rd and 5th years of follow-up. Multiple imputation was performed to deal with missing values. Hazard ratios (HR) of mortality for BMI or WC alone (continuous and categorical), and BMI and WC together (continuous) were estimated by extended Cox regression models, which were fitted for clinical, socioeconomic and behavioral confounders. Adjusted absolute rates of death at 10-year follow-up were estimated for the participants with complete data at baseline. Continuous BMI (HR 0.85; 95% CI 0.80-0.90) was inversely related to mortality, even after exclusion of smokers (HR 0.85; 0.80-0.90), and participants who had weight variation and died within the first 5 years of follow-up (HR 0.83; CI 95% 0.73-0.94). Overweight (BMI 25-30 kg/m(2)) was inversely (HR 0.76; 95% CI 0.61-0.93) and obesity (BMI >= 30 kg/m(2); HR 0.85; 95% CI 0.64-1.14) not significantly associated with mortality. Subjects with BMI between 25-35 kg/m(2) (23.8-25.9%) had the lowest absolute rates of death at 10-years follow-up. The association between WC and death was not significant, except after adjusting WC for BMI levels, when the relationship turned into marginally positive (HR 1.01; CI 95% 1.00-1.02). Conclusions: The usual BMI and WC cut-off points should not be used to guide public health and clinical weight control interventions in elderly in Brazil.	[Beleigoli, Alline M.; Diniz, Maria de Fatima H.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Diniz, Maria de Fatima H.; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Lima-Costa, Maria Fernanda] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Erasmus University Rotterdam; Erasmus MC; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Beleigoli, AM (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	beleigoli@yahoo.com	Ribeiro, Ana Cristina/HHN-7466-2022; Ribeiro, Antonio L/C-2707-2009; Iats, Inct/K-2300-2013; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021	Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Beleigoli, Alline/0000-0002-7848-3183	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil; Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil(Financiadora de Inovacao e Pesquisa (Finep)); Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil	This work was supported by the Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; the Ministerio da Saude, Brasilia, Brazil; and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil. M.F. Lima-Costa and A.L. Ribeiro are fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. A.M. Beleigoli was supported by the Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Beleigoli AM, 2011, PEPTIDES, V32, P1787, DOI 10.1016/j.peptides.2011.08.013; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Clark AL, 2011, J CARD FAIL, V17, P374, DOI 10.1016/j.cardfail.2011.01.009; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Guallar-Castillon P, 2009, OBESITY, V17, P2232, DOI 10.1038/oby.2009.115; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; He JH, 2009, INT J ENV RES PUB HE, V6, P3115, DOI 10.3390/ijerph6123115; Hu F., 2008, OBESITY EPIDEMIOLOGY, P53, DOI DOI 10.1093/ACPROF:OSO/9780195312911; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Klebanoff MA, 2008, AM J EPIDEMIOL, V168, P355, DOI 10.1093/aje/kwn071; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kulminski AM, 2008, J AM GERIATR SOC, V56, P105, DOI 10.1111/j.1532-5415.2007.01494.x; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; McAuley P, 2009, J GERONTOL A-BIOL, V64, P695, DOI 10.1093/gerona/gln039; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; McAuley PA, 2010, MAYO CLIN PROC, V85, P115, DOI 10.4065/mcp.2009.0562; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Prineas R., 1982, MINNESOTA CODE MANUA; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Storti KL, 2006, OBESITY, V14, P244, DOI 10.1038/oby.2006.31; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Tavares E L, 1999, Cad Saude Publica, V15, P759, DOI 10.1590/S0102-311X1999000400010; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Weber MA, 2001, J AM COLL CARDIOL, V37, P169, DOI 10.1016/S0735-1097(00)01103-7; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	51	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52111	10.1371/journal.pone.0052111	http://dx.doi.org/10.1371/journal.pone.0052111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251690	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800142
J	Dettai, A; Gallut, C; Brouillet, S; Pothier, J; Lecointre, G; Debruyne, R				Dettai, Agnes; Gallut, Cyril; Brouillet, Sophie; Pothier, Joel; Lecointre, Guillaume; Debruyne, Regis			Conveniently Pre-Tagged and Pre-Packaged: Extended Molecular Identification and Metagenomics Using Complete Metazoan Mitochondrial Genomes	PLOS ONE			English	Article							DNA BARCODES; SPECIES IDENTIFICATION; SEQUENCE EVOLUTION; PURIFICATION; PSEUDOGENES; PERFORMANCE; PHYLOGENETICS; HETEROPLASMY; VARIABILITY; ALIGNMENT	Background: Researchers sorely need markers and approaches for biodiversity exploration (both specimen linked and metagenomics) using the full potential of next generation sequencing technologies (NGST). Currently, most studies rely on expensive multiple tagging, PCR primer universality and/or the use of few markers, sometimes with insufficient variability. Methodology/Principal Findings: We propose a novel approach for the isolation and sequencing of a universal, useful and popular marker across distant, non-model metazoans: the complete mitochondrial genome. It relies on the properties of metazoan mitogenomes for enrichment, on careful choice of the organisms to multiplex, as well as on the wide collection of accumulated mitochondrial reference datasets for post-sequencing sorting and identification instead of individual tagging. Multiple divergent organisms can be sequenced simultaneously, and their complete mitogenome obtained at a very low cost. We provide in silico testing of dataset assembly for a selected set of example datasets. Conclusions/Significance: This approach generates large mitogenome datasets. These sequences are useful for phylogenetics, molecular identification and molecular ecology studies, and are compatible with all existing projects or available datasets based on mitochondrial sequences, such as the Barcode of Life project. Our method can yield sequences both from identified samples and metagenomic samples. The use of the same datasets for both kinds of studies makes for a powerful approach, especially since the datasets have a high variability even at species level, and would be a useful complement to the less variable 18S rDNA currently prevailing in metagenomic studies.	[Dettai, Agnes; Gallut, Cyril; Lecointre, Guillaume] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat 7138, Evolut UPMC CNRS MNHN IRD ENS, F-75231 Paris, France; [Brouillet, Sophie] Univ Paris 06, UMR Systemat Adaptat Evolut 7138, UPMC CNRS MNHN IRD ENS, Paris, France; [Pothier, Joel] Univ Paris 06, UFR 927, Paris, France; [Debruyne, Regis] Museum Natl Hist Nat, Dept Systemat & Evolut, UMS CNRS 2700, MNHN, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN)	Dettai, A (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat 7138, Evolut UPMC CNRS MNHN IRD ENS, F-75231 Paris, France.	adettai@mnhn.fr	Debruyne, Régis/G-7839-2011; Dettai, Agnes/Q-6743-2019	Debruyne, Régis/0000-0002-7002-3940; Gallut, Cyril/0000-0002-6486-0179; Pothier, Joel/0000-0002-4021-6055	Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'')	Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'')	This work was supported by the Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'') (fondation.total.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2012, MITOCHONDR DNA, V23, P84, DOI 10.3109/19401736.2011.653801; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; [Anonymous], 2012, LIFE TECHNOLOGIES RE; Avise John C., 2004, P1; Beckman K. B., 1993, PROMEGA NOTES, V43, P10; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Brockhurst MA, 2011, MOL ECOL, V20, P972, DOI 10.1111/j.1365-294X.2010.04835.x; Brokeland W, 2009, ZOOTAXA, P6, DOI 10.11646/zootaxa.2096.1.2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P40, DOI 10.1016/j.dsr2.2009.08.005; Carr SM, 2008, GENETICS, V180, P381, DOI 10.1534/genetics.108.089730; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; Chapman AD, 2009, NUMBERS LIVING SPECI; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dettai A, 2011, POLAR SCI, V5, P298, DOI 10.1016/j.polar.2011.02.002; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Engel K, 2012, J MICROBIOL METH, V88, P35, DOI 10.1016/j.mimet.2011.10.007; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hardy CM, 2011, MAR FRESHWATER RES, V62, P887, DOI 10.1071/MF11027; Harvey JBJ, 2012, J EXP MAR BIOL ECOL, V413, P60, DOI 10.1016/j.jembe.2011.11.022; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Heimeier D, 2010, MAR GENOM, V3, P165, DOI 10.1016/j.margen.2010.09.004; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2012, PARASITOLOGY, P1; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Luddington IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045664; Lysholm Fredrik, 2011, BMC Res Notes, V4, P449, DOI 10.1186/1756-0500-4-449; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Monniot F, 2011, ZOOTAXA, P1; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Powell AF, 2012, MOL PHYLOGENET EVOL; Prosdocimi F, 2012, MOL BIOL REP, V39, P2767, DOI 10.1007/s11033-011-1034-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Summerer D, 2009, GENOMICS, V94, P363, DOI 10.1016/j.ygeno.2009.08.012; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wilson JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010525; Xu JP, 2009, MOL PHYLOGENET EVOL, V52, P157, DOI 10.1016/j.ympev.2009.03.031; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	93	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51263	10.1371/journal.pone.0051263	http://dx.doi.org/10.1371/journal.pone.0051263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251474	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800036
J	Invernizzi, G; Aprile, FA; Natalello, A; Ghisleni, A; Penco, A; Relini, A; Doglia, SM; Tortora, P; Regonesi, ME				Invernizzi, Gaetano; Aprile, Francesco A.; Natalello, Antonino; Ghisleni, Andrea; Penco, Amanda; Relini, Annalisa; Doglia, Silvia M.; Tortora, Paolo; Regonesi, Maria E.			The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli	PLOS ONE			English	Article							INCLUSION-BODY FORMATION; N-TERMINAL HUNTINGTIN; PROTEIN OLIGOMERS; MUTANT HUNTINGTIN; AMYLOID FIBRILS; BODIES; FIBRILLOGENESIS; EXPRESSION; REVEALS; REPEATS	Several neurodegenerative diseases are triggered by proteins containing a polyglutamine (polyQ) stretch expanded beyond a critical threshold. Among these, ataxin-3 (AT3) is the causative agent of spinocerebellar ataxia type-3. We expressed three authentic AT3 variants in Escherichia coli: one normal (AT3-Q24), one expanded (AT3-Q55) and one truncated immediately upstream of the polyQ (AT3-291 Delta). Then, based on growth rate reduction, we quantified protein toxicity. We show that AT3-Q55 and -291 Delta strongly reduced the growth rate in the early stages (2-4 h), unlike AT3-Q24. This correlated well with the appearance of soluble cytosolic oligomers, but not with the amount of insoluble protein in inclusion bodies (IBs). The impact of AT3-291 Delta on cell growth suggests an intrinsic toxicity of the AT3 fragment. Besides the typical Fourier Transform Infrared Spectroscopy (FTIR) signal for intermolecular beta-sheets, the expanded form displayed an additional infrared signature, which was assigned to glutamine side-chain hydrogen bonding and associated with SDS-insoluble fibrils. The elongation of the latter was monitored by Atomic Force Microscopy (AFM). This mirrors the well-known in vitro two-step aggregation pattern of expanded AT3. We also demonstrated that final aggregates of strains expressing expanded or truncated AT3 play a protective role against toxicity. Furthermore, our findings suggest that the mechanisms of toxicity are evolutionarily conserved. Citation: Invernizzi G, Aprile FA, Natalello A, Ghisleni A, Penco A, et al. (2012) The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli. PLoS ONE 7(12): e51890. doi:10.1371/journal.pone.0051890	[Invernizzi, Gaetano; Aprile, Francesco A.; Natalello, Antonino; Ghisleni, Andrea; Doglia, Silvia M.; Tortora, Paolo; Regonesi, Maria E.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy	University of Milano-Bicocca; University of Genoa	Invernizzi, G (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	gaetano.invernizzi@unimib.it; paolo.tortora@unimib.it	Natalello, Antonino/B-9659-2012; Relini, Annalisa/AHC-3105-2022; invernizzi, gaetano/K-4375-2014	Natalello, Antonino/0000-0002-1489-272X; Tortora, Paolo/0000-0001-5234-601X; Ghisleni, Andrea/0000-0001-8456-5903; RELINI, ANNALISA/0000-0002-4040-9279; Aprile, Francesco Antonio/0000-0002-5040-4420	Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research, PRIN 2007 project [2007XY59ZJ_004]; Regione Lombardia (Network Enabled Drug Design); University of Genoa (Progetti di Ateneo)	Fondazione Cariplo (N.O.B.E.L. project)(Fondazione Cariplo); Italian Ministry for Instruction, University and Research, PRIN 2007 project(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia (Network Enabled Drug Design)(Regione Lombardia); University of Genoa (Progetti di Ateneo)	This work was supported by the following: Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research, PRIN 2007 project n. 2007XY59ZJ_004; Regione Lombardia (Network Enabled Drug Design); A.N. and G.I. acknowledge postdoctoral fellowships of the University of Milano-Bicocca. This work was partially supported by University of Genoa (Progetti di Ateneo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2003, BBA-GEN SUBJECTS, V1624, P6, DOI 10.1016/j.bbagen.2003.09.008; Ami D, 2009, BBA-PROTEINS PROTEOM, V1794, P263, DOI 10.1016/j.bbapap.2008.10.015; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dasari M, 2011, CHEMBIOCHEM, V12, P407, DOI 10.1002/cbic.201000602; de Groot NS, 2008, FUTURE MICROBIOL, V3, P423, DOI 10.2217/17460913.3.4.423; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hinz J, 2008, BIOCHEMISTRY-US, V47, P4196, DOI 10.1021/bi800002j; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Invernizzi G, 2008, PROTEIN EXPRES PURIF, V62, P111, DOI 10.1016/j.pep.2008.06.012; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2002, BIOCHEM SOC T, V30, P548, DOI 10.1042/bst0300548; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nagao Y, 2000, BBA-MOL BASIS DIS, V1502, P247, DOI 10.1016/S0925-4439(00)00047-8; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Onodera O, 1996, FEBS LETT, V399, P135, DOI 10.1016/S0014-5793(96)01301-4; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Santambrogio C, 2012, FEBS J, V279, P451, DOI 10.1111/j.1742-4658.2011.08438.x; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang X, 2008, J MOL BIOL, V380, P570, DOI 10.1016/j.jmb.2008.05.019; Wasmer C, 2009, ANGEW CHEM INT EDIT, V48, P4858, DOI 10.1002/anie.200806100; Winkelmann J, 2010, J MOL BIOL, V398, P600, DOI 10.1016/j.jmb.2010.03.030; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51890	10.1371/journal.pone.0051890	http://dx.doi.org/10.1371/journal.pone.0051890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251648	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800104
J	Kaur, M; Lagopoulos, J; Ward, PB; Watson, TL; Naismith, SL; Hickie, IB; Hermens, DF				Kaur, Manreena; Lagopoulos, Jim; Ward, Philip B.; Watson, Tamara L.; Naismith, Sharon L.; Hickie, Ian B.; Hermens, Daniel F.			Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis	PLOS ONE			English	Article							AUDITORY SENSORY MEMORY; MENTAL-HEALTH-SERVICES; BIPOLAR DISORDER; NEUROPHYSIOLOGICAL ENDOPHENOTYPES; ELECTROPHYSIOLOGICAL INDEXES; 1ST-EPISODE SCHIZOPHRENIA; PREATTENTIVE DYSFUNCTION; COGNITIVE DEFICITS; 1ST EPISODE; GLUTAMATE	Background: We have recently shown that the event-related potential biomarkers, mismatch negativity (MMN) and P3a, are similarly impaired in young patients with schizophrenia- and affective-spectrum psychoses as well as those with bipolar disorder. A data driven approach may help to further elucidate novel patterns of MMN/P3a amplitudes that characterise distinct subgroups in patients with emerging psychiatric disorders. Methods: Eighty seven outpatients (16 to 30 years) were assessed: 19 diagnosed with a depressive disorder; 26 with a bipolar disorder; and 42 with a psychotic disorder. The MMN/P3a complex was elicited using a two-tone passive auditory oddball paradigm with duration deviant tones. Hierarchical cluster analysis utilising frontal, central and temporal neurophysiological variables was conducted. Results: Three clusters were determined: the 'globally impaired' cluster (n = 53) displayed reduced frontal and temporal MMN as well as reduced central P3a amplitudes; the 'largest frontal MMN' cluster (n = 17) were distinguished by increased frontal MMN amplitudes and the 'largest temporal MMN' cluster (n = 17) was characterised by increases in temporal MMN only. Notably, 55% of those in the globally impaired cluster were diagnosed with schizophrenia-spectrum disorder, whereas the three patient subgroups were equally represented in the remaining two clusters. The three cluster-groups did not differ in their current symptomatology; however, the globally impaired cluster was the most neuropsychologically impaired, compared with controls. Conclusions: These findings suggest that in emerging psychiatric disorders there are distinct MMN/P3a profiles of patient subgroups independent of current symptomatology. Schizophrenia-spectrum patients tended to show the most global impairments in this neurophysiological complex. Two other subgroups of patients were found to have neurophysiological profiles suggestive of quite different neurobiological (and hence, treatment) implications. Citation: Kaur M, Lagopoulos J, Ward PB, Watson TL, Naismith SL, et al. (2012) Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis. PLoS ONE 7(12): e51871. doi:10.1371/journal.pone.0051871	[Kaur, Manreena; Lagopoulos, Jim; Watson, Tamara L.; Naismith, Sharon L.; Hickie, Ian B.; Hermens, Daniel F.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia; [Ward, Philip B.] Liverpool Hosp, SW Sydney Local Hlth Network, Schizophrenia Res Unit, Liverpool, Merseyside, England; [Watson, Tamara L.] Univ Western Sydney, Sch Social Sci & Psychol, Kingswood, NSW, Australia	University of Sydney; University of New South Wales Sydney; Western Sydney University	Kaur, M (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia.	manreena.kaur@sydney.edu.au	Ward, Philip/E-3959-2010; Watson, Tamara/AAD-2575-2020; Hickie, Ian B/K-8975-2015; Watson, Tamara/F-9920-2010	Ward, Philip/0000-0002-5779-7722; Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Watson, Tamara/0000-0001-7899-0858; Naismith, Sharon/0000-0001-9076-2778	National Health & Medical Research Council (NHMRC) program grant [566529]; NHMRC Australia Fellowship [464914]; NMHRC Clinical Research Fellowship [464914]; NHRMC Postgraduate Scholarship	National Health & Medical Research Council (NHMRC) program grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NMHRC Clinical Research Fellowship; NHRMC Postgraduate Scholarship	This work was funded by a National Health & Medical Research Council (NHMRC) program grant (No. 566529) and a NHMRC Australia Fellowship (No. 464914) awarded to IBH. SLN was funded by a NMHRC Clinical Research Fellowship (No. 464914). MK was supported by an NHRMC Postgraduate Scholarship. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2008, BIPOLAR DISORD, V10, P888, DOI 10.1111/j.1399-5618.2008.00638.x; Andreasen NC, 1980, BRIT J PSYCHIAT, V33, P1157; APA, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Babor TF, 2001, ALCOHOL USE DISORDER; Baldeweg T, 2002, INT J PSYCHOPHYSIOL, V43, P111, DOI 10.1016/S0167-8760(01)00183-0; Bestelmeyer PEG, 2012, PSYCHIAT RES, V197, P140, DOI 10.1016/j.psychres.2011.09.030; BLASHFIELD RK, 1979, COMPR PSYCHIAT, V20, P516, DOI 10.1016/S0010-440X(79)80004-8; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; de Bartolomeis A, 2012, EUR J PHARMACOL, V682, P1, DOI 10.1016/j.ejphar.2012.02.033; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; DINGEMANS PMAJ, 1995, PSYCHOPHARMACOLOGY, V122, P263, DOI 10.1007/BF02246547; Dixon JF, 1998, P NATL ACAD SCI USA, V95, P8363, DOI 10.1073/pnas.95.14.8363; First M. B., 2007, STRUCTURED CLIN INTE; Ford JM, 2012, INT J PSYCHOPHYSIOL, V83, P232, DOI 10.1016/j.ijpsycho.2011.09.004; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Goldstein G, 1990, Arch Clin Neuropsychol, V5, P251, DOI 10.1016/0887-6177(90)90024-J; Hafner H, 2008, EUR ARCH PSY CLIN N, V258, P85, DOI 10.1007/s00406-008-2011-4; Hahn CG, 2004, J CLIN PSYCHIAT, V65, P791; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hermann B, 2007, J INT NEUROPSYCH SOC, V13, P12, DOI 10.1017/S135561770707004X; Hermens DF, 2011, J INT NEUROPSYCH SOC, V17, P267, DOI 10.1017/S1355617710001566; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Hirayasu Y, 1998, AM J PSYCHIAT, V155, P1384, DOI 10.1176/ajp.155.10.1384; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jahshan C, 2012, BIPOLAR DISORD, V14, P239, DOI 10.1111/j.1399-5618.2012.01008.x; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kaur M, 2012, J PSYCHIATR NEUROSCI, V37, P313, DOI 10.1503/jpn.110081; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; Kawakubo Y, 2006, NEUROREPORT, V17, P1043, DOI 10.1097/01.wnr.0000221828.10846.ba; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Lagopoulos J, 1997, NEUROL RES, V19, P609; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Lepisto T, 2004, CLIN NEUROPHYSIOL, V115, P620, DOI 10.1016/j.clinph.2003.10.020; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; Mager R, 2005, APPL PSYCHOPHYS BIOF, V30, P233, DOI 10.1007/s10484-005-6380-4; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naismith SL, 2012, J AFFECT DISORDERS, V138, P71, DOI 10.1016/j.jad.2011.12.028; Norusis M.J., 2010, PASW STAT 18 GUIDE D; Oades RD, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-7; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shinozaki N, 2002, BIOL PSYCHOL, V59, P105, DOI 10.1016/S0301-0511(01)00129-6; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Strauss E, 2006, COMPENDIUM NEUROPSYC; Strelnikov K, 2007, BRAIN COGNITION, V65, P244, DOI 10.1016/j.bandc.2007.04.002; Takei Y, 2010, PROG NEURO-PSYCHOPH, V34, P903, DOI 10.1016/j.pnpbp.2010.04.014; Takei Y, 2009, PSYCHOPHYSIOLOGY, V46, P52, DOI 10.1111/j.1469-8986.2008.00748.x; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Wechsler D, 2002, WECHSLER TEST ADULT; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	83	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51871	10.1371/journal.pone.0051871	http://dx.doi.org/10.1371/journal.pone.0051871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251645	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800101
J	Chao, CT; Hou, CC; Wu, VC; Lu, HM; Wang, CY; Chen, L; Kao, TW				Chao, Chia-Ter; Hou, Chun-Cheng; Wu, Vin-Cent; Lu, Hsin-Ming; Wang, Cheng-Yi; Chen, Likwang; Kao, Tze-Wah			The Impact of Dialysis-Requiring Acute Kidney Injury on Long-Term Prognosis of Patients Requiring Prolonged Mechanical Ventilation: Nationwide Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; REPLACEMENT THERAPY; RESOURCE UTILIZATION; RISK-FACTORS; MORTALITY; OUTCOMES; DEATH; DISEASE	Background: Prolonged mechanical ventilation (PMV) is increasingly common worldwide, consuming enormous healthcare resources. Factors that modify PMV outcome are still obscure. Methods: We selected patients without preceding mechanical ventilation within the one past year and who developed PMV during index admission in Taiwan's National Health Insurance (NHI) system during 1998-2007 for comparison of mortality and resource use. They were divided into three groups: (1) patients with end-stage renal diseases (ESRD) before the index admission for PMV onset; (2) patients with dialysis-requiring acute kidney injury (AKI-dialysis) during the hospitalization course; and (3) patients without AKI or with non dialysis-requiring AKI during the hospitalization course (non-AKI). We used a random-effects logistic regression model to identify factors associated with mortality. Results: Compared with the other two groups, patients with AKI-dialysis had significantly longer mechanical ventilation, more frequent use of vasopressors, longer intensive care unit/hospital stay and higher inpatient expenditures during the index admission. Relative to non-AKI patients, patients with AKI-dialysis had an elevated mortality hazard; the adjusted relative risk ratios were 1.51 (95% confidence interval [CI]:1.46-1.56), 1.27 (95% CI: 1.23-1.32), and 1.10 (95% CI: 1.08-1.12) for mortality rates at discharge, 3 months, and 4 years after PMV, respectively. Patients with AKI-dialysis also consumed significantly higher total in-patient expenditure than the other two patient groups (p < 0.001). Conclusions: Among patients that need PMV care during an admission, the presence of de novo AKI requiring dialysis significantly increased short and long term mortality, and demand for health care resources.	[Chao, Chia-Ter; Wu, Vin-Cent; Kao, Tze-Wah] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Hou, Chun-Cheng] Min Sheng Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Lu, Hsin-Ming; Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Wang, Cheng-Yi] Cardinal Tien Hosp, Dept Internal Med, Xindian, Taiwan; [Hou, Chun-Cheng] Taipei Med Univ, Sch Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; Taipei Medical University	Chen, L (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.	likwang@nhri.org.tw; twkao2@ntuh.gov.tw	Chen, Li-Kwang/E-3934-2010; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; WU, VIN-CENT/0000-0001-7935-0991	Taiwan's National Health Research Institutes [PH-100-PP-19, PH-101-PP-16]; National Taiwan University Hospital	Taiwan's National Health Research Institutes; National Taiwan University Hospital(National Taiwan University)	This study was financially supported by Taiwan's National Health Research Institutes, through grants PH-100-PP-19 and PH-101-PP-16; and by intramural funding from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Alkandari O, 2011, CRIT CARE, V15, DOI 10.1186/cc10269; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2006, CURR OPIN CRIT CARE, V12, P405, DOI 10.1097/01.ccx.0000244118.08753.dc; Carson SS, 2012, CRIT CARE MED, V40, P1171, DOI 10.1097/CCM.0b013e3182387d43; Carson SS, 2001, CHEST, V120, P928, DOI 10.1378/chest.120.3.928; Chelluri L, 2004, CRIT CARE MED, V32, P61, DOI 10.1097/01.CCM.0000098029.65347.F9; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Flori HR, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/854142; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Hutchison CA, 2007, CRIT CARE, V11, DOI 10.1186/cc5785; Jassal SV, 2011, NEPHRON CLIN PRACT, V119, pC5, DOI 10.1159/000328017; Kao KC, 2011, J CRIT CARE, V26, P600, DOI 10.1016/j.jcrc.2011.03.005; Kojicic M, 2011, RESP CARE, V56, P1765, DOI 10.4187/respcare.01096; Kong WY, 2012, NEPHROLOGY, V17, P445, DOI 10.1111/j.1440-1797.2012.01593.x; Liano F, 1998, KIDNEY INT, V53, pS16; Lien YC, 2009, ANN THORAC SURG, V88, P1124, DOI 10.1016/j.athoracsur.2009.06.002; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Lone NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10117; Lu HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-100; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Needham DM, 2004, CRIT CARE MED, V32, P1504, DOI 10.1097/01.CCM.0000129972.31533.37; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Nierman DM, 2002, CRIT CARE CLIN, V18, P477, DOI 10.1016/S0749-0704(02)00010-6; Nin N, 2010, SHOCK, V34, P109, DOI 10.1097/SHK.0b013e3181d671a6; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Pan SW, 2011, J CRIT CARE, V26, P586, DOI 10.1016/j.jcrc.2011.04.009; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Rocha E, 2009, NEPHROL DIAL TRANSPL, V24, P1925, DOI 10.1093/ndt/gfn750; Scheinhorn DJ, 1998, CRIT CARE CLIN, V14, P819, DOI 10.1016/S0749-0704(05)70032-4; Seferian EG, 2008, CRIT CARE MED, V36, P2779, DOI 10.1097/CCM.0b013e318186ab1b; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Uchino S, 2003, BLOOD PURIFICAT, V21, P170, DOI 10.1159/000069156; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Vieira JM, 2007, CRIT CARE MED, V35, P184, DOI 10.1097/01.CCM.0000249828.81705.65; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	49	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50675	10.1371/journal.pone.0050675	http://dx.doi.org/10.1371/journal.pone.0050675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251377	gold, Green Submitted, Green Published			2022-12-25	WOS:000313236200034
J	Makkoch, J; Suwannakarn, K; Payungporn, S; Prachayangprecha, S; Cheiocharnsin, T; Linsuwanon, P; Theamboonlers, A; Poovorawan, Y				Makkoch, Jarika; Suwannakarn, Kamol; Payungporn, Sunchai; Prachayangprecha, Slinporn; Cheiocharnsin, Thaweesak; Linsuwanon, Piyada; Theamboonlers, Apiradee; Poovorawan, Yong			Whole Genome Characterization, Phylogenetic and Genome Signature Analysis of Human Pandemic H1N1 Virus in Thailand, 2009-2012	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; ANTIGENIC EVOLUTION	Background: Three waves of human pandemic influenza occurred in Thailand in 2009-2012. The genome signature features and evolution of pH1N1 need to be characterized to elucidate the aspects responsible for the multiple waves of pandemic. Methodology/Findings: Forty whole genome sequences and 584 partial sequences of pH1N1 circulating in Thailand, divided into 1st, 2nd and 3rd wave and post-pandemic were characterized and 77 genome signatures were analyzed. Phylogenetic trees of concatenated whole genome and HA gene sequences were constructed calculating substitution rate and d(N)/d(S) of each gene. Phylogenetic analysis showed a distinct pattern of pH1N1 circulation in Thailand, with the first two isolates from May, 2009 belonging to clade 5 while clades 5, 6 and 7 co-circulated during the first wave of pH1N1 pandemic in Thailand. Clade 8 predominated during the second wave and different proportions of the pH1N1 viruses circulating during the third wave and post pandemic period belonged to clades 8, 11.1 and 11.2. The mutation analysis of pH1N1 revealed many adaptive mutations which have become the signature of each clade and may be responsible for the multiple pandemic waves in Thailand, especially with regard to clades 11.1 and 11.2 as evidenced with V731I, G154D of PB1 gene, PA I330V, HA A214T S160G and S202T. The substitution rate of pH1N1 in Thailand ranged from 2.53 x 10(-3) +/- 0.02 (M2 genes) to 5.27 x 10(-3) +/- 0.03 per site per year (NA gene). Conclusions: All results suggested that this virus is still adaptive, maybe to evade the host's immune response and tends to remain in the human host although the d(N)/d(S) were under purifying selection in all 8 genes. Due to the gradual evolution of pH1N1 in Thailand, continuous monitoring is essential for evaluation and surveillance to be prepared for and able to control future influenza activities.	[Makkoch, Jarika; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Cheiocharnsin, Thaweesak; Linsuwanon, Piyada; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	yong.p@chula.ac.th	Linsuwanon, Piyada/AAS-7642-2020; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807	Commission on Higher Education; Ministry of Education; Center of Excellence in Clinical Virology; Chulalongkorn University; Dutsadi Piphat Scholarship; CU Centenary Academic Development Project; King Chulalongkorn Memorial Hospital; Graduate School of Biomedical Science; RGJ PhD program of the Thailand Research Fund; Thailand Research Fund [DPG5480002]; National Research University Project of Thailand; Office of the Higher Education Commission [HR1155A-55]; MK Restaurant Company Limited; NIAID, United States National Institutes of Health, Department of Health and Human Services [HHSN266200700007c]	Commission on Higher Education; Ministry of Education; Center of Excellence in Clinical Virology; Chulalongkorn University(Chulalongkorn University); Dutsadi Piphat Scholarship; CU Centenary Academic Development Project; King Chulalongkorn Memorial Hospital(Chulalongkorn University); Graduate School of Biomedical Science; RGJ PhD program of the Thailand Research Fund; Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project of Thailand; Office of the Higher Education Commission; MK Restaurant Company Limited; NIAID, United States National Institutes of Health, Department of Health and Human Services	The authors would like to express their gratitude to the Commission on Higher Education, Ministry of Education, the Center of Excellence in Clinical Virology, Chulalongkorn University, Dutsadi Piphat Scholarship, Chulalongkorn University, CU Centenary Academic Development Project, King Chulalongkorn Memorial Hospital, Graduate School of Biomedical Science, Chulalongkorn University, the RGJ PhD program of the Thailand Research Fund, Thailand Research Fund (DPG5480002), National Research University Project of Thailand, Office of the Higher Education Commission (HR1155A-55), MK Restaurant Company Limited and in part with federal funds from the NIAID, United States National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN266200700007c for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chieochansin T, 2009, ASIAN BIOMED, V3, P469; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Espinola Emilio E, 2012, Open Virol J, V6, P59, DOI 10.2174/1874357901206010059; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Nelson M, 2009, PLOS CURR, V3; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Payungporn S, 2010, ACTA VIROL, V54, P155, DOI 10.4149/av_2010_03_155; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Sarkar M, 2011, ARCH VIROL, V156, P207, DOI 10.1007/s00705-010-0842-6; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thai Meteorological Department, 2012, THAIL ANN WEATH SUMM; Thai Ministry of Public Health, 2009, PUBL HLTH ADV 5 SUBJ; WHO, 2012, REC COMP INFL VIR VA; World Health Organization website, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028288; Zhao Jiu-ru, 2011, Virologica Sinica, V26, P418, DOI 10.1007/s12250-011-3228-3	31	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51275	10.1371/journal.pone.0051275	http://dx.doi.org/10.1371/journal.pone.0051275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251479	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200082
J	Coudeville, L; Garnett, GP				Coudeville, Laurent; Garnett, Geoff P.			Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; PRIMARY-SCHOOL CHILDREN; COST-EFFECTIVENESS; HEMORRHAGIC-FEVER; KAMPHAENG PHET; INFECTION; EPIDEMIOLOGY; BURDEN; MODELS; DETERMINANTS	Background: With approximately 2.5 billion people at risk, dengue is a major international public health concern. Dengue vaccines currently in development should help reduce the burden associated with this disease but the most efficient way of using future dengue vaccines remains to be defined. Mathematical models of transmission can provide insight into the expected impact of different vaccination strategies at a population level and contribute to this definition. Methods and Findings: We developed and analyzed an age-structured, host-vector and serotype-specific compartmental model, including seasonality. We first used this transmission model to identify the immunological interactions between serotypes that affect the risks and consequences of secondary infections (cross-protection, increased susceptibility, increased severity, and increased infectiousness) and reproduce the observed epidemiology of dengue. For populating this model, we used routine surveillance data from Southern Vietnam and the results of a prospective cohort study conducted in the same area. The model provided a good fit to the observed data for age, severity of cases, serotype distribution, and dynamics over time, using two scenarios of immunological interaction : short term cross-protection alone (6-17 months) or a combination of short term cross-protection with cross-enhancement (increased susceptibility, severity and infectiousness in the case of secondary infections). Finally, we explored the potential impact of vaccination for these two scenarios. Both highlighted that vaccination can substantially decrease dengue burden by reducing the magnitude and frequency of outbreaks. Conclusion: Our model suggests that seasonality and short term cross-protection are key factors for explaining dengue dynamics in Southern Vietnam. Vaccination was predicted to significantly reduce the disease burden, even in the situation where immunological cross-enhancement affects the risks and consequences of secondary infections. Citation: Coudeville L, Garnett GP (2012) Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination. PLoS ONE 7(12): e51244. doi:10.1371/journal.pone.0051244	[Coudeville, Laurent] Sanofi Pasteur, Dengue Co, Lyon, France; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England	Sanofi-Aventis; Sanofi France; Imperial College London	Coudeville, L (corresponding author), Sanofi Pasteur, Dengue Co, Lyon, France.	laurent.coudeville@sanofipasteur.com	Garnett, Geoffrey P/A-9312-2008		Sanofi Pasteur	Sanofi Pasteur	This work was sponsored by Sanofi Pasteur. LC is an employee of Sanofi Pasteur and contributed with GG to model design, data analysis and preparation of the manuscript.	Adams B, 2006, J THEOR BIOL, V242, P337, DOI 10.1016/j.jtbi.2006.03.002; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Brockwell P.J., 1991, TIME SERIES THEORY M; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Chompoosri J, 2012, THAI J VET MED, V42, P185; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; FISCHER DB, 1970, YALE J BIOL MED, V42, P329; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guy B, 2011, LANCET, V377, P381, DOI 10.1016/S0140-6736(11)60128-1; Guy B, 2010, HUM VACCINES, V6, P696, DOI [10.4161/hv.6.9.12739, 10.4161.hv.6.9.12739]; Ha DQ, 2000, EMERG INFECT DIS, V6, P422; HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Halstead SB, 2007, LANCET, V369, P1410, DOI 10.1016/S0140-6736(07)60645-X; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Phuong HL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-123; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Pongsumpun P, 2003, MATH COMPUT MODEL, V37, P949, DOI 10.1016/S0895-7177(03)00111-0; Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Stocki R., 2005, COMPUT ASSIST MECH E, V12, P87; Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; WHO, 1997, DENG HAEM FEV DIAGN; WHO, 2012, DENG DENG HAEM FEV; Wikramaratna PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012347; Word DP, 2012, J R SOC INTERFACE, V9, P1983, DOI 10.1098/rsif.2011.0829; World Health Organization, 2009, DENGUE GUIDELINES DI	62	51	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51244	10.1371/journal.pone.0051244	http://dx.doi.org/10.1371/journal.pone.0051244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251466	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900058
J	Heni, M; Hennenlotter, J; Scharpf, M; Lutz, SZ; Schwentner, C; Todenhofer, T; Schilling, D; Kuhs, U; Gerber, V; Machicao, F; Staiger, H; Haring, HU; Stenzl, A				Heni, Martin; Hennenlotter, Joerg; Scharpf, Marcus; Lutz, Stefan Z.; Schwentner, Christian; Todenhoefer, Tilman; Schilling, David; Kuehs, Ursula; Gerber, Valentina; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich; Stenzl, Arnulf			Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and-2 Are Differentially Expressed in Prostate Cancer	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR RECEPTOR; TISSUE ADJACENT; IRS PROTEINS; RISK; METASTASIS; CONSENSUS; STRATEGY; PATHWAY; DISEASE	Aims/Hypothesis: In different cancers types, insulin receptor isoform composition or insulin receptor substrate (IRS) isoforms are different to healthy tissue. This may be a molecular link to increased cancer risk in diabetes and obesity. Since this is yet unclear for prostate cancer, we investigated IR isoform composition and IRS balance in prostate cancer compared to benign and tumor adjacent benign prostate tissue and brought this into relation to cell proliferation. Methods: We studied 23 benign prostate samples from radical cystectomy or benign prostatic hyperplasia surgery, 30 samples from benign tissue directly adjacent to prostate cancer foci and 35 cancer samples from different patients. RNA expression levels for insulin receptor isoforms A and B, IRS-1, IRS-2, and IGF-1 receptor were assessed by quantitative real-time RT-PCR. In addition, RNA-and protein expression of the cell cycle regulator p27(Kip1) was quantified by real-time RT-PCR and immunohistochemistry. Results: Insulin receptor isoform A to B ratio was significantly higher in cancer as well as in tumor adjacent benign prostate tissue compared to purely benign prostates (p<0.05). IRS-1 to IRS-2 ratios were lower in malignant than in benign prostatic tissue (p<0.05). These altered ratios both in cancer and adjacent tissue were significantly associated with reduced p27(Kip1) content (p<0.02). Interestingly, IGF-1 receptor levels were significantly lower in patients with type 2 diabetes (p = 0.0019). Conclusions/Interpretation: We found significant differences in the insulin signaling cascade between benign prostate tissue and prostate cancer. Histological benign tissue adjacent to cancer showed expression patterns similar to the malignancies. Our findings suggest a role of the insulin signaling pathway in prostate cancer and surrounding tissue and can hence be relevant for both novel diagnostic and therapeutic approaches in this malignancy.	[Heni, Martin; Lutz, Stefan Z.; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; [Hennenlotter, Joerg; Schwentner, Christian; Todenhoefer, Tilman; Schilling, David; Kuehs, Ursula; Gerber, Valentina; Stenzl, Arnulf] Univ Tubingen, Dept Urol, D-7400 Tubingen, Germany; [Scharpf, Marcus] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, German Ctr Diabet Res DZD, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333	German Federal Ministry of Education and Research (BMBF) [01GI0925]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Hellawell GO, 2002, CANCER RES, V62, P2942; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; Hribal ML, 2003, FASEB J, V17, P1340, DOI 10.1096/fj.02-0685fje; Kasper JS, 2008, CANCER CAUSE CONTROL, V19, P703, DOI 10.1007/s10552-008-9133-x; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; Merseburger AS, 2006, ONCOL REP, V16, P79; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mussig K, 2011, DIABETIC MED, V28, P276, DOI 10.1111/j.1464-5491.2010.03132.x; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Theodorescu D, 1997, J UROLOGY, V158, P131, DOI 10.1097/00005392-199707000-00040; Waalkes S, 2010, ONCOL REP, V23, P1257, DOI 10.3892/or_00000758; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu C, 2011, PROSTATE CANCER P D, V14, P326, DOI 10.1038/pcan.2011.28; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467	27	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50953	10.1371/journal.pone.0050953	http://dx.doi.org/10.1371/journal.pone.0050953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251408	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900029
J	Beggs, AD; Domingo, E; Abulafi, M; Hodgson, SV; Tomlinson, IPM				Beggs, A. D.; Domingo, E.; Abulafi, M.; Hodgson, S. V.; Tomlinson, I. P. M.			A study of genomic instability in early preneoplastic colonic lesions	ONCOGENE			English	Article						colorectal cancer; gland; heterogeneity; methylation; microsatellite instability	MICROSATELLITE INSTABILITY; COLORECTAL ADENOMAS; NORMAL MUCOSA; CANCER; METHYLATION; HYPERMETHYLATION; PROMOTER; POLYPS; MUTATIONS; TUMORS	It is difficult to explain the differential rates of progression of premalignant colonic lesions and differences in behaviour of morphologically similar lesions. Heterogeneity for microsatellite instability (MSI) and promoter methylation in driving these phenomena forward may explain this; however, no previous analysis has examined this in detail at the gland level, the smallest unit of colorectal premalignant lesions. We aimed to carry out an analysis of gland level genomic instability for MSI and promoter methylation. MSI occurred significantly more frequently (20%) in colonic glands than has previously been observed in whole colorectal polyps. Significant promoter methylation was seen in MLH1, PMS2, MLH3 and MSH3 as well as significant heterogeneity for both MSI and promoter methylation. Methylation and MSI may have a significant role in driving forward colorectal carcinogenesis, although in the case of MSI, this association is less clear as it occurs significantly more frequently than previously thought, and may simply be a passenger in the adenoma-carcinoma sequence. Promoter methylation in MLH1, MLH3, MSH3 and PMS2 was also found to be significantly associated with MSI and should be investigated further. A total of 273 colorectal glands (126 hyperplastic, 147 adenomatous) were isolated via laser capture microdissection (targeted at regions of MLH1 loss) from 93 colonic polyps and tested for MSI, and promoter methylation of the DNA mismatch repair genes MLH1, MSH2, MLH3, MSH6, PMS2, MGMT and MLH3 via methylation specific multiplex ligation-dependent probe amplification. Logistic regression modelling was then used to identify significant associations between promoter methylation and gland histological type and MSI status.	[Beggs, A. D.; Domingo, E.; Tomlinson, I. P. M.] Univ Oxford, Mol & Populat Genet Lab, Oxford OX3 7BN, England; [Beggs, A. D.; Domingo, E.; Tomlinson, I. P. M.] Univ Oxford, NIHR Comprehens Biomed Res Ctr, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Beggs, A. D.; Abulafi, M.] Croydon Univ Hosp, Dept Surg, Croydon, England; [Hodgson, S. V.] St Georges Univ London, Dept Med Genet, London, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Croydon University Hospital; St Georges University London	Beggs, AD (corresponding author), Univ Oxford, Mol & Populat Genet Lab, Roosevelt Dr, Oxford OX3 7BN, England.	a.beggs@bham.ac.uk	Beggs, Andrew D/A-6912-2013; Domingo, Enric/A-9099-2018	Beggs, Andrew D/0000-0003-0784-2967; Domingo, Enric/0000-0003-4390-8767	Mason Medical Foundation; Peel Medical Research Trust; St George's Hospital Charity; Cancer Research UK; Wellcome Trust [090532/Z/09/Z]; Cancer Research UK [16459] Funding Source: researchfish	Mason Medical Foundation; Peel Medical Research Trust; St George's Hospital Charity; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	ADB was funded by a Mason Medical Foundation Research Fellowship and grants from the Peel Medical Research Trust and St George's Hospital Charity; IPMT acknowledges funding from Cancer Research UK and the Wellcome Trust 090532/Z/09/Z.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Belshaw NJ, 2010, CARCINOGENESIS, V31, P1158, DOI 10.1093/carcin/bgq077; Brueckl WM, 2000, INT J COLORECTAL DIS, V15, P189, DOI 10.1007/s003840000241; Cunningham JM, 1998, CANCER RES, V58, P3455; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; Koh DC, 2007, COLORECTAL DIS, V9, P521, DOI 10.1111/j.1463-1318.2007.01175.x; Lanza G, 2002, MODERN PATHOL, V15, P741, DOI 10.1097/01.MP.0000018979.68686.B2; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; LOTHE RA, 1995, GENE CHROMOSOME CANC, V14, P182, DOI 10.1002/gcc.2870140305; Park CK, 2011, NEURO-ONCOLOGY, V13, P195, DOI 10.1093/neuonc/noq162; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Rashid A, 1999, GUT, V44, P826, DOI 10.1136/gut.44.6.826; Samowitz WS, 1997, AM J PATHOL, V151, P33; Samowitz WS, 1997, GASTROENTEROLOGY, V112, P1515, DOI 10.1016/S0016-5085(97)70032-5; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Umetani N, 2006, MOL CANCER RES, V4, P303, DOI 10.1158/1541-7786.MCR-05-0199; Yurgelun MB, 2012, CANCER PREV RES, V5, P574, DOI 10.1158/1940-6207.CAPR-11-0519	21	20	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5333	5337		10.1038/onc.2012.584	http://dx.doi.org/10.1038/onc.2012.584			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23246972	hybrid, Green Published			2022-12-25	WOS:000326922400003
J	Okamoto, R; Li, YX; Noma, K; Hiroi, Y; Liu, PY; Taniguchi, M; Ito, M; Liao, JK				Okamoto, Ryuji; Li, Yuxin; Noma, Kensuke; Hiroi, Yukio; Liu, Ping-Yen; Taniguchi, Masaya; Ito, Masaaki; Liao, James K.			FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2	FASEB JOURNAL			English	Article						Rho kinase; angiotensin; four-and-a-half LIM-only protein; serum response factor; extracellular regulated signaling kinase	SERUM RESPONSE FACTOR; LONG-TERM INHIBITION; RHO-FAMILY GTPASES; ACTIN CYTOSKELETON; MYOCARDIAL-INFARCTION; PROTEIN FHL2; IN-VIVO; KINASE; MUSCLE; CELLS	The Rho-associated coiled-coil containing kinases, ROCK1 and ROCK2, are important regulators of cell shape, migration, and proliferation through effects on the actin cytoskeleton. However, it is not known whether ROCK2 plays an important role in the development of cardiac hypertrophy. To determine whether the loss of ROCK2 could prevent cardiac hypertrophy, cardiomyocyte-specific ROCK2-null (c-ROCK2(-/-)) were generated using conditional ROCK2(flox/flox) mice and alpha-myosin heavy-chain promoter-driven Cre recombinase transgenic mice. Cardiac hypertrophy was induced by Ang II infusion (400 ng/kg/min, 28 d) or transverse aortic constriction (TAC). Under basal conditions, hemodynamic parameters, cardiac anatomy, and function of c-ROCK2(-/-) mice were comparable to wild-type (WT) mice. However, following Ang II infusion or TAC, c-ROCK2(-/-) mice exhibited a substantially smaller increase in heart-to-body weight ratio, left ventricular mass, myocyte cross-sectional area, hypertrophy-related fetal gene expression, intraventricular fibrosis, cardiac apoptosis, and oxidative stress compared to control mice. Deletion of ROCK2 in cardiomyocytes leads to increased expression of four-and-a-half LIM-only protein-2 (FHL2) and FHL2-mediated inhibition of serum response factor (SRF) and extracellular signal-regulated mitogen-activated protein kinase (ERK). Knockdown of FHL2 expression in ROCK2-deficient cardiomyocytes or placing ROCK2-haploinsufficient (ROCK2(+/-)) mice on FHL2(+/-)-haploinsufficient background restored the hypertrophic response to Ang II. These results indicate that cardiomyocyte ROCK2 is essential for the development of cardiac hypertrophy and that up-regulation of FHL2 may contribute to the antihypertrophic phenotype that is observed in cardiac-specific ROCK2-deficient mice.-Okamoto, R., Li, Y., Noma, K., Hiroi, Y., Liu, P.-Y., Taniguchi, M., Ito, M., Liao, J. K. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2. FASEB J. 27, 1439-1449 (2013). www.fasebj.org	[Okamoto, Ryuji; Li, Yuxin; Noma, Kensuke; Hiroi, Yukio; Liu, Ping-Yen; Liao, James K.] Brigham & Womens Hosp, Vasc Med Res Unit, Boston, MA 02115 USA; [Okamoto, Ryuji; Li, Yuxin; Noma, Kensuke; Hiroi, Yukio; Liu, Ping-Yen; Liao, James K.] Harvard Univ, Sch Med, Boston, MA USA; [Okamoto, Ryuji; Taniguchi, Masaya; Ito, Masaaki] Mie Univ, Sch Med, Dept Cardiol & Nephrol, Tsu, Mie, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mie University	Liao, JK (corresponding author), Brigham & Womens Hosp, 65 Landsdowne St,PRB 275, Cambridge, MA 02139 USA.	jliao@rics.bwh.harvard.edu	Li, yuxin/GSD-1668-2022; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022		U.S. National Institutes of Health [HL-052233, HL-080187, DK-086005, NS-070001]; Mie University School of Medicine; Mie Medical Association and Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080187, R01HL052233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070001] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mie University School of Medicine; Mie Medical Association and Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Ju Chen (University of California, San Diego, CA, USA) for providing us with FHL2 KO mice. In addition, we are grateful for the following reagents: C2C12 cells (Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, USA); Sf9 cells (Karin M. Hoffmeister, Brigham and Women's Hospital, Boston, MA, USA); baculovirus containing CA-ROCK2 and plasmids of ROCK2, CAROCK2, and DN-ROCK2 (Kozo Kaibuchi, Nagoya University, Nagoya, Japan); ROCK1 cDNA (Shuh Narumiya, Kyoto University, Kyoto, Japan), and adenovirus containing CA-ROCK (Zhihong Yang, University of Fribourg, Fribourg, Switzerland). This work was supported by grants from the U.S. National Institutes of Health (HL-052233, HL-080187, DK-086005, NS-070001), Mie University School of Medicine, Mie Medical Association and Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan. R.O. was supported by a research fellowship from the Uehara Memorial Foundation.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Aikawa R, 1999, CIRC RES, V84, P458, DOI 10.1161/01.RES.84.4.458; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kong YF, 2001, CIRCULATION, V103, P2731; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Rikitake Y, 2005, CIRCULATION, V111, P3261, DOI 10.1161/CIRCULATIONAHA.105.534024; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Wang YX, 2005, EUR J PHARMACOL, V512, P215, DOI 10.1016/j.ejphar.2005.02.024; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	44	66	69	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1439	1449		10.1096/fj.12-217018	http://dx.doi.org/10.1096/fj.12-217018			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23271052	Green Published			2022-12-25	WOS:000316940800016
J	Fernandez-Castaneda, A; Arandjelovic, S; Stiles, TL; Schlobach, RK; Mowen, KA; Gonias, SL; Gaultier, A				Fernandez-Castaneda, Anthony; Arandjelovic, Sanja; Stiles, Travis L.; Schlobach, Ryan K.; Mowen, Kerri A.; Gonias, Steven L.; Gaultier, Alban			Identification of the Low Density Lipoprotein (LDL) Receptor-related Protein-1 Interactome in Central Nervous System Myelin Suggests a Role in the Clearance of Necrotic Cell Debris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; MULTIPLE-SCLEROSIS; BASIC-PROTEIN; PEPTIDYLARGININE DEIMINASE; SURFACE CALRETICULIN; APOPTOTIC CELLS; BINDING; BRAIN; 3-PHOSPHODIESTERASE; OVEREXPRESSION	In the central nervous system (CNS), fast neuronal signals are facilitated by the oligodendrocyte-produced myelin sheath. Oligodendrocyte turnover or injury generates myelin debris that is usually promptly cleared by phagocytic cells. Failure to remove dying oligodendrocytes leads to accumulation of degraded myelin, which, if recognized by the immune system, may contribute to the development of autoimmunity in diseases such as multiple sclerosis. We recently identified low density lipoprotein receptor-related protein-1 (LRP1) as a novel phagocytic receptor for myelin debris. Here, we report characterization of the LRP1 interactome in CNS myelin. Fusion proteins were designed corresponding to the extracellular ligand-binding domains of LRP1. LRP1 partners were isolated by affinity purification and characterized by mass spectrometry. We report that LRP1 binds intracellular proteins via its extracellular domain and functions as a receptor for necrotic cells. Peptidyl arginine deiminase-2 and cyclic nucleotide phosphodiesterase are novel LRP1 ligands identified in our screen, which interact with full-length LRP1. Furthermore, the extracellular domain of LRP1 is a target of peptidyl arginine deiminase-2-mediated deimination in vitro. We propose that LRP1 functions as a receptor for endocytosis of intracellular components released during cellular damage and necrosis.	[Fernandez-Castaneda, Anthony; Schlobach, Ryan K.; Gaultier, Alban] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Fernandez-Castaneda, Anthony; Schlobach, Ryan K.; Gaultier, Alban] Univ Virginia, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Arandjelovic, Sanja; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Stiles, Travis L.; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Virginia; University of Virginia; Scripps Research Institute; University of California System; University of California San Diego	Gaultier, A (corresponding author), Univ Virginia, Dept Neurosci, 409 Lane Rd, Charlottesville, VA 22908 USA.	ag7h@virginia.edu			National Institutes of Health [R21 NS071347, R01 HL-060551, R01 GM085117, R01 AI067460]; Arthritis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21 NS071347 (to A.G.), R01 HL-060551 (to S.L.G.), and R01 GM085117 and R01 AI067460 (to K.A.M.). This work was also supported by the Philip S. Magaram, Esq., Research Award from the Arthritis Foundation (to S.A.).	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Buser AM, 2009, MOL CELL NEUROSCI, V40, P156, DOI 10.1016/j.mcn.2008.10.002; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2010, J PROTEOME RES, V9, P6689, DOI 10.1021/pr1008288; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mastronardi FG, 2007, J NEUROSCI RES, V85, P2006, DOI 10.1002/jnr.21329; Miyaoka Y, 2010, DEVELOPMENT, V137, P159, DOI 10.1242/dev.041574; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Musse AA, 2007, INT REV NEUROBIOL, V79, P149, DOI 10.1016/S0074-7742(07)79007-4; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Rosener M, 1997, J NEUROIMMUNOL, V75, P28, DOI 10.1016/S0165-5728(96)00230-5; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Stern M, 1996, AM J PATHOL, V149, P911; Stiles T. L., 2012, J CELL SCI; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Studzinski DM, 2003, J NEUROSCI RES, V73, P31, DOI 10.1002/jnr.10642; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	50	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4538	4548		10.1074/jbc.M112.384693	http://dx.doi.org/10.1074/jbc.M112.384693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264627	Green Published, hybrid			2022-12-25	WOS:000315340400004
J	Kato, U; Inadome, H; Yamamoto, M; Emoto, K; Kobayashi, T; Umeda, M				Kato, Utako; Inadome, Hironori; Yamamoto, Masatoshi; Emoto, Kazuo; Kobayashi, Toshihide; Umeda, Masato			Role for Phospholipid Flippase Complex of ATP8A1 and CDC50A Proteins in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASES; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; LIPID ASYMMETRY; TRANSPORT; DYNAMICS; PHOSPHATIDYLSERINE; IDENTIFICATION; P4-ATPASE	Type IV P-type ATPases (P4-ATPases) and CDC50 family proteins form a putative phospholipid flippase complex that mediates the translocation of aminophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine (PE) from the outer to inner leaflets of the plasma membrane. In Chinese hamster ovary (CHO) cells, at least eight members of P4-ATPases were identified, but only a single CDC50 family protein, CDC50A, was expressed. We demonstrated that CDC50A associated with and recruited P4-ATPase ATP8A1 to the plasma membrane. Overexpression of CDC50A induced extensive cell spreading and greatly enhanced cell migration. Depletion of either CDC50A or ATP8A1 caused a severe defect in the formation of membrane ruffles, thereby inhibiting cell migration. Analyses of phospholipid translocation at the plasma membrane revealed that the depletion of CDC50A inhibited the inward translocation of both PS and PE, whereas the depletion of ATP8A1 inhibited the translocation of PE but not that of PS, suggesting that the inward translocation of cell-surface PE is involved in cell migration. This hypothesis was further examined by using a PE-binding peptide and a mutant cell line with defective PE synthesis; either cell-surface immobilization of PE by the PE-binding peptide or reduction in the cell-surface content of PE inhibited the formation of membrane ruffles, causing a severe defect in cell migration. These results indicate that the phospholipid flippase complex of ATP8A1 and CDC50A plays a major role in cell migration and suggest that the flippase-mediated translocation of PE at the plasma membrane is involved in the formation of membrane ruffles to promote cell migration.	[Kato, Utako; Yamamoto, Masatoshi; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Inadome, Hironori] Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Emoto, Kazuo] Osaka Biosci Inst, Dept Cell Biol, Suita, Osaka 5650874, Japan; [Kobayashi, Toshihide] RIKEN, Discovery Res Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan	Kyoto University; Kirin Holdings Co Ltd; RIKEN	Umeda, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	umeda@sbchem.kyoto-u.ac.jp	Kobayashi, Toshihide/B-6298-2015; KOBAYASHI, TOSHIHIDE/S-8313-2019; EMOTO, KAZUO/G-4992-2014	Kobayashi, Toshihide/0000-0002-4811-7270; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders	This work was supported by a grant-in-aid for scientific research, the 21st Century COE Program "Genome Science," a grant-in-aid for the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a research grant from Astellas Foundation for Research on Metabolic Disorders.	Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 1999, P NATL ACAD SCI USA, V96, P12400, DOI 10.1073/pnas.96.22.12400; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; NAM KS, 1990, BIOCHIM BIOPHYS ACTA, V1046, P89, DOI 10.1016/0005-2760(90)90098-I; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Smriti, 2007, BIOCHEMISTRY-US, V46, P2249, DOI 10.1021/bi061333x; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	66	61	66	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4922	4934		10.1074/jbc.M112.402701	http://dx.doi.org/10.1074/jbc.M112.402701			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269685	hybrid, Green Published			2022-12-25	WOS:000315340400040
J	Leung, MC; Hitchen, PG; Ward, DG; Messer, AE; Marston, SB				Leung, Man-Ching; Hitchen, Paul G.; Ward, Douglas G.; Messer, Andrew E.; Marston, Steven B.			Z-band Alternatively Spliced PDZ Motif Protein (ZASP) Is the Major O-Linked beta-N-Acetylglucosamine-substituted Protein in Human Heart Myofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C PHOSPHORYLATION; BINDING; MUSCLE; DOMAIN; CARDIOMYOPATHY; GLCNACYLATION; TRANSFERASE; MUTATIONS; CYPHER	We studied O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of contractile proteins in human heart using SDS-PAGE and three detection methods: specific enzymatic conjugation of O-GlcNAc with UDP-N-azidoacetylgalactosamine (UDP-GalNAz) that is then linked to a tetramethylrhodamine fluorescent tag and CTD110.6 and RL2 monoclonal antibodies to O-GlcNAc. All three methods showed that O-GlcNAc modification was predominantly in a group of bands similar to 90 kDa that did not correspond to any of the major myofibrillar proteins. MALDI-MS/MS identified the 90-kDa band as the protein ZASP (Z-band alternatively spliced PDZ motif protein), a minor component of the Z-disc (about 1 per 400 alpha-actinin) important for myofibrillar development and mechanotransduction. This was confirmed by the co-localization of O-GlcNAc and ZASP in Western blotting and by immunofluorescence microscopy. O-GlcNAcylation of ZASP increased in diseased heart, being 49 +/- 5% of all O-GlcNAc in donor, 68 +/- 9% in end-stage failing heart, and 76 +/- 6% in myectomy muscle samples (donor versus myectomy p < 0.05). ZASP is only 22% of all O-GlcNAcylated proteins in mouse heart myofibrils.	[Leung, Man-Ching; Messer, Andrew E.; Marston, Steven B.] Univ London Imperial Coll Sci Technol & Med, NHLI, Myocardial Funct Sect, London W12 0NN, England; [Hitchen, Paul G.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Ward, Douglas G.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	Imperial College London; Imperial College London; University of Birmingham	Marston, SB (corresponding author), Imperial Ctr Translat & Expt Med, Du Cane Rd, London W12 0NN, England.	s.marston@imperial.ac.uk		Ward, Douglas/0000-0002-2328-1445	British Heart Foundation; European Community [241577]; British Heart Foundation [PG/08/077/25587, RG/11/20/29266] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Community(European Commission); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the British Heart Foundation and European Community Seventh Framework Programme (2007-2013) Grant Agreement 241577 (BIG-Heart).	Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Belke DD, 2011, J APPL PHYSIOL, V111, P157, DOI 10.1152/japplphysiol.00147.2011; Brainard RE, 2011, CIRCULATION, V124; Buyandelger B, 2011, J CARDIOVASC TRANSL, V4, P238, DOI 10.1007/s12265-011-9262-6; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hedou J, 2007, J BIOL CHEM, V282, P10360, DOI 10.1074/jbc.M606787200; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Ramirez G, 2011, CIRCULATION, V124; Ramirez-Correa GA, 2011, BIOPHYS J, V100, P451; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	39	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4891	4898		10.1074/jbc.M112.410316	http://dx.doi.org/10.1074/jbc.M112.410316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271734	Green Published, hybrid			2022-12-25	WOS:000315340400037
J	Tomanicek, SJ; Standaert, RF; Weiss, KL; Ostermann, A; Schrader, TE; Ng, JD; Coates, L				Tomanicek, Stephen J.; Standaert, Robert F.; Weiss, Kevin L.; Ostermann, Andreas; Schrader, Tobias E.; Ng, Joseph D.; Coates, Leighton			Neutron and X-ray Crystal Structures of a Perdeuterated Enzyme Inhibitor Complex Reveal the Catalytic Proton Network of the Toho-1 beta-Lactamase for the Acylation Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAHIGH-RESOLUTION STRUCTURE; SITE-DIRECTED MUTAGENESIS; EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; GENERAL BASE; MECHANISM; SPECIFICITY; GLU166; STATE; QM/MM	The mechanism by which class A beta-lactamases hydrolyze beta-lactam antibiotics has been the subject of intensive investigation using many different experimental techniques. Here, we report on the novel use of both neutron and high resolution x-ray diffraction to help elucidate the identity of the catalytic base in the acylation part of the catalytic cycle, wherein the beta-lactam ring is opened and an acyl-enzyme intermediate forms. To generate protein crystals optimized for neutron diffraction, we produced a perdeuterated form of the Toho-1 beta-lactamase R274N/R276N mutant. Protein perdeuteration, which involves replacing all of the hydrogen atoms in a protein with deuterium, gives a much stronger signal in neutron diffraction and enables the positions of individual deuterium atoms to be located. We also synthesized a perdeuterated acylation transition state analog, benzothiophene-2-boronic acid, which was also isotopically enriched with B-11, as B-10 is a known neutron absorber. Using the neutron diffraction data from the perdeuterated enzyme-inhibitor complex, we were able to determine the positions of deuterium atoms in the active site directly rather than by inference. The neutron diffraction results, along with supporting bond-length analysis from high resolution x-ray diffraction, strongly suggest that Glu-166 acts as the general base during the acylation reaction.	[Tomanicek, Stephen J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Standaert, Robert F.; Weiss, Kevin L.; Coates, Leighton] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Standaert, Robert F.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Standaert, Robert F.] Univ Tennessee, Dept Biochem & Mol & Cellular Biol, Knoxville, TN 37996 USA; [Ostermann, Andreas] Tech Univ Munich, Forsch Neutronenquelle Heinz Maier Leibnitz FRM 2, D-85747 Garching, Germany; [Schrader, Tobias E.] Forschungszentrum Julich, Outstn FRM 2, Julich Ctr Neutron Sci, D-85747 Garching, Germany; [Ng, Joseph D.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Technical University of Munich; Helmholtz Association; Research Center Julich; University of Alabama System; University of Alabama Huntsville	Coates, L (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, POB 2008, Oak Ridge, TN 37831 USA.	coatesl@ornl.gov	Standaert, Robert F/D-9467-2013; Weiss, Kevin/I-4669-2013; Coates, Leighton/AAJ-7148-2021; Standaert, Robert F./AAI-1532-2021	Standaert, Robert F/0000-0002-5684-1322; Weiss, Kevin/0000-0002-6486-8007; Coates, Leighton/0000-0003-2342-049X; Ostermann, Andreas/0000-0002-1477-5590; Schrader, Tobias Erich/0000-0001-5159-0846	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); United States Department of Energy [DE-AC05-00OR22725]; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); United States Department of Energy(United States Department of Energy (DOE)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL), managed by UT-Battelle LLC for the United States Department of Energy under Contract DE-AC05-00OR22725.; The Office of Biological and Environmental Research supported research at the Oak Ridge National Laboratory Center for Structural Molecular Biology (CSMB), using facilities supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy. Results shown in this study are derived from work performed at Argonne National Laboratory (ANL), Structural Biology Center at the Advanced Photon Source. ANL is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We thank Nancy Engle and Dr. Timothy Tschaplinski for assistance with GC-MS.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P. V., 2005, CCP4 NEWSLETTETTER P; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Atanasov BP, 2000, P NATL ACAD SCI USA, V97, P3160, DOI 10.1073/pnas.060027897; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Blakeley MP, 2008, P NATL ACAD SCI USA, V105, P1844, DOI 10.1073/pnas.0711659105; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Chen Y, 2005, J AM CHEM SOC, V127, P5423, DOI 10.1021/ja042850a; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Chen Y, 2007, J AM CHEM SOC, V129, P5378, DOI 10.1021/ja0712064; CLARK PD, 1993, PHOSPHORUS SULFUR, V84, P149, DOI 10.1080/10426509308034326; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; DUBOIS SK, 1995, J ANTIMICROB CHEMOTH, V35, P7; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Gardberg AS, 2010, ACTA CRYSTALLOGR D, V66, P558, DOI 10.1107/S0907444910005494; GIBSON RM, 1990, BIOCHEM J, V272, P613, DOI 10.1042/bj2720613; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; HAWTHORNE SB, 1989, FRESEN Z ANAL CHEM, V334, P421, DOI 10.1007/BF00469464; Hermann JC, 2005, J AM CHEM SOC, V127, P4454, DOI 10.1021/ja044210d; Hermann JC, 2003, J AM CHEM SOC, V125, P9590, DOI 10.1021/ja034434g; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269, DOI 10.1128/AAC.39.10.2269; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Lietz EJ, 2000, BIOCHEMISTRY-US, V39, P4971, DOI 10.1021/bi992681k; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Maveyraud L, 1998, BIOCHEMISTRY-US, V37, P2622, DOI 10.1021/bi972501b; Meilleur F, 2004, BIOCHEMISTRY-US, V43, P8744, DOI 10.1021/bi049418q; Meilleur F, 2009, METHODS MOL BIOL, V544, P281, DOI 10.1007/978-1-59745-483-4_18; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nitanai Y, 2010, BBA-PROTEINS PROTEOM, V1804, P684, DOI 10.1016/j.bbapap.2009.10.023; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Shimamura T, 2009, ACTA CRYSTALLOGR F, V65, P379, DOI 10.1107/S1744309109008240; Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Thomas VL, 2005, BIOCHEMISTRY-US, V44, P9330, DOI 10.1021/bi0502700; Tomanicek SJ, 2011, FEBS LETT, V585, P364, DOI 10.1016/j.febslet.2010.12.017; Tomanicek SJ, 2010, J MOL BIOL, V396, P1070, DOI 10.1016/j.jmb.2009.12.036; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X	50	39	39	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4715	4722		10.1074/jbc.M112.436238	http://dx.doi.org/10.1074/jbc.M112.436238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255594	Green Published, hybrid			2022-12-25	WOS:000315340400020
J	Fan, HP; Zhao, XF; Sun, SG; Luo, M; Guan, JL				Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin			Function of Focal Adhesion Kinase Scaffolding to Mediate Endophilin A2 Phosphorylation Promotes Epithelial-Mesenchymal Transition and Mammary Cancer Stem Cell Activities in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; TRANSGENIC MOUSE MODEL; BREAST-CANCER; TYROSINE PHOSPHORYLATION; TUMOR PROGRESSION; E-CADHERIN; FAK; SRC; DISRUPTION; MIGRATION	Tyrosine kinases have been shown to play critical roles in cancer development and progression, and their inhibitors hold the potential as effective targeted therapies for breast and other cancers. However, some of these kinases like focal adhesion kinase (FAK) also possess scaffolding functions in intracellular signaling, but such kinase-independent functions of FAK or other kinases have not been examined in cancer directly in vivo. Here, we report that disruption of the function of FAK scaffolding through its Pro-878/881 motif suppressed mammary tumor growth and metastasis in a well characterized murine model of human breast cancer. P878A/P881A mutation in the endogenous FAK gene decreased the expression of markers for epithelial-mesenchymal transition (EMT) and mammary cancer stem cell (MaCSC) activities in tumors derived from mutant mice. This mutation disrupted the function of FAK scaffolding to mediate endophilin A2 phosphorylation at Tyr-315 by Src, leading to the decreased surface expression of MT1-MMP, as observed previously in transformed fibroblasts in vitro. Inhibition of the downstream components of this FAK scaffolding function by Y315F endophilin A2 mutant or MT1-MMP knockdown reduced markers for EMT and MaCSC activities. Conversely, bypass of the scaffolding function using the phosphorylation mimic mutant Y315E endophilin A2 or endophilin A2 knockdown rescued the decreased markers for EMT and MaCSCs as well as surface expression of MT1-MMP in tumor cells harboring the P878A/P881A mutation. Together, these results identify a novel role of FAK scaffolding function in breast cancer, which could serve as a new target in combination with kinase inhibition for more effective treatment strategies.	[Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA; [Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Fan, Huaping/B-8762-2012		National Institutes of Health [CA163493, CA150926, CA046592]; John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA150926, R01CA163493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA163493 and CA150926. This work was also supported in part by the John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center (to J.-L. G.).; We are grateful to Dr. Thom Saunders of the University of Michigan for advice on the generation of knock-in mice and C. Bian and A. Serna for technical assistance. We thank Dr. Stephen Weiss of the University of Michigan and members of the Guan laboratory for discussions and helpful comments. We acknowledge E. Hughes, Y. Y. Qu, K. Childs, and G. Gavrilina for the preparation of gene-targeted mice and the University of Michigan Biomedical Research Core Facility, which was supported in part by National Institutes of Health Grant CA046592.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XY, 2011, J CELL BIOL, V195, P729, DOI 10.1083/jcb.201105103; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Messina S, 2003, J NEUROCHEM, V84, P253, DOI 10.1046/j.1471-4159.2003.01519.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Parsons JT, 2008, CLIN CANCER RES, V14, P627, DOI 10.1158/1078-0432.CCR-07-2220; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rodrigo JP, 2007, ARCH OTOLARYNGOL, V133, P145, DOI 10.1001/archotol.133.2.145; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	58	59	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3322	3333		10.1074/jbc.M112.420497	http://dx.doi.org/10.1074/jbc.M112.420497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255596	Green Published, hybrid			2022-12-25	WOS:000314397900038
J	Kim, A; Shin, TH; Shin, SM; Pham, CD; Choi, DK; Kwon, MH; Kim, YS				Kim, Aeyung; Shin, Tae-Hwan; Shin, Seung-Min; Pham, Chuong D.; Choi, Dong-Ki; Kwon, Myung-Hee; Kim, Yong-Sung			Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT Peptide	PLOS ONE			English	Article							CAVEOLAE-MEDIATED ENDOCYTOSIS; PROTEIN TRANSDUCTION DOMAIN; MAMMALIAN-CELLS; DEPENDENT ENDOCYTOSIS; FUSION PROTEINS; GENE-TRANSFER; IN-VIVO; ANTIBODIES; DNA; BINDING	Cellular internalization of bacteriophage by surface-displayed cell penetrating peptides has been reported, though the underlying mechanism remains elusive. Here we describe in detail the internalization mechanism and intracellular trafficking and stability of filamentous M13 phages, the cellular entry of which is mediated by surface-displayed cell-penetrating light chain variable domain 3D8 VL transbody (3D8 VL-M13) or TAT peptide (TAT-M13). Recombinant 3D8 VL-M13 and TAT-M13 phages were efficiently internalized into living mammalian cells via physiologically relevant, energy-dependent endocytosis and were recovered from the cells in their infective form with the yield of 3D8 VL-M13 being higher (0.005 similar to 0.01%) than that of TAT-M13 (0.001 similar to 0.005%). Biochemical and genetic studies revealed that 3D8 VL-M13 was internalized principally by caveolae-mediated endocytosis via interaction with heparan sulfate proteoglycans as cell surface receptors, whereas TAT-M13 was internalized by clathrin- and caveolae-mediated endocytosis utilizing chondroitin sulfate proteoglycans as cell surface receptors, suggesting that phage internalization occurs by physiological endocytotic mechanism through specific cell surface receptors rather than non-specific transcytotic pathways. Internalized 3D8 VL-M13 phages routed to the cytosol and remained stable for more than 18 h without further trafficking to other subcellular compartments, whereas TAT-M13 phages routed to several subcellular compartments before being degraded in lysosomes even after 2 h of internalization. Our results suggest that the internalizing mechanism and intracellular trafficking of filamentous M13 bacteriophages largely follow the attributes of the displayed cell-penetrating moiety. Efficient internalization and cytosolic localization of 3D8 VL transbody-displayed phages will provide a useful tool for intracellular delivery of polar macromolecules such as proteins, peptides, and siRNAs. Citation: Kim A, Shin T-H, Shin S-M, Pham CD, Choi D-K, et al. (2012) Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT Peptide. PLoS ONE 7(12): e51813. doi:10.1371/journal.pone.0051813	[Kim, Aeyung; Shin, Tae-Hwan; Shin, Seung-Min; Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Pham, Chuong D.; Kwon, Myung-Hee] Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea	Ajou University; Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	kimys@ajou.ac.kr	Pham, Dinh-Chuong/L-8930-2018; Shin, Tae Hwan/AAE-4763-2022	Pham, Dinh-Chuong/0000-0002-3074-6941; Shin, Tae Hwan/0000-0001-9686-4556; Kim, Yong-Sung/0000-0003-2673-1509; Shin, Seung-min/0000-0002-3014-502X	Mid-career Researcher Program [2010-0009760]; Priority Research Center Program [2012-0006687]; Global Frontier Project grant from the National Research Foundation [2012M3A6A4054252]; Korea government (MEST)	Mid-career Researcher Program; Priority Research Center Program; Global Frontier Project grant from the National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	The authors would like to thank Dr. Sang Jick Kim (KRIBB, Korea) for providing the phagemid pDR-D1 vector and bacterial strain ER2738. This work was supported by Mid-career Researcher Program (2010-0009760), the Priority Research Center Program (2012-0006687), and the Global Frontier Project grant (2012M3A6A4054252) grants from the National Research Foundation, funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, J BIOTECHNOL, V151, P225, DOI 10.1016/j.jbiotec.2010.12.004; Becerril B, 1999, BIOCHEM BIOPH RES CO, V255, P386, DOI 10.1006/bbrc.1999.0177; Burg MA, 2002, CANCER RES, V62, P977; Coia G, 2001, J IMMUNOL METHODS, V251, P187, DOI 10.1016/S0022-1759(01)00300-3; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; Gao CS, 2002, BIOORGAN MED CHEM, V10, P4057, DOI 10.1016/S0968-0896(02)00340-1; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; HART SL, 1994, J BIOL CHEM, V269, P12468; Imai S, 2008, PHARMAZIE, V63, P760, DOI 10.1691/ph.2008.8132; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P450, DOI 10.1016/S0167-4889(98)00162-1; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P463, DOI 10.1016/S0167-4889(98)00163-3; Jang JY, 2009, CELL MOL LIFE SCI, V66, P1985, DOI 10.1007/s00018-009-9179-2; Jang YJ, 2003, CELL MOL LIFE SCI, V60, P309, DOI 10.1007/s000180300026; Kim A, 2012, ANTIVIR RES, V94, P157, DOI 10.1016/j.antiviral.2012.03.007; Kim A, 2012, BIOTECHNOL BIOPROC E, V17, P413, DOI 10.1007/s12257-011-0609-2; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Lee SH, 2010, MOL IMMUNOL, V47, P816, DOI 10.1016/j.molimm.2009.09.041; Lee WR, 2010, NUCLEIC ACIDS RES, V38, P1596, DOI 10.1093/nar/gkp1145; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Marschall ALJ, 2011, MABS-AUSTIN, V3, P3, DOI 10.4161/mabs.3.1.14110; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; Park SY, 2008, PROTEINS, V71, P2091, DOI 10.1002/prot.22011; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sapinoro R, 2008, VIROLOGY, V373, P274, DOI 10.1016/j.virol.2007.12.013; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Zhou Y, 2010, J MOL BIOL, V404, P88, DOI 10.1016/j.jmb.2010.09.006	42	37	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51813	10.1371/journal.pone.0051813	http://dx.doi.org/10.1371/journal.pone.0051813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251631	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800090
J	Carter, SP; Chambers, MA; Rushton, SP; Shirley, MDF; Schuchert, P; Pietravalle, S; Murray, A; Rogers, F; Gettinby, G; Smith, GC; Delahay, RJ; Hewinson, RG; McDonald, RA				Carter, Stephen P.; Chambers, Mark A.; Rushton, Stephen P.; Shirley, Mark D. F.; Schuchert, Pia; Pietravalle, Stephane; Murray, Alistair; Rogers, Fiona; Gettinby, George; Smith, Graham C.; Delahay, Richard J.; Hewinson, R. Glyn; McDonald, Robbie A.			BCG Vaccination Reduces Risk of Tuberculosis Infection in Vaccinated Badgers and Unvaccinated Badger Cubs	PLOS ONE			English	Article							MELES-MELES; BOVINE TUBERCULOSIS; CATTLE TUBERCULOSIS; IMPACT; ORGANIZATION; ERADICATION; POPULATION; CESSATION; SEVERITY; MOVEMENT	Wildlife is a global source of endemic and emerging infectious diseases. The control of tuberculosis (TB) in cattle in Britain and Ireland is hindered by persistent infection in wild badgers (Meles meles). Vaccination with Bacillus Calmette-Guerin (BCG) has been shown to reduce the severity and progression of experimentally induced TB in captive badgers. Analysis of data from a four-year clinical field study, conducted at the social group level, suggested a similar, direct protective effect of BCG in a wild badger population. Here we present new evidence from the same study identifying both a direct beneficial effect of vaccination in individual badgers and an indirect protective effect in unvaccinated cubs. We show that intramuscular injection of BCG reduced by 76% (Odds ratio = 0.24, 95% confidence interval (CI) 0.11-0.52) the risk of free-living vaccinated individuals testing positive to a diagnostic test combination to detect progressive infection. A more sensitive panel of tests for the detection of infection per se identified a reduction of 54% (Odds ratio = 0.46, 95% CI 0.26-0.88) in the risk of a positive result following vaccination. In addition, we show the risk of unvaccinated badger cubs, but not adults, testing positive to an even more sensitive panel of diagnostic tests decreased significantly as the proportion of vaccinated individuals in their social group increased (Odds ratio = 0.08, 95% CI 0.01-0.76; P = 0.03). When more than a third of their social group had been vaccinated, the risk to unvaccinated cubs was reduced by 79% (Odds ratio = 0.21, 95% CI 0.05-0.81; P = 0.02).	[Carter, Stephen P.; Pietravalle, Stephane; Murray, Alistair; Rogers, Fiona; Smith, Graham C.; Delahay, Richard J.] Food & Environm Res Agcy, York, N Yorkshire, England; [Chambers, Mark A.; Hewinson, R. Glyn] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Rushton, Stephen P.; Shirley, Mark D. F.; Schuchert, Pia] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gettinby, George] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Food & Environment Research Agency; Veterinary Laboratories Agency; Newcastle University - UK; University of Strathclyde; University of Exeter	Carter, SP (corresponding author), Food & Environm Res Agcy, York, N Yorkshire, England.	steve.carter@fera.gsi.gov.uk	Chambers, Mark A/C-9470-2009; Delahay, Richard/J-2261-2014; Chambers, Mark/M-6189-2019; Carter, Steve P/J-1686-2014; McDonald, Robbie A/A-2931-2012; Hewinson, Glyn/AAA-2364-2019; Smith, Graham C/J-2593-2013; Delahay, Richard/GSI-4663-2022; McDonald, Robbie/AAK-2718-2020; Hewinson, Glyn/J-1902-2014	Chambers, Mark A/0000-0002-8073-8069; Chambers, Mark/0000-0002-8073-8069; Carter, Steve P/0000-0002-9487-7377; McDonald, Robbie A/0000-0002-6922-3195; Smith, Graham C/0000-0002-9897-6794; McDonald, Robbie/0000-0002-6922-3195; Shirley, Mark/0000-0002-6220-2578; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs [SE3254]	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra project number SE3254, http://www.defra.gov.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript but provided helpful comments to earlier versions of the manuscript.	ANDERSON RM, 1986, NATURE, V322, P304, DOI 10.1038/322304a0; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2011, VET REC, V169, P425, DOI 10.1136/vr.d6781; [Anonymous], 2011, BOV TB ER PROGR ENGL; [Anonymous], 2010, FIELD TRIAL ASSESS S; Bishop P, 2012, J ENVIRON LAW, V24, P145, DOI 10.1093/jel/eqs001; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Brostrom G, 2011, GEN LINEAR MODELS CL; Brostrom G., 2011, GLMMML GEN LINEAR MO; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; Delahay RJ, 2011, J ZOOL, V284, P183, DOI 10.1111/j.1469-7998.2011.00796.x; Delahay RJ, 2000, MAMMAL REV, V30, P73, DOI 10.1046/j.1365-2907.2000.00058.x; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Donnelly CA, 2012, NATURE, V485, P582, DOI 10.1038/485582a; Eves JA, 1999, IRISH VET J, V52, P199; Farr W, 1840, 2 ANN REPORT REGISTR; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Henschel V, 2009, INTCOX COMPENDIUM AP; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaden V, 2003, BERL MUNCH TIERARZTL, V116, P362; Krebs J. (Chairman), 1997, Bovine tuberculosis in cattle and badgers.; Lesellier S, 2011, VACCINE, V29, P3782, DOI 10.1016/j.vaccine.2011.03.028; Neal E., 1996, BADGERS; O Mairtin D, 1998, PREV VET MED, V34, P47, DOI 10.1016/S0167-5877(97)00067-6; Rogers LM, 1998, P ROY SOC B-BIOL SCI, V265, P1269, DOI 10.1098/rspb.1998.0429; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rushton SP, 2009, EPIDEMIOL INFECT, V137, P1099, DOI 10.1017/S095026880800188X; Sheridan M, 2011, VET MICROBIOL, V151, P160, DOI 10.1016/j.vetmic.2011.02.040; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Tomlinson A, 2012, VET IMMUNOL IN PRESS; Topley WWC, 1923, J HYG-CAMBRIDGE, V21, P243, DOI 10.1017/S0022172400031478; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022	50	59	59	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49833	10.1371/journal.pone.0049833	http://dx.doi.org/10.1371/journal.pone.0049833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251352	Green Published, Green Accepted, gold			2022-12-25	WOS:000313236200020
J	Graves, TA; Royle, JA; Kendall, KC; Beier, P; Stetz, JB; Macleod, AC				Graves, Tabitha A.; Royle, J. Andrew; Kendall, Katherine C.; Beier, Paul; Stetz, Jeffrey B.; Macleod, Amy C.			Balancing Precision and Risk: Should Multiple Detection Methods Be Analyzed Separately in N-Mixture Models?	PLOS ONE			English	Article							ESTIMATING ABUNDANCE; COUNTS	Using multiple detection methods can increase the number, kind, and distribution of individuals sampled, which may increase accuracy and precision and reduce cost of population abundance estimates. However, when variables influencing abundance are of interest, if individuals detected via different methods are influenced by the landscape differently, separate analysis of multiple detection methods may be more appropriate. We evaluated the effects of combining two detection methods on the identification of variables important to local abundance using detections of grizzly bears with hair traps (systematic) and bear rubs (opportunistic). We used hierarchical abundance models (N-mixture models) with separate model components for each detection method. If both methods sample the same population, the use of either data set alone should (1) lead to the selection of the same variables as important and (2) provide similar estimates of relative local abundance. We hypothesized that the inclusion of 2 detection methods versus either method alone should (3) yield more support for variables identified in single method analyses (i.e. fewer variables and models with greater weight), and (4) improve precision of covariate estimates for variables selected in both separate and combined analyses because sample size is larger. As expected, joint analysis of both methods increased precision as well as certainty in variable and model selection. However, the single-method analyses identified different variables and the resulting predicted abundances had different spatial distributions. We recommend comparing single-method and jointly modeled results to identify the presence of individual heterogeneity between detection methods in N-mixture models, along with consideration of detection probabilities, correlations among variables, and tolerance to risk of failing to identify variables important to a subset of the population. The benefits of increased precision should be weighed against those risks. The analysis framework presented here will be useful for other species exhibiting heterogeneity by detection method.	[Graves, Tabitha A.; Beier, Paul] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Kendall, Katherine C.] US Geol Survey, No Rocky Mt Sci Ctr, Glacier Field Stn, Glacier Natl Pk, MT USA; [Stetz, Jeffrey B.] Univ Montana, Montana Cooperat Wildlife Res Unit, Missoula, MT 59812 USA; [Macleod, Amy C.] Univ Montana, Glacier Field Stn, Cooperat Ecosyst Studies Unit, Glacier Natl Pk, MT USA	Northern Arizona University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; University of Montana System; University of Montana	Graves, TA (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	Tabitha.Graves@colostate.edu	Beier, Paul/K-9294-2013; MACLEOD, AMY C/A-5724-2009	Beier, Paul/0000-0002-4297-4343; MACLEOD, AMY C/0000-0002-6966-2278; Royle, Jeffrey/0000-0003-3135-2167	NSF-IGERT; NAU School of Forestry; Hafen Scholarship; Prather Scholarship; David-German Scholarship; P.E.O. Scholar Award; AAUW American Fellowship; David H. Smith Conservation Research Fellowship	NSF-IGERT(National Science Foundation (NSF)); NAU School of Forestry; Hafen Scholarship; Prather Scholarship; David-German Scholarship; P.E.O. Scholar Award; AAUW American Fellowship; David H. Smith Conservation Research Fellowship	Tabitha was supported by NSF-IGERT, NAU School of Forestry, the Hafen, Prather, and David-German Scholarships, the P.E.O. Scholar Award, the AAUW American Fellowship, and the David H. Smith Conservation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Conway CJ, 2005, AUK, V122, P26, DOI 10.1642/0004-8038(2005)122[0026:EOCSFM]2.0.CO;2; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Graves TA, 2011, ANIM CONSERV, V14, P652, DOI 10.1111/j.1469-1795.2011.00471.x; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Meyer CFJ, 2010, BIOL CONSERV, V143, P2797, DOI 10.1016/j.biocon.2010.07.029; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; [No title captured]	24	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49410	10.1371/journal.pone.0049410	http://dx.doi.org/10.1371/journal.pone.0049410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251342	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200015
J	Inogwabini, BI; Leader-Williams, N				Inogwabini, Bila-Isia; Leader-Williams, Nigel			Effects of Epidemic Diseases on the Distribution of Bonobos	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; GEOGRAPHIC-DISTRIBUTION; PAN-PANISCUS; GREAT APES; TRANSMISSION; CHIMPANZEES; CONGO; PATHOGENS; OUTBREAKS; WILDLIFE	This study examined how outbreaks and the occurrence of Anthrax, Ebola, Monkeypox and Trypanosomiasis may differentially affect the distribution of bonobos (Pan paniscus). Using a combination of mapping, Jaccard overlapping coefficients and binary regressions, the study determined how each disease correlated with the extent of occurrence of, and the areas occupied by, bonobos. Anthrax has only been reported to occur outside the range of bonobos and so was not considered further. Ebola, Monkeypox and Trypanosomiasis were each reported within the area of occupancy of bonobos. Their respective overlap coefficients were: J = 0.10; Q(alpha = 0.05) = 2.00 (odds ratios = 0.0001, 95% CI = 0.0057; Z = -19.41, significant) for Ebola; J = 1.00; Q(alpha = 0.05) = 24.0 (odds ratios = 1.504, 95% CI = 0.5066-2.6122) for Monkeypox; and, J = 0.33; Q(alpha = 0.05) = 11.5 (Z = 1.14, significant) for Trypanosomiasis. There were significant relationships for the presence and absence of Monkeypox and Trypanosomiasis and the known extent of occurrence of bonobos, based on the equations y = 0.2368Ln(x)+0.8006 (R-2 = 0.9772) and y = -0.2942Ln(x)+0.7155 (R-2 = 0.698), respectively. The positive relationship suggested that bonobos tolerated the presence of Monkeypox. In contrast, the significant negative coefficient suggested that bonobos were absent in areas where Trypanosomiasis is endemic. Our results suggest that large rivers may have prevented Ebola from spreading into the range of bonobos. Meanwhile, Trypanosomiasis has been recorded among humans within the area of occurrence of bonobos, and appears the most important disease in shaping the area of occupancy of bonobos within their overall extent of occupancy.	[Inogwabini, Bila-Isia; Leader-Williams, Nigel] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	University of Kent	Inogwabini, BI (corresponding author), Swedish Univ Agr Sci, Uppsala, Sweden.	bi4@kentforlife.net		Inogwabini, Bila-Isia/0000-0002-6897-2477	UNESCO Young Scholar Award; AWF Charlotte Grant	UNESCO Young Scholar Award; AWF Charlotte Grant	The research that led to this paper was conducted in UK with funding from UNESCO Young Scholar Award and AWF Charlotte Grant to Bila-Isia Inogwabini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JB, 2004, JAVMA-J AM VET MED A, V224, P1105, DOI 10.2460/javma.2004.224.1105; Conway KJ, 1999, STAT MODELING USING; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DASZAK P., 2003, J PARASITOL, V89, P78; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Ellis CK, 2008, THESIS KANSAS STATE; Fenart R., 1973, Annales Mus r Afr cent (Ser 8 Sci zool), V204, P1; Formenty Pierre, 2003, P169; Hance J, 2009, ANTHRAX DEAD HIPPO C; Henderson H, 2008, JAVMA-J AM VET MED A, V232, P848, DOI 10.2460/javma.232.6.848; Homsy J., 1999, APE TOURISM HUMAN DI; Horn AD, 1976, THESIS YALE U NEW HA THESIS YALE U NEW HA; Inogwabini BI, 2009, OPEN CONSERV BIOL J, V3, P1; Inogwabini BI, 2007, ORYX, V41, P532, DOI 10.1017/S0030605307414120; Inogwabini Bila-Isia, 2005, Endangered Species Update, V22, P116; Inogwabini BI, 2008, DEV PRIMATOL-PROG PR, P273, DOI 10.1007/978-0-387-74787-3_14; IRCS (International Red Cross and Red Crescent Societies), 2009, DEM REP CONG EB FEV; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; KANO T, 1984, FOLIA PRIMATOL, V43, P36, DOI 10.1159/000156169; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kingdon J, 1997, KINGDON FIELD GUIDE; Kortlandt Adriaan, 1996, Primate Conservation, V16, P21; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; Malenky R.K., 1989, P362; Mugisha L, 2010, J MED PRIMATOL, V39, P123, DOI 10.1111/j.1600-0684.2010.00400.x; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Remis MJ, 2000, ORYX, V34, P56, DOI 10.1017/S0030605300030908; Ringvall A, 2005, FOREST ECOL MANAG, V212, P109, DOI 10.1016/j.foreco.2005.03.002; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Thompson-Handler N., 1995, ACTION PLAN PAN PANI; Vitousek PM, 1996, AM SCI, V84, P468; Vogel G, 2000, SCIENCE, V287, P2386, DOI 10.1126/science.287.5462.2386; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Wrangham RW, 1994, CHIMPANZEE CULTURES, P21	43	6	7	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51112	10.1371/journal.pone.0051112	http://dx.doi.org/10.1371/journal.pone.0051112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251431	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200059
J	Li, M; Fu, XY; Ma, G; Sun, XD; Dong, XY; Nagy, T; Xing, CS; Li, J; Dong, JT				Li, Mei; Fu, Xiaoying; Ma, Gui; Sun, Xiaodong; Dong, Xueyuan; Nagy, Tamas; Xing, Changsheng; Li, Jie; Dong, Jin-Tang			Atbf1 Regulates Pubertal Mammary Gland Development Likely by Inhibiting the Pro-Proliferative Function of Estrogen-ER Signaling	PLOS ONE			English	Article							BREAST-CANCER-CELLS; GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; DEVELOPING RAT-BRAIN; RECEPTOR-ALPHA; NEURONAL DIFFERENTIATION; STEM-CELLS; REPRESSES TRANSCRIPTION; MYOEPITHELIAL CELLS; CARCINOMA-CELLS	ATBF1 is a candidate tumor suppressor that interacts with estrogen receptor (ER) to inhibit the function of estrogen-ER signaling in gene regulation and cell proliferation control in human breast cancer cells. We therefore tested whether Atbf1 and its interaction with ER modulate the development of pubertal mammary gland, where estrogen is the predominant steroid hormone. In an in vitro model of cell differentiation, i.e., MCF10A cells cultured in Matrigel, ATBF1 expression was significantly increased, and knockdown of ATBF1 inhibited acinus formation. During mouse mammary gland development, Atbf1 was expressed at varying levels at different stages, with higher levels during puberty, lower during pregnancy, and the highest during lactation. Knockout of Atbf1 at the onset of puberty enhanced ductal elongation and bifurcation and promoted cell proliferation in both ducts and terminal end buds of pubertal mammary glands. Enhanced cell proliferation primarily occurred in ER-positive cells and was accompanied by increased expression of ER target genes. Furthermore, inactivation of Atbf1 reduced the expression of basal cell markers (CK5, CK14 and CD44) but not luminal cell markers. These findings indicate that Atbf1 plays a role in the development of pubertal mammary gland likely by modulating the function of estrogen-ER signaling in luminal cells and by modulating gene expression in basal cells.	[Li, Mei; Ma, Gui; Dong, Jin-Tang] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Li, Mei; Fu, Xiaoying; Sun, Xiaodong; Dong, Xueyuan; Xing, Changsheng; Li, Jie; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Emory Winship Canc Inst, Atlanta, GA 30322 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Nankai University; Emory University; University System of Georgia; University of Georgia	Dong, XY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Emory Winship Canc Inst, Atlanta, GA 30322 USA.	dxueyua@emory.edu; j.dong@emory.edu	Li, Jie/K-8812-2015	Xing, Changsheng/0000-0001-6582-9037; Dong, Jin-Tang/0000-0003-2349-5782	NIH [CA121459]; NATIONAL CANCER INSTITUTE [R01CA121459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA121459. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Barsky SH, 2003, EXP MOL PATHOL, V74, P113, DOI 10.1016/S0014-4800(03)00011-X; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clarke RB, 1997, CANCER RES, V57, P4987; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Coppock HA, 2007, CELL PROLIFERAT, V40, P721, DOI 10.1111/j.1365-2184.2007.00463.x; Cunha GR, 1997, J MAMMARY GLAND BIOL, V2, P393, DOI 10.1023/A:1026303630843; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DUBIK D, 1987, CANCER RES, V47, P6517; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Gudjonsson T, 2002, J CELL SCI, V115, P39; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Huh JI, 2007, ENDOCRINOLOGY, V148, P1266, DOI 10.1210/en.2006-0964; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Jones L, 2008, ONCOGENE, V27, P794, DOI 10.1038/sj.onc.1210674; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kataoka H, 2003, CANCER RES, V63, P5785; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kurley SJ, 2012, DEVELOPMENT, V139, P1754, DOI 10.1242/dev.072769; LaRocca J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024432; Li G, 2002, DEVELOPMENT, V129, P4159; Li W, 2009, P NATL ACAD SCI USA, V106, P4725, DOI 10.1073/pnas.0807640106; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Louderbough Jeanne M V, 2011, Genes Cancer, V2, P771, DOI 10.1177/1947601911428223; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; MICHELS KM, 1993, ENDOCRINOLOGY, V132, P23, DOI 10.1210/en.132.1.23; Miura Y, 2004, MICROBIOL IMMUNOL, V48, P137, DOI 10.1111/j.1348-0421.2004.tb03491.x; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; MURPHY LJ, 1990, ENDOCR REV, V11, P443, DOI 10.1210/edrv-11-3-443; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Nogami S, 2005, J COMP NEUROL, V482, P33, DOI 10.1002/cne.20382; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Shao ZM, 1998, EXP CELL RES, V241, P394, DOI 10.1006/excr.1998.4066; Siegel PM, 2010, ONCOGENE, V29, P2753, DOI 10.1038/onc.2010.43; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Sternlicht MD, 2008, J MAMMARY GLAND BIOL, V13, P181, DOI 10.1007/s10911-008-9084-6; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Sun X, 2012, GENESIS; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang ZH, 2005, CLIN CANCER RES, V11, P193	69	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51283	10.1371/journal.pone.0051283	http://dx.doi.org/10.1371/journal.pone.0051283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251482	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200084
J	Lomas, KF; Greenwood, DR; Windmill, JFC; Jackson, JC; Corfield, J; Parsons, S				Lomas, Kathryn F.; Greenwood, David R.; Windmill, James F. C.; Jackson, Joseph C.; Corfield, Jeremy; Parsons, Stuart			Discovery of a Lipid Synthesising Organ in the Auditory System of an Insect	PLOS ONE			English	Article							HEMIDEINA-CRASSIDENS BLANCHARD; BUSH-CRICKETS TETTIGONIIDAE; ZEALAND WETAS ORTHOPTERA; PRIMITIVE ENSIFERAN; SOUND-TRANSMISSION; EVOLUTION; HEARING; GRYLLACRIDOIDEA; STENOPELMATIDAE; MORPHOLOGY	Weta possess typical Ensifera ears. Each ear comprises three functional parts: two equally sized tympanal membranes, an underlying system of modified tracheal chambers, and the auditory sensory organ, the crista acustica. This organ sits within an enclosed fluid-filled channel-previously presumed to be hemolymph. The role this channel plays in insect hearing is unknown. We discovered that the fluid within the channel is not actually hemolymph, but a medium composed principally of lipid from a new class. Three-dimensional imaging of this lipid channel revealed a previously undescribed tissue structure within the channel, which we refer to as the olivarius organ. Investigations into the function of the olivarius reveal de novo lipid synthesis indicating that it is producing these lipids in situ from acetate. The auditory role of this lipid channel was investigated using Laser Doppler vibrometry of the tympanal membrane, which shows that the displacement of the membrane is significantly increased when the lipid is removed from the auditory system. Neural sensitivity of the system, however, decreased upon removal of the lipid-a surprising result considering that in a typical auditory system both the mechanical and auditory sensitivity are positively correlated. These two results coupled with 3D modelling of the auditory system lead us to hypothesize a model for weta audition, relying strongly on the presence of the lipid channel. This is the first instance of lipids being associated with an auditory system outside of the Odentocete cetaceans, demonstrating convergence for the use of lipids in hearing.	[Lomas, Kathryn F.; Greenwood, David R.; Corfield, Jeremy; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Lomas, Kathryn F.; Greenwood, David R.; Corfield, Jeremy; Parsons, Stuart] Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Windmill, James F. C.; Jackson, Joseph C.] Univ Strathclyde, Dept Elect & Elect Engn, Ctr Ultrason Engn, Glasgow G1 1XW, Lanark, Scotland	University of Auckland; New Zealand Institute for Plant & Food Research Ltd; University of Strathclyde	Greenwood, DR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	david.greenwood@auckland.ac.nz	Greenwood, David R/D-2375-2016; Jackson, Joseph/AAE-1204-2021; Windmill, James F C/I-1117-2019	Greenwood, David R/0000-0001-5280-042X; Windmill, James F C/0000-0003-4878-349X; Parsons, Stuart/0000-0003-1025-5616; Jackson, Joseph/0000-0001-9302-8157	University of Auckland; School of Biological Sciences, University of Auckland; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H02848X/1] Funding Source: researchfish; BBSRC [BB/H004637/1] Funding Source: UKRI; EPSRC [EP/H02848X/1] Funding Source: UKRI	University of Auckland; School of Biological Sciences, University of Auckland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by a doctoral scholarship to KFL, University of Auckland and the School of Biological Sciences, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Autrum Hansjochem, 1940, ZEITSCHR VERGLEICH PHYSIOL, V28, P326, DOI 10.1007/BF00342439; BALL EE, 1981, CELL TISSUE RES, V217, P321, DOI 10.1007/BF00233584; BALL EE, 1981, CELL TISSUE RES, V217, P345, DOI 10.1007/BF00233585; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; EIBL E, 1978, ZOOMORPHOLOGIE, V89, P185, DOI 10.1007/BF00993947; FIELD LH, 1992, J ZOOL, V228, P371, DOI 10.1111/j.1469-7998.1992.tb04442.x; FIELD LH, 1982, INT J INSECT MORPHOL, V11, P39, DOI 10.1016/0020-7322(82)90036-8; FIELD LH, 1993, INT J INSECT MORPHOL, V22, P163, DOI 10.1016/0020-7322(93)90008-O; FIELD LH, 1980, J COMP PHYSIOL, V141, P31, DOI 10.1007/BF00611875; HEINRICH R, 1993, J ACOUST SOC AM, V93, P3481, DOI 10.1121/1.405678; HILL KG, 1981, J COMP PHYSIOL, V142, P169, DOI 10.1007/BF00605735; Imaizumi K, 1999, J NEUROSCI, V19, P1508; Koopman HN, 2006, IEEE J OCEANIC ENG, V31, P95, DOI 10.1109/JOE.2006.872205; LEWIS DB, 1974, J EXP BIOL, V60, P821; Lomas K, 2011, J EXP BIOL, V214, P778, DOI 10.1242/jeb.050187; MASON AC, 1991, J COMP PHYSIOL A, V168, P351; MICHELSEN A, 1978, J COMP PHYSIOL, V123, P193, DOI 10.1007/BF00656872; Mohl B, 1999, J ACOUST SOC AM, V105, P3421, DOI 10.1121/1.426959; Nishino H, 2003, J COMP NEUROL, V464, P327, DOI 10.1002/cne.10780; Norris K S, 1964, MARINE BIOACOUSTICS, P316; NORRIS KS, 1974, J ACOUST SOC AM, V56, P659, DOI 10.1121/1.1903305; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; Trewick SA, 2005, J BIOGEOGR, V32, P295, DOI 10.1111/j.1365-2699.2004.01179.x; Triblehorn JD, 2001, J ZOOL, V254, P27, DOI 10.1017/S095283690100053X; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; VARANASI U, 1975, NATURE, V255, P340, DOI 10.1038/255340a0; VARANASI U, 1982, CHEM PHYS LIPIDS, V31, P237, DOI 10.1016/0009-3084(82)90059-7; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	32	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51486	10.1371/journal.pone.0051486	http://dx.doi.org/10.1371/journal.pone.0051486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251553	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000313236200120
J	Muller, J; Klaus, VH; Kleinebecker, T; Prati, D; Holzel, N; Fischer, M				Mueller, Joerg; Klaus, Valentin H.; Kleinebecker, Till; Prati, Daniel; Hoelzel, Norbert; Fischer, Markus			Impact of Land-Use Intensity and Productivity on Bryophyte Diversity in Agricultural Grasslands	PLOS ONE			English	Article							MONTANE CALCAREOUS FENS; PLANT-SPECIES RICHNESS; VASCULAR PLANTS; CHALK GRASSLAND; FERTILIZER APPLICATION; SEEDLING EMERGENCE; COMMUNITY BIOMASS; INDICATOR VALUES; NITROGEN; VEGETATION	While bryophytes greatly contribute to plant diversity of semi-natural grasslands, little is known about the relationships between land-use intensity, productivity, and bryophyte diversity in these habitats. We recorded vascular plant and bryophyte vegetation in 85 agricultural used grasslands in two regions in northern and central Germany and gathered information on land-use intensity. To assess grassland productivity, we harvested aboveground vascular plant biomass and analyzed nutrient concentrations of N, P, K, Ca and Mg. Further we calculated mean Ellenberg indicator values of vascular plant vegetation. We tested for effects of land-use intensity and productivity on total bryophyte species richness and on the species richness of acrocarpous (small & erect) and pleurocarpous (creeping, including liverworts) growth forms separately. Bryophyte species were found in almost all studied grasslands, but species richness differed considerably between study regions in northern Germany (2.8 species per 16 m(2)) and central Germany (6.4 species per 16 m(2)) due environmental differences as well as land-use history. Increased fertilizer application, coinciding with high mowing frequency, reduced bryophyte species richness significantly. Accordingly, productivity estimates such as plant biomass and nitrogen concentration were strongly negatively related to bryophyte species richness, although productivity decreased only pleurocarpous species. Ellenberg indicator values for nutrients proved to be useful indicators of species richness and productivity. In conclusion, bryophyte composition was strongly dependent on productivity, with smaller bryophytes that were likely negatively affected by greater competition for light. Intensive land-use, however, can also indirectly decrease bryophyte species richness by promoting grassland productivity. Thus, increasing productivity is likely to cause a loss of bryophyte species and a decrease in species diversity.	[Mueller, Joerg; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Klaus, Valentin H.; Kleinebecker, Till; Hoelzel, Norbert] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Potsdam; University of Munster; University of Bern	Muller, J (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	muellerj@uni-potsdam.de	Hölzel, Norbert/H-8753-2013; Fischer, Markus/C-6411-2008	Hölzel, Norbert/0000-0002-6367-3400; Fischer, Markus/0000-0002-5589-5900; Kleinebecker, Till/0000-0003-1121-2861; Klaus, Valentin H./0000-0002-7469-6800	DFG (German Research Foundation) [SSP 1374 (FI 1246/6-1)]; DFG [FI 1246/6-1, FI 1246/9-1, HO 3830/2-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 (FI 1246/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all project members, field teams and managers of the Exploratories, Sonja Gockel, Andreas Hemp and Martin Gorke and Simone Pfeiffer for their work in maintaining the plot and project infrastructure. Furthermore, we thank Franc, ois Buscot, Dominik Hessenmoller, the late Elisabeth Kalko, Eduard Linsenmair, Jens Nieschulze, Ingo Schoning, Ernst-Detlef Schulze and Wolfgang W. Weisser for their role in setting up the Biodiversity Exploratories. Further we thank Ariel Bergamini and Ewald Weber for review and critical remarks on an earlier draft of this manuscript. The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (grants FI 1246/ 6-1, FI 1246/9-1, HO 3830/2-1). Field work permits were obtained from the responsible state environmental offices of Thuringia and Brandenburg (according to 1 72 BbgNatSchG).	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Aude E, 2005, OIKOS, V109, P323, DOI 10.1111/j.0030-1299.2005.13268.x; Austrheim G, 2007, ECOSCIENCE, V14, P178, DOI 10.2980/1195-6860(2007)14[178:IBSRGA]2.0.CO;2; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bergamini A, 2001, J BRYOL, V23, P331, DOI 10.1179/jbr.2001.23.4.331; Bergamini A, 2001, J ECOL, V89, P920, DOI 10.1111/j.1365-2745.2001.00613.x; Bergamini A, 2001, FLORA, V196, P180, DOI 10.1016/S0367-2530(17)30040-3; Beringer J, 2001, J CLIMATE, V14, P3324, DOI 10.1175/1520-0442(2001)014<3324:TROASI>2.0.CO;2; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bortoluzzi E, 2006, NEW PHYTOL, V172, P708, DOI 10.1111/j.1469-8137.2006.01859.x; Broll G, 1994, VDLUFA SCHR, V38, P915; Chytry M, 2009, APPL VEG SCI, V12, P167, DOI 10.1111/j.1654-109X.2009.01011.x; Cornelissen JHC, 2007, ANN BOT-LONDON, V99, P987, DOI 10.1093/aob/mcm030; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; DURING HJ, 1990, BOT J LINN SOC, V104, P79, DOI 10.1111/j.1095-8339.1990.tb02212.x; Ellenberg H., 2001, SCRIPTA GEOBOT, V18, P1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Haworth BJ., 2007, WATER AIR SOIL POLLU, V7, P111, DOI [10.1007/s11267-006-9071-0, DOI 10.1007/S11267-006-9071-0]; Hejcman M, 2010, ENVIRON MONIT ASSESS, V166, P653, DOI 10.1007/s10661-009-1030-6; Hill MO., 2007, BRYOATT ATTRIBUTES B; JEFFREY DW, 1973, J ECOL, V61, P85, DOI 10.2307/2258918; KEIZER PJ, 1985, J ECOL, V73, P493, DOI 10.2307/2260489; Klaus VH, 2011, PERSPECT PLANT ECOL, V13, P287, DOI 10.1016/j.ppees.2011.07.001; Klaus VH, 2012, DIRECT INDIREC UNPUB; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; KOPERSKI M., 2000, SCHRIFTENREIHE VEGET, V34, P1; Lobel S, 2006, FOLIA GEOBOT, V41, P377, DOI 10.1007/BF02806555; Losvik MH, 2006, NORWEGIAN J GEOGRAPH, V60, P312; Malson K, 2008, APPL VEG SCI, V11, P99, DOI 10.1111/j.1654-109X.2008.tb00208.x; Mickiewicz J, 1976, POL ECOL STUD, V2, P57; Mundel G, 1997, ARCH AGRON SOIL SCI, V41, P277; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; Peintinger M, 2006, PLANT ECOL, V185, P1, DOI 10.1007/s11258-005-9079-y; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; van der Wal R, 2005, OECOLOGIA, V142, P159, DOI 10.1007/s00442-004-1706-0; Vanderpoorten A, 2004, BIOL CONSERV, V117, P11, DOI 10.1016/S0006-3207(03)00257-X; VANTOOREN BF, 1990, LINDBERGIA, V16, P153; VANTOOREN BF, 1988, OIKOS, V53, P41, DOI 10.2307/3565661; Venterink HO, 2009, BIOGEOCHEMISTRY, V93, P235, DOI 10.1007/s10533-009-9300-5; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; Virtanen R, 2000, PLANT ECOL, V151, P129, DOI 10.1023/A:1026533418357; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; WATSON EV, 1960, J ECOL, V48, P397, DOI 10.2307/2257525; Zamfir M, 2000, OIKOS, V88, P603, DOI 10.1034/j.1600-0706.2000.880317.x; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	50	22	23	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51520	10.1371/journal.pone.0051520	http://dx.doi.org/10.1371/journal.pone.0051520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251563	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200129
J	Sala, JE; Wilson, RP; Quintana, F				Sala, Juan E.; Wilson, Rory P.; Quintana, Flavio			How Much Is Too Much? Assessment of Prey Consumption by Magellanic Penguins in Patagonian Colonies	PLOS ONE			English	Article							FORAGING EFFORT; PYGOSCELIS-ADELIAE; FOOD-CONSUMPTION; JACKASS PENGUINS; ENERGY BUDGETS; BEHAVIOR; TIME; DIGESTION; SEABIRDS; FISH	Penguins are major consumers in the southern oceans although quantification of this has been problematic. One suggestion proposes the use of points of inflection in diving profiles ('wiggles') for this, a method that has been validated for the estimation of prey consumption by Magellanic penguins (Spheniscus magellanicus) by Simeone and Wilson (2003). Following them, we used wiggles from 31 depth logger-equipped Magellanic penguins foraging from four Patagonian colonies; Punta Norte (PN), Bahia Bustamente (BB), Puerto Deseado (PD) and Puerto San Julian (PSJ), all located in Argentina between 42-49 degrees S, to estimate the prey captured and calculate the catch per unit time (CPUT) for birds foraging during the early chick-rearing period. Numbers of prey caught and CPUT were significantly different between colonies. Birds from PD caught the highest number of prey per foraging trip, with CPUT values of 68 +/- 19 prey per hour underwater (almost two times greater than for the three remaining colonies). We modeled consumption from these data and calculate that the world Magellanic penguin population consumes about 2 million tons of prey per year. Possible errors in this calculation are discussed. Despite this, the analysis of wiggles seems a powerful and simple tool to begin to quantify prey consumption by Magellanic penguins, allowing comparison between different breeding sites. The total number of wiggles and/or CPUT do not reflect, by themselves, the availability of food for each colony, as the number of prey consumed by foraging trip is strongly associated with the energy content and wet mass of each colony-specific 'prey type'. Individuals consuming more profitable prey could be optimizing the time spent underwater, thereby optimizing the energy expenditure associated with the dives.	[Sala, Juan E.; Quintana, Flavio] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Wilson, Rory P.] Swansea Univ, Coll Sci, Swansea Moving Anim Res Team, Swansea, W Glam, Wales; [Quintana, Flavio] Wildlife Conservat Soc, Buenos Aires, DF, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Swansea University	Sala, JE (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	juansala@cenpat.edu.ar		Quintana, Flavio/0000-0003-0696-2545; Sala, Juan Emilio/0000-0001-9435-1351	Wildlife Conservation Society (WCS); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica; Rolex Award for Enterprise; CONICET; POGO (Partnership for Observation of the Global Oceans)	Wildlife Conservation Society (WCS); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Rolex Award for Enterprise; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); POGO (Partnership for Observation of the Global Oceans)	Research was funded by grants from the Wildlife Conservation Society (WCS), Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET), and Agencia Nacional de Promocion Cientifica y Tecnologica to FQ and by a Rolex Award for Enterprise awarded to RPW. JES is supported by a PhD fellowship from CONICET. We also want to thank POGO (Partnership for Observation of the Global Oceans, http://www.ocean-partners.org/) for the award to Juan Emilio Sala to enable him to conduct a training period at Swansea University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; Ancel A, 1997, J EXP BIOL, V200, P149; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; BANNASCH R, 1994, J EXP BIOL, V194, P83; BirdLife International, 2010, I U C N RED LIST THR; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Ciancio JE, 2007, T AM FISH SOC, V136, P1415, DOI 10.1577/T06-173.1; COOPER J, 1977, Zoologica Africana, V12, P201; Croxall J.P., 1987, P101; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; FAO, 2012, GLOB CAPT PROD 1950; Frere E., 1996, NEOTROPICA, V7, P35; FURNESS RW, 1982, MAR ECOL PROG SER, V8, P243, DOI 10.3354/meps008243; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Guerra CG, 1992, 900599 FONDECYT U AN; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hilton GM, 2000, J AVIAN BIOL, V31, P36, DOI 10.1034/j.1600-048X.2000.310106.x; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Ladin ZS, 2011, J WILDLIFE MANAGE, V75, P273, DOI 10.1002/jwmg.58; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; LEBOEUF BJ, 1992, CAN J ZOOL, V70, P786, DOI 10.1139/z92-111; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; NAGY KA, 1984, ECOLOGY, V65, P1648, DOI 10.2307/1939143; Naito Yasuhiko, 2007, Polar Science, V1, P101, DOI 10.1016/j.polar.2007.10.001; Papastamatiou YP, 2004, J EXP BIOL, V207, P225, DOI 10.1242/jeb.00741; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; PUTZ K, 1994, ECOLOGY, V75, P489, DOI 10.2307/1939552; Rey AR, 2012, EMU, V112, P90, DOI 10.1071/MU11065; Rodary D, 2000, POLAR BIOL, V23, P113, DOI 10.1007/s003000050016; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P460, DOI 10.1007/s003000100234; Ropert-Coudert Yan, 2000, Polar Bioscience, V13, P101; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Schiavini Adrián, 2005, Hornero, V20, P5; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Takahashi A, 2004, MAR ORNITHOL, V32, P7; WEATHERS WW, 1984, AUK, V101, P459, DOI 10.1093/auk/101.3.459; Williams T.D., 1995, PENGUINS; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; Wilson Rory P., 1997, Marine Ornithology, V25, P72; Wilson Rory P., 2007, Marine Ornithology, V35, P109; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; WILSON RP, 1995, J EXP BIOL, V198, P1115; Wilson RP, 2005, ECOL MONOGR, V75, P379, DOI 10.1890/04-1238; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1989, COMP BIOCHEM PHYS A, V94, P461, DOI 10.1016/0300-9629(89)90121-7; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Wilson RP, 2004, J EXP BIOL, V207, P1789, DOI 10.1242/jeb.00967; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; WILSON RP, 1986, ARDEA, V74, P211; WILSON RP, 1985, ORNIS SCAND, V16, P77, DOI 10.2307/3676580; Woehler EJ, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P266; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmer I, 2010, AQUAT BIOL, V8, P269, DOI 10.3354/ab00213; Zuur Alain F., 2009, P1	68	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51487	10.1371/journal.pone.0051487	http://dx.doi.org/10.1371/journal.pone.0051487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251554	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200121
J	Stollar, EJ; Lin, H; Davidson, AR; Forman-Kay, JD				Stollar, Elliott J.; Lin, Hong; Davidson, Alan R.; Forman-Kay, Julie D.			Differential Dynamic Engagement within 24 SH3 Domain: Peptide Complexes Revealed by Co-Linear Chemical Shift Perturbation Analysis	PLOS ONE			English	Article							UNSTRUCTURED REGION; BINDING-AFFINITY; NMR-SPECTROSCOPY; PROTEIN; RECOGNITION; DNA; SPECIFICITY; ALLOSTERY; STATES; VISUALIZATION	There is increasing evidence for the functional importance of multiple dynamically populated states within single proteins. However, peptide binding by protein-protein interaction domains, such as the SH3 domain, has generally been considered to involve the full engagement of peptide to the binding surface with minimal dynamics and simple methods to determine dynamics at the binding surface for multiple related complexes have not been described. We have used NMR spectroscopy combined with isothermal titration calorimetry to comprehensively examine the extent of engagement to the yeast Abp1p SH3 domain for 24 different peptides. Over one quarter of the domain residues display co-linear chemical shift perturbation (CCSP) behavior, in which the position of a given chemical shift in a complex is co-linear with the same chemical shift in the other complexes, providing evidence that each complex exists as a unique dynamic rapidly inter-converting ensemble. The extent the specificity determining sub-surface of AbpSH3 is engaged as judged by CCSP analysis correlates with structural and thermodynamic measurements as well as with functional data, revealing the basis for significant structural and functional diversity amongst the related complexes. Thus, CCSP analysis can distinguish peptide complexes that may appear identical in terms of general structure and percent peptide occupancy but have significant local binding differences across the interface, affecting their ability to transmit conformational change across the domain and resulting in functional differences.	[Stollar, Elliott J.; Lin, Hong; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Stollar, Elliott J.; Lin, Hong; Davidson, Alan R.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Stollar, Elliott J.; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Stollar, EJ (corresponding author), Eastern New Mexico Univ, Dept Phys Sci, Portales, NM USA.	elliott.stollar@enmu.edu; forman@sickkids.ca		Forman-Kay, Julie/0000-0001-8265-972X	Canadian Cancer Society; Canadian Institutes of Health Research [MOP-13609]; National Center for Research Resources [5P20RR016480-12]; National Institute of General Medical Sciences of the National Institutes of Health [8P20GM103451-12]; CIHR Training Program in Protein Folding award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIHR Training Program in Protein Folding award(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by operating grants from the Canadian Cancer Society (JFK), the Canadian Institutes of Health Research, Grant MOP-13609 (ARD). EJS was supported by grants from the National Center for Research Resources (5P20RR016480-12) and the National Institute of General Medical Sciences (8P20GM103451-12) of the National Institutes of Health as well as a CIHR Training Program in Protein Folding award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Candel AM, 2008, J MOL BIOL, V377, P117, DOI 10.1016/j.jmb.2007.11.060; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Kuhlmann UC, 2000, J MOL BIOL, V301, P1163, DOI 10.1006/jmbi.2000.3945; Landry SJ, 2003, BIOCHEMISTRY-US, V42, P4926, DOI 10.1021/bi027070y; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; ROHL CA, 1994, BIOCHEMISTRY-US, V33, P7760, DOI 10.1021/bi00191a003; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51282	10.1371/journal.pone.0051282	http://dx.doi.org/10.1371/journal.pone.0051282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251481	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200083
J	Suppipat, K; Park, CS; Shen, Y; Zhu, X; Lacorazza, HD				Suppipat, Koramit; Park, Chun Shik; Shen, Ye; Zhu, Xiao; Lacorazza, H. Daniel			Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; PROSTATE-CANCER; CRUCIFEROUS VEGETABLES; GENE-EXPRESSION; INHIBITION; ISOTHIOCYANATE; CONSUMPTION; INDUCTION; BROCCOLI; PATHWAY	Acute lymphoblastic leukemia (ALL) is the most common hematological cancer in children. Although risk-adaptive therapy, CNS-directed chemotherapy, and supportive care have improved the survival of ALL patients, disease relapse is still the leading cause of cancer-related death in children. Therefore, new drugs are needed as frontline treatments in high-risk disease and as salvage agents in relapsed ALL. In this study, we report that purified sulforaphane, a natural isothiocyanate found in cruciferous vegetables, has anti-leukemic properties in a broad range of ALL cell lines and primary lymphoblasts from pediatric T-ALL and pre-B ALL patients. The treatment of ALL leukemic cells with sulforaphane resulted in dose-dependent apoptosis and G2/M cell cycle arrest, which was associated with the activation of caspases (3, 8, and 9), inactivation of PARP, p53-independent upregulation of p21(CIP1/WAF1), and inhibition of the Cdc2/Cyclin B1 complex. Interestingly, sulforaphane also inhibited the AKT and mTOR survival pathways in most of the tested cell lines by lowering the levels of both total and phosphorylated proteins. Finally, the administration of sulforaphane to the ALL xenograft models resulted in a reduction of tumor burden, particularly following oral administration, suggesting a potential role as an adjunctive agent to improve the therapeutic response in high-risk ALL patients with activated AKT signaling.	[Suppipat, Koramit] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Suppipat, Koramit] Texas Childrens Hosp, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Park, Chun Shik; Shen, Ye; Lacorazza, H. Daniel] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Zhu, Xiao] Baylor Coll Med, Summer Med & Res Training Program, Houston, TX 77030 USA; [Lacorazza, H. Daniel] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lacorazza, HD (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	hdl@bcm.edu		Park, Chun Shik/0000-0002-4329-3953; Lacorazza, Daniel/0000-0003-0660-617X	Gabrielle's Angel Foundation for Cancer Research; Alkek Foundation	Gabrielle's Angel Foundation for Cancer Research; Alkek Foundation	This work was supported by Gabrielle's Angel Foundation for Cancer Research and Alkek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Bornhauser BC, 2007, BLOOD, V110, P2084, DOI 10.1182/blood-2006-12-060970; Bourquin JP, 2010, CANCER TREAT REV, V36, P298, DOI 10.1016/j.ctrv.2010.02.005; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Fimognari C, 2002, CARCINOGENESIS, V23, P581, DOI 10.1093/carcin/23.4.581; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Herman-Antosiewicz A, 2007, MOL CANCER THER, V6, P1673, DOI 10.1158/1535-7163.MCT-06-0807; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Keum YS, 2009, PHARM RES-DORDR, V26, P2324, DOI 10.1007/s11095-009-9948-5; Larson RA, 2007, SEMIN ONCOL, V34, pS13, DOI 10.1053/j.seminoncol.2007.11.002; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maheo K, 1997, CANCER RES, V57, P3649; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Pham NA, 2004, MOL CANCER THER, V3, P1239; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Probst-Hensch NM, 1998, CANCER EPIDEM BIOMAR, V7, P635; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Rooney CM, 2002, ANN HEMATOL, V81, pS39; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; Traka MH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-189; Uddin S, 2004, BIOCHEM BIOPH RES CO, V320, P932, DOI 10.1016/j.bbrc.2004.06.038; Vermeulen M, 2008, J AGR FOOD CHEM, V56, P10505, DOI 10.1021/jf801989e; Wang LH, 1998, ANTICANCER RES, V18, P321; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Wells NJ, 1999, J CELL SCI, V112, P3361; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6	62	71	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51251	10.1371/journal.pone.0051251	http://dx.doi.org/10.1371/journal.pone.0051251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251470	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200075
J	Butler, EK; Boulware, DR; Bohjanen, PR; Meya, DB				Butler, Elissa K.; Boulware, David R.; Bohjanen, Paul R.; Meya, David B.			Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda	PLOS ONE			English	Article							HIGH-DOSE FLUCONAZOLE; RECONSTITUTION INFLAMMATORY SYNDROME; RANDOMIZED CONTROLLED-TRIAL; COURSE AMPHOTERICIN-B; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; FLUCYTOSINE; COHORT; COMBINATION; PROGRAM	Data presented previously as an abstract at the 2011 CUGH Global Health Conference in Montreal, Canada on 15 Nov 2011. The long-term survival of HIV-infected persons with symptomatic cryptococcal meningitis and asymptomatic, subclinical cryptococcal antigenemia (CRAG+) is unknown. We prospectively enrolled 25 asymptomatic, antiretroviral therapy (ART)-naive CRAG+ Ugandans with CD4<100 cells/mcL who received pre-emptive fluconazole treatment (CRAG+ cohort) and 189 ART-naive Ugandans with symptomatic cryptococcal meningitis treated with amphotericin (CM cohort). The 10-week survival was 84% (95% CI: 70-98%) in the CRAG+ cohort and 57% (95% CI: 50%-64%) in the CM cohort. The CRAG+ cohort had improved five-year survival of 76% (95% CI: 59%-93%) compared to 42% (95% CI: 35%-50%) in the CM cohort (P = 0.001). The two cohorts had similar immunosuppression pre-ART with median CD4 counts of 15 vs. 21 CD4/mcL in the CRAG+ and CM cohorts, respectively (P = 0.45). Despite substantial early mortality, subsequent 5-year survival of persons surviving 6-months was excellent (>88%), demonstrating that long term survival is possible in resource-limited settings. Pre-ART CRAG screening with preemptive fluconazole treatment and improved CM treatment(s) are needed to reduce AIDS-attributable mortality due to cryptococcosis which remains 20-25% in sub-Saharan Africa.	[Butler, Elissa K.; Boulware, David R.; Bohjanen, Paul R.; Meya, David B.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.; Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Meya, David B.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Makerere University	Boulware, DR (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	boulw001@umn.edu	Bohjanen, Paul/B-2329-2015; Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Boulware, David/I-4533-2013; Meya, David/AAO-2796-2020	Bohjanen, Paul/0000-0002-2772-3597; Boulware, David R/0000-0002-4715-0060; Meya, David/0000-0002-4138-240X; , David/0000-0002-8854-0321	National Institutes of Health [U01AI089244, R21NS065713, K23AI073192, K24AI096925]; University of Minnesota Academic Health Center; Minnesota Medical Foundation; Tibotec REACH Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089244, K24AI096925, K23AI073192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Minnesota Medical Foundation; Tibotec REACH Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was made possible through support from the National Institutes of Health (U01AI089244, R21NS065713; K23AI073192, K24AI096925), University of Minnesota Academic Health Center, Minnesota Medical Foundation, and Tibotec REACH Initiative. Fluconazole was provided via the Pfizer Diflucan Donation Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WORLD AIDS DAY REP; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Chottanapund Suthat, 2007, Journal of the Medical Association of Thailand, V90, P2104; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jackson AT, 2012, AIDS, V26, P1363, DOI 10.1097/QAD.0b013e328354b419; Jarvis JN, 2012, J INT ASS P IN PRESS; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Jarvis JN, 2010, CLIN INFECT DIS, V51, P1463, DOI 10.1086/657405; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Manosuthi W, 2008, JAIDS-J ACQ IMM DEF, V48, P508, DOI 10.1097/QAI.0b013e318168573d; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pitisuttithum P, 2001, J INFECTION, V43, P226, DOI 10.1053/jinf.2001.0916; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, CLIN INFECT IN PRESS; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Sloan D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005647.pub2; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	31	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51291	10.1371/journal.pone.0051291	http://dx.doi.org/10.1371/journal.pone.0051291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251485	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900061
J	Liu, CQ; Desikan, R; Ying, ZK; Gushchina, L; Kampfrath, T; Deiuliis, J; Wang, AX; Xu, XH; Zhong, JX; Rao, XQ; Sun, QH; Maiseyeu, A; Parthasarathy, S; Rajagopalan, S				Liu, Cuiqing; Desikan, Rajagopal; Ying, Zhekang; Gushchina, Liubov; Kampfrath, Thomas; Deiuliis, Jeffrey; Wang, Aixia; Xu, Xiaohua; Zhong, Jixin; Rao, Xiaoquan; Sun, Qinghua; Maiseyeu, Andrei; Parthasarathy, Sampath; Rajagopalan, Sanjay			Effects of a Novel Pharmacologic Inhibitor of Myeloperoxidase in a Mouse Atherosclerosis Model	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; AIR-POLLUTION EXPOSURE; APOLIPOPROTEIN-A-I; MICE; ACTIVATION; NITRATION; OXIDANTS; DISEASE; CHLORINATION; OBESITY	Inflammation and oxidative stress play fundamental roles in the pathogenesis of atherosclerosis. Myeloperoxidase has been extensively implicated as a key mediator of inflammatory and redox-dependent processes in atherosclerosis. However, the effect of synthetic myeloperoxidase inhibitors on atherosclerosis has been insufficiently studied. In this study, ApoE (-/-) mice were randomized to low-and high-dose INV-315 groups for 16 weeks on high-fat diet. INV-315 resulted in reduced plaque burden and improved endothelial function in response to acetylcholine. These effects occurred without adverse events or changes in body weight or blood pressure. INV-315 treatment resulted in a decrease in iNOS gene expression, superoxide production and nitrotyrosine content in the aorta. Circulating IL-6 and inflammatory CD11b(+)/Ly6G(low)/7/4(hi) monocytes were significantly decreased in response to INV-315 treatment. Acute pretreatment with INV-315 blocked TNF alpha-mediated leukocyte adhesion in cremasteric venules and inhibited myeloperoxidase activity. Cholesterol efflux was significantly increased by high-dose INV-315 via ex-vivo reverse cholesterol transport assays. Our results suggest that myeloperoxidase inhibition may exert anti-atherosclerotic effects via inhibition of oxidative stress and enhancement of cholesterol efflux. These findings demonstrate a role for pharmacologic modulation of myeloperoxidase in atherosclerosis.	[Liu, Cuiqing; Ying, Zhekang; Gushchina, Liubov; Kampfrath, Thomas; Deiuliis, Jeffrey; Wang, Aixia; Xu, Xiaohua; Zhong, Jixin; Rao, Xiaoquan; Sun, Qinghua; Maiseyeu, Andrei; Parthasarathy, Sampath; Rajagopalan, Sanjay] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Liu, Cuiqing] Hangzhou Normal Univ, Dept Physiol, Hangzhou, Zhejiang, Peoples R China; [Desikan, Rajagopal] InVasc Therapeut, Tucker, GA USA	University System of Ohio; Ohio State University; Hangzhou Normal University	Rajagopalan, S (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	sanjay.rajagopalan@osumc.edu	Parthasarathy, Sampath/AAP-3361-2020; Gushchina, Liubov/AAN-1037-2021; Zhong, Jixin/ABE-3768-2020	Maiseyeu, Andrei/0000-0001-8830-1809; Liu, Cuiqing/0000-0002-0393-7806; Rao, Xiaoquan/0000-0001-7316-4530; Deiuliis, Jeffrey/0000-0002-5665-8894; Zhong, Jixin/0000-0002-3534-7480	National Institutes of Health (NIH) [R01ES017290, R21 DK088522, R01AT004106]; NIH SBIR [R43HL103269-01]; American Heart Association [10POST4150090, 11POST7640030]; NRSA [F32-DK083903]; National Institutes of Health SBIR [R43HL103269]; OSU; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL103269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088522, F32DK083903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017290] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OSU; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is partially supported by National Institutes of Health (NIH) grants R01ES017290 and R21 DK088522 (SR) R01AT004106 (SP) and NIH SBIR (R43HL103269-01) to InVasc Therapeutics (subcontract to OSU). Dr. Maiseyeu and Dr. Ying are supported by American Heart Association Great Rivers Affiliate Postdoctoral Fellowship Program (10POST4150090, 11POST7640030); Dr. Deiuliis is supported by NRSA grant (F32-DK083903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge that this work was made possible via a collaborative effort between InVasc Therapeutics and Ohio State University. InVasc Therapeutics is a non-publicly traded private company based in Columbus, OH. Dr. Rajagopal Desiakan, one of the co-authors, was fully employed by InVasc Therapeutics at the time of this work. Cuiqing Liu was a co-founder of the company along with Sampath Parthasarathy and have patents on INV315 and related myeloperoxidase inhibitors that are currently pending approval at the US Patent and Trade office. The molecules that were investigated in this work were licensed for use by InVasc Therapeutics. Funding for this work was through a National Institutes of Health SBIR grant (R43HL103269) awarded to InVasc Therapeutics with OSU as a subcontractor. Neither Dr. Parthasarathy nor Cuiqing Liu are employees of InVasc but do function in an advisory role to the company. The authors declare that the relationship with InVasc does not alter their adherence to all of the PLOS ONE policies on sharing data and materials.	Bachoual R, 2011, FOOD CHEM TOXICOL, V49, P1224, DOI 10.1016/j.fct.2011.02.024; Bergt C, 2004, J BIOL CHEM, V279, P7856, DOI 10.1074/jbc.M309046200; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hazen SL, 1999, CIRC RES, V85, P950; Hochholzer W, 2010, AM HEART J, V160, P583, DOI 10.1016/j.ahj.2010.06.010; Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KOEFFLER HP, 1985, BLOOD, V65, P484; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; Nestel P, 2011, INT J OBES LOND; Nguyen AB, 2011, ARTERIOSCL THROM VAS, V31, P2136, DOI 10.1161/ATVBAHA.111.228692; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Rodrigues MR, 2002, BIOCHEM BIOPH RES CO, V292, P869, DOI 10.1006/bbrc.2002.6724; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Wang X, 2007, CIRC RES, V100, P1008, DOI 10.1161/01.RES.0000263011.34709.c5; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350	29	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50767	10.1371/journal.pone.0050767	http://dx.doi.org/10.1371/journal.pone.0050767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251382	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900016
J	van Ravensway, J; Benbow, ME; Tsonis, AA; Pierce, SJ; Campbell, LP; Fyfe, JAM; Hayman, JA; Johnson, PDR; Wallace, JR; Qi, JG				van Ravensway, Jenni; Benbow, M. Eric; Tsonis, Anastasios A.; Pierce, Steven J.; Campbell, Lindsay P.; Fyfe, Janet A. M.; Hayman, John A.; Johnson, Paul D. R.; Wallace, John R.; Qi, Jiaguo			Climate and Landscape Factors Associated with Buruli Ulcer Incidence in Victoria, Australia	PLOS ONE			English	Article							MYCOBACTERIUM-ULCERANS; ENVIRONMENTAL-SAMPLES; CILIATE POPULATIONS; RISK-FACTORS; DISEASE; INFECTION; OUTBREAK; ECOLOGY; MODEL; IDENTIFICATION	Background: Buruli ulcer (BU), caused by Mycobacterium ulcerans (M. ulcerans), is a necrotizing skin disease found in more than 30 countries worldwide. BU incidence is highest in West Africa; however, cases have substantially increased in coastal regions of southern Australia over the past 30 years. Although the mode of transmission remains uncertain, the spatial pattern of BU emergence in recent years seems to suggest that there is an environmental niche for M. ulcerans and BU prevalence. Methodology/Principal Findings: Network analysis was applied to BU cases in Victoria, Australia, from 1981-2008. Results revealed a non-random spatio-temporal pattern at the regional scale as well as a stable and efficient BU disease network, indicating that deterministic factors influence the occurrence of this disease. Monthly BU incidence reported by locality was analyzed with landscape and climate data using a multilevel Poisson regression approach. The results suggest the highest BU risk areas occur at low elevations with forested land cover, similar to previous studies of BU risk in West Africa. Additionally, climate conditions as far as 1.5 years in advance appear to impact disease incidence. Warmer and wetter conditions 18-19 months prior to case emergence, followed by a dry period approximately 5 months prior to case emergence seem to favor the occurrence of BU. Conclusions/Significance: The BU network structure in Victoria, Australia, suggests external environmental factors favor M. ulcerans transmission and, therefore, BU incidence. A unique combination of environmental conditions, including land cover type, temperature and a wet-dry sequence, may produce habitat characteristics that support M. ulcerans transmission and BU prevalence. These findings imply that future BU research efforts on transmission mechanisms should focus on potential vectors/reservoirs found in those environmental niches. Further, this study is the first to quantitatively estimate environmental lag times associated with BU outbreaks, providing insights for future transmission investigations.	[van Ravensway, Jenni; Qi, Jiaguo] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Benbow, M. Eric] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Tsonis, Anastasios A.] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Pierce, Steven J.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA; [Campbell, Lindsay P.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Fyfe, Janet A. M.] Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Mycobacterium Ulcerans, Melbourne, Vic, Australia; [Hayman, John A.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Johnson, Paul D. R.] Austin Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Wallace, John R.] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Qi, Jiaguo] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA	Michigan State University; University of Dayton; University of Wisconsin System; University of Wisconsin Milwaukee; Michigan State University; University of Kansas; Victorian Infectious Diseases Reference Laboratory; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Michigan State University	Qi, JG (corresponding author), Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.	qi@msu.edu	Qi, Jiaguo/AAC-4106-2020; Benbow, Mark/V-5895-2019; Pierce, Steven J./X-8821-2019	Pierce, Steven J./0000-0002-0679-3019	World Health Organization; National Institutes of Health and Fogarty International Center [NIH - R01TW007550]; NIH [R01TW007550]; FOGARTY INTERNATIONAL CENTER [R01TW007550] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); National Institutes of Health and Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by the World Health Organization and the National Institutes of Health and Fogarty International Center (NIH - R01TW007550). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. R. W. Merritt is gratefully acknowledged for supporting this research as part of NIH grant R01TW007550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrushchyshyn O, 2003, FRESHWATER BIOL, V48, P548, DOI 10.1046/j.1365-2427.2003.01028.x; Andrushchyshyn OP, 2006, AQUAT MICROB ECOL, V42, P293, DOI 10.3354/ame042293; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P194; [Anonymous], 2001, MISSING DATA; Baker ME, 2009, ECOLOGY, V90, P145, DOI 10.1890/07-1242.1; Bates D., 2010, LINEAR FIXED EFFECTS; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Benbow ME, 2008, EMERG INFECT DIS, V14, P1247, DOI 10.3201/eid1408.071503; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [DOI 10.1080/02626667909491834, 10.1080/02626667909491834, 10.1080/ 02626667909491834]; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Commonwealth of Australia, 2011, REG POP GROWTH AUSTR; Commonwealth of Australia 2012, 2011, MAPS AV COND; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Dobos KM, 1999, EMERG INFECT DIS, V5, P367, DOI 10.3201/eid0503.990307; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; HAYMAN J, 1991, INT J EPIDEMIOL, V20, P1093, DOI 10.1093/ije/20.4.1093; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HUME ID, 1989, P NUTR SOC, V48, P69, DOI 10.1079/PNS19890011; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson PDR, 2009, EMERG INFECT DIS, V15, P614, DOI 10.3201/eid1504.081162; Johnson PDR, 1996, MED J AUSTRALIA, V164, P76, DOI 10.5694/j.1326-5377.1996.tb101352.x; Johnston K, 2003, USING ARCGIS GEOSTAT, P306; Kerle A., 2001, POSSUMS BRUSHTAILS R; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Kuhn K., 2005, USING CLIMATE PREDIC; Kurtzman D, 1999, CLIMATE RES, V13, P33, DOI 10.3354/cr013033; Lavender CJ, 2008, FEMS MICROBIOL LETT, V287, P250, DOI 10.1111/j.1574-6968.2008.01328.x; Liljeros F, 2001, CONDMAT0106507 ARXIV; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Mather P., 2004, COMPUTER PROCESSING, V3rd; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Quek TYJ, 2007, EMERG INFECT DIS, V13, P1661, DOI 10.3201/eid1311.061206; R Development Core Team, 2009, R FDN STAT COMP; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Tsonis AA, 2008, J CLIMATE, V21, P2990, DOI 10.1175/2007JCLI1907.1; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Wagner T, 2008, ECOHEALTH, V5, P69, DOI 10.1007/s10393-007-0148-7; Wagner T, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-25; Wallace JR, 2010, APPL ENVIRON MICROB, V76, P6215, DOI 10.1128/AEM.00340-10; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; World Health Organization, 2007, BUR ULC DIS MYC ULC	62	41	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51074	10.1371/journal.pone.0051074	http://dx.doi.org/10.1371/journal.pone.0051074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251425	Green Published, gold			2022-12-25	WOS:000312201900039
J	Vandenberg, LN; Stevenson, C; Levin, M				Vandenberg, Laura N.; Stevenson, Claire; Levin, Michael			Low Frequency Vibrations Induce Malformations in Two Aquatic Species in a Frequency-, Waveform-, and Direction-Specific Manner	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; LEFT-RIGHT ASYMMETRY; VERTEBRATE DEVELOPMENT; MECHANICAL VIBRATIONS; GENE-EXPRESSION; THYROID-HORMONE; XENOPUS-LAEVIS; T-LYMPHOCYTES; ZEBRAFISH; EXPOSURE	Environmental toxicants such as industrial wastes, air particulates from machinery and transportation vehicles, and pesticide run-offs, as well as many chemicals, have been widely studied for their effects on human and wildlife populations. Yet other potentially harmful environmental pollutants such as electromagnetic pulses, noise and vibrations have remained incompletely understood. Because developing embryos undergo complex morphological changes that can be affected detrimentally by alterations in physical forces, they may be particularly susceptible to exposure to these types of pollutants. We investigated the effects of low frequency vibrations on early embryonic development of two aquatic species, Xenopus laevis (frogs) and Danio rerio (zebrafish), specifically focusing on the effects of varying frequencies, waveforms, and applied direction. We observed treatment-specific effects on the incidence of neural tube defects, left-right patterning defects and abnormal tail morphogenesis in Xenopus tadpoles. Additionally, we found that low frequency vibrations altered left-right patterning and tail morphogenesis, but did not induce neural tube defects, in zebrafish. The results of this study support the conclusion that low frequency vibrations are toxic to aquatic vertebrates, with detrimental effects observed in two important model species with very different embryonic architectures.	[Vandenberg, Laura N.; Stevenson, Claire; Levin, Michael] Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA	Tufts University	Levin, M (corresponding author), Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	American Heart Association [0740088N]; NIH [R01-GM077425]; NRSA [1F32GM087107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077425, F32GM087107] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Established Investigator Grant 0740088N and NIH grant R01-GM077425 to ML, and NRSA grant 1F32GM087107 to LNV. The funders had no additional role in the study design, data analysis, or decision to submit this manuscript.	Abbate C, 2004, PSYCHOTHER PSYCHOSOM, V73, P375, DOI 10.1159/000080391; Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Aggio RBM, 2012, METABOLOMICS, V8, P670, DOI 10.1007/s11306-011-0360-x; BANTLE JA, 1971, AEROSPACE MED, V42, P1087; Bovenzi M, 1999, INT ARCH OCC ENV HEA, V72, P351, DOI 10.1007/s004200050387; Callery EM, 2006, SEMIN CELL DEV BIOL, V17, P80, DOI 10.1016/j.semcdb.2005.11.001; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642; Fini JB, 2012, TOXICOL SCI, V125, P359, DOI 10.1093/toxsci/kfr312; Futatsuka M, 1998, IND HEALTH, V36, P127, DOI 10.2486/indhealth.36.127; GAGNON R, 1989, AM J OBSTET GYNECOL, V161, P1479, DOI 10.1016/0002-9378(89)90908-3; Gerhardt K. J, 2000, J PERINATOLOGY, V20, pS20, DOI [10.1038/sj.jp.7200446, DOI 10.1038/SJ.JP.7200446]; Gibert Y, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-4; Gilbert SF, 2006, DEV BIOL; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; HEMMINKI K, 1981, J EPIDEMIOL COMMUN H, V35, P5, DOI 10.1136/jech.35.1.5; Herman GE, 2002, CYTOGENET GENOME RES, V99, P229, DOI 10.1159/000071598; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Lewis ML, 2001, FASEB J, V15, P1783, DOI 10.1096/fj.00-0820fje; MCDONALD AD, 1988, BRIT J IND MED, V45, P148; Meunier R, 2012, STUD HIST PHI PART C, V43, P522, DOI 10.1016/j.shpsc.2011.11.013; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; NAKAMURA H, 1992, ENVIRON RES, V58, P220, DOI 10.1016/S0013-9351(05)80217-8; Neumann CJ, 2002, SEMIN CELL DEV BIOL, V13, P469, DOI 10.1016/S108495210200099X; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paschold H.W., 2011, PROF SAF, V56, P30; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Reeder AL, 2005, ENVIRON HEALTH PERSP, V113, P261, DOI 10.1289/ehp.7276; Sabo V., 1982, Pol'nohospodarstvo, V28, P527; SEIDEL H, 1986, INT ARCH OCC ENV HEA, V58, P1, DOI 10.1007/BF00378536; Shannon SG, 1994, EFFECT VIBRATION FRE; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Solecki L, 2010, ANN AGR ENV MED, V17, P243; Strathmann RR, 2000, SEMIN CELL DEV BIOL, V11, P395, DOI 10.1006/scdb.2000.0192; Taggart LC, 1990, EFFECT VIBRATION FRE; Terrien X, 2011, AQUAT TOXICOL, V105, P13, DOI 10.1016/j.aquatox.2011.04.007; TORAASON MA, 1980, ENVIRON RES, V23, P341, DOI 10.1016/0013-9351(80)90069-9; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023306; Vandenberg LN, 2010, DEV DYNAM, V239, P3131, DOI 10.1002/dvdy.22450; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wenger KH, 2010, BONE, V47, P746, DOI 10.1016/j.bone.2010.07.014; Westerfield M, 1995, ZEBRAFISH BOOK; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; ZOTIN A. I., 1967, IZV AKAD NAUK SSSR SER BIOL, V6, P879	46	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51473	10.1371/journal.pone.0051473	http://dx.doi.org/10.1371/journal.pone.0051473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251546	gold, Green Published			2022-12-25	WOS:000312201900092
J	Zhu, MX; Wang, J; Liu, M; Du, DS; Xia, CM; Shen, LL; Zhu, DN				Zhu, Minxia; Wang, Jin; Liu, Min; Du, Dongshu; Xia, Chunmei; Shen, Linlin; Zhu, Danian			Upregulation of Protein Phosphatase 2A and NR3A-Pleiotropic Effect of Simvastatin on Ischemic Stroke Rats	PLOS ONE			English	Article							NMDA RECEPTOR; INCREASED PHOSPHORYLATION; NR3A SUBUNIT; NR1 SUBUNIT; KINASE-A; STATINS; CALCIUM; NEUROPROTECTION; EXPRESSION; NEURONS	Ca2+ influxes are regulated by the functional state of N-methyl-D-aspartate receptors (NMDARs). Dephosphorylation of NMDARs subunits decreases Ca2+ influxes. NR3, a novel subunit of NMDARs, also decreases Ca2+ influxes by forming new NMDARs with NR1 and NR2. It is meaningful to uncover whether protein phosphatase 2A (PP2A) and NR3A play a role in the protective effect of Simvastatin on ischemic stroke. In the present study, the Sprague-Dawley rats were pretreated with Simvastatin for 7 days before middle cerebral artery occlusion was performed to mimic ischemic stroke. The results showed that Simvastatin decreased brain ischemic infarct area significantly while increasing the expression levels of PP2A and NR3A, thus dephosphorylating the serine sites of NR1 (ser896 and ser897) along with increased enzymatic activities of PP2A. The protein levels of NR3A decreased as the enzymatic activities of PP2A were inhibited by okadaic acid. The results indicated that Simvastatin could protect the cerebrum from ischemic injury through a signaling mechanism involving elevated levels of PP2A and NR3A, and that PP2A might involve in the regulatory mechanism of NR3A expression.	[Zhu, Minxia; Wang, Jin; Liu, Min; Du, Dongshu; Xia, Chunmei; Shen, Linlin; Zhu, Danian] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Minxia] Tibet Univ Nationalities, Coll Med, Xianyang, Shaanxi, Peoples R China	Fudan University; Xizang Minzu University	Zhu, DN (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	dnzhu@shmu.edu.cn		Zhu, Minxia/0000-0001-8775-1226	Shanghai Leading Academic Discipline Project [B112]; The Second Major Projects of Science and Technology Department in Tibet Autonomous Region	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); The Second Major Projects of Science and Technology Department in Tibet Autonomous Region	This work was supported by Shanghai Leading Academic Discipline Project (B112), URL: http://www.shmec.gov.cn and The Second Major Projects of Science and Technology Department in Tibet Autonomous Region (No Project Number), URL: http://www.tibetsti.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 2008, BRAIN RES REV, V58, P48, DOI 10.1016/j.brainresrev.2007.10.010; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bickler PE, 2004, J NEUROCHEM, V88, P878, DOI 10.1046/j.1471-4159.2003.02203.x; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheung HH, 2001, J NEUROCHEM, V78, P1179, DOI 10.1046/j.1471-4159.2001.0780051179.x; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cui LL, 2010, BRAIN RES, V1325, P164, DOI 10.1016/j.brainres.2010.02.036; Garcia-Bonilla L, 2012, J NEUROCHEM, V122, P233, DOI 10.1111/j.1471-4159.2012.07773.x; Henson MA, 2008, CEREB CORTEX, V18, P2560, DOI 10.1093/cercor/bhn017; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Khalessi AA, 2011, WORLD NEUROSURG, V76, P248, DOI 10.1016/j.wneu.2011.06.054; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Laufs U, 2003, ARTERIOSCL THROM VAS, V23, P156, DOI 10.1161/01.ATV.0000051360.79309.4E; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma OK, 2004, NEUROREPORT, V15, P1447, DOI 10.1097/01.wnr.0000132773.41720.2d; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; Montaner Joan, 2005, Expert Rev Neurother, V5, P211, DOI 10.1586/14737175.5.2.211; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Szczepanska-Szerej A, 2007, PHARMACOL REP, V59, P94; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Yi KD, 2008, ENDOCRINOLOGY, V149, P5235, DOI 10.1210/en.2008-0610	34	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51552	10.1371/journal.pone.0051552	http://dx.doi.org/10.1371/journal.pone.0051552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251573	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900102
J	Cho, HJ; Oh, YJ; Han, SH; Chung, HJ; Kim, CH; Lee, NS; Kim, WJ; Choi, JM; Kim, H				Cho, Hyun Jung; Oh, Yun Jung; Han, Seung Hun; Chung, Hee Jin; Kim, Chang Hee; Lee, Nam Soo; Kim, Won-Ju; Choi, Je-Min; Kim, Hongtae			Cdk1 Protein-mediated Phosphorylation of Receptor-associated Protein 80 (RAP80) Serine 677 Modulates DNA Damage-induced G(2)/M Checkpoint and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETS BRCA1; REPAIR; COMPLEX; SITES; CYCLE; CANCERS; CCDC98	Post-translational phosphorylation plays critical roles in the assembly of signaling and repair proteins in the DNA damage response pathway. RAP80, a component of the BRCA1-A complex, is crucial in cell cycle checkpoint activation and DNA damage repair. However, its molecular mechanism is unclear. In this study, we identified Cdk1 as a new RAP80-binding protein and demonstrated that the Cdk1-cyclin B-1 complex phosphorylates RAP80 at Ser-677 using an in vitro kinase assay and a phosphopeptide-specific antibody against phospho-Ser-677 of RAP80. RAP80 Ser-677 phosphorylation occurred in the M phase of the cell cycle when Cdk1 was in an active state. In addition, ionizing radiation (IR) induced RAP80 phosphorylation at Ser-677. Mutation of Ser-677 to alanine sensitized cells to IR and functioned in G(2)/M checkpoint control. These results suggest that post-translational phosphorylation of RAP80 by the Cdk1-cyclin B-1 complex is important for RAP80 functional sensitivity to IR and G(2)/M checkpoint control.	[Cho, Hyun Jung; Oh, Yun Jung; Han, Seung Hun; Chung, Hee Jin; Kim, Chang Hee; Lee, Nam Soo; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Kim, Won-Ju; Choi, Je-Min] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Hanyang University	Choi, JM (corresponding author), Hanyang Univ, 55 Wangsimni Ro, Seoul 133791, South Korea.	jeminchoi@hanyang.ac.kr; khtcat@skku.edu		Kim, Wonju/0000-0002-1800-0485; Choi, Je-Min/0000-0002-9482-710X	National Research Foundation of Korea (NRF) from the Korean Ministry of Education, Science and Technology (MEST) [20110030831]; National R&D Program for Cancer Control from the Ministry for Health, Welfare and Family Affairs, Republic of Korea [A111643]	National Research Foundation of Korea (NRF) from the Korean Ministry of Education, Science and Technology (MEST); National R&D Program for Cancer Control from the Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant 20110030831 from the Korean Ministry of Education, Science and Technology (MEST) and National R&D Program for Cancer Control Grant A111643 from the Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Cho HJ, 2012, MOL CANCER RES, V10, P615, DOI 10.1158/1541-7786.MCR-11-0481; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gupta M, 2007, J BIOL CHEM, V282, P4301, DOI 10.1074/jbc.M607910200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	24	23	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3768	3776		10.1074/jbc.M112.401299	http://dx.doi.org/10.1074/jbc.M112.401299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264621	Green Published, hybrid			2022-12-25	WOS:000314845000008
J	Jung, WH; Jang, JH; Shin, NY; Kim, SN; Choi, CH; An, SK; Kwon, JS				Jung, Wi Hoon; Jang, Joon Hwan; Shin, Na Young; Kim, Sung Nyun; Choi, Chi-Hoon; An, Suk Kyoon; Kwon, Jun Soo			Regional Brain Atrophy and Functional Disconnection in Broca's Area in Individuals at Ultra-High Risk for Psychosis and Schizophrenia	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; RESTING-STATE; WORKING-MEMORY; GLOBAL SIGNAL; MENTAL STATE; CONNECTIVITY; NETWORKS; FMRI; ABNORMALITIES; LANGUAGE	Background: Abnormalities in cognitive abilities such as verbal fluency and in cognitive-related brain regions, particularly Broca's area, have been reported in patients with schizophrenia. Additionally, previous studies have demonstrated that structural and functional abnormalities in Broca's area were associated with clinical symptoms and cognitive deficits in patients with schizophrenia, suggesting that deficits in this area may reflect the core pathology of schizophrenia. Thus, it is important to understand how the structural volume and functional connectivity in this area changes at rest according to the course of the illness. Methods/Principal Findings: We used magnetic resonance imaging (MRI) to measure the structural volume of Broca's area as a region of interest in 16 schizophrenia, 16 ultra-high risk (UHR), and 23 healthy matched controls. We also assessed verbal fluency and analyzed differences across groups in the functional connectivity patterns using resting-state functional MRI. The UHR group showed significantly reduced structural volume in Broca's area and significantly reduced functional connectivity between Broca's area and the lateral and medial frontal cortex as well as decreased cognitive performance. Altered functional connectivity in patients was correlated with their positive symptoms. Conclusions/Significance: Our results suggest the existence of functional disconnections in Broca's area, even during resting-states, among those with schizophrenia as well as those at UHR for this disorder. These alterations may contribute to their clinical symptoms, suggesting that this is one of the key regions involved in the pathophysiology of schizophrenia.	[Jung, Wi Hoon; Shin, Na Young; Kwon, Jun Soo] Seoul Natl Univ, Med Res Ctr, Inst Neurosci, Clin Cognit Neurosci Ctr, Seoul, South Korea; [Jung, Wi Hoon; Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 151742, South Korea; [Jang, Joon Hwan; Kim, Sung Nyun; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul 151742, South Korea; [Choi, Chi-Hoon] Natl Med Ctr, Dept Diagnost Radiol, Seoul, South Korea; [An, Suk Kyoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, World Class Univ Program, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Neurosci, Clin Cognit Neurosci Ctr, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019	Jung, Wi Hoon/0000-0002-8697-9584	Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090096]	Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A090096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Becker HE, 2010, EUR PSYCHIAT, V25, P105, DOI 10.1016/j.eurpsy.2009.08.003; Bertolino A, 2000, AM J PSYCHIAT, V157, P26, DOI 10.1176/ajp.157.1.26; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Byun MS, 2009, PSYCHIAT INVEST, V6, P264, DOI 10.4306/pi.2009.6.4.264; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Ceccherini-Nelli A, 2003, BRIT J PSYCHIAT, V182, P233, DOI 10.1192/bjp.182.3.233; Choi JS, 2011, SCHIZOPHR B IN PRESS; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; DeLisi LE, 2001, SCHIZOPHRENIA BULL, V27, P481, DOI 10.1093/oxfordjournals.schbul.a006889; Farris EA, 2011, NEUROCASE, V17, P425, DOI 10.1080/13554794.2010.532141; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jeong B, 2010, PSYCHIAT RES-NEUROIM, V181, P114, DOI 10.1016/j.pscychresns.2009.09.005; Jung WH, 2010, J KOREAN MED SCI, V25, P1700, DOI 10.3346/jkms.2010.25.12.1700; Jung WH, 2011, SCHIZOPHRENIA BULL, V37, P839, DOI 10.1093/schbul/sbp151; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Li XB, 2010, BRAIN IMAGING BEHAV, V4, P109, DOI 10.1007/s11682-010-9090-3; Li XB, 2009, CURR OPIN PSYCHIATR, V22, P131, DOI 10.1097/YCO.0b013e328324bc43; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Mecklinger A, 2000, HUM BRAIN MAPP, V11, P146; Morey RA, 2005, ARCH GEN PSYCHIAT, V62, P254, DOI 10.1001/archpsyc.62.3.254; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Paulus MP, 2002, BIOL PSYCHIAT, V51, P995, DOI 10.1016/S0006-3223(01)01358-0; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; Simon AE, 2007, SCHIZOPHRENIA BULL, V33, P761, DOI 10.1093/schbul/sbm018; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	47	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51975	10.1371/journal.pone.0051975	http://dx.doi.org/10.1371/journal.pone.0051975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251669	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800124
J	Xiang, XG; Li, DZ; Jin, XH; Hu, H; Zhou, HL; Jin, WT; Lai, YJ				Xiang, Xiaoguo; Li, Dezhu; Jin, Xiaohua; Hu, Hao; Zhou, Hailang; Jin, Weitao; Lai, Yangjun			Monophyly or Paraphyly - The Taxonomy of Holcoglossum (Aeridinae: Orchidaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; EVOLUTIONARY; TAXA; DNA; CLASSIFICATIONS; POLLINATION; ANCESTORS; NUCLEAR; SYSTEM; MODEL	Recently, there have been a lot of intense debates about the acceptance/rejection of paraphyletic groups in biological classification. On the one hand, evolutionary classification states that similarity and common descent are two criteria for biological classification and paraphyletic groups are natural units of biological classification. On the other hand, cladistic classification considers that common descent is the only criterion in biological classification and monophyly should be strictly adhered to. Holcoglossum is used herein as a case to illustrate this problem. Although Holcoglossum is a small orchid genus of less than 20 species, there is little consensus about its generic circumscription since it was established, which leads to confusion in taxonomic treatments in the Aerides-Vanda group. Based on the analyses of molecular and morphological evidence, our results suggest that the clade comprising Holcoglossum s.s., Ascolabium, Penkimia and Ascocentrum himalaicum is strongly supported as a monophyly, and that the three taxa are nested within different subclades of Holcoglossum s.s. Thus, it is reasonable to recognize a monophyletic circumscription of Holcoglossum, which is also well supported by some vegetative and floral characters. The Holcoglossum s.l. would facilitate a better understanding of pollinator-driven floral divergence and vegetative stasis than a paraphyletic and narrowly defined genus. Citation: Xiang X, Li D, Jin X, Hu H, Zhou H, et al. (2012) Monophyly or Paraphyly- The Taxonomy of Holcoglossum (Aeridinae: Orchidaceae). PLoS ONE 7(12): e52050. doi:10.1371/journal.pone.0052050	[Xiang, Xiaoguo; Jin, Xiaohua; Zhou, Hailang; Jin, Weitao; Lai, Yangjun] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Dezhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Hu, Hao] Xian Bot Garden, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaohuajin@ibcas.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31170176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (31170176 for Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averyanov LV, 1988, BOTANICESKIJ ZH LENI, V73, P101; Bininda-Emonds ORP, 1998, BIOL J LINN SOC, V64, P101; Brummitt RK, 2008, TAXON, V57, P1049, DOI 10.1002/tax.574002; Brummitt RK, 2006, TAXON, V55, P268, DOI 10.2307/25065576; Brummitt RK, 2002, TAXON, V51, P31, DOI 10.2307/1554961; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson Eric A., 1998, Lindleyana, V13, P121; Crisp Michael D., 1996, Telopea, V6, P813; DONOGHUE MJ, 1988, BOT REV, V54, P107, DOI 10.1007/BF02858525; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; Ebach MC, 2006, TAXON, V55, P831, DOI 10.2307/25065678; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Freudenstein JV, 1998, TAXON, V47, P95, DOI 10.2307/1224023; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Garay LA, 1974, BOT MUS LEAFL HARVAR, V23, P369; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Horandl E, 2007, TAXON, V56, P1; Horandl E, 2010, TAXON, V59, P1641, DOI 10.1002/tax.596001; Horandl E, 2010, TAXON, V59, P345, DOI 10.1002/tax.592001; Horandl E, 2006, TAXON, V55, P564, DOI 10.2307/25065631; HUMPHRIES CJ, 1988, BOT REV, V54, P129, DOI 10.1007/BF02858526; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2005, PLANT SYST EVOL, V254, P31, DOI 10.1007/s00606-005-0310-z; Jin XH, 2009, FLORA CHINA, V25, P499; Jin XH, 2007, NORDIC J BOT, V25; Jin XH, 2007, BOT J LINN SOC, V154, P283, DOI 10.1111/j.1095-8339.2007.00654.x; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P2433; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Mayr E, 2002, J ZOOL SYST EVOL RES, V40, P169, DOI 10.1046/j.1439-0469.2002.00211.x; Nordal H, 2005, TAXON, V54, P5; Podani J, 2010, TAXON, V59, P1011, DOI 10.1002/tax.594002; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Schmidt-Lebuhn AN, 2012, CLADISTICS, V28, P174, DOI 10.1111/j.1096-0031.2011.00367.x; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stpiczynska M, 2011, ANN BOT-LONDON, V107, P327, DOI 10.1093/aob/mcq246; Stuessy TF, 2008, TAXON, V57, P594, DOI 10.2307/25066026; Stuessy TF, 2010, TAXON, V59, P689, DOI 10.1002/tax.593001; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Ying SS, 1977, ORCHIDS TAIWAN, V1, P54	57	14	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52050	10.1371/journal.pone.0052050	http://dx.doi.org/10.1371/journal.pone.0052050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251681	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800134
J	Yang, S; Hwang, JS; Park, HK; Lee, HS; Kim, HS; Kim, EY; Lim, JS				Yang, Seung; Hwang, Jin Soon; Park, Hong Kyu; Lee, Hae Sang; Kim, Hae Soon; Kim, Eun Young; Lim, Jung Sub			Serum Lipid Concentrations, Prevalence of Dyslipidemia, and Percentage Eligible for Pharmacological Treatment of Korean Children and Adolescents; Data from the Korea National Health and Nutrition Examination Survey IV (2007-2009)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; DENSITY-LIPOPROTEIN CHOLESTEROL; UNITED-STATES; JAPANESE CHILDREN; CHILDHOOD; TRENDS; ADULTS; ATHEROSCLEROSIS; ASSOCIATION	Objectives: Dyslipidemia is one of the important modifiable risk factors for cardiovascular disease. Thus, to know the prevalence of dyslipidemia is the 1st step to make guidelines of screening and management plan. Although, American Academy of Pediatrics updated the guidelines for lipid in childhood, Asian study is rare. Methods: The authors aimed to make a reference of each serum lipid level of Korean children and adolescents (2,363 subjects aged 10 to 18 years) from the data of Korea National Health and Nutrition Examination Survey IV (2007-2009). Results: The mean serum concentrations for total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were 158 mg/dL, 90 mg/dL, 90 mg/dL, and 49 mg/dL, respectively. The 95th percentile values for TC, LDL-C, and TG were 203 mg/dL, 129 mg/dL, and 185 mg/dL, respectively. The 5th percentile value for HDL-C was 36 mg/dL. The prevalence of hypercholesterolemia, high LDL-C, high TG, and low HDL-C was 6.5%, 4.7%, 10.1%, and 7.1%, respectively. Considering the risk factors such as obesity, hypertension, smoking, and diabetes, approximately 0.41% of the subjects were potentially eligible for pharmacological treatment. Conclusions: This information may be useful in not only Korean but also Asian planning programs for the prevention of cardiovascular disease through lipid control from childhood. Citation: Yang S, Hwang JS, Park HK, Lee HS, Kim HS, et al. (2012) Serum Lipid Concentrations, Prevalence of Dyslipidemia, and Percentage Eligible for Pharmacological Treatment of Korean Children and Adolescents; Data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS ONE 7(12): e49253. doi: 10.1371/journal.pone.0049253	[Lim, Jung Sub] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Yang, Seung; Park, Hong Kyu] Hallym Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Hwang, Jin Soon; Lee, Hae Sang] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon 441749, South Korea; [Kim, Hae Soon] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Eun Young] Chosun Univ, Coll Med, Dept Pediat, Kwangju, South Korea	National Cancer Center - Korea (NCC); Hallym University; Ajou University; Ajou University Hospital; Ewha Womans University; Chosun University	Lim, JS (corresponding author), Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea.	limjs@kcch.re.kr	lee, haesang/AAG-6951-2022; LIM, JUNG SUB/GLU-0130-2022; lee, Hae Sang/AFL-6833-2022	lee, Hae Sang/0000-0002-9684-4042				American Academy of Pediatrics, 1992, PEDIATRICS, V89, P525; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Committee for Establishing Treatment Instruction for Dyslipidemia of the Korean Society of Lipidology and Atherosclerosis, 2009, GUID MAN DYSL; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; Hickman TB, 1998, PREV MED, V27, P879, DOI 10.1006/pmed.1998.0376; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251; Kim S, 2000, AM J CLIN NUTR, V71, P44; Ko MJ, 2006, INT J CARDIOL, V110, P184, DOI 10.1016/j.ijcard.2005.07.030; Korea National Statistical Office, 2010, ANN REP CAUS DEATH S; Kouda K, 2004, J EPIDEMIOL, V14, P78, DOI 10.2188/jea.14.78; LAUER RM, 1988, PEDIATRICS, V82, P309; Lee CG, 2011, KOREAN J PEDIAT, V51, P463; Lee Hyung Min, 2011, J Prev Med Public Health, V44, P74, DOI 10.3961/jpmph.2011.44.2.74; Liao Y, 2008, ACTA PAEDIATR, V97, P1449, DOI 10.1111/j.1651-2227.2008.00946.x; Liu LL, 2009, DIABETES CARE, V32, pS133, DOI 10.2337/dc09-S205; May A. L., 2010, Morbidity and Mortality Weekly Report, V59, P29; McGill HC, 2001, CIRCULATION, V103, P1546; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Moon Jin Soo, 2011, Korean J Pediatr, V54, P436, DOI 10.3345/kjp.2011.54.11.436; Okada T, 2002, PEDIATR INT, V44, P596, DOI 10.1046/j.1442-200X.2002.01634.x; PARK C B, 1955, Bull World Health Organ, V13, P69; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Sone H, 2011, J CLIN ENDOCR METAB, V96, P3448, DOI 10.1210/jc.2011-0622; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Wang S, 2011, PLOS ONE, V6; World Health Organization (WHO), 2004, GLOB BURD DIS 2004; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	39	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49253	10.1371/journal.pone.0049253	http://dx.doi.org/10.1371/journal.pone.0049253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251338	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800005
J	Haeseker, MB; Dukers-Muijrers, NHTM; Hoebe, CJPA; Bruggeman, CA; Cals, JWL; Verbon, A				Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Cals, Jochen W. L.; Verbon, Annelies			Trends in Antibiotic Prescribing in Adults in Dutch General Practice	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; ANTIMICROBIAL CONSUMPTION ESAC; INAPPROPRIATE MEDICATION USE; PRIMARY-CARE; EUROPEAN SURVEILLANCE; UNITED-STATES; OLDER-ADULTS; INFECTIONS; EVENTS; POPULATION	Background: Antibiotic consumption is associated with adverse drug events (ADE) and increasing antibiotic resistance. Detailed information of antibiotic prescribing in different age categories is scarce, but necessary to develop strategies for prudent antibiotic use. The aim of this study was to determine the antibiotic prescriptions of different antibiotic classes in general practice in relation to age. Methodology: Retrospective study of 22 rural and urban general practices from the Dutch Registration Network Family Practices (RNH). Antibiotic prescribing data were extracted from the RNH database from 2000-2009. Trends over time in antibiotic prescriptions were assessed with multivariate logistic regression including interaction terms with age. Registered ADEs as a result of antibiotic prescriptions were also analyzed. Principal Findings: In total 658,940 patients years were analyzed. In 11.5% (n = 75,796) of the patient years at least one antibiotic was prescribed. Antibiotic prescriptions increased for all age categories during 2000-2009, but the increase in elderly patients (>80 years) was most prominent. In 2000 9% of the patients >80 years was prescribed at least one antibiotic to 22% in 2009 (P<0.001). Elderly patients had more ADEs with antibiotics and co-medication was identified as the only independent determinant for ADEs. Conclusion/Discussion: The rate of antibiotic prescribing for patients who made a visit to the GP is increasing in the Netherlands with the most evident increase in the elderly patients. This may lead to more ADEs, which might lead to higher consumption of health care and more antibiotic resistance.	[Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Verbon, Annelies] Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] Publ Hlth Serv S Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Cals, Jochen W. L.] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands; [Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Cals, Jochen W. L.] Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [Verbon, Annelies] Erasmus MC, Dept Internal Med Sect, Rotterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Haeseker, MB (corresponding author), Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands.	m.haeseker@mumc.nl	Cals, Jochen WL/A-1262-2007; Dukers-Muijrers, Nicole/M-7178-2014	Cals, Jochen WL/0000-0001-9550-5674; Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; BEARD K, 1992, DRUG AGING, V2, P356, DOI 10.2165/00002512-199202040-00008; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Eurostat, 2010, POP PROJ 2010 2060; Faulkner CM, 2005, CLIN INFECT DIS, V40, P997, DOI 10.1086/428125; Feldman C, 2001, MED CLIN N AM, V85, P1441, DOI 10.1016/S0025-7125(05)70390-4; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Goossens H, 2007, CLIN INFECT DIS, V44, P1091, DOI 10.1086/512810; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Herring AR, 2007, CLIN GERIATR MED, V23, P481, DOI 10.1016/j.cger.2007.03.009; HofmansOkkes IM, 1996, FAM PRACT, V13, P294, DOI 10.1093/fampra/13.3.294; HUTCHINSON TA, 1986, J CHRON DIS, V39, P533, DOI 10.1016/0021-9681(86)90198-0; KNOTTNERUS JA, 1992, FAM PRACT, V9, P15, DOI 10.1093/fampra/9.1.15; Kuyvenhoven MM, 2003, J ANTIMICROB CHEMOTH, V52, P675, DOI 10.1093/jac/dkg412; Laroche ML, 2007, BRIT J CLIN PHARMACO, V63, P177, DOI 10.1111/j.1365-2125.2006.02831.x; Laube S, 2004, AGEING RES REV, V3, P69, DOI 10.1016/j.arr.2003.08.003; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Majeed A, 1999, BRIT J GEN PRACT, V49, P735; Metsemakers JFM, 1996, INT J BIOMED COMPUT, V42, P43, DOI 10.1016/0020-7101(96)01180-4; Norris P, 2011, J ANTIMICROB CHEMOTH, V66, P1921, DOI 10.1093/jac/dkr194; O'Mahony D, 2008, AGE AGEING, V37, P138, DOI 10.1093/ageing/Afm189; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Pan A, 2011, CLIN MICROBIOL INFEC, V17, P1698, DOI 10.1111/j.1469-0691.2011.03500.x; Richards Chesley L., 2004, International Urology and Nephrology, V36, P457, DOI 10.1007/s11255-004-4870-6; SFK, 2010, ANT GROEIT GEST; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; VANDENAKKER M, 2004, GEN PRACTICE GOLD MI	32	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51860	10.1371/journal.pone.0051860	http://dx.doi.org/10.1371/journal.pone.0051860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251643	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200170
J	Kuribayashi-Shigetomi, K; Onoe, H; Takeuchi, S				Kuribayashi-Shigetomi, Kaori; Onoe, Hiroaki; Takeuchi, Shoji			Cell Origami: Self-Folding of Three-Dimensional Cell-Laden Microstructures Driven by Cell Traction Force	PLOS ONE			English	Article							ENCAPSULATION; FABRICATION; DNA	This paper describes a method of generating three-dimensional (3D) cell-laden microstructures by applying the principle of origami folding technique and cell traction force (CTF). We harness the CTF as a biological driving force to fold the microstructures. Cells stretch and adhere across multiple microplates. Upon detaching the microplates from a substrate, CTF causes the plates to lift and fold according to a prescribed pattern. This self-folding technique using cells is highly biocompatible and does not involve special material requirements for the microplates and hinges to induce folding. We successfully produced various 3D cell-laden microstructures by just changing the geometry of the patterned 2D plates. We also achieved mass-production of the 3D cell-laden microstructures without causing damage to the cells. We believe that our methods will be useful for biotechnology applications that require analysis of cells in 3D configurations and for self-assembly of cell-based micro-medical devices.	[Kuribayashi-Shigetomi, Kaori; Onoe, Hiroaki; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Onoe, Hiroaki; Takeuchi, Shoji] Japan Sci & Technol Agcy JST, Takeuchi Biohybrid Innovat Project, Exploratory Res Adv Technol ERATO, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Onoe, Hiroaki/A-3724-2012; Takeuchi, Shoji/J-5349-2019	Takeuchi, Shoji/0000-0001-6946-0409	Takeuchi Biohybrid Innovation Project; Exploratory Research for Advanced Technology (ERATO); Japan Science and Technology (JST), Japan; Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan [23106005]	Takeuchi Biohybrid Innovation Project; Exploratory Research for Advanced Technology (ERATO)(Japan Science & Technology Agency (JST)); Japan Science and Technology (JST), Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan, and Grant-in-Aid for Scientific Research on Innovative Areas "Bio Assembler" (23106005) from the Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BY, 2010, ADV MATER, V22, P2251, DOI 10.1002/adma.200904232; Azam A, 2011, BIOMED MICRODEVICES, V13, P51, DOI 10.1007/s10544-010-9470-x; Bassik N, 2008, ADV MATER, V20, P4760, DOI 10.1002/adma.200801759; Brittain ST, 2001, J PHYS CHEM B, V105, P347, DOI 10.1021/jp002556e; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Gimi B, 2005, BIOMED MICRODEVICES, V7, P341, DOI 10.1007/s10544-005-6076-9; Green PW, 1995, J MICROELECTROMECH S, V4, P170, DOI 10.1109/84.475543; Guest SD, 1996, J APPL MECH-T ASME, V63, P77, DOI 10.1115/1.2787212; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Ionov L, 2011, SOFT MATTER, V7, P6786, DOI 10.1039/c1sm05476g; Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7; Iwase E, 2006, SENSOR ACTUAT A-PHYS, V127, P310, DOI 10.1016/j.sna.2006.01.025; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Jamal M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1531; Jamal M, 2010, BIOMATERIALS, V31, P1683, DOI 10.1016/j.biomaterials.2009.11.056; Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64; Kuribayashi K, 2006, MAT SCI ENG A-STRUCT, V419, P131, DOI 10.1016/j.msea.2005.12.016; Leong TG, 2008, LAB CHIP, V8, P1621, DOI 10.1039/b809098j; Leong TG, 2010, SMALL, V6, P792, DOI 10.1002/smll.200901704; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Merali Z, 2011, SCIENCE, V332, P1376, DOI 10.1126/science.332.6036.1376; Miura K., 1993, INT J SPACE STRUCT, V8, P3, DOI 10.1177/0266351193008001-202; Nagayama K, 2011, CELL MOL BIOENG, V4, P348, DOI 10.1007/s12195-011-0166-y; Ohashi Toshiro, 2010, Journal of Biomechanical Science and Engineering, V5, P262, DOI 10.1299/jbse.5.262; Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013; Randall CL, 2011, NANOMED-NANOTECHNOL, V7, P686, DOI 10.1016/j.nano.2011.08.020; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Stewart I, 2007, NATURE, V448, P419, DOI 10.1038/448419a; SUZUKI K, 1994, J MICROELECTROMECH S, V3, P4, DOI 10.1109/84.285718; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Taylor R, 2009, ENDOVASULAR TODAY, VI, P27; Zakharchenko S, 2010, SOFT MATTER, V6, P2633, DOI 10.1039/c0sm00088d	32	146	151	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51085	10.1371/journal.pone.0051085	http://dx.doi.org/10.1371/journal.pone.0051085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251426	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200057
J	Parnmen, S; Cking, RL; Lumbsch, HT				Parnmen, Sittiporn; Cking, Robert Lu; Lumbsch, H. Thorsten			Phylogenetic Classification at Generic Level in the Absence of Distinct Phylogenetic Patterns of Phenotypical Variation: A Case Study in Graphidaceae (Ascomycota)	PLOS ONE			English	Article							RIBOSOMAL DNA; MOLECULAR PHYLOGENY; SPECIES-DIVERSITY; MORPHOLOGY; EVOLUTION; TREE; PSEUDOMURIELLA; CHLOROPHYCEAE; BRACTEACOCCUS; DICTYOCOCCUS	Molecular phylogenies often reveal that taxa circumscribed by phenotypical characters are not monophyletic. While re-examination of phenotypical characters often identifies the presence of characters characterizing clades, there is a growing number of studies that fail to identify diagnostic characters, especially in organismal groups lacking complex morphologies. Taxonomists then can either merge the groups or split taxa into smaller entities. Due to the nature of binomial nomenclature, this decision is of special importance at the generic level. Here we propose a new approach to choose among classification alternatives using a combination of morphology-based phylogenetic binning and a multiresponse permutation procedure to test for morphological differences among clades. We illustrate the use of this method in the tribe Thelotremateae focusing on the genus Chapsa, a group of lichenized fungi in which our phylogenetic estimate is in conflict with traditional classification and the morphological and chemical characters do not show a clear phylogenetic pattern. We generated 75 new DNA sequences of mitochondrial SSU rDNA, nuclear LSU rDNA and the protein-coding RPB2. This data set was used to infer phylogenetic estimates using maximum likelihood and Bayesian approaches. The genus Chapsa was found to be polyphyletic, forming four well-supported clades, three of which clustering into one unsupported clade, and the other, supported clade forming two supported subclades. While these clades cannot be readily separated morphologically, the combined binning/multiresponse permutation procedure showed that accepting the four clades as different genera each reflects the phenotypical pattern significantly better than accepting two genera (or five genera if splitting the first clade). Another species within the Thelotremateae, Thelotrema petractoides, a unique taxon with carbonized excipulum resembling Schizotrema, was shown to fall outside Thelotrema. Consequently, the new genera Astrochapsa, Crutarndina, Pseudochapsa, and Pseudotopeliopsis are described here and 39 new combinations are proposed.	[Parnmen, Sittiporn; Cking, Robert Lu; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA	Field Museum of Natural History (Chicago)	Lumbsch, HT (corresponding author), Field Museum, Dept Bot, Chicago, IL USA.	tlumbsch@fieldmuseum.org	Parnmen, Sittiporn/B-9203-2014	Lucking, Robert/0000-0002-3431-4636; Parnmen, Sittiporn/0000-0002-0116-9436	National Science Foundation (NSF) [DEB-1025861, 1025861]; NSF [DEB-1025861, DEB-0206125, DEB-0516116, DEB-0715660]; Direct For Biological Sciences [1025861] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by National Science Foundation (NSF), DEB-1025861 to The Field Museum; PI HTL, CoPI RL, "ATM - Assembling a taxonomic monograph: The lichen family Graphidaceae". Website: http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 1025861. Collection of material and sequencing work for this study was supported by four NSF grants: TICOLICHEN (DEB-0206125 to The Field Museum; PI RL), Phylogeny and Taxonomy of Ostropalean Fungi, with Emphasis on the Lichen-forming Thelotremataceae (DEB-0516116 to The Field Museum; PI HTL; Co-PI RL), Neotropical Epiphytic Microlichens - An Innovative Inventory of a Highly Diverse yet Little Known Group of Symbiotic Organisms (DEB-0715660 to The Field Museum; PI RL), and ATM - Assembling a taxonomic monograph: The lichen family Graphidaceae (DEB-1025861 to The Field Museum; PI HTL, CoPI RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; ARUP U, 1993, LICHENOLOGIST, V25, P61; Barton N. H., 2007, EVOLUTION; Berger SA, 2011, TAXON, V60, P1450, DOI 10.1002/tax.605020; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Drummond A., 2011, GENEIOUS V5 5; Ertz D, 2008, AM J BOT, V95, P1548, DOI 10.3732/ajb.0800232; Frisch Andreas, 2006, V92, P3; Fucikova K, 2011, J PHYCOL, V47, pS39; Fucikova K, 2011, PHYCOLOGIA, V50, P422, DOI 10.2216/10-69.1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hibbett DS, 2007, MYCOL RES, V111, P1001, DOI 10.1016/j.mycres.2007.01.012; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hodkinson BP, 2012, MYCOL PROG, V11, P827, DOI 10.1007/s11557-011-0800-z; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jahns HM, 1994, NATO ADV SCI I SERIE, P57; Kirk P. M., 2009, AINSWORTH BISBYS DIC, V10th; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lumbsch HT, 2007, MYCOL RES, V111, P1064, DOI 10.1016/j.mycres.2007.04.004; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Mangold A, 2008, TAXON, V57, P476, DOI 10.2307/25066016; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCune B, 2002, ANAL ECOLOGICAL COMM; McCune B., 2011, PC ORD MULTIVARIATE; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Mielke P. W., 2001, PERMUTATION METHODS; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Orange A., 2001, MICROCHEMICAL METHOD; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papong K, 2009, FUNGAL DIVERS, V38, P147; Plata ER, 2012, FUNGAL DIVERS, V52, P107, DOI 10.1007/s13225-011-0135-8; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Plata ER, 2010, LICHENOLOGIST, V42, P139, DOI 10.1017/S0024282909990491; Rivas Plata E., 2011, HIST BIOGEOGRAPHY EC; Rivas Plata E, 2012, MYCOKEYS IN PRESS; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stearns S.C., 2005, EVOLUTION INTRO; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; THOMAS RH, 1993, MOL BIOL EVOL, V10, P362; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Sickle John, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P370; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vilnet AA, 2007, RUSS J GENET+, V43, P1306, DOI 10.1134/S1022795407110142; Wang HY, 2010, SCI CHINA LIFE SCI, V53, P1163, DOI 10.1007/s11427-010-4063-8; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wiens JJ, 2000, SYST BIOL, V49, P69; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zoller S, 1999, LICHENOLOGIST, V31, P511; [No title captured]	63	33	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51392	10.1371/journal.pone.0051392	http://dx.doi.org/10.1371/journal.pone.0051392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251515	gold, Green Published, Green Submitted			2022-12-25	WOS:000313236200100
J	Amezquita-Lopez, BA; Quinones, B; Cooley, MB; Leon-Felix, J; Castro-del Campo, N; Mandrell, RE; Jimenez, M; Chaidez, C				Amezquita-Lopez, Bianca A.; Quinones, Beatriz; Cooley, Michael B.; Leon-Felix, Josefina; Castro-del Campo, Nohelia; Mandrell, Robert E.; Jimenez, Maribel; Chaidez, Cristobal			Genotypic Analyses of Shiga Toxin-Producing Escherichia coli O157 and Non-O157 Recovered from Feces of Domestic Animals on Rural Farms in Mexico	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; IMMUNOMAGNETIC SEPARATION; VIRULENCE GENES; SHEEP; SEROTYPES; CATTLE; PREVALENCE; SLAUGHTER; STRAINS	Shiga toxin-producing Escherichia coli (STEC) are zoonotic enteric pathogens associated with human gastroenteritis worldwide. Cattle and small ruminants are important animal reservoirs of STEC. The present study investigated animal reservoirs for STEC in small rural farms in the Culiacan Valley, an important agricultural region located in Northwest Mexico. A total of 240 fecal samples from domestic animals were collected from five sampling sites in the Culiacan Valley and were subjected to an enrichment protocol followed by either direct plating or immunomagnetic separation before plating on selective media. Serotype O157:H7 isolates with the virulence genes stx2, eae, and ehxA were identified in 40% (26/65) of the recovered isolates from cattle, sheep and chicken feces. Pulse-field gel electrophoresis (PFGE) analysis grouped most O157: H7 isolates into two clusters with 98.6% homology. The use of multiple-locus variable-number tandem repeat analysis (MLVA) differentiated isolates that were indistinguishable by PFGE. Analysis of the allelic diversity of MLVA loci suggested that the O157: H7 isolates from this region were highly related. In contrast to O157: H7 isolates, a greater genotypic diversity was observed in the non-O157 isolates, resulting in 23 PFGE types and 14 MLVA types. The relevant non-O157 serotypes O8:H19, O75:H8, O111:H8 and O146:H21 represented 35.4% (23/65) of the recovered isolates. In particular, 18.5% (12/65) of all the isolates were serotype O75: H8, which was the most variable serotype by both PFGE and MLVA. The non-O157 isolates were predominantly recovered from sheep and were identified to harbor either one or two stx genes. Most non-O157 isolates were ehxA-positive (86.5%, 32/37) but only 10.8% (4/37) harbored eae. These findings indicate that zoonotic STEC with genotypes associated with human illness are present in animals on small farms within rural communities in the Culiacan Valley and emphasize the need for the development of control measures to decrease risks associated with zoonotic STEC.	[Amezquita-Lopez, Bianca A.; Leon-Felix, Josefina; Castro-del Campo, Nohelia; Chaidez, Cristobal] Ctr Invest Alimentac & Desarrollo, Culiacan, Sinaloa, Mexico; [Quinones, Beatriz; Cooley, Michael B.; Mandrell, Robert E.] ARS, USDA, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, Albany, CA USA; [Jimenez, Maribel] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Culiacan, Sinaloa, Mexico	CIAD - Centro de Investigacion en Alimentacion y Desarrollo; United States Department of Agriculture (USDA); Universidad Autonoma de Sinaloa	Quinones, B (corresponding author), Ctr Invest Alimentac & Desarrollo, Culiacan, Sinaloa, Mexico.	Beatriz.Quinones@ars.usda.gov; chaqui@ciad.edu.mx	Mandrell, Robert E/O-9814-2018; Félix, Josefina León/U-5369-2019	Félix, Josefina León/0000-0003-3755-881X; Quinones, Beatriz/0000-0001-5010-9889; Jimenez-Edeza, Maribel/0000-0002-9835-9665; Castro-del Campo, Nohelia/0000-0002-0738-492X	U.S. Department of Agriculture, Agricultural Research Service CRIS project [5325-42000-047]; The National Council of Science and Technology in Mexico (CONACyT) [234885]	U.S. Department of Agriculture, Agricultural Research Service CRIS project; The National Council of Science and Technology in Mexico (CONACyT)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service CRIS project number 5325-42000-047 and by a Postgraduate Studies Scholarship from The National Council of Science and Technology in Mexico (CONACyT grant #234885) to BAAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan I, 2004, VET MICROBIOL, V102, P43, DOI 10.1016/j.vetmic.2004.04.013; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Blanco M, 2003, J CLIN MICROBIOL, V41, P1351, DOI 10.1128/JCM.41.4.1351-1356.2003; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Bolton DJ, 2011, FOODBORNE PATHOG DIS, V8, P357, DOI 10.1089/fpd.2010.0699; Brett KN, 2003, J CLIN MICROBIOL, V41, P926, DOI 10.1128/JCM.41.3.926-936.2003; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Bustamante AV, 2010, INT J MED MICROBIOL, V300, P212, DOI 10.1016/j.ijmm.2009.08.020; Callaway TR, 2004, J FOOD PROTECT, V67, P2274, DOI 10.4315/0362-028X-67.10.2274; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424, DOI 10.1099/00222615-40-6-424; Cookson AL, 2006, NEW ZEAL VET J, V54, P78, DOI 10.1080/00480169.2006.36616; Cookson AL, 2007, APPL ENVIRON MICROB, V73, P6360, DOI 10.1128/AEM.00316-07; Cookson AL, 2002, J MED MICROBIOL, V51, P1041, DOI 10.1099/0022-1317-51-12-1041; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Coombes BK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00090; Djordjevic SP, 2004, APPL ENVIRON MICROB, V70, P3910, DOI 10.1128/AEM.70.7.3910-3917.2004; Djordjevic SP, 2001, J CLIN MICROBIOL, V39, P2017, DOI 10.1128/JCM.39.5.2017-2021.2001; Doane CA, 2007, J FOOD PROTECT, V70, P6, DOI 10.4315/0362-028X-70.1.6; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Fegan N, 1999, LETT APPL MICROBIOL, V28, P335, DOI 10.1046/j.1365-2672.1999.00556.x; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Franci T, 2011, FOODBORNE PATHOG DIS, V8, P1019, DOI 10.1089/fpd.2010.0814; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Gallegos M., 2009, Revista Cientifica, Facultad de Ciencias Veterinarias, Universidad del Zulia, V19, P139; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Heuvelink AE, 1998, J CLIN MICROBIOL, V36, P878, DOI 10.1128/JCM.36.4.878-882.1998; Hornitzky MA, 2002, APPL ENVIRON MICROB, V68, P6439, DOI 10.1128/AEM.68.12.6439-6445.2002; Hornitzky MA, 2001, FEMS MICROBIOL LETT, V198, P17, DOI 10.1111/j.1574-6968.2001.tb10613.x; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hussein HS, 2008, FOODBORNE PATHOG DIS, V5, P227, DOI 10.1089/fpd.2008.0081; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jimenez M, 2011, MICROB ECOL, V61, P811, DOI 10.1007/s00248-010-9792-5; Kalchayanand N, 2007, J FOOD PROTECT, V70, P1811, DOI 10.4315/0362-028X-70.8.1811; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Keys C, 2005, J APPL MICROBIOL, V98, P928, DOI 10.1111/j.1365-2672.2004.02532.x; La Ragione RM, 2009, FEMS MICROBIOL REV, V33, P394, DOI 10.1111/j.1574-6976.2008.00138.x; Lindstedt BA, 2004, J MICROBIOL METH, V58, P213, DOI 10.1016/j.mimet.2004.03.016; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lindstedt Bjorn-Arne, 2003, Ann Clin Microbiol Antimicrob, V2, P12, DOI 10.1186/1476-0711-2-12; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Lopez-Saucedo C, 2010, CLIN INFECT DIS, V50, P450, DOI 10.1086/649888; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Meng JH, 1998, INT J FOOD MICROBIOL, V45, P229, DOI 10.1016/S0168-1605(98)00163-9; Muniesa M, 2006, ENVIRON SCI TECHNOL, V40, P7141, DOI 10.1021/es060927k; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; Ogden ID, 2005, J APPL MICROBIOL, V98, P646, DOI 10.1111/j.1365-2672.2004.02493.x; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Quinones B, 2011, FOODBORNE PATHOG DIS, V8, P705, DOI 10.1089/fpd.2010.0753; Rey J, 2006, INT J FOOD MICROBIOL, V107, P212, DOI 10.1016/j.ijfoodmicro.2005.08.025; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schmidt H, 1996, J CLIN MICROBIOL, V34, P2364, DOI 10.1128/JCM.34.10.2364-2367.1996; Siller-Cepeda JH, 2009, FOOD SCI TECH-INT SE, P309, DOI 10.1016/B978-0-12-374186-8.00013-6; Sosa Hernandez LA, 2008, RECVET REV ELECT CLI, VIII, P1; Tristao LCS, 2007, VET MICROBIOL, V119, P358, DOI 10.1016/j.vetmic.2006.09.006; Varela-Hernandez JJ, 2007, INT J FOOD MICROBIOL, V113, P237, DOI 10.1016/j.ijfoodmicro.2006.06.028; Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004; Vettorato MP, 2003, VET MICROBIOL, V95, P103, DOI 10.1016/S0378-1135(03)00153-6; WRIGHT DJ, 1994, EPIDEMIOL INFECT, V113, P31, DOI 10.1017/S0950268800051438	68	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51565	10.1371/journal.pone.0051565	http://dx.doi.org/10.1371/journal.pone.0051565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251577	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900104
J	Jackman, RW; Wu, CL; Kandarian, SC				Jackman, Robert W.; Wu, Chia-Ling; Kandarian, Susan C.			The ChIP-seq-Defined Networks of Bcl-3 Gene Binding Support Its Required Role in Skeletal Muscle Atrophy	PLOS ONE			English	Article							KAPPA-B P50; ACTIVATION; PATHWAY; PLATFORM; ENCODES; PROTEIN; ALPHA	NF-kappaB transcriptional activation is required for skeletal muscle disuse atrophy. We are continuing to study how the activation of NF-kB regulates the genes that encode the protein products that cause atrophy. Using ChIP-sequencing we found that Bcl-3, an NF-kB transcriptional activator required for atrophy, binds to the promoters of a number of genes whose collective function describes two major aspects of muscle wasting. By means of bioinformatics analysis of ChIP-sequencing data we found Bcl-3 to be directing transcription networks of proteolysis and energy metabolism. The proteolytic arm of the Bcl-3 networks includes many E3 ligases associated with proteasomal protein degradation, including that of the N-end rule pathway. The metabolic arm appears to be involved in organizing the change from oxidative phosphorylation to glycolysis in atrophying muscle. For one gene, MuRF1, ChIP-sequencing data identified the location of Bcl-3 and p50 binding in the promoter region which directed the creation of deletant and base-substitution mutations of MuRF1 promoter constructs to determine the effect on gene transcription. The results provide the first direct confirmation that the NF-kB binding site is involved in the muscle unloading regulation of MuRF1. Finally, we have combined the ChIP-sequencing results with gene expression microarray data from unloaded muscle to map several direct targets of Bcl-3 that are transcription factors whose own targets describe a set of indirect targets for NF-kB in atrophy. ChIP-sequencing provides the first molecular explanation for the finding that Bcl3 knockout mice are resistant to disuse muscle atrophy. Mapping the transcriptional regulation of muscle atrophy requires an unbiased analysis of the whole genome, which we show is now possible with ChIP-sequencing.	[Jackman, Robert W.; Wu, Chia-Ling; Kandarian, Susan C.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu			National Institutes of Health (NIH) [AR041705, AR060217]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217, R01AR041705, R29AR041705] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) awards AR041705 and AR060217. (http://grants.nih.gov/grants/oer.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeva V, 2012, BIOINFORMATICS; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Delano Matthew J, 2006, Nutr Clin Pract, V21, P68, DOI 10.1177/011542650602100168; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Fu YT, 2004, NUCLEIC ACIDS RES, V32, pW420, DOI 10.1093/nar/gkh426; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Qin J, 2011, NUCLEIC ACIDS RES, V39, pW430, DOI 10.1093/nar/gkr332; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schefold JC, 2010, J CACHEXIA SARCOPENI, V1, P147, DOI 10.1007/s13539-010-0010-6; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; Stein TP, 2002, J NUTR BIOCHEM, V13, P471, DOI 10.1016/S0955-2863(02)00195-X; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51478	10.1371/journal.pone.0051478	http://dx.doi.org/10.1371/journal.pone.0051478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251550	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900094
J	Inoue, Y; Kubota-Koketsu, R; Yamashita, A; Nishimura, M; Ideno, S; Ono, K; Okuno, Y; Ikuta, K				Inoue, Yuji; Kubota-Koketsu, Ritsuko; Yamashita, Akifumi; Nishimura, Mitsuhiro; Ideno, Shoji; Ono, Ken-ichiro; Okuno, Yoshinobu; Ikuta, Kazuyoshi			Induction of Anti-influenza Immunity by Modified Green Fluorescent Protein (GFP) Carrying Hemagglutinin-derived Epitope Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; H1N1 VIRUS; VACCINE; SEQUENCE; BETA	The development of vaccination methods that can overcome the emergence of new types of influenza strains caused by escape mutations is desirable to avoid future pandemics. Here, a novel type of immunogen was designed that targeted the conformation of a highly conserved region of influenza A virus hemagglutinin (HA) composed of two separate sequences that associate to form an anti-parallel beta-sheet structure. Our previous study identified this beta-sheet region as the structural core in the epitope of a characteristic antibody (B-1) that strongly neutralizes a wide variety of strains within the H3N2 serotype, and therefore this beta-sheet region was considered a good target to induce broadly reactive immunity against the influenza A virus. To design the immunogen, residues derived from the B-1 epitope were introduced directly onto a part of enhanced green fluorescent protein (EGFP), whose surface is mostly composed of beta-sheets. Through site-directed mutagenesis, several modified EGFPs with an epitope-mimicking structure embedded in their surface were prepared. Two EGFP variants, differing from wild-type (parental) EGFP by only five and nine residues, induced mice to produce antibodies that specifically bind to H3-type HA and neutralize H3N2 virus. Moreover, three of five mice immunized with each of these EGFP variants followed by a booster with equivalent mCherry variants acquired anti-viral immunity against challenge with H3N2 virus at a lethal dosage. In contrast to conventional methods, such as split HA vaccine, preparation of this type of immunogen requires less time and is therefore expected to be quickly responsive to newly emerged influenza viral strains.	[Inoue, Yuji; Kubota-Koketsu, Ritsuko; Nishimura, Mitsuhiro; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Res Ctr Infect Dis Control, Dept Virol, Suita, Osaka 5650871, Japan; [Yamashita, Akifumi] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Dept Genome Informat, Suita, Osaka 5650871, Japan; [Kubota-Koketsu, Ritsuko; Okuno, Yoshinobu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Kanonji, Kagawa 7680061, Japan; [Ideno, Shoji] Benesis Corp, Osaka Lab, Infect Pathogen Res Grp, Osaka 5328505, Japan; [Ono, Ken-ichiro] Med & Biol Labs Corp Ltd, Ina Lab, Ina, Nagano 3960002, Japan	Osaka University; Osaka University; Osaka University	Inoue, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Res Ctr Infect Dis Control, Dept Virol, Suita, Osaka 5650871, Japan.	uzinoue@biken.osaka-u.ac.jp			Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Tanabe Pharma Corp.; Benesis Corp.; Medical and Biological Laboratories Corp.; Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Tanabe Pharma Corp.; Benesis Corp.; Medical and Biological Laboratories Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by Mitsubishi Tanabe Pharma Corp., Benesis Corp., and Medical and Biological Laboratories Corp.	AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Amendola A, 2011, J Prev Med Hyg, V52, P107; Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Takahashi T, 2007, CHEMBIOCHEM, V8, P985, DOI 10.1002/cbic.200700108; Takahashi T, 2010, PROTEINS, V78, P336, DOI 10.1002/prot.22546; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Yamashita A, 2010, BIOCHEM BIOPH RES CO, V393, P614, DOI 10.1016/j.bbrc.2010.02.031	23	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4981	4990		10.1074/jbc.M112.420547	http://dx.doi.org/10.1074/jbc.M112.420547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264630	Green Published, hybrid			2022-12-25	WOS:000315340400045
J	Hawkins, AS; Han, YJ; Bennett, RK; Adams, MWW; Kelly, RM				Hawkins, Aaron S.; Han, Yejun; Bennett, Robert K.; Adams, Michael W. W.; Kelly, Robert M.			Role of 4-Hydroxybutyrate-CoA Synthetase in the CO2 Fixation Cycle in Thermoacidophilic Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOTROPHIC CARBON FIXATION; METALLOSPHAERA-SEDULA; 3-HYDROXYPROPIONATE CYCLE; CRYSTAL-STRUCTURE; ELEMENTAL SULFUR; ACETYL-COENZYME; SULFOLOBUS; OXIDATION; REDUCTASE; GENUS	Metallosphaera sedula is an extremely thermoacidophilic archaeon that grows heterotrophically on peptides and chemolithoautotrophically on hydrogen, sulfur, or reduced metals as energy sources. During autotrophic growth, carbon dioxide is incorporated into cellular carbon via the 3-hydroxypropionate/4-hydroxybutyrate cycle (3HP/4HB). To date, all of the steps in the pathway have been connected to enzymes encoded in specific genes, except for the one responsible for ligation of coenzyme A (CoA) to 4HB. Although several candidates for this step have been identified through bioinformatic analysis of the M. sedula genome, none have been shown to catalyze this biotransformation. In this report, transcriptomic analysis of cells grown under strict H-2-CO2 autotrophy was consistent with the involvement of Msed_0406 and Msed_0394. Recombinant versions of these enzymes catalyzed the ligation of CoA to 4HB, with similar affinities for 4HB (K-m values of 1.9 and 1.5 mM for Msed_0406 and Msed_0394, respectively) but with different rates (1.69 and 0.22 mu mol x min(-1) x mg(-1) for Msed_0406 and Msed_0394, respectively). Neither Msed_0406 nor Msed_0394 have close homologs in other Sulfolobales, although low sequence similarity is not unusual for acyl-adenylate-forming enzymes. The capacity of these two enzymes to use 4HB as a substrate may have arisen from simple modifications to acyl-adenylate-forming enzymes. For example, a single amino acid substitution (W424G) in the active site of the acetate/propionate synthetase (Msed_1353), an enzyme that is highly conserved among the Sulfolobales, changed its substrate specificity to include 4HB. The identification of the 4-HB CoA synthetase now completes the set of enzymes comprising the 3HP/4HB cycle.	[Hawkins, Aaron S.; Han, Yejun; Bennett, Robert K.; Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia	Kelly, RM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, 911 Partners Way,EB-1,Box 7905, Raleigh, NC 27695 USA.	rmkelly@ncsu.edu	Han, Yejun/AAC-7411-2019	Kelly, Robert/0000-0002-0639-3592; Adams, Michael/0000-0002-9796-5014	National Institutes of Health [R01GM90209]; Department of Energy Advanced Research Project Agency-Energy Grant [DE-AR0000081]; Department of Energy Advanced Research Project Defense Threat Reduction Agency Grant [HDTRA1-09-1-0030]; United States Department of Education [P200A070582-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Advanced Research Project Agency-Energy Grant; Department of Energy Advanced Research Project Defense Threat Reduction Agency Grant; United States Department of Education(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM90209. This work was also supported by Department of Energy Advanced Research Projects Agency-Energy Grant DE-AR0000081 and Defense Threat Reduction Agency Grant HDTRA1-09-1-0030.; Supported by Graduate Assistance in Areas on National Need Molecular Biotechnology Fellowship P200A070582-09 from the United States Department of Education.	Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; Auernik KS, 2010, APPL ENVIRON MICROB, V76, P931, DOI 10.1128/AEM.01336-09; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Brasen C, 2005, EXTREMOPHILES, V9, P355, DOI 10.1007/s00792-005-0449-0; Brasen C, 2005, FEBS LETT, V579, P477, DOI 10.1016/j.febslet.2004.12.016; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Estelmann S, 2011, J BACTERIOL, V193, P1191, DOI 10.1128/JB.01155-10; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Han YJ, 2012, APPL ENVIRON MICROB, V78, P6194, DOI 10.1128/AEM.01312-12; Hawkins AS, 2011, ACS CATAL, V1, P1043, DOI 10.1021/cs2003017; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ingram-Smith C, 2006, BIOCHEMISTRY-US, V45, P11482, DOI 10.1021/bi061023e; Ingram-Smith Cheryl, 2007, Archaea, V2, P95; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Kockelkorn D, 2009, J BACTERIOL, V191, P6352, DOI 10.1128/JB.00794-09; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; SHIVVERS DW, 1973, J BACTERIOL, V114, P706, DOI 10.1128/JB.114.2.706-710.1973; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003	43	20	23	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4012	4022		10.1074/jbc.M112.413195	http://dx.doi.org/10.1074/jbc.M112.413195			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258541	Green Published, hybrid			2022-12-25	WOS:000314845000030
J	Liberton, M; Page, LE; O'Dell, WB; O'Neill, H; Mamontov, E; Urban, VS; Pakrasi, HB				Liberton, Michelle; Page, Lawrence E.; O'Dell, William B.; O'Neill, Hugh; Mamontov, Eugene; Urban, Volker S.; Pakrasi, Himadri B.			Organization and Flexibility of Cyanobacterial Thylakoid Membranes Examined by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS; MUTANTS	Cyanobacteria are prokaryotes that can use photosynthesis to convert sunlight into cellular fuel. Knowledge of the organization of the membrane systems in cyanobacteria is critical to understanding the metabolic processes in these organisms. We examined the wild-type strain of Synechocystis sp. PCC6803 and a series of mutants with altered light-harvesting phycobilisome antenna systems for changes in thylakoid membrane architecture under different conditions. Using small-angle neutron scattering, it was possible to resolve correlation distances of subcellular structures in live cells on the nanometer scale and capture dynamic light-induced changes to these distances. Measurements made from samples with varied scattering contrasts confirmed that these distances could be attributed to the thylakoid lamellar system. We found that the changes to the thylakoid system were reversible between light-and dark-adapted states, demonstrating a robust structural flexibility in the architecture of cyanobacterial cells. Chemical disruption of photosynthetic electron transfer diminished these changes, confirming the involvement of the photosynthetic apparatus. We have correlated these findings with electron microscopy data to understand the origin of the changes in the membranes and found that light induces an expansion in the center-to-center distances between the thylakoid membrane layers. These combined data lend a dynamic dimension to the intracellular organization in cyanobacterial cells.	[Liberton, Michelle; Page, Lawrence E.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [O'Dell, William B.; O'Neill, Hugh; Urban, Volker S.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Mamontov, Eugene] Oak Ridge Natl Lab, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA	Washington University (WUSTL); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu	O'Dell, William B/R-2753-2017; Urban, Volker S/N-5361-2015; Mamontov, Eugene/Q-1003-2015	O'Dell, William B/0000-0002-8063-5190; Urban, Volker S/0000-0002-7962-3408; Mamontov, Eugene/0000-0002-5684-2675; O'Neill, Hugh/0000-0003-2966-5527	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project [ERKP291]; United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project(United States Department of Energy (DOE)); United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Ghada Ajlani for the kind gift of the phycobilisome mutant strains used in this study. We thank all members of the Pakrasi laboratory for helpful discussions and Howard Berg (Donald Danforth Plant Science Center Integrated Microscopy Facility) for TEM assistance. We thank Sai Venkatesh Pingali for implementing software used for SANS data analysis. This material is based upon work supported as part of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-SC 0001035. The Bio-SANS instrument used in these studies is a resource of the Center for Structural Molecular Biology at Oak Ridge National Laboratory, which is supported by United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project ERKP291. Bio-SANS is located at the Oak Ridge National Laboratory High Flux Isotope Reactor, and the BASIS instrument is located at the Spallation Neutron Source. Both neutron sources are sponsored by the United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences.	Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Kirchhoff H, 2011, P NATL ACAD SCI USA, V108, P20248, DOI 10.1073/pnas.1104141109; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P11; Liberton M., 2008, CYANOBACTERIA MOL BI, P217; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Mamontov E, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626214; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; MURAKAMI S, 1970, PLANT PHYSIOL, V45, P289, DOI 10.1104/pp.45.3.289; Murugova T.N., 2011, NEUTRON NEWS, V22, P11, DOI [10.1080/10448632.2011.598800, DOI 10.1080/10448632.2011.598800]; Nagy G, 2012, PHOTOSYNTH RES, V111, P71, DOI 10.1007/s11120-011-9693-6; Nagy G, 2011, BIOCHEM J, V436, P225, DOI 10.1042/BJ20110180; Nevo R, 2009, ADV PHOTOSYNTH RESP, V30, P295; Olive J, 1997, BBA-BIOENERGETICS, V1319, P275, DOI 10.1016/S0005-2728(96)00168-5; SADLER DM, 1982, J MOL BIOL, V159, P467, DOI 10.1016/0022-2836(82)90295-9; Tang KH, 2012, PHOTOSYNTH RES, V111, P205, DOI 10.1007/s11120-011-9665-x; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van de Meene AMT, 2012, BBA-BIOMEMBRANES, V1818, P1427, DOI 10.1016/j.bbamem.2012.01.019; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y	24	75	76	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3632	3640		10.1074/jbc.M112.416933	http://dx.doi.org/10.1074/jbc.M112.416933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255600	hybrid, Green Published			2022-12-25	WOS:000314397900067
J	Alex, A; Vasconcelos, V; Tamagnini, P; Santos, A; Antunes, A				Alex, Anoop; Vasconcelos, Vitor; Tamagnini, Paula; Santos, Arlete; Antunes, Agostinho			Unusual Symbiotic Cyanobacteria Association in the Genetically Diverse Intertidal Marine Sponge Hymeniacidon perlevis (Demospongiae, Halichondrida)	PLOS ONE			English	Article							OSCILLATORIA-SPONGELIAE; NITROGEN-FIXATION; PHYLOGENETIC DIVERSITY; MOLECULAR EVIDENCE; MTDNA SEQUENCES; REEF; ACTINOBACTERIA; COMMUNITIES; EVOLUTION; ECOLOGY	Cyanobacteria represent one of the most common members of the sponge-associated bacterial community and are abundant symbionts of coral reef ecosystems. In this study we used Transmission Electron Microscopy (TEM) and molecular techniques (16S rRNA gene marker) to characterize the spatial distribution of cyanobionts in the widely dispersed marine intertidal sponge Hymeniacidon perlevis along the coast of Portugal (Atlantic Ocean). We described new sponge associated cyanobacterial morphotypes (Xenococcus-like) and we further observed Acaryochloris sp. as a sponge symbiont, previously only reported in association with ascidians. Besides these two unique cyanobacteria, H. perlevis predominantly harbored Synechococcus sp. and uncultured marine cyanobacteria. Our study supports the hypothesis that the community of sponge cyanobionts varies irrespective of the geographical location and is likely influenced by seasonal fluctuations. The observed multiple cyanobacterial association among sponges of the same host species over a large distance may be attributed to horizontal transfer of symbionts. This may explain the absence of a co-evolutionary pattern between the sponge host and its symbionts. Finally, in spite of the short geographic sampling distance covered, we observed an unexpected high intra-specific genetic diversity in H. perlevis using the mitochondrial genes ATP6 (pi = 0.00177), COI (pi = 0.00241) and intergenic spacer SP1 (pi = 0.00277) relative to the levels of genetic variation of marine sponges elsewhere. Our study suggests that genotypic variation among the sponge host H. perlevis and the associated symbiotic cyanobacteria diversity may be larger than previously recognized. Citation: Alex A, Vasconcelos V, Tamagnini P, Santos A, Antunes A (2012) Unusual Symbiotic Cyanobacteria Association in the Genetically Diverse Intertidal Marine Sponge Hymeniacidon perlevis (Demospongiae, Halichondrida). PLoS ONE 7(12): e51834. doi:10.1371/journal.pone.0051834	[Alex, Anoop; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Alex, Anoop; Vasconcelos, Vitor; Tamagnini, Paula; Santos, Arlete; Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Tamagnini, Paula; Santos, Arlete] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Tamagnini, Paula/AGF-3206-2022; Tamagnini, Paula/A-6613-2010; Vasconcelos, Vitor/A-8933-2008	Tamagnini, Paula/0000-0003-4396-2122; Tamagnini, Paula/0000-0003-4396-2122; Vasconcelos, Vitor/0000-0003-3585-2417; Alex, Anoop/0000-0001-5788-1089; Antunes, Agostinho/0000-0002-1328-1732; Santos Pinto, Arlete/0000-0001-5235-9160	FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BD/62356/2009, PTDC/MAR/099642/2008, PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029)]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	This research was supported by FCT (Fundacao para a Ciencia e a Tecnologia) grant SFRH/BD/62356/2009 conferred to Anoop Alex and in part by the FCT project PTDC/MAR/099642/2008 and PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers R.G., 1992, SPONGES BRIT ISLES S; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERTHOLD RJ, 1982, PHYCOLOGIA, V21, P327, DOI 10.2216/i0031-8884-21-3-327.1; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; Cabioch L, 1968, CAHIERS BIOL MARINE; Carballo JL, 2004, MAR ECOL PROG SER, V279, P93, DOI 10.3354/meps279093; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheshire AC, 1997, MAR FRESHWATER RES, V48, P589, DOI 10.1071/MF96070; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Diaz Maria Cristina, 1997, P1399; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026806; Feldmann J, 1935, ARCH ZOOLOGIE EXPT G, V75, P381; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Fromont J., 1999, Memoirs of the Queensland Museum, V44, P185; Gaino Elda, 2010, Open Marine Biology Journal, V4, P47, DOI 10.2174/1874450801004010047; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; GOLDMORGAN M, 1994, ARCH PROTISTENKD, V144, P383, DOI 10.1016/S0003-9365(11)80241-1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoshino S, 2008, HYDROBIOLOGIA, V603, P313, DOI 10.1007/s10750-008-9295-2; Jin Yan, 2006, Weishengwu Xuebao, V46, P875; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Lambert G, 1996, INVERTEBR BIOL, V115, P67, DOI 10.2307/3226942; LARKUM AWD, 1988, MAR BIOL, V98, P143, DOI 10.1007/BF00392669; Larkum L, 1999, B I OCEANOGRAPH MONA, P149; Lee YK, 2001, J MICROBIOL, V39, P254; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Legentil S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023938; Maldonado M, 1996, MAR ECOL PROG SER, V138, P169, DOI 10.3354/meps138169; Maldonado M, 1998, LIMITS BATHYMETRIC D; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; Ohkubo S, 2006, APPL ENVIRON MICROB, V72, P7912, DOI 10.1128/AEM.01148-06; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; PROTEAU PJ, 1993, EXPERIENTIA, V49, P825, DOI 10.1007/BF01923559; Read DJ, 2000, PHILOS T R SOC B, V355, P815, DOI 10.1098/rstb.2000.0617; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; Ridley CP, 2005, APPL ENVIRON MICROB, V71, P7366, DOI 10.1128/AEM.71.11.7366-7375.2005; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sara M, 1998, SYMBIOSIS, V25, P57; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Seabra R, 2009, FEMS MICROBIOL LETT, V292, P57, DOI 10.1111/j.1574-6968.2008.01471.x; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Stone AR, 2009, J ZOOL, V161, P443, DOI [10.1111/j.1469-7998.1970.tb02048.x, DOI 10.1111/J.1469-7998.1970.TB02048.X]; TAJIMA F, 1983, GENETICS, V105, P437; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Usher KM, 2008, MAR ECOL-EVOL PERSP, V29, P178, DOI 10.1111/j.1439-0485.2008.00245.x; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; WILKINSON CR, 1987, SYMBIOSIS, V4, P135; WILKINSON CR, 1984, PROC R SOC SER B-BIO, V220, P509, DOI 10.1098/rspb.1984.0017; WILKINSON CR, 1978, MAR BIOL, V49, P161, DOI 10.1007/BF00387115; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wilmotte A, 2004, MOL BIOL CYANOBACTER, V1, P1, DOI DOI 10.1007/0-306-48205-3_1; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xin YJ, 2008, ANTON LEEUW INT J G, V94, P533, DOI 10.1007/s10482-008-9270-y; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	79	28	29	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51834	10.1371/journal.pone.0051834	http://dx.doi.org/10.1371/journal.pone.0051834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251637	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800094
J	Andresen, V; Pollok, K; Rinnenthal, JL; Oehme, L; Gunther, R; Spiecker, H; Radbruch, H; Gerhard, J; Sporbert, A; Cseresnyes, Z; Hauser, AE; Niesner, R				Andresen, Volker; Pollok, Karolin; Rinnenthal, Jan-Leo; Oehme, Laura; Guenther, Robert; Spiecker, Heinrich; Radbruch, Helena; Gerhard, Jenny; Sporbert, Anje; Cseresnyes, Zoltan; Hauser, Anja E.; Niesner, Raluca			High-Resolution Intravital Microscopy	PLOS ONE			English	Article							2-PHOTON MICROSCOPY; DEEP TISSUE; CELLS; SINGLE; NANOSCOPY; SYSTEM; LIVE	Cellular communication constitutes a fundamental mechanism of life, for instance by permitting transfer of information through synapses in the nervous system and by leading to activation of cells during the course of immune responses. Monitoring cell-cell interactions within living adult organisms is crucial in order to draw conclusions on their behavior with respect to the fate of cells, tissues and organs. Until now, there is no technology available that enables dynamic imaging deep within the tissue of living adult organisms at sub-cellular resolution, i.e. detection at the level of few protein molecules. Here we present a novel approach called multi-beam striped- illumination which applies for the first time the principle and advantages of structured-illumination, spatial modulation of the excitation pattern, to laser-scanning-microscopy. We use this approach in two-photon-microscopy - the most adequate optical deep-tissue imaging-technique. As compared to standard two-photon-microscopy, it achieves significant contrast enhancement and up to 3-fold improved axial resolution (optical sectioning) while photobleaching, photodamage and acquisition speed are similar. Its imaging depth is comparable to multifocal two-photon-microscopy and only slightly less than in standard single-beam two-photon-microscopy. Precisely, our studies within mouse lymph nodes demonstrated 216% improved axial and 23% improved lateral resolutions at a depth of 80 mm below the surface. Thus, we are for the first time able to visualize the dynamic interactions between B cells and immune complex deposits on follicular dendritic cells within germinal centers (GCs) of live mice. These interactions play a decisive role in the process of clonal selection, leading to affinity maturation of the humoral immune response. This novel high-resolution intravital microscopy method has a huge potential for numerous applications in neurosciences, immunology, cancer research and developmental biology. Moreover, our striped- illumination approach is able to improve the resolution of any laser-scanning-microscope, including confocal microscopes, by simply choosing an appropriate detector. Citation: Andresen V, Pollok K, Rinnenthal J-L, Oehme L, Gunther R, et al. (2012) High-Resolution Intravital Microscopy. PLoS ONE 7(12): e50915. doi:10.1371/journal.pone. 0050915	[Pollok, Karolin; Rinnenthal, Jan-Leo; Oehme, Laura; Guenther, Robert; Radbruch, Helena; Gerhard, Jenny; Hauser, Anja E.; Niesner, Raluca] German Rheumatism Res Ctr, Berlin, Germany; [Andresen, Volker; Spiecker, Heinrich] LaVis Biotec GmbH, Bielefeld, Germany; [Pollok, Karolin; Rinnenthal, Jan-Leo; Radbruch, Helena; Gerhard, Jenny; Niesner, Raluca] Charite, D-13353 Berlin, Germany; [Sporbert, Anje; Cseresnyes, Zoltan] Max Delbruck Ctr Mol Med, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Niesner, R (corresponding author), German Rheumatism Res Ctr, Berlin, Germany.	niesner@drfz.de	Cseresnyes, Zoltan/AAG-4266-2020	Andresen, Volker/0000-0002-8960-6599; Cseresnyes, Zoltan/0000-0002-6574-2588; Hauser, Anja Erika/0000-0002-7725-9526; Radbruch, Helena/0000-0001-6941-3397	Deutsche Forschungs-gemeinschaft [NI1167/2-1, HA5354/4-1, SFB633, A15]; Charite under grant Rahel-Hirsch Fellowship; MAMOCELL EU FP6	Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG)); Charite under grant Rahel-Hirsch Fellowship; MAMOCELL EU FP6	The authors acknowledge the Deutsche Forschungs-gemeinschaft under grant NI1167/2-1 (to RN), HA5354/4-1 and SFB633, project A15 (to AEH), the Charite under grant Rahel-Hirsch Fellowship (to RN) and MAMOCELL EU FP6 (to AEH) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie SG, 2012, P NATL ACAD SCI USA, V109, P7175, DOI 10.1073/pnas.1121193109; Andresen V, 2001, OPT LETT, V26, P75, DOI 10.1364/OL.26.000075; [Anonymous], [No title captured]; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; de Gauw CJ, 1999, APPL OPTICS, V38, P5995; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Eisenhoffer GT, 2011, J VIS EXP, V2689; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hell SW, 2009, NATURE, V461, P1069, DOI 10.1038/4611069a; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herz J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-131; Herz J, 2010, BIOPHYS J, V98, P715, DOI 10.1016/j.bpj.2009.10.035; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Lu J, 2009, NANO LETT, V9, P3883, DOI 10.1021/nl902087d; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; Niesner RA, 2011, CYTOM PART A, V79A, P789, DOI 10.1002/cyto.a.21140; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Tang JY, 2012, P NATL ACAD SCI USA, V109, P8434, DOI 10.1073/pnas.1119590109; Wang E, 2005, J MICROSC-OXFORD, V218, P148, DOI 10.1111/j.1365-2818.2005.01473.x; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	41	28	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50915	10.1371/journal.pone.0050915	http://dx.doi.org/10.1371/journal.pone.0050915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251402	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312386800021
J	Kador, PF; Zhang, P; Makita, J; Zhang, ZF; Guo, CM; Randazzo, J; Kawada, H; Haider, N; Blessing, K				Kador, Peter F.; Zhang, Peng; Makita, Jun; Zhang, Zifeng; Guo, Changmei; Randazzo, James; Kawada, Hiroyoshi; Haider, Neena; Blessing, Karen			Novel Diabetic Mouse Models as Tools for Investigating Diabetic Retinopathy	PLOS ONE			English	Article							GALACTOSE-FED DOGS; ALDOSE REDUCTASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; RETINAL VESSEL CHANGES; PIGMENT EPITHELIAL-CELLS; CAPILLARY PERICYTES; AQUEOUS-HUMOR; BARRIER BREAKDOWN; VASCULAR PATTERNS; POLYOL FORMATION	Objective: Mouse models possessing green fluorescent protein (GFP) and/or human aldose reductase (hAR) in vascular tissues have been established and crossed with naturally diabetic Akita mice to produce new diabetic mouse models. Research Design and Methods: Colonies of transgenic C57BL mice expressing GFP (SMAA-GFP), hAR (SMAA-hAR) or both (SMAA-GFP-hAR) in vascular tissues expressing smooth muscle actin were established and crossbred with C57BL/6-Ins2(Akita)/J (AK) mice to produce naturally diabetic offspring AK-SMAA-GFP and AK-SMAA-GFP-hAR. Aldose reductase inhibitor AL1576 (ARI) was administered in chow. Retinal and lenticular sorbitol levels were determined by HPLC. Retinal functions were evaluated by electroretinography (ERGs). Growth factor and signaling changes were determined by Western Blots using commercially available antibodies. Retinal vasculatures were isolated from the neural retina by enzymatic digestion. Flat mounts were stained with PAS-hematoxylin and analyzed. Results: Akita transgenics developed DM by 8 weeks of age with blood glucose levels higher in males than females. Sorbitol levels were higher in neural retinas of AK-SMAA-GFP-hAR compared to AK-SMAA-GFP mice. AK-SMAA-GFP-hAR mice also had higher VEGF levels and reduced ERG scotopic b-wave function, both of which were normalized by AL1576. AK-SMAA-GFP-hAR mice showed induction of the retinal growth factors bFGF, IGF-1, and TGF beta, as well as signaling changes in P-Akt, P-SAPK/JNK and P-44/42 MAPK that were also reduced by ARI treatment. Quantitative analysis of flat mounts in 18 week AK-SMAA-GFP-hAR mice revealed increased loss of nuclei/capillary length and a significant increase in the percentage of acellular capillaries present which was not seen in AK-SMAA-GFP-hAR treated with ARI. Conclusions/Significance: These new mouse models of early onset diabetes may be valuable tools for assessing both the role of hyperglycemia and AR in the development of retinal lesions associated with diabetic retinopathy.	[Kador, Peter F.; Zhang, Peng; Makita, Jun; Zhang, Zifeng; Guo, Changmei; Randazzo, James; Kawada, Hiroyoshi; Blessing, Karen] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA; [Kador, Peter F.; Haider, Neena] Univ Nebraska Med Ctr, Coll Med, Dept Ophthalmol, Omaha, NE USA; [Haider, Neena] Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kador, PF (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA.	pkador@unmc.edu			National Institutes of Health [EY016730]; NATIONAL EYE INSTITUTE [R01EY016730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY016730. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI Y, 1986, CURR EYE RES, V5, P883, DOI 10.3109/02713688609029241; AKAGI Y, 1984, DIABETES, V33, P562, DOI 10.2337/diabetes.33.6.562; AKAGI Y, 1983, INVEST OPHTH VIS SCI, V24, P1516; Amano S, 2002, BIOCHEM BIOPH RES CO, V299, P183, DOI 10.1016/S0006-291X(02)02584-6; ANTONELLIORLIDGE A, 1989, AM REV RESPIR DIS, V140, P1129, DOI 10.1164/ajrccm/140.4.1129; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Beck SC, 2010, INVEST OPHTH VIS SCI, V51, P493, DOI 10.1167/iovs.09-4003; Betsholtz C, 2005, EXP SUPPL, V94, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J, 2002, EYE, V16, P242, DOI 10.1038/sj.eye.6700133; CHAN LS, 1986, EXP EYE RES, V43, P41, DOI 10.1016/S0014-4835(86)80044-6; Chen Y, 2009, OCUL SURF, V7, P176, DOI 10.1016/S1542-0124(12)70185-4; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; CUTHBERTSON RA, 1987, TRANSPLANT P, V19, P2919; CUTHBERTSON RA, 1986, INVEST OPHTH VIS SCI, V27, P1659; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Dreixler JC, 2011, EXP EYE RES, V93, P340, DOI 10.1016/j.exer.2010.10.011; DRENCKHAHN D, 1977, CELL TISSUE RES, V181, P493; Frank RN, 1997, ARCH OPHTHALMOL-CHIC, V115, P1036, DOI 10.1001/archopht.1997.01100160206011; FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519; Henry DN, 2000, INVEST OPHTH VIS SCI, V41, P1554; Hickman F., 2002, INVEST OPHTH VIS SCI, V43, P742; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; HOTTA N, 1995, EXP PHYSIOL, V80, P981, DOI 10.1113/expphysiol.1995.sp003909; Hotta N, 1995, EUR J CLIN INVEST, V25, P948, DOI 10.1111/j.1365-2362.1995.tb01972.x; Iyengar L, 2006, EXP EYE RES, V83, P667, DOI 10.1016/j.exer.2006.03.008; Joussen AM, 2009, MOL VIS, V15, P1418; Kador PF, 2009, J OCUL PHARMACOL TH, V25, P299, DOI 10.1089/jop.2008.0070; KADOR PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1099, DOI 10.1001/archopht.1988.01060140255036; KADOR PF, 1990, ARCH OPHTHALMOL-CHIC, V108, P1301, DOI 10.1001/archopht.1990.01070110117035; Kador PF, 2002, INVEST OPHTH VIS SCI, V43, P1916; KADOR PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P352, DOI 10.1001/archopht.1995.01100030108031; Kivela T, 1998, PROG RETIN EYE RES, V17, P385, DOI 10.1016/S1350-9462(98)00001-9; KUWABARA T, 1961, ARCH OPHTHALMOL-CHIC, V65, P708, DOI 10.1001/archopht.1961.01840020710019; Mochizuki M, 2000, CORNEA, V19, pS24, DOI 10.1097/00003226-200005001-00006; Murata M, 2002, J DIABETES COMPLICAT, V16, P363, DOI 10.1016/S1056-8727(01)00171-4; Neuenschwander H, 1997, J OCUL PHARMACOL TH, V13, P517, DOI 10.1089/jop.1997.13.517; Nystuen AM, 2008, MAMM GENOME, V19, P623, DOI 10.1007/s00335-008-9138-5; Obrosova IG, 2006, DIABETOLOGIA, V49, P2525, DOI 10.1007/s00125-006-0356-7; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; ROBINSON WG, 1991, CURR EYE RES, V10, P339, DOI 10.3109/02713689108996340; ROBISON WG, 1983, SCIENCE, V221, P1177, DOI 10.1126/science.6612330; Robison WG, 1995, ROLE ALDOSE REDUCTAS, P593; Robison WG, 2000, GALACTOSEMIC ANIMAL, P273; Sato S, 1999, INVEST OPHTH VIS SCI, V40, P697; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; Sun W, 2006, DIABETES, V55, P2757, DOI 10.2337/db06-0138; TAKAHASHI Y, 1993, J OCUL PHARMACOL, V9, P257, DOI 10.1089/jop.1993.9.257; TAKAHASHI Y, 1992, ARCH OPHTHALMOL-CHIC, V110, P1295, DOI 10.1001/archopht.1992.01080210113037; TILTON RG, 1986, INVEST OPHTH VIS SCI, V27, P716; TILTON RG, 1985, INVEST OPHTH VIS SCI, V26, P68; Tsai J, 2002, INVEST OPHTH VIS SCI, V43, P192; Tsai J-Y, 2001, INVEST OPHTH VIS SCI, V42, P2001; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; VINORES SA, 1993, EXP EYE RES, V57, P723, DOI 10.1006/exer.1993.1180; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Welge-Lussen U, 2001, CURR OPIN OPHTHALMOL, V12, P94, DOI 10.1097/00055735-200104000-00003; WILSON GL, 1990, CURR TOP MICROBIOL, V156, P27; YAMAOKA T, 1995, DIABETOLOGIA, V38, P255, DOI 10.1007/s001250050278; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	69	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49422	10.1371/journal.pone.0049422	http://dx.doi.org/10.1371/journal.pone.0049422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251343	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200016
J	Pace, E; Di Sano, C; La Grutta, S; Ferraro, M; Albeggiani, G; Liotta, G; Di Vincenzo, S; Uasuf, CG; Bousquet, J; Gjomarkaj, M				Pace, Elisabetta; Di Sano, Caterina; La Grutta, Stefania; Ferraro, Maria; Albeggiani, Giuseppe; Liotta, Giuseppe; Di Vincenzo, Serena; Uasuf, Carina Gabriela; Bousquet, Jean; Gjomarkaj, Mark			Multiple In Vitro and In Vivo Regulatory Effects of Budesonide in CD4+T Lymphocyte Subpopulations of Allergic Asthmatics	PLOS ONE			English	Article							T-CELLS; GLUCOCORTICOID ACTION; APOPTOSIS; ICOS; EXPRESSION; EOSINOPHILS; GENERATION; RESISTANCE; INDUCTION; TOLERANCE	Background: Increased activation and increased survival of T lymphocytes characterise bronchial asthma. Objectives: In this study the effect of budesonide on T cell survival, on inducible co-stimulator T cells (ICOS), on Foxp3 and on IL-10 molecules in T lymphocyte sub-populations was assessed. Methods: Cell survival (by annexin V binding) and ICOS in total lymphocytes, in CD4+/CD25+ and in CD4+/CD25-and Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25-cells was evaluated, by cytofluorimetric analysis, in mild intermittent asthmatics (n = 19) and in controls (n = 15). Allergen induced T lymphocyte proliferation and the in vivo effects of budesonide in mild persistent asthmatics (n = 6) were also explored. Results: Foxp3 was reduced in CD4+/CD25- and in CD4+/CD25+ cells and ICOS was reduced in CD4+/CD25+ cells but it was increased in CD4+ CD25-in asthmatics when compared to controls. In asthmatics, in vitro, budesonide was able to: 1) increase annexin V binding and to reduce ICOS in total lymphocytes; 2) increase annexin V binding and Foxp3 and to reduce ICOS in CD4+/CD25-cells; 3) reduce annexin V binding and to increase IL-10 and ICOS in CD4+/CD25+ cells; 4) reduce cell allergen induced proliferation. In vivo, budesonide increased ICOS in CD4+/CD25+ while it increased Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25- cells. Conclusions: Budesonide modulates T cell survival, ICOS, Foxp3 and IL-10 molecules differently in T lymphocyte sub-populations. The findings provided shed light on new mechanisms by which corticosteroids, drugs widely used for the clinical management of bronchial asthma, control T lymphocyte activation.	[Pace, Elisabetta; Di Sano, Caterina; La Grutta, Stefania; Ferraro, Maria; Albeggiani, Giuseppe; Liotta, Giuseppe; Di Vincenzo, Serena; Uasuf, Carina Gabriela; Gjomarkaj, Mark] CNR, Ist Biomed & Immunol Mol, Unita Immunopatol & Farmacol Clin & Sperimentale, Palermo, Italy; [La Grutta, Stefania] ARPA, Palermo, Italy; [Bousquet, Jean] Univ Hosp, Montpellier, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Regional Environmental Protection Agency - Italy; Universite de Montpellier; CHU de Montpellier	Pace, E (corresponding author), CNR, Ist Biomed & Immunol Mol, Unita Immunopatol & Farmacol Clin & Sperimentale, Palermo, Italy.	pace@ibim.cnr.it	DI SANO, CATERINA/AAX-7536-2020; Bousquet, Jean/O-4221-2019; Ferraro, Maria/AAX-8156-2020; Uasuf, Carina Gabriela/AAG-9329-2019; La Grutta, Stefania/N-3615-2014; Pace, Elisabetta/AAL-2537-2020; Di Vincenzo, Serena/Q-7852-2019; Di Vincenzo, Serena/K-3330-2018	Uasuf, Carina Gabriela/0000-0003-4158-8333; La Grutta, Stefania/0000-0001-8026-0715; Pace, Elisabetta/0000-0003-1141-9010; Di Vincenzo, Serena/0000-0003-1695-9307; FERRARO, MARIA/0000-0003-2533-7446; DI SANO, CATERINA/0000-0003-3904-3465	Italian National Research Council; Italchimici	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Italchimici	This work was funded by the Italian National Research Council and by Italchimici. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bentley AM, 1996, AM J RESP CRIT CARE, V153, P551, DOI 10.1164/ajrccm.153.2.8564096; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chen YQ, 2006, ALLERGY, V61, P15, DOI 10.1111/j.1398-9995.2006.01008.x; Deng JM, 2005, CLIN IMMUNOL, V115, P178, DOI 10.1016/j.clim.2005.01.002; Duperrier K, 2005, MOL IMMUNOL, V42, P1531, DOI 10.1016/j.molimm.2005.01.006; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Gregori S, 2009, HUM IMMUNOL, V70, P966, DOI 10.1016/j.humimm.2009.07.022; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Ho CY, 2002, CHEST, V122, P1751, DOI 10.1378/chest.122.5.1751; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Ma JX, 2011, J ALLERGY CLIN IMMUN, V127, P1447, DOI 10.1016/j.jaci.2011.01.032; Mayer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029355; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Melis M, 2002, EUR RESPIR J, V19, P257, DOI 10.1183/09031936.02.00239202; Oneda K, 1999, Arerugi, V48, P13; Pace E, 2004, J ALLERGY CLIN IMMUN, V114, P1216, DOI 10.1016/j.jaci.2004.07.052; Pace E, 2010, ALLERGY, V65, P1495, DOI 10.1111/j.1398-9995.2010.02403.x; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Pochard P, 2010, J ALLERGY CLIN IMMUN, V126, P92, DOI 10.1016/j.jaci.2010.04.003; Prado C, 2011, IMMUNOBIOLOGY, V216, P386, DOI 10.1016/j.imbio.2010.06.013; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Taylor A, 2007, J ALLERGY CLIN IMMUN, V120, P76, DOI 10.1016/j.jaci.2007.04.004; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhan YF, 2008, J IMMUNOL, V181, P5405, DOI 10.4049/jimmunol.181.8.5405	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48816	10.1371/journal.pone.0048816	http://dx.doi.org/10.1371/journal.pone.0048816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251336	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200010
J	Ramsey, JM; Schwarz, E; Guest, PC; van Beveren, NJM; Leweke, FM; Rothermundt, M; Bogerts, B; Steiner, J; Ruta, L; Baron-Cohen, S; Bahn, S				Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; van Beveren, Nico J. M.; Leweke, F. Markus; Rothermundt, Matthias; Bogerts, Bernhard; Steiner, Johann; Ruta, Liliana; Baron-Cohen, Simon; Bahn, Sabine			Molecular Sex Differences in Human Serum	PLOS ONE			English	Article							GENDER-DIFFERENCES; DIMORPHISM; INFLAMMATION; TESTOSTERONE; ADIPONECTIN; SENSITIVITY; MECHANISMS; BIOMARKERS; STRESS; RISK	Background: Sex is an important factor in the prevalence, incidence, progression, and response to treatment of many medical conditions, including autoimmune and cardiovascular diseases and psychiatric conditions. Identification of molecular differences between typical males and females can provide a valuable basis for exploring conditions differentially affected by sex. Methodology/Principal Findings: Using multiplexed immunoassays, we analyzed 174 serum molecules in 9 independent cohorts of typical individuals, comprising 196 males and 196 females. Sex differences in analyte levels were quantified using a meta-analysis approach and put into biological context using k-means to generate clusters of analytes with distinct biological functions. Natural sex differences were established in these analyte groups and these were applied to illustrate sexually dimorphic analyte expression in a cohort of 22 males and 22 females with Asperger syndrome. Reproducible sex differences were found in the levels of 77 analytes in serum of typical controls, and these comprised clusters of molecules enriched with distinct biological functions. Analytes involved in fatty acid oxidation/hormone regulation, immune cell growth and activation, and cell death were found at higher levels in females, and analytes involved in immune cell chemotaxis and other indistinct functions were higher in males. Comparison of these naturally occurring sex differences against a cohort of people with Asperger syndrome indicated that a cluster of analytes that had functions related to fatty acid oxidation/hormone regulation was associated with sex and the occurrence of this condition. Conclusions/Significance: Sex-specific molecular differences were detected in serum of typical controls and these were reproducible across independent cohorts. This study extends current knowledge of sex differences in biological functions involved in metabolism and immune function. Deviations from typical sex differences were found in a cluster of molecules in Asperger syndrome. These findings illustrate the importance of investigating the influence of sex on medical conditions.	[Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [Leweke, F. Markus] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Leweke, F. Markus] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany; [Rothermundt, Matthias] Univ Munster, Dept Psychiat, Munster, Germany; [Bogerts, Bernhard; Steiner, Johann] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; [Ruta, Liliana; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Bahn, Sabine] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; University of Cologne; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munster; Otto von Guericke University; University of Cambridge; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Leweke, F. Markus/D-5435-2009; Ruta, Liliana/B-2440-2012; Ruta, Liliana/AGF-5918-2022; Leweke, Markus/GVS-7897-2022	Leweke, F. Markus/0000-0002-8163-195X; Ruta, Liliana/0000-0003-4615-7495; guest, paul/0000-0002-5030-7137; Steiner, Johann/0000-0002-2611-2268; Baron-Cohen, Simon/0000-0001-9217-2544	Psynova Neurotech Inc; European Union FP7 SchizDX research programme [223427]; Dutch Fund for Economic Structure Reinforcement (FES) [0908]; AutismSpeaks grant [6009]; MRC; Wellcome Trust; Edmonton Churchill Scholarship (Canada); Natural Sciences and Engineering Research Council of Canada (NSERC); Cambridge Commonwealth Trust; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	Psynova Neurotech Inc; European Union FP7 SchizDX research programme; Dutch Fund for Economic Structure Reinforcement (FES); AutismSpeaks grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Edmonton Churchill Scholarship (Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cambridge Commonwealth Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Psynova Neurotech Inc; the European Union FP7 SchizDX research programme (grant reference 223427); the Dutch Fund for Economic Structure Reinforcement (FES) under grant agreement number 0908 (the "NeuroBasic PharmaPhenomics project"); and the AutismSpeaks grant (#6009). SBC, BA, and LR were supported by the MRC and the Wellcome Trust during the period of this work. JMR was supported by the Edmonton Churchill Scholarship (Canada), the Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship, and the Cambridge Commonwealth Trust for the duration of the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Cannon JG, 1997, J PSYCHIAT RES, V31, P99, DOI 10.1016/S0022-3956(96)00055-6; Casimir GJA, 2011, J CLIN MICROBIOL, V49, P478, DOI 10.1128/JCM.02096-10; Chen DC, 2011, NANOELECTRONIC CIRCUIT DESIGN, P1, DOI 10.1007/978-1-4419-7609-3_1; Cliff N., 2004, J MODERN APPL STAT M, V3, P322, DOI [10.22237/jmasm/1099267560, DOI 10.22237/JMASM/1099267560, DOI 10.22237/jmasm/1099267560]; Cliff N, 1996, ORDINAL METHODS BEHA, P123; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; DASILVA JAP, 1994, J RHEUMATOL, V21, P330; Delaleu N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2375; Denton K, 2007, AM J PHYSIOL-REG I, V292, pR697, DOI 10.1152/ajpregu.00766.2006; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Ghobrial IM, 2011, AM J HEMATOL, V86, P573, DOI 10.1002/ajh.22048; GROSSMAN C, 1989, J STEROID BIOCHEM, V34, P241, DOI 10.1016/0022-4731(89)90088-5; Hess MR, 2004, ANN M AM ED RES ASS; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kang K, 2012, FASEB J, V26, P259, DOI 10.1096/fj.11-191460; KROMREY JD, 2005, JOINT STAT M MINN MN; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Luster A.D., 2001, ENCY LIFE SCI, P1; Mahr S, 2003, ANN RHEUM DIS, V62, P1234, DOI 10.1136/ard.2002.005041; McCullough AJ, 2002, J CLIN GASTROENTEROL, V34, P255, DOI 10.1097/00004836-200203000-00013; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Miller VM, 2012, LANCET, V379, P873, DOI 10.1016/S0140-6736(12)60200-1; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Nalbandian Greg, 2005, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V5, P85, DOI 10.2174/1568013053005418; Pelfrey CM, 2001, CLIN APPL IMMUNOLOGY, V1, P331; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Saad F, 2011, J OBES, V2011, DOI 10.1155/2011/471584; Saltevo J, 2009, GENDER MED, V6, P463, DOI 10.1016/j.genm.2009.09.006; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Spitzer JA, 1999, LUPUS, V8, P380, DOI 10.1177/096120339900800510; STAPRANS I, 1990, ARTERIOSCLEROSIS, V10, P591, DOI 10.1161/01.ATV.10.4.591; Sutton AJAK, 2000, METHODS METAANALYSIS; Thangavel C, 2007, ENDOCRINOLOGY, V148, P2894, DOI 10.1210/en.2006-1333; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tingen CM, 2010, WOMENS HEALTH, V6, P511, DOI 10.2217/WHE.10.45; Umstead TM, 2012, ARTIF ORGANS, V36, pE1, DOI 10.1111/j.1525-1594.2011.01412.x; VAMVAKOPOULOS NV, 1995, MEDIAT INFLAMM, V4, P163, DOI 10.1155/S0962935195000275; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; vonEckardstein A, 1997, J CLIN ENDOCR METAB, V82, P3367, DOI 10.1210/jc.82.10.3367; Wang M, 2007, AM J PHYSIOL-ENDOC M, V293, pE872, DOI 10.1152/ajpendo.00251.2007; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045	50	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51504	10.1371/journal.pone.0051504	http://dx.doi.org/10.1371/journal.pone.0051504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251558	Green Published, gold			2022-12-25	WOS:000313236200125
J	Wang, DY; Han, XJ; Li, SF; Liu, DQ; Yan, CG; Zuo, XN; Zhu, CZ; He, Y; Kiviniemi, V; Zang, YF				Wang, De-Yi; Han, Xiu-Jie; Li, Su-Fang; Liu, Dong-Qiang; Yan, Chao-Gan; Zuo, Xi-Nian; Zhu, Chao-Zhe; He, Yong; Kiviniemi, Vesa; Zang, Yu-Feng			Effects of Apolipoprotein E Genotype on the Off-Line Memory Consolidation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; REGIONAL HOMOGENEITY; FUNCTIONAL MRI; BRAIN ACTIVITY; STATE; SYNCHRONIZATION; HIPPOCAMPUS; EXPERIENCES; CELLS	Spontaneous brain activity or off-line activity after memory encoding is associated with memory consolidation. A few recent resting-state functional magnetic resonance imaging (RS-fMRI) studies indicate that the RS-fMRI could map off-line memory consolidation effects. However, the gene effects on memory consolidation process remain largely unknown. Here we collected two RS-fMRI sessions, one before and another after an episodic memory encoding task, from two groups of healthy young adults, one with apolipoprotein E (APOE) epsilon 2/epsilon 3 and the other with APOE epsilon 3/epsilon 4. The ratio of regional homogeneity (ReHo), a measure of local synchronization of spontaneous RS-fMRI signal, of the two sessions was used as an index of memory-consolidation. APOE epsilon 3/epsilon 4 group showed greater ReHo ratio within the medial temporal lobe (MTL). The ReHo ratio in MTL was significantly correlated with the recognition memory performance in the APOE epsilon 3/epsilon 4 group but not in epsilon 2/epsilon 3 group. Additionally, APOE epsilon 3/epsilon 4 group showed lower ReHo ratio in the occipital and parietal picture-encoding areas. Our results indicate that APOE epsilon 3/epsilon 4 group may have a different off-line memory consolidation process compared to epsilon 2/epsilon 3 group. These results may help generate future hypotheses that the off-line memory consolidation might be impaired in Alzheimer's disease.	[Wang, De-Yi; Han, Xiu-Jie; Li, Su-Fang; Yan, Chao-Gan; Zuo, Xi-Nian; Zhu, Chao-Zhe; He, Yong; Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Han, Xiu-Jie] Anshan Changda Hosp, Dept Neurol, Anshan, Liaoning, Peoples R China; [Liu, Dong-Qiang; Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liu, Dong-Qiang; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Yan, Chao-Gan] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Kiviniemi, Vesa] Univ Hosp Oulu, Dept Diagnost Radiol, Oulu, Finland	Beijing Normal University; Hangzhou Normal University; Hangzhou Normal University; Nathan Kline Institute for Psychiatric Research; Chinese Academy of Sciences; Institute of Psychology, CAS	Zang, YF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@gmail.com	ZANG, Yu-Feng/J-1558-2012; Li, Sufang/N-5697-2016; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Zuo, Xi-Nian/A-7273-2009; Yan, Chao-Gan/D-1713-2015	ZANG, Yu-Feng/0000-0003-1833-8010; Li, Sufang/0000-0002-4716-4761; Zuo, Xi-Nian/0000-0001-9110-585X; Yan, Chao-Gan/0000-0003-3413-5977; He, Yong/0000-0002-7039-2850	NSFC [81020108022, 30770594]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Ministry of Education of China [B07008]	NSFC(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ministry of Education of China(Ministry of Education, China)	This study was supported by NSFC (81020108022, 30770594), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT), and the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Clement F, 2010, CORTEX, V46, P1005, DOI 10.1016/j.cortex.2009.07.003; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Daselaar SM, 2010, NEUROBIOL LEARN MEM, V93, P422, DOI 10.1016/j.nlm.2009.12.009; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Green DM, 1966, SIGNAL DETECTION THE, pxi; Groen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019985; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lang P.J., 2008, A8 U FLOR; Lechner HA, 1999, LEARN MEMORY, V6, P77; Lopez-Aranda MF, 2009, SCIENCE, V325, P87, DOI 10.1126/science.1170869; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Smith JF, 2010, NEUROIMAGE, V50, P826, DOI 10.1016/j.neuroimage.2009.11.053; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Souchay C, 2009, CURR ALZHEIMER RES, V6, P186, DOI 10.2174/156720509788486545; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Teipel SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P244, DOI 10.1016/j.pscychresns.2010.03.003; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Trivedi MA, 2008, NEUROPSYCHOLOGIA, V46, P1667, DOI 10.1016/j.neuropsychologia.2007.11.035; TSAI MS, 1994, AM J HUM GENET, V54, P643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wang DY, 2012, NEUROREPORT, V23, P873, DOI 10.1097/WNR.0b013e3283587c96; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007	39	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51617	10.1371/journal.pone.0051617	http://dx.doi.org/10.1371/journal.pone.0051617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251595	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200147
J	Yanagihara, AA; Shohet, RV				Yanagihara, Angel A.; Shohet, Ralph V.			Cubozoan Venom-Induced Cardiovascular Collapse Is Caused by Hyperkalemia and Prevented by Zinc Gluconate in Mice	PLOS ONE			English	Article							JELLYFISH CHIRONEX-FLECKERI; BOX JELLYFISH; PARTIAL-PURIFICATION; HYDRA NEMATOCYSTS; IN-VIVO; TOXINS; ENVENOMATION; ANTIVENOM; HEMOLYSIS; VERAPAMIL	Chironex fleckeri (Australian box jellyfish) stings can cause acute cardiovascular collapse and death. We developed methods to recover venom with high specific activity, and evaluated the effects of both total venom and constituent porins at doses equivalent to lethal envenomation. Marked potassium release occurred within 5 min and hemolysis within 20 min in human red blood cells (RBC) exposed to venom or purified venom porin. Electron microscopy revealed abundant, similar to 12-nm transmembrane pores in RBC exposed to purified venom porins. C57BL/6 mice injected with venom showed rapid decline in ejection fraction with progression to electromechanical dissociation and electrocardiographic findings consistent with acute hyperkalemia. Recognizing that porin assembly can be inhibited by zinc, we found that zinc gluconate inhibited potassium efflux from RBC exposed to total venom or purified porin, and prolonged survival time in mice following venom injection. These findings suggest that hyperkalemia is the critical event following Chironex fleckeri envenomation and that rapid administration of zinc could be life saving in human sting victims.	[Yanagihara, Angel A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA; [Shohet, Ralph V.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Yanagihara, AA (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	angel@pbrc.hawaii.edu	Yanagihara, Angel/O-5664-2016	Yanagihara, Angel/0000-0001-6908-8176	Hawaii Community Foundation [958935, 991879, 20001741, 20011908, 20061497, 20071368, 47031]; Institute of Neurological Disorders and Stroke [U54NS039406]; National Heart Lung and Blood Institute [UH1HL073449]; National Center for Research Resources [P20RR016453, G12RR003061]; National Institute on Drug Abuse, National Institutes of Health [R21DA024444]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL073449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024444] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	Hawaii Community Foundation; Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants 958935, 991879, 20001741, 20011908, 20061497, 20071368, and 47031 from the Hawaii Community Foundation, as well as grants U54NS039406 from the Institute of Neurological Disorders and Stroke, UH1HL073449 from the National Heart Lung and Blood Institute, P20RR016453 and G12RR003061 from the National Center for Research Resources, and grant R21DA024444 from the National Institute on Drug Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVIGAD LS, 1976, INFECT IMMUN, V13, P1378, DOI 10.1128/IAI.13.5.1378-1381.1976; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; BARNES J. H., 1960, MED JOUR AUSTRALIA II, V47, P993; BASHFORD CL, 1986, J BIOL CHEM, V261, P9300; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; BERNHEIMER AW, 1979, TOXICON, V17, P69, DOI 10.1016/0041-0101(79)90257-5; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Carrette T, 2004, TOXICON, V44, P135, DOI 10.1016/j.toxicon.2004.04.008; Chung JJ, 2001, TOXICON, V39, P981, DOI 10.1016/S0041-0101(00)00237-3; Cuypers E, 2006, FEBS LETT, V580, P5728, DOI 10.1016/j.febslet.2006.09.030; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; FLECKER H, 1952, Med J Aust, V1, P35; Flecker H., 1945, MED J AUSTRALIA, V20, P128; FREEMAN SE, 1969, BRIT J PHARMACOL, V35, P510, DOI 10.1111/j.1476-5381.1969.tb08292.x; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Koch AW, 1998, J CELL SCI, V111, P1545; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; MUSTAFA MR, 1995, TOXICOL APPL PHARM, V133, P196, DOI 10.1006/taap.1995.1142; Ramasamy S, 2004, TOXICON, V43, P685, DOI 10.1016/j.toxicon.2004.02.024; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ruediger GF, 1903, J AMER MED ASSOC, V41, P962; Sonthichai C, 2009, OUTBREAK SURVEILLANC, V2, P9; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P40, DOI 10.1177/0310057X9802600105; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; WINKEL K, 2003, J TOXICOL-TOXIN REV, V22, P13; Winkel KD, 2005, CLIN EXP PHARMACOL P, V32, P777, DOI 10.1111/j.1440-1681.2005.04258.x	27	37	40	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51368	10.1371/journal.pone.0051368	http://dx.doi.org/10.1371/journal.pone.0051368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251508	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200096
J	Bydlon, TM; Barry, WT; Kennedy, SA; Brown, JQ; Gallagher, JE; Wilke, LG; Geradts, J; Ramanujam, N				Bydlon, Torre M.; Barry, William T.; Kennedy, Stephanie A.; Brown, J. Quincy; Gallagher, Jennifer E.; Wilke, Lee G.; Geradts, Joseph; Ramanujam, Nimmi			Advancing Optical Imaging for Breast Margin Assessment: An Analysis of Excisional Time, Cautery, and Patent Blue Dye on Underlying Sources of Contrast	PLOS ONE			English	Article							FROZEN-SECTION ANALYSIS; DIFFUSE-REFLECTANCE SPECTROSCOPY; TOUCH PREPARATION CYTOLOGY; LUMPECTOMY MARGINS; SURGICAL MARGINS; RE-EXCISION; MONTE-CARLO; INTRAOPERATIVE EVALUATION; PARTIAL MASTECTOMY; POSITIVE MARGINS	Breast conserving surgery (BCS) is a recommended treatment for breast cancer patients where the goal is to remove the tumor and a surrounding rim of normal tissue. Unfortunately, a high percentage of patients return for additional surgeries to remove all of the cancer. Post-operative pathology is the gold standard for evaluating BCS margins but is limited due to the amount of tissue that can be sampled. Frozen section analysis and touch-preparation cytology have been proposed to address the surgical needs but also have sampling limitations. These issues represent an unmet clinical need for guidance in resecting malignant tissue intra-operatively and for pathological sampling. We have developed a quantitative spectral imaging device to examine margins intra-operatively. The context in which this technology is applied (intra-operative or post-operative setting) is influenced by time after excision and surgical factors including cautery and the presence of patent blue dye (specifically Lymphazurin(TM), used for sentinel lymph node mapping). Optical endpoints of hemoglobin ([THb]), fat ([beta-carotene]), and fibroglandular content via light scattering (<mu s'>) measurements were quantified from diffuse reflectance spectra of lumpectomy and mastectomy specimens using a Monte Carlo model. A linear longitudinal mixed-effects model was used to fit the optical endpoints for the cautery and kinetics studies. Monte Carlo simulations and tissue mimicking phantoms were used for the patent blue dye experiments. [THb], [beta-carotene], and <mu s'> were affected by < 3.3% error with < 80 mu M of patent blue dye. The percent change in [beta-carotene], <mu s'>, and [beta-carotene]/<mu s'>. was < 14% in 30 minutes, while percent change in [THb] was > 40%. [beta-carotene] and [beta-carotene]/<mu s'>. were the only parameters not affected by cautery. This work demonstrates the importance of understanding the post-excision kinetics of ex-vivo tissue and the presence of cautery and patent blue dye for breast tumor margin assessment, to accurately interpret data and exploit underling sources of contrast.	[Bydlon, Torre M.; Kennedy, Stephanie A.; Brown, J. Quincy; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Barry, William T.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Brown, J. Quincy; Ramanujam, Nimmi] Zenalux, Res Triangle Pk, NC USA; [Gallagher, Jennifer E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilke, Lee G.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27706 USA	Duke University; Harvard University; Dana-Farber Cancer Institute; Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University	Ramanujam, N (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	nimmi@duke.edu	Ramanujam, Nimmi/AAA-7575-2021; Brown, J. Quincy/F-6090-2012	Ramanujam, Nimmi/0000-0001-7319-8415; 	Department of Defense Breast Cancer Predoctoral Traineeship [W81XWH-04-1-0340]; Department of Defense [W81XWH-05-1-036]; National Institute of Health [1R41CA128160-01]; Duke University's CTSA from NCRR/NIH [1 UL1 RR024128-01]; NATIONAL CANCER INSTITUTE [R41CA128160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Predoctoral Traineeship; Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University's CTSA from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the following grants: the Department of Defense Breast Cancer Predoctoral Traineeship W81XWH-04-1-0340, the Department of Defense award W81XWH-05-1-036, National Institute of Health award 1R41CA128160-01, and was supported in part by Duke University's CTSA grant 1 UL1 RR024128-01 from NCRR/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Balch GC, 2005, AM SURGEON, V71, P22; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Bigio IJ, 2000, J BIOMED OPT, V5, P221, DOI 10.1117/1.429990; Breslin TM, 2004, ANN SURG ONCOL, V11, P65, DOI 10.1007/BF02524348; Brown J, 2010, IEEE J SELE IN PRESS; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Cabioglu N, 2007, ANN SURG ONCOL, V14, P1458, DOI 10.1245/s10434-006-9236-0; Cendan JC, 2005, J AM COLL SURGEONS, V201, P194, DOI 10.1016/j.jamcollsurg.2005.03.014; Cerussi AE, 2001, ACAD RADIOL, V8, P211, DOI 10.1016/S1076-6332(03)80529-9; Chagpar A, 2003, AM J SURG, V186, P371, DOI 10.1016/S0002-9610(03)00264-2; COX CE, 1991, ARCH SURG-CHICAGO, V126, P490; Creager AJ, 2002, ARCH PATHOL LAB MED, V126, P846; Demos SG, 2006, J MAMMARY GLAND BIOL, V11, P165, DOI 10.1007/s10911-006-9022-4; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Ghosh N, 2001, APPL OPTICS, V40, P176, DOI 10.1364/AO.40.000176; Guidi AJ, 1997, CANCER, V79, P1568, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1568::AID-CNCR19>3.0.CO;2-W; Haka AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247154; Haka AS, 2006, CANCER RES, V66, P3317, DOI 10.1158/0008-5472.CAn-05-2815; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Hsiung PL, 2007, RADIOLOGY, V244, P865, DOI 10.1148/radiol.2443061536; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Johnson A T, 2001, Breast Dis, V12, P35; Keller MD, 2010, LASER SURG MED, V42, P15, DOI 10.1002/lsm.20865; Keller MD, 2009, OPT LETT, V34, P926, DOI 10.1364/OL.34.000926; Keller MD, 2012, LASER SURG MED, V42, P15; Kennedy S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2770; Klimberg VS, 1998, ANN SURG ONCOL, V5, P220, DOI 10.1007/BF02303776; Kobbermann A, 2010, ANN SURG ONCOL; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Laughney AM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3516594; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Majumder SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975962; Mann RM, 2010, BREAST CANCER RES TR, V119, P415, DOI 10.1007/s10549-009-0616-6; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Nachabe R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3611010; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Noguchi, 1995, Breast Cancer, V2, P27, DOI 10.1007/BF02966893; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Palmer GM, 2006, APPL OPTICS, V45, P1072, DOI 10.1364/AO.45.001072; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2003, IEEE T BIO-MED ENG, V50, P1233, DOI 10.1109/TBME.2003.818488; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Pogue BW, 2004, J BIOMED OPT, V9, P541, DOI 10.1117/1.1691028; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Ruidiaz ME, 2011, J SURG ONCOL, V104, P746, DOI 10.1002/jso.22012; Saarela AO, 1997, J SURG ONCOL, V66, P248, DOI 10.1002/(SICI)1096-9098(199712)66:4<248::AID-JSO5>3.0.CO;2-B; Sanchez C, 2010, AM SURGEON, V76, P331; SAUTER ER, 1994, CANCER-AM CANCER SOC, V73, P2607, DOI 10.1002/1097-0142(19940515)73:10<2607::AID-CNCR2820731023>3.0.CO;2-1; Shah N, 2001, P NATL ACAD SCI USA, V98, P4420, DOI 10.1073/pnas.071511098; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546; Valdes EK, 2007, ANN SURG ONCOL, V14, P1045, DOI 10.1245/s10434-006-9263-x; Volynskaya Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2909672; Weber S, 1997, CANCER J SCI AM, V3, P273; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Zhu CF, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897398; Zhu CF, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2931078; Zhu CF, 2008, OPT EXPRESS, V16, P14961, DOI 10.1364/OE.16.014961; Zhu CF, 2006, LASER SURG MED, V38, P714, DOI 10.1002/lsm.20356; Zysk AM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2358964	65	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51418	10.1371/journal.pone.0051418	http://dx.doi.org/10.1371/journal.pone.0051418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251526	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900084
J	Dahdul, WM; Balhoff, JP; Blackburn, DC; Diehl, AD; Haendel, MA; Hall, BK; Lapp, H; Lundberg, JG; Mungall, CJ; Ringwald, M; Segerdell, E; Van Slyke, CE; Vickaryous, MK; Westerfield, M; Mabee, PM				Dahdul, Wasila M.; Balhoff, James P.; Blackburn, David C.; Diehl, Alexander D.; Haendel, Melissa A.; Hall, Brian K.; Lapp, Hilmar; Lundberg, John G.; Mungall, Christopher J.; Ringwald, Martin; Segerdell, Erik; Van Slyke, Ceri E.; Vickaryous, Matthew K.; Westerfield, Monte; Mabee, Paula M.			A Unified Anatomy Ontology of the Vertebrate Skeletal System	PLOS ONE			English	Article							PHENOTYPE ONTOLOGIES; GENOMICS; MODEL; INFORMATICS; MORPHOLOGY; EVOLUTION; DATABASE	The skeleton is of fundamental importance in research in comparative vertebrate morphology, paleontology, biomechanics, developmental biology, and systematics. Motivated by research questions that require computational access to and comparative reasoning across the diverse skeletal phenotypes of vertebrates, we developed a module of anatomical concepts for the skeletal system, the Vertebrate Skeletal Anatomy Ontology (VSAO), to accommodate and unify the existing skeletal terminologies for the species-specific (mouse, the frog Xenopus, zebrafish) and multispecies (teleost, amphibian) vertebrate anatomy ontologies. Previous differences between these terminologies prevented even simple queries across databases pertaining to vertebrate morphology. This module of upper-level and specific skeletal terms currently includes 223 defined terms and 179 synonyms that integrate skeletal cells, tissues, biological processes, organs (skeletal elements such as bones and cartilages), and subdivisions of the skeletal system. The VSAO is designed to integrate with other ontologies, including the Common Anatomy Reference Ontology (CARO), Gene Ontology (GO), Uberon, and Cell Ontology (CL), and it is freely available to the community to be updated with additional terms required for research. Its structure accommodates anatomical variation among vertebrate species in development, structure, and composition. Annotation of diverse vertebrate phenotypes with this ontology will enable novel inquiries across the full spectrum of phenotypic diversity.	[Dahdul, Wasila M.; Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Dahdul, Wasila M.; Balhoff, James P.; Lapp, Hilmar] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Blackburn, David C.] Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA; [Diehl, Alexander D.] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Haendel, Melissa A.; Segerdell, Erik] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Lundberg, John G.] Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Ringwald, Martin] Jackson Lab, Bar Harbor, ME 04609 USA; [Van Slyke, Ceri E.; Westerfield, Monte] Univ Oregon, Zebrafish Informat Network, Eugene, OR 97403 USA; [Vickaryous, Matthew K.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of South Dakota; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; California Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University; Dalhousie University; Drexel University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Jackson Laboratory; University of Oregon; University of Guelph; University of Oregon	Dahdul, WM (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	wasila.dahdul@usd.edu	Blackburn, David/L-3812-2019; Diehl, Alexander/G-9883-2016; Mungall, Chris/I-6006-2019; Lapp, Hilmar/A-8275-2009	Blackburn, David/0000-0002-1810-9886; Diehl, Alexander/0000-0001-9990-8331; Mungall, Chris/0000-0002-6601-2165; Balhoff, James/0000-0002-8688-6599; Haendel, Melissa/0000-0001-9114-8737; Lapp, Hilmar/0000-0001-9107-0714; Van Slyke, Ceri/0000-0002-2244-7917; Segerdell, Erik/0000-0002-9611-1279; Dahdul, Wasila/0000-0003-3162-7490; Mabee, Paula/0000-0002-8455-3213	National Science Foundation [DBI-0641025, DBI-1062404, DBI-1062542]; National Institutes of Health [HG002659]; National Evolutionary Synthesis Center [NSF EF-0423641, EF-0905606]; Direct For Biological Sciences [1062542] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062404] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grants from the National Science Foundation (www.nsf.gov) (DBI-0641025, DBI-1062404, DBI-1062542), National Institutes of Health (www.nih.gov) (HG002659), and the National Evolutionary Synthesis Center (www.nescent.org) (NSF EF-0423641, NSF #EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arratia G, 2001, J MORPHOL, V250, P101, DOI 10.1002/jmor.1062; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Blake J. A., 2008, CURR PROTOC BIOINFOR, V23, P721; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Burger A., 2008, ANATOMY ONTOLOGIES B; Burke AC, 1991, DEV PATTERNING VERTE; Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Dahdul WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010708; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Dettai A, 2004, SYST BIOL, V53, P822, DOI 10.1080/10635150490522313; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Hall BK, 2005, ZOOLOGY, V108, P269, DOI 10.1016/j.zool.2005.09.005; Hall BK, 2005, J EXP ZOOL PART B, V304B, P548, DOI 10.1002/jez.b.21057; Hall Brian K., 2007, P13; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Janvier P, 2011, CURR BIOL, V21, pR661, DOI 10.1016/j.cub.2011.07.014; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maglia AM, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P367; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Niknejad A, 2012, BIOINFORMATICS, V28, P1017, DOI 10.1093/bioinformatics/bts048; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson C, 1977, PROBLEMS VERTEBRATE, P121; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; SCOTTSAVAGE P, 1979, J MORPHOL, V162, P453, DOI 10.1002/jmor.1051620310; Segerdell E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-92; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Vickaryous Matthew K., 2007, P323; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	40	30	30	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51070	10.1371/journal.pone.0051070	http://dx.doi.org/10.1371/journal.pone.0051070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251424	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900038
J	Espinoza, JL; Takami, A; Trung, LQ; Kato, S; Nakao, S				Espinoza, J. Luis; Takami, Akiyoshi; Ly Quoc Trung; Kato, Shunichi; Nakao, Shinji			Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; LATENT MEMBRANE-PROTEIN-1; MIR-155; PROLIFERATION; EXPRESSION; APOPTOSIS; LYMPHOMA; STAT3	Background: Epstein Barr virus-associated lymphoproliferative disease is an increasing complication in patients with immunosuppressive conditions. Although the current therapies for this disorder are effective, they are also associated with significant toxicity. In an attempt to identify newer therapeutic agents, this study investigated the effects of Resveratrol, a naturally occurring polyphenolic compound, on the EBV transformation of human B cells. Methodology/Principal Findings: This study demonstrates that resveratrol prevents EBV transformation in human B cells. These effects are mediated by specific cytotoxic activities of resveratrol against EBV-infected B cells that are associated with the downregulation of the anti-apoptotic proteins Mcl-1 and survivin. This occurs as a consequence of the inhibition of EBV-induced NFkB and STAT-3 signaling pathways and a resveratrol-induced decrease in the expression of the oncogenic viral product LMP1 in EBV-infected B cells. In addition, resveratrol decreased the expression of miR-155 and miR-34a in EBV-infected B cells, blocked the expression of the anti-apoptotic viral gene BHRF1, and thus interrupted events that are critical for EBV transformation and the survival of EBV-transformed cells. Conclusions/Significance: These results suggest that resveratrol may therefore be a potentially effective therapeutic alternative for preventing EBV-associated lymphoproliferative diseases in immune compromised patients.	[Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Espinoza, J. Luis; Ly Quoc Trung; Nakao, Shinji] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kato, Shunichi] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan	Kanazawa University; Kanazawa University; Tokai University	Takami, A (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@staff.kanazawa-u.ac.jp	Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; Hokkoku Gan Kikin Fund (Kanazawa, Japan); Research on Allergic Disease and Immunology in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan [H23-010]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkoku Gan Kikin Fund (Kanazawa, Japan); Research on Allergic Disease and Immunology in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan, and a fund by Hokkoku Gan Kikin Fund (Kanazawa, Japan). This work was supported in part by the Research on Allergic Disease and Immunology (H23-010) in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Blaes AH, 2010, EXPERT REV HEMATOL, V3, P35, DOI [10.1586/ehm.09.76, 10.1586/EHM.09.76]; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Dirmeier U, 2003, CANCER RES, V63, P2982; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Espinoza JL, 2012, HAEMATOLOGICA; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Halder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007214; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Knowles DM, 1999, MODERN PATHOL, V12, P200; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Kundu JK, 2004, MUTAT RES-FUND MOL M, V555, P65, DOI 10.1016/j.mrfmmm.2004.05.019; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lay MLJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-252; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Merlo A, 2011, INT J HEMATOL, V93, P281, DOI 10.1007/s12185-011-0782-2; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Reddy N, 2011, BIOL BLOOD MARROW TR, V17, P591, DOI 10.1016/j.bbmt.2010.08.007; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Thornburg NJ, 2006, ONCOGENE, V25, P288, DOI 10.1038/sj.onc.1209023; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Yiu CY, 2010, MOLECULES, V15, P7115, DOI 10.3390/molecules15107115; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	44	66	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51306	10.1371/journal.pone.0051306	http://dx.doi.org/10.1371/journal.pone.0051306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251493	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900066
J	Gomez-Abellan, P; Diez-Noguera, A; Madrid, JA; Lujan, JA; Ordovas, JM; Garaulet, M				Gomez-Abellan, Purificacion; Diez-Noguera, Antoni; Madrid, Juan A.; Lujan, Juan A.; Ordovas, Jose M.; Garaulet, Marta			Glucocorticoids Affect 24 h Clock Genes Expression in Human Adipose Tissue Explant Cultures	PLOS ONE			English	Article							METABOLIC SYNDROME; CIRCADIAN EXPRESSION; OBESITY; MONONUCLEAR; ASSOCIATION; PATTERNS	Aims: to examine firstly whether CLOCK exhibits a circadian expression in human visceral (V) and subcutaneous (S) adipose tissue (AT) in vitro as compared with BMAL1 and PER2, and secondly to investigate the possible effect of the glucocorticoid analogue dexamethasone (DEX) on positive and negative clock genes expression. Subjects and Methods: VAT and SAT biopsies were obtained from morbid obese women (body mass index >= 40 kg/m(2)) (n = 6). In order to investigate rhythmic expression pattern of clock genes and the effect of DEX on CLOCK, PER2 and BMAL1 expression, control AT (without DEX) and AT explants treated with DEX (2 hours) were cultured during 24 h and gene expression was analyzed at the following times: 10:00 h, 14:00 h, 18:00 h, 22:00 h, 02:00 h and 06:00 h, using qRT-PCR. Results: CLOCK, BMAL1 and PER2 expression exhibited circadian patterns in both VAT and SAT explants that were adjusted to a typical 24 h sinusoidal curve. PER2 expression (negative element) was in antiphase with respect to CLOCK and in phase with BMAL1 expression (both positive elements) in the SAT (situation not present in VAT). A marked effect of DEX exposure on both positive and negative clock genes expression patterns was observed. Indeed, DEX treatment modified the rhythmicity pattern towards altered patterns with a period lower than 24 hours in all genes and in both tissues. Conclusions: 24 h patterns in CLOCK and BMAL1 (positive clock elements) and PER2 (negative element) mRNA levels were observed in human adipose explants. These patterns were altered by dexamethasone exposure.	[Gomez-Abellan, Purificacion; Madrid, Juan A.; Garaulet, Marta] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Diez-Noguera, Antoni] Univ Barcelona, Dept Physiol, Fac Pharm, Barcelona, Spain; [Lujan, Juan A.] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA, Human Nutr Res Ctr, Boston, MA 02111 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain	University of Murcia; University of Barcelona; Hospital Clinico Universitario Virgen de la Arrixaca; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain.	garaulet@um.es	Garaulet, Marta/K-6625-2014; Ordovas, Jose/B-8727-2013	Garaulet, Marta/0000-0002-4066-3509; Ordovas, Jose/0000-0002-7581-5680; Lujan Mompean, Juan Antonio/0000-0003-4987-7578; Madrid, Juan Antonio/0000-0002-9286-1371	Tomas Pascual Foundation; Pilar Gomez-Cuetara Foundation; Spanish Government of Science and Innovation [BFU2011-24720]; Seneca Foundation from the Government of Murcia [15123/PI/10]; National Heart, Lung, and Blood Institute [HL-54776]; National Institute of Diabetes and Digestive and Kidney Diseases [DK075030]; United States Department of Agriculture Research [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER	Tomas Pascual Foundation; Pilar Gomez-Cuetara Foundation; Spanish Government of Science and Innovation(Spanish Government); Seneca Foundation from the Government of Murcia(Fundacion Seneca); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Agriculture Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from Tomas Pascual and Pilar Gomez-Cuetara Foundations, Spanish Government of Science and Innovation (BFU2011-24720), Seneca Foundation from the Government of Murcia (15123/PI/10), National Heart, Lung, and Blood Institute grants HL-54776, National Institute of Diabetes and Digestive and Kidney Diseases, grant number DK075030 and by contracts 53-K06-5-10 and 58-1950-9-001 from the United States Department of Agriculture Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Batschelet E, 1981, CIRCULAR STAT BIOL; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Burioka N, 2010, ADV DRUG DELIVER REV, V62, P946, DOI 10.1016/j.addr.2010.03.012; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2006, OBESITY, V14, P1181, DOI 10.1038/oby.2006.135; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Abellan PG, 2011, NUTR HOSP, V26, P1394, DOI [10.3305/nh.2011.26.6.5305, 10.1590/S0212-16112011000600029]; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Granda TG, 2004, FASEB J, V18, P304, DOI 10.1096/fj.04-2665fje; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hernandez-Morante JJ, 2009, INT J OBESITY, V33, P473, DOI 10.1038/ijo.2009.4; Kusanagi H, 2004, NEUROSCI LETT, V365, P124, DOI 10.1016/j.neulet.2004.04.065; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-7; Nebzydoski SJ, 2010, VET IMMUNOL IMMUNOP, V138, P183, DOI 10.1016/j.vetimm.2010.07.017; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Tanaka K, 2007, HEART VESSELS, V22, P254, DOI 10.1007/s00380-006-0968-3; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Veilleux A, 2010, J STEROID BIOCHEM, V122, P28, DOI 10.1016/j.jsbmb.2010.02.024; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308	34	39	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50435	10.1371/journal.pone.0050435	http://dx.doi.org/10.1371/journal.pone.0050435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251369	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900012
J	Hassouna, R; Zizzari, P; Viltart, O; Yang, SK; Gardette, R; Videau, C; Badoer, E; Epelbaum, J; Tolle, V				Hassouna, Rim; Zizzari, Philippe; Viltart, Odile; Yang, Seung-Kwon; Gardette, Robert; Videau, Catherine; Badoer, Emilio; Epelbaum, Jacques; Tolle, Virginie			A Natural Variant of Obestatin, Q90L, Inhibits Ghrelin's Action on Food Intake and GH Secretion and Targets NPY and GHRH Neurons in Mice	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; HYPOTHALAMIC ARCUATE NUCLEUS; GREEN FLUORESCENT PROTEIN; NEUROPEPTIDE-Y NEURONS; FAMILY TRIOS ANALYSIS; MESSENGER-RNA; PREPROGHRELIN GENE; PERIPHERAL GHRELIN; PEPTIDE; RECEPTOR	Background: Ghrelin and obestatin are two gut-derived peptides originating from the same ghrelin/obestatin prepropeptide gene (GHRL). While ghrelin stimulates growth hormone (GH) secretion and food intake and inhibits gamma-aminobutyric-acid synaptic transmission onto GHRH (Growth Hormone Releasing Hormone) neurons, obestatin blocks these effects. In Humans, GHRL gene polymorphisms have been associated with pathologies linked to an unbalanced energy homeostasis. We hypothesized that one polymorphism located in the obestatin sequence (Q to L substitution in position 90 of the ghrelin/obestatin prepropeptide, rs4684677) may impact on the function of obestatin. In the present study, we tested the activity of native and Q90L obestatin to modulate ghrelin-induced food intake, GH secretion, cFos activity in GHRH and Neuropeptide Y (NPY) neurons and gamma-aminobutyric-acid activity onto GHRH neurons. Methodology/Principal findings: Food intake, GH secretion and electrophysiological recordings were assessed in C57BL/6 mice. cFos activity was measured in NPY-Renilla-GFP and GHRH-eGFP mice. Mice received saline, ghrelin or ghrelin combined to native or Q90L obestatin (30 nmol each) in the early light phase. Ghrelin stimulation of food intake and GH secretion varied considerably among individual mice with 59-77% eliciting a robust response. In these high-responders, ghrelin-induced food intake and GH secretion were reduced equally by native and Q90L obestatin. In contrast to in vivo observations, Q90L was slightly more efficient than native obestatin in inhibiting ghrelin-induced cFos activation within the hypothalamic arcuate nucleus and the nucleus tractus solitarius of the brainstem. After ghrelin injection, 26% of NPY neurons in the arcuate nucleus expressed cFos protein and this number was significantly reduced by co-administration of Q90L obestatin. Q90L was also more potent that native obestatin in reducing ghrelin-induced inhibition of gamma-aminobutyric-acid synaptic transmission onto GHRH neurons. Conclusions/Significance: These data support the hypothesis that Q90L obestatin partially blocks ghrelin-induced food intake and GH secretion by acting through NPY and GHRH neurons.	[Hassouna, Rim; Zizzari, Philippe; Gardette, Robert; Videau, Catherine; Epelbaum, Jacques; Tolle, Virginie] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S 894, Paris, France; [Viltart, Odile] INSERM, Lab Dev & Plasticite Cerveau Postnatal, Ctr Rech JPARC, UMR 837, F-59045 Lille, France; [Viltart, Odile] Univ Lille Nord France USTL Lille 1, Lille, France; [Yang, Seung-Kwon] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Badoer, Emilio] RMIT Univ, Sch Med Sci, Melbourne, Australia; [Badoer, Emilio] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Tolle, V (corresponding author), Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S 894, Paris, France.	virginie.tolle@inserm.fr	Hassouna, Rim/AAS-5664-2021; Epelbaum, Jacques/B-2263-2013; Tolle, Virginie S/H-5264-2015	Tolle, Virginie S/0000-0003-4456-0002; Zizzari, Philippe/0000-0001-8838-0762	INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE)	INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE)	This work was supported by an INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2006, AM J MED GENET B, V141B, P929, DOI 10.1002/ajmg.b.30387; Annemie V, 2009, REGUL PEPTIDES, V156, P77, DOI 10.1016/j.regpep.2009.04.014; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Cellini E, 2006, PSYCHIAT GENET, V16, P51, DOI 10.1097/01.ypg.0000194444.89436.e9; Chartrel N, 2007, SCIENCE, p766c; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Dardennes RM, 2007, PSYCHONEUROENDOCRINO, V32, P106, DOI 10.1016/j.psyneuen.2006.11.003; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; DICKSON SL, 1993, NEUROSCIENCE, V53, P303, DOI 10.1016/0306-4522(93)90197-N; Feng DD, 2011, EUR J NEUROSCI, V34, P732, DOI 10.1111/j.1460-9568.2011.07787.x; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hassouna R, 2010, J NEUROENDOCRINOL, P794; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Hinney A, 2002, J CLIN ENDOCR METAB, V87, P2716, DOI 10.1210/jc.87.6.2716; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Kamegai J, 1996, ENDOCRINOLOGY, V137, P2109, DOI 10.1210/en.137.5.2109; Katayama M, 2000, NEUROENDOCRINOLOGY, V72, P333, DOI 10.1159/000054602; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Larsen LH, 2005, CLIN BIOCHEM, V38, P420, DOI 10.1016/j.clinbiochem.2005.01.008; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, pRC13, DOI 10.1007/BF03344174; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Steinle NI, 2005, J CLIN ENDOCR METAB, V90, P6672, DOI 10.1210/jc.2005-0549; Stengel A, 2010, PHYSIOL BEHAV, V101, P614, DOI 10.1016/j.physbeh.2010.09.009; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Tolle V, 2001, NEUROENDOCRINOLOGY, V73, P54, DOI 10.1159/000054620; Tomasetto C, 2000, GASTROENTEROLOGY, V119, P395, DOI 10.1053/gast.2000.9371; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wang LX, 2011, PEPTIDES, V32, P51, DOI 10.1016/j.peptides.2010.10.017; Wang LX, 2002, NEUROSCI LETT, V325, P47; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yu YH, 2009, APPETITE, V52, P372, DOI 10.1016/j.appet.2008.11.011; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zizzari P, 2007, ENDOCRINOLOGY, V148, P1648, DOI 10.1210/en.2006-1231	45	33	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51135	10.1371/journal.pone.0051135	http://dx.doi.org/10.1371/journal.pone.0051135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251435	gold, Green Published, Green Submitted			2022-12-25	WOS:000312201900044
J	Langkilde, A; Petersen, J; Klausen, HH; Henriksen, JH; Eugen-Olsen, J; Andersen, O				Langkilde, Anne; Petersen, Janne; Klausen, Henrik Hedegaard; Henriksen, Jens Henrik; Eugen-Olsen, Jesper; Andersen, Ove			Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography - A Cross Sectional Cohort Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UROKINASE RECEPTOR; METABOLIC SYNDROME; MORTALITY; PLASMA; SURVIVAL; DISEASE; MARKER; CANCER; ADULTS	Objectives: To examine mechanisms underlying the increased inflammatory state of HIV-infected patients, by investigating the association of HIV-related factors, demography, lifestyle, and body composition with the inflammatory marker soluble urokinase plasminogen activator receptor (suPAR). Methods: suPAR was measured in EDTA-plasma and associated with HIV-related factors (HIV-duration, combination antiretroviral treatment (cART), nadir CD4+ cell count, CD4+ cell count, and HIV RNA); demography; lifestyle; and body composition determined by Dual energy X-ray Absorptiometry (DXA) scan, in multiple linear regression analyses adjusted for biological relevant covariates, in a cross-sectional study of 1142 HIV-infected patients. Results: Increased suPAR levels were significantly associated with age, female sex, daily smoking, metabolic syndrome and waist circumference. cART was associated with 17% lower suPAR levels. In cART-treated patients 10-fold higher HIV RNA was associated with 21% higher suPAR, whereas there was no association in untreated patients. Patients with CD4+ cell count<350 cells/mu L had 7% higher suPAR, but we found no association with nadir CD4+ cell count or with duration of HIV-infection. Finally, suPAR was not associated with adipose tissue distribution, but strongly associated with low muscle mass. In patients infected through intravenous drug use (IDU), CD4+ cell counts<350 cells/mu L were associated with 27% lower suPAR (p = 0.03), and suPAR was 4% lower pr.year during treatment (p = 0.05); however, there was no association with HIV RNA, duration of HIV-infection, nor cART. Conclusion: We found elevated suPAR levels in untreated patients compared to patients on cART. Moreover, we observed a significant positive association between suPAR and HIV RNA levels in cART-treated patients. Age, HIV-transmission through IDU, metabolic syndrome, smoking, and low leg muscle mass were also significantly associated with suPAR levels. Our study therefore indicates, that also other aspects of living with HIV than virologic and immunologic markers add to the increased inflammation in HIV-infected patients.	[Langkilde, Anne; Petersen, Janne; Klausen, Henrik Hedegaard; Eugen-Olsen, Jesper; Andersen, Ove] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Henriksen, Jens Henrik] Copenhagen Univ Hosp, Dept Clin Physiol & Nucl Med, Hvidovre, Denmark; [Andersen, Ove] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Langkilde, A (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark.	annelangkilde@gmail.com	Andersen, Ove/D-3091-2019	Andersen, Ove/0000-0002-2274-548X; Eugen-Olsen, Jesper/0000-0002-4630-4275; Petersen, Janne/0000-0001-7323-2548	ViroGates A/S	ViroGates A/S	ViroGates A/S donated the suPARnostic (R) kits for suPAR measurements. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Andersen O, 2008, J INFECTION, V57, P55, DOI 10.1016/j.jinf.2008.01.014; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonnet E, 2005, J CLIN DENSITOM, V8, P287, DOI 10.1385/JCD:8:3:287; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Galli L, 2012, EUR J EPIDEMIOL, V27, P657, DOI 10.1007/s10654-012-9707-5; Gore-Felton C, 2008, PSYCHOSOM MED, V70, P569, DOI 10.1097/PSY.0b013e318177353e; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hansen BR, 2009, HIV MED, V10, P378, DOI 10.1111/j.1468-1293.2009.00697.x; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Langkilde A, 2011, CANCER EPIDEM BIOMAR, V20, P609, DOI 10.1158/1055-9965.EPI-10-1009; Larsen MV, 2010, ADDICTION, V105, P529, DOI 10.1111/j.1360-0443.2009.02827.x; Lee JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034218; Lifson Alan R, 2012, Curr HIV/AIDS Rep, V9, P223, DOI 10.1007/s11904-012-0121-0; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lyngbaek S, 2012, INT J CARDIOL; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Ostrowski SR, 2010, SOLUBLE FACTORS MEDIATING INNATE IMMUNE RESPONSES TO HIV INFECTION, P81; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Ostrowski SR, 2004, JAIDS-J ACQ IMM DEF, V35, P337, DOI 10.1097/00126334-200404010-00002; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Scherzer R, 2011, AIDS, V25, P1405, DOI 10.1097/QAD.0b013e32834884e6; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Sidenius N, 2000, BLOOD, V96, P4091; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Toldi G, 2012, CLIN CHEM LAB MED, V0, P1, DOI DOI 10.1515/CCLM-2012-0221; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wood E, 2003, CAN MED ASSOC J, V169, P656	41	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51698	10.1371/journal.pone.0051698	http://dx.doi.org/10.1371/journal.pone.0051698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251607	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900114
J	Zhang, X; Huang, YP; Gao, HN; Yang, MF; Zhao, H; Hu, JH; Chen, XM; Ma, WH; Fan, J				Zhang, Xuan; Huang, Ya Ping; Gao, Hai Nv; Yang, Mei Fang; Zhao, Hong; Hu, Jian Hua; Chen, Xiao Ming; Ma, Wei Hang; Fan, Jun			Quantification of Cytomegalovirus Glycoprotein Bn DNA in Hematopoietic Stem Cell Transplant Recipients by Real-time PCR	PLOS ONE			English	Article							PP65 ANTIGENEMIA; GENOTYPES; OUTCOMES; THERAPY; LOAD	Based on sequence variation in the N-terminus of the UL55 gene, which encodes glycoprotein B (gB), human cytomegalovirus (CMV) can be classified into four gBn genotypes. We assessed the distribution of CMV gBn genotypes and the correlation between CMV gBn DNA (detected by real-time PCR) and CMV-positive pp65 cells (identified by immunohistochemical staining) in a cohort of hematopoietic stem cell transplant patients. The distribution of gB genotypes was as follows: gBn1, 60% of patients; gBn2, 13.3%; mixed gBn1 and gBn3 infection, 26.7%; and gBn4 and other mixed infections, 0%. CMV gBn1 was the most common genotype. The detected level of CMV gB DNA correlated well with the number of CMV-positive pp65 cells detected by immunostaining (r = 0.585).	[Zhang, Xuan; Huang, Ya Ping; Gao, Hai Nv; Yang, Mei Fang; Zhao, Hong; Hu, Jian Hua; Chen, Xiao Ming; Ma, Wei Hang; Fan, Jun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fan, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	fanjunzju@163.com		Zhang, Xuan/0000-0001-9186-4741	National Natural Science Foundation of China [30872239]; Research of Health Department of China Province-Ministry Co-construct [WKJ2009-2-023]; Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment [2009R50041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research of Health Department of China Province-Ministry Co-construct; Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment	This study was supported by the National Natural Science Foundation of China (30872239), Research of Health Department of China Province-Ministry Co-construct (WKJ2009-2-023), and the Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment (2009R50041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 1998, CLIN MICROBIOL REV, V11, P533, DOI 10.1128/CMR.11.3.533; CHOU SW, 1992, VIROLOGY, V188, P388, DOI 10.1016/0042-6822(92)90771-G; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Fan J, 2009, J VIROL METHODS, V160, P74, DOI 10.1016/j.jviromet.2009.04.018; Fan J, 2006, HEPATOB PANCREAT DIS, V1, P34; Fan J, 2006, CHINESE MED J-PEKING, V119, P871, DOI 10.1097/00029330-200605020-00014; Kusne S, 1999, TRANSPLANTATION, V68, P1125, DOI 10.1097/00007890-199910270-00011; Lukacsi A, 2001, J MED VIROL, V65, P537, DOI 10.1002/jmv.2070; Nichols WG, 2001, BLOOD, V97, P867, DOI 10.1182/blood.V97.4.867; Sarcinella L, 2002, J CLIN VIROL, V24, P99, DOI 10.1016/S1386-6532(01)00238-4; TorokStorb B, 1997, BLOOD, V90, P2097, DOI 10.1182/blood.V90.5.2097; Yan S. S., 2001, Clinical and Applied Immunology Reviews, V2, P155, DOI 10.1016/S1529-1049(02)00045-4; Zhou L, 2007, TRANSPL INFECT DIS, V9, P73, DOI 10.1111/j.1399-3062.2006.00173.x	13	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51224	10.1371/journal.pone.0051224	http://dx.doi.org/10.1371/journal.pone.0051224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251460	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900054
J	Zyzynska-Granica, B; Koziak, K				Zyzynska-Granica, Barbara; Koziak, Katarzyna			Identification of Suitable Reference Genes for Real-Time PCR Analysis of Statin-Treated Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; RT-PCR; NORMALIZATION; EXPRESSION; VALIDATION; GUIDELINES	Proper data normalization in quantitative real-time reverse-transcription polymerase chain reaction (RT-qPCR) is of critical importance for reliable mRNA expression analysis. Due to a diversity in putative reference genes expression stability in different in vitro models, a validation of an internal control gene should be made for each particular tissue or cell type and every specific experimental design. A few approaches have been proposed for reference gene selection, including pair-wise comparison approach and model-based approach. In this article we have assessed the expression stability of eight putative reference genes: ACTB, B2M, GADD45A, GAPDH, HPRT1, PES1, PSMC4, YWHAZ, in human umbilical vein endothelial cells (HUVEC) treated with different statins and with TNF-alpha. The analysis was performed with three reference gene validation programs: geNorm, NormFinder and BestKeeper. We have shown that hypoxanthine phosphoribosyltransferase 1 gene (HPRT1) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide gene (YWHAZ) are the most stably expressed genes among the analyzed ones. Furthermore, our results show that beta-actin gene (ACTB) is downregulated by statins and thus should not be used as a normalizing gene in a discussed experimental setup. A ranking of candidate reference genes stability values is provided and might serve as a valuable guide for future gene expression studies in endothelial cells. This is the first report on reference gene selection for RT-qPCR applications in statin-treated HUVEC model.	[Zyzynska-Granica, Barbara; Koziak, Katarzyna] Med Univ Warsaw, Dept Gen & Nutrit Biochem, Warsaw, Poland	Medical University of Warsaw	Zyzynska-Granica, B (corresponding author), Med Univ Warsaw, Dept Gen & Nutrit Biochem, Warsaw, Poland.	barbara.zyzynska@wum.edu.pl	Koziak, Katarzyna/V-2323-2019	Zyzynska-Granica, Barbara/0000-0002-1641-0018	National Centre for Research and Development [N R13 0094 06]; National Science Centre [N N301 521838]	National Centre for Research and Development(National Centre for Research & Development, Poland); National Science Centre(National Science Centre, Poland)	Funding for this study was from National Centre for Research and Development (N R13 0094 06) and the National Science Centre (N N301 521838). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstaett OL, 2010, VET IMMUNOL IMMUNOP, V137, P201, DOI 10.1016/j.vetimm.2010.05.006; Balogh A, 2008, J PHOTOCH PHOTOBIO B, V93, P133, DOI 10.1016/j.jphotobiol.2008.07.010; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Gresner SM, 2011, ANAL BIOCHEM, V408, P163, DOI 10.1016/j.ab.2010.09.010; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	20	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51547	10.1371/journal.pone.0051547	http://dx.doi.org/10.1371/journal.pone.0051547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251572	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900101
J	Noth, J; Krawietz, D; Hemschemeier, A; Happe, T				Noth, Jens; Krawietz, Danuta; Hemschemeier, Anja; Happe, Thomas			Pyruvate: Ferredoxin Oxidoreductase Is Coupled to Light-independent Hydrogen Production in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FORMATE-LYASE; CLOSTRIDIUM-ACETOBUTYLICUM; FERMENTATIVE METABOLISM; PYRUVATEFERREDOXIN OXIDOREDUCTASE; CRYSTAL-STRUCTURES; FEFE HYDROGENASES; ENERGY-METABOLISM; EXPRESSION; GENE	In anaerobiosis, the green alga Chlamydomonas reinhardtii evolves molecular hydrogen (H-2) as one of several fermentation products. H-2 is generated mostly by the [Fe-Fe]-hydrogenase HYDA1, which uses plant type ferredoxin PETF/FDX1 (PETF) as an electron donor. Dark fermentation of the alga is mainly of the mixed acid type, because formate, ethanol, and acetate are generated by a pyruvate: formate lyase pathway similar to Escherichia coli. However, C. reinhardtii also possesses the pyruvate: ferredoxin oxidoreductase PFR1, which, like pyruvate: formate lyase and HYDA1, is localized in the chloroplast. PFR1 has long been suggested to be responsible for the low but significant H-2 accumulation in the dark because the catalytic mechanism of pyruvate: ferredoxin oxidoreductase involves the reduction of ferredoxin. With the aim of proving the biochemical feasibility of the postulated reaction, we have heterologously expressed the PFR1 gene in E. coli. Purified recombinant PFR1 is able to transfer electrons from pyruvate to HYDA1, using the ferredoxins PETF and FDX2 as electron carriers. The high reactivity of PFR1 toward oxaloacetate indicates that in vivo, fermentation might also be coupled to an anaerobically active glyoxylate cycle. Our results suggest that C. reinhardtii employs a clostridial type H-2 production pathway in the dark, especially because C. reinhardtii PFR1 was also able to allow H-2 evolution in reaction mixtures containing Clostridium acetobutylicum 2[4Fe-4S]-ferredoxin and [Fe-Fe]-hydrogenase HYDA.	[Noth, Jens; Krawietz, Danuta; Hemschemeier, Anja; Happe, Thomas] Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, D-44801 Bochum, Germany	Ruhr University Bochum	Happe, T (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, Univ Str 150, D-44801 Bochum, Germany.	thomas.happe@rub.de		Hemschemeier, Anja/0000-0001-8879-3348; Happe, Thomas/0000-0003-1206-5234	Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES); Volkswagen Foundation (LigH2t)	Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES); Volkswagen Foundation (LigH2t)	This work was supported by grants from the Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES) and the Volkswagen Foundation (LigH2t) ( to T. H.).	Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; BLAMEY JM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P19, DOI 10.1016/0167-4838(93)90190-3; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; Carere CR, 2008, INDIAN J MICROBIOL, V48, P252, DOI 10.1007/s12088-008-0036-z; CARPENTER CE, 1987, APPL ENVIRON MICROB, V53, P549, DOI 10.1128/AEM.53.3.549-552.1987; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Cavazza C, 2006, STRUCTURE, V14, P217, DOI 10.1016/j.str.2005.10.013; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Chen HC, 2005, PHOTOSYNTH RES, V84, P289, DOI 10.1007/s11120-004-7157-y; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; CINCO RM, 1993, PHOTOSYNTH RES, V38, P27, DOI 10.1007/BF00015058; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies JP, 1996, EMBO J, V15, P2150, DOI 10.1002/j.1460-2075.1996.tb00568.x; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; FRANZEN LG, 1990, FEBS LETT, V260, P165, DOI 10.1016/0014-5793(90)80094-Y; Fukuda E, 2001, EUR J BIOCHEM, V268, P5639, DOI 10.1046/j.1432-1033.2001.02504.x; Furdui C, 2000, J BIOL CHEM, V275, P28494, DOI 10.1074/jbc.M003291200; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Grossman AR, 2011, NEW PHYTOL, V190, P279, DOI 10.1111/j.1469-8137.2010.03534.x; Guerrini O, 2008, CURR MICROBIOL, V56, P261, DOI 10.1007/s00284-007-9072-x; Hackstein JHP, 1999, TRENDS MICROBIOL, V7, P441, DOI 10.1016/S0966-842X(99)01613-3; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; KIM BH, 1984, APPL ENVIRON MICROB, V48, P764, DOI 10.1128/AEM.48.4.764-770.1984; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lambertz C, 2010, EUKARYOT CELL, V9, P1747, DOI 10.1128/EC.00127-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin WC, 2003, ARCH MICROBIOL, V179, P444, DOI 10.1007/s00203-003-0554-3; Magneschi L, 2012, PLANT PHYSIOL, V158, P1293, DOI 10.1104/pp.111.191569; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MEINECKE B, 1989, ARCH MICROBIOL, V152, P244, DOI 10.1007/BF00409658; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Mignolet E, 2012, J BIOTECHNOL, V162, P81, DOI 10.1016/j.jbiotec.2012.07.002; MULLER YA, 1993, STRUCTURE, V1, P95, DOI 10.1016/0969-2126(93)90025-C; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Pape M, 2012, PLANT PHYSIOL, V159, P1700, DOI 10.1104/pp.112.200162; Park YJ, 2006, J BIOCHEM MOL BIOL, V39, P46; Philipps G, 2012, PLANTA, V235, P729, DOI 10.1007/s00425-011-1537-2; Philipps G, 2011, PLANT J, V66, P330, DOI 10.1111/j.1365-313X.2011.04494.x; Pieulle L, 1997, J BACTERIOL, V179, P5684, DOI 10.1128/jb.179.18.5684-5692.1997; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Pineda E, 2010, FEBS J, V277, P3382, DOI 10.1111/j.1742-4658.2010.07743.x; Ragsdale SW, 2003, CHEM REV, V103, P2333, DOI 10.1021/cr020423e; Ruhle T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-107; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sambrook J, 2006, CSH PROTOC, V2006; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; STUART TS, 1972, PLANTA, V106, P101, DOI 10.1007/BF00383990; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; UYEDA K, 1971, J BIOL CHEM, V246, P3111; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P788, DOI 10.1104/pp.90.3.788; Winkler M, 2002, BBA-GENE STRUCT EXPR, V1576, P330, DOI 10.1016/S0167-4781(02)00239-7; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Yakunin AF, 1998, BBA-BIOENERGETICS, V1409, P39, DOI 10.1016/S0005-2728(98)00145-5; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	92	52	54	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4368	4377		10.1074/jbc.M112.429985	http://dx.doi.org/10.1074/jbc.M112.429985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258532	Green Published, hybrid			2022-12-25	WOS:000314845000064
J	Owatworakit, A; Townsend, B; Louveau, T; Jenner, H; Rejzek, M; Hughes, RK; Saalbach, G; Qi, XQ; Bakht, S; Roy, AD; Mugford, ST; Goss, RJM; Field, RA; Osbourn, A				Owatworakit, Amorn; Townsend, Belinda; Louveau, Thomas; Jenner, Helen; Rejzek, Martin; Hughes, Richard K.; Saalbach, Gerhard; Qi, Xiaoquan; Bakht, Saleha; Roy, Abhijeet Deb; Mugford, Sam T.; Goss, Rebecca J. M.; Field, Robert A.; Osbourn, Anne			Glycosyltransferases from Oat (Avena) Implicated in the Acylation of Avenacins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYPEPTIDASE-LIKE PROTEIN; SERINE CARBOXYPEPTIDASE; SECONDARY METABOLISM; SALICYLIC-ACID; UGT74F2 GLUCOSYLTRANSFERASE; OXIDOSQUALENE CYCLASES; DISEASE RESISTANCE; ARABIDOPSIS; EVOLUTION; FAMILY	Plants produce a huge array of specialized metabolites that have important functions in defense against biotic and abiotic stresses. Many of these compounds are glycosylated by family 1 glycosyltransferases (GTs). Oats (Avena spp.) make root-derived antimicrobial triterpenes (avenacins) that provide protection against soil-borne diseases. The ability to synthesize avenacins has evolved since the divergence of oats from other cereals and grasses. The major avenacin, A-1, is acylated with N-methylanthranilic acid. Previously, we have cloned and characterized three genes for avenacin synthesis (for the triterpene synthase SAD1, a triterpene-modifying cytochrome P450 SAD2, and the serine carboxypeptidase-like acyl transferase SAD7), which form part of a biosynthetic gene cluster. Here, we identify a fourth member of this gene cluster encoding a GT belonging to clade L of family 1 (UGT74H5), and show that this enzyme is an N-methylanthranilic acid O-glucosyltransferase implicated in the synthesis of avenacin A-1. Two other closely related family 1 GTs (UGT74H6 and UGT74H7) are also expressed in oat roots. One of these (UGT74H6) is able to glucosylate both N-methylanthranilic acid and benzoic acid, whereas the function of the other (UGT74H7) remains unknown. Our investigations indicate that UGT74H5 is likely to be key for the generation of the activated acyl donor used by SAD7 in the synthesis of the major avenacin, A-1, whereas UGT74H6 may contribute to the synthesis of other forms of avenacin that are acylated with benzoic acid.	[Owatworakit, Amorn; Louveau, Thomas; Qi, Xiaoquan; Bakht, Saleha; Mugford, Sam T.; Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Rejzek, Martin; Hughes, Richard K.; Saalbach, Gerhard; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Townsend, Belinda; Jenner, Helen] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Roy, Abhijeet Deb; Goss, Rebecca J. M.] Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Osbourn, A (corresponding author), John Innes Ctr, Dept Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	anne.osbourn@jic.ac.uk	Hughes, Richard K./E-9642-2015; Qi, Xiaoquan/G-1545-2010	Hughes, Richard K./0000-0001-9910-6566; Qi, Xiaoquan/0000-0001-7175-115X; Jenner, Helen/0000-0003-1095-8469; Louveau, Thomas/0000-0002-2902-2735; Mugford, Sam/0000-0002-8537-5578; Field, Rob/0000-0001-8574-0275	Thai Royal Government Studentship award; Biotechnology and Biological Sciences Research Council [BBSRC 83/P13269, BB/C504435/1]; DuPont Agricultural Products; Biotechnology and Biological Sciences Research Council Institute Strategic Programme [BB/J004596/1]; John Innes Foundation; BBSRC [BB/K005952/1, BB/E009913/1, BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K005952/1, BB/E009913/1, BBS/E/J/000C0618, BBS/E/J/00000614] Funding Source: researchfish	Thai Royal Government Studentship award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DuPont Agricultural Products; Biotechnology and Biological Sciences Research Council Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Thai Royal Government Studentship award (to A. O.), Biotechnology and Biological Sciences Research Council Grants BBSRC 83/P13269 and BB/C504435/1 (to X. Q., S. B., and B. T.) and DuPont Agricultural Products (to H. J.).; Supported by the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant "Understanding and Exploiting Plant and Microbial Secondary Metabolism" (BB/J004596/1) and the John Innes Foundation.	Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CROMBIE WML, 1986, PHYTOCHEMISTRY, V25, P2069, DOI 10.1016/0031-9422(86)80069-3; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; Fraser CM, 2007, PLANT PHYSIOL, V144, P1986, DOI 10.1104/pp.107.098970; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Hansen KS, 2003, PHYTOCHEMISTRY, V64, P143, DOI 10.1016/S0031-9422(03)00261-9; Haralampidis K, 2001, P NATL ACAD SCI USA, V98, P13431, DOI 10.1073/pnas.231324698; Kliebenstein DJ, 2012, CURR OPIN PLANT BIOL, V15, P415, DOI 10.1016/j.pbi.2012.05.005; Landmann C, 2007, PLANTA, V226, P417, DOI 10.1007/s00425-007-0492-4; Lanot A, 2006, PLANT J, V48, P286, DOI 10.1111/j.1365-313X.2006.02872.x; Lee H, 1999, J BIOL CHEM, V274, P36637, DOI 10.1074/jbc.274.51.36637; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Lim EK, 2003, GLYCOBIOLOGY, V13, P139, DOI 10.1093/glycob/cwg017; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Maniatis T., 1989, MOL CLONING LAB MANU; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Mugford ST, 2009, PLANT CELL, V21, P2473, DOI 10.1105/tpc.109.065870; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quiel JA, 2003, J BIOL CHEM, V278, P6275, DOI 10.1074/jbc.M211822200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarraga S, 2010, J EXP BOT, V61, P4325, DOI 10.1093/jxb/erq234; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x	43	35	38	0	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3696	3704		10.1074/jbc.M112.426155	http://dx.doi.org/10.1074/jbc.M112.426155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258535	Green Published, hybrid			2022-12-25	WOS:000314845000002
J	Yu, JX; Deng, R; Zhu, HH; Zhang, SS; Zhu, CH; Montminy, M; Davis, R; Feng, GS				Yu, Jianxiu; Deng, Rong; Zhu, Helen H.; Zhang, Sharon S.; Zhu, Changhong; Montminy, Marc; Davis, Roger; Feng, Gen-Sheng			Modulation of Fatty Acid Synthase Degradation by Concerted Action of p38 MAP Kinase, E3 Ligase COP1, and SH2-Tyrosine Phosphatase Shp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE PHOSPHATASE; CANCER; INHIBITION; EXPRESSION; PATHWAY; ALPHA	The Src-homology 2 (SH2) domain-containing tyrosine phosphatase Shp2 has been known to regulate various signaling pathways triggered by receptor and cytoplasmic tyrosine kinases. Here we describe a novel function of Shp2 in control of lipid metabolism by mediating degradation of fatty acid synthase (FASN). p38-phosphorylated COP1 accumulates in the cytoplasm and subsequently binds FASN through Shp2 here as an adapter, leading to FASN-Shp2-COP1 complex formation and FASN degradation mediated by ubiquitination pathway. By fasting p38 is activated and stimulates FASN protein degradation in mice. Consistently, the FASN protein levels are dramatically elevated in mouse liver and pancreas in which Shp2/Ptpn11 is selectively deleted. Thus, this study identifies a new activity for Shp2 in lipid metabolism.	[Yu, Jianxiu; Deng, Rong; Zhu, Changhong] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med SJTU SM, Shanghai 200025, Peoples R China; [Yu, Jianxiu; Deng, Rong; Zhu, Changhong] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med SJTU SM, Shanghai 200025, Peoples R China; [Yu, Jianxiu; Zhu, Helen H.; Zhang, Sharon S.; Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Montminy, Marc] Salk Inst Biol Sci, La Jolla, CA 92037 USA; [Davis, Roger] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med SJTU SM, Shanghai 200025, Peoples R China.	Jianxiu.Yu@gmail.com; gfeng@ucsd.edu		Davis, Roger/0000-0002-0130-1652	National Institutes of Health [R01DK075916, R01DK073945]; National Natural Science Foundation China [31071230, 91129726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073945, R01DK075916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK075916 and R01DK073945 (to G. S. F.) and by National Natural Science Foundation China Grants 31071230 and 91129726 (to J. Y.).	Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Gibbons G, 2005, NAT MED, V11, P722, DOI 10.1038/nm0705-722; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Lai LA, 2004, TOP CURR GENET, V5, P275; Marine JC, 2012, NAT REV CANCER, V12, P455, DOI 10.1038/nrc3271; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Morikawa Y, 2004, J NEUROENDOCRINOL, V16, P105, DOI 10.1111/j.0953-8194.2004.01135.x; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Su CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-243; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P7531, DOI 10.1073/pnas.0811715106; Zhou YL, 2012, MOL BIOL REP, V39, P9733, DOI 10.1007/s11033-012-1838-y	31	27	28	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3823	3830		10.1074/jbc.M112.397885	http://dx.doi.org/10.1074/jbc.M112.397885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269672	hybrid, Green Published			2022-12-25	WOS:000314845000014
J	Brumm, H; Teschke, I				Brumm, Henrik; Teschke, Irmgard			Juvenile Galapagos Pelicans Increase Their Foraging Success by Copying Adult Behaviour	PLOS ONE			English	Article							BROWN-PELICAN; SOCIAL INFLUENCES; HUNTING SUCCESS; ANIMALS; EVOLUTION; AGE; FISH; TRANSMISSION; INFORMATION; MECHANISMS	Social learning is the building block of culture and traditions in humans and nonhuman animals, and its study has a long history. Most investigations have addressed either the causation or the function of social learning. Though much is known about the underlying mechanisms of social learning, demonstrations of its adaptive value in a natural setting are lacking. Here we show that juvenile brown pelicans (Pelecanus occidentalis) can increase their foraging efficiency by copying adult diving behaviour, suggesting that social learning helps juveniles to find profitable food patches. Our findings demonstrate the potential fitness consequences of behavioural copying and thus highlight the possible adaptive importance of social learning. Citation: Brumm H, Teschke I (2012) Juvenile Galapagos Pelicans Increase Their Foraging Success by Copying Adult Behaviour. PLoS ONE 7(12): e51881. doi:10.1371/journal.pone.0051881	[Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Teschke, Irmgard] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	Max Planck Society; Max Planck Society	Brumm, H (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	brumm@orn.mpg.de			German Research Foundation [Br2309/6-1]; Association for the Study of Animal Behaviour	German Research Foundation(German Research Foundation (DFG)); Association for the Study of Animal Behaviour	Financial support was provided by the German Research Foundation (award Br2309/6-1), and the Association for the Study of Animal Behaviour (Christopher Barnard Award for Outstanding Contributions by a New Investigator to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISNER R, 1992, ANIM BEHAV, V44, P327, DOI 10.1016/0003-3472(92)90038-B; ARNQVIST G, 1992, CONDOR, V94, P521, DOI 10.2307/1369223; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Boyd R., 1985, CULTURE EVOLUTIONARY; BRANDT CA, 1984, OECOLOGIA, V62, P132, DOI 10.1007/BF00377386; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; CARL RA, 1987, CONDOR, V89, P525, DOI 10.2307/1368642; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Coblentz BE, 1986, J FIELD ORNITHOL, V57, P62; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Enquist M, 2007, AM ANTHROPOL, V109, P727, DOI 10.1525/AA.2007.109.4.727; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Galef B.G. Jr, 1988, P3; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Holzhaider JC, 2010, LEARN BEHAV, V38, P206, DOI 10.3758/LB.38.3.206; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hultsch H, 2008, NEUROSCIENCE BIRDSON, P204; Jackson MH, 1993, GALAPAGOS NATURAL HI; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Kitowski I, 2009, J ETHOL, V27, P327, DOI 10.1007/s10164-008-0123-y; KREBS JR, 1972, IBIS, V114, P507, DOI 10.1111/j.1474-919X.1972.tb00852.x; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Langen TA, 1996, ETHOLOGY, V102, P157; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LEFEBVRE L, 1986, ETHOLOGY, V71, P295; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; ORIANS GH, 1969, ANIM BEHAV, V17, P316, DOI 10.1016/0003-3472(69)90016-5; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Pike TW, 2012, BIOL LETT, V6, P466; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; Reader SM, 2010, LEARN BEHAV, V38, P265, DOI 10.3758/LB.38.3.265; SCHREIBER RW, 1975, AUK, V92, P649, DOI 10.2307/4084778; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thorpe, 1963, LEARNING INSTINCT AN; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Weigl PD, 1980, ECOLOGY, V61, P214; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381	54	7	7	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51881	10.1371/journal.pone.0051881	http://dx.doi.org/10.1371/journal.pone.0051881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251646	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800102
J	Buren, S; Ortega-Villasante, C; Otvos, K; Samuelsson, G; Bako, L; Villarejo, A				Buren, Stefan; Ortega-Villasante, Cristina; Otvos, Krisztina; Samuelsson, Goran; Bako, Laszlo; Villarejo, Arsenio			Use of the Foot-and-Mouth Disease Virus 2A Peptide Co-Expression System to Study Intracellular Protein Trafficking in Arabidopsis	PLOS ONE			English	Article							FLUORESCENT FUSION PROTEINS; ADP-RIBOSYLATION FACTOR-1; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; COORDINATE EXPRESSION; TRANSIENT EXPRESSION; SECRETORY PATHWAY; MULTIPLE PROTEINS; EXPORT SITES; TRANSPORT	Background: A tool for stoichiometric co-expression of effector and target proteins to study intracellular protein trafficking processes has been provided by the so called 2A peptide technology. In this system, the 16-20 amino acid 2A peptide from RNA viruses allows synthesis of multiple gene products from single transcripts. However, so far the use of the 2A technology in plant systems has been limited. Methodology/Principal Findings: The aim of this work was to assess the suitability of the 2A peptide technology to study the effects exerted by dominant mutant forms of three small GTPase proteins, RABD2a, SAR1, and ARF1 on intracellular protein trafficking in plant cells. Special emphasis was given to CAH1 protein from Arabidopsis, which is trafficking to the chloroplast via a poorly characterized endoplasmic reticulum-to-Golgi pathway. Dominant negative mutants for these GTPases were co-expressed with fluorescent marker proteins as polyproteins separated by a 20 residue self-cleaving 2A peptide. Cleavage efficiency analysis of the generated polyproteins showed that functionality of the 2A peptide was influenced by several factors. This enabled us to design constructs with greatly increased cleavage efficiency compared to previous studies. The dominant negative GTPase variants resulting from cleavage of these 2A peptide constructs were found to be stable and active, and were successfully used to study the inhibitory effect on trafficking of the N-glycosylated CAH1 protein through the endomembrane system. Conclusions/Significance: We demonstrate that the 2A peptide is a suitable tool when studying plant intracellular protein trafficking and that transient protoplast and in planta expression of mutant forms of SAR1 and RABD2a disrupts CAH1 trafficking. Similarly, expression of dominant ARF1 mutants also caused inhibition of CAH1 trafficking to a different extent. These results indicate that early trafficking of the plastid glycoprotein CAH1 depends on canonical vesicular transport mechanisms operating between the endoplasmic reticulum and Golgi apparatus.	[Buren, Stefan; Otvos, Krisztina; Samuelsson, Goran; Bako, Laszlo] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Ortega-Villasante, Cristina; Villarejo, Arsenio] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Otvos, Krisztina] Hungarian Acad Sci, Biol Res Ctr, H-6701 Szeged, Hungary	Umea University; Autonomous University of Madrid; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Buren, S (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.	stefan.buren@gmail.com	Burén, Stefan/L-6705-2014; Otvos, Krisztina/AAL-5796-2021; Samuelsson, Goran/E-1824-2015; Ortega-Villasante, Cristina/F-6719-2012	Burén, Stefan/0000-0002-8487-2732; Otvos, Krisztina/0000-0002-5503-4983; Ortega-Villasante, Cristina/0000-0003-1224-6676	Spanish Ministerio de Ciencia e Innovacion [BIO2006-08946]; Swedish National Research Council, FORMAS; Swedish Foundation for Strategic Research	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Swedish National Research Council, FORMAS(Swedish Research Council Formas); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by Spanish Ministerio de Ciencia e Innovacion (grant BIO2006-08946) to AV and Swedish National Research Council, FORMAS, and the Swedish Foundation for Strategic Research to GS and LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andreeva AV, 2000, BIOCHEM SOC T, V28, P505, DOI 10.1042/0300-5127:0280505; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021021; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DaSilva LLP, 2004, PLANT CELL, V16, P1753, DOI 10.1105/tpc.022673; Davidson PJ, 2006, GLYCOBIOLOGY, V16, P602, DOI 10.1093/glycob/cwj088; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; El Amrani A, 2004, PLANT PHYSIOL, V135, P16, DOI 10.1104/pp.103.032649; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Hancock KR, 1997, BIOTECHNIQUES, V22, P861, DOI 10.2144/97225bm16; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Matheson LA, 2006, CURR OPIN PLANT BIOL, V9, P601, DOI 10.1016/j.pbi.2006.09.016; Memon AR, 2004, BBA-BIOMEMBRANES, V1664, P9, DOI 10.1016/j.bbamem.2004.04.005; Min MK, 2007, PLANT PHYSIOL, V143, P1601, DOI 10.1104/pp.106.095091; Nanjo Y, 2006, PLANT CELL, V18, P2582, DOI 10.1105/tpc.105.039891; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Pimpl P, 2003, PLANT CELL, V15, P1242, DOI 10.1105/tpc.010140; Pinheiro H, 2009, J CELL SCI, V122, P3749, DOI 10.1242/jcs.050625; Radhamony RN, 2006, TRENDS CELL BIOL, V16, P385, DOI 10.1016/j.tcb.2006.06.003; Randall J, 2004, PLANT SCI, V167, P367, DOI 10.1016/j.plantsci.2004.04.005; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Samalova M, 2006, TRAFFIC, V7, P1701, DOI 10.1111/j.1600-0854.2006.00502.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stefano G, 2006, PLANT J, V46, P95, DOI 10.1111/j.1365-313X.2006.02675.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takeuchi M, 2002, PLANT J, V31, P499, DOI 10.1046/j.1365-313X.2002.01372.x; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	47	19	21	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51973	10.1371/journal.pone.0051973	http://dx.doi.org/10.1371/journal.pone.0051973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251667	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800122
J	Carl, C; Poole, AJ; Williams, MR; de Nys, R				Carl, Christina; Poole, Andrew J.; Williams, Mike R.; de Nys, Rocky			Where to Settle-Settlement Preferences of Mytilus galloprovincialis and Choice of Habitat at a Micro Spatial Scale	PLOS ONE			English	Article							NORTHERN NEW-ZEALAND; SECONDARY SETTLEMENT; LARVAL SETTLEMENT; PERNA-CANALICULUS; EDULIS-L; MUSSEL; BEHAVIOR; MICROTOPOGRAPHY; TOMOGRAPHY; MORPHOLOGY	The global mussel aquaculture industry uses specialised spat catching and nursery culture ropes made of multi-filament synthetic and natural fibres to optimise settlement and retention of mussels for on-growing. However, the settlement ecology and preferences of mussels are poorly understood and only sparse information exists in a commercial context. This study quantified the settlement preferences of pediveligers and plantigrades of Mytilus galloprovincialis on increasingly complex surfaces and settlement locations at a micro spatial scale on and within ropes under commercial hatchery operating conditions using optical microscopy and X-ray micro-computed tomography (mu CT). M. galloprovincialis has clear settlement preferences for more complex materials and high selectivity for settlement sites from the pediveliger through to the plantigrade stage. Pediveligers of M. galloprovincialis initially settle inside specialised culture ropes. Larger pediveligers were located close to the exterior of ropes as they increased in size over time. In contrast, smaller individuals were located deeper inside of the ropes over time. This study demonstrates that X-ray mu CT is an excellent non-destructive technique for mapping settlement and attachment sites of individuals as early as one day post settlement, and quantifies the number and location of settled individuals on and within ropes as a tool to understand and optimise settlement in complex multi-dimensional materials and environments.	[Carl, Christina; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Poole, Andrew J.] CSIRO Mat Sci Engn, Belmont, MA USA; [Williams, Mike R.] Fisheries Victoria, Fisheries Res Branch, Queenscliff, Australia; [Williams, Mike R.] Victorian Shellfish Hatcheries Pty Ltd, Queenscliff, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Carl, C (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	tine.carl@my.jcu.edu.au	de Nys, Rocky/D-6741-2012; Praeger, Christina/A-7224-2013	de Nys, Rocky/0000-0003-3869-4928; Praeger, Christina/0000-0002-1947-122X; Poole, Andrew/0000-0001-9584-6452	James Cook University; CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship; James Cook University Postgraduate Research Scholarship; CSIRO's Wealth from Oceans Flagship	James Cook University; CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship; James Cook University Postgraduate Research Scholarship; CSIRO's Wealth from Oceans Flagship	Financial support was provided by CSIRO's Wealth from Oceans Flagship and James Cook University. CC was further supported by a CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship and a James Cook University Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro AC, 2004, AQUACULTURE, V241, P269, DOI 10.1016/j.aquaculture.2004.07.029; Alfaro AC, 2002, MALACOLOGIA, V44, P1; BAYNE B. L., 1965, OPHELIA, V2, P1; BAYNE BL, 1964, J ANIM ECOL, V33, P513, DOI 10.2307/2569; BAYNE BL, 1976, MARINE MUSSELS THEIR, P81; Brenner M, 2010, AQUACULT ENG, V42, P128, DOI 10.1016/j.aquaeng.2010.02.001; Buchanan S, 1997, J SHELLFISH RES, V16, P71; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Filgueira R, 2007, AQUACULT ENG, V37, P195, DOI 10.1016/j.aquaeng.2007.06.001; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gribben PE, 2011, AQUACULTURE, V319, P240, DOI 10.1016/j.aquaculture.2011.06.026; Hayden BJ, 2011, AQUACULT INT, V19, P957, DOI 10.1007/s10499-010-9413-9; Helm M. M., 2004, 471 FAO; HICKMAN RW, 1992, MUSSEL MYTILUS ECOLO, P465; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Koehl MAR, 2007, BIOFOULING, V23, P357, DOI 10.1080/08927010701492250; Kohler J, 1999, BIOFOULING, V14, P237; LUTZ RA, 1992, MUSSEL MYTILUS ECOLO, P53; Marshall DJ, 2003, MAR ECOL PROG SER, V246, P153, DOI 10.3354/meps246153; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; Pernet F, 2003, MAR ECOL PROG SER, V260, P125, DOI 10.3354/meps260125; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; Pettersen AK, 2010, AQUACULTURE, V309, P115, DOI 10.1016/j.aquaculture.2010.09.024; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Seed R., 1976, MARINE MUSSELS THEIR, P13; Silverman HG, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P273, DOI 10.1007/978-3-7091-0286-2_18; Stevens C, 2008, AQUACULT ENG, V38, P145, DOI 10.1016/j.aquaeng.2008.01.006; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Walter U, 2003, BIOMOL ENG, V20, P407, DOI 10.1016/S1389-0344(03)00064-9; Walters LJ, 1996, MAR ECOL PROG SER, V137, P161, DOI 10.3354/meps137161	35	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52358	10.1371/journal.pone.0052358	http://dx.doi.org/10.1371/journal.pone.0052358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251710	Green Published, Green Accepted, gold			2022-12-25	WOS:000312386800162
J	Cheng, D; Guo, YJ; Li, ZZ; Liu, YJ; Gao, X; Gao, Y; Cheng, X; Hu, JH; Wang, HY				Cheng, De; Guo, Yanjie; Li, Zhenzhen; Liu, Yajun; Gao, Xing; Gao, Yi; Cheng, Xiang; Hu, Junhe; Wang, Huayan			Porcine Induced Pluripotent Stem Cells Require LIF and Maintain Their Developmental Potential in Early Stage of Embryos	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; GENERATION; FIBROBLASTS; FETAL; LINES; DERIVATION; MICE	Porcine induced pluripotent stem (piPS) cell lines have been generated recently by using a cocktail of defined transcription factors, however, the features of authentic piPS cells have not been agreed upon and most of published iPS clones did not meet the stringent requirements of pluripotency. Here, we report the generation of piPS cells from fibroblasts using retrovirus carrying four mouse transcription factors (mOct4, mSox2, mKlf4 and mc-Myc, 4F). Multiple LIF-dependent piPS cell lines were generated and these cells showed the morphology similar to mouse embryonic stem cells and other pluripotent stem cells. In addition to the routine characterization, piPS cells were injected into porcine pre-compacted embryos to generate chimera embryos and nuclear transfer (NT) embryos. The results showed that piPS cells retain the ability to integrate into inner and outer layers of the blastocysts, and support the NT embryos development to blastocysts. The generations of chimera embryos and NT embryos derived from piPS clones are a practical means to determine the quality of iPS cells ex vivo. Citation: Cheng D, Guo Y, Li Z, Liu Y, Gao X, et al. (2012) Porcine Induced Pluripotent Stem Cells Require LIF and Maintain Their Developmental Potential in Early Stage of Embryos. PLoS ONE 7(12): e51778. doi:10.1371/journal.pone.0051778	[Cheng, De; Guo, Yanjie; Li, Zhenzhen; Liu, Yajun; Gao, Xing; Gao, Yi; Cheng, Xiang; Hu, Junhe; Wang, Huayan] NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, HY (corresponding author), NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	hhwang101@163.com	Yajun, Liu/F-2581-2015; cheng, xiang/C-9987-2016; Yajun, Liu/R-2758-2016; Liu, Yajun/ABE-5076-2020	Yajun, Liu/0000-0002-8203-5762; Yajun, Liu/0000-0002-8203-5762; Liu, Yajun/0000-0002-8203-5762; cheng, xiang/0000-0001-5315-9830	National Basic Research Program of China [2009CB941002]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by The National Basic Research Program of China (2009CB941002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Bao L, 2011, CELL RES, V21, P600, DOI 10.1038/cr.2011.6; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cheng D, 2012, CELL REPROGRAM, V14, P312, DOI 10.1089/cell.2012.0025; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Hu J, 2012, REPROD DOMEST ANIM, V47, P873, DOI 10.1111/j.1439-0531.2011.01982.x; Hu JH, 2011, ZYGOTE, V19, P191, DOI 10.1017/S0967199410000663; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ishizuka T, 2011, EUR J PHARMACOL, V668, P42, DOI 10.1016/j.ejphar.2011.06.026; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kou ZH, 2010, BIOL REPROD, V83, P238, DOI 10.1095/biolreprod.110.084731; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Luo JS, 2011, STEM CELLS DEV, V20, P1669, DOI 10.1089/scd.2011.0127; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ren JT, 2011, CELL RES, V21, P849, DOI 10.1038/cr.2011.37; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	43	61	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51778	10.1371/journal.pone.0051778	http://dx.doi.org/10.1371/journal.pone.0051778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251622	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800085
J	Liu, WM; Zhang, F; Moshiach, S; Zhou, B; Huang, C; Srinivasan, K; Khurana, S; Zheng, Y; Lahti, JM; Zhang, XA				Liu, Wei M.; Zhang, Feng; Moshiach, Simon; Zhou, Bin; Huang, Chao; Srinivasan, Kamalakkannan; Khurana, Seema; Zheng, Yi; Lahti, Jill M.; Zhang, Xin A.			Tetraspanin CD82 Inhibits Protrusion and Retraction in Cell Movement by Attenuating the Plasma Membrane-Dependent Actin Organization	PLOS ONE			English	Article							METASTASIS SUPPRESSOR KAI1/CD82; TRANSMEMBRANE PROTEIN FAMILY; STRESS FIBER FORMATION; PROSTATE-CANCER CELLS; HUMAN T-CELLS; ARP2/3 COMPLEX; GROWTH-FACTOR; RHO-GTPASES; LEADING-EDGE; MORPHOLOGICAL-CHANGES	To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we assessed which cellular events critical for motility are altered by KAI1/CD82 and how KAI1/CD82 regulates these events. We found that KAI1/CD82-expressing cells typically exhibited elongated cellular tails and diminished lamellipodia. Live imaging demonstrated that the polarized protrusion and retraction of the plasma membrane became deficient upon KAI1/CD82 expression. The deficiency in developing these motility-related cellular events was caused by poor formations of actin cortical network and stress fiber and by aberrant dynamics in actin organization. Rac1 activity was reduced by KAI1/CD82, consistent with the diminution of lamellipodia and actin cortical network; while the growth factor-stimulated RhoA activity was blocked by KAI1/CD82, consistent with the loss of stress fiber and attenuation in cellular retraction. Upon KAI1/CD82 expression, Rac effector cofilin was not enriched at the cell periphery to facilitate lamellipodia formation while Rho kinase exhibited a significantly lower activity leading to less retraction. Phosphatidylinositol 4, 5-biphosphate, which initiates actin polymerization from the plasma membrane, became less detectable at the cell periphery in KAI1/CD82-expressing cells. Moreover, KAI1/CD82-induced phenotypes likely resulted from the suppression of multiple signaling pathways such as integrin and growth factor signaling. In summary, at the cellular level KAI1/CD82 inhibited polarized protrusion and retraction events by disrupting actin reorganization; at the molecular level, KAI1/CD82 deregulated Rac1, RhoA, and their effectors cofilin and Rho kinase by perturbing the plasma membrane lipids. Citation: Liu WM, Zhang F, Moshiach S, Zhou B, Huang C, et al. (2012) Tetraspanin CD82 Inhibits Protrusion and Retraction in Cell Movement by Attenuating the Plasma Membrane-Dependent Actin Organization. PLoS ONE 7(12): e51797. doi:10.1371/journal.pone.0051797	[Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc, Memphis, TN USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA; [Moshiach, Simon; Lahti, Jill M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Srinivasan, Kamalakkannan; Khurana, Seema] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Zheng, Yi] Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zhang, XA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA.	xin-zhang-1@ouhsc.edu	Zheng, Yi/J-7235-2015; Huang, Chao/O-6170-2017	Zheng, Yi/0000-0001-7089-6074; Huang, Chao/0000-0002-5747-4560; Liu, Wei/0000-0003-2846-9233; Zhang, Feng/0000-0002-6103-1498	National Institutes of Health [CA096991, W81XWH-04-1-0156]; Department of Defense Prostate Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health and Department of Defense Prostate Cancer Research Program. This work was supported by research grants CA096991 and W81XWH-04-1-0156 (to XAZ) from National Institutes of Health and Department of Defense Prostate Cancer Research Program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bari R, 2009, AM J PATHOL, V174, P647, DOI 10.2353/ajpath.2009.080685; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Berditchevski F, 2001, J CELL SCI, V114, P4143; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Delaguillaumie A, 2004, J CELL SCI, V117, P5269, DOI 10.1242/jcs.01380; Delaguillaumie A, 2002, J CELL SCI, V115, P433; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; DUGINA VB, 1995, J CELL SCI, V108, P1659; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Guo XZ, 1996, CANCER RES, V56, P4876; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Higashiyama M, 1998, CANCER, V83, P466, DOI 10.1002/(SICI)1097-0142(19980801)83:3<466::AID-CNCR15>3.0.CO;2-U; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Iwata S, 2002, EUR J IMMUNOL, V32, P1328, DOI 10.1002/1521-4141(200205)32:5<1328::AID-IMMU1328>3.0.CO;2-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jee B, 2003, EXP MOL MED, V35, P30, DOI 10.1038/emm.2003.5; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kroczynska B, 2006, P NATL ACAD SCI USA, V103, P14128, DOI 10.1073/pnas.0604544103; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; Lagaudriere-Gesbert C, 1998, EUR J IMMUNOL, V28, P4332, DOI 10.1002/(SICI)1521-4141(199812)28:12<4332::AID-IMMU4332>3.0.CO;2-8; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; LEBELBINAY S, 1995, J IMMUNOL, V155, P101; Lee JH, 2003, CANCER RES, V63, P7247; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marcoux N, 2005, CELL SIGNAL, V17, P1449, DOI 10.1016/j.cellsig.2005.03.001; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Miyake K, 2001, J CELL SCI, V114, P3487; Miyake M, 1999, ONCOGENE, V18, P2397, DOI 10.1038/sj.onc.1202556; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagaishi K, 1999, J BIOCHEM-TOKYO, V125, P891, DOI 10.1093/oxfordjournals.jbchem.a022365; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nebl T, 2000, CURR BIOL, V10, pR351, DOI 10.1016/S0960-9822(00)00465-6; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOJIMA Y, 1993, CELL IMMUNOL, V152, P249, DOI 10.1006/cimm.1993.1285; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Ono M, 1999, CANCER RES, V59, P2335; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Pujades C, 1996, BIOCHEM J, V313, P899, DOI 10.1042/bj3130899; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sauer G, 2003, CLIN CANCER RES, V9, P6426; SCHLOSSMAN SF, 1994, BLOOD, V83, P879; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Shibagaki N, 1998, EUR J IMMUNOL, V28, P1125, DOI 10.1002/(SICI)1521-4141(199804)28:04<1125::AID-IMMU1125>3.0.CO;2-C; Shibagaki N, 1999, EUR J IMMUNOL, V29, P4081, DOI 10.1002/(SICI)1521-4141(199912)29:12<4081::AID-IMMU4081>3.3.CO;2-9; SMALL JV, 1993, SYM SOC EXP BIOL, V47, P57; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Takaoka A, 1998, JPN J CANCER RES, V89, P397, DOI 10.1111/j.1349-7006.1998.tb00577.x; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Uchida S, 1999, BRIT J CANCER, V79, P1168, DOI 10.1038/sj.bjc.6690186; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Verdijk P, 2004, EUR J IMMUNOL, V34, P156, DOI 10.1002/eji.200324241; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Yang XH, 2001, CANCER RES, V61, P5284; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, CANCER RES, V63, P2665; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	108	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51797	10.1371/journal.pone.0051797	http://dx.doi.org/10.1371/journal.pone.0051797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251627	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800086
J	Montenegro, MF; Saez-Ayala, M; Pinero-Madrona, A; Cabezas-Herrera, J; Rodriguez-Lopez, JN				Montenegro, Maria F.; Saez-Ayala, Magali; Pinero-Madrona, Antonio; Cabezas-Herrera, Juan; Neptuno Rodriguez-Lopez, Jose			Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; PHOSPHATASE 2A; MST2 PATHWAY; CELL-DEATH; PROTEIN; DAMAGE; RAS; 3-O-(3,4,5-TRIMETHOXYBENZOYL)-(-)-EPICATECHIN; METHOTREXATE; ACETYLATION	Background: Tumour suppressor genes are often transcriptionally silenced by promoter hypermethylation, and recent research has implicated alterations in chromatin structure as the mechanistic basis for this repression. In addition to DNA methylation, other epigenetic post-translational modifications that modulate the stability and binding of specific transcription factors to gene promoters have emerged as important mechanisms for controlling gene expression. The aim of this study was to analyse the implications of these mechanisms and their molecular connections in the reactivation of RASSF1A in breast cancer. Methods: Compounds that modulate the intracellular concentration of adenosine, such as dipyridamole (DIPY), greatly increase the antiproliferative effects of 3-O-(3,4,5-trimethoxybenzoyl)-(-)-catechin (TMCG), a synthetic antifolate derived from the structure of tea catechins. Quantitative real-time PCR arrays and MALDI-TOF mass spectrometry indicated that this combination (TMCG/DIPY) induced apoptosis in breast cancer cells by modulating the methylation levels of DNA and proteins (such as E2F1), respectively. Chromatin immunoprecipitation (ChIP) assays were employed to confirm that this combination induced chromatin remodelling of the RASSF1A promoter and increased the occupancy of E2F1 at the promoter of this tumour suppressor gene. Results: The TMCG/DIPY combination acted as an epigenetic treatment that reactivated RASSF1A expression and induced apoptosis in breast cancer cells. In addition to modulating DNA methylation and chromatin remodelling, this combination also induced demethylation of the E2F1 transcription factor. The ChIP assay showed enhancement of E2F1 occupancy at the unmethylated RASSF1A promoter after TMCG/DIPY treatment. Interestingly, inhibition of E2F1 demethylation using an irreversible inhibitor of lysine-specific demethylase 1 reduced both TMCG/DIPY-mediated RASSF1A expression and apoptosis in MDA-MB-231 cells, suggesting that DNA and protein demethylation may act together to control these molecular and cellular processes. Conclusions/Significance: This study demonstrates that simultaneous targeting of DNA and E2F1 methylation is an effective epigenetic treatment that reactivates RASSF1A expression and induces apoptosis in breast cancer cells. Citation: Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN (2012) Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation. PLoS ONE 7(12): e52231. doi: 10.1371/journal.pone.0052231	[Montenegro, Maria F.; Saez-Ayala, Magali; Neptuno Rodriguez-Lopez, Jose] Univ Murcia, Dept Biochem & Mol Biol A, Sch Biol, Murcia, Spain; [Pinero-Madrona, Antonio] Univ Hosp Virgen Arrixaca, Inst Murciano Invest Biomed, Dept Surg, Murcia, Spain; [Cabezas-Herrera, Juan] Univ Hosp Virgen Arrixaca, Inst Murciano Invest Biomed, Translat Canc Res Grp, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Rodriguez-Lopez, JN (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Sch Biol, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	neptuno@um.es	CABEZAS-HERRERA, JUAN/J-9434-2015; Piñero-Madrona, Antonio/AAB-5138-2022; Saez Ayala, Magali/T-9810-2017; Montenegro, Maria Fernanda/AAF-2695-2021; Neptuno, Jose/F-5012-2016; Cabezas-Herrera, Juan/F-3850-2016	CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Saez Ayala, Magali/0000-0002-8726-0053; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173; Cabezas-Herrera, Juan/0000-0002-6833-4977; Montenegro, Maria Fernanda/0000-0002-0064-0484; Pinero-Madrona, Antonio/0000-0002-7718-8318	Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-12043-C02-01]; Fundacion Seneca, Region de Murcia (FS-RM) [15230/PI/10]; EU [ERA293514]; Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC)	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca, Region de Murcia (FS-RM)(Fundacion Seneca); EU(European Commission); Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC)	This work was supported by grants from Ministerio de Ciencia e Innovacion (MICINN) (SAF2009-12043-C02-01), Fundacion Seneca, Region de Murcia (FS-RM) (15230/PI/10), and EU ERA293514. J.C-H is contracted by the Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS). M.F.M is contracted by Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012847; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jenal M, 2009, MOL CANCER RES, V7, P916, DOI 10.1158/1541-7786.MCR-08-0359; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kontaki H, 2010, CELL CYCLE, V9, P3836, DOI 10.4161/cc.9.19.13384; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Lin WC, 2001, GENE DEV, V15, P1833; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Louie MC, 2010, MOL CANCER RES, V8, P343, DOI 10.1158/1541-7786.MCR-09-0395; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Saez-Ayala M, 2012, EXP CELL RES, V318, P1146, DOI 10.1016/j.yexcr.2012.03.022; Saez-Ayala M, 2011, CHEMMEDCHEM, V6, P440, DOI 10.1002/cmdc.201000482; Sanchez-del-Campo L, 2008, INT J CANCER, V123, P2446, DOI 10.1002/ijc.23813; Sanchez-del-Campo L, 2009, MOL PHARMACEUT, V6, P883, DOI 10.1021/mp800259k; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tian YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017017; Tommasi S, 2005, CANCER RES, V65, P92; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Winter-Vann AM, 2003, P NATL ACAD SCI USA, V100, P6529, DOI 10.1073/pnas.1135239100; Xie Q, 2011, J RECEPT SIG TRANSD, V31, P139, DOI 10.3109/10799893.2011.552914; Yan PS, 2003, CANCER RES, V63, P6178; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115	41	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52231	10.1371/journal.pone.0052231	http://dx.doi.org/10.1371/journal.pone.0052231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251702	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800153
J	Douglas-Escobar, M; Rossignol, C; Steindler, D; Zheng, T; Weiss, MD				Douglas-Escobar, Martha; Rossignol, Candace; Steindler, Dennis; Zheng, Tong; Weiss, Michael D.			Neurotrophin-Induced Migration and Neuronal Differentiation of Multipotent Astrocytic Stem Cells In Vitro	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEURAL PROGENITOR CELLS; BRAIN-INJURY; OLIGODENDROCYTE PROGENITORS; NEONATAL ENCEPHALOPATHY; SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; MAGNESIUM-SULFATE; MOTOR-NEURONS; SECRETE GDNF	Hypoxic ischemic encephalopathy (HIE) affects 2-3 per 1000 full-term neonates. Up to 75% of newborns with severe HIE die or have severe neurological handicaps. Stem cell therapy offers the potential to replace HIE-damaged cells and enhances the autoregeneration process. Our laboratory implanted Multipotent Astrocytic Stem Cells (MASCs) into a neonatal rat model of hypoxia-ischemia (HI) and demonstrated that MASCs move to areas of injury in the cortex and hippocampus. However, only a small proportion of the implanted MASCs differentiated into neurons. MASCs injected into control pups did not move into the cortex or differentiate into neurons. We do not know the mechanism by which the MASCs moved from the site of injection to the injured cortex. We found neurotrophins present after the hypoxic-ischemic milieu and hypothesized that neurotrophins could enhance the migration and differentiation of MASCs. Using a Boyden chamber device, we demonstrated that neurotrophins potentiate the in vitro migration of stem cells. NGF, GDNF, BDNF and NT-3 increased stem cell migration when compared to a chemokinesis control. Also, MASCs had increased differentiation toward neuronal phenotypes when these neurotrophins were added to MASC culture tissue. Due to this finding, we believed neurotrophins could guide migration and differentiation of stem cell transplants after brain injury.	[Douglas-Escobar, Martha; Weiss, Michael D.] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA; [Rossignol, Candace; Steindler, Dennis; Zheng, Tong] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Steindler, Dennis; Zheng, Tong; Weiss, Michael D.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Douglas-Escobar, M (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32611 USA.	marthave@ufl.edu	Steindler, Dennis/AAJ-5811-2020		AAP Klaus Research Award;  [AHA 0825454E]	AAP Klaus Research Award; 	This work was supported by grants AHA 0825454E grant and AAP Klaus Research Award (MDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasios F, 2012, ARCH GYNECOL OBSTET, V285, P1001, DOI 10.1007/s00404-011-2082-8; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Barrett Robert D., 2007, Birth Defects Research, V81, P163, DOI 10.1002/bdrc.20095; BEILHARZ EJ, 1993, MOL BRAIN RES, V18, P209, DOI 10.1016/0169-328X(93)90191-Q; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bennet L, ANN NEUROLOGY; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cornejo M, 2010, NEUROCHEM RES, V35, P1643, DOI 10.1007/s11064-010-0225-0; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Daadi Marcel M., 2008, V438, P205, DOI 10.1007/978-1-59745-133-8_17; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Glaser T, 2007, STEM CELLS, V25, P3016, DOI 10.1634/stemcells.2007-0218; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LEVENE MI, 1990, DEV MED CHILD NEUROL, V32, P567; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038243; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Low JA, 1996, AM J OBSTET GYNECOL, V175, P1383, DOI 10.1016/S0002-9378(96)70063-7; Ma J, 2007, NEUROCHEM INT, V51, P57, DOI 10.1016/j.neuint.2007.04.012; Mittendorf R, 2006, J PERINATOL, V26, P57, DOI 10.1038/sj.jp.7211419; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Park KI, 2002, GENE THER, V9, P613, DOI 10.1038/sj.gt.3301721; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Petridis AK, 2011, J CLIN NEUROSCI, V18, P265, DOI 10.1016/j.jocn.2010.06.021; Pierrat V, 2005, ARCH DIS CHILD-FETAL, V90, P257, DOI 10.1136/adc.2003.047985; Pineda JR, 2007, GENE THER, V14, P118, DOI 10.1038/sj.gt.3302847; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Sato Y, 2008, REPROD SCI, V15, P613, DOI 10.1177/1933719108317299; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2002, CLIN PERINATOL, V29, P675, DOI 10.1016/S0095-5108(02)00056-8; Shi H, 2008, AM J PHYSIOL-RENAL, V294, pF229, DOI 10.1152/ajprenal.00386.2007; Sizonenko SV, 2007, SEMIN FETAL NEONAT M, V12, P241, DOI 10.1016/j.siny.2007.01.007; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Wolfberg AJ, 2007, SEMIN FETAL NEONAT M, V12, P296, DOI 10.1016/j.siny.2007.01.021; Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015; Zhang L, 2012, INT J DEV NEUROSCI; Zheng T, 2006, BRAIN RES, V1112, P99, DOI 10.1016/j.brainres.2006.07.014; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	64	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51706	10.1371/journal.pone.0051706	http://dx.doi.org/10.1371/journal.pone.0051706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251608	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200155
J	King, GM; Judd, C; Kuske, CR; Smith, C				King, Gary M.; Judd, Craig; Kuske, Cheryl R.; Smith, Conor			Analysis of Stomach and Gut Microbiomes of the Eastern Oyster (Crassostrea virginica) from Coastal Louisiana, USA	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SP-NOV.; PHYLOGENETIC ANALYSIS; COMPLETE GENOME; DIVERSITY; MYCOPLASMA; CULTURE; IDENTIFICATION; HYBRIDIZATION; MICROFLORA	We used high throughput pyrosequencing to characterize stomach and gut content microbiomes of Crassostrea virginica, the Easter oyster, obtained from two sites, one in Barataria Bay (Hackberry Bay) and the other in Terrebonne Bay (Lake Caillou), Louisiana, USA. Stomach microbiomes in oysters from Hackberry Bay were overwhelmingly dominated by Mollicutes most closely related to Mycoplasma; a more rich community dominated by Planctomyctes occurred in Lake Caillou oyster stomachs. Gut communities for oysters from both sites differed from stomach communities, and harbored a relatively diverse assemblage of phylotypes. Phylotypes most closely related to Shewanella and a Chloroflexi strain dominated the Lake Caillou and Hackberry Bay gut microbiota, respectively. While many members of the stomach and gut microbiomes appeared to be transients or opportunists, a putative core microbiome was identified based on phylotypes that occurred in all stomach or gut samples only. The putative core stomach microbiome comprised 5 OTUs in 3 phyla, while the putative core gut microbiome contained 44 OTUs in 12 phyla. These results collectively revealed novel microbial communities within the oyster digestive system, the functions of the oyster microbiome are largely unknown. A comparison of microbiomes from Louisiana oysters with bacterial communities reported for other marine invertebrates and fish indicated that molluscan microbiomes were more similar to each other than to microbiomes of polychaetes, decapods and fish.	[King, Gary M.; Judd, Craig; Smith, Conor] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Los Alamos National Laboratory	King, GM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gkingme@gmail.com			NSF [OCE-1043126]; GoMRI-LSU; Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD) [20080464ER]	NSF(National Science Foundation (NSF)); GoMRI-LSU; Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD)(United States Department of Energy (DOE)Los Alamos National Laboratory)	The authors acknowledge NSF award OCE-1043126 and GoMRI-LSU funding to GK for support of GK, CS and CJ. The 454 Titanium sequencing was provided by a Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD) to CRK (20080464ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; AZEVEDO C, 1993, DIS AQUAT ORGAN, V16, P55, DOI 10.3354/dao016055; Bano N, 2007, ENVIRON MICROBIOL, V9, P2636, DOI 10.1111/j.1462-2920.2007.01381.x; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; BOYLE PJ, 1987, CURR MICROBIOL, V15, P85, DOI 10.1007/BF01589367; Cardoso AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033440; Chen JG, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/209406; Clements KD, 2007, MAR BIOL, V150, P1431, DOI 10.1007/s00227-006-0443-9; Sobrinho PDC, 2010, APPL ENVIRON MICROB, V76, P1290, DOI 10.1128/AEM.00861-09; CROSBY MP, 1990, LIMNOL OCEANOGR, V35, P625, DOI 10.4319/lo.1990.35.3.0625; DAME RF, 1985, NETH J SEA RES, V19, P265, DOI 10.1016/0077-7579(85)90032-8; DAME RF, 1992, J EXP MAR BIOL ECOL, V164, P147, DOI 10.1016/0022-0981(92)90171-6; DEPAOLA A, 1990, APPL ENVIRON MICROB, V56, P2299, DOI 10.1128/AEM.56.8.2299-2302.1990; DOUILLET P, 1993, BIOL BULL-US, V184, P36, DOI 10.2307/1542378; Fall S, 2007, APPL ENVIRON MICROB, V73, P5199, DOI 10.1128/AEM.02616-06; Faury N, 2004, INT J SYST EVOL MICR, V54, P2137, DOI 10.1099/ijs.0.63232-0; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Galtsoff P.S, 1964, AM OYSTER CRASSOSTRE, V64; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Green TJ, 2010, J APPL MICROBIOL, V109, P613, DOI 10.1111/j.1365-2672.2010.04687.x; Gruenthal, 2007, CONSERVATION GENETIC; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; HARSHBARGER JC, 1977, SCIENCE, V196, P666, DOI 10.1126/science.193184; Harwood VJ, 2004, J MICROBIOL METH, V59, P301, DOI 10.1016/j.mimet.2004.08.001; Hernandez-Zarate G, 2006, J APPL MICROBIOL, V100, P664, DOI 10.1111/j.1365-2672.2005.02800.x; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Huang ZB, 2010, AQUAC RES, V41, pe760, DOI 10.1111/j.1365-2109.2010.02577.x; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kassaify ZG, 2009, J COASTAL RES, V25, P469, DOI 10.2112/07-0962.1; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; KIRCHHOFF H, 1987, INT J SYST BACTERIOL, V37, P192, DOI 10.1099/00207713-37-3-192; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; KROL RM, 1991, J INVERTEBR PATHOL, V57, P362, DOI 10.1016/0022-2011(91)90140-L; KUEH CSW, 1985, J APPL BACTERIOL, V59, P41, DOI 10.1111/j.1365-2672.1985.tb01773.x; La Valley KJ, 2009, J SHELLFISH RES, V28, P827, DOI 10.2983/035.028.0412; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li K, 2007, J APPL MICROBIOL, V103, P675, DOI 10.1111/j.1365-2672.2007.03295.x; Li M, 2009, MICROB ECOL, V58, P892, DOI 10.1007/s00248-009-9550-8; MAYASICH SA, 1987, MICROBIAL ECOL, V14, P157, DOI 10.1007/BF02013020; Meziti A, 2010, FEMS MICROBIOL ECOL, V74, P472, DOI 10.1111/j.1574-6941.2010.00964.x; Moran D, 2005, MICROB ECOL, V49, P590, DOI 10.1007/s00248-004-0097-4; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Pujalte M J, 1999, Int Microbiol, V2, P259; Roeselers G, 2011, ISME J, DOI [10.1038/ismeJ2011.38, DOI 10.1038/ISMEJ2011.38]; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WARD N, 1995, APPL ENVIRON MICROB, V61, P2270, DOI 10.1128/AEM.61.6.2270-2275.1995; Ward N., 2006, PROKARYOTES HDB BIOL, V7, P757, DOI DOI 10.1007/0-387-30747-8_; Wetz MS, 2002, AQUAT MICROB ECOL, V28, P87, DOI 10.3354/ame028087; WISEMAN WJ, 1990, ESTUARIES, V13, P265, DOI 10.2307/1351917; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]	70	160	162	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51475	10.1371/journal.pone.0051475	http://dx.doi.org/10.1371/journal.pone.0051475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251548	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200117
J	Vogt, L; Grobe, P; Quast, B; Bartolomaeus, T				Vogt, Lars; Grobe, Peter; Quast, Bjoern; Bartolomaeus, Thomas			Fiat or Bona Fide Boundary-A Matter of Granular Perspective	PLOS ONE			English	Article							EVOLUTION; HOMOLOGY	Background: Distinguishing bona fide (i.e. natural) and fiat (i.e. artificial) physical boundaries plays a key role for distinguishing natural from artificial material entities and is thus relevant to any scientific formal foundational top-level ontology, as for instance the Basic Formal Ontology (BFO). In BFO, the distinction is essential for demarcating two foundational categories of material entity: object and fiat object part. The commonly used basis for demarcating bona fide from fiat boundary refers to two criteria: (i) intrinsic qualities of the boundary bearers (i.e. spatial/physical discontinuity, qualitative heterogeneity) and (ii) mind-independent existence of the boundary. The resulting distinction of bona fide and fiat boundaries is considered to be categorial and exhaustive. Methodology/Principal Findings: By referring to various examples from biology, we demonstrate that the hitherto used distinction of boundaries is not categorial: (i) spatial/physical discontinuity is a matter of scale and the differentiation of bona fide and fiat boundaries is thus granularity-dependent, and (ii) this differentiation is not absolute, but comes in degrees. By reducing the demarcation criteria to mind-independence and by also considering dispositions and historical relations of the bearers of boundaries, instead of only considering their spatio-structural properties, we demonstrate with various examples that spatio-structurally fiat boundaries can nevertheless be mind-independent and in this sense bona fide. Conclusions/Significance: We argue that the ontological status of a given boundary is perspective-dependent and that the strictly spatio-structural demarcation criteria follow a static perspective that is ignorant of causality and the dynamics of reality. Based on a distinction of several ontologically independent perspectives, we suggest different types of boundaries and corresponding material entities, including boundaries based on function (locomotion, physiology, ecology, development, reproduction) and common history (development, heredity, evolution). We argue that for each perspective one can differentiate respective bona fide from fiat boundaries.	[Vogt, Lars; Quast, Bjoern; Bartolomaeus, Thomas] Univ Bonn, Inst Evolut Biol & Onkol, Bonn, Germany; [Grobe, Peter] Forsch Museum Alexander Koenig Bonn, Bonn, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Vogt, L (corresponding author), Univ Bonn, Inst Evolut Biol & Onkol, Bonn, Germany.	lars.m.vogt@gmail.com	Vogt, Lars/K-4166-2012	Vogt, Lars/0000-0002-8280-0487; Quast, Bjorn/0000-0002-3760-5834				Amundson R, 1998, BIOL PHILOS, V13, P153, DOI 10.1023/A:1006599002775; Appel T.A., 1987, CUVIER GEOFFREY DEBA; Arendt D, 2009, PHILOS T R SOC B, V364, P2809, DOI 10.1098/rstb.2009.0104; Bittner T., 2001, Formal Ontology in Information Systems. Collected Papers from the Second International Conference, P309, DOI 10.1145/505168.505197; Bittner T, 2003, FDN GEOGRAPHIC INFOR, P117, DOI DOI 10.1201/9780203009543.CH7; Brentano F, 1988, PHILOS INVESTIGATION; Brinkley James F, 2006, AMIA Annu Symp Proc, P96; Brogaard Berit, 2000, LOG ANAL, V43, P49; Cohn AG, 1994, TOPOLOGICAL FDN COGN, P131; GHISELIN MT, 1974, SYST ZOOL, V23, P536, DOI 10.2307/2412471; Johansson I, 2005, ACTA BIOTHEOR, V53, P153, DOI 10.1007/s10441-005-2525-3; Keet CM, 2008, KRDB DISSERTATION SE; Laubichler MD, 2000, AM ZOOL, V40, P777, DOI 10.1668/0003-1569(2000)040[0777:HIDATD]2.0.CO;2; LEWIS D, 1983, AUSTRALAS J PHILOS, V61, P343, DOI 10.1080/00048408312341131; Mejino Jr J. L. V., 2004, P KR 2004 WORKSH FOR, P48; Mitchell SD, 2006, BIOL THEORY, V1, P98, DOI [10.1162/biot.2006.1.1.98, DOI 10.1162/BIOT.2006.1.1.98]; Rosse Cornelius, 2005, AMIA Annu Symp Proc, P639; Russell ES., 1916, FORM FUNCTION CONTRI; Schulz S, 2009, METHOD INFORM MED, V48, P184, DOI 10.3414/ME9221; Schulz S, 2007, MONIST, V90, P499, DOI 10.5840/monist200790434; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Smith B, 2005, LECT NOTES COMPUT SC, V3693, P149; Smith B, 2004, STUD HEALTH TECHNOL, V102, P39; Smith B, 2001, TOPOI-INT REV PHILOS, V20, P131, DOI 10.1023/A:1017948522031; Smith B, 1999, LECT NOTES COMPUT SC, V1661, P267; Smith B, 1995, LECT NOTES COMPUT SC, V988, P475; Smith B, 1997, LECT NOTES COMPUT SC, V1329, P103; Smith B, 2000, PHILOS PHENOMEN RES, V60, P401, DOI 10.2307/2653492; Smith B., 1997, ELECT J ANAL PHILOS, V5; Smith B., 1994, PARTS WHOLES CONCEPT, P15; Smith B, 2005, J INFORM SYSTEMS, P1; Smith B, 2004, CATEGORIES HIST SYST, P225; Smith Barry, 2006, STUDIES HLTH TECHNOL, V2006, P57; Sorensen R.A., 1988, BLINDSPOTS; Spear AD, 2006, SCIENCE, P1; TYE M, 1990, MIND, V99, P535; Unger P., 1980, MIDWEST STUDIES PHIL, V5, P411, DOI [DOI 10.1111/J.1475-4975.1980.TB00416.X, 10.1111/j.1475-4975.1980.tb00416.x]; Varzi A, 2008, STANFORD ENCY PHILOS; Vogt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030004; Vogt L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018794; Vogt L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-289; Vogt L, 2010, CLADISTICS, V26, P301, DOI 10.1111/j.1096-0031.2009.00286.x; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Williamson Timothy., 1994, VAGUENESS	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48603	10.1371/journal.pone.0048603	http://dx.doi.org/10.1371/journal.pone.0048603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251333	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200006
J	Aubert, D; Naas, T; Nordmann, P				Aubert, Daniel; Naas, Thierry; Nordmann, Patrice			Integrase-Mediated Recombination of the veb1 Gene Cassette Encoding an Extended-Spectrum beta-Lactamase	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; 59-BASE ELEMENT; DNA; SITE; EXPRESSION; INSERTION; IS1999; BINDS	The veb1 gene cassette encodes the extended spectrum beta-lactamase, VEB-1 that is increasingly isolated from worldwide Gram-negative rods. Veb1 is commonly inserted into the variable region of different class 1 integrons in which it is always associated with a downstream-located aadB gene cassette encoding an aminoglycoside adenylyltransferase. In Pseudomonas aeruginosa, the majority of veb1-containing integrons also carry an insertion sequence, IS1999 that is inserted upstream of the veb1 gene cassette and disrupts the integron specific recombination site, attI1. Investigation of the recombination properties of the sites surrounding veb1 revealed that insertion of IS1999 reduces significantly the recombination frequency of attI1 and that veb1 attC is not efficient for recombination in contrast to aadB attC. Subsequent sequence optimisation of veb1 attC by mutagenesis, into a more consensual attC site resembling aadB attC, successfully improved recombination efficiency. Overall, this work gives some insights into the organisation of veb1-containing integrons. We propose that IS1999 and the nature of veb1 attC stabilize the veb1 gene cassette environment likely by impairing recombination events upstream or downstream of veb1, respectively.	[Aubert, Daniel; Naas, Thierry; Nordmann, Patrice] Univ Paris 11, Hop Bicetre, AP HP,LabEx LERMIT,Serv Bacteriol Virol, INSERM,Emerging Resistance Antibiot U914,Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Naas, T (corresponding author), Univ Paris 11, Hop Bicetre, AP HP,LabEx LERMIT,Serv Bacteriol Virol, INSERM,Emerging Resistance Antibiot U914,Fac Med, Paris, France.	thierry.naas@bct.aphp.fr	Naas, Thierry/O-3999-2018	Naas, Thierry/0000-0001-9937-9572	INSERM; Ministere de l'Education Nationale et de la Recherche [UPRES-EA3539]; European Community [241742]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale et de la Recherche; European Community(European Commission)	The research leading to these results has received funding from INSERM, from the Ministere de l'Education Nationale et de la Recherche (UPRES-EA3539), and from the European Community's Seventh Framework Programme FP7/2010-2013 under grant agreement no. 241742 (TEMPOtest-QC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert D, 2003, J BACTERIOL, V185, P5314, DOI 10.1128/JB.185.17.5314-5319.2003; Aubert D, 2006, J BACTERIOL, V188, P6506, DOI 10.1128/JB.00375-06; AVILA P, 1988, J BACTERIOL, V170, P1350, DOI 10.1128/jb.170.3.1350-1353.1988; Bikard D, 2010, MICROBIOL MOL BIOL R, V74, P570, DOI 10.1128/MMBR.00026-10; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Bouvier M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000632; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; COLLIS CM, 1992, MOL MICROBIOL, V6, P2875, DOI 10.1111/j.1365-2958.1992.tb01467.x; COLLIS CM, 1992, J BACTERIOL, V174, P1574, DOI 10.1128/jb.174.5.1574-1585.1992; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Demarre G, 2007, NUCLEIC ACIDS RES, V35, P6475, DOI 10.1093/nar/gkm709; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Girlich D, 2002, CLIN INFECT DIS, V34, P603, DOI 10.1086/338786; Hall RM, 1999, ANN NY ACAD SCI, V870, P68, DOI 10.1111/j.1749-6632.1999.tb08866.x; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larouche A, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-3; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; MARTINEZ E, 1990, EMBO J, V9, P1275, DOI 10.1002/j.1460-2075.1990.tb08236.x; Naas T, 2008, CLIN MICROBIOL INFEC, V14, P42, DOI 10.1111/j.1469-0691.2007.01861.x; Naas T, 1999, FEMS MICROBIOL LETT, V176, P411, DOI 10.1016/S0378-1097(99)00266-9; Naas T, 2006, EMERG INFECT DIS, V12, P1214, DOI 10.3201/eid1708.051547; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; Poirel L, 1999, ANTIMICROB AGENTS CH, V43, P573, DOI 10.1128/AAC.43.3.573; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Sambrook J., 2001, MOL CLONING LAB MANU; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	38	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51602	10.1371/journal.pone.0051602	http://dx.doi.org/10.1371/journal.pone.0051602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251590	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900109
J	Lin, MH; Sivakumaran, H; Apolloni, A; Wei, T; Jans, DA; Harrich, D				Lin, Min-Hsuan; Sivakumaran, Haran; Apolloni, Ann; Wei, Ting; Jans, David A.; Harrich, David			Nullbasic, a Potent Anti-HIV Tat Mutant, Induces CRM1-Dependent Disruption of HIV Rev Trafficking	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR EXPORT FACTOR; TRANSDOMINANT TAT; INTRACELLULAR TRAFFICKING; NUCLEOLAR-LOCALIZATION; BASIC DOMAIN; PROTEIN B23; MATRIN 3; IN-VIVO; REPLICATION	Nullbasic, a mutant of the HIV-1 Tat protein, has anti-HIV-1 activity through mechanisms that include inhibition of Rev function and redistribution of the HIV-1 Rev protein from the nucleolus to the nucleoplasm and cytoplasm. Here we investigate the mechanism of this effect for the first time, establishing that redistribution of Rev by Nullbasic is not due to direct interaction between the two proteins. Rather, Nullbasic affects subcellular localization of cellular proteins that regulate Rev trafficking. In particular, Nullbasic induced redistribution of exportin 1 (CRM1), nucleophosmin (B23) and nucleolin (C23) from the nucleolus to the nucleus when Rev was coexpressed, but never in its absence. Inhibition of the Rev: CRM1 interaction by leptomycin B or a non-interacting RevM10 mutant completely blocked redistribution of Rev by Nullbasic. Finally, Nullbasic did not inhibit importin beta- or transportin 1-mediated nuclear import, suggesting that cytoplasmic accumulation of Rev was due to increased export by CRM1. Overall, our data support the conclusion that CRM1-dependent subcellular redistribution of Rev from the nucleolus by Nullbasic is not through general perturbation of either nuclear import or export. Rather, Nullbasic appears to interact with and disrupt specific components of a Rev trafficking complex required for its nucleocytoplasmic shuttling and, in particular, its nucleolar accumulation.	[Lin, Min-Hsuan; Sivakumaran, Haran; Apolloni, Ann; Wei, Ting; Harrich, David] Queensland Inst Med Res, Mol Virol Lab, Brisbane, Qld 4006, Australia; [Lin, Min-Hsuan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Monash University	Harrich, D (corresponding author), Queensland Inst Med Res, Mol Virol Lab, Brisbane, Qld 4006, Australia.	david.harrich@qimr.edu.au	Lin, Min-Hsuan/ABA-3334-2020; Harrich, David/H-6668-2016	Jans, David/0000-0001-5115-4745; Sivakumaran, Haran/0000-0002-4691-4989; Lin, Min-Hsuan/0000-0001-7074-6041; Harrich, David/0000-0003-3690-0150	National Health and Medical Research Council (NHMRC); Australian Centre for HIV and Hepatitis Research Centre (ACH2); Australian Research Council; University of Queensland Research Scholarship; University of Queensland International Research Tuition Award	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research Centre (ACH2); Australian Research Council(Australian Research Council); University of Queensland Research Scholarship(University of Queensland); University of Queensland International Research Tuition Award	This work in the DH Laboratory was sponsored by the National Health and Medical Research Council (NHMRC) Project grant and the Australian Centre for HIV and Hepatitis Research Centre (ACH2). DH is funded by the Australian Research Council Future Fellowship. MHL is sponsored by a University of Queensland Research Scholarship and a University of Queensland International Research Tuition Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Daelemans D, 2004, J BIOL CHEM, V279, P50167, DOI 10.1074/jbc.M407713200; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DUNDR M, 1995, J CELL SCI, V108, P2811; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; He JJ, 2009, RNA BIOL, V6, P384, DOI 10.4161/rna.6.4.8920; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MARASCO WA, 1994, ARCH VIROL, V139, P133, DOI 10.1007/BF01309460; Matthews DA, 2001, J VIROL, V75, P1031, DOI 10.1128/JVI.75.2.1031-1038.2001; Meredith LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007769; Miyazaki Y, 1996, BIOCHIMIE, V78, P1081, DOI 10.1016/S0300-9084(97)86733-8; MIYAZAKI Y, 1995, EXP CELL RES, V219, P93, DOI 10.1006/excr.1995.1209; MODESTI N, 1991, NEW BIOL, V3, P759; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Orsini MJ, 1996, J VIROL, V70, P8055, DOI 10.1128/JVI.70.11.8055-8063.1996; PEARSON L, 1990, P NATL ACAD SCI USA, V87, P5079, DOI 10.1073/pnas.87.13.5079; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Taliansky ME, 2010, ADV VIRUS RES, V77, P119, DOI 10.1016/S0065-3527(10)77005-6; Truant R, 1999, MOL CELL BIOL, V19, P1210; Ulich C, 1996, J VIROL, V70, P4871, DOI 10.1128/JVI.70.7.4871-4876.1996; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Yedavalli VSRK, 2011, RNA BIOL, V8, P195, DOI 10.4161/rna.8.2.14803; Yi R, 2002, J VIROL, V76, P2036, DOI 10.1128/JVI.76.5.2036-2042.2002; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51466	10.1371/journal.pone.0051466	http://dx.doi.org/10.1371/journal.pone.0051466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251541	Green Published, Green Submitted, gold			2022-12-25	WOS:000312201900089
J	Rafikov, R; Rafikova, O; Aggarwal, S; Gross, C; Sun, XT; Desai, J; Fulton, D; Black, SM				Rafikov, Ruslan; Rafikova, Olga; Aggarwal, Saurabh; Gross, Christine; Sun, Xutong; Desai, Julin; Fulton, David; Black, Stephen M.			Asymmetric Dimethylarginine Induces Endothelial Nitric-oxide Synthase Mitochondrial Redistribution through the Nitration-mediated Activation of Akt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; PROTEIN-KINASE; ADMA LEVELS; AUTOINHIBITORY DOMAIN; SUPEROXIDE-PRODUCTION; TYROSINE NITRATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; PLASMA-LEVELS	We have recently demonstrated that asymmetric dimethylarginine (ADMA) induces the translocation of endothelial nitric-oxide synthase (eNOS) to the mitochondrion via a mechanism that requires protein nitration. Thus, the goal of this study was elucidate how eNOS redistributes to mitochondria and to identify the nitrated protein responsible for this event. Our data indicate that exposure of pulmonary arterial endothelial cells to ADMA enhanced eNOS phosphorylation at the Akt1-dependent phosphorylation sites Ser(617) and Ser(1179). Mutation of these serine residues to alanine (S617A and S1179A) inhibited nitration-mediated eNOS translocation to the mitochondria, whereas the phosphormimic mutations (S617D and S1179D) exhibited increased mitochondrial redistribution in the absence of ADMA. The overexpression of a dominant-negative Akt1 also attenuated ADMA-mediated eNOS mitochondrial translocation. Furthermore, ADMA enhanced Akt1 nitration and increased its activity. Mass spectrometry identified a single nitration site in Akt1 located at the tyrosine residue (Tyr(350)) located within the client-binding domain. Replacement of Tyr(350) with phenylalanine abolished peroxynitrite-mediated eNOS translocation to mitochondria. We also found that in the absence of ADMA, eNOS translocation decreased mitochondrial oxygen consumption and superoxide production without altering cellular ATP level. This suggests that under physiologic conditions, eNOS translocation enhances mitochondria coupling. In conclusion, we have identified a new mechanism by which eNOS translocation to mitochondria is regulated by the phosphorylation of eNOS at Ser(617) and Ser(1179) by Akt1 and that this is enhanced when Akt1 becomes nitrated at Tyr(350).	[Rafikov, Ruslan; Rafikova, Olga; Aggarwal, Saurabh; Gross, Christine; Sun, Xutong; Desai, Julin; Fulton, David; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Black, SM (corresponding author), 1459 Laney Walker Blvd,CB 3211-B, Augusta, GA 30912 USA.	SBLACK@gru.edu	Rafikov, Ruslan/AAG-9352-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL101902]; LeDucq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL060190, P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60190 (to S. M. B.), HL67841 (to S. M. B.), and HL101902 (to S. M. B. and D. F.) and a Transatlantic Network Development Grant from the LeDucq Foundation (to S. M. B.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Boger RH, 2005, VASC MED, V10, pS19, DOI 10.1191/1358863x05vm602oa; Brooks KJ, 2000, DEV NEUROSCI-BASEL, V22, P359, DOI 10.1159/000017461; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castro LA, 1998, ARCH BIOCHEM BIOPHYS, V359, P215, DOI 10.1006/abbi.1998.0898; Cavusoglu E, 2009, CORONARY ARTERY DIS, V20, P112, DOI 10.1097/MCA.0b013e328323982f; Chandrasekar I, 2008, PEDIATR RES, V63, P67, DOI 10.1203/PDR.0b013e31815b43ee; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao SJ, 2004, J BIOL CHEM, V279, P15968, DOI 10.1074/jbc.M308504200; Gorenflo M, 2001, J CARDIOVASC PHARM, V37, P489, DOI 10.1097/00005344-200104000-00016; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hedner T, 2002, BLOOD PRESSURE, V11, P197, DOI 10.1080/08037050213763; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kanski J, 2005, METHOD ENZYMOL, V396, P160, DOI 10.1016/S0076-6879(05)96016-3; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kawasaki H, 2011, FREE RADICAL BIO MED, V50, P419, DOI 10.1016/j.freeradbiomed.2010.10.688; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; Lentz SR, 2003, ATHEROSCLEROSIS SUPP, V4, P61, DOI 10.1016/S1567-5688(03)00035-7; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakamura T, 2009, PHARMACOL RES, V60, P525, DOI 10.1016/j.phrs.2009.04.011; Nash DT, 2002, JAMA-J AM MED ASSOC, V287, P1451, DOI 10.1001/jama.287.11.1451; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Pitocco D, 2009, DIABETES RES CLIN PR, V86, P173, DOI 10.1016/j.diabres.2009.09.019; Puddu P, 2005, CARDIOLOGY, V103, P137, DOI 10.1159/000083440; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schnog JB, 2005, ANN HEMATOL, V84, P282, DOI 10.1007/s00277-004-0983-3; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; SHAUL PW, 1995, AM J RESP CELL MOL, V13, P167, DOI 10.1165/ajrcmb.13.2.7542896; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sun X., 2012, ANTIOXID RE IN PRESS; Sun XT, 2011, AM J RESP CELL MOL, V45, P163, DOI 10.1165/rcmb.2009-0467OC; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tian J, 2010, FREE RADICAL BIO MED, V49, P159, DOI 10.1016/j.freeradbiomed.2010.03.023; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vickers SM, 1999, ARCH SURG-CHICAGO, V134, P245, DOI 10.1001/archsurg.134.3.245; WARBURG O, 1956, SCIENCE, V124, P269; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; Wendt S, 2003, J BIOL CHEM, V278, P1125, DOI 10.1074/jbc.M208572200; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Zhan XQ, 2009, METHODS MOL BIOL, V566, P137, DOI 10.1007/978-1-59745-562-6_10; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483; Zinellu A, 2008, CLIN CHEM LAB MED, V46, P387, DOI 10.1515/CCLM.2008.063	78	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6212	6226		10.1074/jbc.M112.423269	http://dx.doi.org/10.1074/jbc.M112.423269			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23255608	hybrid, Green Published			2022-12-25	WOS:000315820700017
J	Silva, GN; Fatma, S; Floyd, AM; Fischer, F; Chuawong, P; Cruz, AN; Simari, RM; Joshi, N; Kern, D; Hendrickson, TL				Silva, Gayathri N.; Fatma, Shirin; Floyd, Ashley M.; Fischer, Frederic; Chuawong, Pitak; Cruz, Amanda N.; Simari, Rachel M.; Joshi, Nilesh; Kern, Daniel; Hendrickson, Tamara L.			A tRNA-independent Mechanism for Transamidosome Assembly Promotes Aminoacyl-tRNA Transamidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; HELICOBACTER-PYLORI; RIBONUCLEOPROTEIN PARTICLE; SYNTHETASE; AMIDOTRANSFERASE; BINDING; MUTATIONS	Many bacteria lack genes encoding asparaginyl- and/or glutaminyl-tRNA synthetase and consequently rely on an indirect path for the synthesis of both Asn-tRNA(Asn) and Gln-tRNA(Gln). In some bacteria such as Thermus thermophilus, efficient delivery of misacylated tRNA to the downstream amidotransferase (AdT) is ensured by formation of a stable, tRNA-dependent macromolecular complex called the Asn-transamidosome. This complex enables direct delivery of Asp-tRNA(Asn) from the nondiscriminating aspartyl-tRNA synthetase to AdT, where it is converted into Asn-tRNA(Asn). Previous characterization of the analogous Helicobacter pylori Asn-transamidosome revealed that it is dynamic and cannot be stably isolated, suggesting the possibility of an alternative mechanism to facilitate assembly of a stable complex. We have identified a novel protein partner called Hp0100 as a component of a stable, tRNA-independent H. pylori Asn-transamidosome; this complex contains a nondiscriminating aspartyl-tRNA synthetase, AdT, and Hp0100 but does not require tRNA(Asn) for assembly. Hp0100 also enhances the capacity of AdT to convert Asp-tRNA(Asn) into Asn-tRNA(Asn) by similar to 35-fold. Our results demonstrate that bacteria have adopted multiple divergent methods for transamidosome assembly and function.	[Silva, Gayathri N.; Fatma, Shirin; Floyd, Ashley M.; Cruz, Amanda N.; Simari, Rachel M.; Joshi, Nilesh; Hendrickson, Tamara L.] Wayne State Univ, Dept Chem, Detroit, MI 48230 USA; [Fischer, Frederic; Kern, Daniel] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN,UPR 9002, F-67084 Strasbourg, France; [Chuawong, Pitak] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Chuawong, Pitak] Kasetsart Univ, Dept Chem, Fac Sci, Bangkok 10903, Thailand; [Chuawong, Pitak] Kasetsart Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok 10903, Thailand	Wayne State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University; Kasetsart University; Kasetsart University	Hendrickson, TL (corresponding author), Wayne State Univ, Dept Chem, 5101 Cass Ave, Detroit, MI 48230 USA.	tamara.hendrickson@chem.wayne.edu	fatma, shirin/AIE-7476-2022	fatma, shirin/0000-0002-4504-4272; CHUAWONG, PITAK/0000-0001-8969-1351; Silva, Gayathri/0000-0002-2687-2144	National Institutes of Health [GM071480]; Wayne State University; Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships; Universite de Strasbourg, CNRS; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships; Universite de Strasbourg, CNRS; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	work was supported, in whole or in part, by National Institutes of Health Grant GM071480 (to T. L. H.). This work was also supported by Wayne State University (to T. L. H.); Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships (to F. F.); and the Universite de Strasbourg, CNRS, and the Association pour la Recherche sur le Cancer (to D. K.).	Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bhaskaran H, 2011, J MOL BIOL, V411, P854, DOI 10.1016/j.jmb.2011.06.039; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Cathopoulis T, 2007, MOL BIOSYST, V3, P408, DOI 10.1039/b618899k; Cathopoulis TJT, 2008, BIOCHEMISTRY-US, V47, P7610, DOI 10.1021/bi800369q; Chuawong P, 2006, BIOCHEMISTRY-US, V45, P8079, DOI 10.1021/bi060189c; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Deinert K, 2001, J BIOL CHEM, V276, P6000, DOI 10.1074/jbc.M008682200; Fischer F, 2012, NUCLEIC ACIDS RES, V40, P4965, DOI 10.1093/nar/gks167; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Huot JL, 2011, NUCLEIC ACIDS RES, V39, P9306, DOI 10.1093/nar/gkr619; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rampias T, 2010, NUCLEIC ACIDS RES, V38, P5774, DOI 10.1093/nar/gkq336; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zhao LJ, 2012, BIOCHEMISTRY-US, V51, P273, DOI 10.1021/bi201143x	26	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3816	3822		10.1074/jbc.M112.441394	http://dx.doi.org/10.1074/jbc.M112.441394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258533	Green Published, hybrid			2022-12-25	WOS:000314845000013
J	Bekkers, MBM; Brunekreef, B; Koppelman, GH; Kerkhof, M; de Jongste, JC; Smit, HA; Wijga, AH				Bekkers, Marga B. M.; Brunekreef, Bert; Koppelman, Gerard H.; Kerkhof, Marjan; de Jongste, Johan C.; Smit, Henriette A.; Wijga, Alet H.			BMI and Waist Circumference; Cross-Sectional and Prospective Associations with Blood Pressure and Cholesterol in 12-Year-Olds	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; CAUSE-SPECIFIC MORTALITY; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CHILDHOOD OBESITY; BIRTH COHORT; CHILDREN; ADOLESCENTS; PREVENTION	Objective: Childhood and adolescent overweight, defined by body mass index (BMI) are associated with an increased risk of cardiovascular disease in later life. Abdominal adiposity may be more important in associations with cardiovascular diseases but waist circumference (WC) has been rarely studied in children. We studied associations between BMI and WC and blood pressure (BP) and cholesterol in 12-year-old children and prospectively changes in BMI or WC status between age 8 and 12 years and BP and cholesterol at age 12. Study Design: Weight, height, WC, BP and cholesterol concentrations were measured in 1432 children at age 12 years. Linear regression was used to study the associations between high BMI and large WC (>90th percentile) and BP and cholesterol. Results: Systolic BP was 4.9 mmHg higher (95% (CI 2.5, 7.2) in girls and 4.2 mmHg (95% CI 1.9, 6.5) in boys with a high BMI. Large WC was also associated with higher systolic BP in girls (3.7 mmHg (95% CI 1.3, 6.1)) and boys (3.5 mmHg (95% CI 1.2, 5.8)). Diastolic BP and cholesterol concentrations were significantly positively (HDL cholesterol negatively) associated with high BMI and large WC, too. Normal weight children with a history of overweight did not have higher blood pressure levels or adverse cholesterol concentrations than children that were normal weight at both ages. Conclusion: A high BMI and large WC were associated with higher BP levels and adverse cholesterol concentrations. WC should be taken into account when examining cardiovascular risk factors in children. Citation: Bekkers MBM, Brunekreef B, Koppelman GH, Kerkhof M, de Jongste JC, et al. (2012) BMI and Waist Circumference; Cross-Sectional and Prospective Associations with Blood Pressure and Cholesterol in 12-Year-Olds. PLoS ONE 7(12): e51801. doi:10.1371/journal.pone.0051801	[Bekkers, Marga B. M.; Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Bekkers, Marga B. M.; Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol & Bioinformat, Groningen, Netherlands; [de Jongste, Johan C.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Bekkers, MBM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	marga.bekkers@rivm.nl	Koppelman, Gerard/AAG-9187-2020	brunekreef, bert/0000-0001-9908-0060; Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing and the Environment; and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Ashwell M, 2011, OBES REV; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; Efron B., 1994, INTRO BOOTSTRAP; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Larsson C, 2011, ACTA PAEDIATR, V100, P102, DOI 10.1111/j.1651-2227.2010.01969.x; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Mamun AA, 2005, HYPERTENSION, V45, P1083, DOI 10.1161/01.HYP.0000166720.18319.51; Maximova K, 2011, J HYPERTENS, V29, P2075, DOI 10.1097/HJH.0b013e32834be614; Maximova K, 2010, EPIDEMIOLOGY, V21, P324, DOI 10.1097/EDE.0b013e3181d61d10; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Nadeau KJ, 2011, NAT REV CARDIOL, V8, P513, DOI 10.1038/nrcardio.2011.86; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Tybor DJ, 2011, AM J CLIN NUTR, V93, P392, DOI 10.3945/ajcn.110.001719; Watts K, 2008, J PAEDIATR CHILD H, V44, P709, DOI 10.1111/j.1440-1754.2008.01411.x; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	28	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51801	10.1371/journal.pone.0051801	http://dx.doi.org/10.1371/journal.pone.0051801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251628	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800087
J	Carra, S; Foglia, E; Cermenati, S; Bresciani, E; Giampietro, C; Lamia, CL; Dejana, E; Beltrame, M; Cotelli, F				Carra, Silvia; Foglia, Efrem; Cermenati, Solei; Bresciani, Erica; Giampietro, Costanza; Lamia, Carla Lora; Dejana, Elisabetta; Beltrame, Monica; Cotelli, Franco			Ve-ptp Modulates Vascular Integrity by Promoting Adherens Junction Maturation	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BLOOD-VESSEL DEVELOPMENT; CELL-CELL ADHESION; MOLECULAR-ORGANIZATION; PARACELLULAR PATHWAY; ENDOTHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; ZEBRAFISH; CADHERIN	Background: Endothelial cell junctions control blood vessel permeability. Altered permeability can be associated with vascular fragility that leads to vessel weakness and haemorrhage formation. In vivo studies on the function of genes involved in the maintenance of vascular integrity are essential to better understand the molecular basis of diseases linked to permeability defects. Ve-ptp (Vascular Endothelial-Protein Tyrosine Phosphatase) is a transmembrane protein present at endothelial adherens junctions (AJs). Methodology/Principal Findings: We investigated the role of Ve-ptp in AJ maturation/stability and in the modulation of endothelial permeability using zebrafish (Danio rerio). Whole-mount in situ hybridizations revealed zve-ptp expression exclusively in the developing vascular system. Generation of altered zve-ptp transcripts, induced separately by two different splicing morpholinos, resulted in permeability defects closely linked to vascular wall fragility. The ultrastructural analysis revealed a statistically significant reduction of junction complexes and the presence of immature AJs in zve-ptp morphants but not in control embryos. Conclusions/Significance: Here we show the first in vivo evidence of a potentially critical role played by Ve-ptp in AJ maturation, an important event for permeability modulation and for the development of a functional vascular system. Citation: Carra S, Foglia E, Cermenati S, Bresciani E, Giampietro C, et al. (2012) Ve-ptp Modulates Vascular Integrity by Promoting Adherens Junction Maturation. PLoS ONE 7(12): e51245. doi:10.1371/journal.pone.0051245	[Carra, Silvia; Foglia, Efrem; Bresciani, Erica; Lamia, Carla Lora; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Carra, Silvia; Foglia, Efrem; Cermenati, Solei; Lamia, Carla Lora; Dejana, Elisabetta; Beltrame, Monica; Cotelli, Franco] Univ Milan, Dipartimento Biosci, Milan, Italy; [Cermenati, Solei; Dejana, Elisabetta; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Giampietro, Costanza; Dejana, Elisabetta] FIRC Inst Mol Oncol, Milan, Italy	University of Milan; University of Milan; University of Milan; IFOM - FIRC Institute of Molecular Oncology	Cotelli, F (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	franco.cotelli@unimi.it	Beltrame, Monica/D-8093-2017; Foglia, Efrem Alessandro/AAF-1840-2020; Dejana, Elisabetta/A-6274-2016; Foglia, Efrem Alessandro/AGW-8220-2022; Carra, Silvia/P-2627-2019; Carra, Silvia/K-4643-2016; Giampietro, Costanza/D-4643-2016	Foglia, Efrem Alessandro/0000-0002-7446-8365; Carra, Silvia/0000-0002-9321-9508; Carra, Silvia/0000-0002-9321-9508; Giampietro, Costanza/0000-0001-5229-3835; Beltrame, Monica/0000-0001-5094-3494; DEJANA, ELISABETTA/0000-0002-0007-0426	Cassa di Risparmio delle Provincie Lombarde (CARIPLO); Biological and molecular characterization of Cancer Stem Cells; Fondazione CARIPLO [2006.0807]; Associazione Italiana per la Ricerca sul Cancro; Leducq Foundation Transatlantic Network of Excellence; Adriano Buzzati-Traverso foundation	Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Biological and molecular characterization of Cancer Stem Cells; Fondazione CARIPLO(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Leducq Foundation Transatlantic Network of Excellence(Leducq Foundation); Adriano Buzzati-Traverso foundation	Financial support from Cassa di Risparmio delle Provincie Lombarde (CARIPLO) N.O.B.E.L. Biological and molecular characterization of Cancer Stem Cells to F.C., Fondazione CARIPLO (2006.0807) to M.B., Associazione Italiana per la Ricerca sul Cancro and the Leducq Foundation Transatlantic Network of Excellence to E.D. Dr Foglia was funded by a fellowship in memory of Arturo Falaschi from Adriano Buzzati-Traverso foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenton F, 2004, MECH DEVELOP, V121, P131, DOI 10.1016/j.mod.2004.01.001; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bogatcheva NV, 2002, VASC PHARMACOL, V39, P201, DOI 10.1016/S1537-1891(03)00009-0; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Dejana E, 2000, INT J DEV BIOL, V44, P743; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Esser S, 1998, J CELL SCI, V111, P1853; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shi S, 1998, ENDOTHELIUM-J ENDOTH, V6, P153, DOI 10.3109/10623329809072202; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vestweber D, 2000, J PATHOL, V190, P281; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Westerfield M, 1993, ZEBRAFISH BOOK; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002	42	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51245	10.1371/journal.pone.0051245	http://dx.doi.org/10.1371/journal.pone.0051245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251467	Green Published, gold			2022-12-25	WOS:000312386800033
J	Leclercq, S; Cordaux, R				Leclercq, Sebastien; Cordaux, Richard			Selection-Driven Extinction Dynamics for Group II Introns in Enterobacteriales	PLOS ONE			English	Article							HOMING ENDONUCLEASE GENES; TRANSPOSABLE ELEMENTS; INSERTION SEQUENCES; YERSINIA-PESTIS; GENOME; EVOLUTION; RETROTRANSPOSITION; TRANSPOSITION; POPULATION; INSIGHTS	Transposable elements (TEs) are one of the major driving forces of genome evolution, raising the question of the long-term dynamics underlying their evolutionary success. Some TEs were proposed to evolve under a pattern of periodic extinctions-recolonizations, in which elements recurrently invade and quickly proliferate within their host genomes, then start to disappear until total extinction. Depending on the model, TE extinction is assumed to be driven by purifying selection against colonized host genomes (Sel-DE model) or by saturation of host genomes (Sat-DE model). Bacterial group II introns are suspected to follow an extinction-recolonization model of evolution, but whether they follow Sel-DE or Sat-DE dynamics is not known. Our analysis of almost 200 group II intron copies from 90 sequenced Enterobacteriales genomes confirms their extinction-recolonization dynamics: patchy element distributions among genera and even among strains within genera, acquisition of new group II introns through plasmids or other mobile genetic elements, and evidence for recent proliferations in some genomes. Distributions of recent and past proliferations and of their respective homing sites further provide strong support for the Sel-DE model, suggesting that group II introns are deleterious to their hosts. Overall, our observations emphasize the critical impact of host properties on TE dynamics.	[Leclercq, Sebastien; Cordaux, Richard] Univ Poitiers, CNRS UMR Ecol & Biol Interact 7267, Poitiers, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, CNRS UMR Ecol & Biol Interact 7267, Poitiers, France.	richard.cordaux@univ-poitiers.fr		Leclercq, Sebastien/0000-0002-3601-2316	Centre National de la Recherche Scientifique (CNRS); European Research Council Starting Grant; CNRS	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Research Council Starting Grant(European Research Council (ERC)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This research was funded by a Young Investigator ATIP Award from the Centre National de la Recherche Scientifique (CNRS) and a European Research Council Starting Grant to RC. SL was supported by a postdoctoral fellowship from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Belfort Marlene, 2002, P761; Bichsel M, 2010, THEOR POPUL BIOL, V78, P278, DOI 10.1016/j.tpb.2010.08.003; Biondi Emanuele G, 2011, Mob Genet Elements, V1, P2; Boutin TS, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-5; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; Cerveau N, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P291, DOI 10.1007/978-3-642-20763-1_17; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chee GJ, 2005, GENE, V363, P211, DOI 10.1016/j.gene.2005.08.017; Chen YQ, 2005, APPL ENVIRON MICROB, V71, P2576, DOI 10.1128/AEM.71.5.2576-2586.2005; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Chillon I, 2011, NUCLEIC ACIDS RES, V39, P1095, DOI 10.1093/nar/gkq847; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cordaux R, 2009, MOL BIOL EVOL, V26, P1679, DOI 10.1093/molbev/msp093; Cousineau B, 2000, NATURE, V404, P1018, DOI 10.1038/35010029; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai LX, 2002, RNA, V8, P1294, DOI 10.1017/S1355838202023014; Dai LX, 2002, NUCLEIC ACIDS RES, V30, P1091, DOI 10.1093/nar/30.5.1091; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Escobar-Paramo P, 2005, MOL BIOL EVOL, V22, P2297, DOI 10.1093/molbev/msi227; Fernandez-Lopez M, 2005, MOL BIOL EVOL, V22, P1518, DOI 10.1093/molbev/msi144; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Han CG, 2004, J MICROBIOL, V42, P56; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Ichiyanagi K, 2003, P NATL ACAD SCI USA, V100, P15742, DOI 10.1073/pnas.2536659100; Ichiyanagi K, 2002, MOL MICROBIOL, V46, P1259, DOI 10.1046/j.1365-2958.2002.03226.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klein JR, 2002, FRONT BIOSCI-LANDMRK, V7, pD1843, DOI 10.2741/klein1; Koonin EV, 2009, J HERED, V100, P618, DOI 10.1093/jhered/esp056; Kube M, 2008, ENVIRON MICROBIOL, V10, P2211, DOI 10.1111/j.1462-2920.2008.01639.x; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laukkanen-Ninios R, 2011, ENVIRON MICROBIOL, V13, P3114, DOI 10.1111/j.1462-2920.2011.02588.x; LAWRENCE JG, 1992, GENETICS, V131, P9; Le Rouzic A, 2005, GENET RES, V85, P171, DOI 10.1017/S0016672305007585; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Leclercq S, 2011, EVOLUTION, V65, P3327, DOI 10.1111/j.1558-5646.2011.01395.x; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Luchetti A, 2011, MOL GENET GENOMICS, V285, P175, DOI 10.1007/s00438-010-0595-7; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martinez-Abarca F, 2000, NUCLEIC ACIDS RES, V28, P4397, DOI 10.1093/nar/28.21.4397; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Mira A, 2006, TRENDS MICROBIOL, V14, P200, DOI 10.1016/j.tim.2006.03.001; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Raghavan R, 2009, J BACTERIOL, V191, P6193, DOI 10.1128/JB.00675-09; Robart AR, 2007, P NATL ACAD SCI USA, V104, P6620, DOI 10.1073/pnas.0700561104; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Robertson Hugh M., 2002, P1093; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simon DM, 2009, MOL BIOL EVOL, V26, P2795, DOI 10.1093/molbev/msp193; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Staddon JH, 2004, J BACTERIOL, V186, P2393, DOI 10.1128/JB.186.8.2393-2401.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tourasse NJ, 2008, NUCLEIC ACIDS RES, V36, P4529, DOI 10.1093/nar/gkn372; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Wagner A, 2006, MOL BIOL EVOL, V23, P723, DOI 10.1093/molbev/msj085; Wagner A, 2007, NUCLEIC ACIDS RES, V35, P5284, DOI 10.1093/nar/gkm597; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909	82	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52268	10.1371/journal.pone.0052268	http://dx.doi.org/10.1371/journal.pone.0052268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251705	gold, Green Published			2022-12-25	WOS:000312386800156
J	Drechsler, S; Weixelbaumer, K; Raeven, P; Jafarmadar, M; Khadem, A; van Griensven, M; Bahrami, S; Osuchowski, MF				Drechsler, Susanne; Weixelbaumer, Katrin; Raeven, Pierre; Jafarmadar, Mohammad; Khadem, Anna; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip			Relationship between Age/Gender-Induced Survival Changes and the Magnitude of Inflammatory Activation and Organ Dysfunction in Post-Traumatic Sepsis	PLOS ONE			English	Article							BLUNT TRAUMA PATIENTS; INTENSIVE-CARE UNITS; HEMORRHAGIC-SHOCK; GENDER-DIFFERENCES; IMMUNE FUNCTION; ANIMAL-MODELS; SEPTIC SHOCK; MURINE MODEL; MORTALITY; COMPLICATIONS	Age/gender may likely influence the course of septic complications after trauma. We aimed to characterize the influence of age/gender on the response of circulating cytokines, cells and organ function in post-traumatic sepsis. We additionally tested whether post-traumatic responses alone can accurately predict outcomes in subsequent post-traumatic sepsis. A mouse 2-hit model of trauma/hemorrhage (TH, 1st hit) and cecal ligation and puncture (CLP, 2nd hit) was employed. 3, 15 and 20 month (m) old female (female) and male (male) CD-1 mice underwent sublethal TH followed by CLP 2 days later. Blood was sampled daily until day 6 post-TH and survival was followed for 16 days. To compare general response patterns among groups, we calculated two scores: the inflammatory response (including KC, MIP-1 alpha, TNF alpha, MCP-1, IFN gamma, IL-1 beta,-5,-6,-10) and the organ dysfunction score (Urea, ALT, AST and LDH). Moreover, mice were retrospectively divided into survivors (SUR) and dying (DIE) based on post-CLP outcome. In general, females survived better than males and their survival did not correspond to any specific estrus cycle phase. Pre-CLP phase: the post-TH inflammatory score was weakest in 3 m male but there were no changes among remaining groups (similar lack of differences in the organ dysfunction score). TH induced a 40% increase of IFN gamma, MIP-1 alpha and IL-5 in 15 m male SUR (vs. DIE) but predictive accuracy for post-CLP outcomes was moderate. Post-CLP phase: while stable in males, inflammatory response score in 15 m and 20 m females decreased with age at day 1 and 2 post-CLP. SUR vs. DIE differences in inflammatory and organ dysfunction score were evident but their magnitude was comparable across age/gender. Nearly identical activation of the humoral inflammatory and organ function compartments, both across groups and according to sepsis severity, suggests that they are not directly responsible for the age/gender-dependent disparity in TH-CLP survival in the studied young-to-mature population.	[Drechsler, Susanne; Weixelbaumer, Katrin; Raeven, Pierre; Jafarmadar, Mohammad; Khadem, Anna; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip] Trauma Res Ctr Allgemeine, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Osuchowski, MF (corresponding author), Trauma Res Ctr Allgemeine, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	Marcin.Osuchowski@trauma.lbg.ac.at	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Bahrami, Soheyl/0000-0002-4563-6251; Drechsler, Susanne/0000-0002-0758-303X; Osuchowski, Marcin/0000-0002-1321-9883	Vienna Science and Technology Fund (WWTF) [LS07-065]	Vienna Science and Technology Fund (WWTF)	The study was funded by the Vienna Science and Technology Fund (WWTF) Grant LS07-065. http://www.wwtf.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bahrami S, 2010, CRIT CARE MED, V38, P161, DOI 10.1097/CCM.0b013e3181b78a06; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Drechsler S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/357926; EATON GJ, 1980, LAB ANIM, V14, P17, DOI 10.1258/002367780780943141; Foex BA, 1999, BRIT MED BULL, V55, P726, DOI 10.1258/0007142991902745; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Kahlke V, 2000, AM J PHYSIOL-CELL PH, V278, pC509, DOI 10.1152/ajpcell.2000.278.3.C509; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Koch A, 2012, CLIN BIOCHEM, V45, P429, DOI 10.1016/j.clinbiochem.2012.01.009; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Majetschak M, 2000, J TRAUMA, V48, P832, DOI 10.1097/00005373-200005000-00006; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Mees ST, 2007, LANGENBECK ARCH SURG, V392, P629, DOI 10.1007/s00423-007-0152-y; Nachtigall I, 2011, CRIT CARE, V15, DOI 10.1186/cc10277; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; NastKolb D, 1997, J TRAUMA, V42, P446, DOI 10.1097/00005373-199703000-00012; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Osuchowski MF, 2010, SHOCK, V34, P369, DOI 10.1097/SHK.0b013e3181dc40a8; Osuchowski MF, 2012, J IMMUNOL; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Pape HC, 2001, J TRAUMA, V50, P989, DOI 10.1097/00005373-200106000-00004; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Turnbull IR, 2004, SHOCK, V21, P121, DOI 10.1097/01.shk.0000108399.56565.e7; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Uusitalo-Seppala R, 2012, SCAND J INFECT DIS; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Weixelbaumer KM, 2010, SHOCK, V34, P420, DOI 10.1097/SHK.0b013e3181dc0918; Wichmann MW, 1996, ARCH SURG-CHICAGO, V131, P995; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zanotti-Cavazzoni SL, 2009, INTENS CARE MED, V35, P748, DOI 10.1007/s00134-008-1360-9	52	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51457	10.1371/journal.pone.0051457	http://dx.doi.org/10.1371/journal.pone.0051457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251540	Green Submitted, gold, Green Published			2022-12-25	WOS:000313236200113
J	Lauterbach, T; Manna, M; Ruhnow, M; Wisantoso, Y; Wang, YF; Matysik, A; Oglecka, K; Mu, YG; Geifman-Shochat, S; Wohland, T; Kraut, R				Lauterbach, Tim; Manna, Manoj; Ruhnow, Maria; Wisantoso, Yudi; Wang, Yaofeng; Matysik, Artur; Oglecka, Kamila; Mu, Yuguang; Geifman-Shochat, Susana; Wohland, Thorsten; Kraut, Rachel			Weak Glycolipid Binding of a Microdomain-Tracer Peptide Correlates with Aggregation and Slow Diffusion on Cell Membranes	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; SURFACE-PLASMON RESONANCE; A-BETA; CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; MODEL MEMBRANES; GM1 GANGLIOSIDE; LIPID-BILAYERS; MOLECULAR SIMULATION; FIBRIL FORMATION	Organized assembly or aggregation of sphingolipid-binding ligands, such as certain toxins and pathogens, has been suggested to increase binding affinity of the ligand to the cell membrane and cause membrane reorganization or distortion. Here we show that the diffusion behavior of the fluorescently tagged sphingolipid-interacting peptide probe SBD (Sphingolipid Binding Domain) is altered by modifications in the construction of the peptide sequence that both result in a reduction in binding to ganglioside-containing supported lipid membranes, and at the same time increase aggregation on the cell plasma membrane, but that do not change relative amounts of secondary structural features. We tested the effects of modifying the overall charge and construction of the SBD probe on its binding and diffusion behavior, by Surface Plasmon Resonance (SPR; Biacore) analysis on lipid surfaces, and by Fluorescence Correlation Spectroscopy (FCS) on live cells, respectively. SBD binds preferentially to membranes containing the highly sialylated gangliosides GT1b and GD1a. However, simple charge interactions of the peptide with the negative ganglioside do not appear to be a critical determinant of binding. Rather, an aggregation-suppressing amino acid composition and linker between the fluorophore and the peptide are required for optimum binding of the SBD to ganglioside-containing supported lipid bilayer surfaces, as well as for interaction with the membrane. Interestingly, the strength of interactions with ganglioside-containing artificial membranes is mirrored in the diffusion behavior by FCS on cell membranes, with stronger binders displaying similar characteristic diffusion profiles. Our findings indicate that for aggregation-prone peptides, aggregation occurs upon contact with the cell membrane, and rather than giving a stronger interaction with the membrane, aggregation is accompanied by weaker binding and complex diffusion profiles indicative of heterogeneous diffusion behavior in the probe population.	[Lauterbach, Tim; Manna, Manoj; Ruhnow, Maria; Wisantoso, Yudi; Wang, Yaofeng; Matysik, Artur; Oglecka, Kamila; Mu, Yuguang; Geifman-Shochat, Susana; Kraut, Rachel] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lauterbach, Tim; Ruhnow, Maria] Tech Univ Dresden, Inst Lebensmittel & Bioverfahrenstech, D-01062 Dresden, Germany; [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Technische Universitat Dresden; National University of Singapore; National University of Singapore; National University of Singapore	Kraut, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	rskraut@ntu.edu.sg	WOHLAND, THORSTEN/R-6404-2019; w, y w/HGD-6995-2022; W, Yudi/AAF-8649-2019; Wohland, Thorsten/H-8285-2012	Wohland, Thorsten/0000-0002-0148-4321; Matysik, Artur/0000-0003-3702-9491	Nanyang Technological University; Singapore Ministry of Education Academic Research Fund [MOE2009-T2-2-019]; Life Science Institute - Baden Wurttemberg initiative [BE2010-02: R-143-000-422-646]	Nanyang Technological University(Nanyang Technological University); Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); Life Science Institute - Baden Wurttemberg initiative	RK was supported by a start-up grant from Nanyang Technological University and Tier II grant from the Singapore Ministry of Education Academic Research Fund (MOE2009-T2-2-019). TW gratefully acknowledges funding from the Life Science Institute - Baden Wurttemberg initiative (BE2010-02: R-143-000-422-646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES P, 1992, CHEM PHYS LIPIDS, V62, P269, DOI 10.1016/0009-3084(92)90064-V; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Bateman DA, 2010, INT J ALZHEIMERS DIS, V2011; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Dertinger T, 2006, LANGMUIR, V22, P9339, DOI 10.1021/la061389s; Dowhan W, 2008, FUNCTIONAL ROLES LIP; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 2007, CURR MED CHEM, V14, P2911, DOI 10.2174/092986707782360033; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V370, P525, DOI 10.1016/j.bbrc.2008.03.130; Inaba S, 2005, J PEPT RES, V65, P485, DOI 10.1111/j.1399-3011.2005.00250.X; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Kremer JJ, 2003, J BIOCHEM BIOPH METH, V57, P159, DOI 10.1016/S0165-022X(03)00103-9; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Petrasek Z, 2010, METHOD ENZYMOL, V472, P317, DOI 10.1016/S0076-6879(10)72005-X; Poulsen SA, 2000, J STRUCT BIOL, V130, P142, DOI 10.1006/jsbi.2000.4267; Rocheleau JV, 2000, BIOSCIENCE REP, V20, P139, DOI 10.1023/A:1005559317975; Rocheleau JV, 2001, EUR J BIOCHEM, V268, P2924, DOI 10.1046/j.1432-1327.2001.02181.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Sankaran J, 2009, BIOPHYS J, V97, P2630, DOI 10.1016/j.bpj.2009.08.025; Stefl M, 2012, BIOPHYS J, V102, P2104, DOI 10.1016/j.bpj.2012.03.054; Steinert S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002933; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Valdes-Gonzalez T, 2003, SPECTROSC-INT J, V17, P241, DOI 10.1155/2003/185737; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Zanten TS, 2010, P NATL ACAD SCI USA, V107, P15437, DOI 10.1073/pnas.1003876107; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Waschuk SA, 2001, J BIOL CHEM, V276, P33561, DOI 10.1074/jbc.M103598200; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200; Zhang DW, 2009, J CELL SCI, V122, P3715, DOI 10.1242/jcs.051557	75	6	6	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51222	10.1371/journal.pone.0051222	http://dx.doi.org/10.1371/journal.pone.0051222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251459	Green Published, gold			2022-12-25	WOS:000313236200074
J	Lipp, I; Benedek, M; Fink, A; Koschutnig, K; Reishofer, G; Bergner, S; Ischebeck, A; Ebner, F; Neubauer, A				Lipp, Ilona; Benedek, Mathias; Fink, Andreas; Koschutnig, Karl; Reishofer, Gernot; Bergner, Sabine; Ischebeck, Anja; Ebner, Franz; Neubauer, Aljoscha			Investigating Neural Efficiency in the Visuo-Spatial Domain: An fmri Study	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; EEG-ALPHA SYNCHRONIZATION; MENTAL ROTATION TASKS; SEX-DIFFERENCES; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; BRAIN ACTIVATION; SPATIAL ABILITIES; BASIC PRINCIPLES; IQ RELATIONSHIP	The neural efficiency hypothesis postulates an inverse relationship between intelligence and brain activation. Previous research suggests that gender and task modality represent two important moderators of the neural efficiency phenomenon. Since most of the existing studies on neural efficiency have used ERD in the EEG as a measure of brain activation, the central aim of this study was a more detailed analysis of this phenomenon by means of functional MRI. A sample of 20 males and 20 females, who had been screened for their visuo-spatial intelligence, was confronted with a mental rotation task employing an event-related approach. Results suggest that less intelligent individuals show a stronger deactivation of parts of the default mode network, as compared to more intelligent people. Furthermore, we found evidence of an interaction between task difficulty, intelligence and gender, indicating that more intelligent females show an increase in brain activation with an increase in task difficulty. These findings may contribute to a better understanding of the neural efficiency hypothesis, and possibly also of gender differences in the visuo-spatial domain.	[Lipp, Ilona; Benedek, Mathias; Fink, Andreas; Koschutnig, Karl; Bergner, Sabine; Ischebeck, Anja; Neubauer, Aljoscha] Graz Univ, Inst Psychol, Graz, Austria; [Lipp, Ilona] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff CF10 3AX, S Glam, Wales; [Reishofer, Gernot; Ebner, Franz] Med Univ Graz, Dept Radiol, Graz, Austria	University of Graz; Cardiff University; Medical University of Graz	Lipp, I (corresponding author), Graz Univ, Inst Psychol, Graz, Austria.	LippI@cardiff.ac.uk	Benedek, Mathias/B-6110-2012; Reishofer, Gernot/E-9215-2011; Koschutnig, Karl/W-3106-2019; Lipp, Ilona/M-7113-2017	Benedek, Mathias/0000-0001-6258-4476; Reishofer, Gernot/0000-0002-3068-6475; Koschutnig, Karl/0000-0001-6234-0498; Lipp, Ilona/0000-0002-5644-2057; Fink, Andreas/0000-0001-7316-3140; Bergner, Sabine/0000-0003-0027-2949; Ischebeck, Anja/0000-0002-3493-2848	Austrian Science Fund (FWF) [P19842, P23914]; Austrian Science Fund (FWF) [P 23914] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF): P19842 and P23914. http://www.fwf.ac.at/en/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amthauer R, 2001, INTELLIGENZ STRUKTUR; Benedek M, 2011, NEUROPSYCHOLOGIA, V49, P3505, DOI 10.1016/j.neuropsychologia.2011.09.004; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bors DA, 2011, LEARN INDIVID DIFFER, V21, P129, DOI 10.1016/j.lindif.2010.09.014; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Doppelmayr M, 2005, BRAIN RES BULL, V66, P171, DOI 10.1016/j.brainresbull.2005.04.007; Fay E., 2001, INTELLIGENZ STRUKTUR; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; Gould RL, 2006, NEUROIMAGE, V31, P818, DOI 10.1016/j.neuroimage.2005.12.045; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haier RJ, 1995, DEV NEUROPSYCHOL, V11, P405, DOI 10.1080/87565649509540629; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Jordan K, 2010, J INDIVID DIFFER, V31, P83, DOI 10.1027/1614-0001/a000015; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kelly AMC, 2006, NEUROIMAGE, V31, P866, DOI 10.1016/j.neuroimage.2006.01.008; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Larson GE, 1995, INTELLIGENCE, V21, P267, DOI 10.1016/0160-2896(95)90017-9; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laux L., 1981, STATE TRAIT ANGSTINV; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; NEUBAUER A, 1995, INTELLIGENCE, V20, P249, DOI 10.1016/0160-2896(95)90010-1; Neubauer AC, 2005, COGNITIVE BRAIN RES, V25, P217, DOI 10.1016/j.cogbrainres.2005.05.011; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; POSNER MI, 1967, PSYCHOL REV, V74, P392, DOI 10.1037/h0024913; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Preusse F, 2011, FRONT HUM NEUROSCI, V5, P1; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733; Ruff CC, 2003, NEUROPSYCHOLOGIA, V41, P1241, DOI 10.1016/S0028-3932(03)00016-2; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Song M, 2009, IEEE T AUTON MENT DE, V1, P101, DOI 10.1109/TAMD.2009.2029312; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Tagaris GA, 1996, NEUROREPORT, V7, P773, DOI 10.1097/00001756-199602290-00022; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Unterrainer J, 2000, NEUROPSYCHOBIOLOGY, V41, P95, DOI 10.1159/000026639; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	67	23	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51316	10.1371/journal.pone.0051316	http://dx.doi.org/10.1371/journal.pone.0051316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251496	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000313236200088
J	Reitz, C; Tosto, G; Mayeux, R; Luchsinger, JA				Reitz, Christiane; Tosto, Giuseppe; Mayeux, Richard; Luchsinger, Jose A.		NIA-LOAD NCRAD Family Study Grp; Alzheimer's Dis Neuroimaging Initi	Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; IDENTIFIES VARIANTS; COMMON VARIANTS; BLOOD-PRESSURE; DEMENTIA; ADIPOSITY; LOCI; CLU; HYPERINSULINEMIA	Background: Recent studies showed that polymorphisms in the Fat and Obesity-Associated (FTO) gene have robust effects on obesity, obesity-related traits and endophenotypes associated with Alzheimer's disease (AD). Methods: We used 1,877 Caucasian cases and controls from the NIA-LOAD study and 1,093 Caribbean Hispanics to further explore the association of FTO with AD. Using logistic regression, we assessed 42 SNPs in introns 1 and 2, the region previously reported to be associated with AD endophenotypes, which had been derived by genome-wide screenings. In addition, we performed gene expression analyses of neuropathologically confirmed AD cases and controls of two independent datasets (19 AD cases, 10 controls; 176 AD cases, 188 controls) using within-and between-group factors ANOVA of log(10) transformed rank invariant normalized expression data. Results: In the NIALOAD study, one SNP was significantly associated with AD and three additional markers were close to significance (rs6499640, rs10852521, rs16945088, rs8044769, FDR p-value: 0.05<p<0.09). Two of the SNPs are in strong LD (D'>0.9) with the previously reported SNPs. In the Caribbean Hispanic dataset, we identified three SNPs (rs17219084, rs11075996, rs11075997, FDR p-value: 0.009<p<0.01) that were associated with AD. These results were confirmed by haplotype analyses and in a metaanalysis in which we included the ADNI dataset. FTO had a significantly lower expresssion in AD cases compared to controls in two independent datasets derived from human cortex and amygdala tissue, respectively (p = 2.18x10-5 and p<0.0001). Conclusions: Our data support the notion that genetic variation in Introns 1 and 2 of the FTO gene may contribute to AD risk.	[Reitz, Christiane; Tosto, Giuseppe; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard; Luchsinger, Jose A.] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Mayeux, R (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	rpm2@columbia.edu	Preda, Adrian/K-8889-2013; Mayeux, Richard/E-9788-2013; Hsiung, Robin/AAT-1661-2021; Levey, Allan/F-2104-2011; Reitz, Christiane/GNP-0257-2022	Preda, Adrian/0000-0003-3373-2438; Mayeux, Richard/0000-0001-6519-9696; Hsiung, Robin/0000-0002-8017-0856; Levey, Allan/0000-0002-3153-502X; Luchsinger, Jose/0000-0002-5886-3648	National Institutes of Health (NIH); National Institute on Aging [R37-AG15473, P01-AG07232]; Blanchett Hooker Rockefeller Foundation; Paul B. Beeson Career Development Award [K23AG034550]; National Institute on Aging - Late Onset Alzheimer's Disease Family Study [U24AG026390]; National Cell Repository for Alzheimer's Disease (NCRAD) [U24 AG21886]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; National Institute on Aging (NIA); Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; NATIONAL INSTITUTE ON AGING [U24AG021886, R37AG015473, U01AG024904, P30AG010129, P30AG013846, K23AG034550, P01AG007232, P30AG019610, R01AG041797, U19AG010483, R01AG026390, K01AG030514, P50AG008702, R01AG037212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Blanchett Hooker Rockefeller Foundation; Paul B. Beeson Career Development Award; National Institute on Aging - Late Onset Alzheimer's Disease Family Study; National Cell Repository for Alzheimer's Disease (NCRAD); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abbott(Abbott Laboratories); Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NIH) and the National Institute on Aging: R37-AG15473, P01-AG07232, The Blanchett Hooker Rockefeller Foundation, The Charles S. Robertson Gift from the Banbury Fund, and The Merrill Lynch Foundation. Dr. Reitz was further supported by a Paul B. Beeson Career Development Award (K23AG034550). Data and samples from the National Institute on Aging - Late Onset Alzheimer's Disease Family Study, which receives government support under a cooperative agreement grant (U24AG026390), were also used in this study. Samples from the National Cell Repository for Alzheimer's Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. Data collection and sharing for the ADNI project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ADNI is partly funded through generous contributions from the following: Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1976, GERIATRIC PSYCHIAT; [Anonymous], 1981, WAIS R MANUAL; Benedict C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.006; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benton A., 1955, BENTON VISUAL RETENT; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Chen JJ, 2010, CANCER CONTROL, V17, P58, DOI 10.1177/107327481001700108; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hotta K, 2011, J HUM GENET; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Lewandowski NM, 2005, J NEUROSCI, V25, P10341, DOI 10.1523/JNEUROSCI.4006-05.2005; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Luchsinger JA, 2008, EUR J PHARMACOL, V585, P119, DOI 10.1016/j.ejphar.2008.02.048; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nourhashemi F, 2003, NEUROLOGY, V60, P117, DOI 10.1212/01.WNL.0000038910.46217.AA; Pausova Z, 2009, CIRC-CARDIOVASC GENE, V2, P260, DOI 10.1161/CIRCGENETICS.109.857359; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rosen W., 1981, ROSEN DRAWING TEST; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; van Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	54	66	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50354	10.1371/journal.pone.0050354	http://dx.doi.org/10.1371/journal.pone.0050354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251365	Green Published, gold			2022-12-25	WOS:000313236200027
J	Schneider, A; David, VA; Johnson, WE; O'Brien, SJ; Barsh, GS; Menotti-Raymond, M; Eizirik, E				Schneider, Alexsandra; David, Victor A.; Johnson, Warren E.; O'Brien, Stephen J.; Barsh, Gregory S.; Menotti-Raymond, Marilyn; Eizirik, Eduardo			How the Leopard Hides Its Spots: ASIP Mutations and Melanism in Wild Cats	PLOS ONE			English	Article							AGOUTI SIGNALING PROTEIN; COAT-COLOR; GENETICS; PIGMENTATION; EVOLUTION; INHERITANCE; EXTENSION; PATTERNS; RECEPTOR; GENES	The occurrence of melanism (darkening of the background coloration) is documented in 13 felid species, in some cases reaching high frequencies at the population level. Recent analyses have indicated that it arose multiple times in the Felidae, with three different species exhibiting unique mutations associated with this trait. The causative mutations in the remaining species have so far not been identified, precluding a broader assessment of the evolutionary dynamics of melanism in the Felidae. Among these, the leopard (Panthera pardus) is a particularly important target for research, given the iconic status of the 'black panther' and the extremely high frequency of melanism observed in some Asian populations. Another felid species from the same region, the Asian golden cat (Pardofelis temminckii), also exhibits frequent records of melanism in some areas. We have sequenced the coding region of the Agouti Signaling Protein (ASIP) gene in multiple leopard and Asian golden cat individuals, and identified distinct mutations strongly associated with melanism in each of them. The single nucleotide polymorphism (SNP) detected among the P. pardus individuals was caused by a nonsense mutation predicted to completely ablate ASIP function. A different SNP was identified in P. temminckii, causing a predicted amino acid change that should also induce loss of function. Our results reveal two additional cases of species-specific mutations implicated in melanism in the Felidae, and indicate that ASIP mutations may play an important role in naturally-occurring coloration polymorphism.	[Schneider, Alexsandra; Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biol Genom & Mol, Fac Biociencias, Porto Alegre, RS, Brazil; [David, Victor A.; Johnson, Warren E.; O'Brien, Stephen J.; Menotti-Raymond, Marilyn] Frederick Natl Lab Canc Res, Lab Genom Div, Frederick, MD USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Informat, St Petersburg, Russia; [Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Eizirik, Eduardo] Inst Procarnivoros, Sao Paulo, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University; HudsonAlpha Institute for Biotechnology	Schneider, A (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biol Genom & Mol, Fac Biociencias, Porto Alegre, RS, Brazil.	ale-schneider@live.com; eduardo.eizirik@pucrs.br	OBRIEN, STEPHEN/ABD-1346-2020; Johnson, Warren/D-4149-2016; David, Victor A/I-9330-2012; Eizirik, Eduardo/K-8034-2012	Johnson, Warren/0000-0002-5954-186X; Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757; O'Brien, Stephen J./0000-0001-7353-8301	Brazilian National Research Council/CNPq; CAPES/Brazil; USA federal funds from the National Cancer Institute, National Institutes of Health [HHSN26120080001E]	Brazilian National Research Council/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USA federal funds from the National Cancer Institute, National Institutes of Health	This work was funded by the Brazilian National Research Council/CNPq (www.cnpq.br), CAPES/Brazil (www.capes.gov.br), and USA federal funds from the National Cancer Institute, National Institutes of Health (www.nih.gov), under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does its mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angwin D, 1975, B E AFR NAT HIST SOC, V3; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Burton RG, 1928, FIELD, V152, P656; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Coleman L.E., 1974, Carnivore Genet Newsl, V2, P209; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; Dittrich L., 1979, Zoologische Garten, V49, P417; Dunstone N, 1998, CAT NEWS, V29, P18; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik E, 2010, GENETICS, V184, P267, DOI 10.1534/genetics.109.109629; Gibson-Hill CA, 1950, J BOMBAY NAT HIST SO, V19, P375; Hillis David M., 1996, P321; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Junge C, 1975, INT ZOO NEWS, V21, P38; Kaelin C, 2010, PIGM CELL MELANOMA R, V23, P514, DOI 10.1111/j.1755-148X.2010.00723.x; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Lamotte Maxime, 1942, MAMMALIA, V6, P114, DOI 10.1515/mamm.1942.6.3.114; Lonnberg E., 1898, ZOOL JB, V10, P569; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Miltenberger RJ, 2002, GENETICS, V160, P659; Mundy NI, 2006, MAMM GENOME, V17, P1205, DOI 10.1007/s00335-006-0056-0; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Palumbi Stephen R., 1996, P205; Perry WL, 1996, GENETICS, V144, P255; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; ROBINSON R, 1970, GENETICA, V41, P190, DOI 10.1007/BF00958904; Robinson R., 1959, Bibliographia Genetica, V18, P273; ROBINSON R, 1976, GENETICA, V46, P1; ROBINSON R, 1969, Journal of the Bombay Natural History Society, V66, P423; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Searle A.G., 1968, COMP GENETICS COAT C; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1998, Cat News, V28, P17; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; ULMER FRED A., 1941, JOUR MAMMAL, V22, P285, DOI 10.2307/1374954; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Weigel I., 1961, Saugetierkundliche Mitteilungen, V9, P1; Whiting PW, 1918, J EXP ZOOL, V25, P539, DOI 10.1002/jez.1400250207; Wibisono Hariyo T., 2010, Cat News, V52, P9; Wrogemann N., 1975, CHEETAH SUN; Young SP., 1946, PUMA MYSTERIOUS AM C	50	25	30	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50386	10.1371/journal.pone.0050386	http://dx.doi.org/10.1371/journal.pone.0050386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251368	Green Submitted, Green Published, gold			2022-12-25	WOS:000313236200028
J	Wang, YL; Lu, SL; Li, XD; Du, N; Sun, YB; Xing, JY; Pan, XT; Chen, BS; Miao, ZM				Wang, Yunlong; Lu, Shulai; Li, Xinde; Du, Na; Sun, Yunbo; Xing, Jinyan; Pan, Xinting; Chen, Baosheng; Miao, Zhimin			The Lipid-Bound Apolipoprotein A-I Cysteine Mutant (N74C) Inhibits the Activation of NF-kappa B, JNK and p38 in Endotoxemic Mice and RAW264.7 Cells	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; MIMETIC PEPTIDE; SEVERE SEPSIS; LUNG INJURY; APOA-I; PLASMA; MILANO; ANTAGONIST; BACTERIAL	Our previous studies showed that recombinant high-density lipoprotein (rHDL) rHDL74 exhibited higher anti-inflammatory capabilities compared to wild-type rHDL (rHDLwt), while rHDL228 showed hyper-proinflammation. In this paper, we further investigated the potential mechanisms involved in their different inflammatory functions using two models: endotoxemic mice and the RAW264.7 inflammation model. Our results showed that 24 h after the injection of lipopolysaccharide (LPS), mice treated with rHDL74 had a significant decrease in plasma CRP (P < 0.01 vs. rHDLwt; P < 0.01 vs. LPS), MCP-1 (P < 0.05 vs. rHDLwt; P < 0.01 vs. LPS) and CD14 (P < 0.01 vs. LPS) compared with the mice treated with rHDLwt or the controls that received LPS only. Similar to our previous study, rHDL228 increased the plasma level of CRP (P < 0.05 vs. LPS) and MCP-1 (P, 0.01 vs. LPS). Our immunohistochemistry and western blot analysis showed that rHDL74 inhibited the activation of NF-kappa B in endotoxemic mice and JNK and p38 in the RAW264.7 inflammation model, while rHDL228 exacerbated the activation of NF-kappa B and ERK. In summary, our data suggest that rHDL74 exhibits higher anti-inflammatory activity by decreasing inflammatory factors and inhibiting the activation of NF-kappa B, JNK and p38, while rHDL228 appears to be hyper-proinflammation by increasing these inflammatory factors and aggravating the activation of NF-kappa B and ERK.	[Wang, Yunlong; Li, Xinde; Miao, Zhimin] Qingdao Univ, Gout Lab, Affiliated Hosp, Coll Med,Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China; [Lu, Shulai] Qingdao Municipal Hosp, Dept Stomatol, Qingdao, Peoples R China; [Du, Na] Ocean Univ China, Sch Pharm, Minist Educ China, Key Lab Marine Drugs, Qingdao, Peoples R China; [Sun, Yunbo; Xing, Jinyan; Pan, Xinting] Qingdao Univ, Affiliated Hosp, Coll Med, ICU, Qingdao 266071, Peoples R China; [Chen, Baosheng] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Chen, Baosheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Qingdao University; Qingdao Municipal Hospital; Ministry of Education, China; Ocean University of China; Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, YL (corresponding author), Qingdao Univ, Gout Lab, Affiliated Hosp, Coll Med,Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China.	wylapollo@163.com; miaozhm@qdumh.qd.sd.cn			fund of the National Nature Science [30900238]	fund of the National Nature Science	This work was supported by a fund of the National Nature Science (30900238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2009, ADV EXP MED BIOL, V667, P39, DOI 10.1007/978-1-4419-1603-7_4; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baker JV, 2011, AIDS, V25, P2133, DOI 10.1097/QAD.0b013e32834be088; Barlage S, 2009, INTENS CARE MED, V35, P1877, DOI 10.1007/s00134-009-1609-y; Buttenschoen K, 2010, LANGENBECK ARCH SURG, V395, P597, DOI 10.1007/s00423-010-0658-6; Calabresi L, 1997, BIOCHEM BIOPH RES CO, V238, P61, DOI 10.1006/bbrc.1997.7236; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Haas MJ, 2011, CURR OPIN INFECT DIS, V24, P265, DOI 10.1097/QCO.0b013e328344b724; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; KOTANI S, 1985, INFECT IMMUN, V49, P225, DOI 10.1128/IAI.49.1.225-237.1985; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rose JR, 2000, ANTIMICROB AGENTS CH, V44, P504, DOI 10.1128/AAC.44.3.504-510.2000; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Shah PK, 1998, CIRCULATION, V97, P780, DOI 10.1161/01.CIR.97.8.780; Shah PK, 2001, CIRCULATION, V103, P3047, DOI 10.1161/hc2501.092494; Sirtori CR, 2001, CIRCULATION, V103, P1949; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Wang YL, 2008, J LIPID RES, V49, P1640, DOI 10.1194/jlr.M700446-JLR200; Wasan KM, 1999, ANTIMICROB AGENTS CH, V43, P2562, DOI 10.1128/AAC.43.10.2562; Yan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011; Zhu XW, 2005, J LIPID RES, V46, P1303, DOI 10.1194/jlr.M400401-JLR200	29	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51327	10.1371/journal.pone.0051327	http://dx.doi.org/10.1371/journal.pone.0051327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251501	Green Published, Green Submitted, gold			2022-12-25	WOS:000313236200091
J	Mostafa, SA; Davies, MJ; Morris, DH; Yates, T; Srinivasan, BT; Webb, D; Brady, E; Khunti, K				Mostafa, Samiul A.; Davies, Melanie J.; Morris, Danielle H.; Yates, Tom; Srinivasan, Balasubramanian Thiagarajan; Webb, David; Brady, Emer; Khunti, Kamlesh			The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White European and South Asian Men and Women	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOMETABOLIC RISK-FACTORS; GLYCATED HEMOGLOBIN; POTENTIAL IMPACT; GLUCOSE; SENSITIVITY; DISEASE; MARKERS; INDEX	Introduction: There is recent interest surrounding the use of the triglyceride-to-HDL cholesterol ratio as a surrogate marker of insulin resistance in clinical practice, as it may identify people at high risk of developing diabetes or its complications. However, it has been suggested using this lipid ratio may not be appropriate for measuring insulin resistance in African-Americans, particularly women. We investigated if this inconsistency extended to South Asian women in a UK multi-ethnic cohort of White Europeans and South Asians. Methods: Cross-sectional analysis was done of 729 participants from the ADDITION-Leicester study from 2005 to 2009. The association between tertiles of triglyceride-to-HDL cholesterol ratio to fasting insulin, homeostatic model of assessment for insulin resistance (HOMA1-IR), quantitative insulin sensitivity check index (QUICKI) and glucose: insulin ratio was examined with adjustment for confounding variables. Results: Incremental tertiles of the triglyceride-to-HDL cholesterol ratio demonstrated a significant positive association with levels of fasting insulin, HOMA1-IR, glucose: insulin ratio and a negative association with QUICKI in White European men (n = 255) and women (n = 250) and South Asian men (n = 124) (all p<0.05), but not South Asian women (n = 100). A significant interaction was demonstrated between sex and triglyceride-to-HDL cholesterol ratio tertiles in South Asians only (p<0.05). The area under the receiver operating characteristic curve for triglyceride-to-HDL cholesterol ratio to detect insulin resistance, defined as the cohort HOMA1-IR >= 75th percentile (3.08), was 0.74 (0.67 to 0.81), 0.72 (0.65 to 0.79), 0.75 (0.66 to 0.85) and 0.67 (0.56 to 0.78) in White European men and women, South Asian men and women respectively. The optimal cut-points for detecting insulin resistance were 0.9-1.7 in mmol/l (2.0-3.8 in mg/dl) for the triglyceride-to-HDL ratio. Conclusion: In South Asian women the triglyceride-to-HDL cholesterol ratio was not associated with insulin resistance; therefore there may be limitations in its use as a surrogate marker in this group.	[Mostafa, Samiul A.; Davies, Melanie J.; Morris, Danielle H.; Yates, Tom; Srinivasan, Balasubramanian Thiagarajan; Webb, David; Brady, Emer] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester; University of Leicester	Mostafa, SA (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	samiul.mostafa@uhl-tr.nhs.uk	/ABC-9527-2021	Webb, David/0000-0002-3932-3339; Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099; Mostafa, Samiul/0000-0002-0415-7908	United Kingdom NHS Department of Health; Lilly; Sanofi Aventis; MSD; Novo Nordisk; BMS; BI; Roche; Astra Zeneca; Novartis; Pfizer; Servier; Novo Nordisk UK research foundation; NIHR LNR CLAHRC; NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit; National Institute for Health Research [RP-DG-1210-10183, RP-PG-0606-1272] Funding Source: researchfish	United Kingdom NHS Department of Health; Lilly(Eli Lilly); Sanofi Aventis(Sanofi-Aventis); MSD; Novo Nordisk(Novo Nordisk); BMS(Bristol-Myers Squibb); BI; Roche(Roche Holding); Astra Zeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Servier(Servier); Novo Nordisk UK research foundation; NIHR LNR CLAHRC; NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	ADDITION-Leicester study was originally funded for support and treatment costs by United Kingdom NHS Department of Health (ClinicalTrials.gov Registration number: NCT00318032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KK (Chair) and MJD are members of the National Institute for Health and Clinical Excellence Public Health Guidance on prevention of Type 2 diabetes among people with prediabetes. MJD and KK are advisors to the UK Department Health for the NHS Health Checks Programme. MJD has received funds for research, honoraria for speaking at meetings and has served on Advisory Boards for Lilly, Sanofi Aventis, MSD, Novo Nordisk, BMS, BI and Roche. KK has received funds for research, honoraria for speaking at meetings and or served on Advisory Boards for Astra Zeneca, Lilly, Novartis, Pfizer, Servier, Sanofi Aventis, MSD and Novo Nordisk. SAM and DW have received fellowships from Novo Nordisk UK research foundation.; All members of the ADDITION-Leicester team and the participants for their contributions, as well as support from NIHR LNR CLAHRC and NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit.	[Anonymous], UK ETHNICITY NATL ST; Balkau B, 1999, DIABETIC MED, V16, P442; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhalodkar NC, 2004, AM J CARDIOL, V94, P1561, DOI 10.1016/j.amjcard.2004.08.040; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Bovet P, 2006, ARCH INTERN MED, V166, P1236, DOI 10.1001/archinte.166.11.1236-b; Communities and Local Government, 2007, ENGL IND DEPR 2004; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; Di Bonito P, 2012, DIABETES CARE, V35, P158, DOI 10.2337/dc11-1456; Fan XD, 2011, J CLIN PSYCHIAT, V72, P806, DOI 10.4088/JCP.09m05107yel; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Mostafa SA, 2010, DIABETIC MED, V27, P762, DOI 10.1111/j.1464-5491.2010.03015.x; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Musso C, 2011, PEDIATR DIABETES, V12, P229, DOI 10.1111/j.1399-5448.2010.00710.x; Perkins NJ, 2005, BIOMETRICAL J, V47, P428, DOI 10.1002/bimj.200410133; Population estimates by Ethnic group, 2011, METH PAP OFF NAT STA; Quijada Z, 2008, PEDIATR DIABETES, V9, P464, DOI 10.1111/j.1399-5448.2008.00406.x; Report of a WHO Expert Consultation, 2008, REP WHO EXP CONS; Robbins DC, 1996, DIABETES, V45, P242, DOI 10.2337/diabetes.45.2.242; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sumner AE, 2010, METAB SYNDR RELAT D, V8, P511, DOI 10.1089/met.2010.0028; The IDF consensus worldwide definition of the metabolic syndrome, 2006, IDF CONS WORLDW DEF; United States Census Bureau, PROF GEN POP HOUS CH; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Zoppini G, 2012, METABOLISM, V61, P22, DOI 10.1016/j.metabol.2011.05.004	42	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50931	10.1371/journal.pone.0050931	http://dx.doi.org/10.1371/journal.pone.0050931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251403	Green Published, gold, Green Submitted			2022-12-25	WOS:000312201900026
J	Buga, AM; Vintilescu, R; Balseanu, AT; Pop, OT; Streba, C; Toescu, E; Popa-Wagner, A				Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Toescu, Emil; Popa-Wagner, Aurel			Repeated PTZ Treatment at 25-Day Intervals Leads to a Highly Efficient Accumulation of Doublecortin in the Dorsal Hippocampus of Rats	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; ADULT DENTATE GYRUS; NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CRITICAL PERIOD; SPATIAL MEMORY; DOWN-SYNDROME	Background: Neurogenesis persists throughout life in the adult mammalian brain. Because neurogenesis can only be assessed in postmortem tissue, its functional significance remains undetermined, and identifying an in vivo correlate of neurogenesis has become an important goal. By studying pentylenetetrazole-induced brain stimulation in a rat model of kindling we accidentally discovered that 25+/-1 days periodic stimulation of Sprague-Dawley rats led to a highly efficient increase in seizure susceptibility. Methodology/Principal Findings: By EEG, RT-PCR, western blotting and immunohistochemistry, we show that repeated convulsive seizures with a periodicity of 25+/-1 days led to an enrichment of newly generated neurons, that were BrdU-positive in the dentate gyrus at day 25+/-1 post-seizure. At the same time, there was a massive increase in the number of neurons expressing the migratory marker, doublecortin, at the boundary between the granule cell layer and the polymorphic layer in the dorsal hippocampus. Some of these migrating neurons were also positive for NeuN, a marker for adult neurons. Conclusion/Significance: Our results suggest that the increased susceptibility to seizure at day 25+/-1 post-treatment is coincident with a critical time required for newborn neurons to differentiate and integrate into the existing hippocampal network, and outlines the importance of the dorsal hippocampus for seizure-related neurogenesis. This model can be used as an in vivo correlate of neurogenesis to study basic questions related to neurogenesis and to the neurogenic mechanisms that contribute to the development of epilepsy.	[Buga, Ana-Maria; Balseanu, Adrian Tudor; Popa-Wagner, Aurel] Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Popa-Wagner, Aurel] Univ Med & Pharm, Dept Funct Sci, Craiova, Romania; [Toescu, Emil] Univ Birmingham Edgbaston, Coll Med & Dent Sci, Dept Clin & Expt Med, Birmingham, W Midlands, England	University of Rostock; University of Medicine & Pharmacy of Craiova; University of Birmingham	Buga, AM (corresponding author), Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Popa-Wagner, Aurel/E-2541-2013; Buga, Ana-Maria I/P-1478-2014; Vintilescu, Raluca/A-9499-2018; Streba, Costin Teodor T/C-4196-2011; Balseanu, Tudor Adrian/O-2289-2018; Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/I-2581-2019; Buga, Ana Maria/ABA-8108-2021; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019; Scholz, Claus Jürgen/H-3202-2019	Streba, Costin Teodor T/0000-0001-9590-3197; Balseanu, Tudor Adrian/0000-0002-0047-3436; Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Scholz, Claus Jürgen/0000-0002-6406-7859; Sivanesan, Senthilkumar/0000-0001-5133-7090	Ministry of Research and Education of Germany [0314107]; National Council for Scientific Research of Romania [PN-II-ID-PCE-2011-3-0848]; European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania [8555/2011]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Ministry of Research and Education of Germany; National Council for Scientific Research of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); ERA-NET FLARE2/UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Ministry of Research and Education of Germany (No 0314107) and from National Council for Scientific Research of Romania (No PN-II-ID-PCE-2011-3-0848). Dr. Ana-Maria Buga and Dr. Toescu were supported by a grant from the European project ERA-NET FLARE2 of United Kingdom and the Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania (No 8555/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Popa-Wagner was supported by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. We also acknowledge the critical reading of the manuscript by Lary Walker.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Babb T L, 1986, Adv Neurol, V44, P949; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; Devinsky Orrin, 2004, Rev Neurol Dis, V1, P2; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Geoghegan D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-2; Hosseini M, 2009, SEIZURE-EUR J EPILEP, V18, P695, DOI 10.1016/j.seizure.2009.09.008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Parent JM, 1997, J NEUROSCI, V17, P3727; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; PopaWagner A, 1997, EXP NEUROL, V148, P73, DOI 10.1006/exnr.1997.6652; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Scharfman Helen E., 2002, Epilepsy Curr, V2, P63, DOI 10.1046/j.1535-7597.2002.00023.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmoll H, 2003, AM J PATHOL, V162, P1027, DOI 10.1016/S0002-9440(10)63897-7; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39302	10.1371/journal.pone.0039302	http://dx.doi.org/10.1371/journal.pone.0039302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23251410	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100042
J	Li, Z; Zhao, ZJ; Zhu, XQ; Ren, QS; Nie, FF; Gao, JM; Gao, XJ; Yang, TB; Zhou, WL; Shen, JL; Wang, Y; Lu, FL; Chen, XG; Hide, G; Ayala, FJ; Lun, ZR				Li, Zhi; Zhao, Zhi-Jun; Zhu, Xing-Quan; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Shen, Ji-Long; Wang, Yong; Lu, Fang-Li; Chen, Xiao-Guang; Hide, Geoff; Ayala, Francisco J.; Lun, Zhao-Rong			Differences in iNOS and Arginase Expression and Activity in the Macrophages of Rats Are Responsible for the Resistance against T. gondii Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED MURINE MACROPHAGES; L-ARGININE METABOLISM; TOXOPLASMA-GONDII; PERITONEAL-MACROPHAGES; POLYAMINE LEVELS; RH STRAIN; CELLS; MECHANISMS; IMMUNITY	Toxoplasma gondii infects humans and warm blooded animals causing devastating disease worldwide. It has long been a mystery as to why the peritoneal macrophages of rats are naturally resistant to T. gondii infection while those of mice are not. Here, we report that high expression levels and activity of inducible nitric oxide synthase (iNOS) and low levels of arginase-1 (Arg 1) activity in the peritoneal macrophages of rats are responsible for their resistance against T. gondii infection, due to high nitric oxide and low polyamines within these cells. The opposite situation was observed in the peritoneal macrophages of mice. This discovery of the opposing functions of iNOS and Arg 1 in rodent peritoneal macrophages may lead to a better understanding of the resistance mechanisms of mammals, particularly humans and livestock, against T. gondii and other intracellular pathogens.	[Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xing-Quan; Lun, Zhao-Rong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Dept Pathogen Biol, Hefei, Anhui, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiao-Guang] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Sch Environm & Life Sci, Ctr Parasitol & Dis, Salford M5 4WT, Lancs, England; [Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Zhao, Zhi-Jun] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Anhui Medical University; Nanjing Medical University; Southern Medical University - China; University of Salford; University of California System; University of California Irvine; Ningxia Medical University	Li, Z (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsslzr@mail.sysu.edu.cn		Hide, Geoff/0000-0002-3608-0175	National Basic Research Program of China (973 Program) [2010CB530000]; National Special Research Programs for Non-Profit Trades (Agriculture) [200803017]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Special Research Programs for Non-Profit Trades (Agriculture)	The work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530000) and the National Special Research Programs for Non-Profit Trades (Agriculture) (No. 200803017), http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 2001, CELL MOL LIFE SCI, V58, P1350, DOI 10.1007/PL00000947; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blachier F, 1997, NITRIC OXIDE-BIOL CH, V1, P268, DOI 10.1006/niox.1997.0127; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; CHINCHILLA M, 1982, J PARASITOL, V68, P952, DOI 10.2307/3281014; CHINCHILLA M, 1978, INFECT IMMUN, V19, P999, DOI 10.1128/IAI.19.3.999-1012.1978; COOK HT, 1994, AM J PHYSIOL-RENAL, V267, pF646, DOI 10.1152/ajprenal.1994.267.4.F646; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; De Champs C, 1998, PARASITE, V5, P215, DOI 10.1051/parasite/1998053215; DING AH, 1988, J IMMUNOL, V141, P2407; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kempf MC, 1999, MED MICROBIOL IMMUN, V187, P137, DOI 10.1007/s004300050085; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KRAHENBUHL JL, 1975, EXP PARASITOL, V37, P83, DOI 10.1016/0014-4894(75)90055-7; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; MCCABE RE, 1986, INFECT IMMUN, V52, P151, DOI 10.1128/IAI.52.1.151-155.1986; Mullner N, 2002, INT J BIOCHEM CELL B, V34, P1080, DOI 10.1016/S1357-2725(02)00028-6; Munder M, 1998, J IMMUNOL, V160, P5347; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; von Bargen K, 2011, INFECT IMMUN, V79, P2098, DOI 10.1128/IAI.00983-10; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	49	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35834	10.1371/journal.pone.0035834	http://dx.doi.org/10.1371/journal.pone.0035834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558235	Green Accepted, Green Published, gold			2022-12-25	WOS:000305345200084
J	Liu, ZY; Owen, T; Fang, J; Zuo, J				Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian			Overactivation of Notch1 Signaling Induces Ectopic Hair Cells in the Mouse Inner Ear in an Age-Dependent Manner	PLOS ONE			English	Article							OTIC PLACODE; SUPPORTING CELLS; REGULATES DEVELOPMENT; FATE SPECIFICATION; PROSENSORY PATCHES; SENSORY EPITHELIA; MAMMALIAN COCHLEA; EXPRESSION; MATH1; FGF	Background: During mouse inner ear development, Notch1 signaling first specifies sensory progenitors, and subsequently controls progenitors to further differentiate into either hair cells (HCs) or supporting cells (SCs). Overactivation of NICD (Notch1 intracellular domain) at early embryonic stages leads to ectopic HC formation. However, it remains unclear whether such an effect can be elicited at later embryonic or postnatal stages, which has important implications in mouse HC regeneration by reactivation of Notch1 signaling. Methodology/Principal Findings: We performed comprehensive in vivo inducible overactivation of NICD at various developmental stages. In CAG(CreER+); Rosa26-NICDloxp/+ mice, tamoxifen treatment at embryonic day 10.5 (E10.5) generated ectopic HCs in the non-sensory regions in both utricle and cochlea, whereas ectopic HCs only appeared in the utricle when tamoxifen was given at E13. When tamoxifen was injected at postnatal day 0 (P0) and P1, no ectopic HCs were observed in either utricle or cochlea. Interestingly, Notch1 signaling induced new HCs in a non-cell-autonomous manner, because the new HCs did not express NICD. Adjacent to the new HCs were cells expressing the SC marker Sox10 (either NICD+ or NICD-negative). Conclusions/Significance: Our data demonstrate that the developmental stage determines responsiveness of embryonic otic precursors and neonatal non-sensory epithelial cells to NICD overactivation, and that Notch 1 signaling in the wild type, postnatal inner ear is not sufficient for generating new HCs. Thus, our genetic mouse model is suitable to test additional pathways that could synergistically interact with Notch1 pathway to produce HCs at postnatal ages.	[Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiyong] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Owen, Thomas] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Bath	Liu, ZY (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org			National Institutes of Health [DC06471, DC05168, DC008800, CA21765]; Office of Naval Research [N000140911014]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC005168, R21DC008800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by the National Institutes of Health (DC06471, DC05168, DC008800 and CA21765), the Office of Naval Research (N000140911014), the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, The Hartwell Individual Biomedical Research Award, NOHR, Travel Awards from Academic Programs of St. Jude Children's Research Hospital, the University of Tennessee Health Science Center, and the Society of Developmental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Burns J, 2008, J COMP NEUROL, V511, P396, DOI 10.1002/cne.21849; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen P, 2002, DEVELOPMENT, V129, P2495; Collado MS, 2008, CURR OPIN OTOLARYNGO, V16, P465, DOI 10.1097/MOO.0b013e32830f4ab5; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Driver EC, 2008, J NEUROSCI, V28, P7350, DOI 10.1523/JNEUROSCI.0312-08.2008; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Freyer L, 2010, DEV DYNAM, V239, P1708, DOI 10.1002/dvdy.22308; Groves AK, 2000, DEVELOPMENT, V127, P3489; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Huh SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001231; Hwang CH, 2010, DEV DYNAM, V239, P505, DOI 10.1002/dvdy.22200; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kwan T, 2009, ANN NY ACAD SCI, V1170, P28, DOI 10.1111/j.1749-6632.2009.04484.x; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Li HW, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-16; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Mustapha M, 2009, J NEUROSCI, V29, P1212, DOI 10.1523/JNEUROSCI.4957-08.2009; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Sweet EM, 2011, DEV BIOL, V358, P113, DOI 10.1016/j.ydbio.2011.07.019; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wright TJ, 2003, CURR TOP DEV BIOL, V57, P225, DOI 10.1016/S0070-2153(03)57008-9; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	72	41	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34123	10.1371/journal.pone.0034123	http://dx.doi.org/10.1371/journal.pone.0034123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	23251366	Green Published, Green Submitted, gold			2022-12-25	WOS:000303855700080
J	Chen, L; Liu, WQ; Lei, JH; Guan, F; Li, MJ; Song, WJ; Li, YL; Wang, T				Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Song, Wen-jian; Li, Yong-long; Wang, Ting			Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice	PLOS ONE			English	Article							PROTECTIVE EFFICACY; MANSONI INFECTION; IMMUNOGENICITY; METAANALYSIS; ACTIVATION; ANTIBODIES; CHILDREN; INFANTS	Background: Hepatitis B and schistosomiasis are most prevalent in Africa and Asia, and co-infections of both are frequent in these areas. The immunomodulation reported to be induced by schistosome infections might restrict immune control of hepatitis B virus (HBV) leading to more severe viral infection. Vaccination is the most effective measure to control and prevent HBV infection, but there is evidence for a reduced immune response to the vaccine in patients with chronic schistosomiasis japonica. Methodology/Principal Findings: In this paper, we demonstrate in a mouse model that a chronic Schistosoma japonicum infection can inhibit the immune response to hepatitis B vaccine (HBV vaccine) and lead to lower production of anti-HBs antibodies, interferon-gamma (IFN-gamma) and interleukin-2 (IL-2). After deworming with Praziquantel (PZQ), the level of anti-HBs antibodies gradually increased and the Th2-biased profile slowly tapered. At 16 weeks after deworming, the levels of anti-HBs antibodies and Th1/Th2 cytokines returned to the normal levels. Conclusions/Significance: The results suggest that the preexisting Th2-dominated immune profile in the host infected with the parasite may down-regulate levels of anti-HBs antibodies and Th1 cytokines. To improve the efficacy of HBV vaccination in schistosome infected humans it may be valuable to treat them with praziquantel (PZQ) some time prior to HBV vaccination. Citation: Chen L, Liu W-q, Lei J-h, Guan F, Li M-j, et al. (2012) Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice. PLoS ONE 7(12): e51512. doi:10.1371/journal.pone.0051512	[Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Li, Yong-long; Wang, Ting] Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Lin] Jianghan Univ, Wuhan Inst Biomed Sci, Wuhan, Peoples R China; [Song, Wen-jian] Jianghan Univ, Dept Parasitol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Jianghan University; Jianghan University	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China.	wangting139@mail.hust.edu.cn	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614	National Nature and Science Foundation of China [81000738]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Nature and Science Foundation of China (project grant 81000738). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bocher WO, 2000, HEPATOLOGY, V31, P480, DOI 10.1002/hep.510310231; Borkow G, 2006, PARASITE IMMUNOL, V28, P605, DOI 10.1111/j.1365-3024.2006.00918.x; Borkow G, 2002, CLIN DIAGN LAB IMMUN, V9, P505, DOI 10.1128/CDLI.9.3.505-507.2002; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; Bundy D, 2000, PARASITOL TODAY, V16, P273, DOI 10.1016/S0169-4758(00)01689-6; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Eren R, 1998, IMMUNOLOGY, V93, P154; GHAFFAR YA, 1989, LANCET, V2, P272; GHAFFAR YA, 1990, AM J TROP MED HYG, V43, P516, DOI 10.4269/ajtmh.1990.43.516; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guan you-gen, 2008, CHINESE J CHILD HLTH, V16, P494; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; McClary H, 2000, J EXP MED, V192, P289, DOI 10.1084/jem.192.2.289; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Muniz-Junqueira M I, 1996, Rev Soc Bras Med Trop, V29, P441, DOI 10.1590/S0037-86821996000500006; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Song Wen-Jian, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P163; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; SUTTER RW, 1991, LANCET, V338, P715, DOI 10.1016/0140-6736(91)91442-W; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wu G.L., 2005, HUMAN PARASITOLOGY, V3rd ed.; Zai XJ, 2002, RAILWAY MED J, V30, P63; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	36	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51512	10.1371/journal.pone.0051512	http://dx.doi.org/10.1371/journal.pone.0051512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272112	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800050
J	Chen, RL; Song, YQ; Hu, Z; Brunner, EJ				Chen, Ruoling; Song, Yiqing; Hu, Zhi; Brunner, Eric John			Predictors of Diabetes in Older People in Urban China	PLOS ONE			English	Article							GMS-AGECAT PREVALENCE; RISK-FACTORS; MRC-ALPHA; DEPRESSION; HEALTH; COMMUNITY; MELLITUS; WOMEN; MEN; POPULATION	Background: China has the largest number of people with diabetes in the world. Over the last 30 years China has experienced rapid economic growth and a growing income gap between rich and poor. The population is ageing, however diabetes in older people has not been well studied to date. In this study we determined incidence and predictors of diabetes in older Chinese people. Methods: During 2001, using a standard interview method, we examined 1,317 adults aged >= 65 years who did not have diabetes in the city of Hefei, and characterized baseline risk factors. Over 7.5 years of follow up, we documented incident diabetes using self-reported doctor diagnosis and the cause of death in the whole cohort, and HbA(1C) >= 48 mmol/mol in a nested case-control sample. A multivariate Cox regression model was employed to investigate risk of diabetes in relation to baseline risk factors. Results: During follow up, 119 persons had newly diagnosed diabetes. World age-standardised incidence of diabetes was 24.5 (95% CI 19.5-29.5) per 1,000 person-years. Risk of diabetes was significantly and positively associated with income, waist circumference and body mass index, smoking and uncontrolled hypertension, but negatively associated with having a hobby of walking and frequency of visiting children/other relatives and contacting neighbours/friends. Higher income was significantly associated with increased diabetes risk regardless of cardiovascular and psychosocial risk factors. Compared to those with middle income and no psychosocial risk factors, the hazard ratio for incident diabetes among participants with high income and psychosocial risk was 2.13 (95% CI 1.02-4.45). Conclusions: Increasing incidence of diabetes in relation to high income has become an important public health issue in China. Maintaining social networks and gentle physical activities and reducing psychosocial factors may be integrated into current multi-faceted preventive strategies for curbing the epidemic of diabetes in the older population.	[Chen, Ruoling; Hu, Zhi] Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China; [Song, Yiqing] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Brunner, Eric John] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; [Chen, Ruoling] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London, England	Anhui Medical University; Peking University; University of London; University College London; UCL Medical School; University of London; King's College London	Chen, RL (corresponding author), Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China.	ruoling.chen@ucl.ac.uk	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Chen, Ruoling/0000-0002-3033-8753	BUPA Foundation, UK [45NOV06, TBF-M09-50]; British Heart Foundation	BUPA Foundation, UK; British Heart Foundation(British Heart Foundation)	The cohort follow-up data collection work was funded by two research grants from the BUPA Foundation, UK (number of grants: 45NOV06 and TBF-M09-50). Eric Brunner is supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chen R, 2009, PSYCHOL MED, V39, P425, DOI 10.1017/S0033291708003735; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen RL, 2004, INT J GERIATR PSYCH, V19, P407, DOI 10.1002/gps.1103; Chen RL, 2005, EUR J EPIDEMIOL, V20, P141, DOI 10.1007/s10654-004-4498-y; Chen RL, 2008, BRIT J PSYCHIAT, V193, P373, DOI 10.1192/bjp.bp.107.044974; Chen RL, 2012, INT J GERIATR PSYCH, V27, P692, DOI 10.1002/gps.2767; Chen RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024817; COPELAND JRM, 1988, PSYCHOL MED, V18, P219, DOI 10.1017/S003329170000204X; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P340, DOI 10.1192/bjp.175.4.340; Cugati S, 2007, MED J AUSTRALIA, V186, P131, DOI 10.5694/j.1326-5377.2007.tb00836.x; de JP, 2006, DIABETOLOGIA, V49, P2797; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Guize L, 2008, B ACAD NAT MED PARIS, V192, P1707, DOI 10.1016/S0001-4079(19)32638-X; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Liu Meina, 2007, Prim Care Diabetes, V1, P123, DOI 10.1016/j.pcd.2007.05.001; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Peng LN, 2010, AGE AGEING, V39, P125, DOI 10.1093/ageing/afp193; Rockwood K, 2000, CAN MED ASSOC J, V162, P769; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	31	91	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50957	10.1371/journal.pone.0050957	http://dx.doi.org/10.1371/journal.pone.0050957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226432	Green Published, gold, Green Submitted			2022-12-25	WOS:000312376100243
J	Li, ZR; Carlow, CKS				Li, Zhiru; Carlow, Clotilde K. S.			Characterization of Transcription Factors That Regulate the Type IV Secretion System and Riboflavin Biosynthesis in Wolbachia of Brugia malayi	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; MACROFILARICIDAL ACTIVITY; INTRACELLULAR BACTERIA; LEGIONELLA-PNEUMOPHILA; ENDOSYMBIOTIC BACTERIA; DOXYCYCLINE TREATMENT; GENE CLUSTERS; EXPRESSION; PROTEIN; ENDOBACTERIA	The human filarial parasite Brugia malayi harbors an endosymbiotic bacterium Wolbachia (wBm) that is required for parasite survival. Consequently, targeting wBm is a promising approach for anti-filarial drug development. The Type IV secretion system (T4SS) plays an important role in bacteria-host interactions and is under stringent regulation by transcription factors. In wBm, most T4SS genes are contained in two operons. We show the wBm is active since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors (wBmxR1 and wBmxR2) that bind to the promoter region of several genes of the T4SS. Gel shift assays show binding of wBmxR1 to regions upstream of the virB9-2 and wBmxR2 genes, whereas wBmxR2 binds to virB4-2 and wBmxR1 promoter regions. Interestingly, both transcription factors bind to the promoter of the ribA gene that precedes virB8-1, the first gene in operon 1 of the wBm T4SS. RT-PCR reveals ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated by both wBmxR1 and wBmxR2. RibA encodes a bi-functional enzyme that catalyzes two essential steps in riboflavin (Vitamin B2) biosynthesis. Importantly, the riboflavin pathway is absent in B. malayi. We demonstrate the pathway is functional in wBm, and observe vitamin B2 supplementation partially rescues filarial parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host. This is the first characterization of a transcription factor(s) from wBm and first report of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway. In addition, our results demonstrate a requirement of vitamin B2 for worm health and fertility, and imply a nutritional role of the symbiont for the filarial parasite host.	[Li, Zhiru; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com		Hide, Geoff/0000-0002-3608-0175	New England Biolabs	New England Biolabs	This work was funded by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Bennett GM, 2012, FLY, V6; Bennuru S, 2011, P NATL ACAD SCI USA, V108, P9649, DOI 10.1073/pnas.1011481108; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debrah AY, 2007, TROP MED INT HEALTH, V12, P1433, DOI 10.1111/j.1365-3156.2007.01949.x; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Debrah Alexander Yaw, 2006, Filaria J, V5, P1, DOI 10.1186/1475-2883-5-1; Debrah Alexander Yaw, 2011, J Parasitol Res, V2011, P201617, DOI 10.1155/2011/201617; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hilleringmann M, 2006, MICROBIOL-SGM, V152, P2919, DOI 10.1099/mic.0.28984-0; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2009, PARASITOL RES, V104, P437, DOI 10.1007/s00436-008-1217-8; Hoerauf A, 2008, PARASITOL RES, V103, P279, DOI 10.1007/s00436-008-0964-x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Mand S, 2009, AM J TROP MED HYG, V81, P702, DOI 10.4269/ajtmh.2009.09-0155; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Miller MA, 1972, EXPT MOL GENETICS; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Narita S, 2007, APPL ENVIRON MICROB, V73, P4332, DOI 10.1128/AEM.00145-07; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rao RU, 2002, EXP PARASITOL, V101, P77, DOI 10.1016/S0014-4894(02)00019-X; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2009, ANN NY ACAD SCI, V1166, P106, DOI 10.1111/j.1749-6632.2009.04527.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sunish IP, 2011, TROP BIOMED, V28, P569; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Wang XQ, 2007, J BACTERIOL, V189, P4880, DOI 10.1128/JB.00318-07; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	62	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51597	10.1371/journal.pone.0051597	http://dx.doi.org/10.1371/journal.pone.0051597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	22558235	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900107
J	Chen, LF; Chen, HP; Huang, YS; Huang, KY; Chou, P; Lee, CC				Chen, Li-Fu; Chen, Hsin-Pai; Huang, Yung-Sung; Huang, Kuang-Yung; Chou, Pesus; Lee, Ching-Chih			Pneumococcal Pneumonia and the Risk of Stroke: A Population-Based Follow-Up Study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MYOCARDIAL-INFARCTION; DISEASE; ATHEROSCLEROSIS; VACCINATION	Background: To investigate the risk of developing stroke in patients hospitalized following a diagnosis of pneumococcal pneumonia. Methods: The study cohorts comprised of patients hospitalized with a principal diagnosis of pneumococcal pneumonia (n = 745), with a random sampling of control individuals in 2004 (n = 1490). The Cox proportional hazard model was used to compare the stroke-free survival rate between the cohorts after adjusting for possible confounding and risk factors for a two-year follow up. Instrumental variable analysis (IVA) was used to address potential biases associated with measured and unmeasured confounding variables. Results: Of the 153 patients with stroke, 80 (10.7%) were from the pneumococcal pneumonia cohort, and 73 (4.9%) were from the control group. The risk of stroke was 3.65 times higher (95% confidence interval, 2.25-5.90; P<0.001) in patients with pneumococcal pneumonia after adjusting for patient characteristics, co-morbidities, geographic region, urbanization level of residence, and socioeconomic status during the first year. IVA showed an additional 14% risk of stroke for pneumococcal pneumonia patients (odds ratio = 1.14; 95% CI, 1.02-1.26, P = 0.032). Conclusions: Patients with pneumococcal pneumonia carry an increased risk for stroke than the general population. Further studies are warranted for developing better diagnostic and follow-up strategies for patients with increased risk.	[Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency Med, Ilan, Taiwan; [Chen, Hsin-Pai] Natl Yang Ming Univ Hosp, Dept Internal Med, Ilan, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Kuang-Yung; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Gross PL, 2000, SEMIN THROMB HEMOST, V26, P463, DOI 10.1055/s-2000-13202; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Libby P, 1997, CIRCULATION, V96, P4095; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	15	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51452	10.1371/journal.pone.0051452	http://dx.doi.org/10.1371/journal.pone.0051452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23272112	gold, Green Submitted, Green Published			2022-12-25	WOS:000313236200111
J	Park, JI; Steen, EJ; Burd, H; Evans, SS; Redding-Johnson, AM; Batth, T; Benke, PI; D'haeseleer, P; Sun, N; Sale, KL; Keasling, JD; Lee, TS; Petzold, CJ; Mukhopadhyay, A; Singer, SW; Simmons, BA; Gladden, JM				Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.			A Thermophilic Ionic Liquid-Tolerant Cellulase Cocktail for the Production of Cellulosic Biofuels	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE ACTIVITIES; ESCHERICHIA-COLI; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL CONSORTIA; SP-NOV.; BIOMASS; PRETREATMENT; ETHANOL; GROWTH; SWITCHGRASS	Generation of biofuels from sugars in lignocellulosic biomass is a promising alternative to liquid fossil fuels, but efficient and inexpensive bioprocessing configurations must be developed to make this technology commercially viable. One of the major barriers to commercialization is the recalcitrance of plant cell wall polysaccharides to enzymatic hydrolysis. Biomass pretreatment with ionic liquids (ILs) enables efficient saccharification of biomass, but residual ILs inhibit both saccharification and microbial fuel production, requiring extensive washing after IL pretreatment. Pretreatment itself can also produce biomass-derived inhibitory compounds that reduce microbial fuel production. Therefore, there are multiple points in the process from biomass to biofuel production that must be interrogated and optimized to maximize fuel production. Here, we report the development of an IL-tolerant cellulase cocktail by combining thermophilic bacterial glycoside hydrolases produced by a mixed consortia with recombinant glycoside hydrolases. This enzymatic cocktail saccharifies IL-pretreated biomass at higher temperatures and in the presence of much higher IL concentrations than commercial fungal cocktails. Sugars obtained from saccharification of IL-pretreated switchgrass using this cocktail can be converted into biodiesel (fatty acid ethyl-esters or FAEEs) by a metabolically engineered strain of E. coli. During these studies, we found that this biodiesel-producing E. coli strain was sensitive to ILs and inhibitors released by saccharification. This cocktail will enable the development of novel biomass to biofuel bioprocessing configurations that may overcome some of the barriers to production of inexpensive cellulosic biofuels.	[Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst JBEI, Biosci Div, Berkeley, CA 94720 USA; [Park, Joshua I.; Sale, Kenneth L.; Simmons, Blake A.; Gladden, John M.] Sandia Natl Labs, Bioengn & Biomass Sci & Convers Technol Dept, Livermore, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Geochem, Berkeley, CA 94720 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA 94720 USA; [Evans, Sophia S.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Park, JI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	JMGladden@lbl.gov; JMGladden@lbl.gov	Simmons, Blake/N-6022-2016; Mukhopadhyay, Aindrila/AAW-7257-2021; Keasling, Jay D/J-9162-2012; Sun, Ning/D-6709-2012; Sun, Ning/E-4815-2011; Singer, STeven W/I-1851-2014	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Sun, Ning/0000-0002-9689-9430; D'haeseleer, Patrik/0000-0003-0007-8150; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; US Department of Energy	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) and the Joint Genome Institute supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Bjornsdottir SH, 2006, EXTREMOPHILES, V10, P1, DOI 10.1007/s00792-005-0466-z; Brennan TCR, 2010, BIOENERG RES, V3, P123, DOI 10.1007/s12155-010-9091-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chhabra SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021470; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; DECKER J, 2009, RENEWABLE ENERGY WOR, P11; DOE US, 2010, US FEM CAT MAK FUELS; Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049; Ganske F, 2006, BIOTECHNOL LETT, V28, P465, DOI 10.1007/s10529-006-0006-7; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; KUNDU S, 1983, BIOTECHNOL BIOENG, V25, P1109, DOI 10.1002/bit.260250418; Laboratory ORN, 2011, US BILL TON UPD BIOM; Lee SM, 2005, KOREAN J CHEM ENG, V22, P687, DOI 10.1007/BF02705783; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Lyon PF, 2000, CAN J MICROBIOL, V46, P1029, DOI 10.1139/cjm-46-11-1029; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Nakayama S, 2011, APPL ENVIRON MICROB, V77, P6470, DOI 10.1128/AEM.00706-11; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Ouellet M, 2011, GREEN CHEM; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pimentel D, 2003, NAT RESOUR RES, V12, P127, DOI DOI 10.1023/A:1024214812527; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sluiter B., 2011, NRELTP51042618; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tadesse H., 2011, ENERGY ENV SCI; Touzel JP, 2000, INT J SYST EVOL MICR, V50, P315, DOI 10.1099/00207713-50-1-315; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wald M.L., 2011, NY TIMES; Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI 10.1002/bit.23045; Watanabe K, 2007, INT J SYST EVOL MICR, V57, P1473, DOI 10.1099/ijs.0.64672-0; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	43	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37010	10.1371/journal.pone.0037010	http://dx.doi.org/10.1371/journal.pone.0037010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	23251512	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800023
J	Buga, AM; Scholz, CJ; Kumar, S; Herndon, JG; Alexandru, D; Cojocaru, GR; Dandekar, T; Popa-Wagner, A				Buga, Ana-Maria; Scholz, Claus Juergen; Kumar, Senthil; Herndon, James G.; Alexandru, Dragos; Cojocaru, Gabriel Radu; Dandekar, Thomas; Popa-Wagner, Aurel			Identification of New Therapeutic Targets by Genome-Wide Analysis of Gene Expression in the Ipsilateral Cortex of Aged Rats after Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; COLONY-STIMULATING FACTOR; CEREBRAL-ISCHEMIA; RECEPTOR; BRAIN; PROTEIN; INHIBITOR; MOUSE; GAMMA; DIFFERENTIATION	Background: Because most human stroke victims are elderly, studies of experimental stroke in the aged rather than the young rat model may be optimal for identifying clinically relevant cellular responses, as well for pinpointing beneficial interventions. Methodology/Principal Findings: We employed the Affymetrix platform to analyze the whole-gene transcriptome following temporary ligation of the middle cerebral artery in aged and young rats. The correspondence, heat map, and dendrogram analyses independently suggest a differential, age-group-specific behaviour of major gene clusters after stroke. Overall, the pattern of gene expression strongly suggests that the response of the aged rat brain is qualitatively rather than quantitatively different from the young, i.e. the total number of regulated genes is comparable in the two age groups, but the aged rats had great difficulty in mounting a timely response to stroke. Our study indicates that four genes related to neuropathic syndrome, stress, anxiety disorders and depression (Acvr1c, Cort, Htr2b and Pnoc) may have impaired response to stroke in aged rats. New therapeutic options in aged rats may also include Calcrl, Cyp11b1, Prcp, Cebpa, Cfd, Gpnmb, Fcgr2b, Fcgr3a, Tnfrsf26, Adam 17 and Mmp14. An unexpected target is the enzyme 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 in aged rats, a key enzyme in the cholesterol synthesis pathway. Post-stroke axonal growth was compromised in both age groups. Conclusion/Significance: We suggest that a multi-stage, multimodal treatment in aged animals may be more likely to produce positive results. Such a therapeutic approach should be focused on tissue restoration but should also address other aspects of patient post-stroke therapy such as neuropathic syndrome, stress, anxiety disorders, depression, neurotransmission and blood pressure.	[Buga, Ana-Maria; Popa-Wagner, Aurel] Univ Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Alexandru, Dragos; Cojocaru, Gabriel Radu] Univ Med, Dept Funct Sci, Craiova, Romania; [Scholz, Claus Juergen] Univ Wurzburg, Lab Microarray Applicat, Interdisciplinary Ctr Clin Res, D-97070 Wurzburg, Germany; [Kumar, Senthil] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Herndon, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Dandekar, Thomas] Bioctr Hubland, Dept Bioinformat, Wurzburg, Germany	University of Medicine & Pharmacy of Craiova; University of Wurzburg; Iowa State University; Emory University	Popa-Wagner, A (corresponding author), Univ Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Popa-Wagner, Aurel/E-2541-2013; Buga, Ana-Maria I/P-1478-2014; Vintilescu, Raluca/A-9499-2018; Streba, Costin Teodor T/C-4196-2011; Balseanu, Tudor Adrian/O-2289-2018; Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/I-2581-2019; Buga, Ana Maria/ABA-8108-2021; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019; Scholz, Claus Jürgen/H-3202-2019	Streba, Costin Teodor T/0000-0001-9590-3197; Balseanu, Tudor Adrian/0000-0002-0047-3436; Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Scholz, Claus Jürgen/0000-0002-6406-7859; Sivanesan, Senthilkumar/0000-0001-5133-7090	Federal Ministry of Education and Research [01GN0982]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; NIH [OD P51OD11132]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); CNCS-UEFISCDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-NET FLARE2/UEFISCDI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported financially by the Federal Ministry of Education and Research (Grant No 01GN0982) and by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848 to A. P. W. and by NIH grant OD P51OD11132 to the Yerkes National Primate Research Center. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer HL, 2006, AM J MED GENET A, V140A, P691, DOI 10.1002/ajmg.a.31133; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Badan I, 2003, GERONTOLOGY, V49, P356, DOI 10.1159/000073763; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borday C, 2004, PROG BIOPHYS MOL BIO, V84, P89, DOI 10.1016/j.pbiomolbio.2003.11.002; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chiou LC, 2007, CURR DRUG TARGETS, V8, P117, DOI 10.2174/138945007779315605; Chnari E, 2006, BIOMACROMOLECULES, V7, P1796, DOI 10.1021/bm0600872; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Deshmukh HS, 2009, AM J RESP CRIT CARE, V180, P834, DOI 10.1164/rccm.200903-0328OC; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Gierten J, 2008, BRIT J PHARMACOL, V154, P1680, DOI 10.1038/bjp.2008.213; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jang JE, 2012, CIRC RES, V110, P1057, DOI 10.1161/CIRCRESAHA.112.266411; Kagerer SM, 2011, PEPTIDES, V32, P839, DOI 10.1016/j.peptides.2011.01.004; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kennett GA, 1998, NEUROPHARMACOLOGY, V37, P1603, DOI 10.1016/S0028-3908(98)00115-4; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Leitch B, 2009, J COMP NEUROL, V512, P52, DOI 10.1002/cne.21890; Lewis J, 2010, NEURON, V68, P601, DOI 10.1016/j.neuron.2010.11.014; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Lindner MD, 2003, J NEUROSCI, V23, P10913; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Liu RZ, 2004, EUR J BIOCHEM, V271, P339, DOI 10.1046/j.1432-1033.2003.03932.x; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Na IK, 2009, J IMMUNOTHER, V32, P907, DOI 10.1097/CJI.0b013e3181b7be60; Papac-Milicevic N, 2012, CIRC RES, V110, pE50, DOI 10.1161/CIRCRESAHA.111.258814; Popa-Wagner A, 1999, J CEREBR BLOOD F MET, V19, P425, DOI 10.1097/00004647-199904000-00008; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Siehler S, 2008, MOL CELL ENDOCRINOL, V286, P26, DOI 10.1016/j.mce.2007.12.007; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Teronen O, 1997, J DENT RES, V76, P1529, DOI 10.1177/00220345970760090401; Trumbach D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-159; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yamada Y, 2011, EUR J PHARMACOL, V667, P113, DOI 10.1016/j.ejphar.2011.05.072; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GX, 2010, HYPERTENS RES, V33, P478, DOI 10.1038/hr.2010.21; Zhou CY, 2010, J MED CHEM, V53, P7251, DOI 10.1021/jm101013m; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	78	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50985	10.1371/journal.pone.0050985	http://dx.doi.org/10.1371/journal.pone.0050985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251410	Green Published, gold			2022-12-25	WOS:000313236200051
J	Yin, X; Yin, Y; Cao, FL; Chen, YF; Peng, Y; Hou, WG; Sun, SK; Luo, ZJ				Yin, Xin; Yin, Yue; Cao, Fa-Le; Chen, Yu-Fei; Peng, Ye; Hou, Wu-Gang; Sun, Shu-Kai; Luo, Zhuo-Jing			Tanshinone IIA Attenuates the Inflammatory Response and Apoptosis after Traumatic Injury of the Spinal Cord in Adult Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; GLIAL APOPTOSIS; FACTOR-ALPHA; CELL-DEATH; EXPRESSION; CYTOKINES; INHIBITION; ASTROCYTES	Background: Spinal cord injury (SCI), including immediate mechanical injury and secondary injury, is associated with the inflammatory response, apoptosis and oxidative stress in response to traumatic injury. Tanshinone IIA (TIIA) is one of the major extracts obtained from Salvia miltiorrhiza BUNGE, which has anti-inflammatory and anti-apoptotic effects on many diseases. However, little is known about the effects of TIIA treatment on SCI. Therefore, the aim of the present study is to evaluate the pharmacological action of TIIA on secondary damage and the underlying mechanisms of experimental SCI in rats. Methodology/Principal Findings: SCI was generated using a weight drop device on the dorsal spinal cord via a two-level T9-T11 laminectomy. SCI in rats resulted in severe trauma, characterized by locomotor disturbance, edema, neutrophil infiltration, the production of astrocytes and inflammatory mediators, apoptosis and oxidative stress. TIIA treatment (20 mg/kg, i.p.) after SCI induced significant effects: (1) improved motor function (Basso, Beattie and Bresnahan scores), (2) reduced the degree of tissue injury (histological score), neutrophil infiltration (myeloperoxidase activity) and the expression of astrocytes, (3) inhibited the activation of SCI-related pathways, such as NF-kappa B and MAPK signaling pathways, (4) decreased the production of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) and iNOS, (5) reduced apoptosis (TUNEL staining, and Bcl-2 and caspase-3 expression) and (6) reversed the redox state imbalance. Conclusions/Significance: The results clearly show that TIIA has a prominent protective effect against SCI through inhibiting the inflammatory response and apoptosis in the spinal cord tissue after SCI.	[Yin, Xin; Chen, Yu-Fei; Peng, Ye; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China; [Yin, Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China; [Cao, Fa-Le] 222th Hosp CPLA, Dept Neurol & Respirat, Jilin, Peoples R China; [Hou, Wu-Gang] Xijing Hosp, Dept Anesthesia, Xian, Shaanxi, Peoples R China; [Sun, Shu-Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China.	zjluo@fmmu.edu.cn	peng, ye/GXZ-9245-2022	, Chen/0000-0003-3224-5662	Istitute of Orthopaedics, Fourth Military Medical University	Istitute of Orthopaedics, Fourth Military Medical University	This study was supported by a grant from the Istitute of Orthopaedics, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen F, 1999, CLIN CHEM, V45, P7; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fang ZY, 2008, J ETHNOPHARMACOL, V115, P217, DOI 10.1016/j.jep.2007.09.025; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XZ, 1997, J NEUROSCI, V17, P5395; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	40	146	172	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38381	10.1371/journal.pone.0038381	http://dx.doi.org/10.1371/journal.pone.0038381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	23251642	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339900026
J	Ferreira, CM; Chen, JL; Li, JR; Shimomura, K; Yang, XN; Lussier, YA; Pinto, LH; Solway, J				Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Shimomura, Kazuhiro; Yang, Xinan; Lussier, Yves A.; Pinto, Lawrence H.; Solway, Julian			Genetic Interactions between Chromosomes 11 and 18 Contribute to Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SMOOTH-MUSCLE; CHOLESTEROL; ASTHMA; TRAIT; MOUSE; C1; RESPONSIVENESS; ATHEROSCLEROSIS; HYPERREACTIVITY	We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice. We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F-2 and twenty-seven (A/J X C57BL/6J) F2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice. Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype. Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7, Rock1, Limk2; and Npc1, Npc1/1. Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness. Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.	[Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Yang, Xinan; Lussier, Yves A.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ferreira, Caroline M.; Shimomura, Kazuhiro; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Ferreira, CM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jsolway@medicine.bsd.uchicago.edu	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	CNPq (National Council for Scientific and Technological Development) [UL1RR024999-04]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [U54CA121852-5, K22LM008308, R01HL079398]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by CNPq (National Council for Scientific and Technological Development), UL1RR024999-04, National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; U54CA121852-5), K22LM008308, R01HL079398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Chen BH, 2006, J APPL PHYSIOL, V101, P249, DOI 10.1152/japplphysiol.01010.2004; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Davis HR, 2008, ATHEROSCLEROSIS SUPP, V9, P77, DOI 10.1016/j.atherosclerosissup.2008.05.008; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Dowell ML, 2010, EUR RESPIR J, V36, P630, DOI 10.1183/09031936.00160209; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Iyer SPN, 2005, BBA-GEN SUBJECTS, V1722, P282, DOI 10.1016/j.bbagen.2004.12.021; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Nicholson AG, 2006, HISTOPATHOLOGY, V48, P596, DOI 10.1111/j.1365-2559.2006.02355.x; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Otera H, 2009, AM J PHYSIOL-LUNG C, V296, pL594, DOI 10.1152/ajplung.90530.2008; Palmeri S, 2005, NEUROL SCI, V26, P171, DOI 10.1007/s10072-005-0456-z; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer B, 2009, CAN J PHYSIOL PHARM, V87, P180, DOI [10.1139/Y08-114, 10.1139/y08-114]; Tossa P, 2010, AM J RESP CRIT CARE, V182, P738, DOI 10.1164/rccm.200903-0415OC; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC; Woolcock AJ, 1997, ASTHMA, P27; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	49	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					100	106	e29579	10.1371/journal.pone.0029579	http://dx.doi.org/10.1371/journal.pone.0029579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	23071617	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900011
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800088
J	Chen, S; Cai, WP; He, JY; Vidal, N; Lai, CH; Guo, WZ; He, HL; Chen, XJ; Fu, LS; Peeters, M; Delaporte, E; Andrieu, JM; Lu, W				Chen, Song; Cai, Weiping; He, Jingyang; Vidal, Nicole; Lai, Chunhui; Guo, Weizhong; He, Haolan; Chen, Xiejie; Fu, Linsheng; Peeters, Martine; Delaporte, Eric; Andrieu, Jean-Marie; Lu, Wei			Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DRUG-RESISTANCE; SUBTYPE C; HIV-1; TRANSMISSION; RISK; DIVERSITY	Background: Although the outbreak of human immunodeficiency virus type 1 (HIV-1) in Guangdong has been documented for more than a decade, the molecular characteristics of such a regional HIV-1 epidemic remained unknown. Methodology/Principal Findings: By sequencing of HIV-1 pol/env genes and phylogenetic analysis, we performed a molecular epidemiologic study in a representative subset (n = 200) of the 508 HIV-1-seropositive individuals followed up at the center for HIV/AIDS care and treatment of Guangzhou Hospital of Infectious Diseases. Of 157 samples (54.1% heterosexual acquired adults, 20.4% needle-sharing drug users, 5.7% receivers of blood transfusion, 1.3% men who have sex with men, and 18.5% remained unknown) with successful sequencing for both pol and env genes, 105 (66.9%) HIV-1 subtype CRF01_AE and 24 (15.3%) CRF07_BC, 9 (5.7%) B', 5 (3.2%) CRF08_BC, 5 (3.2%) B, 1 (0.6%) C, 3 (1.9%) CRF02_AG, and 5 (3.2%) inter-region recombinants were identified within pol/env sequences. Thirteen (8.3%) samples (3 naives, 6 and 5 received with antiretroviral treatment [ART] 1-21 weeks and >= 24 weeks respectively) showed mutations conferring resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors or protease inhibitors. Among 63 ART-naive patients, 3 (4.8%) showed single or multiple drug resistant mutations. Phylogenetic analysis showed 8 small clusters (2-3 sequences/cluster) with only 17 (10.8%) sequences involved. Conclusion/Significance: This study confirms that sexual transmission with dominant CRF01_AE strain is a major risk for current HIV-1 outbreak in the Guangdong's general population. The transmission with drug-resistant variants is starting to emerge in this region.	[Chen, Song; He, Jingyang; Lai, Chunhui; Guo, Weizhong; Fu, Linsheng; Lu, Wei] Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie] Univ Paris 05, Lab Oncol & Virol Mol, Paris, France; [Cai, Weiping; He, Haolan; Chen, Xiejie] Guangzhou Hosp Infect Dis, Guangzhou, Guangdong, Peoples R China; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Inst Rech Dev, UMI 233, Montpellier, France; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Univ Monpellier 1, Montpellier, France	Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). S. C. was supported by a fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Lin P, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P194; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	33	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48747	10.1371/journal.pone.0048747	http://dx.doi.org/10.1371/journal.pone.0048747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23071617	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800118
J	Ferreira, TH; Gentile, A; Vilela, RD; Costa, GGL; Dias, LI; Endres, L; Menossi, M				Ferreira, Thais Helena; Gentile, Agustina; Vilela, Romel Duarte; Lacerda Costa, Gustavo Gilson; Dias, Lara Isys; Endres, Lauricio; Menossi, Marcelo			microRNAs Associated with Drought Response in the Bioenergy Crop Sugarcane (Saccharum spp.)	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; SMALL RNAS; TRANSCRIPTION FACTORS; SOYBEAN MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; SALT TOLERANCE; ORYZA-SATIVA; ARABIDOPSIS; IDENTIFICATION	Sugarcane (Saccharum spp.) is one of the most important crops in the world. Drought stress is a major abiotic stress factor that significantly reduces sugarcane yields. However the gene network that mediates plant responses to water stress remains largely unknown in several crop species. Although several microRNAs that mediate post-transcriptional regulation during water stress have been described in other species, the role of the sugarcane microRNAs during drought stress has not been studied. The objective of this work was to identify sugarcane miRNAs that are differentially expressed under drought stress and to correlate this expression with the behavior of two sugarcane cultivars with different drought tolerances. The sugarcane cultivars RB867515 (higher drought tolerance) and RB855536 (lower drought tolerance) were cultivated in a greenhouse for three months and then subjected to drought for 2, 4, 6 or 8 days. By deep sequencing of small RNAs, we were able to identify 18 miRNA families. Among all of the miRNAs thus identified, seven were differentially expressed during drought. Six of these miRNAs were differentially expressed at two days of stress, and five miRNAs were differentially expressed at four days. The expression levels of five miRNAs (ssp-miR164, ssp-miR394, ssp-miR397, ssp-miR399-seq 1 and miR528) were validated by RT-qPCR (quantitative reverse transcriptase PCR). Six precursors and the targets of the differentially expressed miRNA were predicted using an in silico approach and validated by RT-qPCR; many of these targets may play important roles in drought tolerance. These findings constitute a significant increase in the number of identified miRNAs in sugarcane and contribute to the elucidation of the complex regulatory network that is activated by drought stress.	[Ferreira, Thais Helena; Gentile, Agustina; Dias, Lara Isys; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vilela, Romel Duarte; Endres, Lauricio] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Lacerda Costa, Gustavo Gilson] Univ Estadual Campinas, Lab Cent Tecnol Alto Desempenho, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alagoas; Universidade Estadual de Campinas	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	menossi@unicamp.br	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation); CNPq (The National Council for Scientific and Technological Development); CAPES (Co-ordination of Improvement of Higher Education Personnel); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Co-ordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the following Brazilian funding institutions: FINEP (The Financiadora de Estudos e Projetos), FAPESP (Sao Paulo Research Foundation), CNPq (The National Council for Scientific and Technological Development) and CAPES (Co-ordination of Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; CACHORRO P, 1993, PHYTON-ANN REI BOT A, V33, P33; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ditt RF, 2011, SCI AGR, V68, P454, DOI 10.1590/S0103-90162011000400010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Islam MS, 2010, HORTIC ENVIRON BIOTE, V51, P556; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	81	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46703	10.1371/journal.pone.0046703	http://dx.doi.org/10.1371/journal.pone.0046703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071617	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700025
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200043
